PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ehteshami, M; Scarth, BJ; Tchesnokov, EP; Dash, C; Le Grice, SFJ; Hallenberger, S; Jochmans, D; Gotte, M				Ehteshami, Maryam; Scarth, Brian J.; Tchesnokov, Egor P.; Dash, Chandravanu; Le Grice, Stuart F. J.; Hallenberger, Sabine; Jochmans, Dirk; Goette, Matthias			Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against "Nucleotide-competing Reverse Transcriptase Inhibitors"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE TRANSLOCATION; DRUG-RESISTANCE; RT INHIBITORS; DNA-SYNTHESIS; SUBSTITUTIONS; MECHANISM; ABACAVIR; SUSCEPTIBILITY; REPLICATION; APHIDICOLIN	Indolopyridones are potent inhibitors of reverse transcriptase (RT) of the human immunodeficiency virus type 1 (HIV-1). Although the structure of these compounds differs from established nucleoside analogue RT inhibitors (NRTIs), previous studies suggest that the prototype compound INDOPY-1 may bind in close proximity to the polymerase active site. NRTI-associated mutations that are clustered around the active site confer decreased, e. g. M184V and Y115F, or increased, e. g. K65R, susceptibility to INDOPY-1. Here we have studied the underlying biochemical mechanism. RT enzymes containing the isolated mutations M184V and Y115F cause 2-3-fold increases in IC50 values, while the combination of the two mutations causes a > 15-fold increase. K65R can partially counteract these effects. Binding studies revealed that the M184V change reduces the affinity to INDOPY-1, while Y115F facilitates binding of the natural nucleotide substrate and the combined effects enhance the ability of the enzyme to discriminate against the inhibitor. Studies with other strategic mutations at residues Phe-61 and Ala-62, as well as the use of chemically modified templates shed further light on the putative binding site of the inhibitor and ternary complex formation. An abasic site residue at position n, i. e. opposite the 3'-end of the primer, prevents binding of INDOPY-1, while an abasic site at the adjacent position n + 1 has no effect. Collectively, our findings provide strong evidence to suggest that INDOPY-1 can compete with natural deoxynucleoside triphosphates (dNTPs). We therefore propose to refer to members of this class of compounds as "nucleotide-competing RT inhibitors" (NcRTIs).	[Ehteshami, Maryam; Scarth, Brian J.; Tchesnokov, Egor P.; Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Goette, Matthias] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Goette, Matthias] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B4, Canada; [Dash, Chandravanu; Le Grice, Stuart F. J.] NCI, RT Biochem Sect, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA; [Hallenberger, Sabine; Jochmans, Dirk] Tibotec BVBA, B-2800 Mechelen, Belgium	McGill University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johnson & Johnson	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca	; JOCHMANS, DIRK/T-6223-2017	Dash, Chandravanu/0000-0003-4466-8355; JOCHMANS, DIRK/0000-0002-9265-6028	Center for Cancer Research, NCI, National Institutes of Health; Tibotec; Canadian Institutes of Health Research (CIHR); NATIONAL CANCER INSTITUTE [ZIABC010495, ZIABC010494] Funding Source: NIH RePORTER	Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tibotec; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the intramural research program of the Center for Cancer Research, NCI, National Institutes of Health (to S. L. G.). This work was also funded in part by Tibotec and a grant from the Canadian Institutes of Health Research (CIHR) (to M. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARTS EJ, 1994, J BIOL CHEM, V269, P14672; Basavapathruni A, 2007, FASEB J, V21, P3795, DOI 10.1096/fj.07-8697rev; CHENG CH, 1993, BIOCHEMISTRY-US, V32, P8568, DOI 10.1021/bi00084a025; Fisher TS, 2003, J MOL BIOL, V325, P443, DOI 10.1016/S0022-2836(02)01225-1; Fisher TS, 2002, J BIOL CHEM, V277, P22345, DOI 10.1074/jbc.M200282200; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JOCHMANS D, 2006, C RETR OPP INF DENV; JOCHMANS D, 2005, C RETR OPP INF BOST; JOCHMANS D, 2007, C RETR OPP INF LOS A; Jochmans D, 2008, VIRUS RES, V134, P171, DOI 10.1016/j.virusres.2008.01.003; Jochmans D, 2006, J VIROL, V80, P12283, DOI 10.1128/JVI.00889-06; Lanier ER, 2004, HIV MED, V5, P394, DOI 10.1111/j.1468-1293.2004.00243.x; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Mandal D, 2006, NUCLEIC ACIDS RES, V34, P2853, DOI 10.1093/nar/gkl360; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; MartinHernandez AM, 1996, EMBO J, V15, P4434, DOI 10.1002/j.1460-2075.1996.tb00816.x; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Miller MD, 2004, AIDS REV, V6, P22; Miller V, 2000, AIDS, V14, P163, DOI 10.1097/00002030-200001280-00012; Ray AS, 2002, J BIOL CHEM, V277, P40479, DOI 10.1074/jbc.M205303200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; SHEAFF R, 1991, BIOCHEMISTRY-US, V30, P8590, DOI 10.1021/bi00099a014; Silverman AP, 2008, BIOCHEMISTRY-US, V47, P4800, DOI 10.1021/bi702427y; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; Wainberg MA, 1999, ANTIVIR THER, V4, P87; Zhang ZJ, 2006, ANTIMICROB AGENTS CH, V50, P2772, DOI 10.1128/AAC.00127-06	32	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29904	29911		10.1074/jbc.M804882200	http://dx.doi.org/10.1074/jbc.M804882200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18728003	hybrid, Green Published			2022-12-25	WOS:000260366900035
J	Lo, WY; Botzolakis, EJ; Tang, X; Macdonald, RL				Lo, Wen-yi; Botzolakis, Emmanuel J.; Tang, Xin; Macdonald, Robert L.			A Conserved Cys-loop Receptor Aspartate Residue in the M3-M4 Cytoplasmic Loop Is Required for GABA(A) Receptor Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; ENDOPLASMIC-RETICULUM; EPILEPSY MUTATION; FEBRILE SEIZURES; ALPHA-1 SUBUNIT; BETA-SUBUNITS; CELL-SURFACE; GLYCINE RECEPTOR; GAMMA-2 SUBUNIT; A RECEPTORS	Members of the Cys-loop superfamily of ligand-gated ion channels, which mediate fast synaptic transmission in the nervous system, are assembled as heteropentamers from a large repertoire of neuronal subunits. Although several motifs in subunit N-terminal domains are known to be important for subunit assembly, increasing evidence points toward a role for C-terminal domains. Using a combination of flow cytometry, patch clamp recording, endoglycosidase H digestion, brefeldin A treatment, and analytic centrifugation, we identified a highly conserved aspartate residue at the boundary of the M3-M4 loop and the M4 domain that was required for binary and ternary gamma-aminobutyric acid type A receptor surface expression. Mutation of this residue caused mutant and partnering subunits to be retained in the endoplasmic reticulum, reflecting impaired forward trafficking. Interestingly although mutant and partnering wild type subunits could be coimmunoprecipitated, analytic centrifugation studies demonstrated decreased formation of pentameric receptors, suggesting that this residue played an important role in later steps of subunit oligomerization. We thus conclude that C-terminal motifs are also important determinants of Cys-loop receptor assembly.	[Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Lo, Wen-yi; Botzolakis, Emmanuel J.; Tang, Xin] Vanderbilt Univ, Program Neurosci, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Macdonald, RL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, 6140 Med Res Bldg 3,465 21st Ave, Nashville, TN 37232 USA.	macdonald@vanderbilt.edu			National Institutes of Health [NS33300]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS33300 to (R. L. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beck M, 2002, J BIOL CHEM, V277, P30079, DOI 10.1074/jbc.M200438200; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Charych EI, 2004, J NEUROCHEM, V90, P173, DOI 10.1111/j.1471-4159.2004.02481.x; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Frugier G, 2007, J BIOL CHEM, V282, P3819, DOI 10.1074/jbc.M608910200; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Gallagher MJ, 2004, J NEUROSCI, V24, P5570, DOI 10.1523/JNEUROSCI.1301-04.2004; GELMAN MS, 1995, J BIOL CHEM, V270, P15085, DOI 10.1074/jbc.270.25.15085; Gorrie GH, 1997, J NEUROSCI, V17, P6587; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Hales TG, 2005, MOL CELL NEUROSCI, V29, P120, DOI 10.1016/j.mcn.2005.01.002; Harkin LA, 2002, AM J HUM GENET, V70, P530, DOI 10.1086/338710; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hinkle DJ, 2003, BIOTECHNIQUES, V35, P472; Kang JQ, 2006, J NEUROSCI, V26, P2590, DOI 10.1523/JNEUROSCI.4243-05.2006; Kang JQ, 2004, J NEUROSCI, V24, P8672, DOI 10.1523/JNEUROSCI.2717-04.2004; Kittler JT, 2000, J NEUROSCI, V20, P7972; Klausberger T, 2001, J NEUROSCI, V21, P9124, DOI 10.1523/JNEUROSCI.21-23-09124.2001; Lagrange AH, 2007, J PHYSIOL-LONDON, V578, P655, DOI 10.1113/jphysiol.2006.122135; Le Novere N, 1999, NUCLEIC ACIDS RES, V27, P340, DOI 10.1093/nar/27.1.340; Leite JF, 2000, J BIOL CHEM, V275, P13683, DOI 10.1074/jbc.275.18.13683; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Maus ADJ, 1998, MOL PHARMACOL, V54, P779, DOI 10.1124/mol.54.5.779; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Niesler B, 2001, PHARMACOGENETICS, V11, P471, DOI 10.1097/00008571-200108000-00002; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Pratt MB, 2000, J BIOL CHEM, V275, P29441, DOI 10.1074/jbc.M004710200; Quiram PA, 1999, J CLIN INVEST, V104, P1403, DOI 10.1172/JCI8179; Roccamo AM, 2007, J NEUROSCI RES, V85, P285, DOI 10.1002/jnr.21123; Shen XM, 2005, BRAIN, V128, P345, DOI 10.1093/brain/awh364; Skok MV, 2003, MOL PHARMACOL, V64, P885, DOI 10.1124/mol.64.4.885; SMITH MM, 1987, J BIOL CHEM, V262, P4367; Taylor PM, 2000, J NEUROSCI, V20, P1297; Taylor PM, 1999, J NEUROSCI, V19, P6360; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wanamaker CP, 2007, J BIOL CHEM, V282, P31113, DOI 10.1074/jbc.M705369200; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918	43	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29740	29752		10.1074/jbc.M802856200	http://dx.doi.org/10.1074/jbc.M802856200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723504	Green Published, hybrid			2022-12-25	WOS:000260366900018
J	Masia, R; Nichols, CG				Masia, Ricard; Nichols, Colin G.			Functional Clustering of Mutations in the Dimer Interface of the Nucleotide Binding Folds of the Sulfonylurea Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNEL; NEONATAL DIABETES-MELLITUS; ABC TRANSPORTER; INSULIN-SECRETION; SUR1; SUBUNIT; DOMAIN; MGADP; PHOSPHORYLATION; TRAFFICKING	ATP-sensitive K+ (K-ATP) channels modulate their activity as a function of inhibitory ATP and stimulatory Mg-nucleotides. They are constituted by two proteins: a pore-forming K+ channel subunit (Kir6.1, Kir6.2) and a regulatory sulfonylurea receptor (SUR) subunit, an ATP-binding cassette (ABC) transporter that confers MgADP stimulation to the channel. Channel regulation by MgADP is dependent on nucleotide interaction with the cytoplasmic nucleotide binding folds (NBF1 and NBF2) of the SUR subunit. Crystal structures of bacterial ABC proteins indicate that NBFs form as dimers, suggesting that NBF1-NBF2 heterodimers may form in SUR and other eukaryotic ABC proteins. We have modeled SUR1 NBF1 and NBF2 as a heterodimer, and tested the validity of the predicted dimer interface by systematic mutagenesis. Engineered cysteine mutations in this region have significant effects, both positive and negative, on MgADP stimulation of K-ATP channels in excised patches and on macroscopic channel activity in intact cells. Additionally, the mutations cluster in the model structure according to their functional effect, such that patterns of alteration emerge. Of note, three gain-of-function mutations, leading to MgADP hyperstimulation of the channel, are located in the D-loop region at the center of the predicted dimer interface. Overall, the data support the idea that SUR1 NBFs assemble as heterodimers and that this interaction is functionally critical.	[Masia, Ricard; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	cnichols@wustl.edu	Nichols, Colin/D-6336-2012		American Diabetes Association; American Heart Association	American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association)	This work was supported by an American Diabetes Association Grant in Aid ( to C. G. N.) and a predoctoral fellowship from the American Heart Association ( Heartland Affiliate, to R. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Campbell JD, 2004, DIABETES, V53, pS123, DOI 10.2337/diabetes.53.suppl_3.S123; Campbell JD, 2003, EMBO REP, V4, P1038, DOI 10.1038/sj.embor.7400003; Cartier EA, 2003, J BIOL CHEM, V278, P7081, DOI 10.1074/jbc.M211395200; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Wet H, 2008, EMBO REP, V9, P648, DOI 10.1038/embor.2008.71; de Wet H, 2007, P NATL ACAD SCI USA, V104, P18988, DOI 10.1073/pnas.0707428104; de Wet H, 2007, FEBS J, V274, P3532, DOI 10.1111/j.1742-4658.2007.05879.x; DeLano WL, 2002, PYMOL USERS MANUAL; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Gribble FM, 1997, J PHYSIOL-LONDON, V504, P35, DOI 10.1111/j.1469-7793.1997.00035.x; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hough E, 2002, BIOCHEM BIOPH RES CO, V294, P191, DOI 10.1016/S0006-291X(02)00454-0; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Masia R, 2005, J MOL CELL CARDIOL, V39, P491, DOI 10.1016/j.yjmcc.2005.03.009; Masia R, 2007, DIABETES, V56, P1357, DOI 10.2337/db06-1746; Matsuo M, 2000, J BIOL CHEM, V275, P28757, DOI 10.1074/jbc.M004818200; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Mikhailov MV, 2000, J BIOL CHEM, V275, P3360, DOI 10.1074/jbc.275.5.3360; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Oloo EO, 2006, J BIOL CHEM, V281, P28397, DOI 10.1074/jbc.M513614200; Proks P, 2007, HUM MOL GENET, V16, P2011, DOI 10.1093/hmg/ddm149; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Shi Y, 2008, J BIOL CHEM, V283, P7523, DOI 10.1074/jbc.M709941200; Shyng SL, 1998, DIABETES, V47, P1145, DOI 10.2337/diabetes.47.7.1145; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tanabe K, 1999, J BIOL CHEM, V274, P3931, DOI 10.1074/jbc.274.7.3931; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	52	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30322	30329		10.1074/jbc.M804318200	http://dx.doi.org/10.1074/jbc.M804318200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18715873	Green Published, hybrid			2022-12-25	WOS:000260366900076
J	Austermann, J; Nazmi, AR; Muller-Tidow, C; Gerke, V				Austermann, Judith; Nazmi, Ali Reza; Mueller-Tidow, Carsten; Gerke, Volker			Characterization of the Ca2+-regulated Ezrin-S100P Interaction and Its Role in Tumor Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERM PROTEINS; CRYSTAL-STRUCTURE; ACTIN-BINDING; FERM DOMAIN; EZRIN; METASTASIS; S100; FAMILY; CANCER; MERLIN	Ezrin is a multidomain protein providing regulated membrane-cytoskeleton contacts that play a role in cell differentiation, adhesion, and migration. Within the cytosol of resting cells ezrin resides in an autoinhibited conformation in which the Nand C-terminal ezrin/radixin/moesin (ERM) association domains (ERMADs) interact with one another. Activation of the ezrin membrane-cytoskeleton linker function requires an opening of this interdomain association that can result from phosphatidylinositol 4,5-bisphosphate binding to the N-ERMAD and threonine 567 phosphorylation in the C-ERMAD. We have shown that ezrin can also be activated by Ca2+-dependent binding of the EF-hand protein S100P. We now provide a quantitative analysis of this interaction and map the respective binding sites to the F2 lobe in the ezrin N-ERMAD and a stretch of hydrophobic residues in the C-terminal extension of S100P. Phospholipid binding assays reveal that S100P and phosphatidylinositol 4,5-bisphosphate compete to some extent for at least partially overlapping binding sites in N-ERMAD. Using interaction-competent as well as interaction-incompetent S100P derivatives and permanently active ezrin mutants, we also show that the protein interaction and a resulting activation of ezrin promote the transendothelial migration of tumor cells. Thus, a prometastatic role of ezrin and S100P that had been proposed based on their overexpression in highly metastatic cancers is probably due to a direct interaction between the two proteins and the S100P-mediated activation of ezrin.	[Austermann, Judith; Nazmi, Ali Reza; Gerke, Volker] Univ Munster, Ctr Mol Biol Inflammat, Inst Med Biochem, D-48149 Munster, Germany; [Mueller-Tidow, Carsten] Univ Munster, Dept Med Hematol & Oncol, D-48149 Munster, Germany	University of Munster; University of Munster	Gerke, V (corresponding author), Univ Munster, Ctr Mol Biol Inflammat, Inst Med Biochem, Esmarch Str 56, D-48149 Munster, Germany.	gerke@uni-muenster.de	Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014	Müller-Tidow, Carsten/0000-0002-7166-5232; Nazmi, Ali Reza/0000-0003-1262-5078	Deutsche Forschungsgemeinschaft [Ge 514/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Deutsche Forschungsgemeinschaft Grant Ge 514/5-2). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; GUERREIRO DS, 2000, INT J ONCOL, V16, P231; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hughes SC, 2007, CURR OPIN CELL BIOL, V19, P51, DOI 10.1016/j.ceb.2006.12.004; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Janke M, 2008, BIOCHEMISTRY-US, V47, P3762, DOI 10.1021/bi702542s; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kielbassa-Schnepp K, 2001, CELL CALCIUM, V30, P29, DOI 10.1054/ceca.2001.0210; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; KUBE E, 1992, J BIOL CHEM, V267, P14175; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Monni R, 2008, BLOOD, V111, P3163, DOI 10.1182/blood-2007-09-110510; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rety S, 2000, STRUCTURE, V8, P175, DOI 10.1016/S0969-2126(00)00093-9; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rossy J, 2007, EXP CELL RES, V313, P1106, DOI 10.1016/j.yexcr.2006.12.023; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Seemann J, 1996, BIOCHEM J, V319, P123, DOI 10.1042/bj3190123; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Smith WJ, 2002, ACTA CRYSTALLOGR D, V58, P1359, DOI [10.1107/S0907444902010004, 10.1107/S0907444902009162]; Wang GZ, 2006, CANCER RES, V66, P1199, DOI 10.1158/0008-5472.CAN-05-2605; Wick W, 2001, J NEUROSCI, V21, P3360, DOI 10.1523/JNEUROSCI.21-10-03360.2001; Yoshinaga-Ohara N, 2002, EXP CELL RES, V278, P112, DOI 10.1006/excr.2002.5571; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang HM, 2003, J MOL BIOL, V325, P785, DOI 10.1016/S0022-2836(02)01278-0	38	59	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29331	29340		10.1074/jbc.M806145200	http://dx.doi.org/10.1074/jbc.M806145200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18725408	hybrid, Green Published			2022-12-25	WOS:000260179900060
J	Guidetti, GF; Lova, P; Bernardi, B; Campus, F; Baldanzi, G; Graziani, A; Balduini, C; Torti, M				Guidetti, Gianni F.; Lova, Paolo; Bernardi, Bruno; Campus, Francesca; Baldanzi, Gianluca; Graziani, Andrea; Balduini, Cesare; Torti, Mauro			The G(i)-coupled P2Y12 Receptor Regulates Diacylglycerol-mediated Signaling in Human Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SMALL GTPASE RAP1B; INTEGRIN ALPHA(IIB)BETA(3); CROSS-TALK; ANTITHROMBOTIC DRUGS; P2Y(12) RECEPTOR; PHOSPHOLIPASE-C; GLYCOPROTEIN-VI; ACTIVATION; AGGREGATION	Stimulation of G(q)-coupled receptors activates phospholipase C and is supposed to promote both intracellular Ca2+ mobilization and protein kinase C (PKC) activation. We found that ADP-induced phosphorylation of pleckstrin, the main platelet substrate for PKC, was completely inhibited not only by an antagonist of the G(q)-coupled P2Y1 receptor but also upon blockade of the G(i)-coupled P2Y12 receptor. The role of G(i) on PKC regulation required stimulation of phosphatidylinositol 3-kinase rather than inhibition of adenylyl cyclase. P2Y12 antagonists also inhibited pleckstrin phosphorylation, Rap1b activation, and platelet aggregation induced upon G(q) stimulation by the thromboxane A(2) analogue U46619. Importantly, activation of phospholipase C and intracellular Ca2+ mobilization occurred normally. Phorbol 12-myristate 13-acetate overcame the inhibitory effect of P2Y12 receptor blockade on PKC activation but not on Rap1b activation and platelet aggregation. By contrast, inhibition of diacylglycerol kinase restored both PKC and Rap1b activity and caused platelet aggregation. Stimulation of P2Y12 receptor or direct inhibition of diacylglycerol kinase potentiated the effect of membrane-permeable sn-1,2-dioctanoylglycerol on platelet aggregation and pleckstrin phosphorylation, in association with inhibition of its phosphorylation to phosphatidic acid. These results reveal a novel and unexpected role of the G(i)-coupled P2Y12 receptor in the regulation of diacylglycerol-mediated events in activated platelets.	[Guidetti, Gianni F.; Lova, Paolo; Bernardi, Bruno; Campus, Francesca; Balduini, Cesare; Torti, Mauro] Univ Pavia, Dept Chem, Ctr Excellence Appl Biol, I-27100 Pavia, Italy; [Baldanzi, Gianluca; Graziani, Andrea] Univ Amedeo Avogadro, Dept Clin & Expt Med, I-28100 Novara, Italy	University of Pavia; University of Eastern Piedmont Amedeo Avogadro	Torti, M (corresponding author), Univ Pavia, Dept Chem, Ctr Excellence Appl Biol, Via Bassi 21, I-27100 Pavia, Italy.	mtorti@unipv.it	Baldanzi, Gianluca/AAO-7673-2021; Graziani, Andrea/AAB-6301-2022; graziani, andrea/B-2554-2009	Baldanzi, Gianluca/0000-0002-1370-9903; Graziani, Andrea/0000-0002-6302-2317; graziani, andrea/0000-0002-6302-2317	Ministero dell'Istruzione, Universita e Ricerca Scientifica (MIUR) [PRIN 2006]; University of Pavia; Consorzio Interuniversitario Biotecnologie	Ministero dell'Istruzione, Universita e Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Pavia; Consorzio Interuniversitario Biotecnologie	This work was supported by grants from the Ministero dell'Istruzione, Universita e Ricerca Scientifica (MIUR, PRIN 2006), from the University of Pavia, and from the Consorzio Interuniversitario Biotecnologie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baldanzi G, 2008, ONCOGENE, V27, P942, DOI 10.1038/sj.onc.1210717; Bernardi B, 2006, BLOOD, V107, P2728, DOI 10.1182/blood-2005-07-3023; Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; BISHOP WR, 1986, J BIOL CHEM, V261, P2513; Campus F, 2005, J BIOL CHEM, V280, P24386, DOI 10.1074/jbc.M501174200; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Dangelmaier C, 2001, THROMB HAEMOSTASIS, V85, P341, DOI 10.1055/s-0037-1615690; Daniel JL, 1999, THROMB HAEMOSTASIS, V82, P1322; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Eckly A, 2001, THROMB HAEMOSTASIS, V85, P694, DOI 10.1055/s-0037-1615655; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Hardy AR, 2004, BLOOD, V104, P1745, DOI 10.1182/blood-2004-02-0534; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Kauffenstein G, 2001, FEBS LETT, V505, P281, DOI 10.1016/S0014-5793(01)02824-1; Larson MK, 2003, BLOOD, V101, P1409, DOI 10.1182/blood-2002-05-1533; Lova P, 2004, J BIOL CHEM, V279, P25299, DOI 10.1074/jbc.M313199200; Lova P, 2003, J BIOL CHEM, V278, P131, DOI 10.1074/jbc.M204821200; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Nieswandt B, 2001, BLOOD, V97, P3829, DOI 10.1182/blood.V97.12.3829; NUNN DL, 1987, BIOCHEM J, V243, P809, DOI 10.1042/bj2430809; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; PACKHAM MA, 1993, BIOCHEM J, V209, P849; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Sage SO, 2000, CELL CALCIUM, V28, P119, DOI 10.1054/ceca.2000.0139; TORTI M, 1992, CELL BIOCHEM FUNCT, V10, P53, DOI 10.1002/cbf.290100109; TYERS M, 1988, NATURE, V333, P470, DOI 10.1038/333470a0; VICKERS JD, 1990, EUR J BIOCHEM, V193, P521, DOI 10.1111/j.1432-1033.1990.tb19367.x; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200; Woulfe DS, 2005, J THROMB HAEMOST, V3, P2193, DOI 10.1111/j.1538-7836.2005.01338.x; YADA Y, 1990, J BIOL CHEM, V265, P19237; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597	39	46	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28795	28805		10.1074/jbc.M801588200	http://dx.doi.org/10.1074/jbc.M801588200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18755689	Green Published, hybrid			2022-12-25	WOS:000260179900004
J	Sahoo, A; Jung, YM; Kwon, HK; Yi, HJ; Lee, S; Chang, S; Park, ZY; Hwang, KC; Im, SH				Sahoo, Anupama; Jung, Yun Min; Kwon, Ho-Keun; Yi, Hwa-Jung; Lee, Suho; Chang, Sunghoe; Park, Zee-Yong; Hwang, Ki-Chul; Im, Sin-Hyeog			A Novel Splicing Variant of Mouse Interleukin (IL)-24 Antagonizes IL-24-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-ASSOCIATED GENE; HUMAN-MELANOMA DIFFERENTIATION; CELL-SPECIFIC APOPTOSIS; TUMOR-SUPPRESSOR; SELECTIVE APOPTOSIS; MESSENGER-RNA; CYTOKINE GENE; ER STRESS; MDA-7/IL-24; MDA-7	Alternative splicing of mRNA enables functionally diverse protein isoforms to be expressed from a single gene, allowing transcriptome diversification. Interleukin (IL)-24/MDA-7 is a member of the IL-10 gene family, and FISP (IL-4-induced secreted protein), its murine homologue, is selectively expressed and secreted by T helper 2 lymphocytes. A novel splice variant of mouse IL-24/FISP, designated FISP-sp, lacks 29 nucleotides from the 5'-end of exon 4 of FISP. The level of FISP-sp expression is 10% of the level of total primary FISP transcription. Unlike FISP, FISP-sp does not induce growth inhibition and apoptosis. FISP-sp is exclusively localized in endoplasmic reticulum, and its expression is up-regulated by endoplasmic reticulum stress. Our results suggest that the novel splicing variant FISP-sp dimerizes with FISP and blocks its secretion and inhibits FISP-induced apoptosis in vivo.	[Sahoo, Anupama; Jung, Yun Min; Kwon, Ho-Keun; Yi, Hwa-Jung; Lee, Suho; Chang, Sunghoe; Park, Zee-Yong; Im, Sin-Hyeog] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Hwang, Ki-Chul] Yonsei Univ, Coll Med, Div Cardiol, Cardiovasc Res Inst, Seoul 120752, South Korea; [Im, Sin-Hyeog] Gwangju Inst Sci & Technol, Ctr Distributed Sensor Network, Kwangju 500712, South Korea	Gwangju Institute of Science & Technology (GIST); Yonsei University; Yonsei University Health System; Gwangju Institute of Science & Technology (GIST)	Im, SH (corresponding author), Gwangju Inst Sci & Technol, Dept Life Sci, 1 Oryong Dong, Kwangju 500712, South Korea.	imsh@gist.ac.kr	Im, Sin-Hyeog/E-6811-2013; Chang, Sunghoe/J-2784-2012; Im, Sin-Hyeog/AAM-9586-2021	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; Sahoo, Anupama/0000-0002-0928-958X	21st Century Frontier Functional Human Genome Project; Korea Health 21 R D Project; Ministry of Health and Welfare [A050533]; KBRDG Initiative Research Program; Regional Technology Innovation Program of the MOCIE [RTI05-01-01]; Gwangju Institute of Science and Technology	21st Century Frontier Functional Human Genome Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Health 21 R D Project; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); KBRDG Initiative Research Program; Regional Technology Innovation Program of the MOCIE(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Gwangju Institute of Science and Technology	This work was supported by grants from the 21st Century Frontier Functional Human Genome Project, Korea Health 21 R & D Project, Ministry of Health and Welfare Grant A050533, the KBRDG Initiative Research Program, Grant RTI05-01-01 from the Regional Technology Innovation Program of the MOCIE, and a Systems Biology Infrastructure Establishment grant provided by Gwangju Institute of Science and Technology in 2008. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Allen M, 2004, J INVEST DERMATOL, V123, P583, DOI 10.1111/j.0022-202X.2004.23321.x; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Bert AG, 2000, PLASMID, V44, P173, DOI 10.1006/plas.2000.1474; Caudell EG, 2002, J IMMUNOL, V168, P6041, DOI 10.4049/jimmunol.168.12.6041; Chada S, 2004, MOL THER, V10, P1085, DOI 10.1016/j.ymthe.2004.08.020; Chada S, 2004, INT IMMUNOPHARMACOL, V4, P649, DOI 10.1016/j.intimp.2004.01.017; Chen WY, 2005, GENES IMMUN, V6, P493, DOI 10.1038/sj.gene.6364233; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Elton TS, 2003, TRENDS ENDOCRIN MET, V14, P66, DOI 10.1016/S1043-2760(02)00038-3; Fisher PB, 2003, CANCER BIOL THER, V2, pS23; Gupta P, 2006, CANCER RES, V66, P8182, DOI 10.1158/0008-5472.CAN-06-0577; Gupta P, 2006, PHARMACOL THERAPEUT, V111, P596, DOI 10.1016/j.pharmthera.2005.11.005; HERSHKO A, 1982, ANNU REV BIOCHEM, V51, P335, DOI 10.1146/annurev.bi.51.070182.002003; Huang EY, 2001, ONCOGENE, V20, P7051, DOI 10.1038/sj.onc.1204897; Im SH, 2004, J BIOL CHEM, V279, P46818, DOI 10.1074/jbc.M401722200; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Jiang HP, 1995, ONCOGENE, V11, P2477; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P9160, DOI 10.1073/pnas.93.17.9160; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Lebedeva IV, 2003, SEMIN CANCER BIOL, V13, P169, DOI 10.1016/S1044-579X(02)00134-7; Lebedeva IV, 2005, MOL THER, V11, P4, DOI 10.1016/j.ymthe.2004.08.012; Lebedeva IV, 2002, ONCOGENE, V21, P708, DOI 10.1038/sj.onc.1205116; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Madireddi MT, 2000, ADV EXP MED BIOL, V465, P239; Maquat LE, 2002, CURR BIOL, V12, pR196, DOI 10.1016/S0960-9822(02)00747-9; Mhashilkar AM, 2001, MOL MED, V7, P271, DOI 10.1007/BF03401847; Philips AV, 2000, CELL MOL LIFE SCI, V57, P235, DOI 10.1007/PL00000687; Ramesh R, 2003, CANCER RES, V63, P5105; Sarkar D, 2005, CANCER RES, V65, P9056, DOI 10.1158/0008-5472.CAN-05-1261; Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199; Sarkar D, 2002, BIOTECHNIQUES, P30; Sauane M, 2004, CANCER RES, V64, P2988, DOI 10.1158/0008-5472.CAN-04-0200; Sauane M, 2003, J CELL PHYSIOL, V196, P334, DOI 10.1002/jcp.10309; Sauane M, 2003, CYTOKINE GROWTH F R, V14, P35, DOI 10.1016/S1359-6101(02)00074-6; Sauane M, 2006, CANCER RES, V66, P11869, DOI 10.1158/0008-5472.CAN-06-1887; Schaefer G, 2001, J IMMUNOL, V166, P5859, DOI 10.4049/jimmunol.166.10.5859; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sieger KA, 2004, MOL THER, V9, P355, DOI 10.1016/j.ymthe.2003.11.014; Soo C, 1999, J CELL BIOCHEM, V74, P1; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Su ZZ, 2005, P NATL ACAD SCI USA, V102, P1059, DOI 10.1073/pnas.0409141102; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; WYLLIE AH, 1992, CANCER METAST REV, V11, P95, DOI 10.1007/BF00048057; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhao LL, 2005, HUM GENE THER, V16, P845, DOI 10.1089/hum.2005.16.845	48	19	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28860	28872		10.1074/jbc.M802510200	http://dx.doi.org/10.1074/jbc.M802510200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708357	Green Published, hybrid			2022-12-25	WOS:000260179900011
J	Wu, SC; Chang, SC; Wu, HY; Liao, PJ; Chang, MF				Wu, Shun-Chi; Chang, Shin C.; Wu, Hung-Yi; Liao, Pei-Ju; Chang, Ming-Fu			Hepatitis C Virus NS5A Protein Down-regulates the Expression of Spindle Gene Aspm through PKR-p38 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL 5A PROTEIN; HEPATOCELLULAR-CARCINOMA; CELL-GROWTH; BRAIN SIZE; KINASE; RNA; HCV; PHOSPHORYLATION; ORGANIZATION; DETERMINANT	Hepatitis C virus often causes persistent infection and hepatocellular carcinoma. Studies have demonstrated the roles of viral nonstructural protein 5A (NS5A) in the induction of chromosome aneuploidy, but the molecular mechanisms are not clear. In this study, hydrodynamics-based in vivo transfection was applied to a mouse system. Mouse hepatocytes that successfully expressed NS5A protein were isolated by laser capture microdissection. Gene expression profiles of the NS5A-expressing hepatocytes were examined by an Affymetrix oligonucleotide microarray system. Aspm (abnormal spindle-like, microcephaly associated), which encodes the mitotic spindle protein ASPM, was identified to be differentially expressed in the absence and the presence of NS5A. The down-regulation of Aspm mRNA and ASPM protein was confirmed by real time polymerase chain reaction and Western blot analysis, respectively, both in mouse model systems and in viral subgenomic replicon and in vitro transfection culturing systems. In addition, cultured cells that constitutively expressed NS5A protein showed G(2)/M cell cycle block and chromosome aneuploidy. Overexpression of ASPM relieved the G(2)/M cell cycle block. Furthermore, NS5A protein repressed the promoter activity of Aspm gene in a dose-dependent manner. The regulatory effect was abolished when amino acid substitutions P2209L, T2214A, and T2217G known to interrupt the NS5A-PKR interaction were introduced into the NS5A protein. This indicates that the down-regulation of Aspm expression is via the PKR-p38 signaling pathway. These results suggest that NS5A protein down-regulates the expression of the mitotic spindle protein ASPM and induces aberrant mitotic cell cycle associated with chromosome instability and hepatocellular carcinoma.	[Wu, Shun-Chi; Wu, Hung-Yi; Chang, Ming-Fu] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei, Taiwan; [Chang, Shin C.; Liao, Pei-Ju] Natl Taiwan Univ, Coll Med, Inst Microbiol, Taipei, Taiwan	National Taiwan University; National Taiwan University	Chang, SC (corresponding author), Natl Taiwan Univ, Coll Med, Inst Microbiol, 1 Jen Ai Rd,1st Sect, Taipei, Taiwan.	scchang093@ntu.edu.tw; mfchang@ntu.edu.tw		CHANG, MING-FU/0000-0001-7062-3578	National Science Council of the Republic of China [NSC 93-3112-B-002-025-Y, NSC 95-2752-B-002-009-PAE, NSC 96-2752-B-002-009-PAE, NSC 96-3112-B-002-028]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by Research Grants NSC 93-3112-B-002025- Y, NSC 95-2752-B-002-009-PAE, NSC 96-2752-B-002-009-PAE and NSC 96-3112-B-002-028 from the National Science Council of the Republic of China. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arima N, 2001, J BIOL CHEM, V276, P12675, DOI 10.1074/jbc.M008329200; Baek KH, 2006, J MOL BIOL, V359, P22, DOI 10.1016/j.jmb.2006.03.020; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; CHANG MF, 1993, J VIROL, V67, P2529, DOI 10.1128/JVI.67.5.2529-2536.1993; Cheng JC, 1999, J VIROL, V73, P7044, DOI 10.1128/JVI.73.8.7044-7049.1999; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; De Mitri MS, 2002, J HEPATOL, V36, P116, DOI 10.1016/S0168-8278(01)00235-5; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Gale MJ, 1998, CLIN DIAGN VIROL, V10, P157; Ghosh AK, 1999, J GEN VIROL, V80, P1179, DOI 10.1099/0022-1317-80-5-1179; He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002; He YP, 2001, J VIROL, V75, P5090, DOI 10.1128/JVI.75.11.5090-5098.2001; HOPF U, 1990, J HEPATOL, V10, P69, DOI 10.1016/0168-8278(90)90075-3; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hsieh PK, 2005, J VIROL, V79, P13848, DOI 10.1128/JVI.79.22.13848-13855.2005; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; Kou YH, 2007, J VIROL, V81, P7999, DOI 10.1128/JVI.00348-07; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Kumar A, 2002, J BIOSCIENCES, V27, P629, DOI 10.1007/BF02708369; Kuo LY, 2006, J CELL PHYSIOL, V207, P729, DOI 10.1002/jcp.20616; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; Nishise Y, 2007, J INFECT DIS, V196, P1006, DOI 10.1086/521309; Park KJ, 2003, J BIOL CHEM, V278, P30711, DOI 10.1074/jbc.M209623200; Rennefahrt U, 2004, CANCER LETT, V215, P113, DOI 10.1016/j.canlet.2004.05.015; Sevinsky JR, 2004, MOL CELL BIOL, V24, P4534, DOI 10.1128/MCB.24.10.4534-4545.2004; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Tagger A, 1999, INT J CANCER, V81, P695, DOI 10.1002/(SICI)1097-0215(19990531)81:5<695::AID-IJC4>3.3.CO;2-N; Takao Y, 2007, MED MICROBIOL IMMUN, V196, P157, DOI 10.1007/s00430-007-0038-1; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; Tang WL, 2007, AM J PATHOL, V171, P1831, DOI 10.2353/ajpath.2007.070413; Towatari M, 2004, HEMATOL J, V5, P262, DOI 10.1038/sj.thj.6200345; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Yu YL, 2005, J BIOL CHEM, V280, P29533, DOI 10.1074/jbc.M506514200; Zhong XY, 2005, CELL CYCLE, V4, P1227, DOI 10.4161/cc.4.9.2029	40	45	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29396	29404		10.1074/jbc.M802821200	http://dx.doi.org/10.1074/jbc.M802821200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728014	Green Published, hybrid			2022-12-25	WOS:000260179900066
J	Woo, EJ; Lee, S; Cha, H; Park, JT; Yoon, SM; Song, HN; Park, KH				Woo, Eui-Jeon; Lee, Seungjae; Cha, Hyunju; Park, Jong-Tae; Yoon, Sei-Mee; Song, Hyung-Nam; Park, Kwan-Hwa			Structural insight into the bifunctional mechanism of the glycogen-debranching enzyme TreX from the archaeon Sulfolobus solfataricus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMYLASE FAMILY; ARTHROBACTER SP Q36; MALTOGENIC AMYLASE; CRYSTAL-STRUCTURE; TREHALOSE BIOSYNTHESIS; SPECIFICITY; ACARBOSE; 4-ALPHA-GLUCANOTRANSFERASE; NEOPULLULANASE; CYCLODEXTRIN	TreX is an archaeal glycogen-debranching enzyme that exists in two oligomeric states in solution, as a dimer and tetramer. Unlike its homologs, TreX from Sulfolobus solfataricus shows dual activities for alpha-1,4-transferase and alpha-1,6-glucosidase. To understand this bifunctional mechanism, we determined the crystal structure of TreX in complex with an acarbose ligand. The acarbose intermediate was covalently bound to Asp(363), occupying subsites -1 to -3. Although generally similar to the monomeric structure of isoamylase, TreX exhibits two different active-site configurations depending on its oligomeric state. The N terminus of one subunit is located at the active site of the other molecule, resulting in a reshaping of the active site in the tetramer. This is accompanied by a large shift in the "flexible loop" (amino acids 399-416), creating connected holes inside the tetramer. Mutations in the N-terminal region result in a sharp increase in alpha-1,4-transferase activity and a reduced level of alpha-1,6-glucosidase activity. On the basis of geometrical analysis of the active site and mutational study, we suggest that the structural lid (acids 99-97) at the active site generated by the tetramerization is closely associated with the bifunctionality and in particular with the alpha-1,4-transferase activity. These results provide a structural basis for the modulation of activities upon TreX oligomerization that may represent a common mode of action for other glycogen-debranching enzymes in higher organisms.	[Woo, Eui-Jeon; Yoon, Sei-Mee; Song, Hyung-Nam] Korea Res Inst Biosci & Biotechnol, Translat Res Ctr, Taejon 305806, South Korea; [Lee, Seungjae; Cha, Hyunju; Park, Jong-Tae; Park, Kwan-Hwa] Seoul Natl Univ, Ctr Agr Biomat, Seoul 151192, South Korea; [Lee, Seungjae; Cha, Hyunju; Park, Jong-Tae; Park, Kwan-Hwa] Seoul Natl Univ, Dept Food Sci & Biotechnol, Seoul 151192, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU)	Woo, EJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Translat Res Ctr, 111 Gwahangno, Taejon 305806, South Korea.	ejwoo@kribb.re.kr; parkkh@plaza.snu.ac.kr		Woo, Eui-Jeon/0000-0001-6983-0270; Lee, Seungjae/0000-0001-9081-2835; Park, Jong-Tae/0000-0002-0650-6948	Korea Research Institute of Bioscience and Biotechnology Research Initiative; Ministry of Marine Affairs and Fisheries, Republic of Korea; Korea Research Foundation Grant [KRF-2006-005-J04703]	Korea Research Institute of Bioscience and Biotechnology Research Initiative; Ministry of Marine Affairs and Fisheries, Republic of Korea; Korea Research Foundation Grant(National Research Foundation of Korea)	This work was supported by a grant from the Korea Research Institute of Bioscience and Biotechnology Research Initiative, by the Marine and Extreme Genome Research Center Program, Ministry of Marine Affairs and Fisheries, Republic of Korea, and in part by Korea Research Foundation Grant KRF-2006-005-J04703. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; BATES EJ, 1975, FEBS LETT, V58, P181, DOI 10.1016/0014-5793(75)80254-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheong KA, 2002, BIOTECHNOL APPL BIOC, V35, P27, DOI 10.1042/BA20010052; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Delano W.L, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOX JD, 1991, ANAL BIOCHEM, V195, P93, DOI 10.1016/0003-2697(91)90300-I; Hondoh H, 2003, J MOL BIOL, V326, P177, DOI 10.1016/S0022-2836(02)01402-X; Imamura H, 2003, J BIOL CHEM, V278, P19378, DOI 10.1074/jbc.M213134200; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; Kim TJ, 1999, APPL ENVIRON MICROB, V65, P1644; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; LIU W, 1991, BIOCHEMISTRY-US, V30, P1419, DOI 10.1021/bi00219a036; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Maruta K, 2000, BBA-PROTEIN STRUCT M, V1476, P377, DOI 10.1016/S0167-4838(99)00253-8; Maruta K, 1996, BBA-GEN SUBJECTS, V1291, P177, DOI 10.1016/S0304-4165(96)00082-7; Maruta K, 1996, BBA-GEN SUBJECTS, V1289, P10, DOI 10.1016/0304-4165(95)00139-5; Mikami B, 2006, J MOL BIOL, V359, P690, DOI 10.1016/j.jmb.2006.03.058; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nakayama A, 2001, J BIOL CHEM, V276, P28824, DOI 10.1074/jbc.M102192200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HS, 2007, BIOSCI BIOTECH BIOCH, V71, P1348, DOI 10.1271/bbb.70016; Park JT, 2008, BIOCATAL BIOTRANSFOR, V26, P76, DOI 10.1080/10242420701806652; Park KH, 2000, BBA-PROTEIN STRUCT M, V1478, P165, DOI 10.1016/S0167-4838(00)00041-8; Przylas I, 2000, EUR J BIOCHEM, V267, P6903, DOI 10.1046/j.1432-1033.2000.01790.x; Roujeinikova A, 2002, J MOL BIOL, V321, P149, DOI 10.1016/S0022-2836(02)00570-3; Schmidt AK, 1998, BIOCHEMISTRY-US, V37, P5909, DOI 10.1021/bi9729918; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Strokopytov B, 1996, BIOCHEMISTRY-US, V35, P4241, DOI 10.1021/bi952339h; Watanabe Y, 2006, J BIOCHEM, V140, P135, DOI 10.1093/jb/mvj129; Yokota T, 2001, BIOSCI BIOTECH BIOCH, V65, P401, DOI 10.1271/bbb.65.401	34	38	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28641	28648		10.1074/jbc.M802560200	http://dx.doi.org/10.1074/jbc.M802560200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18703518	Green Published, hybrid			2022-12-25	WOS:000259969300066
J	Azuma, M; Kabe, Y; Kuramori, C; Kondo, M; Yamaguchi, Y; Handa, H				Azuma, Motoki; Kabe, Yasuaki; Kuramori, Chikanori; Kondo, Masao; Yamaguchi, Yuki; Handa, Hiroshi			Adenine Nucleotide Translocator Transports Haem Precursors into Mitochondria	PLOS ONE			English	Article							ADP/ATP CARRIER; IDENTIFICATION; PORPHYRINS; RESIDUES; SYNTHASE; MMFF94S; BAX	Haem is a prosthetic group for haem proteins, which play an essential role in oxygen transport, respiration, signal transduction, and detoxification. In haem biosynthesis, the haem precursor protoporphyrin IX (PP IX) must be accumulated into the mitochondrial matrix across the inner membrane, but its mechanism is largely unclear. Here we show that adenine nucleotide translocator (ANT), the inner membrane transporter, contributes to haem biosynthesis by facilitating mitochondrial accumulation of its precursors. We identified that haem and PP IX specifically bind to ANT. Mitochondrial uptake of PP IX was inhibited by ADP, a known substrate of ANT. Conversely, ADP uptake into mitochondria was competitively inhibited by haem and its precursors, suggesting that haem-related porphyrins are accumulated into mitochondria via ANT. Furthermore, disruption of the ANT genes in yeast resulted in a reduction of haem biosynthesis by blocking the translocation of haem precursors into the matrix. Our results represent a new model that ANT plays a crucial role in haem biosynthesis by facilitating accumulation of its precursors into the mitochondrial matrix.	[Azuma, Motoki; Kuramori, Chikanori; Yamaguchi, Yuki; Handa, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa, Japan; [Kabe, Yasuaki] Keio Univ, Sch Med, Dept Integrat Med Biol, Tokyo 108, Japan; [Kondo, Masao] Toyoko Gakuen Womens Coll, Dept Early Childhood Care & Ed, Tokyo, Japan; [Handa, Hiroshi] Tokyo Inst Technol, Integrated Rese Inst, Solutions Res Org, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology; Keio University; Tokyo Institute of Technology	Azuma, M (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa, Japan.	handa.h.aa@m.titech.ac.jp	Yamaguchi, Yuki/B-9390-2015	Yamaguchi, Yuki/0000-0002-0197-614X	New Energy and Industrial Technology Development Organization (NEDO); Japan Science and Technology Agency (JST)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by a Grant for Research and Development Projects in Cooperation with Academic Institutions from the New Energy and Industrial Technology Development Organization (NEDO) and by Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST).	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Ascoli F, 1981, Methods Enzymol, V76, P72; Belzacq AS, 2003, CANCER RES, V63, P541; DAUM G, 1982, J BIOL CHEM, V257, P3028; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Hase Y, 2008, BIOCHEM BIOPH RES CO, V366, P66, DOI 10.1016/j.bbrc.2007.11.107; Heidkamper D, 1996, BIOCHEMISTRY-US, V35, P16144, DOI 10.1021/bi960668j; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Kabe Y, 2006, J BIOL CHEM, V281, P31729, DOI 10.1074/jbc.M604729200; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; KONDO M, 1987, LC FAMILY JASCO REPO, V22, P5; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Machida K, 2002, J BIOL CHEM, V277, P31243, DOI 10.1074/jbc.M204564200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Muller V, 1997, BIOCHEMISTRY-US, V36, P16008, DOI 10.1021/bi971867l; Ohtsu Y, 2005, ANAL BIOCHEM, V338, P245, DOI 10.1016/j.ab.2004.10.006; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200; PAUL MF, 1994, J BIOL CHEM, V269, P26158; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; PROULX KL, 1993, PROTEIN SCI, V2, P1092, DOI 10.1002/pro.5560020703; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; SASSA S, 1977, J BIOL CHEM, V252, P2428; Shimizu S, 2000, ONCOGENE, V19, P4309, DOI 10.1038/sj.onc.1203788; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051	27	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3070	10.1371/journal.pone.0003070	http://dx.doi.org/10.1371/journal.pone.0003070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728780	Green Submitted, gold, Green Published			2022-12-25	WOS:000264796400010
J	Taylor, SL; Pollard, KS				Taylor, Sandra L.; Pollard, Katherine S.			Evaluation of Two Methods to Estimate and Monitor Bird Populations	PLOS ONE			English	Article							DETECTION PROBABILITY; ABUNDANCE; RECAPTURE; DENSITY; REMOVAL; CAPTURE	Background: Effective management depends upon accurately estimating trends in abundance of bird populations over time, and in some cases estimating abundance. Two population estimation methods, double observer (DO) and double sampling (DS), have been advocated for avian population studies and the relative merits and short-comings of these methods remain an area of debate. Methodology/Principal Findings: We used simulations to evaluate the performances of these two population estimation methods under a range of realistic scenarios. For three hypothetical populations with different levels of clustering, we generated DO and DS population size estimates for a range of detection probabilities and survey proportions. Population estimates for both methods were centered on the true population size for all levels of population clustering and survey proportions when detection probabilities were greater than 20%. The DO method underestimated the population at detection probabilities less than 30% whereas the DS method remained essentially unbiased. The coverage probability of 95% confidence intervals for population estimates was slightly less than the nominal level for the DS method but was substantially below the nominal level for the DO method at high detection probabilities. Differences in observer detection probabilities did not affect the accuracy and precision of population estimates of the DO method. Population estimates for the DS method remained unbiased as the proportion of units intensively surveyed changed, but the variance of the estimates decreased with increasing proportion intensively surveyed. Conclusions/Significance: The DO and DS methods can be applied in many different settings and our evaluations provide important information on the performance of these two methods that can assist researchers in selecting the method most appropriate for their particular needs.	[Taylor, Sandra L.; Pollard, Katherine S.] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA	University of California System; University of California Davis	Taylor, SL (corresponding author), Univ Calif Davis, Dept Stat, Davis, CA 95616 USA.	sltaylor@ucdavis.edu		Taylor, Sandra/0000-0001-7811-812X				Anderson DR, 2003, WILDLIFE SOC B, V31, P288; Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; [Anonymous], 1982, ESTIMATION ANIMAL AB; Barbraud C, 2004, J FIELD ORNITHOL, V75, P172, DOI 10.1648/0273-8570-75.2.172; Bart J, 2004, WILDLIFE SOC B, V32, P1242, DOI 10.2193/0091-7648(2004)032[1242:DEIWS]2.0.CO;2; Bart J, 2002, AUK, V119, P36, DOI 10.1642/0004-8038(2002)119[0036:DSTEDA]2.0.CO;2; BART J, 1998, SAMPLING STAT METHOD; Brown S, 2007, CONDOR, V109, P1, DOI 10.1650/0010-5422(2007)109[1:SAADOT]2.0.CO;2; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Cochran W.G., 1953, SAMPLING TECHNIQUES, Vsecond; Conway CJ, 2003, J WILDLIFE MANAGE, V67, P501, DOI 10.2307/3802708; COOK RD, 1979, BIOMETRICS, V35, P735, DOI 10.2307/2530104; Diefenbach DR, 2003, AUK, V120, P1168, DOI 10.1642/0004-8038(2003)120[1168:VIGBCR]2.0.CO;2; EARNST SL, 2005, BIRD CONSERVATION IM, P781; Moore JE, 2004, AUK, V121, P865, DOI 10.1642/0004-8038(2004)121[0865:FCORAM]2.0.CO;2; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Norvell RE, 2003, AUK, V120, P1013, DOI 10.1642/0004-8038(2003)120[1013:ASCORA]2.0.CO;2; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pollock KH, 2000, J AM STAT ASSOC, V95, P293; POLLOCK KH, 1991, J AM STAT ASSOC, V86, P225, DOI 10.2307/2289733; *R DEV COR TEAM, 2006, LANG ENV STAT COMP V; Thompson S.K., 2012, SAMPLING, V2nd; Thompson WL, 2002, AUK, V119, P18, DOI 10.1642/0004-8038(2002)119[0018:TRBSAF]2.0.CO;2	23	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3047	10.1371/journal.pone.0003047	http://dx.doi.org/10.1371/journal.pone.0003047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728775	Green Submitted, Green Published, gold			2022-12-25	WOS:000264796400005
J	Willis, ND; Cox, TR; Rahman-Casans, SF; Smits, K; Przyborski, SA; van den Brandt, P; van Engeland, M; Weijenberg, M; Wilson, RG; de Bruine, A; Hutchison, CJ				Willis, Naomi D.; Cox, Thomas R.; Rahman-Casans, Syed F.; Smits, Kim; Przyborski, Stefan A.; van den Brandt, Piet; van Engeland, Manon; Weijenberg, Matty; Wilson, Robert G.; de Bruine, Adriaan; Hutchison, Christopher J.			Lamin A/C Is a Risk Biomarker in Colorectal Cancer	PLOS ONE			English	Article								Background: A-type lamins are type V intermediate filament proteins encoded by the gene LMNA. Mutations in LMNA give rise to diverse degenerative diseases related to premature ageing. A-type lamins also influence the activity of the Retinoblastoma protein (pRb) and oncogenes such a beta-catenin. Consequently, it has been speculated that expression of A-type lamins may also influence tumour progression. Methodology/Principal Findings: An archive of colorectal cancer (CRC) and normal colon tissue was screened for expression of A-type lamins. We used the Cox proportional hazard ratio (HR) method to investigate patient survival. Using CRC cell lines we investigated the effects of lamin A expression on other genes by RT-PCR; on cell growth by FACS analysis; and on invasiveness by cell migration assays and siRNA knockdown of targeted genes. We found that lamin A is expressed in colonic stem cells and that patients with A-type lamin-expressing tumours have significantly worse prognosis than patients with A-type lamin negative tumours (HR = 1.85, p = 0.005). To understand this finding, we established a model system based upon expression of GFP-lamin A in CRC cells. We found that expression of GFP-lamin A in these cells did not affect cell proliferation but did promote greatly increased cell motility and invasiveness. The reason for this increased invasiveness was that expression of lamin A promoted up-regulation of the actin bundling protein T-plastin, leading to down regulation of the cell adhesion molecule E-cadherin. Conclusions: Expression of A-type lamins increases the risk of death from CRC because its presence gives rise to increased invasiveness and potentially a more stem cell-like phenotype. This report directly links A-type lamin expression to tumour progression and raises the profile of LMNA from one implicated in multiple but rare genetic conditions to a gene involved in one of the commonest diseases in the Western World.	[Willis, Naomi D.; Cox, Thomas R.; Przyborski, Stefan A.; Hutchison, Christopher J.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Rahman-Casans, Syed F.; Wilson, Robert G.] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Smits, Kim; van den Brandt, Piet; Weijenberg, Matty] Univ Maastricht, Dept Epidemiol, Maastricht, Netherlands; [van Engeland, Manon; de Bruine, Adriaan] Univ Maastricht, Dept Pathol, Maastricht, Netherlands	Durham University; James Cook University Hospital; Maastricht University; Maastricht University	Willis, ND (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	c.j.hutchison@durham.ac.uk	van Engeland, Manon/A-7479-2009	van Engeland, Manon/0000-0002-7952-6843; Cox, Thomas/0000-0001-9294-1745; van den Brandt, Piet/0000-0001-8781-8099	National Health Service Research and Development Funds; Association for International Cancer Research; European Union Framework Program 6	National Health Service Research and Development Funds; Association for International Cancer Research; European Union Framework Program 6(European Commission)	National Health Service Research and Development Funds, Association for International Cancer Research, European Union Framework Program 6	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; BROERS JLV, 1993, AM J PATHOL, V143, P211; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Cai WB, 1997, INT J RADIAT BIOL, V71, P573, DOI 10.1080/095530097143905; CANCE WG, 1992, J EXP CLIN CANC RES, V11, P233; COX DR, 1972, J R STAT SOC B, V34, P187; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dechat T, 2000, J CELL SCI, V113, P3473; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Dyer JA, 1997, CHROMOSOME RES, V5, P383, DOI 10.1023/A:1018496309156; Foran E, 2006, INT J CANCER, V118, P2098, DOI 10.1002/ijc.21593; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; HOZAK P, 1995, J CELL SCI, V108, P635; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Hutchison CJ, 2001, J CELL SCI, V114, P9; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kill IR, 1995, FEBS LETT, V377, P26, DOI 10.1016/0014-5793(95)01302-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lee KK, 2001, J CELL SCI, V114, P4567; LIN CS, 1993, J BIOL CHEM, V268, P2781; Lin F, 2005, HUM MOL GENET, V14, P437, DOI 10.1093/hmg/ddi040; LIN F, 1993, J BIOL CHEM, V268, P16321; MADSEN P, 1986, J CELL BIOL, V103, P2083, DOI 10.1083/jcb.103.6.2083; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Moss SF, 1999, GUT, V45, P723, DOI 10.1136/gut.45.5.723; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; QIU JM, 1994, EPITHELIAL CELL BIOL, V3, P137; ROBER RA, 1989, DEVELOPMENT, V105, P365; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; STADELMANN B, 1990, LEUKEMIA RES, V14, P815, DOI 10.1016/0145-2126(90)90076-L; Tilli CMLJ, 2003, BRIT J DERMATOL, V148, P102, DOI 10.1046/j.1365-2133.2003.05026.x; Van Berlo JH, 2005, HUM MOL GENET, V14, P2839, DOI 10.1093/hmg/ddi316; VANDENBRANDT PA, 1990, INT J EPIDEMIOL, V19, P553; VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E; Vaughan OA, 2001, J CELL SCI, V114, P2577; Venables RS, 2001, BRIT J CANCER, V84, P512, DOI 10.1054/bjoc.2000.1632; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Zhen YY, 2002, J CELL SCI, V115, P3207	50	165	170	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2988	10.1371/journal.pone.0002988	http://dx.doi.org/10.1371/journal.pone.0002988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714339	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000264420900014
J	Gambhir, M; Michael, E				Gambhir, Manoj; Michael, Edwin			Complex Ecological Dynamics and Eradicability of the Vector Borne Macroparasitic Disease, Lymphatic Filariasis	PLOS ONE			English	Article							WUCHERERIA-BANCROFTI MICROFILARIAE; FACTORS AFFECTING TRANSMISSION; AGE-STRUCTURED MODEL; ANOPHELINE MOSQUITOS; MATHEMATICAL-MODELS; DENSITY-DEPENDENCE; SOUTH-INDIA; LIFE-SPAN; INFECTION; PONDICHERRY	Background: The current global efforts to control the morbidity and mortality caused by infectious diseases affecting developing countries - such as HIV/AIDS, polio, tuberculosis, malaria and the Neglected Tropical Diseases ( NTDs)-have led to an increasing focus on the biological controllability or eradicability of disease transmission by management action. Here, we use an age-structured dynamical model of lymphatic filariasis transmission to show how a quantitative understanding of the dynamic processes underlying infection persistence and extinction is key to evaluating the eradicability of this macroparasitic disease. Methodology/Principal Findings: We investigated the persistence and extinction dynamics of lymphatic filariasis by undertaking a numerical equilibrium analysis of a deterministic model of parasite transmission, based on varying values of the initial L3 larval density in the system. The results highlighted the likely occurrence of complex dynamics in parasite transmission with three major outcomes for the eradicability of filariasis. First, both vector biting and worm breakpoint thresholds are shown to be complex dynamic entities with values dependent on the nature and magnitude of vector-and host specific density-dependent processes and the degree of host infection aggregation prevailing in endemic communities. Second, these thresholds as well as the potential size of the attractor domains and hence system resilience are strongly dependent on peculiarities of infection dynamics in different vector species. Finally, the existence of multiple stable states indicates the presence of hysteresis nonlinearity in the filariasis system dynamics in which infection thresholds for infection invasion are lower but occur at higher biting rates than do the corresponding thresholds for parasite elimination. Conclusions/Significance: The variable dynamic nature of thresholds and parasite system resilience reflecting both initial conditions and vector species-infection specificities, and the existence of hysteresis loop phenomenon, suggests that eradication of filariasis may require taking a more flexible and locally relevant approach to designing elimination programmes compared to the current command and control approach advocated by the global programme.	[Gambhir, Manoj; Michael, Edwin] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Infect Dis Epidemiol, London, England	Imperial College London	Gambhir, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Infect Dis Epidemiol, London, England.	m.gambhir@imperial.ac.uk	Michael, Edwin/D-3388-2014	Gambhir, Manoj/0000-0002-4831-6261	NIH [RO1 AI069387-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069387] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work of MG and EM was financially supported by NIH grant no. RO1 AI069387-01A1.	Allison H., 2006, SCI POLICY NATURAL R; Avise J.C., 2004, MOL MARKERS NATURAL; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; BRYAN JH, 1988, T ROY SOC TROP MED H, V82, P138, DOI 10.1016/0035-9203(88)90288-X; Burgman M., 2005, RISKS DECISIONS CONS; Chan MS, 1998, AM J TROP MED HYG, V59, P606, DOI 10.4269/ajtmh.1998.59.606; CHAN MS, 1995, EPIDEMIOL INFECT, V115, P325, DOI 10.1017/S0950268800058453; DAS PK, 1992, EPIDEMIOL INFECT, V108, P483, DOI 10.1017/S0950268800049992; Duerr HP, 2005, TRENDS PARASITOL, V21, P88, DOI 10.1016/j.pt.2004.11.011; EVANS DB, 1993, ACTA TROP, V53, P1, DOI 10.1016/0001-706X(93)90002-S; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Freeland J., 2005, MOL ECOLOGY CHICHEST; FUNTOWICZ SO, 1993, FUTURES, V25, P739, DOI 10.1016/0016-3287(93)90022-L; GRENFELL BT, 1992, PARASITOLOGY, V104, pS81, DOI 10.1017/S0031182000075260; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Gyorkos TW, 2003, ACTA TROP, V86, P275, DOI 10.1016/S0001-706X(03)00048-2; HAIRSTON NG, 1968, B WORLD HEALTH ORGAN, V38, P935; HO BC, 1967, T ROY SOC TROP MED H, V61, P663, DOI 10.1016/0035-9203(67)90130-7; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holling CrawfordS., 1978, ADAPTIVE ENV ASSESSM; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; Hotez P, 2007, TRENDS PARASITOL, V23, P511, DOI 10.1016/j.pt.2007.08.015; King CL, 2001, PARASITE IMMUNOL, V23, P363, DOI 10.1046/j.1365-3024.2001.00395.x; Lammie PJ, 2006, TRENDS PARASITOL, V22, P313, DOI 10.1016/j.pt.2006.05.009; Lande R., 2003, OXFORD SERIES ECOLOG; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; Ludwig D., 1997, CONSERV ECOL, V1, P1; MAIZELS RM, 1993, NATURE, V365, P797, DOI 10.1038/365797a0; MAY R, 1973, STABILITY COMPLEXICI; MAY RM, 1977, MATH BIOSCI, V35, P301, DOI 10.1016/0025-5564(77)90030-X; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Michael E, 2004, LANCET INFECT DIS, V4, P223, DOI 10.1016/S1473-3099(04)00973-9; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; Michael E, 2007, ADV PARASIT, V65, P191, DOI 10.1016/S0065-308X(07)65003-9; Michael E, 2006, TRENDS PARASITOL, V22, P529, DOI 10.1016/j.pt.2006.08.011; Michael E, 2006, TRENDS PARASITOL, V22, P226, DOI 10.1016/j.pt.2006.03.005; Norman RA, 2000, EPIDEMIOL INFECT, V124, P529, DOI 10.1017/S0950268899003702; OTTESEN EA, 1995, PARASITOL TODAY, V11, P129, DOI 10.1016/0169-4758(95)80128-6; Pichon G, 2002, ANN TROP MED PARASIT, V96, pS143, DOI 10.1179/000349802125002509; Rajagopalan P.K., 1980, Proceedings of the Indian National Science Academy Part B Biological Sciences, V46, P745; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Snow LC, 2006, MED VET ENTOMOL, V20, P261, DOI 10.1111/j.1365-2915.2006.00629.x; Snow LC, 2002, MED VET ENTOMOL, V16, P409, DOI 10.1046/j.1365-2915.2002.00396.x; SOUTHGATE BA, 1992, T ROY SOC TROP MED H, V86, P523, DOI 10.1016/0035-9203(92)90096-U; Stolk WA, 2003, J INFECT DIS, V188, P1371, DOI 10.1086/378354; SUBRAMANIAN S, 1994, AM J TROP MED HYG, V51, P244, DOI 10.4269/ajtmh.1994.51.244; SUBRAMANIAN S, 1989, EPIDEMIOL INFECT, V103, P693, DOI 10.1017/S0950268800031095; Subramanian S, 1998, PARASITOLOGY, V116, P243, DOI 10.1017/S0031182097002254; Turner SJ, 2001, GUIDEBOOK FOR INTEGRATED ECOLOGICAL ASSESSMENTS, P29; Utzinger J, 2006, PLOS MED, V3, P585, DOI 10.1371/journal.pmed.0030112; VANAMAIL P, 1990, INDIAN J MED RES-A, V91, P293; Vanamail P, 1996, T ROY SOC TROP MED H, V90, P119, DOI 10.1016/S0035-9203(96)90106-6; Walker B, 2004, ECOL SOC, V9; Walters C., 1986, ADAPTIVE MANAGEMENT; WANG YH, 1980, J ANIM ECOL, V49, P435, DOI 10.2307/4256	55	56	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2874	10.1371/journal.pone.0002874	http://dx.doi.org/10.1371/journal.pone.0002874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18716676	Green Published, Green Submitted			2022-12-25	WOS:000264366600030
J	Cuneo, MJ; Changela, A; Miklos, AE; Beese, LS; Krueger, JK; Hellinga, HW				Cuneo, Matthew J.; Changela, Anita; Miklos, Aleksandr E.; Beese, Lorena S.; Krueger, Joanna K.; Hellinga, Homme W.			Structural Analysis of a Periplasmic Binding Protein in the Tripartite ATP-independent Transporter Family Reveals a Tetrameric Assembly That May Have a Role in Ligand Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACYTOPLASMIC-SOLUTE-RECEPTOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURES; THERMODYNAMIC STABILITY; MALTOSE TRANSPORT; TRAP TRANSPORTERS; MECHANISM; SEQUENCE; DCTP; PURIFICATION	Several bacterial solute transport mechanisms involve members of the periplasmic binding protein (PBP) superfamily that bind and deliver ligand to integral membrane transport proteins in the ATP-binding cassette, tripartite tricarboxylate transporter, or tripartite ATP-independent (TRAP) families. PBPs involved in ATP-binding cassette transport systems have been well characterized, but only a few PBPs involved in TRAP transport have been studied. We have measured the thermal stability, determined the oligomerization state by small angle x-ray scattering, and solved the x-ray crystal structure to 1.9 angstrom resolution of a TRAP-PBP (open reading frame tm0322) from the hyperthermophilic bacterium Thermotoga maritima (TM0322). The overall fold of TM0322 is similar to other TRAP transport related PBPs, although the structural similarity of backbone atoms (2.5-3.1 angstrom root mean square deviation) is unusually low for PBPs within the same group. Individual monomers within the tetrameric asymmetric unit of TM0322 exhibit high root mean square deviation (0.9 angstrom) to each other as a consequence of conformational heterogeneity in their binding pockets. The gel filtration elution profile and the small angle x-ray scattering analysis indicate that TM0322 assembles as dimers in solution that in turn assemble into a dimer of dimers in the crystallographic asymmetric unit. Tetramerization has been previously observed in another TRAP-PBP (the Rhodobacter sphaeroides alpha-keto acid-binding protein) where quaternary structure formation is postulated to be an important requisite for the transmembrane transport process.	[Cuneo, Matthew J.; Changela, Anita; Miklos, Aleksandr E.; Beese, Lorena S.; Hellinga, Homme W.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Krueger, Joanna K.] Univ N Carolina, Dept Chem, Charlotte, NC 28213 USA	Duke University; University of North Carolina; University of North Carolina Charlotte	Hellinga, HW (corresponding author), 415 Nanaline Duke Bldg,Res Dr, Durham, NC 27710 USA.	hwh@biochem.duke.edu	Krueger, Joanna/A-3110-2011; beese, lorena/G-4993-2010	Miklos, Aleksandr/0000-0001-6375-2304; Cuneo, Matthew/0000-0002-1475-6656	National Institutes of Health [5 DP1 OD000122-02]; Homeland Security Advanced Research Projects Agency [W81XWH-05-C-0161]; National Science Foundation ADVANCE [SBE-0548401]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Homeland Security Advanced Research Projects Agency; National Science Foundation ADVANCE(National Science Foundation (NSF)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant 5 DP1 OD000122-02 ( to H. W. H.). This work was also supported by Homeland Security Advanced Research Projects Agency Grant W81XWH-05-C-0161 ( to H. W. H.), a National Institutes of Health sponsored biological chemistry training grant (to M.J.C.), Bonnie Cone Fellowship National Science Foundation ADVANCE Grant SBE-0548401 (to J.K.K.), and United States Department of Energy, Office of Science, Office of Basic Energy Sciences Contract DE-AC02-98CH10886.	Ashish, 2008, J BIOL CHEM, V283, P2761, DOI 10.1074/jbc.M708325200; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Clarke TE, 2002, J BIOL CHEM, V277, P13966, DOI 10.1074/jbc.M109385200; COHEN DS, 1994, PROTEIN SCI, V3, P1253, DOI 10.1002/pro.5560030811; Cuneo MJ, 2006, J MOL BIOL, V362, P259, DOI 10.1016/j.jmb.2006.06.084; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gonin S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-11; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P41; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOR LI, 1993, J MOL BIOL, V233, P659, DOI 10.1006/jmbi.1993.1543; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Kelly DJ, 2001, FEMS MICROBIOL REV, V25, P405, DOI 10.1111/j.1574-6976.2001.tb00584.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KRIGBAUM WR, 1970, BIOCHEMISTRY-US, V9, P1216, DOI 10.1021/bi00807a024; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; NIKAIDO H, 1994, FEBS LETT, V346, P55, DOI 10.1016/0014-5793(94)00315-7; O Glatter, 1982, SMALL ANGLE XRAY SCA, P18; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Rabus R, 1999, MICROBIOL-SGM, V145, P3431, DOI 10.1099/00221287-145-12-3431; Rucktooa P, 2007, J MOL BIOL, V370, P93, DOI 10.1016/j.jmb.2007.04.047; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; SHAW JG, 1991, MOL MICROBIOL, V5, P3055, DOI 10.1111/j.1365-2958.1991.tb01865.x; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tetsch L, 2002, FEMS MICROBIOL LETT, V211, P213, DOI 10.1111/j.1574-6968.2002.tb11227.x; Thomas GH, 2006, MICROBIOL-SGM, V152, P187, DOI 10.1099/MIC.0.28334-0; WALMSLEY AR, 1992, J BIOL CHEM, V267, P8064; WIDENHORN KA, 1988, J BACTERIOL, V170, P883, DOI 10.1128/jb.170.2.883-888.1988; Winnen B, 2003, RES MICROBIOL, V154, P457, DOI 10.1016/S0923-2508(03)00126-8; Yip Tai-Tung, 2004, Methods Mol Biol, V244, P179; Zeng G, 1998, BIOTECHNIQUES, V25, P206, DOI 10.2144/98252bm05	48	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32812	32820		10.1074/jbc.M803595200	http://dx.doi.org/10.1074/jbc.M803595200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18723845	Green Published, hybrid			2022-12-25	WOS:000260893700070
J	Bartonova, V; Igonet, S; Sticht, J; Glass, B; Habermann, A; Vaney, MC; Sehr, P; Lewis, J; Rey, FA; Krausslich, HG				Bartonova, Vanda; Igonet, Sebastien; Sticht, Jana; Glass, Baerbel; Habermann, Anja; Vaney, Marie-Christine; Sehr, Peter; Lewis, Joe; Rey, Felix A.; Kraeusslich, Hans-Georg			Residues in the HIV-1 Capsid Assembly Inhibitor Binding Site Are Essential for Maintaining the Assembly-competent Quaternary Structure of the Capsid Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; DIMERIZATION DOMAIN; PEPTIDE INHIBITOR; GAG PROTEIN; VIRUS; ORGANIZATION; MEMBRANE; REVEALS; VIRIONS; COMPLEX	Morphogenesis of infectious HIV-1 involves budding of immature virions followed by proteolytic disassembly of the Gag protein shell and subsequent assembly of processed capsid proteins (CA) into the mature HIV-1 core. The dimeric interface between C-terminal domains of CA (C-CA) has been shown to be important for both immature and mature assemblies. We previously reported a CA-binding peptide (CAI) that blocks both assembly steps in vitro. The three-dimensional structure of the C-CA/CAI complex revealed an allosteric effect of CAI that alters the C-CA dimer interface. Based on this structure, we now investigated the phenotypes of mutations in the binding pocket. CA variants carrying mutations Y169A, L211A, or L211S had a reduced affinity for CAI and were unable to form mature-like particles in vitro. These mutations also blocked morphological conversion to mature virions in tissue culture and abolished infectivity. X-ray crystallographic analyses of the variant C-CA domains revealed that these alterations induced the same allosteric change at the dimer interface observed in the C-CA/CAI complex. These results point to a role of key interactions between conserved amino acids in the CAI binding pocket of C-CA in maintaining the correct conformation necessary for mature core assembly.	[Bartonova, Vanda; Sticht, Jana; Glass, Baerbel; Habermann, Anja; Kraeusslich, Hans-Georg] Univ Klinikum Heidelberg, Dept Virol, D-69120 Heidelberg, Germany; [Igonet, Sebastien; Vaney, Marie-Christine; Rey, Felix A.] Inst Pasteur, CNRS URA 3015, Struct Virol Unit, F-75724 Paris 15, France; [Sticht, Jana] Leibniz Inst Mol Pharmacol, Prot Engn Grp, D-13125 Berlin, Germany; [Sehr, Peter; Lewis, Joe] European Mol Biol Lab, Chem Biol Core Facil, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); European Molecular Biology Laboratory (EMBL)	Krausslich, HG (corresponding author), Univ Klinikum Heidelberg, Dept Virol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	hans-georg.kraeusslich@med.uni-heidelberg.de	Rey, Felix/B-6497-2012	Habermann, Anja/0000-0003-3686-9050; Lux, Vanda/0000-0002-0184-8076; Sehr, Peter/0000-0002-4348-5066; Rey, Felix/0000-0002-9953-7988	Deutsche Forschungsgemeinschaft [SFB544, B11]; European Union (HIV-ACE)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (HIV-ACE)(European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB544, B11) (to H.-G. K.) and the FP7 program of the European Union (HIV-ACE) (to H.-G. K. and F. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Briggs JAG, 2006, J MOL BIOL, V355, P157, DOI 10.1016/j.jmb.2005.10.025; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gottlinger HG, 2001, AIDS, V15, pS13; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Gross I, 2000, EMBO J, V19, P103, DOI 10.1093/emboj/19.1.103; Hawkes RA, 1979, DIAGNOSTIC PROCEDURE, P32; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Nermut MV, 1998, J STRUCT BIOL, V123, P143, DOI 10.1006/jsbi.1998.4024; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Wilk T, 2001, J VIROL, V75, P759, DOI 10.1128/JVI.75.2.759-771.2001; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Zhang H, 2008, J MOL BIOL, V378, P565, DOI 10.1016/j.jmb.2008.02.066	37	68	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32024	32033		10.1074/jbc.M804230200	http://dx.doi.org/10.1074/jbc.M804230200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18772135	Green Published, hybrid			2022-12-25	WOS:000260760800084
J	Attia, RR; Gardner, LA; Mahrous, E; Taxman, DJ; LeGros, L; Rowe, S; Ting, JPY; Geller, A; Kotb, M				Attia, Ramy R.; Gardner, Lidia A.; Mahrous, Engy; Taxman, Debra J.; LeGros, Leighton; Rowe, Sarah; Ting, Jenny P. -Y.; Geller, Arthur; Kotb, Malak			Selective Targeting of Leukemic Cell Growth in Vivo and in Vitro Using a Gene Silencing Approach to Diminish S-Adenosylmethionine Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; ACUTE LYMPHOBLASTIC-LEUKEMIA; CONFORMATIONAL ANALOGS; ENZYMATIC-SYNTHESIS; HUMAN-LYMPHOCYTES; AMINO-ACIDS; RAT-LIVER; ADENOSYLTRANSFERASE; INHIBITORS; SYNTHETASE	We exploited the fact that leukemic cells utilize significantly higher levels of S-adenosylmethionine (SAMe) than normal lymphocytes and developed tools that selectively diminished their survival under physiologic conditions. Using RNA interference gene silencing technology, we modulated the kinetics of methionine adenosyltransferase-II (MAT-II), which catalyzes SAMe synthesis from ATP and L-Met. Specifically, we silenced the expression of the regulatory MAT-II beta subunit in Jurkat cells and accordingly shifted the K-m (L-Met) of the enzyme 10-15-fold above the physiologic levels of L-Met, thereby reducing enzyme activity and SAMe pools, inducing excessive apoptosis and diminishing leukemic cell growth in vitro and in vivo. These effects were reversed at unphysiologically high L-Met (>50 mu M), indicating that diminished leukemic cell growth at physiologic L-Met levels was a direct result of the increase in MAT-II K-m (L-Met) due to MAT-II beta ablation and the consequent reduction in SAMe synthesis. In our NOD/Scid IL-2R gamma(null) humanized mouse model of leukemia, control shRNA-transduced Jurkat cells exhibited heightened engraftment, whereas cells lacking MAT-II beta failed to engraft for up to 5 weeks post-transplant. These stark differences in malignant cell survival, effected by MAT-II beta ablation, suggest that it may be possible to use this approach to disadvantage leukemic cell survival in vivo with little to no harm to normal cells.	[Geller, Arthur; Kotb, Malak] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Attia, Ramy R.; Gardner, Lidia A.; Mahrous, Engy; Geller, Arthur; Kotb, Malak] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38104 USA; [Attia, Ramy R.; Gardner, Lidia A.; LeGros, Leighton; Rowe, Sarah; Kotb, Malak] Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA; [Taxman, Debra J.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University System of Ohio; University of Cincinnati; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Kotb, M (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way,POB 670524,2938 CVC Mail Loc, Cincinnati, OH 45267 USA.	mscbskotb@gmail.com	Mahrous, Engy/AAG-6127-2021; Mahrous, Engy/AAG-9883-2021	Mahrous, Engy/0000-0001-8355-6984; 	National Institutes of Health [R01CA108792]; Veterans Affairs Merit Review Award; Senior Research Career Scientist Award; NATIONAL CANCER INSTITUTE [R01CA108792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Senior Research Career Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA108792. This work was also supported by a Veterans Affairs Merit Review Award and a Senior Research Career Scientist Award (to M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; BREILLOUT F, 1990, J NATL CANCER I, V82, P1628, DOI 10.1093/jnci/82.20.1628; BUTRON K, 1956, BIOCHEM J, V62, P315; CANTONI GL, 1953, J BIOL CHEM, V204, P403; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Coffield VM, 2004, J EXP MED, V200, P1315, DOI 10.1084/jem.20040944; COULTER AW, 1974, MOL PHARMACOL, V10, P319; Cunningham L, 2007, EXPERT OPIN PHARMACO, V8, P2519, DOI 10.1517/14656566.8.15.2519; DELAROSA J, 1992, J BIOL CHEM, V267, P10699; DELAROSA J, 1992, CANCER RES, V52, P3361; FEDERICI MM, 1979, BIOCHEM PHARMACOL, V28, P1689, DOI 10.1016/0006-2952(79)90187-4; Finkelstein JD, 2006, J NUTR, V136, p1750S, DOI 10.1093/jn/136.6.1750S; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Fronhoffs S, 2002, MOL CELL PROBE, V16, P99, DOI 10.1006/mcpr.2002.0405; Garcia-Trevijano ER, 2000, FASEB J, V14, P2511, DOI 10.1096/fj.00-0121com; GOSEKI N, 1995, JPN J CANCER RES, V86, P484, DOI 10.1111/j.1349-7006.1995.tb03082.x; GUO HY, 1993, CANCER RES, V53, P5676; Halim AB, 1999, J BIOL CHEM, V274, P29720, DOI 10.1074/jbc.274.42.29720; HOFFMAN JL, 1983, METHOD ENZYMOL, V94, P223; KAPPLER F, 1988, J MED CHEM, V31, P384, DOI 10.1021/jm00397a020; Kokkinakis DM, 2006, MOL CANCER RES, V4, P575, DOI 10.1158/1541-7786.MCR-05-0240; KOTB M, 1985, J BIOL CHEM, V260, P3923; KOTB M, 1990, BIOCHIM BIOPHYS ACTA, V1040, P137, DOI 10.1016/0167-4838(90)90068-Q; Kotb M, 1997, TRENDS GENET, V13, P51, DOI 10.1016/S0168-9525(97)01013-5; KOTB M, 1993, PHARMACOL THERAPEUT, V59, P125, DOI 10.1016/0163-7258(93)90042-C; KOTB M, 2004, Patent No. 6696279; Lavrador K, 1998, J ENZYM INHIB, V13, P361, DOI 10.3109/14756369809021481; LeGros HL, 1997, J BIOL CHEM, V272, P16040, DOI 10.1074/jbc.272.25.16040; LeGros HL, 2000, J BIOL CHEM, V275, P2359, DOI 10.1074/jbc.275.4.2359; Loehrer FMT, 1997, J PHARMACOL EXP THER, V282, P845; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; LOMBARDINI JB, 1983, BIOCHEM PHARMACOL, V32, P489, DOI 10.1016/0006-2952(83)90528-2; Martinez-Chantar ML, 2003, GASTROENTEROLOGY, V124, P940, DOI 10.1053/gast.2003.50151; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Sanz A, 2006, FASEB J, V20, P1064, DOI 10.1096/fj.05-5568com; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SUFRIN JR, 1993, BIOCHIM BIOPHYS ACTA, V1202, P87, DOI 10.1016/0167-4838(93)90067-2; SUFRIN JR, 1979, MOL PHARMACOL, V15, P661; SUMA Y, 1986, J BIOCHEM, V100, P67, DOI 10.1093/oxfordjournals.jbchem.a121707; Sun X, 2003, CANCER RES, V63, P8377; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1984, ADV ENZYMOL RAMB, V56, P251; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; VRUDHULA VM, 1989, J MED CHEM, V32, P885, DOI 10.1021/jm00124a026; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027; Zhang ML, 2004, CANCER RES, V64, P5825, DOI 10.1158/0008-5472.CAN-04-1088	50	15	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30788	30795		10.1074/jbc.M804159200	http://dx.doi.org/10.1074/jbc.M804159200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18753136	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000260544800033
J	Green, JL; Rees-Channer, RR; Howell, SA; Martin, SR; Knuepfer, E; Taylor, HM; Grainger, M; Holder, AA				Green, Judith L.; Rees-Channer, Roxanne R.; Howell, Stephen A.; Martin, Stephen R.; Knuepfer, Ellen; Taylor, Helen M.; Grainger, Munira; Holder, Anthony A.			The Motor Complex of Plasmodium falciparum PHOSPHORYLATION BY A CALCIUM-DEPENDENT PROTEIN KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITE; ERYTHROCYTE INVASION; GLIDING MOTILITY; MYOSIN; MEROZOITE; SURFACE; CALMODULIN; BIOSYNTHESIS; EXPRESSION; VACUOLE	Calcium-dependent protein kinases (CDPKs) of Apicomplexan parasites are crucial for the survival of the parasite throughout its life cycle. CDPK1 is expressed in the asexual blood stages of the parasite, particularly late stage schizonts. We have identified two substrates of Plasmodium falciparum CDPK1: myosin A tail domain-interacting protein (MTIP) and glideosome-associated protein 45 (GAP45), both of which are components of the motor complex that generates the force required by the parasite to actively invade host cells. Indirect immunofluorescence shows that CDPK1 localizes to the periphery of P. falciparum merozoites and is therefore suitably located to act on MTIP and GAP45 at the inner membrane complex. A proportion of both GAP45 and MTIP is phosphorylated in schizonts, and we demonstrate that both proteins can be efficiently phosphorylated by CDPK1 in vitro. A primary phosphorylation of MTIP occurs at serine 47, whereas GAP45 is phosphorylated at two sites, one of which could also be detected in phosphopeptides purified from parasite lysates. Both CDPK1 activity and host cell invasion can be inhibited by the kinase inhibitor K252a, suggesting that CDPK1 is a suitable target for antimalarial drug development.	[Green, Judith L.; Rees-Channer, Roxanne R.; Knuepfer, Ellen; Grainger, Munira; Holder, Anthony A.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Howell, Stephen A.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Rees-Channer, Roxanne R.; Martin, Stephen R.] Natl Inst Med Res, MRC, Div Phys Biochem, London NW7 1AA, England; [Taylor, Helen M.] Univ Glasgow, Glasgow Biomed Res Ctr, Wellcome Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland	MRC National Institute for Medical Research; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of Glasgow	Green, JL (corresponding author), Natl Inst Med Res, MRC, Div Parasitol, Ridgeway, London NW7 1AA, England.	green@nimr.mrc.ac.uk	Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Green, Judith/0000-0001-6825-9404; Knuepfer, Ellen/0000-0002-6090-1877	National Institutes of Health [0600370P7601176]; United Kingdom Medical Research Council; Wellcome Trust [066742]; Medical Research Council [MC_U117570592, MC_U117532067] Funding Source: researchfish; MRC [MC_U117570592, MC_U117532067] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant 0600370P7601176. This work was also supported by the United Kingdom Medical Research Council and Wellcome Trust Grant 066742.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; BLACKMAN MJ, 1992, MOL BIOCHEM PARASIT, V50, P307, DOI 10.1016/0166-6851(92)90228-C; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Fidock DA, 2000, MOL BIOCHEM PARASIT, V110, P1, DOI 10.1016/S0166-6851(00)00249-8; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Green JL, 2006, MOL BIOCHEM PARASIT, V150, P114, DOI 10.1016/j.molbiopara.2006.06.010; HARPER JF, 2005, J MOL BIOL, V357, P400; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hirano K, 2003, MOL CELL BIOCHEM, V248, P105, DOI 10.1023/A:1024180101032; HOLDER AA, 1982, J EXP MED, V156, P1528, DOI 10.1084/jem.156.5.1528; HUFF CG, 1960, J BIOPHYS BIOCHEM CY, V7, P93, DOI 10.1083/jcb.7.1.93; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; Kugelstadt D, 2007, MOL BIOCHEM PARASIT, V151, P111, DOI 10.1016/j.molbiopara.2006.10.012; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; MATSUMOTO Y, 1987, EUR J CELL BIOL, V45, P36; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Pachebat JA, 2007, MOL BIOCHEM PARASIT, V151, P59, DOI 10.1016/j.molbiopara.2006.10.006; Pinder JC, 1998, J CELL SCI, V111, P1831; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657, DOI 10.1152/ajpcell.1986.250.4.C657; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; VORM O, 1994, BIOL MASS SPECTROM, V23, P734, DOI 10.1002/bms.1200231204; WARD GE, 1994, EXP PARASITOL, V79, P480, DOI 10.1006/expr.1994.1109; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wasserman M, 1996, PARASITOL RES, V82, P102, DOI 10.1007/s004360050078; ZHAO Y, 1993, J BIOL CHEM, V268, P4347	40	133	139	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30980	30989		10.1074/jbc.M803129200	http://dx.doi.org/10.1074/jbc.M803129200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768477	Green Published, hybrid			2022-12-25	WOS:000260544800053
J	Fujimoto, M; Oshima, K; Shinkawa, T; Wang, BB; Inouye, S; Hayashida, N; Takii, R; Nakai, A				Fujimoto, Mitsuaki; Oshima, Koji; Shinkawa, Toyohide; Wang, Bei Bei; Inouye, Sachiye; Hayashida, Naoki; Takii, Ryosuke; Nakai, Akira			Analysis of HSF4 Binding Regions Reveals Its Necessity for Gene Regulation during Development and Heat Shock Response in Mouse Lenses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTOR-1; MOLECULAR CHAPERONES; FACTOR-I; TARGETED DISRUPTION; EXPRESSION; STRESS; MICE; ACTIVATOR; THERMOTOLERANCE	Heat shock transcription factors (HSFs) regulate gene expression in response to heat shock and in physiological conditions. In mammals, HSF1 is required for heat-mediated induction of classic heat shock genes; however, we do not know the molecular mechanisms by which HSF4 regulates gene expression or the biological consequences of its binding to chromatin. Here, we identified that HSF4 binds to various genomic regions, including the introns and distal parts of protein-coding genes in vivo in mouse lenses, and a substantial numbers of the regions were also occupied by HSF1 and HSF2. HSF4 regulated expression of some genes at a developmental stage when HSF1 and HSF2 expression decreased. Although HSF4 binding did not affect expression of many genes, it induces demethylated status of histone H3K9 on the binding regions. Unexpectedly, a lot of HSF4 targets were induced by heat shock treatment, and HSF4 is required for induction of a set of non-classic heat shock genes in response to heat shock, in part by facilitating HSF1 binding through chromatin modification. These results suggest novel mechanisms of gene regulation controlled by HSF4 in non-classic heat shock response and in lens development.	[Nakai, Akira] Yamaguchi Univ, Sch Med, Dept Biochem, Ube, Yamaguchi 7558505, Japan; Yamaguchi Univ, Sch Med, Dept Mol Biol, Ube, Yamaguchi 7558505, Japan	Yamaguchi University; Yamaguchi University	Nakai, A (corresponding author), Yamaguchi Univ, Sch Med, Dept Biochem, Minami Kogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	anakai@yamaguchi-u.ac.jp	Hayashida, Naoki/HGA-3453-2022	Hayashida, Naoki/0000-0002-8785-8012	Ministry of Education, Culture, Sports, Science and Technology, Japan; Uehara Foundation; NOVARTIS Foundation; Nakatomi Foundation; Kao Foundation for Arts and Sciences; Mochida Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Foundation(Uehara Memorial Foundation); NOVARTIS Foundation(Novartis); Nakatomi Foundation; Kao Foundation for Arts and Sciences; Mochida Foundation	This work was supported in part by Grants-in-Aid for Scientific Research and on Priority Area-a Nuclear System of DECODE, from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Uehara Foundation, the NOVARTIS Foundation, the Nakatomi Foundation, the Kao Foundation for Arts and Sciences, and the Mochida Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baruch A, 2001, J BIOL CHEM, V276, P28999, DOI 10.1074/jbc.M103628200; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Fernandes M., 1994, BIOL HEAT SHOCK PROT, P375; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hayashida N, 2006, EMBO J, V25, P4773, DOI 10.1038/sj.emboj.7601370; He HY, 2003, J BIOL CHEM, V278, P35465, DOI 10.1074/jbc.M304663200; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; KROEGER PE, 1993, MOL CELL BIOL, V13, P3370, DOI 10.1128/MCB.13.6.3370; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Li LP, 1997, HUM GENE THER, V8, P1695, DOI 10.1089/hum.1997.8.14-1695; McAvoy JW, 1999, EYE, V13, P425, DOI 10.1038/eye.1999.117; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Nakai A, 1999, CELL STRESS CHAPERON, V4, P86, DOI 10.1379/1466-1268(1999)004<0086:NAITVH>2.3.CO;2; Nakai A, 2000, EMBO J, V19, P1545, DOI 10.1093/emboj/19.7.1545; NAKAI A, 1995, MOL CELL BIOL, V15, P5268; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Page TJ, 2006, MOL BIOSYST, V2, P627, DOI 10.1039/b606129j; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Rallu M, 1997, P NATL ACAD SCI USA, V94, P2392, DOI 10.1073/pnas.94.6.2392; Sakamoto M, 2006, CIRC RES, V99, P1411, DOI 10.1161/01.RES.0000252345.80198.97; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; Santos SD, 2004, NEUROSCIENCE, V126, P657, DOI 10.1016/j.neuroscience.2004.03.023; SISTONEN L, 1994, MOL CELL BIOL, V14, P2087, DOI 10.1128/MCB.14.3.2087; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; Somasundaram T, 2004, J BIOL CHEM, V279, P44497, DOI 10.1074/jbc.M405813200; Takaki E, 2006, J BIOL CHEM, V281, P4931, DOI 10.1074/jbc.M506911200; Takaki E, 2007, J BIOL CHEM, V282, P37285, DOI 10.1074/jbc.M704562200; Tanabe M, 1998, EMBO J, V17, P1750, DOI 10.1093/emboj/17.6.1750; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zheng H, 2004, J IMMUNOL, V173, P5929, DOI 10.4049/jimmunol.173.10.5929	65	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29961	29970		10.1074/jbc.M804629200	http://dx.doi.org/10.1074/jbc.M804629200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18755693	Green Published, hybrid			2022-12-25	WOS:000260366900041
J	Jin, W; Chen, Y; Di, GH; Miron, P; Hou, YF; Gao, H; Shao, ZM				Jin, Wei; Chen, Ying; Di, Gen-hong; Miron, Penelope; Hou, Yi-feng; Gao, Hui; Shao, Zhi-ming			Estrogen Receptor (ER)beta or p53 Attenuates ER alpha-mediated Transcriptional Activation on the BRCA2 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC BREAST-CANCER; GENE-EXPRESSION; MESSENGER-RNA; CARCINOMAS; MUTATIONS; P300; BETA; CBP; SUSCEPTIBILITY; COREGULATORS	BRCA2 is closely related to the pathogenesis of breast cancer. In the present study, we found that estrogen can activate BRCA2 transcription, which is estrogen receptor (ER) alpha-dependent. During estrogen treatment, ER alpha interacted with CREB-binding protein/p300, p68/p72, and MyoD and formed an activating transcriptional complex that could bind to many Sp1 sites on the BRCA2 promoter and activate its transcription by inducing histone acetylations. MyoD is a new component of ER alpha complex. ER beta or p53 attenuated ER alpha-mediated transcriptional activation by preventing the recruitment of ER alpha transcriptional complex and histone acetylations on the BRCA2 promoter. ER beta interacted with ER alpha and CREB-binding protein/p300 and formed a weak activating transcriptional complex that competed for binding to Sp1 sites with ER alpha transcriptional complex and slightly attenuated BRCA2 transcription. Different from ER beta, p53 interacted with HDAC1 and CtBP1 and formed an inhibiting transcriptional complex that could compete for binding to Sp1 sites with ER alpha transcriptional complex and inhibit BRCA2 transcription more significantly.	[Jin, Wei; Chen, Ying; Di, Gen-hong; Hou, Yi-feng; Shao, Zhi-ming] Fudan Univ, Breast Canc Inst, Canc Hosp, Dept Oncol,Shanghai Med Coll,Inst Biomed Sci, Shanghai 200032, Peoples R China; [Jin, Wei; Gao, Hui] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ 08901 USA; [Miron, Penelope] Harvard Univ, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA	Fudan University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Harvard University; Dana-Farber Cancer Institute	Shao, ZM (corresponding author), Fudan Univ, Dept Breast Surg, Breast Canc Inst, Canc Hosp Canc Inst, 270 Dong Rd, Shanghai 200032, Peoples R China.	zhimingshao@yahoo.com		Di, Genhong/0000-0003-1171-7907	National Natural Science Foundation of China [30371580, 30572109]; Shanghai Science and Technology Committee [03J14019, 06DJ14004, 06DZ19504]; Cancer Hospital/Cancer Institute of Fudan University [YJ200604]; Shanghai Pujiang Program;  [2006CB0D0901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Cancer Hospital/Cancer Institute of Fudan University; Shanghai Pujiang Program(Shanghai Pujiang Program); 	This work was supported in part by 973 (Grant 2006CB0D0901), the National Natural Science Foundation of China (Grants 30371580 and 30572109), the Shanghai Science and Technology Committee (Grants 03J14019, 06DJ14004, and 06DZ19504); the Cancer Hospital/Cancer Institute of Fudan University (Grant YJ200604), and the Shanghai Pujiang Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Angele S, 2000, CLIN CANCER RES, V6, P3536; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bieche I, 2001, ONCOGENE, V20, P8109, DOI 10.1038/sj.onc.1204917; Blobel GA, 2002, J LEUKOCYTE BIOL, V71, P545; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; COLES C, 1992, CANCER RES, V52, P5291; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gayther SA, 1999, AM J HUM GENET, V65, P1021, DOI 10.1086/302583; Kato S, 2000, GENES CELLS, V5, P593, DOI 10.1046/j.1365-2443.2000.00354.x; Mueller CR, 2003, BREAST CANCER RES, V5, P45, DOI 10.1186/bcr557; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Ogawa S, 1998, BIOCHEM BIOPH RES CO, V243, P122, DOI 10.1006/bbrc.1997.7893; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; SHEK LL, 1989, EUR J CANCER CLIN ON, V25, P243, DOI 10.1016/0277-5379(89)90015-1; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sourvinos G, 1998, BIOCHEM BIOPH RES CO, V245, P75, DOI 10.1006/bbrc.1998.8379; Spillman MA, 1996, ONCOGENE, V13, P1639; Thakur S, 1999, J BIOL CHEM, V274, P8837, DOI 10.1074/jbc.274.13.8837; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Wu K, 2000, J BIOL CHEM, V275, P35548, DOI 10.1074/jbc.M004390200; Wu KJ, 2003, J BIOL CHEM, V278, P15652, DOI 10.1074/jbc.M211297200	29	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29671	29680		10.1074/jbc.M802785200	http://dx.doi.org/10.1074/jbc.M802785200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18765668	hybrid, Green Published			2022-12-25	WOS:000260366900010
J	Lineberry, N; Su, L; Soares, L; Fathman, CG				Lineberry, Neil; Su, Leon; Soares, Luis; Fathman, C. Garrison			The single subunit transmembrane E3 ligase gene related to anergy in lymphocytes (GRAIL) captures and then ubiquitinates transmembrane proteins across the cell membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERRIN RECEPTOR; DOWN-REGULATION; DEGRADATION; SUBSTRATE; SUPERFAMILY; DOMAIN; TETRASPANINS; REGULATORS; INTEGRINS; COMPLEXES	The ubiquitin E3 ligase gene related to anergy in lymphocytes (GRAIL) (Rnf128) is a type 1 transmembrane protein that induces T cell anergy through the ubiquitination activity of its cytosolic RING finger. GRAIL also contains an equally large luminal region consisting primarily of an uncharacterized protease-associated (PA) domain. Using two-hybrid technology to screen for proteins that bound the PA domain we identified CD151, a member of the tetraspanin family of membrane proteins. GRAIL bound to the luminal/extracellular portion of both CD151 and the related tetraspanin CD81 using its PA domain, which promoted ubiquitination of cytosolic lysine residues. GRAIL exhibited specificity for lysines only within the tetraspanin amino terminus even in the presence of other cytosolic lysine residues in the substrate. GRAIL-mediated ubiquitination promoted proteasomal degradation and cell surface down-regulation of tetraspanins via Lys-48 linkages. As a result, the juxtaposition of PA and RING finger domains across a lipid bilayer facilitates the capture of transmembrane substrates for subsequent ubiquitination. These findings identify for the first time a single subunit E3 ligase containing a substrate-binding domain spatially restricted by a membrane from its E2 recruitment domain as well as an E3 ligase for members of the tetraspanin family.	[Lineberry, Neil; Su, Leon; Soares, Luis; Fathman, C. Garrison] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA	Stanford University	Fathman, CG (corresponding author), Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, CCSR Bldg Rm 2225, Stanford, CA 94305 USA.	cfathman@stanford.edu		Su, Leon/0000-0001-7654-9997	National Institutes of Health [CA 65237-17, T32-AI07290-21]; Tom and Susan Ford Fellowship; NATIONAL CANCER INSTITUTE [R01CA065237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tom and Susan Ford Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 65237-17 and T32-AI07290-21 (both to N. L.). This work was also supported by the Tom and Susan Ford Fellowship (to N. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2001, J CELL SCI, V114, P4143; BRUINENBERG PG, 1994, PROTEIN ENG, V7, P991, DOI 10.1093/protein/7.8.991; Fitter S, 1999, BIOCHEM J, V338, P61, DOI 10.1042/0264-6021:3380061; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Guais A, 2006, GENE, V374, P112, DOI 10.1016/j.gene.2006.01.028; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sanderfoot AA, 1998, P NATL ACAD SCI USA, V95, P9920, DOI 10.1073/pnas.95.17.9920; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Stimpson HEM, 2006, EMBO J, V25, P662, DOI 10.1038/sj.emboj.7600984; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; WRIGHT MD, 1994, IMMUNOL TODAY, V15, P588, DOI 10.1016/0167-5699(94)90222-4; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751	36	57	57	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28497	28505		10.1074/jbc.M805092200	http://dx.doi.org/10.1074/jbc.M805092200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713730	Green Published, hybrid			2022-12-25	WOS:000259969300052
J	Yamano, T; Mizukami, S; Murata, S; Chiba, T; Tanaka, K; Udono, H				Yamano, Taketoshi; Mizukami, Shusaku; Murata, Shigeo; Chiba, Tomoki; Tanaka, Keiji; Udono, Heiichiro			Hsp90-mediated assembly of the 26 S proteasome is involved in major histocompatibility complex class I antigen processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC-CLASS-I; CYTOTOXIC T-LYMPHOCYTES; PEPTIDES; PROTEINS; IDENTIFICATION; GENERATION; DEGRADATION; MOLECULES; HSP90; CELLS	Heat shock protein 90 (hsp90) and the proteasome activator PA28 stimulate major histocompatibility complex (MHC) class I antigen processing. It is unknown whether hsp90 influences the proteasome activity to produce T cell epitopes, although association of PA28 with the 20 S proteasome stimulates the enzyme activity. Here, we show that hsp90 is essential in assembly of the 26 S proteasome and as a result, is involved in epitope production. Addition of recombinant hsp90 alpha to cell lysate enhanced chymotrypsinlike activity of the 26 S proteasome in an ATP-dependent manner as determined by an in-gel hydrolysis assay. We successfully pulled down histidine-tagged hsp90 alpha- and PA28 alpha-induced, newly assembled 26 S proteasomes from the cell extracts for in vitro epitope production assay, and we found these structures to be sensitive to geldanamycin, an hsp90 inhibitor. We found a cleaved epitope unique to the proteasome pulled down by both hsp90 alpha and PA28 alpha, whereas two different epitopes were identified in the hsp90 alpha- and PA28 alpha-pulldowns, respectively. Processing of these respective peptides in vivo was enhanced faithfully by the protein combinations used for the proteasome pulldowns. Inhibition of hsp90 in vivo by geldanamycin partly disrupted the 26 S proteasome structure, consistent with down-regulated MHC class I expression. Our results indicate that hsp90 facilitates MHC class I antigen processing through epitope production in a complex of the 26 S proteasome.	[Yamano, Taketoshi; Mizukami, Shusaku; Udono, Heiichiro] RIKEN Yokohama Inst, RCAI, Lab Immunochaperones, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Bunkyo Ku, Tokyo 1130033, Japan; [Chiba, Tomoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan	RIKEN; University of Tokyo; University of Tsukuba; Tokyo Metropolitan Institute of Medical Science	Udono, H (corresponding author), 1-7-22 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.	udonoh@rcai.riken.jp	Mizukami, Shusaku/AAR-7291-2021; Murata, Shigeo/A-1426-2010	Mizukami, Shusaku/0000-0002-7722-4884; Murata, Shigeo/0000-0002-3177-3503	RIKEN RCAI; Ministry of Education, Science, Sports and Culture, Japan	RIKEN RCAI; Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by RIKEN RCAI and by a grant-in-aid for scientific research priority areas from the Ministry of Education, Science, Sports and Culture, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Binder RJ, 2001, J BIOL CHEM, V276, P17163, DOI 10.1074/jbc.M011547200; Bloom MB, 1997, J EXP MED, V185, P453, DOI 10.1084/jem.185.3.453; Callahan MK, 2008, P NATL ACAD SCI USA, V105, P1662, DOI 10.1073/pnas.0711365105; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Ishii T, 1999, J IMMUNOL, V162, P1303; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Udono H, 2001, INT IMMUNOL, V13, P1233, DOI 10.1093/intimm/13.10.1233; UENAKA A, 1994, J EXP MED, V180, P1599, DOI 10.1084/jem.180.5.1599; VAN KL, 1994, IMMUNITY, V1, P533; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; Yamano T, 2002, J EXP MED, V196, P185, DOI 10.1084/jem.20011922	22	30	34	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28060	28065		10.1074/jbc.M803077200	http://dx.doi.org/10.1074/jbc.M803077200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18703510	hybrid, Green Published			2022-12-25	WOS:000259969300007
J	Benoist, JM; Pincede, I; Ballantyne, K; Plaghki, L; Le Bars, D				Benoist, Jean-Michel; Pincede, Ivanne; Ballantyne, Kay; Plaghki, Leon; Le Bars, Daniel			Peripheral and Central Determinants of a Nociceptive Reaction: An Approach to Psychophysics in the Rat	PLOS ONE			English	Article								Background: The quantitative end-point for many behavioral tests of nociception is the reaction time, i.e. the time lapse between the beginning of the application of a stimulus, e.g. heat, and the evoked response. Since it is technically impossible to heat the skin instantaneously by conventional means, the question of the significance of the reaction time to radiant heat remains open. We developed a theoretical framework, a related experimental paradigm and a model to analyze in psychophysical terms the "tail-flick" responses of rats to random variations of noxious radiant heat. Methodology/Principal Findings: A CO2 laser was used to avoid the drawbacks associated with standard methods of thermal stimulation. Heating of the skin was recorded with an infrared camera and was stopped by the reaction of the animal. For the first time, we define and determine two key descriptors of the behavioral response, namely the behavioral threshold (T beta) and the behavioral latency (L beta). By employing more than one site of stimulation, the paradigm allows determination of the conduction velocity of the peripheral fibers that trigger the response (V) and an estimation of the latency (Ld) of the central decision-making process. Ld (similar to 130 ms) is unaffected by ambient or skin temperature changes that affect the behavioral threshold (similar to 42.2-44.9 degrees C in the 20-30 degrees C range), behavioral latency (<500 ms), and the conduction velocity of the peripheral fibers that trigger the response (similar to 0.35-0.76 m/s in the 20-30 degrees C range). We propose a simple model that is verified experimentally and that computes the variations in the so-called "tail-flick latency" (TFL) caused by changes in either the power of the radiant heat source, the initial temperature of the skin, or the site of stimulation along the tail. Conclusions/Significance: This approach enables the behavioral determinations of latent psychophysical (T beta, L beta, Ld) and neurophysiological (V) variables that have been previously inaccessible with conventional methods. Such an approach satisfies the repeated requests for improving nociceptive tests and offers a potentially heuristic progress for studying nociceptive behavior on more firm physiological and psychophysical grounds. The validity of using a reaction time of a behavioral response to an increasing heat stimulus as a "pain index" is challenged. This is illustrated by the predicted temperature-dependent variations of the behavioral TFL elicited by spontaneous variations of the temperature of the tail for thermoregulation.	[Benoist, Jean-Michel] Univ Paris 06, Neurophysiol Lab, Paris, France; [Pincede, Ivanne; Le Bars, Daniel] INSERM, U713, Paris, France; [Benoist, Jean-Michel; Pincede, Ivanne; Le Bars, Daniel] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France; [Ballantyne, Kay] Univ Dundee, Sch Dent, Dundee, Scotland; [Plaghki, Leon] Catholic Univ Louvain, Unite READ, B-1200 Brussels, Belgium	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Dundee; Universite Catholique Louvain	Benoist, JM (corresponding author), Univ Paris 06, Neurophysiol Lab, Paris, France.	lebars@chups.jussieu.fr			"I'Institut National de la Sante et de la Recherche Medicale" (INSERM); "Institut UPSA de la douleur"	"I'Institut National de la Sante et de la Recherche Medicale" (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Institut UPSA de la douleur"	This work was supported by "I'Institut National de la Sante et de la Recherche Medicale" (INSERM) and a grant from the "Institut UPSA de la douleur".	Berge OG, 2002, PAIN BRAIN, P77; BROMM B, 1984, HUM NEUROBIOL, V3, P33; BROMM B, 1983, PFLUG ARCH EUR J PHY, V399, P155, DOI 10.1007/BF00663913; BUETTNER K, 1951, J APPL PHYSIOL, V3, P691, DOI 10.1152/jappl.1951.3.12.691; CALVINO B, 1984, PAIN, V20, P261, DOI 10.1016/0304-3959(84)90015-0; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; CAMPBELL JN, 1983, BRAIN RES, V266, P203, DOI 10.1016/0006-8993(83)90650-9; CARROLL MN, 1959, ARCH INT PHARMACOD T, V123, P48; CARSTENS E, 1993, J NEUROPHYSIOL, V70, P630, DOI 10.1152/jn.1993.70.2.630; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; COVINO BG, 1980, PAIN, V9, P111; DANNEMAN PJ, 1994, PAIN, V58, P39, DOI 10.1016/0304-3959(94)90183-X; DEJESUS PV, 1973, NEUROLOGY, V23, P1182, DOI 10.1212/WNL.23.11.1182; Falmagne J.-C., 1985, ELEMENTS PSYCHOPHYSI; FLEISCHER E, 1983, BRAIN RES, V267, P81, DOI 10.1016/0006-8993(83)91041-7; FRANZ DN, 1968, J PHYSIOL-LONDON, V199, P319, DOI 10.1113/jphysiol.1968.sp008656; GORDON CJ, 1990, PHYSIOL BEHAV, V47, P963, DOI 10.1016/0031-9384(90)90025-Y; GRANAT FR, 1973, ARCH INT PHARMACOD T, V205, P52; GROSSMAN ML, 1982, J COMP NEUROL, V206, P9, DOI 10.1002/cne.902060103; HAIMICOHEN R, 1983, J NEUROSCI METH, V8, P127, DOI 10.1016/0165-0270(83)90113-9; HAMANN SR, 1992, BRAIN RES BULL, V29, P507, DOI 10.1016/0361-9230(92)90090-K; HANDWERKER HO, 1993, PHYSIOL REV, V73, P639, DOI 10.1152/physrev.1993.73.3.639; HANDWERKER HO, 1987, EXP BRAIN RES, V65, P493; HARDY JD, 1956, J APPL PHYSIOL, V9, P257, DOI 10.1152/jappl.1956.9.2.257; HOLE K, 1990, PAIN, V43, P391, DOI 10.1016/0304-3959(90)90039-G; KAWAKITA K, 1987, PHYSIOL BEHAV, V39, P235, DOI 10.1016/0031-9384(87)90015-1; LAMOTTE RH, 1983, FED PROC, V42, P2548; LAMOTTE RH, 1982, J NEUROSCI, V2, P765; LANGFORD LA, 1981, J COMP NEUROL, V203, P745, DOI 10.1002/cne.902030411; Le Bars D, 2001, PHARMACOL REV, V53, P597; LEVINE JD, 1980, BRAIN RES, V201, P129, DOI 10.1016/0006-8993(80)90780-5; Luce RD, 1986, RESPONSE TIMES THEIR; MARTINEZGOMEZ M, 1994, PHYSIOL BEHAV, V55, P651, DOI 10.1016/0031-9384(94)90040-X; McCarthy PW, 1995, BRAIN RES, V704, P79, DOI 10.1016/0006-8993(95)01107-2; MEYER RA, 1976, IEEE T BIO-MED ENG, V23, P54, DOI 10.1109/TBME.1976.324616; MITCHELL D, 1977, PROC R SOC SER B-BIO, V197, P169, DOI 10.1098/rspb.1977.0064; NECKER R, 1978, PAIN, V4, P231, DOI 10.1016/0304-3959(77)90135-X; NESS TJ, 1986, BRAIN RES, V386, P41, DOI 10.1016/0006-8993(86)90139-3; NESS TJ, 1987, BRAIN RES, V426, P169, DOI 10.1016/0006-8993(87)90437-9; PAINTAL AS, 1967, J PHYSIOL-LONDON, V193, P523, DOI 10.1113/jphysiol.1967.sp008376; PAINTAL AS, 1973, NEW DEVELOPMENTS ELE, V2, P19; Plaghki Leon, 2005, Curr Opin Investig Drugs, V6, P58; REN MF, 1979, CHINESE MED J-PEKING, V92, P576; Rothery P, 1993, MODELS BIOL MATH STA; STOLL AM, 1959, J APPL PHYSIOL, V14, P373, DOI 10.1152/jappl.1959.14.3.373; STOLWIJK JA, 1965, J APPL PHYSIOL, V20, P1006, DOI 10.1152/jappl.1965.20.5.1006; TANDRUP T, 1995, J COMP NEUROL, V357, P341, DOI 10.1002/cne.903570302; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P753, DOI 10.1113/jphysiol.1995.sp020766; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P767, DOI 10.1113/jphysiol.1995.sp020767; TREEDE RD, 1995, J PHYSIOL-LONDON, V483, P747, DOI 10.1113/jphysiol.1995.sp020619; TSURUOKA M, 1988, PHYSIOL BEHAV, V43, P79, DOI 10.1016/0031-9384(88)90101-1; WADDELL PJ, 1989, NEUROSCIENCE, V30, P577, DOI 10.1016/0306-4522(89)90152-8; WAIBL H, 1973, ADV ANAT EMBRYOL CEL, V47, P1; Wang YZ, 2005, WORLD J GASTROENTERO, V11, P46, DOI 10.3748/wjg.v11.i1.46; YARNITSKY D, 1990, PAIN, V40, P85, DOI 10.1016/0304-3959(90)91055-N; YARNITSKY D, 1991, BRAIN, V114, P1819, DOI 10.1093/brain/114.4.1819; YOUNG AA, 1982, CAN J PHYSIOL PHARM, V60, P392, DOI 10.1139/y82-057; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	58	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3125	10.1371/journal.pone.0003125	http://dx.doi.org/10.1371/journal.pone.0003125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YG	18769624	Green Submitted, Green Published, gold			2022-12-25	WOS:000207566300001
J	Goncalves, MAFV; Holkers, M; van Nierop, GP; Wieringa, R; Pau, MG; de Vries, AAF				Goncalves, Manuel A. F. V.; Holkers, Maarten; van Nierop, Gijsbert P.; Wieringa, Roeland; Pau, Maria G.; de Vries, Antoine A. F.			Targeted Chromosomal Insertion of Large DNA into the Human Genome by a Fiber-Modified High-Capacity Adenovirus-Based Vector System	PLOS ONE			English	Article							SITE-SPECIFIC INTEGRATION; RECOMBINANT ADENOASSOCIATED VIRUS; GENE-EXPRESSION; VIRAL GENES; CELL-LINE; TRANSDUCTION; GENERATION; SEQUENCE; PROTEIN; HUMAN-CHROMOSOME-19	A prominent goal in gene therapy research concerns the development of gene transfer vehicles that can integrate exogenous DNA at specific chromosomal loci to prevent insertional oncogenesis and provide for long-term transgene expression. Adenovirus (Ad) vectors arguably represent the most efficient delivery systems of episomal DNA into eukaryotic cell nuclei. The most advanced recombinant Ads lack all adenoviral genes. This renders these so-called high-capacity (hc) Ad vectors less cytotoxic/immunogenic than those only deleted in early regions and creates space for the insertion of large/multiple transgenes. The versatility of hcAd vectors is been increased by capsid modifications to alter their tropism and by the incorporation into their genomes of sequences promoting chromosomal insertion of exogenous DNA. Adeno-associated virus (AAV) can insert its genome into a specific human locus designated AAVS1. Trans- and cis-acting elements needed for this reaction are the AAV Rep78/68 proteins and Rep78/68-binding sequences, respectively. Here, we describe the generation, characterization and testing of fiber-modified dual hcAd/AAV hybrid vectors (dHVs) containing both these elements. Due to the inhibitory effects of Rep78/68 on Ad-dependent DNA replication, we deployed a recombinase-inducible gene switch to repress Rep68 synthesis during vector rescue and propagation. Flow cytometric analyses revealed that rep68-positive dHVs can be produced similarly well as rep68-negative control vectors. Western blot experiments and immunofluorescence microscopy analyses demonstrated transfer of recombinase-dependent rep68 genes into target cells. Studies in HeLa cells and in the dystrophin-deficient myoblasts from a Duchenne muscular dystrophy (DMD) patient showed that induction of Rep68 synthesis in cells transduced with fiber-modified and rep68-positive dHVs leads to increased stable transduction levels and AAVS1-targeted integration of vector DNA. These results warrant further investigation especially considering the paucity of vector systems allowing permanent phenotypic correction of patient-own cell types with large DNA (e.g. recombinant full-length DMD genes).	[Goncalves, Manuel A. F. V.; Holkers, Maarten; van Nierop, Gijsbert P.; Wieringa, Roeland; Pau, Maria G.; de Vries, Antoine A. F.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Virus & Stem Cell Biol Lab, Leiden, Netherlands; [Pau, Maria G.] Crucell Holland BV, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johnson & Johnson	Goncalves, MAFV (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Virus & Stem Cell Biol Lab, Leiden, Netherlands.	m.goncalves@lumc.nl	de Vries, Antoine/ABG-5787-2021; van Nierop, Gijsbert/J-1994-2018; Goncalves, Manuel AFV/V-2248-2019	Goncalves, Manuel AFV/0000-0002-8111-1073	Prinses Beatrix Fonds [MAR04-0222]; Association Francaise contre les Myopathies [12259-SR-GROUPE E]	Prinses Beatrix Fonds; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by research grants from the Prinses Beatrix Fonds against neuromuscular diseases (PBF; MAR04-0222) and the Association Francaise contre les Myopathies (AFM; 12259-SR-GROUPE E).	Balamotis MA, 2004, VIROLOGY, V324, P229, DOI 10.1016/j.virol.2004.03.030; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Carlson CA, 2002, METHOD ENZYMOL, V346, P277; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cudre-Mauroux C, 2003, HUM GENE THER, V14, P1525, DOI 10.1089/104303403322495034; Fischer A, 2005, PLOS MED, V2, P22, DOI 10.1371/journal.pmed.0020010; GIRAUD C, 1995, J VIROL, V69, P6917, DOI 10.1128/JVI.69.11.6917-6924.1995; Glauser DL, 2006, CURR GENE THER, V6, P315, DOI 10.2174/156652306777592090; Goncalves MAFV, 2006, REV MED VIROL, V16, P167, DOI 10.1002/rmv.494; Goncalves MAFV, 2005, J VIROL, V79, P3146, DOI 10.1128/JVI.79.5.3146-3162.2005; Goncalves MAFV, 2004, VIROLOGY, V321, P287, DOI 10.1016/j.virol.2004.01.007; Goncalves MAFV, 2001, VIROLOGY, V288, P236, DOI 10.1006/viro.2001.1073; Goncalves MAFV, 2002, J VIROL, V76, P10734, DOI 10.1128/JVI.76.21.10734-10744.2002; Goncalves MAFV, 2006, MOL THER, V13, P976, DOI 10.1016/j.ymthe.2005.11.018; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Hamilton H, 2004, J VIROL, V78, P7874, DOI 10.1128/JVI.78.15.7874-7882.2004; Holkers M, 2006, BIOTECHNIQUES, V41, P711, DOI 10.2144/000112307; Huser D, 2003, J GEN VIROL, V84, P133, DOI 10.1099/vir.0.18726-0; Huser D, 2002, J VIROL, V76, P7554, DOI 10.1128/JVI.76.15.7554-7559.2002; Jager L, 2007, CURR GENE THER, V7, P272; Knaan-Shanzer S, 2005, STEM CELLS, V23, P1598, DOI 10.1634/stemcells.2005-0016; Knaan-Shanzer SS, 2001, HUM GENE THER, V12, P1989, DOI 10.1089/104303401753204562; Kochanek S, 2001, CURR OPIN MOL THER, V3, P454; Kreppel F, 2004, J VIROL, V78, P9, DOI 10.1128/JVI.78.1.9-22.2004; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Mitani K., 2002, Current Gene Therapy, V2, P135, DOI 10.2174/1566523024605591; Palmer DJ, 2005, HUM GENE THER, V16, P1, DOI 10.1089/hum.2005.16.1; Parks RJ, 1997, J VIROL, V71, P3293, DOI 10.1128/JVI.71.4.3293-3298.1997; Philpott NJ, 2002, P NATL ACAD SCI USA, V99, P12381, DOI 10.1073/pnas.182430299; Recchia A, 2004, MOL THER, V10, P660, DOI 10.1016/j.ymthe.2004.07.003; Recchia A, 1999, P NATL ACAD SCI USA, V96, P2615, DOI 10.1073/pnas.96.6.2615; Rinaudo D, 2000, J VIROL, V74, P281, DOI 10.1128/JVI.74.1.281-294.2000; Sambrook J, 2001, MOL CLONING LAB MANU; Saudan P, 2000, EMBO J, V19, P4351, DOI 10.1093/emboj/19.16.4351; Schmidt M, 2000, J VIROL, V74, P9441, DOI 10.1128/JVI.74.20.9441-9450.2000; Shayakhmetov DM, 2000, J VIROL, V74, P2567, DOI 10.1128/JVI.74.6.2567-2583.2000; Skuk D, 2003, J MUSCLE RES CELL M, V24, P285; Smith RH, 2008, GENE THER; Stecher H, 2001, MOL THER, V4, P36, DOI 10.1006/mthe.2000.0410; Steinwaerder DS, 1999, J VIROL, V73, P9303, DOI 10.1128/JVI.73.11.9303-9313.1999; Taboit-Dameron F, 1999, TRANSGENIC RES, V8, P223, DOI 10.1023/A:1008919925303; Timpe JA, 2006, J VIROL, V80, P7807, DOI 10.1128/JVI.00198-06; Wang HJ, 2006, J VIROL, V80, P11699, DOI 10.1128/JVI.00779-06; Weitzman MD, 1996, J VIROL, V70, P1845, DOI 10.1128/JVI.70.3.1845-1854.1996; Xiao X, 1997, J VIROL, V71, P941, DOI 10.1128/JVI.71.2.941-948.1997; Young SM, 2000, J VIROL, V74, P3953, DOI 10.1128/JVI.74.9.3953-3966.2000; Zhang HG, 2001, GENE THER, V8, P704, DOI 10.1038/sj.gt.3301454; Zhou CH, 1999, VIROLOGY, V261, P280, DOI 10.1006/viro.1999.9882	49	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3084	10.1371/journal.pone.0003084	http://dx.doi.org/10.1371/journal.pone.0003084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769728	Green Submitted, Green Published, gold			2022-12-25	WOS:000264796800001
J	Azmy, YY; Gupta, A; Pugh, F				Azmy, Yousry Y.; Gupta, Anshuman; Pugh, Franklin			Computational Modelling of Genome-Side Transcription Assembly Networks Using a Fluidics Analogy	PLOS ONE			English	Article								Understanding how a myriad of transcription regulators work to modulate mRNA output at thousands of genes remains a fundamental challenge in molecular biology. Here we develop a computational tool to aid in assessing the plausibility of gene regulatory models derived from genome-wide expression profiling of cells mutant for transcription regulators. mRNA output is modelled as fluid flow in a pipe lattice, with assembly of the transcription machinery represented by the effect of valves. Transcriptional regulators are represented as external pressure heads that determine flow rate. Modelling mutations in regulatory proteins is achieved by adjusting valves' on/off settings. The topology of the lattice is designed by the experimentalist to resemble the expected interconnection between the modelled agents and their influence on mRNA expression. Users can compare multiple lattice configurations so as to find the one that minimizes the error with experimental data. This computational model provides a means to test the plausibility of transcription regulation models derived from large genomic data sets.	[Azmy, Yousry Y.] Penn State Univ, Dept Mech & Nuclear Engn, University Pk, PA 16802 USA; [Gupta, Anshuman] Penn State Univ, Dept Acad Serv & Emerg Technol, University Pk, PA 16802 USA; [Pugh, Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Azmy, YY (corresponding author), N Carolina State Univ, Dept Nucl Engn, Raleigh, NC 27695 USA.	bfp2@psu.edu			National Science Foundation [BES-0425662]	National Science Foundation(National Science Foundation (NSF))	National Science Foundation BES-0425662	BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; BROOK A, 2005, GAMS USERS GUIDE; Cang Y, 2002, P NATL ACAD SCI USA, V99, P12727, DOI 10.1073/pnas.202236699; Chicca JJ, 1998, MOL CELL BIOL, V18, P1701, DOI 10.1128/MCB.18.3.1701; Crampin EJ, 2004, PROG BIOPHYS MOL BIO, V86, P77, DOI 10.1016/j.pbiomolbio.2004.04.002; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Dasgupta A, 2005, EMBO J, V24, P1717, DOI 10.1038/sj.emboj.7600646; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DRUD A, 1985, MATH PROGRAMMING, V31; DRUD A, 1992, ORSA J COMPUTING, V6, P207, DOI DOI 10.1287/IJ0C.6.2.207; Goppelt A, 1996, NUCLEIC ACIDS RES, V24, P4450, DOI 10.1093/nar/24.22.4450; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Huisinga KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r46; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Klamt S, 2003, BIOINFORMATICS, V19, P261, DOI 10.1093/bioinformatics/19.2.261; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Muldrow TA, 1999, MOL CELL BIOL, V19, P2835; Novak Kerry, 2006, BMC Med Educ, V6, P37, DOI 10.1186/1472-6920-6-37; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335	26	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3095	10.1371/journal.pone.0003095	http://dx.doi.org/10.1371/journal.pone.0003095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769485	Green Published, gold, Green Submitted			2022-12-25	WOS:000264796600012
J	Perdigoto, CNLR; Gervais, L; Overstreet, E; Fischer, J; Guichet, A; Schweisguth, F				Perdigoto, Carolina N. L. R.; Gervais, Louis; Overstreet, Erin; Fischer, Janice; Guichet, Antoine; Schweisguth, Francois			Overexpression of Partner of Numb Induces Asymmetric Distribution of the PI4P 5-Kinase Skittles in Mitotic Sensory Organ Precursor Cells in Drosophila	PLOS ONE			English	Article								Unequal segregation of cell fate determinants at mitosis is a conserved mechanism whereby cell fate diversity can be generated during development. In Drosophila, each sensory organ precursor cell (SOP) divides asymmetrically to produce an anterior pIIb and a posterior pIIa cell. The Par6-aPKC complex localizes at the posterior pole of dividing SOPs and directs the actin-dependent localization of the cell fate determinants Numb, Partner of Numb (Pon) and Neuralized at the opposite pole. The plasma membrane lipid phosphatidylinositol (4,5)-bisphosphate (PIP2) regulates the plasma membrane localization and activity of various proteins, including several actin regulators, thereby modulating actin-based processes. Here, we have examined the distribution of PIP2 and of the PIP2-producing kinase Skittles (Sktl) in mitotic SOPs. Our analysis indicates that both Sktl and PIP2 reporters are uniformly distributed in mitotic SOPs. In the course of this study, we have observed that overexpression of full-length Pon or its localization domain (LD) fused to the Red Fluorescent Protein (RFP::Pon(LD)) results in asymmetric distribution of Sktl and PIP2 reporters in dividing SOPs. Our observation that Pon overexpression alters polar protein distribution is relevant because RFP::Pon(LD) is often used as a polarity marker in dividing progenitors.	[Perdigoto, Carolina N. L. R.; Schweisguth, Francois] Ecole Normale Superieure, CNRS, UMR8542, Paris, France; [Gervais, Louis; Guichet, Antoine] Inst Jacques Monod, CNRS, UMR, Paris, France; [Overstreet, Erin; Fischer, Janice] Univ Texas, Dept Mol, Cell & Dev Biol, Austin, TX USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Texas System; University of Texas Austin	Perdigoto, CNLR (corresponding author), Inst Pasteur, CNRS, URA2578, Paris, France.	fschweis@pasteur.fr	Gervais, Louis/AAG-3543-2021	Gervais, Louis/0000-0002-7284-7900	CNRS; ENS; FCT	CNRS(Centre National de la Recherche Scientifique (CNRS)); ENS; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the CNRS, ENS and FCT (C.P.).	Bardin AJ, 2004, CURR OPIN NEUROBIOL, V14, P6, DOI 10.1016/j.conb.2003.12.002; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Cheng MK, 2004, GENETICS, V167, P1213, DOI 10.1534/genetics.103.018721; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1999, DEVELOPMENT, V126, P3573; Halet G, 2005, BIOL CELL, V97, P501; Hassan BA, 1998, GENETICS, V150, P1527; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Mayer B, 2005, CURR BIOL, V15, P1847, DOI 10.1016/j.cub.2005.08.067; Overstreet E, 2003, CURR BIOL, V13, P854, DOI 10.1016/S0960-9822(03)00326-9; OVERSTREET E, 2005, ROLE EPSINS DROSOPHI; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Skwarek LC, 2007, DEV CELL, V13, P783, DOI 10.1016/j.devcel.2007.10.020; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yaich L, 1998, J BIOL CHEM, V273, P10381, DOI 10.1074/jbc.273.17.10381; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3072	10.1371/journal.pone.0003072	http://dx.doi.org/10.1371/journal.pone.0003072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728778	Green Submitted, gold, Green Published			2022-12-25	WOS:000264796400012
J	Bharadwaj, A; Leelavathi, S; Mazumdar-Leighton, S; Ghosh, A; Ramakumar, S; Reddy, VS				Bharadwaj, Amit; Leelavathi, Sadhu; Mazumdar-Leighton, Sudeshna; Ghosh, Amit; Ramakumar, Suryanarayanarao; Reddy, Vanga S.			The Critical Role of Partially Exposed N-Terminal Valine Residue in Stabilizing GH10 Xylanase from Bacillus sp.NG-27 under Poly-Extreme Conditions	PLOS ONE			English	Article							ALKALI-THERMOSTABLE XYLANASE; HYDROPHOBIC INTERACTIONS; SEQUENCE-ANALYSIS; STRUCTURAL BASIS; X-RAY; PROTEIN; CLONING; ENDOXYLANASE; EXPRESSION; RESISTANCE	Background: Understanding the mechanisms that govern protein stability under poly-extreme conditions continues to be a major challenge. Xylanase (BSX) from Bacillus sp. NG-27, which has a TIM-barrel structure, shows optimum activity at high temperature and alkaline pH, and is resistant to denaturation by SDS and degradation by proteinase K. A comparative circular dichroism analysis was performed on native BSX and a recombinant BSX (R-BSX) with just one additional methionine resulting from the start codon. The results of this analysis revealed the role of the partially exposed N-terminus in the unfolding of BSX in response to an increase in temperature. Methodology: We investigated the poly-extremophilicity of BSX to deduce the structural features responsible for its stability under one set of conditions, in order to gain information about its stability in other extreme conditions. To systematically address the role of the partially exposed N-terminus in BSX stability, a series of mutants was generated in which the first hydrophobic residue, valine (Val1), was either deleted or substituted with various amino acids. Each mutant was subsequently analyzed for its thermal, SDS and proteinase K stability in comparison to native BSX. Conclusions: A single conversion of Val1 to glycine (Gly) changed R-BSX from being thermo- and alkali-stable and proteinase K and SDS resistant, to being thermolabile and proteinase K-, alkali- and SDS- sensitive. This result provided insight into the structure-function relationships of BSX under poly-extreme conditions. Molecular, biochemical and structural data revealed that the poly-extremophilicity of BSX is governed by a partially exposed N-terminus through hydrophobic interactions. Such hitherto unidentified N-terminal hydrophobic interactions may play a similar role in other proteins, especially those with TIM-barrel structures. The results of the present study are therefore of major significance for protein folding and protein engineering.	[Bharadwaj, Amit; Leelavathi, Sadhu; Reddy, Vanga S.] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Bharadwaj, Amit; Mazumdar-Leighton, Sudeshna] Univ Delhi, Dept Bot, Delhi 110007, India; [Ghosh, Amit] Indian Inst Advanced Res, Gandhi Sagar, India; [Ramakumar, Suryanarayanarao] Indian Inst Sci, Dept Phys, Bangalore, Karnataka, India; [Ramakumar, Suryanarayanarao] Indian Inst Sci, Bioinformat Ctr, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Delhi; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Bharadwaj, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, New Delhi, India.	vsreddy@icgeb.res.in	Ghosh, Amit/AAB-3140-2019		International Centre for Genetic Engineering and Biotechnology, New Delhi; Department of Biotechnology (DBT), Government of India	International Centre for Genetic Engineering and Biotechnology, New Delhi; Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work was supported by funds from the International Centre for Genetic Engineering and Biotechnology, New Delhi and the Department of Biotechnology (DBT), Government of India.	ALBERTI E, 2003, ANNU REP NMR SPECTRO, V50, P121; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang PC, 2004, BIOCHEM BIOPH RES CO, V319, P1017, DOI 10.1016/j.bbrc.2004.05.078; FERSHT AR, 1993, CURR OPIN STRUC BIOL, V3, P75, DOI 10.1016/0959-440X(93)90205-Y; Frigerio F, 1996, PROTEIN ENG, V9, P439, DOI 10.1093/protein/9.5.439; Funahashi J, 2000, BIOCHEMISTRY-US, V39, P14448, DOI 10.1021/bi0015717; GOLDENBERG DP, 1982, J BIOL CHEM, V257, P7864; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta N, 2000, APPL ENVIRON MICROB, V66, P2631, DOI 10.1128/AEM.66.6.2631-2635.2000; Ihsanawati, 2005, PROTEINS, V61, P999, DOI 10.1002/prot.20700; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee B, 1997, CURR OPIN BIOTECH, V8, P423, DOI 10.1016/S0958-1669(97)80063-8; Leelavathi S, 2003, MOL BREEDING, V11, P59, DOI 10.1023/A:1022168321380; Machius M, 2003, J BIOL CHEM, V278, P11546, DOI 10.1074/jbc.M212618200; Mamo G, 2006, MOL BIOTECHNOL, V33, P149; Manikandan K, 2005, ACTA CRYSTALLOGR F, V61, P747, DOI 10.1107/S1744309105020518; Manikandan K, 2006, PROTEIN SCI, V15, P1951, DOI 10.1110/ps.062220206; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Markert Y, 2001, PROTEIN ENG, V14, P791, DOI 10.1093/protein/14.10.791; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Nakasako M, 1999, J MOL BIOL, V289, P547, DOI 10.1006/jmbi.1999.2795; PAKULA AA, 1990, NATURE, V344, P363, DOI 10.1038/344363a0; Perl D, 2000, NAT STRUCT BIOL, V7, P380; RUSSELL RJM, 1995, CURR OPIN BIOTECH, V6, P370, DOI 10.1016/0958-1669(95)80064-6; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; SHORTLE D, 1990, BIOCHEMISTRY-US, V29, P8033, DOI 10.1021/bi00487a007; VANDENBURG B, 1994, EUR J BIOCHEM, V220, P981; Xie HF, 2006, J MOL BIOL, V360, P157, DOI 10.1016/j.jmb.2006.05.002	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3063	10.1371/journal.pone.0003063	http://dx.doi.org/10.1371/journal.pone.0003063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725971	Green Submitted, Green Published, gold			2022-12-25	WOS:000264796300009
J	DiGiulio, DB; Romero, R; Amogan, HP; Kusanovic, JP; Bik, EM; Gotsch, F; Kim, CJ; Erez, O; Edwin, S; Relman, DA				DiGiulio, Daniel B.; Romero, Roberto; Amogan, Harold P.; Kusanovic, Juan Pedro; Bik, Elisabeth M.; Gotsch, Francesca; Kim, Chong Jai; Erez, Offer; Edwin, Sam; Relman, David A.			Microbial Prevalence, Diversity and Abundance in Amniotic Fluid During Preterm Labor: A Molecular and Culture-Based Investigation	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; UREAPLASMA-UREALYTICUM; LEPTOTRICHIA-AMNIONII; SNEATHIA-SANGUINEGENS; BACTERIAL VAGINOSIS; SP NOV.; INFECTION; WOMEN; IDENTIFICATION; ASSOCIATION	Background: Preterm delivery causes substantial neonatal mortality and morbidity. Unrecognized intra-amniotic infections caused by cultivation-resistant microbes may play a role. Molecular methods can detect, characterize and quantify microbes independently of traditional culture techniques. However, molecular studies that define the diversity and abundance of microbes invading the amniotic cavity, and evaluate their clinical significance within a causal framework, are lacking. Methods and Findings: In parallel with culture, we used broad-range end-point and real-time PCR assays to amplify, identify and quantify ribosomal DNA (rDNA) of bacteria, fungi and archaea from amniotic fluid of 166 women in preterm labor with intact membranes. We sequenced up to 24 rRNA clones per positive specimen and assigned taxonomic designations to approximately the species level. Microbial prevalence, diversity and abundance were correlated with host inflammation and with gestational and neonatal outcomes. Study subjects who delivered at term served as controls. The combined use of molecular and culture methods revealed a greater prevalence (15% of subjects) and diversity (18 taxa) of microbes in amniotic fluid than did culture alone (9.6% of subjects; 11 taxa). The taxa detected only by PCR included a related group of fastidious bacteria, comprised of Sneathia sanguinegens, Leptotrichia amnionii and an unassigned, uncultivated, and previously-uncharacterized bacterium; one or more members of this group were detected in 25% of positive specimens. A positive PCR was associated with histologic chorioamnionitis (adjusted odds ratio [ OR] 20; 95% CI, 2.4 to 172), and funisitis (adjusted OR 18; 95% CI, 3.1 to 99). The positive predictive value of PCR for preterm delivery was 100 percent. A temporal association between a positive PCR and delivery was supported by a shortened amniocentesis-to-delivery interval (adjusted hazard ratio 4.6; 95% CI, 2.2 to 9.5). A dose-response association was demonstrated between bacterial rDNA abundance and gestational age at delivery (r(2) = 0.42; P, 0.002). Conclusions: The amniotic cavity of women in preterm labor harbors DNA from a greater diversity of microbes than previously suspected, including as-yet uncultivated, previously-uncharacterized taxa. The strength, temporality and gradient with which these microbial sequence types are associated with preterm delivery support a causal relationship.	[DiGiulio, Daniel B.; Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [DiGiulio, Daniel B.; Amogan, Harold P.; Bik, Elisabeth M.; Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Romero, Roberto; Kusanovic, Juan Pedro; Gotsch, Francesca; Kim, Chong Jai; Erez, Offer; Edwin, Sam] NIH, NICHD, Perinatol Res Branch, Bethesda, MD USA; [Romero, Roberto] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Kusanovic, Juan Pedro; Erez, Offer] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48202 USA; [Bik, Elisabeth M.; Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Kim, Chong Jai] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48202 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; Stanford University; Wayne State University	DiGiulio, DB (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	relman@stanford.edu	Kusanovic, Juan Pedro/R-8616-2019; Erez, Offer/F-1466-2012; Bik, Elisabeth M/A-1204-2007; Kusanovic, Juan Pedro/AAM-5782-2020; Romero, Roberto/A-5268-2019	Erez, Offer/0000-0002-2213-8129; Bik, Elisabeth M/0000-0001-5477-0324; Kusanovic, Juan Pedro/0000-0003-0640-2070; Relman, David A./0000-0001-8331-1354; Romero, Roberto/0000-0002-4448-5121	Intramural Research Program of the National Institute of Child Health and Human Development; NIH [T32 AI052073-01, DP1OD000964]; DHHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052073] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in part, by the Intramural Research Program of the National Institute of Child Health and Human Development, NIH, DHHS, and by NIH grant T32 AI052073-01 (Epidemiology of Emerging Infections and Bioterrorism). DAR is supported by an NIH Directors Pioneer Award (NIH DP1OD000964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BLANCHARD A, 1993, CLIN INFECT DIS, V17, pS148, DOI 10.1093/clinids/17.Supplement_1.S148; Bucher HU, 2003, SWISS MED WKLY, V133, P93; Collins MD, 2001, SYST APPL MICROBIOL, V24, P358, DOI 10.1078/0723-2020-00047; *COMM UND PREM BIR, 2006, PRET BIRTH CAUS CONS; De Martino SJ, 2004, J CLIN MICROBIOL, V42, P5940, DOI 10.1128/JCM.42.12.5940-5943.2004; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Gardella C, 2004, AM J PERINAT, V21, P319, DOI 10.1055/s-2004-831884; Gerber S, 2003, J INFECT DIS, V187, P518, DOI 10.1086/368205; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Goldenberg RL, 1998, PRENAT NEONAT MED, V3, P43; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gravett MG, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.064; Green NS, 2005, AM J OBSTET GYNECOL, V193, P626, DOI 10.1016/j.ajog.2005.02.106; Gundi VAKB, 2004, EMERG INFECT DIS, V10, P2056, DOI 10.3201/eid1011.031019; HANFF PA, 1995, CLIN INFECT DIS, V20, pS237, DOI 10.1093/clinids/20.Supplement_2.S237; Hebb JK, 2004, J INFECT DIS, V190, P2109, DOI 10.1086/425929; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hillier SL, 2005, NEW ENGL J MED, V353, P1886, DOI 10.1056/NEJMp058191; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hitti J, 1997, CLIN INFECT DIS, V24, P1228, DOI 10.1086/513669; Hugenholtz P, 2002, GENOME BIOL, V3; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Jalava J, 1996, BRIT J OBSTET GYNAEC, V103, P664, DOI 10.1111/j.1471-0528.1996.tb09835.x; Katsoulis J, 2005, ORAL MICROBIOL IMMUN, V20, P128, DOI 10.1111/j.1399-302X.2004.00200.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Leon R, 2007, J PERIODONTOL, V78, P1249, DOI 10.1902/jop.2007.060368; Lorenz JM, 1998, ARCH PEDIAT ADOL MED, V152, P425, DOI 10.1001/archpedi.152.5.425; Markenson GR, 1997, AM J OBSTET GYNECOL, V177, P1471, DOI 10.1016/S0002-9378(97)70093-0; Miralles R, 2005, PEDIATR RES, V57, P570, DOI 10.1203/01.PDR.0000155944.48195.97; Oyarzun E, 1998, AM J OBSTET GYNECOL, V179, P1115, DOI 10.1016/S0002-9378(98)70115-2; Perni SC, 2004, AM J OBSTET GYNECOL, V191, P1382, DOI 10.1016/j.ajog.2004.05.070; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; Rivers TM, 1937, J BACTERIOL, V33, P1; ROMERO R, 1990, AM J OBSTET GYNECOL, V163, P968, DOI 10.1016/0002-9378(90)91106-M; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P821, DOI 10.1016/0002-9378(91)90423-O; Romero R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/j.1365-3016.2001.00007.x; Shukla SK, 2002, J CLIN MICROBIOL, V40, P3346, DOI 10.1128/JCM.40.9.3346-3349.2002; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Thilesen CM, 2007, J CLIN MICROBIOL, V45, P2344, DOI 10.1128/JCM.00167-07; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; WATTS DH, 1992, OBSTET GYNECOL, V79, P351; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Yi JY, 2005, MOL CELL PROBE, V19, P255, DOI 10.1016/j.mcp.2005.04.002; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4; Yoon BH, 2003, AM J OBSTET GYNECOL, V189, P919, DOI 10.1067/S0002-9378(03)00839-1; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1130, DOI 10.1067/mob.2000.109036	53	515	543	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3056	10.1371/journal.pone.0003056	http://dx.doi.org/10.1371/journal.pone.0003056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725970	Green Submitted, Green Published, gold			2022-12-25	WOS:000264796300003
J	Burgold, T; Spreafico, F; De Santa, F; Totaro, MG; Prosperini, E; Natoli, G; Testa, G				Burgold, Thomas; Spreafico, Fabio; De Santa, Francesca; Totaro, Maria Grazia; Prosperini, Elena; Natoli, Gioacchino; Testa, Giuseppe			The Histone H3 Lysine 27-Specific Demethylase Jmjd3 Is Required for Neural Commitment	PLOS ONE			English	Article								Patterns of methylation at lysine 4 and 27 of histone H3 have been associated with states of gene activation and repression that are developmentally regulated and are thought to underlie the establishment of lineage specific gene expression programs. Recent studies have provided fundamental insight into the problem of lineage specification by comparing global changes in chromatin and transcription between ES and neural stem (NS) cells, points respectively of departure and arrival for neural commitment. With these maps of the differentiated state in place, a central task is now to unravel the chromatin dynamics that enables these differentiation transitions. In particular, the observation that lineage-specific genes repressed in ES cells by Polycomb-mediated H3-K27 trimethylation (H3-K27me3) are demethylated and derepressed in differentiated cells posited the existence of a specific H3-K27 demethylase. In order to gain insight into the epigenetic transitions that enable lineage specification, we investigated the early stages of neural commitment using as model system the monolayer differentiation of mouse ES cells into neural stem (NS) cells. Starting from a comprehensive profiling of JmjC-domain genes, we report here that Jmjd3, recently identified as a H3-K27me3 specific demethylase, controls the expression of key regulators and markers of neurogenesis and is required for commitment to the neural lineage. Our results demonstrate the relevance of an enzymatic activity that antagonizes Polycomb regulation and highlight different modalities through which the dynamics of H3-K27me3 is related to transcriptional output. By showing that the H3-K27 demethylase Jmjd3 is required for commitment to the neural lineage and that it resolves the bivalent domain at the Nestin promoter, our work confirms the functional relevance of bivalent domain resolution that had been posited on the basis of the genome-wide correlation between their controlled resolution and differentiation. In addition, our data indicate that the regulation of H3-K27me3 is highly gene- and context-specific, suggesting that the interplay of methyltransferases and demethylases enables the fine-tuning more than the on/off alternation of methylation states.	[Burgold, Thomas; Spreafico, Fabio; De Santa, Francesca; Totaro, Maria Grazia; Prosperini, Elena; Natoli, Gioacchino; Testa, Giuseppe] European Inst Oncol, Milan, Italy	IRCCS European Institute of Oncology (IEO)	Burgold, T (corresponding author), European Inst Oncol, Milan, Italy.	giuseppe.testa@ifom-ieo-campus.it	DE SANTA, FRANCESCA/AAX-5810-2020; PROSPERINI, ELENA/AAB-1952-2021; Testa, Giuseppe/J-4572-2012; Natoli, gioacchino/J-2100-2018; De Santa, Francesca/A-2954-2014; Natoli, gioacchino/ABB-8679-2020	DE SANTA, FRANCESCA/0000-0002-0034-5450; De Santa, Francesca/0000-0002-0034-5450; Natoli, Gioacchino/0000-0003-0711-2411; Testa, Giuseppe/0000-0002-9104-0918	Marie-Curie Excellence; Italian Association for Cancer Research (AIRC)	Marie-Curie Excellence(European Commission); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	Research in G.N. lab was supported by the EC (Marie-Curie Excellence Grant TRANS-TAR), by a donation from Manetti and Roberts and Fondazione Umberto Veronesi and by the Italian Association for Cancer Research (AIRC). Research in G.T. lab was supported by a grant from the Italian Association for Cancer Research (AIRC).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nagy A., 2002, MANIPULATING MOUSE E; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	27	159	168	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3034	10.1371/journal.pone.0003034	http://dx.doi.org/10.1371/journal.pone.0003034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716661	Green Published, gold, Green Submitted			2022-12-25	WOS:000264426800011
J	Marengo, EB; de Moraes, LV; Faria, M; Fernandes, BL; Carvalho, LV; Tambourgi, DV; Rizzo, LV; Portaro, FCV; Camargo, ACM; Sant'Anna, OA				Marengo, Eliana B.; de Moraes, Luciana V.; Faria, Marcella; Fernandes, Beatriz L.; Carvalho, Luciana V.; Tambourgi, Denise V.; Rizzo, Luiz V.; Portaro, Fernanda C. V.; Camargo, Antonio Carlos M.; Sant'Anna, Osvaldo A.			Administration of M. leprae Hsp65 Interferes with the Murine Lupus Progression	PLOS ONE			English	Article								The heat shock protein [Hsp] family guides several steps during protein synthesis, are abundant in prokaryotic and eukaryotic cells, and are highly conserved during evolution. The Hsp60 family is involved in assembly and transport of proteins, and is expressed at very high levels during autoimmunity or autoinflammatory phenomena. Here, the pathophysiological role of the wild type [WT] and the point mutated K(409)A recombinant Hsp65 of M. leprae in an animal model of Systemic Lupus Erythematosus [SLE] was evaluated in vivo using the genetically homogeneous [NZBxNZW]F-1 mice. Anti-DNA and anti-Hsp65 antibodies responsiveness was individually measured during the animal's life span, and the mean survival time [MST] was determined. The treatment with WT abbreviates the MST in 46%, when compared to non-treated mice [p<0.001]. An increase in the IgG2a/IgG1 anti-DNA antibodies ratio was also observed in animals injected with the WT Hsp65. Incubation of BALB/c macrophages with F1 serum from WT treated mice resulted in acute cell necrosis; treatment of these cells with serum from K(409)A treated mice did not cause any toxic effect. Moreover, the involvement of WT correlates with age and is dose-dependent. Our data suggest that Hsp65 may be a central molecule intervening in the progression of the SLE, and that the point mutated K(409)A recombinant immunogenic molecule, that counteracts the deleterious effect of WT, may act mitigating and delaying the development of SLE in treated mice. This study gives new insights into the general biological role of Hsp and the significant impact of environmental factors during the pathogenesis of this autoimmune process.	[Marengo, Eliana B.; Carvalho, Luciana V.; Tambourgi, Denise V.; Portaro, Fernanda C. V.; Sant'Anna, Osvaldo A.] Inst Butantan, Immunochem Lab, Sao Paulo, Brazil; [de Moraes, Luciana V.; Rizzo, Luiz V.] Univ Sao Paulo, Inst Ciencias Biomed, Clin Immunol Lab, Sao Paulo, Brazil; [Faria, Marcella; Fernandes, Beatriz L.; Camargo, Antonio Carlos M.] Ctr Appl Toxinol, CAT CEPID, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo	Marengo, EB (corresponding author), Inst Butantan, Immunochem Lab, Sao Paulo, Brazil.	gbrazil@usp.br	Portaro, F/B-8397-2012; Tambourgi, Denise/H-7114-2016; de Moraes, Luciana/M-1619-2013; Rizzo, Luiz Vicente/B-4458-2009; Portaro, Fernanda/I-6644-2015	Tambourgi, Denise/0000-0003-1896-9074; de Moraes, Luciana/0000-0001-6605-5547; 	FAPESP [Fundacao de Amparo a Pesquisa do Estado de Sao Paulo] [fellowships]; CNPq-Brazil	FAPESP [Fundacao de Amparo a Pesquisa do Estado de Sao Paulo](Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by funds of FAPESP [Fundacao de Amparo a Pesquisa do Estado de Sao Paulo] through the CAT/CEPID program. E. B. Marengo, L. V. Moraes and L. V. Carvalho are recipient of FAPESP fellowships. D. V. Tambourgi, L. V. Rizzo, A. C. M. Camargo and O.A. Sant'Anna are researchers of CNPq-Brazil.	Bengtsson AA, 2004, CLIN EXP IMMUNOL, V135, P535, DOI 10.1111/j.1365-2249.2003.02386.x; Biozzi G, 1979, Curr Top Microbiol Immunol, V85, P31; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNET FM, 1965, AUSTRALAS ANN MED, V14, P185; COHEN IR, 1991, ANNU REV IMMUNOL, V9, P567, DOI 10.1146/annurev.iy.09.040191.003031; Cohen IR, 2007, J AUTOIMMUN, V29, P246, DOI 10.1016/j.jaut.2007.07.016; da Silva AC, 1998, RES IMMUNOL, V149, P151, DOI 10.1016/S0923-2494(98)80298-8; George J, 1999, CIRCULATION, V99, P2227, DOI 10.1161/01.CIR.99.17.2227; GILES AR, 1987, THROMB HAEMOSTASIS, V58, P1078; Habich C, 2004, FEBS LETT, V568, P65, DOI 10.1016/j.febslet.2004.05.010; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Harats D, 2002, J AM COLL CARDIOL, V40, P1333, DOI 10.1016/S0735-1097(02)02135-6; HELYER BJ, 1963, BRIT J HAEMATOL, V9, P119, DOI 10.1111/j.1365-2141.1963.tb05450.x; HOJNIK M, 1994, LUPUS, V3, P515, DOI 10.1177/096120339400300615; IBANEZ OM, 1992, EUR J IMMUNOL, V22, P2555, DOI 10.1002/eji.1830221014; Ishikawa S, 1998, J IMMUNOL, V161, P1267; JONES DB, 1990, LANCET, V336, P583, DOI 10.1016/0140-6736(90)93390-B; Kaplan MJ, 2004, CLIN IMMUNOL, V112, P210, DOI 10.1016/j.clim.2004.04.007; Kaplan MJ, 2002, J IMMUNOL, V169, P6020, DOI 10.4049/jimmunol.169.10.6020; Kim EY, 2008, CLIN IMMUNOL, V127, P98, DOI 10.1016/j.clim.2008.01.003; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MOUTON D, 1988, LIVEST PROD SCI, V20, P277, DOI 10.1016/0301-6226(88)90023-1; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; Pisetsky DS, 1998, CLIN DIAGN LAB IMMUN, V5, P1; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Pockley AG, 1998, IMMUNOL INVEST, V27, P367, DOI 10.3109/08820139809022710; Poletaev A, 2003, AUTOIMMUN REV, V2, P264, DOI 10.1016/S1568-9972(03)00033-8; Portaro FCV, 2002, BIOCHEMISTRY-US, V41, P7400, DOI 10.1021/bi011999l; Prigogine I, 2003, ANN NY ACAD SCI, V988, P128, DOI 10.1111/j.1749-6632.2003.tb06091.x; PRIGOGINE I, 1978, SCIENCE, V201, P777, DOI 10.1126/science.201.4358.777; Prohaszka Z, 2004, MOL IMMUNOL, V41, P29, DOI 10.1016/j.molimm.2004.02.001; PUTTERMAN C, 1994, AUTOIMMUNE DIS MODEL, P217; Rea IM, 2001, EXP GERONTOL, V36, P341, DOI 10.1016/S0531-5565(00)00215-1; SANTANNA OA, 1982, J IMMUNOGENET, V9, P191; Schett G, 1997, ATHEROSCLEROSIS, V128, P27, DOI 10.1016/S0021-9150(96)05975-8; Schett G, 1995, J CLIN INVEST, V96, P2569, DOI 10.1172/JCI118320; SIQUEIRA M, 1976, EUR J IMMUNOL, V6, P241, DOI 10.1002/eji.1830060403; Stephanou A, 1998, SEMIN ARTHRITIS RHEU, V28, P155, DOI 10.1016/S0049-0172(98)80032-2; STRUHAR D, 1988, LUNG, V166, P107, DOI 10.1007/BF02714034; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; THOLE J, 1990, MOL BIOL MYCOBACTERI; Tsao BP, 2003, TRENDS IMMUNOL, V24, P595, DOI 10.1016/j.it.2003.09.006; VAARALA O, 1993, LANCET, V341, P923, DOI 10.1016/0140-6736(93)91213-6; Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600; Westermeier R, 2002, PROTEOMICS PRACTICE; Wick G, 2001, TRENDS IMMUNOL, V22, P665, DOI 10.1016/S1471-4906(01)02089-0; WINFIELD JB, 1989, ARTHRITIS RHEUM, V32, P1497, DOI 10.1002/anr.1780321202; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; XU QB, 1993, LANCET, V341, P255, DOI 10.1016/0140-6736(93)92613-X; XU QB, 1992, ARTERIOSCLER THROMB, V12, P789, DOI 10.1161/01.ATV.12.7.789; Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P4267, DOI 10.1073/pnas.85.12.4267; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401; YOUNG RA, 1989, CELL, V59, P5, DOI 10.1016/0092-8674(89)90861-1	58	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3025	10.1371/journal.pone.0003025	http://dx.doi.org/10.1371/journal.pone.0003025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716655	gold, Green Submitted, Green Published			2022-12-25	WOS:000264426800004
J	Overgaard, M; Fehl, K; Mouridsen, K; Bergholt, B; Cleeremans, A				Overgaard, Morten; Fehl, Katrin; Mouridsen, Kim; Bergholt, Bo; Cleeremans, Axel			Seeing without Seeing? Degraded Conscious Vision in a Blindsight Patient	PLOS ONE			English	Article							SIGHT	Blindsight patients, whose primary visual cortex is lesioned, exhibit preserved ability to discriminate visual stimuli presented in their "blind'' field, yet report no visual awareness hereof. Blindsight is generally studied in experimental investigations of single patients, as very few patients have been given this "diagnosis''. In our single case study of patient GR, we ask whether blindsight is best described as unconscious vision, or rather as conscious, yet severely degraded vision. In experiment 1 and 2, we successfully replicate the typical findings of previous studies on blindsight. The third experiment, however, suggests that GR's ability to discriminate amongst visual stimuli does not reflect unconscious vision, but rather degraded, yet conscious vision. As our finding results from using a method for obtaining subjective reports that has not previously used in blindsight studies (but validated in studies of healthy subjects and other patients with brain injury), our results call for a reconsideration of blindsight, and, arguably also of many previous studies of unconscious perception in healthy subjects.	[Overgaard, Morten; Fehl, Katrin] Aarhus Univ Hosp, CNRU, Hammel Neurorehabil & Res Ctr, Hammel, Denmark; [Fehl, Katrin] Univ Marburg, Dept Psychol, D-35032 Marburg, Germany; [Mouridsen, Kim] Aarhus Univ Hosp, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Bergholt, Bo] Aarhus Univ Hosp, Dept Neurosurg, Aarhus, Denmark; [Cleeremans, Axel] Free Univ Brussels, Cognitive Sci Res Unit, Brussels, Belgium	Aarhus University; Philipps University Marburg; Aarhus University; Aarhus University; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Overgaard, M (corresponding author), Aarhus Univ Hosp, CNRU, Hammel Neurorehabil & Res Ctr, Hammel, Denmark.	neumov@sc.aaa.dk	Overgaard, Morten/B-3830-2010	Overgaard, Morten/0000-0002-2136-3455	The MindBridge project; European Commission [043457]	The MindBridge project; European Commission(European CommissionEuropean Commission Joint Research Centre)	Morten Overgaard was supported by The MindBridge project, co-funded by the European Commission under the Sixth Framework Programme, Contract No. 043457. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Overgaard M, 2006, CONSCIOUS COGN, V15, P700, DOI 10.1016/j.concog.2006.04.002; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; Ramsoy T.Z., 2004, PHENOMENOL COGNIT SC, V3, P1, DOI [10.1023/b:phen.0000041900.30172.e8, DOI 10.1023/B:PHEN.0000041900.30172.E8, 10.1023/B:PHEN.0000041900.30172.e8]; Sergent C, 2004, PSYCHOL SCI, V15, P720, DOI 10.1111/j.0956-7976.2004.00748.x; Stoerig P, 2001, CONSCIOUS COGN, V10, P574, DOI 10.1006/ccog.2001.0526; Trevethan CT, 2007, COGNITION, V103, P491, DOI 10.1016/j.cognition.2006.04.011; Weiskrantz L, 2002, NAT NEUROSCI, V5, P101, DOI 10.1038/nn793; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25	11	97	97	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3028	10.1371/journal.pone.0003028	http://dx.doi.org/10.1371/journal.pone.0003028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KO	18716654	Green Published, Green Submitted, gold			2022-12-25	WOS:000264426800006
J	Guo, JJ; Zeng, QN; Emami, M; Ellis, BE; Chen, JG				Guo, Jianjun; Zeng, Qingning; Emami, Mohammad; Ellis, Brian E.; Chen, Jin-Gui			The GCR2 Gene Family Is Not Required for ABA Control of Seed Germination and Early Seedling Development in Arabidopsis	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; PLASMA-MEMBRANE RECEPTOR; COUPLED RECEPTOR; CELL-DIVISION; PERCEPTION; BIOSYNTHESIS; SUBUNIT; TIR1	Background: The plant hormone abscisic acid (ABA) regulates diverse processes of plant growth and development. It has recently been proposed that GCR2 functions as a G-protein-coupled receptor (GPCR) for ABA. However, the structural relationships and functionality of GCR2 have been challenged by several independent studies. A central question in this controversy is whether gcr2 mutants are insensitive to ABA, because gcr2 mutants were shown to display reduced sensitivity to ABA under one experimental condition (e. g. 22 degrees C, continuous white light with 150 mu mol m(-2) s(-1)) but were shown to display wild-type sensitivity under another slightly different condition (e. g. 23 degrees C, 14/10 hr photoperiod with 120 mu mol m(-2) s(-1)). It has been hypothesized that gcr2 appears only weakly insensitive to ABA because two other GCR2-like genes in Arabidopsis, GCL1 and GCL2, compensate for the loss of function of GCR2. Principal Findings: In order to test this hypothesis, we isolated a putative loss-of-function allele of GCL2, and then generated all possible combinations of mutations in each member of the GCR2 gene family. We found that all double mutants, including gcr2 gcl1, gcr2 gcl2, gcl1 gcl2, as well as the gcr2 gcl1 gcl2 triple mutant displayed wild-type sensitivity to ABA in seed germination and early seedling development assays, demonstrating that the GCR2 gene family is not required for ABA responses in these processes. Conclusion: These results provide compelling genetic evidence that GCR2 is unlikely to act as a receptor for ABA in the context of either seed germination or early seedling development.	Univ British Columbia, Dept Bot, Vancouver, BC, Canada; Univ British Columbia, Michael Smith Lab, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Guo, JJ (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	jingui@interchange.ubc.ca	Chen, Jin-Gui/AFV-6337-2022; guo, jianjun/G-6852-2013; Chen, Jin-Gui/A-4773-2011; Zeng, Qingning/M-2245-2013	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; 	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work is supported by grants from the Natural Sciences and Engineering Research Council of Canada and the Canada Foundation for Innovation.	Assmann SM, 2002, PLANT CELL, V14, pS355, DOI 10.1105/tpc.001792; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Chen JG, 2008, PLANT SIGNAL BEHAV, V3, P307, DOI 10.4161/psb.3.5.5292; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Finkelstein Ruth R, 2002, Arabidopsis Book, V1, pe0058, DOI 10.1199/tab.0058; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Illingworth CJR, 2008, BIOPHYS CHEM, V133, P28, DOI 10.1016/j.bpc.2007.11.004; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Verslues PE, 2007, CURR OPIN PLANT BIOL, V10, P447, DOI 10.1016/j.pbi.2007.08.004; Wang XF, 2008, ANN BOT-LONDON, V101, P311, DOI 10.1093/aob/mcm284; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	26	52	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2982	10.1371/journal.pone.0002982	http://dx.doi.org/10.1371/journal.pone.0002982			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714360	Green Submitted, Green Published, gold			2022-12-25	WOS:000264420900009
J	Rasheed, S; Yan, JS; Lau, A; Chan, AS				Rasheed, Suraiya; Yan, Jasper S.; Lau, Alex; Chan, Arvan S.			HIV Replication Enhances Production of Free Fatty Acids, Low Density Lipoproteins and Many Key Proteins Involved in Lipid Metabolism: A Proteomics Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RECEPTOR-RELATED PROTEIN; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN SERUM-ALBUMIN; APOLIPOPROTEIN-B METABOLISM; HEAT-SHOCK PROTEINS; LDL RECEPTOR; INSULIN-RESISTANCE; BINDING-PROTEIN; INFECTED PATIENTS	Background: HIV-infected patients develop multiple metabolic abnormalities including insulin resistance, lipodystrophy and dyslipidemia. Although progression of these disorders has been associated with the use of various protease inhibitors and other antiretroviral drugs, HIV-infected individuals who have not received these treatments also develop lipid abnormalities albeit to a lesser extent. How HIV alters lipid metabolism in an infected cell and what molecular changes are affected through protein interaction pathways are not well-understood. Results: Since many genetic, epigenetic, dietary and other factors influence lipid metabolism in vivo, we have chosen to study genome-wide changes in the proteomes of a human T-cell line before and after HIV infection in order to circumvent computational problems associated with multiple variables. Four separate experiments were conducted including one that compared 14 different time points over a period of > 3 months. By subtractive analyses of protein profiles overtime, several hundred differentially expressed proteins were identified in HIV-infected cells by mass spectrometry and each protein was scrutinized for its biological functions by using various bioinformatics programs. Herein, we report 18 HIV-modulated proteins and their interaction pathways that enhance fatty acid synthesis, increase low density lipoproteins (triglycerides), dysregulate lipid transport, oxidize lipids, and alter cellular lipid metabolism. Conclusions: We conclude that HIV replication alone (i.e. without any influence of antiviral drugs, or other human genetic factors), can induce novel cellular enzymes and proteins that are significantly associated with biologically relevant processes involved in lipid synthesis, transport and metabolism (p = < 0.0002-0.01). Translational and clinical studies on the newly discovered proteins may now shed light on how some of these proteins may be useful for early diagnosis of individuals who might be at high risk for developing lipid-related disorders. The target proteins could then be used for future studies in the development of inhibitors for preventing lipid-metabolic anomalies. This is the first direct evidence that HIV-modulates production of proteins that are significantly involved in disrupting the normal lipid-metabolic pathways.	[Rasheed, Suraiya; Yan, Jasper S.; Lau, Alex; Chan, Arvan S.] Univ So Calif, Keck Sch Med, Lab Viral Oncol AIDS & Prote Res, Los Angeles, CA 90033 USA	University of Southern California	Rasheed, S (corresponding author), Univ So Calif, Keck Sch Med, Lab Viral Oncol AIDS & Prote Res, Los Angeles, CA 90033 USA.	srasheed@usc.edu			The Rasheed Research and Endowment Funds at the University of Southern California (USC)	The Rasheed Research and Endowment Funds at the University of Southern California (USC)	The Rasheed Research and Endowment Funds at the University of Southern California (USC) sponsored this research. The funders (USC) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2005, THROMB HAEMOSTASIS, V94, P1048, DOI 10.1160/TH05-06-0384; Anderson DR, 2007, CARDIOVASC RES, V73, P597, DOI 10.1016/j.cardiores.2006.11.029; Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Arnedo M, 2007, PHARMACOGENET GENOM, V17, P755, DOI 10.1097/FPC.0b013e32814db8b7; Barbaro G, 2002, J CARDIOVASC RISK, V9, P295, DOI 10.1097/00043798-200210000-00011; Barbaro G, 2007, CURR PHARM DESIGN, V13, P2208, DOI 10.2174/138161207781039661; BEACH DC, 1982, BIOCHIM BIOPHYS ACTA, V711, P452, DOI 10.1016/0005-2760(82)90059-5; Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001; Behrens GMN, 2000, DRUG SAFETY, V23, P57, DOI 10.2165/00002018-200023010-00004; Ben-Romano R, 2004, DIABETOLOGIA, V47, P1107, DOI 10.1007/s00125-004-1408-5; Bonnet E, 2007, CLIN CHEM LAB MED, V45, P815, DOI 10.1515/CCLM.2007.140; Bozza PT, 1997, J EXP MED, V186, P909, DOI 10.1084/jem.186.6.909; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Burch WL, 2000, J BIOL CHEM, V275, P16267, DOI 10.1074/jbc.M000446200; Camino-Lopez S, 2007, CARDIOVASC RES, V73, P208, DOI 10.1016/j.cardiores.2006.10.017; Carpentier A, 2005, ATHEROSCLEROSIS, V178, P165, DOI 10.1016/j.atherosclerosis.2004.07.035; Carr A, 2002, JAMA-J AM MED ASSOC, V288, P207, DOI 10.1001/jama.288.2.207; Carr A, 2000, CLIN INFECT DIS, V30, pS135, DOI 10.1086/313854; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Carter V M, 2001, HIV Med, V2, P174, DOI 10.1046/j.1468-1293.2001.00073.x; Chakraborty A, 2008, P NATL ACAD SCI USA, V105, P1134, DOI 10.1073/pnas.0711168105; CHAMBON M, 1989, J STEROID BIOCHEM, V33, P915, DOI 10.1016/0022-4731(89)90240-9; Chan EY, 2007, J VIROL, V81, P7571, DOI 10.1128/JVI.00288-07; CHAPPELL DA, 1993, J BIOL CHEM, V268, P14168; CharnockJones DS, 1996, INT J BIOCHEM CELL B, V28, P81, DOI 10.1016/1357-2725(95)00120-4; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Cheng WH, 1998, J NUTR, V128, P1070, DOI 10.1093/jn/128.7.1070; CHULKOVA TM, 1993, FEBS LETT, V336, P327, DOI 10.1016/0014-5793(93)80830-N; Coll B, 2006, CYTOKINE, V34, P51, DOI 10.1016/j.cyto.2006.03.013; CONSTANS J, 1994, EUR J CLIN INVEST, V24, P416, DOI 10.1111/j.1365-2362.1994.tb02185.x; CURRIER J, 2008, J ACQUIR IMMUNE DEFI; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Dadaian M, 1999, J LIPID RES, V40, P940; Das S, 2006, DIABETOLOGIA, V49, P538, DOI 10.1007/s00125-005-0085-3; DE FS, 2008, CLIN CHEM; Desruisseaux MS, 2007, INFECT IMMUN, V75, P1066, DOI 10.1128/IAI.01455-06; Domingo P, 2003, JAIDS-J ACQ IMM DEF, V33, P114, DOI 10.1097/00126334-200305010-00017; DUCHARME NA, 2008, ENDOCRINOLOGY; Engstrom G, 2007, EUR J CARDIOV PREV R, V14, P392, DOI 10.1097/01.hjr.0000244582.30421.b2; FEINGOLD KR, 1993, J CLIN ENDOCR METAB, V76, P1423, DOI 10.1210/jc.76.6.1423; Feng ZH, 2006, MUTAT RES-FUND MOL M, V601, P125, DOI 10.1016/j.mrfmmm.2006.06.003; Fisher SD, 2006, ATHEROSCLEROSIS, V185, P1, DOI 10.1016/j.atherosclerosis.2005.09.025; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Fujiwara SI, 2008, BIOPHYS J, V94, P95, DOI 10.1529/biophysj.107.111377; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Giralt M, 2006, ANTIVIR THER, V11, P729; GOMEZ E, 1998, AIDS COALIT N Y, V34, P34; Grinspoon Steven K, 2005, Am J Med, V118 Suppl 2, p23S; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; Ha JS, 2006, BBA-MOL CELL BIOL L, V1761, P717, DOI 10.1016/j.bbalip.2006.05.016; Hashiguchi N, 2001, J TRAUMA, V51, P1104, DOI 10.1097/00005373-200112000-00015; Hazan U, 2002, FASEB J, V16, P1254, DOI 10.1096/fj.01-0947fje; Hertzel AV, 2002, J LIPID RES, V43, P2105, DOI 10.1194/jlr.M200227-JLR200; Hodgetts A, 2007, FUTURE MICROBIOL, V2, P35, DOI 10.2217/17460913.2.1.35; Huang H, 2005, BIOCHEMISTRY-US, V44, P10282, DOI 10.1021/bi0477891; Hurlimann D, 2005, HERZ, V30, P472, DOI 10.1007/s00059-005-2740-3; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Kadin I, 2007, J IMMUNOL, V178, P6404, DOI 10.4049/jimmunol.178.10.6404; Kim SS, 2007, J PROTEOME RES, V6, P180, DOI 10.1021/pr060323f; Knowlton AA, 1998, J MOL CELL CARDIOL, V30, P811, DOI 10.1006/jmcc.1998.0646; Krishnaswamy G, 2000, Cardiol Rev, V8, P260, DOI 10.1097/00045415-200008050-00005; Lainka E, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e56; Lamberg A, 1996, BIOCHEM J, V315, P533, DOI 10.1042/bj3150533; Lamia KA, 2004, MOL CELL BIOL, V24, P5080, DOI 10.1128/MCB.24.11.5080-5087.2004; Laspiur JP, 2007, J NEUROIMMUNOL, V192, P157, DOI 10.1016/j.jneuroim.2007.08.004; Lee L, 2007, J INVEST DERMATOL, V127, P16, DOI 10.1038/sj.jid.5700511; Leonard EG, 2005, INFECT DIS CLIN N AM, V19, P713, DOI 10.1016/j.idc.2005.05.006; LEROY A, 1995, CURR OPIN LIPIDOL, V6, P281, DOI 10.1097/00041433-199510000-00007; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Llorente-Cortes V, 2007, J LIPID RES, V48, P2133, DOI 10.1194/jlr.M700039-JLR200; Llorente-Cortes V, 2005, ARTERIOSCL THROM VAS, V25, P497, DOI 10.1161/01.ATV.0000154280.62072.fd; Llorente-Cortes V, 2007, CARDIOVASC RES, V74, P526, DOI 10.1016/j.cardiores.2007.02.020; Longshaw VM, 2004, J CELL SCI, V117, P701, DOI 10.1242/jcs.00905; LORENZ MW, ATHEROSCLEROSIS; MacDougall ED, 2006, AM J PATHOL, V168, P2064, DOI 10.2353/ajpath.2006.051009; Maggi P, 2006, AIDS REV, V8, P204; Mallon PWG, 2007, AIDS REV, V9, P3; Mallon PWG, 2006, PLOS MED, V3, P291, DOI 10.1371/journal.pmed.0030085; Mandrup S, 1998, J BIOL CHEM, V273, P23897, DOI 10.1074/jbc.273.37.23897; Maurin T, 2005, EXP CELL RES, V304, P544, DOI 10.1016/j.yexcr.2004.12.003; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mizrak SC, 2006, MOL REPROD DEV, V73, P1361, DOI 10.1002/mrd.20548; Molina L, 2007, PROTEOMICS, V7, P3116, DOI 10.1002/pmic.200700306; Moon YS, 2002, J LIPID RES, V43, P691; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Murray I, 2000, ENDOCRINOLOGY, V141, P1041, DOI 10.1210/en.141.3.1041; Ng TWK, 2005, DIABETES, V54, P795, DOI 10.2337/diabetes.54.3.795; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; ONSOVILLAVERDE C, 2003, AIDS, V17, P1173; Packard CJ, 2000, J LIPID RES, V41, P305; Panin L. E., 2003, Voprosy Virusologii, V48, P24; Park JJ, 2004, P NATL ACAD SCI USA, V101, P1022, DOI 10.1073/pnas.0307847100; Park SS, 2007, NUCLEOS NUCLEOT NUCL, V26, P453, DOI 10.1080/15257770701426203; Park TS, 2007, CURR OPIN LIPIDOL, V18, P277, DOI 10.1097/MOL.0b013e32814a57db; Parkes HA, 2006, AM J PHYSIOL-ENDOC M, V291, pE737, DOI 10.1152/ajpendo.00112.2006; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Pendaries C, 2005, ADV ENZYME REGUL, V45, P201, DOI 10.1016/j.advenzreg.2005.02.006; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rasheed S, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-14; RASHEED S, 1986, VIROLOGY, V154, P395, DOI 10.1016/0042-6822(86)90465-4; Raulin J, 2002, PROG LIPID RES, V41, P27, DOI 10.1016/S0163-7827(01)00019-4; Rehberg EF, 1996, J BIOL CHEM, V271, P29945, DOI 10.1074/jbc.271.47.29945; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; ROHLFS EM, 1993, J CELL PHYSIOL, V157, P469, DOI 10.1002/jcp.1041570306; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; Santo SMSE, 2005, J LIPID RES, V46, P1097, DOI 10.1194/jlr.C500007-JLR200; Shahmanesh M, 2005, J CLIN ENDOCR METAB, V90, P755, DOI 10.1210/jc.2004-1273; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; Shih SC, 1999, J BIOL CHEM, V274, P15407, DOI 10.1074/jbc.274.22.15407; SIEGENTHALER G, 1994, BIOCHEM J, V302, P363, DOI 10.1042/bj3020363; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; SRINIVAS RV, 1990, VIROLOGY, V176, P48, DOI 10.1016/0042-6822(90)90229-K; Stephensen CB, 2007, AM J CLIN NUTR, V85, P173, DOI 10.1093/ajcn/85.1.173; STOIBER H, 1995, IMMUNOBIOLOGY, V193, P98, DOI 10.1016/S0171-2985(11)80158-0; Stoiber H, 2001, IMMUNOL REV, V180, P168, DOI 10.1034/j.1600-065X.2001.1800115.x; Susal C, 1996, BLOOD, V87, P2329, DOI 10.1182/blood.V87.6.2329.bloodjournal8762329; Tanwani LK, 2003, SOUTH MED J, V96, P180, DOI 10.1097/01.SMJ.0000051731.69719.2E; Tong FM, 2006, ARCH BIOCHEM BIOPHYS, V447, P46, DOI 10.1016/j.abb.2006.01.005; Umpleby AM, 2005, ANTIVIR THER, V10, P663; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; Vigouroux C, 1999, DIABETES METAB, V25, P225; Wakasaki H, 1997, P NATL ACAD SCI USA, V94, P9320, DOI 10.1073/pnas.94.17.9320; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Way KJ, 2001, DIABETIC MED, V18, P945, DOI 10.1046/j.0742-3071.2001.00638.x; Wetsel RA, 1999, J BIOL CHEM, V274, P19429, DOI 10.1074/jbc.274.27.19429; WRIGHT D, 2008, CLIN TRIALS, V9, P103; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu WP, 2001, J BIOL CHEM, V276, P36454, DOI 10.1074/jbc.M105093200; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200; Yu WG, 2000, BLOOD, V95, P1078, DOI 10.1182/blood.V95.3.1078.003k16_1078_1085; Zhao LJ, 2006, BIOFACTORS, V27, P93, DOI 10.1002/biof.5520270109	139	56	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3003	10.1371/journal.pone.0003003	http://dx.doi.org/10.1371/journal.pone.0003003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714345	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900028
J	Staiger, H; Machicao, F; Kantartzis, K; Schafer, SA; Kirchhoff, K; Guthoff, M; Silbernagel, G; Stefan, N; Fritsche, A; Haering, HU				Staiger, Harald; Machicao, Fausto; Kantartzis, Konstantinos; Schaefer, Silke A.; Kirchhoff, Kerstin; Guthoff, Martina; Silbernagel, Guenther; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich			Novel Meta-Analysis-Derived Type 2 Diabetes Risk Loci Do Not Determine Prediabetic Phenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RELEASE; SUSCEPTIBILITY LOCI; COMMON VARIANTS; HHEX; POLYMORPHISMS; GENES; REPLICATION; RESISTANCE; REGION	Background: Genome-wide association (GWA) studies identified a series of novel type 2 diabetes risk loci. Most of them were subsequently demonstrated to affect insulin secretion of pancreatic beta-cells. Very recently, a meta-analysis of GWA data revealed nine additional risk loci with still undefined roles in the pathogenesis of type 2 diabetes. Using our thoroughly phenotyped cohort of subjects at an increased risk for type 2 diabetes, we assessed the association of the nine latest genetic variants with the predominant prediabetes traits, i.e., obesity, impaired insulin secretion, and insulin resistance. Methodology/Principal Findings: One thousand five hundred and seventy-eight metabolically characterized non-diabetic German subjects were genotyped for the reported candidate single nucleotide polymorphisms (SNPs) JAZF1 rs864745, CDC123/CAMK1D rs12779790, TSPAN8/LGR5 rs7961581, THADA rs7578597, ADAMTS9 rs4607103, NOTCH2 rs10923931, DCD rs1153188, VEGFA rs9472138, and BCL11A rs10490072. Insulin sensitivity was derived from fasting glucose and insulin concentrations, oral glucose tolerance test (OGTT), and hyperinsulinemic-euglycemic clamp. Insulin secretion was estimated from OGTT data. After appropriate adjustment for confounding variables and Bonferroni correction for multiple comparisons (corrected alpha-level: p = 0.0014), none of the SNPs was reliably associated with adiposity, insulin sensitivity, or insulin secretion (all p >= 0.0117, dominant inheritance model). The risk alleles of ADAMTS9 SNP rs4607103 and VEGFA SNP rs9472138 tended to associate with more than one measure of insulin sensitivity and insulin secretion, respectively, but did not reach formal statistical significance. The study was sufficiently powered (1-beta=0.8) to detect effect sizes of 0.19 <= d <= 0.25 (alpha = 0.0014) and 0.13 <= d <= 0.16 (alpha = 0.05). Conclusions/Significance: In contrast to the first series of GWA-derived type 2 diabetes candidate SNPs, we could not detect reliable associations of the novel risk loci with prediabetic phenotypes. Possible weak effects of ADAMTS9 SNP rs4607103 and VEGFA SNP rs9472138 on insulin sensitivity and insulin secretion, respectively, await further confirmation by larger studies.	[Staiger, Harald; Machicao, Fausto; Kantartzis, Konstantinos; Schaefer, Silke A.; Kirchhoff, Kerstin; Guthoff, Martina; Silbernagel, Guenther; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Staiger, H (corresponding author), Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany.	harald.staiger@med.uni-tuebingen.de	Guthoff, Martina/D-3960-2018; Staiger, Harald/N-5871-2014; Kantartzis, Konstantinos/AAC-3999-2019	Guthoff, Martina/0000-0002-4294-980X; Stefan, Norbert/0000-0002-2186-9595; Silbernagel, Guenther/0000-0001-9323-329X; Kantartzis, Konstantinos/0000-0002-0584-1138; Staiger, Harald/0000-0002-9507-5333	German Research Foundation [KFO 114/2]	German Research Foundation(German Research Foundation (DFG))	The study was supported by a grant from the German Research Foundation (KFO 114/2). The funding organisation is a non-profit organisation and was not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Duesing K, 2008, DIABETOLOGIA, V51, P821, DOI 10.1007/s00125-008-0973-4; Freeman H, 2006, HUM MOL GENET, V15, pR202, DOI 10.1093/hmg/ddl191; Furukawa Y, 2008, J CLIN ENDOCR METAB, V93, P310, DOI 10.1210/jc.2007-1029; GRARUP N, 2008, DIABETES; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Hertel JK, 2008, DIABETOLOGIA, V51, P971, DOI 10.1007/s00125-008-0982-3; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schulze MB, 2007, DIABETOLOGIA, V50, P2405, DOI 10.1007/s00125-007-0766-1; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; STANCAKOVA A, 2008, J CLIN ENDOCRINOL ME; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; van Vliet-Ostaptchouk JV, 2008, EUR J HUM GENET, V16, P652, DOI 10.1038/sj.ejhg.5202008; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	25	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3019	10.1371/journal.pone.0003019	http://dx.doi.org/10.1371/journal.pone.0003019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714373	Green Published, gold, Green Submitted			2022-12-25	WOS:000264420900042
J	Wan, HQ; Sorrell, EM; Song, HC; Hossain, MJ; Ramirez-Nieto, G; Monne, I; Stevens, J; Cattoli, G; Capua, I; Chen, LM; Donis, RO; Busch, J; Paulson, JC; Brockwell, C; Webby, R; Blanco, J; Al-Natour, MQ; Perez, DR				Wan, Hongquan; Sorrell, Erin M.; Song, Haichen; Hossain, Md Jaber; Ramirez-Nieto, Gloria; Monne, Isabella; Stevens, James; Cattoli, Giovanni; Capua, Ilaria; Chen, Li-Mei; Donis, Ruben O.; Busch, Julia; Paulson, James C.; Brockwell, Christy; Webby, Richard; Blanco, Jorge; Al-Natour, Mohammad Q.; Perez, Daniel R.			Replication and Transmission of H9N2 Influenza Viruses in Ferrets: Evaluation of Pandemic Potential	PLOS ONE			English	Article							TO-HUMAN TRANSMISSION; AVIAN INFLUENZA; A VIRUSES; RECEPTOR SPECIFICITY; SOUTHERN CHINA; MOLECULAR EPIDEMIOLOGY; HUMAN INFECTION; HEMAGGLUTININ; POULTRY; EVOLUTION	H9N2 avian influenza A viruses are endemic in poultry of many Eurasian countries and have caused repeated human infections in Asia since 1998. To evaluate the potential threat of H9N2 viruses to humans, we investigated the replication and transmission efficiency of H9N2 viruses in the ferret model. Five wild-type (WT) H9N2 viruses, isolated from different avian species from 1988 through 2003, were tested in vivo and found to replicate in ferrets. However these viruses achieved mild peak viral titers in nasal washes when compared to those observed with a human H3N2 virus. Two of these H9N2 viruses transmitted to direct contact ferrets, however no aerosol transmission was detected in the virus displaying the most efficient direct contact transmission. A leucine (Leu) residue at amino acid position 226 in the hemagglutinin ( HA) receptor-binding site (RBS), responsible for human virus-like receptor specificity, was found to be important for the transmission of the H9N2 viruses in ferrets. In addition, an H9N2 avian-human reassortant virus, which contains the surface glycoprotein genes from an H9N2 virus and the six internal genes of a human H3N2 virus, showed enhanced replication and efficient transmission to direct contacts. Although no aerosol transmission was observed, the virus replicated in multiple respiratory tissues and induced clinical signs similar to those observed with the parental human H3N2 virus. Our results suggest that the establishment and prevalence of H9N2 viruses in poultry pose a significant threat for humans.	[Wan, Hongquan; Sorrell, Erin M.; Song, Haichen; Hossain, Md Jaber; Ramirez-Nieto, Gloria; Perez, Daniel R.] Univ Maryland, Dept Vet Med, Virginia Maryland Regional Coll Vet Med, College Pk, MD USA; [Monne, Isabella; Cattoli, Giovanni; Capua, Ilaria] Viale Univ, Ist Zooprofilattico Sperimentale Venezie, Natl Reference Lab Avian Influenza & Newcastle Dis, FAO, OIE, Padua, Italy; [Stevens, James; Chen, Li-Mei; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Mol Virol & Vaccines Branch, Atlanta, GA USA; [Busch, Julia; Paulson, James C.] Scripps Rese Inst, Dept Chem Physiol, La Jolla, CA USA; [Busch, Julia; Paulson, James C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA USA; [Brockwell, Christy; Webby, Richard] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN USA; [Blanco, Jorge] Virion Syst Inc, Rockville, MD USA; [Al-Natour, Mohammad Q.] Jordan Univ Sci & Technol, Fac Vet Med, Dept Pathol & Anim Hlth, Irbid, Jordan	University System of Maryland; University of Maryland College Park; Food & Agriculture Organization of the United Nations (FAO); IZS delle Venezie; Centers for Disease Control & Prevention - USA; Scripps Research Institute; St Jude Children's Research Hospital; Jordan University of Science & Technology	Wan, HQ (corresponding author), Univ Maryland, Dept Vet Med, Virginia Maryland Regional Coll Vet Med, College Pk, MD USA.	dperez1@umd.edu	Monne, Isabella/K-7652-2016; Webby, Richard J/N-5657-2018; Perez, Daniel R./D-5044-2016; Ramirez-Nieto, Gloria C/N-2600-2018; Paulson, James/AAG-3565-2019; Blanco, Jorge/AAW-3752-2020; Stevens, James/GQH-1081-2022	Monne, Isabella/0000-0002-6564-4689; Perez, Daniel R./0000-0002-6569-5689; Ramirez-Nieto, Gloria C/0000-0002-8313-1609; Wan, Hongquan/0000-0002-6374-0343	CDC-HHS [1U01CI000355]; NIAID-NIH [R01AI052155]; CSREES-USDA [2005-05523]; NIGMS [GM062116]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	CDC-HHS; NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CSREES-USDA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was made possible through funding by the CDC-HHS grant (1U01CI000355), NIAID-NIH, grant (R01AI052155) and CSREES-USDA grant (2005-05523). The authors thank the Scripps Research Institute and the Consortium for Functional Glycomics, funded by NIGMS grant GM062116, for the use of the glycan microarray technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Brown IH, 2006, DEV BIOLOGICALS, V124, P45; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Humberd J, 2006, J VIROL, V80, P2151, DOI 10.1128/JVI.80.5.2151-2161.2006; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Kaverin NV, 2004, J VIROL, V78, P240, DOI 10.1128/JVI.78.1.240-249.2004; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Lee CW, 2000, AVIAN DIS, V44, P527, DOI 10.2307/1593091; LEIGH MW, 1995, VACCINE, V13, P1468, DOI 10.1016/0264-410X(95)00004-K; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Naeem K, 1999, VET REC, V145, P560, DOI 10.1136/vr.145.19.560; Nili H, 2007, AVIAN DIS, V51, P390, DOI 10.1637/7550-033106R1.1; Nili H, 2002, AVIAN PATHOL, V31, P247, DOI 10.1080/03079450220136567; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Perez DR, 2003, AVIAN DIS, V47, P1114, DOI 10.1637/0005-2086-47.s3.1114; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Perk S, 2006, DEV BIOLOGICALS, V124, P201; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; Shi WF, 2008, ARCH VIROL, V153, P211, DOI 10.1007/s00705-007-1083-1; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Song H, 2007, J VIROL, V81, P9238, DOI 10.1128/JVI.00893-07; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; STEVENS J, 2008, J MOL BIOL IN PRESS; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	51	221	248	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2923	10.1371/journal.pone.0002923	http://dx.doi.org/10.1371/journal.pone.0002923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698430	Green Published, gold			2022-12-25	WOS:000264412600009
J	Bergin, DA; Greene, CM; Sterchi, EE; Kenna, C; Geraghty, P; Belaaouaj, A; Taggart, CC; O'Neill, SJ; McElvaney, NG				Bergin, David A.; Greene, Catherine M.; Sterchi, Erwin E.; Kenna, Cliona; Geraghty, Patrick; Belaaouaj, Abderazzaq; Taggart, Clifford C.; O'Neill, Shane J.; McElvaney, Noel G.			Activation of the Epidermal Growth Factor Receptor (EGFR) by a Novel Metalloprotease Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MEPRIN-ALPHA; NEUTROPHIL ELASTASE; MUCIN EXPRESSION; COLORECTAL-CANCER; EPITHELIAL-CELLS; PROTEASES; INFLAMMATION; RESPONSES; MEMBRANE; PROTEINS	Neutrophil Elastase (NE) is a pro-inflammatory protease present at higher than normal levels in the lung during inflammatory disease. NE regulates IL-8 production from airway epithelial cells and can activate both EGFR and TLR4. TACE/ADAM17 has been reported to trans-activate EGFR in response to NE. Here, using 16HBE14o-human bronchial epithelial cells we demonstrate anew mechanism by which NE regulates both of these events. A high molecular weight soluble metalloprotease activity detectable only in supernatants from NE-treated cells by gelatin and casein zymography was confirmed to be meprin alpha by Western immunoblotting. In vitro studies demonstrated the ability of NE to activate meprin alpha, which in turn could release soluble TGF alpha and induce IL-8 production from 16HBE14o-cells. These effects were abrogated by actinonin, a specific meprin inhibitor. NE-induced IL-8 expression was also inhibited by meprin alpha siRNA. Immunoprecipitation studies detected EGFR/TLR4 complexes in NE-stimulated cells overexpressing these receptors. Confocal studies confirmed colocalization of EGFR and TLR4 in 16HBE14o-cells stimulated with meprin alpha. NF kappa B was also activated via MyD88 in these cells by meprin alpha. In bronchoalveolar lavage fluid from NE knock-out mice infected intra-tracheally with Pseudomonas aeruginosa meprin alpha was significantly decreased compared with control mice, and was significantly increased and correlated with NE activity, in bronchoalveolar lavage fluid from individuals with cystic fibrosis but not healthy controls. The data describe a previously unidentified lung metalloprotease meprin alpha, and its role in NE-induced EGFR and TLR4 activation and IL-8 production.	[Bergin, David A.; Greene, Catherine M.; Kenna, Cliona; Geraghty, Patrick; Taggart, Clifford C.; O'Neill, Shane J.; McElvaney, Noel G.] Royal Coll Surgeons Ireland, Resp Res Div, Educ & Res Ctr, Beaumont Hosp,Dept Med, Dublin 9, Ireland; [Sterchi, Erwin E.] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Belaaouaj, Abderazzaq] CHU Reimis, Hosp Maison Blanche, UMR514, INSERM,IFR 53, Reims, France	Royal College of Surgeons - Ireland; University of Bern; CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm)	Greene, CM (corresponding author), Royal Coll Surgeons Ireland, Resp Res Div, Educ & Res Ctr, Beaumont Hosp,Dept Med, Dublin 9, Ireland.	cmgreene@rcsi.ie; c.taggart@qub.ac.uk	McElvaney, Noel/A-6809-2010; A, Bentaher/F-6531-2018; Greene, Catherine M/D-3513-2012; Bentaher, Abderrazzaq/M-4424-2017; Taggart, Clifford C/G-4492-2014	A, Bentaher/0000-0001-6001-5456; Greene, Catherine M/0000-0003-2549-2569; Geraghty, Patrick/0000-0003-1647-5505; mcelvaney, Noel/0000-0002-0152-4370; Taggart, Clifford/0000-0002-9930-2978	The Alpha One Foundation; The Medical Research Charities Group/Health Research Board; The Children's Research Centre; Crumlin Hospital; The Swiss National Science Foundation	The Alpha One Foundation; The Medical Research Charities Group/Health Research Board; The Children's Research Centre; Crumlin Hospital; The Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	This work was supported by The Alpha One Foundation, The Medical Research Charities Group/Health Research Board, The Children's Research Centre, Crumlin Hospital, and The Swiss National Science Foundation.	ABE H, 1994, J LAB CLIN MED, V123, P874; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; BRACHMANN R, 1989, CELL, V56, P691, DOI 10.1016/0092-8674(89)90591-6; Carden D, 1998, AM J PHYSIOL-HEART C, V275, pH385, DOI 10.1152/ajpheart.1998.275.2.H385; Carroll TP, 2005, J IMMUNOL, V175, P7594, DOI 10.4049/jimmunol.175.11.7594; CHOUDRY Y, 1991, BIOCHEM J, V280, P57, DOI 10.1042/bj2800057; CRAIG SS, 1991, J HISTOCHEM CYTOCHEM, V39, P123, DOI 10.1177/39.1.1701182; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; DiCamillo SJ, 2002, J BIOL CHEM, V277, P18938, DOI 10.1074/jbc.M200243200; DORING G, 1994, AM J RESP CRIT CARE, V150, pS114; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Griffin S, 2007, CELL MICROBIOL, V9, P670, DOI 10.1111/j.1462-5822.2006.00819.x; Grogan A, 1997, J CELL SCI, V110, P3071; Hamilton LM, 2003, CLIN EXP ALLERGY, V33, P233, DOI 10.1046/j.1365-2222.2003.01593.x; Hardie WD, 1999, PEDIATR DEVEL PATHOL, V2, P415, DOI 10.1007/s100249900144; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; HIBBS MS, 1987, J CLIN INVEST, V80, P1644, DOI 10.1172/JCI113253; Hirano M, 2005, J IMMUNOL, V175, P3177, DOI 10.4049/jimmunol.175.5.3177; Hirche TO, 2004, AM J RESP CELL MOL, V30, P576, DOI 10.1165/rcmb.2003-0253OC; JANOFF A, 1968, J EXP MED, V128, P1137, DOI 10.1084/jem.128.5.1137; KLINGEMANN HG, 1982, THROMB RES, V28, P793, DOI 10.1016/0049-3848(82)90105-0; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Kohri K, 2002, AM J PHYSIOL-LUNG C, V283, pL531, DOI 10.1152/ajplung.00455.2001; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Kuwahara I, 2006, AM J PHYSIOL-LUNG C, V291, pL407, DOI 10.1152/ajplung.00471.2005; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Liau DF, 1996, BBA-LIPID LIPID MET, V1302, P117, DOI 10.1016/0005-2760(96)00042-2; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Matters GL, 1999, MOL CARCINOGEN, V25, P169, DOI 10.1002/(SICI)1098-2744(199907)25:3<169::AID-MC3>3.0.CO;2-Y; Matters GL, 2005, CLIN EXP METASTAS, V22, P331, DOI 10.1007/s10585-005-0660-5; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Rafiq K, 2008, CIRC RES, V102, P32, DOI 10.1161/CIRCRESAHA.107.150573; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Rosmann S, 2002, J BIOL CHEM, V277, P40650, DOI 10.1074/jbc.M206203200; Rouhani F, 2000, CHEST, V117, p250S, DOI 10.1378/chest.117.5_suppl_1.250S; SALO T, 1991, J BIOL CHEM, V266, P11436; Schlondorff J, 2001, J BIOL CHEM, V276, P14665, DOI 10.1074/jbc.M010741200; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Shao MXG, 2003, P NATL ACAD SCI USA, V100, P11618, DOI 10.1073/pnas.1534804100; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P105, DOI 10.1016/0003-9861(88)90376-1; STROUPE ST, 1991, AM J PHYSIOL, V261, pE354, DOI 10.1152/ajpendo.1991.261.3.E354; Takayama J, 2007, BIOL PHARM BULL, V30, P1905, DOI 10.1248/bpb.30.1905; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Wan YS, 2001, CELL SIGNAL, V13, P139, DOI 10.1016/S0898-6568(00)00146-7; WOLZ RL, 1994, ARCH BIOCHEM BIOPHYS, V310, P144, DOI 10.1006/abbi.1994.1150; Yao PM, 1996, J BIOL CHEM, V271, P15580, DOI 10.1074/jbc.271.26.15580	54	85	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31736	31744		10.1074/jbc.M803732200	http://dx.doi.org/10.1074/jbc.M803732200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18772136	hybrid, Green Published			2022-12-25	WOS:000260760800056
J	Jeganathan, S; Hascher, A; Chinnathambi, S; Biernat, J; Mandelkow, EM; Mandelkow, E				Jeganathan, Sadasivam; Hascher, Antje; Chinnathambi, Subashchandrabose; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard			Proline-directed Pseudo-phosphorylation at AT8 and PHF1 Epitopes Induces a Compaction of the Paperclip Folding of Tau and Generates a Pathological (MC-1) Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; GLYCOGEN-SYNTHASE KINASE-3-BETA; ALZHEIMER-LIKE STATE; PROTEIN-KINASE; MICROTUBULES; BINDING; SERINE; SITES; RECOGNIZES; POLYMERIZATION	Tau, a neuronal microtubule-associated protein that aggregates in Alzheimer disease is a natively unfolded protein. In solution, Tau adopts a "paperclip" conformation, whereby the N- and C-terminal domains approach each other and the repeat domain (Jeganathan, S., von Bergen, M., Brutlach, H., Steinhoff, H. J., and Mandelkow, E. (2006) Biochemistry 45, 2283-2293). In AD, Tau is in a hyperphosphorylated state. The consequences for microtubule binding or aggregation are a matter of debate. We therefore tested whether phosphorylation alters the conformation of Tau. To avoid the ambiguities of heterogeneous phosphorylation we cloned "pseudophosphorylation" mutants of Tau where combinations of Ser or Thr residues were converted into Glu. These mutations were combined with FRET pairs inserted in different locations to allow distance measurements. The results show that the paperclip conformation becomes tighter or looser, depending on the pseudo-phosphorylation state. In particular, pseudo-phosphorylation at the epitope of the diagnostic antibody AT8* (S199E + S202E + T205E) moves the N- terminal domain away from the C-terminal domain. Pseudo-phosphorylation at the PHF1 epitope (S396E + S404E) moves the C-terminal domain away from the repeat domain. In both cases the paperclip conformation is opened up. By contrast, the combination of AT8* and PHF1 sites leads to compaction of the paperclip, such that the N- terminus approaches the repeat domain. The compaction becomes even stronger by combining pseudo-phosphorylated AT8*, AT100, and PHF1 epitopes. This is accompanied by a strong increase in the reaction with conformation-dependent antibody MC1, suggesting the generation of a pathological conformation characteristic for Tau in AD. Furthermore, the compact paperclip conformation enhances the aggregation to paired helical filaments but has little influence on microtubule interactions. The data provide a framework for the global folding of Tau dependent on proline-directed phosphorylation in the domains flanking the repeats and the consequences for pathological properties of Tau.	[Jeganathan, Sadasivam; Hascher, Antje; Chinnathambi, Subashchandrabose; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard] Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany	Max Planck Society	Mandelkow, E (corresponding author), Max Planck Unit Struct Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.	mand@mpasmb.desy.de	Chinnathambi, Subashchandrabose/T-8471-2019	Jeganathan, Sadasivam/0000-0002-2811-2595; Chinnathambi, Subashchandrabose/0000-0002-5468-2129	Deutsche Forschungsgemeinschaft (DFG); Volkswagen (VW) Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Volkswagen (VW) Foundation(Volkswagen)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Volkswagen (VW) Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Barghorn Stefan, 2004, V299, P35; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Berry RW, 2003, BIOCHEMISTRY-US, V42, P8325, DOI 10.1021/bi027348m; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRANDT R, 1994, J BIOL CHEM, V269, P11776; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101; Gamblin TC, 2003, BIOCHEMISTRY-US, V42, P15009, DOI 10.1021/bi035722s; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Ghoshal N, 2001, J NEUROCHEM, V77, P1372, DOI 10.1046/j.1471-4159.2001.00346.x; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kampers T, 1999, FEBS LETT, V451, P39, DOI 10.1016/S0014-5793(99)00522-0; Kim YG, 2008, BIOCONJUGATE CHEM, V19, P786, DOI 10.1021/bc7002499; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MATSUMOTO S, 1975, BIOCHEMISTRY-US, V14, P214, DOI 10.1021/bi00673a004; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Skrabana R, 2004, FEBS LETT, V568, P178, DOI 10.1016/j.febslet.2004.04.098; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	64	171	177	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32066	32076		10.1074/jbc.M805300200	http://dx.doi.org/10.1074/jbc.M805300200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18725412	hybrid			2022-12-25	WOS:000260760800088
J	Dumez, ME; Teller, N; Mercier, F; Tanaka, T; Vandenberghe, I; Vandenbranden, M; Devreese, B; Luxen, A; Frere, JM; Matagne, A; Jacquet, A; Galleni, M; Chevigne, A				Dumez, Marie-Eve; Teller, Nathalie; Mercier, Frederic; Tanaka, Tetsuya; Vandenberghe, Isabel; Vandenbranden, Michel; Devreese, Bart; Luxen, Andre; Frere, Jean-Marie; Matagne, Andre; Jacquet, Alain; Galleni, Moreno; Chevigne, Andy			Activation mechanism of recombinant Der p 3 allergen zymogen - Contribution of cysteine protease Der p 1 and effect of propeptide glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUST-MITE ALLERGEN; HUMAN CATIONIC TRYPSINOGEN; GROUP-III ALLERGEN; DERMATOPHAGOIDES-PTERONYSSINUS; SERINE-PROTEASE; SLOW-BINDING; CATHEPSIN-B; CLONING; PURIFICATION; INHIBITION	The trypsin-like protease Der p 3, a major allergen of the house dust mite Dermatophagoides pteronyssinus, is synthesized as a zymogen, termed proDer p 3. No recombinant source of Der p 3 has been described yet, and the zymogen maturation mechanism remains to be elucidated. The Der p 3 zymogen was produced in Pichia pastoris. We demonstrated that the recombinant zymogen is glycosylated at the level of its propeptide. We showed that the activation mechanism of proDer p 3 is intermolecular and is mediated by the house dust mite cysteine protease Der p 1. The primary structure of the proDer p 3 propeptide is associated with a unique zymogen activation mechanism, which is different from those described for the trypsin-like family and relies on the house dust mite papain-like protease Der p 1. This is the first report of a recombinant source of Der p 3, with the same enzymatic activity as the natural enzyme and trypsin. Glycosylation of the propeptide was found to decrease the rate of maturation. Finally, we showed that recombinant Der p 3 is inhibited by the free modified prosequence TP1R.	[Tanaka, Tetsuya; Jacquet, Alain; Chevigne, Andy] Free Univ Brussels, Lab Allergol Expt, Inst Biol & Med Mol, Brussels, Belgium; [Dumez, Marie-Eve; Frere, Jean-Marie; Matagne, Andre; Galleni, Moreno; Chevigne, Andy] Univ Liege, Ctr Prot Engn, Lab Enzymol, B-4000 Liege, Belgium; [Teller, Nathalie; Mercier, Frederic; Luxen, Andre] Univ Liege, Ctr Rech Cyclotron, B-4000 Liege, Belgium; [Vandenberghe, Isabel; Devreese, Bart] Lab Prot Biochem & Prot Engn, B-9000 Ghent, Belgium; [Vandenbranden, Michel] Free Univ Brussels, Lab Struct & Fonct Membranes Biol, B-1050 Brussels, Belgium; [Dumez, Marie-Eve] Fonds Rech Ind & Agr, Brussels, Belgium; [Matagne, Andre; Chevigne, Andy] Natl Fund Sci Res, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Liege; University of Liege; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Fonds de la Recherche Scientifique - FNRS	Jacquet, A (corresponding author), Free Univ Brussels, Lab Allergol Expt, Inst Biol & Med Mol, Gosselies Charleroi 6041, Brussels, Belgium.	alain.jacquet@ulb.ac.be; mgalleni@ulg.ac.be	Devreese, Bart/B-2011-2009; Jacquet, Alain/T-8611-2019; Jacquet, Alain/GQI-0546-2022; luxen, andre/C-2116-2009; Devreese, Bart/K-2841-2019	Devreese, Bart/0000-0002-9764-2581; Jacquet, Alain/0000-0002-0980-9741; Jacquet, Alain/0000-0002-0980-9741; Devreese, Bart/0000-0002-9764-2581; Chevigne, Andy/0000-0003-4768-6743; Matagne, Andre/0000-0001-6417-6791	Fonds de la Recherche Fondamentale et Collective [2.4550.05, 2.4511.06, 1.5.209.07, 2.4561.07]	Fonds de la Recherche Fondamentale et Collective(Fonds de la Recherche Scientifique - FNRS)	This work was supported in part by Fonds de la Recherche Fondamentale et Collective Grants 2.4561.07, 1.5.209.07, 2.4511.06 and 2.4550.05 by the Direction Generale des Technologies de la Recherche et de l'Energie, Region Wallonne, and by GlaxoSmithKline Biologicals (Rixensart, Belgium). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact.	ANDO T, 1993, CLIN EXP ALLERGY, V23, P777, DOI 10.1111/j.1365-2222.1993.tb00366.x; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Bennett BJ, 1996, CLIN EXP ALLERGY, V26, P1150, DOI 10.1111/j.1365-2222.1996.tb00501.x; BRODRICK JW, 1978, J BIOL CHEM, V253, P2732; BRUNGER AT, 1987, BIOCHEMISTRY-US, V26, P5153; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; Chen JM, 2003, MOL BIOL EVOL, V20, P1767, DOI 10.1093/molbev/msg183; Cheong N, 2003, ALLERGY, V58, P352, DOI 10.1034/j.1398-9995.2003.00033.x; Chevigne A, 2007, J MOL BIOL, V374, P170, DOI 10.1016/j.jmb.2007.08.025; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Frick TW, 1997, GUT, V41, P339, DOI 10.1136/gut.41.3.339; Gombos L, 2008, BIOCHEMISTRY-US, V47, P1675, DOI 10.1021/bi701454e; GREENBAUM LM, 1959, J BIOL CHEM, V234, P2885; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hales BJ, 2006, J ALLERGY CLIN IMMUN, V118, P361, DOI 10.1016/j.jaci.2006.04.001; HALFON S, 2004, HDB PROTEOLYTIC ENZY, P1483; Harris J, 2004, CHEM BIOL, V11, P1361, DOI 10.1016/j.chembiol.2004.08.008; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Jacquet A, 2002, CLIN EXP ALLERGY, V32, P1048, DOI 10.1046/j.1365-2222.2002.01437.x; KAY J, 1971, J BIOL CHEM, V246, P6661; King C, 1996, J ALLERGY CLIN IMMUN, V98, P739, DOI 10.1016/S0091-6749(96)70121-5; Kukor Z, 2003, EUR J BIOCHEM, V270, P2047, DOI 10.1046/j.1432-1033.2003.03581.x; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Lazure C, 2002, CURR PHARM DESIGN, V8, P511, DOI 10.2174/1381612023395691; Lund O., 2002, CASP5 C, pA102; Maruo K, 1997, J ALLERGY CLIN IMMUN, V100, P253, DOI 10.1016/S0091-6749(97)70233-1; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; Morrison J.F., 1985, COMMENTS MOL CELL BI, V2, P347; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Nishiyama C, 1995, FEBS LETT, V377, P62, DOI 10.1016/0014-5793(95)01291-5; Pasternak A, 1998, BIOCHEMISTRY-US, V37, P16201, DOI 10.1021/bi980951d; PLATTSMILLS TAE, 1987, J ALLERGY CLIN IMMUN, V80, P755, DOI 10.1016/S0091-6749(87)80261-0; Quraishi O, 2001, J BIOL CHEM, V276, P8118, DOI 10.1074/jbc.M005851200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schulz O, 1998, J CLIN PATHOL-MOL PA, V51, P222, DOI 10.1136/mp.51.4.222; Smith WA, 1996, INT ARCH ALLERGY IMM, V109, P133, DOI 10.1159/000237212; SMITH WA, 1994, CLIN EXP ALLERGY, V24, P220, DOI 10.1111/j.1365-2222.1994.tb00223.x; STEWART GA, 1989, LANCET, V2, P154, DOI 10.1016/S0140-6736(89)90203-1; STEWART GA, 1992, IMMUNOLOGY, V75, P29; STEWART GA, 1989, LANCET, V2, P462; STEWART GA, 1994, ALLERGY, V49, P553, DOI 10.1111/j.1398-9995.1994.tb01128.x; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Szilagyi L, 2001, J BIOL CHEM, V276, P24574, DOI 10.1074/jbc.M011374200; Takai T, 2006, INT ARCH ALLERGY IMM, V139, P181, DOI 10.1159/000091163; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; VANSTOKKUM IHM, 1995, BIOCHEMISTRY-US, V34, P10508, DOI 10.1021/bi00033a024; Vernon HM, 1914, BIOCHEM J, V8, P494, DOI 10.1042/bj0080494; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; YASUEDA H, 1993, CLIN EXP ALLERGY, V23, P384, DOI 10.1111/j.1365-2222.1993.tb00343.x	52	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30606	30617		10.1074/jbc.M803041200	http://dx.doi.org/10.1074/jbc.M803041200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18725410	Green Published, hybrid			2022-12-25	WOS:000260544800084
J	Mariappan, MM; Shetty, M; Sataranatarajan, K; Choudhury, GG; Kasinath, BS				Mariappan, Meenalakshmi M.; Shetty, Megan; Sataranatarajan, Kavithalakshmi; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.			Glycogen Synthase Kinase 3 beta Is a Novel Regulator of High Glucose- and High Insulin-induced Extracellular Matrix Protein Synthesis in Renal Proximal Tubular Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; SIGNAL-TRANSDUCTION PATHWAYS; SKELETAL-MUSCLE; GROWTH-FACTOR; CARDIAC-HYPERTROPHY; DIABETIC-NEPHROPATHY; GENE-EXPRESSION; POTENTIAL ROLE; PHOSPHORYLATION; KINASE-3-BETA	High glucose (30 mM) and high insulin (1 nM), pathogenic factors of type 2 diabetes, increased mRNA expression and synthesis of laminin beta 1 and fibronectin after 24 h of incubation in kidney proximal tubular epithelial (MCT) cells. We tested the hypothesis that inactivation of glycogen synthase kinase 3 beta(GSK3 beta) by high glucose and high insulin induces increase in synthesis of laminin beta 1 via activation of eIF2B epsilon. Both high glucose and high insulin induced Ser-9 phosphorylation and inactivation of GSK3 beta at 2 h that lasted for up to 48 h. This was associated with dephosphorylation of eIF2B epsilon and eEF2, and increase in phosphorylation of 4E-BP1 and eIF4E. Expression of the kinase-dead mutant of GSK3 beta or constitutively active kinase led to increased and diminished laminin beta 1 synthesis, respectively. Incubation with selective kinase inhibitors showed that high glucose- and high insulin-induced laminin beta 1 synthesis and phosphorylation of GSK3 beta were dependent on PI 3-kinase, Erk, and mTOR. High glucose and high insulin augmented activation of Akt, Erk, and p70S6 kinase. Dominant negative Akt, but not dominant negative p70S6 kinase, inhibited GSK3 beta phosphorylation induced by high glucose and high insulin, suggesting Akt but not p70S6 kinase was upstream of GSK3 beta. Status of GSK3 beta was examined in vivo in renal cortex of db/db mice with type 2 diabetes at 2 weeks and 2 months of diabetes. Diabetic mice showed increased phosphorylation of renal cortical GSK3 beta and decreased phosphorylation of eIF2B epsilon, which correlated with renal hypertrophy at 2 weeks, and increased laminin beta 1 and fibronectin protein content at 2 months. GSK3 beta and eIF2B epsilon play a role in augmented protein synthesis associated with high glucose- and high insulin-stimulated hypertrophy and matrix accumulation in renal disease in type 2 diabetes.	[Mariappan, Meenalakshmi M.; Shetty, Megan; Sataranatarajan, Kavithalakshmi; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, OBrien Kidney Res Ctr, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Kasinath, BS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med MC7882, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Kasinath@uthscsa.edu			National Institutes of Health [DK061597, DK077295, DK050190]; Juvenile Diabetes Research Foundation [3-2007-245, 1-2008-185]; American Diabetes Association [7-05-RA-60]; Veterans Administration Research Service; American Heart Association [SDG 0630283N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK050190, R01DK050190, P50DK061597, R01DK077295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Veterans Administration Research Service(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK061597 and DK077295 (to B. S. K.) and DK050190 (to G. G. C.). These studies were also supported by Juvenile Diabetes Research Foundation Grants 3-2007-245 (to M. M. M. and B. S. K.) and 1-2008-185 (to G. G. C.), American Diabetes Association Grant 7-05-RA-60 (to B. S. K.), the Veterans Administration Research Service (to B. S. K. and G. G. C.), and American Heart Association Grant SDG 0630283N (to D. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Beurel E, 2004, EXP CELL RES, V300, P354, DOI 10.1016/j.yexcr.2004.08.001; Bhandari BK, 2001, KIDNEY INT, V59, P866; Chen JC, 2006, J AM SOC NEPHROL, V17, P1615, DOI 10.1681/ASN.2005111163; Choudhury GG, 2001, J BIOL CHEM, V276, P35636, DOI 10.1074/jbc.M100946200; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cordes N, 2003, BRIT J CANCER, V88, P1470, DOI 10.1038/sj.bjc.6600912; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cui H, 1998, DEV BRAIN RES, V111, P177, DOI 10.1016/S0165-3806(98)00136-9; DAMSBO P, 1991, DIABETOLOGIA, V34, P239, DOI 10.1007/BF00405082; De Servi B, 2005, ONCOGENE, V24, P4946, DOI 10.1038/sj.onc.1208676; DENG H, 2008, J BIOL CHEM; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Feliers D, 2001, KIDNEY INT, V60, P495, DOI 10.1046/j.1523-1755.2001.060002495.x; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Ha TS, 1999, J AM SOC NEPHROL, V10, P1931; Hagen T, 2006, J BIOL CHEM, V281, P35021, DOI 10.1074/jbc.M607003200; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kasinath B. S., 2003, CONT DIABETES DIABET, P97; Kasinath BS, 2006, J AM SOC NEPHROL, V17, P3281, DOI 10.1681/ASN.2006050488; Kerkela R, 2007, TRENDS CARDIOVAS MED, V17, P91, DOI 10.1016/j.tcm.2007.01.004; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; LAUGHLIN MR, 1990, AM J PHYSIOL, V258, pE184, DOI 10.1152/ajpendo.1990.258.1.E184; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Mariappan MM, 2005, J BIOL CHEM, V280, P28402, DOI 10.1074/jbc.M504861200; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Nikoulina SE, 1997, DIABETES, V46, P1017, DOI 10.2337/diabetes.46.6.1017; Ossipova O, 2003, NAT CELL BIOL, V5, P889, DOI 10.1038/ncb1048; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; Rhoads RE, 1999, J BIOL CHEM, V274, P30337, DOI 10.1074/jbc.274.43.30337; Sakaguchi M, 2006, BIOCHEM BIOPH RES CO, V340, P296, DOI 10.1016/j.bbrc.2005.12.012; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Senthil D, 2003, KIDNEY INT, V64, P468, DOI 10.1046/j.1523-1755.2003.00135.x; Senthil D, 2002, BIOCHEM J, V368, P49, DOI 10.1042/BJ20020137; Senthil D, 2002, AM J PHYSIOL-RENAL, V283, pF1226, DOI 10.1152/ajprenal.00109.2002; Senthil D, 2001, BIOCHEM J, V360, P87, DOI 10.1042/0264-6021:3600087; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Thornton S, 2003, J MOL MED, V81, P536, DOI 10.1007/s00109-003-0461-8; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019	58	56	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30566	30575		10.1074/jbc.M801756200	http://dx.doi.org/10.1074/jbc.M801756200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18701453	hybrid, Green Published			2022-12-25	WOS:000260544800015
J	Dines, M; Sendersky, E; David, L; Schwarz, R; Adir, N				Dines, Monica; Sendersky, Eleonora; David, Liron; Schwarz, Rakefet; Adir, Noam			Structural, Functional, and Mutational Analysis of the NblA Protein Provides Insight into Possible Modes of Interaction with the Phycobilisome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIUM SYNECHOCOCCUS-VULCANUS; CRYSTAL-STRUCTURE ANALYSIS; ANABAENA SP PCC-7120; 2.2 ANGSTROM; THERMAL-STABILITY; C-PHYCOCYANIN; DEGRADATION; CRYSTALLIZATION; EXPRESSION; NITROGEN	The enormous macromolecular phycobilisome antenna complex (>4 MDa) in cyanobacteria and red algae undergoes controlled degradation during certain forms of nutrient starvation. The NblA protein (similar to 6 kDa) has been identified as an essential component in this process. We have used structural, biochemical, and genetic methods to obtain molecular details on the mode of action of the NblA protein. We have determined the three-dimensional structure of the NblA protein from both the thermophilic cyanobacterium Thermosynechococcus vulcanus and the mesophilic cyanobacterium Synechococcus elongatus sp. PCC 7942. The NblA monomer has a helix-loop-helix motif which dimerizes into an open, four-helical bundle, identical to the previously determined NblA structure from Anabaena. Previous studies indicated that mutations to NblA residues near the C terminus impaired its binding to phycobilisome proteins in vitro, whereas the only mutation known to affect NblA function in vivo is located near the protein N terminus. We performed random mutagenesis of the S. elongatus nblA gene which enabled the identification of four additional amino acids crucial for NblA function in vivo. This data shows that essential amino acids are not confined to the protein termini. We also show that expression of the Anabaena nblA gene complements phycobilisome degradation in an S. elongatus NblA-null mutant despite the low homology between NblAs of these cyanobacteria. We propose that the NblA interacts with the phycobilisome via "structural mimicry" due to similarity in structural motifs found in all phycobiliproteins. This suggestion leads to a new model for the mode of NblA action which involves the entire NblA protein.	[Sendersky, Eleonora; Schwarz, Rakefet] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Dines, Monica; David, Liron; Adir, Noam] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Technion, Haifa, Israel; [Dines, Monica; David, Liron; Adir, Noam] Technion Israel Inst Technol, Inst Catalysis Sci & Technol, IL-32000 Technion, Haifa, Israel	Bar Ilan University; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Schwarz, R (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	schwarr2@mail.biu.ac.il; nadir@tx.technion.ac.il	Adir, Noam/ABE-6990-2020		Israel Science Foundation [1045/06, 683/03-17.1]; German Israel Foundation [I-729-27.9/2002]	Israel Science Foundation(Israel Science Foundation); German Israel Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the Israel Science Foundation founded by the Israel Academy of Sciences and Humanities (Grants 1045/06 and 683/03-17.1 (to N. A. and R. S., respectively) and German Israel Foundation Grant I-729-27.9/2002 (to R. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Adir N, 2002, BBA-BIOENERGETICS, V1556, P168, DOI 10.1016/S0005-2728(02)00359-6; Adir N, 2001, J MOL BIOL, V313, P71, DOI 10.1006/jmbi.2001.5030; ADIR N, 2006, MICROBIOLOGY MONOGRA, P47; APT KE, 1995, J MOL BIOL, V248, P79, DOI 10.1006/jmbi.1995.0203; Baier K, 2004, MICROBIOL-SGM, V150, P2739, DOI 10.1099/mic.0.27153-0; Baier K, 2001, FEMS MICROBIOL LETT, V195, P35, DOI 10.1111/j.1574-6968.2001.tb10494.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bienert R, 2006, J BIOL CHEM, V281, P5216, DOI 10.1074/jbc.M507243200; BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Contreras-Martel C, 2001, ACTA CRYSTALLOGR D, V57, P52, DOI 10.1107/S0907444900015274; de Alda JAGO, 2004, MICROBIOL-SGM, V150, P1377, DOI 10.1099/mic.0.26992-0; Dines M, 2007, J STRUCT BIOL, V158, P116, DOI 10.1016/j.jsb.2006.10.021; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Lahmi R, 2006, J BACTERIOL, V188, P5258, DOI 10.1128/JB.00209-06; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li H, 2002, ARCH MICROBIOL, V178, P256, DOI 10.1007/s00203-002-0446-y; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; Luque I, 2003, MOL MICROBIOL, V50, P1043, DOI 10.1046/j.1365-2958.2003.03768.x; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCREE DE, 1999, PRACTICAL PROTEIN CH, P2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OTWINOWSKI Z, 1993, DATA COLLECTION PROC; Parbel A, 2000, INT J PHOTOENERGY, V2, P31, DOI 10.1155/S1110662X00000052; Perelman A, 2004, BIOTECHNIQUES, V36, P948, DOI 10.2144/04366BM05; Reuter W, 1999, P NATL ACAD SCI USA, V96, P1363, DOI 10.1073/pnas.96.4.1363; Richaud C, 2001, J BACTERIOL, V183, P2989, DOI 10.1128/JB.183.10.2989-2994.2001; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; Schmidt M, 2006, BBA-PROTEINS PROTEOM, V1764, P55, DOI 10.1016/j.bbapap.2005.10.022; Schuermann JP, 2003, ACTA CRYSTALLOGR D, V59, P1731, DOI 10.1107/S0907444903015725; Schwarz R, 1998, P NATL ACAD SCI USA, V95, P11008, DOI 10.1073/pnas.95.18.11008; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sendersky E, 2005, MOL MICROBIOL, V58, P659, DOI 10.1111/j.1365-2958.2005.04844.x; Sheldrick GM, 1998, NATO ADV SCI I C-MAT, V507, P131; Strauss H, 2002, EUR J BIOCHEM, V269, P4617, DOI 10.1046/j.1432-1033.2002.03161.x; van Waasbergen LG, 2002, J BACTERIOL, V184, P2481, DOI 10.1128/JB.184.9.2481-2490.2002; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3	45	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30330	30340		10.1074/jbc.M804241200	http://dx.doi.org/10.1074/jbc.M804241200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18718907	hybrid, Green Published			2022-12-25	WOS:000260366900077
J	Lee, JY; Mogen, JL; Chavez, A; Johnson, FB				Lee, Julia Y.; Mogen, Jonathan L.; Chavez, Alejandro; Johnson, F. Brad			Sgs1 RecQ Helicase Inhibits Survival of Saccharomyces cerevisiae Cells Lacking Telomerase and Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNERS-SYNDROME GENES; LARGE DNA PALINDROME; BUDDING YEAST; GENOMIC INSTABILITY; REPLICATION FORKS; SYNDROME PROTEIN; STRAND SYNTHESIS; BLOOMS-SYNDROME; MAINTENANCE; SENESCENCE	In yeast telomerase mutants, the Sgs1 RecQ helicase slows the rate of senescence and also facilitates the appearance of certain types of survivors of critical telomere shortening via mechanisms dependent on Rad52-dependent homologous recombination (HR). Here we describe a third function for Sgs1 in telomerase-deficient cells, inhibition of survivors that grow independent of Rad52. Unlike tlc1 rad52 double mutants, which do not form survivors of telomere dysfunction, tlc1 rad52 sgs1 triple mutants readily generated survivors. After emerging from growth crisis, the triple mutants progressively lost telomeric and subtelomeric sequences, yet grew for more than 1 year. Analysis of cloned chromosome termini and of copy number changes of loci genome-wide using tiling arrays revealed terminal deletions extending up to 57 kb, as well as changes in Ty retrotransposon copy numbers. Amplification of the remaining terminal sequences generated large palindromes at some chromosome termini. Sgs1 helicase activity but not checkpoint function was essential for inhibiting the appearance of the survivors, and the continued absence of Sgs1 was required for the growth of the established survivors. Thus, in addition to facilitating the maintenance of telomere repeat sequences via HR-dependent mechanisms, a RecQ helicase can prevent the adoption of HR-independent mechanisms that stabilize chromosome termini without the use of natural telomere sequences. This provides a novel mechanism by which RecQ helicases may help maintain genome integrity and thus prevent age-related diseases and cancer.	[Lee, Julia Y.; Mogen, Jonathan L.; Chavez, Alejandro; Johnson, F. Brad] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lee, Julia Y.] St Josephs Univ, Dept Biol, Philadelphia, PA 19131 USA	University of Pennsylvania; Saint Joseph's University	Johnson, FB (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	johnsonb@mail.med.upenn.edu			National Institutes of Health [5R01AG021521]; Ruth L. Kirschstein National Research Service Award [F32 AG22769-01]; NATIONAL INSTITUTE ON AGING [R01AG021521, F32AG022769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01AG021521 (National Institute on Aging) (to F. B. J.). This work was also supported by Ruth L. Kirschstein National Research Service Award F32 AG22769-01 (to J. Y. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMBERG DC, 2005, METHODS YEAST GENETI, P43; Azam M, 2006, NUCLEIC ACIDS RES, V34, P506, DOI 10.1093/nar/gkj452; BATEMAN AJ, 1975, NATURE, V253, P379, DOI 10.1038/253379a0; Beamish H, 2002, J BIOL CHEM, V277, P30515, DOI 10.1074/jbc.M203801200; Bennett RJ, 1999, J MOL BIOL, V289, P235, DOI 10.1006/jmbi.1999.2739; Bertuch AA, 2006, CURR OPIN CELL BIOL, V18, P247, DOI 10.1016/j.ceb.2006.04.005; Bjergbaek L, 2005, EMBO J, V24, P405, DOI 10.1038/sj.emboj.7600511; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Bryk M, 2001, MOL CELL BIOL, V21, P5374, DOI 10.1128/MCB.21.16.5374-5388.2001; Bucholc M, 2001, MOL CELL BIOL, V21, P6559, DOI 10.1128/MCB.21.19.6559-6573.2001; Butler DK, 1996, CELL, V87, P1115, DOI 10.1016/S0092-8674(00)81805-X; BUTLER DK, 1995, MOL CELL BIOL, V15, P7117; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Campisi J, 2008, AGING CELL, V7, P281, DOI 10.1111/j.1474-9726.2008.00383.x; CAVALIER.T, 1974, NATURE, V250, P467, DOI 10.1038/250467a0; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Cohen H, 2001, P NATL ACAD SCI USA, V98, P3174, DOI 10.1073/pnas.061579598; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Doe CL, 2002, J BIOL CHEM, V277, P32753, DOI 10.1074/jbc.M202120200; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Frei C, 2000, GENE DEV, V14, P81; Gaskell LJ, 2007, EMBO J, V26, P1891, DOI 10.1038/sj.emboj.7601645; GERRING SL, 1991, METHOD ENZYMOL, V194, P57; Han FP, 2006, P NATL ACAD SCI USA, V103, P3238, DOI 10.1073/pnas.0509650103; Hayashi N, 2002, MOL GENET GENOMICS, V267, P806, DOI 10.1007/s00438-002-0712-3; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kaneko H, 1999, CLIN EXP IMMUNOL, V118, P285; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lillard-Wetherell K, 2005, CANCER RES, V65, P5520, DOI 10.1158/0008-5472.CAN-05-0632; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Maringele L, 2004, GENETICS, V166, P1641, DOI 10.1534/genetics.166.4.1641; Maxwell PH, 2007, GENE DEV, V21, P3308, DOI 10.1101/gad.1604707; Maxwell PH, 2004, MOL CELL BIOL, V24, P9887, DOI 10.1128/MCB.24.22.9887-9898.2004; McVey M, 2001, GENETICS, V157, P1531; MERCHLINSKY M, 1990, J VIROL, V64, P3437, DOI 10.1128/JVI.64.7.3437-3446.1990; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Mullen JR, 2000, GENETICS, V154, P1101; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Onoda F, 2004, DNA REPAIR, V3, P1355, DOI 10.1016/j.dnarep.2004.05.008; Opresko PL, 2008, MECH AGEING DEV, V129, P79, DOI 10.1016/j.mad.2007.10.007; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Palaniyar N, 1999, J MOL BIOL, V287, P9, DOI 10.1006/jmbi.1999.2586; Pardue ML, 2005, CHROMOSOME RES, V13, P443, DOI 10.1007/s10577-005-0993-6; POCHART P, 1993, NUCLEIC ACIDS RES, V21, P3513, DOI 10.1093/nar/21.15.3513; Qin ZJ, 2000, GENE DEV, V14, P1789; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; Scholes DT, 2003, P NATL ACAD SCI USA, V100, P15736, DOI 10.1073/pnas.2136609100; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tanaka Hisashi, 2006, Hum Cell, V19, P17, DOI 10.1111/j.1749-0774.2005.00003.x; Tanaka H, 2007, MOL CELL BIOL, V27, P1993, DOI 10.1128/MCB.01313-06; Teng SC, 1999, MOL CELL BIOL, V19, P8083; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; VOYTAS DF, 2001, MOBILE DNA, V2, P631; Watt PM, 1996, GENETICS, V144, P935; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897; Yu X, 1999, MOL CELL, V4, P873, DOI 10.1016/S1097-2765(00)80397-4; Zhang ZH, 2007, GENOME RES, V17, P503, DOI 10.1101/gr.6049107	79	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29847	29858		10.1074/jbc.M804760200	http://dx.doi.org/10.1074/jbc.M804760200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18757364	Green Published, hybrid			2022-12-25	WOS:000260366900029
J	Sanders, C; Turkarslan, S; Lee, DW; Onder, O; Kranz, RG; Daldal, F				Sanders, Carsten; Turkarslan, Serdar; Lee, Dong-Woo; Onder, Ozlem; Kranz, Robert G.; Daldal, Fevzi			The Cytochrome c Maturation Components CcmF, CcmH, and CcmI Form a Membrane-integral Multisubunit Heme Ligation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOBACTER-CAPSULATUS; RHODOPSEUDOMONAS-CAPSULATA; APOCYTOCHROME-C; PHOTOSYNTHETIC GROWTH; BIOGENESIS DEFECT; NULL MUTANTS; PROTEIN; SPHAEROIDES; PATHWAY; MITOCHONDRIA	Cytochrome c maturation (Ccm) is a post-translational and post-export protein modification process that involves ten (CcmABCDEFGHI and CcdA or DsbD) components in most Gram-negative bacteria. The absence of any of these components abolishes the ability of cells to form cytochrome c, leading in the case of Rhodobacter capsulatus to the loss of photosynthetic proficiency and respiratory cytochrome oxidase activity. Based on earlier molecular genetic studies, we inferred that R. capsulatus CcmF, CcmH, and CcmI interact with each other to perform heme-apocytochrome c ligation. Here, using functional epitope-tagged derivatives of these components coproduced in appropriate mutant strains, we determined protein-protein interactions between them in detergent-dispersed membranes. Reciprocal affinity purification as well as tandem size exclusion and affinity chromatography analyses provided the first biochemical evidence that CcmF, CcmH, and CcmI associate stably with each other, indicating that these Ccm components form a membrane-integral complex. Under the conditions used, the CcmFHI complex does not contain CcmG, suggesting that the latter thio-reduction component is not always associated with the heme ligation components. The findings are discussed with respect to defining the obligatory components of a minimalistic heme-apocytochrome c ligation complex in R. capsulatus.	[Sanders, Carsten; Turkarslan, Serdar; Lee, Dong-Woo; Onder, Ozlem; Daldal, Fevzi] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kranz, Robert G.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of Pennsylvania; Washington University (WUSTL)	Daldal, F (corresponding author), 433 S Univ Ave 103B Lynch Bldg, Philadelphia, PA 19104 USA.	fdaldal@sas.upenn.edu	Onder, Ozlem/AAA-5301-2020	Onder, Ozlem/0000-0003-0850-1216	National Institutes of Health [GM38237, GM47909]; Department of Energy [91ER20052]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047909, R01GM038237, R55GM047909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	fThis work was supported, in whole or in part, by National Institutes of Health Grant GM38237 (to F. D.) and GM47909 (to R. G. K.). This work was also supported by Department of Energy Grant 91ER20052 (to F. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENNING C, 1992, J BACTERIOL, V174, P2352, DOI 10.1128/JB.174.7.2352-2360.1992; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; DALDAL F, 1986, P NATL ACAD SCI USA, V83, P2012, DOI 10.1073/pnas.83.7.2012; Deshmukh M, 2003, J BACTERIOL, V185, P3361, DOI 10.1128/JB.185.11.3361-3372.2003; Deshmukh M, 2002, MOL MICROBIOL, V46, P1069, DOI 10.1046/j.1365-2958.2002.03212.x; Di Matteo A, 2007, J BIOL CHEM, V282, P27012, DOI 10.1074/jbc.M702702200; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; Erlendsson LS, 2003, J BIOL CHEM, V278, P17852, DOI 10.1074/jbc.M300103200; Erlendsson LS, 2002, J BACTERIOL, V184, P1423, DOI 10.1128/JB.184.5.1423-1429.2002; Fabianek RA, 1999, ARCH MICROBIOL, V171, P92, DOI 10.1007/s002030050683; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; Giege P, 2004, FEBS LETT, V563, P165, DOI 10.1016/S0014-5793(04)00291-1; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; Han D, 2008, PROTEINS, V70, P900, DOI 10.1002/prot.21597; JENNEY FE, 1993, EMBO J, V12, P1283, DOI 10.1002/j.1460-2075.1993.tb05773.x; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KEEN NT, 1988, GENE, V70, P1991; Koch HG, 1998, METHOD ENZYMOL, V297, P81; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang SE, 1996, J BACTERIOL, V178, P5279, DOI 10.1128/jb.178.17.5279-5290.1996; Lee JH, 2007, BBA-BIOMEMBRANES, V1768, P2164, DOI 10.1016/j.bbamem.2007.04.022; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Monika EM, 1997, J MOL BIOL, V271, P679, DOI 10.1006/jmbi.1997.1227; Myllykallio H, 1999, P NATL ACAD SCI USA, V96, P4348, DOI 10.1073/pnas.96.8.4348; Pettigrew G.W., 1987, CYTOCHROMES C BIOL A; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Sambrook J, 2001, MOL CLONING LAB MANU; Sanders C, 2005, J BACTERIOL, V187, P4245, DOI 10.1128/JB.187.12.4245-4256.2005; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; SANDERS C, 2008, PURPLE PHOTOTROPHIC, P407; SANDERS C, 2005, PHOTOSYNTHESIS FUNDA, P421; Sanders C, 2007, J BACTERIOL, V189, P789, DOI 10.1128/JB.01441-06; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; SISTROM WR, 1960, J GEN MICROBIOL, V22, P778, DOI 10.1099/00221287-22-3-778; Turkarslan S, 2006, MOL MICROBIOL, V60, P537, DOI 10.1111/j.1365-2958.2006.05148.x; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x; YEN HC, 1979, J MOL BIOL, V131, P157, DOI 10.1016/0022-2836(79)90071-8	39	35	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29715	29722		10.1074/jbc.M805413200	http://dx.doi.org/10.1074/jbc.M805413200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18753134	hybrid, Green Published			2022-12-25	WOS:000260366900015
J	Bocharov, EV; Mayzel, ML; Volynsky, PE; Goncharuk, MV; Ermolyuk, YS; Schulga, AA; Artemenko, EO; Efremov, RG; Arseniev, AS				Bocharov, Eduard V.; Mayzel, Maxim L.; Volynsky, Pavel E.; Goncharuk, Marina V.; Ermolyuk, Yaroslav S.; Schulga, Alexey A.; Artemenko, Elena O.; Efremov, Roman G.; Arseniev, Alexander S.			Spatial Structure and pH-dependent Conformational Diversity of Dimeric Transmembrane Domain of the Receptor Tyrosine Kinase EphA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN SKIN; PROTEIN; ACTIVATION; EXPRESSION; HYPOXIA; EPHRINS; STABILITY; SEQUENCE; BICELLES	Eph receptors are found in a wide variety of cells in developing and mature tissues and represent the largest family of receptor tyrosine kinases, regulating cell shape, movements, and attachment. The receptor tyrosine kinases conduct biochemical signals across plasma membrane via lateral dimerization in which their transmembrane domains play an important role. Structural-dynamic properties of the homodimeric transmembrane domain of the EphA1 receptor were investigated with the aid of solution NMR in lipid bicelles and molecular dynamics in explicit lipid bilayer. EphA1 transmembrane segments associate in a right-handed parallel alpha-helical bundle, region (544-569)(2), through the N-terminal glycine zipper motif A(550)X(3)G(554)X(3)G(558). Under acidic conditions, the N terminus of the transmembrane helix is stabilized by an N-capping box formed by the uncharged carboxyl group of Glu(547), whereas its deprotonation results in a rearrangement of hydrogen bonds, fractional unfolding of the helix, and a realignment of the helix-helix packing with appearance of additional minor dimer conformation utilizing seemingly the C-terminal GG4-like dimerization motif A(560)X(3)G(564). This can be interpreted as the ability of the EphA1 receptor to adjust its response to ligand binding according to extracellular pH. The dependence of the pK(a) value of Glu(547) and the dimer conformational equilibrium on the lipid head charge suggests that both local environment and membrane surface potential can modulate dimerization and activation of the receptor. This makes the EphA1 receptor unique among the Eph family, implying its possible physiological role as an "extracellular pH sensor," and can have relevant physiological implications.	[Bocharov, Eduard V.; Mayzel, Maxim L.; Volynsky, Pavel E.; Artemenko, Elena O.; Efremov, Roman G.; Arseniev, Alexander S.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Div Struct Biol, Moscow 117997, Russia; [Goncharuk, Marina V.; Ermolyuk, Yaroslav S.; Schulga, Alexey A.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Prot Engn, Moscow 117997, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Bocharov, EV (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Div Struct Biol, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	bon@nmr.ru; aars@nmr.ru	Volynsky, Pavel/A-8360-2014; Mayzel, Maksim/AAM-1393-2020; Goncharuk, Marina/V-1558-2018; Schulga, Alexey/T-3856-2018; Roman, Efremov/A-7460-2014	Volynsky, Pavel/0000-0002-0471-4188; Schulga, Alexey/0000-0003-3425-0828; Roman, Efremov/0000-0002-5474-4721	Russian Foundation for Basic Research [06-04-49740, 07-04-01514, 08-04-01372]; Russian Federation Federal Agency for Science and Innovations [02.512.12.0019]; Russian Funds Investment Group	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI)); Russian Funds Investment Group	This work was supported by the Russian Foundation for Basic Research (Grant 06-04-49740 and in part by Grants 07-04-01514 and 08-04-01372), the Russian Federation Federal Agency for Science and Innovations (State Contract 02.512.12.0019), and the Russian Funds Investment Group. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; [Anonymous], 1997, Cell, V90, P403; ARSENIEV AS, 1984, FEBS LETT, V165, P57, DOI 10.1016/0014-5793(84)80014-9; Artemenko EO, 2008, BBA-BIOMEMBRANES, V1778, P2361, DOI 10.1016/j.bbamem.2008.06.003; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Bocharov EV, 2008, J BIOL CHEM, V283, P6950, DOI 10.1074/jbc.M709202200; Bocharov EV, 2007, J BIOL CHEM, V282, P16256, DOI 10.1074/jbc.M701745200; Bocharov EV, 2002, J BIOL CHEM, V277, P46273, DOI 10.1074/jbc.M206274200; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; CHAKRABARTI P, 1975, BIOCHEMISTRY-US, V14, P5021, DOI 10.1021/bi00694a001; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Coulthard MG, 2001, GROWTH FACTORS, V18, P303, DOI 10.3109/08977190109029118; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doig AJ, 2002, BIOPHYS CHEM, V101, P281, DOI 10.1016/S0301-4622(02)00170-9; EFREMOV RG, 1995, J PHYS CHEM-US, V99, P10658, DOI 10.1021/j100026a033; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Fonseca NA, 2008, PROTEINS, V70, P188, DOI 10.1002/prot.21525; Gauthier LR, 2003, LIFE SCI, V74, P207, DOI 10.1016/j.lfs.2003.09.029; Gerlai R, 2001, NAT REV NEUROSCI, V2, P205, DOI 10.1038/35058582; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Hafner C, 2006, MODERN PATHOL, V19, P1369, DOI 10.1038/modpathol.3800660; Halloran MC, 2006, CURR OPIN CELL BIOL, V18, P533, DOI 10.1016/j.ceb.2006.08.010; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Iqbalsyah TM, 2004, PROTEIN SCI, V13, P32, DOI 10.1110/ps.03341804; Ivanov AI, 2006, IUBMB LIFE, V58, P389, DOI 10.1080/15216540600756004; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Langosch D, 1998, PROTEINS, V31, P150, DOI 10.1002/(SICI)1097-0134(19980501)31:2<150::AID-PROT5>3.0.CO;2-Q; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MARKLEY JL, 1975, ACCOUNTS CHEM RES, V8, P70, DOI 10.1021/ar50086a004; Masuda J, 2008, J BIOL CHEM, V283, P13148, DOI 10.1074/jbc.M702164200; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Orekhov VY, 1995, APPL MAGN RESON, V9, P581, DOI 10.1007/BF03162365; Pabbisetty KB, 2007, PROTEIN SCI, V16, P355, DOI 10.1110/ps.062608807; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Prosser RS, 2006, BIOCHEMISTRY-US, V45, P8453, DOI 10.1021/bi060615u; Raghunand N, 2003, BRIT J RADIOL, V76, pS11, DOI 10.1259/bjr/12913493; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmid-Wendtner MH, 2006, SKIN PHARMACOL PHYS, V19, P296, DOI 10.1159/000094670; Smith SO, 1996, NAT STRUCT BIOL, V3, P252, DOI 10.1038/nsb0396-252; Struppe J, 2000, BIOPHYS J, V78, P281, DOI 10.1016/S0006-3495(00)76591-X; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; SZYPERSKI T, 1994, BIOCHEMISTRY-US, V33, P9303, DOI 10.1021/bi00197a034; Vearing CJ, 2005, GROWTH FACTORS, V23, P67, DOI 10.1080/08977190500055869; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; WAGNER G, 1983, J AM CHEM SOC, V105, P5948, DOI 10.1021/ja00356a056; Wagner H, 2003, EUR J PHARM BIOPHARM, V55, P57, DOI 10.1016/S0939-6411(02)00125-X; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Xu K, 2006, J APPL PHYSIOL, V100, P725, DOI 10.1152/japplphysiol.00940.2005; Zhu HJ, 2003, GROWTH FACTORS, V21, P15, DOI 10.1080/0897719031000096424; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	67	93	95	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29385	29395		10.1074/jbc.M803089200	http://dx.doi.org/10.1074/jbc.M803089200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728013	Green Published, hybrid			2022-12-25	WOS:000260179900065
J	Flannery, AR; Stevens, TH				Flannery, Andrew R.; Stevens, Tom H.			Functional Characterization of the N-terminal Domain of Subunit H (Vma13p) of the Yeast Vacuolar ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; MUTATIONAL ANALYSIS; PROTON PUMPS; ACIDIFICATION; MEMBRANE; ENCODES; COMPLEX; CELLS; PCR	The yeast Saccharomyces cerevisiae vacuolar H+-ATPase (V-ATPase) is a multisubunit complex responsible for acidifying intracellular organelles and is highly regulated. One of the regulatory subunits, subunit H, is encoded by the VMA13 gene in yeast and is composed of two domains, the N-terminal domain (amino acids (aa) 1-352) and the C-terminal domain (aa 353 478). The N-terminal domain is required for the activation of the complex, whereas the C-terminal domain is required for coupling ATP hydrolysis to proton translocation (Liu, M., Tarsio, M., Charsky, C. M., and Kane, P. M. (2005) J. Biol. Chem. 280, 36978-36985). Experiments with epitope-tagged copies of Vma13p revealed that there is only one copy of Vma13p/subunit H per V-ATPase complex. Analysis of the N-terminal domain shows that the first 179 amino acids are not required for the activation and full function of the V-ATPase complex and that the minimal region of Vma13p/subunit H capable of activating the V-ATPase is aa 180-353 of the N-terminal domain. Subunit H is expressed as two splice variants in mammals, and deletion of 18 amino acids in yeast Vma13p corresponding to the mammalian subunit H beta isoform results in reduced V-ATPase activity and significantly lower coupling of ATPase hydrolysis to proton translocation. Intriguingly, the yeast Vma13p mimicking the mammalian subunit H beta isoform is functionally equivalent to Vma13p lacking the entire C-terminal domain. These results suggest that the mammalian V-ATPase complexes with subunit H splice variant SFD-alpha or SFD-beta are likely to have different activities and may perform distinct cellular functions.	[Stevens, Tom H.] Univ Oregon, Dept Chem, Eugene, OR 97403 USA; [Stevens, Tom H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Flannery, Andrew R.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	University of Oregon; University of Oregon; Yale University	Stevens, TH (corresponding author), Univ Oregon, Dept Chem, Eugene, OR 97403 USA.	stevens@molbio.uoregon.edu		Stevens, Tom/0000-0001-6427-6848	National Institutes of Health [GM38006];  [5 T32 GM007759-30]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759, R01GM038006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM38006 (to T. H. S.) and Training Grant 5 T32 GM007759-30 (to A. R. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Conibear E, 2002, METHOD ENZYMOL, V351, P408; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Davis-Kaplan SR, 2006, J BIOL CHEM, V281, P32025, DOI 10.1074/jbc.M606451200; FENG Y, 1992, J BIOL CHEM, V267, P5817; Flannery AR, 2004, J BIOL CHEM, V279, P39856, DOI 10.1074/jbc.M406767200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; HO MN, 1993, J BIOL CHEM, V268, P18286; Hui DQ, 1999, MAMM GENOME, V10, P266, DOI 10.1007/s003359900984; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; NOTHWEHR SF, 1995, J CELL BIOL, V129, P35, DOI 10.1083/jcb.129.1.35; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Rizzo JM, 2007, J BIOL CHEM, V282, P8521, DOI 10.1074/jbc.M607092200; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith AN, 2005, J AM SOC NEPHROL, V16, P1245, DOI 10.1681/ASN.2004090761; Sun-Wada GH, 2003, J BIOENERG BIOMEMBR, V35, P347, DOI 10.1023/A:1025780932403; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; XIE XS, 1994, J BIOL CHEM, V269, P25809; Xu YF, 1999, BIOTECHNIQUES, V26, P639, DOI 10.2144/99264bm10; Zhou ZM, 1999, J BIOL CHEM, V274, P15913, DOI 10.1074/jbc.274.22.15913; Zhou ZM, 1998, J BIOL CHEM, V273, P5878, DOI 10.1074/jbc.273.10.5878	33	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29099	29108		10.1074/jbc.M803280200	http://dx.doi.org/10.1074/jbc.M803280200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708638	Green Published, hybrid			2022-12-25	WOS:000260179900037
J	Lin, KT; Sloniowski, S; Ethell, DW; Ethell, IM				Lin, Kai-Ti; Sloniowski, Slawomir; Ethell, Douglas W.; Ethell, Iryna M.			Ephrin-B2-induced Cleavage of EphB2 Receptor Is Mediated by Matrix Metalloproteinases to Trigger Cell Repulsion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC SPINE MORPHOGENESIS; TYROSINE-PHOSPHATASE; R-RAS; ACTIVATION; KINASE; NOTCH; MATRIX-METALLOPROTEINASE-9; RHO; PROTEOLYSIS; ENDOCYTOSIS	EphB receptors provide crucial adhesive and repulsive signals during cell migration and axon guidance, but it is unclear how they switch between these opposing responses. Here we provide evidence of an important role for matrix metalloproteinases (MMPs) in repulsive EphB2 signaling. We found that EphB2 is cleaved by MMPs both in vitro and in vivo, and that this cleavage is induced by interaction with its ligand ephrin-B2. Our findings demonstrate that MMP-2/MMP-9-specific inhibition or cleavage-resistant mutations in the ectodomain of EphB2 can prevent EphB2-mediated cell-cell repulsion in HEK293 cells, and block ephrin-B1-induced growth cone withdrawal in cultured hippocampal neurons. Transient expression of wtEphB2, but not noncleavable EphB2-4/5 mutant, restored ephrin-B1-induced growth cone collapse and withdrawal in EphB-deficient neurons. The inhibition of EphB2 cleavage also had potent regulatory effects on EphB2 activity. This study provides the first evidence that MMP-mediated cleavage of EphB2 is induced by receptor-ligand interactions at the cell surface and that this event triggers cell-repulsive responses.	[Lin, Kai-Ti; Sloniowski, Slawomir; Ethell, Douglas W.; Ethell, Iryna M.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Ethell, IM (corresponding author), Univ Calif Riverside, Div Biomed Sci, 900 Univ Ave, Riverside, CA 92521 USA.	iryna.ethell@ucr.edu	Lin, Kai-Ti/B-3840-2016	Lin, Kai-Ti/0000-0001-8656-5755; Ethell, Iryna/0000-0002-1324-6611; Ethell, Douglas/0000-0002-9237-0265	National Institutes of Health [MH67121]; Dorothy M. Pease Fund for Cancer Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorothy M. Pease Fund for Cancer Research; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH67121 (to I. E.). This work was also supported by the Dorothy M. Pease Fund for Cancer Research (to K. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bilousova TV, 2006, J NEUROCHEM, V97, P44, DOI 10.1111/j.1471-4159.2006.03701.x; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Parri M, 2005, J BIOL CHEM, V280, P34008, DOI 10.1074/jbc.M502879200; PASQUALE EB, 1991, CELL REGUL, V2, P523, DOI 10.1091/mbc.2.7.523; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Ulrich R, 2005, DEV NEUROSCI-BASEL, V27, P408, DOI 10.1159/000088455; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Yong VW, 2007, NEUROTHERAPEUTICS, V4, P580, DOI 10.1016/j.nurt.2007.07.005; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	42	82	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28969	28979		10.1074/jbc.M804401200	http://dx.doi.org/10.1074/jbc.M804401200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18713744	Green Published, hybrid			2022-12-25	WOS:000260179900022
J	Makino, CL; Peshenko, IV; Wen, XH; Olshevskaya, EV; Barrett, R; Dizhoor, AM				Makino, Clint L.; Peshenko, Igor V.; Wen, Xiao-Hong; Olshevskaya, Elena V.; Barrett, Ronald; Dizhoor, Alexander M.			A Role for GCAP2 in Regulating the Photoresponse GUANYLYL CYCLASE ACTIVATION AND ROD ELECTROPHYSIOLOGY IN GUCA1B KNOCK-OUT MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOTRANSDUCTION CASCADE; PROTEINS GCAPS; CALCIUM; EXPRESSION; CGMP; CLONING; RETGC; CA2+; PHOSPHODIESTERASE; INACTIVATION	Cyclic GMP serves as the second messenger in visual transduction, linking photon absorption by rhodopsin to the activity of ion channels. Synthesis of cGMP in photoreceptors is supported by a pair of retina-specific guanylyl cyclases, retGC1 and -2. Two neuronal calcium sensors, GCAP1 and GCAP2, confer Ca2+ sensitivity to guanylyl cyclase activity, but the importance and the contribution of each GCAP is controversial. To explore this issue, the gene GUCA1B, coding for GCAP2, was disrupted in mice, and the capacity for knock-out rods to regulate retGC and generate photoresponses was tested. The knock-out did not compromise rod viability or alter outer segment ultrastructure. Levels of retGC1, retGC2, and GCAP-1 expression did not undergo compensatory changes, but the absence of GCAP2 affected guanylyl cyclase activity in two ways; (a) the maximal rate of cGMP synthesis at low [Ca2+] dropped 2-fold and (b) the half-maximal rate of cGMP synthesis was attained at a higher than normal [Ca2+]. The addition of an antibody raised against mouse GCAP2 produced similar effects on the guanylyl cyclase activity in wild type retinas. Flash responses of GCAP2 knockout rods recovered more slowly than normal. Knock-out rods became more sensitive to flashes and to steps of illumination but tended to saturate at lower intensities, as compared with wild type rods. Therefore, GCAP2 regulation of guanylyl cyclase activity quickens the recovery of flash and step responses and adjusts the operating range of rods to higher intensities of ambient illumination.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, PA Coll Optometry, Basic Sci & Hafter Res Labs, Elkins Pk, PA 19027 USA; [Makino, Clint L.; Wen, Xiao-Hong] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Makino, Clint L.; Wen, Xiao-Hong] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Barrett, Ronald] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Wayne State University	Dizhoor, AM (corresponding author), Salus Univ, PA Coll Optometry, Basic Sci & Hafter Res Labs, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu	Makino, Clint Lawrence/H-8428-2019	Makino, Clint Lawrence/0000-0002-6005-9069; Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health [EY11522, EY011358, EY014104]; Massachusetts Lions Eye Research Fund; Pennsylvania Lions Sight Conservation and Eye Research Foundation; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE [P30EY014104, R01EY011358, R29EY011358, R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research Fund; Pennsylvania Lions Sight Conservation and Eye Research Foundation; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY11522, EY011358, and EY014104. This work was also supported by the Massachusetts Lions Eye Research Fund, the Pennsylvania Lions Sight Conservation and Eye Research Foundation, and the Pennsylvania Department of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; BUSH RA, 2006, NEURONAL CALCIUM SEN, P153; Calvert PD, 2002, ADV EXP MED BIOL, V514, P37; Chen CH, 2003, J PHYSIOL-LONDON, V553, P125, DOI 10.1113/jphysiol.2003.053280; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Duda T, 2005, BIOCHEMISTRY-US, V44, P7336, DOI 10.1021/bi050068x; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Garbers DL, 1999, METHODS, V19, P477, DOI 10.1006/meth.1999.0890; GILLESPIE PG, 1989, P NATL ACAD SCI USA, V86, P4311, DOI 10.1073/pnas.86.11.4311; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Hurley JB, 2000, METHOD ENZYMOL, V315, P708; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Jeon CJ, 1998, J NEUROSCI, V18, P8936; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P891, DOI 10.1085/jgp.106.5.891; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Lyubarsky A, 1996, J GEN PHYSIOL, V107, P19, DOI 10.1085/jgp.107.1.19; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; Makino CL, 2003, CURR OPIN NEUROBIOL, V13, P404, DOI 10.1016/S0959-4388(03)00091-6; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Moriondo A, 2003, PHOTOCH PHOTOBIO SCI, V2, P1292, DOI 10.1039/b303871h; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Philippov PP, 2006, NEURONAL CALCIUM SEN, P139; Sagoo MS, 1997, NATURE, V389, P392, DOI 10.1038/38750; SITARAMAYYA A, 1986, BIOCHEMISTRY-US, V25, P651, DOI 10.1021/bi00351a021; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Woodruff ML, 2008, J NEUROSCI, V28, P2064, DOI 10.1523/JNEUROSCI.2973-07.2008; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602	52	68	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29135	29143		10.1074/jbc.M804445200	http://dx.doi.org/10.1074/jbc.M804445200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18723510	Green Published, hybrid			2022-12-25	WOS:000260179900041
J	Manchekar, M; Richardson, PE; Sun, Z; Liu, Y; Segrest, JP; Dashti, N				Manchekar, Medha; Richardson, Paul E.; Sun, Zhihuan; Liu, Yanwen; Segrest, Jere P.; Dashti, Nassrin			Charged Amino Acid Residues 997-1000 of Human Apolipoprotein B100 Are Critical for the Initiation of Lipoprotein Assembly and the Formation of a Stable Lipidated Primordial Particle in McA-RH7777 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; TRIGLYCERIDE TRANSFER PROTEIN; B-CONTAINING LIPOPROTEINS; RAT HEPATOMA-CELLS; HEP G2 CELLS; ENDOPLASMIC-RETICULUM; APO-B; INTRACELLULAR DEGRADATION; CRYOELECTRON MICROSCOPY; SECRETORY PATHWAY	We previously demonstrated that a portion, or perhaps all, of the residues between 931 and 1000 of apolipoprotein (apo) B100 are required for the initiation of apoB-containing particle assembly. Based on our structural model of the first 1000 residues of apoB (designated as apoB:1000), we hypothesized that this domain folds into a three-sided lipovitellin-like "lipid pocket" via a hairpinbridge mechanism.We proposed that salt bridges are formed between four tandem charged residues 717-720 in the turn of the hairpin bridge and four tandem complementary residues 997-1000 located at the C-terminal end of the model. To identify the specific motif within residues 931 and 1000 that is critical for apoB particle assembly, apoB:956 and apoB:986 were produced. To test the hairpin-bridge hypothesis, the following mutations were made: 1) residues 997-1000 deletion (apoB:996), 2) residues 717-720 deletion (apoB:1000 Delta 717-720), and 3) substitution of charged residues 997-1000 with alanines(apoB:996+4Ala). Characterization of particles secreted by stable transformants of McA-RH7777 cells demonstrated the following. 1) ApoB:956 did not form stable particles and was secreted as large lipid-rich aggregates. 2) ApoB:986 formed both a lipidated particle that was denser than HDL3 and large lipid-rich aggregates. 3) Compared with wild-type apoB:1000, apoB:1000 Delta 717-720 displayed the following: (i) significantly diminished capacity to form intact lipidated particles and (ii) increased propensity to form large lipid-rich aggregates. 4) Instriking contrast to wild-type apoB:1000, (i) apoB:996 and apoB:996+4Ala were highly susceptible to intracellular degradation, (ii) only a small proportion of the secreted proteins formed stable HDL3-like lipoproteins, and (iii) a majority of the secreted proteins formed large lipid-rich aggregates. We conclude that the first 1000 amino acid residues of human apoB100 are required for the initiation of nascent apoB-containing lipoprotein assembly, and residues 717-720 and 997-1000 play key roles in this process, perhaps via a hairpinbridge mechanism.	[Manchekar, Medha; Sun, Zhihuan; Liu, Yanwen; Segrest, Jere P.; Dashti, Nassrin] Univ Alabama Birmingham, Atherosclerosis Res Unit, Basic Sci Sect, Dept Med, Birmingham, AL 35294 USA; [Segrest, Jere P.] Univ Alabama Birmingham, Med Ctr, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Dashti, Nassrin] Univ Alabama Birmingham, Med Ctr, Dept Cell Biol, Birmingham, AL 35294 USA; [Richardson, Paul E.] Coastal Carolina Univ, Dept Chem & Phys, Conway, SC 29528 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Coastal Carolina University	Dashti, N (corresponding author), Univ Alabama Birmingham, Dept Med, 1808 7th Ave S,BDB-D680, Birmingham, AL 35292 USA.	ndashti@uab.edu			National Institutes of Health [HL084685, PO1 HL34343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084685, P01HL034343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084685 and PO1 HL34343. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson TA, 1998, STRUCT FOLD DES, V6, P895, DOI 10.1016/S0969-2126(98)00091-4; ATKINSON D, 1977, P NATL ACAD SCI USA, V74, P1042, DOI 10.1073/pnas.74.3.1042; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; BOSTROM K, 1986, J BIOL CHEM, V261, P3800; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cardozo C, 2002, BIOCHEMISTRY-US, V41, P10105, DOI 10.1021/bi025749w; Carraway M, 2000, BIOCHEMISTRY-US, V39, P9737, DOI 10.1021/bi000791h; Cavallo D, 1998, J BIOL CHEM, V273, P33397, DOI 10.1074/jbc.273.50.33397; Cavallo D, 1999, J BIOL CHEM, V274, P23135, DOI 10.1074/jbc.274.33.23135; CHATTERTON JE, 1995, J LIPID RES, V36, P2027; CHEN GC, 1989, BIOCHEMISTRY-US, V28, P2477, DOI 10.1021/bi00432a019; CHEN SH, 1986, J BIOL CHEM, V261, P2918; CHUNG BH, 1986, METHOD ENZYMOL, V128, P181; CLADARAS C, 1986, EMBO J, V5, P3495, DOI 10.1002/j.1460-2075.1986.tb04675.x; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dashti N, 2002, BIOCHEMISTRY-US, V41, P6978, DOI 10.1021/bi011757l; Dashti N, 2002, J NUTR, V132, P2651, DOI 10.1093/jn/132.9.2651; DASHTI N, 1992, J BIOL CHEM, V267, P7160; Dashti N, 2007, J BIOL CHEM, V282, P28597, DOI 10.1074/jbc.M700229200; DECKELBAUM RJ, 1977, J BIOL CHEM, V252, P744; DECKELBAUM RJ, 1975, SCIENCE, V190, P392, DOI 10.1126/science.170681; DELOOF H, 1987, J LIPID RES, V28, P1455; Dixon JL, 2002, J HISTOCHEM CYTOCHEM, V50, P629, DOI 10.1177/002215540205000504; DIXON JL, 1993, J LIPID RES, V34, P167; DIXON JL, 1991, J BIOL CHEM, V266, P5080; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; ELOVSON J, 1988, J LIPID RES, V29, P1461; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fisher EA, 2001, J BIOL CHEM, V276, P27855, DOI 10.1074/jbc.M008885200; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gantz DL, 2000, J LIPID RES, V41, P1464; Gordon DA, 1997, CURR OPIN LIPIDOL, V8, P131, DOI 10.1097/00041433-199706000-00002; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johs A, 2006, J BIOL CHEM, V281, P19732, DOI 10.1074/jbc.M601688200; KANE JP, 1983, ANNU REV PHYSIOL, V45, P637, DOI 10.1146/annurev.ph.45.030183.003225; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liao W, 1998, J BIOL CHEM, V273, P27225, DOI 10.1074/jbc.273.42.27225; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manchekar M, 2004, J BIOL CHEM, V279, P39757, DOI 10.1074/jbc.M406302200; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; Orlova EV, 1999, P NATL ACAD SCI USA, V96, P8420, DOI 10.1073/pnas.96.15.8420; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; PULLINGER CR, 1989, J LIPID RES, V30, P1065; RAAG R, 1988, J MOL BIOL, V200, P553, DOI 10.1016/0022-2836(88)90542-6; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; SCHUMAKER VN, 1994, ADV PROTEIN CHEM, V45, P205; Segrest JP, 1998, J LIPID RES, V39, P85; Segrest JP, 1999, J LIPID RES, V40, P1401; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; Segrest JP, 2001, J LIPID RES, V42, P1346; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674, DOI 10.1161/01.ATV.14.10.1674; SHARROCK WJ, 1992, J MOL BIOL, V226, P903, DOI 10.1016/0022-2836(92)90642-W; Shelness GS, 2003, J BIOL CHEM, V278, P44702, DOI 10.1074/jbc.M307562200; SHOULDERS CC, 1994, NAT STRUCT BIOL, V1, P285, DOI 10.1038/nsb0594-285; SPARKS JD, 1990, J BIOL CHEM, V265, P8854; SPIN JM, 1995, BIOPHYS J, V68, P2115, DOI 10.1016/S0006-3495(95)80392-9; van Antwerpen R, 1999, J LIPID RES, V40, P1827; WANG CN, 1995, J BIOL CHEM, V270, P24924, DOI 10.1074/jbc.270.42.24924; WHITE AL, 1992, J BIOL CHEM, V267, P15657; Yamaguchi J, 2006, J BIOL CHEM, V281, P27063, DOI 10.1074/jbc.M606809200; YANG CY, 1989, ARTERIOSCLEROSIS, V9, P96, DOI 10.1161/01.ATV.9.1.96; YAO ZM, 1992, J BIOL CHEM, V267, P1175; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777; Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649	68	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29251	29265		10.1074/jbc.M804912200	http://dx.doi.org/10.1074/jbc.M804912200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18725409	Green Published, hybrid			2022-12-25	WOS:000260179900052
J	Di Natale, C; Martinelli, E; Paolesse, R; D'Amico, A; Filippini, D; Lundstrom, I				Di Natale, Corrado; Martinelli, Eugenio; Paolesse, Roberto; D'Amico, Arnaldo; Filippini, Daniel; Lundstrom, Ingemar			An Experimental Biomimetic Platform for Artificial Olfaction	PLOS ONE			English	Article								Artificial olfactory systems have been studied for the last two decades mainly from the point of view of the features of olfactory neuron receptor fields. Other fundamental olfaction properties have only been episodically considered in artificial systems. As a result, current artificial olfactory systems are mostly intended as instruments and are of poor benefit for biologists who may need tools to model and test olfactory models. Herewith, we show how a simple experimental approach can be used to account for several phenomena observed in olfaction. An artificial epithelium is formed as a disordered distributed layer of broadly selective color indicators dispersed in a transparent polymer layer. The whole epithelium is probed with colored light, imaged with a digital camera and the olfactory response upon exposure to an odor is the change of the multispectral image. The pixels are treated as olfactory receptor neurons, whose optical properties are used to build a convergence classifier into a number of mathematically defined artificial glomeruli. A non-homogenous exposure of the test structure to the odours gives rise to a time and spatial dependence of the response of the different glomeruli strikingly similar to patterns observed in the olfactory bulb. The model seems to mimick both the formation of glomeruli, the zonal nature of olfactory epithelium, and the spatio-temporal signal patterns at the glomeruli level. This platform is able to provide a readily available test vehicle for chemists developing optical indicators for chemical sensing purposes and for biologists to test models of olfactory system organization.	[Di Natale, Corrado; Martinelli, Eugenio; D'Amico, Arnaldo] Univ Roma Tor Vergata, Dept Elect Engn, Rome, Italy; [Paolesse, Roberto] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy; [Filippini, Daniel; Lundstrom, Ingemar] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden	University of Rome Tor Vergata; University of Rome Tor Vergata; Linkoping University	Di Natale, C (corresponding author), Univ Roma Tor Vergata, Dept Elect Engn, Rome, Italy.	dinatale@uniroma2.it	Di Natale, Corrado/M-8701-2014; Paolesse, Roberto/AAI-3182-2020; Martinelli, Eugenio/AAA-9105-2019; Paolesse, Roberto/B-8966-2013	Di Natale, Corrado/0000-0002-0543-4348; Martinelli, Eugenio/0000-0002-6673-2066; Paolesse, Roberto/0000-0002-2380-1404				Acebes A, 2001, J NEUROSCI, V21, P6264, DOI 10.1523/JNEUROSCI.21-16-06264.2001; Anslyn EV, 2007, J ORG CHEM, V72, P687, DOI 10.1021/jo0617971; Di Natale C, 2005, IEEE SENS J, V5, P1165, DOI 10.1109/JSEN.2005.858932; Dickinson TA, 1999, ANAL CHEM, V71, P2192, DOI 10.1021/ac981457i; Dickinson TA, 1996, NATURE, V382, P697, DOI 10.1038/382697a0; Filippini D, 2003, CHEM COMMUN, P240, DOI 10.1039/b210677a; Filippini D, 2006, ANGEW CHEM INT EDIT, V45, P3800, DOI 10.1002/anie.200600050; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Galizia CG, 2000, CURR OPIN NEUROBIOL, V10, P504, DOI 10.1016/S0959-4388(00)00109-4; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Kent PF, 2003, BRAIN RES, V981, P1, DOI 10.1016/S0006-8993(03)02512-5; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; PERSAUD K, 1982, NATURE, V299, P352, DOI 10.1038/299352a0; Rakow NA, 2000, NATURE, V406, P710, DOI 10.1038/35021028; Rock F, 2008, CHEM REV, V108, P705, DOI 10.1021/cr068121q; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Scott JW, 1997, J NEUROPHYSIOL, V77, P1950, DOI 10.1152/jn.1997.77.4.1950; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207	24	45	45	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3139	10.1371/journal.pone.0003139	http://dx.doi.org/10.1371/journal.pone.0003139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769554	gold, Green Published, Green Submitted			2022-12-25	WOS:000264419100007
J	Wang, FL; Grigorieva, EV; Li, JF; Senchenko, VN; Pavlova, TV; Anedchenko, EA; Kudryavtseva, AV; Tsimanis, A; Angeloni, D; Lerman, MI; Kashuba, VI; Klein, G; Zabarovsky, ER				Wang, Fuli; Grigorieva, Elvira V.; Li, Jingfeng; Senchenko, Vera N.; Pavlova, Tatiana V.; Anedchenko, Ekaterina A.; Kudryavtseva, Anna V.; Tsimanis, Alexander; Angeloni, Debora; Lerman, Michael I.; Kashuba, Vladimir I.; Klein, George; Zabarovsky, Eugene R.			HYAL1 and HYAL2 Inhibit Tumour Growth In Vivo but Not In Vitro	PLOS ONE			English	Article							HUMAN-CHROMOSOME 3P21.3; HUMAN EPITHELIAL MALIGNANCIES; JAAGSIEKTE SHEEP RETROVIRUS; HOMOZYGOUS DELETION REGION; REAL-TIME PCR; SUPPRESSOR GENE; CELL FUSION; LUNG; INACTIVATION; HYALURONAN	Background: We identified two 3p21.3 regions (LUCA and AP20) as most frequently affected in lung, breast and other carcinomas and reported their fine physical and gene maps. It is becoming increasingly clear that each of these two regions contains several TSGs. Until now TSGs which were isolated from AP20 and LUCA regions (e. g. G21/NPRL2, RASSF1A, RASSF1C, SEMA3B, SEMA3F, RBSP3) were shown to inhibit tumour cell growth both in vitro and in vivo. Methodology/Principal Findings: The effect of expression HYAL1 and HYAL2 was studied by colony formation inhibition, growth curve and cell proliferation tests in vitro and tumour growth assay in vivo. Very modest growth inhibition was detected in vitro in U2020 lung and KRC/Y renal carcinoma cell lines. In the in vivo experiment stably transfected KRC/Y cells expressing HYAL1 or HYAL2 were inoculated into SCID mice (10 and 12 mice respectively). Tumours grew in eight mice inoculated with HYAL1. Ectopic HYAL1 was deleted in all of them. HYAL2 was inoculated into 12 mice and only four tumours were obtained. In 3 of them the gene was deleted. In one tumour it was present but not expressed. As expected for tumour suppressor genes HYAL1 and HYAL2 were down-expressed in 15 fresh lung squamous cell carcinomas (100%) and clear cell RCC tumours (60-67%). Conclusions/Significance: The results suggest that the expression of either gene has led to inhibition of tumour growth in vivo without noticeable effect on growth in vitro. HYAL1 and HYAL2 thus differ in this aspect from other tumour suppressors like P53 or RASSF1A that inhibit growth both in vitro and in vivo. Targeting the microenvironment of cancer cells is one of the most promising venues of cancer therapeutics. As major hyaluronidases in human cells, HYAL1 and HYAL2 may control intercellular interactions and microenvironment of tumour cells providing excellent targets for cancer treatment.	[Wang, Fuli; Grigorieva, Elvira V.; Li, Jingfeng; Pavlova, Tatiana V.; Kashuba, Vladimir I.; Klein, George; Zabarovsky, Eugene R.] Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden; [Grigorieva, Elvira V.] SD RAMS, Inst Mol Biol & Biophys, Novosibirsk, Russia; [Senchenko, Vera N.; Pavlova, Tatiana V.; Anedchenko, Ekaterina A.; Kudryavtseva, Anna V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Tsimanis, Alexander] Bioactivity Ltd, Rehovot, Israel; [Angeloni, Debora; Lerman, Michael I.] NCI, Ctr Canc Res, Lab Immunobiol, Canc Causing Genes Sect, Frederick, MD USA; [Angeloni, Debora] CNR, Inst Clin Physiol, Scuola Superiore SantAnna, Pisa, Italy; [Kashuba, Vladimir I.] Ukrainian Acad Scie, Inst Mol Biol & Genet, Kiev, Ukraine	Karolinska Institutet; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Scuola Superiore Sant'Anna; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Wang, FL (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden.	eugzab@ki.se	Zabarovsky, Eugene R/A-6645-2010; Kudryavtseva, Anna V/C-9032-2014; Senchenko, Vera N/C-8992-2014; Grigorieva, Elvira/A-4937-2010; Kashuba, Vladimir/AAO-7742-2020; Kashuba, Vladimir I/N-3732-2017	Kudryavtseva, Anna V/0000-0002-3722-8207; Senchenko, Vera N/0000-0002-3119-515X; Grigorieva, Elvira/0000-0003-2457-9179; Kashuba, Vladimir I/0000-0001-9416-8282; Angeloni, Debora/0000-0002-3850-5392; Pavlova, Tatiana/0000-0002-2857-5696	Swedish Cancer Society; Swedish Research Council; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish Institute; Royal Swedish Academy of Sciences; INTAS; Karolinska Institute; Russian Federal Agency of Science and Innovations [02.512.11.21.01, 02.512.11.2241]; Russian Foundation for Basic Research [008-04-01577]; Concern Foundation in Los Angeles [fellowship]; Cancer Research Institute in New York; Intramural Research Program of the Center for Cancer Research, National Cancer Institute	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish Institute; Royal Swedish Academy of Sciences; INTAS(INTASEuropean Commission); Karolinska Institute(Karolinska Institutet); Russian Federal Agency of Science and Innovations(Federal Agency for Science & Innovations (FASI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Concern Foundation in Los Angeles; Cancer Research Institute in New York; Intramural Research Program of the Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grants from the Swedish Cancer Society, the Swedish Research Council, the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), the Swedish Institute, the Royal Swedish Academy of Sciences, INTAS and Karolinska Institute. VNS, EAA and AVK received grants from the Russian Federal Agency of Science and Innovations (State Contract no 02.512.11.21.01 and 02.512.11.2241) and the Russian Foundation for Basic Research (Project no. 008-04-01577). EVG was recipient of fellowship from the Concern Foundation in Los Angeles and the Cancer Research Institute in New York. TVP was supported by fellowship from The Swedish Institute. MIL and DA were supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimov A, 2000, ONCOGENE, V19, P1392, DOI 10.1038/sj.onc.1203449; Braga E, 2002, INT J CANCER, V100, P534, DOI 10.1002/ijc.10511; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Danilkovitch-Miagkova A, 2003, P NATL ACAD SCI USA, V100, P4580, DOI 10.1073/pnas.0837136100; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Frost GI, 2000, ONCOGENE, V19, P870, DOI 10.1038/sj.onc.1203317; GLANTZ SA, 1994, PRIMER BIOSTATISTICS, P1; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HARRIS H, 1969, NATURE, V223, P363, DOI 10.1038/223363a0; Heppell-Parton AC, 1999, CANCER GENET CYTOGEN, V108, P110, DOI 10.1016/S0165-4608(98)00130-7; Imreh S, 2003, GENE CHROMOSOME CANC, V38, P307, DOI 10.1002/gcc.10271; Ji L, 2002, CANCER RES, V62, P2715; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Klein G, 2007, ADV CANCER RES, V98, P1, DOI 10.1016/S0065-230X(06)98001-4; Kosaki R, 1999, CANCER RES, V59, P1141; Lerman MI, 2000, CANCER RES, V60, P6116; Li F, 2004, CANCER RES, V64, P6438, DOI 10.1158/0008-5472.CAN-03-3869; Li JF, 2004, ONCOGENE, V23, P5941, DOI 10.1038/sj.onc.1207789; Li JF, 2002, P NATL ACAD SCI USA, V99, P10724, DOI 10.1073/pnas.132271699; Li JF, 1999, FEBS LETT, V451, P289, DOI 10.1016/S0014-5793(99)00598-0; Liu NF, 2001, CANCER RES, V61, P5207; Protopopov A, 2003, CANCER RES, V63, P404; Protopopov AI, 2002, J GENE MED, V4, P397, DOI 10.1002/jgm.283; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Senchenko V, 2003, ONCOGENE, V22, P2984, DOI 10.1038/sj.onc.1206429; Senchenko VN, 2004, ONCOGENE, V23, P5719, DOI 10.1038/sj.onc.1207760; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; WEINER F, 1971, J CELL SCI, V8, P681; ZABAROVSKY ER, 1990, NUCLEIC ACIDS RES, V18, P6319, DOI 10.1093/nar/18.21.6319; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835; ZHANG LR, 1995, CANCER RES, V55, P428	32	37	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3031	10.1371/journal.pone.0003031	http://dx.doi.org/10.1371/journal.pone.0003031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725949	gold, Green Published, Green Submitted			2022-12-25	WOS:000264428800002
J	Baumgart, JP; Vitko, I; Bidaud, I; Kondratskyi, A; Lory, P; Perez-Reyes, E				Baumgart, Joel P.; Vitko, Iuliia; Bidaud, Isabelle; Kondratskyi, Artem; Lory, Philippe; Perez-Reyes, Edward			I-II Loop Structural Determinants in the Gating and Surface Expression of Low Voltage-Activated Calcium Channels	PLOS ONE			English	Article								The intracellular loops that interlink the four transmembrane domains of Ca2+- and Na+-channels (Ca-v, Na-v) have critical roles in numerous forms of channel regulation. In particular, the intracellular loop that joins repeats I and II (I-II loop) in high voltage-activated (HVA) Ca2+ channels possesses the binding site for Ca-v beta subunits and plays significant roles in channel function, including trafficking the alpha(1) subunits of HVA channels to the plasma membrane and channel gating. Although there is considerable divergence in the primary sequence of the I-II loop of Ca(v)1/Ca(v)2 HVA channels and Ca(v)3 LVA/T-type channels, evidence for a regulatory role of the I-II loop in T-channel function has recently emerged for Ca(v)3.2 channels. In order to provide a comprehensive view of the role this intracellular region may play in the gating and surface expression in Ca(v)3 channels, we have performed a structure-function analysis of the I-II loop in Ca(v)3.1 and Ca(v)3.3 channels using selective deletion mutants. Here we show the first 60 amino acids of the loop (post IS6) are involved in Ca(v)3.1 and Ca(v)3.3 channel gating and kinetics, which establishes a conserved property of this locus for all Ca(v)3 channels. In contrast to findings in Ca(v)3.2, deletion of the central region of the I-II loop in Ca(v)3.1 and Ca(v)3.3 yielded a modest increase (+30%) and a reduction (-30%) in current density and surface expression, respectively. These experiments enrich our understanding of the structural determinants involved in Ca(v)3 function by highlighting the unique role played by the intracellular I-II loop in Ca(v)3.2 channel trafficking, and illustrating the prominent role of the gating brake in setting the slow and distinctive slow activation kinetics of Ca(v)3.3.	[Baumgart, Joel P.; Vitko, Iuliia; Perez-Reyes, Edward] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Baumgart, Joel P.; Perez-Reyes, Edward] Univ Virginia, Neurosci Grad Program, Charlottesville, VA 22903 USA; [Bidaud, Isabelle; Lory, Philippe] Inst Genom Fonct, CNRS, UMR 5203, Montpellier, France; [Bidaud, Isabelle; Lory, Philippe] INSERM, U661, Montpellier, France; [Bidaud, Isabelle; Lory, Philippe] Univ Montpellier 1, F-34006 Montpellier, France; [Bidaud, Isabelle; Lory, Philippe] Univ Montpellier 2, F-34095 Montpellier, France; [Kondratskyi, Artem] Bogomoletz Inst Physiol, Dept Gen Physiol, Kiev, Ukraine	University of Virginia; University of Virginia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Baumgart, JP (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	eperez@virginia.edu	Baumgart, Joel/K-3139-2014	Baumgart, Joel/0000-0002-1109-2567; BIDAUD, Isabelle/0000-0002-1812-1447; LORY, philippe/0000-0002-1638-7604; Kondratskyi, Artem/0000-0003-3290-0524	National Institute of Health; Agence Nationale pour la Recherche [06-NEURO-035-01]; Fondation pour la Recherche sur le Cerveau; Epilepsy Foundation [Predoctoral Fellowship]; Sigma Xi [Grant-in-Aid]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche sur le Cerveau; Epilepsy Foundation; Sigma Xi	This work was supported by a National Institute of Health Grant (to EPR), Agence Nationale pour la Recherche 06-NEURO-035-01 (to PL), Fondation pour la Recherche sur le Cerveau (to PL), an Epilepsy Foundation Predoctoral Fellowship (to JPB) and a Sigma Xi Grant-in-Aid of Research (to JPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler HL, 2005, NEURON, V46, P891, DOI 10.1016/j.neuron.2005.05.011; Arias JM, 2005, FEBS LETT, V579, P3907, DOI 10.1016/j.febslet.2005.06.008; Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Frazier CJ, 2001, J GEN PHYSIOL, V118, P457, DOI 10.1085/jgp.118.5.457; Hamid J, 2006, NEUROSCIENCE, V143, P717, DOI 10.1016/j.neuroscience.2006.08.023; HAMID J, 2006, NEUROSCIENCE; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; Kozlov AS, 1999, EUR J NEUROSCI, V11, P4149, DOI 10.1046/j.1460-9568.1999.00841.x; Lacinova L, 2002, FEBS LETT, V531, P235, DOI 10.1016/S0014-5793(02)03509-3; Lam AD, 2005, PFLUG ARCH EUR J PHY, V451, P349, DOI 10.1007/s00424-005-1407-5; Lambert RC, 1997, J NEUROSCI, V17, P6621; Lee JH, 1999, J NEUROSCI, V19, P1912; Leuranguer V, 1998, NEUROPHARMACOLOGY, V37, P701, DOI 10.1016/S0028-3908(98)00060-4; Marksteiner R, 2001, J PHYSIOL-LONDON, V537, P27, DOI 10.1111/j.1469-7793.2001.0027k.x; Monteil A, 2000, J BIOL CHEM, V275, P16530, DOI 10.1074/jbc.C000090200; Murbartian J, 2004, J NEUROPHYSIOL, V92, P3399, DOI 10.1152/jn.00498.2004; Nelson MT, 2007, J NEUROSCI, V27, P12577, DOI 10.1523/JNEUROSCI.2206-07.2007; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Park JY, 2004, J BIOL CHEM, V279, P21707, DOI 10.1074/jbc.M400684200; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Singh Baljinder, 2007, Hum Mutat, V28, P524, DOI 10.1002/humu.9491; Staes M, 2001, J PHYSIOL-LONDON, V530, P35, DOI 10.1111/j.1469-7793.2001.0035m.x; Stotz SC, 2001, TRENDS NEUROSCI, V24, P176, DOI 10.1016/S0166-2236(00)01738-0; Su H, 2002, J NEUROSCI, V22, P3645; Talavera K, 2003, J GEN PHYSIOL, V121, P529, DOI 10.1085/jgp.200308794; Talavera K, 2006, PFLUG ARCH EUR J PHY, V453, P189, DOI 10.1007/s00424-006-0129-7; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; TRABOULSIE A, 2006, J PHYSL; Vitko I, 2005, J NEUROSCI, V25, P4844, DOI 10.1523/JNEUROSCI.0847-05.2005; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772	39	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2976	10.1371/journal.pone.0002976	http://dx.doi.org/10.1371/journal.pone.0002976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714336	Green Published, gold, Green Submitted			2022-12-25	WOS:000264420900003
J	Bruederle, CE; Hnasko, RM; Kraemer, T; Garcia, RA; Haas, MJ; Marmer, WN; Carter, JM				Bruederle, Cathrin E.; Hnasko, Robert M.; Kraemer, Thomas; Garcia, Rafael A.; Haas, Michael J.; Marmer, William N.; Carter, John Mark			Prion Infected Meat-and-Bone Meal Is Still Infectious after Biodiesel Production	PLOS ONE			English	Article							SPONGIFORM ENCEPHALOPATHY; DISEASE; SAFETY	The epidemic of bovine spongiform encephalopathy (BSE) has led to a world-wide drop in the market for beef by-products, such as Meat-and-Bone Meal (MBM), a fat-containing but mainly proteinaceaous product traditionally used as an animal feed supplement. While normal rendering is insufficient, the production of biodiesel from MBM has been suggested to destroy infectivity from transmissible spongiform encephalopathies (TSEs). In addition to producing fuel, this method simultaneously generates a nutritious solid residue. In our study we produced biodiesel from MBM under defined conditions using a modified form of alkaline methanolysis. We evaluated the presence of prion in the three resulting phases of the biodiesel reaction (Biodiesel, Glycerol and Solid Residue) in vitro and in vivo. Analysis of the reaction products from 263K scrapie infected MBM led to no detectable immunoreactivity by Western Blot. Importantly, and in contrast to the biochemical results the solid MBM residue from the reaction retained infectivity when tested in an animal bioassay. Histochemical analysis of hamster brains inoculated with the solid residue showed typical spongiform degeneration and vacuolation. Re-inoculation of these brains into a new cohort of hamsters led to onset of clinical scrapie symptoms within 75 days, suggesting that the specific infectivity of the prion protein was not changed during the biodiesel process. The biodiesel reaction cannot be considered a viable prion decontamination method for MBM, although we observed increased survival time of hamsters and reduced infectivity greater than 6 log orders in the solid MBM residue. Furthermore, results from our study compare for the first time prion detection by Western Blot versus an infectivity bioassay for analysis of biodiesel reaction products. We could show that biochemical analysis alone is insufficient for detection of prion infectivity after a biodiesel process.	[Bruederle, Cathrin E.; Hnasko, Robert M.; Carter, John Mark] USDA ARS, WRRC, Foodborne Contaminants Res Unit, Albany, CA USA; [Kraemer, Thomas] Saarland Univ, Inst Legal Med, Homburg, Germany; [Garcia, Rafael A.; Haas, Michael J.; Marmer, William N.] USDA ARS, ERRC, Fats, Oils & Anim Coproducts Res Unit, Wyndmoor, PA USA	United States Department of Agriculture (USDA); Universitatsklinikum des Saarlandes; United States Department of Agriculture (USDA)	Bruederle, CE (corresponding author), USDA ARS, WRRC, Foodborne Contaminants Res Unit, Albany, CA USA.	cathrin.bruederle@gmail.com	Garcia, Rafael A./D-2796-2009; Carter, John Mark/K-2485-2015; Carter, John Mark/P-9919-2019; Kraemer, Thomas/R-8407-2018	Garcia, Rafael A./0000-0002-5452-3929; Carter, John Mark/0000-0001-8251-4168; Carter, John Mark/0000-0001-8251-4168; Kraemer, Thomas/0000-0002-3283-606X	CRIS [5325-32000-007-00D, 5325-32000-008-00D]	CRIS	CRIS 5325-32000-007-00D and CRIS 5325-32000-008-00D	[Anonymous], 2000, LANCET, V356, P1535; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Fishbein L, 1998, SCI TOTAL ENVIRON, V217, P71, DOI 10.1016/S0048-9697(98)00164-8; Garcia RA, 2006, APPL ENG AGRIC, V22, P729; Haas MJ, 2007, J AM OIL CHEM SOC, V84, P963, DOI 10.1007/s11746-007-1119-4; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Huang ZW, 1996, FOLD DES, V1, P13, DOI 10.1016/S1359-0278(96)00007-7; JENDROSKA K, 1991, NEUROLOGY, V41, P1482, DOI 10.1212/WNL.41.9.1482; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Mittelbach M, 2007, EUR J LIPID SCI TECH, V109, P79, DOI 10.1002/ejlt.200600172; *OFF USGA, 2005, GAO05101 OFF USGA; Prusiner S B, 1981, Adv Exp Med Biol, V134, P385; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1994, PHILOS T ROY SOC B, V343, P447, DOI 10.1098/rstb.1994.0043; PRUSINER SB, 1993, DEV BIOL STAND, V80, P31; Seidel B, 2006, ENVIRON SCI POLLUT R, V13, P125, DOI 10.1065/espr2005.08.283; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; TAYLOR DM, 1991, DEV BIOLOGICALS, V75, P97; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Thiry Etienne, 2004, Biotechnologie Agronomie Societe et Environnement, V8, P221; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199	22	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2969	10.1371/journal.pone.0002969	http://dx.doi.org/10.1371/journal.pone.0002969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698417	Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600054
J	Wallis, RH; Collins, SC; Kaisaki, PJ; Argoud, K; Wilder, SP; Wallace, KJ; Ria, M; Ktorza, A; Rorsman, P; Bihoreau, MT; Gauguier, D				Wallis, Robert H.; Collins, Stephan C.; Kaisaki, Pamela J.; Argoud, Karene; Wilder, Steven P.; Wallace, Karin J.; Ria, Massimiliano; Ktorza, Alain; Rorsman, Patrik; Bihoreau, Marie-Therese; Gauguier, Dominique			Pathophysiological, Genetic and Gene Expression Features of a Novel Rodent Model of the Cardio-Metabolic Syndrome	PLOS ONE			English	Article								Background: Complex etiology and pathogenesis of pathophysiological components of the cardio-metabolic syndrome have been demonstrated in humans and animal models. Methodology/Principal Findings: We have generated extensive physiological, genetic and genome-wide gene expression profiles in a congenic strain of the spontaneously diabetic Goto-Kakizaki (GK) rat containing a large region (110 cM, 170 Mb) of rat chromosome 1 (RNO1), which covers diabetes and obesity quantitative trait loci (QTL), introgressed onto the genetic background of the normoglycaemic Brown Norway (BN) strain. This novel disease model, which by the length of the congenic region closely mirrors the situation of a chromosome substitution strain, exhibits a wide range of abnormalities directly relevant to components of the cardio-metabolic syndrome and diabetes complications, including hyperglycaemia, hyperinsulinaemia, enhanced insulin secretion both in vivo and in vitro, insulin resistance, hypertriglyceridemia and altered pancreatic and renal histological structures. Gene transcription data in kidney, liver, skeletal muscle and white adipose tissue indicate that a disproportionately high number (43-83%) of genes differentially expressed between congenic and BN rats map to the GK genomic interval targeted in the congenic strain, which represents less than 5% of the total length of the rat genome. Genotype analysis of single nucleotide polymorphisms (SNPs) in strains genetically related to the GK highlights clusters of conserved and strain-specific variants in RNO1 that can assist the identification of naturally occurring variants isolated in diabetic and hypertensive strains when different phenotype selection procedures were applied. Conclusions: Our results emphasize the importance of rat congenic models for defining the impact of genetic variants in well-characterised QTL regions on in vivo pathophysiological features and cis-/trans-regulation of gene expression. The congenic strain reported here provides a novel and sustainable model for investigating the pathogenesis and genetic basis of risks factors for the cardio-metabolic syndrome.			Wallis, RH (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	gdomi@well.ox.ac.uk	collins, stephan c/P-4409-2016; Rorsman, Patrik/A-4331-2016; Gauguier, Dominique/G-2190-2016	collins, stephan c/0000-0002-1533-3380; Rorsman, Patrik/0000-0001-7578-0767; Gauguier, Dominique/0000-0001-6156-9530; Wilder, Steven/0000-0001-8049-2559	Wellcome Trust Cardiovascular Functional Genomics Initiative [066780]; European Commission [LSHG-CT-2004-005235, LSHG-CT-2005-019015, LSHG-CT-2006-037683]; Wellcome Prize studentships; Swedish Research Council [524-2007-7839]; Wellcome Trust senior fellowship in basic biomedical science [057733]	Wellcome Trust Cardiovascular Functional Genomics Initiative(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Prize studentships; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wellcome Trust senior fellowship in basic biomedical science(Wellcome Trust)	This work is supported by the Wellcome Trust Cardiovascular Functional Genomics Initiative (066780) and grants from the European Commission (STAR, LSHG-CT-2004-005235; EURATools, LSHG-CT-2005-019015; FGENTCARD, LSHG-CT-2006-037683). Part of this work was supported by Wellcome Prize studentships (to Stephan C Collins and Steven P Wilder). Massimiliano.Ria is supported by a postdoctoral fellowship from the Swedish Research Council (524-2007-7839). Dominique Gauguier holds a Wellcome Trust senior fellowship in basic biomedical science (057733).	Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Argoud K, 2006, DIABETOLOGIA, V49, P2679, DOI 10.1007/s00125-006-0396-z; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bihoreau MT, 1997, GENOME RES, V7, P434, DOI 10.1101/gr.7.5.434; Brown DM, 1996, NAT GENET, V12, P44, DOI 10.1038/ng0196-44; Chung WK, 1997, GENOMICS, V41, P332, DOI 10.1006/geno.1997.4672; Collins SC, 2003, MAMM GENOME, V14, P350, DOI 10.1007/s00335-002-3058-6; Collins SC, 2006, MAMM GENOME, V17, P538, DOI 10.1007/s00335-005-0168-y; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Galli J, 1999, DIABETES, V48, P2463, DOI 10.2337/diabetes.48.12.2463; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GAUGUIER D, 2006, ENCY GENETICS, P1154; Granhall C, 2006, DIABETES, V55, P3494, DOI 10.2337/db06-0796; Kahn R, 2005, DIABETOLOGIA, V48, P1684, DOI 10.1007/s00125-005-1876-2; Marion E, 2002, DIABETES, V51, P2012, DOI 10.2337/diabetes.51.7.2012; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rogner UC, 2003, NAT REV IMMUNOL, V3, P243, DOI 10.1038/nri1031; Rubattu S, 1996, NAT GENET, V13, P429, DOI 10.1038/ng0896-429; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; Thams P, 1999, EUR J ENDOCRINOL, V140, P87, DOI 10.1530/eje.0.1400087; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; Watanabe TK, 2005, CLIN EXP PHARMACOL P, V32, P355, DOI 10.1111/j.1440-1681.2005.04196.x; Watanabe TK, 1999, GENOMICS, V58, P233, DOI 10.1006/geno.1999.5789	29	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2962	10.1371/journal.pone.0002962	http://dx.doi.org/10.1371/journal.pone.0002962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698428	gold, Green Published, Green Submitted			2022-12-25	WOS:000264412600047
J	Wang, YH; Campbell, MA				Wang, Yi-Hong; Campbell, Michael A.			Agrobacterium-Mediated Transformation of Tomato Elicits Unexpected Flower Phenotypes with Similar Gene Expression Profiles	PLOS ONE			English	Article							MADS-BOX GENE; T-DNA INSERTION; ARABIDOPSIS-THALIANA; PLANTS; INTEGRATION; ETHYLENE	Background: Genetic transformation mediated by Agrobacterium tumefaciens is known to cause unexpected phenotypes. Mutations of a specific set of homeotic genes can result in alterred floral structure. Methodology/Principal Findings: Previously we identified two genes (LeTGA1 and SOLly GLB1) induced by nutrient availability in tomato. To further elucidate their function, we sought to knock out the genes using antisense RNAi. When antisense constructs for the two different tomato genes were each transformed into Micro-Tina tomato plants, one primary transformant with similar mutant flower phenotypes was identified from transformation of each construct. Microarray analysis shows that a similar set of genes were up- or downregulated in both mutants. Sequencing of insertion sites indicates that each is inserted into a repetitive region which could impact expression of affected genes but direct alteration of floral homeotic gene sequences was not detected. Conclusion: This is the first report that dominant flower mutations could be caused by genetic transformation designed to knock out two nutrient stress related genes.	[Wang, Yi-Hong; Campbell, Michael A.] Penn State Univ, Behrend Coll, Sch Sci, Erie, PA 16563 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Wang, YH (corresponding author), Penn State Univ, Behrend Coll, Sch Sci, Erie, PA 16563 USA.	yxw23@psu.edu	Campbell, Michael A/ABF-1509-2020	Campbell, Michael A/0000-0002-0739-8838	Penn State University Behrend College	Penn State University Behrend College	Penn State University Behrend College. The funders had no role other than financial in the work presented in the manuscript.	Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Ampomah-Dwamena C, 2002, PLANT PHYSIOL, V130, P605, DOI 10.1104/pp.005223; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; CASTLE LA, 1993, MOL GEN GENET, V241, P504, DOI 10.1007/BF00279892; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Chen PY, 2003, MOL BREEDING, V11, P287, DOI 10.1023/A:1023475710642; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Ferrario S, 2004, CURR OPIN PLANT BIOL, V7, P84, DOI 10.1016/j.pbi.2003.11.003; Filleur S, 2001, FEBS LETT, V489, P220, DOI 10.1016/S0014-5793(01)02096-8; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kaya H, 2000, PLANT CELL PHYSIOL, V41, P1055, DOI 10.1093/pcp/pcd032; Krizek BA, 1996, DEVELOPMENT, V122, P11; Laufs P, 1999, PLANT J, V18, P131, DOI 10.1046/j.1365-313X.1999.00436.x; Lemaux PG, 2008, ANNU REV PLANT BIOL, V59, P771, DOI 10.1146/annurev.arplant.58.032806.103840; Li JG, 2006, BIOCHEM BIOPH RES CO, V341, P1155, DOI 10.1016/j.bbrc.2006.01.077; Mao L, 2000, NATURE, V406, P910, DOI 10.1038/35022611; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; Nacry P, 1998, GENETICS, V149, P641; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Ray S, 1997, DEVELOPMENT, V124, P2489; Revenkova E, 1999, EMBO J, V18, P490, DOI 10.1093/emboj/18.2.490; Scott JW, 2000, HORTSCIENCE, V35, P774, DOI 10.21273/HORTSCI.35.4.774; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Somers DA, 2004, CURR OPIN BIOTECH, V15, P126, DOI 10.1016/j.copbio.2004.02.007; Tax FE, 2001, PLANT PHYSIOL, V126, P1527, DOI 10.1104/pp.126.4.1527; Tzfira T, 2006, CURR OPIN BIOTECH, V17, P147, DOI 10.1016/j.copbio.2006.01.009; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang YH, 2003, PLANT CELL ENVIRON, V26, P673, DOI 10.1046/j.1365-3040.2003.01002.x; Wang YH, 2002, PLANT PHYSIOL, V130, P1361, DOI 10.1104/pp.008854; Wilson A, 2005, NAT BIOTECHNOL, V23, P785, DOI 10.1038/nbt0705-785b; Wilson Allison K, 2006, Biotechnol Genet Eng Rev, V23, P209; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2974	10.1371/journal.pone.0002974	http://dx.doi.org/10.1371/journal.pone.0002974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698418	Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600058
J	Dilda, PJ; Ramsay, EE; Corti, A; Pompella, A; Hogg, PJ				Dilda, Pierre J.; Ramsay, Emma E.; Corti, Alessandro; Pompella, Alfonso; Hogg, Philip J.			Metabolism of the Tumor Angiogenesis Inhibitor 4-(N-(S-Glutathionylacetyl)amino) phenylarsonous Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; GAMMA-GLUTAMYL-TRANSPEPTIDASE; MEMBRANE; FAMILY; CELLS; TRANSFERASE; INVOLVEMENT; CONJUGATE; MECHANISM; TRANSPORT	4-(N-(S-glutathionylacetyl)amino) phenylarsonous acid (GSAO) is a small, synthetic mitochondrial poison that targets angiogenic endothelial cells and is currently being tested in a Phase I/IIa clinical trial. The trivalent arsenical of GSAO reacts with and perturbs adenine nucleotide translocase of the inner mitochondrial membrane of endothelial cells, which leads to proliferation arrest. Three observations indicated that the gamma-glutamyl residue of GSAO is cleaved at the endothelial cell surface by gamma-glutamyl transpeptidase (gamma GT). GSAO was found to be an efficient substrate for gamma GT, endothelial cell accumulation and antiproliferative activity of GSAO was blunted by a competitive substrate and an active site inhibitor of gamma GT, and the level of cell surface gamma GT correlated strongly with the sensitivity of cells to GSAO. Using transport inhibitors, it was revealed that the resulting metabolite of GSAO cleavage by gamma GT, 4-(N-(S-cysteinylglycylacetyl) amino) phenylarsonous acid (GCAO), was transported across the plasma membrane by an organic anion transporter. Furthermore, GCAO is likely processed by dipeptidases in the cytosol to 4-(N-(S-cysteinylacetyl) amino) phenylarsonous acid (CAO), and it is this metabolite that reacts with mitochondrial adenine nucleotide translocase. Taken together, our findings indicate that gamma GT processing of GSAO at the cell surface is the rate-limiting step in its antiangiogenic activity. This information can explain the kidney toxicity at high doses of GSAO noted in preclinical studies and will aid in the anticipation of potential side effects in humans and in the design of better antimitochondrial cancer drugs.	[Dilda, Pierre J.; Ramsay, Emma E.; Pompella, Alfonso; Hogg, Philip J.] Univ New S Wales, Ctr Canc Res, Sydney, NSW 2052, Australia; [Corti, Alessandro] Univ Pisa, Sch Med, I-56126 Pisa, Italy; [Hogg, Philip J.] Childrens Canc Inst Australia Med Res, Randwick, NSW 2031, Australia	University of New South Wales Sydney; University of Pisa; Children's Cancer Institute	Hogg, PJ (corresponding author), Univ New S Wales, Ctr Canc Res, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au	Pompella, Alfonso/G-6785-2012	Pompella, Alfonso/0000-0002-6435-9325; Hogg, Philip/0000-0001-6486-2863; Ramsay, Emma/0000-0001-7273-5397	National Health and Medical Research Council of Australia; Cancer Council New South Wales (NSW); Cancer Institute NSW and the Istituto Toscano Tumori (Firenze, Italy)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales (NSW)(Cancer Council New South Wales); Cancer Institute NSW and the Istituto Toscano Tumori (Firenze, Italy)	This study was supported by grants from the National Health and Medical Research Council of Australia, the Cancer Council New South Wales (NSW), the Cancer Institute NSW and the Istituto Toscano Tumori (Firenze, Italy). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belzacq AS, 2001, ONCOGENE, V20, P7579, DOI 10.1038/sj.onc.1204953; Cannon VT, 2000, J AM SOC NEPHROL, V11, P394, DOI 10.1681/ASN.V113394; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Dilda PJ, 2005, CANCER RES, V65, P11729, DOI 10.1158/0008-5472.CAN-05-2797; Dilda PJ, 2005, JNCI-J NATL CANCER I, V97, P1539, DOI 10.1093/jnci/dji316; Don AS, 2004, TRENDS MOL MED, V10, P372, DOI 10.1016/j.molmed.2004.06.005; Don AS, 2003, CANCER CELL, V3, P497, DOI 10.1016/S1535-6108(03)00109-0; Donoghue N, 2000, PROTEIN SCI, V9, P2436, DOI 10.1110/ps.9.12.2436; Enoiu M, 2002, ARCH BIOCHEM BIOPHYS, V397, P18, DOI 10.1006/abbi.2001.2633; Franzini M, 2006, EUR J CANCER, V42, P2623, DOI 10.1016/j.ejca.2006.04.016; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; HORIUCHI S, 1978, EUR J BIOCHEM, V87, P429, DOI 10.1111/j.1432-1033.1978.tb12392.x; HUSEBY NE, 1974, SCAND J CLIN LAB INV, V34, P357, DOI 10.3109/00365517409049892; Josch C, 1998, BIOCHEM PHARMACOL, V56, P763, DOI 10.1016/S0006-2952(98)00065-3; Kobayashi D, 2003, J PHARMACOL EXP THER, V306, P703, DOI 10.1124/jpet.103.051300; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Larochette N, 1999, EXP CELL RES, V249, P413, DOI 10.1006/excr.1999.4519; Lee W, 2005, J BIOL CHEM, V280, P9610, DOI 10.1074/jbc.M411092200; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Pajor AM, 2006, PFLUG ARCH EUR J PHY, V451, P597, DOI 10.1007/s00424-005-1487-2; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056	23	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35428	35434		10.1074/jbc.M804470200	http://dx.doi.org/10.1074/jbc.M804470200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18723877	hybrid			2022-12-25	WOS:000261687900014
J	McKinnon, CM; Lygoe, KA; Skelton, L; Mitter, R; Mellor, H				McKinnon, C. M.; Lygoe, K. A.; Skelton, L.; Mitter, R.; Mellor, H.			The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells	ONCOGENE			English	Article						Rho GTPase; BTB domain; microarray; cancer; tumor microenvironment; chemokine	MUTATION ANALYSIS; DENDRITIC CELLS; BREAST-CANCER; PROBE LEVEL; IN-VIVO; DBC2; GENE; BRAK; CANDIDATE; TISSUE	The Rho family of small GTPases control cell migration, cell invasion and cell cycle. Many of these processes are perturbed in cancer and several family members show altered expression in a number of tumor types. RhoBTB2/DBC2 is an atypical member of this family of signaling proteins, containing two BTB domains in addition to its conserved Rho GTPase domain. RhoBTB2 is mutated, deleted or silenced in a large percentage of breast and lung cancers; however, the functional consequences of this loss are unclear. Here we use RNA interference in primary human epithelial cells to mimic the loss of RhoBTB2 seen in cancer cells. Through microarray analysis of global gene expression, we show that loss of RhoBTB2 results in downregulation of CXCL14 - a chemokine that controls leukocyte migration and angiogenesis, and whose expression is lost through unknown mechanisms in a wide range of epithelial cancers. Loss of RhoBTB2 expression correlates with loss of CXCL14 secretion by head and neck squamous cell carcinoma cell lines, whereas reintroduction of RhoBTB2 restores CXCL14 secretion. Our studies identify CXCL14 as a gene target of RhoBTB2 and support downregulation of CXCL14 as a functional outcome of RhoBTB2 loss in cancer. Oncogene (2008) 27, 6856 - 6865; doi: 10.1038/onc.2008.317;published online 1 September 2008	[McKinnon, C. M.; Lygoe, K. A.; Skelton, L.; Mellor, H.] Univ Bristol, Dept Biochem, Sch Med Sci, Bristol BS8 1TD, Avon, England; [Mitter, R.] Canc Res UK, London, England	University of Bristol; Cancer Research UK	Mellor, H (corresponding author), Univ Bristol, Dept Biochem, Sch Med Sci, Bristol BS8 1TD, Avon, England.	h.mellor@bris.ac.uk		Mitter, Richard/0000-0002-1279-3760; Mellor, Harry/0000-0003-3894-0623	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank Ian Paterson for providing the HNSCC cell lines and Adrian Thrasher for the provision of lentiviral reagents. We particularly thank James Doherty, who provided initial analysis of the microarray data. This work was supported by a grant awarded to HM by Cancer Research UK.	Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Beder LB, 2006, J CANCER RES CLIN, V132, P19, DOI 10.1007/s00432-005-0033-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chang FK, 2006, J MOL BIOL, V364, P302, DOI 10.1016/j.jmb.2006.09.026; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Frederick MJ, 2000, AM J PATHOL, V156, P1937, DOI 10.1016/S0002-9440(10)65067-5; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Knowles MA, 2005, CANCER LETT, V225, P121, DOI 10.1016/j.canlet.2004.10.047; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Ohadi M, 2007, ACTA ONCOL, V46, P770, DOI 10.1080/02841860601047752; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Prime S, 2004, J PATHOL, V203, P927, DOI 10.1002/path.1603; Ramos S, 2002, GENE, V298, P147, DOI 10.1016/S0378-1119(02)00980-0; Redner RL, 2002, LEUKEMIA, V16, P1927, DOI 10.1038/sj.leu.2402720; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rivero F, 2001, NUCLEIC ACIDS RES, V29, P1068, DOI 10.1093/nar/29.5.1068; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schaerli P, 2005, IMMUNITY, V23, P331, DOI 10.1016/j.immuni.2005.08.012; Schwarze SR, 2002, J BIOL CHEM, V277, P14877, DOI 10.1074/jbc.M200373200; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Shurin GV, 2005, J IMMUNOL, V174, P5490, DOI 10.4049/jimmunol.174.9.5490; Siripurapu V, 2005, J MOL BIOL, V346, P83, DOI 10.1016/j.jmb.2004.11.043; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Starnes T, 2006, EXP HEMATOL, V34, P1101, DOI 10.1016/j.exphem.2006.05.015; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Yang L, 2004, ADV CANCER RES, V92, P13, DOI 10.1016/S0065-230X(04)92002-7	36	31	31	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2008	27	54					6856	6865		10.1038/onc.2008.317	http://dx.doi.org/10.1038/onc.2008.317			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	375IS	18762809				2022-12-25	WOS:000261108000006
J	Domsic, JF; Avvaru, BS; Kim, CU; Gruner, SM; Agbandje-McKenna, M; Silverman, DN; Mckenna, R				Domsic, John F.; Avvaru, Balendu Sankara; Kim, Chae Un; Gruner, Sol M.; Agbandje-McKenna, Mavis; Silverman, David N.; Mckenna, Robert			Entrapment of Carbon Dioxide in the Active Site of Carbonic Anhydrase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSFER; HYDROPHOBIC POCKET; CATALYTIC MECHANISM; MOLECULAR-DYNAMICS; BINDING; SUBSTRATE; CO2; CRYSTAL; HCO3; ZINC	The visualization at near atomic resolution of transient substrates in the active site of enzymes is fundamental to fully understanding their mechanism of action. Here we show the application of using CO2-pressurized, cryo-cooled crystals to capture the first step of CO2 hydration catalyzed by the zinc-metalloenzyme human carbonic anhydrase II, the binding of substrate CO2, for both the holo and the apo (without zinc) enzyme to 1.1 angstrom resolution. Until now, the feasibility of such a study was thought to be technically too challenging because of the low solubility of CO2 and the fast turnover to bicarbonate by the enzyme (Liang, J. Y., and Lipscomb, W. N. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 3675-3679). These structures provide insight into the long hypothesized binding of CO2 in a hydrophobic pocket at the active site and demonstrate that the zinc does not play a critical role in the binding or orientation of CO2. This method may also have a much broader implication for the study of other enzymes for which CO2 is a substrate or product and for the capturing of transient substrates and revealing hydrophobic pockets in proteins.	[Domsic, John F.; Avvaru, Balendu Sankara; Agbandje-McKenna, Mavis; Silverman, David N.; Mckenna, Robert] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Silverman, David N.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Kim, Chae Un; Gruner, Sol M.] Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; [Gruner, Sol M.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Cornell University; Cornell University	Mckenna, R (corresponding author), 1600 SW Archer Rd,POB 100245, Gainesville, FL 32610 USA.	rmckenna@ufl.edu	Gruner, Sol/G-2924-2010; Kim, Chae Un/D-2956-2014	Gruner, Sol/0000-0002-1171-4426; 	National Institutes of Health [GM25154, RR001646]; MacCHESS; Thomas Maren Foundation; U. S. Department of Energy [DE-FG02-97ER62443]; CHESS; U. S. National Science Foundation (NSF); National Institutes of Health-NIGMS [DMR-0225180]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MacCHESS; Thomas Maren Foundation; U. S. Department of Energy(United States Department of Energy (DOE)); CHESS(Defence Research & Development Organisation (DRDO)); U. S. National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM25154 (to D. N. S. and R. M.) and the MacCHESS grant (National Institutes of Health Grant RR001646). This work was also supported by grants from the Thomas Maren Foundation (to R. M.), U. S. Department of Energy Grant DE-FG02-97ER62443, and CHESS, which is supported by the U. S. National Science Foundation (NSF) and National Institutes of Health-NIGMS through NSF grant DMR-0225180. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALEXANDER RS, 1991, BIOCHEMISTRY-US, V30, P11064, DOI 10.1021/bi00110a008; BERTINI I, 1987, J AM CHEM SOC, V109, P7855, DOI 10.1021/ja00259a038; BERTINI I, 1992, INORG CHEM, V31, P3975, DOI 10.1021/ic00045a022; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BUTLER JN, 1982, CARBON DIOXIDE EQUIL, P15; Chegwidden W. R., 2000, CARBONIC ANHYDRASES, DOI [10.1007/978-3-0348-8446-4_9, DOI 10.1007/978-3-0348-8446-4_9]; Christianson DW, 1996, ACCOUNTS CHEM RES, V29, P331, DOI 10.1021/ar9501232; DAVENPORT HW, 1984, ANN NY ACAD SCI, V429, P4, DOI 10.1111/j.1749-6632.1984.tb12310.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FIERKE CA, 1991, BIOCHEMISTRY-US, V30, P11054, DOI 10.1021/bi00110a007; Fisher SZ, 2007, BIOCHEMISTRY-US, V46, P2930, DOI 10.1021/bi062066y; FORSMAN C, 1988, ACTA CHEM SCAND B, V42, P314, DOI 10.3891/acta.chem.scand.42b-0314; HAKANSSON K, 1992, J MOL BIOL, V227, P1192, DOI 10.1016/0022-2836(92)90531-N; Jonasson P, 1997, BIOCHEMISTRY-US, V36, P5142, DOI 10.1021/bi961882a; KHALIFAH RG, 1977, BIOCHEMISTRY-US, V16, P2241, DOI 10.1021/bi00629a031; Kim CU, 2005, ACTA CRYSTALLOGR D, V61, P881, DOI 10.1107/S090744490500836X; KREBS JF, 1993, BIOCHEMISTRY-US, V32, P4496, DOI 10.1021/bi00068a004; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIANG JY, 1990, P NATL ACAD SCI USA, V87, P3675, DOI 10.1073/pnas.87.10.3675; LIANG JY, 1987, BIOCHEMISTRY-US, V26, P5293, DOI 10.1021/bi00391a012; LINDAHL M, 1993, PROTEINS, V15, P177, DOI 10.1002/prot.340150207; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Lindskog S., 1983, ZINC ENZYMES, P78; McPherson A, 1982, PREPARATION ANAL PRO; MERZ KM, 1991, J AM CHEM SOC, V113, P406, DOI 10.1021/ja00002a004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roy A, 2007, J PHYS CHEM B, V111, P10563, DOI 10.1021/jp073499t; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silverman DN, 2007, ACCOUNTS CHEM RES, V40, P669, DOI 10.1021/ar7000588; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; TU CK, 1989, BIOCHEMISTRY-US, V28, P7913, DOI 10.1021/bi00445a054; WILLIAMS TJ, 1985, BIOCHEMISTRY-US, V24, P2459, DOI 10.1021/bi00331a010; Xu Y, 2008, NATURE, V452, P56, DOI 10.1038/nature06636; XUE YF, 1993, PROTEINS, V15, P80, DOI 10.1002/prot.340150110	34	169	173	1	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30766	30771		10.1074/jbc.M805353200	http://dx.doi.org/10.1074/jbc.M805353200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768466	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000260544800031
J	Olsen, JD; Tucker, JD; Timney, JA; Qian, P; Vassilev, C; Hunter, CN				Olsen, John D.; Tucker, Jaimey D.; Timney, John A.; Qian, Pu; Vassilev, Cvetelin; Hunter, C. Neil			The Organization of LH2 Complexes in Membranes from Rhodobacter sphaeroides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; LIGHT-HARVESTING COMPLEX; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; PHOTOSYNTHETIC APPARATUS; RHODOSPIRILLUM-PHOTOMETRICUM; RHODOPSEUDOMONAS-VIRIDIS; ANGSTROM RESOLUTION; ANTENNA COMPLEXES; NATIVE MEMBRANES	The mapping of the photosynthetic membrane of Rhodobacter sphaeroides by atomic force microscopy (AFM) revealed a unique organization of arrays of dimeric reaction center-light harvesting I-PufX (RC-LH1-PufX) core complexes surrounded and interconnected by light-harvesting LH2 complexes (Baha-tyrova, S., Frese, R. N., Siebert, C. A., Olsen, J. D., van der Werf, K. O., van Grondelle, R., Niederman, R. A., Bullough, P. A., Otto, C., and Hunter, C. N. (2004) Nature 430, 1058-1062). However, membrane regions consisting solely of LH2 complexes were under-represented in these images because these small, highly curved areas of membrane rendered them difficult to image even using gentle tapping mode AFM and impossible with contact mode AFM. We report AFM imaging of membranes prepared from a mutant of R. sphaeroides, DPF2G, that synthesizes only the LH2 complexes, which assembles spherical intracytoplasmic membrane vesicles of similar to 53 nm diameter in vivo. By opening these vesicles and adsorbing them onto mica to form small, <= 120 nm, largely flat sheets we have been able to visualize the organization of these LH2-only membranes for the first time. The transition from highly curved vesicle to the planar sheet is accompanied by a change in the packing of the LH2 complexes such that approximately half of the complexes are raised off the mica surface by similar to 1 nm relative to the rest. This vertical displacement produces a very regular corrugated appearance of the planar membrane sheets. Analysis of the topographs was used to measure the distances and angles between the complexes. These data are used to model the organization of LH2 complexes in the original, curved membrane. The implications of this architecture for the light harvesting function and diffusion of quinones in native membranes of R. sphaeroides are discussed.	[Olsen, John D.; Tucker, Jaimey D.; Timney, John A.; Qian, Pu; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TH, S Yorkshire, England; [Vassilev, Cvetelin] Univ Sheffield, Dept Phys & Astron, Sheffield S10 2TH, S Yorkshire, England	University of Sheffield; University of Sheffield	Olsen, JD (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TH, S Yorkshire, England.	j.olsen@sheffield.ac.uk	Qian, Pu/GZM-2400-2022; Vasilev, Cvetelin/B-3937-2016	Vasilev, Cvetelin/0000-0002-0536-882X	Biotechnology and Biological Sciences Research Council UK; Engineering and Physical Sciences Research Council UK; EPSRC [EP/F027591/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F027591/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by funding from the Biotechnology and Biological Sciences Research Council UK (to J. D. O., J. D. T., P. Q., J. A. T., and C. N. H.) and from the Engineering and Physical Sciences Research Council UK(to C. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Agarwal R, 2002, J PHYS CHEM A, V106, P7573, DOI 10.1021/jp014054m; Bahatyrova S, 2004, J BIOL CHEM, V279, P21327, DOI 10.1074/jbc.M313039200; Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; BRUNISHOLZ RA, 1992, J PHOTOCH PHOTOBIO B, V15, P113, DOI 10.1016/1011-1344(92)87010-7; Goncalves RP, 2005, J STRUCT BIOL, V152, P221, DOI 10.1016/j.jsb.2005.10.002; Hess S, 1995, P NATL ACAD SCI USA, V92, P12333, DOI 10.1073/pnas.92.26.12333; HUNTER CN, 1988, BIOCHEMISTRY-US, V27, P3459, DOI 10.1021/bi00409a050; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; Liu LN, 2008, FEBS J, V275, P3157, DOI 10.1111/j.1742-4658.2008.06469.x; LOMMEN MAJ, 1978, J BACTERIOL, V136, P730, DOI 10.1128/JB.136.2.730-741.1978; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; MICHEL H, 1986, EMBO J, V5, P2445, DOI 10.1002/j.1460-2075.1986.tb04520.x; Muller DJ, 2003, J MOL BIOL, V327, P925, DOI 10.1016/S0022-2836(03)00206-7; Nagarajan V, 1997, BIOCHEMISTRY-US, V36, P2300, DOI 10.1021/bi962534b; Noy D, 2006, BBA-BIOENERGETICS, V1757, P90, DOI 10.1016/j.bbabio.2005.11.010; OLSEN JD, 1994, P NATL ACAD SCI USA, V91, P7124, DOI 10.1073/pnas.91.15.7124; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian P, 2008, J BIOL CHEM, V283, P14002, DOI 10.1074/jbc.M800625200; Scheuring S, 2006, J MOL BIOL, V358, P83, DOI 10.1016/j.jmb.2006.01.085; Scheuring S, 2004, EMBO J, V23, P4127, DOI 10.1038/sj.emboj.7600429; Scheuring S, 2005, J BIOL CHEM, V280, P1426, DOI 10.1074/jbc.M411334200; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Scheuring S, 2003, J MOL BIOL, V325, P569, DOI 10.1016/S0022-2836(02)01241-X; Scheuring S, 2001, EMBO J, V20, P3029, DOI 10.1093/emboj/20.12.3029; Scheuring S, 2006, BIOPHYS J, V91, P3707, DOI 10.1529/biophysj.106.083709; SENER MK, 2008, P NATL ACAD SCI USA, V104, P15273; Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092; Sturgis JN, 2008, PHOTOSYNTH RES, V95, P269, DOI 10.1007/s11120-007-9239-0; Timpmann K, 2000, J PHYS CHEM B, V104, P9769, DOI 10.1021/jp001993q; Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	35	53	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30772	30779		10.1074/jbc.M804824200	http://dx.doi.org/10.1074/jbc.M804824200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18723509	Green Published, hybrid			2022-12-25	WOS:000260544800032
J	Cucinotta, M; Visalli, M; Aguennouz, M; Valenti, A; Loddo, S; Altucci, L; Teti, D				Cucinotta, Maria; Visalli, Maria; Aguennouz, Mohamed; Valenti, Andrea; Loddo, Saverio; Altucci, Lucia; Teti, Diana			Regulation of Interleukin-8 Gene at a Distinct Site of Its Promoter by CCAAT Enhancer-binding Protein Homologous Protein in Prostaglandin E-2-treated Human T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS C/EBP; AMINO-ACID LIMITATION; GROWTH ARREST; CHOP GADD153; ACTIVATION; EXPRESSION; DIFFERENTIATION; STRESS; BETA; IDENTIFICATION	For a long period of time, the transcription factor CCAAT/enhancer-binding protein homologous protein (CHOP) has been thought to inhibit transcriptional activity for its ability to interact with CCAAT enhancer-binding protein family factors, thus preventing their binding to DNA. We have previously shown that in human T lymphocytes the CHOP phosphorylation induced by prostaglandin E-2 (PGE(2))-increased interleukin-8 ( IL-8) gene expression. Given the CHOP positive role in the regulation of transcription, here we have investigated the molecular mechanism(s) by which CHOP increases IL-8 gene activity under PGE2 stimulus. Transfection experiments with mutants showed both that the CHOP transactivation domain is essential for IL-8 transcription and that the IL-8/activator protein 1 (AP-1) promoter mutated in NF-kappa B and NF-IL-6, but not in the AP-1 site, harbors essential CHOP-responsive elements. CHOP silencing confirmed its role in the IL- 8 transcriptional regulation and protein production, whereas c-Jun small interfering RNA experiments showed that the PGE(2)-induced activation of IL- 8 promoter is mainly c-Jun-independent. Moreover, PGE2 induced CHOP-DNA complexes only when the entire IL-8/AP-1 promoter or the wild type sequences encompassing the AP-1 upstream region were employed. Mutations introduced in these sequences prevented the DNA-CHOP complex formation. The IL-8/AP-1 mutant promoter lacking the sequence immediately upstream the AP-1 site is PGE2-unresponsive. Finally, chromatin immunoprecipitation data confirmed in vivo that PGE2 induces CHOP binding to the IL- 8 promoter. Taken together, our results suggest that the increased expression of CHOP in response to PGE2 exerts a positive transcriptional regulation of the IL- 8 promoter mediated by direct binding to a novel consensus site.	[Cucinotta, Maria; Visalli, Maria; Valenti, Andrea; Loddo, Saverio; Teti, Diana] Univ Messina, Dept Expt Pathol & Microbiol, I-98100 Messina, Italy; [Aguennouz, Mohamed] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol, I-98100 Messina, Italy; [Altucci, Lucia] Univ Naples 2, Dept Gen Pathol, I-80138 Naples, Italy	University of Messina; University of Messina; Universita della Campania Vanvitelli	Teti, D (corresponding author), Torre Biol IV P, Dept Expt Pathol & Microbiol, Policlin Univ Via Consolare Valeria 1, I-98125 Messina, Italy.	dteti@unime.it	Altucci, Lucia/S-8031-2019; Loddo, Saverio/I-7397-2012; Aguennouz, M'hammed/U-7420-2017	Loddo, Saverio/0000-0002-3338-9599; Aguennouz, M'hammed/0000-0003-0440-0354; altucci, lucia/0000-0002-7312-5387	Dottorato di Ricerca in Patologia della proliferazione cellulare e del differenziamento; Progetto di Ricerca di Ateneo; School of Specialization in Clinical Pathology (University of Messina)	Dottorato di Ricerca in Patologia della proliferazione cellulare e del differenziamento; Progetto di Ricerca di Ateneo; School of Specialization in Clinical Pathology (University of Messina)	This work was supported by grants from the Dottorato di Ricerca in Patologia della proliferazione cellulare e del differenziamento, the Progetto di Ricerca di Ateneo (to D. T.), and the School of Specialization in Clinical Pathology (University of Messina). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARTLETT JD, 1992, J BIOL CHEM, V267, P20465; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Caristi S, 2005, J BIOL CHEM, V280, P14433, DOI 10.1074/jbc.M410725200; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; CHEN Q, 1992, J BIOL CHEM, V267, P8207; Chipitsyna G, 2006, J CELL PHYSIOL, V207, P605, DOI 10.1002/jcp.20612; Cui KY, 2000, J BIOL CHEM, V275, P7591, DOI 10.1074/jbc.275.11.7591; Fawcett TW, 1996, J BIOL CHEM, V271, P14285, DOI 10.1074/jbc.271.24.14285; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; FRIEDMAN AD, 1990, GENE DEV, V4, P1416, DOI 10.1101/gad.4.8.1416; Friedman AD, 1996, CANCER RES, V56, P3250; Hattori T, 2003, FEBS LETT, V541, P33, DOI 10.1016/S0014-5793(03)00283-7; Hattori T, 2001, J INTERF CYTOK RES, V21, P323, DOI 10.1089/107999001300177510; Kodama K, 2005, AM J PHYSIOL-CELL PH, V289, pC582, DOI 10.1152/ajpcell.00558.2004; MARTEN NW, 1994, FASEB J, V8, P538, DOI 10.1096/fasebj.8.8.8181673; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; PRICE BD, 1992, CANCER RES, V52, P3814; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Sauter K, 2005, J BIOL CHEM, V280, P33566, DOI 10.1074/jbc.M503482200; Schmitt-Ney M, 2000, J BIOL CHEM, V275, P40839, DOI 10.1074/jbc.M007440200; Shirakawa K, 2006, MOL CELL BIOL, V26, P6105, DOI 10.1128/MCB.02429-05; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Vij N, 2008, AM J RESP CELL MOL, V38, P176, DOI 10.1165/rcmb.2007-0197OC; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	30	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29760	29769		10.1074/jbc.M803145200	http://dx.doi.org/10.1074/jbc.M803145200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18772138	Green Published, hybrid			2022-12-25	WOS:000260366900020
J	Lum, R; Niggemann, M; Glover, JR				Lum, Ronnie; Niggemann, Monika; Glover, John R.			Peptide and Protein Binding in the Axial Channel of Hsp104 INSIGHTS INTO THE MECHANISM OF PROTEIN UNFOLDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; N-TERMINAL DOMAIN; ATP-DEPENDENT PROTEASE; MOLECULAR CHAPERONE; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PRION PROPAGATION; CENTRAL PORE	The AAA+ molecular chaperone Hsp104 mediates the extraction of proteins from aggregates by unfolding and threading them through its axial channel in an ATP-driven process. An Hsp104-binding peptide selected from solid phase arrays enhanced the refolding of a firefly luciferase-peptide fusion protein. Analysis of peptide binding using tryptophan fluorescence revealed two distinct binding sites, one in each AAA+ module of Hsp104. As a further indication of the relevance of peptide binding to the Hsp104 mechanism, we found that it competes with the binding of a model unfolded protein, reduced carboxymethylated alpha-lactalbumin. Inactivation of the pore loops in either AAA+ module prevented stable peptide and protein binding. However, when the loop in the first AAA+ was inactivated, stimulation of ATPase turnover in the second AAA+ module of this mutant was abolished. Drawing on these data, we propose a detailed mechanistic model of protein unfolding by Hsp104 in which an initial unstable interaction involving the loop in the first AAA+ module simultaneously promotes penetration of the substrate into the second axial channel binding site and activates ATP turnover in the second AAA+ module.	[Lum, Ronnie; Niggemann, Monika; Glover, John R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	Glover, JR (corresponding author), Univ Toronto, Dept Biochem, Rm 5302,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	john.glover@utoronto.ca			Canadian Institutes for Health Research; Ontario Graduate Scholarship; National Sciences and Engineering Research Council of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by the Canadian Institutes for Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by an Ontario Graduate Scholarship and a National Sciences and Engineering Research Council of Canada Postgraduate Scholarship.	Barnett ME, 2005, J BIOL CHEM, V280, P34940, DOI 10.1074/jbc.M505653200; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cunningham F, 2007, METHODS, V41, P370, DOI 10.1016/j.ymeth.2006.07.003; CYR DM, 1992, J BIOL CHEM, V267, P20927; Derkatch IL, 1997, GENETICS, V147, P507; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Haebel PW, 2004, CURR OPIN STRUC BIOL, V14, P58, DOI 10.1016/j.sbi.2004.01.010; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093; Kim DY, 2003, J BIOL CHEM, V278, P50664, DOI 10.1074/jbc.M305882200; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kong CG, 2004, MOL CELL, V14, P233, DOI 10.1016/S1097-2765(04)00206-0; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Liu ZH, 2002, J MOL BIOL, V321, P111, DOI 10.1016/S0022-2836(02)00591-0; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Tanaka N, 2004, PROTEIN SCI, V13, P3214, DOI 10.1110/ps.04780704; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Thibault G, 2006, P NATL ACAD SCI USA, V103, P17724, DOI 10.1073/pnas.0601505103; Tkach JM, 2004, J BIOL CHEM, V279, P35692, DOI 10.1074/jbc.M400782200; Tkach JM, 2006, TOP CURR GENET, V16, P65; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200	62	66	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30139	30150		10.1074/jbc.M804849200	http://dx.doi.org/10.1074/jbc.M804849200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18755692	Green Published, hybrid			2022-12-25	WOS:000260366900059
J	Noberini, R; Koolpe, M; Peddibhotla, S; Dahl, R; Su, Y; Cosford, NDP; Roth, GP; Pasquale, EB				Noberini, Roberta; Koolpe, Mitchell; Peddibhotla, Satyamaheshwar; Dahl, Russell; Su, Ying; Cosford, Nicholas D. P.; Roth, Gregory P.; Pasquale, Elena B.			Small Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA INDUCTION; TYROSINE KINASE; ENDOTHELIAL-CELLS; VISUAL-SYSTEM; TUMOR NEOVASCULARIZATION; VASCULOGENIC MIMICRY; INDUCED ANGIOGENESIS; PROTEIN INTERACTIONS; NERVOUS-SYSTEM; CANCER-THERAPY	The erythropoietin-producing hepatocellular (Eph) family of receptor tyrosine kinases regulates a multitude of physiological and pathological processes. Despite the numerous possible research and therapeutic applications of agents capable of modulating Eph receptor function, no small molecule inhibitors targeting the extracellular domain of these receptors have been identified. We have performed a high throughput screen to search for small molecules that inhibit ligand binding to the extracellular domain of the EphA4 receptor. This yielded a 2,5-dimethylpyrrolyl benzoic acid derivative able to inhibit the interaction of EphA4 with a peptide ligand as well as the natural ephrin ligands. Evaluation of a series of analogs identified an isomer with similar inhibitory properties and other less potent compounds. The two isomeric compounds act as competitive inhibitors, suggesting that they target the high affinity ligand-binding pocket of EphA4 and inhibit ephrin-A5 binding to EphA4 with K-i values of 7 and 9 mu M in enzyme-linked immunosorbent assays. Interestingly, despite the ability of each ephrin ligand to promiscuously bind many Eph receptors, the two compounds selectively target EphA4 and the closely related EphA2 receptor. The compounds also inhibit ephrin-induced phosphorylation of EphA4 and EphA2 in cells, without affecting cell viability or the phosphorylation of other receptor tyrosine kinases. Furthermore, the compounds inhibit EphA4-mediated growth cone collapse in retinal explants and EphA2-dependent retraction of the cell periphery in prostate cancer cells. These data demonstrate that the Eph receptor-ephrin interface can be targeted by inhibitory small molecules and suggest that the two compounds identified will be useful to discriminate the activities of EphA4 and EphA2 from those of other co-expressed Eph receptors that are activated by the same ephrin ligands. Furthermore, the newly identified inhibitors represent possible leads for the development of therapies to treat pathologies in which EphA4 and EphA2 are involved, including nerve injuries and cancer.	[Noberini, Roberta; Koolpe, Mitchell; Dahl, Russell; Su, Ying; Cosford, Nicholas D. P.; Pasquale, Elena B.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Noberini, Roberta] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Peddibhotla, Satyamaheshwar; Roth, Gregory P.] Burnham Inst Med Res Lake Nona, Orlando, FL 32819 USA; [Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Parma; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Pasquale, EB (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	elenap@burnham.org	Noberini, Roberta/AAP-4527-2020	Cosford, Nic/0000-0001-7228-4709; Dahl, Russell/0000-0002-2939-1004; Noberini, Roberta/0000-0002-7267-1079	National Institutes of Health; Department of Defense	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense)	This work was supported, in whole or in part, by a National Institutes of Health grant (to E. B. P.). This work was also supported by the Department of Defense (to E. B. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams RH, 2002, SEMIN CELL DEV BIOL, V13, P55, DOI 10.1006/scdb.2001.0289; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Baldwin C, 2006, AM J PHYSIOL-RENAL, V291, pF960, DOI 10.1152/ajprenal.00020.2006; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Brantley-Sieders Dana M., 2004, Angiogenesis, V7, P17, DOI 10.1023/B:AGEN.0000037340.33788.87; Brantley-Sieders DM, 2005, FASEB J, V19, P1884, DOI 10.1096/fj.05-4038fje; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Caligiuri M, 2006, CHEM BIOL, V13, P711, DOI 10.1016/j.chembiol.2006.05.008; Chen J, 2006, EXP EYE RES, V82, P664, DOI 10.1016/j.exer.2005.09.004; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Cheng N, 2002, MOL CANCER RES, V1, P2; Cheng N, 2003, NEOPLASIA, V5, P445, DOI 10.1016/S1476-5586(03)80047-7; Cheng N, 2001, J BIOL CHEM, V276, P13771, DOI 10.1074/jbc.M009147200; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chrencik JE, 2006, STRUCTURE, V14, P321, DOI 10.1016/j.str.2005.11.011; Chrencik JE, 2007, J BIOL CHEM, V282, P36505, DOI 10.1074/jbc.M706340200; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fox BP, 2006, BIOCHEM BIOPH RES CO, V342, P1263, DOI 10.1016/j.bbrc.2006.02.099; Fry DC, 2005, J MOL MED, V83, P955, DOI 10.1007/s00109-005-0705-x; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Hess AR, 2006, CANCER BIOL THER, V5, P228, DOI 10.4161/cbt.5.2.2510; Hess AR, 2001, CANCER RES, V61, P3250; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Holash JA, 1995, DEV BIOL, V172, P683, DOI 10.1006/dbio.1995.8039; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Hunter SG, 2006, MOL CELL BIOL, V26, P4830, DOI 10.1128/MCB.02215-05; Iiizumi M, 2006, CANCER SCI, V97, P1211, DOI 10.1111/j.1349-7006.2006.00313.x; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kolb P, 2008, PROTEINS, V73, P11, DOI 10.1002/prot.22028; Koolpe M, 2005, J BIOL CHEM, V280, P17301, DOI 10.1074/jbc.M500363200; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Landen CN, 2005, EXPERT OPIN THER TAR, V9, P1179, DOI 10.1517/14728222.9.6.1179; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Liang YC, 1997, J CELL BIOCHEM, V67, P55, DOI 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Menzel P, 2001, DEV BIOL, V230, P74, DOI 10.1006/dbio.2000.0109; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miyazaki Y, 2008, BIOORG MED CHEM LETT, V18, P1967, DOI 10.1016/j.bmcl.2008.01.113; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Noren NK, 2007, CANCER RES, V67, P3994, DOI 10.1158/0008-5472.CAN-07-0525; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Qin HN, 2008, J BIOL CHEM, V283, P29473, DOI 10.1074/jbc.M804114200; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; SOANS C, 1994, ONCOGENE, V9, P3353; Tang FY, 2007, J NUTR BIOCHEM, V18, P391, DOI 10.1016/j.jnutbio.2006.07.004; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wen ZX, 2006, CURR OPIN NEUROBIOL, V16, P52, DOI 10.1016/j.conb.2005.12.005; Wimmer-Kleikamp SH, 2005, IUBMB LIFE, V57, P421, DOI 10.1080/15216540500138337; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yamashita T, 2008, J BIOL CHEM, V283, P18926, DOI 10.1074/jbc.M709133200; Yao VJ, 2005, AM J PATHOL, V166, P625, DOI 10.1016/S0002-9440(10)62283-3	74	116	124	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29461	29472		10.1074/jbc.M804103200	http://dx.doi.org/10.1074/jbc.M804103200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728010	Green Published, hybrid			2022-12-25	WOS:000260179900072
J	Whiteford, JR; Ko, S; Lee, W; Couchman, JR				Whiteford, James R.; Ko, Sunggeon; Lee, Weontae; Couchman, John R.			Structural and Cell Adhesion Properties of Zebrafish Syndecan-4 Are Shared with Higher Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; COMBINATORIAL EXPRESSION PATTERNS; PROTEIN-KINASE-C; CYTOPLASMIC DOMAIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; DIRECTIONAL MIGRATION; NMR-SPECTROSCOPY; BINDING DOMAIN; PDZ PROTEIN; SULFOTRANSFERASES	The syndecan proteoglycans are an ancient class of receptor, bearing heparan sulfate chains that interact with numerous potential ligands including growth factors, morphogens, and extracellular matrix molecules. The single syndecan of invertebrates appears not to have cell adhesion roles, but these have been described for mammalian paralogues, especially syndecan-4. This member is best understood in terms of interactions, signaling, and structure of its cytoplasmic domain. The zebrafish homologue of syndecan-4 has been genetically linked to cell adhesion and migration in zebrafish embryos, but no molecular and cellular studies have been reported. Here it is demonstrated that key functional attributes of syndecan-4 are common to both zebrafish and mammalian homologues. These include glycosaminoglycan substitution, a NXIP motif in the extracellular domain that promotes integrin-mediated cell adhesion, and a transmembrane GXXXG motif that promotes dimer formation. In addition, despite some amino acid substitutions in the cytoplasmic domain, its ability to form twisted clamp dimers is preserved, as revealed by nuclear magnetic resonance spectroscopy. This technique also showed that phosphatidylinositol 4,5-bisphosphate can interact with the zebrafish syndecan-4 cytoplasmic domain, and that the molecule in its entirety supports focal adhesion formation, and complements the murine null cells to restore a normal actin cytoskeleton identically to the rat homologue. Therefore, the cell adhesion properties of syndecan-4 are consistent across the vertebrate spectrum and reflect an early acquisition of specialization after syndecan gene duplication events at the invertebrate/early chordate boundary.	[Whiteford, James R.; Couchman, John R.] Univ Copenhagen, Inst Biomed, Bioctr, DK-2200 Copenhagen N, Denmark; [Ko, Sunggeon; Lee, Weontae] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Ko, Sunggeon; Lee, Weontae] Yonsei Univ, Coll Life Sci & Biotechnol, Mol Biophys Lab, Seoul 120749, South Korea	University of Copenhagen; Yonsei University; Yonsei University	Couchman, JR (corresponding author), Univ Copenhagen, Inst Biomed, Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	john.couchman@bric.dk	LEE, WEON TAE/AAQ-9088-2021	Lee, Weontae/0000-0003-2347-1262; Whiteford, James/0000-0002-8967-7389	Wellcome Trust Programme [065940]; Korea Science and Engineering Foundation (KOSEF) [R01-2007-000-10161-0]; Korea government (MOST)	Wellcome Trust Programme(Wellcome Trust); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government)	This work was supported in part by Wellcome Trust Programme Grant 065940 (to J. R. C.). This work was also supported by a Korea Science and Engineering Foundation (KOSEF) Grant R01-2007-000-10161-0 funded by the Korea government (MOST) (to W. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadwallader AB, 2007, DEV DYNAM, V236, P581, DOI 10.1002/dvdy.21051; Cadwallader AB, 2006, DEV DYNAM, V235, P3432, DOI 10.1002/dvdy.20990; Cadwallader AB, 2006, DEV DYNAM, V235, P3423, DOI 10.1002/dvdy.20991; Chakravarti R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-83; Chen E, 2004, BLOOD, V103, P1710, DOI 10.1182/blood-2003-06-1783; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Couchman JR, 2002, J BIOL CHEM, V277, P49296, DOI 10.1074/jbc.M209679200; DAVID G, 1992, J CELL BIOL, V118, P961, DOI 10.1083/jcb.118.4.961; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Greene DK, 2003, J BIOL CHEM, V278, P7617, DOI 10.1074/jbc.M207123200; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Horowitz A, 1999, BIOCHEMISTRY-US, V38, P15871, DOI 10.1021/bi991363i; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Lee D, 1998, J BIOL CHEM, V273, P13022, DOI 10.1074/jbc.273.21.13022; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Longley RL, 1999, J CELL SCI, V112, P3421; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; McFall AJ, 1998, J BIOL CHEM, V273, P28270, DOI 10.1074/jbc.273.43.28270; Mehrotra B, 1997, J BIOL CHEM, V272, P4237, DOI 10.1074/jbc.272.7.4237; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Oh ES, 1998, J BIOL CHEM, V273, P10624, DOI 10.1074/jbc.273.17.10624; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Shin J, 2001, BIOCHEMISTRY-US, V40, P8471, DOI 10.1021/bi002750r; Siekmann AF, 2005, DEV DYNAM, V232, P498, DOI 10.1002/dvdy.20248; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295	46	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29322	29330		10.1074/jbc.M803505200	http://dx.doi.org/10.1074/jbc.M803505200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18753130	hybrid, Green Published			2022-12-25	WOS:000260179900059
J	Zhang, YM; Frank, MW; Zhu, K; Mayasundari, A; Rock, CO				Zhang, Yong-Mei; Frank, Matthew W.; Zhu, Kun; Mayasundari, Anand; Rock, Charles O.			PqsD Is Responsible for the Synthesis of 2,4-Dihydroxyquinoline, an Extracellular Metabolite Produced by Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID BIOSYNTHESIS; TO-CELL COMMUNICATION; ESCHERICHIA-COLI; COENZYME-A; ROLES; MOLECULES; SYNTHASES; MUTANTS; REVEALS	2,4-Dihydroxyquinoline (DHQ) is an abundant extracellular metabolite of the opportunistic pathogen Pseudomonas aeruginosa that is secreted into growth medium in stationary phase to concentrations comparable with those of the Pseudomonas quinolone signal. Using a combination of biochemical and genetic approaches, we show that PqsD, a condensing enzyme in the pqs operon that is essential for Pseudomonas quinolone signal synthesis, accounts for DHQ formation in vivo. First, the anthraniloyl moiety is transferred to the active-site Cys of PqsD to form an anthraniloyl-PqsD intermediate, which then condenses with either malonyl-CoA or malonyl-acyl carrier protein to produce 3-(2-aminophenyl)-3-oxopropanoyl-CoA. This short-lived intermediate undergoes an intramolecular rearrangement to form DHQ. DHQ was produced by Escherichia coli coexpressing PqsA and PqsD, illustrating that these two proteins are the only factors necessary for DHQ synthesis. Thus, PqsD is responsible for the production of DHQ in P. aeruginosa.	[Zhang, Yong-Mei] St Jude Childrens Hosp, Dept Infect Dis, Prot Sci Div, Memphis, TN 38105 USA; [Mayasundari, Anand] St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Zhang, YM (corresponding author), St Jude Childrens Hosp, Dept Infect Dis, Prot Sci Div, 332 N Lauderdale, Memphis, TN 38105 USA.	yongmei.zhang@stjude.org		Frank, Matthew/0000-0002-4914-1440	National Institutes of Health [GM 34496]; Cancer Center CORE Support [CA 21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center CORE Support; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 34496 and Cancer Center CORE Support Grant CA 21765. This work was also supported by the American Lebanese Syrian Associated Charities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bredenbruch F, 2005, J BACTERIOL, V187, P3630, DOI 10.1128/JB.187.11.3630-3635.2005; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Diggle SP, 2006, INT J MED MICROBIOL, V296, P83, DOI 10.1016/j.ijmm.2006.01.038; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Diggle SP, 2006, CHEM BIOL, V13, P701, DOI 10.1016/j.chembiol.2006.05.006; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; HEATH RJ, 1995, J BIOL CHEM, V270, P15531, DOI 10.1074/jbc.270.26.15531; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Hutchinson CR, 1999, P NATL ACAD SCI USA, V96, P3336, DOI 10.1073/pnas.96.7.3336; JACKOWSKI S, 1986, J BACTERIOL, V166, P866, DOI 10.1128/jb.166.3.866-871.1986; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Lepine F, 2007, BIOL CHEM, V388, P839, DOI 10.1515/BC.2007.100; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Swift S, 2001, ADV MICROB PHYSIOL, V45, P199, DOI 10.1016/S0065-2911(01)45005-3; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Zhang YM, 2006, J BIOL CHEM, V281, P17390, DOI 10.1074/jbc.M513199200; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x	27	63	69	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28788	28794		10.1074/jbc.M804555200	http://dx.doi.org/10.1074/jbc.M804555200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728009	hybrid, Green Published			2022-12-25	WOS:000260179900003
J	Bae, D; Lu, S; Taglienti, CA; Mercurio, AM				Bae, Donggoo; Lu, Shaolei; Taglienti, Cherie A.; Mercurio, Arthur M.			Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-CELLS; CARCINOMA CELLS; SEMAPHORIN-III; BREAST-CANCER; PROGRESSION; RECEPTOR; ANGIOGENESIS; EXPRESSION; PROTEINS	The neuropilins-1 and -2 (NRP1 and NRP2) function as receptors for both the semaphorins and vascular endothelial growth factor. In addition to their contribution to the development of the nervous system, NRP1 and NRP2 have been implicated in angiogenesis and tumor progression. Given their importance to cancer and endothelial biology and their potential as therapeutic targets, an important issue that has not been addressed is the impact of metabolic stress conditions characteristic of the tumor microenvironment on their expression and function. Here, we demonstrate that hypoxia and nutrient deprivation stimulate the rapid loss of NRP1 expression in both endothelial and carcinoma cells. NRP2 expression, in contrast, is maintained under these conditions. The lysosomal inhibitors chloroquine and bafilomycin A1 prevented the loss of NRP1 expression, but proteasomal inhibitors had no effect. The hypothesis that NRP1 is degraded by autophagy is supported by the findings that its expression is lost rapidly in response to metabolic stress, prevented with 3-methyladenine and induced by rapamycin. Targeted depletion of NRP2 using small hairpin RNA revealed that NRP2 can function in the absence of NRP1 to mediate endothelial tube formation in hypoxia. Studies aimed at assessing NRP function and targeted therapy in cancer and angiogenesis should consider the impact of metabolic stress.	[Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Mercurio, AM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB-408,364 Plantat St, Worcester, MA 01605 USA.	arthur.mercurio@umassmed.edu		Lu, Shaolei/0000-0003-2870-5793	National Institutes of Health [CA89209]; NATIONAL CANCER INSTITUTE [R01CA089209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA89209. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Bachelder RE, 2001, CANCER RES, V61, P5736; Bachelder RE, 2002, CANCER RES, V62, P7203; Bielenberg DR, 2007, CANCER METAST REV, V26, P421, DOI 10.1007/s10555-007-9097-4; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brown JM, 1999, CANCER RES, V59, P5863; Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541; Castro-Rivera E, 2004, P NATL ACAD SCI USA, V101, P11432, DOI 10.1073/pnas.0403969101; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Cuervo AM, 1998, J MOL MED-JMM, V76, P6, DOI 10.1007/s109-1998-8099-y; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; FURUCHI T, 1993, J BIOL CHEM, V268, P27345; GERARD KW, 1988, J BIOL CHEM, V263, P18886; Gray MJ, 2008, J NATL CANCER I, V100, P109, DOI 10.1093/jnci/djm279; Gray MJ, 2005, CANCER RES, V65, P3664, DOI 10.1158/0008-5472.CAN-04-2229; Guttmann-Raviv N, 2006, CANCER LETT, V231, P1, DOI 10.1016/j.canlet.2004.12.047; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Ishihama H, 2001, INVEST OPHTH VIS SCI, V42, P1172; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mathupala SP, 2001, J BIOL CHEM, V276, P43407, DOI 10.1074/jbc.M108181200; Matsushita A, 2007, CANCER RES, V67, P10309, DOI 10.1158/0008-5472.CAN-07-3256; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Narazaki M, 2008, BLOOD, V111, P4126, DOI 10.1182/blood-2007-09-112474; Neufeld G, 2002, ADV EXP MED BIOL, V515, P81; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stephenson JM, 2002, INT J CANCER, V101, P409, DOI 10.1002/ijc.10611; Sulpice E, 2008, BLOOD, V111, P2036, DOI 10.1182/blood-2007-04-084269; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Wang L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001161	42	37	38	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28074	28080		10.1074/jbc.M804203200	http://dx.doi.org/10.1074/jbc.M804203200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18708346	Green Published, hybrid			2022-12-25	WOS:000259969300009
J	Yang, SQ; Ma, HW; Yu, L; Yu, CA				Yang, Shaoqing; Ma, He-Wen; Yu, Linda; Yu, Chang-An			On the mechanism of quinol oxidation at the Q(P) site in the cytochrome bc(1) complex - Studied using mutants lacking cytochrome b(L) or b(H)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; BOVINE HEART-MITOCHONDRIA; RHODOBACTER-SPHAEROIDES; Q-CYCLE; ELECTRON-TRANSFER; DOMAIN MOVEMENT; BC1 COMPLEX; C REDUCTASE; Q(O) SITE; SUPEROXIDE-PRODUCTION	To elucidate the mechanism of bifurcated oxidation of quinol in the cytochrome bc(1) complex, Rhodobacter sphaeroides mutants, H198N and H111N, lacking heme b(L) and heme b(H), respectively, were constructed and characterized. Purified mutant complexes have the same subunit composition as that of the wild-type complex, but have only 9-11% of the electron transfer activity, which is sensitive to stigmatellin or myxothiazol. The E-m values for hemes bL and bH in the H111N and H198N complexes are -95 and -35 mV, respectively. The pseudo first-order reduction rate constants for hemes b(L) and b(H) in H111N and H198N, by ubiquiniol, are 16.3 and 12.4 s(-1), respectively. These indicate that the Q(P) site in the H111N mutant complex is similar to that in the wild-type complex. Pre-steady state reduction rates of heme c(1) by these two mutant complexes decrease to a similar extent of their activity, suggesting that the decrease in electron transfer activity is due to impairment of movement of the head domain of reduced iron-sulfur protein, caused by disruption of electron transfer from heme b(L) to heme b(H). Both mutant complexes produce as much superoxide as does antimycin A-treated wild-type complex. Ascorbate eliminates all superoxide generating activity in the intact or antimycin inhibited wild-type or mutant complexes.	[Yang, Shaoqing; Ma, He-Wen; Yu, Linda; Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Yu, CA (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	cayuq@okstate.edu	yang, shaoqing/C-9761-2012		NIGMS NIH HHS [GM30721] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030721, R01GM030721] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDRE A, 1979, J BIOL CHEM, V254, P1555; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BRANDT U, 1991, J BIOL CHEM, V266, P19958; BRANDT U, 1991, EUR J BIOCHEM, V195, P163, DOI 10.1111/j.1432-1033.1991.tb15690.x; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Cen XW, 2008, FEBS LETT, V582, P523, DOI 10.1016/j.febslet.2008.01.016; Covian R, 2004, J BIOL CHEM, V279, P15040, DOI 10.1074/jbc.M400193200; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15827, DOI 10.1021/bi990963e; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Crofts AR, 2003, J BIOL CHEM, V278, P36191, DOI 10.1074/jbc.M305461200; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; Darrouzet E, 2002, J BIOL CHEM, V277, P3471, DOI 10.1074/jbc.M107974200; Darrouzet E, 2000, BIOCHEMISTRY-US, V39, P15475, DOI 10.1021/bi000750l; DENICOLA A, 1995, FREE RADICAL BIO MED, V19, P11, DOI 10.1016/0891-5849(94)00239-G; DEVRIES S, 1981, J BIOL CHEM, V256, P1996; DEVRIES S, 1983, BIOCHIM BIOPHYS ACTA, V723, P91, DOI 10.1016/0005-2728(83)90013-0; DEVRIES S, 1982, BIOCHIM BIOPHYS ACTA, V681, P41, DOI 10.1016/0005-2728(82)90276-6; Dutton P L, 1978, Methods Enzymol, V54, P411; Elberry M, 2006, BBA-BIOENERGETICS, V1757, P835, DOI 10.1016/j.bbabio.2006.05.031; ERECINSKA M, 1972, P NATL ACAD SCI USA, V69, P50, DOI 10.1073/pnas.69.1.50; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; Gong X, 2005, J BIOL CHEM, V280, P9251, DOI 10.1074/jbc.M409994200; Hunte C, 2001, FEBS LETT, V504, P126, DOI 10.1016/S0014-5793(01)02744-2; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Junemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; KING TE, 1975, ELECTRON TRANSFER CH, P105; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; Liu XY, 2004, J BIOL CHEM, V279, P47363, DOI 10.1074/jbc.M406497200; MATHER MW, 1995, J BIOL CHEM, V270, P28668, DOI 10.1074/jbc.270.48.28668; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; NAKANO M, 1990, METHOD ENZYMOL, V186, P585; NOHL H, 1986, BIOCHEM BIOPH RES CO, V138, P533, DOI 10.1016/S0006-291X(86)80529-0; Rotsaert FAJ, 2008, BBA-BIOENERGETICS, V1777, P211, DOI 10.1016/j.bbabio.2007.10.011; Snyder CH, 1999, J BIOL CHEM, V274, P31209, DOI 10.1074/jbc.274.44.31209; Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; Tian H, 1999, J BIOL CHEM, V274, P7146, DOI 10.1074/jbc.274.11.7146; Tian H, 1998, J BIOL CHEM, V273, P27953, DOI 10.1074/jbc.273.43.27953; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; WIKSTROM MK, 1972, BIOCHIM BIOPHYS ACTA, V283, P403, DOI 10.1016/0005-2728(72)90258-7; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xia D, 2007, PHOTOSYNTH RES, V92, P17, DOI 10.1007/s11120-007-9155-3; Xiao KH, 2004, BIOCHEMISTRY-US, V43, P1488, DOI 10.1021/bi035378z; Xiao KH, 2000, J BIOL CHEM, V275, P38597, DOI 10.1074/jbc.M007444200; YU C, 1980, BIOCHIM BIOPHYS ACTA, V591, P409, DOI 10.1016/0005-2728(80)90172-3; YU CA, 1982, BIOCHEMISTRY-US, V21, P4096, DOI 10.1021/bi00260a028; Yu CA, 2008, BBA-BIOENERGETICS, V1777, P1038, DOI 10.1016/j.bbabio.2008.03.033; YU L, 1984, J BIOL CHEM, V259, P5752; YUN CH, 1991, BIOCHEMISTRY-US, V30, P6747, DOI 10.1021/bi00241a017; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104	60	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28767	28776		10.1074/jbc.M803013200	http://dx.doi.org/10.1074/jbc.M803013200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713733	Green Published, hybrid			2022-12-25	WOS:000259969300079
J	Anzai, N; Ichida, K; Jutabha, P; Kimura, T; Babu, E; Jin, CJ; Srivastava, S; Kitamura, K; Hisatome, I; Endou, H; Sakurai, H				Anzai, Naohiko; Ichida, Kimiyoshi; Jutabha, Promsuk; Kimura, Toru; Babu, Ellappan; Jin, Chun Ji; Srivastava, Sunena; Kitamura, Kenichiro; Hisatome, Ichiro; Endou, Hitoshi; Sakurai, Hiroyuki			Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL HYPOURICEMIA; URIC-ACID; APICAL MEMBRANE; IDENTIFICATION; FAMILY; EXCRETION; GLUT9; FACILITATORS; EXPRESSION; CLONING	Hyperuricemia is a significant factor in a variety of diseases, including gout and cardiovascular diseases. Although renal excretion largely determines plasma urate concentration, the molecular mechanism of renal urate handling remains elusive. Previously, we identified a major urate reabsorptive transporter, URAT1 (SLC22A12), on the apical side of the renal proximal tubular cells. However, it is not known how urate taken up by URAT1 exits from the tubular cell to the systemic circulation. Here, we report that a sugar transport facilitator family member protein GLUT9 (SLC2A9) functions as an efflux transporter of urate from the tubular cell. GLUT9-expressed Xenopus oocytes mediated saturable urate transport (K-m: 365 +/- 42 mu m). The transport was Na+-independent and enhanced at high concentrations of extracellular potassium favoring negative to positive potential direction. Substrate specificity and pyrazinoate sensitivity of GLUT9 was distinct from those of URAT1. The in vivo role of GLUT9 is supported by the fact that a renal hypouricemia patient without any mutations in SLC22A12 was found to have a missense mutation in SLC2A9, which reduced urate transport activity in vitro. Based on these data, we propose a novel model of transcellular urate transport in the kidney; Remunurate is taken up via apically located URAT1 and exits the cell via basolaterally located GLUT9, which we suggest be renamed URATv1 (voltage-driven urate transporter 1).	[Anzai, Naohiko; Kimura, Toru; Babu, Ellappan; Jin, Chun Ji; Srivastava, Sunena; Endou, Hitoshi; Sakurai, Hiroyuki] Kyorin Univ, Dept Pharmacol & Toxicol, Sch Med, Tokyo 1818611, Japan; [Ichida, Kimiyoshi] Tokyo Univ Pharm & Life Sci, Dept Pathophysiol, Tokyo 1930392, Japan; [Jutabha, Promsuk; Endou, Hitoshi] Fuji Biomedix Co Ltd, Kobuchisawa Res Labs, Yamanashi 4080044, Japan; [Kitamura, Kenichiro] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Dept Nephrol, Kumamoto 8608556, Japan; [Hisatome, Ichiro] Tottori Univ, Fac Med, Dept Cardiovasc Med, Tottori 6808550, Japan; [Endou, Hitoshi] J Pharma Co Ltd, Tokyo 1600022, Japan	Kyorin University; Tokyo University of Pharmacy & Life Sciences; Kumamoto University; Tottori University	Anzai, N (corresponding author), 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	anzai@ks.kyorin-u.ac.jp	Jutabha, Promsuk/AAE-9872-2022; Jutabha, Promsuk/AFF-4363-2022; ANZAI, NAOHIKO/K-9492-2017	ANZAI, NAOHIKO/0000-0003-0605-0458	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation; Salt Science Research Foundation [0721]; Gout Research Foundation of Japan; Shimabara Foundation and Kyorin University School of Medicine	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Salt Science Research Foundation; Gout Research Foundation of Japan(Gout Research Foundation of Japan); Shimabara Foundation and Kyorin University School of Medicine	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Society for the Promotion of Science, the Takeda Science Foundation, the Salt Science Research Foundation (Grant 0721), the Gout Research Foundation of Japan, and the Shimabara Foundation and Kyorin University School of Medicine (Collaborative Project 2008). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anzai N, 2005, J PHARMACOL EXP THER, V315, P534, DOI 10.1124/jpet.105.088583; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; Anzai Naohiko, 2005, Curr Rheumatol Rep, V7, P227, DOI 10.1007/s11926-996-0044-0; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Bahn A, 2008, J BIOL CHEM, V283, P16332, DOI 10.1074/jbc.M800737200; Becker MA, 2006, RHEUM DIS CLIN N AM, V32, P275, DOI 10.1016/j.rdc.2006.02.005; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Doege H, 2000, BIOCHEM J, V350, P771, DOI 10.1042/0264-6021:3500771; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Emmerson BT, 1996, NEW ENGL J MED, V334, P445, DOI 10.1056/NEJM199602153340707; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Ichida K, 2004, J AM SOC NEPHROL, V15, P164, DOI 10.1097/01.ASN.0000105320.04395.D0; Islam R, 2008, J PHARMACOL SCI, V106, P525, DOI 10.1254/jphs.SC0070291; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Jutabha P, 2003, J BIOL CHEM, V278, P27930, DOI 10.1074/jbc.M303210200; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Mori K, 1997, FEBS LETT, V417, P371, DOI 10.1016/S0014-5793(97)01325-2; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Rafey MA, 2003, CURR OPIN NEPHROL HY, V12, P511, DOI 10.1097/00041552-200309000-00005; Sakata T, 2004, BIOCHEM BIOPH RES CO, V313, P789, DOI 10.1016/j.bbrc.2003.11.175; Sica DA, 2000, KIDNEY, P680; Sperling O, 2006, MOL GENET METAB, V89, P14, DOI 10.1016/j.ymgme.2006.03.015; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wakida N, 2005, J CLIN ENDOCR METAB, V90, P2169, DOI 10.1210/jc.2004-1111; Yokoyama H, 2008, CELL PHYSIOL BIOCHEM, V21, P269, DOI 10.1159/000129385	30	255	282	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26834	26838		10.1074/jbc.C800156200	http://dx.doi.org/10.1074/jbc.C800156200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18701466	hybrid			2022-12-25	WOS:000259586600002
J	Lindell, DM; Berlin, AA; Schaller, MA; Lukacs, NW				Lindell, Dennis M.; Berlin, Aaron A.; Schaller, Matthew A.; Lukacs, Nicholas W.			B Cell Antigen Presentation Promotes Th2 Responses and Immunopathology during Chronic Allergic Lung Disease	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INDUCED AIRWAY HYPERRESPONSIVENESS; DENDRITIC CELLS; T-CELL; IN-VIVO; ASTHMA; IL-4; INFLAMMATION; MICE; LYMPHOCYTES	Background: The role of B cells in allergic asthma remains undefined. One mechanism by which B cells clearly contribute to allergic disease is via the production of specific immunoglobulin, and especially IgE. Cognate interactions with specific T cells result in T cell help for B cells, resulting in differentiation and immunoglobulin secretion. Proximal to (and required for) T cell-dependent immunoglobulin production, however, is antigen presentation by B cells. While interaction with T cells clearly has implications for B cell function and differentiation, this study investigated the role that B cells have in shaping the T cell response during chronic allergic lung disease. Methodology/Principal Findings: In these studies, we used a clinically relevant mouse model of chronic allergic lung disease to study the role of B cells and B cell antigen presentation in this disease. In these studies we present several novel findings: 1) Lung B cells from chronically allergen challenged mice up-regulated MHC II and costimulatory molecules CD40, CD80 and CD86. 2) Using in vitro studies, B cells from the lungs of allergen challenged mice could present antigen to T cells, as assessed by T cell proliferation and the preferential production of Th2 cytokines. 3) Following chronic allergen challenge, the levels of Th2 cytokines IL-4 and IL-5 in the lungs and airways were significantly attenuated in B cell -/- mice, relative to controls. 4) B cell driven Th2 responses and mucus hyper secretion in the lungs were dependent upon MHC II expression by B cells. Conclusions/Significance: Collectively, these results provide evidence for antigen presentation as a novel mechanism by which B cells contribute to chronic allergic disease. These findings give new insight into the mechanisms by which B cells promote asthma and other chronic diseases.	[Lindell, Dennis M.; Berlin, Aaron A.; Schaller, Matthew A.; Lukacs, Nicholas W.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Lindell, DM (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	denmklin@umich.edu	Schaller, Matthew/AAL-7640-2020; Lukacs, Nicholas W/ABH-5583-2020		National Institutes of Health [HL031963, HL059178, T32HL007749]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059178, T32HL007749, P01HL031963] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL031963, HL059178 (NWL), and T32HL007749 (DML). The sponsors played no role in the design, conduct, collection, analysis, interpretation, review, or approval of the manuscript.	ABERG N, 1995, CLIN EXP ALLERGY, V25, P815, DOI 10.1111/j.1365-2222.1995.tb00023.x; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Arnaboldi PM, 2005, J IMMUNOL, V175, P1276, DOI 10.4049/jimmunol.175.2.1276; Bandukwala HS, 2007, J EXP MED, V204, P1875, DOI 10.1084/jem.20061134; Berlin AA, 2006, LAB INVEST, V86, P557, DOI 10.1038/labinvest.3700419; Blease K, 2001, J IMMUNOL, V166, P5219, DOI 10.4049/jimmunol.166.8.5219; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Christensen JP, 2003, J IMMUNOL, V171, P4733, DOI 10.4049/jimmunol.171.9.4733; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; DEBRUIJN MLH, 1992, EUR J IMMUNOL, V22, P3013, DOI 10.1002/eji.1830221137; Garcia-Marcos L, 2004, ALLERGY, V59, P1301, DOI 10.1111/j.1398-9995.2004.00562.x; Gosman MME, 2006, EUR RESPIR J, V27, P60, DOI 10.1183/09031936.06.00007005; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guery JC, 1996, J EXP MED, V183, P751, DOI 10.1084/jem.183.3.751; GUERY JC, 1995, J IMMUNOL, V154, P536; Haczku A, 1999, AM J RESP CRIT CARE, V159, P1638, DOI 10.1164/ajrccm.159.5.9711040; Hamelmann E, 1999, AM J RESP CELL MOL, V21, P480, DOI 10.1165/ajrcmb.21.4.3659; Harris DP, 2005, J IMMUNOL, V175, P7103, DOI 10.4049/jimmunol.175.11.7103; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hashimoto K, 2005, J ALLERGY CLIN IMMUN, V116, P550, DOI 10.1016/j.jaci.2005.03.051; Hashimoto K, 2004, AM J RESP CRIT CARE, V170, P306, DOI 10.1164/rccm.200301-030OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Inoue S, 2006, CANCER RES, V66, P7741, DOI 10.1158/0008-5472.CAN-05-3766; John AE, 2005, EUR J IMMUNOL, V35, P108, DOI 10.1002/eji.200425439; Kitamura K, 2007, J IMMUNOL, V178, P480, DOI 10.4049/jimmunol.178.1.480; Korsgren M, 1997, J EXP MED, V185, P885, DOI 10.1084/jem.185.5.885; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; LACK C, 1995, AM J RESP CRIT CARE, V152, P1765, DOI 10.1164/ajrccm.152.6.8520735; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LEVIN D, 1993, J IMMUNOL, V151, P6742; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Lund FE, 2006, J IMMUNOL, V176, P6147, DOI 10.4049/jimmunol.176.10.6147; Lundy SK, 2005, INFLAMM RES, V54, P514, DOI 10.1007/s00011-005-1387-0; Lundy SK, 2005, J IMMUNOL, V174, P2054, DOI 10.4049/jimmunol.174.4.2054; Macaubas Claudia, 2003, Current Drug Targets - Inflammation and Allergy, V2, P175, DOI 10.2174/1568010033484304; Martinez-Gamboa L, 2006, AUTOIMMUN REV, V5, P437, DOI 10.1016/j.autrev.2006.02.004; Masten BJ, 1999, J IMMUNOL, V162, P1310; Meinl E, 2006, ANN NEUROL, V59, P880, DOI 10.1002/ana.20890; Miller AL, 2003, J IMMUNOL, V170, P3348, DOI 10.4049/jimmunol.170.6.3348; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Moulin V, 2000, J EXP MED, V192, P475, DOI 10.1084/jem.192.4.475; Noorchashm H, 2006, J IMMUNOL, V177, P7715, DOI 10.4049/jimmunol.177.11.7715; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Renz H, 2002, EUR RESPIR J, V19, P158, DOI 10.1183/09031936.02.00254202; Schaller MA, 2005, EUR J IMMUNOL, V35, P2061, DOI 10.1002/eji.200425715; Schaller MA, 2008, AM J PATHOL, V172, P386, DOI 10.2353/ajpath.2008.070537; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Smit JJ, 2007, AM J PATHOL, V171, P1944, DOI 10.2353/ajpath.2007.070578; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Tomkinson A, 2001, J IMMUNOL, V166, P5792, DOI 10.4049/jimmunol.166.9.5792; Tournoy KG, 2001, J IMMUNOL, V166, P6982, DOI 10.4049/jimmunol.166.11.6982; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; von Mutius E, 1998, LANCET, V351, P862, DOI 10.1016/S0140-6736(97)10100-3; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Watanabe T, 2004, AM J RESP CRIT CARE, V169, P105, DOI 10.1164/rccm.200302-239OC; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Yu P, 2002, J IMMUNOL, V168, P5117, DOI 10.4049/jimmunol.168.10.5117; Zhong GM, 1997, J EXP MED, V186, P673, DOI 10.1084/jem.186.5.673; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu J, 2007, AM J RESP CRIT CARE, V175, P1125, DOI 10.1164/rccm.200602-161OC; Zollner IK, 2005, THORAX, V60, P545, DOI 10.1136/thx.2004.029561	66	58	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3129	10.1371/journal.pone.0003129	http://dx.doi.org/10.1371/journal.pone.0003129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769622	Green Published, gold, Green Submitted			2022-12-25	WOS:000264418300010
J	Hennig, P; Moller, R; Egelhaaf, M				Hennig, Patrick; Moeller, Ralf; Egelhaaf, Martin			Distributed Dendritic Processing Facilitates Object Detection: A Computational Analysis on the Visual System of the Fly	PLOS ONE			English	Article							FIGURE-GROUND DISCRIMINATION; MOTION SENSITIVE INTERNEURONS; NEURONAL BASIS; RELATIVE MOTION; SUPERIOR COLLICULUS; SENSORY ANALYZER; OPTOMOTOR SYSTEM; HORIZONTAL CELLS; RECEPTIVE-FIELD; LOBULA PLATE	Background: Detecting objects is an important task when moving through a natural environment. Flies, for example, may land on salient objects or may avoid collisions with them. The neuronal ensemble of Figure Detection cells (FD-cells) in the visual system of the fly is likely to be involved in controlling these behaviours, as these cells are more sensitive to objects than to extended background structures. Until now the computations in the presynaptic neuronal network of FD-cells and, in particular, the functional significance of the experimentally established distributed dendritic processing of excitatory and inhibitory inputs is not understood. Methodology/Principal Findings: We use model simulations to analyse the neuronal computations responsible for the preference of FD-cells for small objects. We employed a new modelling approach which allowed us to account for the spatial spread of electrical signals in the dendrites while avoiding detailed compartmental modelling. The models are based on available physiological and anatomical data. Three models were tested each implementing an inhibitory neural circuit, but differing by the spatial arrangement of the inhibitory interaction. Parameter optimisation with an evolutionary algorithm revealed that only distributed dendritic processing satisfies the constraints arising from electrophysiological experiments. In contrast to a direct dendro-dendritic inhibition of the FD-cell (Direct Distributed Inhibition model), an inhibition of its presynaptic retinotopic elements (Indirect Distributed Inhibition model) requires smaller changes in input resistance in the inhibited neurons during visual stimulation. Conclusions/Significance: Distributed dendritic inhibition of retinotopic elements as implemented in our Indirect Distributed Inhibition model is the most plausible wiring scheme for the neuronal circuit of FD-cells. This microcircuit is computationally similar to lateral inhibition between the retinotopic elements. Hence, distributed inhibition might be an alternative explanation of perceptual phenomena currently explained by lateral inhibition networks.	[Hennig, Patrick] Univ Bielefeld, Dept Neurobiol, Bielefeld, Germany; [Moeller, Ralf] Univ Bielefeld, Ctr Excellence, Dept Comp Engn, D-4800 Bielefeld, Germany; [Egelhaaf, Martin] Univ Bielefeld, Ctr Excellence, Dept Neurobiol, Fak Biol, D-4800 Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld	Hennig, P (corresponding author), Univ Bielefeld, Dept Neurobiol, Bielefeld, Germany.	phennig@uni-bielefeld.de	Möller, Ralf/B-9717-2017; Egelhaaf, Martin/A-9824-2010	Egelhaaf, Martin/0000-0002-9336-4270; Moller, Ralf/0000-0001-7389-3696	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Barnett PD, 2007, CURR BIOL, V17, P569, DOI 10.1016/j.cub.2007.02.039; Bekesy GV, 1967, SENSORY INHIBITION; BORST A, 1993, BRAIN THEORY, P47; COLLETT T, 1972, J COMP PHYSIOL, V78, P396, DOI 10.1007/BF01417943; COLLETT T, 1971, NATURE, V232, P127, DOI 10.1038/232127a0; Collett T., 1975, P437; Cuntz H, 2003, P NATL ACAD SCI USA, V100, P11082, DOI 10.1073/pnas.1830705100; DAVIDSON RM, 1991, J NEUROPHYSIOL, V65, P1115, DOI 10.1152/jn.1991.65.5.1115; EGELHAAF M, 1985, BIOL CYBERN, V52, P267, DOI 10.1007/BF00336983; EGELHAAF M, 1993, J NEUROPHYSIOL, V69, P340, DOI 10.1152/jn.1993.69.2.340; EGELHAAF M, 1985, BIOL CYBERN, V52, P195; EGELHAAF M, 1985, BIOL CYBERN, V52, P123, DOI 10.1007/BF00364003; EGELHAAF M, 1993, VISUAL MOTION ITS RO; Egelhaaf M, 2006, INVERTEBRATE VISION, P399; FROST BJ, 1988, J COMP PHYSIOL A, V162, P639, DOI 10.1007/BF01342639; FROST BJ, 1981, EXP BRAIN RES, V43, P173; FROST BJ, 1983, SCIENCE, V220, P744, DOI 10.1126/science.6836313; Gauck V, 1997, J COMP NEUROL, V381, P489; Gauck V, 1999, J COMP NEUROL, V406, P51, DOI 10.1002/(SICI)1096-9861(19990329)406:1<51::AID-CNE4>3.0.CO;2-I; Geurten BRH, 2007, J EXP BIOL, V210, P3277, DOI 10.1242/jeb.008425; Grewe J, 2006, J NEUROPHYSIOL, V96, P1838, DOI 10.1152/jn.00170.2006; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; HAUSEN K, 1976, Z NATURFORSCH C, V31, P629; HAUSEN K, 1976, THESIS U TUEBINGEN; HENGSTENBERG R, 1980, NEUROANATOMICAL TECH, P307; Higgins CM, 2004, BIOL CYBERN, V91, P417, DOI 10.1007/s00422-004-0518-y; Kimmerle B, 2000, J COMP PHYSIOL A, V186, P21, DOI 10.1007/s003590050003; Kimmerle B, 1997, J COMP PHYSIOL A, V181, P247, DOI 10.1007/s003590050111; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; KOCH C, 1999, BIOPHYS COMPUTATION; KOCH C, 1998, METHOODS NEURAL MODE; Krapp HG, 2001, J NEUROPHYSIOL, V85, P724, DOI 10.1152/jn.2001.85.2.724; Kretzberg J, 2001, J COMPUT NEUROSCI, V10, P79, DOI 10.1023/A:1008972111122; MACH E, 1865, WIRKUNG RAUMLICHEN V, P131; MANDL G, 1985, VISION RES, V25, P267, DOI 10.1016/0042-6989(85)90119-1; MASON R, 1979, EXP BRAIN RES, V37, P231; OCARROLL D, 1993, NATURE, V362, P541, DOI 10.1038/362541a0; OLBERG RM, 1986, J COMP PHYSIOL A, V159, P827, DOI 10.1007/BF00603736; OLBERG RM, 1981, J COMP PHYSIOL, V141, P327, DOI 10.1007/BF00609935; Price K. V., 1999, NEW IDEAS OPTIMIZATI, P79; REICHARDT W, 1983, BIOL CYBERN, V46, P1, DOI 10.1007/BF00595226; RIZZOLATTI G, 1977, EXP BRAIN RES, V29, P107; ROWELL CHF, 1977, J EXP BIOL, V68, P157; ROWELL CHF, 1976, J EXP BIOL, V65, P617; Single S, 1997, J NEUROSCI, V17, P6023; STERLING P, 1969, J NEUROPHYSIOL, V32, P1, DOI 10.1152/jn.1969.32.1.1; TANAKA K, 1986, J NEUROSCI, V6, P134; TSAI HJ, 1990, J COMP PHYSIOL A, V167, P857; VONGRUNAU M, 1983, EXP BRAIN RES, V49, P84, DOI 10.1007/BF00235544; WARZECHA AK, 1993, J NEUROPHYSIOL, V69, P329, DOI 10.1152/jn.1993.69.2.329	53	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3092	10.1371/journal.pone.0003092	http://dx.doi.org/10.1371/journal.pone.0003092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769475	gold, Green Published, Green Submitted			2022-12-25	WOS:000264796600010
J	Fitzpatrick, SM; Nelson, GC; Clark, G				Fitzpatrick, Scott M.; Nelson, Greg C.; Clark, Geoffrey			Small Scattered Fragments Do Not a Dwarf Make: Biological and Archaeological Data Indicate that Prehistoric Inhabitants of Palau Were Normal Sized	PLOS ONE			English	Article							SOUTH-AFRICA; ISLANDS; MICRONESIA; PACIFIC; SITE; SKELETAL; FLORES	Current archaeological evidence from Palau in western Micronesia indicates that the archipelago was settled around 3000-3300 BP by normal sized populations; contrary to recent claims, they did not succumb to insular dwarfism. Background: Previous and ongoing archaeological research of both human burial and occupation sites throughout the Palauan archipelago during the last 50 years has produced a robust data set to test hypotheses regarding initial colonization and subsequent adaptations over the past three millennia. Principal Findings: Close examination of human burials at the early (ca. 3000 BP) and stratified site of Chelechol ra Orrak indicates that these were normal sized individuals. This is contrary to the recent claim of contemporaneous "small-bodied'' individuals found at two cave sites by Berger et al. (2008). As we argue, their analyses are flawed on a number of different analytical levels. First, their sample size is too small and fragmentary to adequately address the variation inherent in modern humans within and outside of Palau. Second, the size and stature of all other prehistoric (both older and contemporaneous) skeletal assemblages found in Palau fall within the normal parameters of modern human variation in the region, indicating this was not a case of insular dwarfism or a separate migratory group. Third, measurements taken on several skeletal elements by Berger et al. may appear to be from smaller-bodied individuals, but the sizes of these people compares well with samples from Chelechol ra Orrak. Last, archaeological, linguistic, and historical evidence demonstrates a great deal of cultural continuity in Palau through time as expected if the same population was inhabiting the archipelago. Conclusions: Prehistoric Palauan populations were normal sized and exhibit traits that fall within the normal variation for Homo sapiens-they do not support the claims by Berger et al. (2008) that there were smaller-bodied populations living in Palau or that insular dwarfism took place such as may be the case for Homo floresiensis.	[Fitzpatrick, Scott M.] N Carolina State Univ, Dept Sociol & Anthropol, Raleigh, NC 27695 USA; [Nelson, Greg C.] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Clark, Geoffrey] Australian Natl Univ, Res Sch Pacific & Asian Stud, Div Soc & Environm, Acton, Australia	University of North Carolina; North Carolina State University; University of Oregon; Australian National University	Fitzpatrick, SM (corresponding author), N Carolina State Univ, Dept Sociol & Anthropol, Raleigh, NC 27695 USA.	scott_fitzpatrick@ncsu.edu		Clark, Geoffrey/0000-0002-9055-655X	National Science Foundation; Sigma Xi	National Science Foundation(National Science Foundation (NSF)); Sigma Xi	National Science Foundation, Sigma Xi	Anderson A, 2005, RADIOCARBON, V47, P1; Anderson A, 2001, INT J OSTEOARCHAEOL, V11, P14, DOI 10.1002/oa.542; ANDERSON AJ, 2001, RECORDS AUSTR MUSE S, V27; [Anonymous], ARCHAEOLOGICAL SURVE; Athens J.S., 2005, PALAU COMPACT ROAD A; Athens JS, 2004, REC AUST MUS, P15; Athens JS, 2001, PACIFIC 2000: PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON EASTER ISLAND AND THE PACIFIC, P165; ATHENS JS, 1999, ARCHAEOLOGICAL DATA; Auerbach BM, 2004, AM J PHYS ANTHROPOL, V125, P331, DOI 10.1002/ajpa.20032; Bedford S, 2006, ANTIQUITY, V80, P812, DOI 10.1017/S0003598X00094448; BENNETT KA, 1975, PUBLICATIONS ARCHA F, V7; Berger LR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001780; Blust R, 2000, OCEAN LINGUIST, V39, P83, DOI 10.2307/3623218; BRACE CL, 1981, CURR ANTHROPOL, V22, P549, DOI 10.1086/202726; BRACE CL, 1990, MICRONESICA S, V2, P323; BRAZAITIS P, 1992, US TRUST TERRITORY P, P42; BROWN M, 1981, CHILDRENS UNDERSTAND, V11, P23; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Callaghan R, 2007, INT J NAUT ARCHAEOL, V36, P353, DOI 10.1111/j.1095-9270.2007.00147.x; Callieri M, 2008, IEEE COMPUT GRAPH, V28, P44, DOI 10.1109/MCG.2008.20; Carucci J., 1992, THESIS SO ILLINOIS U; Clark G, 2005, ASIAN PERSPECT, V44, P349, DOI DOI 10.1353/ASI.2005.0020; CLARK G, 2007, VASTLY INGENIOUS ARC, P173; CLARK G, 2003, CAHIERS ARCHEOLOGIE, V15, P85; Clark Geoffery, 2005, Micronesica, V38, P67; Clark Geoffrey, 2004, Archaeology in Oceania, V39, P26; Clark GR., 2006, J ISL COAST ARCHAEOL, V1, P215, DOI [10.1080/15564890600831705, DOI 10.1080/15564890600831705]; CORWIN CG, 1956, MILITARY GEOLOGY PAL; Dickinson WR., 2007, J ISL COAST ARCHAEOL, V2, P175, DOI [10.1080/15564890701623639, DOI 10.1080/15564890701623639]; Donaldson Terry J., 1996, Pacific Science, V50, P285; Donaldson TJ, 2002, ENVIRON BIOL FISH, V65, P241, DOI 10.1023/A:1020067931910; Donaldson TJ, 2002, ENVIRON BIOL FISH, V65, P139, DOI 10.1023/A:1020050931158; Douglas MT, 1997, AM J PHYS ANTHROPOL, V104, P291; Erlandson JM, 2001, J ARCHAEOL RES, V9, P287, DOI 10.1023/A:1013062712695; Fitzpatrick SM, 2008, INT J OSTEOARCHAEOL, V18, P439, DOI 10.1002/oa.951; Fitzpatrick SM, 2007, CORAL REEFS, V26, P915, DOI 10.1007/s00338-007-0226-x; Fitzpatrick SM, 2008, J ANTHROPOL ARCHAEOL, V27, P131, DOI 10.1016/j.jaa.2007.12.002; Fitzpatrick Scott M., 2003, Journal of Ethnobiology, V23, P101; Fitzpatrick SM, 2003, ANTIQUITY, V77, P719, DOI 10.1017/S0003598X00061664; Fitzpatrick SM, 2003, J ARCHAEOL SCI, V30, P1175, DOI 10.1016/S0305-4403(03)00014-1; Fitzpatrick SM, 2002, RADIOCARBON, V44, P217, DOI 10.1017/S003382220006481X; FITZPATRICK SM, STABLE ISOTOPE UNPUB; FITZPATRICK SM, 2002, RADIOCARBON, V44, P1; FITZPATRICK SM, 2003, THESIS U OREGON; Hanihara T, 1996, AM J PHYS ANTHROPOL, V99, P389, DOI 10.1002/(SICI)1096-8644(199603)99:3<389::AID-AJPA3>3.0.CO;2-S; Hazell LC, 2006, ARCHAEOL OCEAN, V41, P12, DOI 10.1002/j.1834-4453.2006.tb00601.x; Hillson S., 1996, DENTAL ANTHROPOLOGY; Howells W. W, 1989, SKULL SHAPES MAP CRA; Johannes R.E., 1981, WORDS LAGOON FISHING; KIRCH PV, 1989, AM J PHYS ANTHROPOL, V79, P63, DOI 10.1002/ajpa.1330790107; Klein RG, 2004, P NATL ACAD SCI USA, V101, P5708, DOI 10.1073/pnas.0400528101; Liston J, 2005, RADIOCARBON, V47, P295, DOI 10.1017/S0033822200019780; LISTON J, 1998, HIST PRESERVATION IN, V2; Liston J., 2006, ARCHAEOLOGY WARFARE, P148; Lucking L.J., 1984, THESIS U MINNESOTA M; Lum JK, 2000, AM J PHYS ANTHROPOL, V113, P151; Maragos JE, 1995, CORAL REEFS, V14, P237; MARAGOS JE, 1993, RAPID ECOLOGICAL A 1; MARAGOS JE, 1994, SYNTHESIS REPORT RAP; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Masse WB, 2006, QUATERN INT, V151, P106, DOI 10.1016/j.quaint.2006.01.017; MASSE WB, 1989, ARCHAEOLOGY ECOLOG U; MASSE WB, 1990, MICRONESICA S, V2, P213; MASSE WB, 1989, ARCHAEOLOGY ECOLOG 2; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Morwood MJ, 1999, ANTIQUITY, V73, P273, DOI 10.1017/S0003598X00088244; Morwood MJ, 1998, NATURE, V392, P173, DOI 10.1038/32401; Myers RF, 1999, MICRONESIAN REEF FIS, V3rd; NELSON GC, 1992, AM J PHYS ANTHROPOL, V88, P135, DOI 10.1002/ajpa.1330880203; NELSON GC, 1998, OCCLUSAL VARIATION M; NELSON GC, SKELETAL REMAI UNPUB; Nelson GC, 2006, ANTHROPOL SCI, V114, P1, DOI 10.1537/ase.040710; OSBORNE D, 1958, ARCHAEOLOGY, V11, P162; OSBORNE D, 1979, MICRONESICA S1; Osborne D., 1966, BISHOP MUSEUM B, V230; *PAL INT COR REEF, 2007, COR REEFS PAL; PALKOVICH AM, 1980, ARROYO HONDO SKELETA, V3; Parmentier Richard J., 1987, SACRED REMAINS MYTH; PATEL S, 2008, DISCOVERY FUELS HOBB; PAWLEY A, 1999, SEL PAP 8 INT C AUST; PHEAR S, 2003, CAHIERS ARCHEOLOGIE, V15, P241; PIETRUSEWSKY M, 1990, AM J PHYS ANTHROPOL, V82, P319, DOI 10.1002/ajpa.1330820309; Pietrusewsky M, 1997, AM J PHYS ANTHROPOL, V104, P315; Pietrusewsky M., 2006, BIOARCHAEOLOGY SE AS, P59; Pietrusewsky M., 2008, BIOL ANTHR HUMAN SKE, P487; Pietrusewsky M., 2005, PEOPLING E ASIA PUTT, P203; PIETRUSEWSKY M, 1990, MICRONESICA S, V2, P373; Pietrusewsky M., 1990, MICRONESICA S, V2, P317; Pietrusewsky Michael, 2006, AUSTRONESIAN DIASPOR, P320; RIETH TM, 2001, ARCHAEOLOGICAL DATA; Sem G., 1994, IMPLICATIONS CLIMATE; SNYDER D, 1997, MICRONESIAN RESOURCE; SNYDER DM, 1989, CHRONOMETRIC MODELS; Specht J, 2006, ASIAN PERSPECT, V45, P24; WICKLER S, 2002, PACIFIC LANDSCAPES A, P63; YESNER DR, 1980, CURR ANTHROPOL, V21, P727, DOI 10.1086/202568; ZOBEL E, 2002, PACIFIC LINGUISTICS, V518, P405	98	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3015	10.1371/journal.pone.0003015	http://dx.doi.org/10.1371/journal.pone.0003015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RM	18728774	Green Published, gold, Green Submitted			2022-12-25	WOS:000264796400001
J	Inoue, T; Meyer, T				Inoue, Takanari; Meyer, Tobias			Synthetic Activation of Endogenous PI3K and Rac Identifies an AND-Gate Switch for Cell Polarization and Migration	PLOS ONE			English	Article								Phosphatidylinositol 3-OH kinase (PI3K) has been widely studied as a principal regulator of cell polarization, migration, and chemotaxis [1,2,3,4]. Surprisingly, recent studies showed that mammalian neutrophils and Dictyostelium discoideum cells can polarize and migrate in the absence of PI3K activity [5,6,7]. Here we directly probe the roles of PI3K and its downstream effector, Rac, in HL-60 neutrophils by using a chemical biology approach whereby the endogenously present enzymes are synthetically activated in less than one minute [8,9,10]. We show that uniform activation of endogenous PI3K is sufficient to polarize previously unpolarized neutrophils and trigger effective cell migration. After a delay following symmetrical phosphatidylinositol (3,4,5)-triphosphate (PIP3) production, a polarized distribution of PIP3 was induced by positive feedback requiring actin polymerization. Pharmacological studies argue that this process does not require receptor-coupled trimeric G proteins. Contrary to the current working model, rapid activation of endogenous Rac proteins triggered effective actin polymerization but failed to feed back to PI3K to generate PIP3 or induce cell polarization. Thus, the increase in PIP3 concentration at the leading edge is generated by positive feedback with an AND gate logic with a PI3K-Rac-actin polymerization pathway as a first input and a PI3K initiated non-Rac pathway as a second input. This AND-gate control for cell polarization can explain how Rac can be employed for both PI3K-dependent and -independent signaling pathways coexisting in the same cell.	[Inoue, Takanari; Meyer, Tobias] Stanford Univ, Bio X Program, Stanford, CA 94305 USA	Stanford University	Inoue, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Inst Basic Biomed Sci,Ctr Cell Dynam, Baltimore, MD 21218 USA.	jctinoue@jhmi.edu; tobias1@stanford.edu		Meyer, Tobias/0000-0003-4339-3804	 [GM063702];  [PN2 EY1018241]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063702] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GM063702 and PN2 EY1018241 to TM	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Buchanan FG, 2000, J BIOL CHEM, V275, P9742, DOI 10.1074/jbc.275.13.9742; Burridge K, 1999, SCIENCE, V283, P2028, DOI 10.1126/science.283.5410.2028; Chen DF, 2007, MICROFLUID NANOFLUID, V3, P603, DOI 10.1007/s10404-007-0151-x; de Curtis I, 2001, EMBO REP, V2, P277, DOI 10.1093/embo-reports/kve072; Derman MP, 1997, J BIOL CHEM, V272, P6465, DOI 10.1074/jbc.272.10.6465; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Franca-Koh J, 2007, NAT CELL BIOL, V9, P15, DOI 10.1038/ncb0107-15; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Meinhardt H, 1999, J CELL SCI, V112, P2867; Niggli V, 2000, FEBS LETT, V473, P217, DOI 10.1016/S0014-5793(00)01534-9; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Peyrollier K, 2000, BIOCHEM J, V352, P617, DOI 10.1042/0264-6021:3520617; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; van Es S, 1999, CELL MOL LIFE SCI, V55, P1341, DOI 10.1007/s000180050374; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Wang JX, 2002, INT J MOL SCI, V3, P4, DOI 10.3390/i3010004; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	37	101	106	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3068	10.1371/journal.pone.0003068	http://dx.doi.org/10.1371/journal.pone.0003068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728784	Green Published, gold			2022-12-25	WOS:000264796400008
J	Burgess, HJ; Fogg, LF				Burgess, Helen J.; Fogg, Louis F.			Individual Differences in the Amount and Timing of Salivary Melatonin Secretion	PLOS ONE			English	Article							PLASMA MELATONIN; CIRCADIAN PHASE; MENSTRUAL-CYCLE; BREAST-CANCER; BRIGHT LIGHT; SUPPRESS MELATONIN; URINARY MELATONIN; HEALTHY-SUBJECTS; ACTION SPECTRUM; SLEEP	Background: The aim of this study was to examine individual differences in a large sample of complete melatonin profiles not suppressed by light and search for possible associations between the amount and timing of melatonin secretion and a multitude of lifestyle variables. The melatonin profiles were derived from saliva samples collected every 30 minutes in dim light from 85 healthy women and 85 healthy men aged 18-45 years. There was a large individual variability in the amount of melatonin secreted with peak values ranging from 2 to 84 pg/ml. The onset of melatonin secretion ranged from 18: 13 to 00: 26 hours. The use of hormonal birth control, reduced levels of employment, a smaller number of days on a fixed sleep schedule, increased day length and lower weight were associated with an increased amplitude of melatonin secretion. The use of hormonal birth control, contact lenses, a younger age, and lower ratings of mania and paranoia were associated with a longer duration of melatonin secretion. An earlier occurrence of the onset of melatonin secretion was associated with an earlier wake time, more morningness and the absence of a bed partner. Lifestyle and behavioral variables were only able to explain about 15% of the individual variability in the amount of melatonin secretion, which is likely because of a substantial genetic influence on the levels of melatonin secretion.	[Burgess, Helen J.; Fogg, Louis F.] Rush Univ, Biol Rhythms Res Lab, Dept Behav Sci, Med Ctr, Chicago, IL 60612 USA	Rush University	Burgess, HJ (corresponding author), Rush Univ, Biol Rhythms Res Lab, Dept Behav Sci, Med Ctr, Chicago, IL 60612 USA.	Helen_J_Burgess@rush.edu			National Institutes of Health (NIH) [R01 NR07677, R01 OH003954, R01 NS35695, R01 NS23421]; Centers for Disease Control and Prevention (CDC); National Institute of Occupational Safety and Health (NIOSH); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH003954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035695, R01NS023421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR007677] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was made possible by grants from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC) and the National Institute of Occupational Safety and Health (NIOSH) including R01 NR07677, R01 OH003954, R01 NS35695 and R01 NS23421 to Charmane I. Eastman, Ph.D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, CDC or NIOSH. The NIH, CDC and NIOSH had no role in study design, data collection and analysis, interpretation of the data, and in the preparation, review or approval of manuscript.	Babkoff H, 2002, AVIAT SPACE ENVIR MD, V73, P341; Baskett JJ, 2001, SLEEP, V24, P418, DOI 10.1093/sleep/24.4.418; BERGA SL, 1990, NEUROENDOCRINOLOGY, V51, P606, DOI 10.1159/000125398; Blask DE, 2005, CANCER RES, V65, P11174, DOI 10.1158/0008-5472.CAN-05-1945; BOJKOWSKI CJ, 1988, ACTA ENDOCRINOL-COP, V117, P470, DOI 10.1530/acta.0.1170470; Brainard GC, 2001, J NEUROSCI, V21, P6405; Brunet AG, 2002, J ENDOCRINOL, V172, P397, DOI 10.1677/joe.0.1720397; BRZEZINSKI A, 1988, J CLIN ENDOCR METAB, V66, P891, DOI 10.1210/jcem-66-5-891; Burgess HJ, 2006, NEUROSCI LETT, V395, P191, DOI 10.1016/j.neulet.2005.10.082; Butcher J.N., 1989, MMPI2 MINNESOTA MULT; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CARDINALI DP, 1987, J STEROID BIOCHEM, V27, P565, DOI 10.1016/0022-4731(87)90355-4; CLAUSTRAT B, 1986, J PINEAL RES, V3, P301, DOI 10.1111/j.1600-079X.1986.tb00753.x; Cole RJ, 1995, J BIOL RHYTHM, V10, P324, DOI 10.1177/074873049501000406; Drapeau C, 2005, SLEEP, V28, pA49; Eastman CI, 2000, CHRONOBIOL INT, V17, P807, DOI 10.1081/CBI-100102116; EKMAN AC, 1993, J CLIN ENDOCR METAB, V77, P780, DOI 10.1210/jc.77.3.780; Graham JR, 1990, MMPI 2 ASSESSING PER; Hallam KT, 2006, PSYCHONEUROENDOCRINO, V31, P867, DOI 10.1016/j.psyneuen.2006.04.004; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; ILLNEROVA H, 1985, BRAIN RES, V328, P186, DOI 10.1016/0006-8993(85)91342-3; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kantermann T, 2007, CURR BIOL, V17, P1996, DOI 10.1016/j.cub.2007.10.025; Kayumov L, 2005, J CLIN ENDOCR METAB, V90, P2755, DOI 10.1210/jc.2004-2062; Kennaway DJ, 1999, J PINEAL RES, V27, P210, DOI 10.1111/j.1600-079X.1999.tb00617.x; Klerman EB, 2002, J BIOL RHYTHM, V17, P181, DOI 10.1177/074873002129002474; Knight JA, 2005, AM J EPIDEMIOL, V162, P1114, DOI 10.1093/aje/kwi327; Kostoglou-Athanassiou I, 1998, CLIN ENDOCRINOL, V49, P209, DOI 10.1046/j.1365-2265.1998.00504.x; Kunz D, 1999, NEUROPSYCHOPHARMACOL, V21, P765, DOI 10.1016/S0893-133X(99)00069-X; Lee C, 2006, CHRONOBIOL INT, V23, P859, DOI 10.1080/07420520600827160; Levallois P, 2001, AM J EPIDEMIOL, V154, P601, DOI 10.1093/aje/154.7.601; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; Lewy AJ, 1999, J BIOL RHYTHM, V14, P227, DOI 10.1177/074873099129000641; Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245; Mahlberg R, 2006, PSYCHONEUROENDOCRINO, V31, P634, DOI 10.1016/j.psyneuen.2006.01.009; Megdal SP, 2005, EUR J CANCER, V41, P2023, DOI 10.1016/j.ejca.2005.05.010; Moore R.Y., 1978, PROGRESS IN REPRODUCTIVE BIOLOGY, V4, P1; Murphy Patricia J., 1996, Physiology and Behavior, V59, P133, DOI 10.1016/0031-9384(95)02036-5; Park SJ, 1999, CHRONOBIOL INT, V16, P359, DOI 10.3109/07420529909116864; Parry BL, 1997, J BIOL RHYTHM, V12, P47, DOI 10.1177/074873049701200107; Quesnel Nadia-Marie, 2001, CLAO Journal, V27, P23; Rahman SA, 2006, SLEEP, V29, pA58; Revell VL, 2005, J PINEAL RES, V39, P195, DOI 10.1111/j.1600-079X.2005.00236.x; Revell VL, 2005, J BIOL RHYTHM, V20, P353, DOI 10.1177/0748730405277233; Roenneberg T, 2007, CURR BIOL, V17, pR44, DOI 10.1016/j.cub.2006.12.011; ROSENTHAL FS, 1986, AM J PUBLIC HEALTH, V76, P1216, DOI 10.2105/AJPH.76.10.1216; Rubin DB, 2004, MULTIPLE IMPUTATION; SACK RL, 1986, J PINEAL RES, V3, P379, DOI 10.1111/j.1600-079X.1986.tb00760.x; Salas Einarhille S.L, 1982, CALCULUS ONE SEVERAL, Vfourth; Sasseville A, 2006, J PINEAL RES, V41, P73, DOI 10.1111/j.1600-079X.2006.00332.x; Schernhammer ES, 2006, J PINEAL RES, V40, P116, DOI 10.1111/j.1600-079X.2005.00285.x; Schernhammer ES, 2005, J NATL CANCER I, V97, P1084, DOI 10.1093/jnci/dji190; Sharkey KM, 2002, AM J PHYSIOL-REG I, V282, pR454, DOI 10.1152/ajpregu.00135.2001; SMITH MR, SLEEP MED IN PRESS; Stevens RG, 2000, EPIDEMIOLOGY, V11, P660, DOI 10.1097/00001648-200011000-00008; Takasu NN, 2006, AM J PHYSIOL-REG I, V291, pR1799, DOI 10.1152/ajpregu.00211.2006; TESSONNEAUD A, 1995, J NEUROENDOCRINOL, V7, P145, DOI 10.1111/j.1365-2826.1995.tb00677.x; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Travis RC, 2004, JNCI-J NATL CANCER I, V96, P475, DOI 10.1093/jnci/djh077; Ursing C, 2003, J ENDOCRINOL INVEST, V26, P403, DOI 10.1007/BF03345194; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; Wehr TA, 2001, ARCH GEN PSYCHIAT, V58, P1108, DOI 10.1001/archpsyc.58.12.1108; WEHR TA, 1995, AM J PHYSIOL-REG I, V269, pR173, DOI 10.1152/ajpregu.1995.269.1.R173; WEHR TA, 1993, AM J PHYSIOL, V265, pR846, DOI 10.1152/ajpregu.1993.265.4.R846; Wetterberg L, 1999, PSYCHONEUROENDOCRINO, V24, P209, DOI 10.1016/S0306-4530(98)00076-6; Wright KP, 1997, BRAIN RES, V747, P78, DOI 10.1016/S0006-8993(96)01268-1; Wright KP, 1999, BEHAV BRAIN RES, V103, P185, DOI 10.1016/S0166-4328(99)00042-X; Zarazaga LA, 1998, AM J PHYSIOL-ENDOC M, V274, pE1086, DOI 10.1152/ajpendo.1998.274.6.E1086; Zeitzer JM, 2007, SLEEP, V30, P1437, DOI 10.1093/sleep/30.11.1437; Zeitzer JM, 1999, AM J MED, V107, P432, DOI 10.1016/S0002-9343(99)00266-1; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x	72	160	176	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3055	10.1371/journal.pone.0003055	http://dx.doi.org/10.1371/journal.pone.0003055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725972	Green Published, gold			2022-12-25	WOS:000264796300002
J	Lesica, NA; Ishii, T; Stanley, GB; Hosoya, T				Lesica, Nicholas A.; Ishii, Toshiyuki; Stanley, Garrett B.; Hosoya, Toshihiko			Estimating Receptive Fields from Responses to Natural Stimuli with Asymmetric Intensity Distributions	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; INFORMATION-TRANSMISSION; SIMPLE CELLS; STATISTICS; NEURONS; ADAPTATION; CONTRAST; SOUNDS; IMAGES	The reasons for using natural stimuli to study sensory function are quickly mounting, as recent studies have revealed important differences in neural responses to natural and artificial stimuli. However, natural stimuli typically contain strong correlations and are spherically asymmetric (i.e. stimulus intensities are not symmetrically distributed around the mean), and these statistical complexities can bias receptive field (RF) estimates when standard techniques such as spike-triggered averaging or reverse correlation are used. While a number of approaches have been developed to explicitly correct the bias due to stimulus correlations, there is no complementary technique to correct the bias due to stimulus asymmetries. Here, we develop a method for RF estimation that corrects reverse correlation RF estimates for the spherical asymmetries present in natural stimuli. Using simulated neural responses, we demonstrate how stimulus asymmetries can bias reverse-correlation RF estimates (even for uncorrelated stimuli) and illustrate how this bias can be removed by explicit correction. We demonstrate the utility of the asymmetry correction method under experimental conditions by estimating RFs from the responses of retinal ganglion cells to natural stimuli and using these RFs to predict responses to novel stimuli.	[Lesica, Nicholas A.; Ishii, Toshiyuki; Hosoya, Toshihiko] RIKEN Brain Sci Inst, Wako, Saitama, Japan; [Lesica, Nicholas A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ishii, Toshiyuki] Toho Univ, Funabashi, Chiba, Japan; [Stanley, Garrett B.] Emory Univ, Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30322 USA	RIKEN; Harvard University; Toho University; Emory University; University System of Georgia; Georgia Institute of Technology	Lesica, NA (corresponding author), Bernstein Ctr Computat Neurosci, Munich, Germany.	lesica@zi.biologie.uni-muenchen.de	Hosoya, Toshihiko/Q-2514-2018; Ishii, Toshiyuki/ABD-1165-2020	Hosoya, Toshihiko/0000-0001-8559-8344; Stanley, Garrett/0000-0003-2039-7706; Lesica, Nicholas/0000-0001-5238-4462	Sigma Xi Grant-In-Aid of Research; Japan Society for the Promotion of Science [Post-doctoral Fellowship]; National Geospatial-Intelligence Agency [HM1582-05-C-0009]; RIKEN Research Fund	Sigma Xi Grant-In-Aid of Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Geospatial-Intelligence Agency; RIKEN Research Fund	NAL was supported by a Sigma Xi Grant-In-Aid of Research, a Post-doctoral Fellowship from the Japan Society for the Promotion of Science, and National Geospatial-Intelligence Agency Grant HM1582-05-C-0009. TI and TH were supported by the RIKEN Research Fund.	Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Bussgang J. J., 1952, 216 MIT RES LAB EL; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Christianson GB, 2008, J NEUROSCI, V28, P446, DOI 10.1523/JNEUROSCI.1775-07.2007; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Dan Y, 1996, J NEUROSCI, V16, P3351; David SV, 2007, NETWORK-COMP NEURAL, V18, P191, DOI 10.1080/09548980701609235; David SV, 2005, NETWORK-COMP NEURAL, V16, P239, DOI 10.1080/09548980500464030; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Escabi MA, 2003, J NEUROSCI, V23, P11489; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; Klug A, 2002, J NEUROPHYSIOL, V88, P1941, DOI 10.1152/jn.2002.88.4.1941; Lesica NA, 2005, IEEE T NEUR SYS REH, V13, P194, DOI 10.1109/TNSRE.2005.848339; Lesica NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001655; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; Lesica NA, 2006, NETWORK-COMP NEURAL, V17, P43, DOI 10.1080/09548980500328409; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2003, NETWORK-COMP NEURAL, V14, P437, DOI 10.1088/0954-898X/14/3/304; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 2004, J PHYSIOL-LONDON, V558, P717, DOI 10.1113/jphysiol.2004.065771; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Sahani M, 2002, ADV NEURAL INFORM PR, V15, P317; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; SIMONCELLI EP, 2003, COGNITIVE NEUROSCIEN; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Smyth D, 2003, J NEUROSCI, V23, P4746; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Thomson MGA, 1999, NETWORK-COMP NEURAL, V10, P123, DOI 10.1088/0954-898X/10/2/302; Touryan J, 2005, NEURON, V45, P781, DOI 10.1016/j.neuron.2005.01.029; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Willmore B, 2003, NETWORK-COMP NEURAL, V14, P553, DOI 10.1088/0954-898X/14/3/309	46	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3060	10.1371/journal.pone.0003060	http://dx.doi.org/10.1371/journal.pone.0003060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725977	Green Published, gold, Green Submitted			2022-12-25	WOS:000264796300006
J	Moroni, L; Hamann, D; Paoluzzi, L; Pieper, J; de Wijn, JR; van Blitterswijk, CA				Moroni, Lorenzo; Hamann, Doreen; Paoluzzi, Luca; Pieper, Jeroen; de Wijn, Joost R.; van Blitterswijk, Clemens A.			Regenerating Articular Tissue by Converging Technologies	PLOS ONE			English	Article							FIBER-DEPOSITED SCAFFOLDS; DEMINERALIZED BONE-MATRIX; IN-VITRO; OSTEOCHONDRAL DEFECTS; CELL-DIFFERENTIATION; DESIGN; OSTEOINDUCTION; ARCHITECTURE; OXYGEN; REPAIR	Scaffolds for osteochondral tissue engineering should provide mechanical stability, while offering specific signals for chondral and bone regeneration with a completely interconnected porous network for cell migration, attachment, and proliferation. Composites of polymers and ceramics are often considered to satisfy these requirements. As such methods largely rely on interfacial bonding between the ceramic and polymer phase, they may often compromise the use of the interface as an instrument to direct cell fate. Alternatively, here, we have designed hybrid 3D scaffolds using a novel concept based on biomaterial assembly, thereby omitting the drawbacks of interfacial bonding. Rapid prototyped ceramic particles were integrated into the pores of polymeric 3D fiber-deposited (3DF) matrices and infused with demineralized bone matrix (DBM) to obtain constructs that display the mechanical robustness of ceramics and the flexibility of polymers, mimicking bone tissue properties. Ostechondral scaffolds were then fabricated by directly depositing a 3DF structure optimized for cartilage regeneration adjacent to the bone scaffold. Stem cell seeded scaffolds regenerated both cartilage and bone in vivo.	[Moroni, Lorenzo; Hamann, Doreen; de Wijn, Joost R.; van Blitterswijk, Clemens A.] Univ Twente, BMTI, NL-7500 AE Enschede, Netherlands; [Paoluzzi, Luca] Univ Politecn Marche, Mech Engn Inst, Ancona, Italy; [Pieper, Jeroen] Isotis OrthoBiologics SA, Irvine, CA USA; [Moroni, Lorenzo] MuscoloSkeletal Cell & Tissue Bank, Rizzoli Orthopaed Inst, Bologna, Italy	University of Twente; Marche Polytechnic University; IRCCS Istituto Ortopedico Rizzoli	Moroni, L (corresponding author), Univ Twente, BMTI, POB 217, NL-7500 AE Enschede, Netherlands.	lmoroni@gmail.com	Moroni, Lorenzo/D-2826-2014	Moroni, Lorenzo/0000-0003-1298-6025; van Blitterswijk, Clemens/0000-0003-2371-4615	European Community project Intelliscaf [GSRD_2002_00697]	European Community project Intelliscaf	This project was funded by the European Community project Intelliscaf GSRD_2002_00697.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083; BAKKER D, 1988, BIOMATERIALS, V9, P14, DOI 10.1016/0142-9612(88)90064-6; Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023; BEUMER GJ, 1994, BIOMATERIALS, V15, P551, DOI 10.1016/0142-9612(94)90022-1; BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504; Bezemer JM, 1999, J CONTROL RELEASE, V62, P393, DOI 10.1016/S0168-3659(99)00170-4; Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806; Chakkalakal DA, 2001, TISSUE ENG, V7, P161, DOI 10.1089/107632701300062778; Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495; Demarteau O, 2003, BIOCHEM BIOPH RES CO, V310, P580, DOI 10.1016/j.bbrc.2003.09.099; Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7; FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104; Garcia VP, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/63518; Guldberg V. M., 1992, BONE IMPLANT GRAFTIN, P9; Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712; Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010; Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114; Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1; Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792; Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19; Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046; Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031; Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020; Mensik I., 2002, Cell and Tissue Banking, V3, P245; Moroni L, 2007, TISSUE ENG, V13, P361, DOI 10.1089/ten.2006.0127; Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023; Moroni L, 2006, J BIOMED MATER RES A, V78A, P605, DOI 10.1002/jbm.a.30716; Moroni L, 2005, J BIOMED MATER RES A, V75A, P957, DOI 10.1002/jbm.a.30499; Murphy CL, 2001, CONNECT TISSUE RES, V42, P87, DOI 10.3109/03008200109014251; Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016; REDDI AH, 1981, COLLAGEN REL RES, V1, P209; Reuss A, 1929, Z ANGEW MATH MECH, V9, P49, DOI 10.1002/zamm.19290090104; Rice JM, 2003, CALCIFIED TISSUE INT, V72, P726, DOI 10.1007/s00223-002-2045-y; Schek R M, 2005, Orthod Craniofac Res, V8, P313, DOI 10.1111/j.1601-6343.2005.00354.x; Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539; Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040; Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5; URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; VONDERMARK K, 1979, CLIN ORTHOP RELAT R, P185; Wang DW, 2005, J CELL PHYSIOL, V204, P184, DOI 10.1002/jcp.20324; Wilson CE, 2006, BIOMATERIALS, V27, P302, DOI 10.1016/j.biomaterials.2005.06.041; Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032; Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056; Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047; Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0	51	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3032	10.1371/journal.pone.0003032	http://dx.doi.org/10.1371/journal.pone.0003032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716660	Green Published, gold			2022-12-25	WOS:000264426800009
J	Albiston, AL; Morton, CJ; Ng, HL; Pham, V; Yeatman, HR; Ye, S; Fernando, RN; De Bundel, D; Ascher, DB; Mendelsohn, FAO; Parker, MW; Chai, SY				Albiston, Anthony L.; Morton, Craig J.; Ng, Hooi Ling; Pham, Vi; Yeatman, Holly R.; Ye, Siying; Fernando, Ruani N.; De Bundel, Dimitri; Ascher, David B.; Mendelsohn, Frederick A. O.; Parker, Michael W.; Chai, Siew Yeen			Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase	FASEB JOURNAL			English	Article						facilitation of memory; drug development; virtual screening; homology model; glucose uptake	ANGIOTENSIN-IV BINDING; RECEPTOR SUBTYPE; AT(4) RECEPTOR; PASSIVE-AVOIDANCE; MEMBRANE AMINOPEPTIDASE; DRUG DISCOVERY; POTENTIAL ROLE; WATER MAZE; MEMORY; GLUCOSE	Approximately one-quarter of people over the age of 65 are estimated to suffer some form of cognitive impairment, underscoring the need for effective cognitive-enhancing agents. Insulin-regulated aminopeptidase (IRAP) is potentially an innovative target for the development of cognitive enhancers, as its peptide inhibitors exhibit memory-enhancing effects in both normal and memory-impaired rodents. Using a homology model of the catalytic domain of IRAP and virtual screening, we have identified a class of nonpeptide, small-molecule inhibitors of IRAP. Structure-based computational development of an initial "hit" resulted in the identification of two divergent families of compounds. Subsequent medicinal chemistry performed on the highest affinity compound produced inhibitors with nanomolar affinities (K-i 20-700 nM) for IRAP. In vivo efficacy of one of these inhibitors was demonstrated in rats with an acute dose (1 nmol in 1 mu l) administered into the lateral ventricles, improving performance in both spatial working and recognition memory paradigms. We have identified a family of specific IRAP inhibitors that is biologically active which will be useful both in understanding the physiological role of IRAP and potentially in the development of clinically useful cognitive enhancers. Notably, this study also provides unequivocal proof of principal that inhibition of IRAP results in memory enhancement.	[Albiston, Anthony L.; Pham, Vi; Yeatman, Holly R.; Ye, Siying; Fernando, Ruani N.; De Bundel, Dimitri; Mendelsohn, Frederick A. O.; Chai, Siew Yeen] Univ Melbourne, Howard Florey Inst, Florey Neurosci Inst, Parkville, Vic 3010, Australia; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Chai, Siew Yeen] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia; [Morton, Craig J.; Ng, Hooi Ling; Ascher, David B.; Parker, Michael W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research	Chai, SY (corresponding author), Univ Melbourne, Howard Florey Inst, Florey Neurosci Inst, Parkville, Vic 3010, Australia.	sychai@florey.edu.au	Ye, Siying/H-3156-2013; De Bundel, Dimitri/AAG-9453-2020; Parker, Michael W/F-9069-2013; De Bundel, Dimitri/C-5701-2015; Morton, Craig/GON-8638-2022	Ye, Siying/0000-0002-0882-1642; Parker, Michael W/0000-0002-3101-1138; Morton, Craig/0000-0001-5452-5193; De Bundel, Dimitri/0000-0002-6234-9908; Yeatman, Holly/0000-0002-3963-4540; Ascher, David/0000-0003-2948-2413; Chai, Siew Yeen/0000-0001-7209-4112	National Health and Medical Research Council of Australia (NHMRC) [454714, 520695]; Neurosciences Victoria; Alzheimer's Drug DiscoveryFoundation/ Institute for the Study of Aging, USA; Research Foundation, Flanders, Belgium; Australian Postgraduate Award; Colin North and Major Engineering; Australian Research Council Federation	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Neurosciences Victoria; Alzheimer's Drug DiscoveryFoundation/ Institute for the Study of Aging, USA; Research Foundation, Flanders, Belgium(FWO); Australian Postgraduate Award(Australian Government); Colin North and Major Engineering; Australian Research Council Federation(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC development grants 454714 and 520695), Neurosciences Victoria, and Alzheimer's Drug Discovery Foundation/ Institute for the Study of Aging, USA. D.D.B. is a Scientific Research Fellow of the Research Foundation, Flanders, Belgium. D.B.A is an Australian Postgraduate Award Scholar and a recipient of a St. Vincent's Institute Foundation Scholarship sponsored by Colin North and Major Engineering. M.W.P. is an Australian Research Council Federation Fellow and an NHMRC Honorary Fellow. S.Y.C. is an NHMRC Senior Research Fellow. The authors acknowledge the contribution of Dr. Keith Watson in the design of the analogues of HFI-142, Prof. William Charman for the solubility and blood brain barrier permeability studies, and Mr. Tom Vale for assistance with the animal surgery.	Al-Mousawi SM, 1999, ORG PREP PROCED INT, V31, P305, DOI 10.1080/00304949909458324; Albiston AL, 2004, BEHAV BRAIN RES, V154, P239, DOI 10.1016/j.bbr.2004.02.012; Albiston AL, 2003, TRENDS ENDOCRIN MET, V14, P72, DOI 10.1016/S1043-2760(02)00037-1; Albiston AL, 2001, J BIOL CHEM, V276, P48623, DOI 10.1074/jbc.C100512200; Albiston AL, 2007, PHARMACOL THERAPEUT, V116, P417, DOI 10.1016/j.pharmthera.2007.07.006; Axen A, 2006, J PEPT SCI, V12, P705, DOI 10.1002/psc.782; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; BRASZKO JJ, 1988, NEUROSCIENCE, V27, P777, DOI 10.1016/0306-4522(88)90182-0; Chai SY, 2004, CELL MOL LIFE SCI, V61, P2728, DOI 10.1007/s00018-004-4246-1; Chai SY, 2000, J CHEM NEUROANAT, V20, P339, DOI 10.1016/S0891-0618(00)00112-5; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Demaegdt H, 2006, EUR J PHARMACOL, V546, P19, DOI 10.1016/j.ejphar.2006.07.005; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fernando RN, 2005, J COMP NEUROL, V487, P372, DOI 10.1002/cne.20585; Fernando RN, 2008, EUR J NEUROSCI, V28, P588, DOI 10.1111/j.1460-9568.2008.06347.x; Funahashi S, 2006, NEUROSCIENCE, V139, P251, DOI 10.1016/j.neuroscience.2005.07.003; Furey ML, 2000, SCIENCE, V290, P2315, DOI 10.1126/science.290.5500.2315; Garreau I, 1998, PEPTIDES, V19, P1339, DOI 10.1016/S0196-9781(98)00075-8; Herbst JJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE600, DOI 10.1152/ajpendo.1997.272.4.E600; Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kesner RP, 2001, LEARN MEMORY, V8, P87, DOI 10.1101/lm.29401; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; KOBORI T, 2000, Patent No. 6066672; Korol DL, 1998, AM J CLIN NUTR, V67, p764S, DOI 10.1093/ajcn/67.4.764S; Kramar EA, 2001, BRAIN RES, V897, P114, DOI 10.1016/S0006-8993(01)02100-X; Lee J, 2004, NEUROSCIENCE, V124, P341, DOI 10.1016/j.neuroscience.2003.12.006; Lee J, 2001, NEUROPHARMACOLOGY, V40, P618, DOI 10.1016/S0028-3908(00)00188-X; LEE MK, 1988, BEHAV NEUROSCI, V102, P591, DOI 10.1037/0735-7044.102.4.591; Lew RA, 2003, J NEUROCHEM, V86, P344, DOI 10.1046/j.1471-4159.2003.01852.x; Loging W, 2007, NAT REV DRUG DISCOV, V6, P220, DOI 10.1038/nrd2265; MANNING CA, 1993, NEUROBIOL AGING, V14, P523, DOI 10.1016/0197-4580(93)90034-9; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Moeller I, 1996, BRAIN RES, V712, P307, DOI 10.1016/0006-8993(95)01482-9; Nyberg G, 1996, J CHROMATOGR A, V723, P43, DOI 10.1016/0021-9673(95)00811-X; Olson ML, 2004, PEPTIDES, V25, P233, DOI 10.1016/j.peptides.2003.12.005; Parent MB, 1997, NEUROBIOL LEARN MEM, V68, P75, DOI 10.1006/nlme.1997.3769; Parkes M, 2000, BEHAV NEUROSCI, V114, P307, DOI 10.1037/0735-7044.114.2.307; Pederson ES, 2001, REGUL PEPTIDES, V102, P147, DOI 10.1016/S0167-0115(01)00312-3; Pederson ES, 1998, REGUL PEPTIDES, V74, P97, DOI 10.1016/S0167-0115(98)00028-7; Ragozzino ME, 1998, J NEUROSCI, V18, P1595; Rogi T, 1996, J BIOL CHEM, V271, P56, DOI 10.1074/jbc.271.1.56; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; Wayner MJ, 2001, PEPTIDES, V22, P1403, DOI 10.1016/S0196-9781(01)00475-2; Wisniewski Konstanty, 1993, Polish Journal of Pharmacology, V45, P23; Wright JW, 2008, PROG NEUROBIOL, V84, P157, DOI 10.1016/j.pneurobio.2007.10.009; WRIGHT JW, 1993, BRAIN RES BULL, V32, P497, DOI 10.1016/0361-9230(93)90297-O; Wright JW, 1999, J NEUROSCI, V19, P3952; Wright JW, 1996, PEPTIDES, V17, P1365, DOI 10.1016/S0196-9781(96)00226-4; Wright JW, 1996, BRAIN RES, V717, P1, DOI 10.1016/0006-8993(95)01454-3	53	83	84	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4209	4217		10.1096/fj.08-112227	http://dx.doi.org/10.1096/fj.08-112227			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18716029				2022-12-25	WOS:000261254800020
J	Keserue, B; Barbosa-Sicard, E; Popp, R; Fisslthaler, B; Dietrich, A; Gudermann, T; Hammock, BD; Falck, JR; Weissmann, N; Busse, R; Fleming, I				Keserue, Benjamin; Barbosa-Sicard, Eduardo; Popp, Ruediger; Fisslthaler, Beate; Dietrich, Alexander; Gudermann, Thomas; Hammock, Bruce D.; Falck, John R.; Weissmann, Norbert; Busse, Rudi; Fleming, Ingrid			Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response	FASEB JOURNAL			English	Article						cytochrome P-450; Rho kinase; TRP channels; caveolae	20-HYDROXYEICOSATETRAENOIC ACID; CYTOCHROME-P450 EPOXYGENASES; CORONARY-ARTERIES; P-450 METABOLITES; RHO-KINASE; HYPERTENSION; LUNG; ENDOTHELIUM; CHANNELS; RABBIT	Recent findings have indicated a role for cytochrome P-450 (CYP) epoxygenase-derived epoxyeicosatrienoic acids (EETs) in acute hypoxic pulmonary vasoconstriction (HPV). Given that the intracellular concentration of EETs is determined by the soluble epoxide hydrolase (sEH), we assessed the influence of the sEH and 11,12-EET on pulmonary artery pressure and HPV in the isolated mouse lung. In lungs from wild-type mice, HPV was significantly increased by sEH inhibition, an effect abolished by pretreatment with CYP epoxygenase inhibitors and the EET antagonist 14,15-EEZE. HPV and EET production were greater in lungs from sEH(-/-) mice than from wild-type mice and sEH inhibition had no further effect on HPV, while MSPPOH and 14,15-EEZE decreased the response. 11,12-EET increased pulmonary artery pressure in a concentration-dependent manner and enhanced HPV via a Rho-dependent mechanism. Both 11,12-EET and hypoxia elicited the membrane translocation of a transient receptor potential (TRP) C6-V5 fusion protein, the latter effect was sensitive to 14,15-EEZE. Moreover, while acute hypoxia and 11,12-EET increased pulmonary pressure in lungs from TRPC6(+/-) mice, lungs from TRPC6(-/-) mice did not respond to either stimuli. These data demonstrate that CYP-derived EETs are involved in HPV and that EET-induced pulmonary contraction under normoxic and hypoxic conditions involves a TRPC6-dependent pathway.-Keseru, B., Barbosa-Sicard, E., Popp, R., Fisslthaler, B., Dietrich, A., Gudermann, T., Hammock, B. D., Falck, J. R., Weissmann, N., Busse, R., Fleming, I. Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response. FASEB J. 22, 4306-4315 (2008)	[Keserue, Benjamin; Barbosa-Sicard, Eduardo; Popp, Ruediger; Fisslthaler, Beate; Busse, Rudi; Fleming, Ingrid] Goethe Univ, Inst Kardiovaskulare Physiol, Vasc Signalling Grp, D-60590 Frankfurt, Germany; [Dietrich, Alexander; Gudermann, Thomas] Univ Marburg, Inst Pharmakol & Toxikol, D-3550 Marburg, Germany; [Weissmann, Norbert] Univ Giessen, Univ Giessen Lung Ctr, Dept Internal Med 2 5, Giessen, Germany; [Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Goethe University Frankfurt; Philipps University Marburg; Justus Liebig University Giessen; University of California System; University of California Davis; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fleming, I (corresponding author), Goethe Univ, Inst Kardiovaskulare Physiol, Vasc Signalling Grp, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	fleming@em.uni-frankfurt.de	Fleming, Ingrid/L-1225-2014; Fleming, Ingrid/AAB-6123-2022; Dietrich, Alexander/G-8619-2013; Falck, John R/B-3030-2011	Fleming, Ingrid/0000-0003-1881-3635; Fleming, Ingrid/0000-0003-1881-3635; Dietrich, Alexander/0000-0002-1168-8707; Falck, John R/0000-0002-9219-7845; Weissmann, Norbert/0000-0003-2675-3871	Deutsche Forschungsgemeinschaft [FI 830/2-3, GRK 757]; National Institute of Environmental Health Sciences [R37 ES02710, P42 ES004699]; U.S. Public Health Service; National Institutes of Health [GM-31278, HL-85727]; Robert A. Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R37ES002710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are indebted to Isabel Winter and Ewa Bieniek for expert technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (FI 830/2-3, GRK 757, and Exzellenzcluster 147 "Cardio-Pulmonary Systems"). Partial support was provided by National Institute of Environmental Health Sciences R37 ES02710 and P42 ES004699, as well as by the U.S. Public Health Service, National Institutes of Health (GM-31278 and HL-85727), and the Robert A. Welch Foundation.	Alvarez DF, 2004, AM J PHYSIOL-LUNG C, V286, pL445, DOI 10.1152/ajplung.00150.2003; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Basora N, 2003, J BIOL CHEM, V278, P31709, DOI 10.1074/jbc.M304437200; Birks EK, 1997, AM J PHYSIOL-LUNG C, V272, pL823, DOI 10.1152/ajplung.1997.272.5.L823; Chiamvimonvat N, 2007, J CARDIOVASC PHARM, V50, P225, DOI 10.1097/FJC.0b013e3181506445; Corenblum MJ, 2008, HYPERTENSION, V51, P567, DOI 10.1161/HYPERTENSIONAHA.107.102160; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dorrance AM, 2005, J CARDIOVASC PHARM, V46, P842, DOI 10.1097/01.fjc.0000189600.74157.6d; Earley S, 2003, AM J PHYSIOL-HEART C, V285, pH127, DOI 10.1152/ajpheart.01052.2002; ESCALANTE B, 1993, EUR J PHARMACOL, V235, P1, DOI 10.1016/0014-2999(93)90812-V; Fagan KA, 2004, AM J PHYSIOL-LUNG C, V287, pL656, DOI 10.1152/ajplung.00090.2003; Fleming I, 2007, ARTERIOSCL THROM VAS, V27, P2612, DOI 10.1161/ATVBAHA.107.152074; Fleming I, 2007, TRENDS PHARMACOL SCI, V28, P448, DOI 10.1016/j.tips.2007.08.002; Gauthier KM, 2002, CIRC RES, V90, P1028, DOI 10.1161/01.RES.0000018162.87285.F8; Gschwendtner A, 2008, STROKE, V39, P1593, DOI 10.1161/STROKEAHA.107.502179; Hutchens MP, 2008, RESUSCITATION, V76, P89, DOI 10.1016/j.resuscitation.2007.06.031; Ichinose F, 2002, J CLIN INVEST, V109, P1493, DOI 10.1172/JCI200214294; Jung O, 2005, HYPERTENSION, V45, P759, DOI 10.1161/01.HYP.0000153792.29478.1d; Kiss L, 2008, ANAL BIOANAL CHEM, V390, P697, DOI 10.1007/s00216-007-1718-9; Lin MJ, 2004, CIRC RES, V95, P496, DOI 10.1161/01.RES.0000138952.16382.ad; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; MA YH, 1993, CIRC RES, V72, P126, DOI 10.1161/01.RES.72.1.126; Michaelis UR, 2006, PHARMACOL THERAPEUT, V111, P584, DOI 10.1016/j.pharmthera.2005.11.003; Michaelis UR, 2005, J CELL SCI, V118, P5489, DOI 10.1242/jcs.02674; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Moudgil R, 2005, J APPL PHYSIOL, V98, P390, DOI 10.1152/japplphysiol.00733.2004; Moudgil R, 2006, MICROCIRCULATION, V13, P615, DOI 10.1080/10739680600930222; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Pokreisz P, 2006, HYPERTENSION, V47, P762, DOI 10.1161/01.HYP.0000208299.62535.58; Randriamboavonjy V, 2003, HYPERTENSION, V41, P801, DOI 10.1161/01.HYP.0000047240.33861.6B; Robertson TP, 2000, BRIT J PHARMACOL, V131, P5, DOI 10.1038/sj.bjp.0703537; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Stephenson AH, 2003, AM J PHYSIOL-HEART C, V284, pH2153, DOI 10.1152/ajpheart.00844.2002; Tan JZ, 1997, ADV EXP MED BIOL, V407, P561; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Weir EK, 2006, CARDIOVASC RES, V71, P630, DOI 10.1016/j.cardiores.2006.04.014; Weissmann N, 2004, RESP PHYSIOL NEUROBI, V139, P191, DOI 10.1016/j.resp.2003.10.003; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhu DL, 2000, AM J PHYSIOL-LUNG C, V278, pL335, DOI 10.1152/ajplung.2000.278.2.L335; Zhu DL, 2000, AM J PHYSIOL-HEART C, V279, pH1526, DOI 10.1152/ajpheart.2000.279.4.H1526	45	93	95	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4306	4315		10.1096/fj.08-112821	http://dx.doi.org/10.1096/fj.08-112821			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18725458	Green Published			2022-12-25	WOS:000261254800029
J	Pan, YF; Wansa, KDSA; Liu, MH; Zhao, B; Hong, SZ; Tan, PY; Lim, KS; Bourque, G; Liu, ET; Cheung, E				Pan, You Fu; Wansa, K. D. Senali Abayratna; Liu, Mei Hui; Zhao, Bing; Hong, Shu Zhen; Tan, Peck Yean; Lim, Kar Sian; Bourque, Guillaume; Liu, Edison T.; Cheung, Edwin			Regulation of Estrogen Receptor-mediated Long Range Transcription via Evolutionarily Conserved Distal Response Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBIN LOCUS REQUIRES; CANCER CELL-LINE; CHROMOSOME CONFORMATION; INTRACHROMOSOMAL INTERACTIONS; 1,25-DIHYDROXYVITAMIN D-3; ANDROGEN RECEPTOR; BINDING-SITES; ALPHA BINDING; PS2 GENE; ORGANIZATION	Nuclear signaling by estrogens rapidly induces the global recruitment of estrogen receptors (ERs) to thousands of highly specific locations in the genome. Here, we have examined whether ER binding sites that are located distal from the transcription start sites of estrogen target genes are functionally relevant. Similar to ER binding sites near the proximal promoter region, ER binding sites located at distal locations are occupied by ERs after estrogen stimulation. And, like proximal bound ERs, ERs occupied at distal sites can recruit coactivators and the RNA polymerase transcription machinery and mediate specific structural changes to chromatin. Furthermore, ERs occupied at the distal sites are capable of communicating with ERs bound at the promoter region, possibly via long range chromosome looping. In functional analysis, disruption of the response elements in the distal ER binding sites abrogated ER binding and significantly reduced transcriptional response. Finally, sequence comparison of the response elements at the distal sites suggests a high level of conservation across different species. Together, our data indicate that distal ER binding sites are bona fide transcriptional enhancers that are involved in long range chromosomal interaction, transcription complex formation, and distinct structural modifications of chromatin across large genomic spans.	[Pan, You Fu; Wansa, K. D. Senali Abayratna; Liu, Mei Hui; Zhao, Bing; Hong, Shu Zhen; Tan, Peck Yean; Lim, Kar Sian; Bourque, Guillaume; Liu, Edison T.; Cheung, Edwin] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Cheung, Edwin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117543, Singapore; [Cheung, Edwin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Cheung, E (corresponding author), ASTAR, Genome Inst Singapore, 60 Biopolis St,02-01, Singapore 138672, Singapore.	cheungcwe@gis.a-star.edu.sg	Liu, Edison/C-4141-2008; Liu, Mei Hui/J-9750-2013; Bourque, Guillaume/AFR-2927-2022	Bourque, Guillaume/0000-0002-3933-9656; Liu, Mei Hui/0000-0001-7405-7008; Pan, You-Fu/0000-0002-9996-8892	Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore	Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported in part by the Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Supported by an A*STAR graduate scholarship.	Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cheung E, 2003, EMBO J, V22, P600, DOI 10.1093/emboj/cdg037; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; JAKOWLEW SB, 1984, NUCLEIC ACIDS RES, V12, P2861, DOI 10.1093/nar/12.6.2861; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kininis Miltiadis, 2008, Nucl Recept Signal, V6, pe005, DOI 10.1621/nrs.06005; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; KRAUS WL, 1994, MOL ENDOCRINOL, V8, P952, DOI 10.1210/me.8.8.952; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	35	71	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32977	32988		10.1074/jbc.M802024200	http://dx.doi.org/10.1074/jbc.M802024200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18728018	hybrid			2022-12-25	WOS:000260893700086
J	Adle, DJ; Lee, J				Adle, David J.; Lee, Jaekwon			Expressional Control of a Cadmium-transporting P-1B-type ATPase by a Metal Sensing Degradation Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS-DISEASE PROTEIN; BINDING SITES; FERRICHROME TRANSPORTER; CANDIDA-ALBICANS; COPPER-BINDING; YEAST; DOMAIN; RESISTANCE; INSIGHTS; ATP7B	Cadmium is a highly toxic environmental contaminant implicated in various diseases. Our previous data demonstrated that Pca1, a P-1B-type ATPase, plays a critical role in cadmium resistance in yeast S. cerevisiae by extruding intracellular cadmium. This illustrates the first cadmium-specific efflux pump in eukaryotes. In response to cadmium, yeast cells rapidly enhance expression of Pca1 by a post-transcriptional mechanism. To gain mechanistic insights into the cadmium-dependent control of Pca1 expression, we have characterized the pathway for Pca1 turnover and the mechanism of cadmium sensing that leads to up-regulation of Pca1. Pca1 is a short-lived protein (t(1/2) < 5 min) and is subject to ubiquitination when cells are growing in media lacking cadmium. Distinct from many plasma membrane transporters targeted to the vacuole for degradation via endocytosis, cells defective in this pathway did not stabilize Pca1. Rather, Pca1 turnover was dependent on the proteasome. These data suggest that, in the absence of cadmium, Pca1 is targeted for degradation before reaching the plasma membrane. Mapping of the N terminus of Pca1 identified a metal-responding degradation signal encompassing amino acids 250-350. Fusion of this domain to a stable protein demonstrated that it functions autonomously in a metal-responsive manner. Cadmium sensing by cysteine residues within this domain circumvents ubiquitination and degradation of Pca1. These data reveal a new mechanism for substrate-mediated control of P-1B-type ATPase expression. Cells have likely evolved this mode of regulation for a rapid and specific cellular response to cadmium.	[Adle, David J.; Lee, Jaekwon] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Lee, J (corresponding author), Univ Nebraska, Dept Biochem, Redox Biol Ctr, N210 Beadle Ctr, Lincoln, NE 68588 USA.	jlee7@unlnotes.unl.edu			National Institutes of Health [DK79209, P20RR-17657]; Hatch Act in the University of Nebraska Research Division; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hatch Act in the University of Nebraska Research Division; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK79209 (to J. L.) and P20RR-17657 (to the Nebraska Redox Biology Center). This work was also supported by funds provided through the Hatch Act in the University of Nebraska Research Division. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Adle DJ, 2007, J BIOL CHEM, V282, P947, DOI 10.1074/jbc.M609535200; *AG TOX SUBST DIS, 1999, 7440439 CAS AG TOX S; ALLOWAY BJ, 1990, SCI TOTAL ENVIRON, V91, P223, DOI 10.1016/0048-9697(90)90300-J; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Brennan RJ, 1996, MUTAT RES-FUND MOL M, V356, P171, DOI 10.1016/0027-5107(96)00051-6; Bressler JP, 2004, ANN NY ACAD SCI, V1012, P142, DOI 10.1196/annals.1306.011; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; Chaney RL, 1997, CURR OPIN BIOTECH, V8, P279, DOI 10.1016/S0958-1669(97)80004-3; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Gitan RS, 2003, J BIOL CHEM, V278, P39558, DOI 10.1074/jbc.M302760200; Gomes DS, 2002, BBA-GEN SUBJECTS, V1573, P21, DOI 10.1016/S0304-4165(02)00324-0; Hampton RY, 2002, ANNU REV CELL DEV BI, V18, P345, DOI 10.1146/annurev.cellbio.18.032002.131219; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; Henson MC, 2004, EXP BIOL MED, V229, P383, DOI 10.1177/153537020422900506; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Kim Y, 2005, EMBO J, V24, P952, DOI 10.1038/sj.emboj.7600579; Kim Y, 2002, EMBO J, V21, P3632, DOI 10.1093/emboj/cdf382; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; Ko JH, 2006, J CELL BIOCHEM, V99, P719, DOI 10.1002/jcb.20980; Lemmon SK, 2000, CURR OPIN CELL BIOL, V12, P457, DOI 10.1016/S0955-0674(00)00117-4; Leslie EM, 2006, MOL PHARMACOL, V69, P629, DOI 10.1124/mol.105.014241; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Lim CM, 2006, BIOCHEM BIOPH RES CO, V348, P428, DOI 10.1016/j.bbrc.2006.07.067; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mana-Capelli S, 2003, J BIOL CHEM, V278, P40534, DOI 10.1074/jbc.M306907200; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; Perfus-Barbeoch L, 2002, PLANT J, V32, P539, DOI 10.1046/j.1365-313X.2002.01442.x; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Rebbeor JF, 1998, J BIOL CHEM, V273, P33449, DOI 10.1074/jbc.273.50.33449; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Riggle PJ, 2000, J BACTERIOL, V182, P4899, DOI 10.1128/JB.182.17.4899-4905.2000; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Safe S, 2003, NAT MED, V9, P1000, DOI 10.1038/nm0803-1000; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; SINGHAL RK, 1987, FASEB J, V1, P220, DOI 10.1096/fasebj.1.3.2887478; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Tao TY, 2003, HEPATOLOGY, V37, P1241, DOI 10.1053/jhep.2003.50281; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Weissman Z, 2000, P NATL ACAD SCI USA, V97, P3520, DOI 10.1073/pnas.97.7.3520; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Wimmer U, 2005, NUCLEIC ACIDS RES, V33, P5715, DOI 10.1093/nar/gki881; Yang Y, 2007, BBA-BIOMEMBRANES, V1768, P495, DOI 10.1016/j.bbamem.2006.09.013; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; ZHOU PB, 1993, BIOFACTORS, V4, P105	74	25	26	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31460	31468		10.1074/jbc.M806054200	http://dx.doi.org/10.1074/jbc.M806054200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18753133	hybrid, Green Published			2022-12-25	WOS:000260760800025
J	Guizzetti, M; Moore, NH; Giordano, G; Costa, LG				Guizzetti, Marina; Moore, Nadia H.; Giordano, Gennaro; Costa, Lucio G.			Modulation of Neuritogenesis by Astrocyte Muscarinic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NEURITE OUTGROWTH; HIPPOCAMPAL-NEURONS; DNA-SYNTHESIS; GLIAL-CELLS; NEUROTRANSMITTER REGULATION; ASTROGLIAL CELLS; N-CADHERIN; ACETYLCHOLINE; GROWTH	Astrocytes have been shown to release factors that have promoting or inhibiting effects on neuronal development. However, mechanisms controlling the release of such factors from astrocytes are not well established. Astrocytes express muscarinic receptors whose activation stimulates a robust intracellular signaling, although the role of these receptors in glial cells is not well understood. Acetylcholine and acetylcholine receptors are present in the brain before synaptogenesis occurs and are believed to be involved in neuronal maturation. The present study was undertaken to investigate whether stimulation of muscarinic receptors in astrocytes would modulate neurite outgrowth in hippocampal neurons. Rat hippocampal neurons, cocultured with rat cortical astrocytes previously exposed to the cholinergic agonist carbachol, displayed longer neurites. The effect of carbachol in astrocytes was due to the activation of M3 muscarinic receptors. Exposure of astrocytes to carbachol increased the expression of the extracellular matrix proteins fibronectin and laminin-1 in these cells. This effect was mediated in part by an increase in laminin-1 and fibronectin mRNA levels and in part by the up-regulation of the production and release of plasminogen activator inhibitor-1, an inhibitor of the proteolytic degradation of the extracellular matrix. The inhibition of fibronectin activity strongly reduced the effect of carbachol on the elongation of all the neurites, whereas inhibition of laminin-1 activity reduced the elongation of minor neurites only. Plasminogen activator inhibitor-1 also induced neurite elongation through a direct effect on neurons. Taken together, these results demonstrate that cholinergic muscarinic stimulation of astrocytes induces the release of permissive factors that accelerate neuronal development.	[Guizzetti, Marina; Moore, Nadia H.; Giordano, Gennaro; Costa, Lucio G.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98105 USA; [Costa, Lucio G.] Univ Parma, Sch Med, Dept Human Anat Pharmacol & Forens Sci, I-43100 Parma, Italy	University of Washington; University of Washington Seattle; University of Parma	Guizzetti, M (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, 4225 Roosevelt Way NE 100, Seattle, WA 98105 USA.	marinag@u.washington.edu			National Institutes of Health [AA-08154, ES-07033]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007032, P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA-08154 and ES-07033.	Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; ARMSTRONG DM, 1987, DEV BRAIN RES, V36, P249, DOI 10.1016/0165-3806(87)90028-9; Asher RA, 2000, J NEUROSCI, V20, P2427; ASHKENAZI A, 1989, NATURE, V340, P146, DOI 10.1038/340146a0; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Berger-Sweeney J, 2003, NEUROSCI BIOBEHAV R, V27, P401, DOI 10.1016/S0149-7634(03)00070-8; Blondel O, 2000, J NEUROSCI, V20, P8012; Booth GE, 2000, DEVELOPMENT, V127, P237; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BUZNIKOV GA, 1984, PHARMACOL THERAPEUT, V25, P23, DOI 10.1016/0163-7258(84)90023-8; Catlin MC, 2000, CYTOMETRY, V41, P123; Chotard C, 2004, TRENDS NEUROSCI, V27, P655, DOI 10.1016/j.tins.2004.09.001; Costa LG, 2001, GROWTH FACTORS, V18, P227, DOI 10.3109/08977190109029112; DAUBAS P, 1990, NEURON, V5, P49, DOI 10.1016/0896-6273(90)90032-B; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Giau R, 2005, J NEUROSCI, V25, P8995, DOI 10.1523/JNEUROSCI.2430-05.2005; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Guizzetti M, 1998, EUR J PHARMACOL, V359, P223, DOI 10.1016/S0014-2999(98)00620-7; Guizzetti M, 2000, BIOCHEM PHARMACOL, V60, P1457, DOI 10.1016/S0006-2952(00)00468-8; Guizzetti M, 2003, NEUROSCIENCE, V120, P941, DOI 10.1016/S0306-4522(03)00401-9; Guizzetti M, 1996, EUR J PHARMACOL, V297, P265, DOI 10.1016/0014-2999(95)00746-6; GUSTAFSON T, 1970, EXP CELL RES, V62, P102, DOI 10.1016/0014-4827(79)90512-3; Hamel MG, 2005, J NEUROCHEM, V93, P1533, DOI 10.1111/j.1471-4159.2005.03144.x; Higgins D, 1997, CURR OPIN NEUROBIOL, V7, P599, DOI 10.1016/S0959-4388(97)80078-5; Hohmann CF, 2003, NEUROSCI BIOBEHAV R, V27, P351, DOI 10.1016/S0149-7634(03)00066-6; HUNTER DD, 1992, J COMP NEUROL, V323, P238, DOI 10.1002/cne.903230208; Irigoyen JP, 1999, CELL MOL LIFE SCI, V56, P104, DOI 10.1007/PL00000615; Karczmar Alexander G., 2007, P1; KINNEY HC, 1993, NEUROSCIENCE, V55, P1127, DOI 10.1016/0306-4522(93)90326-B; Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015; LAASBERG T, 1990, COMP BIOCHEM PHYS C, V97, P9, DOI 10.1016/0742-8413(90)90164-5; LANDER AD, 1985, P NATL ACAD SCI USA, V82, P2183, DOI 10.1073/pnas.82.7.2183; Lauder JM, 1999, ENVIRON HEALTH PERSP, V107, P65, DOI 10.2307/3434473; Lein PJ, 2002, J NEUROSCI, V22, P10377; LIESI P, 1986, EXP CELL RES, V163, P175, DOI 10.1016/0014-4827(86)90570-7; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Martinez R, 2002, J BIOL CHEM, V277, P49311, DOI 10.1074/jbc.M209284200; Masaki T, 2001, ACTA NEUROPATHOL, V101, P174; MATTHIESSEN HP, 1989, GLIA, V2, P177, DOI 10.1002/glia.440020307; MULLER HW, 1995, PHARMACOL THERAPEUT, V65, P1, DOI 10.1016/0163-7258(94)00047-7; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; Nguyen L, 2001, CELL TISSUE RES, V305, P187, DOI 10.1007/s004410000343; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Porter JT, 1997, PROG NEUROBIOL, V51, P439, DOI 10.1016/S0301-0082(96)00068-8; PRICE J, 1985, J NEUROSCI, V5, P2205; Richards LJ, 2002, BRAZ J MED BIOL RES, V35, P1431, DOI 10.1590/S0100-879X2002001200004; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0; ROGERS SL, 1989, DEV NEUROSCI-BASEL, V11, P248, DOI 10.1159/000111904; SCHAMBRA UB, 1989, J COMP NEUROL, V288, P101, DOI 10.1002/cne.902880109; SCHLUMPF M, 1991, NEUROSCIENCE, V45, P347, DOI 10.1016/0306-4522(91)90232-D; SCHMIDT H, 1981, HISTOCHEMISTRY, V71, P89, DOI 10.1007/BF00592573; Schwamborn JC, 2006, METHOD ENZYMOL, V406, P715, DOI 10.1016/S0076-6879(06)06056-3; Seigneur J, 2006, CEREB CORTEX, V16, P655, DOI 10.1093/cercor/bhj011; Smit M, 2003, BIOTECHNIQUES, V35, P254, DOI 10.2144/03352bm01; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Soeda S, 2006, NEUROSCIENCE, V141, P101, DOI 10.1016/j.neuroscience.2006.03.026; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Viviani B, 1998, TOXICOL APPL PHARM, V150, P271, DOI 10.1006/taap.1998.8406; WEE EL, 1980, J EMBRYOL EXP MORPH, V58, P177; Weiss ER, 1998, PERSPECT DEV NEUROBI, V5, P323; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wong WT, 2000, J NEUROSCI, V20, P5024; WUJEK JR, 1990, DEV BRAIN RES, V55, P237, DOI 10.1016/0165-3806(90)90205-D; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; Yagle K, 2001, GLIA, V35, P111, DOI 10.1002/glia.1076; Yamada H, 1997, J NEUROSCI, V17, P7784; Yao WD, 2000, J NEUROSCI, V20, P2626	75	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31884	31897		10.1074/jbc.M801316200	http://dx.doi.org/10.1074/jbc.M801316200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18755690	Green Published, hybrid			2022-12-25	WOS:000260760800071
J	Li, X; Placencio, V; Iturregui, JM; Uwamariya, C; Sharif-Afshar, AR; Koyama, T; Hayward, SW; Bhowmick, NA				Li, X.; Placencio, V.; Iturregui, J. M.; Uwamariya, C.; Sharif-Afshar, A-R; Koyama, T.; Hayward, S. W.; Bhowmick, N. A.			Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis	ONCOGENE			English	Article						prostate cancer; T beta RII; prostate stroma; Tgfbr2(fspKO); Wnt3a; Stat3	GROWTH-FACTOR-BETA; TGF-BETA; INTRAEPITHELIAL NEOPLASIA; HGF TRANSCRIPTION; EPITHELIAL-CELLS; CANCER PATIENTS; UP-REGULATION; II RECEPTOR; EXPRESSION; CATENIN	Transforming growth factor (TGF)-beta is an important paracrine factor in tumorigenesis. Ligand binding of the type I and II TGF-beta receptors initiate downstream signaling. The role of stromal TGF-beta signaling in prostate cancer progression is unknown. In mice, the conditional stromal knockout of the TGF-beta type II receptor expression (Tgfbr2(fspKO)) resulted in the development of prostatic intraepithelial neoplasia and progression to adenocarcinoma within 7 months. Clinically, we observed a loss of TGF-beta receptor type II expression in 69% of human prostate cancer-associated stroma, compared to 15% of stroma associated with benign tissues (n = 140, P-value <0.0001). To investigate the mechanism of paracrine TGF-beta signaling in prostate cancer progression, we compared the effect of the prostatic stromal cells from Tgfbr2(fspKO) and floxed TGF-beta type II receptor Tgfbr2(floxE2/floxE2) mice on LNCaP human prostate cancer cells in vitro and tissue recombination xenografts. Induction of LNCaP cell proliferation and tumorigenesis was observed by Tgfbr2(fspKO) prostate stroma as a result of elevated Wnt3a expression. Neutralizing antibodies to Wnt3a reversed LNCaP tumorigenesis. The TGF-beta inhibition of Wnt3a expression was in part through the suppression of Stat3 activity on the Wnt3a promoter. In conclusion, the frequent loss of stromal TGF-beta type II receptor expression in human prostate cancer can relieve the paracrine suppression of Wnt3a expression.	[Li, X.; Uwamariya, C.; Sharif-Afshar, A-R; Hayward, S. W.; Bhowmick, N. A.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Sch Med, Dept Urol Surg, Nashville, TN 37232 USA; [Placencio, V.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Placencio, V.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Koyama, T.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Bhowmick, NA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Urol Surg, 1161 21st Ave S,A-1302 Med Ctr, Nashville, TN 37232 USA.	neil.bhowmick@vanderbilt.edu	Bhowmick, Neil/AAA-7302-2019; Hayward, Simon/A-1688-2011	Bhowmick, Neil/0000-0001-8747-5989; Hayward, Simon/0000-0002-6059-6550; , Xiaohong/0000-0001-5074-193X; Sharif Afshar, Ali Reza/0000-0003-0949-2630	DOD; DAMD [W81XWH-04-1-0046 to NAB]; NIH [CA108646, CA126505, FGM079879A]; NATIONAL CANCER INSTITUTE [T32CA009592, U54CA126505, R01CA108646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM079879] Funding Source: NIH RePORTER	DOD(United States Department of Defense); DAMD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr Xiuping Yu (Vanderbilt University) generously provided primers for the Wnt isoforms. This study was supported by the DOD through DAMD (W81XWH-04-1-0046 to NAB) as well as through NIH Grants (CA108646, CA126505 to NAB and FGM079879A to VRP).	Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Bright JJ, 1998, J IMMUNOL, V161, P1772; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Calin GA, 2000, INT J CANCER, V89, P230, DOI 10.1002/1097-0215(20000520)89:3<230::AID-IJC4>3.3.CO;2-A; Cardillo MR, 2000, ANAL QUANT CYTOL, V22, P1; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CUNHA GR, 1994, CANCER, V74, P1030, DOI 10.1002/1097-0142(19940801)74:3+<1030::AID-CNCR2820741510>3.0.CO;2-Q; DAVIDSON D, 1995, J UROLOGY, V154, P1295, DOI 10.1016/S0022-5347(01)66840-X; DONJACOUR AA, 1990, ENDOCRINOLOGY, V126, P1343, DOI 10.1210/endo-126-3-1343; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; FUJII H, 1982, J UROLOGY, V128, P858, DOI 10.1016/S0022-5347(17)53221-8; Gerdes MJ, 1998, J HISTOCHEM CYTOCHEM, V46, P379, DOI 10.1177/002215549804600312; Goggins M, 1998, CANCER RES, V58, P5329; Grady WM, 1999, CANCER RES, V59, P320; Guo YP, 1999, CANCER RES, V59, P1366; Hayward SW, 2001, CANCER RES, V61, P8135; HAYWARD SW, 1992, J CELL SCI, V102, P361; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Johnson ML, 2006, REV ENDOCR METAB DIS, V7, P41, DOI 10.1007/s1154-006-9003-3; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kim IY, 1998, CLIN CANCER RES, V4, P1625; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Kwok WK, 2007, CARCINOGENESIS, V28, P2467, DOI 10.1093/carcin/bgm185; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; NUSSE R, 1991, CELL, V64, P231, DOI 10.1016/0092-8674(91)90633-A; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Pasche B, 2001, J CELL PHYSIOL, V186, P153, DOI 10.1002/1097-4652(200002)186:2<153::AID-JCP1016>3.0.CO;2-J; QIAN JQ, 1995, CANCER RES, V55, P5408; Qiao H, 2002, J CELL BIOCHEM, V86, P665, DOI 10.1002/jcb.10239; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Royuela M, 1998, GROWTH FACTORS, V16, P101, DOI 10.3109/08977199809002121; Sam MR, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-69; SCHMID P, 1995, CARCINOGENESIS, V16, P1499, DOI 10.1093/carcin/16.7.1499; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shibamoto S, 1998, GENES CELLS, V3, P659; TURNER T, 1990, IN VITRO CELL DEV B, V26, P722; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Voeller HJ, 1998, CANCER RES, V58, P2520; Wang YH, 2000, CANCER RES, V60, P6008; Wojcik EJ, 2006, ONCOGENE, V25, P2773, DOI 10.1038/sj.onc.1209306; WONG YC, 1992, ACTA ANAT, V143, P139; Yardy GW, 2005, PROSTATE CANCER P D, V8, P119, DOI 10.1038/sj.pcan.4500794; Zhang Z, 2007, HUM PATHOL, V38, P598, DOI 10.1016/j.humpath.2006.10.004	56	119	120	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2008	27	56					7118	7130		10.1038/onc.2008.293	http://dx.doi.org/10.1038/onc.2008.293			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	376PQ	18724388	Green Accepted			2022-12-25	WOS:000261195900006
J	Hunt, J; Bracher, MG; Shi, J; Fleury, S; Dombrowicz, D; Gould, HJ; Sutton, BJ; Beavil, AJ				Hunt, James; Bracher, Marguerite G.; Shi, Jianguo; Fleury, Sebastien; Dombrowicz, David; Gould, Hannah J.; Sutton, Brian J.; Beavil, Andrew J.			Attenuation of IgE Affinity for Fc epsilon RI Radically Reduces the Allergic Response in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNOGLOBULIN-E; PROTEIN INTERFACES; HOT-SPOTS; RECEPTOR; BINDING; FRAGMENT; ALPHA; ANAPHYLAXIS; FLEXIBILITY; ANTIBODIES	The high affinity of IgE for its receptor, Fc epsilon RI (K-a similar to 10(10)M(-1)), is responsible for the persistence of mast cell sensitization. Crosslinking of Fc epsilon RI-bound IgE by multivalent allergen leads to cellular activation and release of pro-inflammatory mediators responsible for the symptoms of allergic disease. We previously demonstrated that limiting the IgE-Fc epsilon RI interaction to just one of the two C epsilon 3 domains in IgE-Fc, which together constitute the high affinity binding site, results in 1000-fold reduced affinity. Such attenuation, effected by a small molecule binding to part of the IgE: Fc epsilon RI interface or a distant allosteric site, rather than complete blocking of the interaction, may represent a viable approach to the treatment of allergic disease. However, the degree to which the interaction would need to be disrupted is unclear, because the importance of high affinity for immediate hypersensitivity has never been investigated. We have incorporated into human IgE a mutation, R334S, previously characterized in IgE-Fc, which reduces its affinity for Fc epsilon RI similar to 50- fold. We have compared the ability of wild type and R334S IgE to stimulate allergen-induced mast cell activation in vitro and in vivo. We confirmed the expected difference in affinity between wild type and mutant IgE for Fc epsilon RI (similar to 50-fold) and found that, in vitro, mast cell degranulation was reduced proportionately. The effect in vivo was also marked, with a 75% reduction in the passive cutaneous anaphylaxis response. We have therefore demonstrated that the high affinity of IgE for Fc epsilon RI is critical to the allergic response, and that even moderate attenuation of this affinity has a substantial effect in vivo.	[Hunt, James; Bracher, Marguerite G.; Shi, Jianguo; Gould, Hannah J.; Sutton, Brian J.; Beavil, Andrew J.] Kings Coll London, Randall Div Cell & Mol Biophys, Med Res Council, London SE1 1UL, England; [Hunt, James; Bracher, Marguerite G.; Shi, Jianguo; Gould, Hannah J.; Sutton, Brian J.; Beavil, Andrew J.] Kings Coll London, Randall Div Cell & Mol Biophys, Asthma UK Ctr Allerg Mech Asthma, London SE1 1UL, England; [Hunt, James; Bracher, Marguerite G.; Shi, Jianguo; Gould, Hannah J.; Sutton, Brian J.; Beavil, Andrew J.] Kings Coll London, Div Asthma Allergy & Lung Biol, London SE1 1UL, England; [Fleury, Sebastien; Dombrowicz, David] Univ Lille 2, Inst Pasteur, INSERM, U547, F-59019 Lille, France	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; University of London; King's College London; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Beavil, AJ (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, Med Res Council, New Hunts House,Guys Campus, London SE1 1UL, England.	andrew.beavil@kcl.ac.uk	Beavil, Andrew/B-5624-2009; Dombrowicz, David/F-7044-2013	Beavil, Andrew/0000-0002-0768-122X; Dombrowicz, David/0000-0002-0485-8923; Gould, Hannah/0000-0003-0411-688X; Fleury, Sebastien/0000-0002-0679-3086	Asthma UK, Biotechnology and Biological Sciences Research Council (UK); Medical Research Council (UK); Marie Curie Cancer Care; Medical Research Council [G0400503B, G0501494] Funding Source: researchfish; Asthma UK [05/061] Funding Source: researchfish; MRC [G0501494] Funding Source: UKRI	Asthma UK, Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Cancer Care; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Asthma UK, Biotechnology and Biological Sciences Research Council (UK), Medical Research Council (UK), and Marie Curie Cancer Care. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Chang TW, 2000, NAT BIOTECHNOL, V18, P157, DOI 10.1038/72601; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Dombrowicz D, 1996, J IMMUNOL, V157, P1645; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 2001, J MOL BIOL, V311, P1049, DOI 10.1006/jmbi.2001.4929; GEHA RS, 1985, NATURE, V315, P577, DOI 10.1038/315577a0; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hammond G., 2006, CELL BIOL, P221; Harwood NE, 2007, BIOMED PHARMACOTHER, V61, P61, DOI 10.1016/j.biopha.2006.11.004; Henry AJ, 1997, BIOCHEMISTRY-US, V36, P15568, DOI 10.1021/bi971299+; Hunt J, 2005, J BIOL CHEM, V280, P16808, DOI 10.1074/jbc.M500965200; Ishizaka K., 1971, PROGR IMMUNOLOGY, V1st, P859; MacGlashan D, 1999, J ALLERGY CLIN IMMUN, V104, P492, DOI 10.1016/S0091-6749(99)70399-4; MacGlashan D, 2005, ANN NY ACAD SCI, V1050, P73, DOI 10.1196/annals.1313.009; McCloskey N, 2007, J BIOL CHEM, V282, P24083, DOI 10.1074/jbc.M703195200; MILLER L, 1989, SCIENCE, V244, P334, DOI 10.1126/science.2523561; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; TADA T, 1975, INT ARCH ALLER A IMM, V48, P116, DOI 10.1159/000231297; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wiegand TW, 1996, J IMMUNOL, V157, P221; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; Yamasaki S, 2004, BLOOD, V103, P3093, DOI 10.1182/blood-2003-08-2944	28	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29882	29887		10.1074/jbc.M804742200	http://dx.doi.org/10.1074/jbc.M804742200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18703499	hybrid, Green Published			2022-12-25	WOS:000260366900032
J	Johnson, CM; Chichili, GR; Rodgers, W				Johnson, Corey M.; Chichili, Gurunadh R.; Rodgers, William			Compartmentalization of Phosphatidylinositol 4,5-Bisphosphate Signaling Evidenced Using Targeted Phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED MEMBRANE DOMAINS; T-CELL-ACTIVATION; PLECKSTRIN HOMOLOGY DOMAINS; FC-EPSILON-RI; PLASMA-MEMBRANE; ACTIN CYTOSKELETON; LIPID RAFTS; CRITICAL REEVALUATION; KINASE SUBSTRATE; PHOSPHOINOSITIDES	Phosphatidylinositol 4,5-bisphosphate (PIP2) is a prevalent phosphoinositide in cell membranes, with important functions in cell signaling and activation. A large fraction of PIP2 associates with the detergent-resistant membrane "raft" fraction, but the functional significance of this association remains controversial. To measure the properties of raft and nonraft PIP2 in cell signaling, we targeted the PIP2-specific phosphatase Inp54p to either the raft or nonraft membrane fraction using minimal membrane anchors. Interestingly, we observed that targeting Inp54p to the nonraft fraction resulted in an enrichment of raft-associated PIP2 and striking changes in cell morphology, including a wortmannin-sensitive increase in cell filopodia and cell spreading. In contrast, raft-targeted Inp54p depleted the raft pool of PIP2 and produced smooth T cells void of membrane ruffling and filopodia. Furthermore, raft-targeted Inp54p inhibited capping in T cells stimulated by cross-linking the T cell receptor, but without affecting the T cell receptor-dependent Ca2+ flux. Altogether, these results provide evidence of compartmentalization of PIP2-dependent signaling in cell membranes such as predicted by the membrane raft model.	[Johnson, Corey M.; Chichili, Gurunadh R.; Rodgers, William] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rodgers, W (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St,MS 45, Oklahoma City, OK 73104 USA.	william-rodgers@omrf.org		Johnson, Corey/0000-0002-0536-0449	National Institutes of Health [RO1 GM070001]; American Heart Association [0625648Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM070001. This work was also supported by American Heart Association Grant 0625648Z. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Arrieumerlou C, 2000, J IMMUNOL, V165, P3182, DOI 10.4049/jimmunol.165.6.3182; Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jordan S, 2003, J IMMUNOL, V171, P78, DOI 10.4049/jimmunol.171.1.78; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; MAJERUS PW, 1986, SCIENCE, V234, P1519, DOI 10.1126/science.3024320; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Parmryd I, 2003, EXP CELL RES, V285, P27, DOI 10.1016/S0014-4827(02)00048-4; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Pizzo P, 2002, EUR J IMMUNOL, V32, P3082, DOI 10.1002/1521-4141(200211)32:11<3082::AID-IMMU3082>3.0.CO;2-2; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Rodgers W, 2005, TRENDS IMMUNOL, V26, P97, DOI 10.1016/j.it.2004.11.016; Rodgers W, 2002, BIOTECHNIQUES, V32, P1044, DOI 10.2144/02325st05; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rodgers W, 2001, EXP CELL RES, V267, P173, DOI 10.1006/excr.2001.5253; ROELANTS G, 1973, J EXP MED, V137, P1060, DOI 10.1084/jem.137.4.1060; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Wiradjaja F, 2001, J BIOL CHEM, V276, P7643, DOI 10.1074/jbc.M010471200; Young RM, 2005, J BIOL CHEM, V280, P1230, DOI 10.1074/jbc.M408339200; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu MH, 2005, J IMMUNOL, V174, P31, DOI 10.4049/jimmunol.174.1.31	55	55	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29920	29928		10.1074/jbc.M805921200	http://dx.doi.org/10.1074/jbc.M805921200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723502	hybrid, Green Published			2022-12-25	WOS:000260366900037
J	Ju, JS; Miller, SE; Hanson, PI; Weihl, CC				Ju, Jeong-Sun; Miller, Sara E.; Hanson, Phyllis I.; Weihl, Conrad C.			Impaired Protein Aggregate Handling and Clearance Underlie the Pathogenesis of p97/VCP-associated Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING-PROTEIN; FRONTOTEMPORAL DEMENTIA; AUTOPHAGIC CLEARANCE; DEGRADATION; AGGRESOMES; MUTATIONS; INCLUSIONS; ROLES; CELLS; HDAC6	Mutations in p97/VCP cause the multisystem disease inclusion body myopathy, Paget disease of the bone and frontotemporal dementia (IBMPFD). p97/VCP is a member of the AAA+ (ATPase associated with a variety of activities) protein family and has been implicated in multiple cellular processes. One pathologic feature in IBMPFD is ubiquitinated inclusions, suggesting that mutations in p97/VCP may affect protein degradation. The present study shows that IBMPFD mutant expression increases ubiquitinated proteins and susceptibility to proteasome inhibition. Co-expression of an aggregate prone protein such as expanded polyglutamine in IBMPFD mutant cells results in an increase in aggregated protein that localizes to small inclusions instead of a single perinuclear aggresome. These small inclusions fail to co-localize with autophagic machinery. IBMPFD mutants avidly bind to these small inclusions and may not allow them to traffic to an aggresome. This is rescued by HDAC6, a p97/VCP-binding protein that facilitates the autophagic degradation of protein aggregates. Expression of HDAC6 improves aggresome formation and protects IBMPFD mutant cells from polyglutamine-induced cell death. Our study emphasizes the importance of protein aggregate trafficking to inclusion bodies in degenerative diseases and the therapeutic benefit of inclusion body formation.	[Ju, Jeong-Sun; Miller, Sara E.; Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Hanson, Phyllis I.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Weihl, CC (corresponding author), Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.	weihlc@neuro.wustl.edu	Hanson, Phyllis/E-9420-2012	Ju, Jeong-sun/0000-0001-7276-9941	National Institutes of Health [K08 AG026271]; National Institutes of Health Neuroscience Blueprint Core [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG026271, R01AG031867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Neuroscience Blueprint Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant K08 AG026271 (to C. C. W.). This work was also supported by National Institutes of Health Neuroscience Blueprint Core Grant P30 NS057105 to Washington University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Forman MS, 2006, J NEUROPATH EXP NEUR, V65, P571, DOI 10.1097/00005072-200606000-00005; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Ishigaki S, 2004, J BIOL CHEM, V279, P51376, DOI 10.1074/jbc.M406683200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitami MI, 2006, FEBS LETT, V580, P474, DOI 10.1016/j.febslet.2005.12.044; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lee CS, 2004, J NEUROCHEM, V91, P996, DOI 10.1111/j.1471-4159.2004.02813.x; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Nishino Ichizo, 2003, Curr Neurol Neurosci Rep, V3, P64, DOI 10.1007/s11910-003-0040-y; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Schwartz AL, 1999, ANNU REV MED, V50, P57; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Song CC, 2008, TOXICOL APPL PHARM, V228, P351, DOI 10.1016/j.taap.2007.12.026; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yamanaka K, 2004, J STRUCT BIOL, V146, P242, DOI 10.1016/j.jsb.2003.11.017; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031	42	99	100	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30289	30299		10.1074/jbc.M805517200	http://dx.doi.org/10.1074/jbc.M805517200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18715868	Green Published, hybrid			2022-12-25	WOS:000260366900073
J	Chen, H; Lin, AS; Li, YH; Reiter, CEN; Ver, MR; Quon, MJ				Chen, Hui; Lin, Alice Seraphina; Li, Yunhua; Reiter, Chad E. N.; Ver, Maria R.; Quon, Michael J.			Dehydroepiandrosterone Stimulates Phosphorylation of FoxO1 in Vascular Endothelial Cells via Phosphatidylinositol 3-Kinase- and Protein Kinase A-dependent Signaling Pathways to Regulate ET-1 Synthesis and Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIOVASCULAR-DISEASE RISK; NITRIC-OXIDE; TRANSCRIPTION FACTOR; INSULIN SENSITIVITY; IN-VITRO; CIRCULATING DEHYDROEPIANDROSTERONE; SERUM CONCENTRATIONS; ESTROGEN-RECEPTORS; TUMOR SUPPRESSION; PLASMA-MEMBRANE	Dehydroepiandrosterone (DHEA) is an endogenous adrenal steroid hormone with controversial actions in humans. We previously reported that DHEA has opposing actions in endothelial cells to stimulate phosphatidylinositol (PI) 3-kinase/Akt/endothelial nitric-oxide synthase leading to increased production of nitric oxide while simultaneously stimulating MAPK-dependent secretion of the vasoconstrictor ET-1. In the present study we hypothesized that DHEA may stimulate PI 3-kinase-dependent phosphorylation of FoxO1 in endothelial cells to help regulate endothelial function. In bovine or human aortic endothelial cells (BAEC and HAEC), treatment with DHEA(100 nM) acutely enhanced phosphorylation of FoxO1. DHEA-stimulated phosphorylation of FoxO1 was inhibited by pretreatment of cells with wortmannin (PI 3-kinase inhibitor) or H89 (protein kinase A (PKA) inhibitor) but not ICI182780 (estrogen receptor blocker), or PD98059 (MEK (MAPK/extracellular signal-regulated kinase kinase) inhibitor). Small interfering RNA knockdown of PKA inhibited DHEA-stimulated phosphorylation of FoxO1. DHEA promoted nuclear exclusion of FoxO1 that was blocked by pretreatment of cells with wortmannin, H89, or by small interfering RNA knockdown of PKA. DHEA treatment of endothelial cells increased PKA activity and intracellular cAMP concentrations. Transfection of BAEC with a constitutively nuclear FoxO1 mutant transactivated a co-transfected ET-1 promoter luciferase reporter. Treatment of BAEC with DHEA inhibited transactivation of the ET-1 promoter reporter in cells overexpressing FoxO1. ET-1 promoter activity and secretion in response to DHEA treatment was augmented by PI 3-kinase blockade and inhibited by MAPK blockade. We conclude that DHEA stimulates phosphorylation of FoxO1 via PI 3-kinase and PKA-dependent pathways in endothelial cells that negatively regulates ET-1 promoter activity and secretion. Balance between PI 3-kinase-dependent inhibition and MAPK-dependent stimulation of ET-1 secretion in response to DHEA may determine whether DHEA supplementation improves or worsens cardiovascular and metabolic function.	[Chen, Hui; Lin, Alice Seraphina; Li, Yunhua; Reiter, Chad E. N.; Ver, Maria R.; Quon, Michael J.] NIH, Diabet Unit, NCCAM, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Quon, MJ (corresponding author), NIH, Diabet Unit, NCCAM, 9 Mem Dr,Bldg 9,Rm 1N-105, Bethesda, MD 20892 USA.	quonm@nih.gov		QUON, MICHAEL/0000-0002-5289-3707; Quon, Michael/0000-0002-9601-9915	National Institutes of Health; American Diabetes Association; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [Z02AT000001, Z01AT000001, ZIAAT000001] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [ZIFAT000001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in part, by the National Institutes of Health (Intramural Research Program, NCCAM) and by a Mentor-based award from the American Diabetes Association (to M. J. Q.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aitsebaomo J, 2001, J BIOL CHEM, V276, P39197, DOI 10.1074/jbc.M105166200; Aoki K, 1999, DIABETES, V48, P1579, DOI 10.2337/diabetes.48.8.1579; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Barnhart KT, 1999, J CLIN ENDOCR METAB, V84, P3896, DOI 10.1210/jc.84.11.3896; BarrettConnor E, 1995, ANN NY ACAD SCI, V774, P259, DOI 10.1111/j.1749-6632.1995.tb17386.x-i1; BARRETTCONNOR E, 1986, NEW ENGL J MED, V315, P1519, DOI 10.1056/NEJM198612113152405; BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Chen F, 2005, ENDOCRINOLOGY, V146, P4568, DOI 10.1210/en.2005-0368; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; DEPERETTI E, 1978, J CLIN ENDOCR METAB, V47, P572, DOI 10.1210/jcem-47-3-572; ELBeltagy K, 2007, FERTIL STERIL, V88, P1135, DOI 10.1016/j.fertnstert.2007.01.008; Fisslthaler B, 2007, CIRC RES, V100, pE12, DOI 10.1161/01.RES.0000257747.74358.1c; Formoso G, 2006, MOL ENDOCRINOL, V20, P1153, DOI 10.1210/me.2005-0266; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Giachini FRC, 2008, EXPERT OPIN THER TAR, V12, P327, DOI 10.1517/14728222.12.3.327; GORDON GB, 1988, J CLIN INVEST, V82, P712, DOI 10.1172/JCI113652; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Iglarz M, 2007, J CARDIOVASC PHARM, V50, P621, DOI 10.1097/FJC.0b013e31813c6cc3; Iruthayanathan M, 2005, ENDOCRINOLOGY, V146, P5176, DOI 10.1210/en.2005-0811; Ishizuka T, 2007, ACTA DIABETOL, V44, P219, DOI 10.1007/s00592-007-0009-4; Johannes CB, 1999, J CLIN EPIDEMIOL, V52, P95, DOI 10.1016/S0895-4356(98)00144-9; KALIMI M, 1994, MOL CELL BIOCHEM, V131, P99, DOI 10.1007/BF00925945; Kawano H, 2003, J CLIN ENDOCR METAB, V88, P3190, DOI 10.1210/jc.2002-021603; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396; Lasley BL, 2002, J CLIN ENDOCR METAB, V87, P3760, DOI 10.1210/jc.87.8.3760; LEITER EH, 1987, METABOLISM, V36, P863, DOI 10.1016/0026-0495(87)90095-3; Liu DM, 2002, J BIOL CHEM, V277, P21379, DOI 10.1074/jbc.M200491200; Liu DM, 2004, STEROIDS, V69, P279, DOI 10.1016/j.steroids.2004.02.004; Liu DM, 2007, ENDOCRINOLOGY, V148, P3068, DOI 10.1210/en.2006-1378; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mazat L, 2001, P NATL ACAD SCI USA, V98, P8145, DOI 10.1073/pnas.121177998; MORALES AJ, 1994, J CLIN ENDOCR METAB, V78, P1360, DOI 10.1210/jc.78.6.1360; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nakazora H, 2005, INTERNAL MED, V44, P1247, DOI 10.2169/internalmedicine.44.1247; Narushima I, 1999, N-S ARCH PHARMACOL, V360, P639, DOI 10.1007/s002109900137; Percheron G, 2003, ARCH INTERN MED, V163, P720, DOI 10.1001/archinte.163.6.720; Perrini S, 2004, DIABETES, V53, P41, DOI 10.2337/diabetes.53.1.41; Porter LP, 2000, MICROCIRCULATION, V7, P347, DOI 10.1038/sj.mn.7300120; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Potenza MA, 2005, AM J PHYSIOL-HEART C, V289, pH813, DOI 10.1152/ajpheart.00092.2005; Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006; Potenza MA, 2006, DIABETES, V55, P3594, DOI 10.2337/db06-0667; Reiter C, 2007, DIABETES, V56, pA14; SCHRIOCK ED, 1988, J CLIN ENDOCR METAB, V66, P1329, DOI 10.1210/jcem-66-6-1329; Simoncini T, 2003, ENDOCRINOLOGY, V144, P3449, DOI 10.1210/en.2003-0044; SLOWINSKASRZEDNICKA J, 1991, J INTERN MED, V230, P551; Stomati M, 2000, GYNECOL ENDOCRINOL, V14, P342, DOI 10.3109/09513590009167703; Tamler R, 2007, ENDOCRIN METAB CLIN, V36, P533, DOI 10.1016/j.ecl.2007.03.005; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tchernof A, 2004, EUR J ENDOCRINOL, V151, P1, DOI 10.1530/eje.0.1510001; USISKIN KS, 1990, INT J OBESITY, V14, P457; Valenti G, 2004, J GERONTOL A-BIOL, V59, P466; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Villareal DT, 2000, CLIN ENDOCRINOL, V53, P561, DOI 10.1046/j.1365-2265.2000.01131.x; WELLE S, 1990, J CLIN ENDOCR METAB, V71, P1259, DOI 10.1210/jcem-71-5-1259; Williams JR, 2000, LIPIDS, V35, P325, DOI 10.1007/s11745-000-0529-7; Williams MRI, 2004, J CLIN ENDOCR METAB, V89, P4708, DOI 10.1210/jc.2003-031560; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yen SSC, 2001, P NATL ACAD SCI USA, V98, P8167, DOI 10.1073/pnas.161278698	72	40	40	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29228	29238		10.1074/jbc.M802906200	http://dx.doi.org/10.1074/jbc.M802906200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18718910	Green Published, hybrid			2022-12-25	WOS:000260179900050
J	Gin, P; Yin, LY; Davies, BSJ; Weinstein, MM; Ryan, RO; Bensadoun, A; Fong, LG; Young, SG; Beigneux, AP				Gin, Peter; Yin, Liya; Davies, Brandon S. J.; Weinstein, Michael M.; Ryan, Robert O.; Bensadoun, Andre; Fong, Loren G.; Young, Stephen G.; Beigneux, Anne P.			The Acidic Domain of GPIHBP1 Is Important for the Binding of Lipoprotein Lipase and Chylomicrons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-V; SITE-DIRECTED MUTAGENESIS; PLASMINOGEN-ACTIVATOR; HEPARIN-BINDING; TERMINAL DOMAIN; CLEARING FACTOR; LIGAND-BINDING; RECEPTOR GENE; IDENTIFICATION; RESIDUES	GPIHBP1, a glycosylphosphatidylinositol-anchored endothelial cell protein of the lymphocyte antigen 6 (Ly6) family, plays a key role in the lipolysis of triglyceride-rich lipoproteins (e. g. chylomicrons). GPIHBP1 is expressed along the luminal surface of endothelial cells of heart, skeletal muscle, and adipose tissue, and GPIHBP1-expressing cells bind lipoprotein lipase (LPL) and chylomicrons avidly. GPIHBP1 contains an aminoterminal acidic domain (amino acids 24-48) that is enriched in aspartate and glutamate residues, and we previously speculated that this domain might be important in binding ligands. To explore the functional importance of the acidic domain, we tested the ability of polyaspartate or polyglutamate peptides to block the binding of ligands to pgsA-745 Chinese hamster ovary cells that overexpress GPIHBP1. Both polyaspartate and polyglutamate blocked LPL and chylomicron binding to GPIHBP1. Also, a rabbit antiserum against the acidic domain of GPIHBP1 blocked LPL and chylomicron binding to GPIHBP1-expressing cells. Replacing the acidic amino acids within GPIHBP1 residues 38-48 with alanine eliminated the ability of GPIHBP1 to bind LPL and chylomicrons. Finally, mutation of the positively charged heparin-binding domains within LPL and apolipoprotein AV abolished the ability of these proteins to bind to GPIHBP1. These studies indicate that the acidic domain of GPIHBP1 is important and that electrostatic interactions play a key role in ligand binding.	[Gin, Peter; Yin, Liya; Davies, Brandon S. J.; Weinstein, Michael M.; Fong, Loren G.; Young, Stephen G.; Beigneux, Anne P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Weinstein, Michael M.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Ryan, Robert O.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Beigneux, AP (corresponding author), 675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	abeigneux@mednet.ucla.edu		Davies, Brandon/0000-0002-7168-8522; Young, Stephen/0000-0001-7270-3176	Scientist Development Award; American Heart Association, National Office; BayGenomics [HL66621, HL66600, R01HL087228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073061, U01HL066600, R01HL087228, U01HL066621] Funding Source: NIH RePORTER	Scientist Development Award; American Heart Association, National Office(American Heart Association); BayGenomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Scientist Development Award from the American Heart Association, National Office ( to A. P. B.), BayGenomics Grants HL66621 and HL66600, R01HL087228( to S. G. Y.), and HL073061( to R. O. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beckstead JA, 2003, BIOCHEMISTRY-US, V42, P9416, DOI 10.1021/bi034509t; BEHRENDT N, 1991, J BIOL CHEM, V266, P7842; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Ben-Zeev O, 2002, J BIOL CHEM, V277, P10727, DOI 10.1074/jbc.M108128200; Bensadoun A, 1999, METH MOL B, V109, P145; BERRYMAN DE, 1993, J BIOL CHEM, V268, P3272; BRAGDON JH, 1954, SCIENCE, V120, P113, DOI 10.1126/science.120.3107.113-a; CISAR LA, 1989, J BIOL CHEM, V264, P1767; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Hahn PF, 1943, SCIENCE, V98, P19, DOI 10.1126/science.98.2531.19; HATA A, 1993, J BIOL CHEM, V268, P8447; HULTIN M, 1994, BIOCHEM J, V304, P959, DOI 10.1042/bj3040959; Ioka RX, 2003, J BIOL CHEM, V278, P7344, DOI 10.1074/jbc.M211932200; KORN ED, 1955, J BIOL CHEM, V215, P1; KORN ED, 1955, J BIOL CHEM, V215, P15; LECLAIR KP, 1987, P NATL ACAD SCI USA, V84, P1638, DOI 10.1073/pnas.84.6.1638; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lookene A, 2005, J BIOL CHEM, V280, P25383, DOI 10.1074/jbc.M501589200; Lookene A, 2000, BIOCHEM BIOPH RES CO, V271, P15, DOI 10.1006/bbrc.2000.2530; LOW MG, 1992, PHOSPHOLIPASES DEGRA; MA YH, 1994, J LIPID RES, V35, P2049; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; Ploug M, 1998, BIOCHEMISTRY-US, V37, P16494, DOI 10.1021/bi981203r; Sendak RA, 1998, J LIPID RES, V39, P1310; WANG Y, 1995, EUR J BIOCHEM, V227, P116, DOI 10.1111/j.1432-1033.1995.tb20366.x; Young SG, 2007, CURR OPIN LIPIDOL, V18, P389, DOI 10.1097/MOL.0b013e3281527914	26	66	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29554	29562		10.1074/jbc.M802579200	http://dx.doi.org/10.1074/jbc.M802579200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18713736	Green Published, hybrid			2022-12-25	WOS:000260179900081
J	Valant, C; Gregory, KJ; Hall, NE; Scammells, PJ; Lew, MJ; Sexton, PM; Christopoulos, A				Valant, Celine; Gregory, Karen J.; Hall, Nathan E.; Scammells, Peter J.; Lew, Michael J.; Sexton, Patrick M.; Christopoulos, Arthur			A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity MUSCARINIC PARTIAL AGONIST McN-A-343 AS A BITOPIC ORTHOSTERIC/ALLOSTERIC LIGAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTORS; CRYSTAL-STRUCTURE; BINDING-SITE; PHARMACOLOGY; MUTAGENESIS; MODULATORS; EFFICACY; DRUGS; MODE	Many G protein-coupled receptors (GPCRs) possess allosteric binding sites distinct from the orthosteric site utilized by their cognate ligands, but most GPCR allosteric modulators reported to date lack signaling efficacy in their own right. McN-A-343 (4-(N-(3-chlorophenyl)carbamoyloxy)-2-butynyltrimethylammonium chloride) is a functionally selective muscarinic acetylcholine receptor (mAChR) partial agonist that can also interact allosterically at the M-2 mAChR. We hypothesized that this molecule simultaneously utilizes both an allosteric and the orthosteric site on the M-2 mAChR to mediate these effects. By synthesizing progressively truncated McN-A-343 derivatives, we identified two, which minimally contain 3- chlorophenylcarbamate, as pure allosteric modulators. These compounds were positive modulators of the orthosteric antagonist N-[H-3] methylscopolamine, but in functional assays of M-2 mAChR-mediated ERK1/2 phosphorylation and guanosine 5'-3-O-([S-35]thio)triphosphate binding, they were negative modulators of agonist efficacy. This negative allosteric effect was diminished upon mutation of Y177A in the second extracellular (E2) loop of the M(2)mAChR that is known to reduce prototypical allosteric modulator potency. Our results are consistent with McN-A-343 being a bitopic orthosteric/allosteric ligand with the allosteric moiety engendering partial agonism and functional selectivity. This finding suggests a novel and largely unappreciated mechanism of "directed efficacy" whereby functional selectivity may be engendered in a GPCR by utilizing an allosteric ligand to direct the signaling of an orthosteric ligand encoded within the same molecule.	[Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Drug Discovery Biol Lab, Clayton, Vic 3800, Australia; [Scammells, Peter J.] Monash Inst Pharmaceut Sci, Dept Med Chem, Parkville, Vic 3052, Australia; [Lew, Michael J.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia; [Valant, Celine; Gregory, Karen J.; Hall, Nathan E.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Inst Pharmaceut Sci, Drug Discovery Biol Lab, Parkville, Vic 3052, Australia	Monash University; University of Melbourne	Christopoulos, A (corresponding author), Monash Univ, Dept Pharmacol, Drug Discovery Biol Lab, Clayton, Vic 3800, Australia.	arthur.christopoulos@med.monash.edu.au	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008; Lew, Michael/E-1247-2012	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Gregory, Karen/0000-0002-3833-2137; Hall, Nathan/0000-0001-8942-0498; Valant, Celine/0000-0002-2509-7465; Lew, Michael/0000-0002-2523-7990; Scammells, Peter/0000-0003-2930-895X	National Health and Medical Research Council (NHMRC) of Australia [400134]; Australian Research Council Discovery [DP0877497]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery(Australian Research Council)	This work was supported in part by National Health and Medical Research Council (NHMRC) of Australia Grant 400134 and Australian Research Council Discovery Grant DP0877497. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; BIRDSALL NJM, 1983, BRIT J PHARMACOL, V78, P257, DOI 10.1111/j.1476-5381.1983.tb09388.x; BLACK J, 1989, SCIENCE, V245, P486, DOI 10.1126/science.2569237; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caulfield MP, 1998, PHARMACOL REV, V50, P279; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christopoulos A, 1999, BIOCHEM PHARMACOL, V58, P735, DOI 10.1016/S0006-2952(99)00087-8; Christopoulos A, 1997, EUR J PHARMACOL, V339, P153, DOI 10.1016/S0014-2999(97)01379-4; Christopoulos A, 2000, J PHARMACOL TOXICOL, V43, P55, DOI 10.1016/S1056-8719(00)00078-2; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Griffin MT, 2007, J PHARMACOL EXP THER, V321, P1193, DOI 10.1124/jpet.107.120857; Heitz F, 1999, EUR J PHARMACOL, V380, P183, DOI 10.1016/S0014-2999(99)00439-2; JAKUBIK J, 1995, J PHARMACOL EXP THER, V274, P1077; Kostenis E, 1996, EUR J PHARMACOL, V314, P385, DOI 10.1016/S0014-2999(96)00568-7; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; LEFF P, 1993, BRIT J PHARMACOL, V110, P239, DOI 10.1111/j.1476-5381.1993.tb13799.x; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; MELLIN C, 1989, J MED CHEM, V32, P1590, DOI 10.1021/jm00127a031; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; ROSZKOWSKI A, 1961, J PHARMACOL EXP THER, V132, P156; ROSZKOWSKI AP, 1967, J PHARMACOL EXP THER, V156, P238; SCHWARZ RD, 1995, LIFE SCI, V56, P923, DOI 10.1016/0024-3205(95)00029-6; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; WAELBROECK M, 1994, MOL PHARMACOL, V46, P685; Wess J, 2005, MOL PHARMACOL, V68, P1506, DOI 10.1124/mol.105.019141	36	142	144	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29312	29321		10.1074/jbc.M803801200	http://dx.doi.org/10.1074/jbc.M803801200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18723515	Green Published, hybrid			2022-12-25	WOS:000260179900058
J	Zhu, JM; Zhu, SS; Guzzo, CM; Ellis, NA; Sung, KS; Choi, CY; Matunis, MJ				Zhu, Jianmei; Zhu, Shanshan; Guzzo, Catherine M.; Ellis, Nathan A.; Sung, Ki Sa; Choi, Cheol Yong; Matunis, Michael J.			Small Ubiquitin-related Modifier (SUMO) Binding Determines Substrate Recognition and Paralog-selective SUMO Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; NUCLEAR-PORE COMPLEX; CONJUGATING ENZYME; BLM HELICASE; CLEFT-LIP; UBC9; MOTIF; MONOUBIQUITINATION; IDENTIFICATION; TRAFFICKING	Small ubiquitin-related modifiers (SUMOs) regulate diverse cellular processes through their covalent attachment to target proteins. Vertebrates express three SUMO paralogs: SUMO-1, SUMO-2, and SUMO-3 (SUMO-2 and SUMO-3 are similar to 96% identical and referred to as SUMO-2/3). SUMO-1 and SUMO-2/3 are conjugated, at least in part, to unique subsets of proteins and thus regulate distinct cellular pathways. However, how different proteins are selectively modified by SUMO-1 and SUMO-2/3 is unknown. We demonstrate that BLM, the RecQ DNA helicase mutated in Bloom syndrome, is preferentially modified by SUMO-2/3 both in vitro and in vivo. Our findings indicate that non-covalent interactions between SUMO and BLM are required for modification at non-consensus sites and that preferential SUMO-2/3 modification is determined by preferential SUMO-2/3 binding. We also present evidence that sumoylation of a C-terminal fragment of HIPK2 is dependent on SUMO binding, indicating that non-covalent interactions between SUMO and target proteins provide a general mechanism for SUMO substrate selection and possible paralogselective modification.	[Zhu, Jianmei; Zhu, Shanshan; Guzzo, Catherine M.; Matunis, Michael J.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Ellis, Nathan A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sung, Ki Sa; Choi, Cheol Yong] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Chicago; Sungkyunkwan University (SKKU)	Matunis, MJ (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, 615 N Wolfe St,Rm W8041, Baltimore, MD 21205 USA.	mmatunis@jhsph.edu		Matunis, Michael/0000-0002-9350-6611; Zhu, Jianmei/0000-0001-6172-7180	National Institutes of Health [GM060980, U54RR020839]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM060980 and U54RR020839. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alkuraya FS, 2006, SCIENCE, V313, P1751, DOI 10.1126/science.1128406; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Beresten SF, 1999, PROTEIN EXPRES PURIF, V17, P239, DOI 10.1006/prep.1999.1135; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Matunis MJ, 2006, DEV CELL, V11, P596, DOI 10.1016/j.devcel.2006.10.011; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Pauws E, 2007, TRENDS GENET, V23, P631, DOI 10.1016/j.tig.2007.09.002; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Wu L, 2007, DNA REPAIR, V6, P936, DOI 10.1016/j.dnarep.2007.02.007; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013	46	104	107	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29405	29415		10.1074/jbc.M803632200	http://dx.doi.org/10.1074/jbc.M803632200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708356	Green Published, hybrid			2022-12-25	WOS:000260179900067
J	Gurung, B; Yu, L; Yu, CA				Gurung, Buddha; Yu, Linda; Yu, Chang-An			Stigmatellin induces reduction of iron-sulfur protein in the oxidized cytochrome bc(1) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ELECTRON-TRANSFER; BOVINE HEART-MITOCHONDRIA; OXYGEN-EVOLVING SYSTEM; Q-CYCLE MECHANISM; DOMAIN MOVEMENT; UBIQUINOL OXIDATION; SACCHAROMYCES-CEREVISIAE; SUPEROXIDE FORMATION; YEAST MITOCHONDRIA; HYDROGEN-PEROXIDE	Stigmatellin, a Q(P) site inhibitor, inhibits electron transfer from iron-sulfur protein (ISP) to cytochrome c(1) in the bc(1) complex. Stigmatellin raises the midpoint potential of ISP from 290 mV to 540 mV. The binding of stigmatellin to the fully oxidized complex, oxidized completely by catalytic amounts of cytochrome c oxidase and cytochrome c, results in ISP reduction. The extent of ISP reduction is proportional to the amount of inhibitor used and reaches a maximum when the ratio of inhibitor to enzyme complex reaches unity. A g = 2.005 EPR peak, characteristic of an organic free radical, is also observed when stigmatellin is added to the oxidized complex, and its signal intensity depends on the amount of stigmatellin. Addition of ferricyanide, a strong oxidant, to the oxidized complex also generates a g = 2.005 EPR peak that is oxidant concentration-dependent. Oxygen radicals are generated when stigmatellin is added to the oxidized complex in the absence of the exogenous substrate, ubiquinol. The amount of oxygen radical formed is proportional to the amount of stigmatellin added. Oxygen radicals are not generated when stigmatellin is added to a mutant bc1 complex lacking the Rieske iron-sulfur cluster. Based on these results, it is proposed that ISP becomes a strong oxidant upon stigmatellin binding, extracting electrons from an organic compound, likely an amino acid residue. This results in the reduction of ISP and generation of organic radicals.	[Gurung, Buddha; Yu, Linda; Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Yu, CA (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, 255A NRC-D, Stillwater, OK 74078 USA.	cayuq@okstate.edu			National Institutes of Health [GM 30721]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030721, R01GM030721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 30721 (to C.-A. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARRY BA, 1987, P NATL ACAD SCI USA, V84, P7099, DOI 10.1073/pnas.84.20.7099; BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brandt U, 1997, BIOCHEMISTRY-US, V36, P11234, DOI 10.1021/bi970968g; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Chen YR, 2004, J BIOL CHEM, V279, P18054, DOI 10.1074/jbc.M307706200; Covian R, 2004, J BIOL CHEM, V279, P15040, DOI 10.1074/jbc.M400193200; Crofts AR, 2004, BBA-BIOENERGETICS, V1655, P77, DOI 10.1016/j.bbabio.2003.10.012; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; DEBUS RJ, 1988, P NATL ACAD SCI USA, V85, P427, DOI 10.1073/pnas.85.2.427; DENICOLA A, 1995, FREE RADICAL BIO MED, V19, P11, DOI 10.1016/0891-5849(94)00239-G; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Ghosh M, 2001, BIOCHEMISTRY-US, V40, P327, DOI 10.1021/bi001708t; Gurung B, 2005, J BIOL CHEM, V280, P24895, DOI 10.1074/jbc.M503319200; Gutierrez-Cirlos EB, 2002, J BIOL CHEM, V277, P1195, DOI 10.1074/jbc.M109097200; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Hunte C, 2001, FEBS LETT, V504, P126, DOI 10.1016/S0014-5793(01)02744-2; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Junemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCURLEY JP, 1990, BIOCHIM BIOPHYS ACTA, V1020, P176, DOI 10.1016/0005-2728(90)90049-A; MIKI T, 1992, ARCH BIOCHEM BIOPHYS, V293, P61, DOI 10.1016/0003-9861(92)90365-4; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Nett JH, 2000, EUR J BIOCHEM, V267, P5777, DOI 10.1046/j.1432-1327.2000.01650.x; NOHL H, 1986, BIOCHEM BIOPH RES CO, V138, P533, DOI 10.1016/S0006-291X(86)80529-0; Obungu VH, 2000, BBA-BIOENERGETICS, V1457, P36, DOI 10.1016/S0005-2728(99)00116-4; ORMEJOHNSON NR, 1974, BIOCHEM BIOPH RES CO, V45, P871; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; PUMPHREY AM, 1960, BIOCHEM J, V76, P61, DOI 10.1042/bj0760061; Ritter M, 2004, BIOCHEMISTRY-US, V43, P8439, DOI 10.1021/bi049649x; Snyder CH, 1999, J BIOENERG BIOMEMBR, V31, P235, DOI 10.1023/A:1005419712731; Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; THIERBACH G, 1984, BIOCHIM BIOPHYS ACTA, V765, P227, DOI 10.1016/0005-2728(84)90017-3; Tian H, 1999, J BIOL CHEM, V274, P7146, DOI 10.1074/jbc.274.11.7146; Tian H, 1998, J BIOL CHEM, V273, P27953, DOI 10.1074/jbc.273.43.27953; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; VONJAGOW G, 1985, FEBS LETT, V185, P311, DOI 10.1016/0014-5793(85)80929-7; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xiao KH, 2000, J BIOL CHEM, V275, P38597, DOI 10.1074/jbc.M007444200; YU CA, 1978, BIOCHEM BIOPH RES CO, V82, P1070, DOI 10.1016/0006-291X(78)90296-6; YU L, 1978, J BIOL CHEM, V253, P2657; YU L, 1986, BIOCHIM BIOPHYS ACTA, V852, P203, DOI 10.1016/0005-2728(86)90225-2; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	54	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28087	28094		10.1074/jbc.M804229200	http://dx.doi.org/10.1074/jbc.M804229200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701458	Green Published, hybrid			2022-12-25	WOS:000259969300011
J	Tauxe, C; Xie, X; Joffraud, M; Martinez, M; Schapira, M; Spertini, O				Tauxe, Caroline; Xie, Xun; Joffraud, Magali; Martinez, Manuel; Schapira, Marc; Spertini, Olivier			P-selectin glycoprotein ligand-1 decameric repeats regulate selectin-dependent rolling under flow conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VWF TETHER BOND; IN-VIVO; LEUKOCYTE ADHESION; TYROSINE SULFATION; PLATELET-ADHESION; MOLECULAR-BASIS; CELL-ADHESION; CATCH BONDS; IB-ALPHA; PSGL-1	P-selectin glycoprotein ligand-1 ( PSGL-1) interacts with selectins to support leukocyte rolling along vascular wall. L-and P-selectin bind to N-terminal tyrosine sulfate residues and to core-2 O-glycans attached to Thr-57, whereas tyrosine sulfation is not required for E-selectin binding. PSGL-1 extracellular domain contains decameric repeats, which extend L-and P-selectin binding sites far above the plasma membrane. We hypothesized that decamers may play a role in regulating PSGL-1 interactions with selectins. Chinese hamster ovary cells expressing wild-type PSGL-1 or PSGL-1 molecules exhibiting deletion or substitution of decamers with the tandem repeats of platelet glycoprotein Ib alpha were compared in their ability to roll on selectins and to bind soluble L-or P-selectin. Deletion of decamers abrogated soluble L-selectin binding and cell rolling on L-selectin, whereas their substitution partially reversed these diminutions. P-selectin-dependent interactions with PSGL-1 were less affected by decamer deletion. Videomicroscopy analysis showed that decamers are required to stabilize L-selectin-dependent rolling. Importantly, adhesion assays performed on recombinant decamers demonstrated that they directly bind to E-selectin and promote slow rolling. Our results indicate that the role of decamers is to extend PSGL-1 N terminus far above the cell surface to support and stabilize leukocyte rolling on L-or P-selectin. In addition, they function as a cell adhesion receptor, which supports similar to 80% of E-selectin-dependent rolling.	[Tauxe, Caroline; Xie, Xun; Joffraud, Magali; Martinez, Manuel; Schapira, Marc; Spertini, Olivier] CHU Vaudois, Cent Hematol Lab, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Spertini, O (corresponding author), CHU Vaudois, Cent Hematol Lab, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	Olivier.Spertini@chuv.ch			Swiss National Foundation for Scientific Research [3200B0-105593]	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Foundation for Scientific Research (Grant 3200B0-105593). The authors have no conflict of interest disclosures. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Afshar-Kharghan V, 2001, BLOOD, V97, P3306, DOI 10.1182/blood.V97.10.3306; Baisse B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-166; Bernimoulin MP, 2003, J BIOL CHEM, V278, P37, DOI 10.1074/jbc.M204360200; Bugert P, 2004, CLIN CHEM LAB MED, V42, P997, DOI 10.1515/CCLM.2004.202; Doggett TA, 2003, BLOOD, V102, P152, DOI 10.1182/blood-2003-01-0072; Doggett TA, 2002, BIOPHYS J, V83, P194, DOI 10.1016/S0006-3495(02)75161-8; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Fong AM, 2000, J BIOL CHEM, V275, P3781, DOI 10.1074/jbc.275.6.3781; Fukuda M, 1999, J CELL BIOL, V147, P467, DOI 10.1083/jcb.147.3.467; Goetz DJ, 1997, J CELL BIOL, V137, P509, DOI 10.1083/jcb.137.2.509; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Leppanen A, 2003, J BIOL CHEM, V278, P26391, DOI 10.1074/jbc.M303551200; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Liu W, 1998, J BIOL CHEM, V273, P7078, DOI 10.1074/jbc.273.12.7078; LOPEZ JA, 1992, J BIOL CHEM, V267, P10055; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Lozano ML, 2001, BRIT J HAEMATOL, V115, P969, DOI 10.1046/j.1365-2141.2001.03151.x; MARCHESE P, 1995, J BIOL CHEM, V270, P9571, DOI 10.1074/jbc.270.16.9571; Martinez M, 2005, J BIOL CHEM, V280, P5378, DOI 10.1074/jbc.M410899200; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; NORMAN KE, 1995, BLOOD, V86, P4417, DOI 10.1182/blood.V86.12.4417.bloodjournal86124417; Norman KE, 2000, BLOOD, V96, P3585; Ozben B, 2007, J THROMB THROMBOLYS, V23, P181, DOI 10.1007/s11239-006-9020-9; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Romo GM, 1999, J EXP MED, V190, P803, DOI 10.1084/jem.190.6.803; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; Tregouet DA, 2003, ANN HUM GENET, V67, P504, DOI 10.1046/j.1529-8817.2003.00053.x; Xie X, 2000, J BIOL CHEM, V275, P34818, DOI 10.1074/jbc.M001257200; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Zhu C, 2005, BIORHEOLOGY, V42, P443	43	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28536	28545		10.1074/jbc.M802865200	http://dx.doi.org/10.1074/jbc.M802865200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713749	Green Published, hybrid			2022-12-25	WOS:000259969300057
J	Zineh, I; Beitelshees, AL; Welder, GJ; Hou, W; Chegini, N; Wu, J; Cresci, S; Province, MA; Spertus, JA				Zineh, Issam; Beitelshees, Amber L.; Welder, Gregory J.; Hou, Wei; Chegini, Nasser; Wu, Jun; Cresci, Sharon; Province, Michael A.; Spertus, John A.			Epithelial Neutrophil-Activating Peptide (ENA-78), Acute Coronary Syndrome Prognosis, and Modulatory Effect of Statins	PLOS ONE			English	Article								Endothelial inflammation with chemokine involvement contributes to acute coronary syndromes (ACS). We tested the hypothesis that variation in the chemokine gene CXCL5, which encodes epithelial neutrophil-activating peptide (ENA-78), is associated with ACS prognosis. We also investigated whether statin use, a potent modulator of inflammation, modifies CXCL5's association with outcomes and characterized the in vitro effect of atorvastatin on endothelial ENA-78 production. Using a prospective cohort of ACS patients (n = 704) the association of the CXCL5 2156 G. C polymorphism (rs352046) with 3-year all-cause mortality was estimated with hazard ratios (HR). Models were stratified by genotype and race. To characterize the influence of statins on this association, a statin*genotype interaction was tested. To validate ENA-78 as a statin target in inflammation typical of ACS, endothelial cells (HUVECs) were treated with IL-1 beta and atorvastatin with subsequent quantification of CXCL5 expression and ENA-78 protein concentrations. C/C genotype was associated with a 2.7-fold increase in 3-year all-cause mortality compared to G/G+G/C (95% CI 1.19-5.87; p = 0.017). Statins significantly reduced mortality in G/G individuals only (58% relative risk reduction; p = 0.0009). In HUVECs, atorvastatin dose-dependently decreased IL-1 beta-stimulated ENA-78 concentrations (p<0.0001). Drug effects persisted over 48 hours (p<0.01). CXCL5 genotype is associated with outcomes after ACS with potential statin modification of this effect. Atorvastatin lowered endothelial ENA-78 production during inflammation typical of ACS. These findings implicate CXCL5/ENA-78 in ACS and the statin response.	[Zineh, Issam; Beitelshees, Amber L.; Welder, Gregory J.] Univ Florida, Coll Pharm, Ctr Pharmacogenom, Gainesville, FL 32610 USA; [Hou, Wei] Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA; [Chegini, Nasser] Univ Florida, Coll Med, Dept Obstet & Gynecol, Gainesville, FL USA; [Wu, Jun; Province, Michael A.] Washington Univ, Sch Med, Ctr Genome Sci, Div Stat Genom, St Louis, MO USA; [Cresci, Sharon] Washington Univ, Sch Med, Dept Med, St Louis, MO USA; [Spertus, John A.] Mid America Heart Inst, Kansas City, MO USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington University (WUSTL); Washington University (WUSTL); Saint Luke's Mid America Heart Institute	Zineh, I (corresponding author), Univ Florida, Coll Pharm, Ctr Pharmacogenom, Gainesville, FL 32610 USA.	zineh@cop.ufl.edu	Spertus, John/ABD-3075-2021; hou, wei/GWM-4800-2022		American Heart Association [0435278B]; NIH [RR17568, HL077113]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017568] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077113] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Florida/Puerto Rico Affiliate Scientist Development Grant 0435278B, NIH C06 Grant RR17568, and NIH P50 Grant HL077113. The sponsors did not have a role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Aarons CB, 2007, ANN SURG, V245, P176, DOI 10.1097/01.sla.0000236627.07927.7c; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chello M, 2007, ANN THORAC SURG, V83, P1374, DOI 10.1016/j.athoracsur.2006.10.065; Cowled PA, 2007, J SURG RES, V141, P267, DOI 10.1016/j.jss.2006.11.021; Damas JK, 2000, CARDIOVASC RES, V45, P428, DOI 10.1016/S0008-6363(99)00262-X; Damas JK, 2000, CARDIOVASC RES, V47, P778, DOI 10.1016/S0008-6363(00)00142-5; de Lemos JA, 2007, J AM COLL CARDIOL, V50, P2117, DOI 10.1016/j.jacc.2007.06.057; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1991, BLOOD, V77, P1627; Furman C, 2004, ATHEROSCLEROSIS, V174, P93, DOI 10.1016/j.atherosclerosis.2004.01.009; Guasti L, 2006, J HYPERTENS, V24, P2423, DOI 10.1097/01.hjh.0000251903.62804.77; Haller MJ, 2006, J PEDIATR ENDOCR MET, V19, P267; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Imaizumi T, 2003, PROSTAG LEUKOTR ESS, V69, P323, DOI 10.1016/S0952-3278(03)00145-5; Kiener PA, 2001, INT IMMUNOPHARMACOL, V1, P105, DOI 10.1016/S0162-3109(00)00272-1; Kruk M, 2008, CIRC J, V72, P205, DOI 10.1253/circj.72.205; Lanfear DE, 2005, JAMA-J AM MED ASSOC, V294, P1526, DOI 10.1001/jama.294.12.1526; Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lindholm MW, 2007, VASC PHARMACOL, V46, P91, DOI 10.1016/j.vph.2006.07.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194; Marino F, 2007, J CARDIOVASC PHARM, V49, P299, DOI 10.1097/FJC.0b013e31803d35ce; Muhlestein JB, 2001, AM J CARDIOL, V87, P257, DOI 10.1016/S0002-9149(00)01354-0; Nijm J, 2005, AM J CARDIOL, V95, P452, DOI 10.1016/j.amjcard.2004.10.009; Ota K, 2005, METABOLISM, V54, P142, DOI 10.1016/j.metabol.2004.06.018; Park HJ, 2006, STEM CELL REV, V2, P93, DOI 10.1007/s12015-006-0015-x; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; SCHMOUDER RL, 1995, TRANSPLANTATION, V59, P118, DOI 10.1097/00007890-199501150-00021; Schwartz GG, 2005, AM J CARDIOL, V96, p45F, DOI 10.1016/j.amjcard.2005.06.026; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Smith C, 2006, J AM COLL CARDIOL, V48, P1591, DOI 10.1016/j.jacc.2006.06.060; STRIETER RM, 1992, IMMUNOL INVEST, V21, P589, DOI 10.3109/08820139209069393; Sugano R, 2005, ARTERIOSCL THROM VAS, V25, P1262, DOI 10.1161/01.ATV.0000163842.91226.ba; Takeshita S, 1997, ATHEROSCLEROSIS, V135, P187, DOI 10.1016/S0021-9150(97)00160-3; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; Zaremba J., 2006, Folia Morphologica, V65, P1; Zineh I, 2006, CYTOKINE, V33, P258, DOI 10.1016/j.cyto.2006.02.008; Zineh I, 2006, PHARMACOTHERAPY, V26, P333; Zineh I, 2007, DIABETES CARE, V30, P689, DOI 10.2337/dc06-1697; Zineh I, 2006, CLIN CHIM ACTA, V370, P72, DOI 10.1016/j.cca.2006.01.025	43	27	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3117	10.1371/journal.pone.0003117	http://dx.doi.org/10.1371/journal.pone.0003117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769620	Green Submitted, Green Published, gold			2022-12-25	WOS:000264418300008
J	Dehmer, M; Borgert, S; Emmert-Streib, F				Dehmer, Matthias; Borgert, Stephan; Emmert-Streib, Frank			Entropy Bounds for Hierarchical Molecular Networks	PLOS ONE			English	Article							INFORMATION-CONTENT; GRAPH ENTROPY; COMPLEXITY; SIMILARITY; SUPERTREE; INDEX	In this paper we derive entropy bounds for hierarchical networks. More precisely, starting from a recently introduced measure to determine the topological entropy of non-hierarchical networks, we provide bounds for estimating the entropy of hierarchical graphs. Apart from bounds to estimate the entropy of a single hierarchical graph, we see that the derived bounds can also be used for characterizing graph classes. Our contribution is an important extension to previous results about the entropy of non-hierarchical networks because for practical applications hierarchical networks are playing an important role in chemistry and biology. In addition to the derivation of the entropy bounds, we provide a numerical analysis for two special graph classes, rooted trees and generalized trees, and demonstrate hereby not only the computational feasibility of our method but also learn about its characteristics and interpretability with respect to data analysis.	[Dehmer, Matthias] Univ Vienna Technol, Inst Discrete Math & Geomet, A-1010 Vienna, Austria; [Borgert, Stephan] Univ Siegen, Dept Phys, Siegen, Germany; [Emmert-Streib, Frank] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Dept Biomed Sci, Belfast BT7 1NN, Antrim, North Ireland	Technische Universitat Wien; Universitat Siegen; Queens University Belfast	Dehmer, M (corresponding author), Univ Coimbra, Ctr Math, Coimbra, Portugal.	mdehmer@geometrie.tuwien.ac.at	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641	European FP6-NEST-Adventure Programme [028875]	European FP6-NEST-Adventure Programme(European Commission)	Matthias Dehmer has been supported by the European FP6-NEST-Adventure Programme, contract No. 028875.	[Anonymous], MINING GRAPH DATA; [Anonymous], P INT C INT MATH CHE; [Anonymous], INT J MATH STAT SCI; [Anonymous], ELECT RES ANNOUNCEME; Aringhieri R, 2001, J CHEM INF COMP SCI, V41, P958, DOI 10.1021/ci0001536; Aringhieri R, 2003, 4OR-Q J OPER RES, V1, P67, DOI 10.1007/s10288-002-0008-9; BangJensen Jorgen, 2002, DIGRAPHS THEORY ALGO; Barabasi A.L., 2003, LINKED EVERYTHING IS; Benigni R, 2003, QUANTITATIVE STRUCTU; BOHANEC S, 1993, J CHEM INF COMP SCI, V33, P719, DOI 10.1021/ci00015a010; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D, 2000, J CHEM INF COMP SCI, V40, P934, DOI 10.1021/ci990120u; BONCHEV D, 1989, THEOCHEM-J MOL STRUC, V54, P155, DOI 10.1016/0166-1280(89)85011-0; Bonchev D., 2003, COMPLEXITY INTRO FUN, DOI DOI 10.1201/9781482288247; Bonchev D., 1991, CHEM GRAPH THEORY IN; Bonchev D., 2005, COMPLEXITY CHEM BIOL, DOI 10.1007/b136300; Bonchev D, 1983, INFORM THEORETIC IND; Brillouin L., 1956, SCI INFORM THEORY; Brinkmeier M, 2005, LECT NOTES COMPUT SC, V3418, P293; Bunke H, 2000, INT C PATT RECOG, P117, DOI 10.1109/ICPR.2000.906030; BUNKE H, 1983, B EATCS, V20, P35; Chepoi V, 1996, J CHEM INF COMP SCI, V36, P1169, DOI 10.1021/ci9600869; Dancoff SM, 1953, ESSAYS USE INFORM TH, P263; DEHMER M, 2006, INT J COMPUTATIONAL, V3, P1; Dehmer M, 2008, APPL MATH COMPUT, V201, P82, DOI 10.1016/j.amc.2007.12.010; Dehmer M, 2008, COMPUT BIOL CHEM, V32, P131, DOI 10.1016/j.compbiolchem.2007.09.007; Devillers J., 2000, TOPOLOGICAL INDICES; Diudea M, 2001, MOL TOPOLOGY; Diudea M.V., 2001, QSPR QSAR STUDIES MO; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Elk SB, 1990, J MATH CHEM, V4, P55, DOI 10.1007/BF01170004; Emmert-Streib F, 2005, DMIN '05: PROCEEDINGS OF THE 2005 INTERNATIONAL CONFERENCE ON DATA MINING, P200; EMMERTSTREIB F, 2006, INT J BIOMEDICAL SCI, V1, P17; Felsenstein J., 2004, INFERRING PHYLOGENIE; Foulds L.R, 1992, GRAPH THEORY APPL; GAMBIN A, 2005, CR BIOL, V328, P1; Gutman I., 1986, MATH CONCEPTS ORGANI, DOI [DOI 10.1007/978-3-642-70982-1, 10.1007/978-3-642-70982-1]; HALIN R, 1989, GRAPHENTHEORIE; Harary F., 1969, GRAPH THEORY; Hochsmann M, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P159, DOI 10.1109/CSB.2003.1227315; HORVATH T, 2005, P 2004 ACM SIGKDD IN, P158; KADEN F, AKAD WISS DDR, V2, P1; Korner J., 1973, T 6 PRAG C INF THEOR, P411; LINSHITZ H, 1953, ESSAYS USE INFORM TH, P14; Liu SC, 2000, INT J QUANTUM CHEM, V78, P331, DOI 10.1002/(SICI)1097-461X(2000)78:5<331::AID-QUA4>3.0.CO;2-V; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; MATULA DW, 1968, SIAM REV, V10, P273; MEHLER A, 2004, P 4 INT WORKSH INN I, V3473, P136; MORIHIRO H, 2006, IPSJ SIG TECHNICAL R, V99, P1; Morowitz H, 1953, B MATH BIOPHYS, V17, P81; MOWSHOWI.A, 1968, B MATH BIOPHYS, V30, P533, DOI 10.1007/BF02476673; MOWSHOWI A, 1968, B MATH BIOPHYS, V30, P387, DOI 10.1007/BF02476603; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P225, DOI 10.1007/BF02476692; MULLER WR, 1995, J CHEM INF COMP SCI, V35, P211; Quastler H., 1953, INFORM THEORY BIOL; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; Rupp M, 2007, J CHEM INF MODEL, V47, P2280, DOI 10.1021/ci700274r; SAHU PK, 2008, CHEM PHYS L IN PRESS; Semple C, 2000, DISCRETE APPL MATH, V105, P147, DOI 10.1016/S0166-218X(00)00202-X; Semple C., 2003, GRADUATE SERIES MATH; Shannon CE, 1997, MATH THEORY COMMUNIC; SHAPIRO BA, 1990, COMPUT APPL BIOSCI, V6, P309; Simonyi G, 2001, WIL INT S D, P293; Skorobogatov VA, 1988, MATCH-COMMUN MATH CO, V23, P105; Skvortsova MI, 1998, J CHEM INF COMP SCI, V38, P785, DOI 10.1021/ci970037b; Sobik F, 1982, AKAD WISS DDR, V2, P63; SOBIK F, 1986, AKAD WISS DDR, V4, P104; Steel M, 2000, SYST BIOL, V49, P363, DOI 10.1093/sysbio/49.2.363; Trinajstic N., 2018, CHEM GRAPH THEORY; TRUCCO ERNESTO, 1956, BULL MATH BIOPHYS, V18, P129, DOI 10.1007/BF02477836; Visco DP, 2002, J MOL GRAPH MODEL, V20, P429, DOI 10.1016/S1093-3263(01)00144-9; Zelinka A, 1975, CASOPIS PEST MAT, V100, P371, DOI DOI 10.21136/CPM.1975.117890; ZHU P, 2005, 16 BRIT MACH VIS C O; Zmazek B, 2007, CROAT CHEM ACTA, V80, P75	75	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3079	10.1371/journal.pone.0003079	http://dx.doi.org/10.1371/journal.pone.0003079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769487	Green Published, gold, Green Submitted			2022-12-25	WOS:000264796600001
J	MacArthur, BD; Please, CP; Oreffo, ROC				MacArthur, Ben D.; Please, Colin P.; Oreffo, Richard O. C.			Stochasticity and the Molecular Mechanisms of Induced Pluripotency	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; LINEAGE SPECIFICATION; POSITIVE-FEEDBACK; SELF-RENEWAL; IN-VITRO; DIFFERENTIATION; MOUSE; MODEL	The generation of induced pluripotent stem cells from adult somatic cells by ectopic expression of key transcription factors holds significant medical promise. However, current techniques for inducing pluripotency rely on viral infection and are therefore not, at present, viable within a clinical setting. Thus, there is now a need to better understand the molecular basis of stem cell pluripotency and lineage specification in order to investigate alternative methods to induce pluripotency for clinical application. However, the complexity of the underlying molecular circuitry makes this a conceptually difficult task. In order to address these issues, we considered a computational model of transcriptional control of cell fate specification. The model comprises two mutually interacting sub-circuits: a central pluripotency circuit consisting of interactions between stem-cell specific transcription factors OCT4, SOX2 and NANOG coupled to a differentiation circuit consisting of interactions between lineage-specifying master genes. The molecular switches which arise from feedback loops within these circuits give rise to a well-defined sequence of successive gene restrictions corresponding to a controlled differentiation cascade in response to environmental stimuli. Furthermore, we found that this differentiation cascade is strongly unidirectional: once silenced, core transcription factors cannot easily be reactivated. In the context of induced pluripotency, this indicates that differentiated cells are robustly resistant to reprogramming to a more primitive state. However, our model suggests that under certain circumstances, amplification of low-level fluctuations in transcriptional status (transcriptional "noise'') may be sufficient to trigger reactivation of the core pluripotency switch and reprogramming to a pluripotent state. This interpretation offers an explanation of a number of experimental observations concerning the molecular mechanisms of cellular reprogramming by defined factors and suggests a role for stochasticity in reprogramming of somatic cells to pluripotency.	[MacArthur, Ben D.; Oreffo, Richard O. C.] Univ Southampton, Inst Dev Sci, Ctr Human Dev, Bone & Joint Res Grp, Southampton, Hants, England; [MacArthur, Ben D.; Please, Colin P.] Univ Southampton, Sch Math, Southampton, Hants, England	University of Southampton; University of Southampton	MacArthur, BD (corresponding author), Univ Southampton, Inst Dev Sci, Ctr Human Dev, Bone & Joint Res Grp, Southampton, Hants, England.	bdm@soton.ac.uk	Please, Colin/G-6247-2011; Oreffo, Richard OC/A-4615-2011	Oreffo, Richard OC/0000-0001-5995-6726; MacArthur, Ben/0000-0002-5396-9750; Please, Colin/0000-0001-8917-8574	EPSRC [EP/C003497/1]; Engineering and Physical Sciences Research Council [EP/C003497/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by EPSRC grant number EP/C003497/1.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Cinquin O, 2005, J THEOR BIOL, V233, P391, DOI 10.1016/j.jtbi.2004.10.027; Cinquin O, 2007, B MATH BIOL, V69, P483, DOI 10.1007/s11538-006-9114-8; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; *ED, 2008, NATURE, V452, P913; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Furusawa C, 2001, J THEOR BIOL, V209, P395, DOI 10.1006/jtbi.2001.2264; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Glauche I, 2007, STEM CELLS, V25, P1791, DOI 10.1634/stemcells.2007-0025; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; HALL PA, 1989, DEVELOPMENT, V106, P619; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang Sui, 2006, Breast Dis, V26, P27; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kauffman S.A., 1993, ORIGINS ORDER; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; KELLER AD, 1995, J THEOR BIOL, V172, P169, DOI 10.1006/jtbi.1995.0014; Khan E, 2003, J LAB CLIN MED, V142, P29, DOI 10.1016/S0022-2143(03)00058-1; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kirkland MA, 2004, EXP HEMATOL, V32, P511, DOI 10.1016/j.exphem.2004.02.013; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Preisler HD, 1999, LEUKEMIA RES, V23, P685, DOI 10.1016/S0145-2126(99)00077-6; Roeder I, 2002, EXP HEMATOL, V30, P853, DOI 10.1016/S0301-472X(02)00832-9; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rothenberg EV, 1999, BIOESSAYS, V21, P726, DOI 10.1002/(SICI)1521-1878(199909)21:9<726::AID-BIES4>3.0.CO;2-S; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Soule C, 2006, CR BIOL, V329, P13, DOI 10.1016/j.crvi.2005.10.002; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tai GP, 2004, TISSUE ENG, V10, P1456, DOI 10.1089/1076327042500300; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theise ND, 2003, NATURE, V425, P21, DOI 10.1038/425021a; THOMAS R, 1978, J THEOR BIOL, V73, P631, DOI 10.1016/0022-5193(78)90127-3; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tosh D, 2002, NAT REV MOL CELL BIO, V3, P187, DOI 10.1038/nrm761; Waddington C., 1957, STRATEGY GENES; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	96	71	71	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3086	10.1371/journal.pone.0003086	http://dx.doi.org/10.1371/journal.pone.0003086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769478	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000264796600005
J	Brody, T; Yavatkar, AS; Lin, Y; Ross, J; Kuzin, A; Kundu, M; Fann, Y; Odenwald, WF				Brody, Thomas; Yavatkar, Amarendra S.; Lin, Yong; Ross, Jermaine; Kuzin, Alexander; Kundu, Mukta; Fann, Yang; Odenwald, Ward F.			Horizontal Gene Transfers Link a Human MRSA Pathogen to Contagious Bovine Mastitis Bacteria	PLOS ONE			English	Article								Background: Acquisition of virulence factors and antibiotic resistance by many clinically important bacteria can be traced to horizontal gene transfer (HGT) between related or evolutionarily distant microflora. Comparative genomic analysis has become an important tool for identifying HGT DNA in emerging pathogens. We have adapted the multi-genome alignment tool EvoPrinter to facilitate discovery of HGT DNA sequences within bacterial genomes and within their mobile genetic elements. Principal Findings: EvoPrinter analysis of 13 different Staphylococcus aureus genomes revealed that one of the human isolates, the hospital epidemic methicillin-resistant MRSA252 strain, uniquely shares multiple putative HGT DNA sequences with different causative agents of bovine mastitis that are not found in the other human S. aureus isolates. MRSA252 shares over 14 different DNA sequence blocks with the bovine mastitis ET3 S. aureus strain RF122, and many of the HGT DNAs encode virulence factors. EvoPrinter analysis of the MRSA252 chromosome also uncovered virulence-factor encoding HGT events with the genome of Listeria monocytogenes and a Staphylococcus saprophyticus associated plasmid. Both bacteria are also causal agents of contagious bovine mastitis. Conclusions: EvoPrinter analysis reveals that the human MRSA252 strain uniquely shares multiple DNA sequence blocks with different causative agents of bovine mastitis, suggesting that HGT events may be occurring between these pathogens. These findings have important implications with regard to animal husbandry practices that inadvertently enhance the contact of human and livestock bacterial pathogens.	[Brody, Thomas; Ross, Jermaine; Kuzin, Alexander; Kundu, Mukta; Odenwald, Ward F.] NIH, Neural Cell Fate Determinants Sect, Bethesda, MD 20892 USA; [Yavatkar, Amarendra S.; Lin, Yong; Fann, Yang] NINDS, NIH, Div Intramural Res Informat Technol Program, Bethesda, MD USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Brody, T (corresponding author), NIH, Neural Cell Fate Determinants Sect, Bldg 10, Bethesda, MD 20892 USA.	brodyt@ninds.nih.gov; ward@codon.nih.gov			Intramural Research Program of the NIH, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIHNS002820, ZIANS002820, Z01NS002820] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the NIH, NINDS.	Adams MA, 2006, J MOL BIOL, V359, P455, DOI 10.1016/j.jmb.2006.03.053; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; BOURRY A, 1995, J MED MICROBIOL, V43, P125, DOI 10.1099/00222615-43-2-125; Boyd EF, 2001, TRENDS MICROBIOL, V9, P137, DOI 10.1016/S0966-842X(01)01960-6; BROWN DFJ, 1980, FEBS LETT, V122, P275, DOI 10.1016/0014-5793(80)80455-8; COOKSEY DA, 1994, FEMS MICROBIOL REV, V14, P381, DOI 10.1016/0168-6445(94)90056-6; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Field J, 2000, MOL MICROBIOL, V38, P446, DOI 10.1046/j.1365-2958.2000.02143.x; Guinane CM, 2008, J INFECT DIS, V197, P205, DOI 10.1086/524689; Haveri M, 2007, J APPL MICROBIOL, V103, P993, DOI 10.1111/j.1365-2672.2007.03356.x; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Hinnebusch BJ, 2002, MOL MICROBIOL, V46, P349, DOI 10.1046/j.1365-2958.2002.03159.x; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Hughes AL, 2005, J BACTERIOL, V187, P2698, DOI 10.1128/JB.187.8.2698-2704.2005; Jarvis WR, 2007, AM J INFECT CONTROL, V35, P631, DOI 10.1016/j.ajic.2007.10.009; Juhasz-Kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P630, DOI 10.3201/eid1304.060833; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Loisel-Meyer S, 2006, INFECT IMMUN, V74, P1973, DOI 10.1128/IAI.74.3.1973-1976.2006; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Moon JS, 2007, J DAIRY SCI, V90, P1716, DOI 10.3168/jds.2006-512; Moubareck C, 2003, ANTIMICROB AGENTS CH, V47, P2993, DOI 10.1128/AAC.47.9.2993-2996.2003; Nakaminami H, 2007, BIOL PHARM BULL, V30, P1412, DOI 10.1248/bpb.30.1412; NOBLE WC, 1992, FEMS MICROBIOL LETT, V93, P195; NOVICK RP, 1968, J BACTERIOL, V95, P1335, DOI 10.1128/JB.95.4.1335-1342.1968; Nwaneshiudu AI, 2007, J BACTERIOL, V189, P6074, DOI 10.1128/JB.00349-07; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pittman MS, 2007, MOL MICROBIOL, V63, P575, DOI 10.1111/j.1365-2958.2006.05532.x; PORTER FD, 1982, ANTIMICROB AGENTS CH, V22, P852, DOI 10.1128/AAC.22.5.852; Riekerink RGMO, 2008, J DAIRY SCI, V91, P1366, DOI 10.3168/jds.2007-0757; ROWLAND SJ, 1990, MOL MICROBIOL, V4, P961, DOI 10.1111/j.1365-2958.1990.tb00669.x; Saiman L, 2003, CLIN INFECT DIS, V37, P1313, DOI 10.1086/379022; Sigurdardottir B, 2006, INFECT CONT HOSP EP, V27, P913, DOI 10.1086/507278; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0; Yavatkar AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-106; Zaneveld JR, 2008, MICROBIOL-SGM, V154, P1, DOI 10.1099/mic.0.2007/011833-0; Zhu LX, 2007, J CLIN MICROBIOL, V45, P3514, DOI 10.1128/JCM.02340-06	47	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3074	10.1371/journal.pone.0003074	http://dx.doi.org/10.1371/journal.pone.0003074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728754	Green Submitted, Green Published, gold			2022-12-25	WOS:000264796400014
J	Fukushima, S; Coppen, SR; Lee, J; Yamahara, K; Felkin, LE; Terracciano, CMN; Barton, PJR; Yacoub, MH; Suzuki, K				Fukushima, Satsuki; Coppen, Steven R.; Lee, Joon; Yamahara, Kenichi; Felkin, Leanne E.; Terracciano, Cesare M. N.; Barton, Paul J. R.; Yacoub, Magdi H.; Suzuki, Ken			Choice of Cell-Delivery Route for Skeletal Myoblast Transplantation for Treating Post-Infarction Chronic Heart Failure in Rat	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; STEM-CELLS; FOLLOW-UP; INJECTION; CARDIOMYOCYTES; INCREASES; INJURY	Background: Intramyocardial injection of skeletal myoblasts (SMB) has been shown to be a promising strategy for treating post-infarction chronic heart failure. However, insufficient therapeutic benefit and occurrence of ventricular arrhythmias are concerns. We hypothesised that the use of a retrograde intracoronary route for SMB-delivery might favourably alter the behaviour of the grafted SMB, consequently modulating the therapeutic effects and arrhythmogenicity. Methods and Results: Three weeks after coronary artery ligation in female wild-type rats, 5x10(6) GFP-expressing SMB or PBS only (control) were injected via either the intramyocardial or retrograde intracoronary routes. Injection of SMB via either route similarly improved cardiac performance and physical activity, associated with reduced cardiomyocyte-hypertrophy and fibrosis. Grafted SMB via either route were only present in low numbers in the myocardium, analysed by real-time PCR for the Y-chromosome specific gene, Sry. Cardiomyogenic differentiation of grafted SMB was extremely rare. Continuous ECG monitoring by telemetry revealed that only intramyocardial injection of SMB produced spontaneous ventricular tachycardia up to 14 days, associated with local myocardial heterogeneity generated by clusters of injected SMB and accumulated inflammatory cells. A small number of ventricular premature contractions with latent ventricular tachycardia were detected in the late-phase of SMB injection regardless of the injection-route. Conclusion: Retrograde intracoronary injection of SMB provided significant therapeutic benefits with attenuated early-phase arrhythmogenicity in treating ischaemic cardiomyopathy, indicating the promising utility of this route for SMB-delivery. Late-phase arrhythmogenicity remains a concern, regardless of the delivery route.	[Fukushima, Satsuki; Lee, Joon; Yamahara, Kenichi; Felkin, Leanne E.; Terracciano, Cesare M. N.; Barton, Paul J. R.; Yacoub, Magdi H.; Suzuki, Ken] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield Heart Sci Ctr, Harefield, Middx, England; [Coppen, Steven R.; Suzuki, Ken] Barts & London Queen Marys Sch Med & Dent, Barts a& The London, William Harvey Res Inst, London, England	Imperial College London; University of London; Queen Mary University London	Fukushima, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield Heart Sci Ctr, Harefield, Middx, England.	ken.suzuki@qmul.ac.uk		Barton, Paul/0000-0002-1165-7767; Felkin, Leanne/0000-0003-1402-8314	Magdi Yacoub Institute; UK Medical Research Council; Heart Research UK; Great Britain Sasakawa Foundation; MRC [G116/158] Funding Source: UKRI; Medical Research Council [G116/158] Funding Source: researchfish	Magdi Yacoub Institute; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Heart Research UK; Great Britain Sasakawa Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Magdi Yacoub Institute, The UK Medical Research Council, Heart Research UK and Great Britain Sasakawa Foundation, UK/Japan contributed to the study financially without any other roles	Abraham MR, 2005, CIRC RES, V97, P159, DOI 10.1161/01.RES.0000174794.22491.a0; Bonaros Nikolaos, 2008, Interact Cardiovasc Thorac Surg, V7, P249; Bonaros N, 2006, J THORAC CARDIOV SUR, V132, P1321, DOI 10.1016/j.jtcvs.2006.07.023; Chachques JC, 2004, INT J CARDIOL, V95, pS29, DOI 10.1016/S0167-5273(04)90009-5; Coppen SR, 1999, J HISTOCHEM CYTOCHEM, V47, P907, DOI 10.1177/002215549904700708; Dib N, 2005, CIRCULATION, V112, P1748, DOI 10.1161/CIRCULATIONAHA.105.547810; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Felkin LE, 2006, J HEART LUNG TRANSPL, V25, P1413, DOI 10.1016/j.healun.2006.09.006; Fernandes S, 2006, CARDIOVASC RES, V69, P348, DOI 10.1016/j.cardiores.2005.10.003; Fouts K, 2006, HEART RHYTHM, V3, P452, DOI 10.1016/j.hrthm.2005.12.016; Fukushima S, 2007, CIRCULATION, V115, P2254, DOI 10.1161/CIRCULATIONAHA.106.662577; Hagege AA, 2006, CIRCULATION, V114, pI108, DOI 10.1161/CIRCULATIONAHA.105.000521; HERING S, 1983, J MOL CELL CARDIOL, V15, P431, DOI 10.1016/0022-2828(83)90263-8; Howarth FC, 2006, CLIN EXP PHARMACOL P, V33, P327, DOI 10.1111/j.1440-1681.2006.04370.x; Kovacs SJ, 1997, HYPERTENSION, V30, P788, DOI 10.1161/01.HYP.30.4.788; MacDonnell SM, 2005, CIRCULATION, V111, P3420, DOI 10.1161/CIRCULATIONAHA.104.505784; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Niagara MI, 2007, CIRC RES, V100, P545, DOI 10.1161/01.RES.0000258460.41160.ef; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Orofino MG, 2006, TRANSPLANTATION, V82, P1529, DOI 10.1097/01.tp.0000235822.46197.61; Ott HC, 2005, EUR J CARDIO-THORAC, V27, P1017, DOI 10.1016/j.ejcts.2005.01.065; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507; Siminiak T, 2004, AM HEART J, V148, P531, DOI 10.1016/j.ahj.2004.03.043; Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017; Suzuki K, 2000, CIRCULATION, V102, P359; Suzuki K, 1997, J CLIN INVEST, V99, P1645, DOI 10.1172/JCI119327; Suzuki K, 2004, CIRCULATION, V110, pII225, DOI 10.1161/01.CIR.0000138191.11580.e3; Suzuki K, 2001, CIRCULATION, V104, pI207; Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8; Yang XP, 1999, AM J PHYSIOL-HEART C, V277, pH1967, DOI 10.1152/ajpheart.1999.277.5.H1967; Zheng ZZ, 2006, MOL MED, V12, P214, DOI 10.2119/2006-00037.Zheng	33	49	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3071	10.1371/journal.pone.0003071	http://dx.doi.org/10.1371/journal.pone.0003071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728781	Green Submitted, gold, Green Published			2022-12-25	WOS:000264796400011
J	Levina, V; Marrangoni, AM; DeMarco, R; Gorelik, E; Lokshin, AE				Levina, Vera; Marrangoni, Adele M.; DeMarco, Richard; Gorelik, Elieser; Lokshin, Anna E.			Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties	PLOS ONE			English	Article								Background: Cancer stem cells (CSCs) are thought to be responsible for tumor regeneration after chemotherapy, although direct confirmation of this remains forthcoming. We therefore investigated whether drug treatment could enrich and maintain CSCs and whether the high tumorogenic and metastatic abilities of CSCs were based on their marked ability to produce growth and angiogenic factors and express their cognate receptors to stimulate tumor cell proliferation and stroma formation. Methodology/Findings: Treatment of lung tumor cells with doxorubicin, cisplatin, or etoposide resulted in the selection of drug surviving cells (DSCs). These cells expressed CD133, CD117, SSEA-3, TRA1-81, Oct-4, and nuclear beta-catenin and lost expression of the differentiation markers cytokeratins 8/18 (CK 8/18). DSCs were able to grow as tumor spheres, maintain self-renewal capacity, and differentiate. Differentiated progenitors lost expression of CD133, gained CK 8/18 and acquired drug sensitivity. In the presence of drugs, differentiation of DSCs was abrogated allowing propagation of cells with CSC-like characteristics. Lung DSCs demonstrated high tumorogenic and metastatic potential following inoculation into SCID mice, which supported their classification as CSCs. Luminex analysis of human and murine cytokines in sonicated lysates of parental- and CSC-derived tumors revealed that CSC-derived tumors contained two- to three-fold higher levels of human angiogenic and growth factors (VEGF, bFGF, IL-6, IL-8, HGF, PDGF-BB, G-CSF, and SCGF-beta). CSCs also showed elevated levels of expression of human VEGFR2, FGFR2, CXCR1, 2 and 4 receptors. Moreover, human CSCs growing in SCID mice stimulated murine stroma to produce elevated levels of angiogenic and growth factors. Conclusions/Significance: These findings suggest that chemotherapy can lead to propagation of CSCs and prevention of their differentiation. The high tumorigenic and metastatic potentials of CSCs are associated with efficient cytokine network production that may represent a target for increased efficacy of cancer therapy.	[Levina, Vera; Marrangoni, Adele M.; DeMarco, Richard; Gorelik, Elieser; Lokshin, Anna E.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA; [Lokshin, Anna E.] Univ Pittsburgh, Inst Canc, Dept Med, Pittsburgh, PA 15260 USA; [Gorelik, Elieser] Univ Pittsburgh, Inst Canc, Dept Pathol, Pittsburgh, PA 15260 USA; [Gorelik, Elieser] Univ Pittsburgh, Inst Canc, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Levina, V (corresponding author), Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA.	levinav@upmc.edu			NIH/NCI [RO1 CA098642, R01 CA108990]; Susan Komen Foundation; Harry Lloyd Charitable Trust; Hillman Foundation; Pennsylvania Department of Health;  [DOD BC051720]; NATIONAL CANCER INSTITUTE [R01CA108990, R01CA098642] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); Harry Lloyd Charitable Trust; Hillman Foundation; Pennsylvania Department of Health; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by grants from RO1 CA098642, R01 CA108990, Avon (NIH/NCI), Susan Komen Foundation (AEL), and DOD BC051720 grant, grants from Harry Lloyd Charitable Trust, Hillman Foundation and Pennsylvania Department of Health (E.G).	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Almeida GM, 2008, INT J CANCER, V122, P1810, DOI 10.1002/ijc.23188; Bar-Eli M, 1999, PATHOBIOLOGY, V67, P12, DOI 10.1159/000028045; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Buccheri G, 2001, LUNG CANCER, V34, pS65, DOI 10.1016/S0169-5002(01)00347-6; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; GABRILOVE JL, 1994, BLOOD, V83, P907; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; GORELIK E, 1982, INT J CANCER, V30, P107, DOI 10.1002/ijc.2910300118; Hassan R, 2006, CLIN CANCER RES, V12, P447, DOI 10.1158/1078-0432.CCR-05-1477; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Kanaji N, 2007, LUNG CANCER, V55, P295, DOI 10.1016/j.lungcan.2006.11.004; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Korkaya H, 2007, BIODRUGS, V21, P299, DOI 10.2165/00063030-200721050-00002; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; LEVINA V, 2008, INT J CANC IN PRESS; Levina V, 2008, EXP CELL RES, V314, P1605, DOI 10.1016/j.yexcr.2007.12.027; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Miedouge M, 1999, BRIT J CANCER, V81, P1059, DOI 10.1038/sj.bjc.6690807; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Morales-Arias J, 2007, CANCER-AM CANCER SOC, V110, P1568, DOI 10.1002/cncr.22964; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roninson IB, 2003, CANCER RES, V63, P2705; Rosen LS, 2001, CANCER J, V7, pS120; Samara RN, 2007, CANCER RES, V67, P4774, DOI 10.1158/0008-5472.CAN-06-4315; Schopperle WM, 2007, STEM CELLS, V25, P723, DOI 10.1634/stemcells.2005-0597; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Strieter RM, 2004, ANN NY ACAD SCI, V1028, P351, DOI 10.1196/annals.1322.041; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Todaro M, 2008, CELL CYCLE, V7, P309, DOI 10.4161/cc.7.3.5389; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zhu ZY, 2001, CANCER RES, V61, P1707	59	343	367	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3077	10.1371/journal.pone.0003077	http://dx.doi.org/10.1371/journal.pone.0003077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728788	Green Accepted, gold, Green Published			2022-12-25	WOS:000264796400017
J	Gilbert, JA; Field, D; Huang, Y; Edwards, R; Li, WZ; Gilna, P; Joint, I				Gilbert, Jack A.; Field, Dawn; Huang, Ying; Edwards, Rob; Li, Weizhong; Gilna, Paul; Joint, Ian			Detection of Large Numbers of Novel Sequences in the Metatranscriptomes of Complex Marine Microbial Communities	PLOS ONE			English	Article							RNA; DNA; PROKARYOTES; EXPRESSION; PROTEIN	Background: Sequencing the expressed genetic information of an ecosystem (metatranscriptome) can provide information about the response of organisms to varying environmental conditions. Until recently, metatranscriptomics has been limited to microarray technology and random cloning methodologies. The application of high-throughput sequencing technology is now enabling access to both known and previously unknown transcripts in natural communities. Methodology/Principal Findings: We present a study of a complex marine metatranscriptome obtained from random whole-community mRNA using the GS-FLX Pyrosequencing technology. Eight samples, four DNA and four mRNA, were processed from two time points in a controlled coastal ocean mesocosm study (Bergen, Norway) involving an induced phytoplankton bloom producing a total of 323,161,989 base pairs. Our study confirms the finding of the first published metatranscriptomic studies of marine and soil environments that metatranscriptomics targets highly expressed sequences which are frequently novel. Our alternative methodology increases the range of experimental options available for conducting such studies and is characterized by an exceptional enrichment of mRNA (99.92%) versus ribosomal RNA. Analysis of corresponding metagenomes confirms much higher levels of assembly in the metatranscriptomic samples and a far higher yield of large gene families with >100 members, similar to 91% of which were novel. Conclusions/Significance: This study provides further evidence that metatranscriptomic studies of natural microbial communities are not only feasible, but when paired with metagenomic data sets, offer an unprecedented opportunity to explore both structure and function of microbial communities-if we can overcome the challenges of elucidating the functions of so many never-seen-before gene families.	[Gilbert, Jack A.; Joint, Ian] Plymouth Marine Lab, Plymouth, Devon, England; [Field, Dawn] CEH Oxford, NERC Ctr Ecol & Hydrol, Oxford, England; [Huang, Ying; Li, Weizhong; Gilna, Paul] Univ Calif San Diego, Calif Inst Telecommun & Informat Technol, La Jolla, CA 92093 USA; [Edwards, Rob] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Edwards, Rob] Argonne Natl Lab, Math & Comp Sci Div, Argonne, IL USA	Plymouth Marine Laboratory; UK Centre for Ecology & Hydrology (UKCEH); University of California System; University of California San Diego; California State University System; San Diego State University; United States Department of Energy (DOE); Argonne National Laboratory	Gilbert, JA (corresponding author), Plymouth Marine Lab, Prospect Pl, Plymouth, Devon, England.	jagi@pml.ac.uk	Gilbert, Jack/AAF-3270-2019; Edwards, Robert/Q-1691-2019; Gilna, Paul/I-3608-2016; Field, Dawn/C-1653-2010; Li, Weizhong/A-9735-2008	Edwards, Robert/0000-0001-8383-8949; Gilna, Paul/0000-0002-6542-0191; Li, Weizhong/0000-0003-1804-9403	Natural Environment Research Council [NE/C507902/1]; Plymouth Marine Laboratory; Biodiversity Program of the Centre for Ecology and Hydrology [Science Budget award]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200400042C]; Gordon and Betty Moore Foundation; NERC [NBAF010002] Funding Source: UKRI; Natural Environment Research Council [NBAF010002, CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Plymouth Marine Laboratory(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biodiversity Program of the Centre for Ecology and Hydrology; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is supported by a grant from the Natural Environment Research Council (NE/C507902/1) and is part of the core research program of the Plymouth Marine Laboratory, a collaborative centre of NERC. Supplementary funds for pyrosequencing were from a Science Budget award from the Biodiversity Program of the Centre for Ecology and Hydrology. The project has been partially funded with US Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN266200400042C. Funding for CAMERA was provided by the Gordon and Betty Moore Foundation. No sponsors or funding agencies were involved in any of the design, or conduct of the study, nor the collection, analysis or interpretation of the data, nor the preparation, review or approval of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Francois P, 2007, J MICROBIOL METH, V68, P385, DOI 10.1016/j.mimet.2006.09.022; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; GILBERT JA, 2008, ENV MI IN PRESS 0720; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Handelsman J., 2007, NEW SCI METAGENOMICS, DOI 10.17226/11902; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Neufeld JD, 2007, ISME J, V1, P480, DOI 10.1038/ismej.2007.65; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Parro V, 2007, ENVIRON MICROBIOL, V9, P453, DOI 10.1111/j.1462-2920.2006.01162.x; Poretsky RS, 2005, APPL ENVIRON MICROB, V71, P4121, DOI 10.1128/AEM.71.7.4121-4126.2005; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sansone SA, 2008, OMICS, V12, P143, DOI 10.1089/omi.2008.0019; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wendisch VF, 2001, ANAL BIOCHEM, V290, P205, DOI 10.1006/abio.2000.4982; Wilson GA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000324; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	24	252	268	2	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3042	10.1371/journal.pone.0003042	http://dx.doi.org/10.1371/journal.pone.0003042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725995	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000264428800008
J	Blais, C; Jack, RE; Scheepers, C; Fiset, D; Caldara, R				Blais, Caroline; Jack, Rachael E.; Scheepers, Christoph; Fiset, Daniel; Caldara, Roberto			Culture Shapes How We Look at Faces	PLOS ONE			English	Article							EYE-MOVEMENTS; ENVIRONMENT; CONTEXT; MEMORY; OWN	Background: Face processing, amongst many basic visual skills, is thought to be invariant across all humans. From as early as 1965, studies of eye movements have consistently revealed a systematic triangular sequence of fixations over the eyes and the mouth, suggesting that faces elicit a universal, biologically-determined information extraction pattern. Methodology/Principal Findings: Here we monitored the eye movements of Western Caucasian and East Asian observers while they learned, recognized, and categorized by race Western Caucasian and East Asian faces. Western Caucasian observers reproduced a scattered triangular pattern of fixations for faces of both races and across tasks. Contrary to intuition, East Asian observers focused more on the central region of the face. Conclusions/Significance: These results demonstrate that face processing can no longer be considered as arising from a universal series of perceptual events. The strategy employed to extract visual information from faces differs across cultures.	[Blais, Caroline; Jack, Rachael E.; Scheepers, Christoph; Fiset, Daniel; Caldara, Roberto] Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland; [Blais, Caroline; Fiset, Daniel] Univ Montreal, Dept Psychol, Montreal, PQ, Canada	University of Glasgow; Universite de Montreal	Blais, C (corresponding author), Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland.	r.caldara@psy.gla.ac.uk	Jack, Rachael/A-4692-2012; Fiset, Daniel/Y-7799-2019; Caldara, Roberto/H-1929-2011	Jack, Rachael/0000-0003-3687-0799; Caldara, Roberto/0000-0002-8260-9949	Economic and Social Research Council and Medical Research Council (ESRC) [RES-060-25-0010, PTA-031-2006-00192]; Fonds Quebecois de Recherche en Nature et Technologies (FQRNT) [PhD studentship, post-doctoral fellowship]; Economic and Social Research Council [ES/E020933/1] Funding Source: researchfish; ESRC [ES/E020933/1] Funding Source: UKRI	Economic and Social Research Council and Medical Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Fonds Quebecois de Recherche en Nature et Technologies (FQRNT)(FQRNT); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was supported by The Economic and Social Research Council and Medical Research Council (ESRC) (RES-060-25-0010). REJ was supported by a PhD studentship awarded by ESRC (PTA-031-2006-00192), CB by a PhD studentship provided by the Fonds Quebecois de Recherche en Nature et Technologies (FQRNT) and DF by a FQRNT post-doctoral fellowship.	Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Argyle M., 1976, GAZE MUTUAL GAZE; Bang S., 2001, ASIAN FACE IMAGE DAT; Caldara R, 2006, PERCEPTION, V35, P659, DOI 10.1068/p5360; Caldara R, 2004, NEUROREPORT, V15, P905, DOI 10.1097/00001756-200404090-00034; Caldara R, 2006, NEUROIMAGE, V31, P313, DOI 10.1016/j.neuroimage.2005.12.011; Chauvin A, 2005, J VISION, V5, P659, DOI 10.1167/5.9.1; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Feingold GA, 1914, J AM INST CRIM LAW C, V5, P39, DOI 10.2307/1133283; Findlay J. M., 2003, ACTIVE VISION PSYCHO; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P191, DOI 10.3758/BF03335056; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P187, DOI 10.3758/BF03335055; Groner R, 1984, THEORETICAL APPL ASP, P523; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; HENDERSON JM, 2001, FRAGMENTS OBJECTS SE, P463, DOI DOI 10.1016/S0166-4115(01)80034-0; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Norenzayan A, 2002, COGNITIVE SCI, V26, P653, DOI 10.1207/s15516709cog2605_4; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Yarbus A.L., 1965, ROLE EYE MOVEMENTS V	30	335	348	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3022	10.1371/journal.pone.0003022	http://dx.doi.org/10.1371/journal.pone.0003022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422IM	18714387	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000264420900044
J	Plessy, C; Fagiolini, M; Wagatsuma, A; Harasawa, N; Kuji, T; Asaka-Oba, A; Kanzaki, Y; Fujishima, S; Waki, K; Nakahara, H; Hensch, TK; Carninci, P				Plessy, Charles; Fagiolini, Michela; Wagatsuma, Akiko; Harasawa, Norihiro; Kuji, Takenobu; Asaka-Oba, Atsuko; Kanzaki, Yukari; Fujishima, Sayaka; Waki, Kazunori; Nakahara, Hiroyuki; Hensch, Takao K.; Carninci, Piero			A Resource for Transcriptomic Analysis in the Mouse Brain	PLOS ONE			English	Article							LENGTH CDNA SEQUENCES; GENE-EXPRESSION; CAP ANALYSIS; GENOME; PARVALBUMIN; NEURONS; INTERNEURONS; COMPLEXITY; CALRETININ; DISCOVERY	Background: The transcriptome of the cerebral cortex is remarkably homogeneous, with variations being stronger between individuals than between areas. It is thought that due to the presence of many distinct cell types, differences within one cell population will be averaged with the noise from others. Studies of sorted cells expressing the same transgene have shown that cell populations can be distinguished according to their transcriptional profile. Methodology: We have prepared a low-redundancy set of 16,209 full-length cDNA clones which represents the transcriptome of the mouse visual cortex in its coding and non-coding aspects. Using an independent tag-based approach, CAGE, we confirmed the cortical expression of 72% of the clones. Clones were amplified by PCR and spotted on glass slides, and we interrogated the microarrays with RNA from flow-sorted fluorescent cells from the cerebral cortex of parvalbumin-egfp transgenic mice. Conclusions: We provide an annotated cDNA clone collection which is particularly suitable for transcriptomic analysis in the mouse brain. Spotting it on microarrays, we compared the transcriptome of EGFP positive and negative cells in a parvalbumin-egfp transgenic background and showed that more than 30% of clones are differentially expressed. Our clone collection will be a useful resource for the study of the transcriptome of single cell types in the cerebral cortex.	[Plessy, Charles; Carninci, Piero] RIKEN, Yokohama Inst, Funct Genom Technol Team, Om Sci Ctr, Kanagawa, Japan; [Fagiolini, Michela; Wagatsuma, Akiko; Kuji, Takenobu; Asaka-Oba, Atsuko; Kanzaki, Yukari; Fujishima, Sayaka; Hensch, Takao K.] RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, Wako, Saitama, Japan; [Harasawa, Norihiro; Nakahara, Hiroyuki] RIKEN, Brain Sci Inst, Lab Integrated Theoretical Neurosci, Wako, Saitama, Japan; [Waki, Kazunori] RIKEN, Wako Inst, Discovery & Res Inst, Genome Sci Lab, Wako, Saitama, Japan	RIKEN; RIKEN; RIKEN; RIKEN	Plessy, C (corresponding author), RIKEN, Yokohama Inst, Funct Genom Technol Team, Om Sci Ctr, Kanagawa, Japan.	hensch@riken.jp; carninci@riken.jp	Hensch, Takao/L-4182-2019; Plessy, Charles/N-5054-2015; Carninci, Piero/K-1568-2014; Nakahara, Hiroyuki/N-5411-2015; Waki, Kazunori/T-6444-2019	Plessy, Charles/0000-0001-7410-6295; Carninci, Piero/0000-0001-7202-7243; Nakahara, Hiroyuki/0000-0001-6891-1175; fagiolini, michela/0000-0003-2807-803X; Waki, Kazunori/0000-0001-7311-7208	6th Framework of the EU commission to the NFG consortium; RIKEN; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [Grant-in-Aid, 18020034]; Japanese Society for the Promotion of Science (JSPS) [P05880, 17680029]	6th Framework of the EU commission to the NFG consortium; RIKEN; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant of the 6th Framework of the EU commission to the NFG consortium (to PC), a RIKEN presidential grant for collaborative research (to PC and TKH), a Grant-in-Aid for Scientific Research on Priority Areas - Integrative Brain Research - from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to TKH), a Japanese Society for the Promotion of Science (JSPS) grant. CP was supported by a fellowship from the JSPS (number P05880). HN is supported by Grant-in-Aids on Priority Area Research (C) from MEXT (number 18020034), and for Young Scientists (A) from JSPS, Japan (number 17680029).	Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Burke J, 1998, GENOME RES, V8, P276, DOI 10.1101/gr.8.3.276; Burke J, 1999, GENOME RES, V9, P1135, DOI 10.1101/gr.9.11.1135; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Forrest ARR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r5; Fukunishi Y, 2001, PHYSIOL GENOMICS, V5, P81, DOI 10.1152/physiolgenomics.2001.5.2.81; GUIGO R, 1992, J MOL BIOL, V226, P141, DOI 10.1016/0022-2836(92)90130-C; Gustincich S, 2003, GENOME RES, V13, P1395, DOI 10.1101/gr.1135303; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hirozane-Kishikawa T, 2003, BIOTECHNIQUES, V35, P510, DOI 10.2144/03353st04; Hof PR, 1999, J CHEM NEUROANAT, V16, P77, DOI 10.1016/S0891-0618(98)00065-9; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Meyer AH, 2002, J NEUROSCI, V22, P7055; Miller RT, 1999, GENOME RES, V9, P1143, DOI 10.1101/gr.9.11.1143; Nelson SB, 2006, CURR OPIN NEUROBIOL, V16, P571, DOI 10.1016/j.conb.2006.08.006; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pearson WR, 1998, J MOL BIOL, V276, P71, DOI 10.1006/jmbi.1997.1525; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; R Development Core Team, 2007, R LANG ENV STAT COMP; Shibata K, 2000, GENOME RES, V10, P1757, DOI 10.1101/gr.152600; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Xiang CC, 2002, NAT BIOTECHNOL, V20, P738, DOI 10.1038/nb0702-738; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yuste R, 2005, NEURON, V48, P524, DOI 10.1016/j.neuron.2005.11.012	41	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3012	10.1371/journal.pone.0003012	http://dx.doi.org/10.1371/journal.pone.0003012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714383	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900037
J	Cohen, CD; Lindenmeyer, MT; Eichinger, F; Hahn, A; Seifert, M; Moll, AG; Schmid, H; Kiss, E; Grone, E; Grone, HJ; Kretzler, M; Werner, T; Nelson, PJ				Cohen, Clemens D.; Lindenmeyer, Maja T.; Eichinger, Felix; Hahn, Alexander; Seifert, Martin; Moll, Anton G.; Schmid, Holger; Kiss, Eva; Groene, Elisabeth; Groene, Hermann-Josef; Kretzler, Matthias; Werner, Thomas; Nelson, Peter J.			Improved Elucidation of Biological Processes Linked to Diabetic Nephropathy by Single Probe-Based Microarray Data Analysis	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS	Background: Diabetic nephropathy (DN) is a complex and chronic metabolic disease that evolves into a progressive fibrosing renal disorder. Effective transcriptomic profiling of slowly evolving disease processes such as DN can be problematic. The changes that occur are often subtle and can escape detection by conventional oligonucleotide DNA array analyses. Methodology/Principal Findings: We examined microdissected human renal tissue with or without DN using Affymetrix oligonucleotide microarrays (HG-U133A) by standard Robust Multi-array Analysis (RMA). Subsequent gene ontology analysis by Database for Annotation, Visualization and Integrated Discovery (DAVID) showed limited detection of biological processes previously identified as central mechanisms in the development of DN ( e. g. inflammation and angiogenesis). This apparent lack of sensitivity may be associated with the gene-oriented averaging of oligonucleotide probe signals, as this includes signals from cross-hybridizing probes and gene annotation that is based on out of date genomic data. We then examined the same CEL file data using a different methodology to determine how well it could correlate transcriptomic data with observed biology. ChipInspector (CI) is based on single probe analysis and de novo gene annotation that bypasses probe set definitions. Both methods, RMA and CI, used at default settings yielded comparable numbers of differentially regulated genes. However, when verified by RT-PCR, the single probe based analysis demonstrated reduced background noise with enhanced sensitivity and fewer false positives. Conclusions/Significance: Using a single probe based analysis approach with de novo gene annotation allowed an improved representation of the biological processes linked to the development and progression of DN. The improved analysis was exemplified by the detection of Wnt signaling pathway activation in DN, a process not previously reported to be involved in this disease.	Univ Hosp, Ctr Integrat Human Physiol, Nephrol Clin, Zurich, Switzerland; Univ Hosp, Ctr Integrat Human Physiol, Inst Physiol, Zurich, Switzerland; Univ Zurich, Zurich, Switzerland; Univ Munich, Med Policlin, Clin Biochem Grp, D-80539 Munich, Germany; Univ Michigan, Dept Med, Div Nephrol, Ann Arbor, MI 48109 USA; Genomatix Software GmbH, Munich, Germany; German Canc Res Ctr, Cellular & Mol Pathol, Heidelberg, Germany; [Cohen, Clemens D.] Univ Hosp & Univ, Ctr Integrat Human Physiol, Inst Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University of Munich; University of Michigan System; University of Michigan; Helmholtz Association; German Cancer Research Center (DKFZ); University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Cohen, CD (corresponding author), Univ Hosp, Ctr Integrat Human Physiol, Nephrol Clin, Zurich, Switzerland.	peter.nelson@med.uni-muenchen.de	Seifert, Martin/GSE-3648-2022	Lindenmeyer, Maja/0000-0003-4162-9107; , Eva/0000-0003-4052-2797	Else Kroner-Fresenius Foundation; DFG [SFB 571]; BMBF Biochance [0313724A]; F6 EU INNOCHEM	Else Kroner-Fresenius Foundation; DFG(German Research Foundation (DFG)); BMBF Biochance(Federal Ministry of Education & Research (BMBF)); F6 EU INNOCHEM	The work was supported by the Else Kroner-Fresenius Foundation to CDC, DFG funding from SFB 571 to PJN and CDC, and BMBF Biochance grant 0313724A to TW, PJN and HJG and F6 EU INNOCHEM to PJN and HJG.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Breyer MD, 2005, ADV CHRONIC KIDNEY D, V12, P128, DOI 10.1053/j.ackd.2005.01.004; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elo LL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni193; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Henger A, 2004, KIDNEY INT, V65, P904, DOI 10.1111/j.1523-1755.2004.00499.x; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lindenmeyer MT, 2007, J AM SOC NEPHROL, V18, P1765, DOI 10.1681/ASN.2006121304; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-108; McLennan SV, 2007, KIDNEY INT, V72, P481, DOI 10.1038/sj.ki.5002357; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448; Ruster C, 2008, FRONT BIOSCI-LANDMRK, V13, P944, DOI 10.2741/2734; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	27	66	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2937	10.1371/journal.pone.0002937	http://dx.doi.org/10.1371/journal.pone.0002937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698414	Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600023
J	Lee, WC; Reniere, ML; Skaar, EP; Murphy, MEP				Lee, Woo Cheol; Reniere, Michelle L.; Skaar, Eric P.; Murphy, Michael E. P.			Ruffling of Metalloporphyrins Bound to IsdG and IsdI, Two Heme-degrading Enzymes in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS; CRYSTAL-STRUCTURES; IRON; OXYGENASE; BINDING; PROTEIN; METABOLISM; MECHANISM; PROGRAM	IsdG and IsdI are paralogous proteins that are intracellular components of a complex heme uptake system in Staphylococcus aureus. IsdG and IsdI were shown previously to reductively degrade hemin. Crystal structures of the apoproteins show that these proteins belong to a newly identified heme degradation family distinct from canonical eukaryotic and prokaryotic heme oxygenases. Here we report the crystal structures of an inactive N7A variant of IsdG in complex with Fe3+ -protoporphyrin IX (IsdG-hemin) and of IsdI in complex with cobalt protoporphyrin IX (IsdI-CoPPIX) to 1.8 angstrom or better resolution. These structures show that the metalloporphyrins are buried into similar deep clefts such that the propionic acids form salt bridges to two Arg residues. His(77) (IsdG) or His(76) (IsdI), a critical residue required for activity, is coordinated to the Fe3+ or Co3+ atoms, respectively. The bound porphyrin rings form extensive steric interactions in the binding cleft such that the rings are highly distorted from the plane. This distortion is best described as ruffled and places the beta- and delta-meso carbons proximal to the distal oxygen-binding site. In the IsdG-hemin structure, Fe3+ is pentacoordinate, and the distal side is occluded by the side chain of Ile(55). However, in the structure of IsdI-CoPPIX, the distal side of the CoPPIX accommodates a chloride ion in a cavity formed through a conformational change in Ile(55). The chloride ion participates in a hydrogen bond to the side chain amide of Asn(6). Together the structures suggest a reaction mechanism in which a reactive peroxide intermediate proceeds with nucleophilic oxidation at the beta- or delta- meso carbon of the hemin.	[Lee, Woo Cheol; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Reniere, Michelle L.; Skaar, Eric P.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA	University of British Columbia; Vanderbilt University	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada.	Michael.Murphy@ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Reniere, Michelle/0000-0002-0770-7784	National Institutes of Health [Al69233, 5 T32 HL07751]; Canadian Institutes of Health Research Operating [MOP-49597]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Operating(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant Al69233 (USPHS from NIAID) (to E. P. S.) and Grant 5 T32 HL07751 (training grant) (to M. L. R.). This work was also supported by Canadian Institutes of Health Research Operating Grant MOP-49597 (to M. E. P. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bozja J, 2004, INT J ANTIMICROB AG, V24, P578, DOI 10.1016/j.ijantimicag.2004.06.008; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brucker EA, 1996, J BIOL CHEM, V271, P25419, DOI 10.1074/jbc.271.41.25419; Chan ACK, 2006, J MOL BIOL, V362, P1108, DOI 10.1016/j.jmb.2006.08.001; *COLL COMP PROJ 4, 1995, ACTA CRYSTALLOGR D, V50, P760; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Friedman J, 2003, J BIOL CHEM, V278, P34654, DOI 10.1074/jbc.M302985200; Friedman J, 2007, J BIOL CHEM, V282, P1066, DOI 10.1074/jbc.M609112200; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Jentzen W, 1998, BIOPHYS J, V74, P753, DOI 10.1016/S0006-3495(98)74000-7; Jentzen W, 1997, J PHYS CHEM B, V101, P1684, DOI 10.1021/jp963142h; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Ma JG, 1998, BIOCHEMISTRY-US, V37, P12431, DOI 10.1021/bi981189i; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murphy ER, 2002, INFECT IMMUN, V70, P5390, DOI 10.1128/IAI.70.10.5390-5403.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Puri S, 2006, J BACTERIOL, V188, P6476, DOI 10.1128/JB.00737-06; Radtke AL, 2006, CELL MICROBIOL, V8, P1720, DOI 10.1111/j.1462-5822.2006.00795.x; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Shokhireva TK, 2003, P NATL ACAD SCI USA, V100, P3778, DOI 10.1073/pnas.0536641100; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; Stojiljkovic I, 1999, MOL MICROBIOL, V31, P429, DOI 10.1046/j.1365-2958.1999.01175.x; Suits MDL, 2006, J BIOL CHEM, V281, P36776, DOI 10.1074/jbc.M607684200; Unno M, 2004, J BIOL CHEM, V279, P21055, DOI 10.1074/jbc.M400491200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Weems JJ, 2001, POSTGRAD MED, V110, P24, DOI 10.3810/pgm.2001.10.1042; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; WILKS A, 1993, J BIOL CHEM, V268, P22357; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; Zeller John L, 2007, JAMA, V298, P1826, DOI 10.1001/jama.298.15.1826	48	89	92	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30957	30963		10.1074/jbc.M709486200	http://dx.doi.org/10.1074/jbc.M709486200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18713745	Green Published, hybrid			2022-12-25	WOS:000260544800050
J	Sandoval, FJ; Zhang, Y; Roje, S				Sandoval, Francisco J.; Zhang, Yi; Roje, Sanja			Flavin Nucleotide Metabolism in Plants MONOFUNCTIONAL ENZYMES SYNTHESIZE FAD IN PLASTIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE SYNTHETASE; SACCHAROMYCES-CEREVISIAE MITOCHONDRIA; RIBOFLAVIN KINASE REVEALS; WEIGHT ACID-PHOSPHATASE; RAT-LIVER MITOCHONDRIA; PARTIAL-PURIFICATION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES; SUBSTRATE-SPECIFICITY	FAD synthetases (EC 2.7.7.2) catalyze biosynthesis of FAD from FMN and ATP. Monofunctional FAD synthetases are known to exist in mammals and yeast; bifunctional enzymes also catalyzing phosphorylation of riboflavin to FMN are known to exist in bacteria. Previously known eukaryotic enzymes with FAD synthetase activity have no sequence similarity to prokaryotic enzymes with riboflavin kinase and FAD synthetase activities. Proteins homologous to bacterial bifunctional FAD synthetases, yet shorter and lacking amino acid motifs at the C terminus, were found by bioinformatic analyses in vascular plant genomes, suggesting that plants contain a type of FAD synthetase previously known to exist only in prokaryotes. The Arabidopsis thaliana genome encodes two of such proteins. Both proteins, which we named AtRibF1 and AtRibF2, carry N-terminal extensions with characteristics of organellar targeting peptides. AtRibF1 and AtRibF2 cDNAs were cloned by reverse transcription-PCR. Only FAD synthetase activity was detected in the recombinant enzymes produced in Escherichia coli. FMN and ATP inhibited both enzymes. Kinetic parameters of AtRibF1 and AtRibF2 for the two substrates were similar. Confocal microscopy of protoplasts transformed with enhanced green fluorescence protein-fused proteins showed that AtRibF1 and AtRibF2 are targeted to plastids. In agreement with subcellular localization to plastids, Percoll-isolated chloroplasts from pea (Pisum sativum) synthesized FAD from imported riboflavin. Riboflavin kinase, FMN hydrolase, and FAD pyrophosphatase activities were detected in Percoll-isolated chloroplasts and mitochondria from pea. We propose from these new findings a model for subcellular distribution of enzymes that synthesize and hydrolyze flavin nucleotides in plants.	[Sandoval, Francisco J.; Roje, Sanja] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Zhang, Yi; Roje, Sanja] Washington State Univ, Grad Program Mol Plant Sci, Pullman, WA 99164 USA	Washington State University; Washington State University	Roje, S (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	sanja@wsu.edu		Roje, Sanja/0000-0002-6302-5382; Zhang, Yi/0000-0002-1566-098X	United States Department of Agriculture National Research Initiative [2007-03559]; Murdoch Foundation	United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); Murdoch Foundation	This work was supported by United States Department of Agriculture National Research Initiative Grant 2007-03559 (to S. R.) and the Murdoch Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	[Anonymous], 2005, PHYLIP PHYLOGENY INF; ARNON DI, 1949, PLANT PHYSIOL, V24, P15; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; BALAKRISHNAN CV, 1977, EUR J BIOCHEM, V78, P95, DOI 10.1111/j.1432-1033.1977.tb11717.x; Barile M, 1997, EUR J BIOCHEM, V249, P777, DOI 10.1111/j.1432-1033.1997.00777.x; BARILE M, 1993, ARCH BIOCHEM BIOPHYS, V305, P442, DOI 10.1006/abbi.1993.1444; Barile M, 2000, EUR J BIOCHEM, V267, P4888, DOI 10.1046/j.1432-1327.2000.01552.x; Bauer S, 2003, J MOL BIOL, V326, P1463, DOI 10.1016/S0022-2836(03)00059-7; BOWERSKOMRO DM, 1989, BIOCHEMISTRY-US, V28, P8439, DOI 10.1021/bi00447a025; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brizio C, 2006, BIOCHEM BIOPH RES CO, V344, P1008, DOI 10.1016/j.bbrc.2006.04.003; BYRD JC, 1985, J BIOL CHEM, V260, P7474; Clarebout G, 2001, ANTIMICROB AGENTS CH, V45, P2280, DOI 10.1128/AAC.45.8.2280-2286.2001; CLINE K, 1986, J BIOL CHEM, V261, P4804; DELUCA C, 1958, BIOCHIM BIOPHYS ACTA, V30, P6, DOI 10.1016/0006-3002(58)90233-6; DOUCE R, 1987, METHOD ENZYMOL, V148, P403; Efimov I, 1998, BIOCHEMISTRY-US, V37, P9716, DOI 10.1021/bi972817j; Fischer M, 2006, PHYSIOL PLANTARUM, V126, P304, DOI 10.1111/j.1399-3054.2006.00607.x; Fischer M, 2004, J BIOL CHEM, V279, P36299, DOI 10.1074/jbc.M404406200; FUCHS KR, 1992, BIOCHEM BIOPH RES CO, V189, P1598, DOI 10.1016/0006-291X(92)90259-N; Galluccio M, 2007, PROTEIN EXPRES PURIF, V52, P175, DOI 10.1016/j.pep.2006.09.002; Garcia NAT, 2004, PLANT PHYSIOL BIOCH, V42, P585, DOI 10.1016/j.plaphy.2004.04.004; GIRI KV, 1957, NATURE, V179, P1134, DOI 10.1038/1791134b0; GIRI KV, 1960, BIOCHEM J, V75, P381, DOI 10.1042/bj0750381; Granjeiro JM, 1997, BIOCHEM MOL BIOL INT, V41, P1201; Herz S, 2000, PHYTOCHEMISTRY, V53, P723, DOI 10.1016/S0031-9422(00)00013-3; Jordan DB, 1999, J BIOL CHEM, V274, P22114, DOI 10.1074/jbc.274.31.22114; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karthikeyan S, 2003, BIOCHEMISTRY-US, V42, P12532, DOI 10.1021/bi035450t; Karthikeyan S, 2003, STRUCTURE, V11, P265, DOI 10.1016/S0969-2126(03)00024-8; KEARNEY EB, 1979, J BIOL CHEM, V254, P9551; KORNBERG A, 1950, J BIOL CHEM, V186, P763; KUMAR SA, 1965, ARCH BIOCHEM BIOPHYS, V111, P646, DOI 10.1016/0003-9861(65)90246-8; LEE RSF, 1988, J BIOL CHEM, V263, P14878; Mack M, 1998, J BACTERIOL, V180, P950, DOI 10.1128/JB.180.4.950-955.1998; MANSTEIN DJ, 1986, J BIOL CHEM, V261, P6169; Mayhew S G, 1980, Methods Enzymol, V66, P323; MERRILL AH, 1980, J BIOL CHEM, V255, P1335; Meyer S. L., 1975, DATA ANAL SCI ENG, P39; MITSUDA H, 1970, J VITAMINOL, V16, P52, DOI 10.5925/jnsv1954.16.52; MITSUDA H, 1965, J VITAMINOL, V11, P20, DOI 10.5925/jnsv1954.11.20; MITSUDA H, 1970, J VITAMINOL, V16, P31; NAKANO H, 1991, J BIOL CHEM, V266, P22125; OKA M, 1987, J BIOL CHEM, V262, P7418; Pallotta ML, 1998, FEBS LETT, V428, P245, DOI 10.1016/S0014-5793(98)00544-4; Quinlivan EP, 2003, J BIOL CHEM, V278, P20731, DOI 10.1074/jbc.M302894200; RAVINDRANATH SD, 1969, ARCH BIOCHEM BIOPHYS, V133, P54, DOI 10.1016/0003-9861(69)90487-1; Roje S, 2002, J BIOL CHEM, V277, P42748, DOI 10.1074/jbc.M205632200; SADASIVAM S, 1966, ENZYMOLOGIA, V31, P203; Sandoval FJ, 2005, J BIOL CHEM, V280, P38337, DOI 10.1074/jbc.M500350200; Santos MA, 2000, J BIOL CHEM, V275, P28618, DOI 10.1074/jbc.M004621200; SENSABAUGH GF, 1978, AM J HUM GENET, V30, P553; SHIN H, 1988, ARCH BIOCHEM BIOPHYS, V267, P95, DOI 10.1016/0003-9861(88)90012-4; SOBHANADITYA J, 1981, BIOCHEM J, V197, P227, DOI 10.1042/bj1970227; Solovieva IM, 1999, MICROBIOL-SGM, V145, P67, DOI 10.1099/13500872-145-1-67; TAGA EM, 1982, ARCH BIOCHEM BIOPHYS, V214, P505, DOI 10.1016/0003-9861(82)90054-6; WIRTZ W, 1980, PLANT PHYSIOL, V66, P187, DOI 10.1104/pp.66.1.187; WU M, 1995, MOL CELL BIOL, V15, P264, DOI 10.1128/MCB.15.1.264; YAMADA Y, 1990, ARCH BIOCHEM BIOPHYS, V278, P125, DOI 10.1016/0003-9861(90)90240-Y; ZHANG ZY, 1990, ARCH BIOCHEM BIOPHYS, V282, P39, DOI 10.1016/0003-9861(90)90084-C; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	61	56	61	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30890	30900		10.1074/jbc.M803416200	http://dx.doi.org/10.1074/jbc.M803416200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18713732	hybrid, Green Published			2022-12-25	WOS:000260544800044
J	Tiao, JY; Bradaia, A; Biermann, B; Kaupmann, K; Metz, M; Haller, C; Rolink, AG; Pless, E; Barlow, PN; Gassmann, M; Bettler, B				Tiao, Jim Y.; Bradaia, Amyaouch; Biermann, Barbara; Kaupmann, Klemens; Metz, Michaela; Haller, Corinne; Rolink, Antonius G.; Pless, Elin; Barlow, Paul N.; Gassmann, Martin; Bettler, Bernhard			The Sushi Domains of Secreted GABA(B1) Isoforms Selectively Impair GABA(B) Heteroreceptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC-ACID RECEPTOR; PRESYNAPTIC INHIBITION; SENSORY NEURONS; RAT-BRAIN; PROTEIN; EXPRESSION; CELLS; MICE; TRANSMISSION; MODULATION	GABA(B) receptors are the G-protein-coupled receptors for gamma-aminobutyric acid (GAB(A)), the main inhibitory neurotransmitter in the brain. GABA(B) receptors are promising drug targets for a wide spectrum of psychiatric and neurological disorders. Receptor subtypes exhibit no pharmacological differences and are based on the subunit isoforms GABA(B1a) and GABA(B1b). GABA(B1a) differs from GABA(B1b) in its ectodomain by the presence of a pair of conserved protein binding motifs, the sushi domains (SDs). Previous work showed that selectively GABA(B1a) contributes to heteroreceptors at glutamatergic terminals, whereas both GABA(B1a) and GABA(B1b) contribute to autoreceptors at GABAergic terminals or to postsynaptic receptors. Here, we describe GABA(B1j), a secreted GABA(B1) isoform comprising the two SDs. We show that the two SDs, when expressed as a soluble protein, bind to neuronal membranes with low nanomolar affinity. Soluble SD protein, when added at nanomolar concentrations to dissociated hippocampal neurons or to acute hippocampal slices, impairs the inhibitory effect of GABA(B) heteroreceptors on evoked and spontaneous glutamate release. In contrast, soluble SD protein neither impairs the activity of GABA(B) autoreceptors nor impairs the activity of postsynaptic GABA(B) receptors. We propose that soluble SD protein scavenges an extracellular binding partner that retains GABA(B1a)-containing heteroreceptors in proximity of the presynaptic release machinery. Soluble GABA(B1) isoforms like GABAB(1j) may therefore act as dominant-negative inhibitors of heteroreceptors and control the level of GABA(B)-mediated inhibition at glutamatergic terminals. Of importance for drug discovery, our data also demonstrate that it is possible to selectively impair GABA(B) heteroreceptors by targeting their SDs.	[Tiao, Jim Y.; Bradaia, Amyaouch; Biermann, Barbara; Metz, Michaela; Haller, Corinne; Gassmann, Martin; Bettler, Bernhard] Univ Basel, Dept Biomed, Pharmazentrum, Inst Physiol, CH-4056 Basel, Switzerland; [Kaupmann, Klemens] Novartis Pharma AG, Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Rolink, Antonius G.] Univ Basel, Dept Biomed Dev & Mol Immunol, CH-4058 Basel, Switzerland; [Pless, Elin; Barlow, Paul N.] Univ Edinburgh, Edinburgh Biomol NMR Unit, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Basel; Novartis; University of Basel; University of Edinburgh	Bettler, B (corresponding author), Univ Basel, Dept Biomed, Pharmazentrum, Inst Physiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	bernhard.bettler@unibas.ch	bettler, bernhard/AAO-8018-2020; Barlow, Paul N/G-2853-2011	Tiao, Jim/0000-0001-6692-9697; Kaupmann, Klemens/0000-0001-8903-2508; BRADAIA, Amyaouch/0000-0001-9664-4641; Bettler, Bernhard/0000-0003-0842-8207	European Community's Seventh Framework Programme [FP7/2007-2013]; Swiss Science Foundation [3100-067100.01]; Novartis Pharma AG;  [201714]	European Community's Seventh Framework Programme; Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Novartis Pharma AG; 	This work was supported by a grant from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 201714. This study was also supported by the Swiss Science Foundation (Grant 3100-067100.01) and a grant from Novartis Pharma AG.	Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bischoff S, 1999, J COMP NEUROL, V412, P1; Blein S, 2004, J BIOL CHEM, V279, P48292, DOI 10.1074/jbc.M406540200; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Bulanova E, 2007, J BIOL CHEM, V282, P13167, DOI 10.1074/jbc.M610036200; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; DUNLAP K, 1981, BRIT J PHARMACOL, V74, P579, DOI 10.1111/j.1476-5381.1981.tb10467.x; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Froestl W, 2004, BIOCHEM PHARMACOL, V68, P1479, DOI 10.1016/j.bcp.2004.07.030; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Goslin K., 1998, CULTURING NERVE CELL, P339; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Hawrot E, 1998, FEBS LETT, V432, P103, DOI 10.1016/S0014-5793(98)00794-7; Holter J, 2005, J MOL NEUROSCI, V26, P99, DOI 10.1385/JMN:26:1:099; Jarolimek W, 1997, J NEUROSCI, V17, P1025; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Lei SB, 2003, J PHYSIOL-LONDON, V546, P439, DOI 10.1113/jphysiol.2002.034017; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; Pagano A, 2001, J NEUROSCI, V21, P1189; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; Steiger JL, 2004, J NEUROSCI, V24, P6115, DOI 10.1523/JNEUROSCI.1200-04.2004; Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Wei KR, 2001, MOL BRAIN RES, V89, P103, DOI 10.1016/S0169-328X(01)00068-7; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4	39	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31005	31011		10.1074/jbc.M804464200	http://dx.doi.org/10.1074/jbc.M804464200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18765663	Green Published, hybrid			2022-12-25	WOS:000260544800055
J	Doni, A; Mantovani, G; Porta, C; Tuckermann, J; Reichardt, HM; Kleiman, A; Sironi, M; Rubino, L; Pasqualini, F; Nebuloni, M; Signorini, S; Peri, G; Sica, A; Beck-Peccoz, P; Bottazzi, B; Mantovani, A				Doni, Andrea; Mantovani, Giovanna; Porta, Chiara; Tuckermann, Jan; Reichardt, Holger M.; Kleiman, Anna; Sironi, Marina; Rubino, Luca; Pasqualini, Fabio; Nebuloni, Manuela; Signorini, Stefano; Peri, Giuseppe; Sica, Antonio; Beck-Peccoz, Paolo; Bottazzi, Barbara; Mantovani, Alberto			Cell-specific Regulation of PTX3 by Glucocorticoid Hormones in Hematopoietic and Nonhematopoietic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG PENTRAXIN PTX3; C-REACTIVE PROTEIN; ACUTE MYOCARDIAL-INFARCTION; RECOGNITION RECEPTOR PTX3; HUMORAL INNATE IMMUNITY; PITUITARY-ADRENAL AXIS; ACUTE PHASE PROTEINS; AMYLOID-P COMPONENT; DENDRITIC CELLS; FEMALE FERTILITY	PTX3 (prototypic long pentraxin 3) is a fluid phase pattern recognition receptor, which plays nonredundant roles in the resistance against diverse pathogens, in the assembly of a hyaluronic acid-rich extracellular matrix, and in female fertility. Inflammatory signals induce production of PTX3 in diverse cell types, including myeloid dendritic cells(DC), fibroblasts, and endothelial cells(EC). The present study was designed to explore the effect of glucocorticoid hormones (GC) on PTX3 production in different cellular contexts. In myeloid DC, GC inhibited the PTX3 production. In contrast, in fibroblasts and EC, GC alone induced and, under inflammatory conditions, enhanced and extended PTX3 production. In vivo administration of GC augmented the blood levels of PTX3 in mice and humans. Moreover, patients with Cushing syndrome had increased levels of circulating PTX3, whereas PTX3 levels were decreased in subjects affected by iatrogenic hypocortisolism. In nonhematopoietic cells, GC receptor (GR) functioned as a ligand-dependent transcription factor (dimerization-dependent) to induce PTX3 gene expression. In contrast, in hematopoietic cells, GR repressed PTX3 gene transcription by interfering (dimerization-independent) with the action of other signaling pathways, probably NF kappa B and AP-1. Thus, divergent effects of GC were found to be due to different GR mechanisms. The results presented here indicate that GC have divergent effects on PTX3 production in hematopoietic (DC and macrophages) and nonhematopoietic (fibroblasts and EC) cells. The divergent effects of GC on PTX3 production probably reflect the different functions of this multifunctional molecule in innate immunity and in the construction of the extracellular matrix.	[Doni, Andrea; Porta, Chiara; Sironi, Marina; Rubino, Luca; Pasqualini, Fabio; Peri, Giuseppe; Sica, Antonio; Bottazzi, Barbara; Mantovani, Alberto] IRCCS, Ist Clin Humanitas, Dept Immunol & Inflammat, I-20089 Milan, Italy; [Mantovani, Giovanna; Beck-Peccoz, Paolo] Univ Milan, IRCCS, Fdn Policlin, Endocrine Unit,Dept Med Sci, Milan, Italy; [Tuckermann, Jan; Kleiman, Anna] Leibniz Inst Age Res Fritz Lipmann, Jena, Germany; [Reichardt, Holger M.] Univ Goettingen, Dept Cellular & Mol Immunol, Gottingen, Germany; [Signorini, Stefano] Hosp Desio, Dept Lab Med, Milan, Italy; [Nebuloni, Manuela] Univ Milan, Luigi Sacco Dept Clin Sci, Pathol Unit, Milan, Italy; [Mantovani, Alberto] Univ Milan, Inst Gen Pathol, Milan, Italy	IRCCS Humanitas Research Hospital; University of Milan; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Gottingen; University of Milan; Luigi Sacco Hospital; University of Milan	Mantovani, A (corresponding author), IRCCS, Ist Clin Humanitas, Dept Immunol & Inflammat, Via Manzoni 56, I-20089 Milan, Italy.	alberto.mantovani@humanitas.it	Mantovani, Alberto/HCI-7449-2022; Sica, Antonio/AAB-9546-2020; Reichardt, Holger/AAF-3048-2020; bottazzi, barbara/ABH-9274-2020; Pasqualini, Fabio/G-5610-2018; sironi, marina/AAB-5757-2020; NEBULONI, MANUELA/L-3969-2017; Mantovani, Giovanna/A-2378-2014	Mantovani, Alberto/0000-0001-5578-236X; Reichardt, Holger/0000-0003-4647-057X; bottazzi, barbara/0000-0002-1930-9257; Pasqualini, Fabio/0000-0003-4852-3794; sironi, marina/0000-0002-3342-1149; NEBULONI, MANUELA/0000-0002-2773-734X; PORTA, Chiara/0000-0002-7183-5561; Doni, Andrea/0000-0001-9203-5814; Mantovani, Giovanna/0000-0002-9065-3886	Associazione Italiana per la Ricerca sul Cancro; Ministero Istruzione, Universita e Ricerca; European Commission Mugen [005203]; Muvapred [503240]; DC-Thera [512074]	Associazione Italiana per la Ricerca sul Cancro; Ministero Istruzione, Universita e Ricerca(Fondazione AIRC per la ricerca sul cancro); European Commission Mugen(European CommissionEuropean Commission Joint Research Centre); Muvapred; DC-Thera	This work was supported by Associazione Italiana per la Ricerca sul Cancro; Ministero Istruzione, Universita e Ricerca; and European Commission Mugen Grant 005203, Muvapred Grant 503240, and DC-Thera Grant 512074. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; ALLES VV, 1994, BLOOD, V84, P3483; ALTMEYER A, 1995, J BIOL CHEM, V270, P25584, DOI 10.1074/jbc.270.43.25584; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Baruah P, 2006, BLOOD, V107, P151, DOI 10.1182/blood-2005-03-1112; Baruah P, 2006, J LEUKOCYTE BIOL, V80, P87, DOI 10.1189/jlb.0805445; Basile A, 1997, J BIOL CHEM, V272, P8172, DOI 10.1074/jbc.272.13.8172; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Bottazzi B, 2006, CURR OPIN IMMUNOL, V18, P10, DOI 10.1016/j.coi.2005.11.009; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2006, J LEUKOCYTE BIOL, V79, P909, DOI 10.1189/jlb.1005557; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Dias AAM, 2001, J LEUKOCYTE BIOL, V69, P928; Diniz SN, 2004, J LEUKOCYTE BIOL, V75, P649, DOI 10.1189/jlb.0803371; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; Doni A, 2006, J LEUKOCYTE BIOL, V79, P797, DOI 10.1189/jlb.0905493; Du Clos TW, 2004, IMMUNOL RES, V30, P261, DOI 10.1385/IR:30:3:261; Duan HO, 2006, J BIOL CHEM, V281, P12451, DOI 10.1074/jbc.M600294200; Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Herr I, 2007, APOPTOSIS, V12, P271, DOI 10.1007/s10495-006-0624-5; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Kim SW, 2004, MOL ENDOCRINOL, V18, P2924, DOI 10.1210/me.2004-0255; KURODA M, 1995, AM J PATHOL, V147, P1221; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; LEE GW, 1993, J IMMUNOL, V150, P1804; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Napoleone E, 1997, BLOOD, V89, P541, DOI 10.1182/blood.V89.2.541; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2004, CURR PHARM DESIGN, V10, P2797, DOI 10.2174/1381612043383575; Rovere P, 2000, BLOOD, V96, P4300; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Silverstein R, 2003, J LEUKOCYTE BIOL, V73, P417, DOI 10.1189/jlb.0702379; Souza DG, 2002, AM J PATHOL, V160, P1755, DOI 10.1016/S0002-9440(10)61122-4; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Thorn CF, 2003, EUR J IMMUNOL, V33, P2630, DOI 10.1002/eji.200323985; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; Vizzardelli C, 2006, EUR J IMMUNOL, V36, P1504, DOI 10.1002/eji.200535488; Webster JI, 2004, J ENDOCRINOL, V181, P207, DOI 10.1677/joe.0.1810207; Willeke F, 2006, EUR J CANCER, V42, P2639, DOI 10.1016/j.ejca.2006.05.035	57	69	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29983	29992		10.1074/jbc.M805631200	http://dx.doi.org/10.1074/jbc.M805631200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18703503	Green Published, hybrid			2022-12-25	WOS:000260366900043
J	Sim, JA; Broomhead, HE; North, RA				Sim, Joan A.; Broomhead, Helen E.; North, R. Alan			Ectodomain Lysines and Suramin Block of P2X(1) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITATORY JUNCTION POTENTIALS; ATP BINDING; POTENCY ANTAGONIST; VAS-DEFERENS; AMINO-ACIDS; ACTIVATION; P2-PURINOCEPTOR; INHIBITOR; PLATELET; SUBUNITS	P2X(1) receptors belong to a family of cation channels gated by extracellular ATP; they are found inter alia in smooth muscle, platelets, and immune cells. Suramin has been widely used as an antagonist at P2X receptors, and its analog 4,4',4 '',4 '''-[carbonylbis((imino-5,1,3-benzenetriylbis(carbonylimino))] tetrakis-benzene-1,3- disulfonic acid (NF449) is selective for the P2X(1) subtype. Human and mouse P2X(1) receptors were expressed in human embryonic kidney cells, and membrane currents evoked by ATP were recorded. ATP (10 nM to 100 mu M) was applied only once to each cell, to avoid the profound desensitization exhibited by P2X(1) receptors. Suramin (10 mu M) and NF449 (3-300 nM)effectively blocked the human receptor. Suramin had little effect on the mouse receptor. Suramin and NF449 are polysulfonates, with six and eight negative charges, respectively. We hypothesized that species differences might result from differences in positive residues presented by the large receptor ectodomain. Four lysines in the human sequence (Lys(111), Lys(127), Lys(138), and Lys(148)) were changed individually and together to their counterparts in the mouse sequence. The substitution K138E, either alone or together with K111Q, K127Q, and K148N, reduced the sensitivity to block by both suramin and NF449. Conversely, when lysine was introduced into the mouse receptor, the sensitivity to block by suramin and NF449 was much increased for E138K, but not for Q111K, Q127K, or N148K. The results explain the marked species difference in antagonist sensitivity and identify an ectodomain lysine residue that plays a key role in the binding of both suramin and NF449 to P2X(1) receptors.	[Sim, Joan A.; Broomhead, Helen E.; North, R. Alan] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Sim, JA (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	joan.sim@manchester.ac.uk	North, Richard/GQA-6156-2022		Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Braun K, 2001, N-S ARCH PHARMACOL, V364, P285, DOI 10.1007/s002100100463; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1; DECLERCQ E, 1979, CANCER LETT, V8, P9, DOI 10.1016/0304-3835(79)90017-X; DUNN PM, 1988, BRIT J PHARMACOL, V93, P243, DOI 10.1111/j.1476-5381.1988.tb11427.x; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; EVANS RJ, 1995, MOL PHARM, V48, P17; Fung CYE, 2007, J THROMB HAEMOST, V5, P910, DOI 10.1111/j.1538-7836.2007.02525.x; Hulsmann M, 2003, EUR J PHARMACOL, V470, P1, DOI 10.1016/S0014-2999(03)01761-8; Ikeda M, 2007, THROMB RES, V119, P343, DOI 10.1016/j.thromres.2006.03.007; LAYTON D, 1974, BIOCHEM BIOPH RES CO, V59, P322, DOI 10.1016/S0006-291X(74)80209-3; Le KT, 1999, J BIOL CHEM, V274, P15415, DOI 10.1074/jbc.274.22.15415; LOMOMINSKI I, 1961, NATURE, V192, P683; Mahaut-Smith MP, 2004, PLATELETS, V15, P131, DOI 10.1080/09537100410001682788; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Rettinger J, 2003, J GEN PHYSIOL, V121, P451, DOI 10.1085/jgp.200208730; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Sim JA, 2007, BRIT J PHARMACOL, V152, P1283, DOI 10.1038/sj.bjp.0707504; SMOLEN JE, 1978, BIOCHIM BIOPHYS ACTA, V512, P525, DOI 10.1016/0005-2736(78)90162-1; SNEDDON P, 1992, BRIT J PHARMACOL, V107, P101, DOI 10.1111/j.1476-5381.1992.tb14469.x; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Surprenant A, 2000, J AUTONOM NERV SYST, V81, P249, DOI 10.1016/S0165-1838(00)00123-5; TOWN BW, 1950, BIOCHEM J, V47, P149, DOI 10.1042/bj0470149; TOWN BW, 1949, NATURE, V163, P735, DOI 10.1038/163735a0; VALERA S, 1994, NATURE, V371, P519; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658	31	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29841	29846		10.1074/jbc.M802523200	http://dx.doi.org/10.1074/jbc.M802523200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18765669	Green Published, hybrid			2022-12-25	WOS:000260366900028
J	Ohrtman, J; Ritter, B; Polster, A; Beam, KG; Papadopoulos, S				Ohrtman, Joshua; Ritter, Barbara; Polster, Alexander; Beam, Kurt G.; Papadopoulos, Symeon			Sequence Differences in the IQ Motifs of Ca(v)1.1 and Ca(v)1.2 Strongly Impact Calmodulin Binding and Calcium-dependent Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II-III LOOP; CA2+ CHANNELS; DIHYDROPYRIDINE-RECEPTOR; CA2+-SENSITIVE INACTIVATION; CA2+-DEPENDENT INACTIVATION; ALPHA(1C) SUBUNIT; SITES; CURRENTS; DOMAIN; DETERMINANTS	The proximal C terminus of the cardiac L-type calcium channel (Ca(V)1.2) contains structural elements important for the binding of calmodulin (CaM) and calcium-dependent inactivation, and exhibits extensive sequence conservation with the corresponding region of the skeletal L-type channel (Ca(V)1.1). However, there are several Ca(V)1.1 residues that are both identical in six species and are non-conservatively changed from the corresponding Ca(V)1.2 residues, including three of the "IQ motif." To investigate the functional significance of these residue differences, we used native gel electrophoresis and expression in intact myotubes to compare the binding of CaM to extended regions (up to 300 residues) of the C termini of Ca(V)1.1 and Ca(V)1.2. We found that in the presence of Ca2+ (either millimolar or that in resting myotubes), CaM bound strongly to C termini of Ca(V)1.2 but not of Ca(V)1.1. Furthermore, replacement of two residues (Tyr(1657) and Lys(1662)) within the IQ motif of a C-terminal Ca(V)1.2 construct with the divergent residues of Ca(V)1.1 (His(1532) and Met(1537)) led to a weakening of CaM binding (native gels), whereas the reciprocal substitution in Ca(V)1.1 caused a gain of CaM binding. In full-length Ca(V)1.2, substitution of these same two divergent residues with those of Ca(V)1.1 (Y1657H, K1662M) eliminated calcium-dependent inactivation of the heterologously expressed channel. Thus, our results reveal that a conserved difference between the IQ motifs of Ca(V)1.2 and Ca(V)1.1 has a profound effect on both CaM binding and calcium-dependent inactivation.	[Ritter, Barbara; Polster, Alexander; Papadopoulos, Symeon] Hannover Med Sch, OE 4200, Dept Physiol, D-30625 Hannover, Germany; [Ohrtman, Joshua; Beam, Kurt G.] Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, Aurora, CO 80045 USA	Hannover Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus	Papadopoulos, S (corresponding author), Carl Neuberg Str 1, D-30625 Hannover, Germany.	symeon@mh-hannover.de			National Institutes of Health [NS24444]; Deutsche Forschungsgemeinschaft; Deutscher Akademischer Austauschdienst; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD041697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS24444 (to K. G. B.). This work was also supported by grants from the Deutsche Forschungsgemeinschaft and Deutscher Akademischer Austauschdienst (DAAD) (to S. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams B, 1997, J GEN PHYSIOL, V110, P379, DOI 10.1085/jgp.110.4.379; Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; Beam KG, 1997, METHOD CELL BIOL, V52, P283, DOI 10.1016/S0091-679X(08)60384-2; BEAM KG, 1988, J GEN PHYSIOL, V91, P781, DOI 10.1085/jgp.91.6.781; BEAM KG, 2004, MYOLOGY, P257; Bernatchez G, 1998, BIOPHYS J, V75, P1727, DOI 10.1016/S0006-3495(98)77614-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; CAVALIE A, 1983, PFLUG ARCH EUR J PHY, V398, P284, DOI 10.1007/BF00657238; Cens T, 2005, MOL B INT U, P95; Cens T, 2006, PROG BIOPHYS MOL BIO, V90, P104, DOI 10.1016/j.pbiomolbio.2005.05.013; CHIARANDINI DJ, 1980, J PHYSIOL-LONDON, V303, P153, DOI 10.1113/jphysiol.1980.sp013277; DASCAL N, 1986, SCIENCE, V231, P1147, DOI 10.1126/science.2418503; De Marco V, 2004, BIOCHEM BIOPH RES CO, V322, P766, DOI 10.1016/j.bbrc.2004.07.189; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; HALLING DB, 2006, SCI STKE, V318, pER1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; KASS RS, 1984, J GEN PHYSIOL, V84, P705, DOI 10.1085/jgp.84.5.705; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lorenzon NM, 2007, J GEN PHYSIOL, V130, P379, DOI 10.1085/jgp.200609730; Lorenzon NM, 2004, J BIOL CHEM, V279, P44057, DOI 10.1074/jbc.M405318200; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; ROMANIN C, 1992, PFLUG ARCH EUR J PHY, V421, P516, DOI 10.1007/BF00370266; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Sencer S, 2001, J BIOL CHEM, V276, P38237; Soldatov MM, 2003, TRENDS PHARMACOL SCI, V24, P167, DOI 10.1016/S0165-6147(03)00065-8; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; Stroffekova K, 2008, PFLUG ARCH EUR J PHY, V455, P873, DOI 10.1007/s00424-007-0344-x; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wilkens CM, 2003, J MUSCLE RES CELL M, V24, P99, DOI 10.1023/A:1024830132118; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	59	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29301	29311		10.1074/jbc.M805152200	http://dx.doi.org/10.1074/jbc.M805152200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18718913	Green Published, hybrid			2022-12-25	WOS:000260179900057
J	Qin, HN; Shi, JH; Noberini, R; Pasquale, EB; Song, JX				Qin, Haina; Shi, Jiahai; Noberini, Roberta; Pasquale, Elena B.; Song, Jianxing			Crystal Structure and NMR Binding Reveal That Two Small Molecule Antagonists Target the High Affinity Ephrin-binding Channel of the EphA4 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; SPECIFICITY; SYSTEM; CRYSTALLOGRAPHY; DETERMINANTS; ANGIOGENESIS; INHIBITORS; EXPRESSION; DIVERSITY; SOFTWARE	The Eph receptor tyrosine kinases regulate a variety of physiological and pathological processes not only during development but also in adult organs, and therefore they represent a promising class of drug targets. The EphA4 receptor plays important roles in the inhibition of the regeneration of injured axons, synaptic plasticity, platelet aggregation, and likely in certain types of cancer. Here we report the first crystal structure of the EphA4 ligand-binding domain, which adopts the same jellyroll beta-sandwich architecture as shown previously for EphB2 and EphB4. The similarity with EphB receptors is high in the core beta-stranded regions, whereas large variations exist in the loops, particularly the D-E and J-K loops, which form the high affinity ephrin binding channel. We also used isothermal titration calorimetry, NMR spectroscopy, and computational docking to characterize the binding to EphA4 of two small molecules, 4- and 5-(2,5 dimethyl-pyrrol-1-yl)-2-hydroxybenzoic acid which antagonize ephrin-induced effects in EphA4-expressing cells. We show that the two molecules bind to the EphA4 ligand-binding domain with K-d values of 20.4 and 26.4 mu M, respectively. NMR heteronuclear single quantum coherence titrations revealed that upon binding, both molecules significantly perturb EphA4 residues Ile(31)-Met(32) in the D-E loop, Gln(43) in the E beta-strand, and Ile(131)-Gly(132) in the J-K loop. Molecular docking shows that they can occupy a cavity in the high affinity ephrin binding channel of EphA4 in a similar manner, by interacting mainly with the EphA4 residues in the E strand and D-E and J-K loops. However, many of the interactions observed in Eph receptor-ephrin complexes are absent, which is consistent with the small size of the two molecules and may account for their relatively weak binding affinity. Thus, our studies provide the first receptor of the A subclass. Furthermore, the results demonstrate that the high affinity ephrin binding channel of the Eph receptors is amenable to targeting with small molecule antagonists and suggest avenues for further optimization.	[Qin, Haina; Shi, Jiahai; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 11926, Singapore; [Noberini, Roberta; Pasquale, Elena B.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Noberini, Roberta] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Song, Jianxing] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 11926, Singapore	National University of Singapore; Sanford Burnham Prebys Medical Discovery Institute; University of Parma; University of California System; University of California San Diego; National University of Singapore	Song, JX (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 11926, Singapore.	bchsj@nus.edu.sg	Qin, Haina/AAB-7486-2020; Shi, Jiahai/AAH-1103-2019; Song, Jianxing/J-3617-2013; Song, Jianxing/H-8026-2012; Noberini, Roberta/AAP-4527-2020; shi, jiahai/D-7650-2013	Shi, Jiahai/0000-0002-6467-8289; shi, jiahai/0000-0002-6467-8289; Song, Jianxing/0000-0003-0224-6322; Haina, Qin/0000-0002-9175-8014; Noberini, Roberta/0000-0002-7267-1079	National Medical Research Council of Singapore [R-154-000-382-213]	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by National Medical Research Council of Singapore Grant R-154-000-382-213 (to J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adams RH, 2002, SEMIN CELL DEV BIOL, V13, P55, DOI 10.1006/scdb.2001.0289; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caligiuri M, 2006, CHEM BIOL, V13, P711, DOI 10.1016/j.chembiol.2006.05.008; Chrencik JE, 2006, STRUCTURE, V14, P321, DOI 10.1016/j.str.2005.11.011; Chrencik JE, 2007, J BIOL CHEM, V282, P36505, DOI 10.1074/jbc.M706340200; Chrencik JE, 2006, J BIOL CHEM, V281, P28185, DOI 10.1074/jbc.M605766200; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Iiizumi M, 2006, CANCER SCI, V97, P1211, DOI 10.1111/j.1349-7006.2006.00313.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kolb P, 2008, PROTEINS, V73, P11, DOI 10.1002/prot.22028; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu JX, 2006, BIOCHEMISTRY-US, V45, P7171, DOI 10.1021/bi060091y; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miyazaki Y, 2008, BIOORG MED CHEM LETT, V18, P1967, DOI 10.1016/j.bmcl.2008.01.113; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Ran XY, 2008, PROTEINS, V72, P1019, DOI 10.1002/prot.21999; Ran XY, 2005, J BIOL CHEM, V280, P19205, DOI 10.1074/jbc.M500330200; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi JH, 2008, J VIROL, V82, P4620, DOI 10.1128/JVI.02680-07; Shi JH, 2008, BIOMATERIALS, V29, P2820, DOI 10.1016/j.biomaterials.2008.03.020; Song JX, 2003, J BIOL CHEM, V278, P24714, DOI 10.1074/jbc.M210625200; Tang FY, 2007, J NUTR BIOCHEM, V18, P391, DOI 10.1016/j.jnutbio.2006.07.004; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yao VJ, 2005, AM J PATHOL, V166, P625, DOI 10.1016/S0002-9440(10)62283-3; Zhang NX, 2006, J MOL BIOL, V363, P188, DOI 10.1016/j.jmb.2006.08.026	54	54	55	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29473	29484		10.1074/jbc.M804114200	http://dx.doi.org/10.1074/jbc.M804114200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708347	hybrid, Green Published			2022-12-25	WOS:000260179900073
J	Xia, ZX; Turner, GC; Hwang, CS; Byrd, C; Varshavsky, A				Xia, Zanxian; Turner, Glenn C.; Hwang, Cheol-Sang; Byrd, Christopher; Varshavsky, Alexander			Amino Acids Induce Peptide Uptake via Accelerated Degradation of CUP9, the Transcriptional Repressor of the PTR2 Peptide Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END RULE PATHWAY; PERMEASE GENE BAP2; SACCHAROMYCES-CEREVISIAE; UBIQUITIN LIGASE; IN-VIVO; ENDOPROTEOLYTIC ACTIVATION; PROTEOLYTIC PATHWAY; PLASMA-MEMBRANE; YEAST; PROTEIN	Multiple pathways link expression of PTR2, the transporter of di- and tripeptides in the yeast Saccharomyces cerevisiae, to the availability and quality of nitrogen sources. Previous work has shown that induction of PTR2 by extracellular amino acids requires, in particular, SSY1 and PTR3. SSY1 is structurally similar to amino acid transporters but functions as a sensor of amino acids. PTR3 acts downstream of SSY1. Expression of the PTR2 peptide transporter is induced not only by amino acids but also by dipeptides with destabilizing N-terminal residues. These dipeptides bind to UBR1, the ubiquitin ligase of the N-end rule pathway, and allosterically accelerate the UBR1-dependent degradation of CUP9, a transcriptional repressor of PTR2. UBR1 targets CUP9 through its internal degron. Here we demonstrate that the repression of PTR2 by CUP9 requires TUP1 and SSN6, the corepressor proteins that form a complex with CUP9. We also show that the induction of PTR2 by amino acids is mediated by the UBR1-dependent acceleration of CUP9 degradation that requires both SSY1 and PTR3. The acceleration of CUP9 degradation is shown to be attained without increasing the activity of the N-end rule pathway toward substrates with destabilizing N-terminal residues. We also found that GAP1, a general amino acid transporter, strongly contributes to the induction of PTR2 by Trp. Although several aspects of this complex circuit remain to be understood, our findings establish new functional links between the amino acids-sensing SPS system, the CUP9-TUP1-SSN6 repressor complex, the PTR2 peptide transporter, and the UBR1-dependent N-end rule pathway.	[Xia, Zanxian; Hwang, Cheol-Sang; Varshavsky, Alexander] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Turner, Glenn C.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Byrd, Christopher] Wilson Sonsini Goodrich & Rosati, Palo Alto, CA 94304 USA	California Institute of Technology; Cold Spring Harbor Laboratory	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957; Turner, Glenn/0000-0002-5341-2784	National Institutes of Health [DK39520, GM31530]; Sandler Program for Asthma Research; Ellison Medical Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520, R37DK039520, R56DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Program for Asthma Research; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK39520 and GM31530 ( to A. V.). This work was also supported by the Sandler Program for Asthma Research, and from the Ellison Medical Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdel-Sater F, 2004, MOL CELL BIOL, V24, P9771, DOI 10.1128/MCB.24.22.9771-9785.2004; Abdel-Sater F, 2004, GENETICS, V166, P1727, DOI 10.1534/genetics.166.4.1727; ALAGRAMAM K, 1995, MOL MICROBIOL, V15, P225, DOI 10.1111/j.1365-2958.1995.tb02237.x; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Bernard F, 2001, FEBS LETT, V496, P81, DOI 10.1016/S0014-5793(01)02412-7; Boban M, 2007, GENETICS, V176, P2087, DOI 10.1534/genetics.107.075077; Boles E, 2004, TOP CURR GENET, V9, P121; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; Cai HJ, 2006, GENETICS, V172, P1459, DOI 10.1534/genetics.105.053041; Cai HJ, 2007, EUKARYOT CELL, V6, P1805, DOI 10.1128/EC.00257-06; CHEN XH, 1994, MOL GEN GENET, V244, P260, DOI 10.1007/BF00285453; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; FOSBERG H, 2001, CURR GENET, V40, P91; FROMMER WB, 1994, FEBS LETT, V347, P185, DOI 10.1016/0014-5793(94)00533-8; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Inobe T, 2008, CURR OPIN STRUC BIOL, V18, P43, DOI 10.1016/j.sbi.2007.12.014; ISLAND MD, 1987, J BACTERIOL, V169, P2132, DOI 10.1128/jb.169.5.2132-2136.1987; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jorgensen MU, 1997, CURR GENET, V31, P241, DOI 10.1007/s002940050201; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Laney JD, 2006, MOL CELL BIOL, V26, P371, DOI 10.1128/MCB.26.1.371-380.2006; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Nielsen PS, 2001, MOL GEN GENET, V264, P613, DOI 10.1007/s004380000347; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; SIKORSKI RS, 1989, GENETICS, V122, P19; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Wiles AM, 2006, MICROBIOL-SGM, V152, P3133, DOI 10.1099/mic.0.29055-0; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	59	36	36	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28958	28968		10.1074/jbc.M803980200	http://dx.doi.org/10.1074/jbc.M803980200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708352	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000260179900021
J	Dluzewski, AR; Ling, IT; Hopkins, JM; Grainger, M; Margos, G; Mitchell, GH; Holder, AA; Bannister, LH				Dluzewski, Anton R.; Ling, Irene T.; Hopkins, John M.; Grainger, Munira; Margos, Gabriele; Mitchell, Graham H.; Holder, Anthony A.; Bannister, Lawrence H.			Formation of the Food Vacuole in Plasmodium falciparum: A Potential Role for the 19 kDa Fragment of Merozoite Surface Protein 1 (MSP1(19))	PLOS ONE			English	Article							HOST-CELL INVASION; MALARIA PARASITE; CHLOROQUINE RESISTANCE; ERYTHROCYTIC STAGES; DIGESTIVE VACUOLE; MEMBRANE-PROTEIN; RING-STAGE; EXPRESSION; ANTIBODIES; PROTEASES	Plasmodium falciparum Merozoite Surface Protein 1 ( MSP1) is synthesized during schizogony as a 195-kDa precursor that is processed into four fragments on the parasite surface. Following a second proteolytic cleavage during merozoite invasion of the red blood cell, most of the protein is shed from the surface except for the C-terminal 19-kDa fragment (MSP1(19)), which is still attached to the merozoite via its GPI-anchor. We have examined the fate of MSP1(19) during the parasite's subsequent intracellular development using immunochemical analysis of metabolically labeled MSP1(19), fluorescence imaging, and immuno-electronmicroscopy. Our data show that MSP1(19) remains intact and persists to the end of the intracellular cycle. This protein is the first marker for the biogenesis of the food vacuole; it is rapidly endocytosed into small vacuoles in the ring stage, which coalesce to form the single food vacuole containing hemozoin, and persists into the discarded residual body. The food vacuole is marked by the presence of both MSP1(19) and the chloroquine resistance transporter (CRT) as components of the vacuolar membrane. Newly synthesized MSP1 is excluded from the vacuole. This behavior indicates that MSP1(19) does not simply follow a classical lysosome-like clearance pathway, instead, it may play a significant role in the biogenesis and function of the food vacuole throughout the intra-erythrocytic phase.	[Dluzewski, Anton R.; Hopkins, John M.; Margos, Gabriele; Mitchell, Graham H.] Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Immunobiol, London SE1 9RT, England; [Hopkins, John M.; Margos, Gabriele; Bannister, Lawrence H.] Guys Hosp, Guys Kings & St Thomas Sch Biomed & Life Sci, Ctr Ultrastruct Imag, London, England; [Dluzewski, Anton R.; Ling, Irene T.; Grainger, Munira; Holder, Anthony A.] NIMR, Div Parasitol, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; MRC National Institute for Medical Research	Dluzewski, AR (corresponding author), Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Immunobiol, London SE1 9RT, England.	anton.dluzewski@nimr.mrc.ac.uk	Mitchell, Graham/AAA-5654-2020; Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; MARGOS, Gabriele/0000-0001-5304-9615; Mitchell, G.H./0000-0002-4922-8044	UK Medical Research Council; Wellcome Trust [069515]; European Commission [QLK2-CT-1999-01293]; Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the 6th Framework Programme [LSHP-CT-2004-503578]; MRC [MC_U117532067] Funding Source: UKRI; Medical Research Council [MC_U117532067] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the 6th Framework Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded in part by the UK Medical Research Council, The Wellcome Trust (Grant No. 069515) and the European Commission (Euromalvac QLK2-CT-1999-01293). This work is part of the activities of the BioMalPar European Network of Excellence supported by a European grant (LSHP-CT-2004-503578) from the Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the 6th Framework Programme.	AIKAWA M, 1966, MIL MED, V131, P969, DOI 10.1093/milmed/131.suppl_9.969; Akompong T, 2002, J BIOL CHEM, V277, P28923, DOI 10.1074/jbc.M201968200; AMOT DE, 2008, CLIN VACCINE IMMUNOL; Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; Bannister LH, 2004, MICROSC MICROANAL, V10, P551, DOI 10.1017/S1431927604040917; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; Black CG, 2001, MOL BIOCHEM PARASIT, V114, P217, DOI 10.1016/S0166-6851(01)00265-1; Blackman MJ, 2004, CELL MICROBIOL, V6, P893, DOI 10.1111/j.1462-5822.2004.00437.x; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Bray PG, 2005, MOL MICROBIOL, V56, P323, DOI 10.1111/j.1365-2958.2005.04556.x; BURGHAUS PA, 1994, MOL BIOCHEM PARASIT, V64, P165, DOI 10.1016/0166-6851(94)90144-9; Burns JM, 2000, INFECT IMMUN, V68, P6189, DOI 10.1128/IAI.68.11.6189-6195.2000; Carruthers VB, 2005, MOL MICROBIOL, V55, P1617, DOI 10.1111/j.1365-2958.2005.04483.x; Chitarra V, 1999, MOL CELL, V3, P457, DOI 10.1016/S1097-2765(00)80473-6; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; DLUZEWSKI AR, 1984, T ROY SOC TROP MED H, V78, P622, DOI 10.1016/0035-9203(84)90221-9; Dowse T, 2004, CURR OPIN MICROBIOL, V7, P388, DOI 10.1016/j.mib.2004.06.013; Drew DR, 2005, INFECT IMMUN, V73, P3912, DOI 10.1128/IAI.73.7.3912-3922.2005; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Elliott DA, 2008, P NATL ACAD SCI USA, V105, P2463, DOI 10.1073/pnas.0711067105; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; HALL R, 1983, MOL BIOCHEM PARASIT, V7, P247, DOI 10.1016/0166-6851(83)90025-7; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; HEIDRICH HG, 1986, Z PARASITENKD, V72, P681, DOI 10.1007/BF00925490; HEMPELMANN E, 1981, MOL BIOCHEM PARASIT, V2, P197, DOI 10.1016/0166-6851(81)90100-6; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; Hiller NL, 2003, J BIOL CHEM, V278, P48413, DOI 10.1074/jbc.M307266200; HOLDER AA, 1992, MEM I OSWALDO CRUZ, V87, P37, DOI 10.1590/S0074-02761992000700004; HOLDER AA, 1982, J EXP MED, V156, P1528, DOI 10.1084/jem.156.5.1528; HOLDER AA, 1987, PARASITOLOGY, V94, P199, DOI 10.1017/S0031182000053889; Howell SA, 2005, MOL MICROBIOL, V57, P1342, DOI 10.1111/j.1365-2958.2005.04772.x; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANGRETH SG, 1978, J PROTOZOOL, V25, P443, DOI 10.1111/j.1550-7408.1978.tb04167.x; Lazarus MD, 2008, J CELL SCI, V121, P1937, DOI 10.1242/jcs.023150; LING IT, 1995, PARASITE IMMUNOL, V17, P425, DOI 10.1111/j.1365-3024.1995.tb00910.x; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; O'Donnell RA, 2005, CURR OPIN MICROBIOL, V8, P422, DOI 10.1016/j.mib.2005.06.018; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; OKA M, 1984, AM J TROP MED HYG, V33, P342, DOI 10.4269/ajtmh.1984.33.342; Pachebat JA, 2007, MOL BIOCHEM PARASIT, V151, P59, DOI 10.1016/j.molbiopara.2006.10.006; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pisciotta JM, 2007, BIOCHEM J, V402, P197, DOI 10.1042/BJ20060986; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Saliba KJ, 2003, J BIOL CHEM, V278, P5605, DOI 10.1074/jbc.M208648200; Shi QF, 2006, MOL BIOCHEM PARASIT, V149, P231, DOI 10.1016/j.molbiopara.2006.06.002; SLOMIANNY C, 1990, BLOOD CELLS, V16, P369; SLOMIANNY C, 1985, PARASITOLOGY, V90, P579, DOI 10.1017/S0031182000055578; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; Tran CV, 2004, MICROBIOL-SGM, V150, P1, DOI 10.1099/mic.0.26818-0; Waller KL, 2003, J BIOL CHEM, V278, P33593, DOI 10.1074/jbc.M302215200; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Wang L, 2003, MOL BIOCHEM PARASIT, V130, P149, DOI 10.1016/S0166-6851(03)00165-8; Waterkeyn JG, 2001, EXP PARASITOL, V97, P115, DOI 10.1006/expr.2000.4593; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006; YAYON A, 1984, J PROTOZOOL, V31, P367, DOI 10.1111/j.1550-7408.1984.tb02981.x	67	63	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3085	10.1371/journal.pone.0003085	http://dx.doi.org/10.1371/journal.pone.0003085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769730	Green Published, gold, Green Submitted			2022-12-25	WOS:000264796800002
J	Lundberg, G; Rosengren, AH; Hakanson, U; Stewenius, H; Jin, YS; Stewenius, Y; Pahlman, S; Gisselsson, D				Lundberg, Gisela; Rosengren, Anders H.; Hakanson, Ulf; Stewenius, Henrik; Jin, Yuesheng; Stewenius, Ylva; Pahlman, Sven; Gisselsson, David			Binomial Mitotic Segregation of MYCN-Carrying Double Minutes in Neuroblastoma Illustrates the Role of Randomness in Oncogene Amplification	PLOS ONE			English	Article								Background: Amplification of the oncogene MYCN in double minutes (DMs) is a common finding in neuroblastoma ( NB). Because DMs lack centromeric sequences it has been unclear how NB cells retain and amplify extrachromosomal MYCN copies during tumour development. Principal Findings: We show that MYCN-carrying DMs in NB cells translocate from the nuclear interior to the periphery of the condensing chromatin at transition from interphase to prophase and are preferentially located adjacent to the telomere repeat sequences of the chromosomes throughout cell division. However, DM segregation was not affected by disruption of the telosome nucleoprotein complex and DMs readily migrated from human to murine chromatin in human/mouse cell hybrids, indicating that they do not bind to specific positional elements in human chromosomes. Scoring DM copy-numbers in ana/telophase cells revealed that DM segregation could be closely approximated by a binomial random distribution. Colony-forming assay demonstrated a strong growth-advantage for NB cells with high DM (MYCN) copy-numbers, compared to NB cells with lower copy-numbers. In fact, the overall distribution of DMs in growing NB cell populations could be readily reproduced by a mathematical model assuming binomial segregation at cell division combined with a proliferative advantage for cells with high DM copy-numbers. Conclusion: Binomial segregation at cell division explains the high degree of MYCN copy-number variability in NB. Our findings also provide a proof-of-principle for oncogene amplification through creation of genetic diversity by random events followed by Darwinian selection.	[Lundberg, Gisela; Jin, Yuesheng; Stewenius, Ylva; Gisselsson, David] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; [Rosengren, Anders H.] Lund Univ, Dept Clin Sci Malmo, S-22100 Lund, Sweden; [Hakanson, Ulf] Lund Univ, Div Solid State Phys, Nanometer Struct Consortium, S-22100 Lund, Sweden; [Stewenius, Henrik] Lund Univ, Dept Math, S-22100 Lund, Sweden; [Pahlman, Sven] Lund Univ, Dept Mol Med, S-22100 Lund, Sweden; [Gisselsson, David] Univ Lund Hosp, Dept Pathol, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Lund University; Lund University; Lund University; Skane University Hospital	Lundberg, G (corresponding author), Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden.	david.gisselsson@med.lu.se	Rosengren, Anders/E-8371-2012; Hakanson, Ulf/A-1862-2009	Rosengren, Anders/0000-0002-9333-5736; 	Swedish Children's Cancer Foundation; Swedish Cancer Society; Swedish Research Council; Swedish Medical Society; Lund University Hospital Donation Funds; Gunnar Nilsson Cancer Foundation; Crafoord Foundation; Erik-Philip Sorensen Foundation; Lundgren Foundation; Medical Faculty at Lund University	Swedish Children's Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Medical Society; Lund University Hospital Donation Funds; Gunnar Nilsson Cancer Foundation; Crafoord Foundation; Erik-Philip Sorensen Foundation; Lundgren Foundation; Medical Faculty at Lund University	This study was supported by the Swedish Children's Cancer Foundation, the Swedish Cancer Society, the Swedish Research Council, the Swedish Medical Society, the Lund University Hospital Donation Funds, the Gunnar Nilsson Cancer Foundation, the Crafoord Foundation, the Erik-Philip Sorensen Foundation, the Lundgren Foundation, and the Medical Faculty at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER PE, 1980, EXP CELL RES, V130, P353, DOI 10.1016/0014-4827(80)90012-9; BARKER PE, 1982, CANCER GENET CYTOGEN, V5, P81, DOI 10.1016/0165-4608(82)90043-7; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Choi LMR, 2000, MED PEDIATR ONCOL, V35, P647, DOI 10.1002/1096-911X(20001201)35:6<647::AID-MPO35>3.0.CO;2-I; Deng XY, 2006, BIOCHEM BIOPH RES CO, V346, P1228, DOI 10.1016/j.bbrc.2006.06.041; Gisselsson David, 2001, Methods in Cell Science, V23, P23, DOI 10.1023/A:1013129212367; Itoh N, 1998, J CELL SCI, V111, P3275; Jin YS, 2007, CLIN CANCER RES, V13, P1703, DOI 10.1158/1078-0432.CCR-06-2705; Kanda T, 2001, J CELL SCI, V114, P49; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kanda T, 2000, J CELL BIOCHEM, P107; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; LEVAN A, 1978, HEREDITAS, V88, P81; LEVAN G, 1976, HEREDITAS, V83, P83; Mejia MD, 2002, ARCH MED RES, V33, P466, DOI 10.1016/S0188-4409(02)00384-3; Moreau LA, 2006, CLIN CANCER RES, V12, P5693, DOI 10.1158/1078-0432.CCR-06-1500; Narath R, 2007, GENE CHROMOSOME CANC, V46, P130, DOI 10.1002/gcc.20393; Norris MD, 1997, EUR J CANCER, V33, P1911, DOI 10.1016/S0959-8049(97)00284-0; Oshimura M, 1997, EUR J CANCER, V33, P710, DOI 10.1016/S0959-8049(97)00090-7; Paffhausen T, 2007, CANCER LETT, V250, P17, DOI 10.1016/j.canlet.2006.09.010; Schneiderman J, 2008, J CLIN ONCOL, V26, P913, DOI 10.1200/JCO.2007.13.9493; Schoenlein PV, 2003, INT J RADIAT ONCOL, V55, P1051, DOI 10.1016/S0360-3016(02)04473-5; SCHWEIGERER L, 1990, CANCER RES, V50, P4411; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Seimiya H, 2002, MOL CANCER THER, V1, P657; Shohet JM, 2002, CANCER RES, V62, P1123; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Solovei I, 2000, GENE CHROMOSOME CANC, V29, P297, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1046>3.0.CO;2-H; Stallings RL, 2007, CYTOGENET GENOME RES, V118, P110, DOI 10.1159/000108291; Stock C, 2008, AM J PATHOL, V172, P203, DOI 10.2353/ajpath.2008.061263; Tang XX, 2006, CANCER RES, V66, P2826, DOI 10.1158/0008-5472.CAN-05-0854; Thorner PS, 2006, AM J SURG PATHOL, V30, P635, DOI 10.1097/01.pas.0000202163.82525.5c; Tonelli R, 2005, MOL CANCER THER, V4, P779, DOI 10.1158/1535-7163.MCT-04-0213; TSUDA T, 1987, CANCER, V60, P820, DOI 10.1002/1097-0142(19870815)60:4<820::AID-CNCR2820600418>3.0.CO;2-Y; Yaari S, 2005, CLIN CANCER RES, V11, P4321, DOI 10.1158/1078-0432.CCR-04-2071	37	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3099	10.1371/journal.pone.0003099	http://dx.doi.org/10.1371/journal.pone.0003099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769732	Green Published, gold, Green Submitted			2022-12-25	WOS:000264796800006
J	Chakravarthy, S; Keck, T; Roelandse, M; Hartman, R; Jeromin, A; Perry, S; Hofer, SB; Mrsic-Flogel, T; Levelt, CN				Chakravarthy, Sridhara; Keck, Tara; Roelandse, Martijn; Hartman, Robin; Jeromin, Andreas; Perry, Sean; Hofer, Sonja B.; Mrsic-Flogel, Thomas; Levelt, Christiaan N.			Cre-Dependent Expression of Multiple Transgenes in Isolated Neurons of the Adult Forebrain	PLOS ONE			English	Article								Background: Transgenic mice with mosaic, Golgi-staining-like expression of enhanced green fluorescent protein (EGFP) have been very useful in studying the dynamics of neuronal structure and function. In order to further investigate the molecular events regulating structural plasticity, it would be useful to express multiple proteins in the same sparse neurons, allowing co-expression of functional proteins or co-labeling of subcellular compartments with other fluorescent proteins. However, it has been difficult to obtain reproducible expression in the same subset of neurons for direct comparison of neurons expressing different functional proteins. Principal Findings: Here we describe a Cre-transgenic line that allows reproducible expression of transgenic proteins of choice in a small number of neurons of the adult cortex, hippocampus, striatum, olfactory bulb, subiculum, hypothalamus, superior colliculus and amygdala. We show that using these Cre-transgenic mice, multiple Cre-dependent transgenes can be expressed together in the same isolated neurons. We also describe a Cre-dependent transgenic line expressing a membrane associated EGFP (EGFP-F). Crossed with the Cre-transgenic line, EGFP-F expression starts in the adolescent forebrain, is present in dendrites, dendritic protrusions, axons and boutons and is strong enough for acute or chronic in vivo imaging. Significance: This triple transgenic approach will aid the morphological and functional characterization of neurons in various Cre-dependent transgenic mice.	[Chakravarthy, Sridhara; Roelandse, Martijn; Hartman, Robin; Perry, Sean; Levelt, Christiaan N.] Netherlands Inst Neurosci, Mol Visual Plast Grp, Amsterdam, Netherlands; [Keck, Tara; Hofer, Sonja B.; Mrsic-Flogel, Thomas] Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, Martinsried, Germany; [Jeromin, Andreas] Allen Inst Brain Sci, Seattle, WA USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Max Planck Society; Allen Institute for Brain Science	Chakravarthy, S (corresponding author), Netherlands Inst Neurosci, Mol Visual Plast Grp, Amsterdam, Netherlands.	c.levelt@nin.knaw.nl	Roelandse, Martijn/B-7154-2013	Roelandse, Martijn/0000-0001-5596-8084; Keck, Tara/0000-0001-6623-1037; Mrsic-Flogel, Tom/0000-0002-8947-408X	Rotterdamse Vereniging Blindenbelangen; Algemeen Nederlandse Vereeniging ter Voorkoming van Blindheid; Stichting Blindenhulp; KWF Kanker Bestijding [NORI 2003-2789]; Royal Netherlands Academy of Arts and Sciences; Netherlands Organization for Scientific Research [VIDI]; SenterNovem [Bsik]	Rotterdamse Vereniging Blindenbelangen; Algemeen Nederlandse Vereeniging ter Voorkoming van Blindheid; Stichting Blindenhulp; KWF Kanker Bestijding; Royal Netherlands Academy of Arts and Sciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); SenterNovem	S.C. was supported by Rotterdamse Vereniging Blindenbelangen, Algemeen Nederlandse Vereeniging ter Voorkoming van Blindheid and Stichting Blindenhulp. M.R. is supported by KWF Kanker Bestijding (NORI 2003-2789). C.N.L. is supported by the Royal Netherlands Academy of Arts and Sciences (K.N.A.W.), A VIDI grant from the Netherlands Organization for Scientific Research (N.W.O.), and a "Bsik" grant from SenterNovem. None of the funders were involved either in the design and implementation of the experiments or in the preparation of the manuscript.	Badea TC, 2003, J NEUROSCI, V23, P2314; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; CATTANACH BM, 1974, GENET RES, V23, P291, DOI 10.1017/S0016672300014932; Chakravarthy S, 2006, P NATL ACAD SCI USA, V103, P1071, DOI 10.1073/pnas.0506305103; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen BE, 2000, LEARN MEMORY, V7, P433, DOI 10.1101/lm.32700; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Dynes JL, 1998, NEURON, V20, P1081, DOI 10.1016/S0896-6273(00)80490-0; Ehrengruber MU, 1999, P NATL ACAD SCI USA, V96, P7041, DOI 10.1073/pnas.96.12.7041; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; GOLGI C, 1989, J MICROSC-OXFORD, V155, P3, DOI 10.1111/j.1365-2818.1989.tb04294.x; HAMILTON DL, 1984, J MOL BIOL, V178, P481, DOI 10.1016/0022-2836(84)90154-2; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Huang ZJ, 2002, GENESIS, V32, P209, DOI 10.1002/gene.10054; Kaech S, 1996, NEURON, V17, P1189, DOI 10.1016/S0896-6273(00)80249-4; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; Knobel KM, 1999, DEVELOPMENT, V126, P4489; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Potter SM, 1996, GENE, V173, P25, DOI 10.1016/0378-1119(95)00681-8; Rensing N, 2005, ANN NEUROL, V58, P888, DOI 10.1002/ana.20658; Sakamoto H, 2003, ENDOCRINOLOGY, V144, P4466, DOI 10.1210/en.2003-0307; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tamamaki N, 2000, NEUROSCI RES, V38, P231, DOI 10.1016/S0168-0102(00)00176-0; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; WU GY, 1995, NEURON, V14, P681, DOI 10.1016/0896-6273(95)90211-2; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	37	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3059	10.1371/journal.pone.0003059	http://dx.doi.org/10.1371/journal.pone.0003059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725976	Green Published, gold			2022-12-25	WOS:000264796300005
J	Coleman, AS; Yang, XL; Kumar, M; Zhang, XY; Promnares, K; Shroder, D; Kenedy, MR; Anderson, JF; Akins, DR; Pal, U				Coleman, Adam S.; Yang, Xiuli; Kumar, Manish; Zhang, Xinyue; Promnares, Kamoltip; Shroder, Deborah; Kenedy, Melisha R.; Anderson, John F.; Akins, Darrin R.; Pal, Utpal			Borrelia burgdorferi Complement Regulator-Acquiring Surface Protein 2 Does Not Contribute to Complement Resistance or Host Infectivity	PLOS ONE			English	Article								Borrelia burgdorferi, the pathogen of Lyme disease, cycles in nature through Ixodes ticks and mammalian hosts. At least five Complement Regulator-Acquiring Surface Proteins ( BbCRASPs) are produced by B. burgdorferi, which are thought to assist spirochetes in host immune evasion. Recent studies established that BbCRASP-2 is preferentially expressed in mammals, and elicits robust antibody response in infected hosts, including humans. We show that BbCRASP-2 is ubiquitously expressed in diverse murine tissues, but not in ticks, reinforcing a role of BbCRASP-2 in conferring B. burgdorferi defense against persistent host immune threats, such as complement. BbCRASP-2 immunization, however, fails to protect mice from B. burgdorferi infection and does not modify disease, as reflected by the development of arthritis. An infectious BbCRASP-2 mutant was generated, therefore, to examine the precise role of the gene product in spirochete infectivity. Similar to wild type B. burgdorferi, BbCRASP-2 mutants remain insensitive to complement-mediated killing in vitro, retain full murine infectivity and induce arthritis. Quantitative RT-PCR assessment indicates that survivability of BbCRASP-2-deficient B. burgdorferi is not due to altered expression of other BbCRASPs. Together, these results suggest that the function of a selectively expressed B. burgdorferi gene, BbCRASP-2, is not essential for complement resistance or infectivity in the murine host.	[Coleman, Adam S.; Yang, Xiuli; Kumar, Manish; Zhang, Xinyue; Promnares, Kamoltip; Shroder, Deborah; Pal, Utpal] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA; [Kenedy, Melisha R.; Akins, Darrin R.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Norman, OK 73019 USA; [Anderson, John F.] Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT USA	University System of Maryland; University of Maryland College Park; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Norman; Connecticut Agricultural Experiment Station	Coleman, AS (corresponding author), Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA.	upal@umd.edu	Pal, Utpal/I-5265-2015; Promnares, Kamoltip/S-6106-2019; KUMAR, MANISH/AAE-3489-2021	KUMAR, MANISH/0000-0001-7997-5676	Arthritis Foundation, Maryland Chapter; National Institutes of Health [AR055323, AI059373, AI064629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064629, R01AI059373, R56AI059373, R01AI080615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055323] Funding Source: NIH RePORTER	Arthritis Foundation, Maryland Chapter; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by grants from Arthritis Foundation, Maryland Chapter (U.P), National Institutes of Health AR055323 (U.P), AI059373 (D.R.A) and AI064629 (D.R.A).	Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847; Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; Barthold S.W., 1992, LYME DIS MOL IMMUNOL, P223; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; BARTHOLD SW, 1993, AM J PATHOL, V143, P959; Bolz DD, 2004, J IMMUNOL, V173, P2003, DOI 10.4049/jimmunol.173.3.2003; Brooks CS, 2006, INFECT IMMUN, V74, P296, DOI 10.1128/IAI.74.1.296-304.2006; Brooks CS, 2005, J IMMUNOL, V175, P3299, DOI 10.4049/jimmunol.175.5.3299; BYKOWSKI T, INT J MED MICROBIOL; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Cassatt DR, 1998, INFECT IMMUN, V66, P5379, DOI 10.1128/IAI.66.11.5379-5387.1998; deSilva AM, 1997, J CLIN INVEST, V99, P377, DOI 10.1172/JCI119169; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Feng SL, 2000, INFECT IMMUN, V68, P4169, DOI 10.1128/IAI.68.7.4169-4173.2000; Feng SL, 2003, INFECT IMMUN, V71, P7211, DOI 10.1128/IAI.71.12.7211-7214.2003; FIKRIG E, 1990, SCIENCE, V250, P553, DOI 10.1126/science.2237407; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilmore RD, 2007, INFECT IMMUN, V75, P2753, DOI 10.1128/IAI.00037-07; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hanson MS, 1998, INFECT IMMUN, V66, P2143, DOI 10.1128/IAI.66.5.2143-2153.1998; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; HAUPT K, INT J MOL MICROBIOL; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Hefty PS, 2001, INFECT IMMUN, V69, P3618, DOI 10.1128/IAI.69.6.3618-3627.2001; Hovis KM, 2006, INFECT IMMUN, V74, P1967, DOI 10.1128/IAI.74.3.1967-1972.2006; Iyer R, 2003, INFECT IMMUN, V71, P3699, DOI 10.1128/IAI.71.7.3699-3706.2003; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Kraiczy P, 2004, INT J MED MICROBIOL, V293, P152, DOI 10.1016/S1433-1128(04)80029-9; Kraiczy P, 2008, CLIN VACCINE IMMUNOL, V15, P484, DOI 10.1128/CVI.00415-07; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; LI X, 2007, MOL MICROBIOL; Li X, 2007, INFECT IMMUN, V75, P4237, DOI 10.1128/IAI.00632-07; Liang FT, 2002, J EXP MED, V196, P275, DOI 10.1084/jem.20020770; Maruskova M, 2008, INFECT IMMUN, V76, P391, DOI 10.1128/IAI.01118-07; McDowell JV, 2006, INFECT IMMUN, V74, P3030, DOI 10.1128/IAI.74.5.3030-3034.2006; McDowell JV, 2003, INFECT IMMUN, V71, P3597, DOI 10.1128/IAI.71.6.3597-3602.2003; McDowell JV, 2001, INFECT IMMUN, V69, P3670, DOI 10.1128/IAI.69.6.3670-3677.2001; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; Neelakanta G, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030033; ORLOSKI KA, 1998, MMWR-MORBID MORTAL W, V49, P1; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pal U, 2008, J EXP MED, V205, P133, DOI 10.1084/jem.20070962; Pal U, 2008, J INFECT DIS, V197, P148, DOI 10.1086/523764; PROBERT WS, 1994, INFECT IMMUN, V62, P1920, DOI 10.1128/IAI.62.5.1920-1926.1994; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Ram S, 1999, MOL IMMUNOL, V36, P915, DOI 10.1016/S0161-5890(99)00114-5; Rogers EA, 2007, INFECT IMMUN, V75, P5272, DOI 10.1128/IAI.00850-07; Rosa P, 2005, NAT MED, V11, P831, DOI 10.1038/nm0805-831; SCHAIBLE UE, 1991, EUR J IMMUNOL, V21, P2397, DOI 10.1002/eji.1830211016; Schwan TG, 2002, EMERG INFECT DIS, V8, P115, DOI 10.3201/eid0802.010198; SIMON MM, 1991, IMMUNOL TODAY, V12, P11, DOI 10.1016/0167-5699(91)90106-4; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Stewart PE, 2008, INFECT IMMUN, V76, P1970, DOI 10.1128/IAI.00714-07; Wang XH, 2005, INFECT IMMUN, V73, P657, DOI 10.1128/IAI.73.1.657-660.2005; Woodman ME, 2007, INFECT IMMUN, V75, P3131, DOI 10.1128/IAI.01923-06; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960	61	53	54	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							3010e	10.1371/journal.pone.0003010	http://dx.doi.org/10.1371/journal.pone.0003010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714378	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900035
J	Wu, WH; Lei, P; Liu, Q; Hu, J; Gunn, AP; Chen, MS; Rui, YF; Su, XY; Xie, ZP; Zhao, YF; Bush, AI; Li, YM				Wu, Wei-hui; Lei, Peng; Liu, Qian; Hu, Jia; Gunn, Adam P.; Chen, Mei-sha; Rui, Yan-fang; Su, Xiao-yang; Xie, Zuo-ping; Zhao, Yu-Fen; Bush, Ashley I.; Li, Yan-mei			Sequestration of Copper from beta-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMER A-BETA; TRANSGENIC MICE; HIPPOCAMPAL-NEURONS; HYDROGEN-PEROXIDE; DISEASE; PEPTIDE; BINDING; OLIGOMERS; CU(II); ZINC	Decelerated degradation of beta-amyloid (A beta) and its interaction with synaptic copper may be pathogenic in Alzheimer disease. Recently, Co(III)-cyclen tagged to an aromatic recognition motif was shown to degrade A beta in vitro. Here, we report that apocyclen attached to selective A beta recognition motifs (KLVFF or curcumin) can capture copper bound to A beta and use the Cu(II) in place of Co(III) to become proteolytically active. The resultant complexes interfere with A beta aggregation, degrade A beta into fragments, preventing H2O2 formation and toxicity in neuronal cell culture. Because A beta binds Cu in amyloid plaques, apocyclen-tagged targeting molecules may be a promising approach to the selective degradation of A beta in Alzheimer disease. The principle of copper capture generalize to other amyloidoses where copper is implicated.	[Li, Yan-mei] Tsinghua Univ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China; [Gunn, Adam P.; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Wu, Wei-hui; Lei, Peng; Liu, Qian; Hu, Jia; Chen, Mei-sha; Rui, Yan-fang; Su, Xiao-yang; Zhao, Yu-Fen; Li, Yan-mei] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China; [Rui, Yan-fang; Xie, Zuo-ping] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Bush, Ashley I.] Univ Melbourne, Mental Hlth Res Inst Victoria, Oxidat Biol Lab, Parkville, Vic 3052, Australia	Tsinghua University; University of Melbourne; Tsinghua University; Tsinghua University; University of Melbourne	Bush, AI (corresponding author), Univ Melbourne, Mental Hlth Res Inst Victoria, Oxidat Biol Lab, 155 Oak St, Parkville, Vic 3052, Australia.	abush@mhri.edu.au; liym@mail.tsinghua.edu.cn	Lei, Peng/F-6326-2010; Rui, Yanfang/A-1372-2012; Zhao, Yufen/G-3445-2010; Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007; Su, Xiaoyang/B-3398-2008; Su, Xiaoyang/Q-4884-2018; Gunn, Adam P/D-5437-2012	Lei, Peng/0000-0001-5652-1962; Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Gunn, Adam P/0000-0002-8181-4975; Su, Xiaoyang/0000-0001-8081-1396	National Natural Science Foundation of China [20825206, 20672067]; Australian Research Council Federation; National Health and Medical Research Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Australian Research Council Federation(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Natural Science Foundation of China Grants 20825206 and 20672067 and by an Australian Research Council Federation fellowship and the National Health and Medical Research Council (to A. I. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BUSH AI, 1994, J BIOL CHEM, V269, P12152; Bush AI, 2003, P NATL ACAD SCI USA, V100, P11193, DOI 10.1073/pnas.2135061100; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Garzon-Rodriguez W, 1999, BIOORG MED CHEM LETT, V9, P2243, DOI 10.1016/S0960-894X(99)00357-1; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; IZATT RM, 1991, CHEM REV, V91, P1721, DOI 10.1021/cr00008a003; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lee JY, 2004, NEUROBIOL AGING, V25, P1315, DOI 10.1016/j.neurobiolaging.2004.01.005; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liu ST, 1999, BIOCHEMISTRY-US, V38, P9373, DOI 10.1021/bi990205o; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Ma QF, 2006, BIOPOLYMERS, V83, P20, DOI 10.1002/bip.20523; Marr RA, 2003, J NEUROSCI, V23, P1992; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; Nunomura A, 1999, J NEUROSCI, V19, P1959; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Suh J, 2003, ACCOUNTS CHEM RES, V36, P562, DOI 10.1021/ar020037j; Suh J, 2007, ANGEW CHEM INT EDIT, V46, P7064, DOI 10.1002/anie.200702399; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Wilkinson-White LE, 2007, BIOCHEMISTRY-US, V46, P9123, DOI 10.1021/bi700607z; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zhang J, 2006, FASEB J, V20, P1212, DOI 10.1096/fj.05-5214fje	48	102	106	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31657	31664		10.1074/jbc.M804722200	http://dx.doi.org/10.1074/jbc.M804722200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18728006	hybrid			2022-12-25	WOS:000260760800047
J	Zhang, YL; Ju, JS; Peng, H; Gao, F; Zhou, C; Zeng, Y; Xue, YF; Li, Y; Henrissat, B; Gao, GF; Ma, YH				Zhang, Yueling; Ju, Jiansong; Peng, Hao; Gao, Feng; Zhou, Cheng; Zeng, Yan; Xue, Yanfen; Li, Yin; Henrissat, Bernard; Gao, George F.; Ma, Yanhe			Biochemical and Structural Characterization of the Intracellular Mannanase AaManA of Alicyclobacillus acidocaldarius Reveals a Novel Glycoside Hydrolase Family Belonging to Clan GH-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRELIMINARY-X-RAY; MUSSEL MYTILUS-EDULIS; BETA-MANNANASE; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; GENE CLONING; BACILLUS SP; SEQUENCE; ENZYMES; CRYSTALLIZATION	An intracellular mannanase was identified from the thermoacidophile Alicyclobacillus acidocaldarius Tc-12-31. This enzyme is particularly interesting, because it shows no significant sequence similarity to any known glycoside hydrolase. Gene cloning, biochemical characterization, and structural studies of this novel mannanase are reported in this paper. The gene consists of 963 bp and encodes a 320-amino acid protein, AaManA. Based on its substrate specificity and product profile, AaManA is classified as an endo-beta-1,4-mannanase that is capable of transglycosylation. Kinetic analysis studies revealed that the enzyme required at least five subsites for efficient hydrolysis. The crystal structure at 1.9 A resolution showed that AaManA adopted a (beta/alpha)8-barrel fold. Two catalytic residues were identified: Glu(151) at theCterminus of beta-stand beta 4 and Glu(231) at the C terminus of beta 7. Based on the structure of the enzyme and evidence of its transglycosylation activity, AaManA is placed in clan GH-A. Superpositioning of its structure with that of other clan GH-A enzymes revealed that six of the eight GH-A key residues were functionally conserved in AaManA, with the exceptions being residues Thr(95) and Cys(150). We propose a model of substrate binding in AaManAin which Glu(282) interacts with the axial OH-C(2) in -2 subsites. Based on sequence comparisons, the enzyme was assigned to a new glycoside hydrolase family (GH113) that belongs to clan GH-A.	[Zhang, Yueling; Ju, Jiansong; Peng, Hao; Gao, Feng; Zhou, Cheng; Zeng, Yan; Xue, Yanfen; Li, Yin; Gao, George F.; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Zhang, Yueling; Zhou, Cheng] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China; [Henrissat, Bernard] CNRS, UMR6098, F-13288 Marseille, France; [Henrissat, Bernard] Univ Aix Marseille 1, F-13288 Marseille, France; [Henrissat, Bernard] Univ Aix Marseille 2, F-13288 Marseille, France	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Ma, YH (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, A3 Datun Rd,Chaoyang Dist, Beijing 100101, Peoples R China.	mayanhe@im.ac.cn	Jiansong, Ju/R-2177-2019; Henrissat, Bernard/J-2475-2012; Zhou, Cheng/Q-4416-2018; MA, YAN/HHN-2912-2022; Li, Yin/C-6644-2009; Gao, George Fu/ABD-5229-2021	Henrissat, Bernard/0000-0002-3434-8588; Zhou, Cheng/0000-0001-9720-9318; Li, Yin/0000-0003-0995-3070; Zhang, Yueling/0000-0002-5619-8410	Chinese Academy of Sciences Knowledge Innovation [KSCX2-SW-33]; National Natural Science Foundation of China [30621005]; Ministry of Sciences and Technology of China [2003CB716001, 2007CB707801]	Chinese Academy of Sciences Knowledge Innovation(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This study was supported by Chinese Academy of Sciences Knowledge Innovation Program Grant KSCX2-SW-33, National Natural Science Foundation of China Grant 30621005, and Ministry of Sciences and Technology of China ( 973 programs) Grants 2003CB716001 and 2007CB707801. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ademark P, 1998, J BIOTECHNOL, V63, P199, DOI 10.1016/S0168-1656(98)00086-8; AKINO T, 1987, APPL MICROBIOL BIOT, V26, P323; Akita M, 2004, ACTA CRYSTALLOGR D, V60, P1490, DOI 10.1107/S0907444904014313; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banik M, 2001, J EXP BOT, V52, P105, DOI 10.1093/jexbot/52.354.105; BETTIOL JP, 2002, Patent No. 6376445; Bourgault R, 2005, PROTEIN SCI, V14, P1233, DOI 10.1110/ps.041260905; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Clarke JH, 2000, APPL MICROBIOL BIOT, V53, P661, DOI 10.1007/s002530000344; Cote N, 2006, BIOCHEM J, V394, P675, DOI 10.1042/BJ20051436; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dekker R F, 1976, Adv Carbohydr Chem Biochem, V32, P277; DeLano W, 2002, PYMOL 0 99; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Durand P, 1997, GLYCOBIOLOGY, V7, P277, DOI 10.1093/glycob/7.2.277; Eckert K, 2002, APPL MICROBIOL BIOT, V60, P428, DOI 10.1007/s00253-002-1131-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ethier N, 1998, APPL ENVIRON MICROB, V64, P4428; Evrard GX, 2007, ACTA CRYSTALLOGR D, V63, P108, DOI 10.1107/S0907444906023389; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fischer M, 2001, CARBOHYD RES, V330, P93, DOI 10.1016/S0008-6215(00)00272-X; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson AM, 2006, J MOL BIOL, V357, P1500, DOI 10.1016/j.jmb.2006.01.044; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; Lo Leggio L, 2002, FEBS LETT, V523, P103, DOI 10.1016/S0014-5793(02)02954-X; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Matzke J, 2000, FEMS MICROBIOL LETT, V183, P55, DOI 10.1016/S0378-1097(99)00630-8; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Niehaus F, 1999, APPL MICROBIOL BIOT, V51, P711, DOI 10.1007/s002530051456; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Politz O, 2000, APPL MICROBIOL BIOT, V53, P715, DOI 10.1007/s002530000351; Ryttersgaard C, 2002, BIOCHEMISTRY-US, V41, P15135, DOI 10.1021/bi026238c; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHWERMANN B, 1994, EUR J BIOCHEM, V226, P981, DOI 10.1111/j.1432-1033.1994.00981.x; Scott M, 1998, ACTA CRYSTALLOGR D, V54, P129, DOI 10.1107/S0907444997009062; Srivastava M, 2005, CHEM BIODIVERS, V2, P295, DOI 10.1002/cbdv.200590013; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timell T. E., 1967, Wood Science and Technology, V1, P45, DOI 10.1007/BF00592255; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Violot S, 2005, J MOL BIOL, V348, P1211, DOI 10.1016/j.jmb.2005.03.026; Wu G, 2005, POULTRY SCI, V84, P894, DOI 10.1093/ps/84.6.894; Xu BZ, 2002, EUR J BIOCHEM, V269, P1753, DOI 10.1046/j.1432-1327.2002.02824.x; Zhang YL, 2008, ACTA CRYSTALLOGR F, V64, P209, DOI 10.1107/S1744309108002832	59	63	77	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31551	31558		10.1074/jbc.M803409200	http://dx.doi.org/10.1074/jbc.M803409200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18755688	hybrid			2022-12-25	WOS:000260760800034
J	Huang, YC; Su, LH; Lee, GA; Chiu, PW; Cho, CC; Wu, JY; Sun, CH				Huang, Yu-Chang; Su, Li-Hsin; Lee, Gilbert A.; Chiu, Pei-Wei; Cho, Chao-Cheng; Wu, Jeng-You; Sun, Chin-Hung			Regulation of Cyst Wall Protein Promoters by Myb2 in Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYB; TRANSCRIPTIONAL ACTIVATION; GENE FAMILY; PRIMITIVE EUKARYOTE; MIM-1 GENE; V-MYB; EXPRESSION; PROTOZOAN; RNA; DNA	Myb family transcription factors are important in regulating cell proliferation, differentiation, and cell cycle progression. Giardia lamblia differentiates into infectious cysts to survive outside of the host. During encystation, genes encoding cyst wall proteins (CWPs) are coordinately induced. We have identified an encystation-induced Myb2 protein, which binds to the promoter regions of the cwp genes and myb2 itself in vitro. To elucidate the role of Myb2 in G. lamblia, we tested the hypothesis that Myb2 can activate encystation-induced genes. We found that overexpression of Myb2 resulted in an increase of expression of CWP1 at both protein and mRNA levels. Interestingly, the Myb2-overexpressing trophozoites had increased capability to differentiate into cysts. In cotransfection assays, Myb2 was able to transactivate the cwp promoters and its own promoter in vivo, suggesting that its gene can be positively autoregulated. Moreover, deletion of the N- or C-terminal domain resulted in a decrease of transactivation and autoregulation function of Myb2. We also found that the promoter of a newly identified encystation-induced gene, the giardial myeloid leukemia factor-like gene, has the Myb2 binding sites and that its mRNA levels were increased by Myb2 overexpression. Chromatin immuno-precipitation assays confirmed that Myb2 was bound to the promoters with its binding sites. Transfection of the myb2 antisense construct reduced the levels of the cwp1 transcripts and cyst formation. Our results suggest that Myb2 is a potent transactivator of the cwp genes and other endogenous genes and plays an important role in G. lamblia differentiation into cysts.	[Huang, Yu-Chang; Su, Li-Hsin; Lee, Gilbert A.; Chiu, Pei-Wei; Cho, Chao-Cheng; Wu, Jeng-You; Sun, Chin-Hung] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan	National Taiwan University	Sun, CH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021; Lee, GA/AAI-4481-2020	SUN, CHIN-HUNG/0000-0002-8604-8085; Wu, Jeng-You/0000-0002-2403-1843; Lee, Gilbert/0000-0003-1262-4702	National Science Council [NSC 94-2320-B-002-093, NSC 96-2320-B-002-040-MY3]; National Health Research Institutes in Taiwan [NHRI-EX96-9510NC, NHRI-EX97-9510NC]; Dept. of Medical Research; NTUH	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan); Dept. of Medical Research; NTUH	This work was supported by grants from the National Science Council (NSC 94-2320-B-002-093 and NSC 96-2320-B-002-040-MY3) and the National Health Research Institutes (NHRI-EX96-9510NC and NHRI-EX97-9510NC) in Taiwan and was also supported in part by the Dept. of Medical Research in NTUH.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; DUDEK H, 1992, P NATL ACAD SCI USA, V89, P1291, DOI 10.1073/pnas.89.4.1291; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; EVANS JL, 1990, MOL CELL BIOL, V10, P5747, DOI 10.1128/MCB.10.11.5747; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; HASHIMOTO T, 1995, MOL BIOL EVOL, V12, P782; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; HSIANG YHH, 1995, J IMMUNOL, V154, P5195; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Katzen AL, 1998, GENE DEV, V12, P831, DOI 10.1101/gad.12.6.831; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; Kolodziejska KM, 2008, CIRC RES, V102, P554, DOI 10.1161/CIRCRESAHA.105.162628; Lidonnici MR, 2008, BLOOD, V111, P4771, DOI 10.1182/blood-2007-08-105072; Lu CA, 2002, PLANT CELL, V14, P1963, DOI 10.1105/tpc.001735; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Marshall MM, 1997, CLIN MICROBIOL REV, V10, P67, DOI 10.1128/CMR.10.1.67; Mercy IS, 2003, J EXP BOT, V54, P1117, DOI 10.1093/jxb/erg118; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; Nair M, 2007, NUCLEIC ACIDS RES, V35, P1687, DOI 10.1093/nar/gkl1141; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Park JS, 2008, PLANT CELL REP, V27, P985, DOI 10.1007/s00299-008-0521-1; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Ramsay RG, 2005, GROWTH FACTORS, V23, P253, DOI 10.1080/08977190500233730; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Sun CH, 1998, MOL BIOCHEM PARASIT, V92, P123, DOI 10.1016/S0166-6851(97)00239-9; Van Keulen H, 1998, J EUKARYOT MICROBIOL, V45, P637, DOI 10.1111/j.1550-7408.1998.tb04560.x; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; WOLFE MS, 1992, CLIN MICROBIOL REV, V5, P93, DOI 10.1128/CMR.5.1.93-100.1992; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432	53	42	44	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31021	31029		10.1074/jbc.M805023200	http://dx.doi.org/10.1074/jbc.M805023200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768462	hybrid, Green Published			2022-12-25	WOS:000260544800057
J	Ko, CY; Hsu, HC; Shen, MR; Chang, WC; Wang, JM				Ko, Chiung-Yuan; Hsu, Hey-Chi; Shen, Meng-Ru; Chang, Wen-Chang; Wang, Ju-Ming			Epigenetic Silencing of CCAAT/Enhancer-binding Protein delta Activity by YY1/Polycomb Group/DNA Methyltransferase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA CYTOSINE-5 METHYLTRANSFERASES; ACUTE MYELOID-LEUKEMIA; EMBRYONIC STEM-CELLS; C/EBP-DELTA; ADIPOCYTE DIFFERENTIATION; BREAST-CANCER; IN-VIVO; HEPATOCELLULAR-CARCINOMA; PROMOTER ACTIVATION; MOLECULAR TARGET	Human CCAAT/enhancer-binding protein delta (CEBPD) has been reported as a tumor suppressor because it both induces growth arrest involved in differentiation and plays a crucial role as a regulator of pro-apoptotic gene expression. In this study, CEBPD gene expression is down-regulated, and " loss of function" alterations in CEBPD gene expression are observed in cervical cancer and hepatocellular carcinoma. Suppressor of zeste 12 (SUZ12), a component of the polycomb repressive complex 2 (PRC2), silences CEBPD promoter activity, enhancing the methylation of exogenous CEBPD promoter through the proximal CpG islands. Moreover, this molecular approach is consistent with the opposite mRNA expression pattern between SUZ12 and CEBPD in cervical cancer and hepatocellular carcinoma patients. We further demonstrated that Yin-Yang-1 (YY1) physically interacts with SUZ12 and can act as a mediator to recruit the polycomb group proteins and DNA methyltransferases to participate in the CEBPD gene silencing process. Taking these results into consideration, we not only demonstrate the advantage of SUZ12-silenced CEBPD expression in tumor formation but also clarify an in vivo evidence for YY1-mediated silencing paths of SUZ12 and DNA methyltransferases on the CEBPD promoter.	[Shen, Meng-Ru; Chang, Wen-Chang] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Ko, Chiung-Yuan; Chang, Wen-Chang] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Natl Cheng Kung Univ, Inst Biosignal Transduct, Tainan 70101, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Natl Cheng Kung Univ, Inst Bioinformat, Coll Biosci & Biotechnol, Tainan 70101, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan; [Hsu, Hey-Chi] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei 10002, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Taiwan University	Chang, WC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, 1 Univ Rd, Tainan 70101, Taiwan.	wcchang@mail.ncku.edu.tw; wwwjm4721@yahoo.com.tw	wang, ju-ming/A-1875-2011		Taiwan National Science Council [96-2320-B-006-044-MY2]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by and the funding to pay the Open Access publication charges for this article were provided by Grant 96-2320-B-006-044-MY2 from the Taiwan National Science Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Arai T, 2006, BREAST CANCER RES TR, V100, P169, DOI 10.1007/s10549-006-9241-9; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Bell DR, 2004, ONCOGENE, V23, P7290, DOI 10.1038/sj.onc.1207949; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brenner S, 2003, J BIOL CHEM, V278, P5597, DOI 10.1074/jbc.M207448200; Brucher BLDM, 2006, INT J CANCER, V119, P1298, DOI 10.1002/ijc.21990; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Croonquist PA, 2005, ONCOGENE, V24, P6269, DOI 10.1038/sj.onc.1208771; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Gery S, 2005, ONCOGENE, V24, P1589, DOI 10.1038/sj.onc.1208393; Gigliotti AP, 2003, EXP BIOL MED, V228, P278, DOI 10.1177/153537020322800306; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; Ikezoe T, 2005, CANCER RES, V65, P4762, DOI 10.1158/0008-5472.CAN-03-3619; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Kim J, 2008, HUM MOL GENET, V17, P391, DOI 10.1093/hmg/ddm316; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lei H, 1996, DEVELOPMENT, V122, P3195; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu YW, 2003, J IMMUNOL, V171, P821, DOI 10.4049/jimmunol.171.2.821; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Mancini DN, 1998, ONCOGENE, V16, P1161, DOI 10.1038/sj.onc.1201630; O'Rourke JP, 1999, J BIOL CHEM, V274, P16582, DOI 10.1074/jbc.274.23.16582; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Peng SY, 2004, INT J CANCER, V112, P44, DOI 10.1002/ijc.20279; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; RUESGA MA, 2006, CANC LETT, V250, P140; Sanford DC, 2005, PROSTATE, V63, P143, DOI 10.1002/pros.20159; Scardocci A, 2006, BRIT J CANCER, V95, P1108, DOI 10.1038/sj.bjc.6603392; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sivko GS, 2004, J CELL BIOCHEM, V93, P830, DOI 10.1002/jcb.20223; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Takeji M, 2004, J AM SOC NEPHROL, V15, P2383, DOI 10.1097/01.ASN.0000136426.01160.2F; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang D, 2006, BREAST CANCER RES TR, V95, P161, DOI 10.1007/s10549-005-9061-3; Tengku-Muhammad TS, 2000, CYTOKINE, V12, P1430, DOI 10.1006/cyto.2000.0711; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang JM, 2006, NUCLEIC ACIDS RES, V34, P217, DOI 10.1093/nar/gkj422; Wang JM, 2005, MOL BIOL CELL, V16, P3365, DOI 10.1091/mbc.E05-02-0105; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	60	67	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30919	30932		10.1074/jbc.M804029200	http://dx.doi.org/10.1074/jbc.M804029200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18753137	Green Published, hybrid			2022-12-25	WOS:000260544800047
J	Stockl, M; Plazzo, AP; Korte, T; Herrmann, A				Stoeckl, Martin; Plazzo, Anna Pia; Korte, Thomas; Herrmann, Andreas			Detection of Lipid Domains in Model and Cell Membranes by Fluorescence Lifetime Imaging Microscopy of Fluorescent Lipid Analogues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; SPIN-LABELED PHOSPHOLIPIDS; TIME-RESOLVED FLUORESCENCE; RESONANCE ENERGY-TRANSFER; LATERAL PHASE SEPARATION; PLASMA-MEMBRANE; ACYL-CHAIN; RAFTS; MIXTURES; MICRODOMAINS	The presence of lipid domains in cellular membranes and their characteristic features are still an issue of dividing discussion. Several recent studies implicate lipid domains in plasma membranes of mammalian cells as short lived and in the submicron range. Measuring the fluorescence lifetime of appropriate lipid analogues is a proper approach to detect domains with such properties. Here, the sensitivity of the fluorescence lifetime of 1-palmitoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl) amino]-hexanoyl]- sn-glycero-3-phospholipid (C6-NBD-phospholipid) analogues has been employed to characterize lipid domains in giant unilamellar vesicles (GUVs) and the plasma membrane of mammalian cells by fluorescence lifetime imaging (FLIM). Fluorescence decay of C6-NBD-phosphatidylcholine is characterized by a short and long lifetime. For GUVs forming microscopically visible lipid domains the longer lifetime in the liquid disordered (ld) and the liquid ordered (lo) phase was clearly distinct, being similar to 7 ns and 11 ns, respectively. Lifetimes were not sensitive to variation of cholesterol concentration of domain-forming GUVs indicating that the lipid composition and physical properties of those lipid domains are well defined entities. Even the existence of submicroscopic domains can be detected by FLIM as demonstrated for GUVs of palmitoyloleoyl phosphatidylcholine/ N-palmitoyl-D-sphingomyelin/cholesterol mixtures. A broad distribution of the long lifetime was found for C6-NBD-phosphatidylcholine inserted in the plasma membrane of HepG2 and HeLa cells centered around 11 ns. FLIM studies on lipid domains forming giant vesicles derived from the plasma membrane of HeLa cells may suggest that a variety of submicroscopic lipid domains exists in the plasma membrane of intact cells.	[Stoeckl, Martin; Plazzo, Anna Pia; Korte, Thomas; Herrmann, Andreas] Humboldt Univ, Math Nat Wissenschaftliche Fak 1, Inst Biol Biophys, D-10115 Berlin, Germany	Humboldt University of Berlin	Herrmann, A (corresponding author), Humboldt Univ, Math Nat Wissenschaftliche Fak 1, Inst Biol Biophys, Invalidenstr 43, D-10115 Berlin, Germany.	andreas.herrmann@rz.hu-berlin.de	Stöckl, Martin T/I-6554-2016; Stöckl, Martin/AAM-6743-2020	Stöckl, Martin T/0000-0001-7986-9291; Stöckl, Martin/0000-0001-7986-9291	Deutsche Forschungsgemeinschaft [FG 475, SFB 740]; European Union [MRTN-CT-2004-005330]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft ( Grants FG 475 and SFB 740) and the European Union (Grant MRTN-CT-2004-005330) ( to A. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alder-Baerens N, 2005, J BIOL CHEM, V280, P26321, DOI 10.1074/jbc.M413993200; Almeida PFF, 2005, BBA-BIOMEMBRANES, V1720, P1, DOI 10.1016/j.bbamem.2005.12.004; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bunge A, 2008, BIOPHYS J, V94, P2680, DOI 10.1529/biophysj.107.112904; CHAHINE JMEH, 1993, P NATL ACAD SCI USA, V90, P447, DOI 10.1073/pnas.90.2.447; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; CHATTOPADHYAY A, 1993, BIOCHEMISTRY-US, V32, P3804, DOI 10.1021/bi00065a037; Collins MD, 2008, P NATL ACAD SCI USA, V105, P124, DOI 10.1073/pnas.0702970105; de Almeida RFM, 2005, J MOL BIOL, V346, P1109, DOI 10.1016/j.jmb.2004.12.026; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; de Almeida RFM, 2007, BIOPHYS J, V93, P539, DOI 10.1529/biophysj.106.098822; Devaux PF, 2002, CHEM PHYS LIPIDS, V116, P115, DOI 10.1016/S0009-3084(02)00023-3; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Huster D, 2001, BIOPHYS J, V80, P822, DOI 10.1016/S0006-3495(01)76061-4; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; KARNOVSKY MJ, 1982, J CELL BIOL, V94, P1, DOI 10.1083/jcb.94.1.1; Kawasaki K, 2001, BIOPHYS J, V80, P738, DOI 10.1016/S0006-3495(01)76053-5; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; LEE AG, 1977, BIOCHIM BIOPHYS ACTA, V472, P285, DOI 10.1016/0304-4157(77)90001-6; MABREY S, 1976, P NATL ACAD SCI USA, V73, P3862, DOI 10.1073/pnas.73.11.3862; Margineanu A, 2007, BIOPHYS J, V93, P2877, DOI 10.1529/biophysj.106.100743; MORROT G, 1986, P NATL ACAD SCI USA, V83, P6863, DOI 10.1073/pnas.83.18.6863; Mukherjee S, 2004, CHEM PHYS LIPIDS, V127, P91, DOI 10.1016/j.chemphyslip.2003.09.004; Mukherjee S, 2004, ANNU REV CELL DEV BI, V20, P839, DOI 10.1146/annurev.cellbio.20.010403.095451; Muller P, 1996, HEPATOLOGY, V24, P1497; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Owen DM, 2006, BIOPHYS J, V90, pL80, DOI 10.1529/biophysj.106.084673; PETIT VA, 1974, SCIENCE, V184, P1183, DOI 10.1126/science.184.4142.1183; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Raghuraman H, 2007, BBA-BIOMEMBRANES, V1768, P1258, DOI 10.1016/j.bbamem.2007.02.001; RECKTENWALD DJ, 1981, BIOCHEMISTRY-US, V20, P4505, DOI 10.1021/bi00518a042; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Shaw JE, 2006, BIOPHYS J, V90, P2170, DOI 10.1529/biophysj.105.073510; SHIMSHICK EJ, 1973, BIOCHEMISTRY-US, V12, P2351, DOI 10.1021/bi00736a026; Silvius JR, 2006, MOL MEMBR BIOL, V23, P5, DOI 10.1080/09687860500473002; Silvius JR, 2003, BIOPHYS J, V85, P1034, DOI 10.1016/S0006-3495(03)74542-1; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tannert A, 2003, J BIOL CHEM, V278, P40631, DOI 10.1074/jbc.M302131200; TILLACK TW, 1983, BIOCHIM BIOPHYS ACTA, V733, P15, DOI 10.1016/0005-2736(83)90086-X; VAN MEER G, 1987, J CELL BIOL, V105, P1623, DOI 10.1083/jcb.105.4.1623; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Veatch SL, 2003, BIOPHYS J, V84, P725, DOI 10.1016/S0006-3495(03)74891-7; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Wustner D, 2001, TRAFFIC, V2, P277, DOI 10.1034/j.1600-0854.2001.9o135.x; Yethiraj A, 2007, BIOPHYS J, V93, P3113, DOI 10.1529/biophysj.106.101931; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	58	61	61	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30828	30837		10.1074/jbc.M801418200	http://dx.doi.org/10.1074/jbc.M801418200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18708353	Green Published, hybrid			2022-12-25	WOS:000260544800038
J	Gijon, MA; Riekhof, WR; Zarini, S; Murphy, RC; Voelker, DR				Gijon, Miguel A.; Riekhof, Wayne R.; Zarini, Simona; Murphy, Robert C.; Voelker, Dennis R.			Lysophospholipid Acyltransferases and Arachidonate Recycling in Human Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; ACYL-COA; IDENTIFICATION; METABOLISM; YEAST; BIOSYNTHESIS; REACYLATION; DISCOVERY; ACYLATION	The cycle of deacylation and reacylation of phospholipids plays a critical role in regulating availability of arachidonic acid for eicosanoid production. The major yeast lysophospholipid acyltransferase, Ale1p, is related to mammalian membrane-bound O-acyltransferase (MBOAT) proteins. We expressed four human MBOATs in yeast strains lacking Ale1p and studied their acyl-CoA and lysophospholipid specificities using novel mass spectrometry-based enzyme assays. MBOAT1 is a lysophosphatidylserine (lyso-PS) acyltransferase with preference for oleoyl-CoA. MBOAT2 also prefers oleoyl-CoA, using lysophosphatidic acid and lysophosphatidylethanolamine as acyl acceptors. MBOAT5 prefers lysophosphatidylcholine and lyso-PS to incorporate linoleoyl and arachidonoyl chains. MBOAT7 is a lysophosphatidylinositol acyltransferase with remarkable specificity for arachidonoyl-CoA. MBOAT5 and MBOAT7 are particularly susceptible to inhibition by thimerosal. Human neutrophils express mRNA for these four enzymes, and neutrophil microsomes incorporate arachidonoyl chains into phosphatidylinositol, phosphatidylcholine, PS, and phosphatidylethanolamine in a thimerosal-sensitive manner. These results strongly implicate MBOAT5 and MBOAT7 in arachidonate recycling, thus regulating free arachidonic acid levels and leukotriene synthesis in neutrophils.	[Gijon, Miguel A.; Zarini, Simona; Murphy, Robert C.; Voelker, Dennis R.] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA; [Riekhof, Wayne R.] Natl Jewish Hlth, Cell Biol Program, Dept Med, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Murphy, RC (corresponding author), Univ Colorado, Dept Pharmacol, 12801 E 17th Ave, Aurora, CO 80045 USA.			Zarini, Simona/0000-0002-7460-3299	National Institutes of Health [GM076798, HL025785, 5R37GM032453, GM081461]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL025785, R01HL025785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076798, R37GM032453, R01GM081461, R01GM032453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM076798 (to W. R. R.), HL025785 (to R. C. M.), 5R37GM032453 (to D. R. V.), and GM081461 (to D. R. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Cao JS, 2008, J BIOL CHEM, V283, P19049, DOI 10.1074/jbc.M800364200; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; CHILTON FH, 1986, J BIOL CHEM, V261, P7771; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hodges E, 2005, MOL CELL PROTEOMICS, V4, P1319, DOI 10.1074/mcp.M500117-MCP200; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; REINHOLD SL, 1989, J BIOL CHEM, V264, P21652; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Stahl U, 2008, FEBS LETT, V582, P305, DOI 10.1016/j.febslet.2007.12.020; SUMPER M, 1973, FEBS LETT, V30, P29, DOI 10.1016/0014-5793(73)80612-X; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200; Zarini S, 2006, J BIOL CHEM, V281, P10134, DOI 10.1074/jbc.M510783200; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	34	135	143	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30235	30245		10.1074/jbc.M806194200	http://dx.doi.org/10.1074/jbc.M806194200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18772128	Green Published, hybrid			2022-12-25	WOS:000260366900068
J	Hermand, P; Pincet, F; Carvalho, S; Ansanay, H; Trinquet, E; Daoudi, M; Combadiere, C; Deterre, P				Hermand, Patricia; Pincet, Frederic; Carvalho, Stephanie; Ansanay, Herve; Trinquet, Eric; Daoudi, Mehdi; Combadiere, Christophe; Deterre, Philippe			Functional Adhesiveness of the CX3CL1 Chemokine Requires Its Aggregation ROLE OF THE TRANSMEMBRANE DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; FRACTALKINE RECEPTOR CX(3)CR1; TIME-RESOLVED FLUORESCENCE; CXC-CHEMOKINE; LIVING CELLS; GLYCOPROTEIN LIGAND-1; ANTITUMOR RESPONSES; INSULIN-RECEPTOR; FIRM ADHESION; TRANSFER BRET	In its native form, the chemokine CX3CL1 is a firmly adhesive molecule promoting leukocyte adhesion and migration and hence involved, along with its unique receptor CX3CR1, in various inflammatory processes. Here we investigated the role of molecular aggregation in the CX3CL1 adhesiveness. Assays of bioluminescence resonance energy transfer (BRET) and homogeneous time-resolved fluorescence (HTRF) in transfected cell lines and in primary cells showed specific signals indicative of CX3CL1 clustering. Truncation experiments showed that the transmembrane domain played a central role in this aggregation. A chimera with mutations of the 12 central transmembrane domain residues had significantly reduced BRET signals and characteristics of a non-clustering molecule. This mutant was weakly adhesive according to flow and dual pipette adhesion assays and was less glycosylated than CX3CL1, although, as we demonstrated, loss of glycosylation did not affect the CX3CL1 adhesive potency. We postulate that cell surfaces express CX3CL1 as a constitutive oligomer and that this oligomerization is essential for its adhesive potency. Inhibition of CX3CL1 self-assembly could limit the recruitment of CX3CR1-positive cells and may be a new pathway for anti-inflammatory therapies.	[Deterre, Philippe] Univ Paris 06, Fac Med Pitie Salpetriere, Lab Immunol Cellulaire, INSERM,U543, F-75013 Paris, France; [Hermand, Patricia; Carvalho, Stephanie; Daoudi, Mehdi; Combadiere, Christophe; Deterre, Philippe] Univ Paris 06, Lab Immunol Cellulaire, INSERM UMR S 543, F-75013 Paris, France; [Pincet, Frederic] Ecole Normale Super, Lab Phys Stat, UMR CNRS 8550, F-75231 Paris, France; [Ansanay, Herve; Trinquet, Eric] Cisbio Int, HTRF Res, F-30204 Bagnols Sur Ceze, France; [Combadiere, Christophe] AP HP, Lab Immunol Cellulaire & Tissulaire, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Deterre, P (corresponding author), Univ Paris 06, Fac Med Pitie Salpetriere, Lab Immunol Cellulaire, INSERM,U543, 91 Blvd Hop, F-75013 Paris, France.	deterre@ccr.jussieu.fr	Deterre, Philippe/O-8984-2017; Combadiere, Christophe/I-5639-2013	Deterre, Philippe/0000-0001-9303-0791; Combadiere, Christophe/0000-0002-1755-4531; HERMAND, Patricia/0000-0003-0628-9733; PINCET, FREDERIC/0000-0002-4243-2157	Association de Recherche contre le Cancer; Institut National de la Sante et de la Recherche Medicale; European FP6 "INNOCHEM" [LSHB-CT-2005-518167]	Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); European FP6 "INNOCHEM"	This work was supported by grants from the Association de Recherche contre le Cancer and the Institut National de la Sante et de la Recherche Medicale (Programme National De Recherche Sur Les Maladies Cardiovasculaires) and by European FP6 "INNOCHEM" Contract LSHB-CT-2005-518167 (to C. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bazin H, 2002, J Biotechnol, V82, P233, DOI 10.1016/S1389-0352(01)00040-X; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Buensuceso C, 2003, J BIOL CHEM, V278, P15217, DOI 10.1074/jbc.M213234200; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Combadiere B, 2007, M S-MED SCI, V23, P173, DOI 10.1051/medsci/2007232173; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Daoudi M, 2004, J BIOL CHEM, V279, P19649, DOI 10.1074/jbc.M313457200; Durkan AM, 2007, J AM SOC NEPHROL, V18, P74, DOI 10.1681/ASN.2006080862; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; Feng LL, 1999, KIDNEY INT, V56, P612, DOI 10.1046/j.1523-1755.1999.00604.x; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Fong AM, 2000, J BIOL CHEM, V275, P3781, DOI 10.1074/jbc.275.6.3781; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; Hermand P, 2000, J BIOL CHEM, V275, P26002, DOI 10.1074/jbc.M002823200; Hoover DM, 2000, J BIOL CHEM, V275, P23187, DOI 10.1074/jbc.M002584200; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Imaizumi T, 2000, TOHOKU J EXP MED, V192, P127, DOI 10.1620/tjem.192.127; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jia Y, 2006, ANAL BIOCHEM, V356, P273, DOI 10.1016/j.ab.2006.05.006; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Lavergne E, 2003, CANCER RES, V63, P7468; LeFevre KR, 2003, P NATL ACAD SCI USA, V100, P2345, DOI 10.1073/pnas.0537925100; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Liu GY, 2005, J BIOL CHEM, V280, P19858, DOI 10.1074/jbc.M413073200; Ludwig A, 2002, J IMMUNOL, V168, P604, DOI 10.4049/jimmunol.168.2.604; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Marullo S, 2007, TRENDS PHARMACOL SCI, V28, P362, DOI 10.1016/j.tips.2007.06.007; Mathis G, 1999, J BIOMOL SCREEN, V4, P309, DOI 10.1177/108705719900400605; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Mizoue LS, 1999, BIOCHEMISTRY-US, V38, P1402, DOI 10.1021/bi9820614; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Nouaille S, 2006, BIOCHEM PHARMACOL, V72, P1355, DOI 10.1016/j.bcp.2006.07.018; Prince SM, 2003, J MOL BIOL, V326, P307, DOI 10.1016/S0022-2836(02)01361-X; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Schulte A, 2007, BIOCHEM BIOPH RES CO, V358, P233, DOI 10.1016/j.bbrc.2007.04.100; Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465; Snapp KR, 1998, J CELL BIOL, V142, P263, DOI 10.1083/jcb.142.1.263; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Trinquet E, 2001, ANAL BIOCHEM, V296, P232, DOI 10.1006/abio.2001.5298; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; Wehrle-Haller B, 2003, J PATHOL, V200, P481, DOI 10.1002/path.1399; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Yu YRA, 2007, INT J CANCER, V121, P316, DOI 10.1002/ijc.22660; Zhou JY, 2003, J PHARMACOL EXP THER, V305, P460, DOI 10.1124/jpet.102.048637	66	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30225	30234		10.1074/jbc.M802638200	http://dx.doi.org/10.1074/jbc.M802638200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18725411	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000260366900067
J	Necela, BM; Su, WD; Thompson, EA				Necela, Brian M.; Su, Weidong; Thompson, E. Aubrey			Peroxisome Proliferator-activated Receptor gamma Down-regulates Follistatin in Intestinal Epithelial Cells through SP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; ACTIVIN-BINDING PROTEIN; PPAR-GAMMA; GENE-EXPRESSION; COLON-CANCER; LIGANDS SUPPRESS; TRANSCRIPTION ACTIVATION; HUMAN PROSTATE; GROWTH; DIFFERENTIATION	Activation of peroxisome proliferator-activated receptor gamma (PPAR gamma) down-regulates the expression of follistatin mRNA in intestinal epithelial cells in vivo. The mechanism of PPAR gamma-mediated down-regulation of follistatin was investigated using non-transformed, rat intestinal epithelial cells (RIE-1). RIE cells expressed activin A, the activin receptors ActRI and ActRII, and the follistatin-315 mRNA. RIE-1 cells responded to endogenous activin A, and this response was antagonized by follistatin, as evidenced by changes in cell growth and regulation of an activin-responsive reporter. Using RIE-1 cells, we show that activation of PPAR gamma by rosiglitazone reduced follistatin mRNA levels in a dose- and concentration-dependent manner. Down-regulation of follistatin by rosiglitazone required the DNA binding domain of PPAR gamma and was dependent upon dimerization with the retinoid X receptor. Inhibition of follistatin expression by rosiglitazone was not associated with decreased follistatin mRNA stability, suggesting that regulation may be at the promoter level. Analysis of the follistatin promoter revealed consensus binding sites for AP-1, AP-2, and Sp1. Targeting the AP-1 pathway with SP600125, an inhibitor of JNK, and TAM67, a dominant negative c-Jun, had no effect on PPAR gamma-mediated down-regulation of follistatin. However, the follistatin promoter was dramatically regulated by Sp1, and this regulation was inhibited by PPAR gamma expression. Knockdown of Sp1 expression relieved repression of follistatin levels by rosiglitazone. Moreover, PPAR gamma was found to interact with Sp1 and repress its transcriptional activation function. Collectively, our data indicate that repression of Sp1 transcriptional activity by PPAR gamma is the underlying mechanism responsible for PPAR gamma-mediated regulation of follistatin expression.	[Necela, Brian M.; Su, Weidong; Thompson, E. Aubrey] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Necela, BM (corresponding author), Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Griffin Canc Res Bld,Rm 241,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	necela.brian@mayo.edu			Crohn's and Colitis Foundation; Mayo Foundation	Crohn's and Colitis Foundation; Mayo Foundation	This work was supported by the Crohn's and Colitis Foundation and the Mayo Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; Bartholin L, 2002, ONCOGENE, V21, P2227, DOI 10.1038/sj.onc.1205294; Bartholin L, 2001, ONCOGENE, V20, P5409, DOI 10.1038/sj.onc.1204720; Bilezikjian LM, 2001, ENDOCRINOLOGY, V142, P1065, DOI 10.1210/en.142.3.1065; BLAY J, 1984, CELL BIOL INT REP, V8, P551, DOI 10.1016/0309-1651(84)90054-7; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; Brockman JA, 1998, GASTROENTEROLOGY, V115, P1049, DOI 10.1016/S0016-5085(98)70072-1; Bush CR, 2007, J BIOL CHEM, V282, P23387, DOI 10.1074/jbc.M702708200; Chang TH, 2000, CANCER RES, V60, P1129; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen L, 2006, J BIOL CHEM, V281, P24575, DOI 10.1074/jbc.M604147200; Chen L, 2006, MOL CELL ENDOCRINOL, V251, P17, DOI 10.1016/j.mce.2006.02.006; Chen YG, 2006, EXP BIOL MED, V231, P534; Chung SS, 2006, BIOCHEM BIOPH RES CO, V348, P253, DOI 10.1016/j.bbrc.2006.07.048; Coyle AT, 2006, BIOCHEM PHARMACOL, V71, P1308, DOI 10.1016/j.bcp.2006.01.011; Crosby MB, 2005, J PHARMACOL EXP THER, V312, P69, DOI 10.1124/jpet.104.074005; DEPAOLO LV, 1991, P SOC EXP BIOL MED, V198, P500; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Dignass AU, 2002, SCAND J GASTROENTERO, V37, P936, DOI 10.1080/003655202760230900; Dohi T, 2005, GASTROENTEROLOGY, V128, P411, DOI 10.1053/j.gastro.2004.11.063; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; Ebert S, 2006, J NEUROL SCI, V250, P50, DOI 10.1016/j.jns.2006.06.026; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Grusch M, 2006, J HEPATOL, V45, P673, DOI 10.1016/j.jhep.2006.06.014; Gupta RA, 2003, J BIOL CHEM, V278, P7431, DOI 10.1074/jbc.M208076200; Han SW, 2005, AM J PHYSIOL-LUNG C, V289, pL419, DOI 10.1152/ajplung.00002.2005; Hardy CL, 2006, CLIN EXP ALLERGY, V36, P941, DOI 10.1111/j.1365-2222.2006.02523.x; Harkonen P, 2003, J CLIN ENDOCR METAB, V88, P705, DOI 10.1210/jc.2002-020236; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Hubner G, 1997, LAB INVEST, V77, P311; Jones KL, 2004, MOL CELL ENDOCRINOL, V225, P119, DOI 10.1016/j.mce.2004.07.010; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; Jones MR, 2007, MOL HUM REPROD, V13, P237, DOI 10.1093/molehr/gal120; Jung BH, 2007, GASTROENTEROLOGY, V132, P633, DOI 10.1053/j.gastro.2006.11.018; Katayama K, 2003, GASTROENTEROLOGY, V124, P1315, DOI 10.1016/S0016-5085(03)00262-2; Kato M, 2004, J CANCER RES CLIN, V130, P73, DOI 10.1007/s00432-003-0510-2; Kitamura S, 1999, JPN J CANCER RES, V90, P75, DOI 10.1111/j.1349-7006.1999.tb00668.x; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Lewis JD, 2001, AM J GASTROENTEROL, V96, P3323; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luisi S, 2001, EUR J ENDOCRINOL, V145, P225, DOI 10.1530/eje.0.1450225; Lytle C, 2005, INFLAMM BOWEL DIS, V11, P231, DOI 10.1097/01.MIB.0000160805.46235.eb; Maeshima A, 2008, ENDOCR J, V55, P1, DOI 10.1507/endocrj.KR-113; Marin HE, 2006, CANCER RES, V66, P4394, DOI 10.1158/0008-5472.CAN-05-4277; McPherson SJ, 1999, ENDOCRINOLOGY, V140, P5303, DOI 10.1210/en.140.11.5303; Meissner M, 2004, CIRC RES, V94, P324, DOI 10.1161/01.RES.0000113781.08139.81; MIYANAGA K, 1993, MOL CELL ENDOCRINOL, V92, P99, DOI 10.1016/0303-7207(93)90080-4; Moore KJ, 2001, CURR OPIN LIPIDOL, V12, P519, DOI 10.1097/00041433-200110000-00007; Mukherjee R, 1997, J BIOL CHEM, V272, P8071, DOI 10.1074/jbc.272.12.8071; Osawa E, 2003, GASTROENTEROLOGY, V124, P361, DOI 10.1053/gast.2003.50067; Pangas SA, 2000, TRENDS ENDOCRIN MET, V11, P309, DOI 10.1016/S1043-2760(00)00294-0; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Phillips DJ, 2000, BIOESSAYS, V22, P689, DOI 10.1002/1521-1878(200008)22:8<689::AID-BIES2>3.0.CO;2-5; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Phillips DJ, 2004, GROWTH FACTORS, V22, P13, DOI 10.1080/08977190410001688687; Risbridger GP, 2001, ENDOCR REV, V22, P836, DOI 10.1210/er.22.6.836; Rossmanith W, 2002, MOL CARCINOGEN, V35, P1, DOI 10.1002/mc.10068; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Saubermann LJ, 2002, INFLAMM BOWEL DIS, V8, P330, DOI 10.1097/00054725-200209000-00004; Schaefer KL, 2005, INFLAMM BOWEL DIS, V11, P244, DOI 10.1097/01.MIB.0000160770.94199.9b; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG657, DOI 10.1152/ajpgi.00381.2006; Shen ZJ, 2005, INT J GYNECOL OBSTET, V88, P336, DOI 10.1016/j.ijgo.2004.12.024; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Sonoyama K, 2000, AM J PHYSIOL-GASTR L, V278, pG89, DOI 10.1152/ajpgi.2000.278.1.G89; Stove C, 2004, ONCOGENE, V23, P5330, DOI 10.1038/sj.onc.1207699; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Su WD, 2007, PHYSIOL GENOMICS, V30, P342, DOI 10.1152/physiolgenomics.00042.2007; Subbaramaiah K, 2001, J BIOL CHEM, V276, P12440, DOI 10.1074/jbc.M007237200; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125; Tanaka T, 2001, CANCER RES, V61, P2424; Thomas TZ, 1997, J CLIN ENDOCR METAB, V82, P3851, DOI 10.1210/jc.82.11.3851; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Vale W, 2004, ANN NY ACAD SCI, V1038, P142, DOI 10.1196/annals.1315.023; Wang QF, 1999, J UROLOGY, V161, P1378, DOI 10.1016/S0022-5347(01)61687-2; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Werner S, 2006, CYTOKINE GROWTH F R, V17, P157, DOI 10.1016/j.cytogfr.2006.01.001; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Yoshizumi T, 2004, INT J ONCOL, V25, P631; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	88	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29784	29794		10.1074/jbc.M804481200	http://dx.doi.org/10.1074/jbc.M804481200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768463	hybrid, Green Published			2022-12-25	WOS:000260366900022
J	Ravindran, S; Narayanan, K; Eapen, AS; Hao, JJ; Ramachandran, A; Blond, S; George, A				Ravindran, Sriram; Narayanan, Karthikeyan; Eapen, Asha Sarah; Hao, Jianjun; Ramachandran, Amsaveni; Blond, Sylvie; George, Anne			Endoplasmic Reticulum Chaperone Protein GRP-78 Mediates Endocytosis of Dentin Matrix Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; CAVEOLAR ENDOCYTOSIS; GENE-TRANSCRIPTION; COXSACKIEVIRUS A9; CANCER CELLS; IDENTIFICATION; EXPRESSION; SURFACE; MEMBRANE; BINDING	Dentin matrix protein 1 (DMP1), a phosphorylated protein present in the mineral phase of both vertebrates and invertebrates, is a key regulatory protein during biogenic formation of mineral deposits. Previously we showed that DMP1 is localized in the nuclear compartment of preosteoblasts and preodontoblasts. In the nucleus DMP1 might play an important role in the regulation of genes that control osteoblast or odontoblast differentiation. Here, we show that cellular uptake of DMP1 occurs through endocytosis. Interestingly, this process is initiated by DMP1 binding to the glucose-regulated protein-78 (GRP-78) localized on the plasma membrane of preodontoblast cells. Binding of DMP1 to GRP-78 receptor was determined to be specific and saturable with a binding dissociation constant K-D = 85 nM. We further depict a road map for the endocytosed DMP1 and demonstrate that the internalization is mediated primarily by caveolae and that the vesicles containing DMP1 are routed to the nucleus along microtubules. Immunohistochemical analysis and binding studies performed with biotin-labeled DMP1 confirm spatial co-localization of DMP1 and GRP-78 in the preodontoblasts of a developing mouse molar. Co-localization of DMP1 with GRP-78 was also observed in T4-4 preodontoblast cells, dental pulp stem cells, and primary preodontoblasts. By small interfering RNA techniques, we demonstrate that the receptor for DMP1 is GRP-78. Therefore, binding of DMP1 with GRP-78 receptor might be an important mechanism by which DMP1 is internalized and transported to the nucleus during bone and tooth development.	[Ravindran, Sriram; Narayanan, Karthikeyan; Eapen, Asha Sarah; Hao, Jianjun; Ramachandran, Amsaveni; George, Anne] Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA; [Blond, Sylvie] Univ Illinois, Dept Pharmaceut Biotechnol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	George, A (corresponding author), Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA.	anneg@uic.edu	Narayanan, Karthikeyan/D-1957-2010	Narayanan, Karthikeyan/0000-0001-5136-2296; GEORGE, ANNE/0000-0002-9008-7642	National Institutes of Health [DE 11657, DE 16533]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011657, R01DE016533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE 11657 and DE 16533. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altmeyer A, 1996, INT J CANCER, V69, P340, DOI 10.1002/(SICI)1097-0215(19960822)69:4<340::AID-IJC18>3.0.CO;2-9; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; BARON DA, 1985, AM J PHYSIOL-RENAL, V249, P464; Batouli S, 2003, J DENT RES, V82, P976, DOI 10.1177/154405910308201208; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; GEORGE A, 1994, J HISTOCHEM CYTOCHEM, V42, P1527, DOI 10.1177/42.12.7983353; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hao JJ, 2002, J BIOL CHEM, V277, P19976, DOI 10.1074/jbc.M112223200; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Inal J, 2005, EXP CELL RES, V310, P54, DOI 10.1016/j.yexcr.2005.07.003; Jain A, 2002, J BIOL CHEM, V277, P13700, DOI 10.1074/jbc.M110757200; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Karadag A, 2005, CANCER RES, V65, P11545, DOI 10.1158/0008-5472.CAN-05-2861; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Luo TC, 2001, J VIROL, V75, P2488, DOI 10.1128/JVI.75.5.2488-2492.2001; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; MacDougall M, 1998, J BONE MINER RES, V13, P422, DOI 10.1359/jbmr.1998.13.3.422; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Prevostel C, 2000, J CELL SCI, V113, P2575; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Schousboe I, 2004, EUR J BIOCHEM, V271, P2998, DOI 10.1111/j.1432-1033.2004.04229.x; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Srinivasan R, 1999, CONNECT TISSUE RES, V40, P251, DOI 10.3109/03008209909000703; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Triantafilou K, 2003, VIROLOGY, V317, P128, DOI 10.1016/j.virol.2003.08.036; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xiao GQ, 1999, MOL BRAIN RES, V72, P121, DOI 10.1016/S0169-328X(99)00188-6; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200	45	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29658	29670		10.1074/jbc.M800786200	http://dx.doi.org/10.1074/jbc.M800786200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18757373	Green Published, hybrid			2022-12-25	WOS:000260366900009
J	Liu, YD; Chen, XY; Enk, JZ; Plant, M; Dillon, TM; Flynn, GC				Liu, Y. Diana; Chen, Xiaoyu; Enk, Jian Zhang-van; Plant, Matt; Dillon, Thomas M.; Flynn, Gregory C.			Human IgG2 Antibody Disulfide Rearrangement in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOMERASE; PLASMA	Proteins destined to circulate in the blood are first folded and assembled in the endoplasmic reticulum of secretory cells. For antibodies, like many other serum proteins, the folding and assembly steps involve the formation of disulfide bonds. Such bonds have been thought to be static features of proteins, stabilizing domains, and linking polypeptide chains, although some cases of extracellular disulfide bond cleavage have been noted. Recently, the human IgG2 antibody subclass was found to possess multiple structures differing in specific disulfide linkages. These structures are naturally occurring and can, in some cases, affect the activity of the antibody. Here we show that these IgG2 disulfide linkages interconvert while circulating in humans. Secretory cells initially produce primarily one form (IgG2-A), which is rapidly converted to a second form (IgG2-A/B) while circulating in the blood, followed by a slower conversion to a third form (IgG2-B). This work demonstrates that the disulfide structure of the IgG2 antibody is dynamic in vivo, on a time scale similar to that of the protein's lifetime. Thus, changes to the IgG2 disulfide structure provide a marker of the protein's age and may alter its activity over its lifetime.	[Liu, Y. Diana; Chen, Xiaoyu; Flynn, Gregory C.] Amgen Inc, Dept Analyt & Formulat Sci, Thousand Oaks, CA 91320 USA; [Enk, Jian Zhang-van] Amgen Inc, Dept Informat Syst, Thousand Oaks, CA 91320 USA; [Plant, Matt] Amgen Inc, Dept Inflammat, Thousand Oaks, CA 91320 USA; [Dillon, Thomas M.] Amgen Inc, Dept Formulat & Analyt Resources, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen	Flynn, GC (corresponding author), Amgen Inc, Dept Analyt & Formulat Sci, 1 Amgen Ctr Dr,Mail Stop 30E-1-C, Thousand Oaks, CA 91320 USA.	gflynn@amgen.com	Liu, Y Diana/AAU-4624-2021					Alarazi P.N., 1988, ANNU REV IMMUNOL, V6, P550; ANDERSSON A, 1993, CLIN CHEM, V39, P1590; Chen XY, 2007, ANAL BIOCHEM, V370, P147, DOI 10.1016/j.ab.2007.08.012; Chow AW, 2006, METH MOL B, V339, P145, DOI 10.1385/1-59745-076-6:145; Di Giuseppe D, 2003, J LAB CLIN MED, V142, P21, DOI 10.1016/S0022-2143(03)00057-X; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Dillon TM, 2006, J CHROMATOGR A, V1120, P112, DOI 10.1016/j.chroma.2006.01.016; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FRANGIONE B, 1968, J MOL BIOL, V33, P983; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOSOWER EM, 1995, METHOD ENZYMOL, V251, P133, DOI 10.1016/0076-6879(95)51117-2; NEWTON GL, 1995, METHOD ENZYMOL, V251, P148, DOI 10.1016/0076-6879(95)51118-0; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200	19	95	99	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29266	29272		10.1074/jbc.M804787200	http://dx.doi.org/10.1074/jbc.M804787200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18713741	Green Published, hybrid			2022-12-25	WOS:000260179900053
J	Mersfelder, EL; Parthun, MR				Mersfelder, Erica L.; Parthun, Mark R.			Involvement of Hat1p (Kat1p) Catalytic Activity and Subcellular Localization in Telomeric Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY FACTOR-I; HISTONE ACETYLTRANSFERASE-B; GCN5 TRANSCRIPTIONAL COACTIVATOR; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; COENZYME-A; ASPARAGINE RESIDUE; ACETYLATION SITES; MAIZE EMBRYOS; HIR PROTEINS	Previous studies have shown that loss of the type B histone acetyltransferase Hat1p leads to defects in telomeric silencing in Saccharomyces cerevisiae. We used this phenotype to explore a number of functional characteristics of this enzyme. To determine whether the enzymatic activity of Hat1p is necessary for its role in telomeric silencing, a structurally conserved glutamic acid residue (Glu-255) that has been proposed to be the enzymes catalytic base was mutated. Surprisingly neither this residue nor any other acidic residues near the enzymes active site were essential for enzymatic activity. This suggests that Hat1p differs from most histone acetyltransferases in that it does not use an acidic amino acid as a catalytic base. The effects of these Hat1p mutants on enzymatic activity correlated with their effects on telomeric silencing indicating that the ability of Hat1p to acetylate substrates is important for its in vivo function. Despite its presumed role in the acetylation of newly synthesized histones in the cytoplasm, Hat1p was found to be a predominantly nuclear protein. This subcellular localization of Hat1p is important for its in vivo function because a construct that prevents its accumulation in the nucleus caused defects in telomeric silencing similar to those seen with a deletion mutant. Therefore, the presence of catalytically active Hat1p in the cytoplasm is not sufficient to support normal telomeric silencing. Hence both enzymatic activity and nuclear localization are necessary characteristics of Hat1p function in telomeric silencing.	[Mersfelder, Erica L.; Parthun, Mark R.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Parthun, MR (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.				National Institutes of Health [GM062970]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062970. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams Alison, 1997, P99; Ahmad A, 2001, NUCLEIC ACIDS RES, V29, P629, DOI 10.1093/nar/29.3.629; Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; Barman HK, 2006, BIOCHEM BIOPH RES CO, V345, P1547, DOI 10.1016/j.bbrc.2006.05.079; Benson LJ, 2007, J BIOL CHEM, V282, P836, DOI 10.1074/jbc.M607464200; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Chang L, 1997, BIOCHEMISTRY-US, V36, P469, DOI 10.1021/bi962069i; CHICOINE LG, 1986, J BIOL CHEM, V261, P1071; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Eberharter A, 1996, FEBS LETT, V386, P75, DOI 10.1016/0014-5793(96)00401-2; Enomoto S, 1997, GENE DEV, V11, P358, DOI 10.1101/gad.11.3.358; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; FENG HP, 1993, BIOCHEMISTRY-US, V32, P7824, DOI 10.1021/bi00081a030; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Ichiyama S, 2004, BBA-PROTEINS PROTEOM, V1698, P27, DOI 10.1016/j.bbapap.2003.10.002; Ichiyama S, 2000, J BIOL CHEM, V275, P40804, DOI 10.1074/jbc.M008065200; Imhof A, 1999, BIOCHEMISTRY-US, V38, P13085, DOI 10.1021/bi9912490; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Kelly TJ, 2000, MOL CELL BIOL, V20, P7051, DOI 10.1128/MCB.20.19.7051-7058.2000; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Langer MR, 2001, J BIOL CHEM, V276, P31321, DOI 10.1074/jbc.M103839200; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; LIN C, 2008, STRUCTURE L IN PRESS; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lusser A, 1999, NUCLEIC ACIDS RES, V27, P4427, DOI 10.1093/nar/27.22.4427; Lusser A, 1997, EUR J CELL BIOL, V74, P102; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Parthun MR, 2007, ONCOGENE, V26, P5319, DOI 10.1038/sj.onc.1210602; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Poveda A, 2008, FEBS J, V275, P2122, DOI 10.1111/j.1742-4658.2008.06367.x; PRIES F, 1995, FEBS LETT, V358, P171, DOI 10.1016/0014-5793(94)01420-6; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; SCHULTZ MC, 1991, P NATL ACAD SCI USA, V88, P1004, DOI 10.1073/pnas.88.3.1004; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; STAVROPOULOS P, 2008, P NATL ACAD SCI US; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Suter B, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-38; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849	59	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29060	29068		10.1074/jbc.M802564200	http://dx.doi.org/10.1074/jbc.M802564200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18753131	Green Published, hybrid			2022-12-25	WOS:000260179900033
J	Smeets, PJH; Teunissen, BEJ; Planavila, A; den Bosch, HVV; Willemsen, PHM; van der Vusse, GJ; van Bilsen, M				Smeets, Pascal J. H.; Teunissen, Birgit E. J.; Planavila, Anna; de Vogel-van den Bosch, Heleen; Willemsen, Peter H. M.; van der Vusse, Ger J.; van Bilsen, Marc			Inflammatory Pathways Are Activated during Cardiomyocyte Hypertrophy and Attenuated by Peroxisome Proliferator-activated Receptors PPAR alpha and PPAR delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; CARDIAC-SPECIFIC OVEREXPRESSION; VENTRICULAR HYPERTROPHY; C-JUN; GAMMA; MICE; EXPRESSION; GROWTH; ROSIGLITAZONE	Accumulating evidence indicates an important role for inflammation in cardiac hypertrophy and failure. Peroxisome proliferator-activated receptors (PPARs) have been reported to attenuate inflammatory signaling pathways and, as such, may interfere with cardiac remodeling. Accordingly, the objectives of the present study were to explore the relationship between cardiomyocyte hypertrophy and inflammation and to investigate whether PPAR alpha and PPAR delta are able to inhibit NF-kappa B activation and, consequently, the hypertrophic growth response of neonatal rat cardiomyocytes (NCM). mRNA levels of markers of both hypertrophy and inflammation were increased following treatment with the pro-hypertrophic factor phenylephrine (PE) or the chemokine TNF-alpha. Induction of inflammatory genes was found to be fast (within 2 h after stimulation) and transient, while induction of hypertrophic marker genes was more gradual (peaking at 24-48 h). Inflammatory and hypertrophic pathways appeared to converge on NF-kappa B as both PE and TNF-alpha increased NF-kappa B binding activity as measured by electrophoretic mobility shift assay. Following transient transfection, the p65-induced transcriptional activation of a NF-kappa B reporter construct was significantly blunted after co-transfection of PPAR alpha or PPAR delta in the presence of their respective ligands. Finally, adenoviral overexpression of PPAR alpha and PPAR delta markedly attenuated cell enlargement and the expression of hypertrophic marker genes in PE-stimulated NCM. The collective findings reveal a close relationship between hypertrophic and inflammatory signaling pathways in the cardiomyocyte. It was shown that both PPAR alpha and PPAR delta are able to mitigate cardiomyocyte hypertrophy in vitro by inhibiting NF-kappa B activation.	[Smeets, Pascal J. H.; Teunissen, Birgit E. J.; Planavila, Anna; de Vogel-van den Bosch, Heleen; Willemsen, Peter H. M.; van der Vusse, Ger J.; van Bilsen, Marc] Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands	Maastricht University	van Bilsen, M (corresponding author), Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht, POB 616, NL-6200 MD Maastricht, Netherlands.	Marc.vanbilsen@fys.unimaas.nl	van Bilsen, Marc/E-8342-2016	Anna, Planavila Porta/0000-0001-5474-4724; de Vogel-van den Bosch, Heleen/0000-0002-7454-1403	Netherlands Organization for Scientific Research [NWO 912-04-017]; EU [LSHM-CT-2005-018833]; Spanish Ministry of Education [EX2005-1376]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); Spanish Ministry of Education(Spanish Government)	This work was supported by a grant from the Netherlands Organization for Scientific Research (NWO 912-04-017, to M. v. B.) and EU FP6 Grant LSHM-CT-2005-018833/EUGeneHeart. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a postdoctoral fellowship from the Spanish Ministry of Education (EX2005-1376). Current address: Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Avda Diagonal 645, 08028-Barcelona, Spain.	Blanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Clerk A, 1999, J MOL CELL CARDIOL, V31, P2087, DOI 10.1006/jmcc.1999.1040; Cuzzocrea S, 2004, EUR J PHARMACOL, V483, P79, DOI 10.1016/j.ejphar.2003.10.056; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; deVries JE, 1997, J LIPID RES, V38, P1384; Ding GL, 2006, J MOL CELL CARDIOL, V40, P821, DOI 10.1016/j.yjmcc.2006.03.422; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Gupta S, 2005, AM J PHYSIOL-HEART C, V289, pH20, DOI 10.1152/ajpheart.00082.2005; Ha TZ, 2005, FREE RADICAL BIO MED, V39, P1570, DOI 10.1016/j.freeradbiomed.2005.08.002; Hall G, 2006, J MOL CELL CARDIOL, V41, P580, DOI 10.1016/j.yjmcc.2006.07.006; Higuchi Y, 2006, AM J PHYSIOL-HEART C, V290, pH590, DOI 10.1152/ajpheart.00379.2005; Irukayama-Tomobe Y, 2004, CIRCULATION, V109, P904, DOI 10.1161/01.CIR.0000112596.06954.00; Jucker BM, 2007, J CARDIOVASC PHARM, V50, P25, DOI 10.1097/FJC.0b013e31804b4163; Kawano S, 2005, CARDIOVASC RES, V67, P689, DOI 10.1016/j.cardiores.2005.04.030; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee KS, 2005, FASEB J, V19, P1033, DOI 10.1096/fj.04-3309fje; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Li YH, 2004, AM J PHYSIOL-HEART C, V287, pH1712, DOI 10.1152/ajpheart.00124.2004; Liang FQ, 2003, ENDOCRINOLOGY, V144, P4187, DOI 10.1210/en.2002-0217; Liu HR, 2004, CARDIOVASC RES, V62, P135, DOI 10.1016/j.cardiores.2003.12.027; Nishikawa K, 2006, AM J PHYSIOL-HEART C, V291, pH176, DOI 10.1152/ajpheart.00269.2005; Ogata T, 2004, J AM COLL CARDIOL, V43, P1481, DOI 10.1016/j.jacc.2003.11.043; Peng TQ, 2004, FASEB J, V18, P293, DOI 10.1096/fj.04-2289fje; Planavila A, 2005, J BIOL CHEM, V280, P17464, DOI 10.1074/jbc.M414220200; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; SHUBEITA HE, 1992, P NATL ACAD SCI USA, V89, P1305, DOI 10.1073/pnas.89.4.1305; Smeets PJH, 2007, ACTA PHYSIOL, V191, P171, DOI 10.1111/j.1748-1716.2007.01752.x; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Takano H, 2000, CIRC RES, V87, P596, DOI 10.1161/01.RES.87.7.596; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; THAIK CM, 1995, J CLIN INVEST, V96, P1093, DOI 10.1172/JCI118095; van Bilsen M, 2002, MOL CELL BIOCHEM, V239, P131, DOI 10.1023/A:1020553428294; Wayman Nicole S, 2002, Med Sci Monit, V8, pBR243; Wayman NS, 2002, FASEB J, V16, P1027, DOI 10.1096/fj.01-0793com; Yeh CH, 2006, SHOCK, V26, P262, DOI 10.1097/01.shk.0000225863.56714.96; Yndestad A, 2006, HEART FAIL REV, V11, P83, DOI 10.1007/s10741-006-9196-2; Yokoyama T, 1997, CIRCULATION, V95, P1247	42	93	108	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29109	29118		10.1074/jbc.M802143200	http://dx.doi.org/10.1074/jbc.M802143200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18701451	hybrid, Green Published			2022-12-25	WOS:000260179900038
J	Wood, JL; Liang, YL; Li, KY; Chen, JJ				Wood, Jamie L.; Liang, Yulong; Li, Kaiyi; Chen, Junjie			Microcephalin/MCPH1 Associates with the Condensin II Complex to Function in Homologous Recombination Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; CHROMOSOME CONDENSATION; GENOMIC STABILITY; PROTEIN; MUTATIONS; MCPH1; SIZE; LOCALIZATION; PATHWAY	Microcephalin/ MCPH1 is one of the causative genes responsible for the autosomal recessive disorder primary microcephaly. Patients with this disease present with mental retardation and dramatic reduction in head size, and cells derived from these patients contain abnormally condensed chromosomes. MCPH1 contains an N-terminal BRCT and tandem C-terminal BRCT domains. More recently, MCPH1 has been implicated in the cellular response to DNA damage; however, the exact mechanism remains unclear. Here, we report the identification Condensin II as a major MCPH1-interacting protein. MCPH1 and Condensin II interact in vivo, mediated by the CAPG2 subunit of Condensin II binding to a middle domain (residues 376-485) of MCPH1. Interestingly, while Condensin II is not required for the IR-induced G2/M checkpoint, Condensin II-depleted cells have a defect in HR repair, which is also present in MCPH1 -/- MEFs. Moreover, the Condensin II binding region of MCPH1 is also required for HR function. Collectively, we have identified a novel function of MCPH1 to modulate HR repair through Condensin II, and thereby maintain genome integrity.Microcephalin/MCPH1 is one of the causative genes responsible for the autosomal recessive disorder primary microcephaly. Patients with this disease present with mental retardation and dramatic reduction in head size, and cells derived from these patients contain abnormally condensed chromosomes. MCPH1 contains an N-terminal BRCT and tandem C- terminal BRCT domains. More recently, MCPH1 has been implicated in the cellular response to DNAdamage; however, the exact mechanism remains unclear. Here, we report the identification Condensin II as a major MCPH1-interacting protein. MCPH1 and Condensin II interact in vivo, mediated by the CAPG2 subunit of Condensin II binding to a middle domain ( residues 376 - 485) of MCPH1. Interestingly, while Condensin II is not required for the IR-induced G2/M checkpoint, Condensin II- depleted cells have a defect in HR repair, which is also present in MCPH1(-/-) MEFs. Moreover, the Condensin II binding region of MCPH1 is also required for HR function. Collectively, we have identified a novel function of MCPH1 to modulate HR repair through Condensin II, and thereby maintain genome integrity.	[Liang, Yulong; Li, Kaiyi] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Wood, Jamie L.; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Biol, New Haven, CT 06473 USA; [Wood, Jamie L.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55901 USA	Baylor College of Medicine; Yale University; Mayo Clinic	Li, KY (corresponding author), Baylor Coll Med, Dept Surg, Houston, TX 77030 USA.	kli@bcm.tmc.edu; Junjie.chen@yale.edu	Liang, Yulong/A-2171-2013	Liang, Yulong/0000-0001-8219-9575	National Institutes of Health [CA92312, CA100100, R01CA109574-01A]; BCTR [R0504162T]; NATIONAL CANCER INSTITUTE [R01CA092312, R01CA109574, R01CA100109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BCTR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92312 and CA100109 (to J. C.) and R01CA109574-01A1 ( to K. L.). This work was also supported by The Susan G. Komen Breast Cancer Foundation Grant BCTR0504162T ( to K. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; Cui YB, 2008, NAT STRUCT MOL BIOL, V15, P411, DOI 10.1038/nsmb.1410; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Onn I, 2007, EMBO J, V26, P1024, DOI 10.1038/sj.emboj.7601562; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Rickmyre JL, 2007, J CELL SCI, V120, P3565, DOI 10.1242/jcs.016626; Strick TR, 2004, CURR BIOL, V14, P874, DOI 10.1016/j.cub.2004.04.038; Strom L, 2007, CURR OPIN CELL BIOL, V19, P344, DOI 10.1016/j.ceb.2007.04.003; Takemoto A, 2004, J BIOL CHEM, V279, P4551, DOI 10.1074/jbc.M310925200; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Trimborn Marc, 2005, Hum Mutat, V26, P496, DOI 10.1002/humu.9382; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	34	74	74	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29586	29592		10.1074/jbc.M804080200	http://dx.doi.org/10.1074/jbc.M804080200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18718915	Green Published, hybrid			2022-12-25	WOS:000260179900084
J	Feng, S; Okenka, GM; Bai, CX; Streets, AJ; Newby, LJ; DeChant, BT; Tsiokas, L; Obara, T; Ong, ACM				Feng, Shuang; Okenka, Genevieve M.; Bai, Chang-Xi; Streets, Andrew J.; Newby, Linda J.; DeChant, Brett T.; Tsiokas, Leonidas; Obara, Tomoko; Ong, Albert C. M.			Identification and functional characterization of an N-terminal oligomerization domain for polycystin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE; CHANNEL; PKD2; COMPLEX; TRPC1; GENE; LOCALIZATION; ZEBRAFISH; CURRENTS; PROTEIN	Autosomal dominant polycystic kidney disease ( ADPKD), the most common inherited cause of kidney failure, is caused by mutations in either PKD1 (85%) or PKD2 (15%). The PKD2 protein, polycystin-2 (PC2 or TRPP2), is a member of the transient receptor potential (TRP) superfamily and functions as a non-selective calcium channel. PC2 has been found to form oligomers in native tissues suggesting that it may form functional homo- or heterotetramers with other subunits, similar to other TRP channels. Our experiments unexpectedly revealed that PC2 mutant proteins lacking the known C-terminal dimerization domain were still able to form oligomers and co-immunoprecipitate full-length PC2, implying the possible existence of a proximal dimerization domain. Using yeast two-hybrid and biochemical assays, we have mapped an alternative dimerization domain to the N terminus of PC2 (NT2-1-223, L224X). Functional characterization of this domain demonstrated that it was sufficient to induce cyst formation in zebrafish embryos and inhibit PC2 surface currents in mIMCD3 cells probably by a dominant-negative mechanism. In summary, we propose a model for PC2 assembly as a functional tetramer which depends on both C- and N-terminal dimerization domains. These results have significant implications for our understanding of PC2 function and disease pathogenesis in ADPKD and provide a new strategy for studying PC2 function.	[Ong, Albert C. M.] Univ Sheffield, Kidney Genet Grp, Henry Wellcome Labs Med Res,Sheffield Kidney Inst, Sch Med & Biomed Sci,Acad Unit Nephrol, Sheffield S10 2RX, S Yorkshire, England; [Okenka, Genevieve M.; DeChant, Brett T.; Obara, Tomoko] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Med, Cleveland, OH 44109 USA; [Obara, Tomoko] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44109 USA; [Bai, Chang-Xi; Tsiokas, Leonidas] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	University of Sheffield; Case Western Reserve University; MetroHealth System; Case Western Reserve University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ong, ACM (corresponding author), Univ Sheffield, Kidney Genet Grp, Henry Wellcome Labs Med Res,Sheffield Kidney Inst, Sch Med & Biomed Sci,Acad Unit Nephrol, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	a.ong@sheffield.ac.uk	Ong, Albert/AAN-9430-2021	Ong, Albert/0000-0002-7211-5400; Tsiokas, Leonidas/0000-0002-3659-1813	National Institutes of Health [R21-DK069604, RO1-DK078209, R01-DK59599]; PKD Foundation [69a2r, 119a2r]; John S. Gammill Endowed Chair in Polycystic Kidney Disease, Research Councils UK [RA108836]; Wellcome Trust [GR071201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059599, R01DK078209, R21DK069604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PKD Foundation; John S. Gammill Endowed Chair in Polycystic Kidney Disease, Research Councils UK(UK Research & Innovation (UKRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-DK069604, RO1-DK078209 (to T. O.), and R01-DK59599 (to L. T.). This work was also funded by grants from the PKD Foundation (69a2r and 119a2r), John S. Gammill Endowed Chair in Polycystic Kidney Disease, Research Councils UK (RA108836) (to A. J. S.), and the Wellcome Trust (GR071201) (to A. C. M. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bai CX, 2008, EMBO J, V27, P1345, DOI 10.1038/emboj.2008.70; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Calvet JP, 2001, SEMIN NEPHROL, V21, P107, DOI 10.1053/snep.2001.20929; Chen XZ, 2001, BIOCHEM BIOPH RES CO, V282, P1251, DOI 10.1006/bbrc.2001.4720; Delmas P, 2004, FASEB J, V18, P740, DOI 10.1096/fj.03-0319fje; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; Ma R, 2003, J BIOL CHEM, V278, P52763, DOI 10.1074/jbc.M309610200; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Obara T, 2006, J AM SOC NEPHROL, V17, P2706, DOI 10.1681/ASN.2006040412; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Ong ACM, 2005, KIDNEY INT, V67, P1234, DOI 10.1111/j.1523-1755.2005.00201.x; Semple JI, 2005, BIOTECHNIQUES, V38, P927, DOI 10.2144/05386RR03; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Streets AJ, 2003, J AM SOC NEPHROL, V14, P1804, DOI 10.1097/01.ASN.0000076075.49819.9B; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161	30	48	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28471	28479		10.1074/jbc.M803834200	http://dx.doi.org/10.1074/jbc.M803834200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701462	hybrid, Green Published			2022-12-25	WOS:000259969300049
J	Jiang, L; Li, ZQ; Rui, LY				Jiang, Lin; Li, Zhiqin; Rui, Liangyou			Leptin stimulates both JAK2-dependent and JAK2-independent signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY-BALANCE; BODY-WEIGHT; DB/DB MICE; GLUCOSE-HOMEOSTASIS; RECEPTOR EXPRESSION; CAUSES OBESITY; ACTIVATION; PROTEIN; KINASE; JAK2	Leptin controls body weight by activating the long form of the leptin receptor (LEPRb). Janus kinase 2 (JAK2) is associated with LEPRb and autophosphorylates in response to leptin. JAK2 also phosphorylates LEPRb, STAT3, and multiple other downstream molecules. Surprisingly, here we show that JAK2 is not required for leptin stimulation of STAT3 phosphorylation. Leptin time- and dose-dependently stimulated tyrosine phosphorylation of STAT3 in both human and mouse JAK2-null cells. Leptin also increased the viability of JAK2-null cells. Overexpression of c-Src or Fyn, two Src family members, promoted STAT3 phosphorylation, whereas inhibition of the endogenous Src family members by either pharmacological inhibitors or dominant negative Src(K298M) decreased the ability of leptin to stimulate the phosphorylation of STAT3 and ERK1/2. Leptin also stimulated tyrosine phosphorylation of kinase-inactive JAK2(K882E) in JAK2-null cells. Overexpression of JAK2(K882E) enhanced the ability of leptin to stimulate STAT3 phosphorylation in JAK2-null cells. Tyr(1138) in LEPRb was required for leptin-stimulated phosphorylation of STAT3 but not JAK2(K882E). These data suggest that leptin stimulates non-JAK2 tyrosine kinase(s), including the Src family members, which phosphorylate JAK2, STAT3, and other molecules downstream of LEPRb. JAK2 mediates leptin signaling by both phosphorylating its substrates and forming a signaling complex as a scaffolding/adaptor protein. The non-JAK2 kinase(s) and JAK2 may act coordinately and synergistically to mediate leptin response.	[Jiang, Lin; Li, Zhiqin; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu	Jiang, Lin/E-7468-2012		National Institutes of Health [RO1 DK 065122, RO1 DK073601, 5P60 DK20572, 5P30 CA46592, P30AG013283, DK34933]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R01DK073601, P60DK020572, R01DK065122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK 065122, RO1 DK073601, 5P60 DK20572, 5P30 CA46592, P30AG013283, and DK34933. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderwald C, 2002, MOL ENDOCRINOL, V16, P1612, DOI 10.1210/me.16.7.1612; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bettowski J, 2006, PEPTIDES, V27, P3234, DOI 10.1016/j.peptides.2006.08.010; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjornholm M, 2007, J CLIN INVEST, V117, P1354, DOI 10.1172/JCI30688; Burfoot MS, 1997, J BIOL CHEM, V272, P24183, DOI 10.1074/jbc.272.39.24183; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Cohen P, 2005, J BIOL CHEM, V280, P10034, DOI 10.1074/jbc.M413684200; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Cui YX, 2004, MOL CELL BIOL, V24, P258, DOI 10.1128/MCB.24.1.258-269.2004; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; Duan CJ, 2004, J BIOL CHEM, V279, P43684, DOI 10.1074/jbc.M408495200; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Kurzer JH, 2004, MOL CELL BIOL, V24, P4557, DOI 10.1128/MCB.24.10.4557-4570.2004; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Li C, 1999, P NATL ACAD SCI USA, V96, P9677, DOI 10.1073/pnas.96.17.9677; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Montecucco F, 2006, ANN NY ACAD SCI, V1069, P463, DOI 10.1196/annals.1351.045; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Park BH, 2006, J BIOL CHEM, V281, P40283, DOI 10.1074/jbc.M607545200; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	45	69	69	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28066	28073		10.1074/jbc.M805545200	http://dx.doi.org/10.1074/jbc.M805545200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18718905	Green Published, hybrid			2022-12-25	WOS:000259969300008
J	Gahr, M; Metzdorf, R; Schmidl, D; Wickler, W				Gahr, Manfred; Metzdorf, Reinhold; Schmidl, Dieter; Wickler, Wolfgang			Bi-Directional Sexual Dimorphisms of the Song Control Nucleus HVC in a Songbird with Unison Song	PLOS ONE			English	Article							AFRICAN FOREST WEAVER; DIFFERENTIATION; TESTOSTERONE; EXPRESSION; PLASTICITY; DIFFERENCE; SYSTEM; BDNF; SIZE	Sexually dimorphic anatomy of brain areas is thought to be causally linked to sex differences in behaviour and cognitive functions. The sex with the regional size advantage (male or female) differs between brain areas and species. Among adult songbirds, males have larger brain areas such as the HVC (proper name) and RA (robust nucleus of the arcopallium) that control the production of learned songs. Forest weavers (Ploceus bicolor) mated pairs sing a unison duet in which male and female mates learn to produce identical songs. We show with histological techniques that the volume and neuron numbers of HVC and RA were >= 1.5 times larger in males than in females despite their identical songs. In contrast, using in-situ hybridizations, females have much higher (30-70%) expression levels of mRNA of a number of synapse-related proteins in HVC and/or RA than their male counterparts. Male-typical and female-typical sexual differentiation appears to act on different aspects of the phenotypes within the same brain areas, leading females and males to produce the same behaviour using different cellular mechanisms.	[Gahr, Manfred; Metzdorf, Reinhold; Schmidl, Dieter; Wickler, Wolfgang] Max Planck Inst Ornithol, Seewiesen, Germany	Max Planck Society	Gahr, M (corresponding author), Max Planck Inst Ornithol, Seewiesen, Germany.	gahr@orn.mpg.de			Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The study was financed by the Max Planck Society.	ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2001, TRENDS COGN SCI, V5, P426, DOI 10.1016/S1364-6613(00)01753-8; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Cyrus D, 1980, BIRD ATLAS NATAL; de Courten-Myers GM, 1999, J NEUROPATH EXP NEUR, V58, P217; DEVOOGD TJ, 1988, J NEUROBIOL, V19, P199, DOI 10.1002/neu.480190303; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; Fusani L, 2003, J NEUROBIOL, V54, P370, DOI 10.1002/neu.10141; Gahr M, 1998, J NEUROSCI, V18, P1124; Gahr M, 1997, BRAIN RES BULL, V44, P509, DOI 10.1016/S0361-9230(97)00233-5; Gahr M, 2004, ANN NY ACAD SCI, V1016, P684, DOI 10.1196/annals.1298.025; Gahr M, 1999, J NEUROSCI, V19, P2628; Gahr Manfred, 1994, P273; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; GERNOUD C, 2004, J NEUROSCI, V24, P2394; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hartley RS, 1997, NEUROBIOL LEARN MEM, V67, P248, DOI 10.1006/nlme.1996.3759; Horch HW, 2004, REV NEUROSCIENCE, V15, P117; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; Kittelberger JM, 2005, J NEUROBIOL, V62, P406, DOI 10.1002/neu.20109; Lang Thorsten, 2008, V184, P107; Langmore NE, 1998, TRENDS ECOL EVOL, V13, P136, DOI 10.1016/S0169-5347(97)01241-X; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Lucas JR, 2004, P ROY SOC B-BIOL SCI, V271, P2423, DOI 10.1098/rspb.2004.2912; MacDougall-Shackleton SA, 1999, TRENDS NEUROSCI, V22, P432, DOI 10.1016/S0166-2236(99)01434-4; McCarthy MM, 2005, FRONT NEUROENDOCRIN, V26, P85, DOI 10.1016/j.yfrne.2005.06.001; MCNEALEN P, 2005, BRAIN RES, V1032, P50; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; NIKOLAKOPOULOUA AM, 2003, P NATL ACAD SCI USA, V100, P4873; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1980, BRAIN RES, V189, P429, DOI 10.1016/0006-8993(80)90102-X; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; RAISMAN G, 1971, SCIENCE, V173, P731, DOI 10.1126/science.173.3998.731; Rutkowska J, 2005, HORM BEHAV, V47, P585, DOI 10.1016/j.yhbeh.2004.12.006; SEARCY WA, 1988, ECOLOGY, V69, P85, DOI 10.2307/1943163; Seibt U, 2002, BEHAVIOUR, V139, P1237, DOI 10.1163/15685390260437362; Stamatakis A, 2004, J COMP NEUROL, V474, P173, DOI 10.1002/cne.20066; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; Voigt C, 2004, J COMP NEUROL, V475, P83, DOI 10.1002/cne.20151; VOIGT C, 2005, THESIS LUDWIG MAXIMI; Voigt C, 2007, P ROY SOC B-BIOL SCI, V274, P2645, DOI 10.1098/rspb.2007.0858; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; WICKLER W, 1980, Z TIERPSYCHOL, V52, P217; Wickler W, 2006, J ORNITHOL, V147, P87, DOI 10.1007/s10336-005-0025-5; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	48	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3073	10.1371/journal.pone.0003073	http://dx.doi.org/10.1371/journal.pone.0003073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728787	gold, Green Published, Green Submitted			2022-12-25	WOS:000264796400013
J	Pignatta, D; Dilkes, B; Wroblewski, T; Michelmore, RW; Comai, L				Pignatta, Daniela; Dilkes, Brian; Wroblewski, Tadeusz; Michelmore, Richard W.; Comai, Luca			Transgene-Induced Gene Silencing Is Not Affected by a Change in Ploidy Level	PLOS ONE			English	Article								Background: Whole genome duplication, which results in polyploidy, is a common feature of plant populations and a recurring event in the evolution of flowering plants. Polyploidy can result in changes to gene expression and epigenetic instability. Several epigenetic phenomena, occurring at the transcriptional or post-transcriptional level, have been documented in allopolyploids (polyploids derived from species hybrids) of Arabidopsis thaliana, yet findings in autopolyploids (polyploids derived from the duplication of the genome of a single species) are limited. Here, we tested the hypothesis that an increase in ploidy enhances transgene-induced post-transcriptional gene silencing using autopolyploids of A. thaliana. Methodology/Principal Findings: Diploid and tetraploid individuals of four independent homozygous transgenic lines of A. thaliana transformed with chalcone synthase (CHS) inverted repeat (hairpin) constructs were generated. For each line diploids and tetraploids were compared for efficiency in post-transcriptional silencing of the endogenous CHS gene. The four lines differed substantially in their silencing efficiency. Yet, diploid and tetraploid plants derived from these plants and containing therefore identical transgene insertions showed no difference in the efficiency silencing CHS as assayed by visual scoring, anthocyanin assays and quantification of CHS mRNA. Conclusions/Significance: Our results in A. thaliana indicated that there is no effect of ploidy level on transgene-induced post-transcriptional gene silencing. Our findings that post-transcriptional mechanisms were equally effective in diploids and tetraploids supports the use of transgene-driven post-transcriptional gene silencing as a useful mechanism to modify gene expression in polyploid species.	[Pignatta, Daniela; Dilkes, Brian; Comai, Luca] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Wroblewski, Tadeusz; Michelmore, Richard W.] Univ Calif Davis, Genome Ctr, Dept Plant Sci, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis	Pignatta, D (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	lcomai@ucdavis.edu	Comai, Luca/F-4279-2010; Dilkes, Brian/C-9293-2012	Comai, Luca/0000-0003-2642-6619; Dilkes, Brian/0000-0003-2799-954X	NSF Plant Genome Program award [DBI 0733857]	NSF Plant Genome Program award	This work was supported by NSF Plant Genome Program award DBI 0733857, Functional genomics of plant polyploids, to L.C. The agency or any other entity not listed as an author had no role in experimental design and interpretation.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Davies GJ, 1997, PLANT J, V12, P791, DOI 10.1046/j.1365-313X.1997.12040791.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Guo M, 1996, GENETICS, V142, P1349; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Henry IM, 2005, GENETICS, V170, P1979, DOI 10.1534/genetics.104.037788; Henry IM, 2006, PLANT J, V48, P307, DOI 10.1111/j.1365-313X.2006.02871.x; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Scheid OM, 2003, NAT GENET, V34, P450, DOI 10.1038/ng1210; Scheid OM, 1996, P NATL ACAD SCI USA, V93, P7114, DOI 10.1073/pnas.93.14.7114; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; STUDENT, 1908, BIOMETRIKA; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; TSUKAYA H, 1991, PLANT PHYSIOL, V97, P1414, DOI 10.1104/pp.97.4.1414; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Wade HK, 2001, PLANT J, V25, P675, DOI 10.1046/j.1365-313x.2001.01001.x; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896	33	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3061	10.1371/journal.pone.0003061	http://dx.doi.org/10.1371/journal.pone.0003061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725969	Green Submitted, Green Published, gold			2022-12-25	WOS:000264796300007
J	Choi, JK; Hwang, S; Kim, YJ				Choi, Jung Kyoon; Hwang, Sohyun; Kim, Young-Joon			Stochastic and Regulatory Role of Chromatin Silencing in Genomic Response to Environmental Changes	PLOS ONE			English	Article								Phenotypic diversity and fidelity can be balanced by controlling stochastic molecular mechanisms. Epigenetic silencing is one that has a critical role in stress response. Here we show that in yeast, incomplete silencing increases stochastic noise in gene expression, probably owing to unstable chromatin structure. Telomere position effect is suggested as one mechanism. Expression diversity in a population achieved in this way may render a subset of cells to readily respond to various acute stresses. By contrast, strong silencing tends to suppress noisy expression of genes, in particular those involved in life cycle control. In this regime, chromatin may act as a noise filter for precisely regulated responses to environmental signals that induce huge phenotypic changes such as a cell fate transition. These results propose modulation of chromatin stability as an important determinant of environmental adaptation and cellular differentiation.	[Choi, Jung Kyoon; Kim, Young-Joon] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Hwang, Sohyun] Korea Res Inst Biosci & Biotechnol, Taejon, South Korea	Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, JK (corresponding author), Yonsei Univ, Dept Biochem, Seoul 120749, South Korea.	yjkim@yonsei.ac.kr	Choi, Jung Kyoon/C-2070-2011		Korean Ministry of Science and Technology	Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by grants from the Korean Ministry of Science and Technology to Y.-J.K. (Epigenomic Research of Human Disease and Global Research Lab).	Ai WD, 2002, MOL CELL, V10, P1295, DOI 10.1016/S1097-2765(02)00695-0; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Attfield PV, 2001, MOL MICROBIOL, V40, P1000, DOI 10.1046/j.1365-2958.2001.02444.x; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bi X, 2004, J MOL BIOL, V344, P893, DOI 10.1016/j.jmb.2004.10.002; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Davie JK, 2003, J BIOL CHEM, V278, P50158, DOI 10.1074/jbc.M309753200; EDO K, 2005, SCIENCE, V309, P2075; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gao Lu, 2006, Briefings in Functional Genomics & Proteomics, V5, P280, DOI 10.1093/bfgp/ell035; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Pedram M, 2006, MOL CELL BIOL, V26, P1865, DOI 10.1128/MCB.26.5.1865-1878.2006; Perez-Martin J, 1999, EMBO J, V18, P2580, DOI 10.1093/emboj/18.9.2580; Pirrotta V, 2005, MOL CELL, V18, P395, DOI 10.1016/j.molcel.2005.04.013; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Sabet N, 2004, MOL CELL BIOL, V24, P8823, DOI 10.1128/MCB.24.20.8823-8833.2004; Sandell L L, 1992, Trends Cell Biol, V2, P10, DOI 10.1016/0962-8924(92)90138-D; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stone EM, 1996, J CELL BIOL, V135, P571, DOI 10.1083/jcb.135.3.571; Sumner ER, 2002, MICROBIOL-SGM, V148, P345, DOI 10.1099/00221287-148-2-345; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Tsankov AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100106; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Zhang Z, 2004, EMBO J, V23, P2246, DOI 10.1038/sj.emboj.7600227	44	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3002	10.1371/journal.pone.0003002	http://dx.doi.org/10.1371/journal.pone.0003002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714342	Green Published, gold, Green Submitted			2022-12-25	WOS:000264420900027
J	Hoffmann, S; Falkenstein, M				Hoffmann, Sven; Falkenstein, Michael			The Correction of Eye Blink Artefacts in the EEG: A Comparison of Two Prominent Methods	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; EOG CORRECTION; REMOVAL; MOVEMENT; DYNAMICS	Background: The study investigated the residual impact of eyeblinks on the electroencephalogram (EEG) after application of different correction procedures, namely a regression method (eye movement correction procedure, EMCP) and a component based method (Independent Component Analysis, ICA). Methodology/Principle Findings: Real and simulated data were investigated with respect to blink-related potentials and the residual mutual information of uncorrected vertical electrooculogram (EOG) and corrected EEG, which is a measure of residual EOG contribution to the EEG. The results reveal an occipital positivity that peaks at about 250ms after the maximum blink excursion following application of either correction procedure. This positivity was not observable in the simulated data. Mutual information of vertical EOG and EEG depended on the applied regression procedure. In addition, different correction results were obtained for real and simulated data. ICA yielded almost perfect correction in all conditions. However, under certain conditions EMCP yielded comparable results to the ICA approach. Conclusion: In conclusion, for EMCP the quality of correction depended on the EMCP variant used and the structure of the data, whereas ICA always yielded almost perfect correction. However, its disadvantage is the much more complex data processing, and that it requires a suitable amount of data.	[Hoffmann, Sven; Falkenstein, Michael] Leibniz Res Ctr Working Environm & Human Factors, Project Grp Ageing & CNS Aalterat, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Hoffmann, S (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Project Grp Ageing & CNS Aalterat, Dortmund, Germany.	shoffmann@ifado.de	Falkenstein, Michael/ABA-7497-2020	Hoffmann, Sven/0000-0002-4521-8332	Leibniz research centre for working environment and human factors	Leibniz research centre for working environment and human factors	Leibniz research centre for working environment and human factors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALM A, 2003, ADLERS PHYSL EYE; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P58, DOI 10.1016/0013-4694(94)90113-9; BERG P, 1986, PSYCHOPHYSIOLOGY, V23, P354, DOI 10.1111/j.1469-8986.1986.tb00646.x; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Croft RJ, 2005, PSYCHOPHYSIOLOGY, V42, P16, DOI 10.1111/j.1468-8986.2005.00264.x; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; Croft RJ, 2002, INT J PSYCHOPHYSIOL, V44, P187, DOI 10.1016/S0167-8760(01)00201-X; Croft RJ, 1998, ELECTROEN CLIN NEURO, V107, P395, DOI 10.1016/S0013-4694(98)00087-X; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Debener S, 2005, COGNITIVE BRAIN RES, V22, P309, DOI 10.1016/j.cogbrainres.2004.09.006; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; HYVARINEN A, 1999, P 1 INT WORKSH ICA S, P473; Iriarte J, 2003, J CLIN NEUROPHYSIOL, V20, P249, DOI 10.1097/00004691-200307000-00004; Joyce CA, 2004, PSYCHOPHYSIOLOGY, V41, P313, DOI 10.1111/j.1469-8986.2003.00141.x; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Lins Otavio G., 1993, Brain Topography, V6, P65, DOI 10.1007/BF01234128; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S., 1996, ADV NEURAL INFORM PR, V8; VERLEGER R, 1991, ELECTROEN CLIN NEURO, V78, P240, DOI 10.1016/0013-4694(91)90039-7; Zhou WD, 2005, EPILEPSIA, V46, P409, DOI 10.1111/j.0013-9580.2005.50704.x	28	177	177	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3004	10.1371/journal.pone.0003004	http://dx.doi.org/10.1371/journal.pone.0003004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714341	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900029
J	Linsel-Nitschke, P; Gotz, A; Erdmann, J; Braenne, I; Braund, P; Hengstenberg, C; Stark, K; Fischer, M; Schreiber, S; El Mokhtari, NE; Schaefer, A; Schrezenmeier, J; Rubin, D; Hinney, A; Reinehr, T; Roth, C; Ortlepp, J; Hanrath, P; Hall, AS; Mangino, M; Lieb, W; Lamina, C; Heid, IM; Doering, A; Gieger, C; Peters, A; Meitinger, T; Wichmann, HE; Konig, IR; Ziegler, A; Kronenberg, F; Samani, NJ; Schunkert, H				Linsel-Nitschke, Patrick; Goetz, Anika; Erdmann, Jeanette; Braenne, Ingrid; Braund, Peter; Hengstenberg, Christian; Stark, Klaus; Fischer, Marcus; Schreiber, Stefan; El Mokhtari, Nour Eddine; Schaefer, Arne; Schrezenmeier, Juergen; Rubin, Diana; Hinney, Anke; Reinehr, Thomas; Roth, Christian; Ortlepp, Jan; Hanrath, Peter; Hall, Alistair S.; Mangino, Massimo; Lieb, Wolfgang; Lamina, Claudia; Heid, Iris M.; Doering, Angela; Gieger, Christian; Peters, Annette; Meitinger, Thomas; Wichmann, H. -Erich; Koenig, Inke R.; Ziegler, Andreas; Kronenberg, Florian; Samani, Nilesh J.; Schunkert, Heribert		WTCCC; Cardiogenics Consortium	Lifelong Reduction of LDL-Cholesterol Related to a Common Variant in the LDL-Receptor Gene Decreases the Risk of Coronary Artery Disease-A Mendelian Randomisation Study	PLOS ONE			English	Article							ASSOCIATION; POLYMORPHISM; HYPERCHOLESTEROLEMIA; METAANALYSIS; PREVALENCE; PHENOTYPE; THERAPY; EVENTS	Background: Rare mutations of the low-density lipoprotein receptor gene (LDLR) cause familial hypercholesterolemia, which increases the risk for coronary artery disease (CAD). Less is known about the implications of common genetic variation in the LDLR gene regarding the variability of cholesterol levels and risk of CAD. Methods: Imputed genotype data at the LDLR locus on 1 644 individuals of a population-based sample were explored for association with LDL-C level. Replication of association with LDL-C level was sought for the most significant single nucleotide polymorphism (SNP) within the LDLR gene in three European samples comprising 6 642 adults and 533 children. Association of this SNP with CAD was examined in six case-control studies involving more than 15 000 individuals. Findings: Each copy of the minor T allele of SNP rs2228671 within LDLR (frequency 11%) was related to a decrease of LDL-C levels by 0.19 mmol/L (95% confidence interval (CI) [0.13-0.24] mmol/L, p = 1.5x10(-10)). This association with LDL-C was uniformly found in children, men, and women of all samples studied. In parallel, the T allele of rs2228671 was associated with a significantly lower risk of CAD (Odds Ratio per copy of the T allele: 0.82, 95% CI [0.76-0.89], p = 2.1x10(-7)). Adjustment for LDL-C levels by logistic regression or Mendelian Randomisation models abolished the significant association between rs2228671 with CAD completely, indicating a functional link between the genetic variant at the LDLR gene locus, change in LDL-C and risk of CAD. Conclusion: A common variant at the LDLR gene locus affects LDL-C levels and, thereby, the risk for CAD.	[Linsel-Nitschke, Patrick; Goetz, Anika; Erdmann, Jeanette; Braenne, Ingrid; Lieb, Wolfgang; Schunkert, Heribert] Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Goetz, Anika; Koenig, Inke R.; Ziegler, Andreas] Univ Lubeck, Inst Med Biometr & Stat, D-2400 Lubeck, Germany; [Braund, Peter; Mangino, Massimo; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England; [Hengstenberg, Christian; Stark, Klaus; Fischer, Marcus] Univ Regensburg, Klin & Poliklin Innere Med II, D-8400 Regensburg, Germany; [Schreiber, Stefan; El Mokhtari, Nour Eddine; Schaefer, Arne] Univ Kiel, Inst Klin Molekularbiol, D-24098 Kiel, Germany; [Schrezenmeier, Juergen; Rubin, Diana] Inst Physiol Biochem Ernahrung, Bundesforschungsanstalt Ernahrung Lebensmittel, Kiel, Germany; [Hinney, Anke] Univ Duisburg Essen, Jugendalters, Rheinische Klin Essen, Klin Psychiat Psychotherap Kindes, D-4100 Essen, Germany; [Reinehr, Thomas] Univ Witten Herdecke, Vestische Kinder Jugendklinik, Witten, Germany; [Roth, Christian] Univ Bonn, Zentrum Kinderheilkunde, D-5300 Bonn, Germany; [Roth, Christian] Univ Washington, Childrens Hosp, Regional Med Ctr, Seattle, WA 98195 USA; [Ortlepp, Jan; Hanrath, Peter] Rheinisch Westfalische Tech Hsch, Klin Innere Med, Aachen, Germany; [Hall, Alistair S.] Univ Leeds, Fac Med & Hlth, Leeds Inst Genet & Therapeut, C NET Group, Leeds LS2 9JT, W Yorkshire, England; [Lamina, Claudia; Heid, Iris M.; Doering, Angela; Gieger, Christian; Peters, Annette; Wichmann, H. -Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Kronenberg, Florian] Med Univ Innsbruck, Dept Med Genet, Mol & Clin Pharmacol, Innsbruck, Austria; [Meitinger, Thomas] Tech Univ Munich, Inst Humangenet, D-8000 Munich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Lubeck; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Regensburg; University of Kiel; University of Duisburg Essen; Witten Herdecke University; University of Bonn; Seattle Children's Hospital; University of Washington; University of Washington Seattle; RWTH Aachen University; University of Leeds; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Medical University of Innsbruck; Technical University of Munich	Linsel-Nitschke, P (corresponding author), Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany.	heribert.schunkert@innere2.uni-luebeck.de	Hall, Alistair/K-1953-2019; Lieb, Wolfgang/AAC-7650-2022; Hinney, Anke/D-6953-2011; Meitinger, Thomas/O-1318-2015; Lamina, Claudia/F-7608-2010; Erdmann, Jeanette/P-7513-2014; Peters, Annette/A-6117-2011; Stark, Klaus/D-3813-2009; Wichmann, Heinz Erich/AAA-5695-2022; Kronenberg, Florian/B-1736-2008; Hengstenberg, Christian/U-5485-2019; Erdmann, Jeanette/A-4417-2009; König, Inke R/A-4544-2009; Stark, Klaus/L-7367-2013; Mangino, Massimo/F-5134-2011; Ziegler, Andreas/G-4246-2012	Hinney, Anke/0000-0001-5659-0706; Lamina, Claudia/0000-0002-5398-5806; Erdmann, Jeanette/0000-0002-4486-6231; Peters, Annette/0000-0001-6645-0985; Stark, Klaus/0000-0002-7832-1942; Kronenberg, Florian/0000-0003-2229-1120; König, Inke R/0000-0003-0504-6465; Stark, Klaus/0000-0002-7832-1942; Mangino, Massimo/0000-0002-2167-7470; Ziegler, Andreas/0000-0002-8386-5397; Meitinger, Thomas/0000-0002-8838-8403; Hall, Alistair/0000-0003-0306-7887; Morgan, Ann/0000-0003-1109-624X; Schaefer, Arne/0000-0001-5816-6765; Gieger, Christian/0000-0001-6986-9554	European Union [LSHM-CT 2006-037593, LSHMCT-2003-503041]; National Genome Network [01GS0418, 01GR0466, 01GS0482]; National Genome Network Plus; German Federal Ministry of Education and Research (BMBF) [01GS0820]; British Heart Foundation; UK Medical Research Council; Helmhotz Zentrum Munchen (former GSF)-National Research Center for Environmental Health, Neuherberg, Germany; Munich Center of Health Sciences; Bonfor Research Foundation, University of Bonn, Germany	European Union(European Commission); National Genome Network; National Genome Network Plus; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Helmhotz Zentrum Munchen (former GSF)-National Research Center for Environmental Health, Neuherberg, Germany; Munich Center of Health Sciences; Bonfor Research Foundation, University of Bonn, Germany	This study was funded by the European Union sponsored projects Cardiogenics (LSHM-CT 2006-037593) and Diabesity (LSHMCT-2003-503041), by the National Genome Network (01GS0418 to Drs Schunkert, Erdmann, and Hengstenberg; 01GR0466 to Dr. Ziegler; 01GS0482 to Dr. Hinney) and by the National Genome Network Plus to Dr. Hinney (01GS0820) sponsored by the German Federal Ministry of Education and Research (BMBF). Recruitment for the WTCCC Study CAD collection was funded by grants from the British Heart Foundation and the UK Medical Research Council. The MONICA/KORA Augsburg studies were financed by the Helmhotz Zentrum Munchen (former GSF)-National Research Center for Environmental Health, Neuherberg, Germany and supported by grants from the BMBF and Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. Recruitment of the Bonn Childhood Obesity Cohort was funded by the Bonfor Research Foundation, University of Bonn, Germany. This work was also supported by the "Genomics of Lipid-associated Disorders GOLD" of the "Austrian Genome Research Programme GEN-AU" (to F.K.).	[Anonymous], 2002, LANCET, V360, P7; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Baessler A, 2005, INT J CARDIOL, V101, P293, DOI 10.1016/j.ijcard.2004.03.053; Bagos PG, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1281; Bauerfeind A, 2006, HUM HERED, V61, P123, DOI 10.1159/000093773; Bautista LE, 2006, ANN EPIDEMIOL, V16, P675, DOI 10.1016/j.annepidem.2006.02.001; BENN M, 2007, J CLIN ENDOCRINOL ME; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; BROWN MS, 1974, SCIENCE, V185, P61, DOI 10.1126/science.185.4145.61; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costanza MC, 2005, AM J EPIDEMIOL, V161, P714, DOI 10.1093/aje/kwi103; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; KATHIRESAN S, 2008, NAT GENET; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lewis SJ, 1998, J AM COLL CARDIOL, V32, P140, DOI 10.1016/S0735-1097(98)00202-2; Lieb W, 2008, CIRCULATION, V117, P185, DOI 10.1161/CIRCULATIONAHA.107.728485; Meisinger C, 2004, DIABETES CARE, V27, P2985, DOI 10.2337/diacare.27.12.2985; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Ortlepp JR, 2003, EUR J CLIN INVEST, V33, P106, DOI 10.1046/j.1365-2362.2003.01124.x; Reinehr T, 2007, J PEDIATR-US, V150, P618, DOI 10.1016/j.jpeds.2007.01.042; Rubin D, 2006, J HUM GENET, V51, P567, DOI 10.1007/s10038-006-0400-y; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; SCHUNKERT H, 2008, CIRCULATION IN PRESS; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Thomas DC, 2004, INT J EPIDEMIOL, V33, P21, DOI 10.1093/ije/dyh048; THOMAS DC, 2007, ANN EPIDEMIOLOGY; Tybjaerg-Hansen A, 1998, NEW ENGL J MED, V338, P1577, DOI 10.1056/NEJM199805283382203; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; WILLER CJ, 2008, NAT GENET; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zhu H, 2007, HUM MOL GENET, V16, P1765, DOI 10.1093/hmg/ddm124; ZIEGLER A, 2008, STAT MED, DOI DOI 10.1002/SIM.3034; METABOLIC MOL BASES	42	125	126	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2986	10.1371/journal.pone.0002986	http://dx.doi.org/10.1371/journal.pone.0002986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714375	Green Published, gold, Green Submitted			2022-12-25	WOS:000264420900012
J	Penteriani, V; Delgado, MD				Penteriani, Vincenzo; del Mar Delgado, Maria			Owls May Use Faeces and Prey Feathers to Signal Current Reproduction	PLOS ONE			English	Article							SCENT-MARKING; VOCAL DISPLAYS; VISUAL CUES; BEHAVIOR; DEFENSE; BADGE; NESTS	Background: Many animals communicate by marking focal elements of their home range with different kinds of materials. Visual signaling has been demonstrated to play a previously unrecognized role in the intraspecific communication of eagle owls (Bubo bubo), in both territorial and parent-offspring contexts. Visual signals may play a role in a variety of circumstances in this crepuscular and nocturnal species. Methodology/ Principal Findings: Here, we report that a large amount of extremely visible white faeces and prey feathers appear during the breeding season on posts and plucking sites in proximity to the nest, potentially representing a way for eagle owls to mark their territory. We present descriptive and experimental evidence showing that faeces and prey remains could act as previously unrecognized visual signals in a nocturnal avian predator. This novel signaling behavior could indicate the owls' current reproductive status to potential intruders, such as other territorial owls or non-breeding floaters. Faeces and prey feather markings may also advertise an owl's reproductive status or function in mate-mate communication. Conclusions/Significance: We speculate that faeces marks and plucking may represent an overlooked but widespread method for communicating current reproduction to conspecifics. Such marking behavior may be common in birds, and we may now be exploring other questions and mechanisms in territoriality.	[Penteriani, Vincenzo; del Mar Delgado, Maria] CSIC, Dept Conservat Biol, Estac Biol Donana, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Penteriani, V (corresponding author), CSIC, Dept Conservat Biol, Estac Biol Donana, E-41080 Seville, Spain.	penteriani@ebd.csic.es		Delgado, Maria del Mar/0000-0002-3009-738X	Spanish Ministry of Education and Science [CGL2004-02780/BOS]; LICOR43; Junta de Andalucia (Consejeria de Educacion y Ciencia); Junta de Andalucia Consejeria de Medio Ambiente [SCFFS-AFR/GGG RS-260/02, SCFFS-AFR/CMM RS-1904/02]	Spanish Ministry of Education and Science(Spanish Government); LICOR43; Junta de Andalucia (Consejeria de Educacion y Ciencia)(Junta de Andalucia); Junta de Andalucia Consejeria de Medio Ambiente(Junta de Andalucia)	Funding for this study was provided by research project No. CGL2004-02780/BOS of the Spanish Ministry of Education and Science and LICOR43 (Diego Zamora S.A.). During this work, M.M. Delgado was supported by a doctoral grant from the Junta de Andalucia (Consejeria de Educacion y Ciencia). We manipulated and marked owls under Junta de Andalucia Consejeria de Medio Ambiente permits No. SCFFS-AFR/GGG RS-260/02 and SCFFS-AFR/CMM RS-1904/02.	ALBERTS AC, 1992, AM NAT, V139, pS62, DOI 10.1086/285305; Bradbury Jack W., 1998, pi; Brashares JS, 1999, ANIM BEHAV, V57, P11, DOI 10.1006/anbe.1998.0942; Bravery BD, 2006, J AVIAN BIOL, V37, P77; Brouwer L, 2004, ANIM BEHAV, V67, P539, DOI 10.1016/j.anbehav.2003.07.005; Brown RE., 1985, SOCIAL ODOURS MAMMAL; Chou IC, 2005, ANIM BEHAV, V69, P1055, DOI 10.1016/j.anbehav.2004.09.010; Delgado MM, 2007, J ZOOL, V271, P3, DOI 10.1111/j.1469-7998.2006.00205.x; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Gese EM, 1997, ANIM BEHAV, V54, P1155, DOI 10.1006/anbe.1997.0561; GOSLING LM, 1982, Z TIERPSYCHOL, V60, P89; GOSLING LM, 1981, Z TIERPSYCHOL, V56, P305; Gosling LM, 2001, ADV STUD BEHAV, V30, P169, DOI 10.1016/S0065-3454(01)80007-3; Gwinner H, 1997, BEHAVIOUR, V134, P337, DOI 10.1163/156853997X00575; Kappeler PM, 1998, BEHAV ECOL SOCIOBIOL, V42, P411, DOI 10.1007/s002650050455; Levey DJ, 2004, NATURE, V431, P39, DOI 10.1038/431039a; Lewis RJ, 2006, AM J PRIMATOL, V68, P622, DOI 10.1002/ajp.20256; Newton I., 1979, POPULATION ECOLOGY R; Ostlund-Nilsson S, 2003, BEHAV ECOL SOCIOBIOL, V53, P214, DOI 10.1007/s00265-002-0574-z; OVASKA K, 1992, ANIM BEHAV, V43, P931, DOI 10.1016/0003-3472(92)90006-U; Penteriani V, 2003, IBIS, V145, pE127, DOI 10.1046/j.1474-919X.2003.00173.x; Penteriani V, 2002, ETHOL ECOL EVOL, V14, P275; Penteriani V, 2006, J AVIAN BIOL, V37, P110, DOI 10.1111/j.0908-8857.2006.03569.x; Penteriani V, 2005, J FIELD ORNITHOL, V76, P237, DOI 10.1648/0273-8570-76.3.237; Penteriani V, 2007, ETHOLOGY, V113, P934, DOI 10.1111/j.1439-0310.2007.01414.x; Penteriani V, 2007, BEHAV ECOL, V18, P143, DOI 10.1093/beheco/arl060; PIGOZZI G, 1990, ANIM BEHAV, V39, P1000, DOI 10.1016/S0003-3472(05)80972-8; ROBERT SC, 1977, J ZOOL LOND, V243, P565; SMITH JLD, 1989, ANIM BEHAV, V37, P1; Soler M, 1996, ANIM BEHAV, V51, P247, DOI 10.1006/anbe.1996.0025; Veiga JP, 2005, BIOL LETT-UK, V1, P334, DOI 10.1098/rsbl.2005.0329; Wronski T, 2006, BEHAV ECOL SOCIOBIOL, V60, P368, DOI 10.1007/s00265-006-0174-4	32	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3014	10.1371/journal.pone.0003014	http://dx.doi.org/10.1371/journal.pone.0003014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714382	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900039
J	Finer, M; Jenkins, CN; Pimm, SL; Keane, B; Ross, C				Finer, Matt; Jenkins, Clinton N.; Pimm, Stuart L.; Keane, Brian; Ross, Carl			Oil and Gas Projects in the Western Amazon: Threats to Wilderness, Biodiversity, and Indigenous Peoples	PLOS ONE			English	Article							RAIN-FOREST; DEFORESTATION; CONSERVATION; ECUADOR; FATE	Background: The western Amazon is the most biologically rich part of the Amazon basin and is home to a great diversity of indigenous ethnic groups, including some of the world's last uncontacted peoples living in voluntary isolation. Unlike the eastern Brazilian Amazon, it is still a largely intact ecosystem. Underlying this landscape are large reserves of oil and gas, many yet untapped. The growing global demand is leading to unprecedented exploration and development in the region. Methodology/Principal Findings: We synthesized information from government sources to quantify the status of oil development in the western Amazon. National governments delimit specific geographic areas or "blocks'' that are zoned for hydrocarbon activities, which they may lease to state and multinational energy companies for exploration and production. About 180 oil and gas blocks now cover, 688,000 km(2) of the western Amazon. These blocks overlap the most species-rich part of the Amazon. We also found that many of the blocks overlap indigenous territories, both titled lands and areas utilized by peoples in voluntary isolation. In Ecuador and Peru, oil and gas blocks now cover more than two-thirds of the Amazon. In Bolivia and western Brazil, major exploration activities are set to increase rapidly. Conclusions/Significance: Without improved policies, the increasing scope and magnitude of planned extraction means that environmental and social impacts are likely to intensify. We review the most pressing oil- and gas-related conservation policy issues confronting the region. These include the need for regional Strategic Environmental Impact Assessments and the adoption of roadless extraction techniques. We also consider the conflicts where the blocks overlap indigenous peoples' territories.	[Finer, Matt; Ross, Carl] Save Amer Forests, Washington, DC USA; [Jenkins, Clinton N.; Pimm, Stuart L.] Duke Univ, Nicholas Sch Environm, Durham, NC USA; [Keane, Brian] Land Is Life, Somerville, MA USA	Duke University	Finer, M (corresponding author), Save Amer Forests, Washington, DC USA.	matt@saveamericasforests.org	Jenkins, Clinton/D-6134-2011; pimm, stuart/ABF-1082-2020	Jenkins, Clinton/0000-0003-2198-0637; 	Forrest C. and Frances H. Lattner Foundation Inc	Forrest C. and Frances H. Lattner Foundation Inc	This work was supported by the Forrest C. and Frances H. Lattner Foundation Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AIDESEP, 2006, RES SEG CONS COORD A; [Anonymous], 2008, LOS ANGELES TIMES; BAKER DR, 2008, CHEVRON COULD LOSE B; BALBI NCL, 2007, SUPERPOSICION IRREGU; BALBIN CG, 2006, REGIMEN ESPECIAL TRA; BARDALES E, 2008, RESERVAS PROBABLES I; Bilsborrow Richard E., 2004, Acta Amaz., V34, P635, DOI 10.1590/S0044-59672004000400015; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; *COM, 2007, LIO OP SIG BLOQ; *CONAIE, 2008, 3 C NAC PUEBL EC; Dew JL, 2003, AM J PHYS ANTHROPOL, P89; *EARTHRIGHTS INT R, 2007, LEG HARM OCC PETR IN; *EL COM, 2008, MIN INV DERR CRUD OR; *EN INF ADM, 2008, COUNT AN BRIEFS AC; ERWIN TL, 2004, P CALIF ACAD SCI, V0056, P00072; FORERO J, 2004, SAFEGUARDING COLOMBI; Franzen M, 2006, ENVIRON CONSERV, V33, P36, DOI 10.1017/S0376892906002712; Greenberg JA, 2005, REMOTE SENS ENVIRON, V96, P202, DOI 10.1016/j.rse.2005.02.010; GRIFFITHS T, 2007, EXIGIENDO RESPONSABI; *GRUP INT TRAB AS, 2007, PUEBL IND AISL VOL C; HEARN K, 2008, PERUS INDIANS LAWSUI; HOY DR, 1963, GEOGR REV, V53, P580, DOI 10.2307/212387; *I BIEN COM, 2008, TITL NAT COMM EX PRO; *IUCN, GLOB AMPH ASS VERS 1; Killeen TJ, 2007, J BIOGEOGR, V34, P1357, DOI 10.1111/j.1365-2699.2006.01682.x; Kimerling J., 1991, AMAZON CRUDE; LARAZON, 2007, GOBIERNO REHACE PLAN; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Napolitano DA, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045005; Nunez-Iturri G, 2007, BIOTROPICA, V39, P348, DOI 10.1111/j.1744-7429.2007.00276.x; O'Rourke D, 2003, ANNU REV ENV RESOUR, V28, P587, DOI 10.1146/annurev.energy.28.050302.105617; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Martinez M, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045006; Parker TA III, 1996, NEOTROPICAL BIRDS EC; PATTERSON BD, 2005, DIGITAL DISTRIBUTION; PERRAULT A, 2007, PARTNERSHIPS SUCCESS, V19, P475; Pimm SL, 2005, SCI AM, V293, P66, DOI 10.1038/scientificamerican0905-66; Ridgely R. S., 2005, DIGITAL DISTRIBUTION, V2.1; ROHTER L, 2007, VAST PIPELINES AMAZO; ROSENFELD AB, 2001, REINVENTING WELL APP; San Sebastian M, 2004, REV PANAM SALUD PUBL, V15, P205; Sawyer Suzana, 2004, CRUDE CHRONICLES IND; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Sierra R, 2000, APPL GEOGR, V20, P1, DOI 10.1016/S0143-6228(99)00014-4; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; The Energy & Biodiversity Initiative, 2003, INT BIOD CONS OIL GA; Thomsen JB, 2001, FOOTPRINTS JUNGLE; Williams B, 1999, OIL GAS J, V97, P19; Wright SJ, 2007, BIOTROPICA, V39, P289, DOI 10.1111/j.1744-7429.2007.00293.x; WUNDER S, 2003, OIL WEALTH FATE FORE; Young B.E., 2004, DISAPPEARING JEWELS; 2002, DECISIONS MEETINGS C	56	313	322	2	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2932	10.1371/journal.pone.0002932	http://dx.doi.org/10.1371/journal.pone.0002932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422FK	18716679	Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600018
J	Cai, ZP; Shen, ZY; Van Kaer, L; Becker, LC				Cai, Zheqing P.; Shen, Zhenyun; Van Kaer, Luc; Becker, Lewis C.			Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency	FASEB JOURNAL			English	Article						ubiquitin-proteasome system; reperfusion injury; ubiquitin; phosphatase and tensin homologue deleted on chromosome 10 PTEN; Akt	TUMOR-SUPPRESSOR PTEN; PROTEIN-DEGRADATION; PROTEASOME SYSTEM; 26S PROTEASOME; UP-REGULATION; KINASE; LMP2; PHYSIOLOGY; INHIBITION; INTERFERON	The ubiquitin-proteasome system plays an important role in many cellular processes through degradation of specific proteins. Low molecular mass polypeptide 2 (LMP-2 or beta(1i)) is one important subunit of the immunoproteasome. Ischemic preconditioning (IPC) activates cell signaling pathways and generates cardioprotection but has not been linked to LMP-2 function previously. LMP-2 knockout mice (C57BL6 background) and wild-type C57BL6 mice were subjected to 30 min of ischemia (I-30) and 120 min of reperfusion (R-120) with or without preceding IPC (10 min of infusion and 5 min of reperfusion). IPC significantly increased left ventricular developed pressure and decreased infarct size in wild-type mice, but this protective effect of IPC was lost in LMP-2 knockout mice. IPC-mediated degradation of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) and activation of the downstream protein kinase Akt were impaired in LMP-2 knockout hearts. The impairment of PTEN degradation was associated with defective immunoproteasomes and decreased proteolytic activities. When LMP-2 knockout mice were pretreated with the PTEN inhibitor bpV(HOpic), cardiac function was significantly improved, and myocardial infarct size was significantly reduced after I-30/R-120. In conclusion, LMP-2 is required for normal proteasomal function and IPC induction in the heart. Its action may be related to PTEN protein degradation.	[Cai, Zheqing P.; Becker, Lewis C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Shen, Zhenyun] Peking Univ, Hosp 3, Dept Thorac Surg, Beijing 100871, Peoples R China; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA	Johns Hopkins University; Peking University; Vanderbilt University	Cai, ZP (corresponding author), 720 Rutland Ave,Ross 333, Baltimore, MD 21205 USA.	czheqin1@jhmi.edu	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309	National Heart, Lung, and Blood Institute, National Institutes of Health [P01-HL65608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL065608] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. Public Health Service grant P01-HL65608 from the National Heart, Lung, and Blood Institute, National Institutes of Health.	Balendran A, 2000, FEBS LETT, V484, P217, DOI 10.1016/S0014-5793(00)02162-1; Barton LF, 2002, J IMMUNOL, V169, P3046, DOI 10.4049/jimmunol.169.6.3046; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Cai ZQ, 2005, CIRC RES, V97, P1351, DOI 10.1161/01.RES.0000195656.52760.30; Callahan MK, 2006, J IMMUNOL, V177, P8393, DOI 10.4049/jimmunol.177.12.8393; Depre C, 2006, CIRCULATION, V114, P1821, DOI 10.1161/CIRCULATIONAHA.106.637827; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P130, DOI 10.1089/ars.2006.8.130; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; FRENTZEL S, 1993, EUR J BIOCHEM, V216, P119, DOI 10.1111/j.1432-1033.1993.tb18123.x; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gomes AV, 2006, ANTIOXID REDOX SIGN, V8, P1677, DOI 10.1089/ars.2006.8.1677; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; GROETTRUP M, 1995, J BIOL CHEM, V270, P23808, DOI 10.1074/jbc.270.40.23808; Huang SJ, 2008, AM J PHYSIOL-HEART C, V294, pH1298, DOI 10.1152/ajpheart.00765.2007; Kotamraju S, 2006, FREE RADICAL BIO MED, V40, P1034, DOI 10.1016/j.freeradbiomed.2005.10.052; Liu C, 2005, NEUROSCIENCE, V134, P69, DOI 10.1016/j.neuroscience.2005.03.036; Mahimainathan L, 2004, J BIOL CHEM, V279, P15258, DOI 10.1074/jbc.M314328200; Martin S, 2004, NEUROSCI LETT, V357, P76, DOI 10.1016/j.neulet.2003.10.085; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Murphy E, 2004, CIRC RES, V94, P7, DOI 10.1161/01.RES.0000108082.76667.F4; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Ping PP, 1997, CIRC RES, V81, P404, DOI 10.1161/01.RES.81.3.404; Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006; Powell SR, 2005, ANTIOXID REDOX SIGN, V7, P538, DOI 10.1089/ars.2005.7.538; Pradillo JM, 2005, J CEREBR BLOOD F MET, V25, P193, DOI 10.1038/sj.jcbfm.9600019; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Schmidt M, 1997, MOL BIOL REP, V24, P103, DOI 10.1023/A:1006826725056; Schmidt M, 1999, J MOL BIOL, V288, P117, DOI 10.1006/jmbi.1999.2660; Schwartzbauer G, 2001, J BIOL CHEM, V276, P35786, DOI 10.1074/jbc.M102479200; Stansfield WE, 2008, AM J PHYSIOL-HEART C, V294, pH645, DOI 10.1152/ajpheart.00196.2007; Strohm C, 2000, J CARDIOVASC PHARM, V36, P218, DOI 10.1097/00005344-200008000-00012; Tong HY, 2000, CIRC RES, V87, P309, DOI 10.1161/01.RES.87.4.309; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; Wang HX, 2006, J CELL PHYSIOL, V206, P616, DOI 10.1002/jcp.20508; Willis MS, 2006, J MOL CELL CARDIOL, V41, P567, DOI 10.1016/j.yjmcc.2006.07.015; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zong C, 2006, CIRC RES, V99, P372, DOI 10.1161/01.RES.0000237389.40000.02	44	47	53	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4248	4257		10.1096/fj.08-105940	http://dx.doi.org/10.1096/fj.08-105940			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18728217	Green Published			2022-12-25	WOS:000261254800024
J	Wang, H; Song, K; Krebs, TL; Yang, J; Danielpour, D				Wang, H.; Song, K.; Krebs, T. L.; Yang, J.; Danielpour, D.			Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55	ONCOGENE			English	Article						Smad; TGF-beta; prostate; Smad2; Smad7; Hic-5	GROWTH-FACTOR-BETA; PLASMINOGEN-ACTIVATOR INHIBITOR-1; FACTOR-KAPPA-B; TGF-BETA; MALIGNANT-TRANSFORMATION; RECEPTOR COACTIVATOR; HIC-5; SUPPRESSION; EXPRESSION; APOPTOSIS	We recently reported that hydrogen peroxide-inducible clone-5 (Hic-5, also named androgen receptor-associated protein 55) can bind to the transforming growth factor-beta (TGF-beta)-signaling regulator Smad3, thereby inhibiting certain Smad3-dependent TGF-beta responses. We now show that Hic-5 can also control TGF-beta responses through an alternative mechanism involving Smad7, a key negative regulator of TGF-beta signaling. Hic-5 binds directly to Smad7. This interaction requires the LIM3 domain of Hic-5, and enhances TGF-beta signaling through causing loss of Smad7 protein but not mRNA. Enforced expression of Hic-5 reverses the ability of Smad7 to suppress TGF-beta-induced phosphorylation of Smads 2 and 3 and activation of the plasminogen activator inhibitor-1 promoter (in NRP-154 and PC3 prostate carcinoma and WPMY-1 prostate myofibroblast cell lines). Lentiviral-mediated small-hairpin RNA silencing of endogenous Hic-5 reduced TGF-beta responses in PC3 and WPMY-1 cells. Further work suggests that the level of Smad7 is modulated by its physical interaction with Hic-5 and targeted to a degradation pathway not likely to be proteasomal. Our findings support that Hic-5 functions as a cell-type-specific activator of TGF-beta signaling through its ability to physically interact with and neutralize Smad7. Oncogene (2008) 27, 6791-6805; doi:10.1038/onc.2008.291;published online 1 September 2008	[Wang, H.; Song, K.; Krebs, T. L.; Danielpour, D.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Div Gen Med Sci Oncol, Dept Pharmacol,Sch Med, Cleveland, OH 44106 USA; [Yang, J.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Danielpour, D (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Div Gen Med Sci Oncol, Dept Pharmacol,Sch Med, Wolstein Res Bldg,Room 3532,2103 Cornell Rd, Cleveland, OH 44106 USA.	david.danielpour@case.edu			NCI [1R01CA102074, 1R01CA092102]; NATIONAL CANCER INSTITUTE [R01CA092102, R01CA102074] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Joan Massague for 3TP-lux plasmid, Dr Bert Vogelstein for SBE4<INF>BV</INF>-luciferase plasmid, Dr Kohei Miyazono for full-length mouse Flag-Smad7-pcDNA3 plasmid, Dr Bing-Cheng Wang for the pcDNA3-Myc plasmid, Dr Ryosuke Takahashi and Dr Yu-Chung Yang for HA-ubiquitin plasmid, Dr Malcolm Whitman for ARE-lux and Myc-FAST-1. This work was supported by NCI grants 1R01CA102074 and 1R01CA092102.	Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chipuk JE, 2002, J BIOL CHEM, V277, P26412, DOI 10.1074/jbc.M201244200; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; DABIRI G, 2008, J INVEST DE IN PRESS; DANIELPOUR D, 1994, CANCER RES, V54, P3413; Danielpour D, 2005, EUR J CANCER, V41, P846, DOI 10.1016/j.ejca.2004.12.027; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Durand MK, 2004, THROMB HAEMOSTASIS, V91, P438, DOI 10.1160/TH03-12-0784; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; Fujita H, 1998, J BIOL CHEM, V273, P26516, DOI 10.1074/jbc.273.41.26516; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heitzer MD, 2006, CANCER RES, V66, P7326, DOI 10.1158/0008-5472.CAN-05-2379; Heitzer MD, 2006, MOL ENDOCRINOL, V20, P56, DOI 10.1210/me.2005-0065; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Horrevoets AJG, 2004, BRIT J HAEMATOL, V125, P12, DOI 10.1111/j.1365-2141.2004.04844.x; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim SG, 2005, MOL BIOL CELL, V16, P4672, DOI 10.1091/mbc.E05-01-0054; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Lallemand F, 2005, J BIOL CHEM, V280, P27645, DOI 10.1074/jbc.M500188200; Lallemand F, 2001, ONCOGENE, V20, P879, DOI 10.1038/sj.onc.1204167; Landstrom M, 2000, CURR BIOL, V10, P535, DOI 10.1016/S0960-9822(00)00470-X; MASSAGUE J, 1992, MOL REPROD DEV, V32, P99, DOI 10.1002/mrd.1080320204; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mazars A, 2001, J BIOL CHEM, V276, P36797, DOI 10.1074/jbc.M101672200; Mori K, 2006, J BIOL CHEM, V281, P22048, DOI 10.1074/jbc.M513111200; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rahman MM, 2003, P NATL ACAD SCI USA, V100, P5124, DOI 10.1073/pnas.0530097100; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; Shibanuma M, 1997, MOL CELL BIOL, V17, P1224, DOI 10.1128/MCB.17.3.1224; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Simonsson M, 2005, J BIOL CHEM, V280, P21797, DOI 10.1074/jbc.M503134200; Song K, 2006, J BIOL CHEM, V281, P7765, DOI 10.1074/jbc.M511781200; Song K, 2003, J BIOL CHEM, V278, P38342, DOI 10.1074/jbc.M304583200; Song K, 2003, CANCER RES, V63, P4358; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Tang BW, 1999, CANCER RES, V59, P4834; Thomas SM, 1999, J CELL SCI, V112, P181; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; von Gersdorff G, 2000, J BIOL CHEM, V275, P11320, DOI 10.1074/jbc.275.15.11320; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; Wang X, 2002, J BIOL CHEM, V277, P15426, DOI 10.1074/jbc.M111218200; Wicks SJ, 2005, ONCOGENE, V24, P8080, DOI 10.1038/sj.onc.1208944; Wilkes MC, 2006, J BIOL CHEM, V281, P27846, DOI 10.1074/jbc.M603721200; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; WRANA JL, 1992, COLD SPRING HARB SYM, V57, P81, DOI 10.1101/SQB.1992.057.01.011; Wrana JL, 1996, TRENDS GENET, V12, P493, DOI 10.1016/S0168-9525(96)30109-1; YANG J, 2008, ONCOGENE IN PRESS; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	59	47	49	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2008	27	54					6791	6805		10.1038/onc.2008.291	http://dx.doi.org/10.1038/onc.2008.291			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	375IS	18762808	Green Accepted			2022-12-25	WOS:000261108000001
J	Cyr, N; Madrid, KP; Strasser, R; Aurousseau, M; Finn, R; Ausio, J; Jardim, A				Cyr, Normand; Madrid, Kleber P.; Strasser, Rona; Aurousseau, Mark; Finn, Ron; Ausio, Juan; Jardim, Armando			Leishmania donovani Peroxin 14 Undergoes a Marked Conformational Change following Association with Peroxin 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI; TARGETING SIGNAL; MEMBRANE-PROTEIN; IMPORT MACHINERY; IMMUNOCYTOCHEMICAL CHARACTERIZATION; HANSENULA-POLYMORPHA; RNA INTERFERENCE; MATRIX PROTEINS; DOCKING PROTEIN; YEAST PEX14P	The import of PTS1 proteins into the glycosome or peroxisome requires binding of a PTS1-laden PEX5 receptor to the membrane-associated protein PEX14 to facilitate translocation of PTS1 proteins into the lumen of these organelles. Quaternary structure analysis of protozoan parasite Leishmania donovani PEX14 (LdPEX14) revealed that this protein forms a homomeric complex with a size > 670 kDa. Moreover, deletion mapping indicated that disruption of LdPEX14 oligomerization correlated with the elimination of the hydrophobic region and coiled-coil motif present in LdPEX14. Analysis of the LdPEX5-LdPEX14 interaction by isothermal titration calorimetry revealed a molar binding stoichiometry of 1: 4 (LdPEX5: LdPEX14) and an in-solution dissociation constant (K-d) of similar to 74 nM. Calorimetry, circular dichroism, intrinsic fluorescence, and analytical ultracentrifugation experiments showed that binding of LdPEX5 resulted in a dramatic conformational change in the LdPEX14 oligomeric complex that involved the reorganization of the hydrophobic segment in LdPEX14. Finally, limited tryptic proteolysis assays established that in the presence of LdPEX5, LdPEX14 became more susceptible to proteolytic degradation consistent with this protein interaction triggering a significant conformational change in the recombinant and native LdPEX14 structures. These structural changes provide essential clues to how LdPEX14 functions in the translocation of folded proteins across the glycosomal membrane.	[Cyr, Normand; Madrid, Kleber P.; Strasser, Rona; Aurousseau, Mark; Jardim, Armando] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Finn, Ron; Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	McGill University; University of Victoria	Jardim, A (corresponding author), McGill Univ, Inst Parasitol, Macdonald Campus,21 111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	armando.jardim@mcgill.ca	Cyr, Normand/G-1614-2011	Cyr, Normand/0000-0002-9024-525X	Canadian Institute of Health Research; Fonds Quebecois de la Recherche sur la Nature et les Technologies	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT)	This work was supported in part by operating grants from the Canadian Institute of Health Research and Regroupement Strategique from the Fonds Quebecois de la Recherche sur la Nature et les Technologies. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a doctoral research scholarship from Fonds Quebecois de la Recherche sur la Nature et les Technologies.; Recipient of a Canadian Institute of Health Research New Investigator Salary Support award.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Allen T, 1995, MOL BIOCHEM PARASIT, V74, P99, DOI 10.1016/0166-6851(95)02475-1; Azevedo JE, 2006, BBA-MOL CELL RES, V1763, P1574, DOI 10.1016/j.bbamcr.2006.09.002; Bakker BM, 2000, P NATL ACAD SCI USA, V97, P2087, DOI 10.1073/pnas.030539197; BLATTNER J, 1992, J CELL BIOL, V119, P1129, DOI 10.1083/jcb.119.5.1129; Brocard C, 1997, EMBO J, V16, P5491, DOI 10.1093/emboj/16.18.5491; Choe J, 2003, BIOCHEMISTRY-US, V42, P10915, DOI 10.1021/bi034248n; CONNELLY PR, 1994, P NATL ACAD SCI USA, V91, P1964, DOI 10.1073/pnas.91.5.1964; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; FAIRLAMB AH, 1989, PARASITOLOGY, V99, pS93, DOI 10.1017/S003118200008344X; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Furuya T, 2002, P NATL ACAD SCI USA, V99, P14177, DOI 10.1073/pnas.222454899; Galland N, 2007, BBA-MOL CELL RES, V1773, P521, DOI 10.1016/j.bbamcr.2007.01.006; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Greenfield Norma J, 2004, Methods Mol Biol, V261, P55; Guerra-Giraidez C, 2002, J CELL SCI, V115, P2651; Itoh R, 2006, J BIOL CHEM, V281, P10196, DOI 10.1074/jbc.M600158200; Jardim A, 2000, J BIOL CHEM, V275, P13637, DOI 10.1074/jbc.275.18.13637; Jardim A, 1999, J BIOL CHEM, V274, P34403, DOI 10.1074/jbc.274.48.34403; Jardim A, 2002, MOL BIOCHEM PARASIT, V124, P51, DOI 10.1016/S0166-6851(02)00164-0; Johnson MA, 2001, YEAST, V18, P621, DOI 10.1002/yea.711; Kessler PS, 2005, J BIOL CHEM, V280, P9030, DOI 10.1074/jbc.M412033200; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Komori M, 1999, FEBS LETT, V457, P397, DOI 10.1016/S0014-5793(99)01087-X; Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Madrid KP, 2005, BIOCHEM J, V391, P105, DOI 10.1042/BJ20050328; Madrid KP, 2004, MOL CELL BIOL, V24, P7331, DOI 10.1128/MCB.24.17.7331-7344.2004; Michels PAM, 2005, MOL MEMBR BIOL, V22, P133, DOI 10.1080/09687860400024186; Moyersoen J, 2003, EUR J BIOCHEM, V270, P2059, DOI 10.1046/j.1432-1033.2003.03582.x; Niederhoff K, 2005, J BIOL CHEM, V280, P35571, DOI 10.1074/jbc.M502460200; Oliveira MEM, 2002, BBA-BIOMEMBRANES, V1567, P13, DOI 10.1016/S0005-2736(02)00635-1; OPPERDOES FR, 1993, BIOCHIMIE, V75, P231, DOI 10.1016/0300-9084(93)90081-3; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parsons M, 2001, MOL BIOCHEM PARASIT, V115, P19, DOI 10.1016/S0166-6851(01)00261-4; Pilar AVC, 2008, MOL BIOCHEM PARASIT, V158, P72, DOI 10.1016/j.molbiopara.2007.11.013; PURDUE PE, 1994, J BIOL CHEM, V269, P30065; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rayapuram N, 2006, BBA-MOL CELL RES, V1763, P1613, DOI 10.1016/j.bbamcr.2006.08.035; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Salomons FA, 2000, J BIOL CHEM, V275, P12603, DOI 10.1074/jbc.275.17.12603; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; Shimozawa N, 2004, HUM MUTAT, V23, P552, DOI 10.1002/humu.20032; Shinohara Y, 1997, GLYCOBIOLOGY, V7, P1201, DOI 10.1093/glycob/7.8.1201; SOMMER JM, 1994, ANNU REV MICROBIOL, V48, P105, DOI 10.1146/annurev.mi.48.100194.000541; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Velazquez-Campoy A, 2000, BIOCHEMISTRY-US, V39, P2201, DOI 10.1021/bi992399d; Will GK, 1999, MOL CELL BIOL, V19, P2265; Zarella-Boitz JM, 2004, MOL BIOCHEM PARASIT, V134, P43, DOI 10.1016/j.molbiopara.2003.08.016	64	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31488	31499		10.1074/jbc.M803529200	http://dx.doi.org/10.1074/jbc.M803529200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18718908	hybrid			2022-12-25	WOS:000260760800028
J	Kruh, NA; Borgaro, JG; Ruzsicska, BP; Xu, H; Tonge, PJ				Kruh, Nicole A.; Borgaro, Janine G.; Ruzsicska, Bela P.; Xu, Hua; Tonge, Peter J.			A Novel Interaction Linking the FAS-II and Phthiocerol Dimycocerosate (PDIM) Biosynthetic Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; MYCOBACTERIUM-TUBERCULOSIS; ENOYL REDUCTASE; MYCOLIC ACIDS; GENE-CLUSTER; SYSTEM; INHA; RESISTANCE; PURIFICATION; ADAPTATION	The fatty acid biosynthesis (FAS-II) pathway in Mycobacterium tuberculosis generates long chain fatty acids that serve as the precursors to mycolic acids, essential components of the mycobacterial cell wall. Enzymes in the FAS-II pathway are thought to form one or more noncovalent multi-enzyme complexes within the cell, and a bacterial two-hybrid screen was used to search for missing components of the pathway and to furnish additional data on interactions involving these enzymes in vivo. Using the FAS-II beta-ketoacyl synthase, KasA, as bait, an extensive bacterial two-hybrid screen of a M. tuberculosis genome fragment library unexpectedly revealed a novel interaction between KasA and PpsB as well as PpsD, two polyketide modules involved in the biosynthesis of the virulence lipid phthiocerol dimycocerosate (PDIM). Sequence analysis revealed that KasA interacts with PpsB and PpsD in the region of the acyl carrier domain of each protein, raising the possibility that lipids could be transferred between the FAS-II and PDIM biosynthetic pathways. Subsequent studies utilizing purified proteins and radiolabeled lipids revealed that fatty acids loaded onto PpsB were transferred to KasA and also incorporated into long chain fatty acids synthesized using a Mycobacterium smegmatis lysate. These data suggest that in addition to producing PDIMs, the growing phthiocerol product can also be shuttled into the FAS-II pathway via KasA as an entry point for further elongation. Interactions between these biosynthetic pathways may exist as a simple means to increase mycobacterial lipid diversity, enhancing functionality and the overall complexity of the cell wall.	[Kruh, Nicole A.; Tonge, Peter J.] SUNY Stony Brook, Grad Program Mol Genet & Microbiol, Dept Chem, Stony Brook, NY 11794 USA; [Kruh, Nicole A.; Borgaro, Janine G.; Ruzsicska, Bela P.; Xu, Hua; Tonge, Peter J.] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Chem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tonge, PJ (corresponding author), SUNY Stony Brook, Grad Program Mol Genet & Microbiol, Dept Chem, Stony Brook, NY 11794 USA.	peter.tonge@sunysb.edu	Kruh-Garcia, Nicole/D-5853-2017; Tonge, Peter J/A-7443-2009	Kruh-Garcia, Nicole/0000-0002-9896-8380; Tonge, Peter J/0000-0003-1606-3471	CSU-Tuberculosis Research Materials and Vaccine Testing; National Institutes of Health [N01-A1-75320, AI44639, T32 AI007539]; U. S. Department of Education Graduate Assistance in Areas of National Need (GAANN); National Research Service Award Predoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044639, N01AI075320, T32AI007539, R21AI044639] Funding Source: NIH RePORTER	CSU-Tuberculosis Research Materials and Vaccine Testing; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Education Graduate Assistance in Areas of National Need (GAANN)(US Department of Education); National Research Service Award Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M. tuberculosis genomic DNA was obtained through the CSU-Tuberculosis Research Materials and Vaccine Testing, National Institutes of Health, NIAID Contract N01-A1-75320.; This work was supported, in whole or in part, by National Institutes of Health Grant AI44639 (to P. J. T.).; Supported by a U. S. Department of Education Graduate Assistance in Areas of National Need (GAANN) grant and by Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship T32 AI007539 from the National Institutes of Health.	Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; ASSELINEAU J, 1950, NATURE, V166, P782, DOI 10.1038/166782a0; Azad AK, 1997, J BIOL CHEM, V272, P16741, DOI 10.1074/jbc.272.27.16741; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Changsen C, 2003, ANTIMICROB AGENTS CH, V47, P3682, DOI 10.1128/AAC.47.12.3682-3687.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DAFFE M, 1988, J GEN MICROBIOL, V134, P2049; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Kruh NA, 2007, PROTEIN SCI, V16, P1617, DOI 10.1110/ps.062749007; La Clair JJ, 2004, CHEM BIOL, V11, P195, DOI 10.1016/j.chembiol.2004.02.010; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Marrakchi H, 2000, MICROBIOL-UK, V146, P289, DOI 10.1099/00221287-146-2-289; ODRIOZOLA JM, 1977, BIOCHIM BIOPHYS ACTA, V488, P207, DOI 10.1016/0005-2760(77)90178-3; PARISH T, 2001, MYCOBACTERIUM TUBERC, P47; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Rao A, 2004, MOL GENET GENOMICS, V272, P571, DOI 10.1007/s00438-004-1088-3; Rawat R, 2003, P NATL ACAD SCI USA, V100, P13881, DOI 10.1073/pnas.2235848100; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Schaeffer ML, 2001, BBA-MOL CELL BIOL L, V1532, P67, DOI 10.1016/S1388-1981(01)00116-0; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Slayden RA, 2000, MOL MICROBIOL, V38, P514, DOI 10.1046/j.1365-2958.2000.02145.x; Slayden RA, 2002, TUBERCULOSIS, V82, P149, DOI 10.1054/tube.2002.0333; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Trivedi OA, 2005, MOL CELL, V17, P631, DOI 10.1016/j.molcel.2005.02.009; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; World Health Organization, 1993, TREATM TUB GUID NAT	37	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31719	31725		10.1074/jbc.M802169200	http://dx.doi.org/10.1074/jbc.M802169200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18703500	Green Published, hybrid			2022-12-25	WOS:000260760800054
J	Chow, JPH; Fujikawa, A; Shimizu, H; Suzuki, R; Noda, M				Chow, Jeremy Pak Hong; Fujikawa, Akihiro; Shimizu, Hidetada; Suzuki, Ryoko; Noda, Masaharu			Metalloproteinase- and gamma-Secretase-mediated Cleavage of Protein-tyrosine Phosphatase Receptor Type Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; SUBSTRATE-TRAPPING SYSTEM; ALPHA-CONVERTING-ENZYME; LONG-TERM POTENTIATION; ZETA RPTP-BETA; MICE DEFICIENT; RAT-BRAIN; IDENTIFICATION; EXPRESSION; INTERACTS	Protein-tyrosine phosphatase receptor type Z (Ptprz) is preferentially expressed in the brain as a major chondroitin sulfate proteoglycan. Three splicing variants, two receptor isoforms and one secretory isoform, are known. Here, we show that the extracellular region of the receptor isoforms of Ptprz are cleaved by metalloproteinases, and subsequently the membrane-tethered fragment is cleaved by presenilin/gamma-secretase, releasing its intracellular region into the cytoplasm; of note, the intracellular fragment of Ptprz shows nuclear localization. Administration of GM6001, an inhibitor of metalloproteinases, to mice demonstrated the metalloproteinase-mediated cleavage of Ptprz under physiological conditions. Furthermore, we identified the cleavage sites in the extracellular juxtamembrane region of Ptprz by tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase 9. This is the first evidence of the metalloproteinase-mediated processing of a receptor-like protein-tyrosine phosphatase in the central nervous system.	[Chow, Jeremy Pak Hong; Fujikawa, Akihiro; Shimizu, Hidetada; Suzuki, Ryoko; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Chow, Jeremy Pak Hong; Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, 5-1 Higashiyama,Myodaijicho, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp	Noda, Masaharu/D-7146-2016; Fujikawa, Akihiro/K-9805-2015	Noda, Masaharu/0000-0002-3796-524X; Fujikawa, Akihiro/0000-0002-3950-0550	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science, Sports, and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borroto A, 2003, J BIOL CHEM, V278, P25933, DOI 10.1074/jbc.M301673200; Canoll PD, 1996, J NEUROSCI RES, V44, P199, DOI 10.1002/(SICI)1097-4547(19960501)44:3<199::AID-JNR1>3.0.CO;2-B; Chow JPH, 2008, NEUROSCI LETT, V442, P208, DOI 10.1016/j.neulet.2008.07.028; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fujikawa A, 2007, J BIOCHEM, V142, P343, DOI 10.1093/jb/mvm140; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Fukada M, 2006, FEBS LETT, V580, P4051, DOI 10.1016/j.febslet.2006.06.041; Garwood J, 2003, J BIOL CHEM, V278, P24164, DOI 10.1074/jbc.M211721200; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Jin GX, 2002, ANAL BIOCHEM, V302, P269, DOI 10.1006/abio.2001.5549; Kasuga K, 2007, BIOCHEM BIOPH RES CO, V360, P90, DOI 10.1016/j.bbrc.2007.06.022; Kawachi H, 1999, MOL BRAIN RES, V72, P47, DOI 10.1016/S0169-328X(99)00204-1; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; LEVY JB, 1993, J BIOL CHEM, V268, P10573; MAEDA N, 1995, NEUROSCIENCE, V67, P23, DOI 10.1016/0306-4522(94)00069-H; MAEDA N, 1994, FEBS LETT, V354, P67, DOI 10.1016/0014-5793(94)01093-5; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Onyango P, 1998, GENOMICS, V50, P187, DOI 10.1006/geno.1997.5186; Peiretti F, 2003, J CELL SCI, V116, P1949, DOI 10.1242/jcs.00415; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Sakurai T, 1996, J NEUROSCI RES, V43, P694, DOI 10.1002/(SICI)1097-4547(19960315)43:6<694::AID-JNR6>3.3.CO;2-9; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Suzuki R, 2000, MECH DEVELOP, V98, P37, DOI 10.1016/S0925-4773(00)00450-0; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039	35	61	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30879	30889		10.1074/jbc.M802976200	http://dx.doi.org/10.1074/jbc.M802976200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18713734	Green Published, hybrid			2022-12-25	WOS:000260544800043
J	Hoffmann, C; Ziegler, N; Reiner, S; Krasel, C; Lohse, MJ				Hoffmann, Carsten; Ziegler, Nicole; Reiner, Susanne; Krasel, Cornelius; Lohse, Martin J.			Agonist-selective, Receptor-specific Interaction of Human P-2Y Receptors with beta-Arrestin-1 and-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2Y(2) NUCLEOTIDE RECEPTOR; PROTEIN-COUPLED RECEPTORS; DIFFERENTIAL REGULATION; BETA-ARRESTINS; DESENSITIZATION; INTERNALIZATION; ACTIVATION; PHOSPHORYLATION; ENDOCYTOSIS; MECHANISMS	Interaction of G-protein-coupled receptors with beta-arrestins is an important step in receptor desensitization and in triggering "alternative" signals. By means of confocal microscopy and fluorescence resonance energy transfer, we have investigated the internalization of the human P2Y receptors 1, 2, 4, 6, 11, and 12 and their interaction with beta-arrestin-1 and -2. Co-transfection of each individual P2Y receptor with beta-arrestin-1-GFP or beta-arrestin-2-YFP into HEK-293 cells and stimulation with the corresponding agonists resulted in a receptor-specific interaction pattern. The P2Y(1) receptor stimulated with ADP strongly translocated beta-arrestin-2-YFP, whereas only a slight translocation was observed for beta-arrestin-1-GFP. The P2Y(4) receptor exhibited equally strong translocation for beta-arrestin-1-GFP and beta-arrestin-2YFP when stimulated with UTP. The P2Y(6), P2Y(11), and P2Y(12) receptor internalized only when GRK2 was additionally cotransfected, but beta-arrestin translocation was only visible for the P2Y(6) and P2Y(11) receptor. The P2Y(2) receptor showed a beta-arrestin translocation pattern that was dependent on the agonist used for stimulation. UTP translocated beta-arrestin-1-GFP and beta-arrestin-2-YFP equally well, whereas ATP translocated beta-arrestin-1-GFP to a much lower extent than beta-arrestin2- YFP. The same agonist-dependent pattern was seen in fluorescence resonance energy transfer experiments between the fluorescently labeled P2Y(2) receptor and beta-arrestins. Thus, the P2Y(2) receptor would be classified as a class A receptor when stimulated with ATP or as a class B receptor when stimulated with UTP. The ligand-specific recruitment of beta-arrestins by ATP and UTP stimulation of P2Y(2) receptors was further found to result in differential stimulation of ERK phosphorylation. This suggests that the two different agonists induce distinct active states of this receptor that show differential interactions with beta-arrestins.	[Hoffmann, Carsten; Ziegler, Nicole; Reiner, Susanne; Krasel, Cornelius; Lohse, Martin J.] Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany		Hoffmann, C (corresponding author), Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	c.Hoffmann@toxi.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012; Krasel, Cornelius/AAH-7074-2019	Lohse, Martin J/0000-0002-0599-3510; Krasel, Cornelius/0000-0001-8309-8696	Deutsche Forschungsgemeinschaft [SFB487]; Fonds der Chemischen Industrie; Ernst-Jung Award	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Ernst-Jung Award	This work was supported by the Deutsche Forschungsgemeinschaft Grant " Sonderforschungsbereich" SFB487 " Regulatory Membrane Proteins," by the Fonds der Chemischen Industrie, and by the Ernst-Jung Award for Medicine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Baurand A, 2005, MOL PHARMACOL, V67, P721, DOI 10.1124/mol.104.004846; Brinson AE, 2001, J BIOL CHEM, V276, P11939, DOI 10.1074/jbc.M009909200; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Camaioni E, 1998, J MED CHEM, V41, P183, DOI 10.1021/jm970433l; del Rey A, 2006, J BIOL CHEM, V281, P35147, DOI 10.1074/jbc.M607713200; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Ecke D, 2008, BIOCHEM J, V409, P107, DOI 10.1042/BJ20070671; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fischer W, 2005, N-S ARCH PHARMACOL, V371, P466, DOI 10.1007/s00210-005-1070-6; Flores RV, 2005, MOL CELL BIOCHEM, V280, P35, DOI 10.1007/s11010-005-8050-5; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Garrad RC, 1998, J BIOL CHEM, V273, P29437, DOI 10.1074/jbc.273.45.29437; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Herold CL, 2004, J BIOL CHEM, V279, P11456, DOI 10.1074/jbc.M301734200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann C, 2008, BRIT J PHARMACOL, V153, pS358, DOI 10.1038/sj.bjp.0707615; Hoffmann C, 1999, J BIOL CHEM, V274, P14639, DOI 10.1074/jbc.274.21.14639; Hoffmann C, 2004, BIOCHEM PHARMACOL, V68, P2075, DOI 10.1016/j.bcp.2004.07.014; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kennedy C, 2000, MOL PHARMACOL, V57, P926; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Nicholas RA, 1996, MOL PHARMACOL, V50, P224; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Otero M, 2000, MOL CELL BIOCHEM, V205, P115, DOI 10.1023/A:1007018001735; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Robaye B, 1997, EUR J PHARMACOL, V329, P231, DOI 10.1016/S0014-2999(97)89184-4; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Schonbrunn A, 2008, MOL CELL ENDOCRINOL, V286, P35, DOI 10.1016/j.mce.2007.09.009; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Sromek SM, 1998, MOL PHARMACOL, V54, P485, DOI 10.1124/mol.54.3.485; Tulapurkar ME, 2006, J NEUROCHEM, V96, P624, DOI 10.1111/j.1471-4159.2005.03594.x; Tulapurkar ME, 2004, BRIT J PHARMACOL, V142, P869, DOI 10.1038/sj.bjp.0705859; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	46	72	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30933	30941		10.1074/jbc.M801472200	http://dx.doi.org/10.1074/jbc.M801472200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18703513	Green Published, hybrid			2022-12-25	WOS:000260544800048
J	Lee, HJ; Park, SJ; Choi, SH; Lee, KH				Lee, Hyun-Jung; Park, Soon-Jung; Choi, Sang Ho; Lee, Kyu-Ho			Vibrio vulnificus rpoS Expression Is Repressed by Direct Binding of cAMP-cAMP Receptor Protein Complex to Its Two Promoter Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY USEFUL; SIGMA-FACTOR SIGMA(S); ESCHERICHIA-COLI; RNA-POLYMERASE; TRANSCRIPTIONAL INDUCTION; PATHOGENIC BACTERIUM; SIGNAL-TRANSDUCTION; GENE; PSEUDOMONAS; REGULATOR	Vibrio vulnificus, a septicemia-causing pathogenic bacterium, acquires resistance against various stresses and expresses virulence factors via an rpoS gene product. In this study, we investigated the transcriptional characteristics of this global regulator. Two distinct transcriptional initiation sites for the rpoS gene, the proximal promoter (Pp) and the distal promoter (P-d), were defined by primer extension experiments. Various rpoS::luxAB transcriptional fusions indicated that Pd is a major promoter of rpoS expression. Western blot analysis showed that RpoS levels were inversely correlated with intracellular levels of 3', 5'-cyclic AMP (cAMP). The expressions of both Pd and Pp were increased in cya and crp mutants. The exogenous addition of cAMP to the cya mutant resulted in repressed expression of rpoS. In addition, rpoS expression was significantly lowered in the cpdA mutant, in which the level of cAMP was elevated because of the absence of 3', 5'-cAMP phosphodiesterase. In vitro transcription assays using the V. vulnificus RNA polymerase showed that the transcripts from both promoters were reduced by addition of the cAMP-cAMP receptor protein (CRP). The cAMP-CRP was shown to bind to two rpoS promoters by electrophoretic mobility shift assays. The alteration of the putative CRP-binding site on each rpoS promoter, via site-directed mutagenesis, abolished the binding of cAMP-CRP as well as regulation by cAMP-CRP. Therefore, this study shows a relationship between the level of intracellular cAMP and the degree of rpoS expression and further demonstrates, for the first time, the direct binding of the cAMP-CRP complex to rpoS upstream regions, which results in repression of rpoS gene expression.	[Lee, Hyun-Jung; Lee, Kyu-Ho] Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin 449791, Kyunggi Do, South Korea; [Park, Soon-Jung] Yonsei Univ, Coll Med, Dept Environm Med Biol, Brain Korea Project 21, Seoul 120752, South Korea; [Park, Soon-Jung] Yonsei Univ, Coll Med, Inst Trop Med, Brain Korea Project 21, Seoul 120752, South Korea; [Choi, Sang Ho] Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Seoul 151921, South Korea; [Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea	Hankuk University Foreign Studies; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU)	Lee, KH (corresponding author), Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin 449791, Kyunggi Do, South Korea.	khlee@hufs.ac.kr		Park, Soon-Jung/0000-0002-0423-1944	KOSEF [R01-2007-000-10159-0]; Ministry of Marine Affairs and Fisheries; Republic of Korea	KOSEF(Korea Science and Engineering Foundation); Ministry of Marine Affairs and Fisheries; Republic of Korea	This work was supported by Grant R01-2007-000-10159-0 (to K.-H. L.) from KOSEF and a grant from the Extreme Molecular Genomics Research Program of the Ministry of Marine Affairs and Fisheries ( to K.-H. L.), Republic of Korea. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARNQVIST A, 1994, MOL MICROBIOL, V13, P1021, DOI 10.1111/j.1365-2958.1994.tb00493.x; Bergendahl V, 2003, PROTEIN EXPRES PURIF, V31, P155, DOI 10.1016/S1046-5928(03)00145-1; BOTSFORD JL, 1981, MICROBIOL REV, V45, P620, DOI 10.1128/MMBR.45.4.620-642.1981; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; Gonzalez-Gil G, 1998, EMBO J, V17, P2877, DOI 10.1093/emboj/17.10.2877; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Hengge-Aronis R, 2000, BACTERIAL STRESS RESPONSES, P161; Hirsch M, 2005, J BACTERIOL, V187, P1568, DOI 10.1128/JB.187.5.1568-1580.2005; Hulsmann A, 2003, APPL ENVIRON MICROB, V69, P6114, DOI 10.1128/AEM.69.10.6114-6120.2003; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jeong HS, 2001, J BIOL CHEM, V276, P13875, DOI 10.1074/jbc.M010567200; Kim YR, 2003, BIOCHEM BIOPH RES CO, V304, P405, DOI 10.1016/S0006-291X(03)00613-2; Kojic M, 2002, J BACTERIOL, V184, P2324, DOI 10.1128/JB.184.8.2324-2330.2002; LANGE R, 1995, J BACTERIOL, V177, P4676, DOI 10.1128/jb.177.16.4676-4680.1995; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lee HJ, 2003, J BACTERIOL, V185, P5891, DOI 10.1128/JB.185.19.5891-5896.2003; Lee HJ, 2007, J BACTERIOL, V189, P2629, DOI 10.1128/JB.01791-06; Litwin CM, 2001, MICROB PATHOGENESIS, V31, P295, DOI 10.1006/mpat.2001.0472; Ma Z, 2003, J BACTERIOL, V185, P6852, DOI 10.1128/JB.185.23.6852-6859.2003; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; MCCANN MP, 1993, J BACTERIOL, V175, P2143, DOI 10.1128/JB.175.7.2143-2149.1993; Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Mukhopadhyay S, 2000, MOL MICROBIOL, V37, P371, DOI 10.1046/j.1365-2958.2000.01999.x; NAGASAWA S, 1992, MOL MICROBIOL, V6, P799, DOI 10.1111/j.1365-2958.1992.tb01530.x; NEWLANDS JT, 1993, J BACTERIOL, V175, P661, DOI 10.1128/JB.175.3.661-668.1993; Park KJ, 2004, J MICROBIOL BIOTECHN, V14, P1063; Park KJ, 2004, J BACTERIOL, V186, P3304, DOI 10.1128/JB.186.11.3304-3312.2004; Roh JB, 2006, J BIOL CHEM, V281, P34775, DOI 10.1074/jbc.M607844200; Sambrook J, 2001, MOL CLONING LAB MANU; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; Studemann A, 2003, EMBO J, V22, P4111, DOI 10.1093/emboj/cdg411; THOMPSON NE, 1992, BIOCHEMISTRY-US, V31, P7003, DOI 10.1021/bi00145a019; Ueguchi C, 2001, J BACTERIOL, V183, P520, DOI 10.1128/JB.183.2.520-527.2001; Venturi V, 2003, MOL MICROBIOL, V49, P1, DOI 10.1046/j.1365-2958.2003.03547.x	41	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30438	30450		10.1074/jbc.M802219200	http://dx.doi.org/10.1074/jbc.M802219200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18713737	Green Published, hybrid			2022-12-25	WOS:000260544800002
J	Mizuno, N; Kosaka, M				Mizuno, Nobuhiko; Kosaka, Mitsuko			Novel Variants of Oct-3/4 Gene Expressed in Mouse Somatic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; SELF-RENEWAL; POU DOMAIN; OCT4 EXPRESSION; DNA-BINDING; ES CELLS; DIFFERENTIATION; TRANSACTIVATION; ENHANCER	It has been suggested that Oct-3/4 may regulate self-renewal in somatic stem cells, as it does in embryonic stem cells. However, recent reports raise the possibility that detection of human Oct-3/4 expression by RT-PCR is prone to artifacts generated by pseudogene transcripts and argue against a role for Oct-3/4 in somatic cells. In this study, we clarified Oct-3/4 expression in mouse somatic tissues using designed PCR primers, which can exclude amplification of its pseudogenes. We found that novel alternative transcripts are indeed expressed in somatic tissues, rather than the normal length transcripts in germline and ES cells. The alternative transcripts indicate the expression of two kinds of truncated proteins. Furthermore, we determined novel promoter regions that are sufficient for the expression of Oct-3/4 transcript variants in somatic cells. These findings provide new insights into the postnatal role of Oct-3/4 in somatic tissues.	[Mizuno, Nobuhiko; Kosaka, Mitsuko] RIKEN, Res Unit Cell Plast, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kosaka, Mitsuko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan	RIKEN; Okayama University	Kosaka, M (corresponding author), RIKEN, Res Unit Cell Plast, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan.	m-kosaka@md.okayama-u.ac.jp	KOSAKA, Mitsuko/B-1603-2011	KOSAKA, Mitsuko/0000-0001-6146-5184	Ministry of Education, Culture, Sports, Science and Technology of Japan [19592048]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid to the Leading Project and 19592048 (to M.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Asami M, 2007, DEV BIOL, V304, P433, DOI 10.1016/j.ydbio.2006.12.047; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Brehm A, 1997, MOL CELL BIOL, V17, P154, DOI 10.1128/MCB.17.1.154; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Engelhardt M, 2004, EXP EYE RES, V78, P1025, DOI 10.1016/j.exer.2003.12.002; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; KOZAK M, 1983, CELL, V34, P971, DOI 10.1016/0092-8674(83)90554-8; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Lin H, 2007, BIOCHEM BIOPH RES CO, V355, P111, DOI 10.1016/j.bbrc.2007.01.106; Minucci S, 1996, EMBO J, V15, P888, DOI 10.1002/j.1460-2075.1996.tb00423.x; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Palma I, 2008, CANCER LETT, V263, P204, DOI 10.1016/j.canlet.2008.01.019; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yeom YI, 1996, DEVELOPMENT, V122, P881	35	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30997	31004		10.1074/jbc.M802992200	http://dx.doi.org/10.1074/jbc.M802992200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18765667	hybrid, Green Published			2022-12-25	WOS:000260544800054
J	Navarro, FJ; Martin, Y; Siverio, JM				Navarro, Francisco J.; Martin, Yuse; Siverio, Jose M.			Phosphorylation of the Yeast Nitrate Transporter Ynt1 Is Essential for Delivery to the Plasma Membrane during Nitrogen Limitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID PERMEASE; SACCHAROMYCES-CEREVISIAE; HANSENULA-POLYMORPHA; TRYPTOPHAN PERMEASE; POSTTRANSLATIONAL REGULATION; INTRACELLULAR TRAFFICKING; EUKARYOTIC NITRATE; URACIL PERMEASE; PEP4 GENE; ASSIMILATION	Ynt1 is the sole high affinity nitrate transporter of the yeast Hansenula polymorpha. It is highly regulated by the nitrogen source, by being down-regulated in response to glutamine by repression of the YNT1 gene and Ynt1 ubiquitinylation, endocytosis, and vacuolar degradation. On the contrary, we show that nitrogen limitation stabilizes Ynt1 levels at the plasma membrane, requiring phosphorylation of the transporter. We determined that Ser-246 in the central intracellular loop plays a key role in the phosphorylation of Ynt1 and that the nitrogen permease reactivator 1 kinase (Npr1) is necessary for Ynt1 phosphorylation. Abolition of phosphorylation led Ynt1 to the vacuole by a pep12-dependent end4-independent pathway, which is also dependent on ubiquitinylation, whereas Ynt1 protein lacking ubiquitinylation sites does not follow this pathway. We found that, under nitrogen limitation, Ynt1 phosphorylation is essential for rapid induction of nitrate assimilation genes. Our results suggest that, under nitrogen limitation, phosphorylation prevents Ynt1 delivery from the secretion route to the vacuole, which, aided by reduced ubiquitinylation, accumulates Ynt1 at the plasma membrane. This mechanism could be part of the response that allows nitrate-assimilatory organisms to cope with nitrogen depletion.	[Navarro, Francisco J.; Martin, Yuse; Siverio, Jose M.] Univ La Laguna, Nitrogen Metab Grp, Dept Bioquim & Biol Mol, Inst Enfermedades Trop & Salud Publ Canarias, E-38206 Tenerife, Canarias, Spain	Universidad de la Laguna	Siverio, JM (corresponding author), Univ La Laguna, Nitrogen Metab Grp, Dept Bioquim & Biol Mol, Inst Enfermedades Trop & Salud Publ Canarias, Astrofis Fco Sanchez S-N, E-38206 Tenerife, Canarias, Spain.	jsiverio@ull.es		NAVARRO, FRANCISCO J./0000-0002-9332-0737	Ministerio de Educacion y Ciencia (MEC, Spain) [BFU2007-60172/BMC]	Ministerio de Educacion y Ciencia (MEC, Spain)(Spanish Government)	This work was supported in part by the Ministerio de Educacion y Ciencia (MEC, Spain) (Grant BFU2007-60172/BMC to J.M.S.).	Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Brito N, 1999, APPL MICROBIOL BIOT, V53, P23, DOI 10.1007/s002530051609; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Chen EJ, 2002, P NATL ACAD SCI USA, V99, P14837, DOI 10.1073/pnas.232591899; CRAWFORD NM, 1993, ANNU REV GENET, V27, P115, DOI 10.1146/annurev.ge.27.120193.000555; CRAWFORD NM, 1995, PLANT CELL, V7, P859, DOI 10.1105/tpc.7.7.859; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; FABER KN, 1994, CURR GENET, V25, P305, DOI 10.1007/BF00351482; Fernandez E, 2007, J EXP BOT, V58, P2279, DOI 10.1093/jxb/erm106; Galvan A, 2001, CELL MOL LIFE SCI, V58, P225, DOI 10.1007/PL00000850; Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Llamas A, 2002, PLANT J, V30, P261, DOI 10.1046/j.1365-313X.2002.01281.x; Machin F, 2004, YEAST, V21, P265, DOI 10.1002/yea.1075; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; MARZLUF GA, 1993, ANNU REV MICROBIOL, V47, P31, DOI 10.1146/annurev.micro.47.1.31; Miller AJ, 2007, J EXP BOT, V58, P2297, DOI 10.1093/jxb/erm066; Montanini B, 2006, BIOCHEM J, V394, P125, DOI 10.1042/BJ20051199; Navarro FJ, 2006, J BIOL CHEM, V281, P13268, DOI 10.1074/jbc.M601253200; Navarro FJ, 2003, FEMS YEAST RES, V4, P149, DOI 10.1016/S1567-1356(03)00163-6; Perez MD, 1997, BIOCHEM J, V321, P397, DOI 10.1042/bj3210397; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Siverio JM, 2002, FEMS MICROBIOL REV, V26, P277, DOI 10.1016/S0168-6445(02)00100-6; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; Wang Y, 2007, NEW PHYTOL, V175, P699, DOI 10.1111/j.1469-8137.2007.02135.x; Wirth J, 2007, J BIOL CHEM, V282, P23541, DOI 10.1074/jbc.M700901200; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500	39	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31208	31217		10.1074/jbc.M802170200	http://dx.doi.org/10.1074/jbc.M802170200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18713738	Green Published, hybrid			2022-12-25	WOS:000260544800074
J	Beran, RKF; Pyle, AM				Beran, Rudolf K. F.; Pyle, Anna Marie			Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3 Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; CRYSTAL-STRUCTURE; ADAPTER PROTEIN; VIRUS; RNA; DOMAIN; NS4A; IDENTIFICATION; TRANSLOCATION; INHIBITORS	Non-structural protein 3 (NS3) is a multifunctional enzyme possessing serine protease, NTPase, and RNA unwinding activities that are required for hepatitis C viral (HCV) replication. HCV non-structural protein 4A (NS4A) binds to the N-terminal NS3 protease domain to stimulate NS3 serine protease activity. In addition, the NS3 protease domain enhances the RNA binding, ATPase, and RNA unwinding activities of the C-terminal NS3 helicase domain (NS3hel). To determine whether NS3hel enhances the NS3 serine protease activity, we purified truncated and full-length NS3-4A complexes and examined their serine protease activities under a variety of salt and pH conditions. Our results indicate that the helicase domain enhances serine protease activity, just as the protease domain enhances helicase activity. Thus, the two enzymatic domains of NS3-4A are highly interdependent. This is the first time that such a complete interdependence has been demonstrated for a multifunctional, single chain enzyme. NS3-4A domain interdependence has important implications for function during the viral lifecycle as well as for the design of inhibitor screens that target the NS3-4A protease.	[Beran, Rudolf K. F.; Pyle, Anna Marie] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pyle, Anna Marie] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Pyle, AM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave,Bass Bldg,Rm 334, New Haven, CT 06520 USA.	anna.pyle@yale.edu			National Institutes of Health [GM60620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060620, F32GM071120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60620. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Beran RKF, 2006, J MOL BIOL, V358, P974, DOI 10.1016/j.jmb.2006.02.078; Binder M, 2007, J VIROL, V81, P5270, DOI 10.1128/JVI.00032-07; Copeland R. A., 2005, EVALUATION ENZYME IN; Dahl G, 2007, ANTIVIR THER, V12, P733; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Dimasi N, 1997, J VIROL, V71, P7461, DOI 10.1128/JVI.71.10.7461-7469.1997; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Gallinari P, 1999, BIOCHEMISTRY-US, V38, P5620, DOI 10.1021/bi982892+; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lam AMI, 2004, NUCLEIC ACIDS RES, V32, P4060, DOI 10.1093/nar/gkh743; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Mao SS, 2008, ANAL BIOCHEM, V373, P1, DOI 10.1016/j.ab.2007.10.041; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Sali DL, 1998, BIOCHEMISTRY-US, V37, P3392, DOI 10.1021/bi972010r; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Steinkuhler C, 1996, J BIOL CHEM, V271, P6367, DOI 10.1074/jbc.271.11.6367; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Taliani M, 1996, ANAL BIOCHEM, V240, P60, DOI 10.1006/abio.1996.0331; Thibeault D, 2004, J VIROL, V78, P7352, DOI 10.1128/JVI.78.14.7352-7359.2004; Wang WY, 2004, J VIROL, V78, P700, DOI 10.1128/JVI.78.2.700-709.2004; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zhang C, 2005, J VIROL, V79, P8687, DOI 10.1128/JVI.79.14.8687-8697.2005	39	82	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29929	29937		10.1074/jbc.M804065200	http://dx.doi.org/10.1074/jbc.M804065200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723512	hybrid, Green Published			2022-12-25	WOS:000260366900038
J	Pagliaccetti, NE; Eduardo, R; Kleinstein, SH; Mu, XJ; Bandi, P; Robek, MD				Pagliaccetti, Nicole E.; Eduardo, Roger; Kleinstein, Steven H.; Mu, Xinmeng Jasmine; Bandi, Prasanthi; Robek, Michael D.			Interleukin-29 Functions Cooperatively with Interferon to Induce Antiviral Gene Expression and Inhibit Hepatitis C Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-LAMBDA; SIGNAL-TRANSDUCTION; RESPONSE ELEMENT; RNA REPLICATION; GAMMA; ALPHA; INFECTION; CELLS; TRANSCRIPTION; SYSTEM	The interferon (IFN)-related cytokine interleukin (IL)-29 (also known as IFN-lambda 1) inhibits virus replication by inducing a cellular antiviral response similar to that activated by IFN-alpha/beta. However, because it binds to a unique receptor, this cytokine may function cooperatively with IFN-alpha/beta or IFN-gamma during natural infections to inhibit virus replication, and might also be useful therapeutically in combination with other cytokines to treat chronic viral infections such as hepatitis C (HCV). We therefore investigated the ability of IL-29 and IFN-alpha or IFN-gamma to cooperatively inhibit virus replication and induce antiviral gene expression. Compared with the individual cytokines alone, the combination of IL-29 with IFN-alpha or IFN-gamma was more effective at blocking vesicular stomatitis virus and HCV replication, and this cooperative antiviral activity correlated with the magnitude of induced antiviral gene expression. Although the combined effects of IL-29 and IFN-alpha were primarily additive, the IL-29/IFN-gamma combination synergistically induced multiple genes and had the greatest antiviral activity. Two different mechanisms contributed to the enhanced gene expression induced by the cytokine combinations: increased activation of ISRE promoter elements and simultaneous activation of both ISRE and GAS elements within the same promoter. These findings provide new insight into the coregulation of a critical innate immune response by functionally distinct cytokine families.	[Pagliaccetti, Nicole E.; Eduardo, Roger; Kleinstein, Steven H.; Mu, Xinmeng Jasmine; Bandi, Prasanthi; Robek, Michael D.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06510 USA	Yale University; Yale University	Robek, MD (corresponding author), POB 208023,310 Cedar St,LH315A, New Haven, CT 06520 USA.	michael.robek@yale.edu	Mu, Xinmeng/P-2562-2016	Mu, Xinmeng/0000-0002-8079-0828	National Institutes of Health Training [AI055403]; Anna Fuller Fund; United States Public Health Service [K22 AI064757]; Northeast Biodefense Center [U54-AI057158-Lipkin]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055403, U54AI057158, K22AI064757] Funding Source: NIH RePORTER	National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anna Fuller Fund; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health Training Grant AI055403 and a fellowship from the Anna Fuller Fund.; Supported by United States Public Health Service Grant K22 AI064757 and a career development award from the Northeast Biodefense Center (U54-AI057158-Lipkin). To whom correspondence should be addressed: P.O. Box 208023, 310 Cedar St., LH315A, New Haven, CT 06520-8023. Tel.: 203785- 6174; Fax: 203-785-6127; E-mail: michael.robek@yale.edu.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Barash Y., 2001, Algorithms in Bioinformatics. First International Workshop, WABI 2001. Proceedings (Lecture Notes in Computer Science Vol.2149), P278; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BLUYSSEN HAR, 1995, P NATL ACAD SCI USA, V92, P5645, DOI 10.1073/pnas.92.12.5645; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brand S, 2005, BIOCHEM BIOPH RES CO, V331, P543, DOI 10.1016/j.bbrc.2005.04.004; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; DECKER T, 1991, MOL CELL BIOL, V11, P5147, DOI 10.1128/MCB.11.10.5147; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; DONOFRIO C, 1992, INT J IMMUNOPHARMACO, V14, P1069, DOI 10.1016/0192-0561(92)90152-B; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Fuchizaki U, 2003, J MED VIROL, V69, P188, DOI 10.1002/jmv.10286; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kennedy RE, 2006, BIOINFORMATICS, V22, P1272, DOI 10.1093/bioinformatics/btl108; Kennedy RE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-154; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Larkin J, 2003, J INTERF CYTOK RES, V23, P247, DOI 10.1089/107999003321829962; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Okuse C, 2005, ANTIVIR RES, V65, P23, DOI 10.1016/j.antiviral.2004.09.002; Pierce AT, 2005, J GEN VIROL, V86, P2421, DOI 10.1099/vir.0.80979-0; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Ramsburg E, 2005, J VIROL, V79, P15043, DOI 10.1128/JVI.79.24.15043-15053.2005; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; RUBINSTEIN S, 1981, J VIROL, V37, P755, DOI 10.1128/JVI.37.2.755-758.1981; Sainz B, 2002, J VIROL, V76, P11541, DOI 10.1128/JVI.76.22.11541-11550.2002; Sainz B, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-14; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stoltz M, 2007, J VIROL, V81, P8685, DOI 10.1128/JVI.00415-07; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; van den Pol AN, 2007, J VIROL, V81, P332, DOI 10.1128/JVI.01592-06; Verna Elizabeth C, 2006, Clin Liver Dis, V10, P919; Wesoly J, 2007, ACTA BIOCHIM POL, V54, P27, DOI 10.18388/abp.2007_3266; *WHO, 2000, WEEKLY EPIDEMIOLOGIC, V74, P421; Zhu HZ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-80; Zhu HZ, 2004, BIOCHEM BIOPH RES CO, V324, P518, DOI 10.1016/j.bbrc.2004.09.081; Zhu HZ, 2003, HEPATOLOGY, V37, P1180, DOI 10.1053/jhep.2003.50184	54	79	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30079	30089		10.1074/jbc.M804296200	http://dx.doi.org/10.1074/jbc.M804296200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18757365	hybrid, Green Published			2022-12-25	WOS:000260366900053
J	Chen, GI; Tisayakorn, S; Jorgensen, C; D'Ambrosio, LM; Goudreault, M; Gingras, AC				Chen, Ginny I.; Tisayakorn, Sally; Jorgensen, Claus; D'Ambrosio, Lisa M.; Goudreault, Marilyn; Gingras, Anne-Claude			PP4R4/KIAA1622 Forms a Novel Stable Cytosolic Complex with Phosphoprotein Phosphatase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; CATALYTIC SUBUNIT; PPP2R1B GENE; 2A; PURIFICATION; PP2A; IDENTIFICATION; REARRANGEMENTS; ORGANIZATION; H4(D10S170)	Protein serine/threonine phosphatase 4 (PP4c) is an essential polypeptide involved in critical cellular processes such as microtubule growth and organization, DNA damage checkpoint recovery, apoptosis, and tumor necrosis factor alpha signaling. Like other phosphatases of the PP2A family, PP4c interacts with regulatory proteins, which specify substrate targeting and intracellular localization. The identification of these regulatory proteins is, therefore, key to fully understanding the function of this enzyme class. Here, using a sensitive affinity purification/mass spectrometry approach, we identify a novel, stable cytosolic PP4c interacting partner, KIAA1622, which we have renamed PP4R4. PP4R4 displays weak sequence homology with the A (scaffolding) subunit of the PP2A holoenzyme and specifically associates with PP4c (and not with the related PP2Ac or PP6c phosphatases). The PP4c.PP4R4 interaction is disrupted by mutations analogous to those abrogating the association of PP2Ac with PP2A A subunit. However, unlike the PP2A A subunit, which plays a scaffolding role, PP4R4 does not bridge PP4c with previously characterized PP4 regulatory subunits. PP4c.PP4R4 complexes exhibit phosphatase activity toward a fluorogenic substrate and gamma H2AX, but this activity is lower than that associated with the PP4c.PP4R2.PP4R3 complex, which itself is less active than the free PP4c catalytic subunit. Our data demonstrate that PP4R4 forms a novel cytosolic complex with PP4c, independent from the complexes containing PP4R1, PP4R2.PP4R3, and alpha 4, and that the regulatory subunits of PP4c have evolved different modes of interaction with the catalytic subunit.	[Chen, Ginny I.; Tisayakorn, Sally; Jorgensen, Claus; D'Ambrosio, Lisa M.; Goudreault, Marilyn; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M4M 2Y8, Canada; [Chen, Ginny I.; Tisayakorn, Sally; D'Ambrosio, Lisa M.; Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Gingras, AC (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave,Rm 992, Toronto, ON M4M 2Y8, Canada.	gingras@mshri.on.ca	Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Jorgensen, Claus/0000-0002-7841-943X	Terry Fox Foundation; National Cancer Institute of Canada	Terry Fox Foundation; National Cancer Institute of Canada(Canadian Cancer Society (CCS))	This work was supported in part by a grant from the Terry Fox Foundation and the National Cancer Institute of Canada (to A. C. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrade MA, 2000, J MOL BIOL, V298, P521, DOI 10.1006/jmbi.2000.3684; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; BREWIS ND, 1992, BIOCHIM BIOPHYS ACTA, V1171, P231, DOI 10.1016/0167-4781(92)90129-N; BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Carnegie GK, 2003, J CELL SCI, V116, P1905, DOI 10.1242/jcs.00409; Celetti A, 2004, ONCOGENE, V23, P109, DOI 10.1038/sj.onc.1206981; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; Drechsler M, 2007, ANN HEMATOL, V86, P353, DOI 10.1007/s00277-006-0247-5; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Forester CM, 2007, P NATL ACAD SCI USA, V104, P19867, DOI 10.1073/pnas.0709879104; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; GRIECO M, 1994, ONCOGENE, V9, P2531; Hastie CJ, 2006, FEBS J, V273, P3322, DOI 10.1111/j.1742-4658.2006.05336.x; Hastie CJ, 1998, FEBS LETT, V431, P357, DOI 10.1016/S0014-5793(98)00775-3; Hastie CJ, 2000, BIOCHEM J, V347, P845, DOI 10.1042/0264-6021:3470845; Helps NR, 1998, J CELL SCI, V111, P1331; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Huang RY, 2005, CANCER RES, V65, P5890, DOI 10.1158/0008-5472.CAN-04-4093; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kikuno R, 2004, NUCLEIC ACIDS RES, V32, pD502, DOI 10.1093/nar/gkh035; Kloeker S, 1999, J BIOL CHEM, V274, P5339, DOI 10.1074/jbc.274.9.5339; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Merolla F, 2007, ONCOGENE, V26, P6167, DOI 10.1038/sj.onc.1210446; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Nagase T, 2000, DNA RES, V7, P273; NAKADA S, 2008, EMBO REP IN PRESS; Puxeddu E, 2005, MUTAT RES-FUND MOL M, V570, P17, DOI 10.1016/j.mrfmmm.2004.09.010; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Shui JW, 2007, MOL CELL BIOL, V27, P79, DOI 10.1128/MCB.00799-06; Takagi Y, 2000, GUT, V47, P268, DOI 10.1136/gut.47.2.268; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Toyo-oka K, 2008, J CELL BIOL, V180, P1133, DOI 10.1083/jcb.200705148; USUI H, 1988, J BIOL CHEM, V263, P3752; Wada T, 2001, J AM SOC NEPHROL, V12, P2601, DOI 10.1681/ASN.V12122601; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Whalen SG, 1996, J BIOL CHEM, V271, P11831, DOI 10.1074/jbc.271.20.11831; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhou GS, 2002, J BIOL CHEM, V277, P6391, DOI 10.1074/jbc.M107014200; Zhou ZL, 1998, EMBO J, V17, P2095, DOI 10.1093/emboj/17.7.2095	51	62	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29273	29284		10.1074/jbc.M803443200	http://dx.doi.org/10.1074/jbc.M803443200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18715871	Green Published, hybrid			2022-12-25	WOS:000260179900054
J	Terrak, M; Sauvage, E; Derouaux, A; Dehareng, D; Bouhss, A; Breukink, E; Jeanjean, S; Nguyen-Disteche, M				Terrak, Mohammed; Sauvage, Eric; Derouaux, Adeline; Dehareng, Dominique; Bouhss, Ahmed; Breukink, Eefjan; Jeanjean, Sylvie; Nguyen-Disteche, Martine			Importance of the conserved residues in the peptidoglycan glycosyltransferase module of the class a penicillin-binding protein 1b of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC CHARACTERIZATION; CELL-DIVISION; PBP1B; MORPHOGENESIS; POLYMERASE; FAMILY	The peptidoglycan glycosyltransferase (GT) module of class A penicillin-binding proteins (PBPs) and monofunctional GTs catalyze glycan chain elongation of the bacterial cell wall. These enzymes belong to the GT51 family, are characterized by five conserved motifs, and have some fold similarity with the phage lambda lysozyme. In this work, we have systematically modified all the conserved amino acid residues of the GT module of Escherichia coli class A PBP1b by site-directed mutagenesis and determined their importance for the in vivo and in vitro activity and the thermostability of the protein. To get an insight into the GT active site of this paradigm enzyme, a model of PBP1b GT domain was constructed based on the available crystal structures (PDB codes 2OLV and 2OLU). The data show that in addition to the essential glutamate residues Glu(233) of motif 1 and Glu(290) of motif 3, the residues Phe(237) and His(240) of motif 1 and Gly(264), Thr(267), Gln(271), and Lys(274) of motif 2, all located in the catalytic cavity of the GT domain, are essential for the in vitro enzymatic activity of the PBP1b and for its in vivo functioning. Thus, the first three conserved motifs contain most of the residues that are required for the GT activity of the PBP1b. The residues Asp(234), Phe(237), His(240), Thr(267), and Gln(271) are proposed to maintain the structure of the active site and the positioning of the catalytic Glu(233).	[Terrak, Mohammed; Sauvage, Eric; Derouaux, Adeline; Dehareng, Dominique; Jeanjean, Sylvie; Nguyen-Disteche, Martine] Univ Liege, Inst Chim, Ctr Ingn Prot, B-4000 Sart Tilman Par Liege, Belgium; [Bouhss, Ahmed] Univ Paris 11, CNRS, Lab Enveloppes Bacteriennes & Antibiot, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, F-91405 Orsay, France; [Breukink, Eefjan] Univ Utrecht, Dept Biochem Membranes, Bijvoet Ctr Biomol Res, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	University of Liege; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Utrecht University		mterrak@ulg.ac.be	Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660				Barrett D, 2005, J BACTERIOL, V187, P2215, DOI 10.1128/JB.187.6.2215-2217.2005; Barrett D, 2007, J BIOL CHEM, V282, P31964, DOI 10.1074/jbc.M705440200; Barrett DS, 2004, BIOCHEMISTRY-US, V43, P12375, DOI 10.1021/bi049142m; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; HARA H, 1984, FEBS LETT, V168, P155, DOI 10.1016/0014-5793(84)80226-4; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; LAKAYE B, 1994, BIOCHEM J, V300, P141, DOI 10.1042/bj3000141; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Marrec-Fairley M, 2000, MOL MICROBIOL, V37, P1019, DOI 10.1046/j.1365-2958.2000.02054.x; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; NANNINGA N, 1991, MOL MICROBIOL, V5, P791, DOI 10.1111/j.1365-2958.1991.tb00751.x; Perlstein DL, 2007, J AM CHEM SOC, V129, P12674, DOI 10.1021/ja075965y; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Schwartz B, 2002, BIOCHEMISTRY-US, V41, P12552, DOI 10.1021/bi026205x; Spratt BG, 1996, MOL MICROBIOL, V19, P639, DOI 10.1046/j.1365-2958.1996.442924.x; SUZUKI H, 1978, P NATL ACAD SCI USA, V75, P664, DOI 10.1073/pnas.75.2.664; SUZUKI H, 1980, FEBS LETT, V110, P245, DOI 10.1016/0014-5793(80)80083-4; TAMAKI S, 1977, P NATL ACAD SCI USA, V74, P5472, DOI 10.1073/pnas.74.12.5472; Terrak M, 1999, MOL MICROBIOL, V34, P350, DOI 10.1046/j.1365-2958.1999.01612.x; Terrak M, 2006, J BACTERIOL, V188, P2528, DOI 10.1128/JB.188.7.2528-2532.2006; van Heijenoort J, 2001, GLYCOBIOLOGY, V11, p25R; VANHEIJENOORT Y, 1992, J BACTERIOL, V174, P3549, DOI 10.1128/JB.174.11.3549-3557.1992; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Yuan YQ, 2007, P NATL ACAD SCI USA, V104, P5348, DOI 10.1073/pnas.0701160104; Zawadzka-Skomial J, 2006, J BACTERIOL, V188, P1875, DOI 10.1128/JB.188.5.1875-1881.2006	32	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28464	28470		10.1074/jbc.M803223200	http://dx.doi.org/10.1074/jbc.M803223200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701463	Green Published, hybrid			2022-12-25	WOS:000259969300048
J	Bill, BR; Balciunas, D; McCarra, JA; Young, ED; Xiong, T; Spahn, AM; Garcia-Lecea, M; Korzh, V; Ekker, SC; Schimmenti, LA				Bill, Brent R.; Balciunas, Darius; McCarra, Joshua A.; Young, Eric D.; Xiong, Toua; Spahn, Ashley M.; Garcia-Lecea, Marta; Korzh, Vladimir; Ekker, Stephen C.; Schimmenti, Lisa A.			Development and Notch Signaling Requirements of the Zebrafish Choroid Plexus	PLOS ONE			English	Article								Background: The choroid plexus (CP) is an epithelial and vascular structure in the ventricular system of the brain that is a critical part of the blood-brain barrier. The CP has two primary functions, 1) to produce and regulate components of the cerebral spinal fluid, and 2) to inhibit entry into the brain of exogenous substances. Despite its importance in neurobiology, little is known about how this structure forms. Methodology and Principal Findings: Here we show that the transposon-mediated enhancer trap zebrafish line Et-Mn16 expresses green fluorescent protein within a population of cells that migrate toward the midline and coalesce to form the definitive CP. We further demonstrate the development of the integral vascular network of the definitive CP. Utilizing pharmacologic pan-notch inhibition and specific morpholino-mediated knockdown, we demonstrate a requirement for Notch signaling in choroid plexus development. We identify three Notch signaling pathway members as mediating this effect, notch1b, deltaA, and deltaD. Conclusions and Significance: This work is the first to identify the zebrafish choroid plexus and to characterize its epithelial and vasculature integration. This study, in the context of other comparative anatomical studies, strongly indicates a conserved mechanism for development of the CP. Finally, we characterize a requirement for Notch signaling in the developing CP. This establishes the zebrafish CP as an important new system for the determination of key signaling pathways in the formation of this essential component of the vertebrate brain.	[Bill, Brent R.; Balciunas, Darius; McCarra, Joshua A.; Young, Eric D.; Xiong, Toua; Spahn, Ashley M.; Ekker, Stephen C.] Univ Minnesota, Dept Genet Cell & Dev, Minneapolis, MN 55455 USA; [Bill, Brent R.; Balciunas, Darius; Ekker, Stephen C.; Schimmenti, Lisa A.] Univ Minnesota, Dev Biol Ctr, Minneapolis, MN USA; [Bill, Brent R.; Ekker, Stephen C.; Schimmenti, Lisa A.] Univ Minnesota, Inst Human Genet, Minneapolis, MN USA; [Balciunas, Darius] Temple Univ, Dept Biol, Philadelphia, PA USA; [Garcia-Lecea, Marta; Korzh, Vladimir] Agcy Sci, Technol & Res, Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Lab Fish Dev Biol, Singapore, Singapore; [Ekker, Stephen C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Schimmenti, Lisa A.] Univ Minnesota, Dept Pediat, Genet & Metabolism, Minneapolis, MN USA; [Schimmenti, Lisa A.] Univ Minnesota, Dept Ophthalmol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bill, BR (corresponding author), Univ Minnesota, Dept Genet Cell & Dev, Minneapolis, MN 55455 USA.	ekker.stephen@mayo.edu; las@umn.edu	Balciunas, Darius/AAD-1420-2019; Korzh, Vladimir P/H-1596-2011	Korzh, Vladimir P/0000-0002-6580-7986; Schimmenti, Lisa/0000-0003-3154-4249; Balciunas, Darius/0000-0003-1938-3243; Bill, Brent/0000-0002-3436-1969; Young, Eric/0000-0002-0014-1482; Ekker, Stephen/0000-0003-0726-4212	National Institute of Health [T32 EY007133-12, GM63904, DA14546]; University of Minnesota Department of Genetics, Cell, and Development, and Department of Pediatrics; Undergraduate Research Opportunities Program; Agency for Science, Technology and Research (A-STAR) of Singapore; Mayo Foundation; University of Minnesota, Department of Pediatrics; Minnesota Medical Foundation; The Graduate Division of the University of Minnesota; The University of Minnesota Medical School; NATIONAL EYE INSTITUTE [T32EY007133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904, R56GM063904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014546] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Department of Genetics, Cell, and Development, and Department of Pediatrics; Undergraduate Research Opportunities Program; Agency for Science, Technology and Research (A-STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Mayo Foundation; University of Minnesota, Department of Pediatrics(University of Minnesota System); Minnesota Medical Foundation; The Graduate Division of the University of Minnesota; The University of Minnesota Medical School; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institute of Health T32 EY007133-12-P.I. McLoon, University of Minnesota Department of Genetics, Cell, and Development, and Department of Pediatrics (BRB), Undergraduate Research Opportunities Program (JAM & EDY), Agency for Science, Technology and Research (A-STAR) of Singapore (VK). National Institute of Health R01 [GM63904 and DA14546 to SCE], Mayo Foundation (SCE), University of Minnesota, Department of Pediatrics (LAS), Minnesota Medical Foundation (LAS) and The Graduate Division of the University of Minnesota (LAS), and The University of Minnesota Medical School (Zebrafish Core Facility) (LAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoyel M, 2005, DEVELOPMENT, V132, P775, DOI 10.1242/dev.01616; Balciunas D, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-62; Barreto ASCD, 2004, ARQ NEURO-PSIQUIAT, V62, P600, DOI 10.1590/S0004-282X2004000400007; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Candal E, 2005, DEV BRAIN RES, V160, P157, DOI 10.1016/j.devbrainres.2005.08.009; GARCIALECEA M, PLOS BIOL IN PRESS; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Hermanson S, 2004, METHOD CELL BIOL, V77, P349; Holley SA, 2002, DEVELOPMENT, V129, P1175; Hunter NL, 2007, DEVELOPMENT, V134, P3449, DOI 10.1242/dev.003095; Irvin DK, 2004, J NEUROSCI RES, V75, P330, DOI 10.1002/jnr.10843; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jacobsen M, 1982, Brain Res, V255, P239; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Lorent K, 2004, DEVELOPMENT, V131, P5753, DOI 10.1242/dev.01411; MARCUS RC, 1995, J COMP NEUROL, V359, P365, DOI 10.1002/cne.903590302; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Netsky MG., 1975, CHOROID PLEXUS HLTH; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Strazielle N, 2000, J NEUROPATH EXP NEUR, V59, P561, DOI 10.1093/jnen/59.7.561; STRONG LH, 1956, AM J ANAT, V99, P249, DOI 10.1002/aja.1000990204; STURROCK RR, 1979, J ANAT, V129, P777; Tanaka M, 2007, HISTOCHEM CELL BIOL, V127, P449, DOI 10.1007/s00418-006-0260-8; Tennyson V M, 1968, Prog Brain Res, V29, P63; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wright GJ, 2004, DEVELOPMENT, V131, P5659, DOI 10.1242/dev.01417; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020	35	34	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3114	10.1371/journal.pone.0003114	http://dx.doi.org/10.1371/journal.pone.0003114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769591	Green Published, Green Submitted, gold			2022-12-25	WOS:000264418300006
J	Chen, XS; White, WTJ; Collins, LJ; Penny, D				Chen, Xiaowei Sylvia; White, W. Timothy J.; Collins, Lesley J.; Penny, David			Computational Identification of Four Spliceosomal snRNAs from the Deep-Branching Eukaryote Giardia intestinalis	PLOS ONE			English	Article							DYNAMIC-PROGRAMMING ALGORITHM; RNA SECONDARY STRUCTURE; SMALL NUCLEAR RNAS; TRICHOMONAS-VAGINALIS; TRYPANOSOMA-BRUCEI; U2; GENE; PROTEIN; INTRON; SEQUENCE	RNAs processing other RNAs is very general in eukaryotes, but is not clear to what extent it is ancestral to eukaryotes. Here we focus on pre-mRNA splicing, one of the most important RNA-processing mechanisms in eukaryotes. In most eukaryotes splicing is predominantly catalysed by the major spliceosome complex, which consists of five uridine-rich small nuclear RNAs (U-snRNAs) and over 200 proteins in humans. Three major spliceosomal introns have been found experimentally in Giardia; one Giardia U-snRNA (U5) and a number of spliceosomal proteins have also been identified. However, because of the low sequence similarity between the Giardia ncRNAs and those of other eukaryotes, the other U-snRNAs of Giardia had not been found. Using two computational methods, candidates for Giardia U1, U2, U4 and U6 snRNAs were identified in this study and shown by RT-PCR to be expressed. We found that identifying a U2 candidate helped identify U6 and U4 based on interactions between them. Secondary structural modelling of the Giardia U-snRNA candidates revealed typical features of eukaryotic U-snRNAs. We demonstrate a successful approach to combine computational and experimental methods to identify expected ncRNAs in a highly divergent protist genome. Our findings reinforce the conclusion that spliceosomal small-nuclear RNAs existed in the last common ancestor of eukaryotes.	[Chen, Xiaowei Sylvia; White, W. Timothy J.; Collins, Lesley J.; Penny, David] Massey Univ, IMBS, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand	Massey University	Chen, XS (corresponding author), Massey Univ, IMBS, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand.	sylvia.x.chen@gmail.com	Penny, David/E-9410-2011		Marsden Fund New Zealand Allan Wilson Centre	Marsden Fund New Zealand Allan Wilson Centre	Marsden Fund New Zealand Allan Wilson Centre The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Ambrosio DL, 2007, MEM I OSWALDO CRUZ, V102, P97, DOI 10.1590/S0074-02762007000100017; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; BROWN JWS, 1989, NUCLEIC ACIDS RES, V17, P8991, DOI 10.1093/nar/17.22.8991; Chen XW, 2007, NUCLEIC ACIDS RES, V35, P4619, DOI 10.1093/nar/gkm474; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; COLLINS LJ, 2003, J INTEGRATIVE BIOINF, V1; Dacks JB, 2002, MOL BIOL EVOL, V19, P830, DOI 10.1093/oxfordjournals.molbev.a004140; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; DATTA B, 1991, NATURE, V352, P821, DOI 10.1038/352821a0; Dix I, 1998, RNA, V4, P1674, DOI 10.1017/S1355838298412998; Eddy SR, 2006, COLD SPRING HARB SYM, V71, P117, DOI 10.1101/sqb.2006.71.003; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; EDLIND TD, 1987, NUCLEIC ACIDS RES, V15, P7889, DOI 10.1093/nar/15.19.7889; Fast NM, 1999, MOL BIOCHEM PARASIT, V99, P275, DOI 10.1016/S0166-6851(99)00017-1; FORTNER DM, 1994, GENE DEV, V8, P221, DOI 10.1101/gad.8.2.221; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; HAUSNER TP, 1990, GENE DEV, V4, P2146, DOI 10.1101/gad.4.12a.2146; Hinas A, 2006, EUKARYOT CELL, V5, P924, DOI 10.1128/EC.00065-06; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFMANN CJB, 1992, MOL BIOL REP, V17, P21, DOI 10.1007/BF01006396; Huppler A, 2002, NAT STRUCT BIOL, V9, P431, DOI 10.1038/nsb800; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Jensen RC, 1998, NUCLEIC ACIDS RES, V26, P616, DOI 10.1093/nar/26.2.616; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; KUNKEL GR, 1988, GENE DEV, V2, P196, DOI 10.1101/gad.2.2.196; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Lehmann K, 2003, CRIT REV BIOCHEM MOL, V38, P249, DOI 10.1080/713609236; Lucke S, 1997, EMBO J, V16, P4433, DOI 10.1093/emboj/16.14.4433; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Marquez SM, 2005, RNA, V11, P739, DOI 10.1261/rna.7211705; Martin W, 2007, SCIENCE, V316, P542; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Mcmanus CJ, 2007, RNA, V13, P2252, DOI 10.1261/rna.699907; Miranda R, 1996, GENE, V180, P37, DOI 10.1016/S0378-1119(96)00397-6; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; NIU XH, 1994, MOL BIOCHEM PARASIT, V66, P49, DOI 10.1016/0166-6851(94)90035-3; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Palfi Z, 2005, NUCLEIC ACIDS RES, V33, P2493, DOI 10.1093/nar/gki548; Russell AG, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-45; Sashital DG, 2004, NAT STRUCT MOL BIOL, V11, P1237, DOI 10.1038/nsmb863; Sashital DG, 2003, BIOCHEMISTRY-US, V42, P1470, DOI 10.1021/bi027137h; Seetharaman M, 2006, RNA, V12, P235, DOI 10.1261/rna.2237806; Simoes-Barbosa A, 2008, RNA, V14, P1617, DOI 10.1261/rna.1045408; SUN JS, 1995, GENE DEV, V9, P843, DOI 10.1101/gad.9.7.843; Valadkhan S, 2005, CURR OPIN CHEM BIOL, V9, P603, DOI 10.1016/j.cbpa.2005.10.008; Valadkhan S, 2007, RNA, V13, P2300, DOI 10.1261/rna.626207; Vanacova S, 2005, P NATL ACAD SCI USA, V102, P4430, DOI 10.1073/pnas.0407500102; Vanacova S, 2003, INT J PARASITOL, V33, P235, DOI 10.1016/S0020-7519(02)00267-9; VANKAN P, 1988, NUCLEIC ACIDS RES, V16, P10425, DOI 10.1093/nar/16.22.10425; Yang CY, 2005, BIOCHEM BIOPH RES CO, V328, P1224, DOI 10.1016/j.bbrc.2005.01.077; YEAN SL, 1991, MOL CELL BIOL, V11, P5571, DOI 10.1128/MCB.11.11.5571; Yuan FQ, 2007, NUCLEIC ACIDS RES, V35, P2833, DOI 10.1093/nar/gkm134	61	18	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3106	10.1371/journal.pone.0003106	http://dx.doi.org/10.1371/journal.pone.0003106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769729	Green Published, Green Submitted, gold			2022-12-25	WOS:000264796800011
J	Love, CJ; Zhang, SG; Mershin, A				Love, Christopher J.; Zhang, Shuguang; Mershin, Andreas			Source of Sustained Voltage Difference between the Xylem of a Potted Ficus benjamina Tree and Its Soil	PLOS ONE			English	Article								It has long been known that there is a sustained electrical potential (voltage) difference between the xylem of many plants and their surrounding soil, but the mechanism behind this voltage has remained controversial. After eliminating any extraneous capacitive or inductive couplings and ground-mediated electric current flows, we have measured sustained differences of 50-200 mV between the xylem region of a Faraday-caged, intact, potted Ficus benjamina tree and its soil, as well as between its cut branches and soils and ionic solutions standardized to various pH values. Using identical platinum electrodes, no correlation between the voltage and time of day, illumination, sap flow, electrode elevation, or ionic composition of soil was found, suggesting no direct connection to simple dissimilar-metal redox reactions or transpirational activity. Instead, a clear relationship between the voltage polarity and magnitude and the pH difference between xylem and soil was observed. We attribute these sustained voltages to a biological concentration cell likely set up by the homeostatic mechanisms of the tree. Potential applications of this finding are briefly explored.	[Love, Christopher J.; Zhang, Shuguang; Mershin, Andreas] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Love, CJ (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mershin@mit.edu		Love, Christopher/0000-0002-7989-2376; Zhang, Shuguang/0000-0002-3856-3752	Magcap, LLC	Magcap, LLC	Stella Karavas and Chris Lagadinos of Magcap, LLC provided an unrestricted gift of $10,000USD to cover Christopher J Love's UROP stipend and in part fund this project. Neither they nor MagCap played any role in the design and conduct of the study, or in the collection, analysis, or interpretation of the data, or the preparation, review, or approval of this manuscript	CALNAN C, 2006, PLUGGED STARTUP HOPE; FENSOM D. S., 1963, CANADIAN JOUR BOT, V41, P831, DOI 10.1139/b63-068; GENSLER W, 1988, J ELECTROCHEM SOC, V135, P2991, DOI 10.1149/1.2095475; Gibert D, 2006, PLANT SCI, V171, P572, DOI 10.1016/j.plantsci.2006.06.012; GREGORI G, 1986, TELLURIC CURRENTS NA, P232; GRODZINSKY AJ, 2003, FIELDS FORCES FLOWS; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; Koppan A, 2000, CR ACAD SCI III-VIE, V323, P559, DOI 10.1016/S0764-4469(00)00179-7; Koppan Andras, 2002, Acta Biologica Szegediensis, V46, P37; Ksenzhek O., 2004, Bulgarian Journal of Plant Physiology, V30, P61; Labady A, 2002, BIOELECTROCHEMISTRY, V57, P47, DOI 10.1016/S1567-5394(01)00175-X; MORAT P, 1994, CR ACAD SCI III-VIE, V317, P98; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; NOBEL PS, 2005, PHYSICOCHEMICAL ENV, P106; Reich PB, 2006, NATURE, V439, P457, DOI 10.1038/nature04282; Wegner LH, 1998, PLANT CELL ENVIRON, V21, P849, DOI 10.1046/j.1365-3040.1998.00335.x; WRIGHT JP, 1981, PLANT PHYSIOL, V67, P845, DOI 10.1104/pp.67.4.845; Yang J, 2003, J MICROMECH MICROENG, V13, P963, DOI 10.1088/0960-1317/13/6/320	18	31	31	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2963	10.1371/journal.pone.0002963	http://dx.doi.org/10.1371/journal.pone.0002963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698415	Green Published, Green Submitted, gold			2022-12-25	WOS:000264412600048
J	Miao, HX; Chen, L; Riordan, SM; Li, WJ; Juarez, S; Crabb, AM; Lukas, TJ; Du, P; Lin, SM; Wise, A; Agapova, OA; Yang, P; Gu, CC; Hernandez, MR				Miao, Haixi; Chen, Lin; Riordan, Sean M.; Li, Wenjun; Juarez, Santiago; Crabb, Andrea M.; Lukas, Thomas J.; Du, Pan; Lin, Simon M.; Wise, Alexandria; Agapova, Olga A.; Yang, Ping; Gu, Charles C.; Hernandez, M. Rosario			Gene Expression and Functional Studies of the Optic Nerve Head Astrocyte Transcriptome from Normal African Americans and Caucasian Americans Donors	PLOS ONE			English	Article								Purpose: To determine whether optic nerve head (ONH) astrocytes, a key cellular component of glaucomatous neuropathy, exhibit differential gene expression in primary cultures of astrocytes from normal African American (AA) donors compared to astrocytes from normal Caucasian American (CA) donors. Methods: We used oligonucleotide Affymetrix microarray (HG U133A & HG U133A 2.0 chips) to compare gene expression levels in cultured ONH astrocytes from twelve CA and twelve AA normal age matched donor eyes. Chips were normalized with Robust Microarray Analysis (RMA) in R using Bioconductor. Significant differential gene expression levels were detected using mixed effects modeling and Statistical Analysis of Microarray (SAM). Functional analysis and Gene Ontology were used to classify differentially expressed genes. Differential gene expression was validated by quantitative real time RT-PCR. Protein levels were detected by Western blots and ELISA. Cell adhesion and migration assays tested physiological responses. Glutathione (GSH) assay detected levels of intracellular GSH. Results: Multiple analyses selected 87 genes differentially expressed between normal AA and CA (P<0.01). The most relevant genes expressed in AA were categorized by function, including: signal transduction, response to stress, ECM genes, migration and cell adhesion. Conclusions: These data show that normal astrocytes from AA and CA normal donors display distinct expression profiles that impact astrocyte functions in the ONH. Our data suggests that differences in gene expression in ONH astrocytes may be specific to the development and/or progression of glaucoma in AA.	[Miao, Haixi; Chen, Lin; Riordan, Sean M.; Li, Wenjun; Juarez, Santiago; Crabb, Andrea M.; Hernandez, M. Rosario] Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA; [Lukas, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL USA; [Du, Pan; Lin, Simon M.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehensive Canc Ctr, Chicago, IL USA; [Wise, Alexandria] CUNY City Coll, Dept Biol, New York, NY USA; [Agapova, Olga A.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO USA; [Yang, Ping] Washington Univ, Sch Med, Dept Pediat, St Louis, MO USA; [Gu, Charles C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; City University of New York (CUNY) System; City College of New York (CUNY); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Miao, HX (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA.	m-hernandez-neufeld@northwestern.edu	Riordan, Sean Michael/A-9053-2012; Gu, C. Charles/A-7934-2010	Riordan, Sean Michael/0000-0001-5727-1221; Gu, C. Charles/0000-0002-8527-8145	NIH [EY-06416]; NATIONAL EYE INSTITUTE [R01EY006416] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY-06416 and an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapova OA, 2001, GLIA, V33, P205, DOI 10.1002/1098-1136(200103)33:3<205::AID-GLIA1019>3.0.CO;2-D; Agapova OA, 2003, BRAIN RES, V967, P132, DOI 10.1016/S0006-8993(02)04234-8; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Drozdz R, 1998, FREE RADICAL BIO MED, V25, P786, DOI 10.1016/S0891-5849(98)00127-0; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; Fuller T, 2003, J CELL SCI, V116, P2461, DOI 10.1242/jcs.00426; GALLAGHER PJ, 1992, J BIOL CHEM, V267, P9450; Gao L, 2006, AM J RESP CELL MOL, V34, P487, DOI 10.1165/rcmb.2005-0404OC; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gersdorff N, 2005, J BIOL CHEM, V280, P22146, DOI 10.1074/jbc.M501875200; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Gutjahr MC, 2005, EXP CELL RES, V308, P422, DOI 10.1016/j.yexcr.2005.05.001; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Heckbert SR, 2003, CIRCULATION, V107, P2021, DOI 10.1161/01.CIR.0000065231.07729.92; Hernandez MR, 2002, GLIA, V38, P45, DOI 10.1002/glia.10051; Hernandez MR, 1997, ARCH OPHTHALMOL-CHIC, V115, P389, DOI 10.1001/archopht.1997.01100150391013; Hu XM, 2003, CANCER CHEMOTH PHARM, V52, P47, DOI 10.1007/s00280-003-0629-5; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Juronen E, 2000, EXP EYE RES, V71, P447, DOI 10.1006/exer.2000.0899; Karonen T, 1997, BRIT J DERMATOL, V137, P51, DOI 10.1046/j.1365-2133.1997.17671859.x; Ke N, 2007, MOL CANCER THER, V6, P1840, DOI 10.1158/1535-7163.MCT-07-0066; Kobayashi S, 1997, GLIA, V20, P262, DOI 10.1002/(SICI)1098-1136(199707)20:3<262::AID-GLIA10>3.0.CO;2-S; Leclerc N, 2000, J NEUROSCI RES, V60, P602, DOI 10.1002/(SICI)1097-4547(20000601)60:5<602::AID-JNR5>3.0.CO;2-F; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; Liang YB, 2005, FEBS J, V272, P791, DOI 10.1111/j.1742-4658.2004.04516.x; Liu B, 2006, J NEUROSCI, V26, P7532, DOI 10.1523/JNEUROSCI.1004-06.2006; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Lutjen-Drecoll E, 2005, EXP EYE RES, V81, P1, DOI 10.1016/j.exer.2005.02.008; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Mi HY, 1999, J NEUROSCI, V19, P1049; Milner R, 2001, MOL CELL NEUROSCI, V18, P108, DOI 10.1006/mcne.2001.1003; Morrison John C, 2006, Trans Am Ophthalmol Soc, V104, P453; Nemesure B, 2003, HUM GENET, V112, P600, DOI 10.1007/s00439-003-0910-z; NETLAND PA, 1995, OPHTHALMOLOGY, V102, P878, DOI 10.1016/S0161-6420(95)30939-6; Neufeld AH, 1997, ARCH OPHTHALMOL-CHIC, V115, P497, DOI 10.1001/archopht.1997.01100150499009; Ohlmann AV, 2005, CURR EYE RES, V30, P27, DOI 10.1080/02713680490894333; Onishi Y, 2003, CLIN EXP METASTAS, V20, P51, DOI 10.1023/A:1022594503657; Pena JDO, 1999, BRIT J OPHTHALMOL, V83, P209, DOI 10.1136/bjo.83.2.209; Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; RANSOHOFF RM, 1991, ARCH NEUROL-CHICAGO, V48, P1244, DOI 10.1001/archneur.1991.00530240048017; Ricard CS, 2000, MOL BRAIN RES, V81, P62, DOI 10.1016/S0169-328X(00)00150-9; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rotimi CN, 2006, INVEST OPHTH VIS SCI, V47, P3262, DOI 10.1167/iovs.05-1537; Rudzinski MN, 2008, ARCH OPHTHALMOL-CHIC, V126, P679, DOI 10.1001/archopht.126.5.679; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; Salvador-Silva M, 2004, GLIA, V45, P364, DOI 10.1002/glia.10342; Sappington RM, 2006, INVEST OPHTH VIS SCI, V47, P3860, DOI 10.1167/iovs.05-1408; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Schmidt JF, 2007, BRIT J OPHTHALMOL, V91, P1219, DOI 10.1136/bjo.2006.112185; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Tezel G, 2000, J NEUROSCI, V20, P8693; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; Tu HM, 2002, J BIOL CHEM, V277, P23092, DOI 10.1074/jbc.M107583200; Unal M, 2007, BRIT J OPHTHALMOL, V91, P527, DOI 10.1136/bjo.2006.102418; Urban Z, 2007, INVEST OPHTH VIS SCI, V48, P3209, DOI 10.1167/iovs.07-0107; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Vuori K, 1999, NAT CELL BIOL, V1, pE85, DOI 10.1038/12081; Wax MB, 2000, BRIT J OPHTHALMOL, V84, P423, DOI 10.1136/bjo.84.4.423; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wordinger R, 2003, MOL VIS, V9, P249; Yang P, 2003, BRAIN RES PROTOC, V12, P67, DOI 10.1016/S1385-299X(03)00073-4; Yildirim O, 2005, GRAEF ARCH CLIN EXP, V243, P327, DOI 10.1007/s00417-004-1013-9	76	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2847	10.1371/journal.pone.0002847	http://dx.doi.org/10.1371/journal.pone.0002847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18716680	Green Published, gold			2022-12-25	WOS:000264366600003
J	Pen, A; Moreno, MJ; Durocher, Y; Deb-Rinker, P; Stanimirovic, DB				Pen, A.; Moreno, M. J.; Durocher, Y.; Deb-Rinker, P.; Stanimirovic, D. B.			Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-beta signaling	ONCOGENE			English	Article						glioblastoma; angiogenesis; IGFBP7; TGF-beta; Smad	GROWTH-FACTOR-BETA; BLOOD-BRAIN-BARRIER; PROSTACYCLIN-STIMULATING FACTOR; PROTEIN-RELATED PROTEIN-1; TUMOR-SUPPRESSIVE ACTIVITY; TRANSFORMING GROWTH-FACTOR-BETA-1; ENDOTHELIAL-CELLS; GENE-EXPRESSION; COLON-CANCER; PROSTATE-CANCER	Insulin-like growth factor-binding protein 7 (IGFBP7) is a selective biomarker of glioblastoma (GBM) vessels, stronglyexpressed in tumor endothelial cells and vascular basement membrane. IGFBP7 gene regulation and its potential role in tumor angiogenesis remain unclear. Mechanisms of IGFBP7 induction and its angiogenic capacity were examined in human brain endothelial cells (HBECs) exposed to tumor-like conditions. HBEC treated with GBM cell (U87MG)-conditioned media (-CM) exhibited fourfold upregulation of IGFBP7 mRNA and protein compared to control cells. IGFBP7 gene regulation in HBEC was methylation independent. U87MG-CM analysed by enzyme-linked immunosorbent assay contained similar to 5 pM transforming growth factor (TGF)-beta 1, a concentration sufficient to stimulate IGFBP7 in HBEC to similar levels as U87MG-CM. Both pan-TGF-beta-neutralizing antibody(1D11) and the TGF-beta 1 receptor (activin receptor-like kinase 5, ALK5) antagonist, SB431542, blocked U87MG-CM-induced IGFBP7 expression in HBEC, indicating that TGF-beta 1 is an important tumor-secreted effector capable of IGFBP7 induction in endothelial cells. HBEC exposed to either U87MG-CM or IGFBP7 protein exhibited increased capillary-like tube (CLT) formation in Matrigel. Both TGF-beta 1- and U87MG-CM-induced Smad-2 phosphorylation and U87MG-CM-induced CLT formation in HBEC were inhibited by the ALK5 antagonist, SB431542. These data suggest that proangiogenic IGFBP7 maybe induced in brain endothelial cells by TGF-beta s secreted by GBM, most likely through TGF-beta 1/ALK5/Smad-2 pathway. Oncogene (2008) 27, 6834-6844; doi: 10.1038/onc.2008.287; published online 18 August 2008	[Pen, A.; Moreno, M. J.; Stanimirovic, D. B.] Natl Res Council Canada, Inst Biol Sci, Cerebrovasc Res Grp, Neurobiol Program, Ottawa, ON K1A 0R6, Canada; [Pen, A.; Stanimirovic, D. B.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Durocher, Y.] Natl Res Council Canada, Biotechnol Res Inst, Anim Cell Technol Grp, Montreal, PQ H4P 2R2, Canada; [Deb-Rinker, P.] Natl Res Council Canada, Inst Biol Sci, Neurogenesis & Brain Repair Grp, Montreal, PQ, Canada	National Research Council Canada; University of Ottawa; National Research Council Canada; National Research Council Canada	Stanimirovic, DB (corresponding author), Natl Res Council Canada, Inst Biol Sci, Cerebrovasc Res Grp, Neurobiol Program, 1200 Montreal Rd,Bldg M-54, Ottawa, ON K1A 0R6, Canada.	danica.stanimirovic@nrc-cnrc.gc.ca	Durocher, Yves/K-8709-2019					Ahmed AA, 2006, NAT PROD COMMUN, V1, P273; AKAOGI K, 1994, BIOCHEM BIOPH RES CO, V198, P1046, DOI 10.1006/bbrc.1994.1149; Akaogi K, 1996, P NATL ACAD SCI USA, V93, P8384, DOI 10.1073/pnas.93.16.8384; Beaty RM, 2007, J NEURO-ONCOL, V81, P241, DOI 10.1007/s11060-006-9227-9; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Burger AM, 1998, ONCOGENE, V16, P2459, DOI 10.1038/sj.onc.1201772; Chen Y, 2007, J PATHOL, V211, P431, DOI 10.1002/path.2132; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; CONSTAM DB, 1992, J IMMUNOL, V148, P1404; Dai CK, 2001, BBA-REV CANCER, V1551, pM19, DOI 10.1016/S0304-419X(01)00027-0; Davies DC, 2002, J ANAT, V200, P639, DOI 10.1046/j.1469-7580.2002.00065.x; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; DINDA AK, 1993, J NEURO-ONCOL, V16, P149, DOI 10.1007/BF01324702; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Hata Y, 2000, J CLIN INVEST, V106, P541, DOI 10.1172/JCI8338; HIRANO A, 1975, HUM PATHOL, V6, P611, DOI 10.1016/S0046-8177(75)80045-1; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Kishibe J, 2000, J BIOL CHEM, V275, P15321, DOI 10.1074/jbc.275.20.15321; KLEIHUES P, 1995, GLIA, V15, P211, DOI 10.1002/glia.440150303; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; Komatsu S, 2000, BIOCHEM BIOPH RES CO, V267, P109, DOI 10.1006/bbrc.1999.1937; Kwak HJ, 2006, MOL CANCER RES, V4, P209, DOI 10.1158/1541-7786.MCR-05-0140; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lin J, 2007, J PATHOL, V212, P83, DOI 10.1002/path.2144; LONG DM, 1970, J NEUROSURG, V32, P127, DOI 10.3171/jns.1970.32.2.0127; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Madden SL, 2004, AM J PATHOL, V165, P601, DOI 10.1016/S0002-9440(10)63324-X; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moreno MJ, 2006, GLIA, V53, P845, DOI 10.1002/glia.20345; MURPHY M, 1993, CELL GROWTH DIFFER, V4, P715; Mutaguchi K, 2003, CANCER RES, V63, P7717; Nagakubo D, 2003, J IMMUNOL, V171, P553, DOI 10.4049/jimmunol.171.2.553; Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322; OLDENDORF WH, 1977, ANN NEUROL, V1, P409, DOI 10.1002/ana.410010502; OLOFSSON A, 1992, J BIOL CHEM, V267, P19482; Pen A, 2007, GLIA, V55, P559, DOI 10.1002/glia.20481; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Poncelet AC, 1998, AM J PHYSIOL-RENAL, V275, pF458; Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533; REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121; Ruan WJ, 2007, CANCER BIOL THER, V6, P354, DOI 10.4161/cbt.6.3.3702; Sato J, 1999, J CELL BIOCHEM, V75, P187, DOI 10.1002/(SICI)1097-4644(19991101)75:2<187::AID-JCB1>3.0.CO;2-R; Sprenger CC, 1999, CANCER RES, V59, P2370; St Croix B, 2000, SCIENCE, V289, P1197; Stanimirovic D, 1996, J CELL PHYSIOL, V169, P455; TENDIJKE P, 1988, P NATL ACAD SCI USA, V85, P4715; Umeda F, 1998, J GASTROENTEROL, V33, P213, DOI 10.1007/s005350050072; Vajkoczy P, 2000, J NEURO-ONCOL, V50, P99, DOI 10.1023/A:1006474832189; Vajkoczy P, 1999, INT J DEV NEUROSCI, V17, P557, DOI 10.1016/S0736-5748(99)00021-0; van Beijnum JR, 2006, BLOOD, V108, P2339, DOI 10.1182/blood-2006-02-004291; Vaupel P, 1998, STRAHLENTHER ONKOL, V174, P6; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; WELLER M, 1995, EXP CELL RES, V221, P395, DOI 10.1006/excr.1995.1390; Wick W, 2001, J NEURO-ONCOL, V53, P177, DOI 10.1023/A:1012209518843; Wilson HMP, 2002, CELL GROWTH DIFFER, V13, P205; Yakmovych I, 2001, FASEB J, V15, P553; YAMADA N, 1995, INT J CANCER, V62, P386, DOI 10.1002/ijc.2910620405; YAMAUCHI T, 1994, BIOCHEM J, V303, P591, DOI 10.1042/bj3030591	67	87	97	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2008	27	54					6834	6844		10.1038/onc.2008.287	http://dx.doi.org/10.1038/onc.2008.287			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	375IS	18711401				2022-12-25	WOS:000261108000004
J	Balloy, V; Sallenave, JM; Wu, YZ; Touqui, L; Latge, JP; Si-Tahar, M; Chignard, M				Balloy, Viviane; Sallenave, Jean-Michel; Wu, Yongzheng; Touqui, Lhousseine; Latge, Jean-Paul; Si-Tahar, Mustapha; Chignard, Michel			Aspergillus fumigatus-induced Interleukin-8 Synthesis by Respiratory Epithelial Cells Is Controlled by the Phosphatidylinositol 3-Kinase, p38 MAPK, and ERK1/2 Pathways and Not by the Toll-like Receptor-MyD88 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INVASIVE PULMONARY ASPERGILLOSIS; BETA-GLUCAN RECEPTOR; INFLUENZA-A-VIRUS; INNATE IMMUNITY; HOST-DEFENSE; SIGNAL-TRANSDUCTION; GENE-TRANSCRIPTION; CYSTIC-FIBROSIS; LUNG	Previous studies have established that phagocytes are key cells of the pulmonary innate immune defense against A. fumigatus, an opportunistic fungus responsible of invasive pulmonary aspergillosis. Macrophages detect A. fumigatus via Toll-like receptors 2 and 4 (TLR2 and -4) and respond by the MyD88-NF-kappa B-dependent synthesis of inflammatory mediators. In the present study, we demonstrate that respiratory epithelial cells also sense A. fumigatus and participate in the host defense. Thus, the interaction of respiratory epithelial cells with germinating but not resting conidia of A. fumigatus results in interleukin (IL)- 8 synthesis that is controlled by phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2. Using MyD88-dominant negative transfected cells, we also show that IL-8 production is not dependent on the TLR-MyD88 pathway, although the MyD88 pathway is activated by A. fumigatus and leads to NF-kappa B activation. Thus, our results provide evidence for the existence of two independent signaling pathways activated in respiratory epithelial cells by A. fumigatus, one that is MyD88-dependent and another that is My88-independent and involved in IL-8 synthesis.	[Chignard, Michel] Inst Pasteur, INSERM, U874, F-75015 Paris, France; [Balloy, Viviane; Sallenave, Jean-Michel; Wu, Yongzheng; Touqui, Lhousseine; Si-Tahar, Mustapha; Chignard, Michel] Inst Pasteur, Unite Def Innee & Inflammat, F-75015 Paris, France; [Latge, Jean-Paul] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chignard, M (corresponding author), Inst Pasteur, INSERM, U874, 25 Rue Dr Roux, F-75015 Paris, France.	chignard@pasteur.fr	SI-TAHAR, Mustapha/L-4149-2014; Chignard, Michel/B-4351-2008; SALLENAVE, Jean-Michel/J-3746-2017; Si-Tahar, Mustapha/W-8034-2019; Latge, Jean Paul/C-9846-2014; Balloy, Viviane/B-8551-2014	SI-TAHAR, Mustapha/0000-0002-5792-7742; Chignard, Michel/0000-0003-3810-6575; SALLENAVE, Jean-Michel/0000-0002-8595-6970; Si-Tahar, Mustapha/0000-0002-5792-7742; Balloy, Viviane/0000-0001-9093-9676	Vaincre la Mucoviscidose	Vaincre la Mucoviscidose	This work was supported by the nonprofit association Vaincre la Mucoviscidose. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexopoulou L, 2005, CELL MOL LIFE SCI, V62, P1349, DOI 10.1007/s00018-005-5039-x; Balloy V, 2005, INFECT IMMUN, V73, P5420, DOI 10.1128/IAI.73.9.5420-5425.2005; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Basu S, 2004, AM J PHYSIOL-LUNG C, V286, pL887, DOI 10.1152/ajplung.00323.2003; Bellocchio S, 2004, J IMMUNOL, V173, P7406, DOI 10.4049/jimmunol.173.12.7406; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Berkova N, 2006, INT IMMUNOL, V18, P139, DOI 10.1093/intimm/dxh356; Blease K, 2001, INFLAMM RES, V50, P552, DOI 10.1007/PL00000233; Borger P, 1999, J INFECT DIS, V180, P1267, DOI 10.1086/315027; Braedel S, 2004, BRIT J HAEMATOL, V125, P392, DOI 10.1111/j.1365-2141.2004.04922.x; Bretz C, 2008, INFECT IMMUN, V76, P952, DOI 10.1128/IAI.00927-07; Chignard M, 2007, CLIN IMMUNOL, V124, P238, DOI 10.1016/j.clim.2007.05.004; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; DENNIS LJ, 1991, CURR OPIN UROL, V1, P16; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Greene CM, 2005, ARCH IMMUNOL THER EX, V53, P418; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Harant H, 1996, J BIOL CHEM, V271, P26954, DOI 10.1074/jbc.271.43.26954; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li J, 2002, AM J PHYSIOL-LUNG C, V283, pL690, DOI 10.1152/ajplung.00060.2002; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; Mehrad B, 2002, AM J RESP CRIT CARE, V166, P1263, DOI 10.1164/rccm.200204-367OC; Mehrad B, 1999, J IMMUNOL, V163, P6086; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Message SD, 2004, J LEUKOCYTE BIOL, V75, P5, DOI 10.1189/jlb.0703315; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; Mukaida N, 2000, INT J HEMATOL, V72, P391; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Netea MG, 2004, J LEUKOCYTE BIOL, V75, P749, DOI 10.1189/jlb.1103543; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Pease James E, 2002, Am J Respir Med, V1, P19; Roilides E, 1998, RES IMMUNOL, V149, P454, DOI 10.1016/S0923-2494(98)80769-4; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; SCHAFFNER A, 1982, J CLIN INVEST, V69, P617, DOI 10.1172/JCI110489; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Sirard JC, 2006, EUR J IMMUNOL, V36, P260, DOI 10.1002/eji.200535777; Slevogt H, 2006, AM J PHYSIOL-LUNG C, V290, pL818, DOI 10.1152/ajplung.00428.2005; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Tomee JFC, 1997, J INFECT DIS, V176, P300, DOI 10.1086/517272; Vanden Berghe W, 2006, BIOCHEM PHARMACOL, V72, P1114, DOI 10.1016/j.bcp.2006.07.012; Walsh TJ, 2005, MED MYCOL, V43, pS165, DOI 10.1080/13693780500064672; Wang JE, 2001, INFECT IMMUN, V69, P2402, DOI 10.1128/IAI.69.4.2402-2406.2001; Wasylnka JA, 2003, J CELL SCI, V116, P1579, DOI 10.1242/jcs.00329; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Wright Jeffrey G, 2003, Am J Respir Med, V2, P211; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Zaas AK, 2005, TRENDS CARDIOVAS MED, V15, P195, DOI 10.1016/j.tcm.2005.07.001; Zhang ZH, 2005, J INFECTION, V51, P375, DOI 10.1016/j.jinf.2004.12.012	63	75	79	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30513	30521		10.1074/jbc.M803149200	http://dx.doi.org/10.1074/jbc.M803149200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18703508	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000260544800009
J	Cheung, J; Hendrickson, WA				Cheung, Jonah; Hendrickson, Wayne A.			Crystal Structures of C-4-Dicarboxylate Ligand Complexes with Sensor Domains of Histidine Kinases DcuS and DctB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SIGNAL-DETECTION; GENE-EXPRESSION; BINDING DOMAIN; SYSTEM; MOLSCRIPT; PROTEINS; PROGRAM; VERSION; SUITE	Two-component signaling systems allow bacteria to adapt to changing environments. Typically, a chemical or other stimulus is detected by the periplasmic sensor domain of a transmembrane histidine kinase sensor, which in turn relays a signal through a phosphotransfer cascade to the cognate cytoplasmic response regulator. Such systems lead ultimately to changes in gene expression or cell motility. Mechanisms of ligand binding and signal transduction through the cell membrane in histidine kinases are not fully understood. In an effort to further understand such processes, we have solved the crystal structures of the periplasmic sensor domains of Escherichia coli DcuS and of Vibrio cholerae DctB in complex with the respective cognate ligands, malate and succinate. Both proteins are involved in the regulation of the transport and metabolism of C-4-dicarboxylates, but they are not highly related by sequence similarity. Our work reveals that despite disparate sizes, both structures contain a similar characteristic alpha/beta PDC (PhoQ-DcuS-CitA) sensor-domain fold and display similar modes of ligand binding, suggesting similar mechanisms of function.	[Cheung, Jonah; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	wayne@convex.hhmi.columbia.edu			National Institutes of Health [GM34102]; New York Structural Biology Center; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR012848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034102, R01GM034102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Structural Biology Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34102, and it made use of Beamline X4A of the National Synchrotron Light Source at Brookhaven National Laboratory ( Department of Energy facility), which is supported by the New York Structural Biology Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CEDERGRENZEPPEZAUER ES, 1994, J MOL BIOL, V240, P459, DOI 10.1006/jmbi.1994.1461; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Giblin L, 1996, FEMS MICROBIOL LETT, V139, P19, DOI 10.1111/j.1574-6968.1996.tb08174.x; GIBLIN L, 1995, FEMS MICROBIOL LETT, V126, P25, DOI 10.1016/0378-1097(94)00520-2; Golby P, 1999, J BACTERIOL, V181, P1238, DOI 10.1128/JB.181.4.1238-1248.1999; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Janausch IG, 2002, J BIOL CHEM, V277, P39809, DOI 10.1074/jbc.M204482200; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Knight SD, 2000, ACTA CRYSTALLOGR D, V56, P42, DOI 10.1107/S0907444999012913; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; METZGER H, 1992, J IMMUNOL, V149, P1477; MINTON AP, 1981, BIOPHYS CHEM, V14, P317, DOI 10.1016/0301-4622(81)85033-8; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reid CJ, 1998, J BACTERIOL, V180, P2660, DOI 10.1128/JB.180.10.2660-2669.1998; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Sevvana M, 2008, J MOL BIOL, V377, P512, DOI 10.1016/j.jmb.2008.01.024; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Waldburger CD, 1996, J BIOL CHEM, V271, P26630, DOI 10.1074/jbc.271.43.26630; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wolanin PM, 2002, GENOME BIOL, V3; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507; Zientz E, 1998, J BACTERIOL, V180, P5421, DOI 10.1128/JB.180.20.5421-5425.1998	42	82	84	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30256	30265		10.1074/jbc.M805253200	http://dx.doi.org/10.1074/jbc.M805253200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18701447	Green Published, hybrid			2022-12-25	WOS:000260366900070
J	Gavard, J; Gutkind, JS				Gavard, Julie; Gutkind, J. Silvio			Protein Kinase C-related Kinase and ROCK Are Required for Thrombin-induced Endothelial Cell Permeability Downstream from G alpha(12/13) and G alpha(11/q)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; LEUKEMIA-ASSOCIATED RHO; TYROSINE PHOSPHORYLATION; DEPENDENT ENDOCYTOSIS; MYOSIN PHOSPHATASE; P115 RHOGEF; CA2+ ENTRY; ACTIVATION; RECEPTOR; DOMAIN	Increase in vascular permeability occurs under many physiological conditions such as wound repair, inflammation, and thrombotic reactions and is central in diverse human pathologies, including tumor-induced angiogenesis, ocular diseases, and septic shock. Thrombin is a pro-coagulant serine protease, which causes the local loss of endothelial barrier integrity thereby enabling the rapid extravasation of plasma proteins and the local formation of fibrin-containing clots. Available information suggests that thrombin induces endothelial permeability by promoting actomyosin contractility through the Rho/ROCK signaling pathway. Here we took advantage of pharmacological inhibitors, knockdown approaches, and the emerging knowledge on how permeability factors affect endothelial junctions to investigate in detail the mechanism underlying thrombin-induced endothelial permeability. We show that thrombin signals through PAR-1 and its coupled G proteins G alpha(12/13) and G alpha(11/q) to induce RhoA activation and intracellular calcium elevation, and that these events are interrelated. In turn, this leads to the stimulation of ROCK, which causes actin stress-fiber formation. However, this alone is not sufficient to account for thrombin-induced permeability. Instead, we found that protein kinase C-related kinase, a Rho-dependent serine/threonine kinase, is activated in endothelial cells upon thrombin stimulation and that its expression is required for endothelial permeability and the remodeling of cell-extracellular matrix and cell-cell adhesions. Our results demonstrate that the signal initiated by thrombin bifurcates at the level of RhoA to promote changes in the cytoskeletal architecture through ROCK, and the remodeling of focal adhesion components through protein kinase C-related kinase. Ultimately, both pathways converge to cause cell-cell junction disruption and provoke vascular leakage.	[Gavard, Julie; Gutkind, J. Silvio] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gavard, J (corresponding author), Univ Paris 05, CNRS, INSERM,U567, Inst Cochin,UMR8104, 22 Rue Mechain, F-75014 Paris, France.	julie.gavard@inserm.fr	Gutkind, J. Silvio/A-1053-2009; Gavard, Julie/I-5487-2012; Gutkind, J. Silvio/J-1201-2016; Gavard, Julie/I-5487-2012	Gavard, Julie/0000-0002-7985-9007; Gutkind, J. Silvio/0000-0002-5150-4482; Gavard, Julie/0000-0003-3107-2026	National Institutes of Health; CNRS; INSERM; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health grant (Intramural Research Program of NIDCR). This work was also supported by CNRS and INSERM. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Basile JR, 2007, J BIOL CHEM, V282, P34888, DOI 10.1074/jbc.M705467200; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Esser S, 1998, J CELL SCI, V111, P1853; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Flynn P, 2000, J BIOL CHEM, V275, P11064, DOI 10.1074/jbc.275.15.11064; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Goeckeler ZM, 2005, J BIOL CHEM, V280, P33083, DOI 10.1074/jbc.M503173200; Gorovoy M, 2005, J BIOL CHEM, V280, P26533, DOI 10.1074/jbc.M502921200; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klarenbach SW, 2003, CIRC RES, V92, P272, DOI 10.1161/01.RES.0000057386.15390.A3; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; Komarova Yulia A, 2007, Sci STKE, V2007, pre8; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Li XC, 2004, BLOOD, V104, P1716, DOI 10.1182/blood-2003-11-3744; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Moy AB, 2002, AM J PHYSIOL-HEART C, V282, pH21, DOI 10.1152/ajpheart.2002.282.1.H21; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Mukai H, 1997, J BIOL CHEM, V272, P4740, DOI 10.1074/jbc.272.8.4740; PALMER RH, 1994, FEBS LETT, V356, P5, DOI 10.1016/0014-5793(94)01202-4; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; UEDA S, 1990, CIRC RES, V66, P957, DOI 10.1161/01.RES.66.4.957; UI M, 1990, ADV SEC MESS PHOSPH, V24, P63; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Vouret-Craviari V, 2003, J THROMB HAEMOST, V1, P1103, DOI 10.1046/j.1538-7836.2003.00238.x; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001	59	69	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29888	29896		10.1074/jbc.M803880200	http://dx.doi.org/10.1074/jbc.M803880200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18713748	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-25	WOS:000260366900033
J	Samayawardhena, LA; Pallen, CJ				Samayawardhena, Lionel A.; Pallen, Catherine J.			Protein-tyrosine Phosphatase alpha Regulates Stem Cell Factor-dependent c-Kit Activation and Migration of Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; PTP-ALPHA; RPTP-ALPHA; HEMATOPOIETIC-CELLS; SIGNALING PATHWAYS; PI 3-KINASE; FYN KINASE; LYN KINASE; RECEPTOR; PHOSPHORYLATION	The role of protein-tyrosine phosphatase alpha (PTP alpha) in mast cell function was investigated in tissues and cells from PTP alpha-deficient mice. Bone marrow-derived mast cells (BMMCs) lacking PTP alpha exhibit defective stem cell factor (SCF)-dependent polarization and migration. Investigation of the molecular basis for this reveals that SCF/c-Kit-stimulated activation of the Fyn tyrosine kinase is impaired in PTP alpha(-/-) BMMCs, with a consequent inhibition of site-specific c-Kit phosphorylation at tyrosines 567/569 and 719. Although c-Kit-mediated activation of phosphatidylinositol 3-kinase and Akt is unaffected, profound defects occur in the activation of downstream signaling proteins, including mitogen-activated protein kinases and Rho GTPases. Phosphorylation and interaction of Fyn effectors Gab2 and Shp2, which are linked to Rac/JNK activation in mast cells, are impaired in PTP alpha(-/-) BMMCs. Thus, PTP alpha is required for SCF-induced c-Kit and Fyn activation, and in this way regulates a Fyn-based c-Kit signaling axis (Fyn/Gab2/Shp2/Vav/ PAK/Rac/JNK) that mediates mast cell migration. These defective signaling events may underlie the altered tissue-resident mast cell populations found in PTP alpha(-/-) mice.	[Samayawardhena, Lionel A.; Pallen, Catherine J.] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 4H4, Canada; [Pallen, Catherine J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Samayawardhena, Lionel A.; Pallen, Catherine J.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada	University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia	Pallen, CJ (corresponding author), 3102-950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	cpallen@interchange.ubc.ca		Pallen, Catherine/0000-0002-3576-5295	Canadian Institutes of Health Research [MOP-49410]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-49410. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agosti V, 2004, J EXP MED, V199, P867, DOI 10.1084/jem.20031983; ALAI M, 1992, J BIOL CHEM, V267, P18021; Apice G, 2006, REV RECENT CLIN TRIA, V1, P35, DOI 10.2174/157488706775246175; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Brown JM, 2008, CLIN EXP ALLERGY, V38, P4, DOI 10.1111/j.1365-2222.2007.02886.x; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Hernandez-Hansen V, 2004, J LEUKOCYTE BIOL, V75, P143, DOI 10.1189/jlb.0503224; Hong L, 2004, MOL CELL BIOL, V24, P1401, DOI 10.1128/MCB.24.3.1401-1410.2004; Kimura Y, 2004, P NATL ACAD SCI USA, V101, P6015, DOI 10.1073/pnas.0305363101; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852; Kovanen PT, 2007, IMMUNOL REV, V217, P105, DOI 10.1111/j.1600-065X.2007.00515.x; Le HT, 2006, J NEUROCHEM, V98, P1798, DOI 10.1111/j.1471-4159.2006.04075.x; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Linnekin D, 1997, J BIOL CHEM, V272, P27450, DOI 10.1074/jbc.272.43.27450; Maksumova L, 2005, J IMMUNOL, V175, P7947, DOI 10.4049/jimmunol.175.12.7947; Maksumova L, 2007, J BIOL CHEM, V282, P20925, DOI 10.1074/jbc.M703157200; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; O'Laughlin-Bunner B, 2001, BLOOD, V98, P343, DOI 10.1182/blood.V98.2.343; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Price DJ, 1997, J BIOL CHEM, V272, P5915, DOI 10.1074/jbc.272.9.5915; Price DJ, 1999, BIOCHEM BIOPH RES CO, V259, P611, DOI 10.1006/bbrc.1999.0840; Renneville A, 2008, LEUKEMIA, V22, P915, DOI 10.1038/leu.2008.19; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Samayawardhena LA, 2007, BLOOD, V109, P3679, DOI 10.1182/blood-2006-11-057315; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; Sayed BA, 2008, ANNU REV IMMUNOL, V26, P705, DOI 10.1146/annurev.immunol.26.021607.090320; SERVE H, 1994, J BIOL CHEM, V269, P6026; Shivakrupa R, 2005, CELL SIGNAL, V17, P103, DOI 10.1016/j.cellsig.2004.06.004; Skelton MR, 2003, BRAIN RES, V984, P1, DOI 10.1016/S0006-8993(03)02839-7; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Tan BL, 2003, BLOOD, V101, P4725, DOI 10.1182/blood-2002-08-2521; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Tiran Z, 2006, MOL BIOL CELL, V17, P4330, DOI 10.1091/mbc.E06-02-0151; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; Ueda S, 2002, BLOOD, V99, P3342, DOI 10.1182/blood.V99.9.3342; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Yang LT, 2002, J BIOL CHEM, V277, P17406, DOI 10.1074/jbc.M111902200; Ye H, 2008, EMBO J, V27, P188, DOI 10.1038/sj.emboj.7601939; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	53	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29175	29185		10.1074/jbc.M804077200	http://dx.doi.org/10.1074/jbc.M804077200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18725415	hybrid, Green Published			2022-12-25	WOS:000260179900045
J	Corriden, R; Chen, Y; Inoue, Y; Beldi, G; Robson, SC; Insel, PA; Junger, WG				Corriden, Ross; Chen, Yu; Inoue, Yoshiaki; Beldi, Guido; Robson, Simon C.; Insel, Paul A.; Junger, Wolfgang G.			Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE; ACTIVATION; EXPRESSION; CD39	Polymorphonuclear neutrophils release ATP in response to stimulation by chemoattractants, such as the peptide N-formyl-methionyl-leucyl-phenylalanine. Released ATP and the hydrolytic product adenosine regulate chemotaxis of neutrophils by sequentially activating purinergic nucleotide and adenosine receptors, respectively. Here we show that that ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1, CD39) is a critical enzyme for hydrolysis of released ATP by neutrophils and for cell migration in response to multiple agonists (N-formyl-methionyl-leucyl-phenylalanine, interleukin-8, and C5a). Upon stimulation of human neutrophils or differentiated HL-60 cells in a chemotactic gradient, E-NTPDase1 tightly associates with the leading edge of polarized cells during chemotaxis. Inhibition of E-NTPDase1 reduces the migration speed of neutrophils but not their ability to detect the orientation of the gradient field. Studies of neutrophils from E-NTPDase1 knockout mice reveal similar impairments of chemotaxis in vitro and in vivo. Thus, E-NTPDase1 plays an important role in regulating neutrophil chemotaxis by facilitating the hydrolysis of extracellular ATP.	[Chen, Yu; Inoue, Yoshiaki; Junger, Wolfgang G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Beldi, Guido; Robson, Simon C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Corriden, Ross; Chen, Yu; Inoue, Yoshiaki; Junger, Wolfgang G.] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Corriden, Ross; Insel, Paul A.] Univ Calif San Diego, Dept Med & Pharmacol, La Jolla, CA 92093 USA; [Corriden, Ross; Insel, Paul A.; Junger, Wolfgang G.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Junger, WG (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA.	wjunger@bidmc.harvard.edu	Junger, Wolfgang G/I-1932-2013; Robson, Simon C./AAA-8537-2021	Junger, Wolfgang G/0000-0003-3350-8452; Beldi, Guido/0000-0002-9914-3807	National Institutes of Health [R01 GM51477, GM60475, HL076540, GM66232]; NIDDK Training Grant [DK 07202]; Congressionally Directed Medical Research Programs Grant [PR043034]; Novo Nordisk Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076540, R01HL063972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232, R01GM060475, T32GM007752, R01GM051477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Congressionally Directed Medical Research Programs Grant; Novo Nordisk Fellowship(Novo Nordisk); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM51477, GM60475 (to W. G. J.), HL076540 (to S. R. C.), and GM66232 (to P. A. I.) and NIDDK Training Grant DK 07202 (R. C.). This work was also supported by Congressionally Directed Medical Research Programs Grant PR043034 ( to W. G. J.) and a Novo Nordisk Fellowship ( to Y. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Burnstock G, 2006, BRIT J PHARMACOL, V147, pS172, DOI 10.1038/sj.bjp.0706429; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; CRACK BE, 1995, BRIT J PHARMACOL, V114, P475, DOI 10.1111/j.1476-5381.1995.tb13251.x; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Fredholm BB, 1997, GEN PHARMACOL-VASC S, V28, P345, DOI 10.1016/S0306-3623(96)00169-3; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Heine P, 1999, EUR J BIOCHEM, V262, P102, DOI 10.1046/j.1432-1327.1999.00347.x; HOHENWALLNER W, 1973, CLIN CHIM ACTA, V45, P169, DOI 10.1016/0009-8981(73)90406-3; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kegel B, 1997, NEUROPHARMACOLOGY, V36, P1189, DOI 10.1016/S0028-3908(97)00115-9; Kirley TL, 1997, J BIOL CHEM, V272, P1076, DOI 10.1074/jbc.272.2.1076; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Muller CE, 2006, BIOORG MED CHEM LETT, V16, P5943, DOI 10.1016/j.bmcl.2006.09.003; North RA, 2006, PFLUG ARCH EUR J PHY, V452, P479, DOI 10.1007/s00424-006-0060-y; OKUN DB, 1978, AM J HEMATOL, V4, P293, DOI 10.1002/ajh.2830040312; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Roman RM, 1999, AM J PHYSIOL-GASTR L, V277, pG1222, DOI 10.1152/ajpgi.1999.277.6.G1222; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Sevigny J, 2002, BLOOD, V99, P2801, DOI 10.1182/blood.V99.8.2801; Vlajkovic SM, 1998, HEARING RES, V117, P71, DOI 10.1016/S0378-5955(98)00004-5; Wang TF, 1998, J BIOL CHEM, V273, P11392, DOI 10.1074/jbc.273.18.11392; Yegutkin G, 2000, BRIT J PHARMACOL, V129, P921, DOI 10.1038/sj.bjp.0703136; ZIMMERMANN H, 2000, HDB EXPT PHARM, P209; Zimmermann Herbert, 2006, Novartis Found Symp, V276, P113	30	94	96	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28480	28486		10.1074/jbc.M800039200	http://dx.doi.org/10.1074/jbc.M800039200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713747	Green Published, hybrid			2022-12-25	WOS:000259969300050
J	Levy, D; Reuven, N; Shaul, Y				Levy, Dan; Reuven, Nina; Shaul, Yosef			A regulatory circuit controlling itch-mediated p73 degradation by Runx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; KINASE C-ABL; DNA-DAMAGE; TYROSINE KINASE; PROTEIN LIGASE; TRANSCRIPTIONAL COACTIVATOR; APOPTOTIC RESPONSE; STABILIZES P73; FEEDBACK LOOP; P53	The members of the tumor suppressor p53 family are under tight regulation by distinct ubiquitin-protein isopeptide (E3) ligases. The level of p73 is regulated by the E3 ligase Itch. Itch levels are sharply reduced in response to DNA damage with concomitant p73 accumulation and activation. The mechanism of controlling Itch level is not known. We show that the Itch promoter is a target of the transcription activator Runx. Yes-associated protein (Yap1) is a shared transcription co-activator of Runx and p73. Under normal conditions, the Runx-Yap1 complex binds the Itch promoter and supports its transcription and p73 degradation. In response to DNA damage, Yap1 is phosphorylated by c-Abl at the position Tyr-357. The modified Yap1 does not co-activate Runx in supporting Itch transcription. The subsequent reduction in the Itch level gives rise to p73 accumulation. These results demonstrate how Yap1 supports degradation of p73 via Runx and how it plays an opposite role in response to DNA damage.	[Levy, Dan; Reuven, Nina; Shaul, Yosef] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shaul, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	Yosef.Shaul@weizmann.ac.il	Levy, Dan/AAF-1871-2021; Levy, Dan/A-3226-2013; Reuven, Nina/AAM-8711-2020	Levy, Dan/0000-0003-0719-0305; Reuven, Nina/0000-0003-1569-3818	Samuel Waxman Cancer Research Foundation; Federal German Ministry for Education and Research; The Israel Science Foundation [1040/03-18.2]	Samuel Waxman Cancer Research Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); The Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the Samuel Waxman Cancer Research Foundation, from the Minerva Foundation with funding from the Federal German Ministry for Education and Research, and from The Israel Science Foundation (Grant 1040/03-18.2). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agami R, 1999, NATURE, V399, P809; Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Danovi SA, 2008, CELL DEATH DIFFER, V15, P217, DOI 10.1038/sj.cdd.4402226; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao BX, 2006, J BIOL CHEM, V281, P29711, DOI 10.1074/jbc.M604596200; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gong JG, 1999, NATURE, V399, P806; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; JUVEN T, 1993, ONCOGENE, V8, P3411; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Lubelsky Y, 2005, MOL CELL BIOL, V25, P10665, DOI 10.1128/MCB.25.23.10665-10673.2005; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Oberst A, 2007, P NATL ACAD SCI USA, V104, P11280, DOI 10.1073/pnas.0701773104; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Sanchez-Prieto R, 2002, ONCOGENE, V21, P974, DOI 10.1038/sj.onc.1205134; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Tsai KKC, 2003, CANCER RES, V63, P3418; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	43	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27462	27468		10.1074/jbc.M803941200	http://dx.doi.org/10.1074/jbc.M803941200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18701449	hybrid			2022-12-25	WOS:000259719200016
J	Damgaard, IN; Jensen, TK; Petersen, JH; Skakkebk, NE; Toppari, J; Main, KM				Damgaard, Ida N.; Jensen, Tina K.; Petersen, Jorgen H.; Skakkebk, Niels E.; Toppari, Jorma; Main, Katharina M.		Nordic Cryptorchidism Study Grp	Risk Factors for Congenital Cryptorchidism in a Prospective Birth Cohort Study	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; GESTATIONAL FACTORS; CLOMIPHENE CITRATE; REPRODUCTIVE-TRACT; TESTICULAR CANCER; PREVALENCE; HYPOSPADIAS; PREGNANCY; DIETHYLSTILBESTROL; ABNORMALITIES	Background: Risk factors for congenital cryptorchidism were investigated in a prospective birth cohort study in Denmark and Finland from 1997 to 2001. Methodology and Principal Findings: In total, 2,496 boys were examined for cryptorchidism at birth (cryptorchid/healthy: 128/2,368) and three months old (33/2,215). Information on risk factors was obtained antenatally (questionnaire/interview) or at birth from birth records. Use of nicotine substitutes during pregnancy (n = 40) and infertility treatment by intrauterine insemination (n = 49) were associated with an increased risk for cryptorchidism, adjusted odds ratio (95% confidence interval) (OR (95% CI)) 3.04 (95% CI 1.00-9.27) and 3.01 (95% CI 1.27-7.15), respectively. No association was seen for mothers (n = 79) who had infertility treatment in form of intracytoplasmic sperm injection (ICSI) or in vitro fertilization (IVF) treatment (OR 0.71 95% CI 0.21-2.38). In total, 728 (29%) reported to have smoked during pregnancy, however, no increased risk among maternal smokers was found. Furthermore, we found statistically significant associations between cryptorchidism and low birth weight, prematurity, being small for gestational age, substantial vaginal bleeding, and breech presentation, which are in accordance with other studies. Conclusions and Significance: Our study revealed two novel risk factors for cryptorchidism: intrauterine insemination and the use of nicotine substitutes in pregnancy. This suggests that cryptorchidism may not only be associated to genetic factors, but also to maternal lifestyle and exposure.	[Damgaard, Ida N.; Jensen, Tina K.; Petersen, Jorgen H.; Skakkebk, Niels E.; Toppari, Jorma; Main, Katharina M.] GR5064 Rigshosp, Univ Dept Growth & Reprod, Copenhagen, Denmark; [Toppari, Jorma] Univ Turku, Dept Physiol & Pediat, Turku, Finland; [Petersen, Jorgen H.] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark	Rigshospitalet; University of Turku; University of Copenhagen	Damgaard, IN (corresponding author), GR5064 Rigshosp, Univ Dept Growth & Reprod, Copenhagen, Denmark.	ind@rh.dk		Jensen, Tina Kold/0000-0003-2311-5778; Petersen, Jorgen Holm/0000-0003-3979-7443; Boisen, Kirsten A./0000-0002-3374-6621; Main, Katharina Maria/0000-0001-7259-1039	University of Copenhagen [9700833, 9700909]; Danish Medical Research Council [9700833, 9700909]; Svend Andersens Foundation; Novo Nordisk Foundation; Academy of Finland; Sigrid Juselius Foundation; Turku University Central Hospital; European Commission;  [BMH4-CT96-0314];  [QLK4-CT1999-01422];  [QLK4-2001-00269];  [QLK4-CT2002-00603]	University of Copenhagen; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Svend Andersens Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Central Hospital; European Commission(European CommissionEuropean Commission Joint Research Centre); ; ; ; 	This work was supported by The University of Copenhagen, The Danish Medical Research Council (no. 9700833 and 9700909), Svend Andersens Foundation, Novo Nordisk Foundation, The Academy of Finland, Sigrid Juselius Foundation, Turku University Central Hospital and the European Commission (contracts BMH4-CT96-0314, QLK4-CT1999-01422, QLK4-2001-00269 and QLK4-CT2002-00603). The Danish National Research Foundation has established the Danish Epidemiology Science Center that initiated and created the DNBC. The cohort is furthermore a result of a major grant from this foundation. Additional support for the DNBC is obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation and the Health Foundation. The authors are solely responsible for the contents of the manuscript. The sponsors had no part in the study neither in design, data collection, analysis nor in interpretation or in writing the paper. The European Community received annual reports concerning the progression of the study but is not responsible for any use that may be made of data appearing therein.	Adham IM, 2004, INT J ANDROL, V27, P257, DOI 10.1111/j.1365-2605.2004.00481.x; Akre O, 1999, EPIDEMIOLOGY, V10, P364, DOI 10.1097/00001648-199907000-00005; Albertsen K, 2004, AM J EPIDEMIOL, V159, P155, DOI 10.1093/aje/kwh034; Andersen AN, 2006, INT J ANDROL, V29, P12, DOI 10.1111/j.1365-2605.2005.00577.x; BEARD CM, 1984, AM J EPIDEMIOL, V120, P707, DOI 10.1093/oxfordjournals.aje.a113938; BERKOWITZ GS, 1993, PEDIATRICS, V92, P44; Berkowitz GS, 1996, PAEDIATR PERINAT EP, V10, P39, DOI 10.1111/j.1365-3016.1996.tb00024.x; BERKOWITZ GS, 1995, EPIDEMIOLOGY, V6, P127, DOI 10.1097/00001648-199503000-00007; Biggs ML, 2002, EPIDEMIOLOGY, V13, P197, DOI 10.1097/00001648-200203000-00015; Boisen KA, 2004, LANCET, V363, P1264, DOI 10.1016/S0140-6736(04)15998-9; Casper RF, 2006, J CLIN ENDOCR METAB, V91, P760, DOI 10.1210/jc.2005-1923; CHILVERS C, 1986, J PEDIATR SURG, V21, P691, DOI 10.1016/S0022-3468(86)80389-X; CHILVERS CED, 1992, ARCH DIS CHILD, V67, P892; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; COSGROVE MD, 1977, J UROLOGY, V117, P220, DOI 10.1016/S0022-5347(17)58407-4; CUNHA GR, 1987, HUM PATHOL, V18, P1132, DOI 10.1016/S0046-8177(87)80381-7; Damgaard IN, 2007, ENVIRON HEALTH PERSP, V115, P272, DOI 10.1289/ehp.9608; DAVIES TW, 1986, INT J EPIDEMIOL, V15, P197, DOI 10.1093/ije/15.2.197; DEPUE RH, 1987, AM J OBSTET GYNECOL, V156, P1137, DOI 10.1016/0002-9378(87)90126-8; DEPUE RH, 1984, INT J EPIDEMIOL, V13, P311, DOI 10.1093/ije/13.3.311; Ericson A, 2001, HUM REPROD, V16, P504, DOI 10.1093/humrep/16.3.504; GILL WB, 1977, J UROLOGY, V117, P477, DOI 10.1016/S0022-5347(17)58502-X; GIWERCMAN A, 1989, J UROLOGY, V142, P998, DOI 10.1016/S0022-5347(17)38967-X; HJERTKVIST M, 1989, J EPIDEMIOL COMMUN H, V43, P324, DOI 10.1136/jech.43.4.324; Kurahashi N, 2005, MED SCI MONITOR, V11, pCR274; Larsen T, 2001, DAN MED BULL, V48, P256; Lie RT, 2005, INT J EPIDEMIOL, V34, P696, DOI 10.1093/ije/dyh363; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Mayr JM, 1999, ACTA PAEDIATR, V88, P1089, DOI 10.1080/08035259950168144; MCBRIDE ML, 1991, INT J EPIDEMIOL, V20, P964, DOI 10.1093/ije/20.4.964; Meijer WM, 2006, BIRTH DEFECTS RES A, V76, P249, DOI 10.1002/bdra.20243; Moller H, 1997, CANCER CAUSE CONTROL, V8, P904, DOI 10.1023/A:1018472530653; Moller H, 1996, INT J CANCER, V66, P287, DOI 10.1002/(SICI)1097-0215(19960503)66:3<287::AID-IJC2>3.0.CO;2-V; Morales-Suarez-Varela MM, 2006, OBSTET GYNECOL, V107, P51, DOI 10.1097/01.AOG.0000194079.66834.d5; Mori Mitsuru, 1992, Kurume Medical Journal, V39, P53; Nagao T, 2001, TERATOGEN CARCIN MUT, V21, P213, DOI 10.1002/tcm.1010; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Paulozzi LJ, 1999, ENVIRON HEALTH PERSP, V107, P297, DOI 10.2307/3434597; Pereira OCM, 2003, COMP BIOCHEM PHYS A, V134, P545, DOI 10.1016/S1095-6433(02)00355-0; Pierik FH, 2004, ENVIRON HEALTH PERSP, V112, P1570, DOI 10.1289/ehp.7243; Pihkala J, 1989, Duodecim, V105, P1540; Preiksa RT, 2005, HUM REPROD, V20, P1928, DOI 10.1093/humrep/deh887; ROTHMAN KJ, 1978, NEW ENGL J MED, V299, P522, DOI 10.1056/NEJM197809072991006; STILLMAN RJ, 1982, AM J OBSTET GYNECOL, V142, P905, DOI 10.1016/S0002-9378(16)32540-6; Suomi AM, 2006, J CLIN ENDOCR METAB, V91, P953, DOI 10.1210/jc.2004-2318; SWERDLOW AJ, 1983, J EPIDEMIOL COMMUN H, V37, P238, DOI 10.1136/jech.37.3.238; Thorup J, 2006, J UROLOGY, V176, P734, DOI 10.1016/j.juro.2006.03.042; Toppari J, 1999, HORM RES, V51, P261, DOI 10.1159/000023412; Toppari J, 2001, HUM REPROD UPDATE, V7, P282, DOI 10.1093/humupd/7.3.282; TORFS CP, 1981, AM J EPIDEMIOL, V113, P563, DOI 10.1093/oxfordjournals.aje.a113133; Weidner IS, 1999, J UROLOGY, V161, P1606, DOI 10.1016/S0022-5347(05)68992-6; *WORLD MED ASS, 2004, WORLD MENT ASS DECL; Young SL, 1999, FERTIL STERIL, V71, P639, DOI 10.1016/S0015-0282(98)00537-8	53	67	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3051	10.1371/journal.pone.0003051	http://dx.doi.org/10.1371/journal.pone.0003051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LJ	18725961	Green Published, Green Submitted, gold			2022-12-25	WOS:000264429000004
J	Zhu, WS; Fan, ZP; Zhang, C; Guo, ZX; Zhao, Y; Zhou, YX; Li, K; Xing, ZH; Chen, GQ; Liang, YM; Jin, L; Xiao, JH				Zhu, Wangsheng; Fan, Zhongpeng; Zhang, Chao; Guo, Zhengxia; Zhao, Ying; Zhou, Yuxun; Li, Kai; Xing, Zhenghong; Chen, Guoqiang; Liang, Yinming; Jin, Li; Xiao, Junhua			A Dominant X-Linked QTL Regulating Pubertal Timing in Mice Found by Whole Genome Scanning and Modified Interval-Specific Congenic Strain Analysis	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENETIC INFLUENCES; POSTNATAL-GROWTH; OBESITY; ONSET; CHROMOSOME; EPISTASIS; BACKCROSS; C57BL/6J; CYCLE	Background: Pubertal timing in mammals is triggered by reactivation of the hypothalamic-pituitary-gonadal (HPG) axis and modulated by both genetic and environmental factors. Strain-dependent differences in vaginal opening among inbred mouse strains suggest that genetic background contribute significantly to the puberty timing, although the exact mechanism remains unknown. Methodology/Principal Findings: We performed a genome-wide scanning for linkage in reciprocal crosses between two strains, C3H/HeJ (C3H) and C57BL6/J (B6), which differed significantly in the pubertal timing. Vaginal opening (VO) was used to characterize pubertal timing in female mice, and the age at VO of all female mice (two parental strains, F1 and F2 progeny) was recorded. A genome-wide search was performed in 260 phenotypically extreme F2 mice out of 464 female progeny of the F1 intercrosses to identify quantitative trait loci (QTLs) controlling this trait. A QTL significantly associated was mapped to the DXMit166 marker (15.5 cM, LOD = 3.86, p<0.01) in the reciprocal cross population (C3HB6F2). This QTL contributed 2.1 days to the timing of VO, which accounted for 32.31% of the difference between the original strains. Further study showed that the QTL was B6-dominant and explained 10.5% of variation to this trait with a power of 99.4% at an alpha level of 0.05. The location of the significant ChrX QTL found by genome scanning was then fine-mapped to a region of similar to 2.5 cM between marker DXMit68 and rs29053133 by generating and phenotyping a panel of 10 modified interval-specific congenic strains (mISCSs). Conclusions/Significance: Such findings in our study lay a foundation for positional cloning of genes regulating the timing of puberty, and also reveal the fact that chromosome X (the sex chromosome) does carry gene(s) which take part in the regulative pathway of the pubertal timing in mice.	[Zhu, Wangsheng; Fan, Zhongpeng; Zhang, Chao; Guo, Zhengxia; Zhao, Ying; Zhou, Yuxun; Li, Kai; Liang, Yinming; Xiao, Junhua] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Songjiang, Peoples R China; [Zhu, Wangsheng; Fan, Zhongpeng; Zhang, Chao; Guo, Zhengxia; Zhao, Ying; Zhou, Yuxun; Li, Kai; Xing, Zhenghong; Chen, Guoqiang; Liang, Yinming; Jin, Li; Xiao, Junhua] Joint Lab Model Anim Biodivers, Shanghai, Peoples R China; [Zhao, Ying; Xing, Zhenghong; Chen, Guoqiang] Shanghai British SIPPR, BK Lab Anim Ltd, Shanghai, Peoples R China; [Jin, Li] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China	Donghua University; Fudan University	Zhu, WS (corresponding author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Songjiang, Peoples R China.	xiaojunhua@dhu.edu.cn	Jin, Li/M-5063-2019; Liang, Yinming/AAM-6226-2020; Jin, Li/C-1468-2009; Yang, Wei/HIA-0360-2022	Liang, Yinming/0000-0001-9174-4037; Jin, Li/0000-0002-4546-2415; Zhu, Wangsheng/0000-0001-7773-3438	National Nature Science Foundation of China [30771191]; Key Programs of the Science and Technology Commission Foundation of Shanghai [071409004]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Programs of the Science and Technology Commission Foundation of Shanghai	grants from the National Nature Science Foundation of China (grant no. 30771191) and Key Programs of the Science and Technology Commission Foundation of Shanghai (grant no. 071409004)	Brockmann GA, 2000, GENOME RES, V10, P1941, DOI 10.1101/gr.GR1499R; Broman KW, 2006, GENETICS, V174, P2151, DOI 10.1534/genetics.106.061176; Carruth LL, 2002, NAT NEUROSCI, V5, P933, DOI 10.1038/nn922; Chehab FF, 1997, SCIENCE, V275, P88, DOI 10.1126/science.275.5296.88; Cheverud James M., 1994, P67; Cocchia M, 2000, GENOMICS, V68, P305, DOI 10.1006/geno.2000.6302; Darvasi A, 1997, MAMM GENOME, V8, P163, DOI 10.1007/s003359900382; DARVASI A, 1995, GENETICS, V141, P1199; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Devi AS, 1998, FERTIL STERIL, V70, P89, DOI 10.1016/S0015-0282(98)00122-8; GARDNER HA, 1983, AM J MED GENET, V14, P647, DOI 10.1002/ajmg.1320140408; GEERKENS C, 1994, AM J MED GENET, V50, P105, DOI 10.1002/ajmg.1320500202; GROSSO S, 1999, J MED GENET, V30, P966; Haston CK, 2002, HUM MOL GENET, V11, P1855, DOI 10.1093/hmg/11.16.1855; Hemberger MC, 1999, GENETICS, V153, P383; HOCKEY A, 1986, AM J MED GENET, V23, P127, DOI 10.1002/ajmg.1320230107; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; Ibanez L, 2006, PEDIATRICS, V117, P117, DOI 10.1542/peds.2005-0664; Ishikawa A, 2000, MAMM GENOME, V11, P824, DOI 10.1007/s003350010145; Ishikawa A, 2005, GENET RES, V85, P127, DOI 10.1017/S001667230500738X; Ishikawa A, 2004, GENES GENET SYST, V79, P27, DOI 10.1266/ggs.79.27; JARVELA IE, 1993, J MED GENET, V30, P966, DOI 10.1136/jmg.30.11.966; Jarvis JP, 2005, J LIPID RES, V46, P1692, DOI 10.1194/jlr.M500073-JLR200; Kadlubar FF, 2003, CANCER EPIDEM BIOMAR, V12, P327; Kadlubar Fred F., 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P408; KENNEDY GC, 1963, J PHYSIOL-LONDON, V166, P395, DOI 10.1113/jphysiol.1963.sp007111; Krewson TD, 2004, ENDOCRINOLOGY, V145, P4447, DOI 10.1210/en.2004-0543; LANDER ES, 1989, GENETICS, V121, P185; Manichaikul A, 2007, GENETICS, V177, P1963, DOI 10.1534/genetics.107.080093; Maraschio P, 1996, HUM GENET, V97, P375, DOI 10.1007/s004390050056; Mark HFL, 1996, CLIN PEDIATR, V35, P62; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Nathan BM, 2006, ENDOCRINOLOGY, V147, P5132, DOI 10.1210/en.2006-0745; NELSON JF, 1992, J REPROD FERTIL, V94, P261, DOI 10.1530/jrf.0.0940261; NELSON JF, 1990, BIOL REPROD, V42, P649, DOI 10.1095/biolreprod42.4.649; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Peluso JJ, 2006, ENDOCRINOLOGY, V147, P3133, DOI 10.1210/en.2006-0114; Rabbee N, 2004, GENET RES, V84, P103, DOI 10.1017/S0016672304007086; Rogner UC, 2003, NAT REV IMMUNOL, V3, P243, DOI 10.1038/nri1031; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Talaban R, 2005, CYTOGENET GENOME RES, V109, P480, DOI 10.1159/000084206; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111; THERMAN E, 1990, HUM GENET, V85, P455; Wallace JM, 2004, BIOL REPROD, V71, P1055, DOI 10.1095/biolreprod.104.030965; Wolf JB, 2002, HEREDITY, V89, P300, DOI 10.1038/sj.hdy.6800140; Xiao ZX, 2006, HEPATOL RES, V34, P150, DOI 10.1016/j.hepres.2005.12.007; Yang RC, 2004, GENETICS, V167, P1493, DOI 10.1534/genetics.103.020016; Zhou YX, 2007, J ENDOCRINOL, V193, P405, DOI 10.1677/joe.1.07049	50	4	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3021	10.1371/journal.pone.0003021	http://dx.doi.org/10.1371/journal.pone.0003021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725948	gold, Green Published, Green Submitted			2022-12-25	WOS:000264428800001
J	Gurzov, EN; Ortis, F; Bakiri, L; Wagner, EF; Eizirik, DL				Gurzov, Esteban N.; Ortis, Fernanda; Bakiri, Latifa; Wagner, Erwin F.; Eizirik, Decio L.			JunB Inhibits ER Stress and Apoptosis in Pancreatic Beta Cells	PLOS ONE			English	Article								Cytokines contribute to pancreatic beta-cell apoptosis in type 1 diabetes (T1D) by modulation of beta-cell gene expression networks. The transcription factor Activator Protein-1 (AP-1) is a key regulator of inflammation and apoptosis. We presently evaluated the function of the AP-1 subunit JunB in cytokine-mediated beta-cell dysfunction and death. The cytokines IL-1 beta+IFN-gamma induced an early and transitory upregulation of JunB by NF-kappa B activation. Knockdown of JunB by RNA interference increased cytokine-mediated expression of inducible nitric oxide synthase (iNOS) and endoplasmic reticulum (ER) stress markers, leading to increased apoptosis in an insulin-producing cell line (INS-1E) and in purified rat primary beta-cells. JunB knockdown beta-cells and junB(-/-) fibroblasts were also more sensitive to the chemical ER stressor cyclopiazonic acid (CPA). Conversely, adenoviral-mediated overexpression of JunB diminished iNOS and ER markers expression and protected beta-cells from cytokine-induced cell death. These findings demonstrate a novel and unexpected role for JunB as a regulator of defense mechanisms against cytokine- and ER stress-mediated apoptosis.	[Gurzov, Esteban N.; Ortis, Fernanda; Eizirik, Decio L.] Free Univ Brussels, Expt Med Lab, Brussels, Belgium; [Bakiri, Latifa; Wagner, Erwin F.] Ctr Nacl Investigac Oncol, Madrid, Spain	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Gurzov, EN (corresponding author), Free Univ Brussels, Expt Med Lab, Brussels, Belgium.	egurzov@ulb.ac.be	Bakiri, Latifa/AAP-1674-2020; Ortis, Fernanda/K-7917-2014; Bakiri, Latifa/N-5780-2014	bakiri, latifa/0000-0002-6300-2420; Gurzov, Esteban/0000-0003-4642-0273; Ortis, Fernanda/0000-0002-9551-2839; Wagner, Erwin F/0000-0001-7872-0196	Communaute Francaise de Belgique-Actions de Recherche Concertees (ARC); Fonds National de la Recherche Scientifique (FNRS) Belgium; Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State; European Union [036903]	Communaute Francaise de Belgique-Actions de Recherche Concertees (ARC); Fonds National de la Recherche Scientifique (FNRS) Belgium(Fonds de la Recherche Scientifique - FNRS); Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State; European Union(European Commission)	This work has been supported by grants from the Communaute Francaise de Belgique-Actions de Recherche Concertees (ARC), Fonds National de la Recherche Scientifique (FNRS) Belgium, the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State (IUAP P6/40) and European Union (STREP Savebeta, contract n 036903, in the Framework Programme 6 of the European Community).	AKERFELDT MC, 2008, DIABETES; Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; Chu SC, 1998, BIOCHEM BIOPH RES CO, V248, P871, DOI 10.1006/bbrc.1998.9062; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Eizirik DL, 2008, BIOCHEM SOC T, V36, P321, DOI 10.1042/BST0360321; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gurzov EN, 2008, ONCOGENE, V27, P641, DOI 10.1038/sj.onc.1210690; Hasselblatt P, 2007, P NATL ACAD SCI USA, V104, P17105, DOI 10.1073/pnas.0706272104; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Janjic D, 1999, BIOCHEM PHARMACOL, V57, P639, DOI 10.1016/S0006-2952(98)00346-3; Karlsen AE, 2004, DIABETOLOGIA, V47, P1998, DOI 10.1007/s00125-004-1568-3; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; KAWAKAMI Z, 1992, NUCLEIC ACIDS RES, V20, P914, DOI 10.1093/nar/20.4.914; Kharroubi I, 2006, DIABETOLOGIA, V49, P2350, DOI 10.1007/s00125-006-0366-5; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kim HS, 2005, BIOCHEM BIOPH RES CO, V336, P847, DOI 10.1016/j.bbrc.2005.08.183; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Mokhtari D, 2008, ENDOCRINOLOGY, V149, P3046, DOI 10.1210/en.2007-0438; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Schmidt D, 2007, EMBO J, V26, P710, DOI 10.1038/sj.emboj.7601539; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Wang M, 2007, INT J BIOCHEM CELL B, V39, P2076, DOI 10.1016/j.biocel.2007.05.022; Ylipaasto P, 2005, DIABETOLOGIA, V48, P1510, DOI 10.1007/s00125-005-1839-7; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011	40	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3030	10.1371/journal.pone.0003030	http://dx.doi.org/10.1371/journal.pone.0003030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716665	gold, Green Submitted, Green Published			2022-12-25	WOS:000264426800008
J	Paauw, A; Caspers, MPM; Schuren, FHJ; Leverstein-van Hall, MA; Deletoile, A; Montijn, RC; Verhoef, J; Fluit, AC				Paauw, Armand; Caspers, Martien P. M.; Schuren, Frank H. J.; Leverstein-van Hall, Maurine A.; Deletoile, Alexis; Montijn, Roy C.; Verhoef, Jan; Fluit, Ad C.			Genomic Diversity within the Enterobacter cloacae Complex	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; PYRROLOQUINOLINE-QUINONE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; EVOLUTIONARY GENOMICS; GENETIC DIVERSITY; SP-NOV; DNA; RESISTANCE; STRAINS	Background: Isolates of the Enterobacter cloacae complex have been increasingly isolated as nosocomial pathogens, but phenotypic identification of the E. cloacae complex is unreliable and irreproducible. Identification of species based on currently available genotyping tools is already superior to phenotypic identification, but the taxonomy of isolates belonging to this complex is cumbersome. Methodology/Principal Findings: This study shows that multilocus sequence analysis and comparative genomic hybridization based on a mixed genome array is a powerful method for studying species assignment within the E. cloacae complex. The E. cloacae complex is shown to be evolutionarily divided into two clades that are genetically distinct from each other. The younger first clade is genetically more homogenous, contains the Enterobacter hormaechei species and is the most frequently cultured Enterobacter species in hospitals. The second and older clade consists of several (sub) species that are genetically more heterogonous. Genetic markers were identified that could discriminate between the two clades and cluster 1. Conclusions/Significance: Based on genomic differences it is concluded that some previously defined (clonal and heterogenic) (sub) species of the E. cloacae complex have to be redefined because of disagreements with known or proposed nomenclature. However, further improved identification of the redefined species will be possible based on novel markers presented here.	[Paauw, Armand; Leverstein-van Hall, Maurine A.; Verhoef, Jan; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Caspers, Martien P. M.; Schuren, Frank H. J.; Montijn, Roy C.] TNO Dept Microbiol, Zeist, Netherlands; [Deletoile, Alexis] Inst Pasteur, Unite Biodivers Bacteries Pathogenes Emergentes, Paris, France	Utrecht University; Utrecht University Medical Center; Netherlands Organization Applied Science Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Paauw, A (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	A.Paauw@umcutrecht.nl			Microbiology Department of the UMCU	Microbiology Department of the UMCU	The study was funded by the Microbiology Department of the UMCU.	ADAMOWICZ M, 1991, APPL ENVIRON MICROB, V57, P2012, DOI 10.1128/AEM.57.7.2012-2015.1991; Akopyants NS, 2001, MOL BIOCHEM PARASIT, V113, P337, DOI 10.1016/S0166-6851(01)00227-4; Borucki MK, 2004, J CLIN MICROBIOL, V42, P5270, DOI 10.1128/JCM.42.11.5270-5276.2004; BRENNER DJ, 1986, J CLIN MICROBIOL, V23, P1114, DOI 10.1128/JCM.23.6.1114-1120.1986; BRENNER DJ, 1982, J CLIN MICROBIOL, V15, P1133, DOI 10.1128/JCM.15.6.1133-1140.1982; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dobrindt U, 2003, J BACTERIOL, V185, P1831, DOI 10.1128/JB.185.6.1831-1840.2003; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fitzgerald JR, 2003, INFECT IMMUN, V71, P2827, DOI 10.1128/IAI.71.5.2827-2838.2003; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Fu YX, 1997, GENETICS, V147, P915; Fukiya S, 2004, J BACTERIOL, V186, P3911, DOI 10.1128/JB.186.12.3911-3921.2004; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hoffmann H, 2005, J CLIN MICROBIOL, V43, P3297, DOI 10.1128/JCM.43.7.3297-3303.2005; Hoffmann H, 2005, SYST APPL MICROBIOL, V28, P196, DOI 10.1016/j.syapm.2004.12.010; Hoffmann H, 2005, SYST APPL MICROBIOL, V28, P206, DOI 10.1016/j.syapm.2004.12.009; Hoffmann H, 2003, APPL ENVIRON MICROB, V69, P5306, DOI 10.1128/AEM.69.9.5306-5318.2003; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Kampfer P, 2008, INT J HYG ENVIR HEAL, V211, P374, DOI 10.1016/j.ijheh.2007.07.021; Kim CC, 2002, GENOME BIOL, V3; Kosako Y, 1996, CURR MICROBIOL, V33, P261, DOI 10.1007/s002849900110; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Leverstein-van Hall MA, 2006, J CLIN MICROBIOL, V44, P518, DOI 10.1128/JCM.44.2.518-524.2006; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Mehlen A, 2004, SYST APPL MICROBIOL, V27, P689, DOI 10.1078/0723202042369875; Misra HS, 2004, FEBS LETT, V578, P26, DOI 10.1016/j.febslet.2004.10.061; Paauw A, 2006, EMERG INFECT DIS, V12, P807; Paauw A, 2007, J CLIN MICROBIOL, V45, P1420, DOI 10.1128/JCM.02242-06; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Salerno A, 2007, J BACTERIOL, V189, P7808, DOI 10.1128/JB.00796-07; Sanders WE, 1997, CLIN MICROBIOL REV, V10, P220, DOI 10.1128/CMR.10.2.220; Streit JM, 2004, INT J ANTIMICROB AG, V24, P111, DOI 10.1016/j.ijantimicag.2003.12.019; TAJIMA F, 1989, GENETICS, V123, P585; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; Vlaminckx BJM, 2007, INFECT IMMUN, V75, P2603, DOI 10.1128/IAI.01291-06; Wirth T, 2007, GENOME RES, V17, P1647, DOI 10.1101/gr.6122607; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	43	93	98	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3018	10.1371/journal.pone.0003018	http://dx.doi.org/10.1371/journal.pone.0003018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716657	gold, Green Published, Green Submitted			2022-12-25	WOS:000264426800003
J	Sasaki, S; He, XS; Holmes, TH; Dekker, CL; Kemble, GW; Arvin, AM; Greenberg, HB				Sasaki, Sanae; He, Xiao-Song; Holmes, Tyson H.; Dekker, Cornelia L.; Kemble, George W.; Arvin, Ann. M.; Greenberg, Harry B.			Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses	PLOS ONE			English	Article							IMMUNE-RESPONSES; ANNUAL IMMUNIZATION; VIRUS VACCINES; WORKING ADULTS; DOSE-RESPONSE; LIVE; TRIVALENT; EFFICACY; CHILDREN; YOUNG	Currently two vaccines, trivalent inactivated influenza vaccine (TIV) and live attenuated influenza vaccine (LAIV), are licensed in the USA. Despite previous studies on immune responses induced by these two vaccines, a comparative study of the influence of prior influenza vaccination on serum antibody and B-cell responses to new LAIV or TIV vaccination has not been reported. During the 2005/6 influenza season, we quantified the serum antibody and B-cell responses to LAIV or TIV in adults with differing influenza vaccination histories in the prior year: LAIV, TIV, or neither. Blood samples were collected on days 0, 7-9 and 21-35 after immunization and used for serum HAI assay and B-cell assays. Total and influenza-specific circulating IgG and IgA antibody secreting cells (ASC) in PBMC were detected by direct ELISPOT assay. Memory B cells were also tested by ELISPOT after polyclonal stimulation of PBMC in vitro. Serum antibody, effector, and memory B-cell responses were greater in TIV recipients than LAIV recipients. Prior year TIV recipients had significantly higher baseline HAI titers, but lower HAI response after vaccination with either TIV or LAIV, and lower IgA ASC response after vaccination with TIV than prior year LAIV or no vaccination recipients. Lower levels of baseline HAI titer were associated with a greater fold-increase of HAI titer and ASC number after vaccination, which also differed by type of vaccine. Our findings suggest that the type of vaccine received in the prior year affects the serum antibody and the B-cell responses to subsequent vaccination. In particular, prior year TIV vaccination is associated with sustained higher HAI titer one year later but lower antibody response to new LAIV or TIV vaccination, and a lower effector B-cell response to new TIV but not LAIV vaccination.	[Sasaki, Sanae; He, Xiao-Song; Greenberg, Harry B.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Sasaki, Sanae; Arvin, Ann. M.; Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [He, Xiao-Song; Greenberg, Harry B.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Holmes, Tyson H.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Biostat, Stanford, CA 94305 USA; [Dekker, Cornelia L.; Arvin, Ann. M.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Kemble, George W.] MedImmune Vaccines Inc, Mountain View, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; AstraZeneca; Medimmune	Sasaki, S (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	harry.greenberg@stanford.edu		greenberg, harry/0000-0002-2128-9080				Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Atmar RL, 2007, VACCINE, V25, P5367, DOI 10.1016/j.vaccine.2007.05.002; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Beyer WEP, 2004, VIRUS RES, V103, P125, DOI 10.1016/j.virusres.2004.02.024; Beyer WEP, 2002, VACCINE, V20, P1340, DOI 10.1016/S0264-410X(01)00471-6; Beyer WEP, 1996, VACCINE, V14, P1331, DOI 10.1016/S0264-410X(96)00058-8; *CDC, 2005, MMWR-MORBID MORTAL W, V54, P631; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; CLEMENTS ML, 1986, J CLIN MICROBIOL, V23, P66, DOI 10.1128/JCM.23.1.66-72.1986; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; CLEMENTS ML, 1983, INFECT IMMUN, V40, P1044, DOI 10.1128/IAI.40.3.1044-1051.1983; Couch R B, 1975, Dev Biol Stand, V28, P295; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; COX RJ, 1994, VACCINE, V12, P993, DOI 10.1016/0264-410X(94)90334-4; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; El-Madhun AS, 1998, J INFECT DIS, V178, P933, DOI 10.1086/515656; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Gross PA, 1996, VACCINE, V14, P1280, DOI 10.1016/S0264-410X(96)00004-7; Gross PA, 1999, VACCINE, V17, P2284, DOI 10.1016/S0264-410X(98)00478-2; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; HOLM S, 1979, SCAND J STAT, V6, P65; HOSKINS TW, 1979, LANCET, V1, P33; Iorio AM, 2006, VACCINE, V24, P6615, DOI 10.1016/j.vaccine.2006.05.037; Keitel WA, 1997, VACCINE, V15, P1114, DOI 10.1016/S0264-410X(97)00003-0; KRYSTAL M, 1983, P NATL ACAD SCI-BIOL, V80, P4527, DOI 10.1073/pnas.80.14.4527; Kunzel W, 1996, VACCINE, V14, P1108, DOI 10.1016/0264-410X(96)00061-8; Lee MS, 2004, PEDIATR INFECT DIS J, V23, P852, DOI 10.1097/01.inf.0000137566.87691.3b; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; McDonald NJ, 2007, J GEN VIROL, V88, P3209, DOI 10.1099/vir.0.83184-0; MOLDOVEANU Z, 1995, VACCINE, V13, P1006, DOI 10.1016/0264-410X(95)00016-T; Nichol KL, 2003, VACCINE, V21, P2207, DOI 10.1016/S0264-410X(03)00029-X; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Noble G R, 1977, Dev Biol Stand, V39, P253; Nolan T, 2003, VACCINE, V21, P1224, DOI 10.1016/S0264-410X(02)00484-X; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; PHILIP R, 1985, J MED VIROL, V17, P325; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; SHETH KJ, 1979, JAMA-J AM MED ASSOC, V242, P1752, DOI 10.1001/jama.242.16.1752; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor JJ, 1999, VACCINE, V18, P899, DOI 10.1016/S0264-410X(99)00334-5; Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b; [No title captured]	46	170	171	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2975	10.1371/journal.pone.0002975	http://dx.doi.org/10.1371/journal.pone.0002975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714352	Green Submitted, Green Published, gold			2022-12-25	WOS:000264420900002
J	Burke, JE; Hsu, YH; Deems, RA; Li, S; Woods, VL; Dennis, EA				Burke, John E.; Hsu, Yuan-Hao; Deems, Raymond A.; Li, Sheng; Woods, Virgil L., Jr.; Dennis, Edward A.			A Phospholipid Substrate Molecule Residing in the Membrane Surface Mediates Opening of the Lid Region in Group IVA Cytosolic Phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; LIPID-BINDING DOMAIN; C2 DOMAIN; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; INTERFACIAL BINDING; HYDROGEN-EXCHANGE; PROTEIN; ACTIVATION; LIPASE	The Group IVA (GIVA) phospholipase A(2) associates with natural membranes in response to an increase in intracellular Ca2+ along with increases in certain lipid mediators. This enzyme associates with the membrane surface as well as binding a single phospholipid molecule in the active site for catalysis. Employing deuterium exchange mass spectrometry, we have identified the regions of the protein binding the lipid surface and conformational changes upon a single phospholipid binding in the absence of a lipid surface. Experiments were carried out using natural palmitoyl arachidonyl phosphatidylcholine vesicles with the intact GIVA enzyme as well as the isolated C2 and catalytic domains. Lipid binding produced changes in deuterium exchange in eight different regions of the protein. The regions with decreased exchange included Ca2+ binding loop one, which has been proposed to penetrate the membrane surface, and a charged patch of residues, which may be important in interacting with the polar head groups of phospholipids. The regions with an increase in exchange are all located either in the hydrophobic core underneath the lid region or near the lid and hinge regions from 403 to 457. Using the GIVA phospholipase A2 irreversible inhibitor methyl-arachidonyl fluorophosphonate, we were able to isolate structural changes caused only by pseudo-substrate binding. This produced results that were very similar to natural lipid binding in the presence of a lipid interface with the exception of the C2 domain and region 466-470. This implies that most of the changes seen in the catalytic domain are due to a substrate-mediated, not interface-mediated, lid opening, which exposes the active site to water. Finally experiments carried out with inhibitor plus phospholipid vesicles showed decreases at the C2 domain as well as charged residues on the putative membrane binding surface of the catalytic domain revealing the binding sites of the enzyme to the lipid surface.	[Li, Sheng; Woods, Virgil L., Jr.] Univ Calif, Dept Med & Biomed Sci, Grad Program, La Jolla, CA 92093 USA; [Burke, John E.; Hsu, Yuan-Hao; Deems, Raymond A.; Dennis, Edward A.] Univ Calif, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Burke, John E.; Hsu, Yuan-Hao; Deems, Raymond A.; Dennis, Edward A.] Univ Calif, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Woods, VL (corresponding author), Univ Calif, Dept Med & Biomed Sci, Grad Program, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; edennis@ucsd.edu	Dennis, Edward A./M-5554-2019; Burke, John/H-3922-2019; hsu, yuan-hao/B-5744-2009; Burke, John/A-5659-2013	Dennis, Edward A./0000-0003-3738-3140; Burke, John/0000-0001-7904-9859; Burke, John/0000-0003-1668-2109	National Institutes of Health [GM20501, CA099835, CA118595, GM037684, AI0220221, AI022160]; University of California Industry.-University Cooperative Research Program [UC10591]; NATIONAL CANCER INSTITUTE [R33CA099835, R21CA118595, R21CA099835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Industry.-University Cooperative Research Program(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM20501 (to E. A. D.) and CA099835, CA118595, GM037684, AI0220221, and AI022160 (to V. L. W.). This work was also supported by Discovery Grant UC10591 from the University of California Industry.-University Cooperative Research Program (to V. L. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ball A, 1999, P NATL ACAD SCI USA, V96, P6637, DOI 10.1073/pnas.96.12.6637; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; Das S, 2002, J BIOL CHEM, V277, P23838, DOI 10.1074/jbc.M202322200; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Evans JH, 2004, J BIOL CHEM, V279, P6005, DOI 10.1074/jbc.M311246200; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hixon MS, 1998, BIOCHEMISTRY-US, V37, P8516, DOI 10.1021/bi980416d; Hoofnagle AN, 2001, P NATL ACAD SCI USA, V98, P956, DOI 10.1073/pnas.98.3.956; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Huang Z., 1994, MEDIAT INFLAMM, V3, P307; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; LESLIE CC, 1991, J BIOL CHEM, V266, P11366; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Malkova S, 2005, BIOPHYS J, V89, P1861, DOI 10.1529/biophysj.105.061515; Malmberg NJ, 2003, BIOCHEMISTRY-US, V42, P13227, DOI 10.1021/bi035119+; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; REYNOLDS LJ, 1993, BIOCHIM BIOPHYS ACTA, V1167, P272, DOI 10.1016/0005-2760(93)90229-3; Roussel A, 2002, J BIOL CHEM, V277, P2266, DOI 10.1074/jbc.M109484200; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; SCHRAG JD, 1991, NATURE, V351, P761, DOI 10.1038/351761a0; Schrag JD, 1997, STRUCTURE, V5, P187, DOI 10.1016/S0969-2126(97)00178-0; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Subramanian P, 2007, J LIPID RES, V48, P2701, DOI 10.1194/jlr.M700356-JLR200; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064	41	43	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31227	31236		10.1074/jbc.M804492200	http://dx.doi.org/10.1074/jbc.M804492200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18753135	Green Published, hybrid			2022-12-25	WOS:000260544800076
J	Kamath, P; Krishnaswamy, S				Kamath, Parvathi; Krishnaswamy, Sriram			Fate of Membrane-bound Reactants and Products during the Activation of Human Prothrombin by Prothrombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-VA; BOVINE PROTHROMBIN; BLOOD-COAGULATION; FACTOR-X; MACROMOLECULAR SUBSTRATE; ENZYME COMPLEXES; ALPHA-THROMBIN; BINDING-SITE; ACTIVE-SITE; FRAGMENT 2	Membrane binding by prothrombin, mediated by its N-terminal fragment 1 (F1) domain, plays an essential role in its proteolytic activation by prothrombinase. Thrombin is produced in two cleavage reactions. One at Arg(320) yields the proteinase meizothrombin that retains membrane binding properties. The second, at Arg(271), yields thrombin and severs covalent linkage with the N-terminal fragment 1.2 (F12) region. Covalent linkage with the membrane binding domain is also lost when prethrombin 2 (P2) and F12 are produced following initial cleavage at Arg(271). We show that at the physiological concentration of prothrombin, thrombin formation results in rapid release of the proteinase into solution. Product release from the surface can be explained by the weak interaction between the proteinase and F12 domains. In contrast, the zymogen intermediate P2, formed following cleavage at Arg(271), accumulates on the surface because of a similar to 20-fold higher affinity for F12. By kinetic studies, we show that this enhanced binding adequately explains the ability of unexpectedly low concentrations of F12 to greatly enhance the conversion of P2 to thrombin. Thus, the utilization of all three possible substrate species by prothrombinase is regulated by their ability to bind membranes regardless of whether covalent linkage to the F12 region is maintained. The product, thrombin, interacts with sufficiently poor affinity with F12 so that it is rapidly released from its site of production to participate in its numerous hemostatic functions.	[Kamath, Parvathi; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Joseph Stokes Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, Joseph Stokes Res Inst, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019		National Institutes of Health (NHLBI) [HL-74124, HL-47465]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047465, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health (NHLBI) Grants HL-74124 and HL-47465 ( to S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson PJ, 2003, J BIOL CHEM, V278, P44482, DOI 10.1074/jbc.M306917200; Anderson PJ, 2003, J BIOL CHEM, V278, P44489, DOI 10.1074/jbc.M306916200; ARMSTRONG SA, 1990, J BIOL CHEM, V265, P6210; ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Bevington P. R., 1992, DATA REDUCTION ERROR, P141; Blostein MD, 2000, J BIOL CHEM, V275, P38120, DOI 10.1074/jbc.M007174200; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Brummel KE, 2002, BLOOD, V100, P148, DOI 10.1182/blood.V100.1.148; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Bukys MA, 2008, THROMB HAEMOSTASIS, V99, P511, DOI 10.1160/TH07-08-0532; Camire RM, 2000, BIOCHEMISTRY-US, V39, P14322, DOI 10.1021/bi001074q; Chen Q, 1997, BIOCHEMISTRY-US, V36, P4701, DOI 10.1021/bi961441r; Dasgupta SK, 2007, J THROMB THROMBOLYS, V24, P157, DOI 10.1007/s11239-007-0018-8; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DOWNING MR, 1975, J BIOL CHEM, V250, P8897; DOYLE MF, 1993, METHOD ENZYMOL, V222, P299; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; ESMON CT, 1974, J BIOL CHEM, V249, P606; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; GITEL SN, 1973, P NATL ACAD SCI USA, V70, P1344, DOI 10.1073/pnas.70.5.1344; HELDEBRANT CM, 1973, J BIOL CHEM, V248, P7149; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; JENNY NS, 2006, HEMOSTASIS THROMBOSI, P193; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P3319, DOI 10.1021/bi9623993; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LIM TK, 1977, BIOCHEMISTRY-US, V16, P4177, DOI 10.1021/bi00638a007; Lundblad R L, 1976, Methods Enzymol, V45, P156; MALHOTRA OP, 1985, J BIOL CHEM, V260, P279; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; MYRMEL KH, 1976, BIOCHEMISTRY-US, V15, P1767, DOI 10.1021/bi00653a027; NESHEIM ME, 1988, J BIOL CHEM, V263, P1037; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; STUBBS MT, 1995, TRENDS BIOCHEM SCI, V20, P23, DOI 10.1016/S0968-0004(00)88945-8; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; WALKER FJ, 1979, J BIOL CHEM, V254, P5618; WALKER RK, 1994, J BIOL CHEM, V269, P27441; WEI GJ, 1982, BIOCHEMISTRY-US, V21, P1949, DOI 10.1021/bi00537a039; Yegneswaran S, 2003, J BIOL CHEM, V278, P33312, DOI 10.1074/jbc.M305906200	50	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30164	30173		10.1074/jbc.M806158200	http://dx.doi.org/10.1074/jbc.M806158200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18765660	Green Published, hybrid			2022-12-25	WOS:000260366900061
J	Thoden, JB; Ryan, LA; Reece, RJ; Holden, HM				Thoden, James B.; Ryan, Louise A.; Reece, Richard J.; Holden, Hazel M.			The Interaction between an Acidic Transcriptional Activator and Its Inhibitor THE MOLECULAR BASIS OF Gal4p RECOGNITION BY Gal80p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSACTIVATION DOMAIN; REGULATORY PROTEIN; TUMOR-SUPPRESSOR; GENETIC SWITCH; YEAST; COMPLEX; GALACTOKINASE; MODEL; PARADIGM	The GAL genes, which encode the enzymes required for normal galactose metabolism in yeast, are transcriptionally regulated by three proteins: Gal4p, an activator; Gal80p, an inhibitor; and Gal3p, a galactose sensor. These proteins control the switch between inert and active gene expression. The transcriptional activation function of Gal4p is rendered inactive in the presence of Gal80p. Here we present the three-dimensional structure of a complex between the acidic activation domain of Gal4p and Gal80p. The transactivation domain initiates with an extended region of polypeptide chain followed by two turns of an amphipathic alpha-helix. It fits into and across a deep cleft within the Gal80p dimer with the protein-protein interface defined primarily by hydrophobic interactions. A disordered loop in the apo-Gal80p structure (Asp-309 to Ser-316) becomes well-defined upon binding of the transactivation domain. This investigation provides a new molecular scaffold for understanding previous biochemical and genetic studies.	[Thoden, James B.; Holden, Hazel M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ryan, Louise A.; Reece, Richard J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Wisconsin System; University of Wisconsin Madison; University of Manchester	Reece, RJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	Richard.Reece@manchester.ac.uk; Hazel_Holden@biochem.wisc.edu			National Institutes of Health [DK47814]; Wellcome Trust and BBSRC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047814, R56DK047814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust and BBSRC(Wellcome Trust); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK47814 (to H. M. H.). This work was also supported by the Wellcome Trust and BBSRC (to R. J. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ansari AZ, 1998, P NATL ACAD SCI USA, V95, P13543, DOI 10.1073/pnas.95.23.13543; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Hidalgo P, 2001, GENE DEV, V15, P1007, DOI 10.1101/gad.873901; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; Kingston RL, 1996, STRUCTURE, V4, P1413, DOI 10.1016/S0969-2126(96)00149-9; Kumar PR, 2008, SCIENCE, V319, P1090, DOI 10.1126/science.1151903; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; LUE NF, 1987, MOL CELL BIOL, V7, P3446, DOI 10.1128/MCB.7.10.3446; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Mapp AK, 2000, P NATL ACAD SCI USA, V97, P3930, DOI 10.1073/pnas.97.8.3930; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2005, GENETICS, V171, P469, DOI 10.1534/genetics.105.045237; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pilauri V, 2005, GENETICS, V169, P1903, DOI 10.1534/genetics.104.036723; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; PTASHNE M, 2002, GENES SIGNALS; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rubio-Texeira M, 2005, FEMS YEAST RES, V5, P1115, DOI 10.1016/j.femsyr.2005.05.003; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; Thoden JB, 2007, J BIOL CHEM, V282, P1534, DOI 10.1074/jbc.C600285200; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; YARGER JG, 1984, MOL CELL BIOCHEM, V61, P173; Zenke FT, 1996, SCIENCE, V272, P1662, DOI 10.1126/science.272.5268.1662	34	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30266	30272		10.1074/jbc.M805200200	http://dx.doi.org/10.1074/jbc.M805200200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18701455	Green Published, hybrid			2022-12-25	WOS:000260366900071
J	Drevland, RM; Jia, YH; Palmer, DRJ; Graham, DE				Drevland, Randy M.; Jia, Yunhua; Palmer, David R. J.; Graham, David E.			Methanogen Homoaconitase Catalyzes Both Hydrolyase Reactions in Coenzyme B Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMINOADIPATE PATHWAY; LYSINE BIOSYNTHESIS; ACID; ENZYME; INTERMEDIATE; PHOSPHATE; SULFUR; IRON; DEHYDROGENASE; ISOCITRATE	Homoaconitase enzymes catalyze hydrolyase reactions in the alpha-aminoadipate pathway for lysine biosynthesis or the 2-oxosuberate pathway for methanogenic coenzyme B biosynthesis. Despite the homology of this iron-sulfur protein to aconitase, previously studied homoaconitases catalyze only the hydration of cis-homoaconitate to form homoisocitrate rather than the complete isomerization of homocitrate to homoisocitrate. The MJ1003 and MJ1271 proteins from the methanogen Methanocaldococcus jannaschii formed the first homoaconitase shown to catalyze both the dehydration of (R)-homocitrate to form cis-homoaconitate, and its hydration is shown to produce homoisocitrate. This heterotetrameric enzyme also used the analogous longer chain substrates cis-(homo)(2)aconitate, cis-(homo)(3)aconitate, and cis-(homo)(4)aconitate, all with similar specificities. A combination of the homoaconitase with the M. jannaschii homoisocitrate dehydrogenase catalyzed all of the isomerization and oxidative decarboxylation reactions required to form 2-oxoadipate, 2-oxopimelate, and 2-oxosuberate, completing three iterations of the 2-oxoacid elongation pathway. Methanogenic archaeal homoaconitases and fungal homoaconitases evolved in parallel in the aconitase superfamily. The archaeal homoaconitases share a common ancestor with isopropylmalate isomerases, and both enzymes catalyzed the hydration of the minimal substrate maleate to form D-malate. The variation in substrate specificity among these enzymes correlated with the amino acid sequences of a flexible loop in the small subunits.	[Drevland, Randy M.; Graham, David E.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Graham, David E.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Jia, Yunhua; Palmer, David R. J.] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 5C9, Canada	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Saskatchewan	Graham, DE (corresponding author), 1 Univ Stn,A5300, Austin, TX 78712 USA.	degraham@mail.utexas.edu	Palmer, David R J/F-1934-2010; Graham, David E/F-8578-2010	Palmer, David R J/0000-0001-9300-7460; Graham, David E/0000-0001-8968-7344	National Science Foundation [MCB-0817903]; Petroleum Research Foundation [44382-G4]; Welch Foundation [F-1576]; Direct For Biological Sciences [1005657] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Petroleum Research Foundation; Welch Foundation(The Welch Foundation); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grant MCB-0817903, Petroleum Research Foundation Grant 44382-G4, and Welch Foundation Grant F-1576. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; BENTLEY R, 1970, MOL ASYMMETRY BIOL, P90; BHATTACHARJEE JK, 1992, EVOLUTION METABOLIC, P47; BULT CJ, 1996, SCIENCE, V273, P1017; Clive DLJ, 1999, J ORG CHEM, V64, P1447, DOI 10.1021/jo9822941; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Drevland RM, 2007, J BACTERIOL, V189, P4391, DOI 10.1128/JB.00166-07; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Graham DE, 2002, NAT PROD REP, V19, P133, DOI 10.1039/b103714p; Grimek TL, 2004, J BACTERIOL, V186, P454, DOI 10.1128/JB.186.2.454-462.2004; HENSON CP, 1967, J BIOL CHEM, V242, P3833; Horng YC, 2001, BIOCHEMISTRY-US, V40, P12875, DOI 10.1021/bi011196y; Howell DM, 1998, BIOCHEMISTRY-US, V37, P10108, DOI 10.1021/bi980662p; Howell DM, 2000, J BACTERIOL, V182, P5013, DOI 10.1128/JB.182.17.5013-5016.2000; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jia YH, 2006, BIOCHEM J, V396, P479, DOI 10.1042/BJ20051711; KOLLMANNKOCH A, 1984, H-S Z PHYSIOL CHEM, V365, P847, DOI 10.1515/bchm2.1984.365.2.847; LAUBLE H, 1992, BIOCHEMISTRY-US, V31, P2735, DOI 10.1021/bi00125a014; Li FL, 2007, J BACTERIOL, V189, P4299, DOI 10.1128/JB.00198-07; Ma GX, 2000, TETRAHEDRON LETT, V41, P9209, DOI 10.1016/S0040-4039(00)01707-X; MASSOUDI HH, 1983, SYNTHESIS-STUTTGART, P1010; Nelson R. B., 1973, ORG PREP PROCED INT, V5, P55; NOLL KM, 1986, P NATL ACAD SCI USA, V83, P4238, DOI 10.1073/pnas.83.12.4238; STRASSMAN M, 1966, J BIOL CHEM, V241, P5401; THOMAS U, 1966, BIOCHEMISTRY-US, V5, P2513, DOI 10.1021/bi00872a004; Weidner G, 1997, MOL GEN GENET, V255, P237, DOI 10.1007/s004380050494; WHITE RH, 1989, BIOCHEMISTRY-US, V28, P860, DOI 10.1021/bi00428a068; Wu SP, 2002, BIOCHEMISTRY-US, V41, P8876, DOI 10.1021/bi0256781; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43; Yamamoto T, 2007, BIOORGAN MED CHEM, V15, P1346, DOI 10.1016/j.bmc.2006.11.008	31	23	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28888	28896		10.1074/jbc.M802159200	http://dx.doi.org/10.1074/jbc.M802159200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18765671	Green Published, hybrid			2022-12-25	WOS:000260179900014
J	Rogojina, AT; Nitiss, JL				Rogojina, Anna T.; Nitiss, John L.			Isolation and Characterization of mAMSA-hypersensitive Mutants CYTOTOXICITY OF Top2 COVALENT COMPLEXES CONTAINING DNA SINGLE STRAND BREAKS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST TOPOISOMERASE-II; ENZYME-DNA; ANTITUMOR DRUGS; CLEAVAGE; RESISTANCE; MUTATION; ETOPOSIDE; AMSACRINE; SENSITIVITY; REPAIR	Topoisomerase II (Top2) is the primary target for active anticancer agents. We developed an efficient approach for identifying hypersensitive Top2 mutants and isolated a panel of mutants in yeast Top2 conferring hypersensitivity to the intercalator N-[4-(9-acridinylamino)-3- methoxyphenyl]methanesulphonanilide (mAMSA). Some mutants conferred hypersensitivity to etoposide as well as mAMSA, whereas other mutants exhibited hypersensitivity only to mAMSA. Two mutants in Top2, changing Pro(473) to Leu and Gly(737) to Val, conferred extraordinary hypersensitivity to mAMSA and were chosen for further characterization. The mutant proteins were purified, and their biochemical activities were assessed. Both mutants encode enzymes that are hypersensitive to inhibition by mAMSA and other intercalating agents and exhibited elevated levels of mAMSA-induced Top2: DNA covalent complexes. While Gly(737)-> Val Top2p generated elevated levels of Top2-mediated double strand breaks in vitro, the Pro(473)-> Leu mutant protein showed only a modest increase in Top2-mediated double strand breaks but much higher levels of Top2-mediated single strand breaks. In addition, the Pro(473) -> Leu mutant protein also generated high levels of mAMSA-stabilized covalent complexes in the absence of ATP. We tested the role of single strand cleavage in cell killing with alleles of Top2 that could generate single strand breaks, but not double strand breaks. Expression in yeast of a Pro(473) -> Leu mutant that could only generate single strand breaks conferred hypersensitivity to mAMSA. These results indicate that generation of single strand breaks by Top2-targeting agents can be an drugs.	[Rogojina, Anna T.; Nitiss, John L.] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Nitiss, JL (corresponding author), St Jude Childrens Res Hosp, Dept Mol Pharmacol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	john.nitiss@stjude.org	Nitiss, John/E-9974-2010	Nitiss, John/0000-0002-1013-4972	NCI [CA21765, CA52814, CA82313]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA082313, R01CA052814, P30CA021765] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA21765, CA52814, and CA82313 from NCI. This work was also supported by American Lebanese Syrian Associated Charities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson VE, 2001, CURR PHARM DESIGN, V7, P337, DOI 10.2174/1381612013398013; BUGG BY, 1991, P NATL ACAD SCI USA, V88, P7654, DOI 10.1073/pnas.88.17.7654; Burden DA, 1996, J BIOL CHEM, V271, P29238, DOI 10.1074/jbc.271.46.29238; Burden DA, 2000, METH MOL B, V95, P283; Dong JW, 2000, J BIOL CHEM, V275, P7980, DOI 10.1074/jbc.275.11.7980; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; ELSEA SH, 1995, J BIOL CHEM, V270, P1913, DOI 10.1074/jbc.270.4.1913; FREUDENREICH CH, 1993, EMBO J, V12, P2085, DOI 10.1002/j.1460-2075.1993.tb05857.x; FREUDENREICH CH, 1994, P NATL ACAD SCI USA, V91, P11007, DOI 10.1073/pnas.91.23.11007; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HSIUNG YC, 1995, J BIOL CHEM, V270, P20359, DOI 10.1074/jbc.270.35.20359; JANNATIPOUR M, 1993, J BIOL CHEM, V268, P18586; Kingma PS, 1998, BBA-GENE STRUCT EXPR, V1400, P223, DOI 10.1016/S0167-4781(98)00138-9; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lindsley JE, 2000, METH MOL B, V95, P57; Liu QY, 1998, J BIOL CHEM, V273, P20252, DOI 10.1074/jbc.273.32.20252; Liu QY, 1999, P NATL ACAD SCI USA, V96, P881, DOI 10.1073/pnas.96.3.881; Malik M, 2004, EUKARYOT CELL, V3, P82, DOI 10.1128/EC.3.1.82-90.2004; Malik M, 2006, MOL CANCER THER, V5, P1405, DOI 10.1158/1535-7163.MCT-05-0263; Mao Y, 1999, BIOCHEMISTRY-US, V38, P10793, DOI 10.1021/bi9909804; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; NITISS JL, 1994, CANCER CHEMOTH PHARM, V34, pS6, DOI 10.1007/BF00684857; Nitiss JL, 1998, CONT CANC RES, P517; NITISS JL, 1993, CANCER RES, V53, P89; Nitiss JL, 1998, BBA-GENE STRUCT EXPR, V1400, P63, DOI 10.1016/S0167-4781(98)00128-6; Nitiss JL, 1996, EUR J CANCER, V32A, P958, DOI 10.1016/0959-8049(96)00056-1; NITISS JL, 1992, CANCER RES, V52, P4467; Nitiss John L, 2002, Curr Opin Investig Drugs, V3, P1512; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; OSHEROFF N, 1987, BIOCHEMISTRY-US, V26, P4303, DOI 10.1021/bi00388a018; POMMIER Y, 1985, BIOCHEMISTRY-US, V24, P6406, DOI 10.1021/bi00344a014; ROBINSON MJ, 1993, BIOCHEMISTRY-US, V32, P3638, DOI 10.1021/bi00065a016; ROBINSON MJ, 1990, BIOCHEMISTRY-US, V29, P2511, DOI 10.1021/bi00462a012; Sabourin M, 1998, J BIOL CHEM, V273, P29086, DOI 10.1074/jbc.273.44.29086; Strumberg D, 1999, J BIOL CHEM, V274, P7292, DOI 10.1074/jbc.274.11.7292; Strumberg D, 1999, J BIOL CHEM, V274, P28246, DOI 10.1074/jbc.274.40.28246; Vaughn J, 2005, J BIOL CHEM, V280, P11920, DOI 10.1074/jbc.M411841200; Walker JV, 2004, J BIOL CHEM, V279, P25947, DOI 10.1074/jbc.M312314200; Walker JV, 2002, CANCER INVEST, V20, P570, DOI 10.1081/CNV-120002156; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WASSERMAN RA, 1994, CANCER RES, V54, P1795; WASSERMAN RA, 1994, J BIOL CHEM, V269, P20943; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; ZECHIEDRICH EL, 1989, BIOCHEMISTRY-US, V28, P6229, DOI 10.1021/bi00441a014; ZWELLING LA, 1989, J BIOL CHEM, V264, P16411	46	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29239	29250		10.1074/jbc.M804058200	http://dx.doi.org/10.1074/jbc.M804058200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18723844	Green Published, hybrid			2022-12-25	WOS:000260179900051
J	Scott, MJ; Billiar, TR				Scott, Melanie J.; Billiar, Timothy R.			beta 2-Integrin-induced p38 MAPK Activation Is a Key Mediator in the CD14/TLR4/MD2-dependent Uptake of Lipopolysaccharide by Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; MACROPHAGE CELL-LINE; KAPPA-B ACTIVATION; SIGNAL-TRANSDUCTION; LIPID RAFTS; GENE-EXPRESSION; BACTERIAL LIPOPOLYSACCHARIDE; SOLUBLE CD14; MD-2; LPS	The liver is the main organ that clears circulating lipopolysaccharide (LPS), and hepatocytes are a major cell type involved in LPS uptake. Little is known about the mechanisms for LPS internalization in hepatocytes and what signaling pathways are involved. Weshow here that LPS uptake is initiated after formation of a multi-receptor complex within lipid rafts. We find that essential components for LPS uptake are CD14, TLR4, MD2, and the beta 2-integrin CD11b/CD18. Activation of p38 MAPK is also essential for the initiation of LPS uptake, and interestingly, we show that this activation is not through TLR4 signaling by MyD88 but through activation of TIRAP via CD11b/CD18. However, TLR4/MD2 remain essential components at the cell surface as part of the LPS receptor complex. We therefore suggest novel roles for TLR4/MD2, CD11b/CD18, TIRAP, and p38 MAPK in LPS uptake by hepatocytes.	[Scott, Melanie J.; Billiar, Timothy R.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Billiar, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, NW607MUH,3459 5th Ave, Pittsburgh, PA 15213 USA.	billiartr@upmc.edu			National Institutes of Health [R01-GM-50441]; National Foundation for Infectious Diseases and the Infectious Disease Society of America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Infectious Diseases and the Infectious Disease Society of America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM-50441. This work was also supported by an Astellas Young Investigator Award 2007 from the National Foundation for Infectious Diseases and the Infectious Disease Society of America (to M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Bikhazi AB, 2001, COMP BIOCHEM PHYS C, V129, P339, DOI 10.1016/S1532-0456(01)00207-1; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; DASILVA CJ, 2002, J BIOL CHEM, V277, P1845, DOI [DOI 10.1074/JBC.M109910200, 10.1074/jbc.M109910200]; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; FEARNS C, 1995, J EXP MED, V181, P857, DOI 10.1084/jem.181.3.857; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; Flaherty SF, 1997, J SURG RES, V73, P85, DOI 10.1006/jsre.1997.5195; Flo TH, 2000, INFECT IMMUN, V68, P6770, DOI 10.1128/IAI.68.12.6770-6776.2000; FREUDENBERG MA, 1982, BRIT J EXP PATHOL, V63, P56; FREUDENBERG N, 1992, VIRCHOWS ARCH B, V61, P343, DOI 10.1007/BF02890437; Fujimoto T, 2004, J BIOL CHEM, V279, P47431, DOI 10.1074/jbc.M408724200; FUKUDA I, 1989, BRIT J EXP PATHOL, V70, P267; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Gangloff SC, 2005, J IMMUNOL, V175, P3940, DOI 10.4049/jimmunol.175.6.3940; GE YM, 1994, J INFECT DIS, V169, P95, DOI 10.1093/infdis/169.1.95; Ge YM, 1997, J INFECT DIS, V176, P1313, DOI 10.1086/514127; Hopf U, 1984, Am J Emerg Med, V2, P13, DOI 10.1016/0735-6757(84)90105-0; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; INGALLS RR, 1995, J EXP MED, V181, P1473, DOI 10.1084/jem.181.4.1473; Ingalls RR, 1997, J IMMUNOL, V159, P433; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; Kraatz J, 1999, SHOCK, V11, P58, DOI 10.1097/00024382-199901000-00009; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; Liu SB, 1998, INFECT IMMUN, V66, P5089, DOI 10.1128/IAI.66.11.5089-5098.1998; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; MATHISON JC, 1979, J IMMUNOL, V123, P2133; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; MIMURA Y, 1995, GASTROENTEROLOGY, V109, P1969, DOI 10.1016/0016-5085(95)90765-3; Moreno C, 2004, MICROBES INFECT, V6, P990, DOI 10.1016/j.micinf.2004.05.010; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; PRAANINGVANDALEN DP, 1981, GASTROENTEROLOGY, V81, P1036; Schmitz G, 2002, CURR OPIN LIPIDOL, V13, P513, DOI 10.1097/00041433-200210000-00007; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shao BM, 2007, J BIOL CHEM, V282, P13726, DOI 10.1074/jbc.M609462200; Tapping RI, 1998, PROG CLIN BIOL RES, V397, P73; TREON SP, 1993, P SOC EXP BIOL MED, V202, P153; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Triantafilou M, 2002, J CELL SCI, V115, P2603; Twining SS, 2001, J BIOL CHEM, V276, P23135, DOI 10.1074/jbc.M010748200; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Vodovotz Y, 2001, J ENDOTOXIN RES, V7, P365, DOI 10.1179/096805101101532936; WILSON RW, 1993, J IMMUNOL, V151, P1571; Wong KF, 2007, FASEB J, V21, P3231, DOI 10.1096/fj.06-7579com; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	57	83	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29433	29446		10.1074/jbc.M803905200	http://dx.doi.org/10.1074/jbc.M803905200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18701460	hybrid, Green Published			2022-12-25	WOS:000260179900070
J	Mustafa, G; Migita, CT; Ishikawa, Y; Kobayashi, K; Tagawa, S; Yamada, M				Mustafa, Golam; Migita, Catharina T.; Ishikawa, Yoshinori; Kobayashi, Kazuo; Tagawa, Seiichi; Yamada, Mamoru			Menaquinone as well as ubiquinone as a bound quinone crucial for catalytic activity and intramolecular electron transfer in Escherichia coli membrane-bound glucose dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; PYRROLOQUINOLINE QUINONE; PULSE-RADIOLYSIS; METHANOL DEHYDROGENASE; NITRITE REDUCTASE; RESPIRATORY-CHAIN; SITE; PQQ; TRANSPORT; BINDING	Escherichia coli membrane-bound glucose dehydrogenase (mGDH), which is one of quinoproteins containing pyrroloquinoline quinone (PQQ) as a coenzyme, is a good model for elucidating the function of bound quinone inside primary dehydrogenases in respiratory chains. Enzymatic analysis of purified mGDH from cells defective in synthesis of ubiquinone (UQ) and/or menaquinone (MQ) revealed that Q-free mGDH has very low levels of activity of glucose dehydrogenase and UQ(2) reductase compared with those of UQ-bearing mGDH, and both activities were significantly increased by reconstitution with UQ(1). On the other hand, MQ-bearing mGDH retains both catalytic abilities at the same levels as those of UQ-bearing mGDH. A radiolytically generated hydrated electron reacted with the bound MQ to form a semiquinone anion radical with an absorption maximum at 400 nm. Subsequently, decay of the absorbance at 400 nm was accompanied by an increase in the absorbance at 380 nm with a first order rate constant of 5.7 x 10(3) s(-1). This indicated that an intramolecular electron transfer from the bound MQ to the PQQ occurred. EPR analysis revealed that characteristics of the semiquinone radical of bound MQ are similar to those of the semiquinone radical of bound UQ and indicated an electron flow from PQQ to MQ as in the case of UQ. Taken together, the results suggest that MQ is incorporated into the same pocket as that for UQ to perform a function almost equivalent to that of UQ and that bound quinone is involved at least partially in the catalytic reaction and primarily in the intramolecular electron transfer of mGDH.	[Mustafa, Golam; Migita, Catharina T.; Yamada, Mamoru] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan; [Ishikawa, Yoshinori; Yamada, Mamoru] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Kobayashi, Kazuo; Tagawa, Seiichi] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Yamaguchi University; Yamaguchi University; Osaka University	Yamada, M (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	m-yamada@yamaguchi-u.ac.jp	Kobayashi, Kazuo/H-9279-2012	Kobayashi, Kazuo/0000-0002-5586-9112; Yamada, Mamoru/0000-0003-4354-7324	Ministry of Education, Science and Culture of Japan	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for basic research from the Ministry of Education, Science and Culture of Japan (to M. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMEYAMA M, 1985, AGR BIOL CHEM TOKYO, V49, P1227, DOI 10.1080/00021369.1985.10866884; AMEYAMA M, 1981, FEBS LETT, V130, P179, DOI 10.1016/0014-5793(81)81114-3; ANTHONY C, 1994, BIOCHEM J, V304, P665, DOI 10.1042/bj3040665; Azarkina N, 2002, J BACTERIOL, V184, P5339, DOI 10.1128/JB.184.19.5339-5347.2002; Bader MW, 2000, J BIOL CHEM, V275, P26082, DOI 10.1074/jbc.M003850200; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Cozier GE, 1999, BIOCHEM J, V340, P639, DOI 10.1042/0264-6021:3400639; Cozier GE, 1995, BIOCHEM J, V312, P679, DOI 10.1042/bj3120679; DUINE JA, 1979, FEBS LETT, V108, P443, DOI 10.1016/0014-5793(79)80584-0; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; Elias MD, 2000, J BIOL CHEM, V275, P7321, DOI 10.1074/jbc.275.10.7321; Elias MD, 2004, J BIOL CHEM, V279, P3078, DOI 10.1074/jbc.M310163200; Elias MD, 2001, J BIOL CHEM, V276, P48356, DOI 10.1074/jbc.M107355200; GORDON S, 1964, J AM CHEM SOC, V86, P5343, DOI 10.1021/ja01077a067; HOMMES RWJ, 1984, FEMS MICROBIOL LETT, V24, P329, DOI 10.1016/0378-1097(84)90274-X; Inaba K, 2005, J BIOL CHEM, V280, P33035, DOI 10.1074/jbc.M506189200; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; Kobayashi K, 2005, BIOCHEMISTRY-US, V44, P13567, DOI 10.1021/bi051347n; Kobayashi K, 1997, BIOCHEMISTRY-US, V36, P13611, DOI 10.1021/bi971045o; Kobayashi K, 2003, J AM CHEM SOC, V125, P10213, DOI 10.1021/ja036211w; Kobayashi K, 2001, J BIOL CHEM, V276, P39864, DOI 10.1074/jbc.M102537200; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; MATSUSHITA K, 1987, J BACTERIOL, V169, P205, DOI 10.1128/jb.169.1.205-209.1987; Matsushita K, 1997, MICROBIOL-UK, V143, P3149, DOI 10.1099/00221287-143-10-3149; Meganathan R, 2001, VITAM HORM, V61, P173; Miyoshi H, 1999, BBA-BIOENERGETICS, V1412, P29, DOI 10.1016/S0005-2728(99)00009-2; Mustafa G, 2008, J BIOL CHEM, V283, P22215, DOI 10.1074/jbc.M800911200; PATEL KB, 1973, J CHEM SOC FARAD T 1, V69, P814, DOI 10.1039/f19736900814; Soballe B, 2000, MICROBIOL-SGM, V146, P787, DOI 10.1099/00221287-146-4-787; Sode K, 1997, BIOTECHNOL LETT, V19, P1073, DOI 10.1023/A:1018428224215; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; SUZUKI S, 1994, J AM CHEM SOC, V116, P11145, DOI 10.1021/ja00103a035; Takahashi YH, 2004, J BIOL CHEM, V279, P47057, DOI 10.1074/jbc.M407153200; VANSCHIE BJ, 1985, J BACTERIOL, V163, P493, DOI 10.1128/JB.163.2.493-499.1985; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; Yamada M, 1998, J BIOL CHEM, V273, P22021, DOI 10.1074/jbc.273.34.22021; YAMADA M, 1993, J BIOL CHEM, V268, P12812; Yamada M, 2003, BBA-PROTEINS PROTEOM, V1647, P185, DOI 10.1016/S1570-9639(03)00100-6; YAMADA M, 1993, J BACTERIOL, V175, P568, DOI 10.1128/JB.175.2.568-571.1993; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200	41	15	16	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28169	28175		10.1074/jbc.M804938200	http://dx.doi.org/10.1074/jbc.M804938200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18708350	Green Published, hybrid			2022-12-25	WOS:000259969300019
J	Fujihara, M; Nagai, N; Sussan, TE; Biswal, S; Handa, JT				Fujihara, Masashi; Nagai, Norihiro; Sussan, Thomas E.; Biswal, Shyam; Handa, James T.			Chronic Cigarette Smoke Causes Oxidative Damage and Apoptosis to Retinal Pigmented Epithelial Cells in Mice	PLOS ONE			English	Article								The purpose of this study was to determine whether mice exposed to chronic cigarette smoke develop features of early age-related macular degeneration (AMD). Two month old C57Bl6 mice were exposed to either filtered air or cigarette smoke in a smoking chamber for 5 h/day, 5 days/week for 6 months. Eyes were fixed in 2.5% glutaraldehyde/2% paraformaldehyde and examined for ultrastructural changes by transmission electron microscopy. The contralateral eye was fixed in 2% paraformaldehyde and examined for oxidative injury to the retinal pigmented epithelium (RPE) by 8-oxo-7,8-dihydro-29-deoxyguanosine (8-OHdG) immunolabeling and apoptosis by TUNEL labeling. Mice exposed to cigarette smoke had immunolabeling for 8-OHdG in 85 +/- 63.7% of RPE cells counted compared to 9.5 +/- 63.9% in controls (p < 0.00001). Bruch membrane was thicker in mice exposed to smoke (1086 +/- 332 nm) than those raised in air (543 +/- 132 nm; p = 0.0069). The two most pronounced ultrastructural changes (severity grading scale from 0- 3) seen were a loss of basal infoldings (mean difference in grade = 1.98; p < 0.0001), and an increase in intracellular vacuoles (mean difference in grade = 1.7; p < 0.0001). Ultrastructural changes to Bruch membrane in cigarette-smoke exposed mice were smaller in magnitude but consistently demonstrated significantly higher grade injury in cigarette- exposed mice, including basal laminar deposits (mean difference in grade = 0.54; p, 0.0001), increased outer collagenous layer deposits (mean difference in grade = 0.59; p = 0.002), and increased basal laminar deposit continuity (mean difference in grade = 0.4; p, 0.0001). TUNEL assay showed a higher percentage of apoptotic RPE from mice exposed to cigarette smoke (average 8.0 +/- 1.1%) than room air (average 0 +/- 0%; p = 0.043). Mice exposed to chronic cigarette smoke develop evidence of oxidative damage with ultrastructural degeneration to the RPE and Bruch membrane, and RPE cell apoptosis. This model could be useful for studying the mechanism of smoke induced changes during early AMD.	[Fujihara, Masashi; Nagai, Norihiro; Handa, James T.] Johns Hopkins Sch Med, Wilmer Eye Inst, Baltimore, MD USA; [Sussan, Thomas E.; Biswal, Shyam] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fujihara, M (corresponding author), Johns Hopkins Sch Med, Wilmer Eye Inst, Baltimore, MD USA.	jthanda@jhmi.edu		Sussan, Thomas/0000-0002-5240-4299	QLT, Inc; NIH [EY14005, HL081205]; Thomas Orton Jones Fellowship in Age-related Macular Degeneration; NIH/NHLBI SCCOR [P50HL084945]; Flight Attendant Medical Research Institute; NIEHS [ES07141]; Wilmer Eye Institute [EY01765]; NATIONAL EYE INSTITUTE [P30EY001765, R01EY014005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084945, R01HL081205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER	QLT, Inc; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas Orton Jones Fellowship in Age-related Macular Degeneration; NIH/NHLBI SCCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Flight Attendant Medical Research Institute; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wilmer Eye Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from QLT, Inc., NIH EY14005 to JTH; Thomas Orton Jones Fellowship in Age-related Macular Degeneration (JTH); NIH HL081205, NIH/NHLBI SCCOR grant P50HL084945, research grant from Flight Attendant Medical Research Institute to SB. TES is supported by the NIEHS training grant ES07141; EY01765 (Microscopy Module Core Grant) and Research to Prevent Blindness to the Wilmer Eye Institute; and generous gifts from Ric and Sandy Forsythe, the Kwok family, the Merlau family, and Aleda Wright. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Brown MM, 2005, CAN J OPHTHALMOL, V40, P277, DOI 10.1016/S0008-4182(05)80070-5; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; Cousins SW, 2002, EXP EYE RES, V75, P543, DOI 10.1006/exer.2002.2047; Curcio CA, 1999, ARCH OPHTHALMOL-CHIC, V117, P329, DOI 10.1001/archopht.117.3.329; Del Priore LV, 2002, INVEST OPHTH VIS SCI, V43, P3312; Dithmar S, 2000, INVEST OPHTH VIS SCI, V41, P2035; DRUEKE T, 1990, KIDNEY INT, V37, P1438, DOI 10.1038/ki.1990.134; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; FEENEYBURNS L, 1990, AM J OPHTHALMOL, V109, P265, DOI 10.1016/S0002-9394(14)74549-0; Ferrington DA, 2006, EXP EYE RES, V83, P638, DOI 10.1016/j.exer.2006.03.003; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; GOTTSCH JD, 1993, ARCH OPHTHALMOL-CHIC, V111, P126, DOI 10.1001/archopht.1993.01090010130039; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Hahn P, 2004, P NATL ACAD SCI USA, V101, P13850, DOI 10.1073/pnas.0405146101; Ida H, 2004, INVEST OPHTH VIS SCI, V45, P2348, DOI 10.1167/iovs.03-1337; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kimura K, 2000, AM J OPHTHALMOL, V130, P769, DOI 10.1016/S0002-9394(00)00552-3; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P115, DOI 10.1001/archopht.126.1.115; Leu ST, 2002, EXP EYE RES, V74, P141, DOI 10.1006/exer.2001.1112; LOFFLER KU, 1986, GRAEF ARCH CLIN EXP, V224, P493, DOI 10.1007/BF02154735; Lu L, 2006, J CELL PHYSIOL, V206, P119, DOI 10.1002/jcp.20439; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Mitchell P, 2002, ARCH OPHTHALMOL-CHIC, V120, P1357, DOI 10.1001/archopht.120.10.1357; Moriarty-Craige SE, 2005, AM J OPHTHALMOL, V140, P1020, DOI 10.1016/j.ajo.2005.06.043; NEWSOME DA, 1987, AM J OPHTHALMOL, V104, P373, DOI 10.1016/0002-9394(87)90227-3; OLSEN S, 1989, MEDICINE, V68, P173, DOI 10.1097/00005792-198905000-00005; OLSEN TS, 1986, ULTRASTRUCT PATHOL, V10, P1; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Spraul CW, 1997, ARCH OPHTHALMOL-CHIC, V115, P267, DOI 10.1001/archopht.1997.01100150269022; Spraul CW, 1996, INVEST OPHTH VIS SCI, V37, P2724; Tanaka T, 1997, LAB INVEST, V77, P145; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Toyokuni S, 1997, LAB INVEST, V76, P365; VANDERSCHAFT TL, 1994, GRAEF ARCH CLIN EXP, V232, P40, DOI 10.1007/BF00176436; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Weigel AL, 2002, FREE RADICAL BIO MED, V33, P1419, DOI 10.1016/S0891-5849(02)01082-1	46	114	118	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3119	10.1371/journal.pone.0003119	http://dx.doi.org/10.1371/journal.pone.0003119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769672	Green Published, Green Submitted, gold			2022-12-25	WOS:000264416600007
J	Kamei, H; Lu, L; Jiao, S; Li, Y; Gyrup, C; Laursen, LS; Oxvig, C; Zhou, JF; Duan, CM				Kamei, Hiroyasu; Lu, Ling; Jiao, Shuang; Li, Yun; Gyrup, Claus; Laursen, Lisbeth S.; Oxvig, Claus; Zhou, Jianfeng; Duan, Cunming			Duplication and Diversification of the Hypoxia-Inducible IGFBP-1 Gene in Zebrafish	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-1; A PAPP-A; GENOME DUPLICATION; GROWTH-RETARDATION; HOX CLUSTERS; IGF; EXPRESSION; MUTAGENESIS; RADIATION; ROLES	Background: Gene duplication is the primary force of new gene evolution. Deciphering whether a pair of duplicated genes has evolved divergent functions is often challenging. The zebrafish is uniquely positioned to provide insight into the process of functional gene evolution due to its amenability to genetic and experimental manipulation and because it possess a large number of duplicated genes. Methodology/Principal Findings: We report the identification and characterization of two hypoxia-inducible genes in zebrafish that are co-ortholgs of human IGF binding protein-1 (IGFBP-1). IGFBP-1 is a secreted protein that binds to IGF and modulates IGF actions in somatic growth, development, and aging. Like their human and mouse counterparts, in adult zebrafish igfbp-1a and igfbp-1b are exclusively expressed in the liver. During embryogenesis, the two genes are expressed in overlapping spatial domains but with distinct temporal patterns. While zebrafish IGFBP-1a mRNA was easily detected throughout embryogenesis, IGFBP-1b mRNA was detectable only in advanced stages. Hypoxia induces igfbp-1a expression in early embryogenesis, but induces the igfbp-1b expression later in embryogenesis. Both IGFBP-1a and -b are capable of IGF binding, but IGFBP-1b has much lower affinities for IGF-I and -II because of greater dissociation rates. Overexpression of IGFBP-1a and -1b in zebrafish embryos caused significant decreases in growth and developmental rates. When tested in cultured zebrafish embryonic cells, IGFBP-1a and -1b both inhibited IGF-1-induced cell proliferation but the activity of IGFBP-1b was significantly weaker. Conclusions/Significance: These results indicate subfunction partitioning of the duplicated IGFBP-1 genes at the levels of gene expression, physiological regulation, protein structure, and biological actions. The duplicated IGFBP-1 may provide additional flexibility in fine-tuning IGF signaling activities under hypoxia and other catabolic conditions.	[Kamei, Hiroyasu; Zhou, Jianfeng; Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Lu, Ling; Jiao, Shuang; Li, Yun; Duan, Cunming] Ocean Univ China, Sch Med & Pharm, Lab Mol Med, Qingdao, Peoples R China; [Gyrup, Claus; Laursen, Lisbeth S.; Oxvig, Claus] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus, Denmark	University of Michigan System; University of Michigan; Ocean University of China; Aarhus University	Kamei, H (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	cduan@umich.edu		KAMEI, HIROYASU/0000-0001-7123-040X; Laursen, Lisbeth Schmidt/0000-0002-8676-5869; Oxvig, Claus/0000-0002-4715-9719	NSF [IOB 0110864]; Changjiang Scholars Program [fellowship]	NSF(National Science Foundation (NSF)); Changjiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was supported by NSF Research Grant IOB 0110864 and by a fellowship from the Changjiang Scholars Program.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Ben Lagha N, 2006, ENDOCRINOLOGY, V147, P4730, DOI 10.1210/en.2006-0171; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; Butler AA, 2001, ENDOCRINOLOGY, V142, P1685, DOI 10.1210/en.142.5.1685; Chen BK, 2002, ENDOCRINOLOGY, V143, P1199, DOI 10.1210/en.143.4.1199; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; Cresko WA, 2003, DEV DYNAM, V228, P480, DOI 10.1002/dvdy.10424; Crossey PA, 2002, J CLIN INVEST, V110, P411, DOI 10.1172/JCI200210077; Duan C, 2000, CIRC RES, V86, P15, DOI 10.1161/01.RES.86.1.15; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; EHRENBORG E, 1992, GENOMICS, V12, P497, DOI 10.1016/0888-7543(92)90440-4; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Force A, 1999, GENETICS, V151, P1531; Froment P, 2002, ENDOCRINOLOGY, V143, P1801, DOI 10.1210/en.143.5.1801; Gay E, 1997, ENDOCRINOLOGY, V138, P2937, DOI 10.1210/en.138.7.2937; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hoegg S, 2005, TRENDS GENET, V21, P421, DOI 10.1016/j.tig.2005.06.004; Hukriede N, 2001, GENOME RES, V11, P2127, DOI 10.1101/gr.210601; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kajimura S, 2007, J FISH BIOL, V71, P309, DOI 10.1111/j.1095-8649.2007.01606.x; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Laursen LS, 2002, BIOCHEM J, V367, P31, DOI 10.1042/BJ20020831; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lee PDK, 1997, P SOC EXP BIOL MED, V216, P319; Maures TJ, 2002, ENDOCRINOLOGY, V143, P2722, DOI 10.1210/en.143.7.2722; Ohno S., 1970, P1; Overgaard MT, 2001, J BIOL CHEM, V276, P21849, DOI 10.1074/jbc.M102191200; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; RAJKUMAR K, 1995, ENDOCRINOLOGY, V136, P4029, DOI 10.1210/en.136.9.4029; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shimizu M, 2000, GEN COMP ENDOCR, V119, P26, DOI 10.1006/gcen.2000.7498; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tazuke SI, 1998, P NATL ACAD SCI USA, V95, P10188, DOI 10.1073/pnas.95.17.10188; Watson CS, 2006, ENDOCRINOLOGY, V147, P1175, DOI 10.1210/en.2005-0606; Wood AW, 2005, INT REV CYTOL, V243, P215, DOI 10.1016/S0074-7696(05)43004-1; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhou R, 2003, J ENDOCRINOL, V178, P177, DOI 10.1677/joe.0.1780177	46	79	84	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3091	10.1371/journal.pone.0003091	http://dx.doi.org/10.1371/journal.pone.0003091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769480	Green Published, gold			2022-12-25	WOS:000264796600009
J	Guidobaldi, HA; Teves, ME; Unates, DR; Anastasia, A; Giojalas, LC				Alejandro Guidobaldi, Hector; Eugenia Teves, Maria; Rafael Unates, Diego; Anastasia, Agustin; Cecilia Giojalas, Laura			Progesterone from the Cumulus Cells Is the Sperm Chemoattractant Secreted by the Rabbit Oocyte Cumulus Complex	PLOS ONE			English	Article							FERTILIZING-CAPACITY; HUMAN SPERMATOZOA; FOLLICULAR-FLUID; RECEPTOR; CHEMOTAXIS; BOAR; IDENTIFICATION; AVAILABILITY; PENETRATION; EGGS	Sperm chemotaxis in mammals have been identified towards several female sources as follicular fluid (FF), oviduct fluid, and conditioned medium from the cumulus oophorus (CU) and the oocyte (O). Though several substances were confirmed as sperm chemoattractant, Progesterone (P) seems to be the best chemoattractant candidate, because: 1) spermatozoa express a cell surface P receptor, 2) capacitated spermatozoa are chemotactically attracted in vitro by gradients of low quantities of P; 3) the CU cells produce and secrete P after ovulation; 4) a gradient of P may be kept stable along the CU; and 5) the most probable site for sperm chemotaxis in vivo could be near and/or inside the CU. The aim of this study was to verify whether P is the sperm chemoattractant secreted by the rabbit oocyte-cumulus complex (OCC) in the rabbit, as a mammalian animal model. By means of videomicroscopy and computer image analysis we observed that only the CU are a stable source of sperm attractants. The CU produce and secrete P since the hormone was localized inside these cells by immunocytochemistry and in the conditioned medium by enzyme immunoassay. In addition, rabbit spermatozoa express a cell surface P receptor detected by western blot and localized over the acrosomal region by immunocytochemistry. To confirm that P is the sperm chemoattractant secreted by the CU, the sperm chemotactic response towards the OCC conditioned medium was inhibited by three different approaches: P from the OCC conditioned medium was removed with an anti-P antibody, the attractant gradient of the OCC conditioned medium was disrupted by a P counter gradient, and the sperm P receptor was blocked with a specific antibody. We concluded that only the CU but not the oocyte secretes P, and the latter chemoattract spermatozoa by means of a cell surface receptor. Our findings may be of interest in assisted reproduction procedures in humans, animals of economic importance and endangered species.	[Alejandro Guidobaldi, Hector; Eugenia Teves, Maria; Rafael Unates, Diego; Anastasia, Agustin; Cecilia Giojalas, Laura] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Biol Celular & Mol, RA-5000 Cordoba, Argentina	National University of Cordoba	Guidobaldi, HA (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Biol Celular & Mol, RA-5000 Cordoba, Argentina.	lcgiojalas@com.uncor.edu	Teves, Maria/AAJ-9523-2020; Guidobaldi, Héctor Alejandro/K-6724-2017	Teves, Maria/0000-0001-7035-2202; Guidobaldi, Héctor Alejandro/0000-0002-5033-2981; Anastasia, Agustin/0000-0001-7238-9041; Giojalas, Laura/0000-0002-1036-1251	SECYT-UNC; CONICET; FONCYT (Argentina)	SECYT-UNC(Secretaria de Ciencia y Tecnologia (SECYT)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCYT (Argentina)(FONCyT)	This work was supported by SECYT-UNC, CONICET and FONCYT (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; AITKEN RJ, 1988, J ANDROL, V9, P367; AUSTIN CR, 1982, GERM CELLS FERTILIZA, P46; Baltes P, 1998, ANDROLOGIA, V30, P249; BARAMI S, 1989, BIOL REPROD, V41, P761, DOI 10.1095/biolreprod41.4.761; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; BREDDERMAN PJ, 1964, J REPROD FERTIL, V7, P401, DOI 10.1530/jrf.0.0070401; Calogero AE, 2000, HUM REPROD, V15, P28, DOI 10.1093/humrep/15.suppl_1.28; CHANG MC, 1955, NATURE, V175, P1036, DOI 10.1038/1751036a0; Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1; Chian RC, 1999, FERTIL STERIL, V71, P61, DOI 10.1016/S0015-0282(98)00416-6; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Fabro G, 2002, BIOL REPROD, V67, P1565, DOI 10.1095/biolreprod.102.006395; GIL PI, 2008, ANIMAL REPR IN PRESS; Giojalas LC, 2004, FERTIL STERIL, V82, P247, DOI 10.1016/j.fertnstert.2003.11.046; HANSEN C, 1991, MOL REPROD DEV, V30, P148, DOI 10.1002/mrd.1080300211; HARPER MJK, 1973, BIOL REPROD, V8, P441, DOI 10.1093/biolreprod/8.4.441; HARPER MJK, 1970, J EXP ZOOL, V173, P47, DOI 10.1002/jez.1401730104; HARPER MJK, 1982, GERM CELLS FERTILIZA, P102; HAUSER R, 1992, INT J ANDROL, V15, P498, DOI 10.1111/j.1365-2605.1992.tb01143.x; Jang S, 2005, J ENDOCRINOL, V184, P417, DOI 10.1677/joe.1.05607; Luconi A, 2004, STEROIDS, V69, P553, DOI 10.1016/j.steroids.2004.05.013; Luconi M, 1998, J CLIN ENDOCR METAB, V83, P877, DOI 10.1210/jc.83.3.877; MILLER RL, 1977, ADV INVERTEBRATE REP, P99; Pietrobon EO, 2003, J ANDROL, V24, P612; Pintado B, 2000, J REPROD FERTIL, V118, P145, DOI 10.1530/reprod/118.1.145; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Sabeur K, 1996, BIOL REPROD, V54, P993, DOI 10.1095/biolreprod54.5.993; Schumacher M, 1999, BEHAV BRAIN RES, V105, P37, DOI 10.1016/S0166-4328(99)00081-9; Shah C, 2005, INT J ANDROL, V28, P360, DOI 10.1111/j.1365-2605.2005.00566.x; Sun F, 2005, HUM REPROD, V20, P761, DOI 10.1093/humrep/deh657; Sun F, 2003, DEV BIOL, V255, P423, DOI 10.1016/S0012-1606(02)00090-8; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; VANDERHYDEN BC, 1995, BIOL REPROD, V53, P1243, DOI 10.1095/biolreprod53.6.1243; Wu JT, 2005, REPROD FERT DEVELOP, V17, P733, DOI 10.1071/RD05074; Wu JT, 2006, ANIM REPROD SCI, V93, P34, DOI 10.1016/j.anireprosci.2005.06.007; Yamano S, 2004, FERTIL STERIL, V81, P605, DOI 10.1016/j.fertnstert.2003.07.036; Yamashita Y, 2003, BIOL REPROD, V68, P1193, DOI 10.1095/biolreprod.102.010934	39	100	102	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3040	10.1371/journal.pone.0003040	http://dx.doi.org/10.1371/journal.pone.0003040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725941	gold, Green Submitted, Green Published			2022-12-25	WOS:000264428800006
J	Barcia, C; Sanderson, NR; Barrett, RJ; Wawrowsky, K; Kroeger, KM; Puntel, M; Liu, CY; Castro, MG; Lowenstein, PR				Barcia, Carlos; Sanderson, NicholasS. R.; Barrett, Robert J.; Wawrowsky, Kolja; Kroeger, Kurt M.; Puntel, Mariana; Liu, Chunyan; Castro, Maria G.; Lowenstein, Pedro R.			T Cells' Immunological Synapses Induce Polarization of Brain Astrocytes In Vivo and In Vitro: A Novel Astrocyte Response Mechanism to Cellular Injury	PLOS ONE			English	Article								Background: Astrocytes usually respond to trauma, stroke, or neurodegeneration by undergoing cellular hypertrophy, yet, their response to a specific immune attack by T cells is poorly understood. Effector T cells establish specific contacts with target cells, known as immunological synapses, during clearance of virally infected cells from the brain. Immunological synapses mediate intercellular communication between T cells and target cells, both in vitro and in vivo. How target virally infected astrocytes respond to the formation of immunological synapses established by effector T cells is unknown. Findings: Herein we demonstrate that, as a consequence of T cell attack, infected astrocytes undergo dramatic morphological changes. From normally multipolar cells, they become unipolar, extending a major protrusion towards the immunological synapse formed by the effector T cells, and withdrawing most of their finer processes. Thus, target astrocytes become polarized towards the contacting T cells. The MTOC, the organizer of cell polarity, is localized to the base of the protrusion, and Golgi stacks are distributed throughout the protrusion, reaching distally towards the immunological synapse. Thus, rather than causing astrocyte hypertrophy, antiviral T cells cause a major structural reorganization of target virally infected astrocytes. Conclusions: Astrocyte polarization, as opposed to hypertrophy, in response to T cell attack may be due to T cells providing a very focused attack, and thus, astrocytes responding in a polarized manner. A similar polarization of Golgi stacks towards contacting T cells was also detected using an in vitro allogeneic model. Thus, different T cells are able to induce polarization of target astrocytes. Polarization of target astrocytes in response to immunological synapses may play an important role in regulating the outcome of the response of astrocytes to attacking effector T cells, whether during antiviral (e. g. infected during HIV, HTLV-1, HSV-1 or LCMV infection), anti-transplant, autoimmune, or anti-tumor immune responses in vivo and in vitro.	[Barcia, Carlos; Sanderson, NicholasS. R.; Barrett, Robert J.; Kroeger, Kurt M.; Puntel, Mariana; Liu, Chunyan; Castro, Maria G.; Lowenstein, Pedro R.] Cedars Sinai Med Ctr, Dept Med, Board Governors Gene Therapeut Res Inst, Los Angeles, CA 90048 USA; [Barcia, Carlos; Sanderson, NicholasS. R.; Barrett, Robert J.; Kroeger, Kurt M.; Puntel, Mariana; Liu, Chunyan; Castro, Maria G.; Lowenstein, Pedro R.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehensive Canc Ctr, Brain Res Inst, Dept Med, Los Angeles, CA 90024 USA; [Barcia, Carlos; Sanderson, NicholasS. R.; Barrett, Robert J.; Kroeger, Kurt M.; Puntel, Mariana; Liu, Chunyan; Castro, Maria G.; Lowenstein, Pedro R.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehensive Canc Ctr, Brain Res Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Wawrowsky, Kolja] Cedars Sinai Med Ctr, Dept Endocrinol, Los Angeles, CA USA	Cedars Sinai Medical Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	Barcia, C (corresponding author), Cedars Sinai Med Ctr, Dept Med, Board Governors Gene Therapeut Res Inst, Los Angeles, CA 90048 USA.	lowensteinp@cshs.org	Castro, Maria/ABC-5182-2021; sanderson, nicholas/GQH-2848-2022; Barrett, Robert/AAG-1941-2021; Barcia, Carlos/I-8205-2014	Castro, Maria/0000-0003-2237-2756; sanderson, nicholas/0000-0003-1711-7275; Barcia, Carlos/0000-0003-0976-4245	National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS) [1R01 NS44556.01, NS445561.01, 1R21-NSO54143.01, 1UO1 NS052465.01, 1 RO3 TW006273-01, 1 RO1 NS 054193.01, RO1 NS 42893.01, 1 R01 NS06117-01, U54 NS045309-01, 1R21 NS047298-01]; Medallions Group Endowed Chairs in Gene Therapeutics; The Linda Tallen & David Paul Kane Foundation; Board of Governors at CSMC; FOGARTY INTERNATIONAL CENTER [R03TW006273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044556, R01NS054193, R21NS047298, U54NS045309, R01NS042893, R01NS061107, U01NS052465] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medallions Group Endowed Chairs in Gene Therapeutics; The Linda Tallen & David Paul Kane Foundation; Board of Governors at CSMC; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS) Grant 1R01 NS44556.01, Minority Supplement NS445561.01; 1R21-NSO54143.01; 1UO1 NS052465.01, 1 RO3 TW006273-01 to M.G.C.; NIH/NINDS Grants 1 RO1 NS 054193.01; RO1 NS 42893.01, 1 R01 NS06117-01, U54 NS045309-01 and 1R21 NS047298-01 to P.R.L.. The Bram and Elaine Goldsmith and the Medallions Group Endowed Chairs in Gene Therapeutics to PRL and MGC, respectively, The Linda Tallen & David Paul Kane Foundation Annual Fellowship and the Board of Governors at CSMC.	Barcia C, 2008, J IMMUNOL, V180, P1344, DOI 10.4049/jimmunol.180.3.1344; Barcia C, 2007, MOL THER, V15, P2154, DOI 10.1038/sj.mt.6300305; Barcia C, 2006, NEURON GLIA BIOL, V2, P309, DOI 10.1017/S1740925X07000579; Barcia C, 2006, J EXP MED, V203, P2095, DOI 10.1084/jem.20060420; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Chvatal A, 2007, J ANAT, V210, P671, DOI 10.1111/j.1469-7580.2007.00724.x; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Dewey RA, 1999, NAT MED, V5, P1256, DOI 10.1038/15207; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 2005, SEMIN IMMUNOL, V17, P400, DOI 10.1016/j.smim.2005.09.002; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2006, METHOD ENZYMOL, V406, P565, DOI 10.1016/S0076-6879(06)06044-7; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; FURER M, 1993, CELL ADHES COMMUN, V1, P223, DOI 10.3109/15419069309097256; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; KAIZUKA Y, 2007, P NATL ACAD SCI US; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lettau M, 2006, P NATL ACAD SCI USA, V103, P5911, DOI 10.1073/pnas.0508562103; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; O'Keefe JP, 2005, J IMMUNOL, V175, P5581, DOI 10.4049/jimmunol.175.9.5581; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rey M, 2007, FRONT BIOSCI-LANDMRK, V12, P437, DOI 10.2741/2073; Sattler R, 2006, HANDB EXP PHARM, V175, P277; Shi L, 2005, J IMMUNOL, V174, P5456, DOI 10.4049/jimmunol.174.9.5456; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Southgate TD, 1999, METAB BRAIN DIS, V14, P205, DOI 10.1023/A:1020728924026; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Taner SB, 2004, TRAFFIC, V5, P651, DOI 10.1111/j.1600-0854.2004.00214.x; Thomas CE, 2000, P NATL ACAD SCI USA, V97, P7482, DOI 10.1073/pnas.120474397; Trautmann A, 2003, CURR OPIN IMMUNOL, V15, P249, DOI 10.1016/S0952-7915(03)00040-2; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; XIA P, 2008, CELL RES; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	69	44	45	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2977	10.1371/journal.pone.0002977	http://dx.doi.org/10.1371/journal.pone.0002977			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714338	Green Submitted, gold, Green Published			2022-12-25	WOS:000264420900004
J	Singaravelan, N; Grishkan, I; Beharav, A; Wakamatsu, K; Ito, S; Nevo, E				Singaravelan, Natarajan; Grishkan, Isabella; Beharav, Alex; Wakamatsu, Kazumasa; Ito, Shosuke; Nevo, Eviatar			Adaptive Melanin Response of the Soil Fungus Aspergillus niger to UV Radiation Stress at "Evolution Canyon'', Mount Carmel, Israel	PLOS ONE			English	Article							B RADIATION; ULTRAVIOLET; ADAPTATION; DECOMPOSITION; BIOSYNTHESIS; BIODIVERSITY; LITTER; COLOR	Background: Adaptation is an evolutionary process in which traits in a population are tailored by natural selection to better meet the challenges presented by the local environment. The major discussion relating to natural selection concerns the portraying of the cause and effect relationship between a presumably adaptive trait and selection agents generating it. Therefore, it is necessary to identify trait(s) that evolve in direct response to selection, enhancing the organism's fitness. "Evolution Canyon'' (EC) in Israel mirrors a microcosmic evolutionary system across life and is ideal to study natural selection and local adaptation under sharply, microclimatically divergent environments. The south-facing, tropical, sunny and xeric "African'' slope (AS) receives 200%-800% higher solar radiation than the north-facing, temperate, shady and mesic "European'' slope (ES), 200 meters apart. Thus, solar ultraviolet radiation (UVR) is a major selection agent in EC influencing the organism-environment interaction. Melanin is a trait postulated to have evolved for UV-screening in microorganisms. Here we investigate the cause and effect relationship between differential UVR on the opposing slopes of EC and the conidial melanin concentration of the filamentous soil fungus Aspergillus niger. We test the working hypothesis that the AS strains exhibit higher melanin content than strains from the ES resulting in higher UV resistance. Methodology/Principal Findings: We measured conidial melanin concentration of 80 strains from the EC using a spectrophotometer. The results indicated that mean conidial melanin concentration of AS strains were threefold higher than ES strains and the former resisted UVA irradiation better than the latter. Comparisons of melanin in the conidia of A. niger strains from sunny and shady microniches on the predominantly sunny AS and predominantly shady ES indicated that shady conditions on the AS have no influence on the selection on melanin; in contrast, the sunny strains from the ES displayed higher melanin concentrations. Conclusions/Significance: We conclude that melanin in A. niger is an adaptive trait against UVR generated by natural selection.	[Singaravelan, Natarajan; Grishkan, Isabella; Beharav, Alex; Nevo, Eviatar] Univ Haifa, Inst Evolut, Har Hakarmel, Israel; [Wakamatsu, Kazumasa; Ito, Shosuke] Fujita Hlth Univ, Sch Hlth Sci, Toyoake, Aichi, Japan	University of Haifa; Fujita Health University	Singaravelan, N (corresponding author), Univ Haifa, Inst Evolut, Har Hakarmel, Israel.	nevo@research.haifa.ac.il	Wakamatsu, Kazumasa/AAZ-5877-2020	Wakamatsu, Kazumasa/0000-0003-1748-9001; Ito, Shosuke/0000-0001-9182-5144	Ancell Teicher Research Foundation for Genetics and Molecular Evolution; Israel Discount BankChair of Evolutionary Biology; Japan Society for the Promotion of Science (JSPS) [20591357]; University of Haifa [postdoctoral fellowship]; Council of Higher Education, Israel	Ancell Teicher Research Foundation for Genetics and Molecular Evolution; Israel Discount BankChair of Evolutionary Biology; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Haifa; Council of Higher Education, Israel	EN acknowledges the financial support of the Ancell Teicher Research Foundation for Genetics and Molecular Evolution, and the Israel Discount BankChair of Evolutionary Biology. KW & SI acknowledge the funding support by Japan Society for the Promotion of Science (JSPS) KAKENHI (No. 20591357). NS acknowledges postdoctoral fellowship support by University of Haifa and Council of Higher Education, Israel.	Anderson TH., 1980, COMPENDIUM SOIL FUNG, V1; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; BOS CJ, 1988, MUTAT RES, V197, P67, DOI 10.1016/0027-5107(88)90141-8; Braga GUL, 2001, PHOTOCHEM PHOTOBIOL, V74, P734, DOI 10.1562/0031-8655(2001)074&lt;0734:BSUAUR&gt;2.0.CO;2; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; Christensen M., 1981, FUNGAL COMMUNITY ITS, P201; Ciccarone C., 1998, Plant Biosystems, V132, P17; Cockell CS, 1999, BIOL REV, V74, P311, DOI 10.1017/S0006323199005356; Darwin, ORIGIN SPECIES MEANS; Davet P, 2000, DETECTION ISOLATION; GEHRKE C, 1995, OIKOS, V72, P213, DOI 10.2307/3546223; Goncalves RDR, 2005, BIOL PHARM BULL, V28, P1129, DOI 10.1248/bpb.28.1129; Grishkan I, 2008, BIOL J LINN SOC, V93, P157, DOI 10.1111/j.1095-8312.2007.00918.x; Gunasekera TS, 1997, PLANT PATHOL, V46, P179, DOI 10.1046/j.1365-3059.1997.d01-216.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hughes KA, 2003, APPL ENVIRON MICROB, V69, P1488, DOI 10.1128/AEM.69.3.1488-1491.2003; IGNOFFO CM, 1992, ENVIRON ENTOMOL, V21, P913, DOI 10.1093/ee/21.4.913; Klich MA, 2002, MYCOLOGIA, V94, P21, DOI 10.2307/3761842; Kuluncsics Z, 1999, J PHOTOCH PHOTOBIO B, V49, P71, DOI 10.1016/S1011-1344(99)00034-2; LAMB BC, 1992, GENET LIFE SCI ADV, V11, P153; Majerus M, 1998, MELANISM EVOLUTION A; Moody SA, 1999, MYCOL RES, V103, P1469, DOI 10.1017/S0953756299008783; Nevo E, 1999, ISR J PLANT SCI, V47, P49, DOI 10.1080/07929978.1999.10676751; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 1998, CATENA, V33, P241, DOI 10.1016/S0341-8162(98)00071-X; Nevo E, 2006, ISR J ECOL EVOL, V52, P485; Newsham KK, 1997, OIKOS, V79, P592, DOI 10.2307/3546903; OZEKI H, 1995, J INVEST DERMATOL, V105, P361, DOI 10.1111/1523-1747.ep12320792; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; PROTA G, 1992, MELANINS MELANOGENES, P290; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; RAY AC, 1975, APPL MICROBIOL, V30, P909, DOI 10.1128/AEM.30.6.909-915.1975; REEVE HK, 1993, Q REV BIOL, V68, P1, DOI 10.1086/417909; ROTEM J, 1985, PHYTOPATHOLOGY, V75, P510, DOI 10.1094/Phyto-75-510; Samson RA, 2006, MED MYCOL, V44, pS133, DOI 10.1080/13693780600913224; Sikorski J, 2005, P NATL ACAD SCI USA, V102, P15924, DOI 10.1073/pnas.0507944102; *SURV ISR, 1985, ATL ISR; Wasser, 2001, SOIL MICROFUNGI ISRA; Williams G. C., 1966, P307; Zhdanova NN, 1988, MELANIN CONTAINING F	41	88	93	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2993	10.1371/journal.pone.0002993	http://dx.doi.org/10.1371/journal.pone.0002993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714346	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900019
J	Shi, CS; Kehrl, JH				Shi, Chong-Shan; Kehrl, John H.			MyD88 and Trif Target Beclin 1 to Trigger Autophagy in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; ADAPTIVE IMMUNITY; SIGNALING PATHWAYS; DENDRITIC CELLS; INNATE IMMUNITY; CUTTING EDGE; DOMAIN; PROTEINS; FAMILY; TOLL-LIKE-RECEPTOR-4	The Toll-like receptors (TLR) play an instructive role in innate and adaptive immunity by recognizing specific molecular patterns from pathogens. Autophagy removes intracellular pathogens and participates in antigen presentation. Here, we demonstrate that not only TLR4, but also other TLR family members induce autophagy in macrophages, which is inhibited by MyD88, Trif, or Beclin 1 shRNA expression. MyD88 and Trif co-immunoprecipitate with Beclin 1, a key factor in autophagosome formation. TLR signaling enhances the interaction of MyD88 and Trif with Beclin 1, and reduces the binding of Beclin 1 to Bcl-2. These findings indicate TLR signaling via its adaptor proteins reduces the binding of Beclin 1 to Bcl-2 by recruiting Beclin 1 into the TLR-signaling complex leading to autophagy.	[Shi, Chong-Shan; Kehrl, John H.] NIAID, B Cell Mol Immunol Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shi, CS (corresponding author), Bldg 10,Rm 11B08,10 Ctr Dr,MSC 1876, Bethesda, MD 20892 USA.	cshi@niaid.nih.gov; kehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000739, Z01AI000739] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	30	291	306	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33175	33182		10.1074/jbc.M804478200	http://dx.doi.org/10.1074/jbc.M804478200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18772134	Green Published, hybrid			2022-12-25	WOS:000261183700020
J	Baraibar, MA; Barbeito, AG; Muhoberac, BB; Vidal, R				Baraibar, Martin A.; Barbeito, Ana G.; Muhoberac, Barry B.; Vidal, Ruben			Iron-mediated Aggregation and a Localized Structural Change Characterize Ferritin from a Mutant Light Chain Polypeptide That Causes Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; RECOMBINANT HUMAN H; HEREDITARY FERRITINOPATHY; CONFORMATIONAL-CHANGE; THERMAL-STABILITY; MUTATION; NEUROFERRITINOPATHY; EXPRESSION; DICHROWEB; TERMINUS	Nucleotide insertions in the ferritin light chain (FTL) polypeptide gene cause hereditary ferritinopathy, a neurodegenerative disease characterized by abnormal accumulation of ferritin and iron in the central nervous system. Here we describe for the first time the protein structure and iron storage function of the FTL mutant p. Phe167SerfsX26 (MT-FTL), which has a C terminus altered in sequence and extended in length. MT-FTL polypeptides assembled spontaneously into soluble, spherical 24-mers that were ultrastructurally indistinguishable from those of the wild type. Far-UV CD showed a decrease in alpha-helical content, and 8-anilino-1- naphthalenesulfonate fluorescence revealed the appearance of hydrophobic binding sites. Near-UV CD and proteolysis studies suggested little or no structural alteration outside of the C-terminal region. In contrast to wild type, MT-FTL homopolymers precipitated at much lower iron loading, had a diminished capacity to incorporate iron, and were less thermostable. However, precipitation was significantly reversed by addition of iron chelators both in vitro and in vivo. Our results reveal substantial protein conformational changes localized at the 4-fold pore of MT-FTL homopolymers and imply that the C terminus of the MT-FTL polypeptide plays an important role in ferritin solubility, stability, and iron management. We propose that the protrusion of some portion of the C terminus above the spherical shell allows it to cross-link with other mutant polypeptides through iron bridging, leading to enhanced mutant precipitation by iron. Our data suggest that hereditary ferritinopathy pathogenesis is likely to result from a combination of reduction in iron storage function and enhanced toxicity associated with iron-induced ferritin aggregates.	[Baraibar, Martin A.; Barbeito, Ana G.; Vidal, Ruben] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Muhoberac, Barry B.] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Vidal, R (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, 635 Barnhill Dr,MSB A136, Indianapolis, IN 46202 USA.	rvidal@iupui.edu			National Institutes of Health [NS050227]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS050227 (to R. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; Bou-Abdallah F, 2002, BIOCHEMISTRY-US, V41, P11184, DOI 10.1021/bi020215g; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Cozzi A, 2006, NEUROBIOL DIS, V23, P644, DOI 10.1016/j.nbd.2006.05.004; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; FONTANA A, 1986, BIOCHEMISTRY-US, V25, P1847, DOI 10.1021/bi00356a001; Granier T, 2001, ACTA CRYSTALLOGR D, V57, P1491, DOI 10.1107/S0907444901008897; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Ingrassia R, 2006, J BIOCHEM, V139, P881, DOI 10.1093/jb/mvj101; JAPPELLI R, 1992, J MOL BIOL, V227, P532, DOI 10.1016/0022-2836(92)90905-Y; Jappelli R, 1998, BIOCHEM BIOPH RES CO, V250, P342, DOI 10.1006/bbrc.1998.9317; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kim SW, 2001, BIOCHEM BIOPH RES CO, V289, P125, DOI 10.1006/bbrc.2001.5931; LEVI S, 1989, BIOCHEMISTRY-US, V28, P5179, DOI 10.1021/bi00438a040; LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325; LEVI S, 1988, J BIOL CHEM, V263, P18086; LEVI S, 1989, BIOCHEM J, V264, P381, DOI 10.1042/bj2640381; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LUZZAGO A, 1989, EMBO J, V8, P569, DOI 10.1002/j.1460-2075.1989.tb03411.x; Maciel P, 2005, NEUROLOGY, V65, P603, DOI 10.1212/01.wnl.0000178224.81169.c2; Mancuso M, 2005, J NEUROPATH EXP NEUR, V64, P280, DOI 10.1093/jnen/64.4.280; Martsev SP, 1998, PROTEIN ENG, V11, P377, DOI 10.1093/protein/11.5.377; Ohta E, 2008, NEUROLOGY, V70, P1493, DOI 10.1212/01.wnl.0000310428.74624.95; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Saneto RP., 1987, NEUROCHEMISTRY PRACT, P27; SANTAMBROGIO P, 1992, J BIOL CHEM, V267, P14077; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; Santambrogio P, 2000, PROTEIN EXPRES PURIF, V19, P212, DOI 10.1006/prep.2000.1212; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stefanini S, 1996, ARCH BIOCHEM BIOPHYS, V325, P58, DOI 10.1006/abbi.1996.0007; Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S; Theil EC, 2006, J BIOL INORG CHEM, V11, P803, DOI 10.1007/s00775-006-0125-6; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P363, DOI 10.1093/jnen/63.4.363; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P787, DOI 10.1093/jnen/63.8.787; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WOLZ RL, 1990, ANAL BIOCHEM, V191, P314; YANG DW, 1994, BBA-PROTEIN STRUCT M, V1206, P173, DOI 10.1016/0167-4838(94)90205-4	47	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31679	31689		10.1074/jbc.M805532200	http://dx.doi.org/10.1074/jbc.M805532200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18755684	Green Published, hybrid			2022-12-25	WOS:000260760800050
J	Park, JI; Semyonov, J; Yi, W; Chang, CL; Hsu, SYT				Park, Jae-Il; Semyonov, Jenia; Yi, Wei; Chang, Chia Lin; Hsu, Sheau Yu Teddy			Regulation of Receptor Signaling by Relaxin A Chain Motifs DERIVATION OF PAN-SPECIFIC AND LGR7-SPECIFIC HUMAN RELAXIN ANALOGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN RELAXIN; INSULIN-LIKE PEPTIDE; A-CHAIN; FAMILY PEPTIDES; BINDING SITE; FACTOR RLF; IDENTIFICATION; MEMBER; GENE; TESTIS	Relaxin peptides are important hormones for the regulation of reproductive tissue remodeling and the renal cardiovascular system during pregnancy. Recent studies demonstrated that two of the seven human relaxin family peptides, relaxin H2 (RLN2) and INSL3, signal exclusively through leucine-rich repeat-containing G protein-coupled receptors, LGR7 and LGR8. Although it was well characterized that an RXXXRXXI motif at the RLN2 B chain confers receptor activation activity, it is not clear what roles RLN2 A chain plays in receptor interaction. Analyses of relaxin family genes on syntenic regions of model tetrapods showed that the A chain of RLN2 orthologs exhibited a greater sequence divergence as compared with the receptor-binding domain-containing B chain, foreshadowing a potential role in receptor interactions; hence, defining receptor selectivity in this fast evolving peptide hormone. To test our hypothesis that select residues in the human RLN2 A chain play key roles in receptor interaction, we studied mutant peptides with residue substitution(s) in the A chain. Here, we showed that alanine substitution at the A16 and A17 positions enhances LGR8-activation activity of RLN2, whereas mutation at the A22-23 region (RLN2(A22-23)) ablates LGR8, but not LGR7, activation activity. In addition, we demonstrated that the functional characteristics of the RLN2(A22-23) mutant are mainly attributed to modifications at the Phe(A23) position. Taken together, our studies indicated that Thr(A16), Lys(A17), and Phe(A23) constitute part of the receptor-binding interface of human RLN2, and that modification of these residues has led to the generation of novel human RLN2 analogs that would allow selective activation of human LGR7, but not LGR8, in vivo.	[Park, Jae-Il; Semyonov, Jenia; Yi, Wei; Hsu, Sheau Yu Teddy] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Reprod Biol & Stem Cell Res Program, Stanford, CA 94305 USA; [Chang, Chia Lin] Chang Gung Univ, Sch Med, Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan, Taiwan	Stanford University; Chang Gung Memorial Hospital; Chang Gung University	Hsu, SYT (corresponding author), 300 Pasteur Dr,Rm A344D, Stanford, CA 94305 USA.	teddyhsu@stanford.edu			National Institutes of Health [R21 HD47606]; March of Dimes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD031398, R21HD047606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 HD47606 (to S. Y. H.). This work was also supported by a March of Dimes research grant (to S. Y. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adham IM, 2000, MOL CELL ENDOCRINOL, V160, P11, DOI 10.1016/S0303-7207(99)00188-4; Adham IM, 2002, MOL ENDOCRINOL, V16, P244, DOI 10.1210/me.16.2.244; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; Bogatcheva NV, 2003, MOL ENDOCRINOL, V17, P2639, DOI 10.1210/me.2003-0096; BULLESBACH EE, 1992, J BIOL CHEM, V267, P22957; BULLESBACH EE, 1991, J BIOL CHEM, V266, P10754; BULLESBACH EE, 1987, J BIOL CHEM, V262, P12496; Bullesbach EE, 2005, J BIOL CHEM, V280, P14051, DOI 10.1074/jbc.M500030200; Bullesbach EE, 1999, J BIOL CHEM, V274, P22354, DOI 10.1074/jbc.274.32.22354; BULLESBACH EE, 1986, BIOCHEMISTRY-US, V25, P5998; Bullesbach EE, 1999, BIOCHEMISTRY-US, V38, P3073, DOI 10.1021/bi982687u; BULLESBACH EE, 1994, J BIOL CHEM, V269, P13124; Bullesbach EE, 2006, J BIOL CHEM, V281, P26136, DOI 10.1074/jbc.M601414200; CHASSIN D, 1995, GENOMICS, V29, P465, DOI 10.1006/geno.1995.9980; CHEN SA, 1993, PHARMACEUT RES, V10, P834, DOI 10.1023/A:1018901009062; Conklin D, 1999, GENOMICS, V60, P50, DOI 10.1006/geno.1999.5899; Dawson NF, 1999, J PEPT RES, V53, P542, DOI 10.1034/j.1399-3011.1999.00060.x; Dschietzig T, 2006, PHARMACOL THERAPEUT, V112, P38, DOI 10.1016/j.pharmthera.2006.03.004; EIGENBROT C, 1991, J MOL BIOL, V221, P15, DOI 10.1016/0022-2836(91)90796-9; Feng S, 2005, ANN NY ACAD SCI, V1041, P82, DOI 10.1196/annals.1282.012; Fu P, 2004, J PEPT RES, V63, P91, DOI 10.1111/j.1399-3011.2003.00118.x; Furst Daniel E., 1998, Current Opinion in Rheumatology, V10, P123, DOI 10.1097/00002281-199803000-00007; Ganesh S, 2007, CANCER RES, V67, P4399, DOI 10.1158/0008-5472.CAN-06-4260; Halls ML, 2005, J PHARMACOL EXP THER, V313, P677, DOI 10.1124/jpet.104.080655; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hsu SY, 1999, MOL ENDOCRINOL, V13, P2163, DOI 10.1210/me.13.12.2163; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Ivell R, 2002, BIOL REPROD, V67, P699, DOI 10.1095/biolreprod.102.005199; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; Kim JH, 2006, JNCI-J NATL CANCER I, V98, P1482, DOI 10.1093/jnci/djj397; Koskimies P, 2003, MOL CELL ENDOCRINOL, V206, P159, DOI 10.1016/S0303-7207(02)00425-2; Krajnc-Franken MAM, 2004, MOL CELL BIOL, V24, P687, DOI 10.1128/MCB.24.2.687-696.2004; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Lee HC, 2000, NATURE, V408, P483, DOI 10.1038/35044106; Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; Lok S, 2000, BIOL REPROD, V62, P1593, DOI 10.1095/biolreprod62.6.1593; MARRIOTT D, 1992, MOL ENDOCRINOL, V6, P1441, DOI 10.1210/me.6.9.1441; Martz E, 2002, TRENDS BIOCHEM SCI, V27, P107, DOI 10.1016/S0968-0004(01)02008-4; Nef S, 2000, GENE DEV, V14, P3075, DOI 10.1101/gad.843800; Park JI, 2008, GENOME RES, V18, P974, DOI 10.1101/gr.7119108; Park JI, 2005, REV ENDOCR METAB DIS, V6, P291, DOI 10.1007/s11154-005-6187-x; Rosengren KJ, 2006, J BIOL CHEM, V281, P28287, DOI 10.1074/jbc.M603829200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seibold JR, 2000, ANN INTERN MED, V132, P871, DOI 10.7326/0003-4819-132-11-200006060-00004; Sherwood O D, 1993, Oxf Rev Reprod Biol, V15, P143; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Spanel-Borowski K, 2001, MOL REPROD DEV, V58, P281, DOI 10.1002/1098-2795(200103)58:3&lt;281::AID-MRD6&gt;3.0.CO;2-0; STEWART D, 2006, SOC STUD REPR 39 ANN; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Tan YY, 1999, BRIT J PHARMACOL, V127, P91, DOI 10.1038/sj.bjp.0702517; Weiss G, 2001, FRONT HORM RES, V27, P105; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; Zarreh-Hoshyari-Khah R, 2001, REGUL PEPTIDES, V97, P139, DOI 10.1016/S0167-0115(00)00205-6; Zhao L, 2000, BIOL REPROD, V63, P697, DOI 10.1095/biolreprod63.3.697; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445	60	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32099	32109		10.1074/jbc.M806817200	http://dx.doi.org/10.1074/jbc.M806817200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18772127	Green Published, hybrid			2022-12-25	WOS:000260760800091
J	Garcia-Pino, A; Christensen-Dalsgaard, M; Wyns, L; Yarmolinsky, M; Magnuson, RD; Gerdes, K; Loris, R				Garcia-Pino, Abel; Christensen-Dalsgaard, Mikkel; Wyns, Lode; Yarmolinsky, Michael; Magnuson, Roy David; Gerdes, Kenn; Loris, Remy			Doc of Prophage P1 Is Inhibited by Its Antitoxin Partner Phd through Fold Complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMID ADDICTION SYSTEM; PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MESSENGER-RNAS; CYCLIC-AMP; TOXIN; PROTEIN; ANTIDOTE	Prokaryotic toxin-antitoxin modules are involved in major physiological events set in motion under stress conditions. The toxin Doc (death on curing) from the phd/doc module on phage P1 hosts the C-terminal domain of its antitoxin partner Phd (prevents host death) through fold complementation. This Phd domain is intrinsically disordered in solution and folds into an alpha-helix upon binding to Doc. The details of the interactions reveal the molecular basis for the inhibitory action of the antitoxin. The complex resembles the Fic (filamentation induced by cAMP) proteins and suggests a possible evolutionary origin for the phd/doc operon. Doc induces growth arrest of Escherichia coli cells in a reversible manner, by targeting the protein synthesis machinery. Moreover, Doc activates the endogenous E. coli RelE mRNA interferase but does not require this or any other known chromosomal toxin-antitoxin locus for its action in vivo.	[Garcia-Pino, Abel; Wyns, Lode; Loris, Remy] Vrije Univ Brussel, Lab Ultrastruct, B-1050 Brussels, Belgium; [Garcia-Pino, Abel; Wyns, Lode; Loris, Remy] Vlaams Interuniv Inst Biotechnol VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Christensen-Dalsgaard, Mikkel; Gerdes, Kenn] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Christensen-Dalsgaard, Mikkel] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Yarmolinsky, Michael] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Magnuson, Roy David] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Newcastle University - UK; University of Southern Denmark; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Alabama System; University of Alabama Huntsville	Loris, R (corresponding author), Vrije Univ Brussel, Lab Ultrastruct, Pl Laan 2, B-1050 Brussels, Belgium.	reloris@vub.ac.be	Loris, Remy/GPG-0894-2022; Gerdes, Kenn/AAS-5548-2021; Gerdes, Kenn/M-2420-2014	Gerdes, Kenn/0000-0002-7462-4612; Gerdes, Kenn/0000-0002-7462-4612; Loris, Remy/0000-0002-8862-3338; Garcia-Pino, Abel/0000-0002-0634-0300	National Institutes of Health [2 R15 GM67668-03]; National Institutes of Health Intramural Research Training Award; VIB; Fonds voor Wetenschappelijk Onderzoek Vlaanderen; Centre for mRNP Biogenesis and Metabolism of the Danish National Research Foundation; Onderzoeksraad of the Vrije Universiteit Brussel; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM067668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Intramural Research Training Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VIB; Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Centre for mRNP Biogenesis and Metabolism of the Danish National Research Foundation(Danmarks Grundforskningsfond); Onderzoeksraad of the Vrije Universiteit Brussel; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 R15 GM67668-03 from the NIGMS (to R. D. M.) and a National Institutes of Health Intramural Research Training Award grant. This work was also supported by grants from the VIB, the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, the Centre for mRNP Biogenesis and Metabolism of the Danish National Research Foundation, and the Onderzoeksraad of the Vrije Universiteit Brussel. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gazit E, 1999, J BIOL CHEM, V274, P16813, DOI 10.1074/jbc.274.24.16813; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Hazan R, 2001, J BACTERIOL, V183, P2046, DOI 10.1128/JB.183.6.2046-2050.2001; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; KAWAMUKAI M, 1989, J BACTERIOL, V171, P4525, DOI 10.1128/JB.171.8.4525-4529.1989; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Loris R, 2003, J BIOL CHEM, V278, P28252, DOI 10.1074/jbc.M302336200; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Magnuson P, 1996, J BIOL CHEM, V271, P18705, DOI 10.1074/jbc.271.31.18705; Magnuson R, 1998, J BACTERIOL, V180, P6342; Marti-Renom MA, 2004, PROTEIN SCI, V13, P1071, DOI 10.1110/ps.03379804; McKinley JE, 2005, J BACTERIOL, V187, P765, DOI 10.1128/JB.187.2.765-770.2005; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Smith JA, 2004, J BACTERIOL, V186, P2692, DOI 10.1128/JB.186.9.2692-2698.2004; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; UTSUMI R, 1982, J BACTERIOL, V151, P807, DOI 10.1128/JB.151.2.807-812.1982; Watson JD, 2002, J MOL BIOL, V315, P171, DOI 10.1006/jmbi.2001.5227; Yan YW, 1998, PROTEIN SCI, V7, P837; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	40	88	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30821	30827		10.1074/jbc.M805654200	http://dx.doi.org/10.1074/jbc.M805654200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18757857	Green Published, hybrid			2022-12-25	WOS:000260544800037
J	Tomasinsig, L; Pizzirani, C; Skerlavaj, B; Pellegatti, P; Gulinelli, S; Tossi, A; Di Virgilio, F; Zanetti, M				Tomasinsig, Linda; Pizzirani, Cinzia; Skerlavaj, Barbara; Pellegatti, Patrizia; Gulinelli, Sara; Tossi, Alessandro; Di Virgilio, Francesco; Zanetti, Margherita			The Human Cathelicidin LL-37 Modulates the Activities of the P2X(7) Receptor in a Structure-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDE LL-37; IN-VITRO; KERATINOCYTE MIGRATION; NUCLEOTIDE RECEPTOR; EXTRACELLULAR ATP; MICROGLIAL CELLS; EPITHELIAL-CELLS; PORE FORMATION; GROWTH-FACTOR; ACTIVATION	Extracellular ATP, released at sites of inflammation or tissue damage, activates the P2X(7) receptor, which in turn triggers a range of responses also including cell proliferation. In this study the ability of the human cathelicidin LL-37 to stimulate fibroblast growth was inhibited by commonly used P2X(7) blockers. We investigated the structural requirements of the growth-promoting activity of LL-37 and found that it did not depend on helix sense (the all-D analog was active) but did require a strong helix-forming propensity in aqueous solution (a scrambled analog and primate LL-37 orthologs devoid of this property were inactive). The involvement of P2X(7) was analyzed using P2X(7)-expressing HEK293 cells. LL-37 induced proliferation of these cells, triggered Ca2+ influx, promoted ethidium bromide uptake, and synergized with benzoyl ATP to enhance the pore and channel functions of P2X(7). The activity of LL-37 had an absolute requirement for P2X(7) expression as it was blocked by the P2X(7) inhibitor KN-62, was absent in cells lacking P2X(7), and was restored by P2X(7) transfection. Of particular interest, LL-37 led to pore-forming activity in cells expressing a truncated P2X(7) receptor unable to generate the non-selective pore typical of the full-length receptor. Our results indicate that P2X(7) is involved in the proliferative cell response to LL-37 and that the structural/aggregational properties of LL-37 determine its capacity to modulate the activation state of P2X(7).	[Tomasinsig, Linda; Skerlavaj, Barbara; Zanetti, Margherita] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Pizzirani, Cinzia; Pellegatti, Patrizia; Gulinelli, Sara; Di Virgilio, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; [Pizzirani, Cinzia; Pellegatti, Patrizia; Gulinelli, Sara; Di Virgilio, Francesco] Univ Ferrara, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy; [Tossi, Alessandro] Univ Trieste, Dept Biochem Biophys & Macromol Chem, I-34127 Trieste, Italy; [Zanetti, Margherita] Natl Lab Interuniv Consortium Biotechnol, I-34012 Trieste, Italy	University of Udine; University of Ferrara; University of Ferrara; University of Trieste	Zanetti, M (corresponding author), Univ Udine, Dept Biomed Sci & Technol, Ple Kolbe 4, I-33100 Udine, Italy.	mzanetti@mail.dstb.uniud.it	Di Virgilio, Francesco/J-3754-2018; DI VIRGILIO, Francesco/O-4634-2019; Tossi, Alessandro/U-2474-2017; Pellegatti, Patrizia/A-1891-2011; Tossi, Alessandro/ABC-9061-2020	Di Virgilio, Francesco/0000-0003-3566-1362; DI VIRGILIO, Francesco/0000-0003-3566-1362; Tossi, Alessandro/0000-0001-9087-5764; SKERLAVAJ, Barbara/0000-0003-0437-802X	Italian Ministry of Education, University and Research [2005068150_001, 2005051341_004]; Regione Friuli-Venezia Giulia [23 L. R. 26/2005]; Italian Association for Cancer Research; Telethon of Italy [GGP06070]; Italian Space Agency (Agenzia Spaziale Italiana-Osteoporosi e Atrofia Muscolare); Commission of European Communities [HEALTH-F2-2007-202231]; University of Ferrara	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Friuli-Venezia Giulia(Regione Friuli Venezia Giulia); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon of Italy(Fondazione Telethon); Italian Space Agency (Agenzia Spaziale Italiana-Osteoporosi e Atrofia Muscolare)(Agenzia Spaziale Italiana (ASI)); Commission of European Communities(European Commission); University of Ferrara	This work was supported by the Italian Ministry of Education, University and Research (Progetti di Ricerca di Interesse Nazionale 2005 Grants 2005068150_001 and 2005051341_004), Regione Friuli-Venezia Giulia (Grant art. 23 L. R. 26/2005), the Italian Association for Cancer Research, Telethon of Italy (Grant GGP06070), the Italian Space Agency (Agenzia Spaziale Italiana-Osteoporosi e Atrofia Muscolare), the Commission of European Communities (7th Framework Program HEALTH-F2-2007-202231), and institutional funds from the University of Ferrara. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Alloisio S, 2006, MOL PHARMACOL, V69, P1975, DOI 10.1124/mol.105.020164; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Bianco F, 2006, J NEUROCHEM, V99, P745, DOI 10.1111/j.1471-4159.2006.04101.x; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Darville T, 2007, J IMMUNOL, V179, P3707, DOI 10.4049/jimmunol.179.6.3707; Denlinger LC, 2001, J IMMUNOL, V167, P1871, DOI 10.4049/jimmunol.167.4.1871; Di Nardo A, 2007, J IMMUNOL, V178, P1829, DOI 10.4049/jimmunol.178.3.1829; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; DiVirgilio F, 1996, CIBA F SYMP, V198, P290; DIVIRGILIO F, 1987, J BIOL CHEM, V262, P9189; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Ferrari D, 2004, J IMMUNOL, V173, P4652, DOI 10.4049/jimmunol.173.7.4652; Ferrari D, 1997, NEUROPHARMACOLOGY, V36, P1295, DOI 10.1016/S0028-3908(97)00137-8; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gerasimovskaya EV, 2002, J BIOL CHEM, V277, P44638, DOI 10.1074/jbc.M203012200; Gerber D, 2005, FASEB J, V19, P1190, DOI 10.1096/fj.04-3498fje; Giacometti A, 2003, J ANTIMICROB CHEMOTH, V51, P843, DOI 10.1093/jac/dkg149; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Heilborn JD, 2005, INT J CANCER, V114, P713, DOI 10.1002/ijc.20795; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; Hibell AD, 2001, J PHARMACOL EXP THER, V296, P947; Humphreys BD, 1998, MOL PHARMACOL, V54, P22, DOI 10.1124/mol.54.1.22; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Michel AD, 2007, BRIT J PHARMACOL, V152, P523, DOI 10.1038/sj.bjp.0707417; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Sal-Man N, 2004, J MOL BIOL, V344, P855, DOI 10.1016/j.jmb.2004.09.066; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Solini A, 1999, J CELL SCI, V112, P297; Sorensen O, 1997, BLOOD, V90, P2796; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Takenouchi T, 2007, J NEUROCHEM, V102, P1518, DOI 10.1111/j.1471-4159.2007.04570.x; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; Tomasinsig L, 2006, J BIOL CHEM, V281, P383, DOI 10.1074/jbc.M510354200; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Tossi A, 2000, BIOPOLYMERS, V55, P4; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2005, BIOCHEM J, V390, P177, DOI 10.1042/BJ20042138; Zelezetsky I, 2006, J BIOL CHEM, V281, P19861, DOI 10.1074/jbc.M511108200	57	120	122	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30471	30481		10.1074/jbc.M802185200	http://dx.doi.org/10.1074/jbc.M802185200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18765670	Green Published, hybrid			2022-12-25	WOS:000260544800005
J	Ungaro, P; Teperino, R; Mirra, P; Cassese, A; Fiory, F; Perruolo, G; Miele, C; Laakso, M; Formisano, P; Beguinot, F				Ungaro, Paola; Teperino, Raffaele; Mirra, Paola; Cassese, Angela; Fiory, Francesca; Perruolo, Giuseppe; Miele, Claudia; Laakso, Markku; Formisano, Pietro; Beguinot, Francesco			Molecular Cloning and Characterization of the Human PED/PEA-15 Gene Promoter Reveal Antagonistic Regulation by Hepatocyte Nuclear Factor 4 alpha and Chicken Ovalbumin Upstream Promoter Transcription Factor II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; PROTEIN-KINASE-C; INSULIN-SECRETION; GLUCOSE-TRANSPORT; PEA15 GENE; COUP-TF; EXPRESSION; PEA-15; ACTIVATION; PHOSPHOPROTEIN	Overexpression of the ped/pea-15 gene in mice impairs glucose tolerance and leads to diabetes in conjunction with high fat diet treatment. PED/PEA-15 is also overexpressed in type 2 diabetics as well as in euglycemic offspring from these subjects. The cause(s) of this abnormality remains unclear. In the present work we have cloned and localized the promoter region of the human PED/PEA-15 gene within the first 230 bp of the 5'-flanking region. A cis-acting regulatory element located between -320 and -335 bps upstream the PED/PEA-15 gene transcriptional start site (+1) is recognized by both the hepatocyte nuclear factor 4 alpha (HNF-4 alpha) and the chicken ovalbumin upstream promoter transcription factor II (COUP-TFII), two members of the steroid/thyroid superfamily of transcription factors, both of which are involved in the control of lipid and glucose homeostasis. HNF-4 alpha represses PED/PEA-15 expression in HeLa cells, whereas COUP-TFII activates its expression. In hepatocytes, the activation of PED/PEA-15 gene transcription is paralleled by the establishment of a partially dedifferentiated phenotype accompanied by a reduction in mRNA levels encoded by genes normally expressed during liver development. Cotransfection of HeLa cells with a reporter construct containing the PED/PEA-15 response element and various combinations of HNF-4 alpha and COUP-TFII expression vectors indicated that COUP-TFII antagonizes the repression of the PED/PEA-15 gene by HNF-4 alpha. Thus, at least in part, transcription of the PED/PEA-15 gene in vivo is dependent upon the intracellular balance of these positive and negative regulatory factors. Abnormalities in HNF-4 alpha and COUP-TFII balance might have important consequences on glucose tolerance in humans.	[Ungaro, Paola; Teperino, Raffaele; Mirra, Paola; Cassese, Angela; Fiory, Francesca; Perruolo, Giuseppe; Miele, Claudia; Formisano, Pietro; Beguinot, Francesco] CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, I-80131 Naples, Italy; [Ungaro, Paola; Teperino, Raffaele; Mirra, Paola; Cassese, Angela; Fiory, Francesca; Perruolo, Giuseppe; Miele, Claudia; Formisano, Pietro; Beguinot, Francesco] Univ Naples Federico II, Dipartimento Biol Patol Cellulare & Mol, I-80131 Naples, Italy; [Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Beguinot, F (corresponding author), CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, Via S Pansini 5, I-80131 Naples, Italy.	beguino@unina.it	Formisano, Pietro/J-4237-2018; giuseppe, perruolo/AAW-3869-2021	Perruolo, Giuseppe/0000-0003-0479-8729; Formisano, Pietro/0000-0001-7020-6870; Teperino, Raffaele/0000-0001-8815-1409	European Community [FP6 EUGENE2, LSHM-CT-2004-512013, FP7 PREPROBEDIA, 201681]; European Foundation for the Study of Diabetes (EFSD)/Lilly; Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Universita e della Ricerca Scientifica	European Community(European Commission); European Foundation for the Study of Diabetes (EFSD)/Lilly(Eli Lilly); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR))	This work was supported, in part, by European Community FP6 EUGENE2 Contract LSHM-CT-2004-512013, FP7 PREPROBEDIA Grant 201681, and by grants from the European Foundation for the Study of Diabetes (EFSD)/Lilly, the Associazione Italiana per la Ricerca sul Cancro), and the Ministero dell'Universita e della Ricerca Scientifica.	ARAUJO H, 1993, J BIOL CHEM, V268, P5911; Barbier O, 2005, MOL PHARMACOL, V67, P241, DOI 10.1124/mol.104.003863; Black MH, 2008, DIABETES, V57, P1048, DOI 10.2337/db07-0848; BONADONNA RC, 1991, DIABETES METAB, V17, P112; BURRIS TP, 1995, P NATL ACAD SCI USA, V92, P9525, DOI 10.1073/pnas.92.21.9525; Cairns W, 1996, J BIOL CHEM, V271, P25269, DOI 10.1074/jbc.271.41.25269; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Condorelli G, 2001, DIABETES, V50, P1244, DOI 10.2337/diabetes.50.6.1244; Condorelli G, 1998, EMBO J, V17, P3858, DOI 10.1093/emboj/17.14.3858; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; DANZIGER N, 1995, J NEUROCHEM, V64, P1016; Eeckhoute J, 2001, MOL ENDOCRINOL, V15, P1200, DOI 10.1210/me.15.7.1200; Estelles A, 1996, J BIOL CHEM, V271, P14800, DOI 10.1074/jbc.271.25.14800; Estelles A, 1999, DEV BIOL, V216, P16, DOI 10.1006/dbio.1999.9510; Formisano P, 2005, ONCOGENE, V24, P7012, DOI 10.1038/sj.onc.1208871; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Fraser JD, 1998, NUCLEIC ACIDS RES, V26, P2702, DOI 10.1093/nar/26.11.2702; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; Glass CK, 2000, GENE DEV, V14, P121; Hao CH, 2001, CANCER RES, V61, P1162; Hatzis P, 2001, MOL CELL BIOL, V21, P7320, DOI 10.1128/MCB.21.21.7320-7330.2001; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; HWUNG YP, 1988, MOL CELL BIOL, V8, P2070, DOI 10.1128/MCB.8.5.2070; Johansson S, 2007, DIABETES, V56, P3112, DOI 10.2337/db07-0513; KIMURA A, 1993, J BIOL CHEM, V268, P11125; KTISTAKI E, 1994, NUCLEIC ACIDS RES, V22, P4689, DOI 10.1093/nar/22.22.4689; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lausen J, 2000, NUCLEIC ACIDS RES, V28, P430, DOI 10.1093/nar/28.2.430; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; Li JX, 2000, GENE DEV, V14, P464; Lou DQ, 1999, J BIOL CHEM, V274, P28385, DOI 10.1074/jbc.274.40.28385; Menjivar M, 2008, CLIN GENET, V73, P185, DOI 10.1111/j.1399-0004.2007.00928.x; Mercado Maria M, 2002, Curr Diab Rep, V2, P83, DOI 10.1007/s11892-002-0063-9; Miele C, 2007, DIABETES, V56, P622, DOI 10.2337/db06-1260; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; ONATE SA, 1995, SCIENCE, V270, P1354; Owen KR, 2007, CURR OPIN GENET DEV, V17, P239, DOI 10.1016/j.gde.2007.04.003; PARK J, 2002, KEIO J MED, V52, P174; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Perfetti A, 2007, J BIOL CHEM, V282, P8648, DOI 10.1074/jbc.M608359200; QIU YH, 1994, P NATL ACAD SCI USA, V91, P4451, DOI 10.1073/pnas.91.10.4451; QIU YH, 1994, TRENDS ENDOCRIN MET, V5, P234, DOI 10.1016/1043-2760(94)P3081-H; Shih DQ, 2000, DIABETES, V49, P832, DOI 10.2337/diabetes.49.5.832; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; Song KH, 2006, J BIOL CHEM, V281, P10081, DOI 10.1074/jbc.M513420200; Trencia A, 2003, MOL CELL BIOL, V23, P4511, DOI 10.1128/MCB.23.13.4511-4521.2003; Valentino R, 2006, DIABETOLOGIA, V49, P3058, DOI 10.1007/s00125-006-0455-5; Vigliotta G, 2004, MOL CELL BIOL, V24, P5005, DOI 10.1128/MCB.24.11.5005-5015.2004; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Wolford JK, 2000, GENE, V241, P143, DOI 10.1016/S0378-1119(99)00455-2; WOLFRUM C, 2003, DIABETES, V52, P2989; XANTHOPOULOS KG, 1991, P NATL ACAD SCI USA, V88, P3807, DOI 10.1073/pnas.88.9.3807; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Zhang Y, 2000, J BIOL CHEM, V275, P35224, DOI 10.1074/jbc.M003329200	61	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30970	30979		10.1074/jbc.M803895200	http://dx.doi.org/10.1074/jbc.M803895200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18765665	Green Published, hybrid			2022-12-25	WOS:000260544800052
J	Aoki, K; Porterfield, M; Lee, SS; Dong, B; Nguyen, K; McGlamry, KH; Tiemeyer, M				Aoki, Kazuhiro; Porterfield, Mindy; Lee, Samuel S.; Dong, Brian; Nguyen, Khoi; McGlamry, Katherine H.; Tiemeyer, Michael			The Diversity of O-Linked Glycans Expressed during Drosophila melanogaster Development Reflects Stage- and Tissue-specific Requirements for Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; CHROMATOGRAPHY-MASS-SPECTROMETRY; HEPARAN-SULFATE PROTEOGLYCANS; MUCIN-TYPE GLYCOPROTEIN; NOTCH-LIGAND BINDING; FUNCTIONAL-CHARACTERIZATION; UDP-GALNAC; PROTEIN O-FUCOSYL-TRANSFERASE-1; PERMETHYLATED OLIGOSACCHARIDES; GLYCOSYLTRANSFERASE FRINGE	Appropriate glycoprotein O-glycosylation is essential for normal development and tissue function in multicellular organisms. To comprehensively assess the developmental and functional impact of altered O-glycosylation, we have extensively analyzed the non-glycosaminoglycan, O-linked glycans expressed in Drosophila embryos. Through multidimensional mass spectrometric analysis of glycans released from glycoproteins by beta-elimination, we detected novel as well as previously reported O-glycans that exhibit developmentally modulated expression. The core 1 mucin-type disaccharide (Gal beta 1-3GalNAc) is the predominant glycan in the total profile. HexNAcitol, hexitol, xylosylated hexitol, and branching extension of core 1 with HexNAc (to generate core 2 glycans) were also evident following release and reduction. After Gal beta 1 3GalNAc, the next most prevalent glycans were a mixture of novel, isobaric, linear, and branched forms of a glucuronyl core 1 disaccharide. Other less prevalent structures were also extended with HexA, including an O-fucose glycan. Although the expected disaccharide product of the Fringe glycosyltransferase, (GlcNAc beta 1-3) fucitol, was not detectable in whole embryos, mass spectrometry fragmentation and exoglycosidase sensitivity defined a novel glucuronyl trisaccharide as GlcNAc beta 1-3(GlcA beta 1-4) fucitol. Consistent with the spatial distribution of the Fringe function, the GlcA-extended form of the Fringe product was enriched in the dorsal portion of the wing imaginal disc. Furthermore, loss of Fringe activity reduced the prevalence of the O-Fuc trisaccharide. Therefore, O-Fuc glycans necessary for the modulation of important signaling events in Drosophila are, as in vertebrates, substrates for extension beyond the addition of a single HexNAc.	[Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Tiemeyer, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	mtiemeyer@ccrc.uga.edu	Aoki, Kazuhiro/H-8283-2014	Aoki, Kazuhiro/0000-0003-0029-4291	1-R01-GM072839 [NIGMS]; 1-U01-CA128454 [NCI]; Toyobo Biotechnology Foundation; NATIONAL CANCER INSTITUTE [U01CA128454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072839] Funding Source: NIH RePORTER	1-R01-GM072839; 1-U01-CA128454; Toyobo Biotechnology Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1-R01-GM072839 from NIGMS and 1-U01-CA128454 from NCI (both to M. T.). This work was also supported by a Toyobo Biotechnology Foundation long-term research grant (to K. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2004, J BIOL CHEM, V279, P32028, DOI 10.1074/jbc.M312918200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ashline DJ, 2007, ANAL CHEM, V79, P3830, DOI 10.1021/ac062383a; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Breloy I, 2008, FEBS LETT, V582, P1593, DOI 10.1016/j.febslet.2008.04.003; CALLAERTS P, 1995, ROUX ARCH DEV BIOL, V204, P229, DOI 10.1007/BF00208490; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; CMELIK SHW, 1969, COMP BIOCHEM PHYSIOL, V31, P65, DOI 10.1016/0010-406X(69)92169-0; Correia T, 2003, P NATL ACAD SCI USA, V100, P6404, DOI 10.1073/pnas.1131007100; DAMICO P, 1995, TISSUE CELL, V27, P23, DOI 10.1016/S0040-8166(95)80005-0; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FREDIEU JR, 1994, ACTA ANAT, V149, P89; Grammont M, 2001, DEVELOPMENT, V128, P2243; GRAVER RC, 1965, J AM OIL CHEM SOC, V42, P294; Greis KD, 1996, ANAL BIOCHEM, V234, P38, DOI 10.1006/abio.1996.0047; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Haines N, 2007, MOL BIOL CELL, V18, P4721, DOI 10.1091/mbc.E07-01-0047; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; HANISCH FG, 1993, EUR J BIOCHEM, V217, P645, DOI 10.1111/j.1432-1033.1993.tb18288.x; HANSSON GC, 1989, BIOCHEMISTRY-US, V28, P6672, DOI 10.1021/bi00442a021; HARDY MR, 1988, ANAL BIOCHEM, V170, P54, DOI 10.1016/0003-2697(88)90089-9; Huang HH, 2001, GLYCOBIOLOGY, V11, P395, DOI 10.1093/glycob/11.5.395; Huang YP, 2002, RAPID COMMUN MASS SP, V16, P1199, DOI 10.1002/rcm.701; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Ishimizu T, 2007, J BIOCHEM, V141, P593, DOI 10.1093/jb/mvm064; Iwaki DD, 2002, MECH DEVELOP, V114, P71, DOI 10.1016/S0925-4773(02)00061-8; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; KARLSSON H, 1989, ANAL BIOCHEM, V182, P438, DOI 10.1016/0003-2697(89)90620-9; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; Kim BT, 2003, J BIOL CHEM, V278, P9116, DOI 10.1074/jbc.M209344200; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200; Kramerov AA, 1997, INSECT BIOCHEM MOLEC, V27, P513, DOI 10.1016/S0965-1748(97)00026-X; Kramerov AA, 1996, FEBS LETT, V378, P213, DOI 10.1016/0014-5793(95)01444-6; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lopez M, 1999, BBA-GEN SUBJECTS, V1427, P49, DOI 10.1016/S0304-4165(98)00176-7; Lyalin D, 2006, GENETICS, V172, P343, DOI 10.1534/genetics.105.049650; Maes E, 2005, CARBOHYD RES, V340, P1852, DOI 10.1016/j.carres.2005.05.008; Martin PT, 2003, GLYCOBIOLOGY, V13, p67R, DOI 10.1093/glycob/cwg077; MartinBlanco E, 1996, P NATL ACAD SCI USA, V93, P6048, DOI 10.1073/pnas.93.12.6048; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Mourad R, 2001, EUR J BIOCHEM, V268, P1990, DOI 10.1046/j.1432-1327.2001.02071.x; Muller R, 2005, FEBS J, V272, P4295, DOI 10.1111/j.1742-4658.2005.04838.x; North SJ, 2006, GLYCOCONJUGATE J, V23, P345, DOI 10.1007/s10719-006-6693-4; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Overgaard J, 2008, J INSECT PHYSIOL, V54, P619, DOI 10.1016/j.jinsphys.2007.12.011; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Prien JM, 2008, GLYCOBIOLOGY, V18, P353, DOI 10.1093/glycob/cwn010; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; SAITO M, 1979, J BIOL CHEM, V254, P7845; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schwientek T, 2007, PROTEOMICS, V7, P3264, DOI 10.1002/pmic.200600793; Seppo A, 2000, EUR J BIOCHEM, V267, P3549, DOI 10.1046/j.1432-1327.2000.01383.x; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Snapp KR, 2001, BLOOD, V97, P3806, DOI 10.1182/blood.V97.12.3806; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; SUGITA M, 1989, J BIOL CHEM, V264, P15028; TAKAHASHI N, 1995, ANAL BIOCHEM, V226, P139, DOI 10.1006/abio.1995.1201; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Theopold U, 2001, INSECT BIOCHEM MOLEC, V31, P189, DOI 10.1016/S0965-1748(00)00117-X; Thomas GB, 2007, DEVELOPMENT, V134, P591, DOI 10.1242/dev.02754; THOMSEN DR, 1990, J CELL BIOCHEM, V43, P67, DOI 10.1002/jcb.240430107; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; UttenweilerJoseph S, 1997, ANAL BIOCHEM, V247, P366, DOI 10.1006/abio.1997.2083; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Walters JW, 2006, DEV BIOL, V297, P323, DOI 10.1016/j.ydbio.2006.04.454; Weitzhandler M, 1996, ANAL BIOCHEM, V241, P128, DOI 10.1006/abio.1996.0386; White SJ, 2001, J IMMUNOL, V167, P628, DOI 10.4049/jimmunol.167.2.628; WIEGANDT H, 1992, BIOCHIM BIOPHYS ACTA, V1123, P117, DOI 10.1016/0005-2760(92)90101-Z; Wilson IBH, 2002, J BIOL CHEM, V277, P21207, DOI 10.1074/jbc.M201634200; WOODS RJ, 1995, J PHYS CHEM-US, V99, P3832, DOI 10.1021/j100011a061; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Zhao DB, 2000, J CELL SCI, V113, P3781	96	100	101	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30385	30400		10.1074/jbc.M804925200	http://dx.doi.org/10.1074/jbc.M804925200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18725413	Green Published, hybrid			2022-12-25	WOS:000260366900082
J	Pincetic, A; Medina, G; Carter, C; Leis, J				Pincetic, Andrew; Medina, Gisselle; Carter, Carol; Leis, Jonathan			Avian Sarcoma Virus and Human Immunodeficiency Virus, Type 1 Use Different Subsets of ESCRT Proteins to Facilitate the Budding Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR ENDOSOMES; PARTICLE RELEASE; ASSEMBLY DOMAIN; SORTING PATHWAY; GAG PROTEIN; HIV-1 GAG; UBIQUITIN; TSG101; COMPLEX; TRAFFICKING	Members of the Nedd4 family of E3 ubiquitin ligases bind the L domain in avian sarcoma virus (ASV) Gag and facilitate viral particle release. Translational fusion of ASV Gag with an L domain deletion (Delta p2b) to proteins that comprise ESCRT-I, -II, and -III (the endocytic sorting complexes required for transport) rescued both Gag ubiquitination and particle release from cells. The ESCRT-I factors Vps37C or Tsg101 were more effective in rescue of Gag/Delta p2b budding than the ESCRT-II factor Eap20 or the ESCRT-III component CHMP6. Thus ESCRT components can substitute for Nedd4 family members in ASV Gag release. Unlike wild type, ASV Gag/Delta p2b-ESCRT chimeras failed to co-immunoprecipitate with co-expressed hemagglutinin-tagged Nedd4, indicating that Nedd4 was not stably associated with these Gag fusions. Release of the Gag-ESCRT-I or -II fusions was inhibited by a dominant negative mutant of Vps4 ATPase similar to wild type ASV Gag. In contrast to ASV Gag, HIV-1 Gag containing an L domain inactivating mutation (P7L) was efficiently rescued by fusion to a component of ESCRT-III (Chmp6) but not ESCRT-II (Eap20). Depletion of the endogenous pool of Eap20 (ESCRT-II) had little effect on HIV-1 Gag release but blocked ASV Gag release. In contrast, depletion of the endogenous pool of Vps37C (ESCRT-I) had little effect on ASV but blocked HIV-1 Gag release. Furthermore, an N-terminal fragment of Chmp6 inhibited both HIV-1 and ASV Gag release in a dominant negative manner. Taken together, these results indicate that ASV and HIV-1 Gag utilize different combinations of ESCRT proteins to facilitate the budding process, although they share some common elements.	[Pincetic, Andrew; Leis, Jonathan] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Medina, Gisselle; Carter, Carol] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	Northwestern University; Feinberg School of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Leis, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-leis@northwestern.edu	Medina, Gisselle N/AAO-3560-2021; Medina, Gisselle N/ACU-5726-2022		National Institutes of Health Predoctoral Training [5T32 CA-09176]; United States Public Health Service [AI054143, AI68463]; Training Program in Viral Replication [T32 AI060523]; W. Burghardt Turner Pre- doctoral Fellowship; Stony Brook University [35583]; NATIONAL CANCER INSTITUTE [T32CA009176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI068463, R56AI054143, R01AI068463, T32AI060523] Funding Source: NIH RePORTER	National Institutes of Health Predoctoral Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Training Program in Viral Replication; W. Burghardt Turner Pre- doctoral Fellowship; Stony Brook University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Predoctoral Training Grant 5T32 CA-09176. This work was also supported by United States Public Health Service Grants AI054143 (to J. L.) and AI68463 (to C. C.). 1 Supported in part by the Training Program in Viral Replication T32 AI060523. 2 Supported in part by a W. Burghardt Turner Pre- doctoral Fellowship and by Grant 35583 from the National Science Foundation-Human Resource Development-funded SUNY AGEP Program at Stony Brook University.	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Eastman SW, 2005, J BIOL CHEM, V280, P628, DOI 10.1074/jbc.M410384200; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goff A, 2003, J VIROL, V77, P9173, DOI 10.1128/JVI.77.17.9173-9182.2003; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Gottwein E, 2006, J VIROL, V80, P6267, DOI 10.1128/JVI.02177-05; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Kyuuma M, 2006, CELL STRUCT FUNCT, V31, P159, DOI 10.1247/csf.06023; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2004, J VIROL, V78, P5554, DOI 10.1128/JVI.78.11.5554-5563.2004; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McDonald B, 2008, MOL BIOL CELL, V19, P754, DOI 10.1091/mbc.E07-09-0957; Medina G, 2005, TRAFFIC, V6, P880, DOI 10.1111/j.1600-0854.2005.00323.x; Medina G, 2008, VIROLOGY, V377, P30, DOI 10.1016/j.virol.2008.04.024; Ott DE, 1998, J VIROL, V72, P2962, DOI 10.1128/JVI.72.4.2962-2968.1998; Ott DE, 2000, VIROLOGY, V278, P111, DOI 10.1006/viro.2000.0648; PARENT LJ, 1995, J VIROL, V69, P5455, DOI 10.1128/JVI.69.9.5455-5460.1995; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; PUTTERMAN D, 1990, VIROLOGY, V176, P633, DOI 10.1016/0042-6822(90)90035-P; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Shehu-Xhilaga M, 2004, J VIROL, V78, P724, DOI 10.1128/JVI.78.2.724-732.2004; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Spidel JL, 2004, J VIROL, V78, P10606, DOI 10.1128/JVI.78.19.10606-10616.2004; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200; Umebayashi K, 2003, CELL STRUCT FUNCT, V28, P443, DOI 10.1247/csf.28.443; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; Vana ML, 2004, J VIROL, V78, P13943, DOI 10.1128/JVI.78.24.13943-13953.2004; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; WILLS JW, 1994, J VIROL, V68, P6605, DOI 10.1128/JVI.68.10.6605-6618.1994; Xiang Y, 1996, J VIROL, V70, P5695, DOI 10.1128/JVI.70.8.5695-5700.1996	44	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29822	29830		10.1074/jbc.M804157200	http://dx.doi.org/10.1074/jbc.M804157200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723511	hybrid, Green Published			2022-12-25	WOS:000260366900026
J	Surucu, B; Bozulic, L; Hynx, D; Parcellier, A; Hemmings, BA				Surucu, Banu; Bozulic, Lana; Hynx, Debby; Parcellier, Arnaud; Hemmings, Brian A.			In Vivo Analysis of Protein Kinase B (PKB)/Akt Regulation in DNA-PKcs-null Mice Reveals a Role for PKB/Akt in DNA Damage Response and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; CATALYTIC SUBUNIT; CANCER CELLS; ACTIVATION; AKT; GROWTH; PATHWAY; MTOR	Full activation of protein kinase B (PKB/Akt) requires phosphorylation on Thr-308 and Ser-473. It is well established that Thr-308 is phosphorylated by 3-phosphoinositide-dependent kinase-1 (PDK1). Ser-473 phosphorylation is mediated by both mammalian target of rapamycin-rictor complex (mTORC2) and DNA-dependent protein kinase (DNA-PK) depending on type of stimulus. However, the physiological role of DNA-PK in the regulation of PKB phosphorylation remains to be established. To address this, we analyzed basal, insulin-induced, and DNA damage-induced PKB Ser-473 phosphorylation in DNA-PK catalytic subunit-null DNA-PKcs(-/-) mice. Our results revealed that DNA-PK is required for DNA damage-induced phosphorylation but dispensable for insulin-and growth factor-induced PKB Ser-473 phosphorylation. Moreover, DNA-PKcs(-/-) mice showed a tissue- specific increase in basal PKB phosphorylation. In particular, persistent PKB hyperactivity in the thymus apparently contributed to spontaneous lymphomagenesis in DNAPKcs(-/-) mice. Significantly, these tumors could be prevented by deletion of PKB alpha. These findings reveal stimulus-specific regulation of PKB activation by specific upstream kinases and provide genetic evidence of PKB deregulation in DNA-PKcs(-/-) mice.	[Surucu, Banu; Bozulic, Lana; Hynx, Debby; Parcellier, Arnaud; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Hemmings, BA (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	brian.hemmings@fmi.ch			Oncosuisse [OCS-01667-02-2005]; Novartis Research Foundation	Oncosuisse; Novartis Research Foundation	This work was supported in part by Oncosuisse Grant OCS-01667-02-2005. Friedrich Miescher Institute is part of the Novartis Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson CM, 2008, GENE DEV, V22, P854, DOI 10.1101/gad.1646208; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Belyanskaya LL, 2005, INT J CANCER, V117, P755, DOI 10.1002/ijc.21242; Boehme KA, 2008, P NATL ACAD SCI USA, V105, P7785, DOI 10.1073/pnas.0703423105; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chang M, 2008, SCIENCE, V320, P60, DOI 10.1126/science.1155132; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Fayard E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000992; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Juntilla MA, 2008, IMMUNOL LETT, V116, P104, DOI 10.1016/j.imlet.2007.12.008; Juntilla MM, 2007, P NATL ACAD SCI USA, V104, P12105, DOI 10.1073/pnas.0705285104; Kanoh J, 2007, GENES CELLS, V12, P1301, DOI 10.1111/j.1365-2443.2007.01142.x; Kim MS, 2006, PHOTOCHEM PHOTOBIOL, V82, P645, DOI 10.1562/2005-09-29-RA-702; Kurimasa A, 1999, P NATL ACAD SCI USA, V96, P1403, DOI 10.1073/pnas.96.4.1403; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; LUPERTZ R, 2008, CARCINOGENESIS  0806, DOI DOI 10.1093/CARCIN/BGN184; Malstrom S, 2001, P NATL ACAD SCI USA, V98, P14967, DOI 10.1073/pnas.231467698; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Nutley BP, 2005, BRIT J CANCER, V93, P1011, DOI 10.1038/sj.bjc.6602823; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Tsuji H, 2004, CANCER RES, V64, P8882, DOI 10.1158/0008-5472.CAN-03-1163; Tsuji H, 2003, CARCINOGENESIS, V24, P1257, DOI 10.1093/carcin/bgg071; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yang X, 2008, BRIT J CANCER, V98, P803, DOI 10.1038/sj.bjc.6604223; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350; Yu HG, 2008, INT J CANCER, V122, P433, DOI 10.1002/ijc.23049; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	78	62	64	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30025	30033		10.1074/jbc.M803053200	http://dx.doi.org/10.1074/jbc.M803053200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18757368	Green Published, hybrid			2022-12-25	WOS:000260366900047
J	Matsunaga, I; Naka, T; Talekar, RS; McConnell, MJ; Katoh, K; Nakao, H; Otsuka, A; Behar, SM; Yano, I; Moody, DB; Sugita, M				Matsunaga, Isamu; Naka, Takashi; Talekar, Rahul S.; McConnell, Matthew J.; Katoh, Kumiko; Nakao, Hitomi; Otsuka, Atsushi; Behar, Samuel M.; Yano, Ikuya; Moody, D. Branch; Sugita, Masahiko			Mycolyltransferase-mediated Glycolipid Exchange in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; LIPID ANTIGENS; TUBERCULOSIS; RECOGNITION; BIOSYNTHESIS; CARBOHYDRATE; INFECTION; RESPONSES; AVIUM; GENE	Trehalose dimycolate (TDM), also known as cord factor, is a major surface glycolipid of the cell wall of mycobacteria. Because of its potent biological functions in models of infection, adjuvancy, and immunotherapy, it is important to determine how its biosynthesis is regulated. Here we show that glucose, a host-derived product that is not readily available in the environment, causes Mycobacterium avium to down-regulate TDM expression while up-regulating production of another major glycolipid with immunological roles in T cell activation, glucose monomycolate (GMM). In vitro, the mechanism of reciprocal regulation of TDM and GMM involves competitive substrate selection by antigen 85A. The switch from TDM to GMM biosynthesis occurs near the physiological concentration of glucose present in mammalian hosts. We further demonstrate that GMM is produced in vivo by mycobacteria growing in mouse lung. These results establish an enzymatic pathway for GMM production. More generally, these observations provide a specific enzymatic mechanism for dynamic alterations of cell wall glycolipid remodeling in response to the transition from noncellular to cellular growth environments, including factors that are monitored by the host immune system.	[Matsunaga, Isamu; Katoh, Kumiko; Nakao, Hitomi; Otsuka, Atsushi; Sugita, Masahiko] Kyoto Univ, Inst Virus Res, Lab Cell Regulat, Kyoto 6068507, Japan; [Matsunaga, Isamu; Katoh, Kumiko; Nakao, Hitomi; Sugita, Masahiko] Kyoto Univ, Grad Sch Biostudies, Lab Cell Regulat & Mol Network, Kyoto 6068507, Japan; [Naka, Takashi; Yano, Ikuya] Japan BCG Lab, Tokyo 2040022, Japan; [Talekar, Rahul S.; McConnell, Matthew J.; Behar, Samuel M.; Moody, D. Branch] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Kyoto University; Kyoto University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sugita, M (corresponding author), 53 Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	msugita@virus.kyoto-u.ac.jp	Behar, Samuel M/C-3541-2009	Matsunaga, Isamu/0000-0001-9541-350X; Sugita, Masahiko/0000-0001-5511-1304; Behar, Samuel/0000-0002-3374-6699	National Institutes of Health (NIAID) [R01 07155]; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour, and Welfare Research on Emerging and Re-emerging Infectious Diseases; Burroughs Wellcome Fund	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare Research on Emerging and Re-emerging Infectious Diseases(Ministry of Health, Labour and Welfare, Japan); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 07155 (NIAID) (to D. B. M.). This work was also supported by grants-in-aid from scientific research on priority areas from the Ministry of Education, Culture, Sports, Science and Technology (to M. S.), grants-in-aid for scientific research B (to M. S.) and C (to I. M.) from the Japan Society for the Promotion of Science, grants from the Ministry of Health, Labour, and Welfare Research on Emerging and Re-emerging Infectious Diseases (to M. S.), and by the Burroughs Wellcome Fund (to D. B. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BRENNAN P, 1967, J BIOL CHEM, V242, P3046; Cheng TY, 2006, EMBO J, V25, P2989, DOI 10.1038/SJ.EMBOJ.7601185; Enomoto Y, 2005, BIOCHEM BIOPH RES CO, V337, P452, DOI 10.1016/j.bbrc.2005.09.070; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Hou JY, 2002, INFECT IMMUN, V70, P3714, DOI 10.1128/IAI.70.7.3714-3726.2002; Kremer L, 2002, LETT APPL MICROBIOL, V34, P233, DOI 10.1046/j.1472-765x.2002.01091.x; Mariani F, 2000, GENE, V253, P281, DOI 10.1016/S0378-1119(00)00249-3; Matsunaga I, 1996, J BIOCHEM-TOKYO, V120, P663; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; MATSUNAGA I, 1990, FEMS MICROBIOL LETT, V67, P49, DOI 10.1111/j.1574-6968.1990.tb13834.x; MATSUNAGA I, 2007, CURR IMMUNOL REV, V3, P145; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; NATSUHARA Y, 1990, CANCER IMMUNOL IMMUN, V31, P99, DOI 10.1007/BF01742373; OHARA N, 1993, INFECT IMMUN, V61, P1173, DOI 10.1128/IAI.61.4.1173-1179.1993; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Ryll R, 2001, MICROBIOL IMMUNOL, V45, P801, DOI 10.1111/j.1348-0421.2001.tb01319.x; SATHYAMOORTHY N, 1987, J BIOL CHEM, V262, P13417; Sugita M, 1997, J IMMUNOL, V159, P2358; Ulrichs T, 2003, INFECT IMMUN, V71, P3076, DOI 10.1128/IAI.71.6.3076-3087.2003	23	41	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28835	28841		10.1074/jbc.M805776200	http://dx.doi.org/10.1074/jbc.M805776200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703502	hybrid, Green Published			2022-12-25	WOS:000260179900008
J	Ronnebaum, SM; Jensen, MV; Hohmeier, HE; Burgess, SC; Zhou, YP; Qian, S; MacNeil, D; Howard, A; Thornberry, N; Ilkayeva, O; Lu, DH; Sherry, AD; Newgard, CB				Ronnebaum, Sarah M.; Jensen, Mette V.; Hohmeier, Hans E.; Burgess, Shawn C.; Zhou, Yun-Ping; Qian, Su; MacNeil, Douglas; Howard, Andrew; Thornberry, Nancy; Ilkayeva, Olga; Lu, Danhong; Sherry, A. Dean; Newgard, Christopher B.			Silencing of Cytosolic or Mitochondrial Isoforms of Malic Enzyme Has No Effect on Glucose-stimulated Insulin Secretion from Rodent Islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR ISOTOPOMER ANALYSIS; PANCREATIC BETA-CELLS; FATTY-ACID SYNTHASE; ATP-CITRATE LYASE; REGULATED ANAPLEROSIS; PYRUVATE-CARBOXYLASE; NULL MUTATION; MOUSE; SUPPRESSION; METABOLISM	We have previously demonstrated a role for pyruvate cycling in glucose-stimulated insulin secretion (GSIS). Some of the possible pyruvate cycling pathways are completed by conversion of malate to pyruvate by malic enzyme. Using INS-1-derived 832/13 cells, it has recently been shown by other laboratories that NADP-dependent cytosolic malic enzyme (MEc), but not NAD-dependent mitochondrial malic enzyme (MEm), regulates GSIS. In the current study, we show that small interfering RNA-mediated suppression of either MEm or MEc results in decreased GSIS in both 832/13 cells and a new and more glucose- and incretin-responsive INS-1-derived cell line, 832/3. The effect of MEm to suppress GSIS in these cell lines was linked to a substantial decrease in cell growth, whereas MEc suppression resulted in decreased NADPH, shown previously to be correlated with GSIS. However, adenovirus-mediated delivery of small interfering RNAs specific to MEc and MEm to isolated rat islets, while leading to effective suppression of the targets transcripts, had no effect on GSIS. Furthermore, islets isolated from MEc-null MOD1(-/-) mice exhibit normal glucose- and potassium-stimulated insulin secretion. These results indicate that pyruvate-malate cycling does not control GSIS in primary rodent islets.	[Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Duke Independence Pk Facil, Durham, NC 27704 USA; [Ronnebaum, Sarah M.; Jensen, Mette V.; Hohmeier, Hans E.; Ilkayeva, Olga; Lu, Danhong; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27704 USA; [Ronnebaum, Sarah M.; Jensen, Mette V.; Hohmeier, Hans E.; Ilkayeva, Olga; Lu, Danhong; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27704 USA; [Hohmeier, Hans E.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27704 USA; [Burgess, Shawn C.; Sherry, A. Dean] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75235 USA; [Burgess, Shawn C.; Sherry, A. Dean] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75235 USA; [Zhou, Yun-Ping; Qian, Su; MacNeil, Douglas; Howard, Andrew; Thornberry, Nancy] Merck Res Labs, Rahway, NJ 07065 USA	Duke University; Duke University; Duke University; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Merck & Company	Newgard, CB (corresponding author), Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Duke Independence Pk Facil, 4321 Med Pk Dr,Ste 200, Durham, NC 27704 USA.	newga002@mc.duke.edu	Sherry, Dean/P-2348-2018	Sherry, Dean/0000-0001-7150-8301; Ronnebaum, Sarah/0000-0003-4787-754X; MacNeil, Doug/0000-0001-7089-0668	National Institutes of Health [DK42583, DK 58398]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK42583 (to C. B. N.) and DK 58398 (to C. B. N. and A. D. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 These authors contributed equally to this work.	Antinozzi PA, 1998, J BIOL CHEM, V273, P16146, DOI 10.1074/jbc.273.26.16146; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; BROWN ML, 1988, J BIOL CHEM, V263, P4494; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; COBB RR, 1990, MUTAT RES, V234, P1, DOI 10.1016/0165-1161(90)90024-I; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Gunawardana SC, 2004, AM J PHYSIOL-ENDOC M, V287, pE828, DOI 10.1152/ajpendo.00381.2003; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; JENSEN MV, 2008, AM J PHYSL IN PRESS; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Komatsu M, 1999, DIABETES, V48, P1543, DOI 10.2337/diabetes.48.8.1543; LEE CY, 1980, MOL CELL BIOCHEM, V30, P143; LEE CY, 1980, BIOCHEMISTRY-US, V19, P5098, DOI 10.1021/bi00563a025; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MacDonald MJ, 2001, MOL CELL BIOCHEM, V220, P117, DOI 10.1023/A:1010821821921; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Mulder H, 2001, J BIOL CHEM, V276, P6479, DOI 10.1074/jbc.M010364200; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Ronnebaum SM, 2008, J BIOL CHEM, V283, P14248, DOI 10.1074/jbc.M800119200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572	40	59	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28909	28917		10.1074/jbc.M804665200	http://dx.doi.org/10.1074/jbc.M804665200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18755687	hybrid, Green Published			2022-12-25	WOS:000260179900016
J	Noor, MAF; Parnell, RS; Grant, BS				Noor, Mohamed A. F.; Parnell, Robin S.; Grant, Bruce S.			A Reversible Color Polyphenism in American Peppered Moth (Biston betularia cognataria) Caterpillars	PLOS ONE			English	Article								Insect body color polyphenisms enhance survival by producing crypsis in diverse backgrounds. While color polyphenisms are often indirectly induced by temperature, rearing density, or diet, insects can benefit from immediate crypsis if they evolve polyphenisms directly induced by exposure to the background color, hence immediately deriving protection from predation. Here, we examine such a directly induced color polyphenism in caterpillars of the geometrid peppered moth (Biston betularia). This larval color polyphenism is unrelated to the genetic polymorphism for melanic phenotypes in adult moths. B. betularia caterpillars are generalist feeders and develop body colors that closely match the brown or green twigs of their host plant. We expand on previous studies examining the proximal cues that stimulate color development. Under controlled rearing conditions, we manipulated diets and background reflectance, using both natural and artificial twigs, and show that visual experience has a much stronger effect than does diet in promoting precise color matching. Their induced body color was not a simple response to reflectance or light intensity but instead specifically matched the wavelength of light to which they were exposed. We also show that the potential to change color is retained until the final ( sixth) larval instar. Given their broad host range, this directly induced color polyphenism likely provides the caterpillars with strong protection from bird predation.	[Noor, Mohamed A. F.; Parnell, Robin S.; Grant, Bruce S.] Coll William & Mary, Biol Dept, Williamsburg, VA 23187 USA	William & Mary	Noor, MAF (corresponding author), Duke Univ, Dept Biol, Durham, NC 27710 USA.	NOOR@DUKE.EDU		Noor, Mohamed/0000-0002-5400-4408				COCKAYNE EA, 1928, P S LOND ENT NAT HIS, P55; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; DERUITER L, 1952, BEHAVIOUR, V4, P222; DYAR HG, 1903, PSYCHE, V10, P78; Futahashi R, 2008, SCIENCE, V319, P1061, DOI 10.1126/science.1149786; Grant BS, 2004, J HERED, V95, P97, DOI 10.1093/jhered/esh022; Grant BS, 2002, J HERED, V93, P86, DOI 10.1093/jhered/93.2.86; Grant BS, 1999, EVOLUTION, V53, P980; GRAYSON J, 1989, BIOL J LINN SOC, V37, P263, DOI 10.1111/j.1095-8312.1989.tb01904.x; GREENE E, 1989, SCIENCE, V243, P643, DOI 10.1126/science.243.4891.643; Greene E, 1996, BIOL J LINN SOC, V58, P277, DOI 10.1006/bijl.1996.0036; HARRIS M, 1766, AURELIAN; HUDSON A, 1966, CAN J ZOOLOG, V44, P541, DOI 10.1139/z66-058; Kettlewell H.B.D., 1973, EVOLUTION MELANISM; LYMBERY AJ, 1992, BIOL J LINN SOC, V45, P71, DOI 10.1111/j.1095-8312.1992.tb00632.x; Nijhout H.F., 1994, INSECT HORMONES; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; POULTON EB, 1892, T ENTOMOL SOC LONDON, P293; Tanaka S, 2004, ANN ENTOMOL SOC AM, V97, P293, DOI 10.1603/0013-8746(2004)097[0293:ECOBPI]2.0.CO;2; Tanaka S, 2006, J INSECT PHYSIOL, V52, P1054, DOI 10.1016/j.jinsphys.2006.07.004; Tietz H. M, 1972, INDEX DESCRIBED LIFE; Verma KK, 2007, J BIOSCIENCES, V32, P415, DOI 10.1007/s12038-007-0039-7	22	35	37	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3142	10.1371/journal.pone.0003142	http://dx.doi.org/10.1371/journal.pone.0003142			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769543	gold, Green Published, Green Submitted			2022-12-25	WOS:000264419100009
J	Tsigelny, IF; Crews, L; Desplats, P; Shaked, GM; Sharikov, Y; Mizuno, H; Spencer, B; Rockenstein, E; Trejo, M; Platoshyn, O; Yuan, JXJ; Masliah, E				Tsigelny, Igor F.; Crews, Leslie; Desplats, Paula; Shaked, Gideon M.; Sharikov, Yuriy; Mizuno, Hideya; Spencer, Brian; Rockenstein, Edward; Trejo, Margarita; Platoshyn, Oleksandr; Yuan, Jason X. -J.; Masliah, Eliezer			Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; LEWY-BODY-DISEASE; PROTOFIBRILLAR ALPHA-SYNUCLEIN; MOLECULAR-DYNAMICS SIMULATION; BODIES DLB REPORT; LIPID RAFTS; A-BETA; PRECURSOR PROTEIN; IN-VITRO; VESICLE PERMEABILIZATION	Background: Misfolding and pathological aggregation of neuronal proteins has been proposed to play a critical role in the pathogenesis of neurodegenerative disorders. Alzheimer's disease (AD) and Parkinson's disease (PD) are frequent neurodegenerative diseases of the aging population. While progressive accumulation of amyloid beta protein (A beta) oligomers has been identified as one of the central toxic events in AD, accumulation of alpha-synuclein (alpha-syn) resulting in the formation of oligomers and protofibrils has been linked to PD and Lewy body Disease (LBD). We have recently shown that A beta promotes alpha-syn aggregation and toxic conversion in vivo, suggesting that abnormal interactions between misfolded proteins might contribute to disease pathogenesis. However the molecular characteristics and consequences of these interactions are not completely clear. Methodology/Principal Findings: In order to understand the molecular mechanisms involved in potential A beta/alpha-syn interactions, immunoblot, molecular modeling, and in vitro studies with alpha-syn and A beta were performed. We showed in vivo in the brains of patients with AD/PD and in transgenic mice, A beta and alpha-synuclein co-immunoprecipitate and form complexes. Molecular modeling and simulations showed that A beta binds alpha-syn monomers, homodimers, and trimers, forming hybrid ringlike pentamers. Interactions occurred between the N-terminus of A beta and the N-terminus and C-terminus of alpha-syn. Interacting alpha-syn and A beta dimers that dock on the membrane incorporated additional alpha-syn molecules, leading to the formation of more stable pentamers and hexamers that adopt a ring-like structure. Consistent with the simulations, under in vitro cell-free conditions, A beta interacted with alpha-syn, forming hybrid pore-like oligomers. Moreover, cells expressing alpha-syn and treated with A beta displayed increased current amplitudes and calcium influx consistent with the formation of cation channels. Conclusion/Significance: These results support the contention that A beta directly interacts with alpha-syn and stabilized the formation of hybrid nanopores that alter neuronal activity and might contribute to the mechanisms of neurodegeneration in AD and PD. The broader implications of such hybrid interactions might be important to the pathogenesis of other disorders of protein misfolding.	[Tsigelny, Igor F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Desplats, Paula; Shaked, Gideon M.; Mizuno, Hideya; Spencer, Brian; Rockenstein, Edward; Trejo, Margarita; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA USA; [Crews, Leslie; Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA USA; [Platoshyn, Oleksandr; Yuan, Jason X. -J.] Univ Calif San Diego, Dept Med, La Jolla, CA USA; [Tsigelny, Igor F.; Sharikov, Yuriy] Univ Calif San Diego, San Diego Super Comp Ctr, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Tsigelny, IF (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	emasliah@UCSD.edu	Desplats, Paula/AFW-5030-2022; Crews, Leslie/B-7584-2014	Crews, Leslie/0000-0003-0704-0067; Desplats, Paula/0000-0002-4758-4280	NIH; DOE;  [AG18440];  [HL066012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018440, R37AG018440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AG18440, HL066012, and DOE INCITE grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2004, J GERIATR PSYCH NEUR, V17, P137, DOI 10.1177/0891988704267470; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710; Bahr BA, 2002, J NEUROCHEM, V83, P481, DOI 10.1046/j.1471-4159.2002.01192.x; Bar-On P, 2006, J NEUROCHEM, V98, P1032, DOI 10.1111/j.1471-4159.2006.04017.x; BARON P, 2008, J NEUROCHEM IN PRESS; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Bouillot C, 1996, J BIOL CHEM, V271, P7640, DOI 10.1074/jbc.271.13.7640; Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Deramecourt V, 2006, J NEUROPATH EXP NEUR, V65, P278, DOI 10.1097/01.jnen.0000205145.54457.ea; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Furukawa K, 2006, J NEUROCHEM, V97, P1071, DOI 10.1111/j.1471-4159.2006.03803.x; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Giannakis E, 2008, BBA-BIOMEMBRANES, V1778, P1112, DOI 10.1016/j.bbamem.2008.01.012; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Grubmuller H, 1991, MOL SIMULAT, V6, P121, DOI 10.1080/08927029108022142; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hashimoto M, 2004, GENE THER, V11, P1713, DOI 10.1038/sj.gt.3302349; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Janvin CC, 2006, MOVEMENT DISORD, V21, P337, DOI 10.1002/mds.20726; Jellinger KA, 1998, J NEURAL TRANSM-SUPP, P77; Jellinger KA, 2006, ACTA NEUROPATHOL, V112, P253, DOI 10.1007/s00401-006-0088-2; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kazlauskaite J, 2005, BIOCHEM SOC SYMP, V72, P211, DOI 10.1042/bss0720211; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Klein WL, 2002, NEUROBIOL AGING, V23, P231, DOI 10.1016/S0197-4580(01)00312-8; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Kurata T, 2007, J NEUROSCI RES, V85, P2246, DOI 10.1002/jnr.21352; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lippa CF, 2007, NEUROLOGY, V68, P812, DOI 10.1212/01.wnl.0000256715.13907.d3; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Lippa Sara M, 2005, Am J Alzheimers Dis Other Demen, V20, P315, DOI 10.1177/153331750502000506; Litvan I, 1998, ARCH NEUROL-CHICAGO, V55, P969, DOI 10.1001/archneur.55.7.969; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; McKeith IG, 2006, J ALZHEIMERS DIS, V9, P417, DOI 10.1212/wnl.47.5.1113; McKeith IG, 2000, NEUROL CLIN, V18, P865, DOI 10.1016/S0733-8619(05)70230-9; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Mishizen-Eberz AJ, 2005, BIOCHEMISTRY-US, V44, P7818, DOI 10.1021/bi047846q; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; Narayanan V, 2001, BIOCHEMISTRY-US, V40, P9927, DOI 10.1021/bi002952n; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; PETTEGREW J, 1989, BIOL MARKERS ALZHEIM, P83; Pletnikova O, 2005, NEUROBIOL AGING, V26, P1183, DOI 10.1016/j.neurobiolaging.2004.10.006; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Rockenstein E, 2002, J NEURAL TRANSM-SUPP, P327; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Sharikov Y, 2008, NAT METHODS, V5, P119, DOI 10.1038/nmeth0208-119; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SISODIA SS, 1995, FASEB J, V9, P366, DOI 10.1096/fasebj.9.5.7896005; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Smith DP, 2008, BIOCHEMISTRY-US, V47, P1425, DOI 10.1021/bi701522m; SOTO C, 1994, J NEUROCHEM, V63, P1191; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeda A, 1998, AM J PATHOL, V152, P367; Terry RD, 2006, J GERIATR PSYCH NEUR, V19, P125, DOI 10.1177/0891988706291079; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Tu K, 1995, BIOPHYS J, V69, P2558, DOI 10.1016/S0006-3495(95)80126-8; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Uversky VN, 2001, J BIOL CHEM, V276, P43495, DOI 10.1074/jbc.C100551200; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Williamson R, 2008, FASEB J, V22, P1552, DOI 10.1096/fj.07-9766com; Yang FS, 2000, BRAIN RES, V853, P381, DOI 10.1016/S0006-8993(99)02207-6; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; YOSHIMOTO M, 1995, P NATL ACAD SCI USA, V92, P9141, DOI 10.1073/pnas.92.20.9141; YU J, 2008, J NEUROIMMUNE PHARM; Zakharov SD, 2007, BIOCHEMISTRY-US, V46, P14369, DOI 10.1021/bi701275p; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	112	203	213	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3135	10.1371/journal.pone.0003135	http://dx.doi.org/10.1371/journal.pone.0003135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769546	Green Published, gold, Green Submitted			2022-12-25	WOS:000264419100005
J	Benjak, A; Forneck, A; Casacuberta, JM				Benjak, Andrej; Forneck, Astrid; Casacuberta, Josep M.			Genome-Wide Analysis of the "Cut-and-Paste'' Transposons of Grapevine	PLOS ONE			English	Article							VITIS-VINIFERA L.; MUTATOR-LIKE ELEMENTS; ARABIDOPSIS-THALIANA; GENE FRAGMENTS; PIF-LIKE; FAMILY; SEQUENCE; EVOLUTION; RICE; DIVERSITY	Background: The grapevine is a widely cultivated crop and a high number of different varieties have been selected since its domestication in the Neolithic period. Although sexual crossing has been a major driver of grapevine evolution, its vegetative propagation enhanced the impact of somatic mutations and has been important for grapevine diversity. Transposable elements are known to be major contributors to genome variability and, in particular, to somatic mutations. Thus, transposable elements have probably played a major role in grapevine domestication and evolution. The recent publication of the complete grapevine genome opens the possibility for an in deep analysis of its transposon content. Principal Findings: We present here a detailed analysis of the "cut-and-paste'' class II transposons present in the genome of grapevine. We characterized 1160 potentially complete grapevine transposons as well as 2086 defective copies. We report on the structure of each element, their potentiality to encode a functional transposase, and the existence of matching ESTs that could suggest their transcription. Conclusions: Our results show that these elements have transduplicated and amplified cellular sequences and some of them have been domesticated and probably fulfill cellular functions. In addition, we provide evidences that the mobility of these elements has contributed to the genomic variability of this species.	[Benjak, Andrej; Casacuberta, Josep M.] CRAG, Dept Genet Mol Vegetal, Barcelona, Spain; [Benjak, Andrej; Forneck, Astrid] Univ Nat Resources & Appl Life Sci, Inst Horticulture & Viticulture, Vienna, Austria	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; University of Natural Resources & Life Sciences, Vienna	Benjak, A (corresponding author), CRAG, Dept Genet Mol Vegetal, Barcelona, Spain.	jcsgmp@cid.csic.es	forneck, astrid/C-2946-2008	Benjak, Andrej/0000-0003-4522-6575; Casacuberta, josep/0000-0002-5609-4152	Ministerio de Educacion y Ciencia [BFU2006-04005]; Xarxa de Referencia en Biotecnologia from the Generalitat de Catalunya; EMBO [ASTF 115-07]	Ministerio de Educacion y Ciencia(Spanish Government); Xarxa de Referencia en Biotecnologia from the Generalitat de Catalunya(Generalitat de Catalunya); EMBO(European Molecular Biology Organization (EMBO))	This work was partially funded by a grant of the Ministerio de Educacion y Ciencia (Grant BFU2006-04005) and the Xarxa de Referencia en Biotecnologia from the Generalitat de Catalunya to J.M.C. A.B. was partially funded by an EMBO Short Term Fellowship (ASTF 115-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Barabas O, 2008, CELL, V132, P208, DOI 10.1016/j.cell.2007.12.029; Bundock P, 2005, NATURE, V436, P282, DOI 10.1038/nature03667; Casola C, 2007, MOL BIOL EVOL, V24, P1872, DOI 10.1093/molbev/msm116; Chalvet F, 2003, MOL BIOL EVOL, V20, P1362, DOI 10.1093/molbev/msg155; Cowan RK, 2005, MOL BIOL EVOL, V22, P2084, DOI 10.1093/molbev/msi202; Feschotte C, 2005, NUCLEIC ACIDS RES, V33, P2153, DOI 10.1093/nar/gki509; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; FORNECK A, 2005, PROGR BOT, P165; Franks T, 2002, THEOR APPL GENET, V104, P192, DOI 10.1007/s001220100683; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guynet C, 2008, MOL CELL, V29, P302, DOI 10.1016/j.molcel.2007.12.008; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hoen DR, 2006, MOL BIOL EVOL, V23, P1254, DOI 10.1093/molbev/msk015; Holligan D, 2006, GENETICS, V174, P2215, DOI 10.1534/genetics.106.062752; Hudson ME, 2003, PLANT J, V34, P453, DOI 10.1046/j.1365-313X.2003.01741.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Juretic N, 2005, GENOME RES, V15, P1292, DOI 10.1101/gr.4064205; JURKA J, 2005, REPBASE REPORTS, V5, P201; JURKA J, 2005, REPBASE REPORTS, V5, P205; Kapitonov VV, 1999, GENETICA, V107, P27, DOI 10.1023/A:1004030922447; Kapitonov VV, 2004, DNA CELL BIOL, V23, P311, DOI 10.1089/104454904323090949; Kawasaki S, 2004, PLANT CELL PHYSIOL, V45, P933, DOI 10.1093/pcp/pch109; Kempken F, 2001, CHROMOSOMA, V110, P1, DOI 10.1007/s004120000118; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LE Q, 2007, MOL GENET GENOMICS, V278, P1617; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; Lijavetzky D, 2006, MOL GENET GENOMICS, V276, P427, DOI 10.1007/s00438-006-0149-1; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Miura A, 2004, MOL GENET GENOMICS, V270, P524, DOI 10.1007/s00438-003-0943-y; Muehlbauer GJ, 2006, MOL GENET GENOMICS, V275, P553, DOI 10.1007/s00438-006-0098-8; Pelsy F, 2002, THEOR APPL GENET, V105, P614, DOI 10.1007/s00122-002-0969-2; ROBERTSON DS, 1978, MUTAT RES, V51, P21, DOI 10.1016/0027-5107(78)90004-0; Rubin E, 2001, GENETICS, V158, P949; Saccaro NJ, 2007, GENE, V392, P117, DOI 10.1016/j.gene.2006.11.017; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turcotte K, 2001, PLANT J, V25, P169, DOI 10.1046/j.1365-313x.2001.00945.x; van Leeuwen H, 2007, MOL GENET GENOMICS, V277, P357, DOI 10.1007/s00438-006-0194-9; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Verries C, 2000, GENOME, V43, P366, DOI 10.1139/gen-43-2-366; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wicker T, 2003, PLANT PHYSIOL, V132, P52, DOI 10.1104/pp.102.015743; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xu ZN, 2004, PLANT CELL, V16, P1105, DOI 10.1105/tpc.019802; Yu ZH, 2000, GENETICS, V156, P2019; Zabala G, 2005, PLANT CELL, V17, P2619, DOI 10.1105/tpc.105.033506; Zabala G, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-38; Zhang XY, 2004, P NATL ACAD SCI USA, V101, P5589, DOI 10.1073/pnas.0401243101; Zhang XY, 2004, GENETICS, V166, P971, DOI 10.1534/genetics.166.2.971	56	40	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3107	10.1371/journal.pone.0003107	http://dx.doi.org/10.1371/journal.pone.0003107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769592	Green Published, gold			2022-12-25	WOS:000264418300002
J	Kivimaki, M; Lawlor, DA; Smith, GD; Kumari, M; Donald, A; Britton, A; Casas, JP; Shah, T; Brunner, E; Timpson, NJ; Halcox, JPJ; Miller, MA; Humphries, SE; Deanfield, J; Marmot, MG; Hingorani, AD				Kivimaeki, Mika; Lawlor, Debbie A.; Smith, George Davey; Kumari, Meena; Donald, Ann; Britton, Annie; Casas, Juan P.; Shah, Tina; Brunner, Eric; Timpson, Nicholas J.; Halcox, Julian P. J.; Miller, Michelle A.; Humphries, Steve E.; Deanfield, John; Marmot, Michael G.; Hingorani, Aroon D.			Does High C-reactive Protein Concentration Increase Atherosclerosis? The Whitehall II Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; CRP GENE POLYMORPHISMS; MENDELIAN RANDOMIZATION; INTERINDIVIDUAL VARIABILITY; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; METABOLIC-SYNDROME; PROMOTER REGION; WEIGHT-LOSS	Background: C-reactive protein (CRP), a marker of systemic inflammation, is associated with risk of coronary events and subclinical measures of atherosclerosis. Evidence in support of this link being causal would include an association robust to adjustments for confounders (multivariable standard regression analysis) and the association of CRP gene polymorphisms with atherosclerosis (Mendelian randomization analysis). Methodology/Principal Findings: We genotyped 3 tag single nucleotide polymorphisms (SNPs) [+ 1444T>C (rs1130864); +2303G>A (rs1205) and +4899T>G (rs 3093077)] in the CRP gene and assessed CRP and carotid intima-media thickness (CIMT), a structural marker of atherosclerosis, in 4941 men and women aged 50-74 (mean 61) years (the Whitehall II Study). The 4 major haplotypes from the SNPs were consistently associated with CRP level, but not with other risk factors that might confound the association between CRP and CIMT. CRP, assessed both at mean age 49 and at mean age 61, was associated both with CIMT in age and sex adjusted standard regression analyses and with potential confounding factors. However, the association of CRP with CIMT attenuated to the null with adjustment for confounding factors in both prospective and cross-sectional analyses. When examined using genetic variants as the instrument for serum CRP, there was no inferred association between CRP and CIMT. Conclusions/Significance: Both multivariable standard regression analysis and Mendelian randomization analysis suggest that the association of CRP with carotid atheroma indexed by CIMT may not be causal.	[Kivimaeki, Mika; Kumari, Meena; Britton, Annie; Brunner, Eric; Marmot, Michael G.; Hingorani, Aroon D.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Lawlor, Debbie A.; Smith, George Davey; Timpson, Nicholas J.] Univ Bristol, Dept Social Med, Ctr Causal Anal Translat Epidemiol, Med Res Council, Bristol BS8 1TH, Avon, England; [Donald, Ann; Halcox, Julian P. J.; Deanfield, John] UCL, Inst Child Hlth, Vasc Physiol Unit, London WC1E 6BT, England; [Donald, Ann; Deanfield, John] Great Ormond St Hosp NHS Trust, London, England; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; [Shah, Tina; Hingorani, Aroon D.] UCL, Dept Med, London WC1E 6BT, England; [Miller, Michelle A.] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Humphries, Steve E.] UCL, Ctr Cardiovasc Genet, London WC1E 6BT, England	University of London; University College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bristol; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Warwick; University of London; University College London	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	m.kivimaki@ucl.ac.uk	Fox, Laura J/C-6249-2016; Marmot, M G/Y-3920-2019; Timpson, Nicholas John/O-7548-2015; Kivimaki, Mika/B-3607-2012; Attrill, Lauren/V-1688-2018; Miller, Michelle A/D-1840-2009; Davey Smith, George/A-7407-2013; Brunner, Eric/H-2114-2011	Marmot, M G/0000-0002-2431-6419; Timpson, Nicholas John/0000-0002-7141-9189; Kivimaki, Mika/0000-0002-4699-5627; Miller, Michelle A/0000-0002-6696-0923; Davey Smith, George/0000-0002-1407-8314; Brunner, Eric/0000-0002-0595-4474; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hingorani, Aroon/0000-0001-8365-0081; Humphries, Stephen E/0000-0002-8221-6547; Shah, Tina/0000-0001-7724-7210; Halcox, Julian/0000-0001-6926-2947; s, hema/0000-0002-3440-9475; Lawlor, Debbie A/0000-0002-6793-2262; Kumari, Meena/0000-0001-9716-1035; Deanfield, John/0000-0001-8806-6052	Medical Research Council [Research Professorship]; British Heart Foundation [PG2005/014, FS/02/086/14760]; Health and Safety Executive; Department of Health [Career Scientist Award]; National Heart Lung and Blood Institute, US, NIH [HL36310]; National Institute on Aging, US, NIH [AG13196]; Agency for Health Care Policy Research [HS06516]; John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Academy of Finland [117604]; MRC; British Heart Foundation (BHF); British Heart Foundation [RG/07/008/23674, RG/08/008/25291] Funding Source: researchfish; Medical Research Council [G0600705, G0100222, G8802774, G19/35] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013196, R01AG013196] Funding Source: NIH RePORTER; MRC [G0600705] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Academy of Finland(Academy of Finland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation (BHF)(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Whitehall II study has been supported by grants from the Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute (HL36310), US, NIH: National Institute on Aging (AG13196), US, NIH; Agency for Health Care Policy Research (HS06516); and the John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. Mi.K. is supported by the Academy of Finland (Projects no. 117604), D.A.L. by a UK Department of Health Career Scientist Award, M.G.M. by a MRC Research Professorship. A.D.H. holds a British Heart Foundation Senior Research Fellowship, and S.E.H. and J.E.D. received Chair support from the British Heart Foundation (BHF). S.E.H. and T.S. are supported by the BHF (PG2005/014 and (FS/02/086/14760). Funders had no role in the design and conduct of the study, in the collection, analysis, interpretation of the data, or in the preparation, review, or approval of the manuscript.	Bots ML, 2006, CURR MED RES OPIN, V22, P2181, DOI 10.1185/030079906X148472; Bots ML, 1997, STROKE, V28, P2442, DOI 10.1161/01.STR.28.12.2442; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Danesh J, 2008, EUR J EPIDEMIOL, V23, P531, DOI 10.1007/s10654-008-9249-z; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de Maat MPM, 2004, CURR OPIN LIPIDOL, V15, P651, DOI 10.1097/00041433-200412000-00005; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Dhingra R, 2007, AM J MED, V120, P1054, DOI 10.1016/j.amjmed.2007.08.037; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Kivimaki M, 2005, ARTERIOSCL THROM VAS, V25, P2197, DOI 10.1161/01.ATV.0000183729.91449.6e; Kivimaki M, 2007, ARTERIOSCL THROM VAS, V27, P978, DOI 10.1161/01.ATV.0000258869.48076.14; Kivimaki M, 2007, AM J EPIDEMIOL, V166, P760, DOI 10.1093/aje/kwm151; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Kovacs A, 2005, ATHEROSCLEROSIS, V178, P193, DOI 10.1016/j.atherosclerosis.2004.08.018; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Lawlor DA, 2005, THROMB HAEMOSTASIS, V93, P955, DOI 10.1160/TH04-12-0805; LAWLOR DA, 2008, PLOS ONE IN PRESS; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lorenz MW, 2007, STROKE, V38, P1774, DOI 10.1161/STROKEAHA.106.476135; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lowe Gordon D O, 2006, Curr Atheroscler Rep, V8, P421, DOI 10.1007/s11883-006-0040-x; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; O'Brien KD, 2005, J CLIN ENDOCR METAB, V90, P2244, DOI 10.1210/jc.2004-1011; Pai JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001395; Pepys MB, 2005, CIRC RES, V97, pE97, DOI 10.1161/01.RES.0000193595.03608.08; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Reilly MP, 2003, ARTERIOSCL THROM VAS, V23, P1851, DOI 10.1161/01.ATV.0000092327.60858.4A; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rose G, 1982, CARDIOVASCULAR SURVE; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, P1051, DOI 10.1161/01.ATV.0000160351.95181.d0; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Suk HJ, 2005, ATHEROSCLEROSIS, V178, P139, DOI 10.1016/j.atherosclerosis.2004.07.033; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Szalai AJ, 2005, RHEUMATOLOGY, V44, P864, DOI 10.1093/rheumatology/keh613; Timpson NJ, 2006, CIRCULATION, V114, pE256, DOI 10.1161/CIRCULATIONAHA.106.638387; Timpson NJ, 2005, LANCET, V366, P1954, DOI 10.1016/S0140-6736(05)67786-0; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Tzoulaki I, 2008, EUR HEART J, V29, P1049, DOI 10.1093/eurheartj/ehn105; Verma S, 2006, CIRCULATION, V113, P2135; Verzilli C, 2008, AM J HUM GENET, V82, P859, DOI 10.1016/j.ajhg.2008.01.016; Wang TJ, 2002, ARTERIOSCL THROM VAS, V22, P1662, DOI 10.1161/01.ATV.0000034543.78801.69; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	56	36	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3013	10.1371/journal.pone.0003013	http://dx.doi.org/10.1371/journal.pone.0003013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714381	Green Published, gold, Green Submitted			2022-12-25	WOS:000264420900038
J	Raizada, N; Chauhan, LS; Khera, A; Sokhey, J; Wares, DF; Sahu, S; Thakur, R; Dewan, PK				Raizada, Neeraj; Chauhan, Lakbir Singh; Khera, Ajay; Sokhey, Jotna; Wares, D. Fraser; Sahu, Suvanand; Thakur, Rahul; Dewan, Puneet Kumar			HIV Seroprevalence among Tuberculosis Patients in India, 2006-2007	PLOS ONE			English	Article								Background: Little information exists regarding the burden of HIV among tuberculosis patients in India, and no population-based surveys have been previously reported. A community-based HIV prevalence survey was conducted among tuberculosis patients treated by the national tuberculosis control programme to evaluate the HIV prevalence among tuberculosis patients in India. Methodology/Principal Findings: Fifteen districts (total population: 40.2 million) across 8 states were stratified by HIV prevalence in antenatal clinic HIV surveillance sites and randomly selected. From December 2006 to May 2007, remnant serum was collected from patients' clinical specimens taken after 2 months of anti-tuberculosis treatment and subjected to anonymous, unlinked HIV testing. Specimens were obtained and successfully tested for 5,995 (73%) of 8,217 tuberculosis patients eligible for the survey. HIV prevalence ranged widely among the 15 surveyed districts, from 1% in Koch Bihar, West Bengal, to 13.8% in Guntur, Andhra Pradesh. HIV infection was 1.3 times more likely among male TB patients than among female patients. Relative to smear-positive tuberculosis, HIV infection was 1.4 times more likely among smear-negative patients and 1.3 times more likely among extrapulmonary patients. In 4 higher-HIV prevalence districts, which had been previously surveyed in 2005-2006, no significant change in HIV prevalence was detected. Conclusions: The burden of HIV among tuberculosis patients varies widely in India. Programme efforts to implement comprehensive TB-HIV services should be targeted to areas with the highest HIV burden. Surveillance through routine reporting or special surveys is necessary to detect areas requiring intensification of TB-HIV collaborative activities.	[Raizada, Neeraj; Wares, D. Fraser; Sahu, Suvanand; Thakur, Rahul] Off WHO Representat India, New Delhi, India; [Chauhan, Lakbir Singh] Directorate Gen Hlth Serv, Cent Tuberculosis Div, New Delhi, India; [Khera, Ajay; Sokhey, Jotna] Minist Hlth & Family Welfare, Natl AIDS Control Org, New Delhi, India; [Dewan, Puneet Kumar] WHO, Southeast Asia Region Office, New Delhi, India	World Health Organization; World Health Organization	Raizada, N (corresponding author), Off WHO Representat India, New Delhi, India.	dewanp@searo.who.int		Raizada, Neeraj/0000-0003-2116-332X				Burman William J, 2003, Semin Respir Infect, V18, P263; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; DECOCK KM, 1992, JAMA-J AM MED ASSOC, V268, P1581, DOI 10.1001/jama.1992.03490120095035; Dey S K, 2003, Indian J Public Health, V47, P37; Hussain T, 2006, TUBERCULOSIS, V86, P54, DOI 10.1016/j.tube.2005.07.001; Hussain T, 2007, TUBERCULOSIS, V87, P7, DOI 10.1016/j.tube.2006.01.001; Lienhardt C, 1997, INT J TUBERC LUNG D, V1, P196; Mawar N, 2005, INDIAN J MED RES, V122, P471; Mehrotra Ravi, 2006, Indian J Pathol Microbiol, V49, P302; *MIN HLTH FAM WELF, 2008, NAT FRAM JOINT TB HI; *MIN HLTH FAM WELF, 2006, RNTCP STAT REP; *MIN HLTH FAM WELF, TECH REP IND HIV EST; *MIN HLTH FAM WELF, 2005, TECHN OP GUID TB CON; *MIN HLTH FAM WELF, TB IND 2007 RNTCP ST; Ministry of Health and Family Welfare Government of India 2008, 2006, HIV SENT SURV HIV ES; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Piramanayagam P, 2007, INDIAN J MED RES, V125, P163; Ramachandran R, 2003, INDIAN J MED RES, V118, P147; Shah I, 2007, HIV MED, V8, P265, DOI 10.1111/j.1468-1293.2007.00457.x; Sharma SK, 2003, INDIAN J MED RES, V117, P239; *WHO, 2004, INT POL COLL TB HIV; *WHO, 2004, WHOHTMTB2004339; WHO, 2007, WHOHTMTB2007376	24	24	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2970	10.1371/journal.pone.0002970	http://dx.doi.org/10.1371/journal.pone.0002970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714335	Green Submitted, Green Published, gold			2022-12-25	WOS:000264420900001
J	Plagnol, V; Uz, E; Wallace, C; Stevens, H; Clayton, D; Ozcelik, T; Todd, JA				Plagnol, Vincent; Uz, Elif; Wallace, Chris; Stevens, Helen; Clayton, David; Ozcelik, Tayfun; Todd, John A.			Extreme Clonality in Lymphoblastoid Cell Lines with Implications for Allele Specific Expression Analyses	PLOS ONE			English	Article								Lymphoblastoid cell lines (LCL) are being actively and extensively used to examine the expression of specific genes and genome-wide expression profiles, including allele specific expression assays. However, it has recently been shown that approximately 10% of human genes exhibit random patterns of monoallelic expression within single clones of LCLs. Consequently allelic imbalance studies could be significantly compromised if bulk populations of donor cells are clonal, or near clonal. Here, using X chromosome inactivation as a readout, we confirm and quantify widespread near monoclonality in two independent sets of cell lines. Consequently, we recommend where possible the use of bulk, non cell line, ex vivo cells for allele specific expression assays.	[Plagnol, Vincent; Stevens, Helen; Clayton, David; Todd, John A.] Univ Cambridge, JDRF WT Diabet & Inflammat Lab, Cambridge, England; [Uz, Elif] Bilkent Univ, Fac Sci, Dept Mol Biol & Genet, Ankara, Turkey; [Wallace, Chris] William Harvey Res Inst, Barts & The London, London, England; [Ozcelik, Tayfun] Bilkent Univ, Inst Mat Sci & Nanotechnol UNAM, Ankara, Turkey	University of Cambridge; Ihsan Dogramaci Bilkent University; University of London; Queen Mary University London; Ihsan Dogramaci Bilkent University	Plagnol, V (corresponding author), Univ Cambridge, JDRF WT Diabet & Inflammat Lab, Cambridge, England.	vincent.plagnol@cimr.cam.ac.uk	Uz, Elif/A-4666-2012; Todd, John A/A-3542-2010; Plagnol, Vincent/A-5667-2011	Todd, John A/0000-0003-2740-8148; Wallace, Chris/0000-0001-9755-1703; Plagnol, Vincent/0000-0002-5597-9215	Juvenile Diabetes Research Foundation [postdoctoral fellow]; National Institute for Health Research (NIHR); Cambridge Biomedical Research Centre; Wellcome Trust [079895]; British Heart Foundation [FS/05/061/19501]; Scientifical and Technical Research Council of Turkey [TUBITAK-SBAG3334]; International Centre for Genetic Engineering and Biotechnology [ICGEB-CRP/TUR04-01]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Cambridge Biomedical Research Centre(General Electric); Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Scientifical and Technical Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); International Centre for Genetic Engineering and Biotechnology	We thank the Juvenile Diabetes Research Foundation, the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre and the Wellcome Trust for funding. The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (079895). CW is funded by the British Heart Foundation (FS/05/061/19501). VP is a Juvenile Diabetes Research Foundation postdoctoral fellow. EU and TO are supported by grants from the Scientifical and Technical Research Council of Turkey (TUBITAK-SBAG3334) an International Centre for Genetic Engineering and Biotechnology (ICGEB-CRP/TUR04-01, to TO).	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Bione S, 2006, AM J MED GENET A, V140A, P1349, DOI 10.1002/ajmg.a.31312; Bretherick KL, 2007, AM J MED GENET A, V143A, P945, DOI 10.1002/ajmg.a.31679; Brix TH, 2005, J CLIN ENDOCR METAB, V90, P5949, DOI 10.1210/jc.2005-1366; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Forton JT, 2007, GENOME RES, V17, P82, DOI 10.1101/gr.5663007; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Lanasa MC, 2001, AM J OBSTET GYNECOL, V185, P563, DOI 10.1067/mob.2001.117670; MIGEON BR, 1988, AM J HUM GENET, V42, P742; Ozbalkan Z, 2005, ARTHRITIS RHEUM-US, V52, P1564, DOI 10.1002/art.21026; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; RAABTRAUB N, 1986, CELL, V47, P883, DOI 10.1016/0092-8674(86)90803-2; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; TRAINOR KJ, 1990, BLOOD, V75, P2220	18	45	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2966	10.1371/journal.pone.0002966	http://dx.doi.org/10.1371/journal.pone.0002966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698422	gold, Green Submitted, Green Published			2022-12-25	WOS:000264412600051
J	Baetz, A; Koelsche, C; Strebovsky, J; Heeg, K; Dalpke, AH				Baetz, Andrea; Koelsche, Christian; Strebovsky, Julia; Heeg, Klaus; Dalpke, Alexander H.			Identification of a nuclear localization signal in suppressor of cytokine signaling 1	FASEB JOURNAL			English	Article						cell activation; cytokine receptors; inflammation; signal transduction	NF-KAPPA-B; SOCS-BOX MOTIF; NEGATIVE REGULATION; UBIQUITIN LIGASE; IFN-GAMMA; IN-VIVO; DEGRADATION; PROTEINS; RECEPTOR; SUBUNIT	Suppressor of cytokine signaling (SOCS) proteins are inducible feedback inhibitors of janus kinase and signal transducer and activators of transcription signaling pathways. In addition, SOCS1 has been identified to regulate stability of nuclear NF-kappa B subunits. However, details about the regulation of the nuclear pool of SOCS1 are unknown. Using different experimental approaches, we observed that SOCS1 but no further SOCS family members localized to the nucleus when expressed in various cell lines. Nuclear transport was confirmed for endogenous SOCS1 in macrophages stimulated with IFN-gamma. Sequence analysis revealed a bipartite nuclear localization signal (NLS) located between the src-homology 2 (SH2) domain and the SOCS box of SOCS1. Deletion of this region, introduction of a series of R/A point mutations, or substitution of this sequence with the respective region of SOCS3 resulted in loss of nuclear localization. Fusion of the SOCS1-NLS to cytokine-inducible SH2 region containing protein (CIS) resulted in nuclear localization of this otherwise cytoplasmic protein. SOCS1 mutants with loss of nuclear localization were still effective in suppressing IFN-alpha-mediated STAT1 tyrosine phosphorylation. However, they showed decreased inhibition of IFN-alpha-mediated induction of CD54. The results identify a hitherto unknown transport of SOCS1 into the nucleus which extends the spectrum of SOCS1 inhibitory activity.-Baetz, A., Koelsche, C., Strebovsky, J., Heeg, K., Dalpke, A. H. Identification of a nuclear localization signal in suppressor of cytokine signaling 1. FASEB J. 22, 4296-4305 (2008)	[Baetz, Andrea; Koelsche, Christian; Strebovsky, Julia; Heeg, Klaus; Dalpke, Alexander H.] Univ Heidelberg, Inst Hyg, Dept Hyg & Med Microbiol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Dalpke, AH (corresponding author), Univ Heidelberg, Inst Hyg, Dept Hyg & Med Microbiol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	alexander.dalpke@med.uni-heidelberg.de	Kölsche, Christian/Q-8854-2019	Koelsche, Christian/0000-0001-8763-8864	German Research Foundation [Da592/2,-3]	German Research Foundation(German Research Foundation (DFG))	This work was supported by grants of the German Research Foundation to A. D. (Da592/2, -3).	Ahmed CMI, 2006, J IMMUNOL, V177, P315, DOI 10.4049/jimmunol.177.1.315; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Ben-Yair L, 2002, PROTEIN EXPRES PURIF, V25, P456, DOI 10.1016/S1046-5928(02)00044-X; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Eyles JL, 2002, J BIOL CHEM, V277, P43735, DOI 10.1074/jbc.M208586200; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Kamio M, 2004, ONCOGENE, V23, P3107, DOI 10.1038/sj.onc.1207453; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Ketteler R, 2003, J BIOL CHEM, V278, P2654, DOI 10.1074/jbc.M211236200; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; Lee KH, 2008, FEBS LETT, V582, P2319, DOI 10.1016/j.febslet.2008.05.039; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Metcalf D, 2002, P NATL ACAD SCI USA, V99, P943, DOI 10.1073/pnas.022628499; Naka T, 2005, ADV IMMUNOL, V87, P61, DOI 10.1016/S0065-2776(05)87003-8; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saleh AZM, 2004, ONCOGENE, V23, P7076, DOI 10.1038/sj.onc.1207955; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Siewert E, 1999, EUR J BIOCHEM, V265, P251, DOI 10.1046/j.1432-1327.1999.00719.x; Subramaniam PS, 2004, FEBS LETT, V578, P207, DOI 10.1016/j.febslet.2004.10.085; Vuong BQ, 2004, MOL CELL BIOL, V24, P9092, DOI 10.1128/MCB.24.20.9092-9101.2004; Yang CH, 2000, P NATL ACAD SCI USA, V97, P13631, DOI 10.1073/pnas.250477397; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498	39	33	35	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4296	4305		10.1096/fj.08-116079	http://dx.doi.org/10.1096/fj.08-116079			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18725457				2022-12-25	WOS:000261254800028
J	Zhao, JM; Wen, YJ; Li, Q; Wang, YS; Wu, HB; Xu, JR; Chen, XC; Wu, Y; Fan, LY; Yang, HS; Liu, T; Ding, ZY; Du, XB; Diao, P; Li, J; Wu, HB; Kan, B; Lei, S; Deng, HX; Mao, YQ; Zhao, X; Wei, YQ				Zhao, Ju-mei; Wen, Yan-jun; Li, Qiu; Wang, Yong-sheng; Wu, Hong-bo; Xu, Jian-rong; Chen, Xian-cheng; Wu, Yang; Fan, Ling-yu; Yang, Han-shuo; Liu, Tao; Ding, Zhen-yu; Du, Xiao-bo; Diao, Peng; Li, Jiong; Wu, Hong-bing; Kan, Bing; Lei, Song; Deng, Hong-xin; Mao, Yong-qiu; Zhao, Xia; Wei, Yu-quan			A promising cancer gene therapy agent based on the matrix protein of vesicular stomatitis virus	FASEB JOURNAL			English	Article						apoptosis; cellular immune response; plasmid DNA; cationic liposome; cytotoxic T lymphocytes; CTLs	T-CELLS; IN-VIVO; DENDRITIC CELLS; TUMOR-CELLS; APOPTOSIS; INDUCTION; IMMUNOTHERAPY; INVOLVEMENT; GROWTH; DNA	The matrix (M) protein of vesicular stomatitis virus (VSV) plays a key role in inducing cell apoptosis during infection. To investigate whether M protein-mediated apoptosis could be used in cancer therapy, its cDNA was amplified and cloned into eukaryotic expression vector pcDNA3.1(+). The recombinant plasmid or the control empty plasmid pcDNA3.1(+) was mixed with cationic liposome and introduced into various tumor cell lines in vitro, including lung cancer cell LLC, A549, colon cancer cell CT26 and fibrosarcoma cell MethA. Our data showed that the M protein induced remarkable apoptosis of cancer cells in vitro compared with controls. Fifty micrograms of plasmid in a complex with 250 mu g cationic liposome was injected intratumorally into mice bearing LLC or MethA tumor model every 3 days for 6 times. It was found that the tumors treated with M protein plasmid grew much more slowly, and the survival of the mice was significantly prolonged compared with the mice treated with the control plasmid. In MethA fibrosarcoma, the tumors treated with M protein plasmid were even completely regressed, and the mice acquired longtime protection against the same tumor cell in rechallenge experiments. Both apoptotic cells and CD8(+) T cells were widely distributed in M protein plasmid-treated tumor tissue. Activated cytotoxic T lymphocytes (CTLs) were further detected by means of 51Cr release assay in the spleen of the treated mice. These results showed that M protein of VSV can act as both apoptosis inducer and immune response initiator, which may account for its extraordinary antitumor effect and warrant its further development in cancer gene therapy.-Zhao, J., Wen, Y., Li, Q., Wang, Y., Wu, H., Xu, J., Chen, X., Wu, Y., Fan, L., Yang, H., Liu, T., Ding, Z., Du, X., Diao, P., Li, J., Wu, H., Kan, B., Lei, S., Deng, H., Mao, Y., Zhao, X., Wei, Y. A promising cancer gene therapy agent based on the matrix protein of vesicular stomatitis virus. FASEB J. 22, 4272-4280 (2008)	[Zhao, Ju-mei; Wen, Yan-jun; Li, Qiu; Wang, Yong-sheng; Wu, Hong-bo; Chen, Xian-cheng; Wu, Yang; Fan, Ling-yu; Yang, Han-shuo; Liu, Tao; Ding, Zhen-yu; Du, Xiao-bo; Diao, Peng; Li, Jiong; Wu, Hong-bing; Kan, Bing; Lei, Song; Deng, Hong-xin; Mao, Yong-qiu; Zhao, Xia; Wei, Yu-quan] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Xu, Jian-rong] Sichuan Univ, Coll Life Sci, Chengdu 610041, Sichuan, Peoples R China; [Zhao, Ju-mei] Yanan Univ, Coll Med, Dept Pharmacol, Yanan, Shanxi, Peoples R China	Sichuan University; Sichuan University; Yanan University	Wen, YJ (corresponding author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China.	julio_wy@sohu.com		Wei, Yu-quan/0000-0002-6211-3217	The National Key Basic Research Program (973 Program) of China [2004CB518800, 2004CB518706]; Hi-tech Research and Development Program ( 863 Program) of China [2007AA021106, 2006AA02Z488]	The National Key Basic Research Program (973 Program) of China(National Basic Research Program of China); Hi-tech Research and Development Program ( 863 Program) of China(National High Technology Research and Development Program of China)	This work is supported by The National Key Basic Research Program (973 Program) of China (2004CB518800 and 2004CB518706), Hi-tech Research and Development Program ( 863 Program) of China (2007AA021106, 2006AA02Z488).	BARRY MA, 1993, CANCER RES, V53, P2349; Ben-Efraim S, 2000, BIOMED PHARMACOTHER, V54, P268, DOI 10.1016/S0753-3322(00)80070-0; Ding HF, 2002, ANN MED, V34, P451, DOI 10.1080/078538902321012405; Fields RC, 1998, P NATL ACAD SCI USA, V95, P9482, DOI 10.1073/pnas.95.16.9482; GORCZYCA W, 1993, CANCER RES, V53, P3186; Kalinke U, 1996, IMMUNITY, V5, P639, DOI 10.1016/S1074-7613(00)80277-0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; PLAUTZ GE, 1993, P NATL ACAD SCI USA, V90, P4645, DOI 10.1073/pnas.90.10.4645; Preynat-Seauve O, 2006, J IMMUNOL, V176, P61, DOI 10.4049/jimmunol.176.1.61; PUDDINGTON L, 1986, J VIROL, V60, P708, DOI 10.1128/JVI.60.2.708-717.1986; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Sauter BV, 2000, P NATL ACAD SCI USA, V97, P4802, DOI 10.1073/pnas.090065597; Schirrmacher V, 1999, GENE THER, V6, P63, DOI 10.1038/sj.gt.3300787; Tousignant JD, 2000, HUM GENE THER, V11, P2493, DOI 10.1089/10430340050207984; WEI YQ, 1994, CANCER RES, V54, P4952; Wei YQ, 1996, CANCER RES, V56, P1104; WEI YQ, 1992, HUM PATHOL, V23, P421, DOI 10.1016/0046-8177(92)90090-P; Yew NS, 2005, ADV GENET, V53, P189, DOI 10.1016/S0065-2660(05)53007-4; YEWDELL JW, 1986, J EXP MED, V163, P1529, DOI 10.1084/jem.163.6.1529; Zhang H., 2007, Experimental Oncology, V29, P85	20	24	24	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4272	4280		10.1096/fj.08-110049	http://dx.doi.org/10.1096/fj.08-110049			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18716030				2022-12-25	WOS:000261254800026
J	Andrews, AJ; Downing, G; Brown, K; Park, YJ; Luger, K				Andrews, Andrew J.; Downing, Gregory; Brown, Kitty; Park, Young-Jun; Luger, Karolin			A Thermodynamic Model for Nap1-Histone Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME ASSEMBLY PROTEIN-1; HISTONE CHAPERONE NAP1; 4-WAY JUNCTION DNA; RECOMBINANT HISTONES; IONIC-STRENGTH; CORE HISTONES; BINDING; RECONSTITUTION; TRANSCRIPTION; ASSOCIATION	The yeast nucleosome assembly protein 1 (yNap1) plays a role in chromatin maintenance by facilitating histone exchange as well as nucleosome assembly and disassembly. It has been suggested that yNap1 carries out these functions by regulating the concentration of free histones. Therefore, a quantitative understanding of yNap1-histone interactions also provides information on the thermodynamics of chromatin. We have developed quantitative methods to study the affinity of yNap1 for histones. We show that yNap1 binds H2A/H2B and H3/H4 histone complexes with low nM affinity, and that each yNap1 dimer binds two histone fold dimers. The yNap1 tails contribute synergistically to histone binding while the histone tails have a slightly repressive effect on binding. The (H3/H4)(2) tetramer binds DNA with higher affinity than it binds yNap1.	[Luger, Karolin] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA; Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University; Howard Hughes Medical Institute; Colorado State University	Luger, K (corresponding author), Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA.	Karolin.Luger@colostate.edu	Park, Young-Jun/AAF-6249-2021	Park, Young-Jun/0000-0003-2901-6949; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331	National Institutes of Health [GM067777]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067777 and by the Howard Hughes Medical Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Banks DD, 2004, PROTEIN SCI, V13, P1304, DOI 10.1110/ps.03535504; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Galichet A, 2006, PLANT PHYSIOL, V142, P1412, DOI 10.1104/pp.106.088344; Karantza V, 1996, BIOCHEMISTRY-US, V35, P2037, DOI 10.1021/bi9518858; KARANTZA V, 1995, BIOCHEMISTRY-US, V34, P5988, DOI 10.1021/bi00017a028; Kepert JF, 2005, J BIOL CHEM, V280, P34063, DOI 10.1074/jbc.M507322200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; LUGER K, 2002, NAT GENET, V16, P16; Luger K., 2000, ENCY LIFE SCI; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; McBryant SJ, 2004, BIOCHEMISTRY-US, V43, P10592, DOI 10.1021/bi035881b; McBryant SJ, 2003, J BIOL CHEM, V278, P44574, DOI 10.1074/jbc.M305636200; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Park YJ, 2008, J MOL BIOL, V375, P1076, DOI 10.1016/j.jmb.2007.11.031; Park YJ, 2006, BIOCHEM CELL BIOL, V84, P549, DOI 10.1139/O06-088; Sharma N, 2008, P NATL ACAD SCI USA, V105, P7959, DOI 10.1073/pnas.0800534105; Starich MR, 1996, J MOL BIOL, V255, P187, DOI 10.1006/jmbi.1996.0016; Toth KF, 2005, J BIOL CHEM, V280, P15690, DOI 10.1074/jbc.M413329200; VARGAWEISZ P, 1994, P NATL ACAD SCI USA, V91, P3525, DOI 10.1073/pnas.91.9.3525; VARGAWEISZ P, 1994, BIOCHEM BIOPH RES CO, V203, P1904, DOI 10.1006/bbrc.1994.2410; Zlatanova J, 2007, FASEB J, V21, P1294, DOI 10.1096/fj.06-7199rev	27	70	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32412	32418		10.1074/jbc.M805918200	http://dx.doi.org/10.1074/jbc.M805918200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18728017	hybrid, Green Published			2022-12-25	WOS:000260893700029
J	Samson, WK; Zhang, JV; Avsian-Kretchmer, O; Cui, K; Yosten, GLC; Klein, C; Lyu, RM; Wang, YX; Chen, XQ; Yang, J; Price, CJ; Hoyda, TD; Ferguson, AV; Yuan, XB; Chang, JK; Hsueh, AJW				Samson, Willis K.; Zhang, Jian V.; Avsian-Kretchmer, Orna; Cui, Kai; Yosten, Gina L. C.; Klein, Cindy; Lyu, Rong-Ming; Wang, Yong Xiong; Chen, Xiang Qun; Yang, Jun; Price, Christopher J.; Hoyda, Ted D.; Ferguson, Alastair V.; Yuan, Xiao-bin; Chang, Jaw Kang; Hsueh, Aaron J. W.			Neuronostatin Encoded by the Somatostatin Gene Regulates Neuronal, Cardiovascular, and Metabolic Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-HORMONE; FOOD-INTAKE; C-FOS; MOLECULAR-BIOLOGY; BLOOD-PRESSURE; SECRETION; RECEPTORS; PEPTIDE; BRAIN	Somatostatin is important in the regulation of diverse neuroendocrine functions. Based on bioinformatic analyses of evolutionarily conserved sequences, we predicted another peptide hormone in pro-somatostatin and named it neuronostatin. Immuno-affinity purification allowed the sequencing of an amidated neuronostatin peptide of 13 residues from porcine tissues. In vivo treatment with neuronostatin induced c-Fos expression in gastrointestinal tissues, anterior pituitary, cerebellum, and hippocampus. In vitro treatment with neuronostatin promoted the migration of cerebellar granule cells and elicited direct depolarizing actions on paraventricular neurons in hypothalamic slices. In a gastric tumor cell line, neuronostatin induced c-Fos expression, stimulated SRE reporter activity, and promoted cell proliferation. Furthermore, intracerebroventricular treatment with neuronostatin increased blood pressure but suppressed food intake and water drinking. Our findings demonstrate diverse neuronal, neuroendocrine, and cardiovascular actions of a somatostatin gene-encoded hormone and provide the basis to investigate the physiological roles of this endogenously produced brain/gut peptide.	[Samson, Willis K.; Yosten, Gina L. C.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Zhang, Jian V.; Avsian-Kretchmer, Orna; Klein, Cindy; Hsueh, Aaron J. W.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Stanford, CA 94305 USA; [Cui, Kai; Yuan, Xiao-bin] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Cui, Kai; Yuan, Xiao-bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; [Lyu, Rong-Ming; Wang, Yong Xiong; Chen, Xiang Qun; Yang, Jun; Chang, Jaw Kang] Phoenix Pharmaceut Inc, Burlingame, CA 94010 USA; [Price, Christopher J.; Hoyda, Ted D.; Ferguson, Alastair V.] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada	Saint Louis University; Stanford University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Queens University - Canada	Samson, WK (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	samsonwk@slu.edu; aaron.hsueh@stanford.edu	ZHANG, Jian/B-5157-2009; Yosten, Gina/R-3885-2019	Yuan, Xiaobing/0000-0002-1632-8460	National Institutes of Health [HL68652, HL66023]; Johnson & Johnson Pharmaceutical Research & Development, L.L.C; Shanghai Institutes of Biological Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068652, R01HL066023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson & Johnson Pharmaceutical Research & Development, L.L.C(Johnson & JohnsonJohnson & Johnson USA); Shanghai Institutes of Biological Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL68652 (to W. K. S.) and HL66023 (to W. K. S. and A. V. F.). This work was also supported by Johnson & Johnson Pharmaceutical Research & Development, L.L.C (to A. J. H.), and a grant from the Shanghai Institutes of Biological Sciences (to X. B. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; BELL GI, 1993, TRENDS NEUROSCI, V16, P34, DOI 10.1016/0166-2236(93)90050-V; BENOIT R, 1987, SCIENCE, V238, P1126, DOI 10.1126/science.2891188; BERSANI M, 1989, J BIOL CHEM, V264, P10633; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; BROWN MR, 1988, NEUROENDOCRINOLOGY, V47, P556, DOI 10.1159/000124975; Caston-Balderrama AL, 1998, J HISTOCHEM CYTOCHEM, V46, P547, DOI 10.1177/002215549804600416; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; deLecea L, 1996, NATURE, V381, P242, DOI 10.1038/381242a0; FEIFEL D, 1990, BRAIN RES, V535, P189, DOI 10.1016/0006-8993(90)91600-L; Hajdu I, 2003, BRAIN RES, V994, P115, DOI 10.1016/j.brainres.2003.09.029; Hajdu I, 2000, AM J PHYSIOL-REG I, V279, pR271, DOI 10.1152/ajpregu.2000.279.1.R271; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; LAMBERTS SWJ, 1988, ENDOCR REV, V9, P417, DOI 10.1210/edrv-9-4-417; LAMBERTS SWJ, 1991, ENDOCR REV, V12, P450, DOI 10.1210/edrv-12-4-450; LARSSON LI, 1979, SCIENCE, V205, P1393, DOI 10.1126/science.382360; LOHOF AM, 1992, J NEUROSCI, V12, P1253; LOTTER EC, 1981, J COMP PHYSIOL PSYCH, V95, P278, DOI 10.1037/h0077777; Low MJ, 2004, BEST PRACT RES CL EN, V18, P607, DOI 10.1016/j.beem.2004.08.005; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; REICHLIN S, 1983, NEW ENGL J MED, V309, P1495, DOI 10.1056/NEJM198312153092406; REISINE T, 1995, ENDOCR REV, V16, P427, DOI 10.1210/er.16.4.427; RETTIG R, 1989, AM J PHYSIOL, V257, pR588, DOI 10.1152/ajpregu.1989.257.3.R588; Samson WK, 2007, AM J PHYSIOL-REG I, V292, pR637, DOI 10.1152/ajpregu.00395.2006; Samson WK, 1999, BRAIN RES, V831, P248, DOI 10.1016/S0006-8993(99)01457-2; SAMSON WK, 1980, PEPTIDES, V1, P325, DOI 10.1016/0196-9781(80)90010-8; SCHMIDT WE, 1985, FEBS LETT, V192, P141, DOI 10.1016/0014-5793(85)80060-0; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; Shimada M, 2003, BIOCHEM BIOPH RES CO, V302, P520, DOI 10.1016/S0006-291X(03)00178-5; Sunter D, 2003, NEUROSCI LETT, V353, P1, DOI 10.1016/S0304-3940(03)00351-3; Taylor MM, 2006, ENDOCRINOLOGY, V147, P859, DOI 10.1210/en.2005-0949; Taylor MM, 2005, AM J PHYSIOL-REG I, V288, pR919, DOI 10.1152/ajpregu.00744.2004; VALE W, 1972, CR ACAD SCI D NAT, V275, P2913; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yacubova E, 2002, NATURE, V415, P77, DOI 10.1038/415077a; YAMADA Y, 1992, P NATL ACAD SCI USA, V89, P251, DOI 10.1073/pnas.89.1.251; Yuill EA, 2007, EUR J NEUROSCI, V25, P425, DOI 10.1111/j.1460-9568.2006.05293.x	42	84	87	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31949	31959		10.1074/jbc.M804784200	http://dx.doi.org/10.1074/jbc.M804784200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18753129	Green Published, hybrid			2022-12-25	WOS:000260760800077
J	Donnelly, S; Stack, CM; O'Neill, SM; Sayed, AA; Williams, DL; Dalton, JP				Donnelly, Sheila; Stack, Colin M.; O'Neill, Sandra M.; Sayed, Ahmed A.; Williams, David L.; Dalton, John P.			Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages	FASEB JOURNAL			English	Article						antioxidant; immune modulation; innate immunity	FASCIOLA-HEPATICA; LIVER FLUKE; BIOCHEMICAL-CHARACTERIZATION; SCHISTOSOMA-JAPONICUM; PARASITIC HELMINTH; CATHEPSIN L1; CELLS; YM1; DIFFERENTIATION; EXPRESSION	During helminth infections, alternatively activated macrophages (AAMacs) are key to promoting Th2 responses and suppressing Th1-driven inflammatory pathology. Th2 cytokines IL-4 and/or IL-13 are believed to be important in the induction and activation of AAMacs. Using murine models for the helminth infections caused by Fasciola hepatica (Fh) and Schistosoma mansoni (Sm), we show that a secreted antioxidant, peroxiredoxin (Prx), induces alternative activation of macrophages. These activated, Ym1-expressing macrophages enhanced the secretion of IL-4, IL-5, and IL-13 from naive CD4(+) T cells. Administration of recombinant FhPrx and SmPrx to wild-type and IL-4(-/-) and IL-13(-/-) mice induced the production of AAMacs. In addition, Prx stimulated the expression of markers of AAMacs (particularly, Ym1) in vitro, and therefore can act independently of IL-4/IL-13 signaling. The immunomodulatory property of Prx is not due to its antioxidant activity, as an inactive recombinant variant with active site Cys residues replaced by Gly could also induce AAMacs and Th2 responses. Immunization of mice with recombinant Prx or passive transfer of anti-Prx antibodies prior to infection with Fh not only blocked the induction of AAMacs but also the development of parasite-specific Th2 responses. We propose that Prx activates macrophages as an initial step in the induction of Th2 responses by helminth parasites and is thereby a novel pathogen-associated molecular pattern.-Donnelly, S., Stack, C. M., O'Neill, S. M., Sayed, A. A., Williams, D. L., Dalton, J. P. Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J. 22, 4022-4032 (2008)	[Donnelly, Sheila; Stack, Colin M.; Dalton, John P.] Univ Technol Sydney, Inst Biotechnol Infect Dis, Sydney, NSW 2007, Australia; [O'Neill, Sandra M.] Dublin City Univ, Sch Nursing, Dublin 9, Ireland; [Sayed, Ahmed A.; Williams, David L.] Illinois State Univ, Dept Biol Sci, Normal, IL 61761 USA	University of Technology Sydney; Dublin City University; Illinois State University	Dalton, JP (corresponding author), Univ Technol Sydney, Inst Biotechnol Infect Dis, Level 6,Bldg 4,Cnr Thomas & Harris St, Sydney, NSW 2007, Australia.	john.dalton@uts.edu.au	Donnelly, Sheila/H-7733-2014; Dalton, John/K-4457-2014; Stack, Colin M/D-4601-2009	Stack, Colin/0000-0002-7539-7677; Donnelly, Sheila/0000-0003-2005-3698	National Health and Medical Research Council of Australia [352912]; New South Wales Government; Australian Research Council (ARC) [DP0557819]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065622] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Government; Australian Research Council (ARC)(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	S.D. and J.P.D. were supported by the National Health and Medical Research Council of Australia Project, grant 352912. J.P.D. is a recipient of a New South Wales Government 2003 BioFirst Award 2004. C. M. S. was funded by the Australian Research Council (ARC), DP0557819. We thank Weibo Xu for excellent technical assistance.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Arora M, 2006, P NATL ACAD SCI USA, V103, P7777, DOI 10.1073/pnas.0508492103; Atochina O, 2001, J IMMUNOL, V167, P4293, DOI 10.4049/jimmunol.167.8.4293; Atochina O, 2008, IMMUNOLOGY, V125, P111, DOI 10.1111/j.1365-2567.2008.02826.x; Brys L, 2005, J IMMUNOL, V174, P6095, DOI 10.4049/jimmunol.174.10.6095; CALLAHAN HL, 1988, PARASITOL TODAY, V4, P218, DOI 10.1016/0169-4758(88)90162-7; Cass CL, 2007, MOL BIOCHEM PARASIT, V155, P84, DOI 10.1016/j.molbiopara.2007.06.002; Chang JW, 2005, FEBS LETT, V579, P2873, DOI 10.1016/j.febslet.2005.04.028; Collins PR, 2004, J BIOL CHEM, V279, P17038, DOI 10.1074/jbc.M308831200; CRABTREE JE, 1986, PARASITE IMMUNOL, V8, P265, DOI 10.1111/j.1365-3024.1986.tb01038.x; Donnelly S, 2005, INFECT IMMUN, V73, P166, DOI 10.1128/IAI.73.1.166-173.2005; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Falcone FH, 2001, J IMMUNOL, V167, P5348, DOI 10.4049/jimmunol.167.9.5348; Giguere P, 2007, FEBS LETT, V581, P3863, DOI 10.1016/j.febslet.2007.07.011; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; Hayashi N, 1999, J IMMUNOL, V163, P6702; Henkle-Duhrsen K, 2001, MOL BIOCHEM PARASIT, V114, P129, DOI 10.1016/S0166-6851(01)00252-3; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hung SL, 2002, J LEUKOCYTE BIOL, V72, P72; Jin HM, 1998, GENOMICS, V54, P316, DOI 10.1006/geno.1998.5593; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Kumagai T, 2006, MOL BIOCHEM PARASIT, V149, P135, DOI 10.1016/j.molbiopara.2006.05.004; Loke P, 2000, EUR J IMMUNOL, V30, P1127, DOI 10.1002/(SICI)1521-4141(200004)30:4&lt;1127::AID-IMMU1127&gt;3.0.CO;2-#; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; MacDonald AS, 2002, INFECT IMMUN, V70, P427, DOI 10.1128/IAI.70.2.427-433.2002; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; McGonigle S, 1998, PARASITOL TODAY, V14, P139, DOI 10.1016/S0169-4758(97)01211-8; McManus DP, 2006, PARASITOLOGY, V133, pS43, DOI 10.1017/S0031182006001806; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Mulcahy G, 2004, ADV DRUG DELIVER REV, V56, P853, DOI 10.1016/j.addr.2003.10.033; Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004; O'Neill SM, 2000, PARASITE IMMUNOL, V22, P147, DOI 10.1046/j.1365-3024.2000.00290.x; Park SY, 2007, CANCER RES, V67, P9294, DOI 10.1158/0008-5472.CAN-07-0651; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Sekiya M, 2006, FEBS LETT, V580, P5016, DOI 10.1016/j.febslet.2006.08.019; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sinha P, 2005, CANCER RES, V65, P11743, DOI 10.1158/0008-5472.CAN-05-0045; Stack CM, 2007, J BIOL CHEM, V282, P16532, DOI 10.1074/jbc.M611501200; Street M, 1999, J IMMUNOL, V163, P4489; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Williams DL, 2001, INFECT IMMUN, V69, P1134, DOI 10.1128/IAI.69.2.1134-1141.2001; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336; 97925196	52	172	182	4	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					4022	4032		10.1096/fj.08-106278	http://dx.doi.org/10.1096/fj.08-106278			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18708590	Green Published			2022-12-25	WOS:000260503000030
J	Tsoporis, JN; Izhar, S; Parker, TG				Tsoporis, James N.; Izhar, Shehla; Parker, Thomas G.			Expression of S100A6 in Cardiac Myocytes Limits Apoptosis Induced by Tumor Necrosis Factor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CALCIUM-BINDING PROTEINS; CALCYCLIN S100A6; GROWTH-FACTOR; NEURITE OUTGROWTH; CELL-SURVIVAL; P53 PROTEIN; GENE; PROMOTER; RECEPTOR	S100A6 is induced in myocardium post-infarction in vivo and in response to growth factors and inflammatory cytokines in vitro. Forced expression of S100A6 in cardiomyocytes inhibits regulation of cardiac specific gene expression in response to trophic stimulation. To define regulation and function of S100A6, we characterized the human S100A6 promoter and mapped upstream regulatory elements in rat neonatal cardiac myocytes, fibroblasts, and vascular smooth muscle cells and defined a functional role for S100A6 in tumor necrosis factor-alpha-induced myocyte apoptosis. The functional S100A6 promoter was localized to region -167/+134 containing 167 upstream base pairs. The S100A6 promoter is regulated by positive (-361/+167 and -588/+361) and negative (-1371/+1194) elements. Tumor necrosis factor-alpha-induced the maximal S100A6 promoter and transcription factor NF-kappa B (p65 subunit). Electrophoretic mobility shift showed that tumor necrosis factor-alpha-induced p65 binding to a potential NF-kappa B-binding site at -460/-451. Chromatin immunoprecipitation analysis revealed p65 is recruited to the S100A6 promoter upon tumor necrosis factor-alpha stimulation. The NF-kappa B inhibitor caffeic acid phenethyl ester and mutation of the NF-kappa B-binding site inhibited S100A6 promoter activation by tumor necrosis factor-alpha. Tumor necrosis factor-alpha-induced cardiac myocyte apoptosis. Specific inhibition of S100A6 using a small interfering RNA directed against S100A6 potentiated tumor necrosis factor-alpha-induced myocyte apoptosis, whereas overexpression of S100A6 by gene transfer prevented tumor necrosis factor-alpha-induced myocyte apoptosis by interfering with p53 phosphorylation. These results demonstrate that S100A6 is induced by tumor necrosis factor-alpha via an NF-kappa B-dependent mechanism, serving a role in homeostasis to limit tumor necrosis factor-alpha-induced apoptosis by regulating p53 phosphorylation.	[Tsoporis, James N.; Izhar, Shehla; Parker, Thomas G.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst,Dept Med, Keenan Res Ctr,Div Cardiol, Toronto, ON M5B 1W8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Parker, TG (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst,Dept Med, Keenan Res Ctr,Div Cardiol, Rm 6-044,Queen Wing,30 Bond St, Toronto, ON M5B 1W8, Canada.	parkertg@smh.toronto.on.ca			Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; Bergmann MW, 2001, J MOL CELL CARDIOL, V33, P1223, DOI 10.1006/jmcc.2001.1385; Breen EC, 2003, J CELL BIOCHEM, V88, P848, DOI 10.1002/jcb.10398; CALABRETTA B, 1986, P NATL ACAD SCI USA, V83, P1495, DOI 10.1073/pnas.83.5.1495; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; Choufani G, 1999, LARYNGOSCOPE, V109, P1825, DOI 10.1097/00005537-199911000-00019; Courtois-Coutry N, 2002, J BIOL CHEM, V277, P25728, DOI 10.1074/jbc.M112435200; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; ENGELKAMP D, 1992, BIOCHEMISTRY-US, V31, P10258, DOI 10.1021/bi00157a012; FEENER EP, 1995, J CLIN INVEST, V95, P1353, DOI 10.1172/JCI117786; GHEZZO F, 1988, J BIOL CHEM, V263, P4758; GONG YW, 1992, CELL GROWTH DIFFER, V3, P847; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; HIRSCHHORN RR, 1984, P NATL ACAD SCI-BIOL, V81, P6004, DOI 10.1073/pnas.81.19.6004; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; HYLAND JK, 1984, P NATL ACAD SCI-BIOL, V81, P400, DOI 10.1073/pnas.81.2.400; Johnson CM, 2007, J BIOL CHEM, V282, P31197, DOI 10.1074/jbc.M705151200; JOHNSON P, 1993, MOL CELL BIOL, V13, P1456, DOI 10.1128/MCB.13.3.1456; Joo JH, 2003, BIOCHEM BIOPH RES CO, V307, P274, DOI 10.1016/S0006-291X(03)01199-9; Joo JH, 2008, J CELL BIOCHEM, V103, P1183, DOI 10.1002/jcb.21496; Kanoh M, 1999, CIRCULATION, V99, P2757, DOI 10.1161/01.CIR.99.21.2757; KARIYA K, 1991, J BIOL CHEM, V266, P10023; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Krown KA, 1996, J CLIN INVEST, V98, P2854, DOI 10.1172/JCI119114; Kubota T, 2001, J MOL CELL CARDIOL, V33, P1331, DOI 10.1006/jmcc.2001.1393; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; KUZNICKI J, 1992, EXP CELL RES, V200, P425, DOI 10.1016/0014-4827(92)90191-A; KUZNICKI J, 1989, FEBS LETT, V254, P141, DOI 10.1016/0014-5793(89)81026-9; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Lesniak W, 2000, ACTA NEUROBIOL EXP, V60, P569; Lesniak W, 2006, J CELL BIOCHEM, V97, P1017, DOI 10.1002/jcb.20699; Lesniak W, 2005, BBA-MOL CELL RES, V1744, P29, DOI 10.1016/j.bbamcr.2004.11.003; Lesniak W, 2000, BBA-GENE STRUCT EXPR, V1517, P73, DOI 10.1016/S0167-4781(00)00259-1; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; LONG CS, 1991, CELL REGUL, V2, P1081, DOI 10.1091/mbc.2.12.1081; Mueller A, 2005, J BIOL CHEM, V280, P29186, DOI 10.1074/jbc.M505000200; Purcell NH, 2003, CIRCULATION, V108, P638, DOI 10.1161/01.CIR.0000085362.40608.DD; Satoh M, 1999, CIRCULATION, V99, P3260, DOI 10.1161/01.CIR.99.25.3260; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Song W, 2000, CARDIOVASC RES, V45, P595, DOI 10.1016/S0008-6363(99)00395-8; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; TIMMONS PM, 1993, J CELL SCI, V104, P187; Tsoporis JN, 2005, EXP CELL RES, V303, P471, DOI 10.1016/j.yexcr.2004.10.018; Tsoporis JN, 2003, AM J PHYSIOL-HEART C, V284, pH193, DOI 10.1152/ajpheart.00161.2002; VANGRONINGEN JJM, 1995, BIOCHEM BIOPH RES CO, V213, P1122, DOI 10.1006/bbrc.1995.2243; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	49	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30174	30183		10.1074/jbc.M805318200	http://dx.doi.org/10.1074/jbc.M805318200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18753141	hybrid, Green Published			2022-12-25	WOS:000260366900062
J	Lim, JC; Choi, HI; Park, YS; Nam, HW; Woo, HA; Kwon, KS; Kim, YS; Rhee, SG; Kim, K; Chae, HZ				Lim, Jung Chae; Choi, Hoon-In; Park, Yu Sun; Nam, Hyung Wook; Woo, Hyun Ae; Kwon, Ki-Sun; Kim, Yu Sam; Rhee, Sue Goo; Kim, Kanghwa; Chae, Ho Zoon			Irreversible Oxidation of the Active-site Cysteine of Peroxiredoxin to Cysteine Sulfonic Acid for Enhanced Molecular Chaperone Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; SULFINIC ACID; IN-VIVO; STRESS; STATE; OVEROXIDATION; INACTIVATION; PEROXIDASE; MECHANISMS; REDUCTION	The thiol (-SH) of the active cysteine residue in peroxiredoxin (Prx) is known to be reversibly hyperoxidized to cysteine sulfinic acid (-SO2H), which can be reduced back to thiol by sulfiredoxin/sestrin. However, hyperoxidized Prx of an irreversible nature has not been reported yet. Using an antibody developed against the sulfonylated (-SO3H) yeast Prx (Tsa1p) active-site peptide (AFTFVCPTEI), we observed an increase in the immunoblot intensity in proportion to the H2O2 concentrations administered to the yeast cells. We identified two species of hyperoxidized Tsa1p: one can be reduced back (reversible) with sulfiredoxin, and the other cannot (irreversible). Irreversibly hyperoxidized Tsa1p was identified as containing the active-site cysteine sulfonic acid (Tsa1p-SO3H) by mass spectrometry. Tsa1p-SO3H was not an autoxidation product of Tsa1p-SO2H and was maintained in yeast cells even after two doubling cycles. Tsa1p-SO3H self-assembled into a ring-shaped multimeric form was shown by electron microscopy. Although the Tsa1p-SO3H multimer lost its peroxidase activity, it gained similar to 4-fold higher chaperone activity compared with Tsa1p-SH. In this study, we identify an irreversibly hyperoxidized Prx, Tsa1p-SO3H, with enhanced molecular chaperone activity and suggest that Tsa1p-SO3H is a marker of cumulative oxidative stress in cells.	[Lim, Jung Chae; Choi, Hoon-In; Park, Yu Sun; Chae, Ho Zoon] Chonnam Natl Univ, Dept Biol Sci, Kwangju 500757, South Korea; [Kim, Kanghwa] Chonnam Natl Univ, Dept Food & Nutr, Kwangju 500757, South Korea; [Chae, Ho Zoon] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Nam, Hyung Wook; Kim, Yu Sam] Yonsei Univ, Coll Sci, Dept Biochem, Prot Network Res Ctr, Seoul 120749, South Korea; [Woo, Hyun Ae; Rhee, Sue Goo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Kwon, Ki-Sun] Korea Res Inst Biosci & Biotechnol, Om & Integrat Res Ctr, Korea Lab Cell Signaling, Taejon 305333, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Yonsei University; Ewha Womans University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Chae, HZ (corresponding author), Chonnam Natl Univ, Dept Biol Sci, Kwangju 500757, South Korea.	hzchae@jnu.ac.kr	Woo, Hyun Ae/AAT-9586-2021		Korea Research Foundation [KRF-20070940]; Korea Science and Engineering Foundation [RO1-2004000-10242-0]; Korean Ministry of Science and Technology [M10642040003, M10648000164]	Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by Korea Research Foundation Grant KRF-20070940 and Korea Science and Engineering Foundation Grant RO1-2004000-10242-0 (to H.Z.C.) and Korean Ministry of Science and Technology Grants M10642040003 and M10648000164 (to K.-S.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"	Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; HAYWARD MA, 1987, METHOD ENZYMOL, V143, P279; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; JABOB C, 2006, BIOL CHEM, V387, P1385; Jacob C, 2003, ANGEW CHEM INT EDIT, V42, P4742, DOI 10.1002/anie.200300573; Jacob C, 2004, ORG BIOMOL CHEM, V2, P1953, DOI 10.1039/b406180b; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; KICE JL, 1980, ADV PHYS ORG CHEM, V17, P65; Kiley PJ, 2004, PLOS BIOL, V2, P1714, DOI 10.1371/journal.pbio.0020400; KIM KW, 1988, J BIOL CHEM, V263, P4704; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Mallis RJ, 2002, BIOL CHEM, V383, P649, DOI 10.1515/BC.2002.067; Mitsumoto A, 2001, FREE RADICAL BIO MED, V30, P625, DOI 10.1016/S0891-5849(00)00503-7; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; POOLE LB, 1989, J BIOL CHEM, V264, P12330; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	44	141	149	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28873	28880		10.1074/jbc.M804087200	http://dx.doi.org/10.1074/jbc.M804087200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18725414	Green Published, hybrid			2022-12-25	WOS:000260179900012
J	Hornig, M; Briese, T; Buie, T; Bauman, ML; Lauwers, G; Siemetzki, U; Hummel, K; Rota, PA; Bellini, WJ; O'Leary, JJ; Sheils, O; Alden, E; Pickering, L; Lipkin, WI				Hornig, Mady; Briese, Thomas; Buie, Timothy; Bauman, Margaret L.; Lauwers, Gregory; Siemetzki, Ulrike; Hummel, Kimberly; Rota, Paul A.; Bellini, William J.; O'Leary, John J.; Sheils, Orla; Alden, Errol; Pickering, Larry; Lipkin, W. Ian			Lack of Association between Measles Virus Vaccine and Autism with Enteropathy: A Case-Control Study	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; MUMPS-RUBELLA VACCINATION; LYMPHOCYTE CYTOKINE PROFILES; INFLAMMATORY-BOWEL-DISEASE; SPECTRUM DISORDER; NO EVIDENCE; GASTROINTESTINAL SYMPTOMS; NODULAR HYPERPLASIA; CAUSAL ASSOCIATION; REGRESSIVE AUTISM	Background: The presence of measles virus (MV) RNA in bowel tissue from children with autism spectrum disorders (ASD) and gastrointestinal (GI) disturbances was reported in 1998. Subsequent investigations found no associations between MV exposure and ASD but did not test for the presence of MV RNA in bowel or focus on children with ASD and GI disturbances. Failure to replicate the original study design may contribute to continued public concern with respect to the safety of the measles, mumps, and rubella (MMR) vaccine. Methodology/Principal Findings: The objective of this case-control study was to determine whether children with GI disturbances and autism are more likely than children with GI disturbances alone to have MV RNA and/or inflammation in bowel tissues and if autism and/or GI episode onset relate temporally to receipt of MMR. The sample was an age-matched group of US children undergoing clinically-indicated ileocolonoscopy. Ileal and cecal tissues from 25 children with autism and GI disturbances and 13 children with GI disturbances alone (controls) were evaluated by real-time reverse transcription (RT)-PCR for presence of MV RNA in three laboratories blinded to diagnosis, including one wherein the original findings suggesting a link between MV and ASD were reported. The temporal order of onset of GI episodes and autism relative to timing of MMR administration was examined. We found no differences between case and control groups in the presence of MV RNA in ileum and cecum. Results were consistent across the three laboratory sites. GI symptom and autism onset were unrelated to MMR timing. Eighty-eight percent of ASD cases had behavioral regression. Conclusions/Significance: This study provides strong evidence against association of autism with persistent MV RNA in the GI tract or MMR exposure. Autism with GI disturbances is associated with elevated rates of regression in language or other skills and may represent an endophenotype distinct from other ASD.	[Hornig, Mady; Briese, Thomas; Siemetzki, Ulrike; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA; [Buie, Timothy] Massachusetts Gen Hosp, Div Pediat Gastroenterol & Nutr, Boston, MA USA; [Bauman, Margaret L.] Massachusetts Gen Hosp, Dept Neurol, Dept Pediat, LADDERS, Boston, MA USA; [Lauwers, Gregory] Massachusetts Gen Hosp, Harvard Med Sch, Dept Pathol, Boston, MA USA; [Hummel, Kimberly; Rota, Paul A.; Bellini, William J.] Ctr Dis Control & Prevent, Measles Mumps Rubella & Herpesvirus Lab Branch, Atlanta, GA USA; [O'Leary, John J.; Sheils, Orla] Trinity Coll Dublin, Dept Histopathol, Dublin, Ireland; [Alden, Errol] American Acad Pediat, Elk Grove Village, IL USA; [Pickering, Larry] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Centers for Disease Control & Prevention - USA; Trinity College Dublin; American Academy of Pediatrics; Centers for Disease Control & Prevention - USA	Hornig, M (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.	mady.hornig@columbia.edu; wil2001@columbia.edu	Lipkin, W. Ian/ABE-6216-2020; Hornig, Mady/AAE-8431-2020; Sheils, Orla Sheils M/B-8461-2015	Lipkin, W. Ian/0000-0002-8768-9386; Hornig, Mady/0000-0001-7572-3092; Sheils, Orla Sheils M/0000-0002-4493-9496; O'Leary, John/0000-0001-7311-9326; Bauman, Margaret/0000-0002-3229-0458	CDC [U50 CCU522351]; National Institutes of Health [AI57158, HL083850, NS47537]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by CDC grant U50 CCU522351 to AAP and by National Institutes of Health awards AI57158 (Northeast Biodefense Center-Lipkin), HL083850, and NS47537. Role of Study Sponsors: Members of the funding organization (AAP) and its sponsor (CDC) participated along with experts in virology and neurovirology, autism pathogenesis, and vaccine design and safety; representatives of the autism advocacy community; and study collaborators in an Oversight Committee that reviewed and agreed to all aspects of study design prior to data collection. The final decision to submit for publication was the responsibility of all study collaborators.	Afzal MA, 2006, J MED VIROL, V78, P623, DOI 10.1002/jmv.20585; *AM AC PED COMM IN, 2008, PEDIATRICS, V121, P219; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Ashwood P, 2006, J NEUROIMMUNOL, V173, P126, DOI 10.1016/j.jneuroim.2005.12.007; Ashwood P, 2004, J CLIN IMMUNOL, V24, P664, DOI 10.1007/s10875-004-6241-6; Ashwood P, 2003, J CLIN IMMUNOL, V23, P504, DOI 10.1023/B:JOCI.0000010427.05143.bb; BAIRD G, 2008, ARCH DIS CHILD; Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; Chen W, 2004, PSYCHOL MED, V34, P543, DOI 10.1017/S0033291703001259; D'Souza Y, 2006, PEDIATRICS, V118, P1664, DOI 10.1542/peds.2006-1262; Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; DeStefano F, 2004, PEDIATRICS, V113, P259, DOI 10.1542/peds.113.2.259; Farrington CP, 2001, VACCINE, V19, P3632, DOI 10.1016/S0264-410X(01)00097-4; Fenson L., 1989, MACARTHUR COMMUNICAT; Fombonne E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e58; Fombonne E, 2006, PEDIATRICS, V118, pE139, DOI 10.1542/peds.2005-2993; Furlano RI, 2001, J PEDIATR-US, V138, P366, DOI 10.1067/mpd.2001.111323; Honda H, 2005, J CHILD PSYCHOL PSYC, V46, P572, DOI 10.1111/j.1469-7610.2005.01425.x; Kawashima H, 2000, DIGEST DIS SCI, V45, P723, DOI 10.1023/A:1005443726670; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; Klagge IM, 2004, J GEN VIROL, V85, P3239, DOI 10.1099/vir.0.80125-0; Lingam R, 2003, ARCH DIS CHILD, V88, P666, DOI 10.1136/adc.88.8.666; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Luyster R, 2005, DEV NEUROPSYCHOL, V27, P311, DOI 10.1207/s15326942dn2703_2; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Makela A, 2002, PEDIATRICS, V110, P957, DOI 10.1542/peds.110.5.957; Molloy CA, 2006, J AUTISM DEV DISORD, V36, P317, DOI 10.1007/s10803-005-0071-0; Niehus R, 2006, J DEV BEHAV PEDIATR, V27, pS120, DOI 10.1097/00004703-200604002-00010; O'Leary JJ, 2003, J CLIN PATHOL-MOL PA, V56, P248, DOI 10.1136/mp.56.4.248; Oleary JJ, 2000, LANCET, V356, P772, DOI 10.1016/S0140-6736(05)73676-X; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Peltola H, 1998, LANCET, V351, P1327, DOI 10.1016/S0140-6736(98)24018-9; Richler J, 2006, J AUTISM DEV DISORD, V36, P299, DOI 10.1007/s10803-005-0070-1; Rima BK, 2006, J PATHOL, V208, P199, DOI 10.1002/path.1873; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Smeeth L, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-2; Smeeth L, 2004, LANCET, V364, P963, DOI 10.1016/S0140-6736(04)17020-7; Takahashi H, 2001, JPN J INFECT DIS, V54, P78; Taylor B, 2002, BRIT MED J, V324, P393, DOI 10.1136/bmj.324.7334.393; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Torrente F, 2002, MOL PSYCHIATR, V7, P375, DOI 10.1038/sj/mp/4001077; Uchiyama T, 2007, J AUTISM DEV DISORD, V37, P210, DOI 10.1007/s10803-006-0157-3; Uhlmann V, 2002, J CLIN PATHOL-MOL PA, V55, P84, DOI 10.1136/mp.55.2.84; Wakefield A, 2002, MOL PSYCHIATR, V7, pS44, DOI 10.1038/sj.mp.4001178; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield AJ, 2005, EUR J GASTROEN HEPAT, V17, P827, DOI 10.1097/00042737-200508000-00009; Wakefield AJ, 2002, ALIMENT PHARM THER, V16, P663, DOI 10.1046/j.1365-2036.2002.01206.x; Wakefield AJ, 2000, AM J GASTROENTEROL, V95, P2285; Wakefield Andrew J., 2000, Adverse Drug Reactions and Toxicological Reviews, V19, P265	49	68	73	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3140	10.1371/journal.pone.0003140	http://dx.doi.org/10.1371/journal.pone.0003140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422HU	18769550	Green Published, gold, Green Submitted			2022-12-25	WOS:000264419100008
J	Boorsma, A; Lu, XJ; Zakrzewska, A; Klis, FM; Bussemaker, HJ				Boorsma, Andre; Lu, Xiang-Jun; Zakrzewska, Anna; Klis, Frans M.; Bussemaker, Harmen J.			Inferring Condition-Specific Modulation of Transcription Factor Activity in Yeast through Regulon-Based Analysis of Genomewide Expression	PLOS ONE			English	Article								Background: A key goal of systems biology is to understand how genomewide mRNA expression levels are controlled by transcription factors (TFs) in a condition-specific fashion. TF activity is frequently modulated at the post-translational level through ligand binding, covalent modification, or changes in sub-cellular localization. In this paper, we demonstrate how prior information about regulatory network connectivity can be exploited to infer condition-specific TF activity as a hidden variable from the genomewide mRNA expression pattern in the yeast Saccharomyces cerevisiae. Methodology/Principal Findings: We first validate experimentally that by scoring differential expression at the level of gene sets or "regulons'' comprised of the putative targets of a TF, we can accurately predict modulation of TF activity at the post-translational level. Next, we create an interactive database of inferred activities for a large number of TFs across a large number of experimental conditions in S. cerevisiae. This allows us to perform TF-centric analysis of the yeast regulatory network. Conclusions/Significance: We analyze the degree to which the mRNA expression level of each TF is predictive of its regulatory activity. We also organize TFs into "co-modulation networks'' based on their inferred activity profile across conditions, and find that this reveals functional and mechanistic relationships. Finally, we present evidence that the PAC and rRPE motifs antagonize TBP-dependent regulation, and function as core promoter elements governed by the transcription regulator NC2. Regulon-based monitoring of TF activity modulation is a powerful tool for analyzing regulatory network function that should be applicable in other organisms. Tools and results are available online at http://bussemakerlab.org/RegulonProfiler/.	[Boorsma, Andre; Zakrzewska, Anna; Klis, Frans M.] Univ Amsterdam, Swammerdam Inst Life Sci, BioCtr Amsterdam, Amsterdam, Netherlands; [Lu, Xiang-Jun; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Bussemaker, Harmen J.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA	University of Amsterdam; Columbia University; Columbia University	Boorsma, A (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, BioCtr Amsterdam, Amsterdam, Netherlands.	hjb2004@columbia.edu	Klis, Frans M/B-9085-2008	Klis, Frans M/0000-0003-0079-9492	Netherlands Foundation for Technical Research; National Institutes of Health [R01HG003008, U54CA121852]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER	Netherlands Foundation for Technical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants from the Netherlands Foundation for Technical Research (STW) to F.K. (APB.5504) and from the National Institutes of Health (R01HG003008 and U54CA121852) to HJB.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Boorsma A, 2004, YEAST, V21, P413, DOI 10.1002/yea.1109; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Burke TW, 1998, COLD SPRING HARB SYM, V63, P75, DOI 10.1101/sqb.1998.63.75; Bussemaker HJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S6; Bussemaker HJ, 2007, ANNU REV BIOPH BIOM, V36, P329, DOI 10.1146/annurev.biophys.36.040306.132725; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; JAMSA E, 1994, YEAST, V10, P355, DOI 10.1002/yea.320100308; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kellis M, 2004, J COMPUT BIOL, V11, P319, DOI 10.1089/1066527041410319; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Liko D, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704762200; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; McCord RP, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100140; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Moshonov S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-92; Nevitt T, 2004, YEAST, V21, P1365, DOI 10.1002/yea.1188; Raitt DC, 2000, MOL BIOL CELL, V11, P2335, DOI 10.1091/mbc.11.7.2335; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Van Helden J, 2000, YEAST, V16, P177, DOI 10.1002/(SICI)1097-0061(20000130)16:2<177::AID-YEA516>3.0.CO;2-9; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200	56	28	30	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3112	10.1371/journal.pone.0003112	http://dx.doi.org/10.1371/journal.pone.0003112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769540	Green Published, gold, Green Submitted			2022-12-25	WOS:000264418300004
J	Lehmann, K; Lowel, S				Lehmann, Konrad; Loewel, Siegrid			Age-Dependent Ocular Dominance Plasticity in Adult Mice	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; MONOCULAR DEPRIVATION; CRITICAL-PERIOD; POSTNATAL-DEVELOPMENT; INTRINSIC SIGNAL; SENSITIVE PERIOD; EYE CLOSURE; EXPERIENCE; VISION; ACUITY	Background: Short monocular deprivation (4 days) induces a shift in the ocular dominance of binocular neurons in the juvenile mouse visual cortex but is ineffective in adults. Recently, it has been shown that an ocular dominance shift can still be elicited in young adults (around 90 days of age) by longer periods of deprivation (7 days). Whether the same is true also for fully mature animals is not yet known. Methodology/Principal Findings: We therefore studied the effects of different periods of monocular deprivation (4, 7, 14 days) on ocular dominance in C57Bl/6 mice of different ages (25 days, 90-100 days, 109-158 days, 208-230 days) using optical imaging of intrinsic signals. In addition, we used a virtual optomotor system to monitor visual acuity of the open eye in the same animals during deprivation. We observed that ocular dominance plasticity after 7 days of monocular deprivation was pronounced in young adult mice (90-100 days) but significantly weaker already in the next age group (109-158 days). In animals older than 208 days, ocular dominance plasticity was absent even after 14 days of monocular deprivation. Visual acuity of the open eye increased in all age groups, but this interocular plasticity also declined with age, although to a much lesser degree than the optically detected ocular dominance shift. Conclusions/Significance: These data indicate that there is an age-dependence of both ocular dominance plasticity and the enhancement of vision after monocular deprivation in mice: ocular dominance plasticity in binocular visual cortex is most pronounced in young animals, reduced but present in adolescence and absent in fully mature animals older than 110 days of age. Mice are thus not basically different in ocular dominance plasticity from cats and monkeys which is an absolutely essential prerequisite for their use as valid model systems of human visual disorders.	[Lehmann, Konrad; Loewel, Siegrid] Univ Jena, Inst Allgemeine Zool & Tierphysiol, Jena, Germany	Friedrich Schiller University of Jena	Lehmann, K (corresponding author), Univ Jena, Inst Allgemeine Zool & Tierphysiol, Jena, Germany.	siegrid.loewel@uni-jena.de	Lehmann, Konrad/AAJ-1017-2020	Lehmann, Konrad/0000-0001-8215-5804	HFSP; BMBF	HFSP(Human Frontier Science Program); BMBF(Federal Ministry of Education & Research (BMBF))	This study was supported by grants from HFSP and BMBF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini A, 1999, J NEUROSCI, V19, P4388; BANKS MS, 1975, SCIENCE, V190, P675, DOI 10.1126/science.1188363; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fischer QS, 2007, LEARN MEMORY, V14, P277, DOI 10.1101/lm.392107; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guire ES, 1999, J NEUROPHYSIOL, V81, P121, DOI 10.1152/jn.1999.81.1.121; He HY, 2007, NAT NEUROSCI, V10, P1134, DOI 10.1038/nn1965; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Heimel JA, 2007, EUR J NEUROSCI, V25, P795, DOI 10.1111/j.1460-9568.2007.05333.x; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Iny K, 2006, J NEUROSCI, V26, P7368, DOI 10.1523/JNEUROSCI.0124-06.2006; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Lauten SD, 2000, COMPARATIVE MED, V50, P175; Moodie KL, 2001, VET OPHTHALMOL, V4, P267, DOI 10.1046/j.1463-5216.2001.00198.x; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; OLSON CR, 1980, EXP BRAIN RES, V39, P17; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Prusky GT, 2000, EUR J NEUROSCI, V12, P3781, DOI 10.1046/j.1460-9568.2000.00236.x; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; Vetencourt JFM, 2008, SCIENCE, V320, P1588; WATANABE H, 1992, J PHARMACOL EXP THER, V263, P1036; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029	37	112	113	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3120	10.1371/journal.pone.0003120	http://dx.doi.org/10.1371/journal.pone.0003120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769674	Green Published, gold			2022-12-25	WOS:000264416600008
J	Toiber, D; Berson, A; Greenberg, D; Melamed-Book, N; Diamant, S; Soreq, H				Toiber, Debra; Berson, Amit; Greenberg, David; Melamed-Book, Naomi; Diamant, Sophia; Soreq, Hermona			N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's Disease	PLOS ONE			English	Article								Background: Alzheimer's disease (AD) involves loss of cholinergic neurons and Tau protein hyper-phosphorylation. Here, we report that overexpression of an N-terminally extended "synaptic'' acetylcholinesterase variant, N-AChE-S is causally involved in both these phenomena. Methodology and Principal Findings: In transfected primary brain cultures, N-AChE-S induced cell death, morphological impairments and caspase 3 activation. Rapid internalization of fluorescently labeled fasciculin-2 to N-AChE-S transfected cells indicated membranal localization. In cultured cell lines, N-AChE-S transfection activated the Tau kinase GSK3, induced Tau hyper-phosphorylation and caused apoptosis. N-AChE-S-induced cell death was suppressible by inhibiting GSK3 or caspases, by enforced overexpression of the anti-apoptotic Bcl2 proteins, or by AChE inhibition or silencing. Moreover, inherent N-AChE-S was upregulated by stressors inducing protein misfolding and calcium imbalances, both characteristic of AD; and in cortical tissues from AD patients, N-AChE-S overexpression coincides with Tau hyper-phosphorylation. Conclusions: Together, these findings attribute an apoptogenic role to N-AChE-S and outline a potential value to AChE inhibitor therapeutics in early AD.	[Toiber, Debra; Berson, Amit; Greenberg, David; Melamed-Book, Naomi; Diamant, Sophia; Soreq, Hermona] Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel; [Soreq, Hermona] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neuron Computat ICNC, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Toiber, D (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel.	soreq@cc.huji.ac.il		Greenberg, David/0000-0001-8959-8640; Soreq, Hermona/0000-0002-0955-526X	European Union's Network of Excellence [LSH-2004-1.1.5-3]; STREP [LSHG-CT-2006-037277]; The German Ministry of Science; German-Israel Project; DIP-G 3.2; Israel Ministry of Science; Interdisciplinary Center for Neuronal Computation (ICNC); The ROSETREES Foundation, UK	European Union's Network of Excellence; STREP; The German Ministry of Science; German-Israel Project; DIP-G 3.2; Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Interdisciplinary Center for Neuronal Computation (ICNC); The ROSETREES Foundation, UK	This research was supported by the European Union's Network of Excellence (LSH-2004-1.1.5-3) and STREP (LSHG-CT-2006-037277), The German Ministry of Science and German-Israel Project, DIP-G 3.2, the Israel Ministry of Science, the Interdisciplinary Center for Neuronal Computation (ICNC) and The ROSETREES Foundation, UK.	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ben-Ari S, 2006, J NEUROCHEM, V97, P24, DOI 10.1111/j.1471-4159.2006.03725.x; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Bourne Y, 2004, P NATL ACAD SCI USA, V101, P1449, DOI 10.1073/pnas.0308206100; Carroll RT, 1999, NEUROREPORT, V10, P127, DOI 10.1097/00001756-199901180-00023; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; Deng R, 2006, ONCOGENE, V25, P7070, DOI 10.1038/sj.onc.1209686; Dickson DW, 2004, J CLIN INVEST, V114, P23, DOI 10.1172/JC1200422317; Eggers C, 2006, NEUROSCI LETT, V408, P46, DOI 10.1016/j.neulet.2006.08.061; Higgins MK, 2002, TRENDS BIOCHEM SCI, V27, P257, DOI 10.1016/S0968-0004(02)02089-3; Hu W, 2003, J NEUROCHEM, V86, P470, DOI 10.1046/j.1471-4159.2003.01855.x; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Huang HC, 2006, CURR DRUG TARGETS, V7, P1389, DOI 10.2174/1389450110607011389; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kaufer D, 2004, NAT NEUROSCI, V7, P947, DOI 10.1038/nn1296; Kehat R, 2007, INVEST OPHTH VIS SCI, V48, P1290, DOI 10.1167/iovs.06-0847; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; LANDWEHRMEYER B, 1993, NEUROSCIENCE, V57, P615, DOI 10.1016/0306-4522(93)90010-D; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; MC IR, 1959, J PHARMACOL EXP THER, V126, P9; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Meshorer E, 2006, TRENDS NEUROSCI, V29, P216, DOI 10.1016/j.tins.2006.02.005; Mesulam M, 2004, LEARN MEMORY, V11, P43, DOI 10.1101/lm.69204; Millard CB, 1999, BIOCHEMISTRY-US, V38, P7032, DOI 10.1021/bi982678l; Nguyen HN, 2005, ARCH PHARM RES, V28, P1073, DOI 10.1007/BF02977404; Nordberg A, 2006, ALZ DIS ASSOC DIS, V20, pS12, DOI 10.1097/01.wad.0000213804.59187.2d; Park SE, 2004, CANCER RES, V64, P2652, DOI 10.1158/0008-5472.CAN-04-0649; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; Recanatini M, 2004, CURR PHARM DESIGN, V10, P3157, DOI 10.2174/1381612043383313; Russ C, 2001, MOL PSYCHIATR, V6, P320, DOI 10.1038/sj.mp.4000852; Sberna G, 1997, J NEUROCHEM, V69, P1177; Sklan EH, 2004, P NATL ACAD SCI USA, V101, P5512, DOI 10.1073/pnas.0307659101; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Toiber D, 2005, NEUROCHEM RES, V30, P909, DOI 10.1007/s11064-005-6963-8; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Zhu H, 2007, INT J BIOCHEM CELL B, V39, P93, DOI 10.1016/j.biocel.2006.06.012	46	83	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3108	10.1371/journal.pone.0003108	http://dx.doi.org/10.1371/journal.pone.0003108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769671	gold, Green Submitted, Green Published			2022-12-25	WOS:000264416600004
J	Anuwatnonthakate, A; Limsomboon, P; Nateniyom, S; Wattanaamornkiat, W; Komsakorn, S; Moolphate, S; Chiengsorn, N; Kaewsa-ard, S; Sombat, P; Siangphoe, U; Mock, PA; Varma, JK				Anuwatnonthakate, Amornrat; Limsomboon, Pranom; Nateniyom, Sriprapa; Wattanaamornkiat, Wanpen; Komsakorn, Sittijate; Moolphate, Saiyud; Chiengsorn, Navarat; Kaewsa-ard, Samroui; Sombat, Potjaman; Siangphoe, Umaporn; Mock, Philip A.; Varma, Jay K.			Directly Observed Therapy and Improved Tuberculosis Treatment Outcomes in Thailand	PLOS ONE			English	Article							OBSERVED TREATMENT DOT	Background: The World Health Organization (WHO) recommends that tuberculosis (TB) patients receive directly observed therapy (DOT). Randomized controlled trials have not consistently shown that this practice improves TB treatment success rates. In Thailand, one of 22 WHO-designated high burden TB countries, patients may have TB treatment observed by a health care worker (HCW), family member, or no one. We studied whether DOT improved TB treatment outcomes in a prospective, observational cohort. Methods and Findings: We prospectively collected epidemiologic data about TB patients treated at public and private facilities in four provinces in Thailand and the national infectious diseases hospital from 2004-2006. Public health staff recorded the type of observed therapy that patients received during the first two months of TB treatment. We limited our analysis to pulmonary TB patients never previously treated for TB and not known to have multidrug-resistant TB. We analyzed the proportion of patients still on treatment at the end of two months and with treatment success at the end of treatment according to DOT type. We used propensity score analysis to control for factors associated with DOT and treatment outcome. Of 8,031 patients eligible for analysis, 24% received HCW DOT, 59% family DOT, and 18% self-administered therapy (SAT). Smear-positive TB was diagnosed in 63%, and 21% were HIV-infected. Of patients either on treatment or that defaulted at two months, 1601/1636 (98%) patients that received HCW DOT remained on treatment at two months compared with 1096/1268 (86%) patients that received SAT (adjusted OR [aOR] 3.8; 95% confidence interval [CI] 2.4-6.0) and 3782/3987 (95%) patients that received family DOT (aOR 2.1; CI, 1.4-3.1). Of patients that had treatment success or that defaulted at the end of treatment, 1369/1477 (93%) patients that received HCW DOT completed treatment compared with 744/1074 (69%) patients that received SAT (aOR 3.3; CI, 2.4-4.5) and 3130/3529 (89%) patients that received family DOT (aOR 1.5; 1.2-1.9). The benefit of HCW DOT compared with SAT was similar, but smaller, when comparing patients with treatment success to those with death, default, or failure. Conclusions: In Thailand, two months of DOT was associated with lower odds of default during treatment. The magnitude of benefit was greater for DOT provided by a HCW compared with a family member. Thailand should consider increasing its use of HCW DOT during TB treatment.	[Anuwatnonthakate, Amornrat; Sombat, Potjaman; Siangphoe, Umaporn; Mock, Philip A.; Varma, Jay K.] Thailand MOPH US CDC Collaborat, Nonthaburi, Thailand; [Limsomboon, Pranom] Phuket Provincial Publ Hlth Office, Phuket, Thailand; [Nateniyom, Sriprapa] Thailand Minist Publ Hlth, Nonthaburi, Thailand; [Wattanaamornkiat, Wanpen] Office Dis Prevent & Control 7, Ubon ratchathani, Thailand; [Komsakorn, Sittijate] Chiang Rai Provincial Publ Hlth Office, Chiang Rai, Thailand; [Moolphate, Saiyud] Res Inst Tuberculosis, Tokyo, Japan; [Chiengsorn, Navarat] Bangkok Metropolitan Hlth Admin, Bangkok, Thailand; [Kaewsa-ard, Samroui] Bamrasnaradura Inst, Nonthaburi, Thailand; [Varma, Jay K.] US Ctr Dis Control & Prevent, Atlanta, GA USA	Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA	Anuwatnonthakate, A (corresponding author), Thailand MOPH US CDC Collaborat, Nonthaburi, Thailand.	jvarma@cdc.gov		Siangphoe, Uma/0000-0002-0560-6314	United States Centers for Disease Control and Prevention (U.S. CDC); United States Agency for International Development 2 (USAID)	United States Centers for Disease Control and Prevention (U.S. CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development 2 (USAID)(United States Agency for International Development (USAID))	This project was supported by the United States Centers for Disease Control and Prevention (U.S. CDC) and United States Agency for International Development 2 (USAID). Some authors from this publication are employed by the U.S. CDC. USAID was not involved in the design, analysis, or writing of this manuscript.	Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; Akkslip S, 1999, INT J TUBERC LUNG D, V3, P1061; BAYER R, 1995, LANCET, V345, P1545, DOI 10.1016/S0140-6736(95)91090-5; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Frieden T, 2002, INT J TUBERC LUNG D, V6, P371; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kamolratanakul P, 1999, T ROY SOC TROP MED H, V93, P552, DOI 10.1016/S0035-9203(99)90379-6; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Okanurak K, 2007, INT J TUBERC LUNG D, V11, P762; Pungrassami P, 2002, INT J TUBERC LUNG D, V6, P389; Pungrassami P, 2002, TROP MED INT HEALTH, V7, P271, DOI 10.1046/j.1365-3156.2002.00849.x; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rusen ID, 2007, INT J TUBERC LUNG D, V11, P120; Varma JK, 2007, B WORLD HEALTH ORGAN, V85, P586, DOI 10.2471/BLT.06.038067; VOLMINK J, 2006, COCHRANE DB SYST REV, V2; WHO, 2007, WHOHTMTB2007376; *WHO S E AS REG OF, 2004, REV NAT TUB PROGR TH, V3; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Zignol M, 2007, CLIN INFECT DIS, V44, P61, DOI 10.1086/509328	24	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3089	10.1371/journal.pone.0003089	http://dx.doi.org/10.1371/journal.pone.0003089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769479	gold, Green Published			2022-12-25	WOS:000264796600008
J	Graham, NAJ; McClanahan, TR; MacNeil, MA; Wilson, SK; Polunin, NVC; Jennings, S; Chabanet, P; Clark, S; Spalding, MD; Letourneur, Y; Bigot, L; Galzin, R; Ohman, MC; Garpe, KC; Edwards, AJ; Sheppard, CRC				Graham, Nicholas A. J.; McClanahan, Tim R.; MacNeil, M. Aaron; Wilson, Shaun K.; Polunin, Nicholas V. C.; Jennings, Simon; Chabanet, Pascale; Clark, Susan; Spalding, Mark D.; Letourneur, Yves; Bigot, Lionel; Galzin, Rene; Ohman, Marcus C.; Garpe, Kajsa C.; Edwards, Alasdair J.; Sheppard, Charles R. C.			Climate Warming, Marine Protected Areas and the Ocean-Scale Integrity of Coral Reef Ecosystems	PLOS ONE			English	Article								Coral reefs have emerged as one of the ecosystems most vulnerable to climate variation and change. While the contribution of a warming climate to the loss of live coral cover has been well documented across large spatial and temporal scales, the associated effects on fish have not. Here, we respond to recent and repeated calls to assess the importance of local management in conserving coral reefs in the context of global climate change. Such information is important, as coral reef fish assemblages are the most species dense vertebrate communities on earth, contributing critical ecosystem functions and providing crucial ecosystem services to human societies in tropical countries. Our assessment of the impacts of the 1998 mass bleaching event on coral cover, reef structural complexity, and reef associated fishes spans 7 countries, 66 sites and 26 degrees of latitude in the Indian Ocean. Using Bayesian meta-analysis we show that changes in the size structure, diversity and trophic composition of the reef fish community have followed coral declines. Although the ocean scale integrity of these coral reef ecosystems has been lost, it is positive to see the effects are spatially variable at multiple scales, with impacts and vulnerability affected by geography but not management regime. Existing no-take marine protected areas still support high biomass of fish, however they had no positive affect on the ecosystem response to large-scale disturbance. This suggests a need for future conservation and management efforts to identify and protect regional refugia, which should be integrated into existing management frameworks and combined with policies to improve system-wide resilience to climate variation and change.	[Graham, Nicholas A. J.; MacNeil, M. Aaron; Wilson, Shaun K.; Polunin, Nicholas V. C.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne, Tyne & Wear, England; [McClanahan, Tim R.] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA; [MacNeil, M. Aaron] NOAA, Panama City Lab, Natl Res Council, Panama City, FL USA; [Wilson, Shaun K.] James Cook Univ, ARC Ctr Excellence Coral Reef Stud, Townsville, Qld, Australia; [Jennings, Simon] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft, Suffolk, England; [Jennings, Simon] Univ E Anglia, Sch Environm Sci, Norwich, Norfolk, England; [Chabanet, Pascale] Inst Rech Dev, Noumea, New Caledonia; [Chabanet, Pascale; Bigot, Lionel] Univ La Reunion, Lab Ecol Marine ECOMAR, St Denis, France; [Clark, Susan] Bridgewater House, Manchester, Lancs, England; [Spalding, Mark D.] Nature Conservancy, Newmarket, Suffolk, England; [Letourneur, Yves] Univ Mediterranee, Ctr Oceanol Marseille, UMR CNRS, 6540 DIMAR, Marseille, France; [Galzin, Rene] Univ Perpignan, CNRS EPHE UPVD, UMR 5244, Perpignan, France; [Ohman, Marcus C.; Garpe, Kajsa C.] Stockholm Univ, Dept Zool, Stockholm, Sweden; [Edwards, Alasdair J.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne, Tyne & Wear, England; [Sheppard, Charles R. C.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	Newcastle University - UK; Wildlife Conservation Society; National Academies of Sciences, Engineering & Medicine; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University; Centre for Environment Fisheries & Aquaculture Science; University of East Anglia; Institut de Recherche pour le Developpement (IRD); University of La Reunion; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Universite de Montpellier; Stockholm University; Newcastle University - UK; University of Warwick	Graham, NAJ (corresponding author), Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne, Tyne & Wear, England.	a.j.graham@ncl.ac.uk	Graham, Nicholas AJ/C-8360-2014; Spalding, Mark/GVU-0739-2022; Chabanet, Pascale/L-9470-2017; LETOURNEUR, Yves/B-4387-2012; McClanahan, Tim/K-4998-2019; MacNeil, M. Aaron/ABD-6444-2021; MacNeil, Aaron/E-8196-2017; Jennings, Simon/F-5085-2012; MacNeil, M Aaron/F-4680-2010; Edwards, Alasdair J/C-9558-2009; Letourneur, Yves/V-6843-2019	Graham, Nicholas AJ/0000-0002-0304-7467; LETOURNEUR, Yves/0000-0003-3157-1976; MacNeil, M. Aaron/0000-0001-8406-325X; MacNeil, Aaron/0000-0001-8406-325X; Jennings, Simon/0000-0002-2390-7225; Edwards, Alasdair J/0000-0002-2979-7389; Letourneur, Yves/0000-0003-3157-1976; McClanahan, Timothy/0000-0001-5821-3584; Polunin, Nick/0000-0002-1480-8794; Chabanet, Pascale/0000-0001-7600-943X; Wilson, Shaun/0000-0002-4590-0948; Spalding, Mark/0000-0001-9456-4533; sheppard, charles/0000-0002-2579-5124	Leverhulme Trust; Western Indian Ocean Marine Science Association; World Bank Targeted Research Group on Coral Bleaching; Fisheries Society of the British Isles; Eppley and Tiffany Foundations; National Science and Engineering Research Council of Canada; British Overseas Development Administration (now DFID); British Foreign and Commonwealth Office	Leverhulme Trust(Leverhulme Trust); Western Indian Ocean Marine Science Association; World Bank Targeted Research Group on Coral Bleaching; Fisheries Society of the British Isles; Eppley and Tiffany Foundations; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); British Overseas Development Administration (now DFID); British Foreign and Commonwealth Office	This research was funded through grants from the Leverhulme Trust, Western Indian Ocean Marine Science Association, World Bank Targeted Research Group on Coral Bleaching, the Fisheries Society of the British Isles, the Eppley and Tiffany Foundations, the National Science and Engineering Research Council of Canada, the British Overseas Development Administration (now DFID) and the British Foreign and Commonwealth Office.	Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Ceccarelli DM, 2001, OCEANOGR MAR BIOL, V39, P355; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Cote IM, 2005, PHILOS T R SOC B, V360, P385, DOI 10.1098/rstb.2004.1591; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; Dorenbosch M, 2005, MAR ECOL PROG SER, V302, P63, DOI 10.3354/meps302063; Efron B., 1994, INTRO BOOTSTRAP; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Garpe KC, 2006, MAR ECOL PROG SER, V315, P237, DOI 10.3354/meps315237; Gelman A., 2004, BAYESIAN DATA ANAL; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.2307/177061; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2004, SYMBIOSIS, V37, P1; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2007, MAR ECOL PROG SER, V340, P221, DOI 10.3354/meps340221; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Munday PL, 1998, OCEANOGR MAR BIOL<D>, V36, P373; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sheppard C, 2005, J NAT HIST, V39, P103, DOI 10.1080/00222930310001657900; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; SHEPPARD CRC, 2000, SEAS MILLENNIUM ENV, V2, P221; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilkinson C., 2005, STATUS CORAL REEFS T; Williams ID, 2001, MAR ECOL PROG SER, V222, P187, DOI 10.3354/meps222187; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	52	198	202	4	178	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3039	10.1371/journal.pone.0003039	http://dx.doi.org/10.1371/journal.pone.0003039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728776	Green Published, gold, Green Accepted			2022-12-25	WOS:000264796400003
J	She, QB; Chandarlapaty, S; Ye, Q; Lobo, J; Haskell, KM; Leander, KR; DeFeo-Jones, D; Huber, HE; Rosen, N				She, Qing-Bai; Chandarlapaty, Sarat; Ye, Qing; Lobo, Jose; Haskell, Kathleen M.; Leander, Karen R.; DeFeo-Jones, Deborah; Huber, Hans E.; Rosen, Neal			Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling	PLOS ONE			English	Article								Background: Dysregulated PI3K/Akt signaling occurs commonly in breast cancers and is due to HER2 amplification, PI3K mutation or PTEN inactivation. The objective of this study was to determine the role of Akt activation in breast cancer as a function of mechanism of activation and whether inhibition of Akt signaling is a feasible approach to therapy. Methodology/Principal Findings: A selective allosteric inhibitor of Akt kinase was used to interrogate a panel of breast cancer cell lines characterized for genetic lesions that activate PI3K/Akt signaling: HER2 amplification or PI3K or PTEN mutations in order to determine the biochemical and biologic consequences of inhibition of this pathway. A variety of molecular techniques and tissue culture and in vivo xenograft models revealed that tumors with mutational activation of Akt signaling were selectively dependent on the pathway. In sensitive cells, pathway inhibition resulted in D-cyclin loss, G1 arrest and induction of apoptosis, whereas cells without pathway activation were unaffected. Most importantly, the drug effectively inhibited Akt kinase and its downstream effectors in vivo and caused complete suppression of the growth of breast cancer xenografts with PI3K mutation or HER2 amplification, including models of the latter selected for resistance to Herceptin. Furthermore, chronic administration of the drug was well-tolerated, causing only transient hyperglycemia without gross toxicity to the host despite the pleiotropic normal functions of Akt. Conclusions/Significance: These data demonstrate that breast cancers with PI3K mutation or HER2 amplification are selectively dependent on Akt signaling, and that effective inhibition of Akt in tumors is feasible and effective in vivo. These findings suggest that direct inhibition of Akt may represent a therapeutic strategy for breast and other cancers that are addicted to the pathway including tumors with resistant to Herceptin.	[She, Qing-Bai; Chandarlapaty, Sarat; Ye, Qing; Lobo, Jose; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA; [Haskell, Kathleen M.; Leander, Karen R.; DeFeo-Jones, Deborah; Huber, Hans E.] Merck Res Lab, Dept Canc Res, West Point, PA USA	Memorial Sloan Kettering Cancer Center; Merck & Company	She, QB (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, 1275 York Ave, New York, NY 10021 USA.	rosenn@mskcc.org	Rosen, Neal/ABF-2677-2020	She, Qing-Bai/0000-0002-7207-0599	NIH [P01CA94060]; Breast Cancer Research Foundation; Taub Foundation; NATIONAL CANCER INSTITUTE [P01CA094060] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Taub Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH P01CA94060 (NR), the Breast Cancer Research Foundation (NR), and the Taub Foundation (NR). The funders played no role in the study design, execution, analysis or preparation of the paper.	Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bilodeau MT, 2008, BIOORG MED CHEM LETT, V18, P3178, DOI 10.1016/j.bmcl.2008.04.074; Butler M, 2002, DIABETES, V51, P1028, DOI 10.2337/diabetes.51.4.1028; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Finkle D, 2004, CLIN CANCER RES, V10, P2499, DOI 10.1158/1078-0432.CCR-03-0448; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Johnston S, 2008, J CLIN ONCOL, V26, P1066, DOI 10.1200/JCO.2007.13.9949; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lindsley CW, 2008, CURR CANCER DRUG TAR, V8, P7, DOI 10.2174/156800908783497096; LoPiccolo J, 2007, ANTI-CANCER DRUG, V18, P861; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; NUSSE M, 1990, CYTOMETRY, V11, P813, DOI 10.1002/cyto.990110707; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Robertson GP, 2005, CANCER METAST REV, V24, P273, DOI 10.1007/s10555-005-1577-9; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weng LP, 1999, CANCER RES, V59, P5808; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587	39	233	248	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3065	10.1371/journal.pone.0003065	http://dx.doi.org/10.1371/journal.pone.0003065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725974	Green Submitted, gold, Green Published			2022-12-25	WOS:000264796300011
J	Khaldi, N; Wolfe, KH				Khaldi, Nora; Wolfe, Kenneth H.			Elusive Origins of the Extra Genes in Aspergillus oryzae	PLOS ONE			English	Article							GENOME DUPLICATION; SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; YEAST GENOME; SEQUENCE; EUKARYOTES; DIVERGENCE; EVOLUTION; FUMIGATUS	The genome sequence of Aspergillus oryzae revealed unexpectedly that this species has approximately 20% more genes than its congeneric species A. nidulans and A. fumigatus. Where did these extra genes come from? Here, we evaluate several possible causes of the elevated gene number. Many gene families are expanded in A. oryzae relative to A. nidulans and A. fumigatus, but we find no evidence of ancient whole-genome duplication or other segmental duplications, either in A. oryzae or in the common ancestor of the genus Aspergillus. We show that the presence of divergent pairs of paralogs is a feature peculiar to A. oryzae and is not shared with A. nidulans or A. fumigatus. In phylogenetic trees that include paralog pairs from A. oryzae, we frequently find that one of the genes in a pair from A. oryzae has the expected orthologous relationship with A. nidulans, A. fumigatus and other species in the subphylum Eurotiomycetes, whereas the other A. oryzae gene falls outside this clade but still within the Ascomycota. We identified 456 such gene pairs in A. oryzae. Further phylogenetic analysis did not however indicate a single consistent evolutionary origin for the divergent members of these pairs. Approximately one-third of them showed phylogenies that are suggestive of horizontal gene transfer (HGT) from Sordariomycete species, and these genes are closer together in the A. oryzae genome than expected by chance, but no unique Sordariomycete donor species was identifiable. The postulated HGTs from Sordariomycetes still leave the majority of extra A. oryzae genes unaccounted for. One possible explanation for our observations is that A. oryzae might have been the recipient of many separate HGT events from diverse donors.	[Khaldi, Nora; Wolfe, Kenneth H.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland	Trinity College Dublin	Khaldi, N (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.	khwolfe@tcd.ie		Wolfe, Kenneth/0000-0003-4992-4979	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This study was supported by Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cai JJ, 2006, J MOL EVOL, V63, P1, DOI 10.1007/s00239-004-0372-5; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Conant GC, 2003, GENOME RES, V13, P2052, DOI 10.1101/gr.1252603; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Fares MA, 2006, MOL BIOL EVOL, V23, P245, DOI 10.1093/molbev/msj027; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Garcia-Vallve S, 2000, MOL BIOL EVOL, V17, P352, DOI 10.1093/oxfordjournals.molbev.a026315; Geiser DM, 1998, P NATL ACAD SCI USA, V95, P388, DOI 10.1073/pnas.95.1.388; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Hamada T., 1992, APPL BIOTECHNOLOGY T, P114; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kobayashi T, 2007, BIOSCI BIOTECH BIOCH, V71, P646, DOI 10.1271/bbb.60550; Langkjaer RB, 2003, NATURE, V421, P848, DOI 10.1038/nature01419; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nishida H, 2006, BIOSCI BIOTECH BIOCH, V70, P2646, DOI 10.1271/bbb.60251; Nixon Andrew E., 2002, Current Pharmaceutical Biotechnology, V3, P1; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Tamano K, 2008, FUNGAL GENET BIOL, V45, P139, DOI 10.1016/j.fgb.2007.09.005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van de Peer Y, 2001, J MOL EVOL, V53, P436, DOI 10.1007/s002390010233; Van de Peer Y, 2004, NAT REV GENET, V5, P752, DOI 10.1038/nrg1449; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	40	27	98	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3036	10.1371/journal.pone.0003036	http://dx.doi.org/10.1371/journal.pone.0003036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725939	gold, Green Published, Green Submitted			2022-12-25	WOS:000264428800003
J	Syed, ZA; Hard, T; Uv, A; van Dijk-Hard, IF				Syed, Zulfeqhar A.; Hard, Torleif; Uv, Anne; van Dijk-Hard, Iris F.			A Potential Role for Drosophila Mucins in Development and Physiology	PLOS ONE			English	Article							PERITROPHIC MATRIX; INTESTINAL MUCIN; MELANOGASTER; IDENTIFICATION; EXPRESSION; MAINTAIN	Vital vertebrate organs are protected from the external environment by a barrier that to a large extent consists of mucins. These proteins are characterized by poorly conserved repeated sequences that are rich in prolines and potentially glycosylated threonines and serines (PTS). We have now used the characteristics of the PTS repeat domain to identify Drosophila mucins in a simple bioinformatics approach. Searching the predicted protein database for proteins with at least 4 repeats and a high ST content, more than 30 mucin-like proteins were identified, ranging from 300-23000 amino acids in length. We find that Drosophila mucins are present at all stages of the fly life cycle, and that their transcripts localize to selective organs analogous to sites of vertebrate mucin expression. The results could allow for addressing basic questions about human mucin-related diseases in this model system. Additionally, many of the mucins are expressed in selective tissues during embryogenesis, thus revealing new potential functions for mucins as apical matrix components during organ morphogenesis.	[Syed, Zulfeqhar A.; Hard, Torleif; van Dijk-Hard, Iris F.] Univ Gothenburg, Dept Med Chem & Cell Biol, Inst Biomed, Gothenburg, Sweden; [Uv, Anne] Gothenburg Univ, Inst Biomed, Dept Med Genet, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Syed, ZA (corresponding author), Univ Gothenburg, Dept Med Chem & Cell Biol, Inst Biomed, Gothenburg, Sweden.	iris.hard@gu.se		Hard, Torleif/0000-0001-9813-9913	Swedish Research Council; Swedish Foundation for Strategic Research (SSF) Center MIVAC	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research (SSF) Center MIVAC(Swedish Foundation for Strategic Research)	This work was supported by grants from the Swedish Research Council (VR) to Torleif Hard and Anne Uv, and by the Swedish Foundation for Strategic Research (SSF) Center MIVAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Fraichard S, 2006, GENE EXPR PATTERNS, V6, P772, DOI 10.1016/j.modgep.2006.01.007; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Korayem AM, 2004, INSECT BIOCHEM MOLEC, V34, P1297, DOI 10.1016/j.ibmb.2004.09.001; Lang T, 2004, GLYCOBIOLOGY, V14, P521, DOI 10.1093/glycob/cwh066; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Muller R, 2005, FEBS J, V272, P4295, DOI 10.1111/j.1742-4658.2005.04838.x; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Pocock M., 2000, SIGBIO Newsletter, V20, P10, DOI 10.1145/360262.360266; Schwientek T, 2007, PROTEOMICS, V7, P3264, DOI 10.1002/pmic.200600793; Shi XZ, 2004, INSECT BIOCHEM MOLEC, V34, P1101, DOI 10.1016/j.ibmb.2004.06.015; Theopold U, 2001, INSECT BIOCHEM MOLEC, V31, P189, DOI 10.1016/S0965-1748(00)00117-X; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Wang P, 2004, INSECT BIOCHEM MOLEC, V34, P215, DOI 10.1016/j.ibmb.2003.10.001; Wang P, 1997, J BIOL CHEM, V272, P16663, DOI 10.1074/jbc.272.26.16663; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6	21	57	58	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3041	10.1371/journal.pone.0003041	http://dx.doi.org/10.1371/journal.pone.0003041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725942	Green Submitted, gold, Green Published			2022-12-25	WOS:000264428800007
J	Beres, SB; Sesso, R; Pinto, SWL; Hoe, NP; Porcella, SF; Deleo, FR; Musser, JM				Beres, Stephen B.; Sesso, Ricardo; Pinto, Sergio Wyton L.; Hoe, Nancy P.; Porcella, Stephen F.; Deleo, Frank R.; Musser, James M.			Genome Sequence of a Lancefield Group C Streptococcus zooepidemicus Strain Causing Epidemic Nephritis: New Information about an Old Disease	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; ACUTE POSTSTREPTOCOCCAL GLOMERULONEPHRITIS; SHOCK-LIKE SYNDROME; TRANSFER-RNA GENES; ALPHA-ENOLASE; PLASMIN RECEPTOR; INVASIVE STRAINS; SIGNAL PEPTIDES; BINDING-PROTEIN; SEROTYPE M1	Outbreaks of disease attributable to human error or natural causes can provide unique opportunities to gain new information about host-pathogen interactions and new leads for pathogenesis research. Poststreptococcal glomerulonephritis (PSGN), a sequela of infection with pathogenic streptococci, is a common cause of preventable kidney disease worldwide. Although PSGN usually occurs after infection with group A streptococci, organisms of Lancefield group C and G also can be responsible. Despite decades of study, the molecular pathogenesis of PSGN is poorly understood. As a first step toward gaining new information about PSGN pathogenesis, we sequenced the genome of Streptococcus equi subsp. zooepidemicus strain MGCS10565, a group C organism that caused a very large and unusually severe epidemic of nephritis in Brazil. The genome is a circular chromosome of 2,024,171 bp. The genome shares extensive gene content, including many virulence factors, with genetically related group A streptococci, but unexpectedly lacks prophages. The genome contains many apparently foreign genes interspersed around the chromosome, consistent with the presence of a full array of genes required for natural competence. An inordinately large family of genes encodes secreted extracellular collagen-like proteins with multiple integrin-binding motifs. The absence of a gene related to speB rules out the long-held belief that streptococcal pyrogenic exotoxin B or antibodies reacting with it singularly cause PSGN. Many proteins previously implicated in GAS PSGN, such as streptokinase, are either highly divergent in strain MGCS10565 or are not more closely related between these species than to orthologs present in other streptococci that do not commonly cause PSGN. Our analysis provides a comparative genomics framework for renewed appraisal of molecular events underlying APSGN pathogenesis.	[Beres, Stephen B.; Musser, James M.] Methodist Hosp, Ctr Mol & Translat Human Infect Dis Res, Res Inst, Houston, TX 77030 USA; [Sesso, Ricardo] Univ Fed Sao Paulo, Escola Paulista Med, Div Nephrol, Sao Paulo, Brazil; [Pinto, Sergio Wyton L.] Hosp Sao Joao Deus, Div Nephrol, Divinopolis, Brazil; [Hoe, Nancy P.] NIH, Off Res Serv, Div Occupat Hlth & Safety, Hamilton, MT USA; [Porcella, Stephen F.; Deleo, Frank R.] NIH, NIAID, Rocky Mt Lab, Lab Human Bacterial Pathogenesis, Hamilton, MT USA	The Methodist Hospital System; The Methodist Hospital - Houston; Universidade Federal de Sao Paulo (UNIFESP); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Beres, SB (corresponding author), Methodist Hosp, Ctr Mol & Translat Human Infect Dis Res, Res Inst, 6535 Fannin, Houston, TX 77030 USA.	jmmusser@tmhs.org	Sesso, Ricardo C C/B-4767-2013	DeLeo, Frank/0000-0003-3150-2516; Sesso, Ricardo/0000-0002-1062-0073; Beres, Stephen/0000-0003-3041-0185	National Institute of Allergy and Infectious Diseases [UO1-60595]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001052, ZIAAI001079, Z01AI001052, Z01AI001079] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by grant UO1-60595 from the National Institute of Allergy and Infectious Diseases (to JMM).	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Albarracin C, 1998, W V Med J, V94, P90; Alber J, 2005, VET MICROBIOL, V109, P135, DOI 10.1016/j.vetmic.2005.05.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Artiushin SC, 2002, MICROB PATHOGENESIS, V32, P71, DOI 10.1006/mpat.2001.0482; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balter S, 2000, LANCET, V355, P1776, DOI 10.1016/S0140-6736(00)02265-0; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; BARNHAM M, 1983, LANCET, V1, P945; BARNHAM M, 1987, EPIDEMIOL INFECT, V98, P171, DOI 10.1017/S0950268800061884; BARNHAM M, 1996, ADV EXPT MED BIOL, P149; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BARRETT NJ, 1986, J INFECTION, V12, P265, DOI 10.1016/S0163-4453(86)94320-3; Batsford SR, 2005, KIDNEY INT, V68, P1120, DOI 10.1111/j.1523-1755.2005.00504.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Boekhorst J, 2005, J BACTERIOL, V187, P4928, DOI 10.1128/JB.187.14.4928-4934.2005; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Bordes-Benitez A, 2006, EUR J CLIN MICROBIOL, V25, P242, DOI 10.1007/s10096-006-0119-x; Boucher C, 2002, CAN VET J, V43, P123; BRADLEY SF, 1991, REV INFECT DIS, V13, P270; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Carragoso A, 2007, ACTA REUMATOL PORT, V32, P287; Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x; Catanho Marcos, 2006, Appl Bioinformatics, V5, P49, DOI 10.2165/00822942-200605010-00007; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Claverys JP, 2003, TRENDS MICROBIOL, V11, P161, DOI 10.1016/S0966-842X(03)00064-7; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dirix G, 2004, PEPTIDES, V25, P1425, DOI 10.1016/j.peptides.2003.10.028; Downar J, 2001, J CLIN MICROBIOL, V39, P2358, DOI 10.1128/JCM.39.6.2358-2359.2001; Duca E, 1971, Rev Med Chir Soc Med Nat Iasi, V75, P105; EARLE D P, 1957, J Chronic Dis, V5, P3, DOI 10.1016/0021-9681(57)90120-0; EDWARDS AT, 1988, EPIDEMIOL INFECT, V101, P43, DOI 10.1017/S0950268800029204; Eisen JA, 2000, GENOME BIOL, V1; Ferrandiere M, 1998, EUR J CLIN MICROBIOL, V17, P290, DOI 10.1007/BF01699990; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fontan PA, 2000, J INFECT DIS, V182, P1712, DOI 10.1086/317604; FRANCIS AJ, 1993, J INFECTION, V27, P317, DOI 10.1016/0163-4453(93)92358-4; Fujino M, 2007, J NEPHROL, V20, P364; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; HAASE A, 1994, FEMS IMMUNOL MED MIC, V10, P75, DOI 10.1111/j.1574-695X.1994.tb00013.x; Hashikawa S, 2004, J CLIN MICROBIOL, V42, P186, DOI 10.1128/JCM.42.1.186-192.2004; Hidalgo-Grass C, 2002, MOL MICROBIOL, V46, P87, DOI 10.1046/j.1365-2958.2002.03127.x; Hoe NP, 2007, FEMS MICROBIOL LETT, V277, P142, DOI 10.1111/j.1574-6968.2007.00955.x; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Igwe EI, 2003, FEMS MICROBIOL LETT, V229, P259, DOI 10.1016/S0378-1097(03)00842-5; JOHNSTON KH, 1986, J EXP MED, V163, P697, DOI 10.1084/jem.163.3.697; JOHNSTON KH, 1991, GENETICS AND MOLECULAR BIOLOGY OF STREPTOCOCCI, LACTOCOCCI, AND ENTEROCOCCI, P190; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; KAPUR V, 1995, MOL MICROBIOL, V16, P509, DOI 10.1111/j.1365-2958.1995.tb02415.x; KEFALIDES NA, 1986, J EXP MED, V163, P588, DOI 10.1084/jem.163.3.588; KLEINMAN H, 1954, Minn Med, V37, P479; KODAMA T, 1958, Yokohama Med Bull, V9, P105; KOHLER W, 1976, SCAND J INFECT DIS, V8, P217, DOI 10.3109/inf.1976.8.issue-3.19; Korman TM, 2004, J CLIN MICROBIOL, V42, P2866, DOI 10.1128/JCM.42.6.2866-2869.2004; Kuusi M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-36; Lange K, 1976, Clin Nephrol, V5, P207; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LATORRE M, 1993, CLIN INFECT DIS, V17, P932, DOI 10.1093/clinids/17.5.932; Lee AS, 2004, MED J AUSTRALIA, V180, P366, DOI 10.5694/j.1326-5377.2004.tb05979.x; LOW DE, 1980, ARCH INTERN MED, V140, P977, DOI 10.1001/archinte.140.7.977; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Martin B, 2006, TRENDS MICROBIOL, V14, P339, DOI 10.1016/j.tim.2006.06.007; MARTINEZLUENGAS F, 1982, CAN MED ASSOC J, V127, P13; MCARTHUR JD, 2008, FASEB J; MCKEAGE MJ, 1990, AUST NZ J MED, V20, P177, DOI 10.1111/j.1445-5994.1990.tb01299.x; MEZZANO S, 1992, CLIN NEPHROL, V38, P305; Migliorini P., 2002, Autoimmunity Reviews, V1, P168, DOI 10.1016/S1568-9972(02)00028-9; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; MUNOZ AY, 1990, REV CLIN ESP, V187, P255; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nicholson ML, 2000, J CLIN MICROBIOL, V38, P4126, DOI 10.1128/JCM.38.11.4126-4130.2000; Nordstrand A, 1999, SCAND J INFECT DIS, V31, P523, DOI 10.1080/00365549950164382; OHKUNI H, 1983, CLIN EXP IMMUNOL, V54, P185; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Parra G, 1998, KIDNEY INT, V54, P509, DOI 10.1046/j.1523-1755.1998.00012.x; Pati S, 2007, CLIN NEUROL NEUROSUR, V109, P475, DOI 10.1016/j.clineuro.2007.01.014; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; POONKING R, 1993, J EXP MED, V178, P759, DOI 10.1084/jem.178.2.759; POONKING T, 1967, NEW ENGL J MED, V277, P728, DOI 10.1056/NEJM196710052771403; Poyart C, 1998, J CLIN MICROBIOL, V36, P41, DOI 10.1128/JCM.36.1.41-47.1998; Proft T, 2003, INFECT IMMUN, V71, P1361, DOI 10.1128/IAI.71.3.1361-1369.2003; RAMMELKAMP C H Jr, 1957, J Chronic Dis, V5, P28, DOI 10.1016/0021-9681(57)90122-4; RAMMELKAMP CH, 1952, T ASSOC AM PHYSICIAN, V65, P168; RAMMELKAMP CH, 1953, J CLIN INVEST, V32, P345, DOI 10.1172/JCI102745; RAMMELKAMP CH, 1954, T ASSOC AM PHYSICIAN, V67, P276; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Rastogi P A, 2000, Methods Mol Biol, V132, P47; REID HFM, 1990, J MED MICROBIOL, V32, P111, DOI 10.1099/00222615-32-2-111; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Iturbe B, 2007, KIDNEY INT, V71, P1094, DOI 10.1038/sj.ki.5002169; Rodriguez-Iturbe B, 1976, Clin Nephrol, V5, P197; ROSE HD, 1980, J CLIN MICROBIOL, V11, P76, DOI 10.1128/JCM.11.1.76-78.1980; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salazar L, 1994, Enferm Infecc Microbiol Clin, V12, P223; Shah SS, 2001, PEDIATR INFECT DIS J, V20, P445, DOI 10.1097/00006454-200104000-00016; SHARP JCM, 1985, BRIT MED J, V291, P463, DOI 10.1136/bmj.291.6493.463; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Suarez PR, 2001, ARCH BRONCONEUMOL, V37, P267, DOI 10.1016/S0300-2896(01)75066-1; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; TALAY S, 2008, 17 LANC INT S STRE S; Tapp J, 2003, INT J SYST EVOL MICR, V53, P1861, DOI 10.1099/ijs.0.02639-0; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Terrier B, 2007, AUTOIMMUN REV, V6, P176, DOI 10.1016/j.autrev.2006.10.004; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; TEWODROS W, 1995, MICROB PATHOGENESIS, V18, P53; Thorley AM, 2007, PEDIATR NEPHROL, V22, P597, DOI 10.1007/s00467-006-0364-3; Timoney JF, 2004, VET RES, V35, P397, DOI 10.1051/vetres:2004025; Ural O, 2003, SCAND J INFECT DIS, V35, P206, DOI 10.1080/00365540310000076; Valve K, 1992, Duodecim, V108, P1270; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; VILLARREAL H, 1979, J EXP MED, V149, P459, DOI 10.1084/jem.149.2.459; WERTHEIM AR, 1953, J CLIN INVEST, V32, P359, DOI 10.1172/JCI102746; WONG J, 1982, AUST NZ J SURG, V52, P576, DOI 10.1111/j.1445-2197.1982.tb06115.x; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Yamakami K, 2000, METHODS, V21, P185, DOI 10.1006/meth.2000.0990; YOSHIZAWA N, 1992, J IMMUNOL, V148, P3110; Yoshizawa N, 2004, J AM SOC NEPHROL, V15, P1785, DOI 10.1097/01.ASN.0000130624.94920.6B; YU CE, 1991, INFECT IMMUN, V59, P211, DOI 10.1128/IAI.59.1.211-215.1991; YUEN KY, 1990, J INFECTION, V21, P241, DOI 10.1016/0163-4453(90)93885-V; 1994, COMMUN DIS REP CDR W, V4, P241	142	91	327	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3026	10.1371/journal.pone.0003026	http://dx.doi.org/10.1371/journal.pone.0003026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716664	Green Published, Green Submitted, gold			2022-12-25	WOS:000264426800005
J	Gao, HC; Pattison, D; Yan, TF; Klingeman, DM; Wang, XH; Petrosino, J; Hemphill, L; Wan, XF; Leaphart, AB; Weinstock, GM; Palzkill, T; Zhou, JZ				Gao, Haichun; Pattison, Donna; Yan, Tingfen; Klingeman, Dawn M.; Wang, Xiaohu; Petrosino, Joseph; Hemphill, Lisa; Wan, Xiufeng; Leaphart, Adam B.; Weinstock, George M.; Palzkill, Timothy; Zhou, Jizhong			Generation and Validation of a Shewanella oneidensis MR-1 Clone Set for Protein Expression and Phage Display	PLOS ONE			English	Article							GLOBAL TRANSCRIPTOME ANALYSIS; ANTIBIOTIC-RESISTANCE; ANAEROBIC RESPIRATION; RAPID CONSTRUCTION; RECOMBINANT-DNA; SHOCK RESPONSE; IDENTIFICATION; GENES; REPOSITORY; SEQUENCE	A comprehensive gene collection for S. oneidensis was constructed using the lambda recombinase (Gateway) cloning system. A total of 3584 individual ORFs (85%) have been successfully cloned into the entry plasmids. To validate the use of the clone set, three sets of ORFs were examined within three different destination vectors constructed in this study. Success rates for heterologous protein expression of S. oneidensis His-or His/GST-tagged proteins in E. coli were approximately 70%. The ArcA and NarP transcription factor proteins were tested in an in vitro binding assay to demonstrate that functional proteins can be successfully produced using the clone set. Further functional validation of the clone set was obtained from phage display experiments in which a phage encoding thioredoxin was successfully isolated from a pool of 80 different clones after three rounds of biopanning using immobilized anti-thioredoxin antibody as a target. This clone set complements existing genomic (e. g., whole-genome microarray) and other proteomic tools (e. g., mass spectrometry-based proteomic analysis), and facilitates a wide variety of integrated studies, including protein expression, purification, and functional analyses of proteins both in vivo and in vitro.	[Gao, Haichun; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Gao, Haichun; Yan, Tingfen; Klingeman, Dawn M.; Wan, Xiufeng; Leaphart, Adam B.; Zhou, Jizhong] Oak Ridge Natl Lab, Environm Sci Div, Oak Ridge, TN USA; [Pattison, Donna; Wang, Xiaohu; Petrosino, Joseph; Hemphill, Lisa; Weinstock, George M.; Palzkill, Timothy] Baylor Coll Med, Houston, TX USA	University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Oak Ridge National Laboratory; Baylor College of Medicine	Gao, HC (corresponding author), Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA.	timothyp@bcm.tmc.edu; jzhou@ou.edu	Gao, Haichun/AFU-4588-2022; 吴, 昊/AAB-1620-2020; Weinstock, George M/C-6314-2013; Gao, Haichun/A-2160-2014; Petrosino, Joseph F./AAF-1621-2019; Klingeman, Dawn M/B-9415-2012	Gao, Haichun/0000-0002-2647-6563; Weinstock, George M/0000-0002-2997-4592; Gao, Haichun/0000-0002-2647-6563; Klingeman, Dawn M/0000-0002-4307-2560	U.S. Department of Energy under the Genomics: GTL Program through Shewanella Federation, Office of Biological and Environmental Research, Office of Science; Oak Ridge National Laboratory is managed by University of Tennessee-Battelle LLC for the Department of Energy [DOE-AC05-00OR22725]	U.S. Department of Energy under the Genomics: GTL Program through Shewanella Federation, Office of Biological and Environmental Research, Office of Science(United States Department of Energy (DOE)); Oak Ridge National Laboratory is managed by University of Tennessee-Battelle LLC for the Department of Energy	This research was supported by The U.S. Department of Energy under the Genomics: GTL Program through Shewanella Federation, Office of Biological and Environmental Research, Office of Science. Oak Ridge National Laboratory is managed by University of Tennessee-Battelle LLC for the Department of Energy under contract DOE-AC05-00OR22725.	Aguiar JC, 2004, GENOME RES, V14, P2076, DOI 10.1101/gr.2416604; Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Bencheikh-Latmani R, 2005, APPL ENVIRON MICROB, V71, P7453, DOI 10.1128/AEM.71.11.7453-7460.2005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown SD, 2006, APPL ENVIRON MICROB, V72, P890, DOI 10.1128/AEM.72.1.890-900.2006; Brown SD, 2006, MOL CELL PROTEOMICS, V5, P1054, DOI 10.1074/mcp.M500394-MCP200; Choudhury G, 2006, STOCH ANAL APPL, V24, P1, DOI 10.1080/07362990500397277; Daraselia N., 2003, OMICS A Journal of Integrative Biology, V7, P171, DOI 10.1089/153623103322246566; DARWIN AJ, 1995, J BACTERIOL, V177, P3865, DOI 10.1128/jb.177.13.3865-3869.1995; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Forstner M, 2007, EXPERT REV PROTEOMIC, V4, P67, DOI 10.1586/14789450.4.1.67; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2006, J BACTERIOL, V188, P4560, DOI 10.1128/JB.01908-05; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gralnick JA, 2005, MOL MICROBIOL, V56, P1347, DOI 10.1111/j.1365-2958.2005.04628.x; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Huang WZ, 2000, GENE, V251, P187, DOI 10.1016/S0378-1119(00)00210-9; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Kolker E, 2005, P NATL ACAD SCI USA, V102, P2099, DOI 10.1073/pnas.0409111102; Korenevsky AA, 2002, APPL ENVIRON MICROB, V68, P4653, DOI 10.1128/AEM.68.9.4653-4657.2002; LaBaer J, 2004, GENOME RES, V14, P2190, DOI 10.1101/gr.2482804; Leaphart AB, 2006, J BACTERIOL, V188, P1633, DOI 10.1128/JB.188.4.1633-1642.2006; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Liu YQ, 2005, J BACTERIOL, V187, P2501, DOI 10.1128/JB.187.7.2501-2507.2005; Maier TM, 2001, J BACTERIOL, V183, P4918, DOI 10.1128/JB.183.16.4918-4926.2001; Marsischky G, 2004, GENOME RES, V14, P2020, DOI 10.1101/gr.2528804; McKevitt M, 2005, INFECT IMMUN, V73, P4445, DOI 10.1128/IAI.73.7.4445-4450.2005; McKevitt M, 2003, GENOME RES, V13, P1665, DOI 10.1101/gr.288103; PALZKILL T, 1994, MOL MICROBIOL, V12, P217, DOI 10.1111/j.1365-2958.1994.tb01011.x; Park J, 2005, P NATL ACAD SCI USA, V102, P8114, DOI 10.1073/pnas.0503141102; Phizicky EM, 2006, CRIT REV BIOCHEM MOL, V41, P315, DOI 10.1080/10409230600872872; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; Qiu XY, 2005, J BACTERIOL, V187, P3556, DOI 10.1128/JB.187.10.3556-3564.2005; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; Romine MF, 2008, APPL ENVIRON MICROB, V74, P3257, DOI 10.1128/AEM.02720-07; Romine MF, 2004, OMICS, V8, P239, DOI 10.1089/omi.2004.8.239; Saffarini DA, 2003, J BACTERIOL, V185, P3668, DOI 10.1128/JB.185.12.3668-3671.2003; Salamat-Miller N, 2006, MOL CELL PROTEOMICS, V5, P2263, DOI 10.1074/mcp.M600240-MCP200; Schwalb C, 2003, BIOCHEMISTRY-US, V42, P9491, DOI 10.1021/bi034456f; Tang XT, 2007, J PROTEOME RES, V6, P724, DOI 10.1021/pr060480e; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P718, DOI 10.1128/AEM.01532-06; TYSON KL, 1994, MOL MICROBIOL, V13, P1045, DOI 10.1111/j.1365-2958.1994.tb00495.x; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Xu D, 2002, BIOINFORMATICS, V18, P1432, DOI 10.1093/bioinformatics/18.11.1432; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	55	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2983	10.1371/journal.pone.0002983	http://dx.doi.org/10.1371/journal.pone.0002983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714347	gold, Green Published, Green Submitted			2022-12-25	WOS:000264420900010
J	Makidon, PE; Bielinska, AU; Nigavekar, SS; Janczak, KW; Knowlton, J; Scott, AJ; Mank, N; Cao, ZY; Rathinavelu, S; Beer, MR; Wilkinson, JE; Blanco, LP; Landers, JJ; Baker, JR				Makidon, Paul E.; Bielinska, Anna U.; Nigavekar, Shraddha S.; Janczak, Katarzyna W.; Knowlton, Jessica; Scott, Alison J.; Mank, Nicholas; Cao, Zhengyi; Rathinavelu, Sivaprakash; Beer, Michael R.; Wilkinson, J. Erby; Blanco, Luz P.; Landers, Jeffrey J.; Baker, James R., Jr.			Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine	PLOS ONE			English	Article							T-LYMPHOCYTE RESPONSES; LONG-TERM PERSISTENCE; SURFACE-ANTIGEN; IMMUNE-RESPONSES; INTRANASAL IMMUNIZATION; ALUMINUM-HYDROXIDE; ANTIBODY AVIDITY; POTENT ENHANCER; DNA VACCINES; VIRUS	Background: Hepatitis B virus infection remains an important global health concern despite the availability of safe and effective prophylactic vaccines. Limitations to these vaccines include requirement for refrigeration and three immunizations thereby restricting use in the developing world. A new nasal hepatitis B vaccine composed of recombinant hepatitis B surface antigen (HBsAg) in a novel nanoemulsion (NE) adjuvant (HBsAg-NE) could be effective with fewer administrations. Methodology and Principal Findings: Physical characterization indicated that HBsAg-NE consists of uniform lipid droplets (349+/-17 nm) associated with HBsAg through electrostatic and hydrophobic interactions. Immunogenicity of HBsAg-NE vaccine was evaluated in mice, rats and guinea pigs. Animals immunized intranasally developed robust and sustained systemic IgG, mucosal IgA and strong antigen-specific cellular immune responses. Serum IgG reached >= 10(6) titers and was comparable to intramuscular vaccination with alum-adjuvanted vaccine (HBsAg-Alu). Normalization showed that HBsAg-NE vaccination correlates with a protective immunity equivalent or greater than 1000 IU/ml. Th1 polarized immune response was indicated by IFN-gamma and TNF-alpha cytokine production and elevated levels of IgG(2) subclass of HBsAg-specific antibodies. The vaccine retains full immunogenicity for a year at 4 degrees C, 6 months at 25 degrees C and 6 weeks at 40 degrees C. Comprehensive pre-clinical toxicology evaluation demonstrated that HBsAg-NE vaccine is safe and well tolerated in multiple animal models. Conclusions: Our results suggest that needle-free nasal immunization with HBsAg-NE could be a safe and effective hepatitis B vaccine, or provide an alternative booster administration for the parenteral hepatitis B vaccines. This vaccine induces a Th1 associated cellular immunity and also may provide therapeutic benefit to patients with chronic hepatitis B infection who lack cellular immune responses to adequately control viral replication. Long-term stability of this vaccine formulation at elevated temperatures suggests a direct advantage in the field, since potential excursions from cold chain maintenance could be tolerated without a loss in therapeutic efficacy.	[Makidon, Paul E.; Bielinska, Anna U.; Nigavekar, Shraddha S.; Janczak, Katarzyna W.; Knowlton, Jessica; Scott, Alison J.; Mank, Nicholas; Cao, Zhengyi; Rathinavelu, Sivaprakash; Beer, Michael R.; Blanco, Luz P.; Landers, Jeffrey J.; Baker, James R., Jr.] Univ Michigan, M NIMBS, Ann Arbor, MI 48109 USA; [Makidon, Paul E.; Wilkinson, J. Erby] Univ Michigan, Unit Lab Anim Med ULAM, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Makidon, PE (corresponding author), Univ Michigan, M NIMBS, Ann Arbor, MI 48109 USA.	jbakerjr@umich.edu	Rathinavelu, Sivaprakash/AAT-2526-2021	Scott, Alison/0000-0001-6969-4707; /0000-0002-8468-6518	Bill & Melinda Gates Foundation [Grand Challenges in Global Health Initiative 37868]; Natl Ctr Research Resourses of NIH [T32 RR07008]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007008] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Natl Ctr Research Resourses of NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funded by Bill & Melinda Gates Foundation through Grand Challenges in Global Health Initiative 37868. P. Makidon is supported by T32 RR07008 from Natl Ctr Research Resourses of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JC, 2004, IMMUNOL CELL BIOL, V82, P539, DOI 10.1111/j.0818-9641.2004.01278.x; Aguilar JC, 2003, BIOCHEM BIOPH RES CO, V310, P59, DOI 10.1016/j.bbrc.2003.08.120; Anttila M, 1999, CLIN EXP IMMUNOL, V118, P402; Assad S, 1999, VACCINE, V18, P57, DOI 10.1016/S0264-410X(99)00179-6; BETANCOURT AA, 2007, INT J INFEC IN PRESS; Bielinska AU, 2008, CLIN VACCINE IMMUNOL, V15, P348, DOI 10.1128/CVI.00440-07; Bielinska AU, 2008, AIDS RES HUM RETROV, V24, P271, DOI 10.1089/aid.2007.0148; Bielinska AU, 2007, INFECT IMMUN, V75, P4020, DOI 10.1128/IAI.00070-07; Brewer JM, 2006, IMMUNOL LETT, V102, P10, DOI 10.1016/j.imlet.2005.08.002; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P868; Chen HM, 2000, J CONTROL RELEASE, V67, P117, DOI 10.1016/S0168-3659(00)00199-1; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; CLASSEN DC, 1987, J CLIN MICROBIOL, V25, P600, DOI 10.1128/JCM.25.4.600-604.1987; Conti L, 2008, EUR J IMMUNOL, V38, P750, DOI 10.1002/eji.200737395; Davis SS, 2001, ADV DRUG DELIVER REV, V51, P21, DOI 10.1016/S0169-409X(01)00162-4; Debin A, 2002, VACCINE, V20, P2752, DOI 10.1016/S0264-410X(02)00191-3; Egan MA, 2004, VACCINE, V22, P3774, DOI 10.1016/j.vaccine.2004.03.011; Floreani A, 2004, VACCINE, V22, P607, DOI 10.1016/j.vaccine.2003.09.001; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Geissler M, 1997, GASTROENTEROLOGY, V112, P1307, DOI 10.1016/S0016-5085(97)70145-8; GESEMANN M, 1995, VACCINE, V13, P443, DOI 10.1016/0264-410X(94)00010-K; Gherardi RK, 2001, BRAIN, V124, P1821, DOI 10.1093/brain/124.9.1821; Gilbert RJC, 2005, P NATL ACAD SCI USA, V102, P14783, DOI 10.1073/pnas.0505062102; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Graham BS, 2006, PLOS MED, V3, P18, DOI 10.1371/journal.pmed.0030057; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; Hamouda T, 2000, J APPL MICROBIOL, V89, P397, DOI 10.1046/j.1365-2672.2000.01127.x; Hamouda T, 2001, MICROBIOL RES, V156, P1, DOI 10.1078/0944-5013-00069; Hamouda T, 1999, J INFECT DIS, V180, P1939, DOI 10.1086/315124; Harandi Ali M, 2003, Curr Opin Investig Drugs, V4, P156; *HEP B FDN, 2007, HEP B CLIN TRIALS; HERBERT RA, 1999, PATHOLOGY MOUSE; Hilleman MR, 2001, VACCINE, V19, P1837, DOI 10.1016/S0264-410X(00)00364-9; HogenEsch H, 2002, VACCINE, V20, pS34, DOI 10.1016/S0264-410X(02)00169-X; Illum L, 2001, ADV DRUG DELIVER REV, V51, P1; Isaka M, 2001, VACCINE, V19, P1460, DOI 10.1016/S0264-410X(00)00348-0; Iyer S, 2004, VACCINE, V22, P1475, DOI 10.1016/j.vaccine.2003.10.023; Jaganathan KS, 2006, VACCINE, V24, P4201, DOI 10.1016/j.vaccine.2006.01.011; Katare YK, 2006, VACCINE, V24, P3599, DOI 10.1016/j.vaccine.2006.01.066; Khajuria A, 2007, VACCINE, V25, P4586, DOI 10.1016/j.vaccine.2007.03.051; Lambert PH, 2005, NAT MED, V11, pS54, DOI 10.1038/nm1216; Lemon SM, 1997, NEW ENGL J MED, V336, P196, DOI 10.1056/NEJM199701163360307; LEROUXROELS G, 1994, VACCINE, V12, P812, DOI 10.1016/0264-410X(94)90290-9; Little SF, 2004, BIOLOGICALS, V32, P62, DOI 10.1016/j.biologicals.2004.02.001; Lobaina Y, 2003, BIOCHEM BIOPH RES CO, V300, P745, DOI 10.1016/S0006-291X(02)02897-8; MAKHATADZE GI, 1990, J MOL BIOL, V213, P375, DOI 10.1016/S0022-2836(05)80197-4; McClary H, 2000, J VIROL, V74, P2255, DOI 10.1128/JVI.74.5.2255-2264.2000; McCluskie MJ, 1998, J IMMUNOL, V161, P4463; Michel ML, 2005, J CLIN VIROL, V34, pS108, DOI 10.1016/S1386-6532(05)80019-8; *MICROCAL LLC, 2007, VP ITC MICR US MAN; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Myc A, 2003, VACCINE, V21, P3801, DOI 10.1016/S0264-410X(03)00381-5; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Niu MT, 1998, J CLIN EPIDEMIOL, V51, P503, DOI 10.1016/S0895-4356(98)00014-6; Park MH, 2003, TISSUE ANTIGENS, V62, P505, DOI 10.1046/j.1399-0039.2003.00141.x; Payette PJ, 2006, INTERVIROLOGY, V49, P144, DOI 10.1159/000089375; PETERSON DL, 1987, BIOESSAYS, V6, P258, DOI 10.1002/bies.950060604; Pittman PR, 2002, VACCINE, V20, pS48, DOI 10.1016/S0264-410X(02)00172-X; Poland GA, 2004, NEW ENGL J MED, V351, P2832, DOI 10.1056/NEJMcp041507; Saraf S, 2006, VACCINE, V24, P45, DOI 10.1016/j.vaccine.2005.07.053; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Schirmbeck R, 2001, J IMMUNOL, V166, P1405, DOI 10.4049/jimmunol.166.2.1405; SCHIRMBECK R, 1994, J IMMUNOL, V152, P1110; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; TALARO K, 1993, FDN MICROBIOLOGY, P806; van Ginkel FW, 2005, INFECT IMMUN, V73, P6892, DOI 10.1128/IAI.73.10.6892-6902.2005; Van Herck K, 1998, VACCINE, V16, P1933, DOI 10.1016/S0264-410X(98)00126-1; Vanlandschoot P, 2003, TRENDS IMMUNOL, V24, P144, DOI 10.1016/S1471-4906(03)00026-7; Vermont CL, 2002, INFECT IMMUN, V70, P584, DOI 10.1128/IAI.70.2.584-590.2002; *WHO, 2000, 204 WHO; Wieland SF, 2000, J VIROL, V74, P4165, DOI 10.1128/JVI.74.9.4165-4173.2000; Woo WP, 2006, J VIROL, V80, P3975, DOI 10.1128/JVI.80.8.3975-3984.2006; Yuki Y, 2003, REV MED VIROL, V13, P293, DOI 10.1002/rmv.398; Zuckerman JN, 2006, J MED VIROL, V78, P169, DOI 10.1002/jmv.20524; 2005, GATES FDN GRAND CHAL	75	112	129	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2954	10.1371/journal.pone.0002954	http://dx.doi.org/10.1371/journal.pone.0002954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698426	Green Submitted, gold, Green Published			2022-12-25	WOS:000264412600040
J	Andersen, DS; Tapon, N				Andersen, Ditte S.; Tapon, Nicolas			Drosophila MFAP1 Is Required for Pre-mRNA Processing and G(2)/M Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEAR RIBONUCLEOPROTEIN; CELL-CYCLE PROGRESSION; BOX SPLICING FACTOR; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; PRP19P-ASSOCIATED COMPLEX; SPLICEOSOME ACTIVATION; GENETIC-CONTROL; DIVISION CYCLE; PROTEIN-COMPOSITION	The mammalian spliceosome has mainly been studied using proteomics. The isolation and comparison of different splicing intermediates has revealed the dynamic association of more than 200 splicing factors with the spliceosome, relatively few of which have been studied in detail. Here, we report the characterization of the Drosophila homologue of microfibril-associated protein 1 (dMFAP1), a previously uncharacterized protein found in some human spliceosomal fractions (Jurica, M. S., and Moore, M. J. (2003) Mol. Cell 12, 5-14). We show that dMFAP1 binds directly to the Drosophila homologue of Prp38p (dPrp38), a tri-small nuclear ribonucleoprotein component (Xie, J., Beickman, K., Otte, E., and Rymond, B. C. (1998) EMBO J. 17, 2938 2946), and is required for pre-mRNA processing. dMFAP1, like dPrp38, is essential for viability, and our in vivo data show that cells with reduced levels of dMFAP1 or dPrp38 proliferate more slowly than normal cells and undergo apoptosis. Consistent with this, double-stranded RNA-mediated depletion of dPrp38 or dMFAP1 causes cells to arrest in G(2)/M, and this is paralleled by a reduction in mRNA levels of the mitotic phosphatase string/cdc25. Interestingly double-stranded RNA-mediated depletion of a wide range of core splicing factors elicits a similar phenotype, suggesting that the observed G(2)/M arrest might be a general consequence of interfering with spliceosome function.	[Andersen, Ditte S.; Tapon, Nicolas] London Res Inst, Apoptosis & Proliferat Control Lab, London WC2A 3PX, England		Tapon, N (corresponding author), POB 123,44 Lincolns Inn Fields, London WC2A 3PX, England.	nicolas.tapon@cancer.org.uk		Andersen, Ditte/0000-0003-1209-6102; Tapon, Nicolas/0000-0001-5267-6510	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Bernstein HS, 1998, J BIOL CHEM, V273, P4666, DOI 10.1074/jbc.273.8.4666; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; BLANTON S, 1992, MOL CELL BIOL, V12, P3939, DOI 10.1128/MCB.12.9.3939; Boger-Nadjar E, 1998, MOL GEN GENET, V260, P232, DOI 10.1007/s004380050891; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Burns CG, 2002, MOL CELL BIOL, V22, P801, DOI 10.1128/MCB.22.3.801-815.2002; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chawla G, 2003, NUCLEIC ACIDS RES, V31, P2333, DOI 10.1093/nar/gkg333; Chen CH, 2001, J BIOL CHEM, V276, P488, DOI 10.1074/jbc.M006958200; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; Chen YIG, 2006, J MOL BIOL, V361, P412, DOI 10.1016/j.jmb.2006.06.052; Cho SY, 2007, J BIOL CHEM, V282, P2456, DOI 10.1074/jbc.M608042200; Dahan O, 2004, NUCLEIC ACIDS RES, V32, P2529, DOI 10.1093/nar/gkh574; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Diaz B, 2005, EXP CELL RES, V306, P317, DOI 10.1016/j.yexcr.2005.03.017; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; Habara Y, 2001, RNA, V7, P671, DOI 10.1017/S1355838201001200; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; HARTWELL LH, 1973, GENETICS, V74, P267; HORRIGAN SK, 1992, J BIOL CHEM, V267, P10087; Hwang LH, 1997, MOL BIOL CELL, V8, P1877, DOI 10.1091/mbc.8.10.1877; James SA, 2002, RNA, V8, P1068, DOI 10.1017/S1355838202022033; JOHNSTON LH, 1982, MOL GEN GENET, V186, P439, DOI 10.1007/BF00729466; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Lundgren K, 1996, MOL BIOL CELL, V7, P1083, DOI 10.1091/mbc.7.7.1083; MADHANI HD, 1994, ANNU REV GENET, V28, P1; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Neubauer G, 2005, METHOD ENZYMOL, V405, P236, DOI 10.1016/S0076-6879(05)05010-X; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; Ohi R, 1998, MOL CELL BIOL, V18, P4097, DOI 10.1128/MCB.18.7.4097; OHI R, 1994, EMBO J, V13, P471, DOI 10.1002/j.1460-2075.1994.tb06282.x; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Perriman R, 2000, GENE DEV, V14, P97; Pignoni F, 1997, P NATL ACAD SCI USA, V94, P9220, DOI 10.1073/pnas.94.17.9220; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; ROSBASH M, 1991, TRENDS BIOCHEM SCI, V16, P187, DOI 10.1016/0968-0004(91)90073-5; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUBY SW, 1988, SCIENCE, V242, P1028, DOI 10.1126/science.2973660; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; Schneider S, 2002, J BIOL CHEM, V277, P15452, DOI 10.1074/jbc.M112473200; SHEA JE, 1994, NUCLEIC ACIDS RES, V22, P5555, DOI 10.1093/nar/22.25.5555; Singh R, 2000, RNA, V6, P901, DOI 10.1017/S1355838200000376; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stevens SW, 1999, P NATL ACAD SCI USA, V96, P7226, DOI 10.1073/pnas.96.13.7226; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; Tsai WY, 1999, J BIOL CHEM, V274, P9455, DOI 10.1074/jbc.274.14.9455; UMEN JG, 1995, RNA, V1, P584; Urlaub H, 2002, METHODS, V26, P170, DOI 10.1016/S1046-2023(02)00020-8; Urushiyama S, 1997, GENETICS, V147, P101; VAISMAN N, 1995, MOL GEN GENET, V247, P123, DOI 10.1007/BF00705642; Wang Y, 1998, RNA, V4, P1216, DOI 10.1017/S1355838298980992; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Xie J, 1998, EMBO J, V17, P2938, DOI 10.1093/emboj/17.10.2938; XU T, 1993, DEVELOPMENT, V117, P1223; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597	68	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31256	31267		10.1074/jbc.M803512200	http://dx.doi.org/10.1074/jbc.M803512200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18765666	Green Published, hybrid			2022-12-25	WOS:000260544800079
J	Klein, EA; Campbell, LE; Kothapalli, D; Fournier, AK; Assoian, RK				Klein, Eric A.; Campbell, Latoya E.; Kothapalli, Devashish; Fournier, Alaina K.; Assoian, Richard K.			Joint Requirement for Rac and ERK Activities Underlies the Mid-G1 Phase Induction of Cyclin D1 and S Phase Entry in Both Epithelial and Mesenchymal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; G(1) PHASE; G1 PHASE; CASCADE ACTIVATION; SIGNALING PATHWAY; GENE-EXPRESSION; D-1 EXPRESSION; PROGRESSION; INTEGRINS	Cyclin D1 gene induction is a key event in G1 phase progression. Our previous studies indicated that signaling to cyclin D1 is cell type-dependent because the timing of cyclin D1 gene expression in MCF10A mammary epithelial cells and mesenchymal cells such as fibroblasts and vascular smooth muscle cells is very different, with epithelial cells first expressing cyclin D1 in early rather than mid-G1 phase. In this report, we induced a mesenchymal phenotype in MCF10A cells by long-term exposure to TGF-beta and used the control and transitioned cells to examine cell type specificity of the signaling pathways that regulate cyclin D1 gene expression. We show that early-G1 phase cyclin D1 gene expression in MCF10A cells is under the control of Rac, whereas mid-G1 phase cyclin D1 induction requires parallel signaling from Rac and ERK, both in the control and transitioned cells. This combined requirement for Rac and ERK signaling is associated with an increased requirement for intracellular tension, Rb phosphorylation, and S phase entry. A similar co-regulation of cyclin D1 mRNA by Rac and ERK is seen in primary mesenchymal cells. Overall, our results reveal two mechanistically distinct phases of Rac-dependent cyclin D1 expression and emphasize that the acquisition of Rac/ERK codependence is required for the mid-G1 phase induction of cyclin D1 associated with S phase entry.	[Klein, Eric A.; Campbell, Latoya E.; Kothapalli, Devashish; Fournier, Alaina K.; Assoian, Richard K.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Assoian, RK (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	assoian@mail.med.upenn.edu		Klein, Eric/0000-0003-3941-6233	National Institutes of Health [CA72639, GM069064, HL083367]; NATIONAL CANCER INSTITUTE [R01CA072639] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA72639, GM069064, and HL083367. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aplin AE, 1998, PHARMACOL REV, V50, P197; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Blagosklonny MV, 2002, CELL CYCLE, V1, P103, DOI 10.4161/cc.1.2.108; Bohmer RM, 1996, MOL BIOL CELL, V7, P101; Braga V, 2000, EXP CELL RES, V261, P83, DOI 10.1006/excr.2000.5050; Cook SJ, 1999, MOL CELL BIOL, V19, P330; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Hirsch E, 2002, J CELL BIOL, V157, P481, DOI 10.1083/jcb.200111065; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Klein EA, 2007, METHOD ENZYMOL, V426, P155, DOI 10.1016/S0076-6879(07)26008-2; Klein EA, 2007, CELL CYCLE, V6, P1115, DOI 10.4161/cc.6.9.4147; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Neve RM, 2002, ONCOGENE, V21, P4567, DOI 10.1038/sj.onc.1205555; Page K, 1999, AM J RESP CELL MOL, V20, P1294, DOI 10.1165/ajrcmb.20.6.3597; Page K, 1999, J BIOL CHEM, V274, P22065, DOI 10.1074/jbc.274.31.22065; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Ramakrishnan M, 1998, AM J RESP CELL MOL, V18, P736, DOI 10.1165/ajrcmb.18.6.3152; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; Villanueva J, 2007, MOL BIOL CELL, V18, P1457, DOI 10.1091/mbc.E06-10-0908; Watanabe G, 1996, J BIOL CHEM, V271, P22570, DOI 10.1074/jbc.271.37.22570; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Yang C, 2008, BIOCHEM J, V410, P167, DOI 10.1042/BJ20070781; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	31	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30911	30918		10.1074/jbc.M804537200	http://dx.doi.org/10.1074/jbc.M804537200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18715870	Green Published, hybrid			2022-12-25	WOS:000260544800046
J	Markey, M; Berberich, SJ				Markey, M.; Berberich, S. J.			Full-length hdmX transcripts decrease following genotoxic stress	ONCOGENE			English	Article						HdmX; p53; transcription; splicing; microRNAs	TUMOR-SUPPRESSOR P53; UBIQUITIN LIGASE ACTIVITY; EMBRYONIC LETHALITY; ONCOPROTEIN MDM2; REGULATE P53; DNA-DAMAGE; ACTIVATION; EXPRESSION; STABILITY; PROTEIN	Previous studies have suggested that the mdmX gene is constitutively transcribed, and that MdmX protein activity is instead controlled by cellular localization and DNA damage induced Mdm2-mediated ubiquitination leading to proteasomal degradation. In these studies, we report that the human mdmX (hdmX) mRNA is reproducibly decreased in various human cell lines following treatment with various DNA-damaging agents. Repression of hdmX transcripts is observed in DNA-damaged HCT116 colon cancer cells and in isogenic p53(-/-) cells, suggesting that this effect is p53-independent. Reduction in the amount of hdmX transcript occurs in both human tumor cell lines and primary human diploid fibroblasts, and results in a significant reduction of HdmX protein. Examination of hdmX promoter activity suggests that damage-induced repression of hdmX mRNA is not significantly impacted by transcription initiation. In contrast, changes in hdmX mRNA splicing appear to partly explain the reduction in full-length hdmX mRNA levels in tumor cell lines with the destabilization of full-length hdmX transcripts, potentially through microRNA miR-34a regulation, also impacting transcript levels. Taken together, this study uncovers previously unrecognized cellular mechanisms by which hdmX mRNA levels are kept low following genotoxic stress.	[Markey, M.; Berberich, S. J.] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Berberich, SJ (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.	steven.berberich@wright.edu		Markey, Michael/0000-0002-8593-2290	NIH [CA66430]; NATIONAL CANCER INSTITUTE [R01CA064430] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Berberich laboratory for their insightful discussions. This work was supported by NIH CA66430 (to SJB).	Bartel F, 2005, INT J CANCER, V117, P469, DOI 10.1002/ijc.21206; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; DEOCALUNA R, 1995, NATURE, V0378; Dias CS, 2006, CANCER RES, V66, P9467, DOI 10.1158/0008-5472.CAN-05-3013; Eto I, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-20; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gentiletti F, 2002, ONCOGENE, V21, P867, DOI 10.1038/sj.onc.1205137; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Jackson MW, 1999, DNA CELL BIOL, V18, P693, DOI 10.1089/104454999314971; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Li CG, 2002, MOL CELL BIOL, V22, P7562, DOI 10.1128/MCB.22.21.7562-7571.2002; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Migliorini D, 2002, J BIOL CHEM, V277, P7318, DOI 10.1074/jbc.M108795200; MIYASHITA T, 1995, CELL, V80, P293; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Ramos YFM, 2001, CANCER RES, V61, P1839; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rozen S, 2000, Methods Mol Biol, V132, P365; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yamasaki Lili, 2003, Cancer Treat Res, V115, P209	41	24	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2008	27	52					6657	6666		10.1038/onc.2008.266	http://dx.doi.org/10.1038/onc.2008.266			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	368QY	18711402	Green Accepted			2022-12-25	WOS:000260638800004
J	Blanco, YC; Farias, AS; Goelnitz, U; Lopes, SCP; Arrais-Silva, WW; Carvalho, BO; Amino, R; Wunderlich, G; Santos, LMB; Giorgio, S; Costa, FTM				Blanco, Yara C.; Farias, Alessandro S.; Goelnitz, Uta; Lopes, Stefanie C. P.; Arrais-Silva, Wagner W.; Carvalho, Bruna O.; Amino, Rogerio; Wunderlich, Gerhard; Santos, Leonilda M. B.; Giorgio, Selma; Costa, Fabio T. M.			Hyperbaric Oxygen Prevents Early Death Caused by Experimental Cerebral Malaria	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SEVERE FALCIPARUM-MALARIA; T-CELLS; INTERFERON-GAMMA; BRAIN TRAUMA; ISCHEMIA; CYTOKINES; EXPRESSION; PRESSURE; THERAPY	Background: Cerebral malaria (CM) is a syndrome characterized by neurological signs, seizures and coma. Despite the fact that CM presents similarities with cerebral stroke, few studies have focused on new supportive therapies for the disease. Hyperbaric oxygen (HBO) therapy has been successfully used in patients with numerous brain disorders such as stroke, migraine and atherosclerosis. Methodology/Principal Findings: C57BL/6 mice infected with Plasmodium berghei ANKA (PbA) were exposed to daily doses of HBO (100% O-2, 3.0 ATA, 1-2 h per day) in conditions well-tolerated by humans and animals, before or after parasite establishment. Cumulative survival analyses demonstrated that HBO therapy protected 50% of PbA-infected mice and delayed CM-specific neurological signs when administrated after patent parasitemia. Pressurized oxygen therapy reduced peripheral parasitemia, expression of TNF-alpha, IFN-gamma and IL-10 mRNA levels and percentage of gamma delta and alpha beta CD4(+) and CD8(+) T lymphocytes sequestered in mice brains, thus resulting in a reduction of blood-brain barrier (BBB)dysfunction and hypothermia. Conclusions/Significance: The data presented here is the first indication that HBO treatment could be used as supportive therapy, perhaps in association with neuroprotective drugs, to prevent CM clinical outcomes, including death.	[Blanco, Yara C.; Farias, Alessandro S.; Lopes, Stefanie C. P.; Carvalho, Bruna O.; Santos, Leonilda M. B.; Costa, Fabio T. M.] State Univ Campinas UNICAMP, Dept Microbiol & Immunol, Campinas, SP, Brazil; [Blanco, Yara C.; Lopes, Stefanie C. P.; Arrais-Silva, Wagner W.; Carvalho, Bruna O.; Giorgio, Selma; Costa, Fabio T. M.] State Univ Campinas UNICAMP, Dept Parasitol, Sao Paulo, Brazil; [Goelnitz, Uta; Wunderlich, Gerhard] Univ Sao Paulo, Dept Parasitol ICB, Sao Paulo, Brazil; [Amino, Rogerio] Fed Univ Sao Paulo UNIFESP, Dept Biochem, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Blanco, YC (corresponding author), State Univ Campinas UNICAMP, Dept Microbiol & Immunol, Campinas, SP, Brazil.	costaftm@unicamp.br	Costa, Fabio/E-1181-2012; Wunderlich, Gerhard/G-8245-2012; Farias, Alessandro/AAH-2228-2020; Giorgio, Selma/A-6701-2013; Farias, Alessandro/C-6879-2012; Lopes, Stefanie/A-8314-2012	Costa, Fabio/0000-0001-9969-7300; Wunderlich, Gerhard/0000-0003-1724-0337; Farias, Alessandro/0000-0001-6759-1819; Farias, Alessandro/0000-0001-6759-1819; Lopes, Stefanie/0000-0002-6981-2192	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2004/00638-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant n 2004/00638-6, and from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). YCB, WWA, ASF and SCPL were supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and UG was sponsored by a FAPESP fellowship. GW, SG and FTMC are CNPq fellows.	Al-Waili NS, 2006, THESCIENTIFICWORLDJO, V6, P425, DOI 10.1100/tsw.2006.78; Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; Arrais-Silva WW, 2006, ACTA TROP, V98, P130, DOI 10.1016/j.actatropica.2006.03.001; Arrais-Silva WW, 2005, PARASITOL INT, V54, P1, DOI 10.1016/j.parint.2004.07.002; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Benson RM, 2003, CLIN EXP IMMUNOL, V134, P57, DOI 10.1046/j.1365-2249.2003.02248.x; Buras JA, 2000, AM J PHYSIOL-CELL PH, V278, pC292, DOI 10.1152/ajpcell.2000.278.2.C292; Calvert JW, 2002, BRAIN RES, V951, P1, DOI 10.1016/S0006-8993(02)03094-9; Carter JA, 2005, TROP MED INT HEALTH, V10, P3, DOI 10.1111/j.1365-3156.2004.01345.x; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; DEKOSSODO S, 1993, J IMMUNOL, V151, P4811; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; GADD MA, 1990, CRIT CARE MED, V18, P974, DOI 10.1097/00003246-199009000-00014; Gillman BM, 2004, INFECT IMMUN, V72, P6359, DOI 10.1128/IAI.72.11.6359-6366.2004; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Granowitz EV, 2002, UNDERSEA HYPERBAR M, V29, P216; GUDEWICZ TM, 1987, AVIAT SPACE ENVIR MD, V58, P673; Hermsen CC, 1997, PARASITE IMMUNOL, V19, P571, DOI 10.1046/j.1365-3024.1997.d01-175.x; Hink J, 2001, MED HYPOTHESES, V57, P764, DOI 10.1054/mehy.2001.1488; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; IRANI DN, 1991, J IMMUNOL METHODS, V139, P223, DOI 10.1016/0022-1759(91)90192-I; Jennings VM, 1997, INFECT IMMUN, V65, P4883, DOI 10.1128/IAI.65.11.4883-4887.1997; Jennings VM, 1998, INFECT IMMUN, V66, P5972, DOI 10.1128/IAI.66.12.5972-5979.1998; Kaide CG, 2008, EMERG MED CLIN N AM, V26, P571, DOI 10.1016/j.emc.2008.01.005; Kaiser K, 2006, J INFECT DIS, V193, P987, DOI 10.1086/500844; KAPP JP, 1981, SURG NEUROL, V15, P43, DOI 10.1016/S0090-3019(81)80089-4; Lahat N, 1995, CLIN EXP IMMUNOL, V102, P655; Lee CC, 2006, J BIOMED SCI, V13, P143, DOI 10.1007/s11373-005-9037-7; Li Y, 2005, EXP NEUROL, V191, P198, DOI 10.1016/j.expneurol.2004.08.036; Lou M, 2004, STROKE, V35, P578, DOI 10.1161/01.STR.0000111599.77426.A0; Medana IM, 1997, AM J PATHOL, V150, P1473; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; NEWTON CRJC, 1994, ARCH DIS CHILD, V70, P281, DOI 10.1136/adc.70.4.281; Newton CRJC, 1996, PEDIATR NEUROL, V15, P41, DOI 10.1016/0887-8994(96)00115-4; Niklas A, 2004, J NEUROL SCI, V219, P77, DOI 10.1016/j.jns.2003.12.013; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Ohganli Y, 2008, BRAIN RES BULL, V75, P668, DOI 10.1016/j.brainresbull.2007.11.002; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Overbergh L, 2003, J Biomol Tech, V14, P33; PARK MK, 1992, CLIN INFECT DIS, V14, P720, DOI 10.1093/clinids/14.3.720; Patankar TF, 2002, RADIOLOGY, V224, P811, DOI 10.1148/radiol.2243010588; Piguet PF, 2001, AM J PATHOL, V159, P733, DOI 10.1016/S0002-9440(10)61744-0; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; RENCRICCA NJ, 1981, AVIAT SPACE ENVIR MD, V52, P85; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Rudin W, 1997, EUR J IMMUNOL, V27, P810, DOI 10.1002/eji.1830270403; Schabitz WR, 2004, STROKE, V35, P1175, DOI 10.1161/01.STR.0000125868.86298.8e; Sobolewski P, 2005, INFECT IMMUN, V73, P6704, DOI 10.1128/IAI.73.10.6704-6710.2005; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Thackham JA, 2008, WOUND REPAIR REGEN, V16, P321, DOI 10.1111/j.1524-475X.2008.00372.x; Veltkamp R, 2005, BRAIN RES, V1037, P134, DOI 10.1016/j.brainres.2005.01.006; Veltkamp R, 2005, STROKE, V36, P1679, DOI 10.1161/01.STR.0000173408.94728.79; WARRELL DA, 1988, LANCET, V2, P534; Wassmer SC, 2005, PLOS MED, V2, P885, DOI 10.1371/journal.pmed.0020245; WHITE NJ, 1985, LANCET, V1, P776; Yang ZJ, 2001, EUR J APPL PHYSIOL, V85, P96, DOI 10.1007/s004210100391; Yin DL, 2003, J CEREBR BLOOD F MET, V23, P855, DOI 10.1097/01.WCB.0000073946.29308.55; Yin W, 2002, BRAIN RES, V926, P165, DOI 10.1016/S0006-8993(01)03304-2; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53	64	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3126	10.1371/journal.pone.0003126	http://dx.doi.org/10.1371/journal.pone.0003126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769544	Green Submitted, Green Published, gold			2022-12-25	WOS:000264419100001
J	Dong, BH; Silverman, RH; Kandel, ES				Dong, Beihua; Silverman, Robert H.; Kandel, Eugene S.			A Natural Human Retrovirus Efficiently Complements Vectors Based on Murine Leukemia Virus	PLOS ONE			English	Article								Background: Murine Leukemia Virus (MLV) is a rodent gammaretrovirus that serves as the backbone for common gene delivery tools designed for experimental and therapeutic applications. Recently, an infectious gammaretrovirus designated XMRV has been identified in prostate cancer patients. The similarity between the MLV and XMRV genomes suggests a possibility that the two viruses may interact when present in the same cell. Methodology/Principal Findings: We tested the ability of XMRV to complement replication-deficient MLV vectors upon coinfection of cultured human cells. We observed that XMRV can facilitate the spread of these vectors from infected to uninfected cells. This functional complementation occurred without any gross rearrangements in the vector structure, and the co-infected cells produced as many as 10(4) infectious vector particles per milliliter of culture medium. Conclusions/Significance: The possibility of encountering a helper virus when delivering MLV-based vectors to human cells in vitro and in vivo needs to be considered to ensure the safety of such procedures.	[Dong, Beihua; Silverman, Robert H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Kandel, Eugene S.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet & Virol, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Dong, BH (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA.	eugenekandel@yahoo.com			NIH/NCI [CA098176, CA116060, CA103943]; Prostate Cancer Foundation; Mal and Lea Bank Chair; NATIONAL CANCER INSTITUTE [R01CA103943, R21CA116060, K01CA098176] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; Mal and Lea Bank Chair; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI grants CA098176 and CA116060 to E.K. and an NIH/NCI grant CA103943, a Prostate Cancer Foundation grant, and the Mal and Lea Bank Chair to R.H.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONOFF R, 1991, J VIROL, V65, P71, DOI 10.1128/JVI.65.1.71-80.1991; Barquinero J, 2004, GENE THER, V11, pS3, DOI 10.1038/sj.gt.3302363; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; DORNBURG R, 1988, MOL CELL BIOL, V8, P2328, DOI 10.1128/MCB.8.6.2328; DOUGHERTY JP, 1989, J VIROL, V63, P3209, DOI 10.1128/JVI.63.7.3209-3212.1989; EMBRETSON JE, 1987, J VIROL, V61, P2675, DOI 10.1128/JVI.61.9.2675-2683.1987; GREZ M, 1991, J VIROL, V65, P4691, DOI 10.1128/JVI.65.9.4691-4698.1991; HUANG CC, 1986, CELL, V44, P935, DOI 10.1016/0092-8674(86)90016-4; Kandel ES, 2005, P NATL ACAD SCI USA, V102, P6425, DOI 10.1073/pnas.0502463102; Kandel ES, 2002, MOL CELL, V10, P1495, DOI 10.1016/S1097-2765(02)00777-3; Kandel ES, 1997, SOMAT CELL MOLEC GEN, V23, P325, DOI 10.1007/BF02674280; Li MF, 1996, CANCER RES, V56, P4464; MANN R, 1985, J VIROL, V54, P401, DOI 10.1128/JVI.54.2.401-407.1985; ROSSON D, 1987, P NATL ACAD SCI USA, V84, P3171, DOI 10.1073/pnas.84.10.3171; Schott B, 1997, NUCLEIC ACIDS RES, V25, P2940, DOI 10.1093/nar/25.14.2940; SCHWARTZ JR, 1995, P NATL ACAD SCI USA, V92, P2460, DOI 10.1073/pnas.92.7.2460; SWAIN A, 1992, SCIENCE, V255, P841, DOI 10.1126/science.1371365; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025	18	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3144	10.1371/journal.pone.0003144	http://dx.doi.org/10.1371/journal.pone.0003144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769545	Green Published, Green Submitted, gold			2022-12-25	WOS:000264419100011
J	Pagnoni, G; Cekic, M; Guo, Y				Pagnoni, Giuseppe; Cekic, Milos; Guo, Ying			"Thinking about Not-Thinking": Neural Correlates of Conceptual Processing during Zen Meditation	PLOS ONE			English	Article							EVENT-RELATED FMRI; DEFAULT MODE; PREFRONTAL CORTEX; RESTING-STATE; HUMAN BRAIN; BASE-LINE; WORD; SELF; INFORMATION; ATTENTION	Recent neuroimaging studies have identified a set of brain regions that are metabolically active during wakeful rest and consistently deactivate in a variety the performance of demanding tasks. This "default network'' has been functionally linked to the stream of thoughts occurring automatically in the absence of goal-directed activity and which constitutes an aspect of mental behavior specifically addressed by many meditative practices. Zen meditation, in particular, is traditionally associated with a mental state of full awareness but reduced conceptual content, to be attained via a disciplined regulation of attention and bodily posture. Using fMRI and a simplified meditative condition interspersed with a lexical decision task, we investigated the neural correlates of conceptual processing during meditation in regular Zen practitioners and matched control subjects. While behavioral performance did not differ between groups, Zen practitioners displayed a reduced duration of the neural response linked to conceptual processing in regions of the default network, suggesting that meditative training may foster the ability to control the automatic cascade of semantic associations triggered by a stimulus and, by extension, to voluntarily regulate the flow of spontaneous mentation.	[Pagnoni, Giuseppe] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Cekic, Milos] Emory Univ, Sch Med, Atlanta, GA USA; [Guo, Ying] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA USA	Emory University; Emory University; Emory University; Rollins School Public Health	Pagnoni, G (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	gpagnon@emory.edu	Pagnoni, Giuseppe/F-3398-2015; Cekic, Milos/AAR-8250-2020	Pagnoni, Giuseppe/0000-0002-8272-8091; 	Emory Center for Research on Complementary and Alternative Medicine in Neurodegenerative Diseases, National Institute of Health [P30-AT00609]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P30AT000609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079251] Funding Source: NIH RePORTER	Emory Center for Research on Complementary and Alternative Medicine in Neurodegenerative Diseases, National Institute of Health; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Emory Center for Research on Complementary and Alternative Medicine in Neurodegenerative Diseases (National Institute of Health Grant P30-AT00609).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 1997, BRAIN RES REV, V25, P381, DOI 10.1016/S0165-0173(97)00053-2; ANTROBUS JS, 1968, BRIT J PSYCHOL, V59, P423, DOI 10.1111/j.2044-8295.1968.tb01157.x; Austin JamesH, 1998, ZEN BRAIN UNDERSTAND; Barinaga M, 2003, SCIENCE, V302, P44, DOI 10.1126/science.302.5642.44; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Binder JR, 2005, NEUROIMAGE, V27, P677, DOI 10.1016/j.neuroimage.2005.04.029; Binder JR, 2005, J COGNITIVE NEUROSCI, V17, P905, DOI 10.1162/0898929054021102; Binder JR, 2003, J COGNITIVE NEUROSCI, V15, P372, DOI 10.1162/089892903321593108; Binder JR, 2001, HDB FUNCTIONAL NEURO, P187; BINDER JR, 2008, EPILEPSIA; BREFCZYNSKILEWI.JA, 2007, P NATL ACAD SCI US; Brosschot JF, 2006, J PSYCHOSOM RES, V60, P113, DOI 10.1016/j.jpsychores.2005.06.074; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Carter OL, 2005, CURR BIOL, V15, pR412, DOI 10.1016/j.cub.2005.05.043; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chan D, 2007, J ALTERN COMPLEM MED, V13, P651, DOI 10.1089/acm.2007.7022; Clark D, 2003, NEUROPSYCHOLOGIA, V41, P304, DOI 10.1016/S0028-3932(02)00163-X; Clayton IC, 1999, J ABNORM PSYCHOL, V108, P171, DOI 10.1037/0021-843X.108.1.171; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Daselaar SM, 2004, NEUROIMAGE, V23, P921, DOI 10.1016/j.neuroimage.2004.07.031; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hasson U, 2007, CEREB CORTEX, V17, P2899, DOI 10.1093/cercor/bhm016; Hofmann Stefan G., 2007, Cognitive Behaviour Therapy, V36, P193, DOI 10.1080/16506070701421313; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Humphries C, 2007, NEUROIMAGE, V36, P924, DOI 10.1016/j.neuroimage.2007.03.059; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Kim, 2004, EIHEI DOGEN MYSTICAL; Knight J, 2004, NATURE, V432, P670, DOI 10.1038/432670a; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Ma SH, 2004, J CONSULT CLIN PSYCH, V72, P31, DOI 10.1037/0022-006X.72.1.31; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McGuire PK, 1996, NEUROREPORT, V7, P2095; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Nishitani Keiji, 1982, RELIG NOTHINGNESS; Pagnoni G, 2007, NEUROBIOL AGING, V28, P1623, DOI 10.1016/j.neurobiolaging.2007.06.008; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; Xiao ZW, 2005, HUM BRAIN MAPP, V25, P212, DOI 10.1002/hbm.20105	62	108	110	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3083	10.1371/journal.pone.0003083	http://dx.doi.org/10.1371/journal.pone.0003083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422HM	18769538	Green Published, Green Submitted, gold			2022-12-25	WOS:000264418300001
J	Maithreye, R; Sarkar, RR; Parnaik, VK; Sinha, S				Maithreye, R.; Sarkar, Ram Rup; Parnaik, Veena K.; Sinha, Somdatta			Delay-Induced Transient Increase and Heterogeneity in Gene Expression in Negatively Auto-Regulated Gene Circuits	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; POSITIVE FEEDBACK; NOISE-PROPAGATION; NETWORK MOTIFS; CELL-FATE; STOCHASTICITY; TIME; OSCILLATIONS; BEHAVIOR; LOOP	A generic feature in all intracellular biochemical processes is the time required to complete the whole sequence of reactions to yield any observable quantity-from gene expression to circadian rhythms. This widespread phenomenon points towards the importance of time delay in biological functions. Theoretically time delay is known to be the source of instability, and has been attributed to lead to oscillations or transient dynamics in several biological functions. Negative feedback loops, common in biochemical pathways, have been shown to provide stability and withstand considerable variations and random perturbations of biochemical parameters. The interaction of these two opposing factors-of instability and homeostasis-are features that are widespread in intracellular processes. To test the effect of these divergent forces in the dynamics of gene expression, we have designed and constructed simple negatively auto-regulated gene circuits consisting of a basic regulator and transcriptional repressor module, and compared it with one, which has delayed repression. We show, both theoretically and experimentally, that delayed repression induces transient increase and heterogeneity in gene expression before the gain of stability effected by the negative feedback. This design, therefore, seems to be suitable for conferring both stability and variability in cells required for adaptive response to a noisy environment.	[Maithreye, R.; Sarkar, Ram Rup; Parnaik, Veena K.; Sinha, Somdatta] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Maithreye, R (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	sinha@ccmb.res.in		SARKAR, RAM RUP/0000-0001-7115-163X	UGC-CSIR (Govt. of India);  [fellowships]	UGC-CSIR (Govt. of India)(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); 	R. Maithreye was supported with fellowships from the UGC-CSIR (Govt. of India) for Ph.D.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; ALPERS DH, 1966, J BIOL CHEM, V241, P4434; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Banerjee B, 2004, BIOPHYS J, V86, P3052, DOI 10.1016/S0006-3495(04)74354-4; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Chen LN, 2005, BIOINFORMATICS, V21, P2722, DOI 10.1093/bioinformatics/bti392; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; FREEDMAN HI, 1986, B MATH BIOL, V48, P485, DOI 10.1007/BF02462319; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDBERGER RF, 1965, P NATL ACAD SCI USA, V54, P279, DOI 10.1073/pnas.54.1.279; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Gopalsamy K., 1992, STABILITY OSCILLATIO; Hooshangi S, 2006, CHAOS, V16, DOI 10.1063/1.2208927; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Le TT, 2006, BIOPHYS J, V90, P3315, DOI 10.1529/biophysj.105.073353; Levine E, 2007, P NATL ACAD SCI USA, V104, P9224, DOI 10.1073/pnas.0610987104; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maeda YT, 2006, J MOL BIOL, V359, P1107, DOI 10.1016/j.jmb.2006.03.064; Maithreye R, 2007, PHYS BIOL, V4, P48, DOI 10.1088/1478-3975/4/1/006; Maithreye R, 2004, MATH BIOSCI INTERACT, P251; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MICHAELIS G, 1967, MOL GEN GENET, V100, P210, DOI 10.1007/BF00333607; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; NELSON DL, 2007, LEHNINGER PRINCIPLES; Niculescu S.-I., 1998, IMA Journal of Mathematical Control and Information, V15, P331, DOI 10.1093/imamci/15.4.331; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Ptashne M, 2004, GENETIC SWITCH PHAGE; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; RAPP P E, 1975, Mathematical Biosciences, V25, P165, DOI 10.1016/0025-5564(75)90059-0; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Roenneberg T, 2003, CURR BIOL, V13, pR198, DOI 10.1016/S0960-9822(03)00124-6; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Segel LA., 1980, MATH MODELS MOL CELL; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shin D, 2006, SCIENCE, V314, P1607, DOI 10.1126/science.1134930; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; SINHA S, 1988, J THEOR BIOL, V132, P307, DOI 10.1016/S0022-5193(88)80217-0; Smolen P, 2000, NEURON, V26, P567, DOI 10.1016/S0896-6273(00)81194-0; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; THIEFFRY D, 1995, B MATH BIOL, V57, P277, DOI 10.1016/0092-8240(94)00037-D; Tiana G, 2007, PHYS BIOL, V4, pR1, DOI 10.1088/1478-3975/4/2/R01; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; van Hoek MJA, 2006, BIOPHYS J, V91, P2833, DOI [10.1529/biophysj.105.077420, 10.1529/biophysj.106.077420]; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	71	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2972	10.1371/journal.pone.0002972	http://dx.doi.org/10.1371/journal.pone.0002972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698420	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600056
J	Sohal, D; Yeatts, A; Ye, K; Pellagatti, A; Zhou, L; Pahanish, P; Mo, YK; Bhagat, T; Mariadason, J; Boultwood, J; Melnick, A; Greally, J; Verma, A				Sohal, Davendra; Yeatts, Andrew; Ye, Kenny; Pellagatti, Andrea; Zhou, Li; Pahanish, Perry; Mo, Yongkai; Bhagat, Tushar; Mariadason, John; Boultwood, Jacqueline; Melnick, Ari; Greally, John; Verma, Amit			Meta-Analysis of Microarray Studies Reveals a Novel Hematopoietic Progenitor Cell Signature and Demonstrates Feasibility of Inter-Platform Data Integration	PLOS ONE			English	Article								Microarray-based studies of global gene expression (GE) have resulted in a large amount of data that can be mined for further insights into disease and physiology. Meta-analysis of these data is hampered by technical limitations due to many different platforms, gene annotations and probes used in different studies. We tested the feasibility of conducting a meta-analysis of GE studies to determine a transcriptional signature of hematopoietic progenitor and stem cells. Data from studies that used normal bone marrow-derived hematopoietic progenitors was integrated using both RefSeq and UniGene identifiers. We observed that in spite of variability introduced by experimental conditions and different microarray platforms, our meta-analytical approach can distinguish biologically distinct normal tissues by clustering them based on their cell of origin. When studied in terms of disease states, GE studies of leukemias and myelodysplasia progenitors tend to cluster with normal progenitors and remain distinct from other normal tissues, further validating the discriminatory power of this meta-analysis. Furthermore, analysis of 57 normal hematopoietic stem and progenitor cell GE samples was used to determine a gene expression signature characteristic of these cells. Genes that were most uniformly expressed in progenitors and at the same time differentially expressed when compared to other normal tissues were found to be involved in important biological processes such as cell cycle regulation and hematopoiesis. Validation studies using a different microarray platform demonstrated the enrichment of several genes such as SMARCE, Septin 6 and others not previously implicated in hematopoiesis. Most interestingly, alpha-integrin, the only common stemness gene discovered in a recent comparative murine analysis (Science 302(5644): 393) was also enriched in our dataset, demonstrating the usefulness of this analytical approach.	[Sohal, Davendra; Yeatts, Andrew; Ye, Kenny; Zhou, Li; Pahanish, Perry; Mo, Yongkai; Bhagat, Tushar; Mariadason, John; Melnick, Ari; Greally, John; Verma, Amit] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Pellagatti, Andrea; Boultwood, Jacqueline] John Radcliffe Hosp, Oxford, England	Yeshiva University; Albert Einstein College of Medicine; University of Oxford	Sohal, D (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.	averma@aecom.yu.edu	Mariadason, John/N-2003-2013; Yeatts, Andrew/H-9344-2012; Ye, Kenny/U-2341-2019; Greally, John/AAF-9540-2019; Ye, Kenny/GSM-7731-2022; Melnick, Ari/AAA-5763-2020	Ye, Kenny/0000-0002-1466-855X; Greally, John/0000-0001-6069-7960; Boultwood, Jacqueline/0000-0002-4330-2928; Mariadason, John/0000-0001-9123-7684; Pellagatti, Andrea/0000-0002-6122-0221	NIH [1R01HL082946, RO1AG02913801]; Community foundation for Southwestern Michigan JP McCarthy, Immunooncology Training Program [T32 CA009173]; NATIONAL CANCER INSTITUTE [T32CA009173] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082946] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Community foundation for Southwestern Michigan JP McCarthy, Immunooncology Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH 1R01HL082946, NIH RO1AG02913801, Community foundation for Southwestern Michigan JP McCarthy grant, Immunooncology Training Program T32 CA009173 and a gift from Janet and Arthur N. Hershaft.	*AFF INC, AFF ANN FIL; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Breit S, 2004, BRIT J HAEMATOL, V126, P231, DOI 10.1111/j.1365-2141.2004.05017.x; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; Chen YZ, 2003, J CELL BIOL, V163, P27, DOI 10.1083/jcb.200304003; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Dettling M, 2002, GENOME BIOL, V3; Dobbin KK, 2005, CLIN CANCER RES, V11, P565; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Eisenstein M, 2006, NATURE, V442, P1067, DOI [10.1038/4421067a, 10.1038/4421067b]; Fortunel NO, 2003, SCIENCE, V302, P393; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; Hernandez JM, 2005, LEUKEMIA, V19, P1088, DOI 10.1038/sj.leu.2403753; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Ishida H, 2005, J BIOL CHEM, V280, P24642, DOI 10.1074/jbc.M500189200; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004; Ji Yuan, 2006, Appl Bioinformatics, V5, P89, DOI 10.2165/00822942-200605020-00003; Karur VG, 2006, BLOOD, V108, P1524, DOI 10.1182/blood-2005-09-008243; Kuo WP, 2002, BIOINFORMATICS, V18, P405, DOI 10.1093/bioinformatics/18.3.405; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Marshall E, 2004, SCIENCE, V306, P630, DOI 10.1126/science.306.5696.630; Mermel CH, 2006, BLOOD, V108, P2562, DOI 10.1182/blood-2006-05-024307; *NCBL, NAT CTR BIOT INF NLO; Oswald J, 2006, STEM CELLS, V24, P494, DOI 10.1634/stemcells.2005-0276; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Petersen D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-63; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sternberg A, 2005, BLOOD, V106, P2982, DOI 10.1182/blood-2005-04-1543; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Ruissen F, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-91; Warnat P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-265; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158	42	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2965	10.1371/journal.pone.0002965	http://dx.doi.org/10.1371/journal.pone.0002965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698424	Green Published, gold			2022-12-25	WOS:000264412600050
J	Kioussi, C; Gross, MK				Kioussi, Chrissa; Gross, Michael K.			How to Build Transcriptional Network Models of Mammalian Pattern Formation	PLOS ONE			English	Article								Background: Genetic regulatory networks of sequence specific transcription factors underlie pattern formation in multicellular organisms. Deciphering and representing the mammalian networks is a central problem in development, neurobiology, and regenerative medicine. Transcriptional networks specify intermingled embryonic cell populations during pattern formation in the vertebrate neural tube. Each embryonic population gives rise to a distinct type of adult neuron. The homeodomain transcription factor Lbx1 is expressed in five such populations and loss of Lbx1 leads to distinct respecifications in each of the five populations. Methodology/Principal Findings: We have purified normal and respecified pools of these five populations from embryos bearing one or two copies of the null Lbx1(GFP) allele, respectively. Microarrays were used to show that expression levels of 8% of all transcription factor genes were altered in the respecified pool. These transcription factor genes constitute 20-30% of the active nodes of the transcriptional network that governs neural tube patterning. Half of the 141 regulated nodes were located in the top 150 clusters of ultraconserved non-coding regions. Generally, Lbx1 repressed genes that have expression patterns outside of the Lbx1-expressing domain and activated genes that have expression patterns inside the Lbx1-expressing domain. Conclusions/Significance: Constraining epistasis analysis of Lbx1 to only those cells that normally express Lbx1 allowed unprecedented sensitivity in identifying Lbx1 network interactions and allowed the interactions to be assigned to a specific set of cell populations. We call this method ANCEA, or active node constrained epistasis analysis, and think that it will be generally useful in discovering and assigning network interactions to specific populations. We discuss how ANCEA, coupled with population partitioning analysis, can greatly facilitate the systematic dissection of transcriptional networks that underlie mammalian patterning.	[Kioussi, Chrissa] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Gross, Michael K.] Oregon State Univ, Coll Sci, Dept Biochem & Biophys, Corvallis, OR USA	Oregon State University; Oregon State University	Kioussi, C (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	grossm@onid.orst.edu		Kioussi, Chrissa/0000-0001-8226-9908	Department of Biochemistry and Biophysics and the College of Science; Medical Research Foundation at OHSU [0308]; Environmental Health and Sciences Center at OSU [P30ES00210]; March of Dimes [1-FY05-120]; American Heart Association [0550179Z]; NIH/NIAMS [RO1AR054406]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	Department of Biochemistry and Biophysics and the College of Science; Medical Research Foundation at OHSU; Environmental Health and Sciences Center at OSU; March of Dimes(March of Dimes); American Heart Association(American Heart Association); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Work was funded by start-up funds from the Department of Biochemistry and Biophysics and the College of Science, grants from the Medical Research Foundation at OHSU (0308) and the Environmental Health and Sciences Center at OSU (P30ES00210) to MKG, as well as grants from the March of Dimes (1-FY05-120) and American Heart Association (0550179Z) to CK, and the NIH/NIAMS (RO1AR054406) to CK and MKG.	Bailey PJ, 2006, EXP CELL RES, V312, P3108, DOI 10.1016/j.yexcr.2006.06.017; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bolouri H, 2002, BIOESSAYS, V24, P1118, DOI 10.1002/bies.10189; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Bolouri H, 2002, DEV BIOL, V246, P2, DOI 10.1006/dbio.2002.0617; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2003, P NATL ACAD SCI USA, V100, P1475, DOI 10.1073/pnas.0437746100; Ding YQ, 2004, DEVELOPMENT, V131, P3693, DOI 10.1242/dev.01250; Ensini M, 1998, DEVELOPMENT, V125, P969; ERSELIUS JR, 1990, DEVELOPMENT, V110, P629; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; GRAHAM A, 1991, DEVELOPMENT, V112, P255; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Gross MK, 2000, DEVELOPMENT, V127, P413; Hargrave M, 2000, DEV BIOL, V219, P142, DOI 10.1006/dbio.1999.9581; Hedlund E, 2004, J NEUROSCI RES, V75, P307, DOI 10.1002/jnr.10844; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; John A, 2005, DEV DYNAM, V234, P767, DOI 10.1002/dvdy.20568; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kioussi C, 2006, P NATL ACAD SCI USA, V103, P18621, DOI 10.1073/pnas.0609055103; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Li MZ, 2006, DEV BIOL, V292, P555, DOI 10.1016/j.ydbio.2006.01.033; Longabaugh WJR, 2005, DEV BIOL, V283, P1, DOI 10.1016/j.ydbio.2005.04.023; Marquardt T, 2001, CELL, V106, P651, DOI 10.1016/S0092-8674(01)00499-8; Mizuhara E, 2005, J BIOL CHEM, V280, P3645, DOI 10.1074/jbc.M411652200; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; OLIVER G, 1988, EMBO J, V7, P3199, DOI 10.1002/j.1460-2075.1988.tb03187.x; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; SIMEONE A, 1994, NEURON, V13, P83, DOI 10.1016/0896-6273(94)90461-8; Smith E, 2002, DEV DYNAM, V224, P231, DOI 10.1002/dvdy.10093; Tiret L, 1998, DEVELOPMENT, V125, P279; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wang WD, 2000, MECH DEVELOP, V99, P123, DOI 10.1016/S0925-4773(00)00488-3	45	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2179	10.1371/journal.pone.0002179	http://dx.doi.org/10.1371/journal.pone.0002179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18769640	Green Published, Green Submitted, gold			2022-12-25	WOS:000262172800044
J	Kunduzova, O; Alet, N; Delesque-Touchard, N; Millet, L; Castan-Laurell, I; Muller, C; Dray, C; Schaeffer, P; Herault, JP; Savi, P; Bono, F; Valet, P				Kunduzova, O.; Alet, N.; Delesque-Touchard, N.; Millet, L.; Castan-Laurell, I.; Muller, C.; Dray, C.; Schaeffer, P.; Herault, J. P.; Savi, P.; Bono, F.; Valet, P.			Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes	FASEB JOURNAL			English	Article						apelinergic system; adipocyte; neovascularization; hypoxia; fat grafting; angiogenesis	ENDOGENOUS PEPTIDE LIGAND; HUMAN APJ RECEPTOR; GROWTH-FACTORS; MESSENGER-RNA; HYPOXIA; CELLS; ADIPOCYTES; EXPRESSION; BLOOD; DIFFERENTIATION	Adipose tissue is an active endocrine organ that produces a variety of secretory factors involved in the initiation of angiogenic processes. The bioactive peptide apelin is the endogenous ligand of the G protein-coupled receptor, APJ. Here we investigated the potential role of apelin and its receptor, APJ, in the angiogenic responses of human endothelial cells and the development of a functional vascular network in a model of adipose tissue development in mice. Treatment of human umbilical vein endothelial cells with apelin dose-dependently increased angiogenic responses, including endothelial cell migration, proliferation, and Matrigel (R) capillary tubelike structure formation. These endothelial effects of apelin were due to activation of APJ, because siRNA directed against APJ, which led to long-lasting down-regulation of APJ mRNA, abolished cell migration induced by apelin in contrast to control nonsilencing siRNA. Hypoxia up-regulated the expression of apelin in 3T3F442A adipocytes, and we therefore determined whether apelin could play a role in adipose tissue angiogenesis in vivo. Epididymal white adipose tissue (EWAT) transplantation was performed as a model of adipose tissue angiogenesis. Transplantation led to increased apelin mRNA levels 2 and 5 days after transplantation associated with tissue hypoxia, as evidenced by hydroxyprobe staining on tissue sections. Graft revascularization evolved in parallel, as the first functional vessels in EWAT grafts were observed 2 days after transplantation and a strong angiogenic response was apparent on day 14. This was confirmed by determination of graft hemoglobin levels, which are indicative of functional vascularization and were strongly increased 5 and 14 days after transplantation. The role of apelin in the graft neovascularization was then assessed by local delivery of stable complex apelin-targeting siRNA leading to dramatically reduced apelin mRNA levels and vascularization (quantified by hemogloblin content) in grafted EWAT on day 5 when compared with control siRNA. Taken together, our data provide the first evidence that apelin/APJ signaling pathways play a critical role in the development of the functional vascular network in adipose tissue. In addition, we have shown that adipocyte-derived apelin can be up-regulated by hypoxia. These findings provide novel insights into the complex relationship between adipose tissue and endothelial vascular function and may lead to new therapeutic strategies to modulate angiogenesis.	[Kunduzova, O.] Fac Med Toulouse, INSERM, U858, Toulouse 4, France; [Kunduzova, O.; Castan-Laurell, I.; Muller, C.; Dray, C.; Valet, P.] Univ Toulouse, Inst Med Mol Rangueil, IFR31, Toulouse, France; Sanofi Aventis Res, Angiogenesis & Thrombosis Dept, Toulouse, France; [Muller, C.] CNRS, Inst Pharmacol & Biol Struct, UMR 5089, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Sanofi-Aventis; Sanofi France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Kunduzova, O (corresponding author), Fac Med Toulouse, INSERM, U858, Toulouse 4, France.	oxana.koundouzova@toulouse.inserm.fr	dray, cedric/N-7440-2017; Schaeffer, Paul/D-7069-2014; Valet, Philippe/N-7472-2017; MULLER, Catherine/M-2185-2018; Schaeffer, Paul/AAZ-9961-2020; MULLER, Catherine/E-2060-2011	Schaeffer, Paul/0000-0002-2835-1801; Valet, Philippe/0000-0001-6520-7393; Schaeffer, Paul/0000-0002-2835-1801; Kunduzova, Oksana/0000-0003-2503-6555; DRAY, Cedric/0000-0002-4712-791X; Castan-Laurell, Isabelle/0000-0002-0488-9789				Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Cheng X, 2003, EUR J PHARMACOL, V470, P171, DOI 10.1016/S0014-2999(03)01821-1; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Drabkin DL, 1932, J BIOL CHEM, V98, P719; Farkasfalvi K, 2007, BIOCHEM BIOPH RES CO, V357, P889, DOI 10.1016/j.bbrc.2007.04.017; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Fons P, 2004, J CELL PHYSIOL, V200, P351, DOI 10.1002/jcp.20076; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Glassford AJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1590, DOI 10.1152/ajpendo.00490.2007; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hickey MM, 2006, CURR TOP DEV BIOL, V76, P217, DOI 10.1016/S0070-2153(06)76007-0; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Hosoya M, 2000, J BIOL CHEM, V275, P21061, DOI 10.1074/jbc.M908417199; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Kasai A, 2004, BIOCHEM BIOPH RES CO, V325, P395, DOI 10.1016/j.bbrc.2004.10.042; Lolmede K, 2003, INT J OBESITY, V27, P1187, DOI 10.1038/sj.ijo.0802407; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ruggeri B, 2003, CANCER RES, V63, P5978; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Suhardja A, 2003, MICROSC RES TECHNIQ, V60, P70, DOI 10.1002/jemt.10245; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Taheri S, 2002, BIOCHEM BIOPH RES CO, V291, P1208, DOI 10.1006/bbrc.2002.6575; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Xie H, 2007, APOPTOSIS, V12, P247, DOI 10.1007/s10495-006-0489-7; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	34	83	87	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4146	4153		10.1096/fj.07-104018	http://dx.doi.org/10.1096/fj.07-104018			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18708591				2022-12-25	WOS:000261254800014
J	McLean, P; Kunjara, S; Greenbaum, AL; Gumaa, K; Lopez-Prados, J; Martin-Lomas, M; Rademacher, TW				McLean, Patricia; Kunjara, Sirilaksana; Greenbaum, A. Leslie; Gumaa, Khalid; Lopez-Prados, Javier; Martin-Lomas, Manuel; Rademacher, Thomas W.			Reciprocal Control of Pyruvate Dehydrogenase Kinase and Phosphatase by Inositol Phosphoglycans DYNAMIC STATE SET BY "PUSH-PULL" SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-CHIRO-INOSITOL; INSULIN MEDIATORS; PHOSPHOLIPASE-C; RAT-LIVER; MANGANESE; COMPLEX; ZINC; PHOSPHODIESTERASE; METABOLISM; MECHANISMS	Reversible phosphorylation of proteins regulates numerous aspects of cell function, and abnormal phosphorylation is causal in many diseases. Pyruvate dehydrogenase complex (PDC) is central to the regulation of glucose homeostasis. PDC exists in a dynamic equilibrium between de-phospho-(active) and phosphorylated (inactive) forms controlled by pyruvate dehydrogenase phosphatases (PDP1,2) and pyruvate dehydrogenase kinases (PDK1-4). In contrast to the reciprocal regulation of the phospho/de-phospho cycle of PDC and at the level of expression of the isoforms of PDK and PDP regulated by hormones and diet, there is scant evidence for regulatory factors acting in vivo as reciprocal "on-off" switches. Here we show that the putative insulin mediator inositol phosphoglycan P-type (IPG-P) has a sigmoidal inhibitory action on PDK in addition to its known linear stimulation of PDP. Thus, at critical levels of IPG-P, this sigmoidal/linear model markedly enhances the switchover from the inactive to the active form of PDC, a "push-pull" system that, combined with the developmental and hormonal control of IPG-P, indicates their powerful regulatory function. The release of IPGs from cell membranes by insulin is significant in relation to diabetes. The chelation of IPGs with Mn2+ and Zn2+ suggests a role as "catalytic chelators" coordinating the traffic of metal ions in cells. Synthetic inositol hexosamine analogues are shown here to have a similar linear/sigmoidal reciprocal action on PDC exerting push-pull effects, suggesting their potential for treatment of metabolic disorders, including diabetes.	[McLean, Patricia; Kunjara, Sirilaksana; Greenbaum, A. Leslie; Rademacher, Thomas W.] UCL, Div Infect & Immun, Sch Med, London W1T 4JF, England; [McLean, Patricia; Kunjara, Sirilaksana; Greenbaum, A. Leslie; Gumaa, Khalid; Rademacher, Thomas W.] Sylus Pharmaceut, Oxford OX13 6BH, England; [Lopez-Prados, Javier; Martin-Lomas, Manuel] CSIC, Inst Invest Quim, Seville 41092, Spain; [Gumaa, Khalid] Arabian Gulf Univ, Coll Med & Med Sci, Manama, Bahrain	University of London; University College London; UCL Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ); Arabian Gulf University	Rademacher, TW (corresponding author), UCL, Div Infect & Immun, Sch Med, Windeyer Bldg,46 Cleveland St, London W1T 4JF, England.	t.rademacher@ucl.ac.uk			Medical Research Council; Basil Samuel Charitable Trust	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Basil Samuel Charitable Trust	This work was supported in part by grants from the Medical Research Council and the Basil Samuel Charitable Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adachi Y, 2006, BIOCHEM BIOPH RES CO, V351, P165, DOI 10.1016/j.bbrc.2006.10.014; ASPLIN I, 1993, P NATL ACAD SCI USA, V90, P5924, DOI 10.1073/pnas.90.13.5924; Bajotto G, 2004, LIFE SCI, V75, P2117, DOI 10.1016/j.lfs.2004.04.016; BAQUER NZ, 1975, BIOCHEM BIOPH RES CO, V62, P634, DOI 10.1016/0006-291X(75)90446-5; Basuki W, 2007, J INORG BIOCHEM, V101, P692, DOI 10.1016/j.jinorgbio.2006.12.015; Bonilla JB, 2002, EUR J ORG CHEM, V2002, P889, DOI 10.1002/1099-0690(200203)2002:5<889::AID-EJOC889>3.0.CO;2-3; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; BRAUTIGAN DL, 1994, RECENT PROG HORM RES, V49, P197; Caro HN, 1997, BIOCHEM MOL MED, V61, P214, DOI 10.1006/bmme.1997.2607; Chen YI, 2003, BIOCHEM J, V374, P633, DOI 10.1042/BJ20030268; Cid MB, 2002, EUR J ORG CHEM, V2002, P881; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; COTTAZ S, 1995, J CHEM SOC PERK T 1, P1673, DOI 10.1039/p19950001673; COULSTON L, 1980, DIABETES, V29, P665, DOI 10.2337/diabetes.29.8.665; Culotta VC, 2005, EUKARYOT CELL, V4, P1159, DOI 10.1128/EC.4.7.1159-1165.2005; Denton RM, 1996, ADV ENZYME REGUL, V36, P183, DOI 10.1016/0065-2571(95)00020-8; Fonteles MC, 2000, HORM METAB RES, V32, P129, DOI 10.1055/s-2007-978606; GAULTON GN, 1991, DIABETES, V40, P1297, DOI 10.2337/diabetes.40.10.1297; Haase H, 2005, J TRACE ELEM MED BIO, V19, P37, DOI 10.1016/j.jtemb.2005.02.004; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang BL, 2003, DIABETES, V52, P1371, DOI 10.2337/diabetes.52.6.1371; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Jones DR, 1999, MOL MED, V5, P505, DOI 10.1007/BF03401978; Karpova T, 2003, BBA-PROTEINS PROTEOM, V1652, P126, DOI 10.1016/j.bbapap.2003.08.010; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; KOLABOVA J, 2001, AM J PHYSIOL, V862, P69; Kunjara S, 1999, MOL GENET METAB, V68, P488, DOI 10.1006/mgme.1999.2936; KUNJARA S, 1995, BIOPOLYMERS BIOPRODU, P301; Larner J, 2003, J MED CHEM, V46, P3283, DOI 10.1021/jm030071j; Larner J, 2001, IUBMB LIFE, V51, P139, DOI 10.1080/152165401753544205; Lemire J, 2008, J APPL TOXICOL, V28, P175, DOI 10.1002/jat.1263; LILLEY K, 1992, ARCH BIOCHEM BIOPHYS, V296, P170, DOI 10.1016/0003-9861(92)90559-F; Lopez-Prados J, 2005, ORG BIOMOL CHEM, V3, P764, DOI 10.1039/b418041k; Luk E, 2003, J BIOL INORG CHEM, V8, P803, DOI 10.1007/s00775-003-0482-3; Marangos P J, 1999, Expert Opin Investig Drugs, V8, P373, DOI 10.1517/13543784.8.4.373; Martin-Lomas M, 2000, TETRAHEDRON-ASYMMETR, V11, P37, DOI 10.1016/S0957-4166(99)00588-1; Mayers RM, 2003, BIOCHEM SOC T, V31, P1165; MERIDA I, 1988, FEBS LETT, V236, P251, DOI 10.1016/0014-5793(88)80325-9; Mueller G, 2008, MOL PHARMACOL, V73, P1513, DOI 10.1124/mol.107.043935; Muller G, 1997, ENDOCRINOLOGY, V138, P3459, DOI 10.1210/en.138.8.3459; Muller G, 2000, BIOCHEMISTRY-US, V39, P1475, DOI 10.1021/bi9920432; NESTLER JE, 1991, ENDOCRINOLOGY, V129, P2951, DOI 10.1210/endo-129-6-2951; NEWMAN JD, 1985, ENDOCRINOLOGY, V116, P1912, DOI 10.1210/endo-116-5-1912; PLOURDE R, 1992, J ORG CHEM, V57, P2606, DOI 10.1021/jo00035a015; Poyner RR, 2001, BIOCHEMISTRY-US, V40, P8009, DOI 10.1021/bi0103922; RADEMACHER TW, 1994, BRAZ J MED BIOL RES, V27, P327; RENNIE PIC, 1981, HORM METAB RES, V13, P145, DOI 10.1055/s-2007-1019202; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; RODBELL M, 1964, J BIOL CHEM, V239, P375; Romero G, 1993, Adv Pharmacol, V24, P21, DOI 10.1016/S1054-3589(08)60932-1; Ryan M, 1996, J MED CHEM, V39, P4366, DOI 10.1021/jm960434y; SALTIEL AR, 1987, ENDOCRINOLOGY, V120, P967, DOI 10.1210/endo-120-3-967; SANCHEZARIAS JA, 1992, ENDOCRINOLOGY, V131, P1727, DOI 10.1210/en.131.4.1727; SCORPIO RM, 1970, BIOCHEM J, V118, P391, DOI 10.1042/bj1180391; Shashkin PN, 1997, DIABETOLOGIA, V40, P557, DOI 10.1007/s001250050715; Sleight S, 2002, BIOCHEM BIOPH RES CO, V295, P561, DOI 10.1016/S0006-291X(02)00701-5; Smolenski RT, 2001, EUR J CARDIO-THORAC, V19, P865, DOI 10.1016/S1010-7940(01)00659-5; SUBASINGHE S, 1985, BIOCHEM MED METAB B, V34, P83, DOI 10.1016/0006-2944(85)90064-X; Sugden M. C., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P151, DOI 10.2174/1568008023340785; Sugden MC, 2001, BIOCHEM SOC T, V29, P272, DOI 10.1042/0300-5127:0290272; SUZUKI S, 1987, J BIOL CHEM, V262, P3199; THAMPY KG, 1985, J BIOL CHEM, V260, P6318; VarelaNieto I, 1996, COMP BIOCHEM PHYS B, V115, P223, DOI 10.1016/0305-0491(96)00087-9; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Ye B, 2001, P NATL ACAD SCI USA, V98, P2317, DOI 10.1073/pnas.041619198; YU KT, 1987, J BIOL CHEM, V262, P16677	71	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33428	33436		10.1074/jbc.M801781200	http://dx.doi.org/10.1074/jbc.M801781200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18768479	hybrid, Green Published			2022-12-25	WOS:000261183700047
J	Rost, M; Doering, T; Prange, R				Rost, Martina; Doering, Tatjana; Prange, Reinhild			gamma 2-Adaptin, a Ubiquitin-interacting Adaptor, Is a Substrate to Coupled Ubiquitination by the Ubiquitin Ligase Nedd4 and Functions in the Endosomal Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; B-VIRUS MATURATION; BINDING DOMAINS; GAMMA-ADAPTIN; C2 DOMAIN; RECEPTOR ENDOCYTOSIS; ESCRT-III; PROTEINS; MOTIF; MONOUBIQUITINATION	gamma 2-Adaptin is a putative member of the clathrin adaptor protein family with unknown physiological function. We previously reported that gamma 2-adaptin acts as a ubiquitin receptor by virtue of its ubiquitin-interacting motif. Here we demonstrate that this motif mediates a specific physical interaction with the ubiquitin ligase Nedd4 and promotes ubiquitination of gamma 2-adaptin. By mapping regions of Nedd4 involved in binding to gamma 2-adaptin, we identified its C2 domain to be essential, whereas the WW and HECT domains are dispensable. Consistent with this, we uncovered that the C2 domain of Nedd4 is ubiquitinated itself and as such is recruited by the ubiquitin-interacting motif of gamma 2-adaptin for subsequent ubiquitin conjugation. Unlike known coupled ubiquitination reactions, this novel type of interaction leads to mono- and multi/polyubiquitinated gamma 2-adaptin. In addition, we show that gamma 2-adaptin functions in the endosomal/multivesicular body (MVB) pathway. Depletion of gamma 2-adaptin impairs the degradation of internalized epidermal growth factor and results in defective MVB morphology characterized by significantly enlarged vesicles. These defects cannot be rescued by gamma 1-adaptin, a closely related homolog of gamma 2-adaptin, which is unable to bind ubiquitin. Together, these results indicate that gamma 2-adaptin may operate within the MVB sorting system in a manner different from that of classic adaptins.	[Rost, Martina; Doering, Tatjana; Prange, Reinhild] Johannes Gutenberg Univ Mainz, Dept Med Microbiol & Hyg, D-55101 Mainz, Germany	Johannes Gutenberg University of Mainz	Prange, R (corresponding author), Johannes Gutenberg Univ Mainz, Dept Med Microbiol & Hyg, D-55101 Mainz, Germany.	prange@uni-mainz.de		Prange, Reinhild/0000-0001-8312-4970	Deutsche Forschungsgemeinschaft [SFB 490-D1, PR 305/1-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 490-D1 and PR 305/1-3 (to R. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bouamr F, 2003, J VIROL, V77, P11882, DOI 10.1128/JVI.77.22.11882-11895.2003; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Dolnik O, 2008, CELL MOL LIFE SCI, V65, P756, DOI 10.1007/s00018-007-7406-2; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hartmann-Stuhler C, 2001, J VIROL, V75, P5343, DOI 10.1128/JVI.75.11.5343-5351.2001; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Lambert C, 2007, J VIROL, V81, P9050, DOI 10.1128/JVI.00479-07; Lewin DA, 1998, FEBS LETT, V435, P263, DOI 10.1016/S0014-5793(98)01083-7; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2007, TRAFFIC, V8, P1297, DOI 10.1111/j.1600-0854.2007.00609.x; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rost M, 2006, J BIOL CHEM, V281, P29297, DOI 10.1074/jbc.M603517200; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Shiba Y, 2004, J BIOL CHEM, V279, P7105, DOI 10.1074/jbc.M311702200; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Takatsu H, 1998, J BIOL CHEM, V273, P24693, DOI 10.1074/jbc.273.38.24693; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Watanabe T, 2007, P NATL ACAD SCI USA, V104, P10205, DOI 10.1073/pnas.0704000104; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Yogosawa S, 2006, BIOCHEM BIOPH RES CO, V350, P82, DOI 10.1016/j.bbrc.2006.09.013; Zizioli D, 1999, J BIOL CHEM, V274, P5385, DOI 10.1074/jbc.274.9.5385	49	21	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32119	32130		10.1074/jbc.M802632200	http://dx.doi.org/10.1074/jbc.M802632200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18772139	hybrid			2022-12-25	WOS:000260760800093
J	Baden, EM; Randles, EG; Aboagye, AK; Thompson, JR; Ramirez-Alvarado, M				Baden, Elizabeth M.; Randles, Edward G.; Aboagye, Awo K.; Thompson, James R.; Ramirez-Alvarado, Marina			Structural Insights into the Role of Mutations in Amyloidogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIABLE REGION; LIGHT-CHAINS; MODEL; ASSOCIATION; REPLACEMENT; AMYLOIDOSIS; STABILITY; FEATURES; TOOLS	Mechanisms of amyloidogenesis are not well understood, including potential structural contributions of mutations in the process. Our previous research indicated that the dimer interface of amyloidogenic immunoglobulin light chain protein AL-09 is twisted 90 degrees relative to the protein from its germline sequence, kappa IO18/O8. Here we report a systematic restoration of AL-09 to its germline sequence by mutating the non-conservative somatic mutations located in the light chain dimer interface. Among these mutants, we find a correlation between increased thermodynamic stability and an increase in the lag time for fibril formation. The restorative mutant AL-09 H87Y completes the trifecta and restores the dimer interface observed in kappa I O18/O8, emphasizing the potential importance of the structural integrity of these proteins to protect against amyloidogenicity. We also find that adding amyloidogenic mutations into the germline protein illustrates mutational cooperativity in promoting amyloidogenesis.	[Baden, Elizabeth M.; Randles, Edward G.; Aboagye, Awo K.; Ramirez-Alvarado, Marina] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Ramirez-Alvarado, M (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	ramirezalvarado.marina@mayo.edu		Ramirez-Alvarado, Marina/0000-0003-2325-6773	National Institutes of Health [GM071514]; Biotechnology and Medical Genomics [SPAP-50-013-P-FY06];  [University of Minnesota Supercomputing Institute]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Medical Genomics; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071514 ( to M. R.- A.). This work was also supported by Minnesota Partnership for Biotechnology and Medical Genomics Grant SPAP-50-013-P-FY06 ( to J. R. T.) and the Basic Sciences Computing Laboratory of the University of Minnesota Supercomputing Institute ( to J. R. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Comenzo RL, 1999, BRIT J HAEMATOL, V106, P744, DOI 10.1046/j.1365-2141.1999.01591.x; Davis DP, 2000, IMMUNITY, V13, P433, DOI 10.1016/S1074-7613(00)00043-1; Yauner LD, 2008, PROTEINS, V72, P684, DOI 10.1002/prot.21934; DUL JL, 1990, P NATL ACAD SCI USA, V87, P8135, DOI 10.1073/pnas.87.20.8135; DUL JL, 1992, J IMMUNOL, V149, P1927; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Kim YS, 2000, J BIOL CHEM, V275, P1570, DOI 10.1074/jbc.275.3.1570; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Richardson JS, 2003, METHOD ENZYMOL, V374, P385, DOI 10.1016/S0076-6879(03)74018-X; SCHORMANN N, 1995, P NATL ACAD SCI USA, V92, P9490, DOI 10.1073/pnas.92.21.9490; STEVENS FJ, 1980, P NATL ACAD SCI-BIOL, V77, P1144, DOI 10.1073/pnas.77.2.1144; STEVENS PW, 1995, PROTEIN SCI, V4, P421; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall JS, 2004, J MOL RECOGNIT, V17, P323, DOI 10.1002/jmr.681; Wetzel R, 1997, ADV PROTEIN CHEM, V50, P183, DOI 10.1016/S0065-3233(08)60322-8; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	28	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30950	30956		10.1074/jbc.M804822200	http://dx.doi.org/10.1074/jbc.M804822200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768467	Green Published, hybrid			2022-12-25	WOS:000260544800049
J	Rabaneda, LG; Carrasco, M; Lopez-Toledano, MA; Murillo-Carretero, M; Ruiz, FA; Estrada, C; Castro, C				Rabaneda, Luis G.; Carrasco, Manuel; Lopez-Toledano, Miguel A.; Murillo-Carretero, Maribel; Ruiz, Felix A.; Estrada, Carmen; Castro, Carmen			Homocysteine inhibits proliferation of neuronal precursors in the mouse adult brain by impairing the basic fibroblast growth factor signaling cascade and reducing extracellular regulated kinase 1/2-dependent cyclin E expression	FASEB JOURNAL			English	Article						hyperhomocysteinemia; neurogenesis; subventricular zone; dentate gyrus; dementia	NEURAL STEM-CELLS; MILD COGNITIVE IMPAIRMENT; LONG-TERM POTENTIATION; DENTATE GYRUS; SUBVENTRICULAR ZONE; NITRIC-OXIDE; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; MAMMALIAN BRAIN; OLFACTORY-BULB	Hyperhomocysteinemia (HHcy)-abnormally elevated plasma levels of homocysteine (Hcy)-has been associated with the development of neurodegenerative dementia and mild cognitive impairment. This association suggests that HHcy might facilitate memory loss in the elderly. As memory loss can occur through a deteriorated neurogenic capacity, we have studied the effects of Hcy on neural progenitor cells (NPCs) both in vitro and in vivo. We show that Hcy exerts an antiproliferative effect on basic fibroblast growth factor (bFGF) -stimulated NPCs isolated from the postnatal subventricular zone (SVZ), accompanied by inactivation of the extracellular signal-regulated kinase (Erk1/2) and inhibition of Erk1/2-dependent expression of cyclin E. Using a mice model we show that, under normal folate conditions, HHcy exerts an inhibitory effect on adult brain neurogenesis. This inhibition occurs in the caudal areas of the dentate gyrus (DG) of the hippocampus, a neurogenic area mainly involved in learning and memory performance, and in the SVZ, recently implicated in olfactory learning performance. In both areas reduced number of proliferative neuroblasts were found. Since neuroblasts are primarily bFGF-responsive progenitors already committed to a neuronal phenotype, our results strongly suggest that excess Hcy inhibits neurogenesis in the DG and SVZ by inhibiting the bFGF-dependent activation of Erk1/2 in these cells.-Rabaneda, L. G., Carrasco, M., Lo pez-Toledano, M. A., Murillo-Carretero, M., Ruiz, F. A., Estrada, C., Castro, C. Homocysteine inhibits proliferation of neuronal precursors in the mouse adult brain by impairing the bFGF signaling cascade and reducing Erk1/2-dependent cyclin E expression. FASEB J. 22, 3823-3835 (2008)	[Rabaneda, Luis G.; Carrasco, Manuel; Lopez-Toledano, Miguel A.; Murillo-Carretero, Maribel; Ruiz, Felix A.; Estrada, Carmen; Castro, Carmen] Univ Cadiz, Area Fisiol, Fac Med, Cadiz, Spain; [Ruiz, Felix A.] Hosp Univ Puerta Mar, Cadiz, Spain	Universidad de Cadiz; Universidad de Cadiz; Hospital Universitario Puerta del Mar	Castro, C (corresponding author), Plaza Falla 9, Cadiz 11003, Spain.	carmen.castro@uca.es	Lopez-Toledano, Miguel A./C-3471-2008; Carmen, Castro/C-7813-2009; Ruiz, Felix A./B-1032-2008; Carrasco, Manuel/L-8997-2014	Lopez-Toledano, Miguel A./0000-0002-5743-3750; Carmen, Castro/0000-0002-6802-0572; Ruiz, Felix A./0000-0003-0748-5015; Carrasco, Manuel/0000-0001-6666-676X; Murillo-Carretero, Maria Isabel/0000-0003-4782-937X	Spanish Ministerio de Educacion y Ciencia [SAF2005-05834, AP 2006-3924]	Spanish Ministerio de Educacion y Ciencia(Spanish Government)	We thank Antonio Torres and Jose M. Martinez for technical assistance. This work was supported by grants from the Spanish Ministerio de Educacion y Ciencia (SAF2005-05834). C. C. and F. R. are researchers in the Ramon y Cajal Program of the Spanish Ministerio de Educacion y Ciencia. L. G. R. is the recipient of a fellowship from the Spanish Ministerio de Educacion y Ciencia (AP 2006-3924).	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Algaidi SA, 2006, EXP NEUROL, V197, P8, DOI 10.1016/j.expneurol.2005.07.003; Alvarez-Maqueda M, 2004, ATHEROSCLEROSIS, V172, P229, DOI 10.1016/j.atherosclerosis.2003.11.005; Brown JC, 1998, BIOCHEM BIOPH RES CO, V251, P669, DOI 10.1006/bbrc.1998.9535; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chen ZT, 2005, INT J DEV NEUROSCI, V23, P465, DOI 10.1016/j.ijdevneu.2005.05.007; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Courtemanche C, 2004, J IMMUNOL, V173, P3186, DOI 10.4049/jimmunol.173.5.3186; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Durga J, 2007, LANCET, V369, P208, DOI 10.1016/S0140-6736(07)60109-3; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Gould E, 1997, J NEUROSCI, V17, P2492; Greicius MD, 2003, HIPPOCAMPUS, V13, P164, DOI 10.1002/hipo.10064; Haan MN, 2007, AM J CLIN NUTR, V85, P511, DOI 10.1093/ajcn/85.2.511; Heo JS, 2006, AM J PHYSIOL-CELL PH, V290, pC123, DOI 10.1152/ajpcell.00142.2005; Huang RFS, 1999, J NUTR, V129, P25, DOI 10.1093/jn/129.1.25; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Keilhoff Gerburg, 2006, Neuropsychopharmacology, V31, P1165; Kempermann G, 2000, Prog Brain Res, V127, P35; KOURY MJ, 1994, P NATL ACAD SCI USA, V91, P4067, DOI 10.1073/pnas.91.9.4067; Kruman II, 2005, NEUROREPORT, V16, P1055, DOI 10.1097/00001756-200507130-00005; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 1997, J NEUROSCI, V17, P7103; Matarredona ER, 2004, BRAIN RES, V995, P274, DOI 10.1016/j.brainres.2003.10.010; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Moser MB, 1998, J NEUROSCI, V18, P7535; Quadri P, 2004, AM J CLIN NUTR, V80, P114; Ravaglia G, 2006, DEMENT GERIATR COGN, V21, P51, DOI 10.1159/000089515; Ravaglia G, 2007, NEUROBIOL AGING, V28, P1810, DOI 10.1016/j.neurobiolaging.2006.08.012; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Robert K, 2005, NEUROSCIENCE, V133, P925, DOI 10.1016/j.neuroscience.2005.03.034; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schwahn BC, 2003, FASEB J, V17, P512, DOI 10.1096/fj.02-0456fje; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shi SS, 1999, ANTIOXID REDOX SIGN, V1, P123, DOI 10.1089/ars.1999.1.1-123; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Zhao MR, 2007, BIOL PSYCHIAT, V62, P381, DOI 10.1016/j.biopsych.2006.10.019	57	49	51	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2008	22	11					3823	3835		10.1096/fj.08-109306	http://dx.doi.org/10.1096/fj.08-109306			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18703672				2022-12-25	WOS:000260503000011
J	Ho, TC; Chen, SL; Yang, YC; Chen, CY; Feng, FP; Hsieh, JW; Cheng, HC; Tsao, YP				Ho, Tsung-Chuan; Chen, Show-Li; Yang, Yuh-Cheng; Chen, Chia-Yi; Feng, Fang-Ping; Hsieh, Jui-Wen; Cheng, Huey-Chuan; Tsao, Yeou-Ping			15-Deoxy-Delta(12,14)-prostaglandin J(2) Induces Vascular Endothelial Cell Apoptosis through the Sequential Activation of MAPKS and p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA LIGANDS; FACTOR-KAPPA-B; CYCLOPENTENONE PROSTAGLANDINS; OXIDATIVE STRESS; PPAR-GAMMA; ENDOGENOUS ELECTROPHILE; SIGNALING PATHWAY; UP-REGULATION; LUNG-CANCER; PHOSPHORYLATION	15-Deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) is a potent anti-angiogenic factor and induces endothelial cell apoptosis, although the mechanism remains unclear. In this study, 15d-PGJ(2) was found to increase p53 levels of the human umbilical vein endothelial cells by stabilizing p53. Both 15d-PGJ(2)-induced apoptosis and the induction of p21(Waf1) and Bax can be abolished by p53 small interfering RNA but not by peroxisome proliferator-activated receptor gamma inhibitors. Moreover, 15d-PGJ(2) activated JNK and p38 MAPK while inducing p53 phosphorylation at sites responsible for p53 activity. JNK inhibitor (SP600125) or p38 MAPK inhibitor (SB203580) pretreatment attenuated 15d-PGJ(2)-mediated apoptosis and suppressed the p21Waf1 and Bax expressions without affecting p53 protein accumulation. Pretreatment with SP600125 partially prevented the phosphorylation of p53 at serines 33 and 392 induced by 15d-PGJ(2). 15d-PGJ(2) was also found to induce reactive oxygen species generation and partially blocked nuclear factor-kappa B activity. Pretreatment with antioxidant N-acetylcysteine prevented the p53 accumulation, the phosphorylations of JNK and p38 MAPK, the inhibition of NF-kappa B activity, as well as the apoptosis induced by 15d-PGJ(2). Using a mouse model of corneal neovascularization, it was demonstrated in vivo that 15d-PGJ(2) induced reactive oxygen species generation, activated JNK and p38 MAPK, induced p53 accumulation/phosphorylation, and induced vascular endothelial cell apoptosis, which could be abolished by N-acetylcysteine, SP600125, SB203580, or a virus-derived amphipathic peptides-based p53 small interfering RNA. This is the first study that 15d-PGJ(2) induces vascular endothelial cell apoptosis through the signaling of JNK and p38 MAPK-mediated p53 activation both in vitro and in vivo, further establishing the potential of 15d-PGJ(2) as an anti-angiogenesis agent.	[Ho, Tsung-Chuan; Yang, Yuh-Cheng; Chen, Chia-Yi; Feng, Fang-Ping; Tsao, Yeou-Ping] Natl Taiwan Univ, Sch Med, Dept Med Res, Taipei 251, Taiwan; [Hsieh, Jui-Wen; Cheng, Huey-Chuan; Tsao, Yeou-Ping] Natl Taiwan Univ, Sch Med, Mackay Mem Hosp, Dept Ophthalmol, Taipei 251, Taiwan; [Chen, Show-Li] Natl Taiwan Univ, Sch Med, Dept Microbiol, Taipei 251, Taiwan; [Yang, Yuh-Cheng; Hsieh, Jui-Wen] Taipei Med Univ, Nursing & Management Coll, Taipei 251, Taiwan; [Yang, Yuh-Cheng] Taipei Med Univ, Sch Med, Taipei 251, Taiwan; [Tsao, Yeou-Ping] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei 251, Taiwan	National Taiwan University; Mackay Memorial Hospital; National Taiwan University; National Taiwan University; Mackay Junior College of Medicine, Nursing & Management; Taipei Medical University; Taipei Medical University; National Defense Medical Center	Tsao, YP (corresponding author), Natl Taiwan Univ, Sch Med, Dept Med Res, Taipei 251, Taiwan.	yptsao@yahoo.com			National Science Council, Taiwan [NSC 95-2314-B-195-009-MY3, NSC 96-3112-B-195-001]; Mackay Memorial Hospital [MMH-E-96006]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This work was supported by Grants NSC 95-2314-B-195-009-MY3 and NSC 96-3112-B-195-001 from the National Science Council, Taiwan, and Grant MMH-E-96006 from Mackay Memorial Hospital. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bean LJH, 2001, ONCOGENE, V20, P1076, DOI 10.1038/sj.onc.1204204; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen NG, 2001, BIOCHEM BIOPH RES CO, V282, P717, DOI 10.1006/bbrc.2001.4628; Dong YG, 2004, ACTA PHARMACOL SIN, V25, P47; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Erl W, 2004, EUR J IMMUNOL, V34, P241, DOI 10.1002/eji.200324053; Figarella K, 2006, CELL DEATH DIFFER, V13, P1802, DOI 10.1038/sj.cdd.4401862; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FUKUSHIMA M, 1992, PROSTAG LEUKOTR ESS, V47, P1, DOI 10.1016/0952-3278(92)90178-L; Fulzele SV, 2007, ANTI-CANCER DRUG, V18, P65, DOI 10.1097/CAD.0b013e3280101006; Giaginis C, 2007, EXPERT OPIN INV DRUG, V16, P1561, DOI 10.1517/13543784.16.10.1561; Harmand PO, 2003, INT J ONCOL, V23, P105; Hashimoto K, 2004, PANCREAS, V28, P153, DOI 10.1097/00006676-200403000-00006; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Holownia A, 2003, NEOPLASMA, V50, P266; Kim HS, 1996, PROSTAGLANDINS, V51, P413, DOI 10.1016/0090-6980(96)00047-0; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Landar A, 2006, AM J PHYSIOL-HEART C, V290, pH1777, DOI 10.1152/ajpheart.01087.2005; Li LY, 2001, J BIOL CHEM, V276, P38152; Murakami M, 2000, BBA-MOL CELL BIOL L, V1488, P159, DOI 10.1016/S1388-1981(00)00118-9; Pasquier E, 2004, MOL CANCER THER, V3, P1301; Ray DM, 2006, J IMMUNOL, V177, P5068, DOI 10.4049/jimmunol.177.8.5068; Rizzo G, 2006, CURR OPIN PHARMACOL, V6, P421, DOI 10.1016/j.coph.2006.03.012; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Shan ZZ, 2004, J BIOL CHEM, V279, P37939, DOI 10.1074/jbc.M402424200; Shibata T, 2003, BIOCHEMISTRY-US, V42, P13960, DOI 10.1021/bi035215a; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Tsao YP, 2006, LIFE SCI, V79, P545, DOI 10.1016/j.lfs.2006.01.041; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Vosseler CA, 2003, BIOCHEM BIOPH RES CO, V307, P322, DOI 10.1016/S0006-291X(03)01204-X; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zernecke A, 2003, FASEB J, V17, P1099, DOI 10.1096/fj.02-0485fje; Zhang J, 2006, SPECTROSC SPECT ANAL, V26, P37	45	32	32	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30273	30288		10.1074/jbc.M804196200	http://dx.doi.org/10.1074/jbc.M804196200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18718914	Green Published, hybrid			2022-12-25	WOS:000260366900072
J	Nguyen, T; Ogbi, M; Johnson, JA				Nguyen, Tiffany; Ogbi, Mourad; Johnson, John A.			Delta Protein Kinase C Interacts with the d Subunit of the F1F0 ATPase in Neonatal Cardiac Myocytes Exposed to Hypoxia or Phorbol Ester IMPLICATIONS FOR F1F0 ATPase REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; CYTOCHROME-C; INHIBITOR PROTEIN; OXIDASE ACTIVITY; EPSILON INTERACTS; COMPLEX-I; RAT-HEART; CARDIOLIPIN; SYNTHASE; REPERFUSION	Mitochondrial protein kinase C isozymes have been reported to mediate both cardiac ischemic preconditioning and ischemia/reperfusion injury. In addition, cardiac preconditioning improves the recovery of ATP levels after ischemia/reperfusion injury. We have, therefore, evaluated protein kinase C modulation of the F1F0 ATPase in neonatal cardiac myocytes. Exposure of cells to 3 or 100 nM 4 beta-phorbol 12-myristate-13-acetate induced co-immunoprecipitation of delta protein kinase C (but not alpha,epsilon,or zeta protein kinase C) with the d subunit of the F1F0 ATPase. This co-immunoprecipitation correlated with 40 +/- 3% and 72 +/- 9% inhibitions of oligomycin-sensitive F1F0 ATPase activity, respectively. We observed prominent expression of delta protein kinase C in cardiac myocyte mitochondria, which was enhanced following a 4-h hypoxia exposure. In contrast, hypoxia decreased mitochondrial zeta PKC levels by 85 +/- 1%. Following 4 h of hypoxia, F1F0 ATPase activity was inhibited by 75 +/- 9% and delta protein kinase C co-immunoprecipitated with the d subunit of F1F0 ATPase. In vitro incubation of protein kinase C with F1F0 ATPase enhanced F1F0 activity in the absence of protein kinase C activators and inhibited it in the presence of activators. Recombinant delta protein kinase C also inhibited F1F0 ATPase activity. Protein kinase C overlay assays revealed delta protein kinase C binding to the d subunit of F1F0 ATPase, which was modulated by diacylglycerol, phosphatidylserine, and cardiolipin. Our results suggest a novel regulation of the F1F0 ATPase by the delta protein kinase C isozyme.	[Nguyen, Tiffany; Ogbi, Mourad; Johnson, John A.] Med Coll Georgia, Sch Med, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Nguyen, Tiffany; Ogbi, Mourad; Johnson, John A.] Med Coll Georgia, Inst Mol Med & Genet, Program Regenerat Med, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Johnson, JA (corresponding author), 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	jjohnson@mail.mcg.edu	Nguyen, Tiffany/HGD-2431-2022		National Institutes of Health [R01HL76805]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL76805 (to J. A. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arrell DK, 2006, CIRC RES, V99, P706, DOI 10.1161/01.RES.0000243995.74395.f8; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Buchanan SK, 1996, BIOCHEM J, V318, P343, DOI 10.1042/bj3180343; Carbajo RJ, 2005, J MOL BIOL, V351, P824, DOI 10.1016/j.jmb.2005.06.012; Chen Q, 2006, FREE RADICAL BIO MED, V40, P976, DOI 10.1016/j.freeradbiomed.2005.10.043; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; CONRICODE KM, 1992, J BIOL CHEM, V267, P7199; Di Pancrazio F, 2004, BBA-BIOENERGETICS, V1659, P52, DOI 10.1016/j.bbabio.2004.07.009; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Edmondson RD, 2002, MOL CELL PROTEOMICS, V1, P421, DOI 10.1074/mcp.M100036-MCP200; Gaballo A, 2002, CURR PROTEIN PEPT SC, V3, P451, DOI 10.2174/1389203023380558; Goerke A, 2002, J BIOL CHEM, V277, P32054, DOI 10.1074/jbc.M203734200; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Green DW, 2000, BBA-BIOENERGETICS, V1458, P343, DOI 10.1016/S0005-2728(00)00085-2; Groth G, 1996, BIOCHEM J, V318, P351, DOI 10.1042/bj3180351; Guo DH, 2007, AM J PHYSIOL-HEART C, V293, pH2219, DOI 10.1152/ajpheart.01306.2006; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; Inagaki K, 2003, CIRCULATION, V108, P2304, DOI 10.1161/01.CIR.0000101682.24138.36; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; JENNINGS RB, 1991, J MOL CELL CARDIOL, V23, P1383, DOI 10.1016/0022-2828(91)90185-O; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; JOHNSON JA, 1995, CIRC RES, V76, P654, DOI 10.1161/01.RES.76.4.654; Korzick DH, 2007, AM J PHYSIOL-HEART C, V293, pH2056, DOI 10.1152/ajpheart.00403.2007; KUNZE D, 1984, CLIN CHIM ACTA, V140, P215, DOI 10.1016/0009-8981(84)90202-X; Lesnefsky EJ, 2004, AM J PHYSIOL-HEART C, V287, pH258, DOI 10.1152/ajpheart.00348.2003; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Liang BT, 1997, AM J PHYSIOL-HEART C, V273, pH847, DOI 10.1152/ajpheart.1997.273.2.H847; Malhotra A, 2005, AM J PHYSIOL-HEART C, V289, pH1343, DOI 10.1152/ajpheart.01200.2004; MANAT R, 2006, AM J PHYSIOL-HEART C, V291, pH854; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH946, DOI 10.1152/ajpheart.00878.2003; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH937, DOI 10.1152/ajpheart.00877.2003; McDonald T, 2006, MOL CELL PROTEOMICS, V5, P2392, DOI 10.1074/mcp.T500036-MCP200; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; MOCHLYROSEN D, 1987, J BIOL CHEM, V262, P2291; Moghaddas S, 2002, J GERONTOL A-BIOL, V57, pB22, DOI 10.1093/gerona/57.1.B22; NGUYEN T, 2007, CURR ENZ INHIB, V3, P143; Nishikawa K, 1998, J BIOL CHEM, V273, P23126, DOI 10.1074/jbc.273.36.23126; Ogbi M, 2006, BIOCHEM J, V393, P191, DOI 10.1042/BJ20050757; Ogbi M, 2004, BIOCHEM J, V382, P923, DOI 10.1042/BJ20040468; Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64; QUEST AFG, 1994, PROTEIN KINASE C, P64; RON D, 1995, J BIOL CHEM, V270, P1; Schechtman Deborah, 2003, Methods Mol Biol, V233, P345; Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006; Sparagna GC, 2005, J LIPID RES, V46, P1196, DOI 10.1194/jlr.M500031-JLR200; Vance JE, 2003, PROG NUCLEIC ACID RE, V75, P69, DOI 10.1016/S0079-6603(03)75003-X; VUORINEN K, 1995, CIRCULATION, V91, P2810, DOI 10.1161/01.CIR.91.11.2810; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Wang YG, 1999, CIRC RES, V85, P731, DOI 10.1161/01.RES.85.8.731; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Wood CD, 2007, FEBS LETT, V581, P3494, DOI 10.1016/j.febslet.2007.06.060; Ylitalo K, 2001, BBA-BIOENERGETICS, V1504, P329, DOI 10.1016/S0005-2728(00)00261-9; Zanotti F, 2004, J BIOENERG BIOMEMBR, V36, P447, DOI 10.1023/B:JOBB.0000047327.68173.9b; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	55	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29831	29840		10.1074/jbc.M801642200	http://dx.doi.org/10.1074/jbc.M801642200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18725417	Green Published, hybrid			2022-12-25	WOS:000260366900027
J	Tan, WQ; Wang, K; Lv, DY; Li, PF				Tan, Wei-Qi; Wang, Kun; Lv, Dao-Yuan; Li, Pei-Feng			Foxo3a Inhibits Cardiomyocyte Hypertrophy through Transactivating Catalase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEIN-KINASE CK2; CARDIAC-HYPERTROPHY; TRANSCRIPTION FACTORS; OXIDATIVE MODIFICATION; IN-VIVO; OXYGEN; STRESS; AKT; APOPTOSIS	The forkhead transcription factor Foxo3a is able to inhibit cardiomyocyte hypertrophy. However, its underlying molecular mechanism remains to be fully understood. Our present study demonstrates that Foxo3a can regulate cardiomyocyte hypertrophy through transactivating catalase. Insulin was able to induce cardiomyocyte hypertrophy with an elevated level of reactive oxygen species (ROS). The antioxidant agents, including catalase and N-acetyl- L-cysteine, could inhibit cardiomyocyte hypertrophy induced by insulin, suggesting that ROS is necessary for insulin to induce hypertrophy. Strikingly, we observed that the levels of catalase were decreased in response to insulin treatment. The transcriptional activity of Foxo3a depends on its phosphorylation status with the nonphosphorylated but not phosphorylated form to be functional. Insulin treatment led to an increase in the phosphorylated levels of Foxo3a. To understand the relationship between Foxo3a and catalase in the hypertrophic pathway, we characterized that catalase was a transcriptional target of Foxo3a. Foxo3a bound to the promoter region of catalase and stimulated its activity. The inhibitory effect of Foxo3a on cardiomyocyte hypertrophy depended on its transcriptional regulation of catalase. Finally, we identified that myocardin was a downstream mediator of ROS in conveying the hypertrophic signal of insulin or insulin-like growth factor-1. Foxo3a could negatively regulate myocardin expression levels through up-regulating catalase and the consequent reduction of ROS levels. Taken together, our results reveal that Foxo3a can inhibit hypertrophy by transcriptionally targeting catalase.	[Tan, Wei-Qi; Wang, Kun; Lv, Dao-Yuan; Li, Pei-Feng] Chinese Acad Sci, Div Cardiovasc Res, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China; [Li, Pei-Feng] Univ Illinois, Coll Med, Chicago, IL 60612 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Li, PF (corresponding author), Chinese Acad Sci, Div Cardiovasc Res, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China.	peifli@ioz.ac.cn	Li, Peifeng/AHE-6906-2022; Li, Peifeng/ABD-5663-2021	Li, Peifeng/0000-0002-0969-9407; 	National Natural Science Foundation of China [30730045]; National Basic Research Program of China [2007CB512000]; American Heart Association	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); American Heart Association(American Heart Association)	This work was supported by the National Natural Science Foundation of China (Grant 30730045), the National Basic Research Program of China (973 Program, Grant 2007CB512000), and the American Heart Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ago T, 2007, ANTIOXID REDOX SIGN, V9, P679, DOI 10.1089/ars.2007.1529; Aikawa R, 2001, BIOCHEM BIOPH RES CO, V289, P901, DOI 10.1006/bbrc.2001.6068; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Biswas S, 2007, AM J PHYSIOL-HEART C, V292, pH758, DOI 10.1152/ajpheart.00718.2006; Brasier AR, 2000, MOL CELL BIOCHEM, V212, P155, DOI 10.1023/A:1007133710837; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Higuchi Y, 2002, J MOL CELL CARDIOL, V34, P233, DOI 10.1006/jmcc.2001.1505; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Kassiri Z, 2002, CIRC RES, V90, P578, DOI 10.1161/01.RES.0000012223.86441.A1; Kuster GM, 2006, ANTIOXID REDOX SIGN, V8, P2153, DOI 10.1089/ars.2006.8.2153; Kuster GM, 2005, CIRCULATION, V111, P1192, DOI 10.1161/01.CIR.0000157148.59308.F5; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Nadal-Ginard B, 2003, CIRC RES, V92, P139, DOI 10.1161/01.RES.0000053618.86362.DF; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; PAOLISSO G, 1995, EUR J CLIN INVEST, V25, P529, DOI 10.1111/j.1365-2362.1995.tb01740.x; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Samuelsson AM, 2006, AM J PHYSIOL-HEART C, V291, pH787, DOI 10.1152/ajpheart.00974.2005; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; Sen CK, 2005, AM J PHYSIOL-HEART C, V289, pH17, DOI 10.1152/ajpheart.00250.2005; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Sugden PH, 2003, CIRC RES, V93, P1179, DOI 10.1161/01.RES.0000106132.04301.F5; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; Taniyama Yoshiaki, 2005, J Mol Cell Cardiol, V38, P375, DOI 10.1016/j.yjmcc.2004.12.002; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wollert KC, 2000, CIRCULATION, V101, P1172, DOI 10.1161/01.CIR.101.10.1172; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Xu FP, 2004, CIRCULATION, V110, P1269, DOI 10.1161/01.CIR.0000140766.52771.6D	51	141	146	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29730	29739		10.1074/jbc.M805514200	http://dx.doi.org/10.1074/jbc.M805514200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18772130	Green Published, hybrid			2022-12-25	WOS:000260366900017
J	Gouveia, RM; Gomes, CM; Sousa, M; Alves, PM; Costa, J				Gouveia, Ricardo M.; Gomes, Claudio M.; Sousa, Marcos; Alves, Paula M.; Costa, Julia			Kinetic analysis of L1 homophilic interaction - Role of the first four immunoglobulin domains and implications on binding mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; NEURITE OUTGROWTH; CRYSTAL-STRUCTURE; SITE; MUTATIONS; EXPRESSION; HORSESHOE; PROMOTION; INTEGRIN; SUGGESTS	L1 is a cell adhesion molecule of the immunoglobulin (Ig) superfamily, critical for central nervous system development, and involved in several neuronal biological events. It is a type I membrane glycoprotein. The L1 ectodomain, composed of six Ig-like and five fibronectin (Fn) type-III domains, is involved in homophilic binding. Here, co-immunoprecipitation studies between recombinant truncated forms of human L1 expressed and purified from insect Spodoptera frugiperda Sf9 cells, and endogenous full-length L1 from human NT2N neurons, showed that the L1 ectodomain (L1/ECD) and L1/Ig1-4 interacted homophilically in trans, contrary to mutants L1/Ig1-3 and L1/Ig2-Fn5. All mutants were correctly folded as evaluated by combination of far-UV CD and fluorescence spectroscopy. Surface plasmon resonance analysis showed comparable dissociation constants of 116 +/- 2 and 130 +/- 6 nM for L1/ECD-L1/ECD and L1/ECD-L1/Ig1-4, respectively, whereas deletion mutants for Ig1 or Ig4 did not interact. Accordingly, in vivo, Sf9 cells stably expressing L1 were found to adhere only to L1/ECD-and L1/Ig1-4-coated surfaces. Furthermore, only these mutants bound to HEK293 cells overexpressing L1 at the cell surface. Enhancement of neurite outgrowth, which is the consequence of signaling events caused by L1 homophilic binding, was comparable between L1/ECD and L1/Ig1-4. Altogether, these results showed that domains Ig1 to Ig4 are necessary and sufficient for L1 homophilic binding in trans, and that the rest of the molecule does not contribute to the affinity under the conditions of the current study. Furthermore, they are compatible with a cooperative interaction between modules Ig1-Ig4 in a horseshoe conformation.	[Gouveia, Ricardo M.; Gomes, Claudio M.; Alves, Paula M.; Costa, Julia] Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal; [Sousa, Marcos; Alves, Paula M.; Costa, Julia] Inst Biol Expt & Tecnol, P-2781901 Oeiras, Portugal		Costa, J (corresponding author), Inst Tecnol Quim & Biol, Ave Republ,Apartado 127, P-2780157 Oeiras, Portugal.	jcosta@itqb.unl.pt	Alves, Paula M/C-1070-2008; Costa, Júlia C/B-7131-2008; Gomes, Cláudio M./A-8152-2008	Alves, Paula M/0000-0003-1445-3556; Costa, Júlia C/0000-0001-7782-6319; Gomes, Cláudio M./0000-0003-4662-6933; Gouveia, Ricardo/0000-0002-2968-1298	CellPROM [500039-2]; European Commission [LSHG-CT-2004-503228]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/24013/2005]	CellPROM(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported in part by CellPROM number 500039-2 and Signalling & Traffic number LSHG-CT-2004-503228 from the European Commission. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. Supported by Ph. D. fellowship SFRH/BD/24013/2005 from Fundacao para a Ciencia e a Tecnologia, Portugal.	Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Arevalo E, 2008, P NATL ACAD SCI USA, V105, P371, DOI 10.1073/pnas.0707815105; Bateman A, 1996, EMBO J, V15, P6050, DOI 10.1002/j.1460-2075.1996.tb00993.x; Blaess S, 1998, J NEUROCHEM, V71, P2615, DOI 10.1046/j.1471-4159.1998.71062615.x; Brito C, 2007, J NEUROSCI RES, V85, P1260, DOI 10.1002/jnr.21230; BurdenGulley SM, 1997, CELL TISSUE RES, V290, P415, DOI 10.1007/s004410050948; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; De Angelis E, 2001, J BIOL CHEM, V276, P32738, DOI 10.1074/jbc.M105156200; De Angelis E, 1999, EMBO J, V18, P4744, DOI 10.1093/emboj/18.17.4744; Escrevente C, 2008, BBA-GEN SUBJECTS, V1780, P905, DOI 10.1016/j.bbagen.2008.03.004; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Gouveia RM, 2007, PROTEIN EXPRES PURIF, V52, P182, DOI 10.1016/j.pep.2006.10.008; Hall H, 2000, J NEUROCHEM, V75, P336, DOI 10.1046/j.1471-4159.2000.0750336.x; Hara K, 2008, PROG NEUROBIOL, V85, P318, DOI 10.1016/j.pneurobio.2008.04.005; Haspel J, 2003, FRONT BIOSCI-LANDMRK, V8, pS1210, DOI 10.2741/1108; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Itoh K, 2004, J CELL BIOL, V165, P145, DOI 10.1083/jcb.200312107; Jacob J, 2002, J NEUROBIOL, V51, P177, DOI 10.1002/neu.10052; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kiselyov VV, 1997, J BIOL CHEM, V272, P10125; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mortl M, 2007, PROTEIN SCI, V16, P2174, DOI 10.1110/ps.072802707; Oleszewski M, 2000, J BIOL CHEM, V275, P34478, DOI 10.1074/jbc.M004147200; Retzler C, 1996, J BIOL CHEM, V271, P27304, DOI 10.1074/jbc.271.44.27304; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Stipp CS, 2000, J CELL SCI, V113, P1871; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Yip PM, 2001, J NEUROCHEM, V76, P1552, DOI 10.1046/j.1471-4159.2001.00152.x; Yip PM, 1998, MOL BIOL CELL, V9, P277, DOI 10.1091/mbc.9.2.277; Zhao XN, 1998, J NEUROCHEM, V71, P960; ZHAO XO, 1995, J BIOL CHEM, V270, P29413, DOI 10.1074/jbc.270.49.29413	37	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28038	28047		10.1074/jbc.M804991200	http://dx.doi.org/10.1074/jbc.M804991200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701456	Green Published, hybrid			2022-12-25	WOS:000259969300005
J	Hartmann, M; Skryabin, BV; Muller, T; Gazinski, A; Schroter, J; Gassner, B; Nikolaev, VO; Bunemann, M; Kuhn, M				Hartmann, Michael; Skryabin, Boris V.; Mueller, Thomas; Gazinski, Alexandra; Schroeter, Juliane; Gassner, Birgit; Nikolaev, Viacheslav O.; Buenemann, Moritz; Kuhn, Michaela			Alternative splicing of the guanylyl cyclase-A receptor modulates atrial natriuretic peptide signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL-HYPERTENSION; DOWN-REGULATION; BINDING DOMAIN; HEART-FAILURE; SPLIT GENES; NPR-B; PROTEIN; MICE; IDENTIFICATION; POLYMORPHISMS	Atrial (ANP) and B-type natriuretic peptides (BNP) modulate blood pressure and volume through the stimulation of cyclic GMP production by their guanylyl cyclase-A (GC-A) receptor. A novel isoform of GC-A has been identified that is the result of differential splicing of exon 4. The deletion of a 51-bp sequence is predicted to delete 17 amino acids (Lys(314)-Gln(330)) in the membrane-distal part of the extracellular domain. Reverse transcription-PCR analyses demonstrated low messenger RNA expression levels of spliced GC-A in all tissues. Homology modeling suggested that the alterations in the protein structure could interfere with ANP binding or signaling. Indeed, functional studies in transfected HEK 293 cells demonstrated that binding of ANP and ANP-induced cyclic GMP formation by GC-A Delta(Lys314-Gln330) were totally abolished. Furthermore, cotransfection studies showed that this GC-A variant forms heterodimers with the wild type receptor and inhibits ligand-inducible cGMP generation. Finally, treatment of mice with angiotensin II (300 ng/kg/min during 7 days) resulted in enhanced pulmonary mRNA expression of spliced GC-A, which was concomitant to diminished GC-A/cGMP responses to ANP. We conclude that alternative splicing can regulate endogenous ANP/GC-A signaling. Angiotensin II-induced alternative splicing of GC-A may represent a novel mechanism for reducing the sensitivity to ANP.	[Hartmann, Michael; Gazinski, Alexandra; Schroeter, Juliane; Gassner, Birgit; Kuhn, Michaela] Univ Wurzburg, Inst Physiol, D-97070 Wurzburg, Germany; [Skryabin, Boris V.] Univ Hosp Munster, Inst Expt Pathol, D-48149 Munster, Germany; [Mueller, Thomas] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius von Sachs Inst, Bioctr, D-97070 Wurzburg, Germany; [Nikolaev, Viacheslav O.; Buenemann, Moritz] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany	University of Wurzburg; University of Munster; University of Wurzburg; University of Wurzburg	Kuhn, M (corresponding author), Univ Wurzburg, Inst Physiol, Rontgenring 9, D-97070 Wurzburg, Germany.	michaela.kuhn@mail.uni-wuerzburg.de	Nikolaev, Vyacheslav/AAT-7746-2020; Skryabin, Boris/AAL-3100-2020	Skryabin, Boris/0000-0002-4392-185X; Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft Sonderforschungsbereich 487; Sonderforschungsbereich 688	Deutsche Forschungsgemeinschaft Sonderforschungsbereich 487(German Research Foundation (DFG)); Sonderforschungsbereich 688(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Sonderforschungsbereich 487 (to T. M., M. B., and M. K.) and Sonderforschungsbereich 688 (to M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arise KK, 2006, BIOCHEM BIOPH RES CO, V349, P131, DOI 10.1016/j.bbrc.2006.08.003; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; BEHRENDS S, 1995, J BIOL CHEM, V270, P21109, DOI 10.1074/jbc.270.36.21109; Beige J, 1997, AM J HYPERTENS, V10, P1316; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; Bryan PM, 2006, BIOCHEMISTRY-US, V45, P1295, DOI 10.1021/bi051253d; Bryan PM, 2002, J BIOL CHEM, V277, P16041, DOI 10.1074/jbc.M110626200; Bulut D, 2003, EUR J CLIN INVEST, V33, P567, DOI 10.1046/j.1365-2362.2003.01188.x; BURNETT JC, 1986, SCIENCE, V231, P1145, DOI 10.1126/science.2935937; Fan DH, 2005, MOL PHARMACOL, V67, P174, DOI 10.1124/mol.104.002436; Francoeur F., 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS172, DOI 10.1111/j.1440-1681.1995.tb02869.x; Gupta G, 1997, J CLIN INVEST, V100, P1488, DOI 10.1172/JCI119670; HIROOKA Y, 1990, CIRCULATION, V82, P147, DOI 10.1161/01.CIR.82.1.147; Holtwick R, 2003, J CLIN INVEST, V111, P1399, DOI 10.1172/JCI200317061; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Kilic A, 2005, CIRCULATION, V112, P2307, DOI 10.1161/CIRCULATIONAHA.105.542209; Kuhn M, 2003, CIRC RES, V93, P700, DOI 10.1161/01.RES.0000094745.28948.4D; LOPEZ MJ, 1995, NATURE, V378, P65, DOI 10.1038/378065a0; McNicoll N, 1996, BIOCHEMISTRY-US, V35, P12950, DOI 10.1021/bi960818q; Mei ZZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1022, DOI 10.1152/ajpcell.00606.2005; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; Potthast R, 2001, ENDOCRINOLOGY, V142, P3087, DOI 10.1210/en.142.7.3087; Rubattu S, 2006, J AM COLL CARDIOL, V48, P499, DOI 10.1016/j.jacc.2005.12.081; RUTLEDGE DR, 1995, J HYPERTENS, V13, P953, DOI 10.1097/00004872-199509000-00003; Sala C, 2001, J CLIN ENDOCR METAB, V86, P1957, DOI 10.1210/jc.86.5.1957; Schreier B, 2008, ENDOCRINOLOGY, V149, P4193, DOI 10.1210/en.2008-0212; Sharina IG, 2008, J BIOL CHEM, V283, P15104, DOI 10.1074/jbc.M710269200; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; TALLERICOMELNYK T, 1995, BIOCHEM BIOPH RES CO, V209, P930, DOI 10.1006/bbrc.1995.1587; Tamura N, 2003, J BIOL CHEM, V278, P48880, DOI 10.1074/jbc.M308680200; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; van den Akker F, 2001, J MOL BIOL, V311, P923, DOI 10.1006/jmbi.2001.4922; WILSON EM, 1995, BIOCHEMISTRY-US, V34, P4696, DOI 10.1021/bi00014a025; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738	37	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28313	28320		10.1074/jbc.M805521200	http://dx.doi.org/10.1074/jbc.M805521200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713751	Green Published, hybrid			2022-12-25	WOS:000259969300033
J	Middleton, LE; Mitnitski, A; Fallah, N; Kirkland, SA; Rockwood, K				Middleton, Laura E.; Mitnitski, Arnold; Fallah, Nader; Kirkland, Susan A.; Rockwood, Kenneth			Changes in Cognition and Mortality in Relation to Exercise in Late Life: A Population Based Study	PLOS ONE			English	Article							AGE-RELATED-CHANGES; PHYSICAL-ACTIVITY; HEALTH; DEMENTIA; DECLINE; RISK; TRANSITIONS; IMPAIRMENT; BRAIN; ACCUMULATION	Background: On average, cognition declines with age but this average hides considerable variability, including the chance of improvement. Here, we investigate how exercise is associated with cognitive change and mortality in older people and, particularly, whether exercise might paradoxically increase the risk of dementia by allowing people to live longer. Methods and Principal Findings: In the Canadian Study of Health and Aging (CSHA), of 8403 people who had baseline cognition measured and exercise reported at CSHA-1, 2219 had died and 5376 were re-examined at CSHA-2. We used a parametric Markov chain model to estimate the probabilities of cognitive improvement, decline, and death, adjusted for age and education, from any cognitive state as measured by the Modified Mini-Mental State Examination. High exercisers (at least three times per week, at least as intense as walking, n = 3264) had more frequent stable or improved cognition (42.3%, 95% confidence interval: 40.6-44.0) over 5 years than did low/ no exercisers (all other exercisers and non exercisers, n = 4331) (27.8% (95% CI 26.4-29.2)). The difference widened as baseline cognition worsened. The proportion whose cognition declined was higher amongst the high exercisers but was more similar between exercise groups (39.4% (95% CI 37.7-41.1) for high exercisers versus 34.8% (95% CI 33.4-36.2) otherwise). People who did not exercise were also more likely to die (37.5% (95% CI 36.0-39.0) versus 18.3% (95% CI 16.9-19.7)). Even so, exercise conferred its greatest mortality benefit to people with the highest baseline cognition. Conclusions: Exercise is strongly associated with improving cognition. As the majority of mortality benefit of exercise is at the highest level of cognition, and declines as cognition declines, the net effect of exercise should be to improve cognition at the population level, even with more people living longer.	[Middleton, Laura E.; Mitnitski, Arnold; Fallah, Nader; Rockwood, Kenneth] Ctr Hlth Care Elderly, Geriatr Med Res Unit, Halifax, NS, Canada; [Kirkland, Susan A.] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada	Dalhousie University	Middleton, LE (corresponding author), Ctr Hlth Care Elderly, Geriatr Med Res Unit, Halifax, NS, Canada.	kenneth.rockwood@dal.ca	Mitnitski, Arnold/C-7543-2012; Middleton, Laura/ABG-8940-2021; Rockwood, Kenneth/AAD-8951-2019; Fallah, Nader/D-4145-2012; Middleton, Laura/C-6024-2009	Fallah, Nader/0000-0002-7746-4773; Middleton, Laura/0000-0001-8624-3123; Kirkland, Susan/0000-0002-8182-2369	National Health Research Development Program [6606-3954-MC(S)]; Canadian Institutes of Health Research [MOP-62823]; Killam Foundation; Dalhousie Medical Research Foundation; Fountain Innovation Fund of the QEII Research Foundation	National Health Research Development Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Killam Foundation; Dalhousie Medical Research Foundation; Fountain Innovation Fund of the QEII Research Foundation	All the data reported here was gathered using public funding from the National Health Research Development Program, which administrated a grant from the Seniors' Independence Research program (6606-3954-MC(S)). Funding for these analyses came from the Canadian Institutes of Health Research through an operating grant (MOP-62823). Additional support came from the Killam Foundation (a doctoral student award to LEM), the Dalhousie Medical Research Foundation (career support to KR as Kathryn Allen Weldon Professor of Alzheimer Research) and the Fountain Innovation Fund of the QEII Research Foundation. The decision to submit this paper was entirely the decision of the authors and not the sponsors, who had no role in design, analysis or writing of the paper.	Andrade E, 2008, J SEX MED, V5, P9; Broe GA, 1998, AUST NZ J PUBL HEAL, V22, P621, DOI 10.1111/j.1467-842X.1998.tb01449.x; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Davis HS, 2001, INT PSYCHOGERIATR, V13, P177, DOI 10.1017/S1041610202008128; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Finkel D, 2003, DEV PSYCHOL, V39, P535, DOI 10.1037/0012-1649.39.3.535; Finkel D, 2007, J GERONTOL B-PSYCHOL, V62, pP286, DOI 10.1093/geronb/62.5.P286; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goggins WB, 2005, J GERONTOL A-BIOL, V60, P1046, DOI 10.1093/gerona/60.8.1046; Jones TG, 2002, ARCH CLIN NEUROPSYCH, V17, P171, DOI 10.1016/S0887-6177(00)00108-6; KAY DWK, 1991, INT J GERIATR PSYCH, V6, P827, DOI 10.1002/gps.930061202; Kramer AF, 2007, ALZHEIMERS DEMENT, V3, pS45, DOI 10.1016/j.jalz.2007.01.008; Kryscio RJ, 2006, NEUROLOGY, V66, P828, DOI 10.1212/01.wnl.0000203264.71880.45; Kulminski A, 2006, MECH AGEING DEV, V127, P840, DOI 10.1016/j.mad.2006.08.005; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lytle ME, 2004, ALZ DIS ASSOC DIS, V18, P57, DOI 10.1097/01.wad.0000126614.87955.79; MacDonald SWS, 2003, J GERONTOL B-PSYCHOL, V58, pP187, DOI 10.1093/geronb/58.3.P187; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; McDowell I, 1997, J CLIN EPIDEMIOL, V50, P377, DOI 10.1016/S0895-4356(97)00060-7; McDowell I, 2001, INT PSYCHOGERIATR, V13, P19, DOI 10.1017/S1041610202007950; McDowell I, 2001, AGING CLIN EXP RES, V13, P143, DOI 10.1007/BF03351474; Middleton LE, 2007, J AM GERIATR SOC, V55, P1095, DOI 10.1111/j.1532-5415.2007.01238.x; Mitnitski A, 2006, MECH AGEING DEV, V127, P490, DOI 10.1016/j.mad.2006.01.007; Mitnitski A, 2007, EXP GERONTOL, V42, P1109, DOI 10.1016/j.exger.2007.08.002; Mitnitski Arnold, 2008, BMC Geriatr, V8, P3, DOI 10.1186/1471-2318-8-3; Ravaglia G, 2008, NEUROLOGY, V70, P1786, DOI 10.1212/01.wnl.0000296276.50595.86; Rockwood K, 2007, ALZHEIMERS DEMENT, V3, pS38, DOI 10.1016/j.jalz.2007.01.003; Rockwood K, 2007, NEUROLOGY, V69, P1896, DOI 10.1212/01.wnl.0000265399.77681.40; Rockwood K, 2007, REV CLIN GERONTOL, V17, P1, DOI 10.1017/S0959259807002353; SCHAIE KW, 1989, PSYCHOL AGING, V4, P443, DOI 10.1037/0882-7974.4.4.443; Schuit AJ, 2001, MED SCI SPORT EXER, V33, P772; Scuteri A, 2005, AGING CLIN EXP RES, V17, P367; Sliwinski M, 1999, PSYCHOL AGING, V14, P18, DOI 10.1037/0882-7974.14.1.18; Sumic A, 2007, J AGING HEALTH, V19, P242, DOI 10.1177/0898264307299299; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tyas SL, 2007, AM J EPIDEMIOL, V165, P1231, DOI 10.1093/aje/kwm085; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703	37	91	92	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3124	10.1371/journal.pone.0003124	http://dx.doi.org/10.1371/journal.pone.0003124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422GW	18769616	Green Submitted, Green Published, gold			2022-12-25	WOS:000264416600012
J	Shepard, BD; De Forni, D; McNamara, DR; Foli, A; Rizza, SA; Abraham, RS; Knutson, K; Wettstein, PJ; Lori, F; Badley, AD				Shepard, Brett D.; De Forni, Davide; McNamara, David R.; Foli, Andrea; Rizza, Stacey A.; Abraham, Roshini S.; Knutson, Keith; Wettstein, Peter J.; Lori, Franco; Badley, Andrew D.			Beneficial Effect of TRAIL on HIV Burden, without Detectable Immune Consequences	PLOS ONE			English	Article								Background: During uncontrolled HIV disease, both TNF-related apoptosis inducing ligand ( TRAIL) and TRAIL receptor expression are increased. Enhanced TRAIL sensitivity is due to TRAIL receptor up-regulation induced by gp120. As a result of successful antiretroviral therapy TRAIL is down-regulated, and there are fewer TRAIL-sensitive cells. In this setting, we hypothesized that all cells that contain virus, including those productively- and latently-infected, have necessarily been "primed" by gp120 and remain TRAIL-sensitive, whereas uninfected cells remain relatively TRAIL-resistant. Methods and Findings: We evaluated the immunologic and antiviral effects of TRAIL in peripheral blood lymphocytes collected from HIV-infected patients with suppressed viral replication. The peripheral blood lymphocytes were treated with recombinant TRAIL or an equivalent amount of bovine serum albumin as a negative control. Treated cells were then analyzed by quantitative flow cytometry, ELISPOT for CD4+ and CD8+ T-cell function, and limiting dilution microculture for viral burden. Alterations in the cytokine milieu of treated cells were assessed with a multiplex cytokine assay. Treatment with recombinant TRAIL in vitro reduced viral burden in lymphocytes collected from HIV-infected patients with suppressed viral load. TRAIL treatment did not alter the cytokine milieu of treated cells. Moreover, treatment with recombinant TRAIL had no adverse effect on either the quantity or function of immune cells from HIV-infected patients with suppressed viral replication. Conclusions: TRAIL treatment may be an important adjunct to antiretroviral therapy, even in patients with suppressed viral replication, perhaps by inducing apoptosis in cells with latent HIV reservoirs. The absence of adverse effect on the quantity or function of immune cells from HIV-infected patients suggests that there is not a significant level of "bystander death" in uninfected cells.	[Shepard, Brett D.; McNamara, David R.; Rizza, Stacey A.; Abraham, Roshini S.; Knutson, Keith; Wettstein, Peter J.; Badley, Andrew D.] Mayo Clin, Rochester, MN 55905 USA; [De Forni, Davide] Virostatics srl, Sassari, Italy; [Foli, Andrea] Fdn Ist Ricovero Cura Carattere Sci Policlin San, Pavia, Italy; [Lori, Franco] Res Inst Genet & Human Therapy, Pavia, Italy	Mayo Clinic	Shepard, BD (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	badley.andrew@mayo.edu	badley, andrew d/O-9022-2014	Badley, Andrew/0000-0001-7796-7680	National Institutes of Health [R01 AI62261, R01 AI403840]; Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research [1005160]; National Institutes of Health Exploratory/Developmental Research Award (R21) [1R21DK077575-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); National Institutes of Health Exploratory/Developmental Research Award (R21); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Andrew Badley is supported by grants from the National Institutes of Health (R01 AI62261 and R01 AI403840) and the Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research (ID#1005160). Dr. Stacey Rizza is supported by a grant from the National Institutes of Health Exploratory/Developmental Research Award (R21) (1R21DK077575-01).	Audige A, 2006, J IMMUNOL, V177, P6227, DOI 10.4049/jimmunol.177.9.6227; Badley AD, 1996, J VIROL, V70, P199, DOI 10.1128/JVI.70.1.199-206.1996; Badley AD, 1997, J EXP MED, V185, P55, DOI 10.1084/jem.185.1.55; Balestrieri E, 2007, J MED VIROL, V79, P111, DOI 10.1002/jmv.20768; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Ganten TM, 2006, CLIN CANCER RES, V12, P2640, DOI 10.1158/1078-0432.CCR-05-2635; Gibellini D, 2005, J CELL PHYSIOL, V203, P547, DOI 10.1002/jcp.20252; Gibellini D, 2007, J MED VIROL, V79, P1446, DOI 10.1002/jmv.20938; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; Lum JJ, 2005, AIDS, V19, P1125, DOI 10.1097/01.aids.0000176212.16205.23; Lum JJ, 2004, J VIROL, V78, P6033, DOI 10.1128/JVI.78.11.6033-6042.2004; Lum JJ, 2001, J VIROL, V75, P11128, DOI 10.1128/JVI.75.22.11128-11136.2001; Miura Y, 2001, J EXP MED, V193, P651, DOI 10.1084/jem.193.5.651; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; Zhang MJ, 2001, J BIOMED SCI, V8, P290, DOI 10.1159/000054045; Zheng L, 2007, INTERVIROLOGY, V50, P224, DOI 10.1159/000100565	24	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3096	10.1371/journal.pone.0003096	http://dx.doi.org/10.1371/journal.pone.0003096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769477	Green Published, Green Submitted, gold			2022-12-25	WOS:000264796600013
J	Landman, KZ; Ostermann, J; Crump, JA; Mgonja, A; Mayhood, MK; Itemba, DK; Tribble, AC; Ndosi, EM; Chu, HY; Shao, JF; Bartlett, JA; Thielman, NM				Landman, Keren Z.; Ostermann, Jan; Crump, John A.; Mgonja, Anna; Mayhood, Meghan K.; Itemba, Dafrosa K.; Tribble, Alison C.; Ndosi, Evaline M.; Chu, Helen Y.; Shao, John F.; Bartlett, John A.; Thielman, Nathan M.			Gender Differences in the Risk of HIV Infection among Persons Reporting Abstinence, Monogamy, and Multiple Sexual Partners in Northern Tanzania	PLOS ONE			English	Article								Background: Monogamy, together with abstinence, partner reduction, and condom use, is widely advocated as a key behavioral strategy to prevent HIV infection in sub-Saharan Africa. We examined the association between the number of sexual partners and the risk of HIV seropositivity among men and women presenting for HIV voluntary counseling and testing (VCT) in northern Tanzania. Methodology/Principal Findings: Clients presenting for HIV VCT at a community-based AIDS service organization in Moshi, Tanzania were surveyed between November 2003 and December 2007. Data on sociodemographic characteristics, reasons for testing, sexual behaviors, and symptoms were collected. Men and women were categorized by number of lifetime sexual partners, and rates of seropositivity were reported by category. Factors associated with HIV seropositivity among monogamous males and females were identified by a multivariate logistic regression model. Of 6,549 clients, 3,607 (55%) were female, and the median age was 30 years (IQR 24-40). 939 (25%) females and 293 (10%) males (p < 0.0001) were HIV seropositive. Among 1,244 (34%) monogamous females and 423 (14%) monogamous males, the risk of HIV infection was 19% and 4%, respectively (p < 0.0001). The risk increased monotonically with additional partners up to 45% ( p < 0.001) and 15% (p < 0.001) for women and men, respectively with 5 or more partners. In multivariate analysis, HIV seropositivity among monogamous women was most strongly associated with age (p < 0.0001), lower education (p < 0.004), and reporting a partner with other partners (p=0.015). Only age was a significant risk factor for monogamous men (p=0.0004). Interpretation: Among women presenting for VCT, the number of partners is strongly associated with rates of seropositivity; however, even women reporting lifetime monogamy have a high risk for HIV infection. Partner reduction should be coupled with efforts to place tools in the hands of sexually active women to reduce their risk of contracting HIV.	[Landman, Keren Z.; Ostermann, Jan; Crump, John A.; Mayhood, Meghan K.; Tribble, Alison C.; Ndosi, Evaline M.; Chu, Helen Y.; Bartlett, John A.; Thielman, Nathan M.] Duke Univ, Med Ctr, Durham, NC 27706 USA; [Ostermann, Jan; Crump, John A.; Bartlett, John A.; Thielman, Nathan M.] Duke Univ, Duke Glob Hlth Inst, Durham, NC 27706 USA; [Crump, John A.; Shao, John F.; Bartlett, John A.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Crump, John A.; Itemba, Dafrosa K.; Shao, John F.; Bartlett, John A.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Mgonja, Anna] KIWAKKUKI, Moshi, Tanzania	Duke University; Duke University; Kilimanjaro Christian Medical Centre	Landman, KZ (corresponding author), Duke Univ, Med Ctr, Durham, NC 27706 USA.	n.thielman@duke.edu	Ostermann, Jan/GQB-4743-2022; Crump, John A./AAZ-6412-2020; Thielman, Nathan/R-5142-2019; Crump, John A./AAZ-6289-2020	Crump, John A./0000-0002-4529-102X; Thielman, Nathan/0000-0001-8152-2879; Crump, John A./0000-0002-4529-102X; Ostermann, Jan/0000-0002-8236-9500; Chu, Helen/0000-0001-8502-9600	Roche; AIDS Clinical Trials Group [U01 AI-39156]; Mid-career Investigator Award [K24 AI-0744-01]; International Studies of AIDS -associated Co-infections Award [U01 AI 062563-04]; Duke University Center for AIDS Research [P30 AI64516-03]; National Institute of Allergy and Infectious Diseases; U.S. Department of State Fulbright Program; Fogarty International Center's AIDS International Training and Research Program [D43 TW006732]; Hubert Yeargan Center for Global Health; Duke University Medical Center; University of Rochester Medical Center; FOGARTY INTERNATIONAL CENTER [D43TW006732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI039156, Z01AI000744, U01AI062563] Funding Source: NIH RePORTER	Roche(Roche Holding); AIDS Clinical Trials Group; Mid-career Investigator Award; International Studies of AIDS -associated Co-infections Award; Duke University Center for AIDS Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of State Fulbright Program; Fogarty International Center's AIDS International Training and Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Hubert Yeargan Center for Global Health; Duke University Medical Center; University of Rochester Medical Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by Roche. Additional support was obtained from AIDS Clinical Trials Group (U01 AI-39156; Drs. Bartlett, Crump, and Thielman), Mid-career Investigator Award (K24 AI-0744-01; Dr. Bartlett), International Studies of AIDS -associated Co-infections Award (U01 AI 062563-04; Drs. Bartlett, Crump, and Thielman) and the Duke University Center for AIDS Research (P30 AI64516-03; Drs. Bartlett and Crump) from the National Institute of Allergy and Infectious Diseases, from the U.S. Department of State Fulbright Program (Dr. Thielman), from the Fogarty International Center's AIDS International Training and Research Program (D43 TW006732, Drs. Bartlett, Crump, and Thielman), from the Hubert Yeargan Center for Global Health, Duke University Medical Center (Dr. Tribble) and from the University of Rochester Medical Center (Dr. Landman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Chu HY, 2005, INT J STD AIDS, V16, P691, DOI 10.1258/095646205774357307; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Doherty IA, 2006, SEX TRANSM DIS, V33, P368, DOI 10.1097/01.olq.0000194586.66409.7a; Drumright LN, 2004, SEX TRANSM DIS, V31, P437, DOI 10.1097/01.olq.0000129949.30114.37; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; Gersovitz M, 1998, J AM STAT ASSOC, V93, P875, DOI 10.2307/2669826; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Koumans EH, 2001, SEX TRANSM DIS, V28, P497, DOI 10.1097/00007435-200109000-00004; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; Mayer KH, 2003, AIDS, V17, P321, DOI 10.1097/00002030-200302140-00005; *MIN HLTH, 2005, 19 MIN HLTH; Mitsunaga TM, 2005, JAIDS-J ACQ IMM DEF, V39, P478, DOI 10.1097/01.qai.0000152396.60014.69; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Nnko S, 2004, SOC SCI MED, V59, P299, DOI 10.1016/j.socscimed.2003.10.031; O'Farrell N, 2001, SEX TRANSM DIS, V28, P84, DOI 10.1097/00007435-200102000-00005; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; Singh S, 2003, A B C UGANDA ROLES A; Slaymaker E, 2004, SEX TRANSM INFECT, V80, P85, DOI 10.1136/sti.2004.012054; Smith RJ, 2005, AIDS, V19, P413, DOI 10.1097/01.aids.0000161771.44276.92; Thielman NM, 2006, AM J PUBLIC HEALTH, V96, P114, DOI 10.2105/AJPH.2004.056796	24	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3075	10.1371/journal.pone.0003075	http://dx.doi.org/10.1371/journal.pone.0003075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728779	Green Published, Green Submitted, gold			2022-12-25	WOS:000264796400015
J	Khachatryan, ZA; Ktsoyan, ZA; Manukyan, GP; Kelly, D; Ghazaryan, KA; Aminov, RI				Khachatryan, Zaruhi A.; Ktsoyan, Zhanna A.; Manukyan, Gayane P.; Kelly, Denise; Ghazaryan, Karine A.; Aminov, Rustam I.			Predominant Role of Host Genetics in Controlling the Composition of Gut Microbiota	PLOS ONE			English	Article								Background: The human gastrointestinal tract is inhabited by a very diverse symbiotic microbiota, the composition of which depends on host genetics and the environment. Several studies suggested that the host genetics may influence the composition of gut microbiota but no genes involved in host control were proposed. We investigated the effects of the wild type and mutated alleles of the gene, which encodes the protein called pyrin, one of the regulators of innate immunity, on the composition of gut commensal bacteria. Mutations in MEFV lead to the autoinflammatory disorder, familial Mediterranean fever (FMF, MIM249100), which is characterized by recurrent self-resolving attacks of fever and polyserositis, with no clinical signs of disease in remission. Methodology/Principal Findings: A total of 19 FMF patients and eight healthy individuals were genotyped for mutations in the MEFV gene and gut bacterial diversity was assessed by sequencing 16S rRNA gene libraries and FISH analysis. These analyses demonstrated significant changes in bacterial community structure in FMF characterized by depletion of total numbers of bacteria, loss of diversity, and major shifts in bacterial populations within the Bacteroidetes, Firmicutes and Proteobacteria phyla in attack. In remission with no clinical signs of disease, bacterial diversity values were comparable with control but still, the bacterial composition was substantially deviant from the norm. Discriminant function analyses of gut bacterial diversity revealed highly specific, well-separated and distinct grouping, which depended on the allele carrier status of the host. Conclusions/Significance: This is the first report that clearly establishes the link between the host genotype and the corresponding shifts in the gut microbiota (the latter confirmed by two independent techniques). It suggests that the host genetics is a key factor in host-microbe interaction determining a specific profile of commensal microbiota in the human gut.	[Khachatryan, Zaruhi A.; Ktsoyan, Zhanna A.] Armenian Natl Acad Sci, Mol Genet Lab, Inst Mol Biol, Yerevan, Armenia; [Manukyan, Gayane P.; Ghazaryan, Karine A.] Armenian Natl Acad Sci, Inst Mol Biol, Grp Mol & Cellular Immunol, Yerevan, Armenia; [Kelly, Denise; Aminov, Rustam I.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB9 1FX, Scotland	National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; University of Aberdeen	Khachatryan, ZA (corresponding author), Armenian Natl Acad Sci, Mol Genet Lab, Inst Mol Biol, Yerevan, Armenia.	r.aminov@rowett.ac.uk	Manukyan, Gayane/AAR-7421-2020; Aminov, Rustam/AAF-9052-2019; Aminov, Rustam/C-8764-2016	Manukyan, Gayane/0000-0001-7541-5743; Aminov, Rustam/0000-0002-5811-8322; 	ISTC; RERAD	ISTC; RERAD	This work was funded by the ISTC (project A-1055). RIA is supported by the RERAD.	ADAMS RJ, 2007, AM J GASTROENTE 1006; Ahmad MS, 2000, GUT, V46, P493, DOI 10.1136/gut.46.4.493; Aksentijevich I, 1997, CELL, V90, P797; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Aminov RI, 2006, APPL ENVIRON MICROB, V72, P6371, DOI 10.1128/AEM.00701-06; Aypar E, 2003, J RHEUMATOL, V30, P2011; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bernot A, 1997, NAT GENET, V17, P25; Bonnet R, 2002, INT J SYST EVOL MICR, V52, P757, DOI 10.1099/00207713-52-3-757; Booth DR, 2000, QJM-INT J MED, V93, P217, DOI 10.1093/qjmed/93.4.217; Brydges S, 2006, CURR TOP MICROBIOL, V305, P127, DOI 10.1007/3-540-29714-6_7; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Csordas A, 1996, EUR J CANCER PREV, V5, P221, DOI 10.1097/00008469-199608000-00002; Davtyan TK, 2006, PATHOBIOLOGY, V73, P26, DOI 10.1159/000093089; Diaz A, 2004, ARTHRITIS RHEUM-US, V50, P3679, DOI 10.1002/art.20600; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Falk PG, 1998, MICROBIOL MOL BIOL R, V62, P1157, DOI 10.1128/MMBR.62.4.1157-1170.1998; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gershoni-Baruch R, 2001, EUR J HUM GENET, V9, P634, DOI 10.1038/sj.ejhg.5200672; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; HAGUE A, 1995, EUR J CANCER PREV, V4, P359, DOI 10.1097/00008469-199510000-00005; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Harmsen HJM, 2000, APPL ENVIRON MICROB, V66, P4523, DOI 10.1128/AEM.66.10.4523-4527.2000; Harmsen HJM, 2002, APPL ENVIRON MICROB, V68, P2982, DOI 10.1128/AEM.68.6.2982-2990.2002; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kaparakis M, 2007, IMMUNOL CELL BIOL, V85, P495, DOI 10.1038/sj.icb.7100105; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kogan A, 2001, AM J MED GENET, V102, P272, DOI 10.1002/ajmg.1438; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Manukyan GP, 2008, CLIN BIOCHEM, V41, P920, DOI 10.1016/j.clinbiochem.2008.03.017; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Matzner Y, 2000, BLOOD, V96, P727; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meng D, 2007, AM J PHYSIOL-GASTR L, V293, pG780, DOI 10.1152/ajpgi.00010.2007; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Notarnicola C, 2002, ARTHRITIS RHEUM-US, V46, P2785, DOI 10.1002/art.10575; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ootsubo M, 2002, J APPL MICROBIOL, V93, P60, DOI 10.1046/j.1365-2672.2002.01668.x; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Poland DCW, 2001, ANN RHEUM DIS, V60, P777, DOI 10.1136/ard.60.8.777; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Stoffman N, 2000, EUR J HUM GENET, V8, P307, DOI 10.1038/sj.ejhg.5200446; Suau A, 2001, SYST APPL MICROBIOL, V24, P139, DOI 10.1078/0723-2020-00015; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Toivanen P, 2001, INFECT IMMUN, V69, P2372, DOI 10.1128/IAI.69.4.2372-2377.2001; Tunca M, 1999, LANCET, V353, P1415, DOI 10.1016/S0140-6736(99)00990-3; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Van Limbergen J, 2007, AM J GASTROENTEROL, V102, P2820, DOI 10.1111/j.1572-0241.2007.01527.x; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yilmaz E, 2001, EUR J HUM GENET, V9, P553, DOI 10.1038/sj.ejhg.5200674; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	91	215	229	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3064	10.1371/journal.pone.0003064	http://dx.doi.org/10.1371/journal.pone.0003064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725973	Green Submitted, Green Published, gold			2022-12-25	WOS:000264796300010
J	Medina, PMB; Worthen, RJ; Forsberg, LJ; Brenman, JE				Medina, Paul M. B.; Worthen, Ryan J.; Forsberg, Lawrence J.; Brenman, Jay E.			The Actin-Binding Protein Capulet Genetically Interacts with the Microtubule Motor Kinesin to Maintain Neuronal Dendrite Homeostasis	PLOS ONE			English	Article							CYCLASE-ASSOCIATED PROTEINS; AXONAL-TRANSPORT; ALZHEIMERS-DISEASE; CYTOPLASMIC ACTIN; MEDIATED NEURODEGENERATION; CYTOSKELETAL DYNAMICS; TYROSINE KINASE; COFILIN; DROSOPHILA; PROFILIN	Background: Neurons require precise cytoskeletal regulation within neurites, containing microtubule tracks for cargo transport in axons and dendrites or within synapses containing organized actin. Due to the unique architecture and specialized function of neurons, neurons are particularly susceptible to perturbation of the cytoskeleton. Numerous actinbinding proteins help maintain proper cytoskeletal regulation. Methodology/Principal Findings: From a Drosophila forward genetic screen, we identified a mutation in capulet-encoding a conserved actin-binding protein-that causes abnormal aggregates of actin within dendrites. Through interaction studies, we demonstrate that simultaneous genetic inactivation of capulet and kinesin heavy chain, a microtubule motor protein, produces elongate cofilin-actin rods within dendrites but not axons. These rods resemble actin-rich structures induced in both mammalian neurodegenerative and Drosophila Alzheimer's models, but have not previously been identified by loss of function mutations in vivo. We further demonstrate that mitochondria, which are transported by Kinesin, have impaired distribution along dendrites in a capulet mutant. While Capulet and Cofilin may biochemically cooperate in certain circumstances, in neuronal dendrites they genetically antagonize each other. Conclusions/Significance: The present study is the first molecularly defined loss of function demonstration of actin-cofilin rods in vivo. This study suggests that simultaneous, seemingly minor perturbations in neuronal dendrites can synergize producing severe abnormalities affecting actin, microtubules and mitochondria/energy availability in dendrites. Additionally, as >90% of Alzheimer's and Parkinson's cases are sporadic this study suggests mechanisms by which multiple mutations together may contribute to neurodegeneration instead of reliance on single mutations to produce disease.	[Medina, Paul M. B.; Worthen, Ryan J.; Forsberg, Lawrence J.; Brenman, Jay E.] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27515 USA; [Brenman, Jay E.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Medina, PMB (corresponding author), Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27515 USA.	brenman@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022	Worthen, Ryan Joseph/0000-0002-2010-5876	NIMH; Whitehall Foundation for Neurobiology	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Whitehall Foundation for Neurobiology	Funding to J.E.B. from NIMH and Whitehall Foundation for Neurobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aguda AH, 2006, STRUCTURE, V14, P469, DOI 10.1016/j.str.2005.12.011; Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Baum B, 2000, CURR BIOL, V10, P964, DOI 10.1016/S0960-9822(00)00640-0; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Didry D, 1998, J BIOL CHEM, V273, P25602, DOI 10.1074/jbc.273.40.25602; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Freeman NL, 1996, MOL CELL BIOL, V16, P548; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gallo G, 2007, NAT CELL BIOL, V9, P133, DOI 10.1038/ncb0207-133; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Hurd DD, 1996, GENETICS, V144, P1075; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Idrissi FZ, 2002, MOL BIOL CELL, V13, P4074, DOI 10.1091/mbc.02-04-0052; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lace GL, 2007, CLIN NEUROPATHOL, V26, P43; Maciver SK, 2002, GENOME BIOL, V3; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; Mancuso M, 2007, ANTIOXID REDOX SIGN, V9, P1631, DOI 10.1089/ars.2007.1761; Martin M, 2005, MOL BIOL CELL, V16, P4225, DOI 10.1091/mbc.E05-02-0116; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Medina PMB, 2006, GENETICS, V172, P2325, DOI 10.1534/genetics.105.051276; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Moriyama K, 2002, J CELL SCI, V115, P1591; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Wills Z, 2002, NEURON, V36, P611, DOI 10.1016/S0896-6273(02)01022-X; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280	57	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3054	10.1371/journal.pone.0003054	http://dx.doi.org/10.1371/journal.pone.0003054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LJ	18725959	Green Published, gold, Green Submitted			2022-12-25	WOS:000264429000007
J	Lobner-Olesen, A; Slominska-Wojewodzka, M; Hansen, FG; Marinus, MG				Lobner-Olesen, Anders; Slominska-Wojewodzka, Monika; Hansen, Flemming G.; Marinus, Martin G.			DnaC Inactivation in Escherichia coli K-12 Induces the SOS Response and Expression of Nucleotide Biosynthesis Genes	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE; CHROMOSOME-REPLICATION; TRANSCRIPTION; PROTEIN; INITIATOR; CYCLE; ORIGIN; DAM; IDENTIFICATION; MECHANISM	Background: Initiation of chromosome replication in E. coli requires the DnaA and DnaC proteins and conditionally-lethal dnaA and dnaC mutants are often used to synchronize cell populations. Methodology/Principal Findings: DNA microarrays were used to measure mRNA steady-state levels in initiation-deficient dnaA46 and dnaC2 bacteria at permissive and non-permissive temperatures and their expression profiles were compared to MG1655 wildtype cells. For both mutants there was altered expression of genes involved in nucleotide biosynthesis at the non-permissive temperature. Transcription of the dnaA and dnaC genes was increased at the non-permissive temperature in the respective mutant strains indicating auto-regulation of both genes. Induction of the SOS regulon was observed in dnaC2 cells at 38 degrees C and 42 degrees C. Flow cytometric analysis revealed that dnaC2 mutant cells at non-permissive temperature had completed the early stages of chromosome replication initiation. Conclusion/Significance: We suggest that in dnaC2 cells the SOS response is triggered by persistent open-complex formation at oriC and/or by arrested forks that require DnaC for replication restart.	[Lobner-Olesen, Anders] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark; [Slominska-Wojewodzka, Monika] Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland; [Hansen, Flemming G.] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, Lyngby, Denmark; [Marinus, Martin G.] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA USA	Roskilde University; Fahrenheit Universities; University of Gdansk; Technical University of Denmark; University of Massachusetts System; University of Massachusetts Worcester	Lobner-Olesen, A (corresponding author), Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark.	martin.marinus@umassmed.edu	Løbner-Olesen, Anders/K-4344-2014	Løbner-Olesen, Anders/0000-0002-0344-6417; Slominska-Wojewodzka, Monika/0000-0001-6609-6381	Danish Natural Science Research Council; Danish Medical Research Council; Novo Nordisk Foundation; US National Institutes of Health [GM63790]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063790] Funding Source: NIH RePORTER	Danish Natural Science Research Council(Danish Natural Science Research Council); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Danish Natural Science Research Council, The Danish Medical Research Council, The Novo Nordisk Foundation and the US National Institutes of Heath grant GM63790. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRAJ JA, 1983, J BACTERIOL, V153, P562, DOI 10.1128/JB.153.1.562-565.1983; Borovok I, 2004, MOL MICROBIOL, V54, P1022, DOI 10.1111/j.1365-2958.2004.04325.x; BRAUN RE, 1985, CELL, V40, P159, DOI 10.1016/0092-8674(85)90319-8; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; CHIARAMELLO AE, 1990, J BACTERIOL, V172, P2013, DOI 10.1128/jb.172.4.2013-2019.1990; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; Courcelle J, 2001, GENETICS, V158, P41; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; FILPULA D, 1977, J BACTERIOL, V130, P107, DOI 10.1128/JB.130.1.107-113.1977; FREE A, 1995, MOL MICROBIOL, V18, P101, DOI 10.1111/j.1365-2958.1995.mmi_18010101.x; GIBERT I, 1990, MOL GEN GENET, V220, P400, DOI 10.1007/BF00391745; GILLE H, 1991, EMBO J, V10, P1579, DOI 10.1002/j.1460-2075.1991.tb07678.x; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Goranov AI, 2005, P NATL ACAD SCI USA, V102, P12932, DOI 10.1073/pnas.0506174102; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Ishigo-oka D, 2001, J BACTERIOL, V183, P2148, DOI 10.1128/JB.183.6.2148-2150.2001; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Lobner-Olesen A, 2003, P NATL ACAD SCI USA, V100, P4672, DOI 10.1073/pnas.0538053100; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Maisnier-Patin S, 2001, MOL MICROBIOL, V42, P1371, DOI 10.1046/j.1365-2958.2001.02718.x; MASAI H, 1988, J BIOL CHEM, V263, P15083; McCue LA, 2002, GENOME RES, V12, P1523, DOI 10.1101/gr.323602; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Messer W, 1997, MOL MICROBIOL, V24, P1, DOI 10.1046/j.1365-2958.1997.3171678.x; OGAWA T, 1994, J BACTERIOL, V176, P1609, DOI 10.1128/jb.176.6.1609-1615.1994; Park K, 1998, J BIOL CHEM, V273, P24906, DOI 10.1074/jbc.273.38.24906; PLATT T, 1980, OPERON, P263; Podkovyrov SM, 1996, NUCLEIC ACIDS RES, V24, P1747, DOI 10.1093/nar/24.9.1747; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7131; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; SUN L, 1992, MOL BIOL CELL, V3, P1095, DOI 10.1091/mbc.3.10.1095; SUN L, 1994, J BACTERIOL, V176, P2415, DOI 10.1128/JB.176.8.2415-2426.1994; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Withers HL, 1998, J BACTERIOL, V180, P1624, DOI 10.1128/JB.180.7.1624-1631.1998; Zhang WK, 2006, J BACTERIOL, V188, P5487, DOI 10.1128/JB.00339-06; Zhou P, 1997, J BACTERIOL, V179, P163, DOI 10.1128/jb.179.1.163-169.1997; ZHOU P, 1994, J BACTERIOL, V176, P6100, DOI 10.1128/jb.176.19.6100-6106.1994	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2984	10.1371/journal.pone.0002984	http://dx.doi.org/10.1371/journal.pone.0002984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714349	Green Submitted, Green Published, gold			2022-12-25	WOS:000264420900011
J	Yoon, YJ; Kominami, H; Trimarchi, T; Martin-Caraballo, M				Yoon, Yone Jung; Kominami, Hisashi; Trimarchi, Thomas; Martin-Caraballo, Miguel			Inhibition of Electrical Activity by Retroviral Infection with Kir2.1 Transgenes Disrupts Electrical Differentiation of Motoneurons	PLOS ONE			English	Article								Network-driven spontaneous electrical activity in the chicken spinal cord regulates a variety of developmental processes including neuronal differentiation and formation of neuromuscular structures. In this study we have examined the effect of chronic inhibition of spinal cord activity on motoneuron survival and differentiation. Early spinal cord activity in chick embryos was blocked using an avian replication-competent retroviral vector RCASBP(B) carrying the inward rectifier potassium channel Kir2.1. Chicken embryos were infected with one of the following constructs: RCASBP(B), RCASBP(B)Kir2.1, or RCASBP(B)-GFP. Infection of chicken embryos at E2 resulted in widespread expression of the viral protein marker p27 gag throughout the spinal cord. Electrophysiological recordings revealed the presence of functional Kir2.1 channels in RCASBP(B)-Kir2.1 but not in RCASBP(B)-infected embryos. Kir2.1 expression significantly reduced the generation of spontaneous motor movements in chicken embryos developing in ovo. Suppression of spontaneous electrical activity was not due to a reduction in the number of surviving motoneurons or the number of synapses in hindlimb muscle tissue. Disruption of the normal pattern of activity in chicken embryos resulted in a significant downregulation in the functional expression of large-conductance Ca(2+)-dependent K(+) channels. Reduction of spinal cord activity also generates a significant acceleration in the inactivation rate of A-type K(+) currents without any significant change in current density. Kir2.1 expression did not affect the expression of voltage-gated Na(+) channels or cell capacitance. These experiments demonstrate that chronic inhibition of chicken spinal cord activity causes a significant change in the electrical properties of developing motoneurons.	[Yoon, Yone Jung; Kominami, Hisashi; Trimarchi, Thomas; Martin-Caraballo, Miguel] Univ Vermont, Dept Biol, Burlington, VT USA	University of Vermont	Yoon, YJ (corresponding author), Univ Vermont, Dept Biol, Burlington, VT USA.	miguel.martin-caraballo@uvm.edu		Yoon, YoneJung/0000-0002-1608-2122	NIH [P20 RR016435]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH grant P20 RR016435 from the National Center for Research Resources.	Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Caldero J, 1997, J COMP NEUROL, V387, P73; Caldero J, 1998, J NEUROSCI, V18, P356; Casavant RH, 2004, J NEUROPHYSIOL, V92, P2644, DOI 10.1152/jn.00307.2004; Chen L, 2004, EUR J NEUROSCI, V20, P956, DOI 10.1111/j.1460-9568.2004.03553.x; Chub N, 2006, J NEUROPHYSIOL, V95, P323, DOI 10.1152/jn.00162.2005; Chub N, 1998, J NEUROSCI, V18, P294; Chub N, 2001, J NEUROPHYSIOL, V85, P2166, DOI 10.1152/jn.2001.85.5.2166; CHUWANG IW, 1978, J COMP NEUROL, V177, P33, DOI 10.1002/cne.901770105; DAHM LM, 1991, J NEUROSCI, V11, P238; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Finn TP, 1998, J NEUROBIOL, V34, P283, DOI 10.1002/(SICI)1097-4695(19980215)34:3<283::AID-NEU7>3.0.CO;2-Z; Gonzalez-Islas C, 2006, NEURON, V49, P563, DOI 10.1016/j.neuron.2006.01.017; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; HAMBURGER V, 1963, DEV BIOL, V7, P533, DOI 10.1016/0012-1606(63)90140-4; Hanson MG, 2006, J NEUROSCI, V26, P12769, DOI 10.1523/JNEUROSCI.4170-06.2006; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; HO S, 1993, J NEUROSCI, V13, P1354; Hollenbeck PJ, 2003, METHOD CELL BIOL, V71, P369, DOI 10.1016/S0091-679X(03)01018-5; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Hughes SH, 2004, FOLIA BIOL-PRAGUE, V50, P107; Jarvis JC, 1996, AM J PHYSIOL-CELL PH, V270, pC306, DOI 10.1152/ajpcell.1996.270.1.C306; Johns DC, 1999, J NEUROSCI, V19, P1691; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; LANDMESSER LT, 1986, J PHYSIOL-LONDON, V380, P157, DOI 10.1113/jphysiol.1986.sp016278; LERAY CF, 1993, J NEUROBIOL, V24, P1142, DOI 10.1002/neu.480240903; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Martin-Caraballo M, 2000, J NEUROPHYSIOL, V83, P3497, DOI 10.1152/jn.2000.83.6.3497; Martin-Caraballo M, 2002, J NEUROSCI, V22, P73, DOI 10.1523/JNEUROSCI.22-01-00073.2002; Martin-Caraballo M, 1999, J NEUROPHYSIOL, V81, P1365, DOI 10.1152/jn.1999.81.3.1365; MCCOBB DP, 1990, J NEUROSCI, V10, P2974; Mellor JR, 1998, J NEUROSCI, V18, P2822; Milner LD, 1999, J NEUROSCI, V19, P3007; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Ni X, 2007, DEV NEUROBIOL, V67, P1419, DOI 10.1002/dneu.20517; O'Donovan MJ, 1998, J NEUROBIOL, V37, P131, DOI 10.1002/(SICI)1097-4695(199810)37:1<131::AID-NEU10>3.0.CO;2-H; ODONOVAN MJ, 1987, J NEUROSCI, V7, P3256; Oppenheim RW, 2003, MOL CELL NEUROSCI, V22, P331, DOI 10.1016/S1044-7431(02)00020-9; Oppenheim RW, 1997, J COMP NEUROL, V381, P353, DOI 10.1002/(SICI)1096-9861(19970512)381:3<353::AID-CNE7>3.0.CO;2-1; Oppenheim RW, 2000, J NEUROSCI, V20, P6117, DOI 10.1523/JNEUROSCI.20-16-06117.2000; OPPENHEIM RW, 1989, TRENDS NEUROSCI, V12, P252, DOI 10.1016/0166-2236(89)90021-0; PERSSON M, 1983, J ANAT, V137, P591; PHILLIPS WD, 1987, J NEUROCYTOL, V16, P1, DOI 10.1007/BF02456693; PHILLIPS WD, 1987, J NEUROCYTOL, V16, P785, DOI 10.1007/BF01611986; Sato N, 2002, J NEUROBIOL, V53, P381, DOI 10.1002/neu.10108; Soler RM, 1998, J NEUROSCI, V18, P1230; TANG JC, 1993, J NEUROSCI, V13, P3095; Topert C, 1998, J NEUROSCI, V18, P4096; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Usiak MF, 1999, J NEUROSCI, V19, P7925	55	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2971	10.1371/journal.pone.0002971	http://dx.doi.org/10.1371/journal.pone.0002971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698433	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600055
J	Heisel, SE; Zhang, YJ; Allen, E; Guo, L; Reynolds, TL; Yang, X; Kovalic, D; Roberts, JK				Heisel, Sara E.; Zhang, Yuanji; Allen, Edwards; Guo, Liang; Reynolds, Tracey L.; Yang, Xiao; Kovalic, David; Roberts, James K.			Characterization of Unique Small RNA Populations from Rice Grain	PLOS ONE			English	Article							REGULATORY ROLES; MICRORNAS; DNA; BIOGENESIS; GENES; ACCUMULATION; ARGONAUTE4; RESOURCE; SIRNAS; DICER	Small RNAs (similar to 20 to 24 nucleotides) function as naturally occurring molecules critical in developmental pathways in plants and animals [1,2]. Here we analyze small RNA populations from mature rice grain and seedlings by pyrosequencing. Using a clustering algorithm to locate regions producing small RNAs, we classified hotspots of small RNA generation within the genome. Hotspots here are defined as 1 kb regions within which small RNAs are significantly overproduced relative to the rest of the genome. Hotspots were identified to facilitate characterization of different categories of small RNA regulatory elements. Included in the hotspots, we found known members of 23 miRNA families representing 92 genes, one trans acting siRNA (ta-siRNA) gene, novel siRNA-generating coding genes and phased siRNA generating genes. Interestingly, over 20% of the small RNA population in grain came from a single foldback structure, which generated eight phased 21-nt siRNAs. This is reminiscent of a newly arising miRNA derived from duplication of progenitor genes [3,4]. Our results provide data identifying distinct populations of small RNAs, including phased small RNAs, in mature grain to facilitate characterization of small regulatory RNA expression in monocot species.	[Heisel, Sara E.; Zhang, Yuanji; Allen, Edwards; Guo, Liang; Reynolds, Tracey L.; Yang, Xiao; Kovalic, David; Roberts, James K.] Monsanto Co, Chesterfield, MO USA	Monsanto	Heisel, SE (corresponding author), Monsanto Co, Chesterfield, MO USA.	ed.m.allen@monsanto.com		Allen, Edwards/0000-0002-8318-6319	Monsanto Company	Monsanto Company	This work was funded by Monsanto Company.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; BEWLEY J. D, 2013, SEEDS, V3, DOI [DOI 10.1007/978-1-4614-4693-4_1, 10.1017/S0960258513000287]; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gale MD, 1998, SCIENCE, V282, P656, DOI 10.1126/science.282.5389.656; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hong BJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni109; Johnson C, 2007, NUCLEIC ACIDS RES, V35, pD829, DOI 10.1093/nar/gkl991; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Katiyar-Agarwal S, 2007, GENE DEV, V21, P3123, DOI 10.1101/gad.1595107; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Liu B, 2007, PLANT CELL, V19, P2705, DOI 10.1105/tpc.107.052209; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; LURIN C, 2004, PLANT CELL TPC, V104; MALLORY AC, 2006, NAT GENT S, V38; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mendoza MS, 2005, FEBS LETT, V579, P4666, DOI 10.1016/j.febslet.2005.07.037; Meyers BC, 2004, PLANT PHYSIOL, V135, P801, DOI 10.1104/pp.104.039495; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; QIU S, 2005, NUCL ACIDS RES, V33; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Wang Y, 2004, PLANT PHYSIOL, V135, P400, DOI 10.1104/pp.103.037945; XIE Z, 2005, PLANT PHYSL; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	46	59	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2871	10.1371/journal.pone.0002871	http://dx.doi.org/10.1371/journal.pone.0002871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18716673	Green Submitted, Green Published, gold			2022-12-25	WOS:000264366600027
J	Athirakul, K; Bradbury, JA; Graves, JP; DeGraff, LM; Ma, JX; Zhao, Y; Couse, JF; Quigley, R; Harder, DR; Zhao, XY; Imig, JD; Pedersen, TL; Newman, JW; Hammock, BD; Conley, AJ; Korach, KS; Coffman, TM; Zeldin, DC				Athirakul, Krairerk; Bradbury, J. Alyce; Graves, Joan P.; DeGraff, Laura M.; Ma, Jixiang; Zhao, Yun; Couse, John F.; Quigley, Raymond; Harder, David R.; Zhao, Xueying; Imig, John D.; Pedersen, Theresa L.; Newman, John W.; Hammock, Bruce D.; Conley, Alan J.; Korach, Kenneth S.; Coffman, Thomas M.; Zeldin, Darryl C.			Increased blood pressure in mice lacking cytochrome P450 2J5	FASEB JOURNAL			English	Article						hypertension; estrogen; proximal tubule; vascular responsiveness; eicosanoid	SPONTANEOUSLY HYPERTENSIVE-RATS; ESTROGEN-RECEPTOR-BETA; ARACHIDONIC-ACID; 20-HYDROXYEICOSATETRAENOIC ACID; NITRIC-OXIDE; POSTMENOPAUSAL WOMEN; LUTEINIZING-HORMONE; ANGIOTENSIN-II; EPOXYEICOSATRIENOIC ACIDS; CARDIOVASCULAR FUNCTION	The cytochrome P450 (CYP) enzymes participate in a wide range of biochemical functions, including metabolism of arachidonic acid and steroid hormones. Mouse CYP2J5 is abundant in the kidney where its products, the cis-epoxyeicosatrienoic acids (EETs), modulate sodium transport and vascular tone. To define the physiological role of CYP2J5 in the kidney, knockout mice were generated using a conventional gene targeting approach. Cyp2j5 (-/-) mice develop normally and exhibit no overt renal pathology. While renal EET biosynthesis was apparently unaffected by the absence of CYP2J5, deficiency of this CYP in female mice was associated with increased blood pressure, enhanced proximal tubular transport rates, and exaggerated afferent arteriolar responses to angiotensin II and endothelin I. Interestingly, plasma 17 beta-estradiol levels were reduced in female Cyp2j5 (-/-) mice and estrogen replacement restored blood pressure and vascular responsiveness to normal levels. There was no evidence of enhanced estrogen metabolism, or altered expression or activities of steroidogenic enzymes in female Cyp2j5 (-/-) mice, but their plasma levels of luteinizing hormone and follicle stimulating hormone were inappropriately low. Together, our findings illustrate a sex-specific role for CYP2J5 in regulation of blood pressure, proximal tubular transport, and afferent arteriolar responsiveness via an estrogen-dependent mechanism.	[Bradbury, J. Alyce; Graves, Joan P.; DeGraff, Laura M.; Ma, Jixiang; Zhao, Yun; Couse, John F.; Korach, Kenneth S.; Zeldin, Darryl C.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Athirakul, Krairerk; Coffman, Thomas M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Quigley, Raymond] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Harder, David R.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Zhao, Xueying; Imig, John D.] Med Coll Georgia, Dept Physiol, Augusta, GA 30912 USA; [Pedersen, Theresa L.; Newman, John W.; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Pedersen, Theresa L.; Newman, John W.; Hammock, Bruce D.] Univ Calif Davis, Canc Res Ctr, Davis, CA 95616 USA; [Conley, Alan J.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical College of Wisconsin; University System of Georgia; Augusta University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Zeldin, DC (corresponding author), NIEHS, NIH, 111 T W Alexander Dr,Bldg 101,Rm D236, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307; Imig, John/0000-0002-9668-2899; Newman, John/0000-0001-9632-6571; Korach, Kenneth/0000-0002-7765-418X; Quigley, Raymond/0000-0003-4186-7527	NIH [HL6876, DK38226, ES004699, ES02710, MH39917, DK069896]; National Institute of Environmental Health Sciences [Z01 ES025034]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025034, ZIAES070065] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Drs. Michael Fessler and Robert Langenbach for helpful comments during the preparation of this manuscript, Dr. Howard Rockman for assistance with echocardiography, and Dr. Beverly Koller for assistance with generation of the Cyp2j5 (-/-) mice. This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences Z01 ES025034 (K.S.K., D.C.Z.), and NIH grants HL6876 (D.R.H.), DK38226 (J.D.I.), ES004699 (B.D.H.), ES02710 (B.D.H.), MH39917 (A.J.C.) and DK069896 (T.M.C.).	August P, 1999, J CLIN ENDOCR METAB, V84, P1862, DOI 10.1210/jc.84.6.1862; Bayorh MA, 2001, CLIN EXP HYPERTENS, V23, P241, DOI 10.1081/CEH-100102663; Capdevila JH, 2000, J LIPID RES, V41, P163; CATELLA F, 1990, P NATL ACAD SCI USA, V87, P5893, DOI 10.1073/pnas.87.15.5893; CHAKRAVARTI S, 1976, BRIT MED J, V2, P784, DOI 10.1136/bmj.2.6039.784; Christin-Maitre S, 2003, J CLIN ENDOCR METAB, V88, P5405, DOI 10.1210/jc.2003-030094; Conley AJ, 1997, BIOL REPROD, V56, P789, DOI 10.1095/biolreprod56.4.789; Corbin CJ, 2001, MOL CELL ENDOCRINOL, V172, P115, DOI 10.1016/S0303-7207(00)00373-7; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Couse JF, 2004, ENDOCRINOLOGY, V145, P4693, DOI 10.1210/en.2004-0548; Darblade B, 2002, CIRC RES, V90, P413, DOI 10.1161/hh0402.105096; Dubey RK, 2001, HYPERTENSION, V37, P640, DOI 10.1161/01.HYP.37.2.640; ESCALANTE B, 1993, EUR J PHARMACOL, V235, P1, DOI 10.1016/0014-2999(93)90812-V; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; GEE DM, 1983, BIOL REPROD, V28, P598, DOI 10.1095/biolreprod28.3.598; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Hinojosa-Laborde C, 2004, HYPERTENSION, V44, P405, DOI 10.1161/01.HYP.0000142893.08655.96; HIRT DL, 1989, J CLIN INVEST, V84, P1805, DOI 10.1172/JCI114365; HOEG JM, 1977, AM J PHYSIOL, V233, pH369, DOI 10.1152/ajpheart.1977.233.3.H369; Holla VR, 2001, P NATL ACAD SCI USA, V98, P5211, DOI 10.1073/pnas.081627898; Huang A, 2004, MICROCIRCULATION, V11, P9, DOI 10.1080/10739680490266162; Imig JD, 2000, AM J HYPERTENS, V13, P810, DOI 10.1016/S0895-7061(00)00264-8; Imig JD, 1996, AM J PHYSIOL-REG I, V270, pR217, DOI 10.1152/ajpregu.1996.270.1.R217; Imig JD, 2001, J VASC RES, V38, P247, DOI 10.1159/000051053; Ishizuka Tsuneo, 2004, Nihon Jinzo Gakkai Shi, V46, P685; Jespersen C M, 1983, J Hypertens, V1, P361, DOI 10.1097/00004872-198312000-00007; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; King Lorraine M, 2005, Pharmacogenet Genomics, V15, P7, DOI 10.1097/01213011-200501000-00002; KOLLER BH, 1992, ANNU REV IMMUNOL, V10, P705, DOI 10.1146/annurev.iy.10.040192.003421; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2004, MOL PHARMACOL, V65, P730, DOI 10.1124/mol.65.3.730; Ma JX, 1999, J BIOL CHEM, V274, P17777, DOI 10.1074/jbc.274.25.17777; MADHUN ZT, 1991, J CLIN INVEST, V88, P456, DOI 10.1172/JCI115325; Maier KG, 2001, CURR OPIN NEPHROL HY, V10, P81, DOI 10.1097/00041552-200101000-00013; MAKITA K, 1994, J CLIN INVEST, V94, P2414, DOI 10.1172/JCI117608; Manhem K, 1998, J HUM HYPERTENS, V12, P323, DOI 10.1038/sj.jhh.1000563; Martins D, 2001, J Gend Specif Med, V4, P10; MCGIFF JC, 1991, ANNU REV PHARMACOL, V31, P339, DOI 10.1146/annurev.pa.31.040191.002011; McGiff JC, 2001, CURR OPIN NEPHROL HY, V10, P231, DOI 10.1097/00041552-200103000-00012; Mercuro G, 1997, AM J CARDIOL, V80, P652, DOI 10.1016/S0002-9149(97)00444-X; Muller-Delp JM, 2003, AM J PHYSIOL-HEART C, V285, pH2150, DOI 10.1152/ajpheart.00966.2002; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; NEGROVILAR A, 1985, ENDOCRINOLOGY, V116, P2663, DOI 10.1210/endo-116-6-2663; Newman JW, 2002, J LIPID RES, V43, P1563, DOI 10.1194/jlr.D200018-JLR200; Nickenig G, 1998, CIRCULATION, V97, P2197, DOI 10.1161/01.CIR.97.22.2197; Oltman CL, 1998, CIRC RES, V83, P932; Oyekan AO, 1999, J CLIN INVEST, V104, P1131, DOI 10.1172/JCI6786; Peng N, 2003, HYPERTENSION, V41, P1164, DOI 10.1161/01.HYP.0000065387.09043.2E; Qu W, 2001, J BIOL CHEM, V276, P25467, DOI 10.1074/jbc.M100545200; Quigley R, 2000, AM J PHYSIOL-RENAL, V278, pF949, DOI 10.1152/ajprenal.2000.278.6.F949; Reckelhoff JF, 1999, HYPERTENSION, V34, P920, DOI 10.1161/01.HYP.34.4.920; Reckelhoff JF, 2000, HYPERTENSION, V35, P480, DOI 10.1161/01.HYP.35.1.480; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Sambrook J., 1989, MOL CLONING, V1; SCHALCH DS, 1968, J CLIN INVEST, V47, P665, DOI 10.1172/JCI105762; Schwartzman ML, 1996, NEPHRON, V73, P652; Seely EW, 1999, HYPERTENSION, V33, P1190, DOI 10.1161/01.HYP.33.5.1190; SIMON G, 1995, AM J HYPERTENS, V8, P645, DOI 10.1016/0895-7061(95)00047-S; SNYDER G, 1986, BIOCHEM BIOPH RES CO, V139, P1188, DOI 10.1016/S0006-291X(86)80303-5; Tang AC, 2005, HORM BEHAV, V47, P350, DOI 10.1016/j.yhbeh.2004.10.010; Tsuchiya Y, 2005, CANCER LETT, V227, P115, DOI 10.1016/j.canlet.2004.10.007; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140; Widder J, 2003, HYPERTENSION, V42, P991, DOI 10.1161/01.HYP.0000098661.37637.89; WIINBERG N, 1995, AM J HYPERTENS, V8, P978, DOI 10.1016/0895-7061(95)00216-2; Yu ZG, 2000, MOL PHARMACOL, V57, P1011; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	70	45	46	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4096	4108		10.1096/fj.08-114413	http://dx.doi.org/10.1096/fj.08-114413			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18716027	Green Published			2022-12-25	WOS:000261254800009
J	Briguet, A; Erb, M; Courdier-Fruh, I; Barzaghi, P; Santos, G; Herzner, H; Lescop, C; Siendt, H; Henneboehle, M; Weyermann, P; Magyar, JP; Dubach-Powell, J; Metz, G; Meier, T				Briguet, Alexandre; Erb, Michael; Courdier-Fruh, Isabelle; Barzaghi, Patrizia; Santos, Gesa; Herzner, Holger; Lescop, Cyrille; Siendt, Herve; Henneboehle, Marco; Weyermann, Philipp; Magyar, Josef P.; Dubach-Powell, Judith; Metz, Guenther; Meier, Thomas			Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse	FASEB JOURNAL			English	Article						Duchenne muscular dystrophy; dystrophin deficiency; small-molecule inhibitors; calpastatin; in vivo efficacy	DYSTROPHIN-GLYCOPROTEIN COMPLEX; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MICE; EXPRESSION; PROTEINS; FIBERS; MYOTUBES; CHANNELS; RESCUES	Dystrophin deficiency is the underlying molecular cause of progressive muscle weakness observed in Duchenne muscular dystrophy (DMD). Loss of functional dystrophin leads to elevated levels of intracellular Ca2+, a key step in the cellular pathology of DMD. The cysteine protease calpain is activated in dystrophin-deficient muscle, and its inhibition is regarded as a potential therapeutic approach. In addition, previous work has shown that the ubiquitin-proteasome system also contributes to muscle protein breakdown in dystrophic muscle and, therefore, also qualifies as a potential target for therapeutic intervention in DMD. The relative contribution of calpain- and proteasome-mediated proteolysis induced by increased Ca2+ levels was characterized in cultured muscle cells and revealed initial Ca2+ influx-dependent calpain activity and subsequent Ca2+-independent activity of the ubiquitin-proteasome system. We then set out to optimize novel small-molecule inhibitors that inhibit both calpain as well as the 20S proteasome in a cellular system with impaired Ca2+ homeostasis. On administration of such inhibitors to mdx mice, quantitative histological parameters improved significantly, in particular with compounds strongly inhibiting the 20S proteasome. To investigate the role of calpain inhibition without interfering with the ubiquitin-proteasome system, we crossed mdx mice with transgenic mice, overexpressing the endogenous calpain inhibitor calpastatin. Although our data show that proteolysis by calpain is strongly inhibited in the transgenic mdx mouse, this calpain inhibition did not ameliorate muscle histology. Our results indicate that inhibition of the proteasome rather than calpain is required for histological improvement of dystrophin-deficient muscle. In conclusion, we have identified novel proteasome inhibitors that qualify as potential candidates for pharmacological intervention in muscular dystrophy.	[Briguet, Alexandre; Erb, Michael; Courdier-Fruh, Isabelle; Barzaghi, Patrizia; Santos, Gesa; Herzner, Holger; Lescop, Cyrille; Siendt, Herve; Henneboehle, Marco; Weyermann, Philipp; Magyar, Josef P.; Dubach-Powell, Judith; Metz, Guenther; Meier, Thomas] Santhera Pharmaceut Switzerland Ltd, CH-4410 Liestal, Switzerland		Metz, G (corresponding author), Santhera Pharmaceut Switzerland Ltd, Hammerstr 47, CH-4410 Liestal, Switzerland.	guenther.metz@santhera.com						Adams J, 1999, CANCER RES, V59, P2615; Alderton JM, 2000, J BIOL CHEM, V275, P9452, DOI 10.1074/jbc.275.13.9452; AOYAGI T, 1969, J ANTIBIOT, V22, P558, DOI 10.7164/antibiotics.22.558; ARRIBAS J, 1993, J BIOL CHEM, V268, P21165; Assereto S, 2006, AM J PHYSIOL-CELL PH, V290, pC577, DOI 10.1152/ajpcell.00434.2005; Badalamente MA, 2000, MUSCLE NERVE, V23, P106, DOI 10.1002/(SICI)1097-4598(200001)23:1<106::AID-MUS14>3.0.CO;2-D; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Bonuccelli G, 2003, AM J PATHOL, V163, P1663, DOI 10.1016/S0002-9440(10)63523-7; Bonuccelli G, 2007, CELL CYCLE, V6, P1242, DOI 10.4161/cc.6.10.4182; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Burdi R, 2006, NEUROMUSCULAR DISORD, V16, P237, DOI 10.1016/j.nmd.2006.01.013; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Courdier-Fruh I, 2002, NEUROMUSCULAR DISORD, V12, pS95, DOI 10.1016/S0960-8966(02)00089-5; Donkor IO, 2000, CURR MED CHEM, V7, P1171, DOI 10.2174/0929867003374129; Dunant P, 2003, MOL THER, V8, P80, DOI 10.1016/S1525-0016(03)00129-1; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; HARRIS AS, 1988, J NEUROSCI, V8, P2640; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Lescop C, 2005, BIOORG MED CHEM LETT, V15, P5176, DOI 10.1016/j.bmcl.2005.08.064; Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950; MEHDI S, 1988, BIOCHEM BIOPH RES CO, V157, P1117, DOI 10.1016/S0006-291X(88)80989-6; Menconi MJ, 2004, SURGERY, V136, P135, DOI 10.1016/j.surg.2004.03.014; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; Neuhof C, 2004, BIOL CHEM, V385, P1077, DOI 10.1515/BC.2004.139; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; Otto HH, 1997, CHEM REV, V97, P133, DOI 10.1021/cr950025u; Petrof BJ, 1998, MOL CELL BIOCHEM, V179, P111, DOI 10.1023/A:1006812004945; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; SASAKI T, 1984, J BIOL CHEM, V259, P2489; Spencer MJ, 2002, HUM MOL GENET, V11, P2645, DOI 10.1093/hmg/11.21.2645; SPENCER MJ, 1995, J BIOL CHEM, V270, P10909, DOI 10.1074/jbc.270.18.10909; Tanahashi-Hori T, 2003, J BIOL CHEM, V278, P16237, DOI 10.1074/jbc.M301331200; Tidball JG, 2000, INT J BIOCHEM CELL B, V32, P1, DOI 10.1016/S1357-2725(99)00095-3	35	42	45	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4190	4200		10.1096/fj.07-099036	http://dx.doi.org/10.1096/fj.07-099036			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18728218				2022-12-25	WOS:000261254800018
J	Tohyama, D; Yamaguchi, A; Yamashita, T				Tohyama, Daisuke; Yamaguchi, Atsushi; Yamashita, Toshihide			Inhibition of a eukaryotic initiation factor (eIF2B delta/F11A3.2) during adulthood extends lifespan in Caenorhabditis elegans	FASEB JOURNAL			English	Article						aging; daf-16	SYSTEMATIC RNAI SCREEN; HEAT-SHOCK-FACTOR; TRANSLATION INITIATION; DEVELOPMENTAL ARREST; LONGEVITY; DAF-16; GENES; GENETICS; STRESS; REPRODUCTION	The critical role of protein synthesis in regulating lifespan has been evidenced. This study shows that adult-onset RNAi inactivation of eukaryotic initiation factor 2B delta (eIF2B delta/F11A3.2), a subunit of eIF2B, extends the mean lifespan of Caenorhabditis elegans. eIF2B is a GDP-GTP exchange factor for eIF2-a rate-limiting factor for protein synthesis initiation. S-35-methionine incorporation assay showed that global protein synthesis is reduced by eIF2B delta/F11A3.2 RNAi. Inhibition of eIF2B delta/F11A3.2 during adulthood conferred thermal and oxidative stress resistance and reduced the fecundity and fat storage, suggesting the possible trade-offs of resources between reproduction and somatic maintenance. Lifespan extension by adult-onset eIF2B delta/F11A3.2 RNAi is suppressed in FOXO transcription factor daf-16 deletion mutants. Adult-onset eIF2B delta/F11A3.2 RNAi increases the expression of stress-resistant genes, including hsp-16.2, hsp-70, hsp90, and sod-3, some of which are reported to be targets of DAF-16. Adult-onset eIF2B delta/F11A3.2 RNAi in daf-16 mutants reduced fecundity, but did not extend lifespan. Furthermore, adult-onset eIF2B delta/F11A3.2 RNAi did not extend the lifespan of germline-defective glp-4 organisms. Thus, it is possible that eIF2B delta/F11A3.2 RNAi during adulthood prolongs lifespan via daf-16, which induces stress resistance in organisms. This might be the mechanism, at least in part, for trade-offs of resources between reproduction and somatic maintenance.-Tohyama, D., Yamaguchi, A., Yamashita, T. Inhibition of a eukaryotic initiation factor (eIF2B delta/F11A3.2) during adulthood extends lifespan in Caenorhabditis elegans. FASEB J. 22, 4327-4337 ( 2008)	[Tohyama, Daisuke; Yamaguchi, Atsushi; Yamashita, Toshihide] Chiba Univ, Grad Sch Med, Dept Neurobiol, Chuo Ku, Chiba 2608670, Japan; [Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan	Chiba University; Osaka University	Yamaguchi, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Neurobiol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	atsyama@restaff.chiba-u.jp		Yamashita, Toshihide/0000-0003-4559-7018				Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barnes AI, 2006, P ROY SOC B-BIOL SCI, V273, P939, DOI 10.1098/rspb.2005.3388; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Braeckman BP, 2007, EXP GERONTOL, V42, P90, DOI 10.1016/j.exger.2006.04.010; BRENNER S, 1974, GENETICS, V77, P71; Chen D, 2007, AGING CELL, V6, P525, DOI 10.1111/j.1474-9726.2007.00305.x; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; FRIEDMAN DB, 1988, GENETICS, V118, P75; Gems D, 1998, GENETICS, V150, P129; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Grune T, 2005, FREE RADICAL BIO MED, V39, P1208, DOI 10.1016/j.freeradbiomed.2005.06.009; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; LARSEN PL, 1995, GENETICS, V139, P1567; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li WS, 2007, DEV CELL, V12, P235, DOI 10.1016/j.devcel.2006.12.002; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Medwar P. B., 1952, UNSOLVED PROBLEM BIO; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Proud CG, 2006, BIOCHEM SOC T, V34, P213, DOI 10.1042/BST0340213; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094; Tissenbaum HA, 1998, GENETICS, V148, P703; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; Vernace VA, 2007, AGING CELL, V6, P599, DOI 10.1111/j.1474-9726.2007.00329.x; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042	69	23	34	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4327	4337		10.1096/fj.08-112953	http://dx.doi.org/10.1096/fj.08-112953			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18728216				2022-12-25	WOS:000261254800031
J	Vera, E; Canela, A; Fraga, MF; Esteller, M; Blasco, MA				Vera, E.; Canela, A.; Fraga, M. F.; Esteller, M.; Blasco, M. A.			Epigenetic regulation of telomeres in human cancer	ONCOGENE			English	Article						telomeres; subtelomeres; DNA methylation; epigenetic; telomerase; human cancer	RB FAMILY; LENGTH; RECOMBINATION; DNA; METHYLATION; CELLS; QUANTIFICATION; EXPRESSION; REPEATS	Hypomethylation of repeated elements in the genome is a common feature of human cancer, however, the direct consequences of this epigenetic defect for cancer biology are still largely unknown. Telomeres are specialized chromatin structures at the ends of eukaryotic chromosomes formed by tandem repeats of G-rich sequences and associated proteins, which have an essential role in chromosome end protection and genomic stability. Telomeric DNA repeats cannot be methylated, however, the adjacent subtelomeric DNA is heavily methylated in humans. Here, we show that the methylation status of subtelomeric DNA repeats negatively correlates with telomere length and telomere recombination in a large panel of human cancer cell lines. These findings suggest that tumor telomere length and integrity can be influenced by epigenetic factors. Finally, we show that treatment of human cancer cell lines with demethylating drugs results in hypomethylation of subtelomeric repeats and increased telomere recombination, which in turn may facilitate telomere elongation. All together, these findings suggest that tumor telomere length and integrity can be influenced by the epigenetic status of cancer cells. Oncogene (2008) 27, 6817-6833; doi: 10.1038/onc.2008.289; published online 1 September 2008	[Vera, E.; Canela, A.; Blasco, M. A.] Spanish Natl Canc Ctr CNIO, Telomeres & Telomerase Grp, Mol Oncol Program, E-28029 Madrid, Spain; [Fraga, M. F.; Esteller, M.] Spanish Natl Canc Ctr CNIO, Canc Epigenet Grp, Mol Pathol Program, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Ctr CNIO, Telomeres & Telomerase Grp, Mol Oncol Program, 3 Melchor Fernandez Almagro, E-28029 Madrid, Spain.	mblasco@cnio.es	Esteller, Manel/L-5956-2014; Blasco, Maria A./M-1694-2014; Fraga, Mario F/H-7824-2017	Esteller, Manel/0000-0003-4490-6093; Blasco, Maria A./0000-0002-4211-233X; Fraga, Mario F/0000-0001-8450-2603	Spanish Ministry of Education and Science (MEC); MEC [SAF2005-00277, GEN2001-4856-C1308]; Regional Government of Madrid [GR/SAL/0597/2004]; European Union [TELOSENS FIGH-CT-2002-00217, INTACT LSHC-CT-2003-506803, ZINCAGE FOOD-CT-2003-506850, RISC-RAD FI6R-CT-2003-508842, MOL CANCER MED LSHC-CT-2004-502943]; Josef Steiner Cancer Research Award 2003	Spanish Ministry of Education and Science (MEC)(Spanish Government); MEC(European Commission); Regional Government of Madrid; European Union(European Commission); Josef Steiner Cancer Research Award 2003	EV is a predoctoral fellow of the Spanish Ministry of Education and Science (MEC). MA Blasco's Laboratory is funded by the MEC (SAF2005-00277, GEN2001-4856-C1308), by the Regional Government of Madrid (GR/SAL/0597/2004), European Union (TELOSENS FIGH-CT-2002-00217, INTACT LSHC-CT-2003-506803, ZINCAGE FOOD-CT-2003-506850, RISC-RAD FI6R-CT-2003-508842, MOL CANCER MED LSHC-CT-2004-502943) and the Josef Steiner Cancer Research Award 2003.	Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2004, CARCINOGENESIS, V25, P1083, DOI 10.1093/carcin/bgh185; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fraga MF, 2002, ELECTROPHORESIS, V23, P1677, DOI 10.1002/1522-2683(200206)23:11&lt;1677::AID-ELPS1677&gt;3.0.CO;2-Z; Garcia-Aranda C, 2006, CANCER-AM CANCER SOC, V106, P541, DOI 10.1002/cncr.21625; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Garcia-Cao M, 2002, NAT GENET, V32, P415, DOI 10.1038/ng1011; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gonzalo S, 2005, CELL CYCLE, V4, P752, DOI 10.4161/cc.4.6.1720; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Guilleret I, 2003, EXP CELL RES, V289, P326, DOI 10.1016/S0014-4827(03)00281-7; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Kitagawa Y, 2000, CLIN CANCER RES, V6, P2868; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Steinert S, 2004, MOL CELL BIOL, V24, P4571, DOI 10.1128/MCB.24.10.4571-4580.2004	31	97	99	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2008	27	54					6817	6833		10.1038/onc.2008.289	http://dx.doi.org/10.1038/onc.2008.289			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	375IS	18762811				2022-12-25	WOS:000261108000003
J	Gigout, A; Jolicoeur, M; Nelea, M; Raynal, N; Farndale, R; Buschmann, MD				Gigout, Anne; Jolicoeur, Mario; Nelea, Monica; Raynal, Nicolas; Farndale, Richard; Buschmann, Michael D.			Chondrocyte Aggregation in Suspension Culture Is GFOGER-GPP- and beta 1 Integrin-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; DISCOIDIN DOMAIN RECEPTOR; COLLAGEN-BINDING; ARTICULAR CHONDROCYTES; II COLLAGEN; ULTRASTRUCTURAL ANALYSIS; INTERSTITIAL COLLAGENS; CELL ATTACHMENT; ANNEXIN-V; CARTILAGE	Isolated chondrocytes form aggregates in suspension culture that maintain chondrocyte phenotype in a physiological pericellular environment. The molecular mechanisms involved in chondrocyte aggregation have not been previously identified. Using this novel suspension culture system, we performed mRNA and protein expression analysis along with immunohistochemistry for potential cell adhesion molecules and extracellular matrix integrin ligands. Inhibition of aggregation assays were performed using specific blocking agents. We found that: (i) direct cell-cell interactions were not involved in chondrocyte aggregation, (ii) chondrocytes in aggregates were surrounded by a matrix rich in collagen II and cartilage oligomeric protein (COMP), (iii) aggregation depends on a beta 1-integrin, which binds a triple helical GFOGER sequence found in collagens, (iv) integrin alpha 10-subunit is the most highly expressed alpha-subunit among those tested, including alpha 5, in aggregating chondrocytes. Taken together, this body of evidence suggests that the main molecular interaction involved in aggregation of phenotypically stable chondrocytes is the alpha 10 beta 1-collagen II interaction.	[Gigout, Anne; Jolicoeur, Mario; Nelea, Monica; Buschmann, Michael D.] Ecole Polytech, Dept Chem Engn, Montreal, PQ H3C 3A7, Canada; [Gigout, Anne; Jolicoeur, Mario; Nelea, Monica; Buschmann, Michael D.] Ecole Polytech, Inst Biomed Engn, Montreal, PQ H3C 3A7, Canada; [Raynal, Nicolas; Farndale, Richard] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Polytechnique Montreal; University of Cambridge	Buschmann, MD (corresponding author), Ecole Polytech, Dept Chem Engn, PO 6079 Stn Ctr Ville, Montreal, PQ H3C 3A7, Canada.	michael.buschmann@polymtl.ca	Gigout, Anne/AAN-9566-2020	Gigout, Anne/0000-0003-1399-7957; Buschmann, Michael/0000-0002-2242-6198	Canadian Institutes of Health Research (CIHR); Canada Research Chairs program; Natural Sciences and Engineering Research Council of Canada (NSERC); MRC [G0400701] Funding Source: UKRI; Medical Research Council [G0400701] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Canadian Institutes of Health Research (CIHR), the Canada Research Chairs program, and the Natural Sciences and Engineering Research Council of Canada (NSERC). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Attur MG, 2000, J IMMUNOL, V164, P2684, DOI 10.4049/jimmunol.164.5.2684; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Cao L, 1999, MATRIX BIOL, V18, P343, DOI 10.1016/S0945-053X(99)00027-X; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Di Cesare PE, 2002, MATRIX BIOL, V21, P461, DOI 10.1016/S0945-053X(02)00015-X; Durr J, 1996, EXP CELL RES, V222, P225, DOI 10.1006/excr.1996.0028; DURR J, 1993, EXP CELL RES, V207, P235, DOI 10.1006/excr.1993.1189; ENOMOTO M, 1993, EXP CELL RES, V205, P276, DOI 10.1006/excr.1993.1087; Furukawa KS, 2003, CELL TRANSPLANT, V12, P475, DOI 10.3727/000000003108747037; Gehris AL, 1997, DEV BIOL, V190, P191, DOI 10.1006/dbio.1997.8693; Gigout A, 2005, OSTEOARTHR CARTILAGE, V13, P1012, DOI 10.1016/j.joca.2005.06.003; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; HEDLUND H, 1993, APMIS, V101, P133, DOI 10.1111/j.1699-0463.1993.tb00092.x; Hughes L C, 2005, Eur Cell Mater, V9, P68; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; KIRSCH T, 1992, FEBS LETT, V310, P143, DOI 10.1016/0014-5793(92)81316-E; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; KROG L, 1992, APMIS, V100, P53; LANGE TS, 1994, EXP CELL RES, V214, P381, DOI 10.1006/excr.1994.1271; Lee V, 2000, J CELL BIOCHEM, V79, P322, DOI 10.1002/1097-4644(20001101)79:2<322::AID-JCB150>3.0.CO;2-U; Leitinger B, 2004, J MOL BIOL, V344, P993, DOI 10.1016/j.jmb.2004.09.089; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084; LOESER RF, 1993, ARTHRITIS RHEUM, V36, P1103, DOI 10.1002/art.1780360811; Loeser RF, 2000, BIORHEOLOGY, V37, P109; Lucic D, 2003, CONNECT TISSUE RES, V44, P225, DOI 10.1080/03008200390248632; Mann HH, 2007, MATRIX BIOL, V26, P167, DOI 10.1016/j.matbio.2006.10.010; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; Neame PJ, 1999, CELL MOL LIFE SCI, V55, P1327, DOI 10.1007/s000180050373; Noonan KJ, 1998, J ORTHOPAED RES, V16, P500, DOI 10.1002/jor.1100160416; OBERLENDER SA, 1994, CELL ADHES COMMUN, V2, P521, DOI 10.3109/15419069409014216; Ohno S, 1999, BBA-MOL CELL RES, V1451, P196, DOI 10.1016/S0167-4889(99)00093-2; Onley DJ, 2000, J BIOL CHEM, V275, P24560, DOI 10.1074/jbc.M004111200; PFAFF M, 1993, EXP CELL RES, V206, P167, DOI 10.1006/excr.1993.1134; POOLE CA, 1987, J ORTHOP RES, V5, P509, DOI 10.1002/jor.1100050406; Poole CA, 1997, J ANAT, V191, P1, DOI 10.1046/j.1469-7580.1997.19110001.x; Reid DL, 2000, J ORTHOPAED RES, V18, P364, DOI 10.1002/jor.1100180307; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Salicioni AM, 2004, J BIOL CHEM, V279, P10005, DOI 10.1074/jbc.M306625200; Seiffert D, 1996, J HISTOCHEM CYTOCHEM, V44, P275, DOI 10.1177/44.3.8648088; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Tavella S, 1997, J CELL SCI, V110, P2261; TAVELLA S, 1994, EXP CELL RES, V215, P354, DOI 10.1006/excr.1994.1352; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; TUCKWELL DS, 1994, J CELL SCI, V107, P993; Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; WIDELITZ RB, 1993, J CELL PHYSIOL, V156, P399, DOI 10.1002/jcp.1041560224; Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110; WOODS VL, 1994, ARTHRITIS RHEUM, V37, P537, DOI 10.1002/art.1780370414; Zaucke F, 2001, BIOCHEM J, V358, P17, DOI 10.1042/0264-6021:3580017; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; Zhang ZJ, 2004, J ANAT, V205, P229, DOI 10.1111/j.0021-8782.2004.00327.x	61	40	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31522	31530		10.1074/jbc.M804234200	http://dx.doi.org/10.1074/jbc.M804234200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18723503	hybrid			2022-12-25	WOS:000260760800031
J	O'Brien, TC; Mackey, ZB; Fetter, RD; Choe, Y; O'Donoghue, AJ; Zhou, M; Craik, CS; Caffrey, CR; McKerrow, JH				O'Brien, Theresa C.; Mackey, Zachary B.; Fetter, Richard D.; Choe, Youngchool; O'Donoghue, Anthony J.; Zhou, Min; Craik, Charles S.; Caffrey, Conor R.; McKerrow, James H.			A Parasite Cysteine Protease Is Key to Host Protein Degradation and Iron Acquisition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE GLYCOPROTEIN; TRYPANOSOMA-BRUCEI; TRANSFERRIN RECEPTOR; AFRICAN TRYPANOSOMES; SUBCELLULAR-LOCALIZATION; SUBSTRATE-SPECIFICITY; LEISHMANIA-MEXICANA; CATHEPSIN-B; GRANZYME-B; TRAFFICKING	Cysteine proteases of the Clan CA (papain) family are the predominant protease group in primitive invertebrates. Cysteine protease inhibitors arrest infection by the protozoan parasite, Trypanosoma brucei. RNA interference studies implicated a cathepsin B-like protease, tbcatB, as a key inhibitor target. Utilizing parasites in which one of the two alleles of tbcatb has been deleted, the key role of this protease in degradation of endocytosed host proteins is delineated. TbcatB deficiency results in a decreased growth rate and dysmorphism of the flagellar pocket and the subjacent endocytic compartment. Western blot and microscopic analysis indicate that deficiency in tbcatB results in accumulation of both host and parasite proteins, including the lysosomal marker p67. A critical function for parasitism is the degradation of host transferrin, which is necessary for iron acquisition. Substrate specificity analysis of recombinant tbcatB revealed the optimal peptide cleavage sequences for the enzyme and these were confirmed experimentally using FRET-based substrates. Degradation of transferrin was validated by SDS-PAGE and the specific cleavage sites identified by N-terminal sequencing. Because even a modest deficiency in tbcatB is lethal for the parasite, tbcatB is a logical target for the development of new anti-trypanosomal chemotherapy.	[O'Brien, Theresa C.; Mackey, Zachary B.; Caffrey, Conor R.; McKerrow, James H.] Univ Calif San Francisco, Dept Pathol, Calif Inst Quantitat Biomed Res QB3, San Francisco, CA 94158 USA; [O'Brien, Theresa C.; Mackey, Zachary B.; Caffrey, Conor R.; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, Calif Inst Quantitat Biomed Res QB3, San Francisco, CA 94158 USA; [Fetter, Richard D.; Choe, Youngchool; O'Donoghue, Anthony J.; Zhou, Min; Craik, Charles S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res QB3, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McKerrow, JH (corresponding author), Univ Calif San Francisco, Dept Pathol, Calif Inst Quantitat Biomed Res QB3, 1700,4th St,Box 2550, San Francisco, CA 94158 USA.	jmck@cgl.ucsf.edu		Mackey, Zachary/0000-0002-4533-0973	National Institutes of Health [AI35707]; National Science Foundation Graduate Research Fellowship; Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI35707 from the NIAID Tropical Disease Research Unit. This work was also supported by a National Science Foundation Graduate Research Fellowship (to T. C. O.) and the Sandler Family Supporting Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexander DL, 2002, J CELL SCI, V115, P3253; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogyo M, 2000, CHEM BIOL, V7, P27, DOI 10.1016/S1074-5521(00)00061-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRICKMAN MJ, 1994, J CELL SCI, V107, P3191; Brooks DR, 2000, J CELL SCI, V113, P4035; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Caffrey C. R., 2000, Current Drug Targets, V1, P155, DOI 10.2174/1389450003349290; Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Doyle PS, 2007, ANTIMICROB AGENTS CH, V51, P3932, DOI 10.1128/AAC.00436-07; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gerrits H, 2002, MOL BIOCHEM PARASIT, V119, P237, DOI 10.1016/S0166-6851(01)00417-0; GRAB DJ, 1993, EUR J CELL BIOL, V62, P114; Hall B, 2004, MOL BIOCHEM PARASIT, V138, P67, DOI 10.1016/j.molbiopara.2004.07.007; Hall BS, 2005, EUKARYOT CELL, V4, P971, DOI 10.1128/EC.4.5.971-980.2005; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Kabiri M, 2000, EUR J BIOCHEM, V267, P3309, DOI 10.1046/j.1432-1327.2000.01361.x; Kelley RJ, 1995, MOL BIOCHEM PARASIT, V74, P167, DOI 10.1016/0166-6851(95)02493-X; Kelley RJ, 1999, MOL BIOCHEM PARASIT, V98, P17, DOI 10.1016/S0166-6851(98)00155-8; Loeb CRK, 2006, J BIOL CHEM, V281, P28326, DOI 10.1074/jbc.M604544200; Luscher A, 2007, CURR PHARM DESIGN, V13, P555, DOI 10.2174/138161207780162809; Mackey ZB, 2004, J BIOL CHEM, V279, P48426, DOI 10.1074/jbc.M402470200; Mathieu MA, 2002, MOL BIOCHEM PARASIT, V121, P99, DOI 10.1016/S0166-6851(02)00026-9; Mottram JC, 1997, J BIOL CHEM, V272, P14285, DOI 10.1074/jbc.272.22.14285; Mussmann R, 2004, J BIOL CHEM, V279, P40690, DOI 10.1074/jbc.M404697200; Mussmann R, 2003, MOL MICROBIOL, V47, P23, DOI 10.1046/j.1365-2958.2003.03245.x; Nkemngu NJ, 2003, INT J ANTIMICROB AG, V22, P155, DOI 10.1016/S0924-8579(03)00096-7; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Scory S, 1999, EXP PARASITOL, V91, P327, DOI 10.1006/expr.1998.4381; SCORY S, 2007, KINETOPLASTID BIOL D, V6, P1; Steverding Dietmar, 2000, Parasitology International, V48, P191, DOI 10.1016/S1383-5769(99)00018-5; Triggs VP, 2003, EUKARYOT CELL, V2, P76, DOI 10.1128/EC.2.1.76-83.2003; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; van Luenen HGAM, 2005, MOL MICROBIOL, V58, P151, DOI 10.1111/j.1365-2958.2005.04831.x	41	60	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28934	28943		10.1074/jbc.M805824200	http://dx.doi.org/10.1074/jbc.M805824200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18701454	Green Published, hybrid			2022-12-25	WOS:000260179900019
J	Pakhomova, S; Bartlett, SG; Augustus, A; Kuzuyama, T; Newcomer, ME				Pakhomova, Svetlana; Bartlett, Sue G.; Augustus, Alexandria; Kuzuyama, Tomohisa; Newcomer, Marcia E.			Crystal structure of fosfomycin resistance kinase FomA from Streptomyces wedmorensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; UMP KINASE; PSEUDOMONAS-AERUGINOSA; ARGININE-BIOSYNTHESIS; SECONDARY-STRUCTURE; ENZYME FAMILY; PROTEIN; PHOSPHONOMYCIN; IDENTIFICATION; STATE	The fosfomycin resistance protein FomA inactivates fosfomycin by phosphorylation of the phosphonate group of the antibiotic in the presence of ATP and Mg(II). We report the crystal structure of FomA from the fosfomycin biosynthetic gene cluster of Streptomyces wedmorensis in complex with diphosphate and in ternary complex with the nonhydrolyzable ATP analog adenosine 5'-(beta,gamma-imido)-triphosphate (AMPPNP), Mg(II), and fosfomycin, at 1.53 and 2.2 angstrom resolution, respectively. The polypeptide exhibits an open alpha beta alpha sandwich fold characteristic for the amino acid kinase family of enzymes. The diphosphate complex shows significant disorder in loops surrounding the active site. As a result, the nucleotide-binding site is wide open. Binding of the substrates is followed by the partial closure of the active site and ordering of the alpha 2-helix. Structural comparison with N-acetyl-L-glutamate kinase shows several similarities in the site of phosphoryl transfer: 1) preservation of architecture of the catalytical amino acids of N-acetyl-L-glutamate kinase(Lys(9), Lys(216), and Asp(150) in FomA); 2) good super-position of the phosphate acceptor groups of the substrates, and 3) good super-position of the diphosphate molecule with the beta-and gamma-phosphates of AMPPNP, suggesting that the reaction could proceed by an associative in-line mechanism. However, differences in conformations of the triphosphate moiety of AMPPNP molecules, the long distance (5.1 angstrom) between the phosphate acceptor and donor groups in FomA, and involvement of Lys(18) instead of Lys(9) in binding with the gamma-phosphate may indicate a different reaction mechanism. The present work identifies the active site residues of FomA responsible for substrate binding and specificity and proposes their roles in catalysis.	[Pakhomova, Svetlana; Bartlett, Sue G.; Augustus, Alexandria; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Kuzuyama, Tomohisa] Univ Tokyo, Biotechnol Res Ctr, Lab Cell Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Louisiana State University System; Louisiana State University; University of Tokyo	Pakhomova, S (corresponding author), Louisiana State Univ, Dept Biol Sci, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	sveta@lsu.edu		Kuzuyama, Tomohisa/0000-0002-7221-5858	National Institutes of Health [R03AI074770]; Louisiana Governor's Biotechnology Initiative; National Science Foundation [DBI-9871464]; National Institute for General Medical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI074770] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Governor's Biotechnology Initiative; National Science Foundation(National Science Foundation (NSF)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R03AI074770. This work was also supported in part by the Louisiana Governor's Biotechnology Initiative. The Gulf Coast Protein Crystallography Beamline was supported by National Science Foundation Grant DBI-9871464 with co-funding from the National Institute for General Medical Sciences. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked" advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernat BA, 1997, BIOCHEMISTRY-US, V36, P3050, DOI 10.1021/bi963172a; Briozzo P, 2005, J BIOL CHEM, V280, P25533, DOI 10.1074/jbc.M501849200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao M, 2001, J BACTERIOL, V183, P2380, DOI 10.1128/JB.183.7.2380-2383.2001; Cassone M, 2004, MICROB DRUG RESIST, V10, P43, DOI 10.1089/107662904323047790; CHRISTENSEN BG, 1969, SCIENCE, V166, P123, DOI 10.1126/science.166.3901.123; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Egeblad-Welin L, 2007, FEBS J, V274, P6403, DOI 10.1111/j.1742-4658.2007.06157.x; ETIENNE J, 1989, FEMS MICROBIOL LETT, V61, P133, DOI 10.1016/0378-1097(89)90184-5; Faehnle CR, 2006, ACTA CRYSTALLOGR F, V62, P962, DOI 10.1107/S1744309106038279; Galatti L, 2006, J ANTIMICROB CHEMOTH, V57, P551, DOI 10.1093/jac/dkl008; GARCIALOBO JM, 1982, J BACTERIOL, V151, P477; Gil-Ortiz F, 2003, J MOL BIOL, V331, P231, DOI 10.1016/S0022-2836(03)00716-2; Gobernado M, 2003, Rev Esp Quimioter, V16, P15; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HENDLIN D, 1969, SCIENCE, V166, P122, DOI 10.1126/science.166.3901.122; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Jensen KS, 2007, BIOCHEMISTRY-US, V46, P2745, DOI 10.1021/bi0618159; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KADNER RJ, 1973, J BACTERIOL, V113, P895, DOI 10.1128/JB.113.2.895-900.1973; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kobayashi S, 2000, ANTIMICROB AGENTS CH, V44, P647, DOI 10.1128/AAC.44.3.647-650.2000; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lobel B, 2003, INT J ANTIMICROB AG, V22, pS85, DOI 10.1016/S0924-8579(03)00237-1; Marco-Marin C, 2005, J MOL BIOL, V352, P438, DOI 10.1016/j.jmb.2005.07.045; Marco-Marin C, 2007, J MOL BIOL, V367, P1431, DOI 10.1016/j.jmb.2007.01.073; Marina A, 1999, PROTEIN SCI, V8, P934; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; Mas-Droux C, 2006, PLANT CELL, V18, P1681, DOI 10.1105/tpc.105.040451; MILLER R, 1994, J APPL CRYSTALLOGR, V27, P613, DOI 10.1107/S0021889894000191; Nakazawa Hiroaki, 2003, Journal of Infection and Chemotherapy, V9, P304, DOI 10.1007/s10156-003-0266-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ramon-Maiques S, 2006, J MOL BIOL, V356, P695, DOI 10.1016/j.jmb.2005.11.079; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Shimizu M, 2000, ANTIMICROB AGENTS CH, V44, P2007, DOI 10.1128/AAC.44.7.2007-2008.2000; SHOJI J, 1986, J ANTIBIOT, V39, P1011, DOI 10.7164/antibiotics.39.1011; Stein GE, 1998, ANN PHARMACOTHER, V32, P215, DOI 10.1345/aph.17227; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUAREZ JE, 1991, ANTIMICROB AGENTS CH, V35, P791, DOI 10.1128/AAC.35.5.791; TSURUOKA T, 1975, J ANTIBIOT, V28, P906, DOI 10.7164/antibiotics.28.906; VENKATESWARAN PS, 1972, J BACTERIOL, V110, P935, DOI 10.1128/JB.110.3.935-944.1972; Woodyer RD, 2006, CHEM BIOL, V13, P1171, DOI 10.1016/j.chembiol.2006.09.007	48	20	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28518	28526		10.1074/jbc.M803709200	http://dx.doi.org/10.1074/jbc.M803709200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701452	Green Published, hybrid			2022-12-25	WOS:000259969300055
J	Scherr, C; Simon, M; Spranger, J; Baumgartner, S				Scherr, Claudia; Simon, Meinhard; Spranger, Joerg; Baumgartner, Stephan			Test System Stability and Natural Variability of a Lemna Gibba L. Bioassay	PLOS ONE			English	Article								Background: In ecotoxicological and environmental studies Lemna spp. are used as test organisms due to their small size, rapid predominantly vegetative reproduction, easy handling and high sensitivity to various chemicals. However, there is not much information available concerning spatial and temporal stability of experimental set-ups used for Lemna bioassays, though this is essential for interpretation and reliability of results. We therefore investigated stability and natural variability of a Lemna gibba bioassay assessing area-related and frond number-related growth rates under controlled laboratory conditions over about one year. Methology/Principal Findings: Lemna gibba L. was grown in beakers with Steinberg medium for one week. Area-related and frond number-related growth rates (r((area)) and r((num))) were determined with a non-destructive image processing system. To assess inter-experimental stability, 35 independent experiments were performed with 10 beakers each in the course of one year. We observed changes in growth rates by a factor of two over time. These did not correlate well with temperature or relative humidity in the growth chamber. In order to assess intra-experimental stability, we analysed six systematic negative control experiments (nontoxicant tests) with 96 replicate beakers each. Evaluation showed that the chosen experimental set-up was stable and did not produce false positive results. The coefficient of variation was lower for r((area)) (2.99%) than for r((num)) (4.27%). Conclusions/Significance: It is hypothesised that the variations in growth rates over time under controlled conditions are partly due to endogenic periodicities in Lemna gibba. The relevance of these variations for toxicity investigations should be investigated more closely. Area-related growth rate seems to be more precise as non-destructive calculation parameter than number-related growth rate. Furthermore, we propose two new validity criteria for Lemna gibba bioassays: variability of average specific and section-by-section segmented growth rate, complementary to average specific growth rate as the only validity criterion existing in guidelines for duckweed bioassays.	[Scherr, Claudia; Spranger, Joerg] Res Inst Organ Agr, Frick, Switzerland; [Scherr, Claudia; Baumgartner, Stephan] Ins Hiscia, Soc Canc Res, Arlesheim, Switzerland; [Simon, Meinhard] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Oldenburg, Germany; [Baumgartner, Stephan] Univ Bern, Inst Complementary Med KIKOM, Bern, Switzerland	Carl von Ossietzky Universitat Oldenburg; University of Bern	Scherr, C (corresponding author), Res Inst Organ Agr, Frick, Switzerland.	scherr@vfk.ch			Research Institute of Organic Agriculture; Sampo Foundation, Dornach, Switzerland; Asta Blumfeld Foundation, Dornach, Switzerland	Research Institute of Organic Agriculture; Sampo Foundation, Dornach, Switzerland; Asta Blumfeld Foundation, Dornach, Switzerland	This work was financed by the official budget of the Research Institute of Organic Agriculture. Additional financial support was received from the Sampo Foundation, Dornach, Switzerland and the Asta Blumfeld Foundation, Dornach, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akhtar TA, 2005, ENVIRON TOXICOL CHEM, V24, P1705, DOI 10.1897/04-352R.1; [Anonymous], [No title captured]; [Anonymous], 2004, E141591 ASTM; BORNKAMM R, 1966, PLANTA, V69, P178, DOI 10.1007/BF00399787; Brain RA, 2004, ENVIRON TOXICOL CHEM, V23, P371, DOI 10.1897/02-576; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P1676, DOI 10.1897/04-362R.1; Cedergreen N, 2004, ECOTOX ENVIRON SAFE, V57, P153, DOI 10.1016/S0147-6513(02)00145-8; Fenske C, 2006, INT J HYG ENVIR HEAL, V209, P275, DOI 10.1016/j.ijheh.2005.12.004; Greenberg B. M., 1992, J AQUAT ECOSYSTEM HL, V1, P147, DOI [10.1007/BF00044046, DOI 10.1007/BF00044046]; Grimme L.H., 1998, VORHERSAGBARKEIT BEU; HILLMAN WS, 1961, BOT REV, V27, P221, DOI 10.1007/BF02860083; International Organization for Standardization, 2005, 20079 ISO; Jansen MAK, 2001, PLANT PHYSIOL, V126, P1012, DOI 10.1104/pp.126.3.1012; KANDELER R, 1985, HDB FLOWERING, P251; LANDOLT E, 1986, FAMILY LEMNACEAE MON, V1, P566; Landolt E., 1987, BIOSYSTEMATIC INVEST; *LEMNATEC GMBH, 2002, IM AN SOFT SYST; Mader JC, 2004, J PLANT PHYSIOL, V161, P653, DOI 10.1078/0176-1617-01079; Michel A, 2004, ENVIRON TOXICOL CHEM, V23, P1074, DOI 10.1897/03-256; Miwa K, 2006, PLANT CELL PHYSIOL, V47, P601, DOI 10.1093/pcp/pcj027; Mkandawire M, 2005, AQUAT ECOL, V39, P151, DOI 10.1007/s10452-004-5411-1; Mkandawire M, 2005, SCI TOTAL ENVIRON, V336, P81, DOI 10.1016/j.scitotenv.2004.06.002; Naumann B, 2007, J PLANT PHYSIOL, V164, P1656, DOI 10.1016/j.jplph.2006.10.011; OECD, 2006, 221 OECD; Organisation for Economic Cooperation and Development (OECD), 2006, 201 OECD; PIRSON A., 1953, FLORA, V140, P485; Richards SM, 2004, ENVIRON TOXICOL CHEM, V23, P1035, DOI 10.1897/02-616; Scherr C, 2007, J ALTERN COMPLEM MED, V13, P931, DOI 10.1089/acm.2007.0506; StatSoft Inc. Statistica, 2001, DAT AN SOFTW SYST VE; Szabo S, 1998, AQUAT BOT, V60, P189, DOI 10.1016/S0304-3770(97)00080-6; TILLBERG E, 1979, PHYSIOL PLANTARUM, V46, P5, DOI 10.1111/j.1399-3054.1979.tb03177.x; Tkalec M, 2005, BIOELECTROMAGNETICS, V26, P185, DOI 10.1002/bem.20104; WANG WC, 1990, ENVIRON RES, V52, P7, DOI 10.1016/S0013-9351(05)80147-1; WANG WC, 1987, ENVIRON TOXICOL CHEM, V6, P953, DOI 10.1897/1552-8618(1987)6[953:CIAART]2.0.CO;2	34	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3133	10.1371/journal.pone.0003133	http://dx.doi.org/10.1371/journal.pone.0003133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769541	gold, Green Published, Green Submitted			2022-12-25	WOS:000264419100003
J	Shao, HL; Zheng, WW; Liu, PC; Wang, Q; Wang, JX; Zhao, XF				Shao, Hong-Lian; Zheng, Wei-Wei; Liu, Peng-Cheng; Wang, Qian; Wang, Jin-Xing; Zhao, Xiao-Fan			Establishment of a New Cell Line from Lepidopteran Epidermis and Hormonal Regulation on the Genes	PLOS ONE			English	Article								When an insect molts, old cuticle on the outside of the integument is shed by apolysis and a new cuticle is formed under the old one. This process is completed by the epidermal cells which are controlled by 20-hydroxyecdysone (20E) and juvenile hormone. To understand the molecular mechanisms of integument remolding and hormonal regulation on the gene expression, an epidermal cell line from the 5th instar larval integument of Helicoverpa armigera was established and named HaEpi. The cell line has been cultured continuously for 82 passages beginning on June 30, 2005 until now. Cell doubling time was 64 h. The chromosomes were granular and the chromosome mode was from 70 to 76. Collagenase I was used to detach the cells from the flask bottom. Non-self pathogen AcMNPV induced the cells to apoptosis. The cell line was proved to be an epidermal cell line based on its unique gene expression pattern. It responded to 20E and the non-steroidal ecdysone agonist RH-2485. Its gene expression could be knocked down using RNA interference. Various genes in the cell line were investigated based on their response to 20E. This new cell line represents a platform for investigating the 20E signaling transduction pathway, the immune response mechanism in lepidopteran epidermis and interactions of the genes.	[Shao, Hong-Lian; Zheng, Wei-Wei; Liu, Peng-Cheng; Wang, Qian; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China	Shandong University	Shao, HL (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China.	xfzhao@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021	Liu, Pengcheng/0000-0003-1179-2296; Zhao, Xiao-Fan/0000-0003-1809-4730; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [30710103901, 30670265, 30330070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No: 30710103901,30670265, 30330070).	BROOKHART GL, 1990, INSECT BIOCHEM, V20, P467, DOI 10.1016/0020-1790(90)90028-S; Dong DJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-73; GRACE TDC, 1962, NATURE, V195, P788, DOI 10.1038/195788a0; GRANADOS RR, 1994, J INVERTEBR PATHOL, V64, P260, DOI 10.1016/S0022-2011(94)90400-6; HAYFLICK L, 1980, MECH AGEING DEV, V14, P59, DOI 10.1016/0047-6374(80)90106-2; HENRICH VC, 1994, DEV BIOL, V165, P38, DOI 10.1006/dbio.1994.1232; Hiruma K, 1997, GEN COMP ENDOCR, V107, P84, DOI 10.1006/gcen.1997.6901; Hiruma K, 2004, DEV BIOL, V272, P510, DOI 10.1016/j.ydbio.2004.04.028; Jindra M, 1996, DEV BIOL, V180, P258, DOI 10.1006/dbio.1996.0299; Jindra M, 1997, INSECT MOL BIOL, V6, P41, DOI 10.1046/j.1365-2583.1997.00153.x; KATO Y, 1987, DEVELOPMENT, V99, P137; Keshan B, 2006, DEV BIOL, V295, P623, DOI 10.1016/j.ydbio.2006.03.049; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lan Q, 1997, INSECT MOL BIOL, V6, P3, DOI 10.1046/j.1365-2583.1997.00151.x; Langelan RE, 2000, DEV BIOL, V227, P481, DOI 10.1006/dbio.2000.9895; LYNN DE, 1983, J INSECT PHYSIOL, V29, P591, DOI 10.1016/0022-1910(83)90026-4; LYNN DE, 1982, P NATL ACAD SCI-BIOL, V79, P2589, DOI 10.1073/pnas.79.8.2589; OBERLANDER H, 1984, SCIENCE, V226, P162, DOI 10.1126/science.226.4671.162; Oberlander H, 2000, J INSECT PHYSIOL, V46, P259, DOI 10.1016/S0022-1910(99)00178-X; Palli SR, 1996, VIROLOGY, V222, P201, DOI 10.1006/viro.1996.0411; Riddiford LM, 1999, AM ZOOL, V39, P736; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; RIDDIFORD LM, 1981, AM ZOOL, V21, P751; SAMUELS RI, 1993, ARCH INSECT BIOCHEM, V24, P33, DOI 10.1002/arch.940240104; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Siaussat D, 2007, CELL MOL LIFE SCI, V64, P365, DOI 10.1007/s00018-007-6452-0; Sudeep A. B., 2002, Indian Journal of Experimental Biology, V40, P69; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Terashima J, 2006, CELL DEATH DIFFER, V13, P454, DOI 10.1038/sj.cdd.4401745; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wei Z, 2007, DEV GROWTH DIFFER, V49, P611, DOI 10.1111/j.1440-169X.2007.00957.x; Zhang H, 2006, J INVERTEBR PATHOL, V91, P9, DOI 10.1016/j.jip.2005.10.004; Zhao XF, 2004, INSECT MOL BIOL, V13, P407, DOI 10.1111/j.0962-1075.2004.00499.x; Zhao XF, 2003, CROP PROT, V22, P959, DOI 10.1016/S0261-2194(03)00111-X; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0	35	62	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3127	10.1371/journal.pone.0003127	http://dx.doi.org/10.1371/journal.pone.0003127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769621	Green Published, gold, Green Submitted			2022-12-25	WOS:000264418300009
J	Oren, M; Escande, ML; Paz, G; Fishelson, Z; Rinkevich, B				Oren, Matan; Escande, Marie-line; Paz, Guy; Fishelson, Zvi; Rinkevich, Baruch			Urochordate Histoincompatible Interactions Activate Vertebrate-Like Coagulation System Components	PLOS ONE			English	Article							BLOOD-COAGULATION; BOTRYLLUS-SCHLOSSERI; CIONA-INTESTINALIS; ARTHROPODS; INHIBITION; ASCIDIANS; REJECTION; IMMUNITY; HEPARIN; PLASMA	The colonial ascidian Botryllus schlosseri expresses a unique allorecognition system. When two histoincompatible Botryllus colonies come into direct contact, they develop an inflammatory-like rejection response. A surprising high number of vertebrates' coagulation genes and coagulation-related domains were disclosed in a cDNA library of differentially expressed sequence tags (ESTs), prepared for this allorejection process. Serine proteases, especially from the trypsin family, were highly represented among Botryllus library ortholgues and its "molecular function'' gene ontology analysis. These, together with the built-up clot-like lesions in the interaction area, led us to further test whether a vertebrate-like clotting system participates in Botryllus innate immunity. Three morphologically distinct clot types (points of rejection; POR) were followed. We demonstrated the specific expression of nine coagulation orthologue transcripts in Botryllus rejection processes and effects of the anti-coagulant heparin on POR formation and heartbeats. In situ hybridization of fibrinogen and von Willebrand factor orthologues elucidated enhanced expression patterns specific to histoincompatible reactions as well as common expressions not augmented by innate immunity. Immunohistochemistry for fibrinogen revealed, in naive and immune challenged colonies alike, specific antibody binding to a small population of Botryllus compartment cells. Altogether, molecular, physiological and morphological outcomes suggest the involvement of vertebrates-like coagulation elements in urochordate immunity, not assigned with vasculature injury.	[Oren, Matan; Paz, Guy; Rinkevich, Baruch] Natl Inst Oceanog, Israel Oceanog & Limnol Res, IL-31080 Haifa, Israel; [Escande, Marie-line] Univ Pierre Marie Curie Paris 6, Lab Arago, Banyuls sur Mer, France; [Oren, Matan; Fishelson, Zvi] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, Tel Aviv, Israel	Israel Oceanographic & Limnological Research Institute; UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University; Sackler Faculty of Medicine	Oren, M (corresponding author), Natl Inst Oceanog, Israel Oceanog & Limnol Res, IL-31080 Haifa, Israel.	matan@ocean.org.il	oren, matan/AAX-8770-2021	oren, matan/0000-0002-6162-324X	Marine Genomics Europe Network of Excellence; United States-Israel Bi-National Science Foundation [2003-010]; Israel Academy of Science [550-06]; MACPAD [HPMT-CT-2000-00211]	Marine Genomics Europe Network of Excellence; United States-Israel Bi-National Science Foundation(US-Israel Binational Science Foundation); Israel Academy of Science; MACPAD	This study was supported by grants from the Marine Genomics Europe Network of Excellence (EDD Node), the United States-Israel Bi-National Science Foundation (2003-010) and the Israel Academy of Science (550-06). Matan Oren was a recipient of a European fellowship "Marie Curie" training sites MACPAD contract n HPMT-CT-2000-00211 under the guidance of Anne-Marie Genevier.	ANUMANTHAIAH R, 2002, BLOOD CELL MOL DIS, V29, P57; Ballarin L, 1998, DEV COMP IMMUNOL, V22, P479, DOI 10.1016/S0145-305X(98)00035-4; BARRINGTON EJW, 1957, J MAR BIOL ASSOC UK, V36, P1, DOI 10.1017/S0025315400017021; BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581; Cardilo-Reis L, 2006, BRAZ J MED BIOL RES, V39, P1409, DOI 10.1590/S0100-879X2006001100004; Cavalcante MCM, 2000, J BIOL CHEM, V275, P36189, DOI 10.1074/jbc.M005830200; Cima F, 2003, CELL TISSUE RES, V312, P369, DOI 10.1007/s00441-003-0738-9; Davidson CJ, 2003, J THROMB HAEMOST, V1, P1487, DOI 10.1046/j.1538-7836.2003.00334.x; Doolittle RF, 2008, J MOL EVOL, V66, P185, DOI 10.1007/s00239-008-9074-8; Esmon CT, 2004, TRENDS IMMUNOL, V25, P536, DOI 10.1016/j.it.2004.08.003; GOODBODY I, 1974, ADV MAR BIOL, V12, P1; Grzesiak A, 2000, J BIOL CHEM, V275, P33346, DOI 10.1074/jbc.M006085200; Hirose E, 1997, BIOL BULL, V192, P53, DOI 10.2307/1542575; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Kenjo A, 2001, J BIOL CHEM, V276, P19959, DOI 10.1074/jbc.M011723200; Kulman JD, 2006, P NATL ACAD SCI USA, V103, P15794, DOI 10.1073/pnas.0607543103; Lapidot Z, 2003, MAR BIOTECHNOL, V5, P388, DOI 10.1007/s10126-002-0087-9; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Mellanby J, 1938, PROC R SOC SER B-BIO, V125, P204, DOI 10.1098/rspb.1938.0021; Nagai T, 2000, J BIOL CHEM, V275, P29264, DOI 10.1074/jbc.M002556200; Oren M, 2007, DEV COMP IMMUNOL, V31, P889, DOI 10.1016/j.dci.2006.12.009; Pavao MSG, 1998, J BIOL CHEM, V273, P27848, DOI 10.1074/jbc.273.43.27848; Rinkevich B, 1998, AQUAT LIVING RESOUR, V11, P163, DOI 10.1016/S0990-7440(98)80113-7; RINKEVICH B, 1991, INT IMMUNOL, V3, P1265, DOI 10.1093/intimm/3.12.1265; RINKEVICH B, 1992, IMMUNOLOGY PATHOLOGY, V4, P17; Rinkevich Baruch, 1992, Animal Biology, V1, P17; Sasaki A, 2003, ZOOL SCI, V20, P1025, DOI 10.2108/zsj.20.1025; SCOFIELD VL, 1983, BIOL BULL, V165, P733, DOI 10.2307/1541475; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Shishikura F, 1997, COMP BIOCHEM PHYS B, V118, P131, DOI 10.1016/S0305-0491(97)00217-4; Shrivastava S, 2007, AM J TRANSPLANT, V7, P499, DOI 10.1111/j.1600-6143.2006.01653.x; TAKAHASHI H, 1994, BIOL BULL, V186, P247, DOI 10.2307/1542270; TANAKA K, 1973, CELL IMMUNOL, V7, P427, DOI 10.1016/0008-8749(73)90207-4; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Tuszynski G P, 1988, Prog Clin Biol Res, V283, P211; Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x; WRITE RK, 1981, INVERTEBRATE BLOOD C, V2, P565	40	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3123	10.1371/journal.pone.0003123	http://dx.doi.org/10.1371/journal.pone.0003123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769590	Green Published, Green Submitted, gold			2022-12-25	WOS:000264416600011
J	Kool, M; Koster, J; Bunt, J; Hasselt, NE; Lakeman, A; van Sluis, P; Troost, D; Schouten-van Meeteren, N; Caron, HN; Cloos, J; Mrsic, A; Ylstra, B; Grajkowska, W; Hartmann, W; Pietsch, T; Ellison, D; Clifford, SC; Versteeg, R				Kool, Marcel; Koster, Jan; Bunt, Jens; Hasselt, Nancy E.; Lakeman, Arjan; van Sluis, Peter; Troost, Dirk; Schouten-van Meeteren, Netteke; Caron, Huib N.; Cloos, Jacqueline; Mrsic, Alan; Ylstra, Bauke; Grajkowska, Wieslawa; Hartmann, Wolfgang; Pietsch, Torsten; Ellison, David; Clifford, Steven C.; Versteeg, Rogier			Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features	PLOS ONE			English	Article							PRIMITIVE NEUROECTODERMAL TUMORS; S-ANTIGEN IMMUNOREACTIVITY; CHILDHOOD MEDULLOBLASTOMA; BETA-CATENIN; ARRAY CGH; IMMUNOCYTOCHEMICAL DEMONSTRATION; TRILATERAL RETINOBLASTOMA; PHOTORECEPTOR MARKERS; WNT/WINGLESS PATHWAY; RAS/MAPK PATHWAY	Background: Medulloblastoma is the most common malignant brain tumor in children. Despite recent improvements in cure rates, prediction of disease outcome remains a major challenge and survivors suffer from serious therapy-related side-effects. Recent data showed that patients with WNT-activated tumors have a favorable prognosis, suggesting that these patients could be treated less intensively, thereby reducing the side-effects. This illustrates the potential benefits of a robust classification of medulloblastoma patients and a detailed knowledge of associated biological mechanisms. Methods and Findings: To get a better insight into the molecular biology of medulloblastoma we established mRNA expression profiles of 62 medulloblastomas and analyzed 52 of them also by comparative genomic hybridization (CGH) arrays. Five molecular subtypes were identified, characterized by WNT signaling (A; 9 cases), SHH signaling (B; 15 cases), expression of neuronal differentiation genes (C and D; 16 and 11 cases, respectively) or photoreceptor genes (D and E; both 11 cases). Mutations in beta-catenin were identified in all 9 type A tumors, but not in any other tumor. PTCH1 mutations were exclusively identified in type B tumors. CGH analysis identified several fully or partly subtype-specific chromosomal aberrations. Monosomy of chromosome 6 occurred only in type A tumors, loss of 9q mostly occurred in type B tumors, whereas chromosome 17 aberrations, most common in medulloblastoma, were strongly associated with type C or D tumors. Loss of the inactivated X-chromosome was highly specific for female cases of type C, D and E tumors. Gene expression levels faithfully reflected the chromosomal copy number changes. Clinicopathological features significantly different between the 5 subtypes included metastatic disease and age at diagnosis and histology. Metastatic disease at diagnosis was significantly associated with subtypes C and D and most strongly with subtype E. Patients below 3 yrs of age had type B, D, or E tumors. Type B included most desmoplastic cases. We validated and confirmed the molecular subtypes and their associated clinicopathological features with expression data from a second independent series of 46 medulloblastomas. Conclusions: The new medulloblastoma classification presented in this study will greatly enhance the understanding of this heterogeneous disease. It will enable a better selection and evaluation of patients in clinical trials, and it will support the development of new molecular targeted therapies. Ultimately, our results may lead to more individualized therapies with improved cure rates and a better quality of life.	[Kool, Marcel; Koster, Jan; Bunt, Jens; Hasselt, Nancy E.; Lakeman, Arjan; van Sluis, Peter; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands; [Troost, Dirk] Univ Amsterdam, Acad Med Ctr, Dept Neuropathol, NL-1012 WX Amsterdam, Netherlands; [Schouten-van Meeteren, Netteke; Caron, Huib N.] Univ Amsterdam, Acad Med Ctr, Dept Pediat Oncol, NL-1012 WX Amsterdam, Netherlands; [Cloos, Jacqueline] VU Unive Med Ctr, Dept Pediat Oncol Hematol, Amsterdam, Netherlands; [Mrsic, Alan; Ylstra, Bauke] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Grajkowska, Wieslawa] Childrens Memorial Hlth Inst, Dept Pathol, Warsaw, Poland; [Hartmann, Wolfgang; Pietsch, Torsten] Univ Bonn, Dept Neuropathol, D-5300 Bonn, Germany; [Ellison, David] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA; [Clifford, Steven C.] Univ Newcastle, N Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Children's Memorial Health Institute; University of Bonn; St Jude Children's Research Hospital; Newcastle University - UK	Kool, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Human Genet, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.kool@amc.uva.nl	Ylstra, Bauke/D-2906-2012; Bunt, Jens/C-4775-2014; Kool, Marcel/H-2541-2013; Hartmann, Wolfgang/G-1893-2017; Versteeg, Rogier/AAQ-1765-2020; Koster, Jan/C-5934-2008	Ylstra, Bauke/0000-0001-9479-3010; Bunt, Jens/0000-0003-0397-2019; Hartmann, Wolfgang/0000-0002-7609-5021; Koster, Jan/0000-0002-0890-7585; Cloos, Jacqueline/0000-0001-9150-8026; Versteeg, Rogier/0000-0001-7172-0388; Grajkowska, Wieslawa/0000-0001-8318-5781; Clifford, Steve/0000-0003-4893-2184	Dutch Cancer Society [UVA-2001-2558]; Stichting Kindergeneeskundig Kankeronderzoek (SKK); KIKA foundation	Dutch Cancer Society(KWF Kankerbestrijding); Stichting Kindergeneeskundig Kankeronderzoek (SKK); KIKA foundation	Research was supported by grants from the Dutch Cancer Society (KWF grant no UVA-2001-2558), the Stichting Kindergeneeskundig Kankeronderzoek (SKK) and the KIKA foundation.	Aldosari N, 2002, ARCH PATHOL LAB MED, V126, P540; BADIALI M, 1991, TUMORI, V77, P118, DOI 10.1177/030089169107700205; Bayani J, 2000, J NEUROSURG, V93, P437, DOI 10.3171/jns.2000.93.3.0437; BONNIN JM, 1988, ACTA NEUROPATHOL, V76, P204, DOI 10.1007/BF00688104; Boon K, 2005, CANCER RES, V65, P703; Boon K, 2003, ONCOGENE, V22, P7687, DOI 10.1038/sj.onc.1207043; Clifford SC, 2006, CELL CYCLE, V5, P2666, DOI 10.4161/cc.5.22.3446; CZERWIONKA M, 1989, ACTA NEUROPATHOL, V78, P629, DOI 10.1007/BF00691290; Dahmen RP, 2001, CANCER RES, V61, P7039; de Haas T, 2006, J NEUROPATH EXP NEUR, V65, P176, DOI 10.1097/01.jnen.0000199576.70923.8a; Di CH, 2005, CANCER RES, V65, P919; DONOSO LA, 1985, INVEST OPHTH VIS SCI, V26, P568; DONOSO LA, 1986, ARCH OPHTHALMOL-CHIC, V104, P111, DOI 10.1001/archopht.1986.01050130125035; Eberhart CG, 2002, CANCER-AM CANCER SOC, V94, P552, DOI 10.1002/cncr.10189; Eberhart CG, 2000, J NEUROPATH EXP NEUR, V59, P333, DOI 10.1093/jnen/59.4.333; Elias WJ, 2001, J NEUROSURG, V95, P871, DOI 10.3171/jns.2001.95.5.0871; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Giangaspero F, 1999, J NEUROSURG, V91, P971, DOI 10.3171/jns.1999.91.6.0971; Giangaspero F, 2007, WHO CLASSIFICATION T, P132; Gilbertson R, 2001, BRIT J CANCER, V85, P705, DOI 10.1054/bjoc.2001.1987; Gilbertson RJ, 2006, EUR J CANCER, V42, P646, DOI 10.1016/j.ejca.2005.11.023; Gilbertson RJ, 2003, NAT GENET, V35, P197, DOI 10.1038/ng1103-197; GILBERTSON RJ, 1995, BRIT J CANCER, V71, P473, DOI 10.1038/bjc.1995.96; Grotzer MA, 2000, KLIN PADIATR, V212, P196, DOI 10.1055/s-2000-10044; Grotzer MA, 2001, CLIN CANCER RES, V7, P2425; Herms J, 2000, INT J CANCER, V89, P395; Huang HT, 2000, AM J PATHOL, V156, P433, DOI 10.1016/S0002-9440(10)64747-5; Hui ABY, 2005, CLIN CANCER RES, V11, P4707, DOI 10.1158/1078-0432.CCR-05-0128; IOLASCON A, 1991, MED PEDIATR ONCOL, V19, P240, DOI 10.1002/mpo.2950190406; JAFFEY PB, 1995, J NEUROPATH EXP NEUR, V54, P664, DOI 10.1097/00005072-199509000-00008; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Koch A, 2001, INT J CANCER, V93, P445, DOI 10.1002/ijc.1342; KORF H, 1987, CANCER, V60, P1763, DOI 10.1002/1097-0142(19871015)60:8<1763::AID-CNCR2820600815>3.0.CO;2-3; KORF HW, 1990, J NEUROPATH EXP NEUR, V49, P424, DOI 10.1097/00005072-199007000-00006; KORF HW, 1992, ACTA NEUROPATHOL, V83, P482, DOI 10.1007/BF00310024; KORF HW, 1986, ACTA NEUROPATHOL, V69, P165, DOI 10.1007/BF00687054; KRAMM CM, 1991, ACTA NEUROPATHOL, V81, P296, DOI 10.1007/BF00305871; Lamont JM, 2004, CLIN CANCER RES, V10, P5482, DOI 10.1158/1078-0432.CCR-03-0721; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Marcus DM, 1998, SURV OPHTHALMOL, V43, P59, DOI 10.1016/S0039-6257(98)00019-8; Marino S, 2000, GENE DEV, V14, P994; McCabe MG, 2006, J NEUROPATH EXP NEUR, V65, P549, DOI 10.1097/00005072-200606000-00003; McManamy CS, 2007, BRAIN PATHOL, V17, P151, DOI 10.1111/j.1750-3639.2007.00058.x; Michiels EMC, 1999, PHYSIOL GENOMICS, V1, P83, DOI 10.1152/physiolgenomics.1999.1.2.83; Michiels EMC, 2002, J PEDIAT HEMATOL ONC, V24, P205, DOI 10.1097/00043426-200203000-00009; Olson MV, 2007, CANCER RES, V67, P4005, DOI 10.1158/0008-5472.CAN-06-2973; Pan E, 2005, CLIN CANCER RES, V11, P4733; PERENTES E, 1986, ACTA NEUROPATHOL, V71, P224, DOI 10.1007/BF00688043; Pietsch T, 2004, J NEURO-ONCOL, V70, P203, DOI 10.1007/s11060-004-2750-7; Pietsch T, 1997, CANCER RES, V57, P2085; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Raffel C, 1997, CANCER RES, V57, P842; Rossi MR, 2006, GENE CHROMOSOME CANC, V45, P290, DOI 10.1002/gcc.20292; Rutkowski S, 2005, NEW ENGL J MED, V352, P978, DOI 10.1056/NEJMoa042176; Rutkowski S, 2007, CLIN CANCER RES, V13, P2651, DOI 10.1158/1078-0432.CCR-06-1779; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; THEURING F, 1990, ONCOGENE, V5, P225; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; van den IJssel P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni191; Wolter M, 1997, CANCER RES, V57, P2581; Woo S., 2002, PRINCIPLES PRACTICE; Yokota N, 2002, INT J CANCER, V101, P198, DOI 10.1002/ijc.10559; Yuki D, 2004, ONCOL REP, V12, P275; Zurawel RH, 1998, CANCER RES, V58, P896	68	516	536	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3088	10.1371/journal.pone.0003088	http://dx.doi.org/10.1371/journal.pone.0003088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769486	Green Submitted, Green Published, gold			2022-12-25	WOS:000264796600007
J	Wang, PHM; Campanholle, G; Cenedeze, MA; Feitoza, CQ; Goncalves, GM; Landgraf, RG; Jancar, S; Pesquero, JB; Pacheco-Silva, A; Camara, NOS				Wang, Pamella H. M.; Campanholle, Gabriela; Cenedeze, Marcos A.; Feitoza, Carla Q.; Goncalves, Giselle M.; Landgraf, Richardt G.; Jancar, Sonia; Pesquero, Joao B.; Pacheco-Silva, Alvaro; Camara, Niels O. S.			Brabykinin B1 Receptor Antagonism Is Beneficial in Renal Ischemia-Reperfusion Injury	PLOS ONE			English	Article								Previously we have demonstrated that bradykinin B1 receptor deficient mice (B1KO) were protected against renal ischemia and reperfusion injury (IRI). Here, we aimed to analyze the effect of B1 antagonism on renal IRI and to study whether B1R knockout or antagonism could modulate the renal expression of pro and anti-inflammatory molecules. To this end, mice were subjected to 45 minutes ischemia and reperfused at 4, 24, 48 and 120 hours. Wild-type mice were treated intra-peritoneally with antagonists of either B1 (R-954, 200 mg/kg) or B2 receptor (HOE140, 200 mg/kg) 30 minutes prior to ischemia. Blood samples were collected to ascertain serum creatinine level, and kidneys were harvested for gene transcript analyses by real-time PCR. Herein, B1R antagonism ( R-954) was able to decrease serum creatinine levels, whereas B2R antagonism had no effect. The protection seen under B1R deletion or antagonism was associated with an increased expression of GATA-3, IL-4 and IL-10 and a decreased T-bet and IL-1b transcription. Moreover, treatment with R-954 resulted in lower MCP-1, and higher HO-1 expression. Our results demonstrated that bradykinin B1R antagonism is beneficial in renal IRI.	[Wang, Pamella H. M.; Cenedeze, Marcos A.; Feitoza, Carla Q.; Goncalves, Giselle M.; Pacheco-Silva, Alvaro; Camara, Niels O. S.] Univ Fed Sao Paulo, Div Nephrol, Lab Imunol Clin & Expt, Sao Paulo, Brazil; [Campanholle, Gabriela; Camara, Niels O. S.] Univ Sao Paulo, Dept Immunol, Lab Imunobiol Transplant, BR-05508 Sao Paulo, Brazil; [Landgraf, Richardt G.; Jancar, Sonia] Univ Sao Paulo, Dept Immunol, Lab Imunofarmacol, BR-05508 Sao Paulo, Brazil; [Pesquero, Joao B.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Wang, PHM (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Lab Imunol Clin & Expt, Sao Paulo, Brazil.	niels@icb.usp.br	Pesquero, Joao/C-1470-2012; Camara, Niels OS/G-8336-2011; Landgraf, Richardt/F-7146-2012; camara, niels olsen saraiva/AAX-3269-2020; Jancar, Sonia/C-5153-2012; Complexos, INCT Fluidos/H-9172-2013; Pacheco-Silva, Alvaro/K-3583-2013	Pesquero, Joao/0000-0002-4507-632X; Camara, Niels OS/0000-0001-5436-1248; Landgraf, Richardt/0000-0001-7774-7880; camara, niels olsen saraiva/0000-0001-5436-1248; Jancar, Sonia/0000-0001-7983-3459; 	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) [04/08311-6, 05/50085-6, 06/03982-5, 07/07139-3]; CNPq [04/08311-6, 05/50085-6, 06/03982-5, 07/07139-3]	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) and CNPq. Grant numbers: 04/08311-6, 05/50085-6, 06/03982-5 and 07/07139-3	AHLUWALIA A, 1994, EUR J PHARMACOL, V264, P407, DOI 10.1016/0014-2999(94)00503-6; Araujo RC, 2001, BIOL CHEM, V382, P91, DOI 10.1515/BC.2001.014; Chiang WC, 2006, FREE RADICAL BIO MED, V41, P1304, DOI 10.1016/j.freeradbiomed.2006.07.011; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; Duka I, 2001, CIRC RES, V88, P275, DOI 10.1161/01.RES.88.3.275; Duka I, 2003, HYPERTENSION, V42, P1021, DOI 10.1161/01.HYP.0000097550.98865.35; Emanueli C, 2002, CIRCULATION, V105, P360, DOI 10.1161/hc0302.102142; Feitoza CQ, 2005, INT IMMUNOPHARMACOL, V5, P79, DOI 10.1016/j.intimp.2004.09.024; Kakoki M, 2007, P NATL ACAD SCI USA, V104, P7576, DOI 10.1073/pnas.0701617104; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Koyama S, 2000, AM J RESP CELL MOL, V22, P75, DOI 10.1165/ajrcmb.22.1.3752; Landgraf RG, 2004, INFLAMM RES, V53, P78, DOI 10.1007/s00011-003-1226-0; Landgraf RG, 2003, EUR J PHARMACOL, V460, P75, DOI 10.1016/S0014-2999(02)02880-7; Liesmaa I, 2005, AM J PHYSIOL-HEART C, V288, pH2317, DOI 10.1152/ajpheart.00815.2004; Liu MC, 2006, J AM SOC NEPHROL, V17, P765, DOI 10.1681/ASN.2005010102; Marceau F, 1998, CLIN REV ALLERG IMMU, V16, P385, DOI 10.1007/BF02737658; Marceau F, 1998, PHARMACOL REV, V50, P357; Marques VP, 2006, NEPHRON EXP NEPHROL, V104, pE48, DOI 10.1159/000093676; McLean PG, 1998, NEUROGASTROENT MOTIL, V10, P499; McLean PG, 2000, J EXP MED, V192, P367, DOI 10.1084/jem.192.3.367; Ni AG, 2003, J BIOL CHEM, V278, P219, DOI 10.1074/jbc.M209490200; PERRETTI M, 1993, AGENTS ACTIONS, V38, pC64, DOI 10.1007/BF01991139; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Pinheiro HS, 2007, BRAZ J MED BIOL RES, V40, P557, DOI 10.1590/S0100-879X2007000400015; Rabb H, 1997, KIDNEY INT, V51, P1463, DOI 10.1038/ki.1997.200; Rabb H, 2000, AM J PHYSIOL-RENAL, V279, pF525, DOI 10.1152/ajprenal.2000.279.3.F525; REGOLI D, 1980, PHARMACOL REV, V32, P1; Sacerdoti D, 2005, CELL MOL BIOL, V51, P363, DOI 10.1170/T639; Sato E, 1996, J IMMUNOL, V157, P3122; Schanstra JP, 1998, J CLIN INVEST, V101, P2080, DOI 10.1172/JCI1359; Shen XD, 2003, HEPATOLOGY, V37, P296, DOI 10.1053/jhep.2003.50066; Souza DG, 2004, J IMMUNOL, V172, P2542, DOI 10.4049/jimmunol.172.4.2542; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; TIFFANY CW, 1989, FEBS LETT, V247, P189, DOI 10.1016/0014-5793(89)81331-6; Wang PHM, 2006, INT IMMUNOPHARMACOL, V6, P1960, DOI 10.1016/j.intimp.2006.07.031; Xu J, 2005, HYPERTENSION, V45, P747, DOI 10.1161/01.HYP.0000153322.04859.81; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yokota N, 2003, AM J PHYSIOL-RENAL, V285, pF319, DOI 10.1152/ajprenal.00432.2002; Yokota N, 2002, TRANSPLANTATION, V74, P759, DOI 10.1097/00007890-200209270-00005; Ysebaert DK, 2004, KIDNEY INT, V66, P491, DOI 10.1111/j.1523-1755.2004.761_4.x	40	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3050	10.1371/journal.pone.0003050	http://dx.doi.org/10.1371/journal.pone.0003050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LJ	18725957	Green Published, gold, Green Submitted			2022-12-25	WOS:000264429000003
J	Yamanaka, N; Yamamoto, S; Zitnan, D; Watanabe, K; Kawada, T; Satake, H; Kaneko, Y; Hiruma, K; Tanaka, Y; Shinoda, T; Kataoka, H				Yamanaka, Naoki; Yamamoto, Sachie; Zitnan, Dusan; Watanabe, Ken; Kawada, Tsuyoshi; Satake, Honoo; Kaneko, Yu; Hiruma, Kiyoshi; Tanaka, Yoshiaki; Shinoda, Tetsuro; Kataoka, Hiroshi			Neuropeptide Receptor Transcriptome Reveals Unidentified Neuroendocrine Pathways	PLOS ONE			English	Article								Neuropeptides are an important class of molecules involved in diverse aspects of metazoan development and homeostasis. Insects are ideal model systems to investigate neuropeptide functions, and the major focus of insect neuropeptide research in the last decade has been on the identification of their receptors. Despite these vigorous efforts, receptors for some key neuropeptides in insect development such as prothoracicotropic hormone, eclosion hormone and allatotropin ( AT), remain undefined. In this paper, we report the comprehensive cloning of neuropeptide G protein-coupled receptors from the silkworm, Bombyx mori, and systematic analyses of their expression. Based on the expression patterns of orphan receptors, we identified the long-sought receptor for AT, which is thought to stimulate juvenile hormone biosynthesis in the corpora allata ( CA). Surprisingly, however, the AT receptor was not highly expressed in the CA, but instead was predominantly transcribed in the corpora cardiaca ( CC), an organ adjacent to the CA. Indeed, by using a reverse-physiological approach, we purified and characterized novel allatoregulatory peptides produced in AT receptor-expressing CC cells, which may indirectly mediate AT activity on the CA. All of the above findings confirm the effectiveness of a systematic analysis of the receptor transcriptome, not only in characterizing orphan receptors, but also in identifying novel players and hidden mechanisms in important biological processes. This work illustrates how using a combinatorial approach employing bioinformatic, molecular, biochemical and physiological methods can help solve recalcitrant problems in neuropeptide research.	[Yamanaka, Naoki; Yamamoto, Sachie; Watanabe, Ken; Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan; [Zitnan, Dusan] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Kawada, Tsuyoshi; Satake, Honoo] Suntory Inst Bioorgan Res, Osaka, Japan; [Kaneko, Yu; Hiruma, Kiyoshi] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Tanaka, Yoshiaki; Shinoda, Tetsuro] Natl Inst Agrobiol Sci, Ibaraki, Osaka, Japan	University of Tokyo; Slovak Academy of Sciences; Suntory Holdings Ltd; Hirosaki University; National Institute of Agrobiological Sciences - Japan	Yamanaka, N (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Howard Hughes Med Inst, Minneapolis, MN 55455 USA.	shinoda@affrc.go.jp; kataoka@k.u-tokyo.ac.jp	Kaneko, Yu/F-7460-2013; Yamanaka, Naoki/F-1358-2010	Yamanaka, Naoki/0000-0002-6244-2686	Japan Society for the Promotion of Science [Research Fellow]; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Research for the Future Program of Japan Society for the Promotion of Science (JSPS); National Institute of Health, USA [GM 67310]; Agentura na podporu vyskumu a vyvoja [APVV-51-039105]; Vedecka grantova agentura [VEGA 2-6090-26]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067310] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Research for the Future Program of Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agentura na podporu vyskumu a vyvoja; Vedecka grantova agentura; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N.Y. was a Research Fellow of the Japan Society for the Promotion of Science. This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), grants from Research for the Future Program of Japan Society for the Promotion of Science (JSPS), the National Institute of Health, USA (GM 67310), and Slovak grant agencies, Agentura na podporu vyskumu a vyvoja (APVV-51-039105) and Vedecka grantova agentura (VEGA 2-6090-26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUDSLEY N, 1995, COMP BIOCHEM PHYS A, V110, P87, DOI 10.1016/0300-9629(94)00132-D; BAKER FC, 1987, INSECT BIOCHEM, V17, P989, DOI 10.1016/0020-1790(87)90108-9; Birgul N, 1999, EMBO J, V18, P5892, DOI 10.1093/emboj/18.21.5892; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Cazzamali G, 2003, BIOCHEM BIOPH RES CO, V303, P146, DOI 10.1016/S0006-291X(03)00302-4; Cazzamali G, 2002, BIOCHEM BIOPH RES CO, V298, P31, DOI 10.1016/S0006-291X(02)02398-7; Cazzamali G, 2002, P NATL ACAD SCI USA, V99, P12073, DOI 10.1073/pnas.192442799; Cazzamali G, 2005, BIOCHEM BIOPH RES CO, V335, P14, DOI 10.1016/j.bbrc.2005.07.038; De Loof A, 2001, ARCH INSECT BIOCHEM, V47, P129, DOI 10.1002/arch.1044; Egerod K, 2003, P NATL ACAD SCI USA, V100, P9808, DOI 10.1073/pnas.1632197100; Egerod K, 2003, BIOCHEM BIOPH RES CO, V306, P437, DOI 10.1016/S0006-291X(03)00997-5; Elekonich MM, 2003, PEPTIDES, V24, P1623, DOI 10.1016/j.peptides.2003.08.011; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Ha SD, 2000, MOL CELLS, V10, P13, DOI 10.1007/s10059-000-0013-9; Hauser Frank, 2006, Briefings in Functional Genomics & Proteomics, V4, P321, DOI 10.1093/bfgp/eli003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Homma T, 2006, BIOCHEM BIOPH RES CO, V344, P386, DOI 10.1016/j.bbrc.2006.03.085; Hull JJ, 2004, J BIOL CHEM, V279, P51500, DOI 10.1074/jbc.M408142200; Huybrechts J, 2004, BIOCHEM BIOPH RES CO, V317, P909, DOI 10.1016/j.bbrc.2004.03.136; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Iversen A, 2002, BIOCHEM BIOPH RES CO, V299, P924, DOI 10.1016/S0006-291X(02)02798-5; Iversen A, 2002, BIOCHEM BIOPH RES CO, V299, P628, DOI 10.1016/S0006-291X(02)02709-2; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Johnson EC, 2004, J EXP BIOL, V207, P743, DOI 10.1242/jeb.00818; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Johnson EC, 2003, P NATL ACAD SCI USA, V100, P6198, DOI 10.1073/pnas.1030108100; Jorgensen LM, 2006, BIOCHEM BIOPH RES CO, V340, P696, DOI 10.1016/j.bbrc.2005.12.062; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; Kim YJ, 2006, CURR BIOL, V16, P1395, DOI 10.1016/j.cub.2006.06.027; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; KRAMER SJ, 1991, P NATL ACAD SCI USA, V88, P9458, DOI 10.1073/pnas.88.21.9458; Kreienkamp HJ, 2002, J BIOL CHEM, V277, P39937, DOI 10.1074/jbc.M206931200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kubiak TM, 2002, BIOCHEM BIOPH RES CO, V291, P313, DOI 10.1006/bbrc.2002.6459; Larsen MJ, 2001, BIOCHEM BIOPH RES CO, V286, P895, DOI 10.1006/bbrc.2001.5476; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; LI XJ, 1992, J BIOL CHEM, V267, P9; LI XJ, 1991, EMBO J, V10, P3221, DOI 10.1002/j.1460-2075.1991.tb04885.x; Liu F, 2006, MOL CELL PROTEOMICS, V5, P510, DOI 10.1074/mcp.M400114-MCP200; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Meeusen T, 2002, P NATL ACAD SCI USA, V99, P15363, DOI 10.1073/pnas.252339599; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Metpally RPR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-106; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; MONNIER D, 1992, J BIOL CHEM, V267, P1298; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Oda Y, 2000, ARCH INSECT BIOCHEM, V45, P156, DOI 10.1002/1520-6327(200012)45:4&lt;156::AID-ARCH3&gt;3.0.CO;2-E; Park Y, 2003, J BIOL CHEM, V278, P17710, DOI 10.1074/jbc.M301119200; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; PLANTEVIN G, 1984, GEN COMP ENDOCR, V56, P218, DOI 10.1016/0016-6480(84)90034-0; Radford JC, 2002, J BIOL CHEM, V277, P38810, DOI 10.1074/jbc.M203694200; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Rosenkilde C, 2003, BIOCHEM BIOPH RES CO, V309, P485, DOI 10.1016/j.bbrc.2003.08.022; SAKURAI S, 1997, J INSECT PHYSL, V43, P875; Secher T, 2001, J BIOL CHEM, V276, P47052, DOI 10.1074/jbc.M106675200; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Staubli F, 2002, P NATL ACAD SCI USA, V99, P3446, DOI 10.1073/pnas.052556499; Stay B, 2002, PEPTIDES, V23, P1981, DOI 10.1016/S0196-9781(02)00185-7; Truman JW, 2007, INSECT BIOCHEM MOLEC, V37, P761, DOI 10.1016/j.ibmb.2007.05.011; Truman JW, 2006, P NATL ACAD SCI USA, V103, P8909, DOI 10.1073/pnas.0603252103; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yamanaka N, 2005, J BIOL CHEM, V280, P14684, DOI 10.1074/jbc.M500308200; Yamanaka N, 2006, P NATL ACAD SCI USA, V103, P8622, DOI 10.1073/pnas.0511196103; Zitnan D, 2007, GEN COMP ENDOCR, V153, P88, DOI 10.1016/j.ygcen.2007.04.002	78	151	158	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3048	10.1371/journal.pone.0003048	http://dx.doi.org/10.1371/journal.pone.0003048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LJ	18725956	gold, Green Published, Green Submitted			2022-12-25	WOS:000264429000001
J	Grills, C; Crawford, N; Chacko, A; Johnston, PG; O'Rourke, F; Fennell, DA				Grills, Claire; Crawford, Nyree; Chacko, Alex; Johnston, Patrick G.; O'Rourke, Francesca; Fennell, Dean A.			Dynamical Systems Analysis of Mitochondrial BAK Activation Kinetics Predicts Resistance to BH3 Domains	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; BCL-2 HOMOLOG BAK; ENDOPLASMIC-RETICULUM; CELL-DEATH; IN-VIVO; APOPTOSIS; PROTEINS; HELIX; PERMEABILIZATION; CHANNEL	Introduction: The molecular mechanism underlying mitochondrial BAK activation during apoptosis remains highly controversial. Two seemingly conflicting models have been proposed. In one, BAK requires so-called activating BH3 only proteins (aBH3) to initiate its conformation change. In the other, displacement from inhibitory pro-survival BCL-2 proteins (PBPs) and monomerization of BAK by PBP selective dissociator BH3-only proteins (dBH3) is sufficient. Methodology/Principal Findings: To better understand the kinetic implications of these conflicting but highly evidence-based models, we have conducted a deterministic, dynamical systems analysis to explore the kinetics underlying the first step of BAK activation, as a non-linear reaction system. We show that dBH3 induced BAK activation is efficient, even in the absence of aBH3s, provided constitutive interaction of PBPs with open conformation BAK occurs in an adenoviral E1B 19K-like manner. The pattern of PBP expression robustly predicts the efficacy of dBH3s. Conclusion: Our findings accommodate the prevailing BAK activation models as potentially coexisting mechanisms capable of initiating BAK activation, and supports a model based approach for predicting resistance to therapeutically relevant small molecule BH3 mimetics.	[Grills, Claire; O'Rourke, Francesca] Queens Univ Belfast, Sch Appl Math & Theoret Phys, Belfast, Antrim, North Ireland; [Crawford, Nyree; Chacko, Alex; Johnston, Patrick G.; O'Rourke, Francesca; Fennell, Dean A.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT7 1NN, Antrim, North Ireland; [Johnston, Patrick G.; Fennell, Dean A.] N Ireland Canc Ctr, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Grills, C (corresponding author), Queens Univ Belfast, Sch Appl Math & Theoret Phys, Belfast, Antrim, North Ireland.	d.fennell@qub.ac.uk			Cancer Research UK [Clinician Scientist Fellowship]	Cancer Research UK(Cancer Research UK)	DAF is a recipient of a Cancer Research UK Clinician Scientist Fellowship.	Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen C, 2007, FEBS LETT, V581, P5143, DOI 10.1016/j.febslet.2007.09.063; Chen C, 2007, BIOPHYS J, V92, P4304, DOI 10.1529/biophysj.106.099606; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Degenhardt K, 2002, CANCER CELL, V2, P193, DOI 10.1016/S1535-6108(02)00126-5; Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; KIEFER MC, 1995, NATURE, V374, P736, DOI 10.1038/374736a0; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willison HJ, 2005, NAT CLIN PRACT NEURO, V1, P2, DOI 10.1038/ncpneuro0001	32	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3038	10.1371/journal.pone.0003038	http://dx.doi.org/10.1371/journal.pone.0003038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725943	Green Published, Green Submitted, gold			2022-12-25	WOS:000264428800005
J	Suidan, GL; Mcdole, JR; Chen, Y; Pirko, I; Johnson, AJ				Suidan, Georgette L.; Mcdole, Jeremiah R.; Chen, Yi; Pirko, Istvan; Johnson, Aaron J.			Induction of Blood Brain Barrier Tight Junction Protein Alterations by CD8 T Cells	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN CEREBRAL MALARIA; ENDOTHELIAL-CELLS; INFLAMMATORY PAIN; MULTIPLE-SCLEROSIS; HEMORRHAGIC-FEVER; DISEASE SEVERITY; THEILERS VIRUS; PERMEABILITY; ASTROCYTES	Disruption of the blood brain barrier (BBB) is a hallmark feature of immune-mediated neurological disorders as diverse as viral hemorrhagic fevers, cerebral malaria and acute hemorrhagic leukoencephalitis. Although current models hypothesize that immune cells promote vascular permeability in human disease, the role CD8 T cells play in BBB breakdown remains poorly defined. Our laboratory has developed a novel murine model of CD8 T cell mediated central nervous system (CNS) vascular permeability using a variation of the Theiler's virus model of multiple sclerosis. In previous studies, we observed that MHC class II-/- (CD4 T cell deficient), IFN-gamma R-/-, TNF-alpha(-/-), TNFR1(-/-), TNFR2(-/-), and TNFR1/TNFR2 double knockout mice as well as those with inhibition of IL-1 and LT beta activity were susceptible to CNS vascular permeability. Therefore, the objective of this study was to determine the extent immune effector proteins utilized by CD8 T cells, perforin and FasL, contributed to CNS vascular permeability. Using techniques such as fluorescent activated cell sorting (FACS), T1 gadolinium-enhanced magnetic resonance imaging (MRI), FITC-albumin leakage assays, microvessel isolation, western blotting and immunofluorescent microscopy, we show that in vivo stimulation of CNS infiltrating antigen-specific CD8 T cells initiates astrocyte activation, alteration of BBB tight junction proteins and increased CNS vascular permeability in a non-apoptotic manner. Using the aforementioned techniques, we found that despite having similar expansion of CD8 T cells in the brain as wildtype and Fas Ligand deficient animals, perforin deficient mice were resistant to tight junction alterations and CNS vascular permeability. To our knowledge, this study is the first to demonstrate that CNS infiltrating antigen-specific CD8 T cells have the capacity to initiate BBB tight junction disruption through a non-apoptotic perforin dependent mechanism and our model is one of few that are useful for studies in this field. These novel findings are highly relevant to the development of therapies designed to control immune mediated CNS vascular permeability.	[Suidan, Georgette L.; Mcdole, Jeremiah R.; Pirko, Istvan; Johnson, Aaron J.] Univ Cincinnati, Coll Med, Dept Neurosci, Cincinnati, OH 45221 USA; [Suidan, Georgette L.; Mcdole, Jeremiah R.; Chen, Yi; Pirko, Istvan; Johnson, Aaron J.] Univ Cincinnati, Coll Med, Neurol Dept, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Suidan, GL (corresponding author), Univ Cincinnati, Coll Med, Dept Neurosci, Cincinnati, OH 45221 USA.	johna4@uc.edu			The Neuroscience Institute of Cincinnati, OH	The Neuroscience Institute of Cincinnati, OH	This work was funded by The Neuroscience Institute of Cincinnati, OH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Brooks TA, 2005, AM J PHYSIOL-HEART C, V289, pH738, DOI 10.1152/ajpheart.01288.2004; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Cheng ML, 1999, FREE RADICAL BIO MED, V27, P470, DOI 10.1016/S0891-5849(99)00072-6; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; Fontijn RD, 2006, EUR J CELL BIOL, V85, P1131, DOI 10.1016/j.ejcb.2006.07.005; Galea I, 2007, J EXP MED, V204, P2023, DOI 10.1084/jem.20070064; Hawkins BT, 2004, BRAIN RES, V1027, P48, DOI 10.1016/j.brainres.2004.08.043; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Huber JD, 2002, AM J PHYSIOL-HEART C, V283, pH1531, DOI 10.1152/ajpheart.00027.2002; Huber JD, 2001, AM J PHYSIOL-HEART C, V280, pH1241, DOI 10.1152/ajpheart.2001.280.3.H1241; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jiang WG, 1999, J CELL PHYSIOL, V181, P319, DOI 10.1002/(SICI)1097-4652(199911)181:2<319::AID-JCP14>3.0.CO;2-S; Johnson AJ, 2005, J IMMUNOL, V174, P6854, DOI 10.4049/jimmunol.174.11.6854; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Johnson AJ, 2001, FASEB J, V15, P2760, DOI 10.1096/fj.01-0373fje; Kabakus N, 2005, J TROP PEDIATRICS, V51, P245, DOI 10.1093/tropej/fmh109; Khandelwal S, 2007, J BIOSCIENCES, V32, P1139, DOI 10.1007/s12038-007-0115-z; Kilpatrick ED, 2004, J IMMUNOL, V172, P3297, DOI 10.4049/jimmunol.172.5.3297; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; Lyman MA, 2002, J VIROL, V76, P3125, DOI 10.1128/JVI.76.7.3125-3134.2002; Marti M, 2004, J NEUROSCI, V24, P6659, DOI 10.1523/JNEUROSCI.0987-04.2004; MAXWELL K, 1987, BRAIN RES, V410, P309, DOI 10.1016/0006-8993(87)90329-5; McCarthy KM, 1996, J CELL SCI, V109, P2287; McDole J, 2006, NEUROL RES, V28, P256, DOI 10.1179/016164106X98125; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; NEUHAUS J, 1991, ANN NY ACAD SCI, V633, P578; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohtsuki S, 2007, J CELL PHYSIOL, V210, P81, DOI 10.1002/jcp.20823; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pereira RA, 2000, J VIROL, V74, P1029, DOI 10.1128/JVI.74.2.1029-1032.2000; Potter S, 2006, INT J PARASITOL, V36, P485, DOI 10.1016/j.ijpara.2005.12.005; RODRIGUEZ M, 1987, CRIT REV IMMUNOL, V7, P325; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; SILBERGELD DL, 1991, J NEURO-ONCOL, V11, P49, DOI 10.1007/BF00166997; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; Sobue K, 1999, NEUROSCI RES, V35, P155, DOI 10.1016/S0168-0102(99)00079-6; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Suidan GL, 2006, NEUROL RES, V28, P250, DOI 10.1179/016164106X98116; Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959	45	76	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3037	10.1371/journal.pone.0003037	http://dx.doi.org/10.1371/journal.pone.0003037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725947	Green Published, Green Submitted, gold			2022-12-25	WOS:000264428800004
J	Ventura, R; Latagliata, EC; Morrone, C; La Mela, I; Puglisi-Allegra, S				Ventura, Rossella; Latagliata, Emanuele Claudio; Morrone, Cristina; La Mela, Immacolata; Puglisi-Allegra, Stefano			Prefrontal Norepinephrine Determines Attribution of "High" Motivational Salience	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; DOPAMINE RELEASE; ENVIRONMENTAL STIMULI; INDUCED REWARD; CHRONIC STRESS; CORTEX; NORADRENALINE; BEHAVIOR; AMYGDALA; BRAIN	Intense motivational salience attribution is considered to have a major role in the development of different psychopathologies. Numerous brain areas are involved in "normal'' motivational salience attribution processes; however, it is not clear whether common or different neural mechanisms also underlie intense motivational salience attribution. To elucidate this a brain area and a neural system had to be envisaged that were involved only in motivational salience attribution to highly salient stimuli. Using intracerebral microdialysis, we found that natural stimuli induced an increase in norepinephrine release in the medial prefrontal cortex of mice proportional to their salience, and that selective prefrontal norepinephrine depletion abolished the increase of norepinephrine release in the medial prefrontal cortex induced by exposure to appetitive (palatable food) or aversive (light) stimuli independently of salience. However, selective norepinephrine depletion in the medial prefrontal cortex impaired the place conditioning induced exclusively by highly salient stimuli, thus indicating that prefrontal noradrenergic transmission determines approach or avoidance responses to both reward-and aversion-related natural stimuli only when the salience of the unconditioned natural stimulus is high enough to induce sustained norepinephrine outflow. This affirms that prefrontal noradrenergic transmission determines motivational salience attribution selectively when intense motivational salience is processed, as in conditions that characterize psychopathological outcomes.	[Ventura, Rossella; Latagliata, Emanuele Claudio; Morrone, Cristina; La Mela, Immacolata; Puglisi-Allegra, Stefano] European Ctr Brain Res CERC, Santa Lucia Fdn, Rome, Italy; [Ventura, Rossella] Univ Aquila, Dipartimento Sci Tecnol Biomed, I-67100 Laquila, Italy; [Latagliata, Emanuele Claudio; Morrone, Cristina; La Mela, Immacolata; Puglisi-Allegra, Stefano] Univ Sapienza, Dipartimento Psicol & Ctr Daniel Bovet, Rome, Italy	IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of L'Aquila; Sapienza University Rome	Ventura, R (corresponding author), European Ctr Brain Res CERC, Santa Lucia Fdn, Rome, Italy.	rossella.ventura@cc.univaq.it	Latagliata, Emanuele Claudio/B-5011-2013; Puglisi-Allegra, Stefano/ABI-7468-2020; Morrone, Maria Concetta/C-6756-2014; Ventura, Rossella/AAA-8816-2019	Puglisi-Allegra, Stefano/0000-0002-9433-2000; Morrone, Maria Concetta/0000-0002-1025-0316; Ventura, Rossella/0000-0002-7601-8683; Emanuele Claudio, Latagliata/0000-0001-8402-2757; Lauwereyns, Jan/0000-0003-0551-2550				Anderson AK, 2006, P NATL ACAD SCI USA, V103, P1599, DOI 10.1073/pnas.0506308103; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Beck KD, 1999, BRAIN RES, V830, P56, DOI 10.1016/S0006-8993(99)01380-3; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Borsook D, 2007, EUR J PAIN, V11, P7, DOI 10.1016/j.ejpain.2005.12.005; Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; COLE BJ, 1992, NEUROPSYCHOPHARMACOL, V7, P129; DALLEY JW, 1995, J NEUROCHEM, V65, P2644; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Darracq L, 1998, J NEUROSCI, V18, P2729; Dazzi L, 2003, EUR J PHARMACOL, V476, P55, DOI 10.1016/S0014-2999(03)02130-7; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Feenstra MGP, 2000, NEUROSCIENCE, V100, P741, DOI 10.1016/S0306-4522(00)00319-5; Franklin K, 1998, MOUSE BRAIN STEREOTA; Grossberg S, 2000, BIOL PSYCHIAT, V48, P81, DOI 10.1016/S0006-3223(00)00903-3; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Leonhardt M, 2007, HORM BEHAV, V51, P77, DOI 10.1016/j.yhbeh.2006.08.008; Martin-Soelch C, 2007, NEUROSCI BIOBEHAV R, V31, P426, DOI 10.1016/j.neubiorev.2006.11.002; McGaugh JL, 2006, TRENDS COGN SCI, V10, P345, DOI 10.1016/j.tics.2006.06.001; McQuade R, 1999, PSYCHOPHARMACOLOGY, V145, P393, DOI 10.1007/s002130051073; Milstein JA, 2007, PSYCHOPHARMACOLOGY, V190, P51, DOI 10.1007/s00213-006-0594-x; Mingote S, 2004, J NEUROSCI, V24, P2475, DOI 10.1523/JNEUROSCI.4547-03.2004; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Orsini C, 2005, PSYCHOPHARMACOLOGY, V181, P327, DOI 10.1007/s00213-005-2259-6; Pascucci T, 2007, CEREB CORTEX, V17, P2796, DOI 10.1093/cercor/bhm008; Pecina S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-8; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; SARA SJ, 1991, PROG BRAIN RES, V88, P571; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Ventura R, 2005, CEREB CORTEX, V15, P1877, DOI 10.1093/cercor/bhi066; Ventura R, 2003, J NEUROSCI, V23, P1879; Ventura R, 2005, SYNAPSE, V58, P211, DOI 10.1002/syn.20197; Ventura R, 2007, P NATL ACAD SCI USA, V104, P5181, DOI 10.1073/pnas.0610178104; Wang GJ, 2006, P NATL ACAD SCI USA, V103, P15641, DOI 10.1073/pnas.0601977103; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026	44	56	57	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3044	10.1371/journal.pone.0003044	http://dx.doi.org/10.1371/journal.pone.0003044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725944	Green Published, Green Submitted, gold			2022-12-25	WOS:000264428800009
J	Schierwater, B; Kamm, K; Srivastava, M; Rokhsar, D; Rosengarten, RD; Dellaporta, SL				Schierwater, Bernd; Kamm, Kai; Srivastava, Mansi; Rokhsar, Daniel; Rosengarten, Rafael D.; Dellaporta, Stephen L.			The Early ANTP Gene Repertoire: Insights from the Placozoan Genome	PLOS ONE			English	Article								The evolution of ANTP genes in the Metazoa has been the subject of conflicting hypotheses derived from full or partial gene sequences and genomic organization in higher animals. Whole genome sequences have recently filled in some crucial gaps for the basal metazoan phyla Cnidaria and Porifera. Here we analyze the complete genome of Trichoplax adhaerens, representing the basal metazoan phylum Placozoa, for its set of ANTP class genes. The Trichoplax genome encodes representatives of Hox/ParaHox-like, NKL, and extended Hox genes. This repertoire possibly mirrors the condition of a hypothetical cnidarian-bilaterian ancestor. The evolution of the cnidarian and bilaterian ANTP gene repertoires can be deduced by a limited number of cis-duplications of NKL and "extended Hox'' genes and the presence of a single ancestral "ProtoHox'' gene.	[Schierwater, Bernd; Kamm, Kai] Stiftung Tieraerztliche Hsch Hannover, Div Ecol & Evolut, Hannover, Germany; [Schierwater, Bernd; Rosengarten, Rafael D.; Dellaporta, Stephen L.] Yale Univ, Dept Mol, Cellular & Dev Biol, New Haven, CT USA; [Rokhsar, Daniel] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Srivastava, Mansi; Rokhsar, Daniel] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Berkeley, CA 94720 USA	University of Veterinary Medicine Hannover, Foundation; Yale University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley	Schierwater, B (corresponding author), Stiftung Tieraerztliche Hsch Hannover, Div Ecol & Evolut, Hannover, Germany.	kai.kamm@ecolevol.de		Rokhsar, Daniel/0000-0002-8704-2224; Kamm, Kai/0000-0001-8038-2843	JGI; Human Frontier Science Program [RGP 0221]; Deutsche Forschungsgemeinschaft [Schi 277/20-2]; National Science Foundation [RR 19895, Graduate Research Fellowship]; Yale University Life Sciences Computing Center [RR 19895]; NIH [RR 19895]; University of California, Lawrence Livermore National Laboratory; Lawrence Berkeley National Laboratory; Los Alamos National Laboratory; Gordon and Betty Moore Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER	JGI; Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Yale University Life Sciences Computing Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Lawrence Livermore National Laboratory(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We acknowledge financial support from JGI, Human Frontier Science Program (RGP 0221), Deutsche Forschungsgemeinschaft (Schi 277/20-2), National Science Foundation (NSF RR 19895), National Science Foundation Graduate Research Fellowship (R.D.R) and Yale University Life Sciences Computing Center and NIH grant: RR19895, which funded the instrumentation. Genome sequencing was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and supported by the University of California, Lawrence Livermore National Laboratory, Lawrence Berkeley National Laboratory, and Los Alamos National Laboratory. The Center for Integrative Genomics is supported by a grant from the Gordon and Betty Moore Foundation.	Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Castro LFC, 2003, EVOL DEV, V5, P459, DOI 10.1046/j.1525-142X.2003.03052.x; Chourrout D, 2006, NATURE, V442, P684, DOI 10.1038/nature04863; Coulier F, 2000, J EXP ZOOL, V288, P345, DOI 10.1002/1097-010X(20001215)288:4<345::AID-JEZ7>3.0.CO;2-Y; de Jong DM, 2006, DEV BIOL, V298, P632, DOI 10.1016/j.ydbio.2006.07.034; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; DeSalle R, 2007, INTEGR COMP BIOL, V47, P667, DOI 10.1093/icb/icm042; Ender A, 2003, MOL BIOL EVOL, V20, P130, DOI 10.1093/molbev/msg018; Gall H, 1999, HAUTARZT, V50, P186, DOI 10.1007/s001050050887; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Garcia-Fernandez J, 2005, HEREDITY, V94, P145, DOI 10.1038/sj.hdy.6800621; GEHRING WJ, 1985, CELL, V40, P3, DOI 10.1016/0092-8674(85)90300-9; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hadrys T, 2005, MOL BIOL EVOL, V22, P1569, DOI 10.1093/molbev/msi150; Jakob W, 2004, DEV GENES EVOL, V214, P170, DOI 10.1007/s00427-004-0390-8; Kamm K, 2007, J EXP ZOOL PART B, V308B, P777, DOI 10.1002/jez.b.21196; Kamm K, 2006, J EXP ZOOL PART B, V306B, P589, DOI 10.1002/jez.b.21123; Kamm K, 2006, CURR BIOL, V16, P920, DOI 10.1016/j.cub.2006.03.036; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Luke GN, 2003, P NATL ACAD SCI USA, V100, P5292, DOI 10.1073/pnas.0836141100; Monteiro AS, 2006, EVOL DEV, V8, P174, DOI 10.1111/j.1525-142X.2006.00087.x; Peterson KJ, 2007, EVOL DEV, V9, P405, DOI 10.1111/j.1525-142X.2007.00179.x; Pollard SL, 2000, CURR BIOL, V10, P1059, DOI 10.1016/S0960-9822(00)00676-X; Popovici C, 2001, FEBS LETT, V491, P237, DOI 10.1016/S0014-5793(01)02187-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Ryan JF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r64; SCHIERWATER B, HYPOTHESIS CUR UNPUB; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Signorovitch AY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030013; SRIVASTAVA M, NATURE UNPUB; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701	34	39	39	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e2457	10.1371/journal.pone.0002457	http://dx.doi.org/10.1371/journal.pone.0002457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716659	Green Submitted, Green Published, gold			2022-12-25	WOS:000264426800001
J	Yoshiike, Y; Kimura, T; Yamashita, S; Furudate, H; Mizoroki, T; Murayama, M; Takashima, A				Yoshiike, Yuji; Kimura, Tetsuya; Yamashita, Shunji; Furudate, Hiroyuki; Mizoroki, Tatsuya; Murayama, Miyuki; Takashima, Akihiko			GABA(A) Receptor-Mediated Acceleration of Aging-Associated Memory Decline in APP/PS1 Mice and Its Pharmacological Treatment by Picrotoxin	PLOS ONE			English	Article								Advanced age and mutations in the genes encoding amyloid precursor protein (APP) and presenilin (PS1) are two serious risk factors for Alzheimer's disease (AD). Finding common pathogenic changes originating from these risks may lead to a new therapeutic strategy. We observed a decline in memory performance and reduction in hippocampal long-term potentiation (LTP) in both mature adult (9-15 months) transgenic APP/PS1 mice and old (19-25 months) non-transgenic (nonTg) mice. By contrast, in the presence of bicuculline, a GABA(A) receptor antagonist, LTP in adult APP/PS1 mice and old nonTg mice was larger than that in adult nonTg mice. The increased LTP levels in bicuculline-treated slices suggested that GABA(A) receptor-mediated inhibition in adult APP/PS1 and old nonTg mice was upregulated. Assuming that enhanced inhibition of LTP mediates memory decline in APP/PS1 mice, we rescued memory deficits in adult APP/PS1 mice by treating them with another GABA(A) receptor antagonist, picrotoxin (PTX), at a non-epileptic dose for 10 days. Among the saline vehicle-treated groups, substantially higher levels of synaptic proteins such as GABA(A) receptor alpha 1 subunit, PSD95, and NR2B were observed in APP/PS1 mice than in nonTg control mice. This difference was insignificant among PTX-treated groups, suggesting that memory decline in APP/PS1 mice may result from changes in synaptic protein levels through homeostatic mechanisms. Several independent studies reported previously in aged rodents both an increased level of GABA(A) receptor alpha 1 subunit and improvement of cognitive functions by long term GABA(A) receptor antagonist treatment. Therefore, reduced LTP linked to enhanced GABA(A) receptor-mediated inhibition may be triggered by aging and may be accelerated by familial AD-linked gene products like A beta and mutant PS1, leading to cognitive decline that is pharmacologically treatable at least at this stage of disease progression in mice.	[Yoshiike, Yuji; Kimura, Tetsuya; Yamashita, Shunji; Mizoroki, Tatsuya; Murayama, Miyuki; Takashima, Akihiko] RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan; [Furudate, Hiroyuki] Saitama Univ, Fac Sci, Dept Regulat Biol, Lab Endocrinol & Neuroethol, Saitama, Japan	RIKEN; Saitama University	Yoshiike, Y (corresponding author), RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan.	kenneth@brain.riken.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We have no financial, personal, or professional conflicts of interests for the work presented in this manuscript. This work was partly supported by Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms on Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARISPE N, 1994, ANN NY ACAD SCI, V747, P256; Barnes CA, 2003, PHILOS T R SOC B, V358, P765, DOI 10.1098/rstb.2002.1244; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Chapouthier Georges, 2002, Current Topics in Medicinal Chemistry, V2, P841, DOI 10.2174/1568026023393552; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Cotman C.W, 2000, AGING MIND OPPORTUNI, P114; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Gutierrez A, 1996, NEUROSCIENCE, V74, P341, DOI 10.1016/0306-4522(96)00137-6; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Jeong YH, 2006, FASEB J, V20, P729, DOI 10.1096/fj.05-4265fje; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Nyffeler M, 2007, NEUROBIOL AGING, V28, P143, DOI 10.1016/j.neurobiolaging.2005.11.003; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Parent A, 1999, NEUROBIOL DIS, V6, P56, DOI 10.1006/nbdi.1998.0207; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Pybus R, 2003, NEUROBIOL DIS, V12, P212, DOI 10.1016/S0969-9961(03)00016-0; Rissman RA, 2007, J NEUROCHEM, V103, P1285, DOI 10.1111/j.1471-4159.2007.04832.x; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Ruano D, 2000, J BIOL CHEM, V275, P19585, DOI 10.1074/jbc.M000700200; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schneider I, 2001, J BIOL CHEM, V276, P11539, DOI 10.1074/jbc.M010977200; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Smith-Swintosky V L, 1994, J Neural Transm Suppl, V44, P29; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Squire Larry R., 1994, P203; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; van Gaalen MM, 2000, BEHAV BRAIN RES, V115, P95, DOI 10.1016/S0166-4328(00)00240-0; Vela J, 2003, J NEUROCHEM, V85, P368, DOI 10.1046/j.1471-4159.2003.01681.x; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Zaman SH, 2000, NEUROBIOL DIS, V7, P54, DOI 10.1006/nbdi.1999.0271	49	82	84	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3029	10.1371/journal.pone.0003029	http://dx.doi.org/10.1371/journal.pone.0003029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716656	gold, Green Submitted, Green Published			2022-12-25	WOS:000264426800007
J	Harb, N; Archer, TK; Sato, N				Harb, Nicole; Archer, Trevor K.; Sato, Noboru			The Rho-Rock-Myosin Signaling Axis Determines Cell-Cell Integrity of Self-Renewing Pluripotent Stem Cells	PLOS ONE			English	Article							MOUSE EPIBLAST; DIFFERENTIATION; GTPASES; KINASE; ADHESION; CULTURE; LINES; CONTRACTION; MAINTENANCE; ACTIVATION	Background: Embryonic stem (ES) cells self-renew as coherent colonies in which cells maintain tight cell-cell contact. Although intercellular communications are essential to establish the basis of cell-specific identity, molecular mechanisms underlying intrinsic cell-cell interactions in ES cells at the signaling level remain underexplored. Methodology/Principal Findings: Here we show that endogenous Rho signaling is required for the maintenance of cell-cell contacts in ES cells. siRNA-mediated loss of function experiments demonstrated that Rock, a major effector kinase downstream of Rho, played a key role in the formation of cell-cell junctional assemblies through regulation of myosin II by controlling a myosin light chain phosphatase. Chemical engineering of this signaling axis by a Rock-specific inhibitor revealed that cell-cell adhesion was reversibly controllable and dispensable for self-renewal of mouse ES cells as confirmed by chimera assay. Furthermore, a novel culture system combining a single synthetic matrix, defined medium, and the Rock inhibitor fully warranted human ES cell self-renewal independent of animal-derived matrices, tight cell contacts, or fibroblastic niche-forming cells as determined by teratoma formation assay. Conclusions/Significance: These findings demonstrate an essential role of the Rho-Rock-Myosin signaling axis for the regulation of basic cell-cell communications in both mouse and human ES cells, and would contribute to advance in medically compatible xeno-free environments for human pluripotent stem cells.	[Harb, Nicole; Sato, Noboru] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Archer, Trevor K.] Natl Inst Environm Hlth Sci, Lab Mol Carcinogenesis, Res Triangle Pk, NC USA	University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Harb, N (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	saton@ucr.edu	Archer, Trevor K/E-5191-2019	Archer, Trevor K/0000-0001-7651-3644	University of California Riverside; Intramural Research Program of the National Institute of Environmental Health Sciences, NIH [Z01 ES071006-09]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071006, ZIAES071006] Funding Source: NIH RePORTER	University of California Riverside(University of California System); Intramural Research Program of the National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	N.S. is supported by University of California Riverside. This research was supported in part by the Intramural Research Program of the National Institute of Environmental Health Sciences, NIH project #Z01 ES071006-09 (T.K.A.).	Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chisholm RL, 2004, NAT REV MOL CELL BIO, V5, P531, DOI 10.1038/nrm1427; Clayton L, 1999, DEV BIOL, V205, P322, DOI 10.1006/dbio.1998.9117; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; Debidda M, 2005, J BIOL CHEM, V280, P17275, DOI 10.1074/jbc.M413187200; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FLEMING TP, 1988, ANNU REV CELL BIOL, V4, P459, DOI 10.1146/annurev.cellbio.4.1.459; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kobune M, 2007, MOL CANCER THER, V6, P1774, DOI 10.1158/1535-7163.MCT-06-0684; Krtolica A, 2007, STEM CELLS, V25, P2215, DOI 10.1634/stemcells.2007-0230; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Larue L, 1996, DEVELOPMENT, V122, P3185; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rossant J, 2003, PHILOS T ROY SOC B, V358, P1341, DOI 10.1098/rstb.2003.1329; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sato N, 2006, METH MOL B, V331, P267; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sutherland A, 2003, DEV BIOL, V258, P241, DOI 10.1016/S0012-1606(03)00130-1; Suzuki Atsushi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS114, DOI 10.1038/ncpcardio0442; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; WATANABE K, 2007, NAT BIOTECHNOL; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Wong RCB, 2004, STEM CELLS, V22, P883, DOI 10.1634/stemcells.22-6-883; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zwaka TP, 2005, STEM CELLS, V23, P146, DOI 10.1634/stemcells.2004-0248	62	125	166	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3001	10.1371/journal.pone.0003001	http://dx.doi.org/10.1371/journal.pone.0003001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714354	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900026
J	Yu, XM; Zhou, Q; Li, SC; Luo, QB; Cai, YM; Lin, WC; Chen, H; Yang, Y; Hu, SN; Yu, J				Yu, Xiaomin; Zhou, Qing; Li, Sung-Chou; Luo, Qibin; Cai, Yimei; Lin, Wen-chang; Chen, Huan; Yang, Yue; Hu, Songnian; Yu, Jun			The Silkworm (Bombyx mori) microRNAs and Their Expressions in Multiple Developmental Stages	PLOS ONE			English	Article							SMALL RNAS; REGULATORY ROLES; IDENTIFICATION; DROSOPHILA; REVEALS; CLONING; GENES; SEQUENCE; MIRNAS; LET-7	Background: MicroRNAs (miRNAs) play crucial roles in various physiological processes through post-transcriptional regulation of gene expressions and are involved in development, metabolism, and many other important molecular mechanisms and cellular processes. The Bombyx mori genome sequence provides opportunities for a thorough survey for miRNAs as well as comparative analyses with other sequenced insect species. Methodology/Principal Findings: We identified 114 non-redundant conserved miRNAs and 148 novel putative miRNAs from the B. mori genome with an elaborate computational protocol. We also sequenced 6,720 clones from 14 developmental stage-specific small RNA libraries in which we identified 35 unique miRNAs containing 21 conserved miRNAs (including 17 predicted miRNAs) and 14 novel miRNAs (including 11 predicted novel miRNAs). Among the 114 conserved miRNAs, we found six pairs of clusters evolutionarily conserved cross insect lineages. Our observations on length heterogeneity at 59 and/or 39 ends of nine miRNAs between cloned and predicted sequences, and three mature forms deriving from the same arm of putative pre-miRNAs suggest a mechanism by which miRNAs gain new functions. Analyzing development-related miRNAs expression at 14 developmental stages based on clone-sampling and stem-loop RT PCR, we discovered an unusual abundance of 33 sequences representing 12 different miRNAs and sharply fluctuated expression of miRNAs at larva-molting stage. The potential functions of several stage-biased miRNAs were also analyzed in combination with predicted target genes and silkworm's phenotypic traits; our results indicated that miRNAs may play key regulatory roles in specific developmental stages in the silkworm, such as ecdysis. Conclusions/Significance: Taking a combined approach, we identified 118 conserved miRNAs and 151 novel miRNA candidates from the B. mori genome sequence. Our expression analyses by sampling miRNAs and real-time PCR over multiple developmental stages allowed us to pinpoint molting stages as hotspots of miRNA expression both in sorts and quantities. Based on the analysis of target genes, we hypothesized that miRNAs regulate development through a particular emphasis on complex stages rather than general regulatory mechanisms.	[Yu, Xiaomin; Zhou, Qing; Luo, Qibin; Cai, Yimei; Chen, Huan; Yang, Yue; Hu, Songnian; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Yu, Xiaomin; Zhou, Qing; Cai, Yimei; Yang, Yue] Chinese Acad Sci, Grad Univ, Beijing 100864, Peoples R China; [Luo, Qibin; Chen, Huan] Zhejiang Univ, Watson Inst Genome Sci, Hangzhou, Peoples R China; [Li, Sung-Chou; Lin, Wen-chang] Natl Yang Ming Univ, Inst BioMed Informat, Taipei, Taiwan; [Li, Sung-Chou] Acad Sinica, Taiwan Int Grad Program, Bioinformat Program, Taipei, Taiwan; [Lin, Wen-chang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Yu, XM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China.	junyu@big.ac.cn	Lin, Wen-chang/B-3100-2011; Lin, Wen-chang/ABH-7976-2020; Yu, Xiaomin/I-6407-2016; Chen, Huan/CAH-8180-2022; Li, Sung-Chou/AGZ-8626-2022; Hu, Songnian/C-6509-2013	Lin, Wen-chang/0000-0003-0194-1745; Lin, Wen-chang/0000-0003-0194-1745; Li, Sung-Chou/0000-0002-3016-9718; Hu, Songnian/0000-0003-3966-3111	Ministry of Science and Technology of China [2006CB910400]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	A grant from the Ministry of Science and Technology of China (2006CB910400) awarded to Jun Yu.	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambros Victor, 2004, Methods Mol Biol, V265, P131; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Champlin DT, 1998, DEVELOPMENT, V125, P269; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Ehrenreich IM, 2008, PLANT PHYSIOL, V146, P1974, DOI 10.1104/pp.108.116582; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He PA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-248; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Iwasaki H, 1997, INSECT MOL BIOL, V6, P131, DOI 10.1111/j.1365-2583.1997.tb00081.x; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; KRAMER KJ, 1993, INSECT BIOCHEM MOLEC, V23, P691, DOI 10.1016/0965-1748(93)90043-R; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LI SC, 2007, NUCL ACIDS RES; Li SC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-164; Li SC, 2007, DNA CELL BIOL, V26, P195, DOI 10.1089/dna.2006.0558; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu SP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-88; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MOLNAR A, 2007, NATURE; NAKAGAKI M, 1991, ROUX ARCH DEV BIOL, V200, P223, DOI 10.1007/BF00361341; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; SCHAFER A, 2007, VIROLOGY; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Shimizu I, 2001, BIOCHEM BIOPH RES CO, V287, P27, DOI 10.1006/bbrc.2001.5540; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Tong Chuan-zhou, 2006, J Zhejiang Univ Sci B, V7, P806, DOI 10.1631/jzus.2006.B0806; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	81	94	139	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2997	10.1371/journal.pone.0002997	http://dx.doi.org/10.1371/journal.pone.0002997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714353	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900022
J	Zampieri, M; Soranzo, N; Bianchini, D; Altafini, C				Zampieri, Mattia; Soranzo, Nicola; Bianchini, Daniele; Altafini, Claudio			Origin of Co-Expression Patterns in E. coli and S. cerevisiae Emerging from Reverse Engineering Algorithms	PLOS ONE			English	Article								Background: The concept of reverse engineering a gene network, i.e., of inferring a genome-wide graph of putative gene-gene interactions from compendia of high throughput microarray data has been extensively used in the last few years to deduce/integrate/validate various types of "physical'' networks of interactions among genes or gene products. Results: This paper gives a comprehensive overview of which of these networks emerge significantly when reverse engineering large collections of gene expression data for two model organisms, E. coli and S. cerevisiae, without any prior information. For the first organism the pattern of co-expression is shown to reflect in fine detail both the operonal structure of the DNA and the regulatory effects exerted by the gene products when co-participating in a protein complex. For the second organism we find that direct transcriptional control (e. g., transcription factor-binding site interactions) has little statistical significance in comparison to the other regulatory mechanisms (such as co-sharing a protein complex, colocalization on a metabolic pathway or compartment), which are however resolved at a lower level of detail than in E. coli. Conclusion: The gene co-expression patterns deduced from compendia of profiling experiments tend to unveil functional categories that are mainly associated to stable bindings rather than transient interactions. The inference power of this systematic analysis is substantially reduced when passing from E. coli to S. cerevisiae. This extensive analysis provides a way to describe the different complexity between the two organisms and discusses the critical limitations affecting this type of methodologies.	[Zampieri, Mattia; Soranzo, Nicola; Bianchini, Daniele; Altafini, Claudio] SISSA, ISAS, Int Sch Adv Studies, I-34014 Trieste, Italy	International School for Advanced Studies (SISSA)	Zampieri, M (corresponding author), SISSA, ISAS, Int Sch Adv Studies, I-34014 Trieste, Italy.	altafini@sissa.it	Zampieri, Mattia/ABF-5590-2020; Altafini, Claudio/AAL-4235-2020	Altafini, Claudio/0000-0003-4142-6502; Soranzo, Nicola/0000-0003-3627-5340; Zampieri, Mattia/0000-0002-9339-068X; Soranzo, Nicole/0000-0003-1095-3852	Illy Caffe, Trieste, Italy	Illy Caffe, Trieste, Italy	This work is supported by a grant from Illy Caffe, Trieste, Italy.	Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; BANSAL M, 2007, MOL SYST BIOL, V3; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bilu Y, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r103; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butte A J, 2000, Pac Symp Biocomput, P418; Chen YA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-101; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gan X, 2002, EUR J BIOCHEM, V269, P5203, DOI 10.1046/j.1432-1033.2002.03226.x; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Herrgard MJ, 2003, GENOME RES, V13, P2423, DOI 10.1101/gr.1330003; Hershberg R, 2005, TRENDS GENET, V21, P138, DOI 10.1016/j.tig.2005.01.003; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kim H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-165; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; Kothapalli R, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-22; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li Z, 2004, J BIOL CHEM, V279, P27124, DOI 10.1074/jbc.M403494200; Lin D, 1998, P INT C MACH LEARN; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; POTHEN A, 1990, ACM T MATH SOFTWARE, V16, P303, DOI 10.1145/98267.98287; Qi YJ, 2006, PROTEINS, V63, P490, DOI 10.1002/prot.20865; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Sabatti C, 2002, NUCLEIC ACIDS RES, V30, P2886, DOI 10.1093/nar/gkf388; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Simonis N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r33; Snel B, 2004, NUCLEIC ACIDS RES, V32, P4725, DOI 10.1093/nar/gkh815; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Teichmann SA, 2002, TRENDS BIOTECHNOL, V20, P407, DOI 10.1016/S0167-7799(02)02032-2; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Wuchty S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-24; Yamanishi Y, 2004, BIOINFORMATICS, V20, P363, DOI 10.1093/bioinformatics/bth910; Yanai I, 2006, TRENDS GENET, V22, P132, DOI 10.1016/j.tig.2006.01.006	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2981	10.1371/journal.pone.0002981	http://dx.doi.org/10.1371/journal.pone.0002981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714358	gold, Green Submitted, Green Published			2022-12-25	WOS:000264420900008
J	Gualandris, A; Noghero, A; Geuna, M; Arese, M; Valdembri, D; Serini, G; Bussolino, F				Gualandris, Anna; Noghero, Alessio; Geuna, Massimo; Arese, Marco; Valdembri, Donatella; Serini, Guido; Bussolino, Federico			Microenvironment drives the endothelial or neural fate of differentiating embryonic stem cells coexpressing neuropilin-1 and Flk-1	FASEB JOURNAL			English	Article						cell commitment; endothelial differentiation; embryoid bodies	PROGENITOR CELLS; NERVOUS-SYSTEM; MOUSE EMBRYO; BONE-MARROW; IN-VITRO; ARTERIAL DIFFERENTIATION; VASCULAR MORPHOGENESIS; MEMBRANE-PROTEIN; VESSEL FORMATION; GROWTH-FACTOR	The observation that the architecture of the cardiovascular and nervous systems is drawn by common guidance cues and the closeness between neural progenitors and endothelial cells in the vascular niche strongly suggests the existence of links between endothelial and neural cell fates. We identified an embryonic stem cell-derived discrete, nonclonal cell population expressing the two vascular endothelial growth factor receptors neuropilin-1 (Nrp1) and Flk1 that differentiates in vitro toward endothelial or neural phenotypes depending on microenvironmental cues. When microinjected in the chick embryo, Nrp1(+) cells integrate within the host, developing vessels and brain, and acquire endothelial and neural markers, respectively. These results show that precursors of endothelial cells and precursors of neural cells arise from the same pool of differentiating embryonic stem cells and share the expression of Nrp1 and Flk1. These data reinforce the parallelism between vascular and nervous system at the level of cell fate and commitment and open new perspective in regenerative medicine of neurovascular diseases.-Gualandris, A., Noghero, A., Geuna, M., Arese, M., Valdembri, D., Serini, G., Bussolino, F. Microenvironment drives the endothelial or neural fate of differentiating embryonic stem cells coexpressing neuropilin-1 and Flk-1. FASEB J. 23, 68-78 (2009)	[Gualandris, Anna; Noghero, Alessio; Geuna, Massimo; Arese, Marco; Valdembri, Donatella; Serini, Guido; Bussolino, Federico] Univ Turin, Dept Oncol Sci, Inst Canc Res & Treatment, IRCC,Sch Med, I-10060 Candiolo, TO, Italy; [Gualandris, Anna; Noghero, Alessio; Arese, Marco; Valdembri, Donatella; Serini, Guido; Bussolino, Federico] Univ Turin, Div Mol Angiogenesis, I-10060 Candiolo, TO, Italy; [Geuna, Massimo] Univ Turin, Div Clin & Expt Cytometry, I-10060 Candiolo, TO, Italy	IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Turin; University of Turin	Gualandris, A (corresponding author), Univ Turin, Dept Oncol Sci, Inst Canc Res & Treatment, IRCC,Sch Med, Str Prov 142,Km 3 95, I-10060 Candiolo, TO, Italy.	anna.gualandris@ircc.it	NOGHERO, Alessio/AAL-1573-2020; Serini, Guido/AAF-2873-2021; Bussolino, Federico/AES-3951-2022; arese, marco/J-6119-2013; Geuna, Massimo/AAY-1441-2021; Bussolino, Federico/K-2500-2016	NOGHERO, Alessio/0000-0002-8266-9247; Serini, Guido/0000-0002-3502-8367; arese, marco/0000-0002-7384-9406; Geuna, Massimo/0000-0002-6475-5547; Gualandris, anna/0000-0002-2889-4080; Valdembri, Donatella/0000-0003-4590-417X; Bussolino, Federico/0000-0002-5348-1341	Istituto Superiore di Sanita'; Associazione Italiana per la Ricerca sul Cancro, Regione Piemonte; 6FP European Community [LSHM-CT-2003-503254]; Fondazione Cassa di Risparmio di Torino and Ministero della Salute; Ministero dell'Universita' (PRIN2007); Telethon, Italy [GGP04127]	Istituto Superiore di Sanita'; Associazione Italiana per la Ricerca sul Cancro, Regione Piemonte(Fondazione AIRC per la ricerca sul cancroRegione Piemonte); 6FP European Community(European Commission); Fondazione Cassa di Risparmio di Torino and Ministero della Salute; Ministero dell'Universita' (PRIN2007)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Telethon, Italy(Fondazione Telethon)	This work was supported by Istituto Superiore di Sanita' (Programma Nazionale sulle Cellule Staminali, VI Programma nazionale AIDS), Associazione Italiana per la Ricerca sul Cancro, Regione Piemonte (Progetto di Ricerca sanitaria Finalizzata 2006, Ricerca Scientifica 2004, grants A150 and D10), 6FP European Community (LSHM-CT-2003-503254), Fondazione Cassa di Risparmio di Torino and Ministero della Salute (Programma di Ricerca Finalizzata 2006 and Programma Straordinario di Ricerca Oncologica 2006), Ministero dell'Universita' (PRIN2007), and Telethon, Italy GGP04127. We thank Dr. Alexandra L. Joyner (Developmental Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA) for the gift of W4 129SvEv ES cells, Dr. Andras Nagy (Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto, ON, Canada) and Anna-Katerina Hadjantonakis (Developmental Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA) for R1 EYFP-expressing ES cells, Dr. Timm Schroeder (Institute of Cell Research, Helmholtz Zentrum Munchen-German Research Center for Environmental Health, Neuherberg, Germany) for OP9 and PA6 cells and helpful suggestions, L. Primo for suggestions and comments, and Dr. S. Geuna for assistance with confocal microscopy. We thank Famarco and Susatrasporti S.p.A. for white Leghorn chicken eggs, and the Developmental Studies Hybridoma Bank of the University of Iowa for antibodies.	Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Betsholtz C, 2005, EXP SUPPL, V94, P115; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bussolino F, 2006, ENDOTHELIUM-J ENDOTH, V13, P81, DOI 10.1080/10623320600698003; Buzanska L, 2002, J CELL SCI, V115, P2131; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Choi K, 1998, DEVELOPMENT, V125, P725; Ema M, 2003, TRENDS CARDIOVAS MED, V13, P254, DOI 10.1016/S1050-1738(03)00105-1; Fons P, 2004, J CELL PHYSIOL, V200, P351, DOI 10.1002/jcp.20076; Fujisawa H, 1995, DEV NEUROSCI-BASEL, V17, P343, DOI 10.1159/000111304; Gago N, 2003, MOL CELL NEUROSCI, V22, P162, DOI 10.1016/S1044-7431(02)00030-1; Goolsby J, 2003, P NATL ACAD SCI USA, V100, P14926, DOI 10.1073/pnas.2434383100; Gualandris A, 2000, MOL BIOL CELL, V11, P4295, DOI 10.1091/mbc.11.12.4295; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Kinder SJ, 2001, TRENDS CARDIOVAS MED, V11, P177, DOI 10.1016/S1050-1738(01)00091-3; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Korn J, 2002, J COMP NEUROL, V442, P78, DOI 10.1002/cne.1423; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Li ZJ, 2005, J CELL BIOCHEM, V95, P559, DOI 10.1002/jcb.20436; Maurer MH, 2003, NEUROSCI LETT, V344, P165, DOI 10.1016/S0304-3940(03)00407-5; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nanka O, 2001, ANAT EMBRYOL, V204, P407, DOI 10.1007/s004290100212; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; Shraga-Heled N, 2007, FASEB J, V21, P915, DOI 10.1096/fj.06-6277com; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zappone MV, 2000, DEVELOPMENT, V127, P2367	48	13	14	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2009	23	1					68	78		10.1096/fj.08-112847	http://dx.doi.org/10.1096/fj.08-112847			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18757501				2022-12-25	WOS:000262095500009
J	Flockhart, RJ; Diffey, BL; Farr, PM; Lloyd, J; Reynolds, NJ				Flockhart, R. J.; Diffey, B. L.; Farr, P. M.; Lloyd, J.; Reynolds, N. J.			NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure	FASEB JOURNAL			English	Article						UVB; action spectrum; skin equivalents; cyclosporin A	ACTIVATED T-CELLS; NUCLEAR FACTOR; TRANSCRIPTION FACTORS; ACTION SPECTRUM; CYCLOOXYGENASE-2 TRANSCRIPTION; SKIN-CANCER; EXPRESSION; CALCINEURIN; FAMILY; LOCALIZATION	The nuclear factor of activated T cells (NFAT) transcription factors are regulated by calcium/calcineurin signals and play important roles in T cells, muscle, bone, and neural tissue. NFAT is expressed in the epidermis, and although recent data suggest that NFAT is involved in the skin's responses to ultraviolet radiation (UVR), the wavelengths of radiation that activate NFAT and the biological function of UV-activated NFAT remain undefined. We demonstrate that NFAT transcriptional activity is preferentially induced by UVB wavelengths in keratinocytes. The derived action spectrum for NFAT activation indicates that NFAT transcriptional activity is inversely associated with wavelength. UVR also evoked NFAT2 nuclear translocation in a parallel wavelength-dependent fashion and both transcriptional activation and nuclear translocation were inhibited by the calcineurin inhibitor cyclosporin A. UVR also evoked NFAT2 nuclear translocation in three-dimensional skin equivalents. Evidence suggests that COX-2 contributes to UV-induced carcinogenesis. Inhibiting UV-induced NFAT activation in keratinocytes, reduced COX-2 protein induction, and increased UV-induced apoptosis. COX-2 luciferase reporters lacking functional NFAT binding sites were less responsive to UVR, highlighting that NFAT is required for UV-induced COX-2 induction. Taken together, these data suggest that the proinflammatory, antiapoptotic, and procarcinogenic functions of UV-activated COX-2 may be mediated, in part, by upstream NFAT signaling.	[Flockhart, R. J.; Diffey, B. L.; Reynolds, N. J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Lloyd, J.] Royal Victoria Infirm, Dept Med Phys, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Reynolds, NJ (corresponding author), Newcastle Univ, Inst Cellular Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	n.j.reynolds@ncl.ac.uk		Reynolds, Nick/0000-0002-6484-825X	The British Skin Foundation; Wellcome Trust	The British Skin Foundation; Wellcome Trust(Wellcome Trust)	This work was funded by The British Skin Foundation (R.J.F.) and Wellcome Trust Research Leave Fellowship (N.J.R.). The authors thank D. Cantrell (ICRF, London, UK) for NFAT2 cDNA, D. J. McKean (Mayo Foundation, Rochester, MN, USA) for the NFAT luciferase reporter vector, and M. A. Iniguez (Centro de Biologia Molecular, Madrid, Spain) for COX-2 luciferase reporter vectors.	Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Akunda JK, 2007, MOL CARCINOGEN, V46, P354, DOI 10.1002/mc.20290; Al-Daraji WI, 2002, J INVEST DERMATOL, V118, P779, DOI 10.1046/j.1523-1747.2002.01709.x; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Blanke C, 2004, CANCER INVEST, V22, P271, DOI 10.1081/CNV-120030216; Botti C, 1998, INT J BIOL MARKER, V13, P51; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; Corral RS, 2007, ONCOGENE, V26, P958, DOI 10.1038/sj.onc.1209856; DEGRUIJL FR, 1993, CANCER RES, V53, P53; Diffey BL, 2002, METHODS, V28, P4, DOI 10.1016/S1046-2023(02)00204-9; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; FARR PM, 1991, BRIT J DERMATOL, V124, P443, DOI 10.1111/j.1365-2133.1991.tb00623.x; Fischer SM, 1999, MOL CARCINOGEN, V25, P231; FISCHER T, 1984, INT J DERMATOL, V23, P633, DOI 10.1111/j.1365-4362.1984.tb01220.x; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Heck DE, 2004, TOXICOL APPL PHARM, V195, P288, DOI 10.1016/j.taap.2003.09.028; Hedin KE, 1997, J IMMUNOL, V159, P5431; Hill-Eubanks DC, 2003, TRENDS CARDIOVAS MED, V13, P56, DOI 10.1016/S1050-1738(02)00212-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horio T, 1998, CLIN DERMATOL, V16, P59, DOI 10.1016/S0738-081X(97)00170-3; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Huang CS, 2000, J BIOL CHEM, V275, P9143, DOI 10.1074/jbc.275.13.9143; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Loh C, 1996, MOL CELL BIOL, V16, P3945; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mahns A, 2004, PHOTOCH PHOTOBIO SCI, V3, P257, DOI 10.1039/b309067a; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; Maziere C, 2005, FREE RADICAL BIO MED, V39, P1629, DOI 10.1016/j.freeradbiomed.2005.08.003; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; McKinlay AF., 1987, CIE J, P83; Meric JB, 2006, CRIT REV ONCOL HEMAT, V59, P51, DOI 10.1016/j.critrevonc.2006.01.003; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Onguru O, 2005, ENDOCR PATHOL, V16, P253, DOI 10.1385/EP:16:4:253; PARRISH JA, 1981, J INVEST DERMATOL, V76, P359, DOI 10.1111/1523-1747.ep12520022; Patel RN, 1999, J IMMUNOL, V163, P3459; Penn I, 1998, Clin Transpl, P147; Pu WT, 2003, CIRC RES, V92, P725, DOI 10.1161/01.RES.0000069211.82346.46; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; SETLOW RB, 1974, P NATL ACAD SCI USA, V71, P3363, DOI 10.1073/pnas.71.9.3363; Sevigny MB, 2006, FEBS LETT, V580, P6533, DOI 10.1016/j.febslet.2006.10.073; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Sheil AGR, 1998, TRANSPLANT P, V30, P2055, DOI 10.1016/S0041-1345(98)00539-9; Sinicrope FA, 2004, CANCER METAST REV, V23, P63, DOI 10.1023/A:1025863029529; Tang QB, 2001, CANCER RES, V61, P4329; Tang QB, 2001, ONCOGENE, V20, P5164, DOI 10.1038/sj.onc.1204667; Turner H, 1998, J EXP MED, V188, P527, DOI 10.1084/jem.188.3.527; Vyas DR, 2002, AM J PHYSIOL-CELL PH, V283, pC545, DOI 10.1152/ajpcell.00049.2002; Yarosh DB, 2005, J INVEST DERMATOL, V125, P1020, DOI 10.1111/j.0022-202X.2005.23858.x; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	64	48	48	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4218	4227		10.1096/fj.08-113076	http://dx.doi.org/10.1096/fj.08-113076			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18708588	hybrid, Green Published			2022-12-25	WOS:000261254800021
J	Taghavi, P; Verhoeven, E; Jacobs, JJL; Lambooij, JP; Stortelers, C; Tanger, E; Moolenaar, WH; van Lohuizen, M				Taghavi, P.; Verhoeven, E.; Jacobs, J. J. L.; Lambooij, J. P.; Stortelers, C.; Tanger, E.; Moolenaar, W. H.; van Lohuizen, M.			In vitro genetic screen identifies a cooperative role for LPA signaling and c-Myc in cell transformation	ONCOGENE			English	Article						LPA; transformation; screen	PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; TUMOR-SUPPRESSOR; EMBRYO FIBROBLASTS; OVARIAN-CANCER; GROWTH; RAS; KINASE; ACTIVATION; EXPRESSION	c-Myc drives uncontrolled cell proliferation in various human cancers. However, in mouse embryo fibroblasts (MEFs), c-Myc also induces apoptosis by activating the p19Arf tumor suppressor pathway. Tbx2, a transcriptional repressor of p19Arf, can collaborate with c-Myc by suppressing apoptosis. MEFs overexpressing c-Myc and Tbx2 are immortal but not transformed. We have performed an unbiased genetic screen, which identified 12 oncogenes that collaborate with c-Myc and Tbx2 to transform MEFs in vitro. One of them encodes the LPA2 receptor for the lipid growth factor lysophosphatidic acid (LPA). We find that LPA1 and LPA4, but not LPA3, can reproduce the transforming effect of LPA2. Using pharmacological inhibitors, we show that the in vitro cell transformation induced by LPA receptors is dependent on the Gi-linked ERK and PI3K signaling pathways. The transforming ability of LPA1, LPA2 and LPA4 was confirmed by tumor formation assays in vivo and correlated with prolonged ERK1/2 activation in response to LPA. Our results reveal a direct role for LPA receptor signaling in cell transformation and tumorigenesis in conjunction with c-Myc and reduced p19Arf expression. Oncogene (2008) 27, 6806-6816; doi: 10.1038/onc.2008.294;published online 1 September 2008	[Taghavi, P.; Verhoeven, E.; Jacobs, J. J. L.; Lambooij, J. P.; Tanger, E.; van Lohuizen, M.] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Stortelers, C.; Moolenaar, W. H.] Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	van Lohuizen, M (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.v.lohuizen@nki.nl	Jacobs, Jacqueline/ABA-5652-2020	Jacobs, Jacqueline/0000-0002-7704-4795	Dutch Cancer Society [NKI 2003-2935, NKI 2003-2964]	Dutch Cancer Society(KWF Kankerbestrijding)	We thank Laurens A van Meeteren for LPA receptor plasmids and advice, Wendy Lagcher for technical assistance and Nullin Divecha and Daniel S Peeper for helpful discussions. This study was supported by grants from the Dutch Cancer Society, NKI 2003-2935 (to MvL) and NKI 2003-2964 (to WHM).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; BENITO M, 1993, GROWTH REGULAT, V3, P172; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; Datta A, 2004, J BIOL CHEM, V279, P36698, DOI 10.1074/jbc.M312305200; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; Erickson JR, 2001, PROSTAG OTH LIPID M, V64, P63, DOI 10.1016/S0090-6980(01)00100-9; Fu L, 2007, CANCER-AM CANCER SOC, V110, P2672, DOI 10.1002/cncr.23110; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Huang MC, 2004, ONCOGENE, V23, P122, DOI 10.1038/sj.onc.1206986; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Kostenko EV, 2005, J BIOL CHEM, V280, P2807, DOI 10.1074/jbc.M411139200; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; LAND H, 1986, MOL CELL BIOL, V6, P1917, DOI 10.1128/MCB.6.6.1917; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee Z, 2006, CANCER RES, V66, P2740, DOI 10.1158/0008-5472.CAN-05-2947; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Ramjaun AR, 2007, CELL CYCLE, V6, P2902, DOI 10.4161/cc.6.23.4996; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Toyoshima M, 2007, CANCER RES, V67, P5162, DOI 10.1158/0008-5472.CAN-06-2756; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zuber J, 2000, NAT GENET, V24, P144, DOI 10.1038/72799	49	32	36	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2008	27	54					6806	6816		10.1038/onc.2008.294	http://dx.doi.org/10.1038/onc.2008.294			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	375IS	18762810				2022-12-25	WOS:000261108000002
J	Brzeska, H; Hwang, KJ; Korn, ED				Brzeska, Hanna; Hwang, Kae-Jung; Korn, Edward D.			Acanthamoeba Myosin IC Colocalizes with Phosphatidylinositol 4,5-Bisphosphate at the Plasma Membrane Due to the High Concentration of Negative Charge	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING-SITES; PHOSPHOINOSITIDE-BINDING; HEAVY-CHAIN; INTRACELLULAR-LOCALIZATION; PHOSPHORYLATION SITE; CAPPING PROTEIN; LIGHT-CHAIN; SH3 DOMAIN; IN-VIVO; SPECIFICITY	The tail of Acanthamoeba myosin IC (AMIC) has a basic region (BR), which contains a putative pleckstrin homology (PH) domain, followed by two Gly/Pro/Ala (GPA)-rich regions separated by a Src homology 3 (SH3) domain. Cryoelectron microscopy had shown that the tail is folded back on itself at the junction of BR and GPA1, and nuclear magnetic resonance spectroscopy indicated that the SH3 domain may interact with the putative PH domain. The BR binds to acidic phospholipids, and the GPA region binds to F-actin. We now show that the folded tail does not affect the affinity of AMIC for acidic phospholipids. AMIC binds phosphatidylinositol 4,5-bisphosphate (PIP2) with high affinity (similar to 1 mu M), but binding is not stereospecific. When normalized to net negative charge, AMIC binds with equal affinity to phosphatidylserine (PS) and PIP2. This and other data show that the putative PH domain of AMIC is not a typical PIP2-specific PH domain. We have identified a 13-residue sequence of basic-hydrophobic-basic amino acids within the putative PH domain that may be a major determinant of binding of AMIC to acidic phospholipids. Despite the lack of stereospecificity, AMIC binds 10 times more strongly to vesicles containing 5% PIP2 plus 25% PS than to vesicles containing only 25% PS, suggesting that AMIC may be targeted to PIP2-enriched regions of the plasma membrane. In agreement with this, AMIC colocalizes with PIP2 at dynamic, protrusive regions of the plasma membrane. We discuss the possibility that AMIC binding to PIP2 may initiate the formation of a multiprotein complex at the plasma membrane.	[Brzeska, Hanna; Hwang, Kae-Jung; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Brzeska, H (corresponding author), NHLBI, Cell Biol Lab, NIH, 9000 Rockville Pike,Bldg 50,Rm 2515, Bethesda, MD 20892 USA.	brzeskah@mail.nih.gov	Korn, Edward D/F-9929-2012	Korn, Edward/0000-0003-3867-6295	National Institutes of Health; NHLBI, Division of Intramural Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000506, Z01HL000506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported, in whole or in part, by the National Institutes of Health, NHLBI, Division of Intramural Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAINES IC, 1990, J CELL BIOL, V111, P1895, DOI 10.1083/jcb.111.5.1895; BAINES IC, 1992, J CELL BIOL, V119, P1193, DOI 10.1083/jcb.119.5.1193; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; BRZESKA H, 1989, J BIOL CHEM, V264, P19340; Brzeska H, 2004, CELL MOTIL CYTOSKEL, V58, P186, DOI 10.1002/cm.20009; BRZESKA H, 1988, J BIOL CHEM, V263, P427; Bubb MR, 1998, CELL MOTIL CYTOSKEL, V39, P134, DOI 10.1002/(SICI)1097-0169(1998)39:2<134::AID-CM4>3.0.CO;2-6; COOPER JA, 1984, J CELL BIOL, V99, P217, DOI 10.1083/jcb.99.1.217; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; Cullen PJ, 2001, CURR BIOL, V11, pR882, DOI 10.1016/S0960-9822(01)00523-1; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; DOBERSTEIN SK, 1993, NATURE, V365, P841, DOI 10.1038/365841a0; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; Hwang KJ, 2007, P NATL ACAD SCI USA, V104, P784, DOI 10.1073/pnas.0610231104; Ishikawa T, 2004, P NATL ACAD SCI USA, V101, P12189, DOI 10.1073/pnas.0404835101; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; JUNG G, 1987, P NATL ACAD SCI USA, V84, P6720, DOI 10.1073/pnas.84.19.6720; JUNG G, 1993, J BIOL CHEM, V268, P14981; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kong HH, 2002, J CELL SCI, V115, P4993, DOI 10.1242/jcs.00159; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Liu X, 2000, J BIOL CHEM, V275, P24886, DOI 10.1074/jbc.M004287200; Lomize AL, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-44; LYNCH TJ, 1986, J BIOL CHEM, V261, P7156; LYNCH TJ, 1991, METHOD ENZYMOL, V196, P12; LYNCH TJ, 1989, J BIOL CHEM, V264, P19333; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Morita YS, 1996, EUR J CELL BIOL, V71, P371; Niggli V, 2001, TRENDS BIOCHEM SCI, V26, P604, DOI 10.1016/S0968-0004(01)01927-2; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Novak KD, 1998, MOL BIOL CELL, V9, P75, DOI 10.1091/mbc.9.1.75; Ostap EM, 2003, CELL MOTIL CYTOSKEL, V54, P29, DOI 10.1002/cm.10081; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Scott DL, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-17; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Senda S, 2001, J BIOL CHEM, V276, P2898, DOI 10.1074/jbc.M008059200; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; WANG ZY, 1995, J BIOL CHEM, V270, P27969, DOI 10.1074/jbc.270.46.27969; Wang ZY, 1998, P NATL ACAD SCI USA, V95, P15200, DOI 10.1073/pnas.95.26.15200; Wang ZY, 1997, J MUSCLE RES CELL M, V18, P395, DOI 10.1023/A:1018686428955; XU P, 1995, J BIOL CHEM, V270, P25316, DOI 10.1074/jbc.270.43.25316; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8	51	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32014	32023		10.1074/jbc.M804828200	http://dx.doi.org/10.1074/jbc.M804828200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18772133	hybrid, Green Published			2022-12-25	WOS:000260760800083
J	Bai, S; Zha, JK; Zhao, HB; Ross, FP; Teitelbaum, SL				Bai, Shuting; Zha, Jikun; Zhao, Haibo; Ross, F. Patrick; Teitelbaum, Steven L.			Tumor Necrosis Factor Receptor-associated Factor 6 Is an Intranuclear Transcriptional Coactivator in Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIM PROTEIN FHL2; DEFECTIVE INTERLEUKIN-1; UBIQUITIN LIGASE; BETA-CATENIN; TRAF6; ACTIVATION; DIFFERENTIATION; IDENTIFICATION; OSTEOPETROSIS; REQUIRES	Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with the cytoplasmic domain of receptor activator of NF-kappa B (RANK) and is an essential component of the signaling complex mediating osteoclastogenesis. However, the osteoclastic activity of TRAF6 is blunted by its association with four and half LIM domain 2 (FHL2), which functions as an adaptor protein in the cytoplasm and transcriptional regulator in the nucleus. We find that TRAF6 also localizes in the nuclei of osteoclasts but not their bone marrow macrophage precursors and that osteoclast intranuclear abundance is specifically increased by RANK ligand (RANKL). TRAF6 nuclear localization requires FHL2 and is diminished in fhl2(-/-) osteoclasts. Suggesting transcriptional activity, TRAF6 interacts with the transcription factor RUNX1 in the osteoclast nucleus. FHL2 also associates with RUNX1 but does so only in the presence of TRAF6. Importantly, TRAF6 recognizes FHL2 and RUNX1 in osteoclast nuclei, and the three molecules form a DNA-binding complex that recognizes and transactivates the RUNX1 response element in the fhl2 promoter. Finally, TRAF6 and its proximal activator, RANKL, polyubiquitinate FHL2, prompting its proteasomal degradation. These observations suggest a feedback mechanism whereby TRAF6 negatively regulates osteoclast formation by intracytoplasmic sequestration of FHL2 to blunt RANK activation and as a component of a transcription complex promoting FHL2 expression.	[Bai, Shuting; Zha, Jikun; Zhao, Haibo; Ross, F. Patrick; Teitelbaum, Steven L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Teitelbaum, SL (corresponding author), Washington Univ, Sch Med, Dept Pathol, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	teitelbs@wustl.edu	Zhao, Haibo/ABG-9729-2021	ZHAO, HAIBO/0000-0003-0836-7555; Teitelbaum, Steven/0000-0002-4054-6679	National Institutes Health [AR032788, AR046523, AR046852, AR054190]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046852, R37AR046523, R01AR032788, R21AR054190, R01AR046523] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes Health Grants AR032788 and AR046523 ( to S. L. T.) and AR046852 and AR054190 ( to F. P. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bai ST, 2005, J CLIN INVEST, V115, P2742, DOI 10.1172/JCI24921; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Chen YH, 2006, BLOOD, V108, P566, DOI 10.1182/blood-2005-12-4777; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Feng YF, 2007, J BIOL CHEM, V282, P39, DOI 10.1074/jbc.M607399200; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lee JW, 2004, BLOOD, V103, P2308, DOI 10.1182/blood-2003-06-1992; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mikhail FM, 2006, J CELL PHYSIOL, V207, P582, DOI 10.1002/jcp.20538; Nair SS, 2007, MOL ENDOCRINOL, V21, P613, DOI 10.1210/me.2006-0269; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Okada H, 1998, ONCOGENE, V17, P2287, DOI 10.1038/sj.onc.1202151; Rong ZL, 2007, CELL SIGNAL, V19, P1514, DOI 10.1016/j.cellsig.2007.01.025; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Wang MWH, 2004, J CLIN INVEST, V114, P206, DOI 10.1172/JCI200415797; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; ZHANG DE, 1994, MOL CELL BIOL, V14, P8085, DOI 10.1128/MCB.14.12.8085	30	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30861	30867		10.1074/jbc.M802525200	http://dx.doi.org/10.1074/jbc.M802525200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768464	Green Published, hybrid			2022-12-25	WOS:000260544800041
J	Notari, S; Strammiello, R; Capellari, S; Giese, A; Cescatti, M; Grassi, J; Ghetti, B; Langeveld, JPM; Zou, WQ; Gambetti, P; Kretzschmar, HA; Parchi, P				Notari, Silvio; Strammiello, Rosaria; Capellari, Sabina; Giese, Armin; Cescatti, Maura; Grassi, Jacques; Ghetti, Bernardino; Langeveld, Jan P. M.; Zou, Wen-Quan; Gambetti, Pierluigi; Kretzschmar, Hans A.; Parchi, Piero			Characterization of Truncated Forms of Abnormal Prion Protein in Creutzfeldt-Jakob Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAUSSLER-SCHEINKER-DISEASE; PHENOTYPIC VARIABILITY; MOLECULAR-BASIS; SCRAPIE; PRP; IDENTIFICATION; CLASSIFICATION; GENOTYPE; STRAINS; AGENT	In prion disease, the abnormal conformer of the cellular prion protein, PrPSc, deposits in fibrillar protein aggregates in brain and other organs. Limited exposure of PrPSc to proteolytic digestion in vitro generates a core fragment of 19-21 kDa, named PrP27-30, which is also found in vivo. Recent evidence indicates that abnormal truncated fragments other than PrP27-30 may form in prion disease either in vivo or in vitro. We characterized a novel protease-resistant PrP fragment migrating 2-3 kDa faster than PrP27-30 in Creutzfeldt-Jakob disease (CJD) brains. The fragment has a size of about 18.5 kDa when associated with PrP27-30 type 1 (21 kDa) and of 17 kDa when associated with type 2 (19 kDa). Molecular mass and epitope mapping showed that the two fragments share the primary N-terminal sequence with PrP27-30 types 1 and 2, respectively, but lack a few amino acids at the very end of C terminus together with the glycosylphosphatidylinositol anchor. The amounts of the 18.5- or 17-kDa fragments and the previously described 13-kDa PrPSc C-terminal fragment relatively to the PrP27-30 signal significantly differed among CJD subtypes. Furthermore, protease digestion of PrPSc or PrP27-30 in partially denaturing conditions generated an additional truncated fragment of about 16 kDa only in typical sporadic CJD (i.e. MM1). These results show that the physicochemical heterogeneity of PrPSc in CJD extends to abnormal truncated forms of the protein. The findings support the notion of distinct structural "conformers" of PrPSc and indicate that the characterization of truncated PrPSc forms may further improve molecular typing in CJD.	[Notari, Silvio; Strammiello, Rosaria; Capellari, Sabina; Cescatti, Maura; Parchi, Piero] Univ Bologna, Dipartimento Sci Neurol, I-40123 Bologna, Italy; [Giese, Armin; Kretzschmar, Hans A.] Univ Munich, Inst Neuropathol, D-80539 Munich, Germany; [Grassi, Jacques] CEA Saclay, Serv Pharmacol & Immunol, F-91191 Gif Sur Yvette, France; [Ghetti, Bernardino] Indiana Univ, Inst Pathol, Indianapolis, IN 46202 USA; [Langeveld, Jan P. M.] Wageningen Univ, Cent Vet Inst, NL-8200 AB Lelystad, Netherlands; [Zou, Wen-Quan; Gambetti, Pierluigi] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA	University of Bologna; University of Munich; CEA; UDICE-French Research Universities; Universite Paris Saclay; Indiana University System; Indiana University-Purdue University Indianapolis; Wageningen University & Research; Case Western Reserve University	Parchi, P (corresponding author), Univ Bologna, Dipartimento Sci Neurol, Via Foscolo 7, I-40123 Bologna, Italy.	piero.parchi@unibo.it	Parchi, Piero/L-9833-2015; Zou, Wenquan/GWQ-3489-2022; Zou, Wenquan/ABF-2875-2020; Giese, Armin/F-3271-2010; capellari, sabina/F-5545-2012	Parchi, Piero/0000-0002-9444-9524; Giese, Armin/0000-0002-8238-4102; capellari, sabina/0000-0003-1631-1439	European Commission [FOOD-CT-2004-506579]; Italian Ministry of University, Research and Technology [FIRB-2003-RBNE03FMCJ_006]	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of University, Research and Technology(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from the European Commission (Grant FOOD-CT-2004-506579) and the Italian Ministry of University, Research and Technology (Grant FIRB-2003-RBNE03FMCJ_006). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BOLTON DC, 1987, ARCH BIOCHEM BIOPHYS, V258, P579, DOI 10.1016/0003-9861(87)90380-8; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Buschmann A, 1998, BIOCHEM BIOPH RES CO, V253, P693, DOI 10.1006/bbrc.1998.9838; Capellari S, 2000, AM J PATHOL, V157, P613, DOI 10.1016/S0002-9440(10)64572-5; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; KASCSAK RJ, 1986, J VIROL, V59, P676, DOI 10.1128/JVI.59.3.676-683.1986; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kobayashi A, 2007, J BIOL CHEM, V282, P30022, DOI 10.1074/jbc.M704597200; Kocisko DA, 1996, BIOCHEMISTRY-US, V35, P13434, DOI 10.1021/bi9610562; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Kretzschmar H, 2007, PRIONS IN HUMANS AND ANIMALS, P287; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Notari S, 2004, J BIOL CHEM, V279, P16797, DOI 10.1074/jbc.M313220200; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pan T, 2005, J NEUROCHEM, V92, P132, DOI 10.1111/j.1471-4159.2004.02859.x; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 2005, PRIONS: FOOD AND DRUG SAFETY, P77, DOI 10.1007/4-431-29402-3_6; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1999, ALZHEIMER'S DISEASE AND RELATED DISORDERS, P561; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Parchi P, 1997, NATURE, V386, P232, DOI 10.1038/386232a0; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Satoh K, 2003, J GEN VIROL, V84, P2885, DOI 10.1099/vir.0.19236-0; Somerville RA, 1997, NATURE, V386, P564, DOI 10.1038/386564a0; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200; ZOU WQ, 2002, NEUROGENETICS METHOD, P305	54	63	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30557	30565		10.1074/jbc.M801877200	http://dx.doi.org/10.1074/jbc.M801877200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18753138	hybrid, Green Published			2022-12-25	WOS:000260544800014
J	Rabiet, MJ; Huet, E; Boulay, F				Rabiet, Marie-Josephe; Huet, Emilie; Boulay, Francois			Complement Component 5a Receptor Oligomerization and Homologous Receptor Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; C5A ANAPHYLATOXIN RECEPTOR; BETA-ARRESTIN; HL-60 CELLS; MEDIATED INTERNALIZATION; CONFORMATIONAL-CHANGES; PHOSPHORYLATION SITES; SIGNAL-TRANSDUCTION; PAIRED ACTIVATION; CRYSTAL-STRUCTURE	Most G-protein-coupled receptors (GPCRs) form di(oligo)-meric structures that constitute signaling and trafficking units and might be essential for receptor functions. Cell responses to complement C5a receptor (C5aR) are tightly controlled by receptor desensitization and internalization. To examine the implication of dimerization in C5aR regulation, we generated an NH2-terminally modified C5aR mutant, unable to bind C5a, and a phosphorylation-deficient mutant. Neither an intact NH2 terminus nor the presence of COOH-terminal phosphorylation sites appeared to be required for the formation of C5aR dimers. Upon C5a stimulation, mutant receptors did not internalize when individually expressed. C5a stimulation of cells that co-expressed wild type C5aR together with either unliganded or phosphorylation-deficient mutant resulted in co-internalization of mutant receptors with C5aR. Unliganded GPCRs can be cross-phosphorylated within a heterologous receptor dimer or by second messenger-activated kinases. C5a stimulation of P-32-labeled cells that co-expressed the unliganded mutant with either C5aR or the phosphorylation-deficient mutant did not induce phosphorylation of the unliganded mutant. We can thus postulate that, in the case of C5aR, the stimulation and phosphorylation of one monomer is enough to lead to dimer internalization. The existence and functional implication of di(oligo) mer formation may be important for an accurate C5aR down-regulation in pathological conditions.	[Rabiet, Marie-Josephe] Commissariat Energie Atom Grenoble, Lab Biochim & Biophys Syst Integres, Inst Rech Technol & Sci Vivant, UMR 5092, F-38054 Grenoble 9, France; CNRS, UMR 5092, F-38054 Grenoble, France; Univ Grenoble 1, F-38000 Grenoble, France	CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Rabiet, MJ (corresponding author), Commissariat Energie Atom Grenoble, Lab Biochim & Biophys Syst Integres, Inst Rech Technol & Sci Vivant, UMR 5092, 17 Rue Martyrs, F-38054 Grenoble 9, France.	marie-josephe.rabiet@cea.fr			Commissariat a l'Energie Atomique; CNRS; University Joseph Fourier	Commissariat a l'Energie Atomique(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Joseph Fourier	This work was supported by grants from the Commissariat a l'Energie Atomique, CNRS, and the University Joseph Fourier.	Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Braun L, 2003, J BIOL CHEM, V278, P4277, DOI 10.1074/jbc.M210120200; Christophe T, 2000, J BIOL CHEM, V275, P1656, DOI 10.1074/jbc.275.3.1656; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Damian M, 2008, J BIOL CHEM, V283, P21084, DOI 10.1074/jbc.M710419200; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Floyd DH, 2003, J BIOL CHEM, V278, P35354, DOI 10.1074/jbc.M305607200; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; GIANNINI E, 1995, J BIOL CHEM, V270, P19166, DOI 10.1074/jbc.270.32.19166; GIERSCHIK P, 1989, J BIOL CHEM, V264, P21470; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hansen JL, 2004, J BIOL CHEM, V279, P24108, DOI 10.1074/jbc.M400092200; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Klein U, 2001, J BIOL CHEM, V276, P17442, DOI 10.1074/jbc.M009214200; Kobilka BK, 2002, J PEPT RES, V60, P317, DOI 10.1034/j.1399-3011.2002.21062.x; LAEMMLI UK, 1973, NATURE, V227, P680, DOI DOI 10.1038/227680A0; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; MERY L, 1994, J BIOL CHEM, V269, P3457; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Naik N, 1997, J CELL SCI, V110, P2381; Novi F, 2005, J BIOL CHEM, V280, P19768, DOI 10.1074/jbc.M411281200; Novi F, 2004, J BIOL CHEM, V279, P7476, DOI 10.1074/jbc.M306818200; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Sartania N, 2007, CELL SIGNAL, V19, P1928, DOI 10.1016/j.cellsig.2007.05.002; Shi GW, 2005, J BIOL CHEM, V280, P41184, DOI 10.1074/jbc.M506935200; TARDIF M, 1993, J IMMUNOL, V150, P3534; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	51	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31038	31046		10.1074/jbc.M805260200	http://dx.doi.org/10.1074/jbc.M805260200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18772131	Green Published, hybrid			2022-12-25	WOS:000260544800059
J	Nelson, GN; Roh, JD; Mirensky, TL; Wang, Y; Yi, T; Tellides, G; Pober, JS; Shkarin, P; Shapiro, EM; Saltzman, WM; Papademetris, X; Fahmy, TM; Breuer, CK				Nelson, G. N.; Roh, J. D.; Mirensky, T. L.; Wang, Y.; Yi, T.; Tellides, G.; Pober, J. S.; Shkarin, P.; Shapiro, E. M.; Saltzman, W. M.; Papademetris, X.; Fahmy, T. M.; Breuer, C. K.			Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue-engineered vascular grafts in vivo	FASEB JOURNAL			English	Article						SCID/bg; animal model; arterial grafts; MRI	MESENCHYMAL STEM-CELLS; SINGLE MAMMALIAN-CELLS; IRON-OXIDE PARTICLES; BONE-MARROW-CELLS; PROGENITOR CELLS; MOUSE MODEL; NANOPARTICLES; AUTOGRAFTS; RAT; DIFFERENTIATION	This pilot study examines noninvasive MR monitoring of tissue-engineered vascular grafts (TEVGs) in vivo using cells labeled with iron oxide nanoparticles. Human aortic smooth muscle cells (hASMCs) were labeled with ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. The labeled hASMCs, along with human aortic endothelial cells, were incorporated into eight TEVGs and were then surgically implanted as aortic interposition grafts in a C. B-17 SCID/bg mouse host. USPIO-labeled hASMCs persisted in the grafts throughout a 3 wk observation period and allowed noninvasive MR imaging of the human TEVGs for real-time, serial monitoring of hASMC retention. This study demonstrates the feasibility of applying noninvasive imaging techniques for evaluation of in vivo TEVG performance. -Nelson, G. N., Roh, J. D., Mirensky, T. L., Wang, Y., Yi, T., Tellides, G., Pober, J. S., Shkarin, P., Shapiro, E. M., Saltzman, W. M., Papademetris, X., Fahmy, T. M., Breuer, C. K.. Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue-engineered vascular grafts in vivo. FASEB J. 22, 3888-3895 (2008)	[Nelson, G. N.; Roh, J. D.; Mirensky, T. L.; Wang, Y.; Yi, T.; Tellides, G.; Pober, J. S.; Saltzman, W. M.; Fahmy, T. M.; Breuer, C. K.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Shkarin, P.; Shapiro, E. M.; Papademetris, X.] Yale Univ, Dept Radiol, Sch Med, New Haven, CT 06520 USA; [Saltzman, W. M.; Papademetris, X.; Fahmy, T. M.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Breuer, CK (corresponding author), Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, Amistad Res Bldg,10 Amistad St,Rm 301B,POB 208089, New Haven, CT 06520 USA.	christopher.breuer@yale.edu		Breuer, Christopher/0000-0003-0987-3898	U. S. National Institutes of Health [K08HL83980-2, R01 EB006494-01, P01-HL070295]; American Surgical Association; Yale University Office of Student Research; Yale University Department of Surgery Ohse; Howard Hughes Medical Institute Medical Research Training Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070295, K08HL083980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006494] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Surgical Association; Yale University Office of Student Research; Yale University Department of Surgery Ohse; Howard Hughes Medical Institute Medical Research Training Fellowship(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank Nancy Troiano and Chris Coady for their help in GMA and paraffin embedding. This work was supported by grants from the U. S. National Institutes of Health (NIH; K08HL83980-2, R01 EB006494-01 P01-HL070295), the American Surgical Association, the Yale University Office of Student Research, and the Yale University Department of Surgery Ohse Grant Program. In addition, this work was performed as part of an NIH-sponsored Howard Hughes Medical Institute Medical Research Training Fellowship. The authors declare they have no competing financial interests.	Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Anderson SA, 2004, ANN NEUROL, V55, P654, DOI 10.1002/ana.20066; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Blake P, 2003, J NEURO-OPHTHALMOL, V23, P34, DOI 10.1097/00041327-200303000-00009; Breslau J, 1999, AM J NEURORADIOL, V20, P670; Briley-Saebo KC, 2006, INVEST RADIOL, V41, P560, DOI 10.1097/01.rli.0000221321.90261.09; Bulte JWM, 2004, BLOOD, V104, P3410, DOI 10.1182/blood-2004-06-2117; Bulte JWM, 2002, J CEREBR BLOOD F MET, V22, P899, DOI 10.1097/00004647-200208000-00001; Cao F, 2007, J TISSUE ENG REGEN M, V1, P465, DOI 10.1002/term.55; Dodd SJ, 1999, BIOPHYS J, V76, P103, DOI 10.1016/S0006-3495(99)77182-1; Foster-Gareau P, 2003, MAGN RESON MED, V49, P968, DOI 10.1002/mrm.10417; Hilderbrand SA, 2005, BIOCONJUGATE CHEM, V16, P1275, DOI 10.1021/bc0501799; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Ko IK, 2007, ANN BIOMED ENG, V35, P101, DOI 10.1007/s10439-006-9204-7; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Kraitchman DL, 2003, CIRCULATION, V107, P2290, DOI 10.1161/01.CIR.0000070931.62772.4E; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799; Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61; Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7; Modo M, 2005, MOL IMAGING, V4, P143; Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041; Runge V M, 2000, J Magn Reson Imaging, V12, P205, DOI 10.1002/1522-2586(200008)12:2<205::AID-JMRI1>3.0.CO;2-P; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Terrovitis JV, 2006, TISSUE ENG, V12, P2765, DOI 10.1089/ten.2006.12.2765; Zhang Q, 2003, DEFENCE SCI J, V53, P259, DOI 10.14429/dsj.53.2274; Zhang RL, 2003, NEUROSCIENCE, V116, P373, DOI 10.1016/S0306-4522(02)00696-6	30	34	37	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2008	22	11					3888	3895		10.1096/fj.08-107367	http://dx.doi.org/10.1096/fj.08-107367			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18711027	Green Published			2022-12-25	WOS:000260503000017
J	Cheng, D; Iqbal, J; Devenny, J; Chu, CH; Chen, LP; Dong, J; Seethala, R; Keim, WJ; Azzara, AV; Lawrence, RM; Pelleymounter, MA; Hussain, MM				Cheng, Dong; Iqbal, Jahangir; Devenny, James; Chu, Ching-Hsuen; Chen, Luping; Dong, Jessica; Seethala, Ramakrishna; Keim, William J.; Azzara, Anthony V.; Lawrence, R. Michael; Pelleymounter, Mary Ann; Hussain, M. Mahmood			Acylation of Acylglycerols by Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 (DGAT1) FUNCTIONAL IMPORTANCE OF DGAT1 IN THE INTESTINAL FAT ABSORPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA-DIACYLGLYCEROL ACYLTRANSFERASE; TRIGLYCERIDE TRANSFER PROTEIN; DIFFERENTIATED CACO-2 CELLS; MONOACYLGLYCEROL ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; VITAMIN-E; SECRETION; IDENTIFICATION; CHYLOMICRONS; MECHANISMS	Acyl coenzyme A: diacylglycerol acyltransferase 1 (DGAT1) is one of the four intestinal membrane bound acyltransferases implicated in dietary fat absorption. Recently, it was found that, in addition to acylating diacylglycerol (DAG), DGAT1 also possesses robust enzymatic activity for acylating monoacylglycerol (MAG) (Yen, C. L., Monetti, M., Burri, B. J., and Farese, R. V., Jr. (2005) J. Lipid Res. 46, 1502-1511). In the current paper, we have conducted a detailed characterization of this reaction in test tube, intact cell culture, and animal models. Enzymatically, we found that triacylglycerol (TAG) synthesis from MAG by DGAT1 does not behave according to classic Michaelis-Menten kinetics. At low concentrations of 2-MAG (< 50 mu M), the major acylation product by DGAT1 was TAG; however, increased concentrations of 2-MAG (50-200 mu M) resulted in decreased TAG formation. This unique product/substrate relationship is similar to MGAT3 but distinct from DGAT2 and MGAT2. We have also found that XP620 is an inhibitor that selectively inhibits the acylation of MAG by DGAT1(IC50 of human DGAT1: 16.6 +/- 4.0 nM (MAG as substrate) and 1499 +/- 318 nM (DAG as substrate); IC50 values of human DGAT2, MGAT2, and MGAT3 are > 30,000 nM). Using this pharmacological tool, we have shown that similar to 76 and similar to 89% of the in vitro TAG synthesis initiated from MAG is mediated by DGAT1 in Caco-2 cell and rat intestinal mucosal membranes, respectively. When applied to intact cultured cells, XP620 substantially decreased but did not abolish apoB secretion in differentiated Caco-2 cells. It also decreased TAG and DAG syntheses in primary enterocytes. Last, when delivered orally to rats, XP620 decreased absorption of orally administered lipids by similar to 50%. Based on these data, we conclude that the acylation of acylglycerols by DGAT1 is important for dietary fat absorption in the intestine.	[Cheng, Dong; Lawrence, R. Michael] Bristol Myers Squibb Co, Res & Dev, Dept Discovery Chem, Princeton, NJ 08543 USA; [Cheng, Dong; Chu, Ching-Hsuen; Chen, Luping; Keim, William J.; Azzara, Anthony V.; Pelleymounter, Mary Ann] Bristol Myers Squibb Co, Dept Metab Dis, Princeton, NJ 08543 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] SUNY Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] SUNY Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Cheng, D (corresponding author), Bristol Myers Squibb Co, Res & Dev, Dept Discovery Chem, POB 5400, Princeton, NJ 08543 USA.	dong.cheng@bms.com	Iqbal, Jahangir/B-3903-2014	Iqbal, Jahangir/0000-0002-9021-2271				Anwar K, 2007, J LIPID RES, V48, P2028, DOI 10.1194/jlr.M700207-JLR200; Anwar K, 2006, J LIPID RES, V47, P1261, DOI 10.1194/jlr.M500523-JLR200; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bakillah A, 1997, LIPIDS, V32, P1113, DOI 10.1007/s11745-997-0143-8; Bligh EG, 1959, J BIO CHEM PHYSL, V35, P911, DOI DOI 10.1139/059-099.PUBMED:13671378; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; COLEMAN RA, 1986, J BIOL CHEM, V261, P224; Fatma S, 2006, J LIPID RES, V47, P2422, DOI 10.1194/jlr.M600211-JLR200; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Hussain MM, 2000, ATHEROSCLEROSIS, V148, P1; Hussain MM, 1996, BBA-LIPID LIPID MET, V1300, P151, DOI 10.1016/0005-2760(96)00041-0; HUSSAIN MM, 1995, ARTERIOSCL THROM VAS, V15, P485, DOI 10.1161/01.ATV.15.4.485; Hussain MM, 2001, FRONT BIOSCI, V6, pD320, DOI 10.2741/Hussain; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; JAMDAR SC, 1992, ARCH BIOCHEM BIOPHYS, V296, P419, DOI 10.1016/0003-9861(92)90592-K; Jamil H, 1996, P NATL ACAD SCI USA, V93, P11991, DOI 10.1073/pnas.93.21.11991; Lockwood JF, 2003, AM J PHYSIOL-ENDOC M, V285, pE927, DOI 10.1152/ajpendo.00179.2003; Luchoomun J, 1999, J BIOL CHEM, V274, P19565, DOI 10.1074/jbc.274.28.19565; MORAN TH, 1988, AM J PHYSIOL, V254, pR628, DOI 10.1152/ajpregu.1988.254.4.R628; Nayak N, 2001, J LIPID RES, V42, P272; Orland MD, 2005, BBA-MOL CELL BIOL L, V1737, P76, DOI 10.1016/j.bbalip.2005.09.003; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; TROTTER PJ, 1993, J BIOL CHEM, V268, P10017; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899	36	62	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29802	29811		10.1074/jbc.M800494200	http://dx.doi.org/10.1074/jbc.M800494200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768481	Green Published, hybrid			2022-12-25	WOS:000260366900024
J	Houchens, CR; Lu, WY; Chuang, RY; Frattini, MG; Fuller, A; Simancek, P; Kelly, TJ				Houchens, Christopher R.; Lu, Wenyan; Chuang, Ray-Yuan; Frattini, Mark G.; Fuller, Alex; Simancek, Pam; Kelly, Thomas J.			Multiple Mechanisms Contribute to Schizosaccharomyces pombe Origin Recognition Complex-DNA Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROFOLATE-REDUCTASE ORIGIN; ESCHERICHIA-COLI CHROMOSOME; GENOME-WIDE DISTRIBUTION; REPLICATION ORIGINS; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; ADENINE/THYMINE STRETCHES; FUNCTIONAL ELEMENTS; EUKARYOTIC CELLS; INITIATION SITES	Eukaryotic DNA replication requires the assembly of multiprotein pre-replication complexes (pre-RCs) at chromosomal origins of DNA replication. Here we describe the interactions of highly purified Schizosaccharomyces pombe pre-RC components, SpORC, SpCdc18, and SpCdt1, with each other and with ars1 origin DNA. We show that SpORC binds DNA in at least two steps. The first step likely involves electrostatic interactions between the AT-hook motifs of SpOrc4 and AT tracts in ars1 DNA and results in the formation of a salt-sensitive complex. In the second step, the salt-sensitive complex is slowly converted to a salt-stable complex that involves additional interactions between SpORC and DNA. Binding of SpORC to ars1 DNA is facilitated by negative supercoiling and is accompanied by changes in DNA topology, suggesting that SpORC-DNA complexes contain underwound or negatively writhed DNA. Purified human origin recognition complex (ORC) induces similar topological changes in origin DNA, indicating that this property of ORC is conserved in eukaryotic evolution and plays an important role in ORC function. We also show that SpCdc18 and SpCdt1 form a binary complex that has greater affinity for DNA than either protein alone. In addition, both proteins contribute significantly to the stability of the initial SpORC-DNA complex and enhance the SpORC-dependent topology changes in origin DNA. Thus, the formation of stable protein-DNA complexes at S. pombe origins of replication involves binary interactions among all three proteins, as well as interactions of both SpORC and SpCdt1-SpCdc18 with origin DNA. These findings demonstrate that SpORC is not the sole determinant of origin recognition.	[Houchens, Christopher R.; Lu, Wenyan; Fuller, Alex; Simancek, Pam; Kelly, Thomas J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Frattini, Mark G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Houchens, CR (corresponding author), 609 Rockefeller Res Labs,430 E 67th St, New York, NY 10021 USA.	chouchens@sainc.com			National Institutes of Health [GM 50806]; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or part, by National Institutes of Health Grant GM 50806 from the NIGMS (to T. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Arias EE, 2004, FRONT BIOSCI-LANDMRK, V9, P3029, DOI 10.2741/1457; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Biamonti G, 2003, CHROMOSOME RES, V11, P403, DOI 10.1023/A:1024910307162; Biswas SB, 2005, CELL CYCLE, V4, P494; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Breier AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r22; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Chesnokov I, 1999, GENE DEV, V13, P1289, DOI 10.1101/gad.13.10.1289; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; Chuang RY, 2002, J BIOL CHEM, V277, P16920, DOI 10.1074/jbc.M107710200; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; Clyne RK, 1995, EMBO J, V14, P6348, DOI 10.1002/j.1460-2075.1995.tb00326.x; Clyne RK, 1997, METHODS, V13, P221, DOI 10.1006/meth.1997.0522; Cui TJ, 2005, J MOL BIOL, V352, P629, DOI 10.1016/j.jmb.2005.07.048; Dai JL, 2005, P NATL ACAD SCI USA, V102, P337, DOI 10.1073/pnas.0408811102; DIJKWEL PA, 1994, NUCLEIC ACIDS RES, V22, P4989, DOI 10.1093/nar/22.23.4989; Dijkwel PA, 2000, EXP CELL RES, V256, P150, DOI 10.1006/excr.2000.4809; Dijkwel PA, 2002, MOL CELL BIOL, V22, P3053, DOI 10.1128/MCB.22.9.3053-3065.2002; Dubey DD, 1996, CURR BIOL, V6, P467, DOI 10.1016/S0960-9822(02)00514-6; FANGMAN WL, 1983, CELL, V32, P831, DOI 10.1016/0092-8674(83)90069-7; Feng WY, 2007, METHODS, V41, P151, DOI 10.1016/j.ymeth.2006.07.023; Gaczynska M, 2004, P NATL ACAD SCI USA, V101, P17952, DOI 10.1073/pnas.0408369102; Gerbi SA, 2002, CURR OPIN GENET DEV, V12, P243, DOI 10.1016/S0959-437X(02)00292-7; Harvey KJ, 2003, J BIOL CHEM, V278, P48524, DOI 10.1074/jbc.M307661200; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; HUANG RY, 1993, EMBO J, V12, P4521, DOI 10.1002/j.1460-2075.1993.tb06141.x; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; KEARSEY S, 1983, EMBO J, V2, P1571, DOI 10.1002/j.1460-2075.1983.tb01626.x; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kong DC, 2001, MOL CELL BIOL, V21, P8095, DOI 10.1128/MCB.21.23.8095-8103.2001; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; Maher JF, 1996, P NATL ACAD SCI USA, V93, P6716, DOI 10.1073/pnas.93.13.6716; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; MECHALI M, 1984, CELL, V38, P55, DOI 10.1016/0092-8674(84)90526-9; Melendy T, 2001, FRONT BIOSCI-LANDMRK, V6, pD1048, DOI 10.2741/Melendy; Mesner LD, 2003, MOL CELL BIOL, V23, P804, DOI 10.1128/MCB.23.3.804-814.2003; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Moon KY, 1999, P NATL ACAD SCI USA, V96, P12367, DOI 10.1073/pnas.96.22.12367; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Okuno Y, 1999, MOL CELL BIOL, V19, P6699; RAO H, 1994, MOL CELL BIOL, V14, P7643, DOI 10.1128/MCB.14.11.7643; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Rowles A, 1999, J CELL SCI, V112, P2011; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7124; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2007, J BIOL CHEM, V282, P11705, DOI 10.1074/jbc.M700399200; Takahashi T, 2001, GENES CELLS, V6, P837, DOI 10.1046/j.1365-2443.2001.00468.x; Teer Jamie K., 2006, V42, P31, DOI 10.1007/b137221; THEIS JF, 1994, MOL CELL BIOL, V14, P7652, DOI 10.1128/MCB.14.11.7652; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101	61	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30216	30224		10.1074/jbc.M802649200	http://dx.doi.org/10.1074/jbc.M802649200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723846	Green Published, hybrid			2022-12-25	WOS:000260366900066
J	Huang, XW; Li, X; Guo, B				Huang, Xiangwei; Li, Xia; Guo, Bin			KLF6 Induces Apoptosis in Prostate Cancer Cells through Up-regulation of ATF3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; TUMOR-SUPPRESSOR GENE; KRUPPEL-LIKE FACTOR-6; HEPATOCELLULAR-CARCINOMA; RESPONSE GENE; ALLELIC LOSS; C-MYC; EXPRESSION; PROLIFERATION; HOMEOSTASIS	KLF6 (Kruppel-like factor 6) is a zinc finger transcription factor and a tumor suppressor that is frequently mutated in prostate cancer. KLF6 suppresses tumor growth and induces apoptosis in cancer cells through mechanisms still not defined. Here we show that KLF6 induces apoptosis in prostate cancer cells by ATF3 (activating transcription factor 3) expression. KLF6 binds directly to and activates the ATF3 promoter. ATF3 induced apoptosis when ectopically expressed in cells, whereas knockdown of ATF3 by small interference RNA blocked KLF6-induced apoptosis. KLF6 mutants derived from clinical prostate cancers failed to activate the ATF3 promoter and were unable to induce apoptosis. Furthermore, stress conditions (exposure to staurosporine and hypoxia induced by sodium azide) caused significant increase in ATF3 expression and induced apoptosis, whereas knockdown of KLF6 by small interference RNA blocked the increase of ATF3 as well as the induction of apoptosis in these conditions. Thus, ATF3 is a key mediator of KLF6-induced apoptosis in prostate cancer cells.	[Huang, Xiangwei; Li, Xia; Guo, Bin] N Dakota State Univ, Dept Pharmaceut Sci, Coll Pharm, Fargo, ND 58105 USA	North Dakota State University Fargo	Guo, B (corresponding author), N Dakota State Univ, Dept Pharmaceut Sci, Coll Pharm, Fargo, ND 58105 USA.	Bin.Guo@ndsu.edu	Huang, Xiangwei/H-4884-2014; Guo, Bin/AAA-2445-2019	Guo, Bin/0000-0003-3296-9177	National Institutes of Health [5R21CA111765, 2P20RR015566]; NATIONAL CANCER INSTITUTE [R21CA111765] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R21CA111765 (from NCI) and 2P20RR015566 (from the NCRR). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen-Jennings AE, 2001, J BIOL CHEM, V276, P29507, DOI 10.1074/jbc.M100986200; Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943; Benzeno S, 2004, CANCER RES, V64, P3885, DOI 10.1158/0008-5472.CAN-03-2818; Boyle Robert George, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P281; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chen CS, 2003, AM J PATHOL, V162, P1349, DOI 10.1016/S0002-9440(10)63930-2; Chiambaretta F, 2006, INVEST OPHTH VIS SCI, V47, P582, DOI 10.1167/iovs.05-0551; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Ittmann M, 1996, CANCER RES, V56, P2143; Jamerson MH, 2000, ONCOGENE, V19, P1065, DOI 10.1038/sj.onc.1203268; Kremer-Tal S, 2004, HEPATOLOGY, V40, P1047, DOI 10.1002/hep.20460; Li D, 2005, CANCER RES, V65, P9216, DOI 10.1158/0008-5472.CAN-05-1040; Liang GS, 1996, J BIOL CHEM, V271, P1695, DOI 10.1074/jbc.271.3.1695; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Mashima T, 2001, J CELL PHYSIOL, V188, P352, DOI 10.1002/jcp.1130; MIYASHITA T, 1995, CELL, V80, P293; Narla G, 2007, ONCOGENE, V26, P4428, DOI 10.1038/sj.onc.1210223; Narla G, 2005, CANCER RES, V65, P5761, DOI 10.1158/0008-5472.CAN-05-0217; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Pelzer AE, 2006, J UROLOGY, V175, P1517, DOI 10.1016/S0022-5347(05)00651-8; Syed V, 2005, ONCOGENE, V24, P1774, DOI 10.1038/sj.onc.1207991; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Trybus TM, 1996, CANCER RES, V56, P2263; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	31	98	108	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29795	29801		10.1074/jbc.M802515200	http://dx.doi.org/10.1074/jbc.M802515200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18755691	Green Published, hybrid			2022-12-25	WOS:000260366900023
J	Ruusala, A; Pawson, T; Heldin, CH; Aspenstrom, P				Ruusala, Aino; Pawson, Tony; Heldin, Carl-Henrik; Aspenstrom, Pontus			Nck Adapters Are Involved in the Formation of Dorsal Ruffles, Cell Migration, and Rho Signaling Downstream of the Platelet-derived Growth Factor beta Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-INDUCED CHEMOTAXIS; ACTIN POLYMERIZATION; SURFACE-RECEPTORS; PDGF RECEPTOR; BINDING-SITE; PROTEIN; KINASE; TRANSDUCTION; CYTOSKELETON; FIBROBLASTS	The SH3 and SH2 domain-containing adapter proteins Nck1 and Nck2 are known to function downstream of activated tyrosine kinase receptors, such as the platelet-derived growth factor (PDGF) receptors. The SH2 domain of Nck1 binds to phosphorylated tyrosine residue 751 in PDGF beta receptor and has been suggested to have a role in the PDGF-induced mobilization of the actin filament system. Because Tyr-751 is a site for additional receptor interactors, it has been difficult to discriminate the signaling from Nck from signaling via other molecules. For this reason we have used mouse embryonic fibroblasts derived from mice in which the genes for Nck1 and Nck2 have been inactivated by gene targeting (knock-out (KO) cells). The mutant cells had a reduced ability to form edge ruffles in response to PDGF, and the presence of Nck was obligatory for the formation of dorsal ruffles. In addition, the KO cells had a reduced chemotactic and migratory potential. Importantly, KO cells had reduced cell attachment properties and a reduced ability to form focal adhesions in response to serum stimulation. Moreover, signaling involving the Rho GTPases was defective in KO cells. In summary, our observations suggest that the Nck adapters are needed for signaling to Rho GTPases and actin dynamics downstream of the PDGF beta receptor.	[Ruusala, Aino; Heldin, Carl-Henrik; Aspenstrom, Pontus] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Aspenstrom, Pontus] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, SE-17177 Stockholm, Sweden	Ludwig Institute for Cancer Research; Uppsala University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Karolinska Institutet	Aspenstrom, P (corresponding author), Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden.	pontus.aspenstrom@ki.se	Pawson, Tony J/E-4578-2013		Swedish Cancer Society; Swedish Research Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported in part by grants from the Swedish Cancer Society and the Swedish Research Council.	Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Braverman LE, 1999, J BIOL CHEM, V274, P5542, DOI 10.1074/jbc.274.9.5542; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Chen M, 2000, MOL CELL BIOL, V20, P7867, DOI 10.1128/MCB.20.21.7867-7880.2000; CHOU MM, 1992, MOL CELL BIOL, V12, P5834, DOI 10.1128/MCB.12.12.5834; Demoulin JB, 2003, BIOCHEM J, V376, P505, DOI 10.1042/BJ20030385; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Higaki M, 1996, J BIOL CHEM, V271, P29342, DOI 10.1074/jbc.271.46.29342; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; KASHISHIAN A, 1992, EMBO J, V11, P1373, DOI 10.1002/j.1460-2075.1992.tb05182.x; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; Legg JA, 2007, MOL BIOL CELL, V18, P678, DOI 10.1091/mbc.E06-06-0569; LEHMANN JM, 1990, NUCLEIC ACIDS RES, V18, P1048, DOI 10.1093/nar/18.4.1048; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; Li W, 2001, ONCOGENE, V20, P6403, DOI 10.1038/sj.onc.1204782; NISHIMURA R, 1993, MOL CELL BIOL, V13, P6889, DOI 10.1128/MCB.13.11.6889; NOBES CD, 1995, J CELL SCI, V108, P225; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Rao Y, 2005, INT J BIOL SCI, V1, P80; Rijken PJ, 1998, EXP CELL RES, V243, P254, DOI 10.1006/excr.1998.4142; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Ronnstrand L, 2001, INT J CANCER, V91, P757, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1136>3.0.CO;2-J; Ronnstrand L, 1999, ONCOGENE, V18, P3696, DOI 10.1038/sj.onc.1202705; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; WENNSTROM S, 1994, ONCOGENE, V9, P651; Wu CY, 1999, J CELL SCI, V112, P4485	39	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30034	30044		10.1074/jbc.M800913200	http://dx.doi.org/10.1074/jbc.M800913200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18765673	Green Published, hybrid			2022-12-25	WOS:000260366900048
J	Benesch, JLP; Ayoub, M; Robinson, CV; Aquilina, JA				Benesch, Justin L. P.; Ayoub, Marina; Robinson, Carol V.; Aquilina, J. Andrew			Small heat shock protein activity is regulated by variable oligomeric substructure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; MASS-SPECTROMETRY REVEALS; DESMIN-RELATED MYOPATHY; A-CRYSTALLIN; CHAPERONE ACTIVITY; MUTATION; PHOSPHORYLATION; DEAMIDATION	The alpha-crystallins are members of the small heat shock protein family of molecular chaperones that have evolved to minimize intracellular protein aggregation; however, they are also implicated in a number of protein deposition diseases. In this study, we employed novel mass spectrometry techniques to investigate the changes in quaternary structure associated with this switch from chaperone to adjuvant of aggregation. We replicated the oligomeric rearrangements observed for post-translationally modified alpha-crystallins, without altering the protein sequence, by refolding the alpha-crystallins in vitro. This refolding resulted in a loss of dimeric substructure concomitant with an augmentation of substrate affinity. We show that packaging of small heat shock proteins into dimeric units is used to control the level of chaperone function by regulating the exposure of hydrophobic surfaces. We propose that a bias toward monomeric substructure is responsible for the aberrant chaperone behavior associated with the alpha-crystallins in protein deposition diseases.	[Benesch, Justin L. P.; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Ayoub, Marina; Aquilina, J. Andrew] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia	University of Cambridge; University of Wollongong		aquilina@uow.edu.au	Aquilina, J. Andrew/A-5366-2013; Aquilina, John Andrew/AGF-4013-2022	Benesch, Justin/0000-0002-1507-3742; robinson, carol/0000-0001-7829-5505	Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by the Engineering and Physical Sciences Research Council and the Biotechnology and Biological Sciences Research Council.	Aquilina JA, 2005, J BIOL CHEM, V280, P14485, DOI 10.1074/jbc.M500135200; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Aquilina JA, 2001, BIOCHEM BIOPH RES CO, V285, P1107, DOI 10.1006/bbrc.2001.5288; Benesch JLP, 2006, CHEM BIOL, V13, P597, DOI 10.1016/j.chembiol.2006.04.006; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Claxton DP, 2008, J MOL BIOL, V375, P1026, DOI 10.1016/j.jmb.2007.11.014; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Gupta R, 2004, INVEST OPHTH VIS SCI, V45, P206, DOI 10.1167/iovs.03-0720; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; Saha S, 2007, PROTEIN J, V26, P315, DOI 10.1007/s10930-007-9074-3; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	22	83	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28513	28517		10.1074/jbc.M804729200	http://dx.doi.org/10.1074/jbc.M804729200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713743	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000259969300054
J	Biliran, H; Jan, YW; Chen, RW; Pasquale, EB; Ruoslahti, E				Biliran, Hector; Jan, Yiwen; Chen, Renwei; Pasquale, Elena B.; Ruoslahti, Erkki			Protein kinase D is a positive regulator of Bit1 apoptotic function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION SITES; SIGNALING PATHWAYS; WIDE PREDICTION; ACTIVATION; ANOIKIS; IDENTIFICATION; INTEGRINS; SURVIVAL; ADHESION	Bit1 (Bcl-2 inhibitor of transcription) is a mitochondrial protein that induces caspase-independent apoptosis upon its release into the cytoplasm. Bit1 is primarily associated with anoikis (cell death induced by detachment from the extracellular matrix), because the apoptotic function of Bit1 is inhibited by integrin-mediated cell attachment but not by many other antiapoptotic treatments. Here, we show that protein kinase D (PKD) regulates Bit1 apoptotic function. Overexpression of constitutively active PKD or PKD activation by treatment with phorbol 12-myristate 13-acetate results in phosphorylation of two serine residues (Ser(5) and Ser(87)) in a form of Bit1 that is confined to the cytoplasm and concomitantly increases the apoptotic activity of cytoplasmic Bit1. Conversely, suppressing PKD activity with pharmacological inhibitors or small interfering RNA approaches attenuates apoptosis induced by cytoplasmic Bit1. Furthermore, PKD regulates induction of cell death by wild-type Bit1 following loss of cell attachment to the extracellular matrix. Activation of PKD enhances Bit1 function in anoikis, whereas inhibiting PKD function with pharmacological inhibitors or small interfering RNA compromises the ability of Bit1 to induce anoikis. The induction of Bit1-mediated apoptosis by PKD is in part attributable to the release of Bit1 from mitochondria to the cytoplasm as a consequence of phosphorylation of Ser5 in the mitochondrial localization sequence of Bit1. Consistent with the regulatory role of PKD in the anoikis function of Bit1, we found that cell attachment to fibronectin inhibits PKD activity. These studies identify the PKD serine/threonine kinase as one of the signaling molecules through which integrin-mediated cell attachment controls Bit1 activity and anoikis.	[Ruoslahti, Erkki] Univ Calif Santa Barbara, MCDB, Burnham Inst Med Res, Santa Barbara, CA 93106 USA; [Jan, Yiwen; Pasquale, Elena B.; Ruoslahti, Erkki] Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara; Sanford Burnham Prebys Medical Discovery Institute	Ruoslahti, E (corresponding author), Univ Calif Santa Barbara, MCDB, Burnham Inst Med Res, 3119 Biol 2 Bldg, Santa Barbara, CA 93106 USA.	ruoslahti@burnham.org	Chen, Renwei/I-7557-2013		National Institutes of Health; NCI [CA102583, CA098162]; NATIONAL CANCER INSTITUTE [R01CA098162, P01CA102583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants CA102583 and CA098162. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bouchentouf M, 2007, AM J TRANSPLANT, V7, P1491, DOI 10.1111/j.1600-6143.2007.01830.x; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; de Pereda JM, 2004, J BIOL CHEM, V279, P8111, DOI 10.1074/jbc.M311449200; England K, 2001, J BIOL CHEM, V276, P10437, DOI 10.1074/jbc.M009421200; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Ivaska J, 2003, BIOCHEM SOC T, V31, P90, DOI 10.1042/bst0310090; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Kairouz-Wahbe R, 2008, P NATL ACAD SCI USA, V105, P1528, DOI 10.1073/pnas.0711357105; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Lemonnier J, 2004, J BIOL CHEM, V279, P259, DOI 10.1074/jbc.M308665200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Okuda H, 1999, ONCOGENE, V18, P5604, DOI 10.1038/sj.onc.1202946; ROSENGURT E, 1984, P NATL ACAD SCI USA, V81, P5748; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Vertommen D, 2000, J BIOL CHEM, V275, P19567, DOI 10.1074/jbc.M001357200; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737	21	28	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28029	28037		10.1074/jbc.M803139200	http://dx.doi.org/10.1074/jbc.M803139200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18703509	Green Published, hybrid			2022-12-25	WOS:000259969300004
J	Liu, DL; Fritz, DT; Rogers, MB; Shatkin, AJ				Liu, Donglin; Fritz, David T.; Rogers, Melissa B.; Shatkin, Aaron J.			Species-specific cis-regulatory elements in the 3 '-untranslated region direct alternative polyadenylation of bone morphogenetic protein 2 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CANDIDATE GENES; BMP2; TRANSCRIPTION; MECHANISM; MOUSE; CELLS; POLYMORPHISM; REPRESSION; GROWTH	BMP2 (bone morphogenetic protein 2) is a multifunctional member of the transforming growth factor-beta family of growth factors. Disruption of BMP2 signaling results in developmental defects, cancers, and other diseases. BMP2 mRNAs are alternatively polyadenylated, resulting in mRNAs with distinct 3'-untranslated regions. The longer mRNA contains additional putative binding sites for post-transcriptional regulatory factors, including micro-RNAs. We combined functional assays with computational analyses of emerging genome data to define site- and species-specific polyadenylation determinants. In all mouse and human cell lines tested, shorter mRNAs resulting from using the first polyadenylation signal (PA1) were more abundant than mRNAs from the second signal (PA2). However, the PA1/PA2 usage ratios were 2-3-fold higher in human than in mouse cells. Expression of human BMP2 constructs in mouse cells and mouse constructs in human cells showed that cis-regulatory elements direct species-specific 3' processing of BMP2 transcripts. A 72-nucleotide region downstream of PA2 in the mouse sequence contains two novel cis-acting elements previously hypothesized to regulate polyadenylation in a bioinformatics analysis. Mutations that humanized the mouse-specific elements lowered the affinity for cleavage stimulation factor CstF64 and significantly weakened the PA2 signal relative to the PA1 signal. Thus, we have experimentally defined for the first time cis-regulatory elements that control a species-specific difference in the 3'-end processing of BMP2 and potentially of other genes.	[Liu, Donglin; Shatkin, Aaron J.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Fritz, David T.; Rogers, Melissa B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Shatkin, AJ (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Ln, Piscataway, NJ 08854 USA.	shatkin@cabm.rutgers.edu			New Jersey Commission on Cancer Research [05-2413-CCR-EO]; Foundation of UMDNJ; Center for Advanced Biotechnology and Medicine	New Jersey Commission on Cancer Research; Foundation of UMDNJ; Center for Advanced Biotechnology and Medicine	This work was supported by New Jersey Commission on Cancer Research Postdoctoral Fellowship 05-2413-CCR-EO (to D. L.), by a grant from the Foundation of UMDNJ (to M. B. R.), and by the Center for Advanced Biotechnology and Medicine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abrams KL, 2004, J BIOL CHEM, V279, P15916, DOI 10.1074/jbc.M313531200; Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cheng YM, 2006, BIOINFORMATICS, V22, P2320, DOI 10.1093/bioinformatics/btl394; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; FENG JQ, 1994, BBA-GENE STRUCT EXPR, V1218, P221, DOI 10.1016/0167-4781(94)90017-5; Fritz DT, 2006, MOL ENDOCRINOL, V20, P1574, DOI 10.1210/me.2005-0469; Fritz DT, 2004, J BIOL CHEM, V279, P48950, DOI 10.1074/jbc.M409620200; Fukui N, 2006, J BIOL CHEM, V281, P27229, DOI 10.1074/jbc.M603385200; Gilmartin GM, 2005, GENE DEV, V19, P2517, DOI 10.1101/gad.1378105; Grzybowska EA, 2001, BIOCHEM BIOPH RES CO, V288, P291, DOI 10.1006/bbrc.2001.5738; Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Heller LC, 1999, J BIOL CHEM, V274, P1394, DOI 10.1074/jbc.274.3.1394; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Horvath LG, 2004, PROSTATE, V59, P234, DOI 10.1002/pros.10361; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Natalizio BJ, 2002, J BIOL CHEM, V277, P42733, DOI 10.1074/jbc.M208070200; Pennisi E, 2004, SCIENCE, V306, P632, DOI 10.1126/science.306.5696.632; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Proudfoot N, 1996, CELL, V87, P779, DOI 10.1016/S0092-8674(00)81982-0; Proudfoot N, 2000, TRENDS BIOCHEM SCI, V25, P290, DOI 10.1016/S0968-0004(00)01591-7; REDDY BM, 2001, INT J HUM GENET, V1, P1; Reinholz MM, 2002, BREAST CANCER RES TR, V74, P255, DOI 10.1023/A:1016339120506; Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006; SAMPATH TK, 1993, P NATL ACAD SCI USA, V90, P6004, DOI 10.1073/pnas.90.13.6004; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Valdes AM, 2006, ARTHRITIS RHEUM-US, V54, P533, DOI 10.1002/art.21621; Wahle E, 1997, PROG NUCLEIC ACID RE, V57, P41, DOI 10.1016/S0079-6603(08)60277-9; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; Weiner AM, 2005, MOL CELL, V20, P168, DOI 10.1016/j.molcel.2005.10.009; Wittrant Y, 2006, INT J ONCOL, V28, P261; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xiong DH, 2006, J BONE MINER RES, V21, P1678, DOI 10.1359/JBMR.060808; Xu JW, 2007, GENE, V392, P221, DOI 10.1016/j.gene.2006.12.032; Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	50	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28010	28019		10.1074/jbc.M804895200	http://dx.doi.org/10.1074/jbc.M804895200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18703506	Green Published, hybrid			2022-12-25	WOS:000259969300002
J	Pedro-Segura, E; Vergara, SV; Rodriguez-Navarro, S; Parker, R; Thiele, DJ; Puig, S				Pedro-Segura, Elisa; Vergara, Sandra V.; Rodriguez-Navarro, Susana; Parker, Roy; Thiele, Dennis J.; Puig, Sergi			The Cth2 ARE-binding protein recruits the Dhh1 helicase to promote the decay of succinate dehydrogenase SDH4 mRNA in response to iron deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; AU-RICH ELEMENTS; SACCHAROMYCES-CEREVISIAE; PROCESSING BODIES; P-BODIES; GENE-EXPRESSION; YEAST; HOMEOSTASIS; TRISTETRAPROLIN; DEGRADATION	Iron is an essential nutrient that participates as a redox cofactor in a broad range of cellular processes. In response to iron deficiency, the budding yeast Saccharomyces cerevisiae induces the expression of the Cth1 and Cth2 mRNA-binding proteins to promote a genome-wide remodeling of cellular metabolism that contributes to the optimal utilization of iron. Cth1 and Cth2 proteins bind to specific AU-rich elements within the 3'-untranslated region of many mRNAs encoding proteins involved in iron-dependent pathways, thereby promoting their degradation. Here, we show that the DEAD box Dhh1 helicase plays a crucial role in the mechanism of Cth2-mediated mRNA turnover. Yeast two-hybrid experiments indicate that Cth2 protein interacts in vivo with the carboxyl-terminal domain of Dhh1. We demonstrate that the degradation of succinate dehydrogenase SDH4 mRNA, a known target of Cth2 on iron-deficient conditions, depends on Dhh1. In addition, we localize the Cth2 protein to cytoplasmic processing bodies in strains defective in the 5' to 3' mRNA decay pathway. Finally, the degradation of trapped SDH4 mRNA intermediates by Cth2 supports the 5' to 3' directionality of mRNA turnover. Taken together, these results suggest that Cth2 protein recruits the Dhh1 helicase to ARE-containing mRNAs to promote mRNA decay.	[Pedro-Segura, Elisa; Puig, Sergi] Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Valencia, Spain; [Vergara, Sandra V.; Thiele, Dennis J.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27710 USA; [Rodriguez-Navarro, Susana] Ctr Invest Principe Felipe, E-46013 Valencia, Spain; [Parker, Roy] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Parker, Roy] Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Valencia; Duke University; Prince Felipe Research Center; University of Arizona; Howard Hughes Medical Institute; University of Arizona	Pedro-Segura, E (corresponding author), Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Valencia, Spain.	sergi.puig@uv.es	Rodríguez-Navarro, Susana/B-5182-2014; Puig, Sergi/E-4788-2010	Rodríguez-Navarro, Susana/0000-0001-7472-3111; Puig, Sergi/0000-0002-1856-490X	National Institutes of Health [GM041840, FDK081304A]; Spanish Ministerio de Educacion y Ciencia [BIO2005-07120]; Generalitat Valenciana Grant [GV05-081]; European Community; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Generalitat Valenciana Grant(Center for Forestry Research & Experimentation (CIEF)); European Community(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM041840 (to D. J. T.) and National Institutes of Health Predoctoral Fellowship FDK081304A (to S. V. V.). This work was also supported by Spanish Ministerio de Educacion y Ciencia Grant BIO2005-07120, Generalitat Valenciana Grant GV05-081, and FEDER funds from the European Community (to S. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAYNES RD, 1990, ANNU REV NUTR, V10, P133, DOI [10.1146/annurev.nutr.10.1.133, 10.1146/annurev.nu.10.070190.001025]; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905; Ciais D, 2008, NUCLEIC ACIDS RES, V36, P3075, DOI 10.1093/nar/gkn160; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Courel M, 2005, MOL CELL BIOL, V25, P6760, DOI 10.1128/MCB.25.15.6760-6771.2005; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; He WH, 1999, METHODS, V17, P3, DOI 10.1006/meth.1998.0701; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Jang LT, 2006, J BIOL CHEM, V281, P29379, DOI 10.1074/jbc.M601573200; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pilkington GR, 2008, MOL CELL BIOL, V28, P1298, DOI 10.1128/MCB.00936-07; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Puig S, 2007, PLANT CELL ENVIRON, V30, P271, DOI 10.1111/j.1365-3040.2007.01642.x; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4	39	58	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28527	28535		10.1074/jbc.M804910200	http://dx.doi.org/10.1074/jbc.M804910200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18715869	Green Published, hybrid			2022-12-25	WOS:000259969300056
J	De La Fuente, IM; Martinez, L; Perez-Samartin, AL; Ormaetxea, L; Amezaga, C; Vera-Lopez, A				De La Fuente, Ildefonso M.; Martinez, Luis; Perez-Samartin, Alberto L.; Ormaetxea, Leire; Amezaga, Cristian; Vera-Lopez, Antonio			Global Self-Organization of the Cellular Metabolic Structure	PLOS ONE			English	Article							CITRIC-ACID CYCLE; AUTONOMOUS OSCILLATIONS; CIRCADIAN OSCILLATIONS; WAVELET ANALYSIS; COMPLEX; COMPARTMENTATION; DEHYDROGENASE; NETWORKS; DYNAMICS; CULTURES	Background: Over many years, it has been assumed that enzymes work either in an isolated way, or organized in small catalytic groups. Several studies performed using "metabolic networks models'' are helping to understand the degree of functional complexity that characterizes enzymatic dynamic systems. In a previous work, we used "dissipative metabolic networks'' (DMNs) to show that enzymes can present a self-organized global functional structure, in which several sets of enzymes are always in an active state, whereas the rest of molecular catalytic sets exhibit dynamics of on-off changing states. We suggested that this kind of global metabolic dynamics might be a genuine and universal functional configuration of the cellular metabolic structure, common to all living cells. Later, a different group has shown experimentally that this kind of functional structure does, indeed, exist in several microorganisms. Methodology/Principal Findings: Here we have analyzed around 2.500.000 different DMNs in order to investigate the underlying mechanism of this dynamic global configuration. The numerical analyses that we have performed show that this global configuration is an emergent property inherent to the cellular metabolic dynamics. Concretely, we have found that the existence of a high number of enzymatic subsystems belonging to the DMNs is the fundamental element for the spontaneous emergence of a functional reactive structure characterized by a metabolic core formed by several sets of enzymes always in an active state. Conclusions/Significance: This self-organized dynamic structure seems to be an intrinsic characteristic of metabolism, common to all living cellular organisms. To better understand cellular functionality, it will be crucial to structurally characterize these enzymatic self-organized global structures.	[De La Fuente, Ildefonso M.; Martinez, Luis; Ormaetxea, Leire; Vera-Lopez, Antonio] Univ Basque Country, Fac Ciencias & Tecnol, Dept Matemat, Vizcaya, Spain; [Perez-Samartin, Alberto L.; Amezaga, Cristian] Univ Basque Country, Fac Med, Dept Neuroci, Vizcaya, Spain	University of Basque Country; University of Basque Country	De La Fuente, IM (corresponding author), Univ Basque Country, Fac Ciencias & Tecnol, Dept Matemat, Vizcaya, Spain.	luis.martinez@ehu.es	Martínez, Luis/G-6266-2012; Vera-López, Antonio/P-3022-2016; Samartín, Alberto Pérez/AAB-1336-2019; Ormaetxea, Leyre/F-9669-2016; Samartín, Alberto Pérez/AAB-6428-2019	Martínez, Luis/0000-0002-6297-1449; Samartín, Alberto Pérez/0000-0003-0834-0424; De la Fuente, Ildefonso/0000-0001-6548-7583; Vera-Lopez, Antonio/0000-0002-0351-2701	Spanish Ministry of Science and Education [MTM2005-01504, MTM2004-04665]; FEDER; Basque Government [IT252-07]	Spanish Ministry of Science and Education(Spanish Government); FEDER(European Commission); Basque Government(Basque Government)	This work has been supported by the Spanish Ministry of Science and Education Grants MTM2005-01504, MTM2004-04665, partly with FEDER funds, and by the Basque Government, Grant IT252-07.	Ainscow EK, 2002, DIABETES, V51, pS162, DOI 10.2337/diabetes.51.2007.S162; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Allegrini P, 1998, PHYS REV E, V57, P4558, DOI 10.1103/PhysRevE.57.4558; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Audit B, 2004, J BIOL PHYS, V30, P33, DOI 10.1023/B:JOBP.0000016438.86794.8e; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BARNES SJ, 1986, FEBS LETT, V201, P267, DOI 10.1016/0014-5793(86)80621-4; Battogtokh D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.148102; BEECKMANS S, 1981, EUR J BIOCHEM, V117, P527; Bernhardsson S, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026104; Chen F, 2007, J PHYS A-MATH THEOR, V40, P5013, DOI 10.1088/1751-8113/40/19/006; Chiam KH, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061901; Das M, 2003, J NEUROPHYSIOL, V89, P833, DOI 10.1152/jn.00757.2002; De la Fuente IM, 2006, ANN BIOMED ENG, V34, P295, DOI 10.1007/s10439-005-9026-z; De La Fuente IM, 1999, B MATH BIOL, V61, P573, DOI 10.1006/bulm.1999.0103; De la Fuente IM, 1999, BIOSYSTEMS, V50, P83, DOI 10.1016/S0303-2647(98)00094-X; DelaFuente IM, 1996, BIOSYSTEMS, V39, P87, DOI 10.1016/0303-2647(95)01603-1; delaFuente IM, 1996, BIOPHYS J, V71, P2375, DOI 10.1016/S0006-3495(96)79431-6; DELAFUENTE MI, 1996, ACTA BIOTHEOR, V46, P37; DROSSEL B, 2008, ANN REV NON IN PRESS, V1; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Getty L, 2000, J CLIN INVEST, V106, P421, DOI 10.1172/JCI7815; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Goldbeter A., 1990, RYTHMES CHAOS SYSTEM; Gonze D, 2004, INT J QUANTUM CHEM, V98, P228, DOI 10.1002/qua.10875; Grimaldi B, 2007, NATURE, V447, P386, DOI 10.1038/447386a; Haimovich AD, 2006, J COMPUT BIOL, V13, P1289, DOI 10.1089/cmb.2006.13.1289; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Heinrich R., 1996, REGULATION CELLULAR; Hess B, 1997, Q REV BIOPHYS, V30, P121, DOI 10.1017/S003358359700334X; Hideshima T, 2006, BIOPHYS CHEM, V124, P100, DOI 10.1016/j.bpc.2006.04.017; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Jovanovic S, 2007, J MOL BIOL, V371, P349, DOI 10.1016/j.jmb.2007.05.081; Jules M, 2005, FEBS J, V272, P1490, DOI 10.1111/j.1742-4658.2005.04588.x; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kauffman S.A., 1993, ORIGINS ORDER; Kazachenko VN, 2007, BIOCHEM MOSC SUPPL S, V1, P169, DOI 10.1134/S1990747807020109; KHOLODENKO BN, 1992, EUR J BIOCHEM, V210, P147, DOI 10.1111/j.1432-1033.1992.tb17402.x; Kim DH, 2005, PHYSICA A, V351, P671, DOI 10.1016/j.physa.2004.12.026; Kindzelskii AL, 1998, BIOPHYS J, V74, P90, DOI 10.1016/S0006-3495(98)77770-7; Klevecz RR, 2001, MOL BIOL REP, V28, P73, DOI 10.1023/A:1017909012215; KURGANOV BI, 1993, TRENDS BIOCHEM SCI, V18, P405, DOI 10.1016/0968-0004(93)90133-8; KWANG G, 2002, P NATL ACAD SCI USA, V99, P12583; LELOUP JC, 2005, COMPUTATIONAL SYSTEM; Long MS, 2005, P NATL ACAD SCI USA, V102, P5920, DOI 10.1073/pnas.0409333102; Lunn JE, 2007, J EXP BOT, V58, P35, DOI 10.1093/jxb/erl134; Lyubarev AE, 1997, BIOSYSTEMS, V42, P103, DOI 10.1016/S0303-2647(96)01698-X; Ma HW, 2004, BIOINFORMATICS, V20, P1870, DOI 10.1093/bioinformatics/bth167; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; Mair T, 2006, BIOSYSTEMS, V83, P188, DOI 10.1016/j.biosystems.2005.05.016; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; MOWBRAY J, 1976, EUR J BIOCHEM, V66, P25, DOI 10.1111/j.1432-1033.1976.tb10421.x; Nelson L. D., 2004, LEHNINGER PRINCIPLES; Newman MEJ, 2000, J STAT PHYS, V101, P819, DOI 10.1023/A:1026485807148; Nicolis G., 1977, SELF ORG NONEQUILIBR; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P83, DOI 10.1023/B:MCBI.0000009860.86969.72; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P5, DOI 10.1023/B:MCBI.0000009855.14648.2c; Ovadi J, 2000, INT REV CYTOL, V192, P255; PORPACZY Z, 1987, J BIOL CHEM, V262, P9509; Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046; Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501; RAPP PE, 1987, PROG NEUROBIOL, V29, P261, DOI 10.1016/0301-0082(87)90023-2; RAPP PE, 1979, J EXP BIOL, V81, P281; Reddy VN, 1996, COMPUT BIOL MED, V26, P9, DOI 10.1016/0010-4825(95)00042-9; Reisig W., 1985, PETRI NETS INTRO, V4, DOI 10.1007/978-3-642-69968-9; Rosenspire AJ, 2001, J CELL SCI, V114, P1515; Sanchez-Armass S, 2006, AM J PHYSIOL-CELL PH, V290, pC524, DOI 10.1152/ajpcell.00290.2005; Schuster S, 2002, BIOINFORMATICS, V18, P351, DOI 10.1093/bioinformatics/18.2.351; SRERE PA, 1997, CHANNELING INTERMEDI; TIGYI G, 1990, P NATL ACAD SCI USA, V87, P1521, DOI 10.1073/pnas.87.4.1521; Tsumoto K, 2006, J THEOR BIOL, V239, P101, DOI 10.1016/j.jtbi.2005.07.017; TU TB, 2006, NATURE REV MOL CELL, V7, P696; Viswanathan GM, 1997, BIOPHYS J, V72, P866, DOI 10.1016/S0006-3495(97)78721-6; WALTER H, 1999, MICROCOMPARTMENTATIO, V192; Winfree AT., 1980, GEOMETRY BIOL TIME; Wittmann C, 2005, BIOTECHNOL BIOENG, V89, P839, DOI 10.1002/bit.20408; Zevedei-Oancea Ionela, 2003, In Silico Biology, V3, P323	83	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3100	10.1371/journal.pone.0003100	http://dx.doi.org/10.1371/journal.pone.0003100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769681	gold, Green Published			2022-12-25	WOS:000264796800007
J	Conte, C; Riant, E; Toutain, C; Pujol, F; Arnal, JF; Lenfant, F; Prats, AC				Conte, Caroline; Riant, Elodie; Toutain, Celine; Pujol, Francoise; Arnal, Jean-Francois; Lenfant, Francoise; Prats, Anne-Catherine			FGF2 Translationally Induced by Hypoxia Is Involved in Negative and Positive Feedback Loops with HIF-1 alpha	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; INTERNAL RIBOSOME ENTRY; MESSENGER-RNA TRANSLATION; SKELETAL-MUSCLE; GENE-EXPRESSION; CELL STRESS; IRES; SITE; INDUCTION; APOPTOSIS	Background: Fibroblast growth factor 2 (FGF2) is a major angiogenic factor involved in angiogenesis and arteriogenesis, however the regulation of its expression during these processes is poorly documented. FGF2 mRNA contains an internal ribosome entry site (IRES), a translational regulator expected to allow mRNA expression during cellular stress. Methodology/Principal Findings: In the present study, we have developed a skin ischemia model in transgenic mice expressing a reporter transgene under the control of the FGF2 IRES. The results reveal that FGF2 is induced at the protein level during ischemia, concomitant with HIF-1 alpha induction and a decrease in FGF2 mRNA. In addition, the FGF2 IRES is strongly activated under these ischemic conditions associated with hypoxia, whereas cap-dependent translation is repressed by 4E-BP hypophosphorylation. We also show that up-regulation of FGF2 protein expression in response to hypoxia correlates with the increase of FGF2 IRES activity in vitro, in human retinoblasts 911. The use of siRNAs targeting HIF or FGF2 indicates that FGF2 and HIF-1 alpha reciprocally regulate their expression/accumulation, by a negative feedback loop in early hypoxia, followed by a positive feedback loop in late hypoxia. Conclusion/Significance: FGF2 expression is up-regulated in vivo and in vitro in response to hypoxia. Strikingly, this up-regulation is not transcriptional. It seems to occur by an IRES-dependent mechanism, revealing new mechanistic aspects of the hypoxic response. In addition, our data show that FGF2 interacts with HIF-1 alpha in a unique crosstalk, with distinct stages in early and late hypoxia. These data reveal the physiological importance of IRES-dependent translation during hypoxic stress and underline the complexity of the cellular response to hypoxia, suggesting a novel role of FGF2 in the regulation of HIF-1 alpha during the induction of angiogenesis.	[Conte, Caroline; Riant, Elodie; Toutain, Celine; Pujol, Francoise; Arnal, Jean-Francois; Lenfant, Francoise; Prats, Anne-Catherine] Fac Med Toulouse, INSERM, U858, Toulouse, France; [Conte, Caroline; Riant, Elodie; Toutain, Celine; Pujol, Francoise; Arnal, Jean-Francois; Lenfant, Francoise; Prats, Anne-Catherine] Univ Toulouse 3, Inst Med Mol Rangueil, IFR31, F-31062 Toulouse, France; [Arnal, Jean-Francois] Ctr Hosp Univ Toulouse, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Conte, C (corresponding author), Fac Med Toulouse, INSERM, U858, Toulouse, France.	Anne-Catherine.Prats@inserm.fr	CONTE, Caroline/F-1445-2010; Prats, Anne-Catherine/E-5051-2016	CONTE, Caroline/0000-0001-6982-0478; Prats, Anne-Catherine/0000-0002-5282-3776; LENFANT, Francoise/0000-0003-0024-7241; ARNAL, Jean Francois/0000-0003-2229-6300	Agence Nationale pour la Recherche; Association Francaise contre les Myopathies; Association pour la Recherche sur le Cancer; Canceropole Grand Sud-Ouest; Conseil Regional Midi-Pyrenees; Fondation de l'Avenir; Ligue Contre le Cancer	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Canceropole Grand Sud-Ouest; Conseil Regional Midi-Pyrenees(Region Pays de la LoireRegion OccitanieRegion Ile-de-France); Fondation de l'Avenir; Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from the Agence Nationale pour la Recherche, Association Francaise contre les Myopathies, Association pour la Recherche sur le Cancer, Canceropole Grand Sud-Ouest, Conseil Regional Midi-Pyrenees, Fondation de l'Avenir, Ligue Contre le Cancer.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Arnaud E, 1999, MOL CELL BIOL, V19, P505; BIKFALVI A, 1995, J CELL BIOL, V129, P233, DOI 10.1083/jcb.129.1.233; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Black SM, 2008, AM J PHYSIOL-CELL PH, V294, pC345, DOI 10.1152/ajpcell.00216.2007; Bornes S, 2007, CIRC RES, V100, P305, DOI 10.1161/01.RES.0000258873.08041.c9; Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; COUDERC B, 1991, CELL REGUL, V2, P709, DOI 10.1091/mbc.2.9.709; Creancier L, 2000, J CELL BIOL, V150, P275, DOI 10.1083/jcb.150.1.275; Delluc-Clavieres A, 2008, GENE THER, V15, P1090, DOI 10.1038/gt.2008.49; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; Garmy-Susini B, 2004, CIRC RES, V94, P1301, DOI 10.1161/01.RES.0000127719.13255.81; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gonzalez-Herrera IG, 2006, BIOCHEM SOC T, V34, P17, DOI 10.1042/BST0340017; Gonzalez-Herrera IG, 2006, FASEB J, V20, P476, DOI 10.1096/fj.04-3314fje; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; Holcik M, 2005, RNA, V11, P1605, DOI 10.1261/rna.2158605; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Javerzat S, 2002, TRENDS MOL MED, V8, P483, DOI 10.1016/S1471-4914(02)02394-8; Junemann C, 2007, J BIOL CHEM, V282, P132, DOI 10.1074/jbc.M608750200; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Lewis SM, 2005, CELL DEATH DIFFER, V12, P547, DOI 10.1038/sj.cdd.4401602; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Prats AC, 2002, PROG NUCLEIC ACID RE, V72, P367, DOI 10.1016/S0079-6603(02)72075-8; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Teshima-Kondo S, 2004, FASEB J, V18, P1583, DOI 10.1096/fj.03-1118fje; Thomas JD, 2007, RNA, V13, P1116, DOI 10.1261/rna.534807; Touriol C, 1999, J BIOL CHEM, V274, P21402, DOI 10.1074/jbc.274.30.21402; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; VAGNER S, 1995, MOL CELL BIOL, V15, P35, DOI 10.1128/MCB.15.1.35; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208	42	58	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3078	10.1371/journal.pone.0003078	http://dx.doi.org/10.1371/journal.pone.0003078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728783	Green Published, Green Submitted, gold			2022-12-25	WOS:000264796400018
J	Reed, LK; LaFlamme, BA; Markow, TA				Reed, Laura K.; LaFlamme, Brooke A.; Markow, Therese A.			Genetic Architecture of Hybrid Male Sterility in Drosophila: Analysis of Intraspecies Variation for Interspecies Isolation	PLOS ONE			English	Article							SHOWING SEGREGATION DISTORTION; MOLECULAR POPULATION-GENETICS; BEETLE TRIBOLIUM-CASTANEUM; MAXIMUM-LIKELIHOOD MODELS; REPRODUCTIVE ISOLATION; SPECIATION; MOJAVENSIS; SEX; DIFFERENTIATION; INCOMPATIBILITY	Background: The genetic basis of postzygotic isolation is a central puzzle in evolutionary biology. Evolutionary forces causing hybrid sterility or inviability act on the responsible genes while they still are polymorphic, thus we have to study these traits as they arise, before isolation is complete. Methodology/Principal Findings: Isofemale strains of D. mojavensis vary significantly in their production of sterile F-1 sons when females are crossed to D. arizonae males. We took advantage of the intraspecific polymorphism, in a novel design, to perform quantitative trait locus (QTL) mapping analyses directly on F-1 hybrid male sterility itself. We found that the genetic architecture of the polymorphism for hybrid male sterility (HMS) in the F-1 is complex, involving multiple QTL, epistasis, and cytoplasmic effects. Conclusions/Significance: The role of extensive intraspecific polymorphism, multiple QTL, and epistatic interactions in HMS in this young species pair shows that HMS is arising as a complex trait in this system. Directional selection alone would be unlikely to maintain polymorphism at multiple loci, thus we hypothesize that directional selection is unlikely to be the only evolutionary force influencing postzygotic isolation.	[Reed, Laura K.; LaFlamme, Brooke A.; Markow, Therese A.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Reed, Laura K.] North Carolina State Univ, Dept Genet, Raleigh, NC USA; [LaFlamme, Brooke A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Markow, Therese A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of Arizona; University of North Carolina; North Carolina State University; Cornell University; University of California System; University of California San Diego	Reed, LK (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	lkreed@ncsu.edu		LaFlamme, Brooke/0000-0003-3010-4209	National Science Foundation [DBI-9602249, DGE-0114420]; University of Arizona [DEB 0414184, DEB 95-10645, DEB 0075312]	National Science Foundation(National Science Foundation (NSF)); University of Arizona	National Science Foundation support for this work was provided by Interdisciplinary Research Training Group on Plant-Insect Interactions (DBI-9602249) to the University of Arizona and the Integrative Graduate Education and Research Training Grant in Evolutionary, Computational, and Molecular Approaches to Genome Structure and Function (DGE-0114420) to the University of Arizona, Doctoral Dissertation Improvement Grant (DEB 0414184) to LKR, and grants (DEB 95-10645 and DEB 0075312) to TAM. In addition, the Undergraduate Biological Research Program (UBRP) at the University of Arizona supported BAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; AYALA FJ, 1974, EVOLUTION, V28, P24, DOI 10.1111/j.1558-5646.1974.tb00723.x; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Barbash DA, 2003, GENETICS, V163, P217; BASTEN CJ, 2002, QTL CARTOGRAPHER; BASTEN CJ, 1994, P 5 WORLD C GEN APPL, P65; Bateson W., 1909, DOI 10.1017/CBO9780511693953.007; BEAVIS WD, 1994, 49 ANN CORN SORGH RE, P252; Begun DJ, 2000, GENETICS, V156, P1879; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Carvajal AR, 1996, GENETICA, V98, P1, DOI 10.1007/BF00120214; CHRISTIE P, 1984, J HERED, V75, P510, DOI 10.1093/oxfordjournals.jhered.a110004; CHURCHILL GA, 1994, GENETICS, V138, P963; Coyne JA, 2000, EVOLUTION, V54, P306, DOI 10.1111/j.0014-3820.2000.tb00033.x; COYNE JA, 1989, EVOLUTION, V43, P362, DOI 10.1111/j.1558-5646.1989.tb04233.x; Coyne JA, 1997, EVOLUTION, V51, P295, DOI 10.1111/j.1558-5646.1997.tb02412.x; Coyne JA, 2004, SPECIATION, V37; Crow J. F., 1942, University of Texas Publications, Vno. 4228, P53; Demuth JP, 2007, EVOLUTION, V61, P494, DOI 10.1111/j.1558-5646.2007.00048.x; Demuth JP, 2007, EVOLUTION, V61, P694, DOI 10.1111/j.1558-5646.2007.00049.x; Demuth JP, 2005, AM NAT, V165, P524, DOI 10.1086/429276; Dobzhansky T., 1937; Falconer D. S, 1996, INTRO QUANTITATIVE G; FISHER RA, 1949, HEREDITY, V3, P215, DOI 10.1038/hdy.1949.13; Gasper J, 2006, AM J HUM GENET, V79, P820, DOI 10.1086/508473; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Goodnight CJ, 2000, EVOLUTION, V54, P317, DOI 10.1111/j.0014-3820.2000.tb00034.x; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hamm D, 2007, AM J HUM GENET, V81, P44, DOI 10.1086/518695; Hollingshead L, 1930, GENETICS, V15, P114; Hutchinson JB, 1932, J GENET, V25, P281, DOI 10.1007/BF02984592; Huxley J, 1940, NEW SYSTEMATICS, P185; Kazianis S, 1998, GENE CHROMOSOME CANC, V22, P210, DOI 10.1002/(SICI)1098-2264(199807)22:3<210::AID-GCC6>3.0.CO;2-Z; KIMURA M, 1969, GENETICS, V61, P763; KIMURA M T, 1987, Kontyu, V55, P429; Kopp A, 2005, GENETICA, V125, P55, DOI 10.1007/s10709-005-4787-8; LANDER E, 1987, CYTOGENET CELL GENET, V46, P642; Levitan DR, 2006, SCIENCE, V312, P267, DOI 10.1126/science.1122183; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; LORIEUX M, 1995, THEOR APPL GENET, V90, P73, DOI 10.1007/BF00220998; Lynch M., 1998, GENETICS ANAL QUANTI; Macknight RH, 1939, GENETICS, V24, P180; Mainland G. B., 1942, University of Texas Publications, Vno. 4228, P74; Markow TA, 1998, ENDLESS FORMS, P234; Masly JP, 2007, PLOS BIOL, V5, P1890, DOI 10.1371/journal.pbio.0050243; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Matzkin LM, 2004, MOL BIOL EVOL, V21, P276, DOI 10.1093/molbev/msh019; Mayr E., 1942, SYSTEMATICS ORIGIN S; MCLEAN RA, 1991, AM STAT, V45, P54, DOI 10.2307/2685241; Moehring AJ, 2004, GENETICS, V167, P1249, DOI 10.1534/genetics.103.024372; Morgan TJ, 2006, HEREDITY, V96, P232, DOI 10.1038/sj.hdy.6800786; Muller HJ, 1942, BIOL S, V6, P71; Nairn RS, 1996, P NATL ACAD SCI USA, V93, P13042, DOI 10.1073/pnas.93.23.13042; Nolte V, 2008, J EVOLUTION BIOL, V21, P551, DOI 10.1111/j.1420-9101.2007.01486.x; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Orr HA, 2005, GENETICS, V169, P671, DOI 10.1534/genetics.104.033274; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 2001, GENETICS, V158, P1089; PANTAZIDIS AC, 1988, HEREDITY, V60, P299, DOI 10.1038/hdy.1988.46; Patterson J. T., 1952, EVOLUTION GENUS DROS; Pontecorvo G, 1943, J GENET, V45, P51, DOI 10.1007/BF02982774; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 2003, GENETICS, V163, P955; Reed LK, 2007, MOL ECOL, V16, P1007, DOI 10.1111/j.1365-294X.2006.02941.x; Reed LK, 2004, P NATL ACAD SCI USA, V101, P9009, DOI 10.1073/pnas.0403106101; Ross CL, 2006, J EVOLUTION BIOL, V19, P1691, DOI 10.1111/j.1420-9101.2006.01111.x; Ross CL, 2003, MOL BIOL EVOL, V20, P1143, DOI 10.1093/molbev/msg137; RUIZ A, 1990, J HERED, V81, P30, DOI 10.1093/oxfordjournals.jhered.a110922; Schartl M, 1999, GENETICS, V153, P1385; Shuker DM, 2005, P ROY SOC B-BIOL SCI, V272, P2491, DOI 10.1098/rspb.2005.3242; Staten R, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-12; STEPHENS SG, 1950, J GENET, V50, P9, DOI 10.1007/BF02986790; Sweigart AL, 2006, GENETICS, V172, P2465, DOI 10.1534/genetics.105.053686; Sweigart AL, 2007, EVOLUTION, V61, P141, DOI 10.1111/j.1558-5646.2007.00011.x; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; TURELLI M, 1995, GENETICS, V140, P389; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; VIGNEAULT G, 1986, EVOLUTION, V40, P1160, DOI 10.1111/j.1558-5646.1986.tb05741.x; Wade MJ, 1997, GENETICS, V147, P1235; WADE MJ, 1994, HEREDITY, V72, P155, DOI 10.1038/hdy.1994.22; Wade MJ, 1998, EVOLUTION, V52, P1537, DOI 10.1111/j.1558-5646.1998.tb02235.x; WU CI, 1992, EVOLUTION, V46, P1584, DOI 10.1111/j.1558-5646.1992.tb01152.x; Xu SZ, 2003, GENETICS, V163, P789; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zouros E., 1991, Molecular techniques in taxonomy., P233; ZOUROS E, 1988, EVOLUTION, V42, P1321, DOI 10.1111/j.1558-5646.1988.tb04191.x; ZOUROS E, 1981, DROS INFORM SERV, V56, P167	88	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3076	10.1371/journal.pone.0003076	http://dx.doi.org/10.1371/journal.pone.0003076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728782	Green Published, gold			2022-12-25	WOS:000264796400016
J	Cuevas, JM; Torres-Puente, M; Jimenez-Hernandez, N; Bracho, MA; Garcia-Robles, I; Wrobel, B; Carnicer, F; del Olmo, J; Ortega, E; Moya, A; Gonzalez-Candelas, F				Cuevas, Jose Manuel; Torres-Puente, Manuela; Jimenez-Hernandez, Nuria; Bracho, Maria Alma; Garcia-Robles, Inmaculada; Wrobel, Boris; Carnicer, Fernando; del Olmo, Juan; Ortega, Enrique; Moya, Andres; Gonzalez-Candelas, Fernando			Genetic Variability of Hepatitis C Virus before and after Combined Therapy of Interferon plus Ribavirin	PLOS ONE			English	Article							SENSITIVITY-DETERMINING REGION; PKR PROTEIN-KINASE; HYPERVARIABLE REGION; NS5A PROTEIN; INITIAL TREATMENT; E2 GLYCOPROTEIN; NON-A; ENVELOPE; SEQUENCE; 1B	We present an analysis of the selective forces acting on two hepatitis C virus genome regions previously postulated to be involved in the viral response to combined antiviral therapy. One includes the three hypervariable regions in the envelope E2 glycoprotein, and the other encompasses the PKR binding domain and the V3 domain in the NS5A region. We used a cohort of 22 non-responder patients to combined therapy (interferon alpha-2a plus ribavirin) for which samples were obtained before initiation of therapy and after 6 or/and 12 months of treatment. A range of 25-100 clones per patient, genome region and time sample were sequenced. These were used to detect general patterns of adaptation, to identify particular adaptation mechanisms and to analyze the patterns of evolutionary change in both genome regions. These analyses failed to detect a common adaptive mechanism for the lack of response to antiviral treatment in these patients. On the contrary, a wide range of situations were observed, from patients showing no positively selected sites to others with many, and with completely different topologies in the reconstructed phylogenetic trees. Altogether, these results suggest that viral strategies to evade selection pressure from the immune system and antiviral therapies do not result from a single mechanism and they are likely based on a range of different alternatives, in which several different changes, or their combination, along the HCV genome confer viruses the ability to overcome strong selective pressures.	[Cuevas, Jose Manuel; Torres-Puente, Manuela; Jimenez-Hernandez, Nuria; Bracho, Maria Alma; Garcia-Robles, Inmaculada; Wrobel, Boris; Moya, Andres; Gonzalez-Candelas, Fernando] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain; [Cuevas, Jose Manuel; Jimenez-Hernandez, Nuria; Bracho, Maria Alma; Moya, Andres; Gonzalez-Candelas, Fernando] CIBERESP, Barcelona, Spain; [Carnicer, Fernando] Hosp Gen Alicante, Unidad de Hepatol, Alicante, Spain; [del Olmo, Juan] Hosp Clin Valencia, Serv Hepatol, Valencia, Spain; [Ortega, Enrique] Hosp Gen Valencia, Unidad Enfermedades Infecciosas, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; General University Hospital of Alicante	Cuevas, JM (corresponding author), Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain.	fernando.gonzalez@uv.es	Torres-Puente, Manuela/P-1791-2016; Candelas, Fernando Gonzalez/G-5681-2010; Moya, Andrés/A-8190-2008; Garcia-Robles, Inmaculada/J-7515-2012; Bracho, Maria/K-6018-2014; Cuevas, Jose M/C-6271-2016; Hernández, Nuria Jiménez/H-1982-2015; Wrobel, Borys/F-3471-2013; Garcia-Robles, Inmaculada/N-1599-2019	Torres-Puente, Manuela/0000-0002-8352-180X; Candelas, Fernando Gonzalez/0000-0002-0879-5798; Moya, Andrés/0000-0002-2867-1119; Garcia-Robles, Inmaculada/0000-0002-0165-399X; Bracho, Maria/0000-0002-9204-5526; Cuevas, Jose M/0000-0003-2049-3554; Hernández, Nuria Jiménez/0000-0002-9107-056X; Wrobel, Borys/0000-0002-4759-725X; Garcia-Robles, Inmaculada/0000-0002-0165-399X	Conselleria de Sanitat i Consum; Generalitat Valenciana (Spain); Ministerio de Educacion y Ciencia, Spain [BFU2005-00503]	Conselleria de Sanitat i Consum; Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF)); Ministerio de Educacion y Ciencia, Spain(Spanish Government)	This work was supported by the Conselleria de Sanitat i Consum, Generalitat Valenciana (Spain) and project BFU2005-00503 from Ministerio de Educacion y Ciencia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bracho MA, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-13; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Chambers TJ, 2005, J VIROL, V79, P3071, DOI 10.1128/JVI.79.5.3071-3083.2005; Chang KM, 1997, J CLIN INVEST, V100, P2376, DOI 10.1172/JCI119778; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Chayama K, 1997, HEPATOLOGY, V25, P745, DOI 10.1002/hep.510250342; Chevaliez S, 2007, J VIROL, V81, P7732, DOI 10.1128/JVI.00382-07; Ciccaglione AR, 1998, VIRUS RES, V55, P157, DOI 10.1016/S0168-1702(98)00041-0; Cocquerel L, 1999, J VIROL, V73, P2641, DOI 10.1128/JVI.73.4.2641-2649.1999; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Cuevas JM, 2008, J VIRAL HEPATITIS, V15, P578, DOI 10.1111/j.1365-2893.2008.00991.x; Cuevas JM, 2002, GENETICS, V162, P533; Curran R, 2002, J GEN VIROL, V83, P11, DOI 10.1099/0022-1317-83-1-11; Dubuisson J, 2000, CURR TOP MICROBIOL, V242, P135; DURANTE ME, 2003, J MED VIROL, V70, P62; Duverlie G, 1998, J GEN VIROL, V79, P1373, DOI 10.1099/0022-1317-79-6-1373; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Farci P, 2002, P NATL ACAD SCI USA, V99, P3081, DOI 10.1073/pnas.052712599; FEINSTONE SM, 1981, J INFECT DIS, V144, P588, DOI 10.1093/infdis/144.6.588; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gale MJ, 1998, CLIN DIAGN VIROL, V10, P157; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Herion D, 1997, HEPATOLOGY, V25, P769, DOI 10.1002/hep.510250346; Hofmann WP, 2007, GASTROENTEROLOGY, V132, P921, DOI 10.1053/j.gastro.2006.12.005; INCHAUSPE G, 1991, P NATL ACAD SCI USA, V88, P10292, DOI 10.1073/pnas.88.22.10292; Jimenez-Hernandez N, 2007, J GEN VIROL, V88, P123, DOI 10.1099/vir.0.82277-0; KATO N, 1993, J VIROL, V67, P3923, DOI 10.1128/JVI.67.7.3923-3930.1993; KATO N, 1992, VIRUS RES, V22, P107, DOI 10.1016/0168-1702(92)90038-B; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Kuiken C, 2006, HEPATOLOGY, V44, P1355, DOI 10.1002/hep.21377; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Layden-Almer JE, 2005, J INFECT DIS, V192, P1078, DOI 10.1086/432760; Lee JW, 1999, J VIROL, V73, P11, DOI 10.1128/JVI.73.1.11-18.1999; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Liu WL, 2007, J INFECT DIS, V196, P425, DOI 10.1086/518894; Lusida MI, 2001, J CLIN MICROBIOL, V39, P3858, DOI 10.1128/JCM.39.11.3858-3864.2001; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Manzin A, 1998, J VIROL, V72, P6271, DOI 10.1128/JVI.72.7.6271-6276.1998; Mondelli MU, 2001, ANTIVIR RES, V52, P153, DOI 10.1016/S0166-3542(01)00180-2; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Nousbaum JB, 2000, J VIROL, V74, P9028, DOI 10.1128/JVI.74.19.9028-9038.2000; OKAMOTO H, 1992, VIROLOGY, V188, P331, DOI 10.1016/0042-6822(92)90762-E; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Pawlotsky JM, 2006, HEPATOLOGY, V43, pS207, DOI 10.1002/hep.21064; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Puig-Basagoiti F, 2005, J GEN VIROL, V86, P1067, DOI 10.1099/vir.0.80526-0; Ray SC, 1999, J VIROL, V73, P2938, DOI 10.1128/JVI.73.4.2938-2946.1999; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; TANIGUCHI S, 1993, VIROLOGY, V195, P297, DOI 10.1006/viro.1993.1378; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torres-Puente M, 2008, J VIRAL HEPATITIS, V15, P188, DOI 10.1111/j.1365-2893.2007.00929.x; Torres-Puente M, 2008, INFECT GENET EVOL, V8, P74, DOI 10.1016/j.meegid.2007.10.005; Torres-Puente M, 2008, J MED VIROL, V80, P247, DOI 10.1002/jmv.21060; Troesch M, 2006, VIROLOGY, V352, P357, DOI 10.1016/j.virol.2006.05.015; WEINER AJ, 1991, VIROLOGY, V180, P842, DOI 10.1016/0042-6822(91)90104-J; WEINER AJ, 1992, P NATL ACAD SCI USA, V89, P3468, DOI 10.1073/pnas.89.8.3468; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Young KC, 2003, HEPATOLOGY, V38, P869, DOI 10.1053/jhep.2003.50445; Zeuzem S, 2004, J HEPATOL, V40, P993, DOI [10.1016/S0168-8278(04)00060-1, 10.1016/j.jhep.2004.02.007]	75	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3058	10.1371/journal.pone.0003058	http://dx.doi.org/10.1371/journal.pone.0003058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725975	Green Submitted, Green Published, gold			2022-12-25	WOS:000264796300004
J	Ferreira, JMS; Drumond, BP; Guedes, MIMC; Pascoal-Xavier, MA; Almeida-Leite, CM; Arantes, RME; Mota, BEF; Abrahao, JS; Alves, PA; Oliveira, FM; Ferreira, PCP; Bonjardim, CA; Lobato, ZIP; Kroon, EG				Siqueira Ferreira, Jaqueline Maria; Drumond, Betania Paiva; Maldonado Coelho Guedes, Maria Isabel; Pascoal-Xavier, Marcelo Antonio; Almeida-Leite, Camila Megale; Esteves Arantes, Rosa Maria; Fernandes Mota, Bruno Eduardo; Abrahao, Jonatas Santos; Alves, Pedro Augusto; Oliveira, Fernando Meireles; Peregrino Ferreira, Paulo Cesar; Bonjardim, Claudio Antonio; Portela Lobato, Zelia Ines; Kroon, Erna Geessien			Virulence in Murine Model Shows the Existence of Two Distinct Populations of Brazilian Vaccinia virus Strains	PLOS ONE			English	Article								Brazilian Vaccinia virus had been isolated from sentinel mice, rodents and recently from humans, cows and calves during outbreaks on dairy farms in several rural areas in Brazil, leading to high economic and social impact. Some phylogenetic studies have demonstrated the existence of two different populations of Brazilian Vaccinia virus strains circulating in nature, but little is known about their biological characteristics. Therefore, our goal was to study the virulence pattern of seven Brazilian Vaccinia virus strains. Infected BALB/c mice were monitored for morbidity, mortality and viral replication in organs as trachea, lungs, heart, kidneys, liver, brain and spleen. Based on the virulence potential, the Brazilian Vaccinia virus strains were grouped into two groups. One group contained GP1V, VBH, SAV and BAV which caused disease and death in infected mice and the second one included ARAV, GP2V and PSTV which did not cause any clinical signals or death in infected BALB/c mice. The subdivision of Brazilian Vaccinia virus strains into two groups is in agreement with previous genetic studies. Those data reinforce the existence of different populations circulating in Brazil regarding the genetic and virulence characteristics.	[Siqueira Ferreira, Jaqueline Maria; Drumond, Betania Paiva; Maldonado Coelho Guedes, Maria Isabel; Pascoal-Xavier, Marcelo Antonio; Fernandes Mota, Bruno Eduardo; Abrahao, Jonatas Santos; Alves, Pedro Augusto; Oliveira, Fernando Meireles; Peregrino Ferreira, Paulo Cesar; Bonjardim, Claudio Antonio; Kroon, Erna Geessien] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Virus Lab, Belo Horizonte, MG, Brazil; [Almeida-Leite, Camila Megale; Esteves Arantes, Rosa Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Lab Neuro Imuno Patol Expt, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Ferreira, JMS (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Ave Antonio Carlos, Belo Horizonte, MG, Brazil.	kroone@icb.ufmg	Alves, Pedro/T-7203-2019; Kroon, Erna/V-5444-2019; Abrahão, Jônatas/B-3895-2015; Arantes, Rosa ME/C-5749-2013; Ferreira, Jaqueline Maria Siqueira/E-4630-2018; Kroon, Erna Geessien/B-3631-2015; Bonjardim, Claudio A/J-2601-2014; brasileira, Inct Pecuaria/J-9542-2013	Alves, Pedro/0000-0002-9659-5621; Abrahão, Jônatas/0000-0001-9420-1791; Arantes, Rosa ME/0000-0003-1428-9717; Ferreira, Jaqueline Maria Siqueira/0000-0002-1779-1975; Kroon, Erna Geessien/0000-0003-2721-3826; Mota, Bruno/0000-0003-0348-4875; Lobato, Zelia/0000-0002-9399-3691	CNPq [fellowship]; CAPES [fellowship]; FAPEMIG; PCPF [fellowship]; CAB [fellowship]; ZILP [fellowship]; RMEA [fellowship]; EGK [fellowship]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); PCPF; CAB; ZILP; RMEA; EGK	Sources of support was provided by CNPq, CAPES and FAPEMIG. J. M. S. Ferreira received fellowship from CAPES and PCPF, CAB, ZILP, RMEA and EGK are CNPq fellows.	Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012; ANDREW ME, 1989, IMMUNOL CELL BIOL, V67, P331, DOI 10.1038/icb.1989.48; Baxby D, 1981, J Hist Med Allied Sci, V36, P218; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Bray M, 2000, J INFECT DIS, V181, P10, DOI 10.1086/315190; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; BRIODY BA, 1959, BACTERIOL REV, V23, P61, DOI 10.1128/MMBR.23.2.61-95.1959; BULLER RML, 1985, CURR TOP MICROBIOL, V122, P148; CAMPOS MAD, 1993, REV MICROBIOL, V24, P104; da Fonseca FG, 2000, J VIROL, V74, P7508, DOI 10.1128/JVI.74.16.7508-7517.2000; da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223; Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603; DAMON IK, 2007, FIELDS VIROLOGY, P2947; Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005; FENNER R, 1988, SMALLPOX ITS ERADICA; Ferrier-Rembert A, 2007, VACCINE, V25, P4809, DOI 10.1016/j.vaccine.2007.04.011; Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365; Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22; Jacobs N, 2006, J GEN VIROL, V87, P1157, DOI 10.1099/vir.0.81556-0; JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1; Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005; Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773; Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9; Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001; LOPES ODS, 1965, AM J TROP MED HYG, V14, P156; MAIBORODA AD, 1982, ACTA VIROL, V26, P288; Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005; Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004; Pahlitzsch R, 2006, CLIN INFECT DIS, V43, P737, DOI 10.1086/506937; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540; SARKAR JK, 1973, B WORLD HEALTH ORGAN, V48, P523; SEHGAL C L, 1977, Journal of Communicable Diseases, V9, P171; Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259; Trindade GD, 2003, EMERG INFECT DIS, V9, P155; Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486; Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0; Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977; Turner G S, 1967, J Gen Virol, V1, P399, DOI 10.1099/0022-1317-1-3-399; UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263	42	35	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3043	10.1371/journal.pone.0003043	http://dx.doi.org/10.1371/journal.pone.0003043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725979	Green Published, gold			2022-12-25	WOS:000264796300001
J	Dahmen, N; Manderscheid, N; Helfrich, J; Musholt, PB; Forst, T; Pfutzner, A; Engel, A				Dahmen, Norbert; Manderscheid, Nina; Helfrich, Jana; Musholt, Petra B.; Forst, Thomas; Pfuetzner, Andreas; Engel, Alice			Elevated Peripheral Visfatin Levels in Narcoleptic Patients	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HYPOCRETIN OREXIN; SIGNIFICANT ASSOCIATION; ENERGY HOMEOSTASIS; PLASMA; INFLAMMATION; CATAPLEXY; SLEEP; GENE; DQB1-ASTERISK-0602	Objective: Narcolepsy is a severe sleep disorder that is characterized by excessive daytime sleepiness, cataplexies and a tendency towards obesity. Recent discoveries indicate that the major pathophysiology is a loss of hypocretin (orexin) producing neurons due to immunologically mediated degeneration. Visfatin is a recently described proinflammatory adipokine. It is identical to the immune modulating pre-B-cell colony enhancing factor (PBEF). Our study examines the hypothesis that visfatin levels are altered in narcoleptic patients. Methods: For the analysis, a total of n = 54 patients (n = 18 males and n = 36 females) with the diagnosis of narcolepsy according to DSM-IV and the International Classification of Sleep Disorders were examined (BMI mean 30.3+/-5.5, age mean 52.5+/-16.1 years). As a control group 39 unrelated (n = 12 males and n = 27 females) healthy volunteers with no sleep disorder according to DSM-IV were included (BMI mean 28.5+/-4.6, age mean 51.1+/-13.6 years). Peripheral visfatin levels were measured using a commercial enzyme immunoassay kit with a measurement range from 0.1-1000 ng/ml. Narcolepsy symptoms, severity and frequency of symptoms as well as the total duration of various aspects of the symptomatology were assessed by unstructured and structured clinical interviews in including the Stanford Center for Narcolepsy Sleep Inventory. Results: Circulating visfatin was found to be significantly increased in HLA DR2 positive narcoleptic patients compared to controls. Conclusion: Taken together, our results add to the evidence of disturbed immunological regulation in patients with narcolepsy.	[Dahmen, Norbert; Manderscheid, Nina; Helfrich, Jana; Engel, Alice] Johannes Gutenberg Univ Mainz, Dept Psychiat, D-6500 Mainz, Germany; [Musholt, Petra B.; Forst, Thomas; Pfuetzner, Andreas] ikfe GmbH, Mainz, Germany	Johannes Gutenberg University of Mainz	Dahmen, N (corresponding author), Johannes Gutenberg Univ Mainz, Dept Psychiat, Untere Zahlbacher Str 8, D-6500 Mainz, Germany.	aliceengel@gmx.net						ALDRICH MS, 1990, NEW ENGL J MED, V323, P389; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Black JL, 2006, INT REV PSYCHIATR, V17, P461, DOI 10.1080/02646830500381492; Chan TF, 2007, FERTIL STERIL, V88, P401, DOI 10.1016/j.fertnstert.2006.11.120; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dahmen N, 2001, EUR ARCH PSY CLIN N, V251, P85, DOI 10.1007/s004060170057; Dauvilliers Y, 2004, ANN NEUROL, V56, P905, DOI 10.1002/ana.20339; Dauvilliers Y, 2001, MOL PSYCHIATR, V6, P367, DOI 10.1038/sj.mp.4000911; Dogru T, 2007, J HUM HYPERTENS, V21, P173, DOI 10.1038/sj.jhh.1002114; Dogru T, 2007, DIABETES RES CLIN PR, V76, P24, DOI 10.1016/j.diabres.2006.07.031; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505; Hector J, 2007, HORM METAB RES, V39, P250, DOI 10.1055/s-2007-973075; Higuchi S, 2002, NEUROSCI LETT, V318, P61, DOI 10.1016/S0304-3940(01)02476-4; Himmerich H, 2006, ARCH INTERN MED, V166, P1739, DOI 10.1001/archinte.166.16.1739; Hinze-Selch D, 1998, NEUROLOGY, V50, P1149, DOI 10.1212/WNL.50.4.1149; Hohjoh H, 1999, TISSUE ANTIGENS, V54, P138, DOI 10.1034/j.1399-0039.1999.540204.x; Hohjoh H, 2000, TISSUE ANTIGENS, V56, P446, DOI 10.1034/j.1399-0039.2000.560508.x; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lopez-Bermejo A, 2006, DIABETES, V55, P2871, DOI 10.2337/db06-0259; Marcinkowska Magdalena, 2007, Endokrynol Pol, V58, P188; Martinez-Rodriguez JE, 2007, MED CLIN-BARCELONA, V128, P361, DOI 10.1157/13099970; MIGNOT E, 1995, ADV NEUROIMMUNOL, V5, P23, DOI 10.1016/0960-5428(94)00043-N; Mignot E, 1997, SLEEP, V20, P1012; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Nishino S, 2001, ANN NEUROL, V50, P381, DOI 10.1002/ana.1130; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Okun ML, 2004, BRAIN BEHAV IMMUN, V18, P326, DOI 10.1016/j.bbi.2003.11.002; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Pfutzner A, 2007, HORM METAB RES, V39, P764, DOI 10.1055/s-2007-985867; Pilz S, 2007, J ENDOCRINOL INVEST, V30, P138, DOI 10.1007/BF03347412; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rogers AE, 1997, NEUROLOGY, V48, P1550, DOI 10.1212/WNL.48.6.1550; Schuld A, 2000, LANCET, V355, P1274, DOI 10.1016/S0140-6736(05)74704-8; THORPY MJ, 1990, ICSD INT CLASSIFICAT; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Varma V, 2007, J CLIN ENDOCR METAB, V92, P666, DOI 10.1210/jc.2006-1303; Vgontzas AN, 2002, ENDOCRIN METAB CLIN, V31, P15, DOI 10.1016/S0889-8529(01)00005-6; Wieczorek S, 2003, TISSUE ANTIGENS, V61, P437, DOI 10.1034/j.1399-0039.2003.00068.x; Wurtman RJ, 2006, METABOLISM, V55, pS36, DOI 10.1016/j.metabol.2006.07.011	42	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2980	10.1371/journal.pone.0002980	http://dx.doi.org/10.1371/journal.pone.0002980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714344	gold, Green Published, Green Submitted			2022-12-25	WOS:000264420900007
J	Loi, P; Matsukawa, K; Ptak, G; Clinton, M; Fulka, J; Nathan, Y; Arav, A				Loi, Pasqualino; Matsukawa, Kazutsugu; Ptak, Grazyna; Clinton, Michael; Fulka, Josef, Jr.; Nathan, Yehudith; Arav, Amir			Freeze-Dried Somatic Cells Direct Embryonic Development after Nuclear Transfer	PLOS ONE			English	Article								The natural capacity of simple organisms to survive in a dehydrated state has long been exploited by man, with lyophylization the method of choice for the long term storage of bacterial and yeast cells. More recently, attempts have been made to apply this procedure to the long term storage of blood cells. However, despite significant progress, practical application in a clinical setting is still some way off. Conversely, to date there are no reports of attempts to lyophilize nucleated somatic cells for possible downstream applications. Here we demonstrate that lyophilised somatic cells stored for 3 years at room temperature are able to direct embryonic development following injection into enucleated oocytes. These remarkable results demonstrate that alternative systems for the long-term storage of cell lines are now possible, and open unprecedented opportunities in the fields of biomedicine and for conservation strategies.	[Loi, Pasqualino; Matsukawa, Kazutsugu; Ptak, Grazyna] Teramo Univ, Dept Comparat Biomed Sci, Teramo, Italy; [Clinton, Michael] Roslin Inst, Royal Sch Vet Stud, Edinburgh, Midlothian, Scotland; [Fulka, Josef, Jr.] Inst Anim Product, Prague, Czech Republic; [Nathan, Yehudith; Arav, Amir] Volcani Ctr, Inst Anim Sci, Agr Res Org, Bet Dagan, Israel	University of Teramo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Loi, P (corresponding author), Teramo Univ, Dept Comparat Biomed Sci, Teramo, Italy.	ploi@unite.it		Ptak, Grazyna/0000-0003-1437-4698	PRIN 2006; Teramo University; European Science Foundation [ERASCT-2003-980409]; BBSRC [BB/E015425/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E015425/2, BBS/E/R/00000681] Funding Source: researchfish	PRIN 2006(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Teramo University; European Science Foundation(European Science Foundation (ESF)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Research in P.L. laboratory is supported by PRIN 2006, Teramo University Founds (60%) 2006, European Science Foundation, contract no. ERASCT-2003-980409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage S, 1999, BONE MARROW TRANSPL, V24, P139, DOI 10.1038/sj.bmt.1701881; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Brumfiel G, 2004, NATURE, V428, P14, DOI 10.1038/428014a; Cairns J, 2002, P NATL ACAD SCI USA, V99, P10567, DOI 10.1073/pnas.162369899; CLARK P, 1974, BIOCHEMISTRY-US, V13, P5098, DOI 10.1021/bi00722a007; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Fischer Thomas H, 2002, Hematology, V7, P359, DOI 10.1080/1024533021000047954; Fuller W, 2004, PHILOS T R SOC B, V359, P1237, DOI 10.1098/rstb.2004.1501; Gacitua H, 2005, THERIOGENOLOGY, V63, P931, DOI 10.1016/j.theriogenology.2004.05.012; GOODRICH RP, 1992, P NATL ACAD SCI USA, V89, P967, DOI 10.1073/pnas.89.3.967; Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P11819, DOI 10.1073/pnas.1834207100; HILTONTAYLOR C, 2004, IUCN RED LIST THREAT; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; LEHMAN CW, 1993, MOL CELL BIOL, V13, P6897, DOI 10.1128/MCB.13.11.6897; LESLIE SB, 1994, BBA-BIOMEMBRANES, V1192, P7, DOI 10.1016/0005-2736(94)90136-8; Loi P, 2002, BIOL REPROD, V67, P126, DOI 10.1095/biolreprod67.1.126; Loi P, 2001, NAT BIOTECHNOL, V19, P962, DOI 10.1038/nbt1001-962; Loi P, 2008, BIOESSAYS, V30, P66, DOI 10.1002/bies.20684; Meissner A, 2006, DEV DYNAM, V235, P2460, DOI 10.1002/dvdy.20915; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PRESTRELSKI SJ, 1993, ARCH BIOCHEM BIOPHYS, V303, P465, DOI 10.1006/abbi.1993.1310; Ptak G, 2002, BIOL REPROD, V67, P1719, DOI 10.1095/biolreprod.102.006171; Ryder OA, 2000, SCIENCE, V288, P275, DOI 10.1126/science.288.5464.275; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wakayama T, 1998, NAT BIOTECHNOL, V16, P639, DOI 10.1038/nbt0798-639; Ward WS, 1996, CRIT REV EUKAR GENE, V6, P139, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.30; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WILMUT I, 1997, NATURE, V385, P813; Wolf SA, 1999, AM J NURS, V99, P60, DOI 10.2307/3472191; Wolkers WF, 2002, COMP BIOCHEM PHYS A, V131, P535, DOI 10.1016/S1095-6433(01)00505-0	32	66	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2978	10.1371/journal.pone.0002978	http://dx.doi.org/10.1371/journal.pone.0002978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714340	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900005
J	Curran, KL; Larue, S; Bronson, B; Solis, J; Trow, A; Sarver, N; Zhu, HS				Curran, Kristen L.; LaRue, Silvia; Bronson, Brittany; Solis, Jessica; Trow, Aaron; Sarver, Nicole; Zhu, Haisun			Circadian Genes Are Expressed during Early Development in Xenopus laevis	PLOS ONE			English	Article								Circadian oscillators are endogenous time-keeping mechanisms that drive twenty four hour rhythmic changes in gene expression, metabolism, hormone levels, and physical activity. We have examined the developmental expression of genes known to regulate circadian rhythms in order to better understand the ontogeny of the circadian clock in a vertebrate. Methodology/Principal Findings: In this study, genes known to function together in part of the core circadian oscillator mechanism (xPeriod1, xPeriod2, and xBmal1) as well as a rhythmic, clock-controlled gene (xNocturnin) were analyzed using in situ hybridization in embryos from neurula to late tailbud stages. Each transcript was present in the developing nervous system in the brain, eye, olfactory pit, otic vesicle and at lower levels in the spinal cord. These genes were also expressed in the developing somites and heart, but at different developmental times in peripheral tissues (pronephros, cement gland, and posterior mesoderm). No difference was observed in transcript levels or localization when similarly staged embryos maintained in cyclic light were compared at two times of day (dawn and dusk) by in situ hybridization. Quantitation of xBmal1 expression in embryonic eyes was also performed using qRT-PCR. Eyes were isolated at dawn, midday, dusk, and midnight (cylic light). No difference in expression level between time-points was found in stage 31 eyes (p = 0.176) but stage 40 eyes showed significantly increased levels of xBmal1 expression at midnight (RQ = 1.98+/-0.094) when compared to dawn (RQ = 1+/-0.133; p = 0.0004). Conclusions/Significance: We hypothesize that when circadian genes are not co-expressed in the same tissue during development that it may indicate pleiotropic functions of these genes that are separate from the timing of circadian rhythm. Our results show that all circadian genes analyzed thus far are present during early brain and eye development, but rhythmic gene expression in the eye is not observed until after stage 31 of development.	[Curran, Kristen L.; Bronson, Brittany; Solis, Jessica; Trow, Aaron; Sarver, Nicole] Univ Wisconsin, Dept Biol Sci, Whitewater, WI 53190 USA; [Curran, Kristen L.; LaRue, Silvia; Zhu, Haisun] Univ Virginia, Dept Biol, Charlottesville, VA USA	University of Wisconsin System; University of Virginia	Curran, KL (corresponding author), Univ Wisconsin, Dept Biol Sci, Whitewater, WI 53190 USA.	currank@uww.edu			NIH [MH61461]; NSF REU [0354140]; Beta Beta Beta Biological Society; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061461] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); Beta Beta Beta Biological Society; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was initially begun in the lab of Carla B. Green at the University of Virginia. She provided some lab space, reagents, and technician salary to help with tissue sectioning (NIH MH61461 (CBG)). After moving to University of Wisconsin-Whitewater I used my startup money as well as money from an internal grant (Faculty Development Grant) to continue the analysis. My summer salary, the salary of two students, and reagents for one summer (2005) was provided by an NSF REU 0354140 (Woller). More recent experiments were also funded by the Beta Beta Beta Biological Society. Experiments were discussed with CBG, but my project was independent from other projects going on in her laboratory (she did not pay me a salary to start these experiments). The NSF REU (Woller) was meant to give undergraduates research training during the summer and Woller had no input on the types of experiments performed. CBG kindly read and edited this manuscript.	Baggs JE, 2003, CURR BIOL, V13, P189, DOI 10.1016/S0960-9822(03)00014-9; Banerjee D, 2005, DEV CELL, V8, P287, DOI 10.1016/j.devcel.2004.12.006; Bell David A., 2005, NAT GENET, P1; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; DONIACH T, 1995, MECH DEVELOP, V53, P403, DOI 10.1016/0925-4773(95)00457-2; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Freitas C, 2005, INT J DEV BIOL, V49, P317, DOI 10.1387/ijdb.041955cf; GABARINOPICO E, 2007, RNA, V13, P745; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Green CB, 1999, DEV BRAIN RES, V117, P109, DOI 10.1016/S0165-3806(99)00109-1; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; Green CB, 2001, MECH DEVELOP, V101, P105, DOI 10.1016/S0925-4773(00)00559-1; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hasegawa K, 2005, CHRONOBIOL INT, V22, P1, DOI 10.1081/CBI-200038149; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Kazimi N, 1999, DEV BRAIN RES, V117, P47, DOI 10.1016/S0165-3806(99)00096-6; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Morgan R, 2002, INT J DEV BIOL, V46, P999; PENG HB, 1991, PRACTICAL USES CELL, V36, P657; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Vallone D, 2007, DEV DYNAM, V236, P142, DOI 10.1002/dvdy.20998; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005; Zhu HS, 2000, MOL BRAIN RES, V75, P303, DOI 10.1016/S0169-328X(99)00309-5; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pnas.0600571103; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	32	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2749	10.1371/journal.pone.0002749	http://dx.doi.org/10.1371/journal.pone.0002749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18716681	gold, Green Submitted, Green Published			2022-12-25	WOS:000264302900020
J	Atanasov, AG; Leiser, D; Roesselet, C; Noti, M; Corazza, N; Schoonjans, K; Brunner, T				Atanasov, Atanas G.; Leiser, Dominic; Roesselet, Corinne; Noti, Mario; Corazza, Nadia; Schoonjans, Kristina; Brunner, Thomas			Cell cycle-dependent regulation of extra-adrenal glucocorticoid synthesis in murine intestinal epithelial cells	FASEB JOURNAL			English	Article						liver receptor homologue-1; nuclear receptors; steroidogenesis; mucosal immunology	INFLAMMATORY-BOWEL-DISEASE; RETINOBLASTOMA PROTEIN; RECEPTOR COACTIVATOR; NUCLEAR RECEPTORS; T-CELLS; IN-VIVO; ACTIVATION; EXPRESSION; LIGAND; LRH-1	Glucocorticoids are anti-inflammatory steroids with important applications in the treatment of inflammatory diseases. Endogenous glucocorticoids are mainly produced by the adrenal glands, although there is increasing evidence for extra-adrenal sources. Recent findings show that intestinal crypt cells produce glucocorticoids, which contribute to the maintenance of intestinal immune homeostasis. Intestinal glucocorticoid synthesis is critically regulated by the transcription factor liver receptor homologue-1 (LRH-1). As expression of steroidogenic enzymes and LRH-1 is restricted to the proliferating cells of the crypts, we aimed to investigate the role of the cell cycle in the regulation of LRH-1 activity and intestinal glucocorticoid synthesis. We here show that either pharmacological or molecular modulation of cell cycle progression significantly inhibited expression of steroidogenic enzymes and synthesis of glucocorticoids in intestinal epithelial cells. Synchronization of intestinal epithelial cells in the cell cycle revealed that expression of steroidogenic enzymes is preferentially induced at the G(1)/S stage. Differentiation of immature intestinal epithelial cells to mature nonproliferating cells also resulted in reduced expression of steroidogenic enzymes. This cell cycle-related effect on intestinal steroidogenesis was found to be mediated through the regulation of LRH-1 transcriptional activity. This mechanism may restrict intestinal glucocorticoid synthesis to the proliferating cells of the crypts.	[Atanasov, Atanas G.; Leiser, Dominic; Roesselet, Corinne; Noti, Mario; Corazza, Nadia; Brunner, Thomas] Univ Bern, Div Immunopathol, Inst Pathol, CH-3010 Bern, Switzerland; [Schoonjans, Kristina] ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France	University of Bern; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Brunner, T (corresponding author), Univ Bern, Div Immunopathol, Inst Pathol, Murtenstr 31, CH-3010 Bern, Switzerland.	tbrunner@pathology.unibe.ch	Noti, Mario/I-6581-2019; Atanasov, Atanas G./C-5535-2013	Noti, Mario/0000-0001-9386-1245; Atanasov, Atanas G./0000-0003-2545-0967; Schoonjans, Kristina/0000-0003-1247-4265	Swiss National Science Foundation; Crohn's and Colitis Foundation of America	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Crohn's and Colitis Foundation of America	The authors thank Seamus Martin (Trinity College, Dublin, Ireland), Robert Whitehead (Vanderbilt University, Nashville, TN, USA), and Ed Harlow (Massachusetts General Hospital Cancer Center, Charlestown, MA, USA) for valuable reagents, and the members of the Brunner Laboratory for helpful advice and input. This work was supported by grants from the Swiss National Science Foundation, the Crohn's and Colitis Foundation of America, and the Bernese Cancer League to T. B.	Batsche E, 2005, J BIOL CHEM, V280, P19746, DOI 10.1074/jbc.M413428200; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Boivin MA, 2007, AM J PHYSIOL-GASTR L, V292, pG590, DOI 10.1152/ajpgi.00252.2006; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Cima I, 2004, J EXP MED, V200, P1635, DOI 10.1084/jem.20031958; Cole TJ, 2006, BIOTECHNOL ANN REV, V12, P269, DOI 10.1016/S1387-2656(06)12008-6; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; Farrell RJ, 2003, J ENDOCRINOL, V178, P339, DOI 10.1677/joe.0.1780339; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; GONZALO JA, 1993, J EXP MED, V177, P1239, DOI 10.1084/jem.177.5.1239; Helin K, 1997, P NATL ACAD SCI USA, V94, P6933, DOI 10.1073/pnas.94.13.6933; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Lange CA, 2004, MOL ENDOCRINOL, V18, P269, DOI 10.1210/me.2003-0331; Lee YK, 2006, J BIOL CHEM, V281, P7850, DOI 10.1074/jbc.M509115200; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller C, 1999, J BIOL CHEM, V274, P38112, DOI 10.1074/jbc.274.53.38112; Mueller M, 2007, ENDOCRINOLOGY, V148, P1445, DOI 10.1210/en.2006-0591; Mueller M, 2006, J EXP MED, V203, P2057, DOI 10.1084/jem.20060357; Nachbur U, 2006, BLOOD, V107, P2790, DOI 10.1182/blood-2005-07-2744; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Parker KL, 2002, RECENT PROG HORM RES, V57, P19, DOI 10.1210/rp.57.1.19; Schoonjans K, 2005, P NATL ACAD SCI USA, V102, P2058, DOI 10.1073/pnas.0409756102; Schoonjans K, 2002, EMBO REP, V3, P1181, DOI 10.1093/embo-reports/kvf238; Siu WY, 1999, FEBS LETT, V461, P299, DOI 10.1016/S0014-5793(99)01481-7; Stasik I, 2007, BBA-MOL CELL RES, V1773, P1483, DOI 10.1016/j.bbamcr.2007.05.011; Tan XQ, 1997, J BIOL CHEM, V272, P9613; Torgler R, 2004, J BIOL CHEM, V279, P37334, DOI 10.1074/jbc.M406913200; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018	31	29	29	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4117	4125		10.1096/fj.08-114157	http://dx.doi.org/10.1096/fj.08-114157			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18711026	Green Submitted			2022-12-25	WOS:000261254800011
J	Gupta, D; Jetton, TL; Mortensen, RM; Duan, SZ; Peshavaria, M; Leahy, JL				Gupta, Dhananjay; Jetton, Thomas L.; Mortensen, Richard M.; Duan, Sheng Zhong; Peshavaria, Mina; Leahy, Jack L.			In Vivo and in Vitro Studies of a Functional Peroxisome Proliferator-activated Receptor gamma Response Element in the Mouse pdx-1 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL FUNCTION; STIMULATED INSULIN-SECRETION; RETINOID-X-RECEPTOR; PPAR-GAMMA; GLUCOSE-HOMEOSTASIS; PANCREATIC DEVELOPMENT; NUCLEAR RECEPTORS; HISPANIC WOMEN; ISLET CELLS; INS-1 CELLS	We reported that peroxisome proliferator-activated receptor gamma(PPAR gamma) transcriptionally regulates the beta-cell differentiation factor pancreatic duodenal homeobox (PDX)-1 based on in vitro RNA interference studies. We have now studied mice depleted of PPAR gamma within the pancreas (PANC PPAR gamma(-/-)) created by a Cre/loxP recombinase system, with Cre driven by the pdx-1 promoter. Male PANC PPAR gamma(-/-) mice were hyperglycemic at 8 weeks of age (8.1 +/- 0.2 mM versus 6.4 +/- 0.3 mM, p = 0.009) with islet cytoarchitecture and pancreatic mass of islet beta-cells that were indistinguishable from the controls. Islet PDX-1 mRNA (p = 0.001) and protein levels (p = 0.003) were lowered 60 and 40%, respectively, in tandem with impaired glucose-induced insulin secretion and loss of thiazolidinedione-induced increase in PDX-1 expression. We next identified a putative PPAR-response element (PPRE) in the mouse pdx-1 promoter with substantial homology to the corresponding region of the human PDX-1 promoter. Electrophoretic mobility supershift assays with nuclear extracts from beta-cell lines and mouse islets, also in vitro translated PPAR gamma and retinoid X receptor, and chromatin immunoprecipitation analysis demonstrated specific binding of PPAR gamma and retinoid X receptor to the human and mouse pdx-1 Chi PPREs. Transient transfection assays of beta-cells with reporter constructs of mutated PPREs showed dramatically reduced pdx-1 promoter activity. In summary, we have presented in vivo and in vitro evidence showing PPAR gamma regulation of pdx-1 transcription in beta-cells, plus our results support an important regulatory role for PPAR gamma in beta-cell physiology and thiazolidinedione pharmacology of type 2 diabetes.	[Leahy, Jack L.] Univ Vermont, Coll Med, Dept Med, Div Endocrinol Diabet & Metab, Burlington, VT 05405 USA; [Mortensen, Richard M.; Duan, Sheng Zhong] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Vermont; University of Michigan System; University of Michigan	Leahy, JL (corresponding author), Univ Vermont, Coll Med, Dept Med, Div Endocrinol Diabet & Metab, Given Bldg C331, Burlington, VT 05405 USA.	jleahy@uvm.edu		duan, sheng zhong/0000-0001-5399-7252	National Institutes of Health [DK56818, DK66635, DK59851]; American Diabetes Association; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK056818, R01DK066635, R01DK056818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56818 and DK66635 (to J.L.L.) and DK59851 (to T.L.J.). This work was also supported by American Diabetes Association (to T.L.J. and M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a mentor-based fellowship award (to J.L.L.) from the American Diabetes Association.; Recipient of a career development award from the Juvenile Diabetes Research Foundation.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Dubois M, 2000, DIABETOLOGIA, V43, P1165, DOI 10.1007/s001250051508; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Hsu MH, 1998, J BIOL CHEM, V273, P27988, DOI 10.1074/jbc.273.43.27988; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Ivashchenko CY, 2007, AM J PHYSIOL-GASTR L, V293, pG319, DOI 10.1152/ajpgi.00056.2007; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Jetton TL, 2001, DIABETOLOGIA, V44, P2056, DOI 10.1007/s001250100011; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lee JY, 2005, BIOCHEM BIOPH RES CO, V334, P764, DOI 10.1016/j.bbrc.2005.06.162; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Lin CY, 2005, J CLIN ENDOCR METAB, V90, P6678, DOI 10.1210/jc.2005-0079; Lin YQ, 2001, DIABETOLOGIA, V44, P1026, DOI 10.1007/s001250100597; Liu YQ, 2000, AM J PHYSIOL-ENDOC M, V279, pE68, DOI 10.1152/ajpendo.2000.279.1.E68; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Niswender KD, 2007, J CLIN INVEST, V117, P2753, DOI 10.1172/JCI33528; Ohtani K, 1998, ENDOCRINOLOGY, V139, P172, DOI 10.1210/en.139.1.172; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Rosen ED, 2003, MOL CELL BIOL, V23, P7222, DOI 10.1128/MCB.23.20.7222-7229.2003; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Temple KA, 2005, J BIOL CHEM, V280, P3529, DOI 10.1074/jbc.M411422200; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Wang H, 2005, DIABETOLOGIA, V48, P720, DOI 10.1007/s00125-005-1692-8; Xiang AH, 2006, DIABETES, V55, P517, DOI 10.2337/diabetes.55.02.06.db05-1066; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	44	51	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32462	32470		10.1074/jbc.M801813200	http://dx.doi.org/10.1074/jbc.M801813200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18718916	Green Published, hybrid			2022-12-25	WOS:000260893700034
J	Estrada, R; Zeng, Q; Lu, HW; Sarojini, H; Lee, JF; Mathis, SP; Sanchez, T; Wang, E; Kontos, CD; Lin, CY; Hla, T; Haribabu, B; Lee, MJ				Estrada, Rosendo; Zeng, Qun; Lu, Hongwei; Sarojini, Harshini; Lee, Jen-Fu; Mathis, Steven P.; Sanchez, Teresa; Wang, Eugenia; Kontos, Christopher D.; Lin, Chen-Yong; Hla, Timothy; Haribabu, Bodduluri; Lee, Menq-Jer			Up-regulating Sphingosine 1-Phosphate Receptor-2 Signaling Impairs Chemotactic, Wound-healing, and Morphogenetic Responses in Senescent Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR SENESCENCE; INHIBITS MIGRATION; OXIDATIVE STRESS; PROTEIN; CERAMIDE; SPHINGOSINE-1-PHOSPHATE; EDG-1; AGE; ATHEROSCLEROSIS; ACTIVATION	Vascular endothelial cells (ECs) have a finite lifespan when cultured in vitro and eventually enter an irreversible growth arrest state called "cellular senescence." It has been shown that sphingo-lipids may be involved in senescence; however, the molecular links involved are poorly understood. In this study, we investigated the signaling and functions of sphingosine 1-phosphate (S1P), a serum-borne bioactive sphingolipid, in ECs of different in vitro ages. We observed that S1P-regulated responses are significantly inhibited and the S1P(1-3) receptor subtypes are markedly increased in senescent ECs. Increased expression of S1P(1) and S1P(2) was also observed in the lesion regions of atherosclerotic endothelium, where senescent ECs have been identified in vivo. S1P-induced Akt and ERK1/2 activation were comparable between ECs of different in vitro ages; however, PTEN (phosphatase and tensin homolog deleted on chromosome 10) activity was significantly elevated and Rac activation was inhibited in senescent ECs. Rac activation and senescent-associated impairments were restored in senescent ECs by the expression of dominant-negative PTEN and by knocking down S1P(2) receptors. Furthermore, the senescent-associated impairments were induced in young ECs by the expression of S1P(2) to a level similar to that of in vitro senescence. These results indicate that the impairment of function in senescent ECs in culture is mediated by an increase in S1P signaling through S1P(2)-mediated activation of the lipid phosphatase PTEN.	[Estrada, Rosendo; Zeng, Qun; Lu, Hongwei; Sarojini, Harshini; Lee, Jen-Fu; Wang, Eugenia; Lee, Menq-Jer] Univ Louisville, Hlth Sci Ctr, Gheens Ctr Aging, Louisville, KY 40202 USA; [Mathis, Steven P.; Haribabu, Bodduluri; Lee, Menq-Jer] Univ Louisville, Hlth Sci Ctr, Dept Microbiol & Immunol, Louisville, KY 40202 USA; [Sanchez, Teresa; Hla, Timothy] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA; [Kontos, Christopher D.] Duke Univ, Med Ctr, Div Cardiol, Dept Med, Durham, NC 27710 USA; [Kontos, Christopher D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Lin, Chen-Yong] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University of Louisville; University of Louisville; University of Connecticut; Duke University; Duke University; University System of Maryland; University of Maryland Baltimore	Lee, MJ (corresponding author), Univ Louisville, Hlth Sci Ctr, Gheens Ctr Aging, 580 S Preston St, Louisville, KY 40202 USA.	menqjer.lee@louisville.edu	Hla, Timothy/G-5873-2012; LEE, JEN-FU/GRO-3670-2022; Bodduluri, Haribabu/A-2584-2010; Sarojini, Harshini/AAD-4870-2019	Hla, Timothy/0000-0001-8355-4065; Bodduluri, Haribabu/0000-0002-8261-3294; Sarojini, Harshini/0000-0002-3103-9712; Kontos, Christopher/0000-0002-8056-3115; Mathis, Steven/0000-0001-7704-1220	National Institutes of Health [R01HL071071]; American Heart Association [0755245B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL071071 (to M. L). This work was also supported by American Heart Association Grant-in-Aid 0755245B (to M. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be herebymarked" advertisement" in accordance with 18U.S.C. Section 1734 solely to indicate this fact.	Albrecht EWJA, 2003, J PATHOL, V199, P8, DOI 10.1002/path.1250; An SZ, 1998, J CELL BIOCHEM, P147; Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Ciacci-Zanella JR, 1998, FOOD CHEM TOXICOL, V36, P791, DOI 10.1016/S0278-6915(98)00034-9; Crivello NA, 2005, NEUROCHEM INT, V47, P573, DOI 10.1016/j.neuint.2005.06.011; Deshpande SS, 2003, ARTERIOSCL THROM VAS, V23, pE1, DOI 10.1161/01.ATV.0000047869.13737.53; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Erusalimsky J D, 2006, Handb Exp Pharmacol, P213; Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010; Freedman DA, 2005, EXP CELL RES, V307, P118, DOI 10.1016/j.yexcr.2005.03.025; Goparaju SK, 2005, MOL CELL BIOL, V25, P4237, DOI 10.1128/MCB.25.10.4237-4249.2005; Hampel B, 2006, EXP GERONTOL, V41, P474, DOI 10.1016/j.exger.2006.03.001; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Huang JH, 2002, J BIOL CHEM, V277, P10760, DOI 10.1074/jbc.M110219200; Huang L, 2005, INVEST OPHTH VIS SCI, V46, P1682, DOI 10.1167/iovs.04-1155; Igarashi Y, 1998, ACTA BIOCHIM POL, V45, P299, DOI 10.18388/abp.1998_4226; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Jala Venkatakrishna R., 2006, V332, P159; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Lepley D, 2005, CANCER RES, V65, P3788, DOI 10.1158/0008-5472.CAN-04-2311; MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499; Minamino T, 2004, J MOL CELL CARDIOL, V36, P175, DOI 10.1016/j.yjmcc.2003.11.010; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Mouton RE, 2000, MECH AGEING DEV, V113, P169, DOI 10.1016/S0047-6374(99)00105-0; Ogretmen B, 2001, J BIOL CHEM, V276, P24901, DOI 10.1074/jbc.M100314200; PASSANITI A, 1992, LAB INVEST, V67, P519; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; SATO I, 1993, BIOCHEM BIOPH RES CO, V195, P1070, DOI 10.1006/bbrc.1993.2153; Spiegel S, 1999, J LEUKOCYTE BIOL, V65, P341, DOI 10.1002/jlb.65.3.341; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Sugimoto N, 2003, MOL CELL BIOL, V23, P1534, DOI 10.1128/MCB.23.5.1534-1545.2003; Tamama K, 2005, ATHEROSCLEROSIS, V178, P19, DOI 10.1016/j.atherosclerosis.2004.07.032; Venable ME, 2006, MECH AGEING DEV, V127, P473, DOI 10.1016/j.mad.2006.01.003; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Wang L, 2008, HISTOCHEM CELL BIOL, V129, P579, DOI 10.1007/s00418-008-0389-8; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Yokoo E, 2004, J BIOCHEM, V135, P673, DOI 10.1093/jb/mvh081; Zondag GCM, 1998, BIOCHEM J, V330, P605, DOI 10.1042/bj3300605	51	38	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30363	30375		10.1074/jbc.M804392200	http://dx.doi.org/10.1074/jbc.M804392200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18765664	Green Published, hybrid			2022-12-25	WOS:000260366900080
J	Miller, TE; Ghoshal, K; Ramaswamy, B; Roy, S; Datta, J; Shapiro, CL; Jacob, S; Majumder, S				Miller, Tyler E.; Ghoshal, Kalpana; Ramaswamy, Bhuvaneswari; Roy, Satavisha; Datta, Jharna; Shapiro, Charles L.; Jacob, Samson; Majumder, Sarmila			MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; P27(KIP1); MECHANISMS; MICRORNAS; DEREGULATION; CARCINOMAS; MIR-222; CELLS	We explored the role of microRNAs (miRNAs) in acquiring resistance to tamoxifen, a drug successfully used to treat women with estrogen receptor-positive breast cancer. miRNA microarray analysis of MCF-7 cell lines that are either sensitive (parental) or resistant (4-hydroxytamoxifen-resistant (OHTR)) to tamoxifen showed significant (> 1.8-fold) up-regulation of eight miRNAs and marked down-regulation (> 50%) of seven miRNAs in OHTR cells compared with parental MCF-7cells. Increased expression of three of the most promising up-regulated (miR-221, miR-222, and miR181) and down-regulated (miR-21, miR-342, and miR-489) miRNAs was validated by real-time reverse transcription-PCR. The expression of miR-221 and miR-222 was also significantly (2-fold) elevated in HER2/neu-positive primary human breast cancer tissues that are known to be resistant to endocrine therapy compared with HER2/neu-negative tissue samples. Ectopic expression of miR-221/222 rendered the parental MCF-7 cells resistant to tamoxifen. The protein level of the cell cycle inhibitor p27(Kip1), a known target of miR-221/222, was reduced by 50% in OHTR cells and by 28-50% in miR-221/222-overexpressing MCF-7 cells. Furthermore, overexpression of p27(Kip1) in the resistant OHTR cells caused enhanced cell death when exposed to tamoxifen. This is the first study demonstrating a relationship between miR-221/222 expression and HER2/neu overexpression in primary breast tumors that are generally resistant to tamoxifen therapy. This finding also provides the rationale for the application of altered expression of specific miRNAs as a predictive tamoxifen-resistant breast cancer marker.	[Miller, Tyler E.; Ghoshal, Kalpana; Roy, Satavisha; Datta, Jharna; Jacob, Samson; Majumder, Sarmila] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Ramaswamy, Bhuvaneswari; Shapiro, Charles L.; Jacob, Samson] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA; [Ghoshal, Kalpana; Ramaswamy, Bhuvaneswari; Shapiro, Charles L.; Jacob, Samson; Majumder, Sarmila] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Majumder, S (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, 690D Tzagournis Med Res Facil,420 W 12th Ave, Columbus, OH 43210 USA.	Sarmila.majumder@osumc.edu	Ramaswamy, Bhuvaneswari/E-3919-2011	Miller, Tyler E/0000-0002-1269-1895	National Institutes of Health [CA101956, CA122523, CA086978]; NATIONAL CANCER INSTITUTE [P01CA101956, R21CA122523, R01CA086978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA101956, CA122523, and CA086978. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Blain SW, 2002, NAT MED, V8, P1076, DOI 10.1038/nm1002-1076; Carlomagno C, 1996, J CLIN ONCOL, V14, P2702, DOI 10.1200/JCO.1996.14.10.2702; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Datta J, 2007, CANCER RES, V67, P2736, DOI 10.1158/0008-5472.CAN-06-4433; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kisanga ER, 2004, CLIN CANCER RES, V10, P2336, DOI 10.1158/1078-0432.CCR-03-0538; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masuda A, 2001, AM J PATHOL, V158, P87, DOI 10.1016/S0002-9440(10)63947-8; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Obrero M, 2002, J BIOL CHEM, V277, P45695, DOI 10.1074/jbc.M208092200; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhu L, 2004, CLIN CANCER RES, V10, P4639, DOI 10.1158/1078-0432.CCR-04-0057	24	613	652	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29897	29903		10.1074/jbc.M804612200	http://dx.doi.org/10.1074/jbc.M804612200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18708351	Green Published, hybrid			2022-12-25	WOS:000260366900034
J	Revert, F; Ventura, I; Martinez-Martinez, P; Granero-Molto, F; Revert-Ros, F; Macias, J; Saus, J				Revert, Fernando; Ventura, Ignacio; Martinez-Martinez, Pilar; Granero-Molto, Froilan; Revert-Ros, Francisco; Macias, Jesus; Saus, Juan			Goodpasture Antigen-binding Protein Is a Soluble Exportable Protein That Interacts with Type IV Collagen IDENTIFICATION OF NOVEL MEMBRANE-BOUND ISOFORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CERAMIDE TRANSPORT PROTEIN; ENDOPLASMIC-RETICULUM; SPLICED VARIANT; KINASE; PHOSPHORYLATION; TRAFFICKING; DOMAIN; START; TRANSLATION; METABOLISM	Goodpasture-antigen binding protein (GPBP) is a nonconventional Ser/Thr kinase for basement membrane type IV collagen. Various studies have questioned these findings and proposed that GPBP serves as transporter of ceramide between the endoplasmic reticulum and the Golgi apparatus. Here we show that cells expressed at least two GPBP isoforms resulting from canonical(77-kDa) and noncanonical (91-kDa) mRNA translation initiation. The 77-kDa polypeptide interacted with type IV collagen and localized as a soluble form in the extracellular compartment. The 91-kDa polypeptide and its derived 120-kDa polypeptide associated with cellular membranes and regulated the extracellular levels of the 77-kDa polypeptide. A short motif containing two phenylalanines in an acidic tract and the 26-residue Ser-rich region were required for efficient 77-kDa polypeptide secretion. Removal of the 26-residue Ser-rich region by alternative exon splicing rendered the protein cytosolic and sensitive to the reduction of sphingomyelin cellular levels. These and previous data implicate GPBPs in a multi-compartmental program for protein secretion (i.e. type IV collagen) that includes: 1) phosphorylation and regulation of protein molecular/supramolecular organization and 2) interorganelle ceramide trafficking and regulation of protein cargo transport to the plasma membrane.	[Revert, Fernando; Ventura, Ignacio; Martinez-Martinez, Pilar; Granero-Molto, Froilan; Revert-Ros, Francisco; Macias, Jesus; Saus, Juan] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Saus, Juan] Univ Valencia, Dept Bioquim & Biol Mol, Valencia 46010, Spain	Prince Felipe Research Center; University of Valencia	Saus, J (corresponding author), Ctr Invest Principe Felipe, Avda Autopista Saler 16, Valencia 46012, Spain.	jsaus@cipf.es	REVERT, FERNANDO/ABF-8171-2021; Granero-Moltó, Froilán/H-6975-2017; Ventura, Ignacio/HCI-8162-2022; Revert-Ros, Francisco/AAB-7055-2019	REVERT, FERNANDO/0000-0002-7304-5846; Granero-Moltó, Froilán/0000-0003-4817-5232; Ventura, Ignacio/0000-0001-6426-2999; Martinez Martinez, Pilar/0000-0002-5990-3373; Revert-Ros, Francisco/0000-0002-6162-3370; Saus, Juan/0000-0003-2082-1597	Ministerio de Educacion y Ciencia [SAF97/0065, SAF2000/0047, SAF2001/0453, SAF2003-09772-C03-01, SAF2006-12520-C02-01]; Fundacion "La Caixa," [98/102-00]; Generalitat Valenciana (Spain) [GV04B-285, BM-001/2002]	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion "La Caixa,"(La Caixa Foundation); Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF))	This work was supported by Grants SAF97/0065, SAF2000/0047, SAF2001/0453, SAF2003-09772-C03-01, and SAF2006-12520-C02-01 from Ministerio de Educacion y Ciencia, Grant 98/102-00 from Fundacion "La Caixa," and Grants GV04B-285 and BM-001/2002 from Generalitat Valenciana (Spain) (to J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Calvete JJ, 2006, PROTEOMICS, V6, pS237, DOI 10.1002/pmic.200500495; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Granero F, 2005, FEBS J, V272, P5291, DOI 10.1111/j.1742-4658.2005.04925.x; Granero-Molto F, 2008, J BIOL CHEM, V283, P20495, DOI 10.1074/jbc.M801806200; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; REVERT F, 1995, J BIOL CHEM, V270, P13254, DOI 10.1074/jbc.270.22.13254; Revert F, 2007, AM J PATHOL, V171, P1419, DOI 10.2353/ajpath.2007.070205; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yang Y, 2005, MOL CELLS, V20, P173; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	30	24	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30246	30255		10.1074/jbc.M805026200	http://dx.doi.org/10.1074/jbc.M805026200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18772132	Green Published, hybrid			2022-12-25	WOS:000260366900069
J	Lokeshwar, VB; Gomez, P; Kramer, M; Knapp, J; McCornack, MA; Lopez, LE; Fregien, N; Dhir, N; Scherer, S; Klumpp, DJ; Manoharan, M; Soloway, MS; Lokeshwar, BL				Lokeshwar, Vinata B.; Gomez, Pablo; Kramer, Mario; Knapp, Judith; McCornack, Melissa A.; Lopez, Luis E.; Fregien, Nevis; Dhir, Neetika; Scherer, Steve; Klumpp, David J.; Manoharan, Murugesan; Soloway, Mark S.; Lokeshwar, Bal L.			Epigenetic Regulation of HYAL-1 Hyaluronidase Expression IDENTIFICATION OF HYAL-1 PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEAK TATA BOX; BLADDER-CANCER; TUMOR-MARKERS; PROSTATE-CANCER; HEPARANASE EXPRESSION; DNA METHYLATION; ACID; GROWTH; HYPOMETHYLATION; TRANSCRIPTION	HYAL-1 (hyaluronoglucosaminidase-1) belongs to the hyaluronidase family of enzymes that degrade hyaluronic acid. HYAL-1 is a marker for cancer diagnosis and a molecular determinant of tumor growth, invasion, and angiogenesis. The regulation of HYAL-1 expression is unknown. Real time reverse transcription-PCR using 11 bladder and prostate cancer cells and 69 bladder tissues showed that HYAL-1 mRNA levels are elevated 10-30-fold in cells/tissues that express high hyaluronidase activity. Although multiple transcription start sites (TSS) for HYAL-1 mRNA were detected in various tissues, the major TSS in many tissues, including bladder and prostate, was at nucleotide 27274 in the cosmid clone LUCA13 (AC002455). By analyzing the 1532 base sequence 5' to this TSS, using cloning and luciferase reporter assays, we identified a TACAAA sequence at position -31 and the minimal promoter region between nucleotides -93 and -38. Mutational analysis identified that nucleotides -73 to -50 (which include overlapping binding consensus sites for SP1, Egr-1, and AP-2), bases C-71 and C-59, and an NF kappa B-binding site (at position -15) are necessary for promoter activity. The chromatin immunoprecipitation assay identified that Egr-1, AP-2, and NF kappa B bind to the promoter in HYAL-1-expressing cells, whereas SP1 binds to the promoter in non-HYAL-1-expressing cells. 5-Aza-2'-deoxycytidine treatment, bisulfite DNA sequencing, and methylation-specific PCR revealed that HYAL-1 expression is regulated by methylation at C-71 and C-59; both Cs are part of the SP1/Egr-1-binding sites. Thus, HYAL-1 expression is epigenetically regulated by the binding of different transcription factors to the methylated and unmethylated HYAL-1 promoter.	[Lokeshwar, Vinata B.; Gomez, Pablo; Kramer, Mario; Knapp, Judith; Lopez, Luis E.; Dhir, Neetika; Manoharan, Murugesan; Soloway, Mark S.; Lokeshwar, Bal L.] Univ Miami, Miller Sch Med, Dept Urol, Miami, FL 33101 USA; [Lokeshwar, Vinata B.; Fregien, Nevis] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33101 USA; [Lokeshwar, Vinata B.; Lokeshwar, Bal L.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33101 USA; [McCornack, Melissa A.] Promega Corp, Madison, WI 53711 USA; [Scherer, Steve] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA	University of Miami; University of Miami; University of Miami; Promega Corporation; Baylor College of Medicine; Northwestern University; Feinberg School of Medicine	Kramer, M (corresponding author), Univ Miami, Miller Sch Med, Dept Urol M 800, POB 016960, Miami, FL 33101 USA.	vlokeshw@med.miami.edu	Kramer, Mario/GZH-1137-2022; Lokeshwar, Bal/O-3196-2019	Lokeshwar, Bal/0000-0002-1763-4718	National Institutes of Health [R01 072821-09, R01 CA 123063-01]; Florida Department of Health Bankhead Coley Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA123063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health Bankhead Coley Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 072821-09 and R01 CA 123063-01 (NCI) (to V. B. L.). This work was also supported by Florida Department of Health Bankhead Coley Cancer Research Program Grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aboughalia AH, 2006, ARCH MED RES, V37, P109, DOI 10.1016/j.arcmed.2005.04.019; Chow G, 2005, J BIOL CHEM, V280, P26904, DOI 10.1074/jbc.M413845200; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Csoka TB, 1997, FEBS LETT, V417, P307, DOI 10.1016/S0014-5793(97)01309-4; Das PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-28; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Droller MJ, 2002, UROL CLIN N AM, V29, P229, DOI 10.1016/S0094-0143(02)00008-3; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Eissa S, 2005, CANCER-AM CANCER SOC, V103, P1356, DOI 10.1002/cncr.20902; Ekici S, 2004, INT J CANCER, V112, P121, DOI 10.1002/ijc.20368; Franzmann EJ, 2003, INT J CANCER, V106, P438, DOI 10.1002/ijc.11252; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; Frost GI, 2000, ONCOGENE, V19, P870, DOI 10.1038/sj.onc.1203317; Golshani R, 2007, INT J CANCER, V120, P1712, DOI 10.1002/ijc.22222; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hautmann SH, 2001, J UROLOGY, V165, P2068, DOI 10.1016/S0022-5347(05)66296-9; Klug J, 1996, MOL CELL BIOL, V16, P6398; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Lokeshwar VB, 2000, J UROLOGY, V163, P348, DOI 10.1016/S0022-5347(05)68050-0; Lokeshwar VB, 2002, CANCER-AM CANCER SOC, V95, P61, DOI 10.1002/cncr.10652; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Lokeshwar VB, 2005, CANCER RES, V65, P2243, DOI 10.1158/0008-5472.CAN-04-2805; Lokeshwar VB, 2002, J BIOL CHEM, V277, P33654, DOI 10.1074/jbc.M203821200; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Lokeshwar VB, 1999, CANCER RES, V59, P4464; Lokeshwar VB, 2006, CANCER RES, V66, P11219, DOI 10.1158/0008-5472.CAN-06-1121; Meyer T, 1997, J BIOL CHEM, V272, P30709, DOI 10.1074/jbc.272.49.30709; Naomoto Y, 2005, ONCOL REP, V14, P3; Ogishima T, 2005, CLIN CANCER RES, V11, P1028; Ogishima T, 2005, ONCOGENE, V24, P6765, DOI 10.1038/sj.onc.1208811; Ohno S, 2002, J PERIODONTOL, V73, P1331, DOI 10.1902/jop.2002.73.11.1331; Pham HT, 1997, CANCER RES, V57, P1622; Poola I, 2008, CLIN CANCER RES, V14, P1274, DOI 10.1158/1078-0432.CCR-07-4053; Posey JT, 2003, CANCER RES, V63, P2638; Sasaki M, 2003, BIOCHEM BIOPH RES CO, V309, P305, DOI 10.1016/j.bbrc.2003.08.005; Schroeder GL, 2004, J UROLOGY, V172, P1123, DOI 10.1097/01.ju.0000134347.14643.ab; Schulz WA, 2006, J CELL MOL MED, V10, P100, DOI 10.1111/j.1582-4934.2006.tb00293.x; Seifert HH, 2007, EXP MOL PATHOL, V82, P292, DOI 10.1016/j.yexmp.2006.08.002; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Shteper PJ, 2003, ONCOGENE, V22, P7737, DOI 10.1038/sj.onc.1207056; Shukeir N, 2006, CANCER RES, V66, P9202, DOI 10.1158/0008-5472.CAN-06-1954; Simpson MA, 2008, FRONT BIOSCI-LANDMRK, V13, P5664; Simpson MA, 2006, AM J PATHOL, V169, P247, DOI 10.2353/ajpath.2006.060032; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2005, PATHOL BIOL, V53, P372, DOI 10.1016/j.patbio.2004.12.021; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Toole BP, 2005, CELLS TISSUES ORGANS, V179, P66, DOI 10.1159/000084510; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Vlodavsky I, 2006, PATHOPHYSIOL HAEMO T, V35, P116, DOI 10.1159/000093553; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207	53	35	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29215	29227		10.1074/jbc.M801101200	http://dx.doi.org/10.1074/jbc.M801101200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18718911	hybrid, Green Published			2022-12-25	WOS:000260179900049
J	Markkanen, PMH; Petaja-Repo, UE				Markkanen, Piia M. H.; Petaja-Repo, Ulla E.			N-Glycan-mediated Quality Control in the Endoplasmic Reticulum Is Required for the Expression of Correctly Folded delta-Opioid Receptors at the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ASPARAGINE-LINKED OLIGOSACCHARIDES; LUTEINIZING-HORMONE RECEPTOR; SITE-DIRECTED MUTAGENESIS; DISULFIDE BOND FORMATION; PLASMA-MEMBRANE; GLYCOSYLATION SITES; PHARMACOLOGICAL CHAPERONES; RHODOPSIN MATURATION; WILD-TYPE	A great majority of G protein-coupled receptors are modified by N-glycosylation, but the functional significance of this modification for receptor folding and intracellular transport has remained elusive. Here we studied these phenomena by mutating the two N-terminal N-glycosylation sites (Asn(18) and Asn(33)) of the human delta-opioid receptor, and expressing the mutants from the same chromosomal integration site in stably transfected inducible HEK293 cells. Both N-glycosylation sites were used, and their abolishment decreased the steady-state level of receptors at the cell surface. However, pulse-chase labeling, cell surface biotinylation, and immunofluorescence microscopy revealed that this was not because of intracellular accumulation. Instead, the non-N-glycosylated receptors were exported from the endoplasmic reticulum with enhanced kinetics. The results also revealed differences in the significance of the individual N-glycans, as the one attached to Asn33 was found to be more important for endoplasmic reticulum retention of the receptor. The non-N-glycosylated receptors did not show gross functional impairment, but flow cytometry revealed that a fraction of them was incapable of ligand binding at the cell surface. In addition, the receptors that were devoid of N-glycans showed accelerated turnover and internalization and were targeted for lysosomal degradation. The results accentuate the importance of protein conformation-based screening before export from the endoplasmic reticulum, and demonstrate how the system is compromised when N-glycosylation is disrupted. We conclude that N-glycosylation of the delta-opioid receptor is needed to maintain the expression of fully functional and stable receptor molecules at the cell surface.	[Markkanen, Piia M. H.; Petaja-Repo, Ulla E.] Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, FI-90014 Oulu, Finland	University of Oulu	Petaja-Repo, UE (corresponding author), Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, POB 5000, FI-90014 Oulu, Finland.	Ulla.Petaja-Repo@oulu.fi	Markkanen, Piia/ABD-8843-2020; Petäjä-Repo, Ulla/AAV-6115-2021	Markkanen, Piia/0000-0002-7200-6490	Academy of Finland [206230]	Academy of Finland(Academy of Finland)	This work was supported by the Biocenter Oulu and Grant 206230 from the Academy of Finland. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLEN S, 1995, J BIOL CHEM, V270, P4797, DOI 10.1074/jbc.270.9.4797; Apaja PM, 2006, MOL BIOL CELL, V17, P2243, DOI 10.1091/mbc.E05-09-0875; Benya RV, 2000, MOL PHARMACOL, V58, P1490, DOI 10.1124/mol.58.6.1490; Boer U, 2000, BIOCHEM J, V350, P839, DOI 10.1042/0264-6021:3500839; Branza-Nichita N, 2000, J BIOL CHEM, V275, P8169, DOI 10.1074/jbc.275.11.8169; Couvineau A, 1996, BIOCHEMISTRY-US, V35, P1745, DOI 10.1021/bi952022h; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; Deslauriers B, 1999, BIOCHEM J, V339, P397, DOI 10.1042/0264-6021:3390397; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Elliott S, 2004, J BIOL CHEM, V279, P16854, DOI 10.1074/jbc.M311095200; Fan J, 2005, MOL ENDOCRINOL, V19, P2579, DOI 10.1210/me.2004-0301; Frang H, 2003, ASSAY DRUG DEV TECHN, V1, P275, DOI 10.1089/15406580360545080; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; FUKUSHIMA Y, 1995, BIOCHEM J, V310, P553, DOI 10.1042/bj3100553; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Imperiali B, 1999, CURR OPIN CHEM BIOL, V3, P643, DOI 10.1016/S1367-5931(99)00021-6; Karpa KD, 1999, MOL PHARMACOL, V56, P1071, DOI 10.1124/mol.56.5.1071; KAUSHAL S, 1994, P NATL ACAD SCI USA, V91, P4024, DOI 10.1073/pnas.91.9.4024; KNAPP RJ, 1995, FASEB J, V9, P516, DOI 10.1096/fasebj.9.7.7737460; Lanctot PM, 1999, BIOCHEMISTRY-US, V38, P8621, DOI 10.1021/bi9830516; LANDOLTMARTICORENA C, 1994, BIOCHEM J, V302, P253, DOI 10.1042/bj3020253; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Li JG, 2007, BIOCHEMISTRY-US, V46, P10960, DOI 10.1021/bi700443j; Liu Y, 2006, J BIOL CHEM, V281, P31457, DOI 10.1074/jbc.M606643200; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; MCDOWELL W, 1988, BIOCHIMIE, V70, P1535, DOI 10.1016/0300-9084(88)90290-8; McGinnes LW, 1997, J VIROL, V71, P3083, DOI 10.1128/JVI.71.4.3083-3089.1997; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Mentesana PE, 2001, BIOCHEMISTRY-US, V40, P9685, DOI 10.1021/bi0108507; Michineau S, 2004, BIOL CHEM, V385, P49, DOI 10.1515/BC.2004.007; Mizrachi D, 2004, MOL ENDOCRINOL, V18, P1768, DOI 10.1210/me.2003-0406; Morello JP, 2001, BIOCHEMISTRY-US, V40, P6766, DOI 10.1021/bi002699r; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Robert J, 2005, J BIOL CHEM, V280, P42198, DOI 10.1074/jbc.M510180200; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Siffroi-Fernandez S, 2002, EUR J BIOCHEM, V269, P4930, DOI 10.1046/j.1432-1033.2002.03192.x; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tuusa JT, 2007, J MOL BIOL, V371, P622, DOI 10.1016/j.jmb.2007.02.108; VANKOPPEN CJ, 1990, J BIOL CHEM, V265, P20887; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Webel R, 2000, J BIOL CHEM, V275, P24752, DOI 10.1074/jbc.M002668200; Wujek P, 2004, J BIOL CHEM, V279, P12827, DOI 10.1074/jbc.M313173200	55	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29086	29098		10.1074/jbc.M801880200	http://dx.doi.org/10.1074/jbc.M801880200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703511	hybrid, Green Published			2022-12-25	WOS:000260179900036
J	Li, YC; Coelho, CM; Liu, T; Wu, S; Wu, JS; Zeng, YR; Li, YC; Hunter, B; Dante, RA; Larkins, BA; Wu, RL				Li, Yanchun; Coelho, Cintia M.; Liu, Tian; Wu, Song; Wu, Jiasheng; Zeng, Yanru; Li, Youchun; Hunter, Brenda; Dante, Ricardo A.; Larkins, Brian A.; Wu, Rongling			A Statistical Model for Estimating Maternal-Zygotic Interactions and Parent-of-Origin Effects of QTLs for Seed Development	PLOS ONE			English	Article							QUANTITATIVE-TRAIT LOCI; MUSCLE MASS; ENDOSPERM DEVELOPMENT; PATTERN-FORMATION; LINKAGE; GENE; SIZE; GENOME; ENDOREDUPLICATION; SUSCEPTIBILITY	Proper development of a seed requires coordinated exchanges of signals among the three components that develop side by side in the seed. One of these is the maternal integument that encloses the other two zygotic components, i.e., the diploid embryo and its nurturing annex, the triploid endosperm. Although the formation of the embryo and endosperm contains the contributions of both maternal and paternal parents, maternally and paternally derived alleles may be expressed differently, leading to a so-called parent-of-origin or imprinting effect. Currently, the nature of how genes from the maternal and zygotic genomes interact to affect seed development remains largely unknown. Here, we present a novel statistical model for estimating the main and interaction effects of quantitative trait loci (QTLs) that are derived from different genomes and further testing the imprinting effects of these QTLs on seed development. The experimental design used is based on reciprocal backcrosses toward both parents, so that the inheritance of parent- specific alleles could be traced. The computing model and algorithm were implemented with the maximum likelihood approach. The new strategy presented was applied to study the mode of inheritance for QTLs that control endoreduplication traits in maize endosperm. Monte Carlo simulation studies were performed to investigate the statistical properties of the new model with the data simulated under different imprinting degrees. The false positive rate of imprinting QTL discovery by the model was examined by analyzing the simulated data that contain no imprinting QTL. The reciprocal design and a series of analytical and testing strategies proposed provide a standard procedure for genomic mapping of QTLs involved in the genetic control of complex seed development traits in flowering plants.	[Li, Yanchun; Wu, Jiasheng; Zeng, Yanru; Wu, Rongling] Zhejiang Forestry Univ, Sch Forestry & Biotechnol, Linan, Zhejiang, Peoples R China; [Li, Yanchun] Fujian Acad Agr Sci, Agr Ecol Res Inst, Fuzhou, Peoples R China; [Coelho, Cintia M.; Li, Youchun; Hunter, Brenda; Dante, Ricardo A.; Larkins, Brian A.] Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; [Liu, Tian] Genome Inst Singapore, Human Genet Grp, Singapore, Singapore; [Wu, Song; Wu, Rongling] Univ Florida, Dept Stat, Gainesville, FL USA; [Wu, Rongling] Princeton Univ, Dept Operat Res & Financial Engn, Princeton, NJ USA	Zhejiang A&F University; Fujian Academy of Agricultural Sciences; University of Arizona; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); State University System of Florida; University of Florida; Princeton University	Li, YC (corresponding author), Zhejiang Forestry Univ, Sch Forestry & Biotechnol, Linan, Zhejiang, Peoples R China.	rongling@princeton.edu	Coelho, Cíntia M/M-9939-2017; li, yan/GTI-4638-2022; Dante, Ricardo A./F-9642-2012	Coelho, Cíntia M/0000-0002-8564-3587; Dante, Ricardo A./0000-0002-2738-4433	Department of Energy [DE-96ER20242]; NSF/NIH [0540745]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Department of Energy(United States Department of Energy (DOE)); NSF/NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research described in this manuscript was supported by a grant from the Department of Energy (DE-96ER20242) to BAL and NSF/NIH grant (No. 0540745) to RLW. C.M.C. and R.A.D. were supported by scholarships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil.	Busch M, 1996, MOL GEN GENET, V250, P681, DOI 10.1007/BF02172979; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; Chaudhury AM, 2001, ANNU REV CELL DEV BI, V17, P677, DOI 10.1146/annurev.cellbio.17.1.677; CHURCHILL GA, 1994, GENETICS, V138, P963; Clapcott SJ, 2000, PARASITE IMMUNOL, V22, P259, DOI 10.1046/j.1365-3024.2000.00308.x; Coelho CM, 2007, THEOR APPL GENET, V115, P1147, DOI 10.1007/s00122-007-0640-z; Cui YH, 2006, GENET RES, V87, P61, DOI 10.1017/S0016672306007956; Cui YH, 2006, GENOMICS, V87, P543, DOI 10.1016/j.ygeno.2005.11.021; Cui YH, 2005, GENET RES, V86, P65, DOI 10.1017/S0016672305007615; Cui YH, 2005, BIOINFORMATICS, V21, P2447, DOI 10.1093/bioinformatics/bti342; Cui YH, 2004, GENETICS, V167, P1017, DOI 10.1534/genetics.103.024398; Cui YH, 2007, GENETICA, V130, P227, DOI 10.1007/s10709-006-9101-x; Cui YH, 2007, J THEOR BIOL, V244, P115, DOI 10.1016/j.jtbi.2006.07.009; de Koning DJ, 2002, GENETICS, V161, P931; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; Dilkes BP, 2002, GENETICS, V160, P1163; Evans MMS, 2001, GENETICS, V159, P303; Garcia D, 2005, PLANT CELL, V17, P52, DOI 10.1105/tpc.104.027136; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Haghighi F, 2002, AM J HUM GENET, V70, P142, DOI 10.1086/324709; Hanson RL, 2001, AM J HUM GENET, V68, P951, DOI 10.1086/319508; Ingouff M, 2006, PLANT CELL, V18, P3491, DOI 10.1105/tpc.106.047266; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Knott SA, 1998, GENETICS, V149, P1069; LANDER ES, 1989, GENETICS, V121, P185; Lin M, 2003, GENETICS, V165, P901; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Mora-Garcia S, 2000, CURR BIOL, V10, pR71, DOI 10.1016/S0960-9822(00)00285-2; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Nezer C, 2003, GENETICS, V165, P277; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Nowack MK, 2007, NATURE, V447, P312, DOI 10.1038/nature05770; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Paterson AD, 1999, HUM HERED, V49, P197, DOI 10.1159/000022875; Pfeifer K, 2000, AM J HUM GENET, V67, P777, DOI 10.1086/303101; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Shete S, 2002, AM J HUM GENET, V70, P751, DOI 10.1086/338931; Shete S, 2003, AM J HUM GENET, V73, P933, DOI 10.1086/378592; Sieber P, 2004, DEV BIOL, V273, P321, DOI 10.1016/j.ydbio.2004.05.037; Sundaresan V, 2005, P NATL ACAD SCI USA, V102, P17887, DOI 10.1073/pnas.0509021102; Tuiskula-Haavisto M, 2004, GENET RES, V84, P57, DOI 10.1017/S0016672304006950; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Vinkenoog R, 2003, MOL BIOTECHNOL, V25, P149, DOI 10.1385/MB:25:2:149; Wu R., 2007, STAT GENETICS QUANTI; Wu RL, 2002, P NATL ACAD SCI USA, V99, P11281, DOI 10.1073/pnas.112345699; Wu RL, 2002, GENETICS, V162, P875; Xiao WY, 2006, PLANT PHYSIOL, V142, P1160, DOI 10.1104/pp.106.088849	52	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3131	10.1371/journal.pone.0003131	http://dx.doi.org/10.1371/journal.pone.0003131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769549	Green Published, gold, Green Submitted			2022-12-25	WOS:000264419100002
J	Liu, LN; Elmalk, AT; Aartsma, TJ; Thomas, JC; Lamers, GEM; Zhou, BC; Zhang, YZ				Liu, Lu-Ning; Elmalk, Abdalmohsen T.; Aartsma, Thijs J.; Thomas, Jean-Claude; Lamers, Gerda E. M.; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Light-Induced Energetic Decoupling as a Mechanism for Phycobilisome-Related Energy Dissipation in Red Algae: A Single Molecule Study	PLOS ONE			English	Article								Background: Photosynthetic organisms have developed multiple protective mechanisms to prevent photodamage in vivo under high-light conditions. Cyanobacteria and red algae use phycobilisomes (PBsomes) as their major light-harvesting antennae complexes. The orange carotenoid protein in some cyanobacteria has been demonstrated to play roles in the photoprotective mechanism. The PBsome-itself-related energy dissipation mechanism is still unclear. Methodology/Principal Findings: Here, single-molecule spectroscopy is applied for the first time on the PBsomes of red alga Porphyridium cruentum, to detect the fluorescence emissions of phycoerythrins (PE) and PBsome core complex simultaneously, and the real-time detection could greatly characterize the fluorescence dynamics of individual PBsomes in response to intense light. Conclusions/Significance: Our data revealed that strong green-light can induce the fluorescence decrease of PBsome, as well as the fluorescence increase of PE at the first stage of photobleaching. It strongly indicated an energetic decoupling occurring between PE and its neighbor. The fluorescence of PE was subsequently observed to be decreased, showing that PE was photobleached when energy transfer in the PBsomes was disrupted. In contrast, the energetic decoupling was not observed in either the PBsomes fixed with glutaraldehyde, or the mutant PBsomes lacking B-PE and remaining b-PE. It was concluded that the energetic decoupling of the PBsomes occurs at the specific association between B-PE and b-PE within the PBsome rod. Assuming that the same process occurs also at the much lower physiological light intensities, such a decoupling process is proposed to be a strategy corresponding to PBsomes to prevent photodamage of the photosynthetic reaction centers. Finally, a novel photoprotective role of c-subunit-containing PE in red algae was discussed.	[Liu, Lu-Ning; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Liu, Lu-Ning; Elmalk, Abdalmohsen T.; Aartsma, Thijs J.] Leiden Univ, Biophys Dept, Huygens Lab, Leiden, Netherlands; [Thomas, Jean-Claude; Lamers, Gerda E. M.] CNRS, Ecole Normale Superieure, UMR 8186, Paris, France; Leiden Univ, Inst Biol, Leiden, Netherlands	Shandong University; Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Leiden University; Leiden University - Excl LUMC	Liu, LN (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn	Liu, Lu-Ning/B-1460-2009	Liu, Lu-Ning/0000-0002-8884-4819	National Natural Science Foundation of China [40676078]; Hi-Tech Research and Development program of China [2008AA09Z404]; Key International S&T Cooperation Project of China [2008DFA30440]; Netherlands Organization for Scientific Research (NWO); Foundation for Earth and Life Sciences (ALW)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); Key International S&T Cooperation Project of China; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Foundation for Earth and Life Sciences (ALW)	The work was supported by the National Natural Science Foundation of China (40676078), Hi-Tech Research and Development program of China (2008AA09Z404), and Key International S&T Cooperation Project of China (2008DFA30440). This project is part of the research programme "From Molecule to Cell" funded by the Netherlands Organization for Scientific Research (NWO) and the Foundation for Earth and Life Sciences (ALW).	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; APT KE, 1995, J MOL BIOL, V248, P79, DOI 10.1006/jmbi.1995.0203; Arteni AA, 2008, PHOTOSYNTH RES, V95, P169, DOI 10.1007/s11120-007-9264-z; BIGGINS J, 1984, BIOCHIM BIOPHYS ACTA, V767, P138, DOI 10.1016/0005-2728(84)90088-4; Bopp MA, 1997, P NATL ACAD SCI USA, V94, P10630, DOI 10.1073/pnas.94.20.10630; Bopp MA, 1999, P NATL ACAD SCI USA, V96, P11271, DOI 10.1073/pnas.96.20.11271; FICNER R, 1993, EUR J BIOCHEM, V218, P103, DOI 10.1111/j.1432-1033.1993.tb18356.x; GANTT E, 1974, BIOCHEMISTRY-US, V13, P2960, DOI 10.1021/bi00711a027; GANTT E, 1972, J CELL BIOL, V54, P313, DOI 10.1083/jcb.54.2.313; GANTT E, 1976, BIOCHIM BIOPHYS ACTA, V430, P375, DOI 10.1016/0005-2728(76)90093-1; GLAZER AN, 1984, BIOCHIM BIOPHYS ACTA, V768, P29, DOI 10.1016/0304-4173(84)90006-5; Hofmann C, 2003, P NATL ACAD SCI USA, V100, P15534, DOI 10.1073/pnas.2533896100; Hofmann C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.013004; JONES RF, 1963, PHYSIOL PLANTARUM, V16, P636, DOI 10.1111/j.1399-3054.1963.tb08342.x; Kirilovsky D, 2007, PHOTOSYNTH RES, V93, P7, DOI 10.1007/s11120-007-9168-y; Lao KQ, 1996, P NATL ACAD SCI USA, V93, P5258, DOI 10.1073/pnas.93.11.5258; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; Luong AK, 2005, J PHYS CHEM B, V109, P15691, DOI 10.1021/jp050465h; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Mackowski S, 2007, BIOPHYS J, V93, P3249, DOI 10.1529/biophysj.107.112094; Rakhimberdieva MG, 2007, FEBS LETT, V581, P2429, DOI 10.1016/j.febslet.2007.04.056; Rakhimberdieva MG, 2004, FEBS LETT, V574, P85, DOI 10.1016/j.febslet.2004.07.087; Rinalducci S, 2008, BBA-BIOENERGETICS, V1777, P417, DOI 10.1016/j.bbabio.2008.02.005; SIVAN A, 1993, PHYCOLOGIA, V32, P68, DOI 10.2216/i0031-8884-32-1-68.1; SIVAN A, 1995, J PHYCOL, V31, P167, DOI 10.1111/j.0022-3646.1995.00167.x; Six C, 2007, PHOTOSYNTH RES, V92, P75, DOI 10.1007/s11120-007-9170-4; Stoitchkova K, 2007, BBA-BIOENERGETICS, V1767, P750, DOI 10.1016/j.bbabio.2007.03.002; SUTER GW, 1984, BIOCHIM BIOPHYS ACTA, V766, P269, DOI 10.1016/0005-2728(84)90241-X; Vacha F, 2005, MICRON, V36, P483, DOI 10.1016/j.micron.2005.04.004; van Oijen AM, 1999, SCIENCE, V285, P400, DOI 10.1126/science.285.5426.400; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Wormke S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2737429; Wu M, 1996, J PHYS CHEM-US, V100, P17406, DOI 10.1021/jp9616775; WYMAN M, 1985, SCIENCE, V230, P818, DOI 10.1126/science.230.4727.818; Ying LM, 1998, J PHYS CHEM B, V102, P10399, DOI 10.1021/jp983227d; Zehetmayer P, 2004, BBA-BIOENERGETICS, V1608, P35, DOI 10.1016/j.bbabio.2003.10.003; Zehetmayer P, 2002, BIOPHYS J, V83, P407, DOI 10.1016/S0006-3495(02)75178-3	38	40	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3134	10.1371/journal.pone.0003134	http://dx.doi.org/10.1371/journal.pone.0003134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769542	Green Published, gold			2022-12-25	WOS:000264419100004
J	Harshbarger, TB; Song, AW				Harshbarger, Todd B.; Song, Allen W.			Differentiating Sensitivity of Post-Stimulus Undershoot under Diffusion Weighting: Implication of Vascular and Neuronal Hierarchy	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SUPPLEMENTARY MOTOR AREAS; OXIDATIVE-METABOLISM; BRAIN ACTIVATION; TEMPORAL CHARACTERISTICS; SPATIAL LOCALIZATION; BALLOON MODEL; BOLD RESPONSE; FMRI SIGNAL; OXYGENATION	The widely used blood oxygenation level dependent (BOLD) signal during brain activation, as measured in typical fMRI methods, is composed of several distinct phases, the last of which, and perhaps the least understood, is the post-stimulus undershoot. Although this undershoot has been consistently observed, its hemodynamic and metabolic sources are still under debate, as evidences for sustained blood volume increases and metabolic activities have been presented. In order to help differentiate the origins of the undershoot from vascular and neuronal perspectives, we applied progressing diffusion weighting gradients to investigate the BOLD signals during visual stimulation. Three distinct regions were established and found to have fundamentally different properties in post-stimulus signal undershoot. The first region, with a small but focal spatial extent, shows a clear undershoot with decreasing magnitude under increasing diffusion weighting, which is inferred to represent intravascular signal from larger vessels with large apparent diffusion coefficients (ADC), or high mobility. The second region, with a large continuous spatial extent in which some surrounds the first region while some spreads beyond, also shows a clear undershoot but no change in undershoot amplitude with progressing diffusion weighting. This would indicate a source based on extravascular and small vessel signal with smaller ADC, or lower mobility. The third region shows no significant undershoot, and is largely confined to higher order visual areas. Given their intermediate ADC, it would likely include both large and small vessels. Thus the consistent observation of this third region would argue against a vascular origin but support a metabolic basis for the post-stimulus undershoot, and would appear to indicate a lack of sustained metabolic rate likely due to a lower oxygen metabolism in these higher visual areas. Our results are the first, to our knowledge, to suggest that the post-stimulus undershoots have a spatial dependence on the vascular and neuronal hierarchy, and that progressing flow-sensitized diffusion weighting can help delineate these dependences.	[Harshbarger, Todd B.; Song, Allen W.] Duke Univ, Brain Imaging & Anal Ctr, Uninc Orange Cty, NC USA	Duke University	Harshbarger, TB (corresponding author), Duke Univ, Brain Imaging & Anal Ctr, Uninc Orange Cty, NC USA.	harshbarger@biac.duke.edu	Harshbarger, Todd/AAR-1317-2020	harshbarger, todd/0000-0001-5030-465X	 [NS41328];  [NS50329]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050329, P01NS041328] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided by research grants NS41328 and NS50329.	Ances BM, 2008, NEUROIMAGE, V39, P1510, DOI 10.1016/j.neuroimage.2007.11.015; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Aubert A, 2007, P NATL ACAD SCI USA, V104, P4188, DOI 10.1073/pnas.0605864104; Bandettini PA, 1997, HUM BRAIN MAPP, V5, P93; BEHZADI Y, 2006, 14 ANN M ISMRM SEATT, P373; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P4, DOI 10.1002/mrm.1910340103; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2001, NEUROIMAGE, V13, P953, DOI 10.1006/nimg.2001.0814; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; CHEN JJ, 2007, 15 ANN M ISMRM BERL, P262; Chen W, 1998, MAGN RESON MED, V39, P520, DOI 10.1002/mrm.1910390404; Chiarelli PA, 2007, MAGN RESON MED, V57, P538, DOI 10.1002/mrm.21171; Darquie A, 2001, P NATL ACAD SCI USA, V98, P9391, DOI 10.1073/pnas.151125698; Frahm J, 1996, MAGNET RESON MED, V35, P143, DOI 10.1002/mrm.1910350202; Fransson P, 1998, MAGNET RESON MED, V39, P912, DOI 10.1002/mrm.1910390608; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Gangstead SL, 2002, MAGNET RESON MED, V48, P385, DOI 10.1002/mrm.10189; Harrison RV, 2002, CEREB CORTEX, V12, P225, DOI 10.1093/cercor/12.3.225; Harshbarger TB, 2004, MAGN RESON MED, V52, P1432, DOI 10.1002/mrm.20293; Hoge RD, 1999, NEUROIMAGE, V9, P573, DOI 10.1006/nimg.1999.0443; Huettel SA, 2004, CEREB CORTEX, V14, P165, DOI 10.1093/cercor/bhg115; Ishii K, 1996, J NUCL MED, V37, P1086; JIN T, 2006, 14 ANN M ISMRM SEATT, P2762; Jones RA, 1999, NMR BIOMED, V12, P301, DOI 10.1002/(SICI)1099-1492(199908)12:5<299::AID-NBM566>3.0.CO;2-H; Jones RA, 1998, MAGNET RESON MED, V40, P112, DOI 10.1002/mrm.1910400116; Kamba M, 2007, J MAGN RESON IMAGING, V26, P1506, DOI 10.1002/jmri.21193; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kruger G, 1996, MAGNET RESON MED, V35, P797, DOI 10.1002/mrm.1910350602; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1992, MAGNET RESON MED, V27, P171, DOI 10.1002/mrm.1910270116; Lu HZ, 2004, J CEREBR BLOOD F MET, V24, P764, DOI 10.1097/01.WCB.0000124322.60992.5C; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; Marcar VL, 2004, MAGN RESON IMAGING, V22, P921, DOI 10.1016/j.mri.2004.02.013; Michelich CR, 2006, NMR BIOMED, V19, P566, DOI 10.1002/nbm.1035; Obata T, 2004, NEUROIMAGE, V21, P144, DOI 10.1016/j.neuroimage.2003.08.040; OBATA T, 2006, 14 ANN M ISMRM SEATT, P2785; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; POSER BA, 2007, 15 ANN M ISMRM BERL, P261; Schroeter ML, 2006, NEUROIMAGE, V30, P349, DOI 10.1016/j.neuroimage.2005.09.048; Song AW, 2002, NEUROIMAGE, V17, P742, DOI 10.1006/nimg.2002.1217; Song AW, 1996, MAGNET RESON MED, V35, P155, DOI 10.1002/mrm.1910350204; Tuunanen PI, 2006, MAGN RESON IMAGING, V24, P993, DOI 10.1016/j.mri.2006.04.017; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013; Wolf M, 2002, NEUROIMAGE, V16, P704, DOI 10.1006/nimg.2002.1128; Yacoub E, 2006, J CEREBR BLOOD F MET, V26, P634, DOI 10.1038/sj.jcbfm.9600239; Zhao FQ, 2007, NEUROIMAGE, V34, P1084, DOI 10.1016/j.neuroimage.2006.10.016; ZHENG D, 1991, J NEUROSCI, V11, P2622; Zhong JH, 1998, MAGNET RESON MED, V40, P526, DOI 10.1002/mrm.1910400405; ZHU XH, 2006, 14 ANN M ISMRM SEATT, P2786	49	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2914	10.1371/journal.pone.0002914	http://dx.doi.org/10.1371/journal.pone.0002914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698432	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600002
J	Jakubowski, H; Boers, GHJ; Strauss, KA				Jakubowski, Hieronim; Boers, Godfried H. J.; Strauss, Kevin A.			Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans	FASEB JOURNAL			English	Article						genetic hyperhomocysteinemia; homocysteine thiolactone; fibrinogen; atherothrombosis	MOLECULAR-BASIS; PATHOLOGICAL CONSEQUENCES; POSSIBLE MECHANISM; HUMAN FIBRINOGEN; THIOLACTONE; AUTOANTIBODIES; HOMOCYSTINURIA; DEFICIENCY; RESISTANCE; DISEASE	Severely elevated plasma homocysteine (Hcy) levels observed in genetic disorders of Hcy metabolism are associated with pathologies in multiple organs and lead to premature death due to vascular complications. In addition to elevating plasma Hcy, mutations in cystathionine beta-synthase (CBS) or methylenetetrahydrofolate reductase (MTHFR) gene lead to markedly elevated levels of circulating Hcy-thiolactone. The thiooester chemistry of Hcy-thiolactone underlies its ability to form isopeptide bonds with protein lysine residues (N-Hcy-protein), which may impair or alter the protein's function. However, it was not known whether genetic deficiencies in Hcy metabolism affect N-Hcy-protein levels in humans. Here we show that plasma N-Hcy-protein levels are significantly elevated in CBS- and MTHFR-deficient patients. We also show that CBS-deficient patients have significantly elevated plasma levels of prothrombotic N-Hcy-fibrinogen. These results provide a possible explanation for increased atherothrombosis observed in CBS-deficient patients.	[Jakubowski, Hieronim] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Int Ctr Publ Hlth, Newark, NJ 07101 USA; [Jakubowski, Hieronim] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Boers, Godfried H. J.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Strauss, Kevin A.] Clin Special Children, Strasburg, PA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Radboud University Nijmegen	Jakubowski, H (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Int Ctr Publ Hlth, 225 Warren St, Newark, NJ 07101 USA.	jakubows@umdnj.edu	Jakubowski, Hieronim/AAA-6834-2019; Jakubowski, Hieronim/A-2510-2017	Jakubowski, Hieronim/0000-0001-5845-4409	American Heart Association; Ministry of Science and Higher Education, Poland	American Heart Association(American Heart Association); Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This work was supported in part by grants from the American Heart Association and the Ministry of Science and Higher Education, Poland.	Chwatko G, 2005, CLIN CHEM, V51, P408, DOI 10.1373/clinchem.2004.042531; Chwatko G, 2005, ANAL BIOCHEM, V337, P271, DOI 10.1016/j.ab.2004.11.035; Chwatko G, 2007, FASEB J, V21, P1707, DOI 10.1096/fj.06-7435com; de las Casas CM, 2003, BIRTH DEFECTS RES A, V67, P35, DOI 10.1002/bdra.10014; Endo N, 2006, BRIT J NUTR, V95, P1088, DOI 10.1079/BJN20061764; Goyette P, 1996, AM J HUM GENET, V59, P1268; Hanss M, 2001, ANN NY ACAD SCI, V936, P89; HARKER LA, 1974, NEW ENGL J MED, V291, P537, DOI 10.1056/NEJM197409122911101; JAKUBOWSKI H, 1993, FEBS LETT, V317, P237, DOI 10.1016/0014-5793(93)81283-6; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; Jakubowski H, 2005, CLIN CHEM LAB MED, V43, P1011, DOI 10.1515/CCLM.2005.177; Jakubowski H, 2004, CELL MOL LIFE SCI, V61, P470, DOI 10.1007/s00018-003-3204-7; Jakubowski H, 2002, J BIOL CHEM, V277, P30425, DOI 10.1074/jbc.C200267200; Jakubowski H, 2002, ANAL BIOCHEM, V308, P112, DOI 10.1016/S0003-2697(02)00224-5; Jakubowski H, 2001, BIOMED PHARMACOTHER, V55, P443, DOI 10.1016/S0753-3322(01)00085-3; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jakubowski H, 2000, J NUTR, V130, p377S, DOI 10.1093/jn/130.2.377S; Jakubowski H, 2008, ANAL BIOCHEM, V380, P257, DOI 10.1016/j.ab.2008.05.049; Jakubowski H, 2007, CLIN CHEM LAB MED, V45, P1704, DOI 10.1515/CCLM.2007.338; Jakubowski H, 2007, ANAL BIOCHEM, V370, P124, DOI 10.1016/j.ab.2007.05.030; Jakubowski H, 2006, J NUTR, V136, p1741S, DOI 10.1093/jn/136.6.1741S; Kluijtmans LAJ, 1999, AM J HUM GENET, V65, P59, DOI 10.1086/302439; MOSESSON MW, 1966, BIOCHEMISTRY-US, V5, P2829, DOI 10.1021/bi00873a008; MUDD SH, 2001, METABOLIC MOL BASES, V2, P2007; Perla-Kajan J, 2008, BIOMED PHARMACOTHER, V62, P473, DOI 10.1016/j.biopha.2008.04.001; Rosenblatt D. S., 2001, METABOLIC MOL BASES, V8th, P3897; Sauls DL, 2006, BIOCHEMISTRY-US, V45, P2480, DOI 10.1021/bi052076j; Strauss KA, 2007, MOL GENET METAB, V91, P165, DOI 10.1016/j.ymgme.2007.02.012; Undas A, 2005, THROMB HAEMOSTASIS, V93, P346, DOI 10.1160/TH04-08-0493; Undas A, 2004, STROKE, V35, P1299, DOI 10.1161/01.STR.0000128412.59768.6e; Undas A, 2006, ARTERIOSCL THROM VAS, V26, P1397, DOI 10.1161/01.ATV.0000219688.43572.75; Yap S, 2001, ARTERIOSCL THROM VAS, V21, P2080, DOI 10.1161/hq1201.100225	33	77	87	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4071	4076		10.1096/fj.08-112086	http://dx.doi.org/10.1096/fj.08-112086			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18708589				2022-12-25	WOS:000261254800006
J	Jing, Y; Mal, N; Williams, PS; Mayorga, M; Penn, MS; Chalmers, JJ; Zborowski, M				Jing, Ying; Mal, Niladri; Williams, P. Stephen; Mayorga, Maritza; Penn, Marc S.; Chalmers, Jeffrey J.; Zborowski, Maciej			Quantitative intracellular magnetic nanoparticle uptake measured by live cell magnetophoresis	FASEB JOURNAL			English	Article						intracellular MRI contrast; stem cell tracking; SPIO; transfection agent; intracellular iron; particle tracking velocimetry	MR CONTRAST AGENTS; TRACKING VELOCIMETRY; STEM-CELLS; INDUCED VELOCITY; EXTERNAL FIELDS; GENE DELIVERY; RAT-BRAIN; IRON; QUANTIFICATION; EXPRESSION	Superparamagnetic iron oxide (SPIO) particles have been used successfully as an intracellular contrast agent for nuclear MRI cell tracking in vivo. We present a method of detecting intracellular SPIO colloid uptake in live cells using cell magnetophoresis, with potential applications in measuring intracellular MRI contrast uptake. The method was evaluated by measuring shifts in mean and distribution of the cell magnetophoretic mobility, and the concomitant changes in population frequency of the magnetically positive cells when compared to the unmanipulated negative control. Seven different transfection agent (TA) -SPIO complexes based on dendrimer, lipid, and polyethylenimine compounds were used as test standards, in combination with 3 different cell types: mesenchymal stem cells, cardiac fibroblasts, and cultured KG-1a hematopoietic stem cells. Transfectol (TRA) -SPIO incubation resulted in the highest frequency of magnetically positive cells (> 90%), and Fugene 6 (FUG) -SPIO incubation the lowest, below that when using SPIO alone. A highly regular process of cell magnetophoresis was amenable to intracellular iron mass calculations. The results were consistent in all the cell types studied and with other reports. The cell magnetophoresis depends on the presence of high- spin iron species and is therefore expected to be directly related to the cell MRI contrast level.	[Jing, Ying; Williams, P. Stephen; Zborowski, Maciej] Cleveland Clin, Dept Biomed Engn ND20, Lerner Res Inst, Cleveland, OH 44195 USA; [Mal, Niladri; Mayorga, Maritza; Penn, Marc S.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Jing, Ying; Chalmers, Jeffrey J.] Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Ohio State University	Zborowski, M (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	zborowm@ccf.org	Chalmers, Jeffrey J/D-2305-2009; Williams, Philip/C-2774-2008	Williams, Philip/0000-0002-5951-2612	U.S. National Institutes of Health [CA62349]; National Science Foundation [BES-0124897]; NATIONAL CANCER INSTITUTE [R01CA062349] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thankfully acknowledge support by the U.S. National Institutes of Health (CA62349 to M.Z.) and the National Science Foundation (BES-0124897 to J J.C.).	Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Bulte JWM, 1996, ACAD RADIOL, V3, pS301, DOI 10.1016/S1076-6332(96)80564-2; Chalmers JJ, 1999, J MAGN MAGN MATER, V194, P231, DOI 10.1016/S0304-8853(98)00557-5; Chalmers JJ, 1999, BIOTECHNOL BIOENG, V64, P519, DOI 10.1002/(SICI)1097-0290(19990905)64:5<519::AID-BIT2>3.3.CO;2-M; Chalmers JJ, 1999, BIOTECHNOL BIOENG, V64, P509, DOI 10.1002/(SICI)1097-0290(19990905)64:5<509::AID-BIT1>3.0.CO;2-Z; Dyer PA, 1998, PRACT APPROACH SER, V193, P191; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Frank JA, 2002, ACAD RADIOL, V9, pS484, DOI 10.1016/S1076-6332(03)80271-4; Gee A.P., 1997, CELL SEP METHODS APP, P175; GUEZENNEC YG, 1994, EXP FLUIDS, V17, P209, DOI 10.1007/BF00203039; Hafeli UO, 2006, SMART NANOPARTICLES, V8, P77; Hecker JG, 2001, MOL THER, V3, P375, DOI 10.1006/mthe.2001.0272; Hergt R, 2004, J MAGN MAGN MATER, V270, P345, DOI 10.1016/j.jmmm.2003.09.001; Jing Y, 2007, EXP HEMATOL, V35, P662, DOI 10.1016/j.exphem.2006.12.009; JUNG CW, 1995, MAGN RESON IMAGING, V13, P661, DOI 10.1016/0730-725X(95)00024-B; Kalish H, 2003, MAGN RESON MED, V50, P275, DOI 10.1002/mrm.10556; Kantor A.B., 1998, CELL SEP METHODS APP, V1, P153; Leigh DR, 2005, CYTOM PART A, V66A, P103, DOI 10.1002/cyto.a.20155; LIBERTI PA, 1991, ACS SYM SER, V464, P268; McCloskey KE, 2000, CYTOMETRY, V40, P307, DOI 10.1002/1097-0320(20000801)40:4<307::AID-CYTO6>3.0.CO;2-H; Mills WR, 2007, J MOL CELL CARDIOL, V42, P304, DOI 10.1016/j.yjmcc.2006.09.011; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; MOLDAY RS, 1982, J IMMUNOL METHODS, V52, P353, DOI 10.1016/0022-1759(82)90007-2; Moore LR, 2006, FASEB J, V20, P747, DOI 10.1096/fj.05-5122fje; Moore LR, 2000, J BIOCHEM BIOPH METH, V44, P115, DOI 10.1016/S0165-022X(00)00085-3; Moore LR, 2004, ANAL CHEM, V76, P3899, DOI 10.1021/ac049910f; Nakamura M, 2001, EXP FLUIDS, V30, P371, DOI 10.1007/s003480000211; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Schneider T, 2006, J BIOCHEM BIOPH METH, V68, P1, DOI 10.1016/j.jbbm.2006.02.011; Sipe JC, 1999, MAGN RESON IMAGING, V17, P1521, DOI 10.1016/S0730-725X(99)00085-5; Stroh A, 2005, NEUROIMAGE, V24, P635, DOI 10.1016/j.neuroimage.2004.09.014; UGELSTAD J, 1993, BLOOD PURIFICAT, V11, P349, DOI 10.1159/000170129; Wilhelm C, 2002, EUR BIOPHYS J BIOPHY, V31, P118, DOI 10.1007/s00249-001-0200-4; WINOTOMORBACH S, 1994, J CLIN LAB ANAL, V8, P400, DOI 10.1002/jcla.1860080610; WINOTOMORBACH S, 1995, J CLIN LAB ANAL, V9, P42, DOI 10.1002/jcla.1860090108; Zborowski M, 2003, BIOPHYS J, V84, P2638, DOI 10.1016/S0006-3495(03)75069-3; Zborowski M, 2008, LAB TECH BIOCHEM MOL, V32, P1; Zhang HD, 2005, ANALYST, V130, P514, DOI 10.1039/b412723d; Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com	44	61	62	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4239	4247		10.1096/fj.07-105544	http://dx.doi.org/10.1096/fj.07-105544			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18725459	Green Published			2022-12-25	WOS:000261254800023
J	Villareal, VA; Pilpa, RM; Robson, SA; Fadeev, EA; Clubb, RT				Villareal, Valerie A.; Pilpa, Rosemarie M.; Robson, Scott A.; Fadeev, Evgeny A.; Clubb, Robert T.			The IsdC Protein from Staphylococcus aureus Uses a Flexible Binding Pocket to Capture Heme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE RELAXATION; NMR STRUCTURE DETERMINATION; MODEL-FREE APPROACH; SURFACE PROTEIN; SORTASE-B; HEMOGLOBIN RECEPTOR; TRANSPORTER DOMAIN; BACKBONE DYNAMICS; DEGRADING ENZYMES; CRYSTAL-STRUCTURE	Staphylococcus aureus scavenges heme-iron from host hemoproteins using iron-regulated surface determinant (Isd) proteins. IsdC is the central conduit through which heme is passed across the cell wall and binds this molecule using a NEAr Transporter (NEAT) domain. NMR spectroscopy was used to determine the structure of IsdC in complex with a heme analog, zinc-substituted protoporphyrin IX (ZnPPIX). The backbone coordinates of the ensemble of conformers representing the structure exhibit a root mean square deviation to the mean structure of 0.53 +/- 0.11 angstrom. IsdC partially buries protoporphyrin within a large hydrophobic pocket that is located at the end of its beta-barrel structure. The central metal ion of the analog adopts a pentacoordinate geometry in which a highly conserved tyrosine residue serves as a proximal ligand. Consistent with the structure and its role in heme transfer across the cell wall, we show that IsdC weakly binds heme (KD = 0.34 +/- 0.12 mu M) and that ZnPPIX rapidly dissociates from the protein at a rate of 126 +/- 30 s(-1). NMR studies of the apo-form of IsdC reveal that a 310 helix within the binding pocket undergoes a flexible to rigid transition as heme is captured. This structural plasticity may increase the efficiency of heme transfer across the cell wall by facilitating protein-protein interactions between apoIsdC and upstream hemoproteins.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, UCLA DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, UCLA DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu		Robson, Scott/0000-0002-0529-0399	National Institutes of Health [R01-AI5221701]; United States Department of Energy [DE-FC-03-87ER60615]; National Institutes of Health NIGMS [F31GM075564]; UCLA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM075564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UCLA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI5221701 (to R. T. C.). This work was also supported by United States Department of Energy Grant DE-FC-03-87ER60615 (to R. T. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health NIGMS Grant F31GM075564.; Supported by a UCLA Dissertation Year Fellowship. Present address: The Salk Institute for Biological Studies, La Jolla, CA 92037.	Andrade MA, 2002, GENOME BIOL, V3; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; ARCHER SJ, 1991, J MAGN RESON, V95, P636, DOI 10.1016/0022-2364(91)90182-S; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; BAX A, 2001, DIPOLAR COUPLINGS MA; Bertini I, 2005, CHEMBIOCHEM, V6, P1536, DOI 10.1002/cbic.200500124; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Bruschweiler R, 2003, CURR OPIN STRUC BIOL, V13, P175, DOI 10.1016/S0959-440X(03)00036-8; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Carlomagno T, 1996, J BIOMOL NMR, V8, P161, DOI 10.1007/BF00211162; Casey AL, 2007, INT J ANTIMICROB AG, V29, pS23, DOI 10.1016/S0924-8579(07)72175-1; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chang WN, 2001, INFECTION, V29, P245, DOI 10.1007/s15010-001-1092-z; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W., 2006, PYMOL MOL GRAPHICS S; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Goddard T. D., 2001, SPARKY NMR ANAL SOFT; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Ilangovan U, 1999, BIOCHEMISTRY-US, V38, P8367, DOI 10.1021/bi990530b; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Iwahara J, 2001, J BIOMOL NMR, V19, P231, DOI 10.1023/A:1011296112710; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Keller R., 2004, COMPUTER AIDED RESON, V1; Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORDEL J, 1992, BIOCHEMISTRY-US, V31, P4856; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Lei BF, 2003, INFECT IMMUN, V71, P5962, DOI 10.1128/IAI.71.10.5962-5969.2003; Lian L. Y., 1993, NMR MACROMOLECULES P, P153; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mandel AM, 1996, BIOCHEMISTRY-US, V35, P16009, DOI 10.1021/bi962089k; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Marraffini LA, 2005, J BIOL CHEM, V280, P16263, DOI 10.1074/jbc.M500071200; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Pilpa RM, 2005, J BIOMOL NMR, V33, P137, DOI 10.1007/s10858-005-2898-2; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; SKELTON NJ, 1993, J MAGN RESON SER B, V102, P253, DOI 10.1006/jmrb.1993.1095; Stojiljkovic I, 1999, MOL MICROBIOL, V31, P429, DOI 10.1046/j.1365-2958.1999.01175.x; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; ZHU H, 2008, J BIOL CHEM	74	66	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31591	31600		10.1074/jbc.M801126200	http://dx.doi.org/10.1074/jbc.M801126200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18715872	hybrid, Green Published			2022-12-25	WOS:000260760800039
J	Yang, YJ; Chen, W; Carrigan, SO; Chen, WM; Roth, K; Akiyama, T; Inoue, JI; Marshall, JS; Berman, JN; Lin, TJ				Yang, Yong Jun; Chen, Wei; Carrigan, Svetlana O.; Chen, Wei-Min; Roth, Kristy; Akiyama, Taishin; Inoue, Jun-ichiro; Marshall, Jean S.; Berman, Jason N.; Lin, Tong-Jun			TRAF6 Specifically Contributes to Fc epsilon RI-mediated Cytokine Production but Not Mast Cell Degranulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; DEFECTIVE INTERLEUKIN-1; TRAF6-DEFICIENT MICE; IKK ACTIVATION; KAPPA-B; TNF; PATHWAYS; KINASES; DOMAIN	TRAF6 (tumor necrosis factor-associated factor 6) is an essential adaptor downstream from the tumor necrosis factor (TNF) receptor and Toll-like receptor superfamily members. This molecule is critical for dendritic cell maturation and T cell homeostasis. Here we show that TRAF6 is important in high affinity IgE receptor, Fc epsilon RI-mediated mast cell activation. In contrast to dendritic cells and T cells, TRAF6-deficient mast cells matured normally and showed normal IgE-dependent degranulation. Importantly, TRAF6-deficient mast cells showed impaired production of cytokine interleukin-6, CCL-9, interleukin-13, and TNF following Fc epsilon RI aggregation. Chromatin immunoprecipitation assay showed decreased NF-kappa B p65 binding to CCL-9 and TNF promoters in TRAF6-deficient mast cells. Antigen and IgE-induced I kappa B phosphorylation and NF-kappa B p65 translocation to the nucleus were diminished in TRAF6-deficient mast cells. NF-kappa B luciferase activity in response to antigen and IgE stimulation was severely impaired in TRAF6-deficient mast cells. In addition, antigen and IgE-induced phosphorylation of mitogen-activated protein kinase p38 and JNK, but not ERK1/2, was significantly reduced in TRAF6-deficient mast cells. These results identified TRAF6 as an important signal transducer in Fc epsilon RI-mediated signaling in mast cells. Our findings implicate TRAF6 as a new adaptor/regulator molecule for allergen-mediated inflammation in allergy.	[Yang, Yong Jun; Chen, Wei; Carrigan, Svetlana O.; Roth, Kristy; Marshall, Jean S.; Berman, Jason N.; Lin, Tong-Jun] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3K 6R8, Canada; [Yang, Yong Jun; Chen, Wei; Carrigan, Svetlana O.; Roth, Kristy; Marshall, Jean S.; Berman, Jason N.; Lin, Tong-Jun] Dalhousie Univ, Dept Pediat, Halifax, NS B3K 6R8, Canada; [Chen, Wei-Min] Fujian Prov Hosp, Dept Hematol, Fuzhou 350001, Peoples R China; [Akiyama, Taishin; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Tokyo 1088639, Japan	Dalhousie University; Dalhousie University; Fujian Provincial Hospital; University of Tokyo	Lin, TJ (corresponding author), IWK Hlth Ctr, Dept Pediat, 5850 Univ Ave, Halifax, NS B3K 6R8, Canada.	tong-jun.lin@dal.ca			Canadian Institutes of Health Research; Nova Scotia Health Research Foundation; Izaak Walton Killam Health Center	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation; Izaak Walton Killam Health Center	This work was supported in part by grants from the Canadian Institutes of Health Research, Nova Scotia Health Research Foundation, and Izaak Walton Killam Health Center (to T. J. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ishizuka T, 1997, P NATL ACAD SCI USA, V94, P6358, DOI 10.1073/pnas.94.12.6358; Kawakami Y, 1998, J IMMUNOL, V161, P1795; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; Li B, 2006, BLOOD, V107, P2814, DOI 10.1182/blood-2005-09-3610; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Maezawa Y, 2006, J IMMUNOL, V176, P1013, DOI 10.4049/jimmunol.176.2.1013; Naito A, 2002, P NATL ACAD SCI USA, V99, P8766, DOI 10.1073/pnas.132636999; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; RAVETCH JV, 1994, CELL, V78, P553, DOI 10.1016/0092-8674(94)90521-5; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	35	19	21	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32110	32118		10.1074/jbc.M802610200	http://dx.doi.org/10.1074/jbc.M802610200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18772140	hybrid			2022-12-25	WOS:000260760800092
J	Kanei-Ishii, C; Nomura, T; Takagi, T; Watanabe, N; Nakayama, KI; Ishii, S				Kanei-Ishii, Chie; Nomura, Teruaki; Takagi, Tsuyoshi; Watanabe, Nobumoto; Nakayama, Keiichi I.; Ishii, Shunsuke			Fbxw7 Acts as an E3 Ubiquitin Ligase That Targets c-Myb for Nemo-like Kinase (NLK)-induced Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-E; TUMOR-SUPPRESSOR; V-MYB; MULTISITE PHOSPHORYLATION; DEPENDENT UBIQUITINATION; PROTEIN-DEGRADATION; COACTIVATOR CBP; B-MYB; GENE; LEUKEMIA	The c-myb proto-oncogene product (c-Myb) is degraded in response to Wnt-1 signaling via a pathway involving TAK1 (transforming growth factor-beta-activated kinase 1), HIPK2 (homeodomain-interacting protein kinase 2), and NLK (Nemo-like kinase). NLK directly binds to c-Myb, which results in the phosphorylation of c-Myb at multiple sites, and induces its ubiquitination and proteasome-dependent degradation. Here, we report that Fbxw7, the F-box protein of an SCF complex, targets c-Myb for degradation in a Wnt-1- and NLK-dependent manner. Fbxw7 alpha directly binds to c-Myb via its C-terminal WD40 domain and induces the ubiquitination of c-Myb in the presence of NLK in vivo and in vitro. The c-Myb phosphorylation site mutant failed to interact with Fbxw7 alpha, suggesting that the c-Myb/Fbxw7 alpha interaction is enhanced by NLK phosphorylation of c-Myb. Treatment of M1 cells with Fbxw7 small interfering RNA (siRNA) rescued the Wnt-induced c-Myb degradation and also the Wnt-induced inhibition of cell proliferation. NLK bound to Cul1, a component of the SCF complex, while HIPK2 interacted with both Fbxw7 alpha and Cul1, suggesting that both kinases enhance the c-Myb/SCF interaction. In contrast to c-Myb, the v-myb gene product (v-Myb) encoded by the avian myeloblastosis virus was resistant to NLK/Fbxw7 alpha-induced degradation. Thus, Fbxw7 is an E3 ubiquitin ligase of c-Myb, and the increased c-Myb levels may contribute, at least partly, to transformation induced by mutation of Fbxw7.	[Kanei-Ishii, Chie; Nomura, Teruaki; Takagi, Tsuyoshi; Ishii, Shunsuke] RIKEN, Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan; [Watanabe, Nobumoto] RIKEN, Discovery Res Inst, Antibiot Lab, Wako, Saitama 3510198, Japan; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan	RIKEN; RIKEN; Kyushu University	Ishii, S (corresponding author), RIKEN, Tsukuba Inst, Mol Genet Lab, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	sishii@rtc.riken.jp	Ishii, Shunsuke/A-5271-2016; Watanabe, Nobumoto/N-6959-2015	Ishii, Shunsuke/0000-0002-6530-2478; Watanabe, Nobumoto/0000-0002-2130-1334	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Charrasse S, 2000, ONCOGENE, V19, P2986, DOI 10.1038/sj.onc.1203618; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; Frampton J, 1996, GENE DEV, V10, P2720, DOI 10.1101/gad.10.21.2720; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Kanei-Ishii C, 2004, J BIOL CHEM, V279, P44582, DOI 10.1074/jbc.M407831200; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; KANEIISHII C, 1992, P NATL ACAD SCI USA, V89, P3088, DOI 10.1073/pnas.89.7.3088; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; KowenzLeutz E, 1997, CELL, V91, P185, DOI 10.1016/S0092-8674(00)80401-8; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Ladendorff NE, 2001, ONCOGENE, V20, P125, DOI 10.1038/sj.onc.1204048; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Morita Y, 2005, MOL BIOL CELL, V16, P5433, DOI 10.1091/mbc.E05-08-0731; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NAKAGOSHI H, 1992, ONCOGENE, V7, P1233; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nomura T, 2004, J BIOL CHEM, V279, P16715, DOI 10.1074/jbc.M313069200; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Petroski MD, 2005, METHOD ENZYMOL, V398, P143, DOI 10.1016/S0076-6879(05)98013-0; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Sano Y, 2001, J BIOL CHEM, V276, P3674, DOI 10.1074/jbc.M006896200; Spruck CH, 2002, CANCER RES, V62, P4535; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Taylor D, 1996, GENE DEV, V10, P2732, DOI 10.1101/gad.10.21.2732; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200	47	50	53	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30540	30548		10.1074/jbc.M804340200	http://dx.doi.org/10.1074/jbc.M804340200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18765672	hybrid, Green Published			2022-12-25	WOS:000260544800012
J	Klein-Hessling, S; Bopp, T; Jha, MK; Schmidt, A; Miyatake, S; Schmitt, E; Serfling, E				Klein-Hessling, Stefan; Bopp, Tobias; Jha, Mithilesh K.; Schmidt, Arthur; Miyatake, Shoichiro; Schmitt, Edgar; Serfling, Edgar			Cyclic AMP-induced Chromatin Changes Support the NFATc-mediated Recruitment of GATA-3 to the Interleukin 5 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-3; PROTEIN-KINASE-A; LOCUS-CONTROL REGION; RANGE INTRACHROMOSOMAL INTERACTIONS; CYTOKINE GENE-EXPRESSION; CIS-REGULATORY ELEMENTS; T-CELL DIFFERENTIATION; NUCLEAR FACTOR; IL-5 GENE; TH2 CELLS	Elevated intracellular cyclic AMP levels, which suppress the proliferation of naive T cells and type 1 T helper (Th1) cells are a property of T helper 2 (Th2) cells and regulatory T cells. While cyclic AMP signals interfere with the IL-2 promoter induction, they support the induction of Th2-type genes, in particular of il-5 gene. We show here that cyclic AMP signals support the generation of three inducible DNase I hypersensitive chromatin sites over the il-5 locus, including its promoter region. In addition, cyclic AMP signals enhance histone H3 acetylation at the IL-5 promoter and the concerted binding of GATA-3 and NFATc to the promoter. This is facilitated by direct protein-protein interactions involving the C-terminal Zn2+-finger of GATA-3 and the C-terminal region of the NFATc1 DNA binding domain. Because inhibition of NFATc binding to the IL-5 promoter in vivo also affects the binding of GATA-3, one may conclude that upon induction of Th2 effector cells NFATc recruits GATA-3 to Th2-type genes. These data demonstrate the functional importance of cyclic AMP signals for the interplay between GATA-3 and NFATc factors in the transcriptional control of lymphokine expression in Th2 effector cells.	[Klein-Hessling, Stefan; Jha, Mithilesh K.; Schmidt, Arthur; Serfling, Edgar] Univ Wurzburg, Inst Pathol, Dept Mol Pathol, D-97080 Wurzburg, Germany; [Bopp, Tobias; Schmitt, Edgar] Johannes Gutenberg Univ Mainz, Inst Immunol, D-55131 Mainz, Germany; [Miyatake, Shoichiro] Tokyo Metropolitan Inst Med Sci, Dept Immunol, Tokyo 1138613, Japan	University of Wurzburg; Johannes Gutenberg University of Mainz; Tokyo Metropolitan Institute of Medical Science	Klein-Hessling, S (corresponding author), Josef Schneider Str 2, D-97080 Wurzburg, Germany.	stefan.klein-hessling@mail.uni-wuerzburg.de; serfling.e@mail.uni-wuerzburg.de	Bopp, Tobias/A-4328-2018; Serfling, Edgar/X-7212-2019	Bopp, Tobias/0000-0002-3232-8065; 	Deutsche Forschungsgemeinschaft; Wilhelm-Sander-Stiftung; Mildred-Scheel-Stiftung/Deutsche Krebshilfe	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm-Sander-Stiftung; Mildred-Scheel-Stiftung/Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Forschungsgemeinschaft, the Wilhelm-Sander-Stiftung, and the Mildred-Scheel-Stiftung/Deutsche Krebshilfe. The costs of publication of this article were defrayed in part by the payment of page charges.	Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Avni O, 2000, CURR OPIN IMMUNOL, V12, P654, DOI 10.1016/S0952-7915(00)00158-8; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; BETZ M, 1991, J IMMUNOL, V146, P108; Blumenthal SG, 1999, J BIOL CHEM, V274, P12910, DOI 10.1074/jbc.274.18.12910; BOHJANEN PR, 1990, P NATL ACAD SCI USA, V87, P5283, DOI 10.1073/pnas.87.14.5283; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Chen CH, 2000, J IMMUNOL, V165, P5597, DOI 10.4049/jimmunol.165.10.5597; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Cockerill P N, 2000, Methods Mol Biol, V130, P29; De Boer ML, 1999, INT J BIOCHEM CELL B, V31, P1221, DOI 10.1016/S1357-2725(99)00069-2; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; KAMMER GM, 1988, IMMUNOL TODAY, V9, P222, DOI 10.1016/0167-5699(88)91220-0; Kel A, 1999, J MOL BIOL, V288, P353, DOI 10.1006/jmbi.1999.2684; Klein-Hessling S, 2003, J IMMUNOL, V170, P2956, DOI 10.4049/jimmunol.170.6.2956; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; LEE HJ, 1995, J BIOL CHEM, V270, P17541, DOI 10.1074/jbc.270.29.17196; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lee HJ, 1998, J IMMUNOL, V160, P2343; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nirula A, 2006, J EXP MED, V203, P1733, DOI 10.1084/jem.20051715; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Serfling E, 2006, TRENDS IMMUNOL, V27, P461, DOI 10.1016/j.it.2006.08.005; Sheridan CM, 2002, J BIOL CHEM, V277, P48664, DOI 10.1074/jbc.M207029200; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stroud JC, 2003, J MOL BIOL, V334, P1009, DOI 10.1016/j.jmb.2003.09.065; Thomas MA, 1999, EUR J BIOCHEM, V265, P300, DOI 10.1046/j.1432-1327.1999.00732.x; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tokoyoda K, 2004, INT IMMUNOL, V16, P643, DOI 10.1093/intimm/dxh072; Urwin DL, 2004, EUR J IMMUNOL, V34, P3633, DOI 10.1002/eji.200425279; Wang J, 2006, INT IMMUNOL, V18, P313, DOI 10.1093/intimm/dxh370; Wu CC, 2003, MOL CELL BIOL, V23, P6442, DOI 10.1128/MCB.23.18.6442-6454.2003; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	52	16	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31030	31037		10.1074/jbc.M805929200	http://dx.doi.org/10.1074/jbc.M805929200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18772129	hybrid, Green Published			2022-12-25	WOS:000260544800058
J	Daskalogianni, C; Apcher, S; Candeias, MM; Naski, N; Calvo, F; Fahraeus, R				Daskalogianni, Chrysoula; Apcher, Sebastien; Candeias, Marco M.; Naski, Nadia; Calvo, Fabien; Fahraeus, Robin			Gly-Ala Repeats Induce Position-and Substrate-specific Regulation of 26 S Proteasome-dependent Partial Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; NF-KAPPA-B; GLYCINE-ALANINE REPEAT; NUCLEAR ANTIGEN 1; TRANSCRIPTION FACTORS; PROTEIN-DEGRADATION; MEDIATED DEGRADATION; UBIQUITIN LIGASE; P53 STABILITY; RICH REGION	Partial degradation or regulated ubiquitin proteasome-dependent processing by the 26 S proteasome has been demonstrated, but the underlying molecular mechanisms and the prevalence of this phenomenon remain obscure. Here we show that the Gly-Ala repeat (GAr) sequence of EBNA1 affects processing of substrates via the ubiquitin-dependent degradation pathway in a substrate- and position-specific fashion. GAr-mediated increase in stability of proteins targeted for degradation via the 26 S proteasome was associated with a fraction of the substrates being partially processed and the release of the free GAr. The GAr did not cause a problem for the proteolytic activity of the proteasome, and its fusion to the N terminus of p53 resulted in an increase in the rate of degradation of the entire chimera. Interestingly the GAr had little effect on the stability of EBNA1 protein itself, and targeting EBNA1 for 26 S proteasome-dependent degradation led to its complete degradation. Taken together, our data suggest a model in which the GAr prevents degradation or promotes endoproteolytic processing of substrates targeted for the 26 S proteasome by interfering with the initiation step of substrate unfolding. These results will help to further understand the underlying mechanisms for partial proteasome-dependent degradation.	[Daskalogianni, Chrysoula; Apcher, Sebastien; Candeias, Marco M.; Naski, Nadia; Calvo, Fabien; Fahraeus, Robin] Univ Paris 07, Hop St Louis, Inst Genet Mol, INSERM,U716, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fahraeus, R (corresponding author), Univ Paris 07, Hop St Louis, Inst Genet Mol, INSERM,U716, 27 Rue Juliette Dodu, F-75010 Paris, France.	robinfahraeus@yahoo.co.uk	Apcher, Sebastien/P-2590-2018; Apcher, Sebastien/B-6356-2015; fahraeus, robin/K-8726-2014	, robin/0000-0003-0402-8492; Candeias, Marco/0000-0002-5731-0179; calvo, fabien/0000-0002-0298-7633; daskalogianni, chrysoula/0000-0001-8177-3141	La Ligue Nationale Contre le Cancer; Agence National de Recherche; INSERM Ile de France; Fundacao para a Ciencia e a Tecnologia of Portugal [SFRH/BD/16697/2004]	La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence National de Recherche(French National Research Agency (ANR)); INSERM Ile de France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology)	This work was supported in part by La Ligue Nationale Contre le Cancer and the Agence National de Recherche. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by INSERM Ile de France.; Supported by Grant SFRH/BD/16697/2004 from the Fundacao para a Ciencia e a Tecnologia of Portugal.	Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Dantuma NP, 2000, P NATL ACAD SCI USA, V97, P8381, DOI 10.1073/pnas.140217397; Dantuma NP, 2002, CURR TOP MICROBIOL, V269, P23; Dantuma NP, 2002, FEBS LETT, V529, P22, DOI 10.1016/S0014-5793(02)03252-0; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heessen S, 2003, FEBS LETT, V555, P397, DOI 10.1016/S0014-5793(03)01296-1; Heessen S, 2002, P NATL ACAD SCI USA, V99, P1532, DOI 10.1073/pnas.022306499; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoppe T, 2001, CURR OPIN CELL BIOL, V13, P344, DOI 10.1016/S0955-0674(00)00218-0; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leonchiks A, 1998, FEBS LETT, V440, P365, DOI 10.1016/S0014-5793(98)01488-4; Leonchiks A, 2002, FEBS LETT, V522, P93, DOI 10.1016/S0014-5793(02)02897-1; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Lin L, 1996, MOL CELL BIOL, V16, P2248; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; MILNER J, 1994, SEMIN CANCER BIOL, V5, P211; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Orian A, 1999, MOL CELL BIOL, V19, P3664; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Piechocki MP, 2001, CELL IMMUNOL, V212, P138, DOI 10.1006/cimm.2001.1853; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Powis SH, 1998, NAT MED, V4, P887, DOI 10.1038/nm0898-887; Prakash S, 2004, TRENDS BIOCHEM SCI, V29, P593, DOI 10.1016/j.tibs.2004.09.011; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; RODRIGUEZ MS, 1995, MOL CELL BIOL, V15, P2413; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sharipo A, 1998, NAT MED, V4, P939, DOI 10.1038/nm0898-939; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P121, DOI 10.1006/bbrc.1999.0296; Tellam J, 2004, J EXP MED, V199, P1421, DOI 10.1084/jem.20040191; Tellam J, 2001, J BIOL CHEM, V276, P33353, DOI 10.1074/jbc.M104535200; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; WHITESIDE ST, 1995, MOL CELL BIOL, V15, P5339; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	51	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30090	30100		10.1074/jbc.M803290200	http://dx.doi.org/10.1074/jbc.M803290200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18757367	hybrid, Green Published			2022-12-25	WOS:000260366900054
J	Huang, JY; Huang, AJ; Zhang, Q; Lin, YC; Yu, HG				Huang, Jianying; Huang, Aijie; Zhang, Qi; Lin, Yen-Chang; Yu, Han-Gang			Novel Mechanism for Suppression of Hyperpolarization-activated Cyclic Nucleotide-gated Pacemaker Channels by Receptor-like Tyrosine Phosphatase-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRICULAR MYOCYTES; SINUS BRADYCARDIA; KINASE; SRC; INHIBITION; MUTATION; CELLS; I(F); GLYCOSYLATION; TRAFFICKING	We have previously reported an important role of increased tyrosine phosphorylation activity by Src in the modulation of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. Here we provide evidence showing a novel mechanism of decreased tyrosine phosphorylation on HCN channel properties. We found that the receptor-like protein-tyrosine phosphatase-alpha (RPTP alpha) significantly inhibited or eliminated HCN2 channel expression in HEK293 cells. Biochemical evidence showed that the surface expression of HCN2 was remarkably reduced by RPTP alpha, which was in parallel to the decreased tyrosine phosphorylation of the channel protein. Confocal imaging confirmed that the membrane surface distribution of the HCN2 channel was inhibited by RPTP alpha. Moreover, we detected the presence of RPTP alpha proteins in cardiac ventricles with expression levels changed during development. Inhibition of tyrosine phosphatase activity by phenylarsine oxide or sodium orthovanadate shifted ventricular hyperpolarization-activated current (I-f, generated by HCN channels) activation from nonphysiological voltages into physiological voltages associated with accelerated activation kinetics. In conclusion, we showed a critical role RPTP alpha plays in HCN channel function via tyrosine dephosphorylation. These findings are also important to neurons where HCN and RPTP alpha are richly expressed.	[Huang, Jianying; Huang, Aijie; Zhang, Qi; Lin, Yen-Chang; Yu, Han-Gang] W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Ctr Interdisciplinary Res Cardiovasc Sci, Morgantown, WV 26506 USA	West Virginia University	Yu, HG (corresponding author), W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Ctr Interdisciplinary Res Cardiovasc Sci, Morgantown, WV 26506 USA.	hyu@hsc.wvu.edu			National Institutes of Health [HL075023]; Office of Research and Graduate Programs/HSC at West Virginia University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Graduate Programs/HSC at West Virginia University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL075023 (NHLBI). This work was also supported by the Office of Research and Graduate Programs/HSC at West Virginia University (to H. G. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahuja P, 2007, EXP CELL RES, V313, P1270, DOI 10.1016/j.yexcr.2007.01.009; Arinsburg SS, 2006, J CARDIOVASC PHARM, V47, P578, DOI 10.1097/01.fjc.0000211740.47960.8b; BARTUTI A, 2008, ANN NY ACAD SCI, V1123, P213; Cerbai E, 1996, CIRCULATION, V94, P1674, DOI 10.1161/01.CIR.94.7.1674; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; DAUM G, 1994, J BIOL CHEM, V269, P10524; DAUM G, 1991, J BIOL CHEM, V266, P12211; GARCIAMORALES P, 1990, P NATL ACAD SCI USA, V87, P9255, DOI 10.1073/pnas.87.23.9255; Gil-Henn H, 2001, J BIOL CHEM, V276, P31772, DOI 10.1074/jbc.M103395200; Hoppe UC, 1998, CARDIOVASC RES, V38, P788, DOI 10.1016/S0008-6363(98)00047-9; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; Li CH, 2008, AM J PHYSIOL-CELL PH, V294, pC355, DOI 10.1152/ajpcell.00236.2007; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Nof E, 2007, CIRCULATION, V116, P463, DOI 10.1161/CIRCULATIONAHA.107.706887; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Robinson RB, 1997, PFLUG ARCH EUR J PHY, V433, P533, DOI 10.1007/s004240050309; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; SEARGEANT LE, 1979, BIOCHEM J, V181, P247, DOI 10.1042/bj1810247; Shi WM, 1999, CIRC RES, V85, pE1; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Ueda K, 2004, J BIOL CHEM, V279, P27194, DOI 10.1074/jbc.M311953200; Wu JY, 2000, BBA-BIOMEMBRANES, V1463, P15, DOI 10.1016/S0005-2736(99)00233-3; Yu HG, 2004, PFLUG ARCH EUR J PHY, V447, P392, DOI 10.1007/s00424-003-1204-y; YU HG, 1995, J PHYSIOL-LONDON, V485, P469, DOI 10.1113/jphysiol.1995.sp020743; YU HG, 1993, PFLUG ARCH EUR J PHY, V422, P614, DOI 10.1007/BF00374010; YU HG, 1993, CIRC RES, V72, P232, DOI 10.1161/01.RES.72.1.232; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	32	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29912	29919		10.1074/jbc.M804205200	http://dx.doi.org/10.1074/jbc.M804205200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768480	Green Published, hybrid			2022-12-25	WOS:000260366900036
J	Maruta, T; Yonemitsu, M; Yabuta, Y; Tamoi, M; Ishikawa, T; Shigeoka, S				Maruta, Takanori; Yonemitsu, Miki; Yabuta, Yukinori; Tamoi, Masahiro; Ishikawa, Takahiro; Shigeoka, Shigeru			Arabidopsis Phosphomannose Isomerase 1, but Not Phosphomannose Isomerase 2, Is Essential for Ascorbic Acid Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-GALACTOSE PHOSPHORYLASE; DE-NOVO BIOSYNTHESIS; VITAMIN-C; CANDIDA-ALBICANS; GENE-EXPRESSION; CELL-WALL; PROTEIN GLYCOSYLATION; SUSPENSION-CULTURE; SUGAR STARVATION; HIGHER-PLANTS	We studied molecular and functional properties of Arabidopsis phosphomannose isomerase isoenzymes (PMI1 and PMI2) that catalyze reversible isomerization between D-fructose 6-phosphate and D-mannose 6-phosphate (Man-6P). The apparent K-m and V-max values for Man-6P of purified recombinant PMI1 were 41.3 +/- 4.2 mu M and 1.89 mu mol/min/mg protein, respectively, whereas those of purified recombinant PMI2 were 372 +/- 13 mu M and 22.5 mu mol/min/mg protein, respectively. Both PMI1 and PMI2 were inhibited by incubation with EDTA, Zn2+, Cd2+, and L-ascorbic acid (AsA). Arabidopsis PMI1 protein was constitutively expressed in both vegetative and reproductive organs under normal growth conditions, whereas the PMI2 protein was not expressed in any organs under light. The induction of PMI1 expression and an increase in the AsA level were observed in leaves under continuous light, whereas the induction of PMI2 expression and a decrease in the AsA level were observed under long term darkness. PMI1 showed a diurnal expression pattern in parallel with the total PMI activity and the total AsA content in leaves. Moreover, a reduction of PMI1 expression through RNA interference resulted in a substantial decrease in the total AsA content of leaves of knock down PMI1 plants, whereas the complete inhibition of PMI2 expression did not affect the total AsA levels in leaves of knock-out PMI2 plants. Consequently, this study improves our understanding of the molecular and functional properties of Arabidopsis PMI isoenzymes and provides genetic evidence of the involvement of PMI1, but not PMI2, in the biosynthesis of AsA in Arabidopsis plants.	[Maruta, Takanori; Yonemitsu, Miki; Tamoi, Masahiro; Shigeoka, Shigeru] Kinki Univ, Fac Agr, Dept Adv Biosci, Nara 6318505, Japan; [Yabuta, Yukinori] Tottori Univ, Fac Agr, Sch Agr Biol & Environm Sci, Tottori 6808550, Japan; [Ishikawa, Takahiro] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan	Kindai University (Kinki University); Tottori University; Shimane University	Shigeoka, S (corresponding author), Kinki Univ, Fac Agr, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.	shigeoka@nara.kindai.ac.jp	Yabuta, Yukinori/T-3615-2019; Ishikawa, Takahiro/AAX-5792-2021; Tamoi, Masahiro/AAJ-1054-2021	Yabuta, Yukinori/0000-0002-6982-8522; Maruta, Takanori/0000-0003-4144-7821	Nara Institute of Science and Technology; Ministry of Education, Culture, Sports, Science and Technology, Japan [19208031]; Ministry of Education, Culture, Sports, Science and Technology	Nara Institute of Science and Technology; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Scientific Research for Plant Graduate Students from the Nara Institute of Science and Technology (to T. M.), Grant-in-aid for Scientific Research 19208031 from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the "Academic Frontier" Project for Private Universities matching fund subsidy from Ministry of Education, Culture, Sports, Science and Technology 2004-2008 (to S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bartoli CG, 2006, J EXP BOT, V57, P1621, DOI 10.1093/jxb/erl005; Bechtold N, 1998, METH MOL B, V82, P259; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouquisse R, 2007, PLANTA, V225, P693, DOI 10.1007/s00425-006-0378-x; Cleasby A, 1996, NAT STRUCT BIOL, V3, P470, DOI 10.1038/nsb0596-470; Conklin PL, 2006, J BIOL CHEM, V281, P15662, DOI 10.1074/jbc.M601409200; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Conklin PL, 1997, PLANT PHYSIOL, V115, P1277, DOI 10.1104/pp.115.3.1277; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Conklin PL, 2000, GENETICS, V154, P847; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; COULIN F, 1993, BIOCHEMISTRY-US, V32, P14139, DOI 10.1021/bi00214a010; DALESSANDRO G, 1986, PLANTA, V169, P564, DOI 10.1007/BF00392108; Davey MW, 1999, PLANT PHYSIOL, V121, P535, DOI 10.1104/pp.121.2.535; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Foyer CH, 1996, J PLANT PHYSIOL, V148, P391, DOI 10.1016/S0176-1617(96)80271-9; Fujiki Y, 2000, PLANT PHYSIOL, V124, P1139, DOI 10.1104/pp.124.3.1139; Fujiki Y, 2001, PHYSIOL PLANTARUM, V111, P345, DOI 10.1034/j.1399-3054.2001.1110312.x; GRACY RW, 1968, J BIOL CHEM, V243, P4109; GRACY RW, 1968, J BIOL CHEM, V243, P5410; HEROLD A, 1977, NEW PHYTOL, V79, P1, DOI 10.1111/j.1469-8137.1977.tb02178.x; Hoeberichts FA, 2008, J BIOL CHEM, V283, P5708, DOI 10.1074/jbc.M704991200; Ishikawa T, 2006, PHYSIOL PLANTARUM, V126, P343, DOI 10.1111/j.1399-3054.2006.00640.x; Ishikawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P1143, DOI 10.1271/bbb.80062; Jain AK, 2000, MOL BREEDING, V6, P73, DOI 10.1023/A:1009680818138; Laing WA, 2004, P NATL ACAD SCI USA, V101, P16976, DOI 10.1073/pnas.0407453101; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Lee EJ, 2007, PLANT CELL PHYSIOL, V48, P405, DOI 10.1093/pcp/pcm009; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Lukowitz W, 2001, P NATL ACAD SCI USA, V98, P2262, DOI 10.1073/pnas.051625798; Mieda T, 2004, PLANT CELL PHYSIOL, V45, P1271, DOI 10.1093/pcp/pch152; MILES JS, 1984, GENE, V32, P41, DOI 10.1016/0378-1119(84)90030-1; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Pallanca JE, 2000, J EXP BOT, V51, P669, DOI 10.1093/jexbot/51.345.669; Proudfoot AEI, 1996, BIOCHEM J, V318, P437, DOI 10.1042/bj3180437; PROUDFOOT AEI, 1994, EUR J BIOCHEM, V219, P415, DOI 10.1111/j.1432-1033.1994.tb19954.x; PROUDFOOT AEI, 1994, J PROTEIN CHEM, V13, P619, DOI 10.1007/BF01890460; Qian WQ, 2007, PLANT J, V49, P399, DOI 10.1111/j.1365-313X.2006.02967.x; REINBOTHE S, 1994, PLANT CELL, V6, P1197, DOI 10.1105/tpc.6.9.1197; Roux C, 2007, J COMPUT CHEM, V28, P938, DOI 10.1002/jcc.20586; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Sharples SC, 2007, PLANT J, V52, P252, DOI 10.1111/j.1365-313X.2007.03225.x; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Smirnoff N, 2000, CRIT REV BIOCHEM MOL, V35, P291, DOI 10.1080/10409230008984166; SMITH DJ, 1994, MOL CELL BIOL, V14, P6030, DOI 10.1128/MCB.14.9.6030; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; WELLS TNC, 1993, BIOCHEMISTRY-US, V32, P1294, DOI 10.1021/bi00056a014; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2005, J EXP BOT, V56, P2527, DOI 10.1093/jxb/eri246; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; YABUTA Y, 2008, BIOSCI BIOT IN PRESS; Yabuta Y, 2007, J EXP BOT, V58, P2661, DOI 10.1093/jxb/erm124; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Zhang W, 2008, PLANT PHYSIOL, V146, P431, DOI 10.1104/pp.107.109934	59	71	81	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28842	28851		10.1074/jbc.M805538200	http://dx.doi.org/10.1074/jbc.M805538200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18755683	hybrid, Green Published			2022-12-25	WOS:000260179900009
J	Sokolova, O; Bozko, PM; Naumann, M				Sokolova, Olga; Bozko, Przemyslaw M.; Naumann, Michael			Helicobacter pylori Suppresses Glycogen Synthase Kinase 3 beta to Promote beta-Catenin Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; MOTOGENIC RESPONSE; SIGNALING PATHWAY; WNT PATHWAY; E-CADHERIN; CYCLIN D1; CANCER; EXPRESSION; PROTEIN; CAGA	The human pathogen Helicobacter pylori influences cell adhesion, proliferation, and apoptosis and is involved in gastric adenocarcinoma formation. In our study we analyzed the impact of H. pylori infection on the regulation of beta-catenin, which plays a central role in both cell adhesion and tumorigenesis. Infection of Madin-Darby canine kidney cells with H. pylori led to suppression of Ser/Thr phosphorylation and ubiquitin-dependent degradation of beta-catenin and to up-regulation of lymphoid enhancer-binding factor/T cell factor (LEF/TCF)dependent transcription. The impaired Ser/Thr phosphorylation of beta-catenin was accompanied by an increase of glycogen synthase kinase 3 beta phosphorylation. Inhibition of Akt kinase, an up-stream regulator of glycogen synthase kinase 3 beta by a specific inhibitor Akti-1/2 or depletion of Akt with siRNA restored Ser/Thr phosphorylation of beta-catenin. We conclude that glycogen synthase kinase 3 beta activity exerts an important role in beta-catenin regulation and LEF/TCF transactivation in H. pylori-infected Madin-Darby canine kidney cells.	[Sokolova, Olga; Bozko, Przemyslaw M.; Naumann, Michael] Otto von Guericke Univ, Inst Expt Internal Med, D-39120 Magdeburg, Germany	Otto von Guericke University	Naumann, M (corresponding author), Otto von Guericke Univ, Inst Expt Internal Med, D-39120 Magdeburg, Germany.	Naumann@med.ovgu.de	Sokolova, Olga/G-2123-2013; Naumann, Michael/B-5285-2011	Sokolova, Olga/0000-0003-1070-504X; Naumann, Michael/0000-0002-8060-2313	Bundesministerium fur Bildung und Forschung [01ZZ0407]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the Bundesministerium fur Bildung und Forschung Grant 01ZZ0407. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Barker N, 2000, ADV CANCER RES, V77, P1; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bebb JR, 2006, J CLIN PATHOL, V59, P1261, DOI 10.1136/jcp.2006.036772; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Chen XY, 2005, HUM PATHOL, V36, P1294, DOI 10.1016/j.humpath.2005.09.003; Chesire DR, 2003, ENDOCR-RELAT CANCER, V10, P537, DOI 10.1677/erc.0.0100537; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Foryst-Ludwig A, 2004, BIOCHEM BIOPH RES CO, V316, P1065, DOI 10.1016/j.bbrc.2004.02.158; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Ikenoue T, 2002, JPN J CANCER RES, V93, P1213, DOI 10.1111/j.1349-7006.2002.tb01226.x; Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957; Kirikoshi H, 2001, INT J ONCOL, V19, P533; Kurashima Y, 2008, INT J CANCER, V122, P823, DOI 10.1002/ijc.23190; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lynch HT, 2005, J SURG ONCOL, V90, P114, DOI 10.1002/jso.20214; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Nabais S, 2003, INT J SURG PATHOL, V11, P1, DOI 10.1177/106689690301100102; Naumann M, 2005, INT J MED MICROBIOL, V295, P335, DOI 10.1016/j.ijmm.2005.06.007; Naumann M, 2004, TRENDS MICROBIOL, V12, P29, DOI 10.1016/j.tim.2003.11.005; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pap M, 2002, MOL CELL BIOL, V22, P578, DOI 10.1128/MCB.22.2.578-586.2002; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Penta R, 2005, J EXP CLIN CANC RES, V24, P337; Polat A, 2002, NEOPLASMA, V49, P95; Romiti A, 2005, WORLD J GASTROENTERO, V11, P4400; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sadot E, 2002, J CELL SCI, V115, P2771; SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x; Sepulveda AR, 2002, ALIMENT PHARM THERAP, V16, P145, DOI 10.1046/j.1365-2036.16.s2.4.x; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Shun CT, 2001, ONCOLOGY-BASEL, V60, P339, DOI 10.1159/000058530; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stoicov C, 2004, GENE, V341, P1, DOI 10.1016/j.gene.2004.07.023; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; van Amsterdam K, 2006, FEMS MICROBIOL REV, V30, P131, DOI 10.1111/j.1574-6976.2005.00006.x; Wallasch C, 2002, BIOCHEM BIOPH RES CO, V295, P695, DOI 10.1016/S0006-291X(02)00740-4; Wessler S, 2002, FASEB J, V16, P417, DOI 10.1096/fj.01-0766fje; Weydig C, 2007, EXP CELL RES, V313, P3459, DOI 10.1016/j.yexcr.2007.07.015; Yamaoka Y, 2006, GUT, V55, P775, DOI 10.1136/gut.2005.083014; Yang Y, 2003, J CLIN PATHOL-MOL PA, V56, P19, DOI 10.1136/mp.56.1.19; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x	60	52	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29367	29374		10.1074/jbc.M801818200	http://dx.doi.org/10.1074/jbc.M801818200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18772141	hybrid, Green Published			2022-12-25	WOS:000260179900063
J	Szabo, R; Hobson, JP; List, K; Molinolo, A; Lin, CY; Bugge, TH				Szabo, Roman; Hobson, John P.; List, Karin; Molinolo, Alfredo; Lin, Chen-Yong; Bugge, Thomas H.			Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL BARRIER FUNCTION; FUNCTIONAL-CHARACTERIZATION; PLACENTAL BIKUNIN; EXPRESSION; DOMAIN; IDENTIFICATION; CLONING; MOUSE; HAI-1; GENE	Hepatocyte growth factor activator inhibitors (HAI)-1 and -2 are recently identified and closely related Kunitz-type transmembrane serine protease inhibitors. Whereas HAI-1 is well established as an inhibitor of the serine proteases matriptase and hepatocyte growth factor activator, the physiological targets of HAI-2 are unknown. Here we show that HAI-2 displays potent inhibitory activity toward matriptase, forms SDS-stable complexes with the serine protease, and blocks matriptase-dependent activation of its candidate physiological substrates pro-prostasin and cell surface-bound pro-urokinase plasminogen activator. To further explore the potential functional relationship between HAI-2 and matriptase, we generated a transgenic mouse strain with a promoterless beta-galactosidase marker gene inserted into the endogenous locus encoding HAI-2 protein and performed a global high resolution mapping of the expression of HAI-2, matriptase, and HAI-1 proteins in all adult tissues. This analysis showed striking co-localization of HAI-2 with matriptase and HAI-1 in epithelial cells of all major organ systems, thus strongly supporting a role of HAI-2 as a physiological regulator of matriptase activity, possibly acting in a redundant or partially redundant manner with HAI-1. Unlike HAI-1 and matriptase, however, HAI-2 expression was also detected in non-epithelial cells of brain and lymph nodes, suggesting that HAI-2 may also be involved in inhibition of serine proteases other than matriptase.	[Szabo, Roman; Hobson, John P.; List, Karin; Molinolo, Alfredo; Bugge, Thomas H.] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Lin, Chen-Yong] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Maryland; University of Maryland Baltimore	Bugge, TH (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov			National Institutes of Health Intramural Program; Department of Defense [DAMD-17-02-1-0693]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000699] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Program. This work was also supported by a Grant DAMD-17-02-1-0693 from the Department of Defense (to T. H. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Fan B, 2007, DEV BIOL, V303, P222, DOI 10.1016/j.ydbio.2006.11.005; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Itoh H, 2000, AM J PHYSIOL-GASTR L, V278, pG635, DOI 10.1152/ajpgi.2000.278.4.G635; Itoh H, 1999, BIOCHEM BIOPH RES CO, V255, P740, DOI 10.1006/bbrc.1999.0268; Kataoka H, 2000, CANCER LETT, V148, P127, DOI 10.1016/S0304-3835(99)00322-5; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; Mathias JR, 2007, J CELL SCI, V120, P3372, DOI 10.1242/jcs.009159; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Muller-Pillasch F, 1998, BBA-GENE STRUCT EXPR, V1395, P88, DOI 10.1016/S0167-4781(97)00129-2; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Parr C, 2004, CLIN CANCER RES, V10, P202, DOI 10.1158/1078-0432.CCR-0553-3; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Qin L, 1998, FEBS LETT, V436, P111, DOI 10.1016/S0014-5793(98)01105-3; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Tanaka H, 2005, MOL CELL BIOL, V25, P5687, DOI 10.1128/MCB.25.13.5687-5698.2005; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; WURST W, 2000, GENE TARGETING PRACT, P207; Yamauchi M, 2004, J UROLOGY, V171, P890, DOI 10.1097/01.ju.0000092861.21122.d2; Yamauchi M, 2002, BIOL CHEM, V383, P1953, DOI 10.1515/BC.2002.220	36	85	85	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29495	29504		10.1074/jbc.M801970200	http://dx.doi.org/10.1074/jbc.M801970200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18713750	hybrid, Green Published			2022-12-25	WOS:000260179900075
J	Loo, TW; Bartlett, MC; Clarke, DM				Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.			Processing mutations disrupt interactions between the nucleotide binding and transmembrane domains of P-glycoprotein and the cystic fibrosis transmembrane conductance regulator (CFTR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-BINDING; MULTIDRUG TRANSPORTER; PROMOTE MATURATION; ABC TRANSPORTER; ATP HYDROLYSIS; CROSS-LINKING; MUTANTS; MECHANISM; SEGMENTS; GENE	P-glycoprotein (P-gp, ABCB1) is an ATP-dependent drug pump. Each of its two homologous halves contains a transmembrane domain (TMD) that has six transmembrane (TM) segments and a nucleotide-binding domain (NBD). Determining how the two halves interact may provide insight into the folding of P-gp as the drug-binding pocket and nucleotide-binding sites are predicted to be at the interface between the two halves. Here, we present evidence for NBD1-TMD2 and NBD2-TMD1 interactions. We also show that TMD-NBD interactions in immature and mature P-gp can be affected by the presence of a processing mutation. We found that the NBD-TMD mutants L443C(NBD1)/S909C(TMD2) and A266C(TMD1)/F1086C(NBD2) could be cross-linked at 0 degrees C with oxidant (copper phenanthroline). Cross-linking was inhibited by vanadate-trapping of nucleotide. The presence of a processing mutation (G268V/L443C(NBD1)/S909C(TMD2); L1260A/A266C(TMD1)/F1086C(NBD2)) resulted in the synthesis of the immature (150 kDa) protein as the major product and the mutants could not be cross-linked with copper phenanthroline. Expression of the processing mutants in the presence of a pharmacological chaperone (cyclosporin A), however, resulted in the expression of mature (170 kDa) protein at the cell surface that could be crosslinked. Similarly, CFTR mutants A274C(TMD1)/L1260C(NBD2) and V510C(NBD1)/A1067C(TMD2) could be cross-linked at 0 degrees C with copper phenanthroline. Introduction of Delta F508 mutation in these mutants, however, resulted in the synthesis of immature CFTR that could not be cross-linked. These results suggest that establishment of NBD interactions with the opposite TMD is a key step in folding of ABC transporters.	[Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	Cystic Fibrosis Foundation [CLARKE08GO]; Canadian Institutes for Health Research [62832, 25043]; National Cancer Institute of Canada; Canadian Cancer Society [19074]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by grants from the Cystic Fibrosis Foundation (Grant CLARKE08GO), Canadian Institutes for Health Research (Grants 62832 and 25043), and the National Cancer Institute of Canada through the Canadian Cancer Society (Grant 19074). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; HE L, 2008, J BIOL CHEM IN PRESS; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Loo TW, 2008, ARCH BIOCHEM BIOPHYS, V476, P51, DOI 10.1016/j.abb.2008.02.025; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2005, J BIOL CHEM, V280, P2522, DOI 10.1074/jbc.M411483200; Loo TW, 2004, J BIOL CHEM, V279, P38395, DOI 10.1074/jbc.M405623200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 1999, FASEB J, V13, P1724, DOI 10.1096/fasebj.13.13.1724; Loo TW, 1999, J BIOL CHEM, V274, P35388, DOI 10.1074/jbc.274.50.35388; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; Loo TW, 1996, J BIOL CHEM, V271, P27482, DOI 10.1074/jbc.271.44.27482; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Loo TW, 2002, J BIOL CHEM, V277, P27585, DOI 10.1074/jbc.C200330200; LOO TW, 1994, J BIOL CHEM, V269, P7243; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Loo TW, 2002, P NATL ACAD SCI USA, V99, P3511, DOI 10.1073/pnas.022049799; LOO TW, 1994, BIOCHEMISTRY-US, V33, P14049, DOI 10.1021/bi00251a013; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1994, J BIOL CHEM, V269, P7750; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; Loo TW, 1998, METHOD ENZYMOL, V292, P480; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; PAGANT S, 2008, J BIOL CHEM IN PRESS; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; RIORDAN JR, 1989, SCIENCE, V245, P1066; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	48	65	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28190	28197		10.1074/jbc.M805834200	http://dx.doi.org/10.1074/jbc.M805834200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18708637	hybrid, Green Published			2022-12-25	WOS:000259969300021
J	Mereghetti, L; Sitkiewicz, I; Green, NM; Musser, JM				Mereghetti, Laurent; Sitkiewicz, Izabela; Green, Nicole M.; Musser, James M.			Extensive Adaptive Changes Occur in the Transcriptome of Streptococcus agalactiae (Group B Streptococcus) in Response to Incubation with Human Blood	PLOS ONE			English	Article								To enhance understanding of how Streptococcus agalactiae (group B streptococcus, GBS) adapts during invasive infection, we performed a whole-genome transcriptome analysis after incubation with whole human blood. Global changes occurred in the GBS transcriptome rapidly in response to blood contact following shift from growth in a rich laboratory medium. Most (83%) of the significantly altered transcripts were down-regulated after 30 minutes of incubation in blood, and all functional categories of genes were abundantly represented. We observed complex dynamic changes in the expression of transcriptional regulators and stress response genes that allow GBS to rapidly adapt to blood. The transcripts of relatively few proven virulence genes were up-regulated during the first 90 minutes. However, a key discovery was that genes encoding proteins involved in interaction with the host coagulation/fibrinolysis system and bacterial-host interactions were rapidly up-regulated. Extensive transcript changes also occurred for genes involved in carbohydrate metabolism, including multi-functional proteins and regulators putatively involved in pathogenesis. Finally, we discovered that an incubation temperature closer to that occurring in patients with severe infection and high fever (40 degrees C) induced additional differences in the GBS transcriptome relative to normal body temperature (37 degrees C). Taken together, the data provide extensive new information about transcriptional adaptation of GBS exposed to human blood, a crucial step during GBS pathogenesis in invasive diseases, and identify many new leads for molecular pathogenesis research.	[Mereghetti, Laurent; Sitkiewicz, Izabela; Green, Nicole M.; Musser, James M.] Methodist Hosp, Dept Pathol, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA; [Mereghetti, Laurent] Ctr Hosp Univ, Univ Francois Rabelais, Fac Med, EA3854, Tours, France	The Methodist Hospital System; The Methodist Hospital - Houston; CHU Tours	Mereghetti, L (corresponding author), Methodist Hosp, Dept Pathol, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA.	jmmusser@tmhs.org	Sitkiewicz, Izabela/G-5058-2011	Sitkiewicz, Izabela/0000-0001-8228-9917				Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Graham MR, 2006, AM J PATHOL, V169, P927, DOI 10.2353/ajpath.2006.060112; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Herbert MA, 2004, CURR OPIN INFECT DIS, V17, P225, DOI 10.1097/00001432-200406000-00009; Hughes MJG, 2002, INFECT IMMUN, V70, P1254, DOI 10.1128/IAI.70.3.1254-1259.2002; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Johri AK, 2003, INFECT IMMUN, V71, P6707, DOI 10.1128/IAI.71.12.6707-6711.2003; Johri AK, 2007, INFECT IMMUN, V75, P1473, DOI 10.1128/IAI.00638-06; Kinnby B, 2008, MICROBIOL-SGM, V154, P924, DOI 10.1099/mic.0.2007/013235-0; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Liu MY, 2006, MICROBIOL-SGM, V152, P967, DOI 10.1099/mic.0.28706-0; Loughman JA, 2006, EMBO J, V25, P5414, DOI 10.1038/sj.emboj.7601393; Magalhaes V, 2007, MICROBES INFECT, V9, P1276, DOI 10.1016/j.micinf.2007.06.001; Malke H, 2007, J MED MICROBIOL, V56, P707, DOI 10.1099/jmm.0.46984-0; MCARTHUR JD, 2008, FASEB J; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Musser JM, 2005, AM J PATHOL, V167, P1461, DOI 10.1016/S0002-9440(10)61232-1; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Pietrocola G, 2005, BLOOD, V105, P1052, DOI 10.1182/blood-2004-06-2149; Pietrocola G, 2006, BIOCHEMISTRY-US, V45, P12840, DOI 10.1021/bi060696u; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Rice KC, 2005, J BACTERIOL, V187, P813, DOI 10.1128/JB.187.3.813-821.2005; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Santi I, 2007, MOL MICROBIOL, V63, P754, DOI 10.1111/j.1365-2958.2006.05555.x; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Schugk J, 1997, SCAND J INFECT DIS, V29, P233, DOI 10.3109/00365549709019034; Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shelburne SA, 2007, INFECT IMMUN, V75, P2981, DOI 10.1128/IAI.00081-07; SITKIEWICZ I, 2008, 17 LANC INT S STREPT; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Spellerberg B, 2000, MICROBES INFECT, V2, P1733, DOI 10.1016/S1286-4579(00)01328-9; Stroeher UH, 2007, J INFECT DIS, V196, P1820, DOI 10.1086/523107; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Teng F, 2005, J INFECT DIS, V191, P472, DOI 10.1086/427191; Throup JP, 2000, MOL MICROBIOL, V35, P566, DOI 10.1046/j.1365-2958.2000.01725.x; Tu LN, 2007, INFECT IMMUN, V75, P2996, DOI 10.1128/IAI.01716-06; Vervloet MG, 1998, SEMIN THROMB HEMOST, V24, P33, DOI 10.1055/s-2007-995821; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; WARD PN, 2008, J MOL BIOL; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990	56	51	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3143	10.1371/journal.pone.0003143	http://dx.doi.org/10.1371/journal.pone.0003143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769548	Green Published, Green Submitted, gold			2022-12-25	WOS:000264419100010
J	Lacour, S; Bechet, E; Cozzone, AJ; Mijakovic, I; Grangeasse, C				Lacour, Soline; Bechet, Emmanuelle; Cozzone, Alain J.; Mijakovic, Ivan; Grangeasse, Christophe			Tyrosine Phosphorylation of the UDP-Glucose Dehydrogenase of Escherichia coli Is at the Crossroads of Colanic Acid Synthesis and Polymyxin Resistance	PLOS ONE			English	Article								Background: In recent years, an idiosyncratic new class of bacterial enzymes, named BY-kinases, has been shown to catalyze protein-tyrosine phosphorylation. These enzymes share no structural and functional similarities with their eukaryotic counterparts and, to date, only few substrates of BY-kinases have been characterized. BY-kinases have been shown to participate in various physiological processes. Nevertheless, we are at a very early stage of defining their importance in the bacterial cell. In Escherichia coli, two BY-kinases, Wzc and Etk, have been characterized biochemically. Wzc has been shown to phosphorylate the UDP-glucose dehydrogenase Ugd in vitro. Not only is Ugd involved in the biosynthesis of extracellular polysaccharides, but also in the production of UDP-4-amino-4-deoxy-L-arabinose, a compound that renders E. coli resistant to cationic antimicrobial peptides. Methodology/Principal Findings: Here, we studied the role of Ugd phosphorylation. We first confirmed in vivo the phosphorylation of Ugd by Wzc and we demonstrated that Ugd is also phosphorylated by Etk, the other BY-kinase identified in E. coli. Tyrosine 71 (Tyr71) was characterized as the Ugd site phosphorylated by both Wzc and Etk. The regulatory role of Tyr71 phosphorylation on Ugd activity was then assessed and Tyr71 mutation was found to prevent Ugd activation by phosphorylation. Further, Ugd phosphorylation by Wzc or Etk was shown to serve distinct physiological purposes. Phosphorylation of Ugd by Wzc was found to participate in the regulation of the amount of the exopolysaccharide colanic acid, whereas Etk-mediated Ugd phosphorylation appeared to participate in the resistance of E. coli to the antibiotic polymyxin. Conclusions/Significance: Ugd phosphorylation seems to be at the junction between two distinct biosynthetic pathways, illustrating the regulatory potential of tyrosine phosphorylation in bacterial physiology.	[Lacour, Soline; Bechet, Emmanuelle; Cozzone, Alain J.; Grangeasse, Christophe] Univ Lyon, Inst Biol & Chim Prot, Lyon, France; [Mijakovic, Ivan] Tech Univ Denmark, BioCentrum, Ctr Microbial Biotechnol, Lyngby, Denmark	Technical University of Denmark	Lacour, S (corresponding author), Univ Lyon, Inst Biol & Chim Prot, Lyon, France.	c.grangeasse@ibcp.fr	Mijakovic, Ivan/Q-5583-2016	Mijakovic, Ivan/0000-0002-8860-6853; Grangeasse, Christophe/0000-0002-5484-4589; BECHET, Emmanuelle/0000-0001-5528-0263	CNRS; University of Lyon; Agence National de la Recherche [ANR-07-JCJC0125-01]; Danish Natural Research Council	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lyon; Agence National de la Recherche(French National Research Agency (ANR)); Danish Natural Research Council(Danish Natural Science Research Council)	This work was supported by grants from the CNRS, the University of Lyon and the Agence National de la Recherche (ANR-07-JCJC0125-01). IM was supported by a grant from the Danish Natural Research Council (FNU).	Bailey MJA, 1997, MOL MICROBIOL, V26, P845, DOI 10.1046/j.1365-2958.1997.6432014.x; Bakal CJ, 2000, TRENDS CELL BIOL, V10, P32, DOI 10.1016/S0962-8924(99)01681-5; Bender MH, 2003, J BACTERIOL, V185, P6057, DOI 10.1128/JB.185.20.6057-6066.2003; Bergmaier D, 2001, APPL MICROBIOL BIOT, V57, P401, DOI 10.1007/s002530100764; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DISCHE Z, 1951, J BIOL CHEM, V192, P579; Doublet P, 2002, J BIOL CHEM, V277, P37339, DOI 10.1074/jbc.M204465200; GOLDHAR J, 1980, MED MICROBIOL IMMUN, V169, P53, DOI 10.1007/BF02123712; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Groisman EA, 2006, NAT REV MICROBIOL, V4, P705, DOI 10.1038/nrmicro1478; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; JERS C, 2008, EXPERT REV IN PRESS, V5; Klein G, 2003, MOL MICROBIOL, V48, P269, DOI 10.1046/j.1365-2958.2003.03449.x; Kolot M, 2008, VIROLOGY, V375, P383, DOI 10.1016/j.virol.2008.02.011; Lacour S, 2006, RES MICROBIOL, V157, P637, DOI 10.1016/j.resmic.2006.01.003; LEE DC, 2008, EMBO J; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; MACEK B, 2006, DECIPHERING PROKARYO; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Meredith TC, 2007, J BIOL CHEM, V282, P7790, DOI 10.1074/jbc.M611034200; Mijakovic I, 2006, NUCLEIC ACIDS RES, V34, P1588, DOI 10.1093/nar/gkj514; Mijakovic I, 2004, J MOL MICROB BIOTECH, V8, P19, DOI 10.1159/000082077; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; Minic Z, 2007, J BACTERIOL, V189, P1351, DOI 10.1128/JB.01122-06; Moorthy S, 2002, J BACTERIOL, V184, P4033, DOI 10.1128/JB.184.14.4033-4038.2002; Morona JK, 2003, J BACTERIOL, V185, P3009, DOI 10.1128/JB.185.10.3009-3019.2003; Mouslim C, 2003, MOL MICROBIOL, V47, P335, DOI 10.1046/j.1365-2958.2003.03318.x; Nakamura T, 2003, RRD HUM PAT, V1, P185; Niemeyer D, 2001, J BACTERIOL, V183, P5163, DOI 10.1128/JB.183.17.5163-5170.2001; Obadia B, 2007, J MOL BIOL, V367, P42, DOI 10.1016/j.jmb.2006.12.048; OLIVARESILLANA V, 2008, PLOS BIOL; Pagni M, 1999, MICROBIOL-UK, V145, P1049, DOI 10.1099/13500872-145-5-1049; Peleg A, 2005, J BACTERIOL, V187, P5259, DOI 10.1128/JB.187.15.5259-5266.2005; Petranovic D, 2007, MOL MICROBIOL, V63, P1797, DOI 10.1111/j.1365-2958.2007.05625.x; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Reid AN, 2005, J BACTERIOL, V187, P5470, DOI 10.1128/JB.187.15.5470-5481.2005; Soulat D, 2007, J MOL MICROB BIOTECH, V13, P45, DOI 10.1159/000103596; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Ventura CL, 2006, MOL MICROBIOL, V61, P723, DOI 10.1111/j.1365-2958.2006.05259.x; Vincent C, 2000, J MOL BIOL, V304, P311, DOI 10.1006/jmbi.2000.4217; Whitfield C, 2008, NAT STRUCT MOL BIOL, V15, P121, DOI 10.1038/nsmb0208-121; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Zheng JM, 2007, MOL MICROBIOL, V63, P1360, DOI 10.1111/j.1365-2958.2007.05611.x	56	66	67	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3053	10.1371/journal.pone.0003053	http://dx.doi.org/10.1371/journal.pone.0003053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LJ	18725960	Green Published, gold, Green Submitted			2022-12-25	WOS:000264429000006
J	Arlt, D; Forslund, P; Jeppsson, T; Part, T				Arlt, Debora; Forslund, Par; Jeppsson, Tobias; Part, Tomas			Habitat-Specific Population Growth of a Farmland Bird	PLOS ONE			English	Article							BREEDING SUCCESS; AGRICULTURAL INTENSIFICATION; ENVIRONMENTAL STOCHASTICITY; TERRITORY QUALITY; FITNESS; CONSERVATION; SURVIVAL; SINKS; PERFORMANCE; DEMOGRAPHY	Background: To assess population persistence of species living in heterogeneous landscapes, the effects of habitat on reproduction and survival have to be investigated. Methodology/Principal Findings: We used a matrix population model to estimate habitat-specific population growth rates for a population of northern wheatears Oenanthe oenanthe breeding in farmland consisting of a mosaic of distinct habitat ( land use) types. Based on extensive long-term data on reproduction and survival, habitats characterised by tall field layers (spring- and autumn-sown crop fields, ungrazed grasslands) displayed negative stochastic population growth rates ( log lambda(s): -0.332, -0.429, -0.168, respectively), that were markedly lower than growth rates of habitats characterised by permanently short field layers (pastures grazed by cattle or horses, and farmyards, log lambda(s): -0.056, +0.081, -0.059). Although habitats differed with respect to reproductive performance, differences in habitat-specific population growth were largely due to differences in adult and first-year survival rates, as shown by a life table response experiment (LTRE). Conclusions/Significance: Our results show that estimation of survival rates is important for realistic assessments of habitat quality. Results also indicate that grazed grasslands and farmyards may act as source habitats, whereas crop fields and ungrazed grasslands with tall field layers may act as sink habitats. We suggest that the strong decline of northern wheatears in Swedish farmland may be linked to the corresponding observed loss of high quality breeding habitat, i.e. grazed semi-natural grasslands.	[Arlt, Debora; Forslund, Par; Jeppsson, Tobias; Part, Tomas] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Arlt, D (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	Debora.Arlt@ekol.slu.se	Jeppsson, Tobias/G-7606-2011; Jeppsson, Tobias/GSE-0414-2022	Jeppsson, Tobias/0000-0002-6671-8096; Part, Tomas/0000-0001-7388-6672	Swedish Research Council; Helge Ax:son Johnson's Foundation; Royal Swedish Academy of Sciences; Alvin's Foundation; Swedish Ornithological Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Helge Ax:son Johnson's Foundation; Royal Swedish Academy of Sciences; Alvin's Foundation; Swedish Ornithological Society	Financial support was obtained from the Swedish Research Council (to TP), Helge Ax:son Johnson's Foundation, Royal Swedish Academy of Sciences, Alvin's Foundation, and Swedish Ornithological Society (to DA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLT D, 2007, ECOLOGY, V77, P211; Arlt D, 2008, J ANIM ECOL, V77, P211, DOI 10.1111/j.1365-2656.2007.01329.x; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; BOWERS MA, 1994, OIKOS, V69, P327, DOI 10.2307/3546154; Brickle NW, 2000, J APPL ECOL, V37, P742, DOI 10.1046/j.1365-2664.2000.00542.x; BROWN JL, 1969, AM NAT, V103, P347, DOI 10.1086/282607; BURFIELD I, 2004, BIRDS EUROPE POPULAT, P374; Burnham KP., 2002, MODEL SELECTION MULT, P496; CARLSON A, 1988, VAR FAGELVARLD S, V12, P293; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed., P722; Clark ME, 2007, ECOL MODEL, V209, P110, DOI 10.1016/j.ecolmodel.2007.06.008; Cramp S., 1988, HDB BIRDS EUROPE MID, V5, P1136; DEBRUIJN O, 1994, ARDEA, V82, P1; Devereux CL, 2004, IBIS, V146, P115, DOI 10.1111/j.1474-919X.2004.00355.x; DOLIGEZ B, 2008, J ANIM ECOL IN PRESS; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Donovan TM, 2001, ECOL APPL, V11, P871; Dugger KM, 2005, CONDOR, V107, P863, DOI 10.1650/7824.1; Ehrlen J, 2003, AM NAT, V162, P796, DOI 10.1086/379350; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GARDENFORS U, 2005, REDLIST SWEDISH SPEC, P496; Holmes RT, 1996, J ANIM ECOL, V65, P183, DOI 10.2307/5721; Holt RD, 1997, EVOL ECOL, V11, P723, DOI 10.1023/A:1018438403047; HOWE RW, 1991, BIOL CONSERV, V57, P239, DOI 10.1016/0006-3207(91)90071-G; Kawecki Tadeusz J., 2004, P387, DOI 10.1016/B978-012323448-3/50018-0; Kendall BE, 1998, ECOL APPL, V8, P184, DOI 10.2307/2641320; Kristan WB, 2003, OIKOS, V103, P457; Lampila S, 2006, OECOLOGIA, V148, P405, DOI 10.1007/s00442-006-0386-3; MacDonald DW, 2004, BIOLOGIA, V59, P235; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; Morris W.F., 2002, QUANTITATIVE CONSERV, P480; Morris WF, 2004, AM NAT, V163, P579, DOI 10.1086/382550; Murphy MT, 2001, ECOLOGY, V82, P1304, DOI 10.1890/0012-9658(2001)082[1304:HSDOAL]2.0.CO;2; Newcombe R. G., 2000, STAT CONFIDENCE, V2, P45; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; PARKER GA, 1986, ANIM BEHAV, V34, P1222, DOI 10.1016/S0003-3472(86)80182-8; Part T, 2001, ANIM BEHAV, V62, P379, DOI 10.1006/anbe.2001.1754; Part T, 2001, P ROY SOC B-BIOL SCI, V268, P2267, DOI 10.1098/rspb.2001.1803; Pidgeon AM, 2006, BIOL CONSERV, V132, P199, DOI 10.1016/j.biocon.2006.03.024; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Rodenhouse NL, 1997, ECOLOGY, V78, P2025, DOI 10.2307/2265942; Saether B.-E., 1990, Current Ornithology, V7, P251; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Schiers J., 2000, P ROY SOC LOND B BIO, V267, P2065; Smith HG, 2002, AGR ECOSYST ENVIRON, V92, P107, DOI 10.1016/S0167-8809(01)00266-3; *STAT SWED, 1996, YB AGR STAT 1996; Suarez-Seoane S, 2002, BIOL CONSERV, V105, P333, DOI 10.1016/S0006-3207(01)00213-0; SUTHERLAND WJ, 1996, INDIVIDUAL BEHAV POP, P213; TYE A, 1992, IBIS, V134, P273, DOI 10.1111/j.1474-919X.1992.tb03810.x; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; WATKINSON AR, 1995, J ANIM ECOL, V64, P126, DOI 10.2307/5833; White GC, 2006, J WILDLIFE MANAGE, V70, P1521, DOI 10.2193/0022-541X(2006)70[1521:MSMATE]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wiens JD, 2005, J RAPTOR RES, V39, P210; Wilson JD, 1997, J APPL ECOL, V34, P1462, DOI 10.2307/2405262; Winkler DW, 2005, J ANIM ECOL, V74, P1080, DOI 10.1111/j.1365-2656.2005.01007.x; Wretenberg J, 2006, J APPL ECOL, V43, P1110, DOI 10.1111/j.1365-2664.2006.01216.x	59	52	52	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3006	10.1371/journal.pone.0003006	http://dx.doi.org/10.1371/journal.pone.0003006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714351	Green Published, gold, Green Submitted			2022-12-25	WOS:000264420900031
J	Cui, Y; Ying, Y; van Hasselt, A; Ng, KM; Yu, J; Zhang, Q; Jin, J; Liu, DX; Rhim, JS; Rha, SY; Loyo, M; Chan, ATC; Srivastava, G; Tsao, GSW; Sellar, GC; Sung, JJY; Sidransky, D; Tao, Q				Cui, Yan; Ying, Ying; van Hasselt, Andrew; Ng, Ka Man; Yu, Jun; Zhang, Qian; Jin, Jie; Liu, Dingxie; Rhim, Johng S.; Rha, Sun Young; Loyo, Myriam; Chan, Anthony T. C.; Srivastava, Gopesh; Tsao, George S. W.; Sellar, Grant C.; Sung, Joseph J. Y.; Sidransky, David; Tao, Qian			OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation	PLOS ONE			English	Article								Background: Identification of tumor suppressor genes (TSGs) silenced by CpG methylation uncovers the molecular mechanism of tumorigenesis and potential tumor biomarkers. Loss of heterozygosity at 11q25 is common in multiple tumors including nasopharyngeal carcinoma (NPC). OPCML, located at 11q25, is one of the downregulated genes we identified through digital expression subtraction. Methodology/Principal Findings: Semi-quantitative RT-PCR showed frequent OPCML silencing in NPC and other common tumors, with no homozygous deletion detected by multiplex differential DNA-PCR. Instead, promoter methylation of OPCML was frequently detected in multiple carcinoma cell lines (nasopharyngeal, esophageal, lung, gastric, colon, liver, breast, cervix, prostate), lymphoma cell lines (non-Hodgkin and Hodgkin lymphoma, nasal NK/T-cell lymphoma) and primary tumors, but not in any non-tumor cell line and seldom weakly methylated in normal epithelial tissues. Pharmacological and genetic demethylation restored OPCML expression, indicating a direct epigenetic silencing. We further found that OPCML is stress-responsive, but this response is epigenetically impaired when its promoter becomes methylated. Ecotopic expression of OPCML led to significant inhibition of both anchorage-dependent and -independent growth of carcinoma cells with endogenous silencing. Conclusions/Significance: Thus, through functional epigenetics, we identified OPCML as a broad tumor suppressor, which is frequently inactivated by methylation in multiple malignancies.	[Cui, Yan; Ying, Ying; Ng, Ka Man; Chan, Anthony T. C.; Tao, Qian] Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Canc Epigenet Lab, State Key Lab Oncol S China,Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China; [van Hasselt, Andrew] Chinese Univ Hong Kong, Dept Surg, Sha Tin 100083, Peoples R China; [Yu, Jun; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Sha Tin 100083, Peoples R China; [Zhang, Qian; Jin, Jie] Peking Univ, Hlth Sci Ctr, Inst Urol, Peking Univ 1 Hosp, Dept Urol, Beijing, Peoples R China; [Liu, Dingxie; Tao, Qian] Johns Hopkins Singapore, Singapore, Singapore; [Rhim, Johng S.] Uniformed Serv Univ Hlth Sci, Ctr Prostate Dis Res, Bethesda, MD USA; [Rha, Sun Young] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea; [Loyo, Myriam; Sidransky, David] Johns Hopkins, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Srivastava, Gopesh] Univ Hong Kong, Dept Pathol, Hong Kong, Peoples R China; [Tsao, George S. W.] Univ Hong Kong, Dept Anat, Hong Kong, Peoples R China; [Sellar, Grant C.] Univ Edinburgh, Canc Res Ctr, Canc Res UK Edinburgh Oncol Unit, Edinburgh EH8 9YL, Midlothian, Scotland	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Peking University; Johns Hopkins University; Johns Hopkins Medicine; Uniformed Services University of the Health Sciences - USA; Yonsei University; Yonsei University Health System; Johns Hopkins University; University of Hong Kong; University of Hong Kong; University of Edinburgh	Cui, Y (corresponding author), Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Canc Epigenet Lab, State Key Lab Oncol S China,Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China.	qtao@clo.cuhk.edu.hk	Tao, Qian/T-4743-2018; Chan, Anthony Tak Cheung/R-3940-2018; Sung, Joseph J. Y./R-3203-2018; Yu, Jun/D-8569-2015	Tao, Qian/0000-0001-5383-4808; Chan, Anthony Tak Cheung/0000-0002-6912-8091; Sung, Joseph J. Y./0000-0003-3125-5199; Yu, Jun/0000-0001-5008-2153; Cui, Yan/0000-0002-6522-8343; Rha, Sun Young/0000-0002-2512-4531	Hong Kong RGC Central Allocation [CA06/07.SC03]; Chinese University of Hong Kong; MRC [G9826762, G9900837] Funding Source: UKRI; Medical Research Council [G9900837, G9826762] Funding Source: researchfish	Hong Kong RGC Central Allocation; Chinese University of Hong Kong(Chinese University of Hong Kong); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by a Hong Kong RGC Central Allocation Grant (CA06/07.SC03 to QT) and a Chinese University of Hong Kong direct grant.	Ai LB, 2006, CARCINOGENESIS, V27, P1341, DOI 10.1093/carcin/bgi379; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Chang HW, 2003, INT J CANCER, V105, P851, DOI 10.1002/ijc.11162; Chen JD, 2003, CANCER CELL, V4, P405, DOI 10.1016/S1535-6108(03)00269-1; Deng W, 2004, ONCOGENE, V23, P9090, DOI 10.1038/sj.onc.1208119; Eagleson KL, 2003, MOL CELL NEUROSCI, V24, P725, DOI 10.1016/S1044-7431(03)00237-9; Funatsu N, 1999, J BIOL CHEM, V274, P8224, DOI 10.1074/jbc.274.12.8224; Gil OD, 1998, J NEUROSCI, V18, P9312; Gil OD, 2002, J NEUROBIOL, V51, P190, DOI 10.1002/neu.10050; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hoque MO, 2008, CANCER RES, V68, P2661, DOI 10.1158/0008-5472.CAN-07-5913; Jin H, 2007, ONCOGENE, V26, P7490, DOI 10.1038/sj.onc.1210559; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kappler Stefanie, 2013, AFR STUD, V1.3, P349; Lo KW, 2001, CANCER RES, V61, P3877; Lodge AP, 2000, MOL BRAIN RES, V82, P84, DOI 10.1016/S0169-328X(00)00184-4; Lung HL, 2005, ONCOGENE, V24, P6525, DOI 10.1038/sj.onc.1208812; Lung HL, 2006, CANCER RES, V66, P9385, DOI 10.1158/0008-5472.CAN-06-0590; McNamee CJ, 2002, J NEUROCHEM, V80, P941, DOI 10.1046/j.0022-3042.2002.00798.x; Pimenta AF, 2004, GENOMICS, V83, P790, DOI 10.1016/j.ygeno.2003.11.013; Qiu GH, 2004, ONCOGENE, V23, P4793, DOI 10.1038/sj.onc.1207632; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Reed J, 2004, J CELL SCI, V117, P3961, DOI 10.1242/jcs.01261; Reed JE, 2007, NEUROPATH APPL NEURO, V33, P77, DOI 10.1111/j.1365-2990.2006.00786.x; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Sellar GC, 2003, NAT GENET, V34, P337, DOI 10.1038/ng1183; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; SHARK KB, 1995, GENE, V155, P213, DOI 10.1016/0378-1119(94)00830-L; Srivastava G, 2000, BLOOD, V95, P2443, DOI 10.1182/blood.V95.7.2443.007k18_2443_2445; Steenbergen RDM, 2004, JNCI-J NATL CANCER I, V96, P294, DOI 10.1093/jnci/djh031; Sun D, 2007, ORAL ONCOL, V43, P82, DOI 10.1016/j.oraloncology.2006.01.007; Tao Q, 1999, AM J PATHOL, V155, P619, DOI 10.1016/S0002-9440(10)65157-7; Tao Q, 1998, J VIROL, V72, P7075, DOI 10.1128/JVI.72.9.7075-7083.1998; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Tao Qian, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000312; Tao Q, 2006, FRONT BIOSCI-LANDMRK, V11, P2672, DOI 10.2741/2000; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Tsou JA, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-70; Wang L, 2006, WORLD J GASTROENTERO, V12, P6949, DOI 10.3748/wjg.v12.i43.6949; Wong ML, 2006, INT J ONCOL, V28, P767; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267	44	96	104	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2990	10.1371/journal.pone.0002990	http://dx.doi.org/10.1371/journal.pone.0002990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714356	Green Submitted, gold, Green Published			2022-12-25	WOS:000264420900016
J	Lawlor, DA; Harbord, RM; Timpson, NJ; Lowe, GDO; Rumley, A; Gaunt, TR; Baker, I; Yarnell, JWG; Kivimaeki, M; Kumari, M; Norman, PE; Jamrozik, K; Hankey, GJ; Almeida, OP; Flicker, L; Warrington, N; Marmot, MG; Ben-Shlomo, Y; Palmer, LJ; Day, INM; Ebrahim, S; Smith, GD				Lawlor, Debbie A.; Harbord, Roger M.; Timpson, Nic J.; Lowe, Gordon D. O.; Rumley, Ann; Gaunt, Tom R.; Baker, Ian; Yarnell, John W. G.; Kivimaeki, Mika; Kumari, Meena; Norman, Paul E.; Jamrozik, Konrad; Hankey, Graeme J.; Almeida, Osvaldo P.; Flicker, Leon; Warrington, Nicole; Marmot, Michael G.; Ben-Shlomo, Yoav; Palmer, Lyle J.; Day, Ian N. M.; Ebrahim, Shah; Smith, George Davey			The Association of C-Reactive Protein and CRP Genotype with Coronary Heart Disease: Findings from Five Studies with 4,610 Cases amongst 18,637 Participants	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; GENE POLYMORPHISMS; MENDELIAN RANDOMIZATION; INTERINDIVIDUAL VARIABILITY; SOCIOECONOMIC POSITION; INFLAMMATORY MARKERS; CARDIOVASCULAR RISK; PROMOTER REGION; HEALTH; LDL	Background: It is unclear whether C-reactive protein (CRP) is causally related to coronary heart disease (CHD). Genetic variants that are known to be associated with CRP levels can be used to provide causal inference of the effect of CRP on CHD. Our objective was to examine the association between CRP genetic variant +1444C>T (rs1130864) and CHD risk in the largest study to date of this association. Methods and Results: We estimated the association of CRP genetic variant +1444C>T (rs1130864) with CRP levels and with CHD in five studies and then pooled these analyses (N= 18,637 participants amongst whom there were 4,610 cases). CRP was associated with potential confounding factors (socioeconomic position, physical activity, smoking and body mass) whereas genotype (rs1130864) was not associated with these confounders. The pooled odds ratio of CHD per doubling of circulating CRP level after adjustment for age and sex was 1.13 (95% CI: 1.06, 1.21), and after further adjustment for confounding factors it was 1.07 (95% CI: 1.02, 1.13). Genotype (rs1130864) was associated with circulating CRP; the pooled ratio of geometric means of CRP level among individuals with the TT genotype compared to those with the CT/CC genotype was 1.21 (95% CI: 1.15, 1.28) and the pooled ratio of geometric means of CRP level per additional T allele was 1.14 (95% CI: 1.11, 1.18), with no strong evidence in either analyses of between study heterogeneity (I-2 = 0%, p>0.9 for both analyses). There was no association of genotype (rs1130864) with CHD: pooled odds ratio 1.01 (95% CI: 0.88, 1.16) comparing individuals with TT genotype to those with CT/CC genotype and 0.96 (95% CI: 0.90, 1.03) per additional T allele (I-2<7.5%, p. 0.6 for both meta-analyses). An instrumental variables analysis (in which the proportion of CRP levels explained by rs1130864 was related to CHD) suggested that circulating CRP was not associated with CHD: the odds ratio for a doubling of CRP level was 1.04 (95% CI: 0.61, 1.80). Conclusions: We found no association of a genetic variant, which is known to be related to CRP levels, (rs1130864) and having CHD. These findings do not support a causal association between circulating CRP and CHD risk, but very large, extended, genetic association studies would be required to rule this out.	[Lawlor, Debbie A.; Timpson, Nic J.; Palmer, Lyle J.; Day, Ian N. M.; Smith, George Davey] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Lawlor, Debbie A.; Harbord, Roger M.; Timpson, Nic J.; Gaunt, Tom R.; Baker, Ian; Ben-Shlomo, Yoav; Day, Ian N. M.; Smith, George Davey] Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England; [Lowe, Gordon D. O.; Rumley, Ann] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Yarnell, John W. G.] Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT7 1NN, Antrim, North Ireland; [Kivimaeki, Mika; Kumari, Meena; Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Norman, Paul E.] Univ Western Australia, Sch Surg & Pathol, Nedlands, WA 6009, Australia; [Jamrozik, Konrad] Univ Queensland, Sch Populat Hlth, St Lucia, Qld 4067, Australia; [Hankey, Graeme J.] Univ Western Australia, Sch Med Pharmacol, Nedlands, WA 6009, Australia; [Almeida, Osvaldo P.; Flicker, Leon] Univ Australia, Western Australian Ctr Hlth & Ageing, Perth, WA, Australia; [Warrington, Nicole; Palmer, Lyle J.] Western Australian Inst Med Res, Lab Genet Epidemiol, Perth, Australia; [Warrington, Nicole; Palmer, Lyle J.] Univ Western Australia, Ctr Med Res, Nedlands, WA 6009, Australia; [Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England	University of Bristol; University of Bristol; University of Glasgow; Queens University Belfast; University of London; University College London; University of Western Australia; University of Queensland; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of London; London School of Hygiene & Tropical Medicine	Lawlor, DA (corresponding author), Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England.	d.a.lawlor@bristol.ac.uk	Norman, Paul E/C-5485-2013; Gaunt, Tom R/O-3918-2014; Fox, Laura J/C-6249-2016; Marmot, M G/Y-3920-2019; Flicker, Leon/A-9039-2008; Kivimaki, Mika/B-3607-2012; Harbord, Roger M/A-8699-2008; Ben-Shlomo, Yoav/ABD-2004-2021; Davey Smith, George/A-7407-2013; Palmer, Lyle John/N-1948-2019; Hankey, Graeme J/H-4968-2014; Attrill, Lauren/V-1688-2018; Almeida, Osvaldo P./A-4925-2008; Flicker, Leon/AAE-1530-2022; Palmer, Lyle John/K-3196-2014; Timpson, Nicholas John/O-7548-2015; Warrington, Nicole/P-4868-2014	Norman, Paul E/0000-0003-3406-0506; Gaunt, Tom R/0000-0003-0924-3247; Marmot, M G/0000-0002-2431-6419; Kivimaki, Mika/0000-0002-4699-5627; Harbord, Roger M/0000-0002-2257-8271; Ben-Shlomo, Yoav/0000-0001-6648-3007; Davey Smith, George/0000-0002-1407-8314; Palmer, Lyle John/0000-0002-1628-3055; Hankey, Graeme J/0000-0002-6044-7328; Almeida, Osvaldo P./0000-0002-8689-6199; Flicker, Leon/0000-0002-3650-0475; Palmer, Lyle John/0000-0002-1628-3055; Timpson, Nicholas John/0000-0002-7141-9189; Warrington, Nicole/0000-0003-4195-775X; Kumari, Meena/0000-0001-9716-1035; Lawlor, Debbie A/0000-0002-6793-2262; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	(UK) Department of Health (DOH) [PHCSA03]; British Heart Foundation (BHF) [FS/05/065]; Medical Research Council (MRC) of the United Kingdom [G9824960, G0601625]; Health and Safety Executive; National Heart Lung and Blood Institute, US, NIH [HL36310]; National Institute on Aging, US, NIH [AG13196]; Agency for Health Care Policy Research [HS06516]; John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; National Health and Medical Research Council of Australia [279408/379600, 458505]; Academy of Finland [117604, 124327, 124332]; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0600705, G0601625] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [G8802774, G0601625, G0600705, G0100222, G19/35] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R37AG013196] Funding Source: NIH RePORTER	(UK) Department of Health (DOH); British Heart Foundation (BHF)(British Heart Foundation); Medical Research Council (MRC) of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health and Safety Executive; National Heart Lung and Blood Institute, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Academy of Finland(Academy of Finland); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The British Women's Heart and Health Study is funded by the (UK) Department of Health (DOH) and the DNA extraction, genotyping and the CRP assay were funded by British Heart Foundation (BHF) grants. The Caerphilly study was funded by the Medical Research Council (MRC) of the United Kingdom. Funding for the Caerphilly DNA Bank was from an MRC grant (G9824960). The Whitehall II study has been supported by grants from the MRC; BHF; Health and Safety Executive; DOH; National Heart Lung and Blood Institute (HL36310), US, NIH: National Institute on Aging (AG13196), US, NIH; Agency for Health Care Policy Research (HS06516); and the John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. The Health in Men Study has received funding from the National Health and Medical Research Council of Australia (279408/379600). DA Lawlor, G Davey Smith and INM Day work in the MRC CAiTE Centre and N Timspon is funded in full by the grant for this center (G0601625). DA Lawlor funded in part by a UK DOH career scientist award ((PHCSA03). R M Harbord is funded in part by an MRC grant (G0601625). T Gaunt is a BHF Intermediate Fellow (FS/05/065). M.Kivimaki is supported by the Academy of Finland (Projects no. 117604, 124327 and 124332). MG Marmot is an MRC Research Professor. PE Norman is supported by a National Health and Medical Research Council of Australia Practitioner Fellowship (458505). The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; *CRP CHD GEN COLL, 2008, EUROPEAN J EPIDEMIOL; D'Aiuto F, 2005, ATHEROSCLEROSIS, V179, P413, DOI 10.1016/j.atherosclerosis.2004.10.036; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; ELWOOD PC, 1984, J EPIDEMIOL COMMUN H, V38, P259, DOI 10.1136/jech.38.3.259; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Gimeno D, 2007, EUR J EPIDEMIOL, V22, P675, DOI 10.1007/s10654-007-9171-9; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hage FG, 2007, J AM COLL CARDIOL, V50, P1115, DOI 10.1016/j.jacc.2007.06.012; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Jamrozik K, 2000, MED J AUSTRALIA, V173, P345, DOI 10.5694/j.1326-5377.2000.tb125684.x; Jousilahti P, 2003, J EPIDEMIOL COMMUN H, V57, P730, DOI 10.1136/jech.57.9.730; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Kivimaki M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003013; Kivimaki M, 2005, ARTERIOSCL THROM VAS, V25, P2197, DOI 10.1161/01.ATV.0000183729.91449.6e; Kivimaki M, 2007, ARTERIOSCL THROM VAS, V27, P978, DOI 10.1161/01.ATV.0000258869.48076.14; Kivimaki M, 2007, AM J EPIDEMIOL, V166, P760, DOI 10.1093/aje/kwm151; Kovacs A, 2005, ATHEROSCLEROSIS, V178, P193, DOI 10.1016/j.atherosclerosis.2004.08.018; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lawlor DA, 2006, EUR HEART J, V27, P1597, DOI 10.1093/eurheartj/ehi833; Lowe GDO, 2005, J THROMB HAEMOST, V3, P1618, DOI 10.1111/j.1538-7836.2005.01416.x; Lowe Gordon D O, 2006, Curr Atheroscler Rep, V8, P421, DOI 10.1007/s11883-006-0040-x; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Pai JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001395; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Rose G, 1982, CARDIOVASCULAR SURVE; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2006, J EPIDEMIOL COMMUN H, V60, P382, DOI 10.1136/jech.2004.031880; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, pE137; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, P1051, DOI 10.1161/01.ATV.0000160351.95181.d0; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Smith GD, 2006, ANN INTERN MED, V145, P70, DOI 10.7326/0003-4819-145-1-200607040-00130; Suk HJ, 2005, ATHEROSCLEROSIS, V178, P139, DOI 10.1016/j.atherosclerosis.2004.07.033; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Timpson NJ, 2006, CIRCULATION, V114, pE256, DOI 10.1161/CIRCULATIONAHA.106.638387; Timpson NJ, 2005, LANCET, V366, P1954, DOI 10.1016/S0140-6736(05)67786-0; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Wannamethee SG, 2002, CIRCULATION, V105, P1785, DOI 10.1161/01.CIR.0000016346.14762.71; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	56	75	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3011	10.1371/journal.pone.0003011	http://dx.doi.org/10.1371/journal.pone.0003011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714384	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000264420900036
J	Bandyopadhyay, BC; Ong, HL; Lockwich, TP; Liu, XB; Paria, BC; Singh, BB; Ambudkar, IS				Bandyopadhyay, Bidhan C.; Ong, Hwei L.; Lockwich, Timothy P.; Liu, Xibao; Paria, Biman C.; Singh, Brij B.; Ambudkar, Indu S.			TRPC3 Controls Agonist-stimulated Intracellular Ca2+ Release by Mediating the Interaction between Inositol 1,4,5-Trisphosphate Receptor and RACK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PLASMA-MEMBRANE; INOSITOL-1,4,5-TRISPHOSPHATE RECEPTOR; CHANNELS; BINDING; ACTIVATION; COMPLEX; SRC; MODULATION; EXPRESSION	Activation of TRPC3 channels is concurrent with inositol 1,4,5-trisphosphate (IP3) receptor (IP3R)-mediated intracellular Ca2+ release and associated with phosphatidylinositol 4,5-bisphosphate hydrolysis and recruitment to the plasma membrane. Here we report that interaction of TRPC3 with receptor for activated C-kinase-1 (RACK1) not only determines plasma membrane localization of the channel but also the interaction of IP3R with RACK1 and IP3-dependent intracellular Ca2+ release. We show that TRPC3 interacts with RACK1 via N-terminal residues Glu-232, Asp-233, Glu-240, and Glu-244. Carbachol (CCh) stimulation of HEK293 cells expressing wild type TRPC3 induced recruitment of a ternary TRPC3-RACK1-IP3R complex and increased surface expression of TRPC3 and Ca2+ entry. Mutation of the putative RACK1 binding sequence in TRPC3 disrupted plasma membrane localization of the channel. CCh-stimulated recruitment of TRPC3-RACK1-IP3R complex as well as increased surface expression of TRPC3 and receptor-operated Ca2+ entry were also attenuated. Importantly, CCh-induced intracellular Ca2+ release was significantly reduced as was RACK1-IP3R association without any change in thapsigargin-stimulated Ca2+ release and entry. Knockdown of endogenous TRPC3 also decreased RACK1-IP3R association and decreased CCh-stimulated Ca2+ entry. Furthermore, an oscillatory pattern of CCh-stimulated intracellular Ca2+ release was seen in these cells compared with the more sustained pattern seen in control cells. Similar oscillatory pattern of Ca2+ release was seen after CCh stimulation of cells expressing the TRPC3 mutant. Together these data demonstrate a novel role for TRPC3 in regulation of IP3R function. We suggest TRPC3 controls agonist-stimulated intracellular Ca2+ release by mediating interaction between IP3R and RACK1.	[Bandyopadhyay, Bidhan C.; Ong, Hwei L.; Lockwich, Timothy P.; Paria, Biman C.; Ambudkar, Indu S.] NIDCR, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Singh, Brij B.] Univ N Dakota, Dept Biochem & Mol Biol, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of North Dakota Grand Forks	Ambudkar, IS (corresponding author), NIDCR, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bldg 10,Rm 1N-113, Bethesda, MD 20892 USA.	indu.ambudkar@nih.gov	Bandyopadhyay, Bidhan/AAC-6828-2022	Bandyopadhyay, Bidhan/0000-0003-2364-8945; Ong, Hwei Ling/0000-0002-7551-6883; Singh, Brij/0000-0003-0535-5997	National Institutes of Health [R01 DE 017102]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017102, ZIADE000438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health Grant R01 DE 017102 ( to B. B. S.).	Ambudkar IS, 2007, PFLUG ARCH EUR J PHY, V455, P187, DOI 10.1007/s00424-007-0252-0; Bandyopadhyay BC, 2005, J BIOL CHEM, V280, P12908, DOI 10.1074/jbc.M410013200; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; Goel M, 2007, AM J PHYSIOL-RENAL, V293, pF1476, DOI 10.1152/ajprenal.00186.2007; Kheifets V, 2007, PHARMACOL RES, V55, P467, DOI 10.1016/j.phrs.2007.04.014; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kiselyov K., 2007, V179, P559; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Liu X, 2004, J MEMBRANE BIOL, V200, P93, DOI 10.1007/s00232-004-0698-3; Lockwich T, 2001, J BIOL CHEM, V276, P42401, DOI 10.1074/jbc.M106956200; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Miller LD, 2004, ONCOGENE, V23, P5682, DOI 10.1038/sj.onc.1207735; MOCHLYROSEN D, 1995, BIOCHEM SOC T, V23, P596, DOI 10.1042/bst0230596; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; REDONDO PC, 2007, BIOCHIM BIOPHYS ACTA, V1783, P1163; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; RON D, 1994, J BIOL CHEM, V269, P21395; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Soboloff J., 2007, V179, P575; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Vanlingen S, 2001, BIOCHEM PHARMACOL, V61, P803, DOI 10.1016/S0006-2952(01)00540-8; Vazquez G, 2001, P NATL ACAD SCI USA, V98, P11777, DOI 10.1073/pnas.201238198; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wedel BJ, 2003, J BIOL CHEM, V278, P25758, DOI 10.1074/jbc.M303890200; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698	41	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32821	32830		10.1074/jbc.M805382200	http://dx.doi.org/10.1074/jbc.M805382200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18755685	Green Published, hybrid			2022-12-25	WOS:000260893700071
J	Hirota, S; Kawahara, T; Beltramini, M; Di Muro, P; Magliozzo, RS; Peisach, J; Powers, LS; Tanaka, N; Nagao, S; Bubacco, L				Hirota, Shun; Kawahara, Takumi; Beltramini, Mariano; Di Muro, Paolo; Magliozzo, Richard S.; Peisach, Jack; Powers, Linda S.; Tanaka, Naoki; Nagao, Satoshi; Bubacco, Luigi			Molecular Basis of the Bohr Effect in Arthropod Hemocyanin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANULIRUS-INTERRUPTUS HEMOCYANIN; LIMULUS-POLYPHEMUS HEMOCYANIN; ABSORPTION-EDGE SPECTROSCOPY; OXYGEN-BINDING; CRYSTAL-STRUCTURE; ELECTRONIC-STRUCTURE; QUATERNARY STRUCTURE; SUBUNIT COMPOSITION; CARBON-MONOXIDE; ACTIVE-SITE	Flash photolysis and K-edge x-ray absorption spectroscopy (XAS) were used to investigate the functional and structural effects of pH on the oxygen affinity of three homologous arthropod hemocyanins (Hcs). Flash photolysis measurements showed that the well-characterized pH dependence of oxygen affinity (Bohr effect) is attributable to changes in the oxygen binding rate constant, k(on), rather than changes in k(off). In parallel, coordination geometry of copper in Hc was evaluated as a function of pH by XAS. It was found that the geometry of copper in the oxygenated protein is unchanged at all pH values investigated, while significant changes were observed for the deoxygenated protein as a function of pH. The interpretation of these changes was based on previously described correlations between spectral lineshape and coordination geometry obtained for model compounds of known structure (Blackburn, N. J., Strange, R. W., Reedijk, J., Volbeda, A., Farooq, A., Karlin, K. D., and Zubieta, J. (1989) Inorg. Chem., 28, 1349-1357). A pH-dependent change in the geometry of cuprous copper in the active site of deoxyHc, from pseudotetrahedral toward trigonal was assigned from the observed intensity dependence of the 1s --> 4p(z) transition in x-ray absorption near edge structure (XANES) spectra. The structural alteration correlated well with increase in oxygen affinity at alkaline pH determined in flash photolysis experiments. These results suggest that the oxygen binding rate in deoxyHc depends on the coordination geometry of Cu(I) and suggest a structural origin for the Bohr effect in arthropod Hcs.	[Hirota, Shun; Tanaka, Naoki; Nagao, Satoshi] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan; [Hirota, Shun; Kawahara, Takumi] Kyoto Pharmaceut Univ, Dept Phys Chem, Kyoto 6078414, Japan; [Hirota, Shun; Kawahara, Takumi] Kyoto Pharmaceut Univ, 21st Century COE Program, Kyoto 6078414, Japan; [Beltramini, Mariano; Di Muro, Paolo; Bubacco, Luigi] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Peisach, Jack] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Powers, Linda S.] Univ Arizona, Natl Ctr Design Mol Funct, Tucson, AZ 85721 USA	Nara Institute of Science & Technology; Kyoto Pharmaceutical University; Kyoto Pharmaceutical University; University of Padua; City University of New York (CUNY) System; Brooklyn College (CUNY); Yeshiva University; Albert Einstein College of Medicine; University of Arizona	Hirota, S (corresponding author), Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan.	hirota@ms.naist.jp; luigi.bubacco@unipd.it	Bubacco, Luigi/B-5602-2012; Di Muro, Paolo/F-5811-2013; Hirota, Shun/AAD-2651-2021	Bubacco, Luigi/0000-0001-7927-9208; Hirota, Shun/0000-0003-3227-8376; Nagao, Satoshi/0000-0003-1674-7697	National Institutes of Health [060014]; MEXT [18031038, 20051016]; JSPS; JST; Progetto di Ateneo; UniPd FIRB; MUR(PRIN);  [GM040168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060014, R56AI060014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040168, R37GM040168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Progetto di Ateneo; UniPd FIRB; MUR(PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 060014 from the NIAID (to R. S. M.) and GM040168 (to J. P.). This work was also supported by Grants-in-Aid for Scientific Research from MEXT (Priority Areas, Nos. 18031038 and 20051016, to S. H.), JSPS (Category C, No. 19550169, and the 21st COE Program (to S. H.)), JST (to S. H.), and by the Progetto di Ateneo, UniPd FIRB and MUR(PRIN) (to L. B. and M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ANDREW CR, 1993, BIOCHIM BIOPHYS ACTA, V1162, P105, DOI 10.1016/0167-4838(93)90135-E; Beltramini M, 2005, FEBS J, V272, P2060, DOI 10.1111/j.1742-4658.2005.04634.x; BLACKBURN NJ, 1989, INORG CHEM, V28, P1349, DOI 10.1021/ic00306a027; BLUMBERG WE, 1976, IRON COPPER PROTEINS, P389; BRENOWITZ M, 1984, ARCH BIOCHEM BIOPHYS, V230, P238, DOI 10.1016/0003-9861(84)90105-X; BRENOWITZ M, 1981, ARCH BIOCHEM BIOPHYS, V210, P748, DOI 10.1016/0003-9861(81)90242-3; BROUWER M, 1978, BIOCHEMISTRY-US, V17, P2148, DOI 10.1021/bi00604a019; BROWN JM, 1980, J AM CHEM SOC, V102, P4210, DOI 10.1021/ja00532a037; BRUNORI M, 1981, J MOL BIOL, V153, P1111, DOI 10.1016/0022-2836(81)90470-8; CRAMER SP, 1976, J AM CHEM SOC, V98, P1287, DOI 10.1021/ja00421a053; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Dainese E, 1998, EUR J BIOCHEM, V256, P350, DOI 10.1046/j.1432-1327.1998.2560350.x; FEITERS MC, 1990, COMMENTS INORG CHEM, V11, P131; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAZES B, 1993, PROTEIN SCI, V2, P597; HEIRWEGH K, 1961, BIOCHIM BIOPHYS ACTA, V48, P517, DOI 10.1016/0006-3002(61)90049-X; Hirota S, 2005, J AM CHEM SOC, V127, P17966, DOI 10.1021/ja0541128; JOLLEY RL, 1974, J BIOL CHEM, V249, P335; Karlin KD, 1997, J MOL CATAL A-CHEM, V117, P215, DOI 10.1016/S1381-1169(96)00250-6; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; KRAUS DW, 1990, J BIOL CHEM, V265, P16043; KUIPER HA, 1980, BIOCHIM BIOPHYS ACTA, V626, P412, DOI 10.1016/0005-2795(80)90136-1; KUIPER HA, 1975, J MOL BIOL, V99, P619, DOI 10.1016/S0022-2836(75)80176-8; MAGLIOZZO RS, 1995, BIOCHEMISTRY-US, V34, P1513, DOI 10.1021/bi00005a007; MAGNUS KA, 1991, PROTEINS, V9, P240, DOI 10.1002/prot.340090403; MAGNUS KA, 1994, PROTEINS, V19, P302, DOI 10.1002/prot.340190405; Markl J., 1992, Advances in Comparative and Environmental Physiology, V13, P325; Martin AG, 2007, J MOL BIOL, V366, P1332, DOI 10.1016/j.jmb.2006.11.075; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Menze MA, 2000, BIOCHEMISTRY-US, V39, P10806, DOI 10.1021/bi000008l; Metz M, 2001, J AM CHEM SOC, V123, P4938, DOI 10.1021/ja004166b; Molon A, 2000, EUR J BIOCHEM, V267, P7046, DOI 10.1046/j.1432-1327.2000.01803.x; Sabatucci A, 2002, J BIOL INORG CHEM, V7, P120, DOI 10.1007/s007750100272; SMITH TA, 1985, J AM CHEM SOC, V107, P5945, DOI 10.1021/ja00307a020; SOLOMON EI, 1993, SCIENCE, V259, P1575, DOI 10.1126/science.8384374; STERNER R, 1994, P NATL ACAD SCI USA, V91, P4835, DOI 10.1073/pnas.91.11.4835; VANHOLDE KE, 1967, BIOCHEMISTRY-US, V6, P93, DOI 10.1021/bi00853a016; VOLBEDA A, 1989, J MOL BIOL, V209, P249, DOI 10.1016/0022-2836(89)90276-3; VOLBEDA A, 1989, EUR J BIOCHEM, V181, P669, DOI 10.1111/j.1432-1033.1989.tb14775.x	40	12	12	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31941	31948		10.1074/jbc.M803433200	http://dx.doi.org/10.1074/jbc.M803433200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18725416	hybrid, Green Published			2022-12-25	WOS:000260760800076
J	Shmelzer, Z; Karter, M; Eisenstein, M; Leto, TL; Hadad, N; Ben-Menahem, D; Gitler, D; Banani, S; Wolach, B; Rotem, M; Levy, R				Shmelzer, Zeev; Karter, Maria; Eisenstein, Miriam; Leto, Thomas L.; Hadad, Nurit; Ben-Menahem, David; Gitler, Daniel; Banani, Shirly; Wolach, Baruch; Rotem, Meir; Levy, Rachel			Cytosolic Phospholipase A(2)alpha Is Targeted to the p47(phox)-PX Domain of the Assembled NADPH Oxidase via a Novel Binding Site in Its C2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION-INDUCED ACTIVATION; PROTEIN-PROTEIN DOCKING; SRC HOMOLOGY-3 DOMAINS; ESSENTIAL REQUIREMENT; RESPIRATORY BURST; HUMAN NEUTROPHILS; INTRAMOLECULAR INTERACTION; DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN	We have previously demonstrated a physical interaction between cytosolic phospholipase A2 alpha (cPLA(2)) and the assembled NADPH oxidase on plasma membranes following neutrophil stimulation. The aim of the present study was to define the exact binding sites between these two enzymes. Here we show, based on blot overlay experiments, Forster resonance energy transfer analysis and studies in neutrophils from patients with chronic granulomatous disease deficient in p67(phox) or p47(phox), that cPLA2 specifically binds to p47(phox) and that p47(phox) is sufficient to anchor cPLA2 to the assembled oxidase on the plasma membranes upon stimulation. Blot overlay and affinity binding experiments using subfragments of cPLA2 and p47(phox) demonstrated that the cPLA(2)-C2 domain and the p47(phox)-PX domain interact to form a complex that is resistant to high salt. Computational docking was used to identify hydrophobic peptides within these two domains that inhibited the association between the two enzymes and NADPH oxidase activity in electro-permeabilized neutrophils. These results were used in new docking computations that produced an interaction model. Based on this model, cPLA(2)-C2 domain mutations were designed to explore its interaction p47(phox) in neutrophillysates. The triple mutant F35A/M38A/L39A of the cPLA(2)-C2 domain caused a slight inhibition of the affinity binding to p47(phox), whereas the single mutant I67A was highly effective. The double mutant M59A/H115A of the p47(phox)-PX domain caused a significant inhibition of the affinity binding to cPLA(2). Thus, Ile(67) of the cPLA(2)-C2 domain is identified as a critical, centrally positioned residue in a hydrophobic interaction in the p47(phox)-PX domain.	[Shmelzer, Zeev; Karter, Maria; Hadad, Nurit; Banani, Shirly; Levy, Rachel] Soroka Univ, Med Ctr, Fac Hlth Sci, Infect Dis Lab,Dept Clin Biochem, IL-84105 Beer Sheva, Israel; [Ben-Menahem, David] Soroka Univ, Med Ctr, Fac Hlth Sci, Dept Pharmacol, IL-84105 Beer Sheva, Israel; [Gitler, Daniel] Soroka Univ, Med Ctr, Fac Hlth Sci, Dept Physiol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Eisenstein, Miriam] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel; [Wolach, Baruch] Meir Hosp, Dept Pediat, Lab Leukocyte Funct, IL-44281 Kefar Sava, Israel; [Rotem, Meir] Ha Emek Hosp, Dept Pediat, IL-18110 Afula, Israel; [Leto, Thomas L.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Levy, R (corresponding author), Soroka Univ, Med Ctr, Fac Hlth Sci, Infect Dis Lab,Dept Clin Biochem, IL-84105 Beer Sheva, Israel.	ral@bgu.ac.il	Gitler, Daniel/F-1304-2012	Gitler, Daniel/0000-0001-9544-3610; Ben-Menahem, David/0000-0002-8985-0591	Israel Sciences Foundation; Israel Academy of Sciences and Humanities [438/03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614, Z01AI000614] Funding Source: NIH RePORTER	Israel Sciences Foundation(Israel Science Foundation); Israel Academy of Sciences and Humanities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Israel Sciences Foundation founded by the Israel Academy of Sciences and Humanities (Grant 438/03).	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Bae YS, 2000, J IMMUNOL, V164, P4089, DOI 10.4049/jimmunol.164.8.4089; Ben-Zeev E, 2003, PROTEINS, V52, P24, DOI 10.1002/prot.10391; Berchanski A, 2004, PROTEINS, V56, P130, DOI 10.1002/prot.20145; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; Das S, 2002, J BIOL CHEM, V277, P23838, DOI 10.1074/jbc.M202322200; DEMENDEZ I, 1994, J BIOL CHEM, V269, P16326; deMendez I, 1997, MOL CELL BIOL, V17, P2177, DOI 10.1128/MCB.17.4.2177; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Dusi S, 1996, BIOCHEM J, V314, P409, DOI 10.1042/bj3140409; Essen LO, 1997, BIOCHEMISTRY-US, V36, P2753, DOI 10.1021/bi962466t; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Girotti M, 2004, J BIOL CHEM, V279, P19113, DOI 10.1074/jbc.M313867200; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; GRINSTEIN S, 1988, J BIOL CHEM, V263, P1779; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hazan I, 1997, BIOCHEM J, V326, P867, DOI 10.1042/bj3260867; Hazan-Halevy I, 2000, J BIOL CHEM, V275, P12416, DOI 10.1074/jbc.275.17.12416; Heifetz A, 2002, PROTEIN SCI, V11, P571, DOI 10.1110/ps.26002; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; LETO TL, 1991, J BIOL CHEM, V266, P19812; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Leto TL., 1999, INFLAMMATION BASIC P, P769; LEVY R, 1990, J IMMUNOL, V145, P2595; Li Q, 1997, J BIOL CHEM, V272, P2404, DOI 10.1074/jbc.272.4.2404; Lowenthal A, 1999, J BIOL CHEM, V274, P21603, DOI 10.1074/jbc.274.31.21603; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; O'Dowd YM, 2004, BIOCHEM PHARMACOL, V67, P183, DOI 10.1016/j.bcp.2003.08.026; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Pessach I, 2001, J BIOL CHEM, V276, P33495, DOI 10.1074/jbc.M011417200; Roos D, 1996, BLOOD, V87, P1663; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; Rubin BB, 2005, J BIOL CHEM, V280, P7519, DOI 10.1074/jbc.M407438200; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; Scaife RM, 2003, J CELL SCI, V116, P463, DOI 10.1242/jcs.00244; Shmelzer Z, 2003, J CELL BIOL, V162, P683, DOI 10.1083/jcb.200211056; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Yuzawa S, 2004, J BIOL CHEM, V279, P29752, DOI 10.1074/jbc.M401457200; Zhen L, 1998, J BIOL CHEM, V273, P6575, DOI 10.1074/jbc.273.11.6575	49	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31898	31908		10.1074/jbc.M804674200	http://dx.doi.org/10.1074/jbc.M804674200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18765662	hybrid			2022-12-25	WOS:000260760800072
J	Hu, JJ; Dong, LX; Outten, CE				Hu, Jingjing; Dong, Lixue; Outten, Caryn E.			The Redox Environment in the Mitochondrial Intermembrane Space Is Maintained Separately from the Cytosol and Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; FLUORESCENT PROTEIN INDICATORS; CYTOCHROME-C PEROXIDASE; SACCHAROMYCES-CEREVISIAE; GLUTATHIONE-REDUCTASE; YEAST MITOCHONDRIA; ESCHERICHIA-COLI; OXIDATIVE STRESS; INTRACELLULAR PH; IMPORT PATHWAY	Redox control in the mitochondrion is essential for the proper functioning of this organelle. Disruption of mitochondrial redox processes contributes to a host of human disorders, including cancer, neurodegenerative diseases, and aging. To better characterize redox control pathways in this organelle, we have targeted a green fluorescent protein-based redox sensor to the intermembrane space (IMS) and matrix of yeast mitochondria. This approach allows us to separately monitor the redox state of the matrix and the IMS, providing a more detailed picture of redox processes in these two compartments. To verify that the sensors respond to localized glutathione (GSH) redox changes, we have genetically manipulated the subcellular redox state using oxidized GSH (GSSG) reductase localization mutants. These studies indicate that redox control in the cytosol and matrix are maintained separately by cytosolic and mitochondrial isoforms of GSSG reductase. Our studies also demonstrate that the mitochondrial IMS is considerably more oxidizing than the cytosol and mitochondrial matrix and is not directly influenced by endogenous GSSGreductase activity. These redox measurements are used to predict the oxidation state of thiol-containing proteins that are imported into the IMS.	[Hu, Jingjing; Dong, Lixue; Outten, Caryn E.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Outten, CE (corresponding author), Univ S Carolina, Dept Chem & Biochem, 631 Sumter St, Columbia, SC 29205 USA.	caryn.outten@chem.sc.edu	Outten, Caryn E./I-9433-2019; Hu, Jingjing/E-2713-2012	Outten, Caryn E./0000-0003-0335-6531; 	National Institutes of Health [ES 13780]; University of South Carolina Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES013780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES 13780 (to C. E. O.). This work was also supported by the University of South Carolina Center for Colon Cancer Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200; Banci L, 2008, J BIOL CHEM, V283, P7912, DOI 10.1074/jbc.M708016200; BEASLEY EM, 1993, EMBO J, V12, P2303, DOI 10.1002/j.1460-2075.1993.tb05884.x; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; Bjornberg O, 2006, ANTIOXID REDOX SIGN, V8, P354, DOI 10.1089/ars.2006.8.354; Breeuwer P, 2000, J MICROBIOL METH, V39, P253, DOI 10.1016/S0167-7012(99)00124-4; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; CORTESE JD, 1992, BIOCHIM BIOPHYS ACTA, V1100, P189; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; DAUM G, 1982, J BIOL CHEM, V257, P3028; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Goldsteins G, 2008, J BIOL CHEM, V283, P8446, DOI 10.1074/jbc.M706111200; Hancock JT, 2003, ANN NY ACAD SCI, V1010, P446, DOI 10.1196/annals.1299.081; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; IMAI T, 1995, J BIOTECHNOL, V38, P165, DOI 10.1016/0168-1656(94)00130-5; Jones DP, 2006, CHEM-BIOL INTERACT, V163, P38, DOI 10.1016/j.cbi.2006.07.008; Khalimonchuk O, 2007, BIOCHIM BIOPHYS ACTA, V1783, P618; Koehler CM, 2006, ANTIOXID REDOX SIGN, V8, P813, DOI 10.1089/ars.2006.8.813; Le Moan N, 2006, J BIOL CHEM, V281, P10420, DOI 10.1074/jbc.M513346200; Lu H, 2005, J MOL BIOL, V353, P897, DOI 10.1016/j.jmb.2005.09.002; MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P7185, DOI 10.1073/pnas.87.18.7185; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Melvin BK, 1996, BIOTECHNOL PROGR, V12, P257, DOI 10.1021/bp9500775; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Monteiro G, 2004, ARCH BIOCHEM BIOPHYS, V425, P14, DOI 10.1016/j.abb.2004.03.005; Morgan B, 2008, BIOCHEM J, V411, P115, DOI 10.1042/BJ20071476; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Porras P, 2006, J BIOL CHEM, V281, P16551, DOI 10.1074/jbc.M600790200; Rebrin I, 2005, FREE RADICAL BIO MED, V39, P549, DOI 10.1016/j.freeradbiomed.2005.04.008; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shen DX, 2005, J BIOL CHEM, V280, P25305, DOI 10.1074/jbc.M500095200; SIKORSKI RS, 1989, GENETICS, V122, P19; STEVENS BJ, 1977, BIOL CELLULAIRE, V28, P37; Stojanovski D, 2008, BBA-MOL CELL RES, V1783, P610, DOI 10.1016/j.bbamcr.2007.10.004; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Ueda S, 2002, ANTIOXID REDOX SIGN, V4, P405, DOI 10.1089/15230860260196209; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Voronova A, 2007, BIOCHEM J, V408, P139, DOI 10.1042/BJ20070804	58	195	197	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29126	29134		10.1074/jbc.M803028200	http://dx.doi.org/10.1074/jbc.M803028200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708636	Green Published, hybrid			2022-12-25	WOS:000260179900040
J	Dong, WB; Tang, XJ; Yu, YH; Nilsen, R; Kim, R; Griffith, J; Arnold, J; Schuttler, HB				Dong, Wubei; Tang, Xiaojia; Yu, Yihai; Nilsen, Roger; Kim, Rosemary; Griffith, James; Arnold, Jonathan; Schuttler, H. Bernd			Systems Biology of the Clock in Neurospora crassa	PLOS ONE			English	Article							CIRCADIAN GENE-EXPRESSION; MICROARRAY ANALYSIS; DEPENDENT REGULATION; SIGNALING PATHWAYS; REGULATORY NETWORK; FILAMENTOUS FUNGUS; OSMOTIC-STRESS; WHITE COLLAR-1; FEEDBACK LOOPS; GENOME	A model-driven discovery process, Computing Life, is used to identify an ensemble of genetic networks that describe the biological clock. A clock mechanism involving the genes white-collar-1 and white-collar-2 (wc-1 and wc-2) that encode a transcriptional activator (as well as a blue-light receptor) and an oscillator frequency (frq) that encodes a cyclin that deactivates the activator is used to guide this discovery process through three cycles of microarray experiments. Central to this discovery process is a new methodology for the rational design of a Maximally Informative Next Experiment (MINE), based on the genetic network ensemble. In each experimentation cycle, the MINE approach is used to select the most informative new experiment in order to mine for clock-controlled genes, the outputs of the clock. As much as 25% of the N. crassa transcriptome appears to be under clock-control. Clock outputs include genes with products in DNA metabolism, ribosome biogenesis in RNA metabolism, cell cycle, protein metabolism, transport, carbon metabolism, isoprenoid (including carotenoid) biosynthesis, development, and varied signaling processes. Genes under the transcription factor complex WCC (= WC-1/WC-2) control were resolved into four classes, circadian only (612 genes), light-responsive only (396), both circadian and light-responsive (328), and neither circadian nor light-responsive (987). In each of three cycles of microarray experiments data support that wc-1 and wc-2 are auto-regulated by WCC. Among 11,000 N. crassa genes a total of 295 genes, including a large fraction of phosphatases/kinases, appear to be under the immediate control of the FRQ oscillator as validated by 4 independent microarray experiments. Ribosomal RNA processing and assembly rather than its transcription appears to be under clock control, suggesting a new mechanism for the post-transcriptional control of clock-controlled genes.	[Dong, Wubei; Arnold, Jonathan] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Tang, Xiaojia; Yu, Yihai; Nilsen, Roger; Kim, Rosemary; Griffith, James; Schuttler, H. Bernd] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Griffith, James] Univ Georgia, Coll Agr & Environm Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Dong, WB (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	arnold@uga.edu	Schuttler, Heinz-Bernd/AFT-0395-2022	Dong, Wubei/0000-0001-8513-8751; arnold, jonathan/0000-0001-5845-1048; Tang, Xiaojia/0000-0003-2457-9953	NSF [DBI-0243574, MCB-0542915, BES-0425762]; Sun Grid [12021957]; University of Minnesota Supercomputer Center; University of Georgia College of Agricultural and Environmental Sciences	NSF(National Science Foundation (NSF)); Sun Grid; University of Minnesota Supercomputer Center; University of Georgia College of Agricultural and Environmental Sciences	NSF DBI-0243574, NSF MCB-0542915, NSF BES-0425762, Sun Grid Grant 12021957, The University of Minnesota Supercomputer Center and the University of Georgia College of Agricultural and Environmental Sciences supported this work. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves R, 2000, BIOINFORMATICS, V16, P534, DOI 10.1093/bioinformatics/16.6.534; ARNOLD J, 2004, HDB IND MYCOLOGY, P597; ARNOLD J, 2006, IEEE P 1 INT C COMP, P119; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Battogtokh D, 2002, P NATL ACAD SCI USA, V99, P16904, DOI 10.1073/pnas.262658899; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloomfield P., 1976, FOURIER ANAL TIME SE; Brown KS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021904; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Correa A, 2003, P NATL ACAD SCI USA, V100, P13597, DOI 10.1073/pnas.2233734100; Correa A, 2002, EUKARYOT CELL, V1, P273, DOI 10.1128/EC.1.2.273-280.2002; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dai JL, 2007, BIOMETRICS, V63, P1245, DOI 10.1111/j.1541-0420.2007.00801.x; Davidian M., 1995, NONLINEAR MODELS REP; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Paula RM, 2006, J BIOL RHYTHM, V21, P159, DOI 10.1177/0748730406288338; DHARMANANDA S, 1980, THESIS U CALIFORNIA; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Dong W, 2007, IET SYST BIOL, V1, P257, DOI 10.1049/iet-syb:20060080; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Emery B, 2004, MOL MICROBIOL, V52, P141, DOI 10.1111/j.1365-2958.2003.03973.x; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; GILES NH, 1991, J HERED, V82, P1; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Gutierrez RA, 2002, P NATL ACAD SCI USA, V99, P11513, DOI 10.1073/pnas.152204099; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Heisenberg W., 1949, PHYS PRINCIPLES QUAN; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Inada M, 2004, P NATL ACAD SCI USA, V101, P434, DOI 10.1073/pnas.0307425100; Jazwinski SM, 2002, ANNU REV MICROBIOL, V56, P769, DOI 10.1146/annurev.micro.56.012302.160830; Jones CA, 2007, MOL BIOL CELL, V18, P2123, DOI 10.1091/mbc.E06-03-0226; Kaldi K, 2006, EMBO REP, V7, P199, DOI 10.1038/sj.embor.7400595; Kasuga T, 2005, NUCLEIC ACIDS RES, V33, P6469, DOI 10.1093/nar/gki953; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lewis ZA, 2002, MOL MICROBIOL, V45, P917, DOI 10.1046/j.1365-2958.2002.03074.x; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Logan DA, 2007, BIOINFORMATION, V1, P390, DOI 10.6026/97320630001390; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Mannhaupt G, 2003, NUCLEIC ACIDS RES, V31, P1944, DOI 10.1093/nar/gkg293; Masloff S, 2002, FUNGAL GENET BIOL, V36, P107, DOI 10.1016/S1087-1845(02)00010-5; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Michael TP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000795; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Michael TP, 2003, PLANT PHYSIOL, V132, P629, DOI 10.1104/pp.021006; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Muirhead R. J., 1982, ASPECTS MULTIVARIATE; NAKASHIMA H, 1981, PLANT CELL PHYSIOL, V22, P231; Nowrousian M, 2003, GENETICS, V164, P923; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Ruoff P, 2005, P NATL ACAD SCI USA, V102, P17681, DOI 10.1073/pnas.0505137102; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Townsend JP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-54; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Vitalini MW, 2007, P NATL ACAD SCI USA, V104, P18223, DOI 10.1073/pnas.0704900104; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Xiong MM, 2004, GENETICS, V166, P1037, DOI 10.1534/genetics.166.2.1037; Yang YH, 2004, GENE DEV, V18, P255, DOI 10.1101/gad.1152604; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; Youssar L, 2006, FUNGAL GENET BIOL, V43, P752, DOI 10.1016/j.fgb.2006.05.003; YU Y, 2005, THESIS U GEORGIA; Yu YH, 2007, P NATL ACAD SCI USA, V104, P2809, DOI 10.1073/pnas.0611005104	95	81	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3105	10.1371/journal.pone.0003105	http://dx.doi.org/10.1371/journal.pone.0003105			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769678	Green Published, Green Submitted, gold			2022-12-25	WOS:000264796800010
J	Kawabata, H; Zeki, S				Kawabata, Hideaki; Zeki, Semir			The Neural Correlates of Desire	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; LATERAL OCCIPITAL COMPLEX; VISUAL SEXUAL STIMULI; ORBITOFRONTAL CORTEX; FACIAL ATTRACTIVENESS; HUMAN BRAIN; FUNCTIONAL SPECIALIZATION; AMYGDALA RESPONSE; NUCLEUS-ACCUMBENS; FACE PERCEPTION	In an event-related fMRI study, we scanned eighteen normal human subjects while they viewed three categories of pictures (events, objects and persons) which they classified according to desirability (desirable, indifferent or undesirable). Each category produced activity in a distinct part of the visual brain, thus reflecting its functional specialization. We used conjunction analysis to learn whether there is a brain area which is always active when a desirable picture is viewed, regardless of the category to which it belongs. The conjunction analysis of the contrast desirable. undesirable revealed activity in the superior orbito-frontal cortex. This activity bore a positive linear relationship to the declared level of desirability. The conjunction analysis of desirable. indifferent revealed activity in the mid-cingulate cortex and in the anterior cingulate cortex. In the former, activity was greater for desirable and undesirable stimuli than for stimuli classed as indifferent. Other conjunction analyses produced no significant effects. These results show that categorizing any stimulus according to its desirability activates three different brain areas: the superior orbito-frontal, the mid-cingulate, and the anterior cingulate cortices.	[Kawabata, Hideaki; Zeki, Semir] UCL, Dept Cell & Dev Biol, Wellcome Lab Neurobiol, London, England; [Kawabata, Hideaki] Kagoshima Univ, Dept Psychol, Kagoshima 890, Japan	University of London; University College London; Kagoshima University	Kawabata, H (corresponding author), UCL, Dept Cell & Dev Biol, Wellcome Lab Neurobiol, London, England.	zeki.pa@ucl.ac.uk	Zeki, Semir/AAA-1789-2020		Wellcome Trust, London, UK; Honda Research Institute, Wako, Japan	Wellcome Trust, London, UK(Wellcome Trust); Honda Research Institute, Wako, Japan	The work was supported by the Wellcome Trust, London, UK; and by the Honda Research Institute, Wako, Japan. Funding bodies had no role in design, execution or analysis of the study.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dackis C, 2005, NAT NEUROSCI, V8, P1431, DOI 10.1038/nn1105-1431; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; Elliott R, 2003, J NEUROSCI, V23, P303; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Gerlach C, 2002, NEUROPSYCHOLOGIA, V40, P1254, DOI 10.1016/S0028-3932(01)00222-6; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Ishai A, 2007, INT J PSYCHOPHYSIOL, V63, P181, DOI 10.1016/j.ijpsycho.2006.03.010; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kelley AE, 2002, J NEUROSCI, V22, P3306; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Lerner Y, 2002, CEREB CORTEX, V12, P163, DOI 10.1093/cercor/12.2.163; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nutt D, 2007, J PSYCHOPHARMACOL, V21, P461, DOI 10.1177/0269881106069938; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Pernet C, 2004, NEUROIMAGE, V22, P1563, DOI 10.1016/j.neuroimage.2004.03.044; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Rolls ET, 2007, EUR J NEUROSCI, V26, P1067, DOI 10.1111/j.1460-9568.2007.05724.x; Rolls ET, 2003, CEREB CORTEX, V13, P308, DOI 10.1093/cercor/13.3.308; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smith KS, 2007, J NEUROSCI, V27, P1594, DOI 10.1523/JNEUROSCI.4205-06.2007; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Wiggs CL, 1999, NEUROPSYCHOLOGIA, V37, P103; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Winston JS, 2007, NEUROPSYCHOLOGIA, V45, P195, DOI 10.1016/j.neuropsychologia.2006.05.009; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 2003, CEREB CORTEX, V13, P189, DOI 10.1093/cercor/13.2.189; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002180; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	60	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3027	10.1371/journal.pone.0003027	http://dx.doi.org/10.1371/journal.pone.0003027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RM	18728753	Green Published, gold, Green Submitted			2022-12-25	WOS:000264796400002
J	Butin-Israeli, V; Uzi, D; Abd-El-Latif, M; Pizov, G; Eden, A; Haviv, YS; Oppenheim, A				Butin-Israeli, Veronika; Uzi, Dotan; Abd-El-Latif, Mahmoud; Pizov, Galina; Eden, Arieh; Haviv, Yosef S.; Oppenheim, Ariella			DNA-Free Recombinant SV40 Capsids Protect Mice from Acute Renal Failure by Inducing Stress Response, Survival Pathway and Apoptotic Arrest	PLOS ONE			English	Article								Viruses induce signaling and host defense during infection. Employing these natural trigger mechanisms to combat organ or tissue failure is hampered by harmful effects of most viruses. Here we demonstrate that SV40 empty capsids (Virus Like Particles-VLPs), with no DNA, induce host Hsp/c70 and Akt-1 survival pathways, key players in cellular survival mechanisms. We postulated that this signaling might protect against organ damage in vivo. Acute kidney injury (AKI) was chosen as target. AKI is critical, prevalent disorder in humans, caused by nephrotoxic agents, sepsis or ischemia, via apoptosis/necrosis of renal tubular cells, with high morbidity and mortality. Systemic administration of VLPs activated Akt-1 and upregulated Hsp/c70 in vivo. Experiments in mercury-induced AKI mouse model demonstrated that apoptosis, oxidative stress and toxic renal failure were significantly attenuated by pretreatment with capsids prior to the mercury insult. Survival rate increased from 12% to >60%, with wide dose response. This study demonstrates that SV40 VLPs, devoid of DNA, may potentially be used as prophylactic agent for AKI. We anticipate that these finding may be projected to a wide range of organ failure, using empty capsids of SV40 as well as other viruses.	[Butin-Israeli, Veronika; Uzi, Dotan; Abd-El-Latif, Mahmoud; Oppenheim, Ariella] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91010 Jerusalem, Israel; [Pizov, Galina] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91010 Jerusalem, Israel; [Eden, Arieh] Carmel Lady Davis Med Ctr, Dept Anesthesiol & Critical Care Med, Haifa, Israel; [Haviv, Yosef S.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Nephrol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Clalit Health Services; Carmel Medical Center; Hebrew University of Jerusalem	Butin-Israeli, V (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91010 Jerusalem, Israel.	Ariella@cc.huji.ac.il	Butin-Israeli, Veronika/AAQ-2391-2020		NIH [R01 CA 100479-01A2]; The Israel Science Foundation [604/07]; NATIONAL CANCER INSTITUTE [R01CA100479] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Israel Science Foundation(Israel Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NIH Grant R01 CA 100479-01A2 and by The Israel Science Foundation Grant No. 604/07.	ACHESON NH, 1981, DNA TUMOR VIRUSES, P125; Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Arad U, 2005, HUM GENE THER, V16, P361, DOI 10.1089/hum.2005.16.361; Aufricht C, 2005, PEDIATR NEPHROL, V20, P707, DOI 10.1007/s00467-004-1812-6; Bai XC, 2002, J BIOCHEM, V131, P207, DOI 10.1093/oxfordjournals.jbchem.a003089; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BLACK PH, 1964, VIROLOGY, V24, P381, DOI 10.1016/0042-6822(64)90175-8; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chromy LR, 2006, J VIROL, V80, P5086, DOI 10.1128/JVI.80.10.5086-5091.2006; DAVENPORT RJ, 2002, SCI AGING KNOWL ENV; Dawn-Linsley M, 2005, J NEUROSCI METH, V141, P219, DOI 10.1016/j.jneumeth.2004.06.010; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Heyman Samuel N, 2002, Curr Opin Crit Care, V8, P526, DOI 10.1097/00075198-200212000-00008; Ignatov A, 2006, BRIT J PHARMACOL, V149, P490, DOI 10.1038/sj.bjp.0706909; Jo SK, 2006, J AM SOC NEPHROL, V17, P3082, DOI 10.1681/ASN.2005101077; Kelly KJ, 2005, CONTRIB NEPHROL, V148, P86, DOI 10.1159/000086054; KHANDJIAN EW, 1983, MOL CELL BIOL, V3, P1; Kimchi-Sarfaty C, 2004, CURR PHARM BIOTECHNO, V5, P451, DOI 10.2174/1389201043376670; Kimchi-Sarfaty C, 2004, BIOTECHNIQUES, V37, P270, DOI 10.2144/04372RR04; Kondo R, 1998, GENE THER, V5, P575, DOI 10.1038/sj.gt.3300623; Lu CY, 2007, CURR OPIN NEPHROL HY, V16, P83, DOI 10.1097/MNH.0b013e3280403c4e; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; McCullough P, 2006, CATHETER CARDIO INTE, V67, P335, DOI 10.1002/ccd.20658; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; Meschi M, 2006, CRIT CARE MED, V34, P2060, DOI 10.1097/01.CCM.0000227651.73500.BA; Mukherjee S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000765; Nilakantan V, 2007, MOL CELL BIOCHEM, V304, P1, DOI 10.1007/s11010-007-9480-z; Norkin LC, 2002, J VIROL, V76, P5156, DOI 10.1128/JVI.76.10.5156-5166.2002; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Preiss S, 2007, CARDIOVASC RES, V73, P833, DOI 10.1016/j.cardiores.2006.12.019; Riordan M, 2006, NAT CLIN PRACT NEPHR, V2, P149, DOI 10.1038/ncpneph0117; SAINIS I, 1994, FEBS LETT, V355, P282, DOI 10.1016/0014-5793(94)01210-5; Sandalon Z, 1997, VIROLOGY, V237, P414, DOI 10.1006/viro.1997.8796; SANDALON Z, 2001, SV40 PROTOCOLS; Stacchiotti A, 2006, J HISTOCHEM CYTOCHEM, V54, P1149, DOI 10.1369/jhc.6A6932.2006; Strayer DS, 2005, CURR GENE THER, V5, P151, DOI 10.2174/1566523053544281; Tanemura M, 2006, TRANSPLANT P, V38, P3315, DOI 10.1016/j.transproceed.2006.10.082; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Weisbord SD, 2006, J AM SOC NEPHROL, V17, P2871, DOI 10.1681/ASN.2006030301; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249	43	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2998	10.1371/journal.pone.0002998	http://dx.doi.org/10.1371/journal.pone.0002998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714386	gold, Green Published			2022-12-25	WOS:000264420900023
J	Estrada-Pena, A; Acevedo, P; Ruiz-Fons, F; Gortazar, C; de la Fuente, J				Estrada-Pena, Agustin; Acevedo, Pelayo; Ruiz-Fons, Francisco; Gortazar, Christian; de la Fuente, Jose			Evidence of the Importance of Host Habitat Use in Predicting the Dilution Effect of Wild Boar for Deer Exposure to Anaplasma spp.	PLOS ONE			English	Article							IBERIAN RED DEER; CERVUS-ELAPHUS-HISPANICUS; TICK-BORNE PATHOGENS; SUS-SCROFA; DISEASE PERSISTENCE; LYME-DISEASE; MARGINALE; DENSITY; PHAGOCYTOPHILUM; RICKETTSIALES	Foci of tick-borne pathogens occur at fine spatial scales, and depend upon a complex arrangement of factors involving climate, host abundance and landscape composition. It has been proposed that the presence of hosts that support tick feeding but not pathogen multiplication may dilute the transmission of the pathogen. However, models need to consider the spatial component to adequately explain how hosts, ticks and pathogens are distributed into the landscape. In this study, a novel, lattice-derived, behavior-based, spatially-explicit model was developed to test how changes in the assumed perception of different landscape elements affect the outcome of the connectivity between patches and therefore the dilution effect. The objective of this study was to explain changes in the exposure rate (ER) of red deer to Anaplasma spp. under different configurations of suitable habitat and landscape fragmentation in the presence of variable densities of the potentially diluting host, wild boar. The model showed that the increase in habitat fragmentation had a deep impact on Habitat Sharing Ratio (HSR), a parameter describing the amount of habitat shared by red deer and wild boar, weighted by the probability of the animals to remain together in the same patch (according to movement rules), the density of ticks and the density of animals at a given vegetation patch, and decreased the dilution effect of wild boar on deer Anaplasma ER. The model was validated with data collected on deer, wild boar and tick densities, climate, landscape composition, host vegetation preferences and deer seropositivity to Anaplasma spp. (as a measure of ER) in 10 study sites in Spain. However, although conditions were appropriate for a dilution effect, empirical results did not show a decrease in deer ER in sites with high wild boar densities. The model showed that the HSR was the most effective parameter to explain the absence of the dilution effect. These results suggest that host habitat usage may weaken the predicted dilution effect for tick-borne pathogens and emphasize the importance of the perceptual capabilities of different hosts in different landscapes and habitat fragmentation conditions for predictions of dilution effects.	[Estrada-Pena, Agustin] Fac Vet, Dept Parasitol, Zaragoza, Spain; [Acevedo, Pelayo; Ruiz-Fons, Francisco; Gortazar, Christian; de la Fuente, Jose] Inst Investigac Recursos Cineget IREC, CSIC UCLM JCCM, Ciudad Real, Spain; [Acevedo, Pelayo] Cent Sci Lab, Wildlife Ecol & Management Grp, York, N Yorkshire, England; [de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Food & Environment Research Agency; Oklahoma State University System; Oklahoma State University - Stillwater	Estrada-Pena, A (corresponding author), Fac Vet, Dept Parasitol, Zaragoza, Spain.	aestrada@unizar.es	Ruiz-Fons, Francisco/K-3161-2014; Acevedo, Pelayo/L-6737-2013; de la Fuente, José/AAU-1197-2020; Gortazar, Christian/E-7918-2012	Ruiz-Fons, Francisco/0000-0002-0820-5292; Acevedo, Pelayo/0000-0002-3509-7696; de la Fuente, José/0000-0001-7383-9649; Gortazar, Christian/0000-0003-0012-4006; Estrada Pena, Agustin/0000-0001-7483-046X	Epidemiologia de zoonosis transmitidas por garrapatas en Castilla La Mancha [06036-00 ICS-JCCM]; Epidemiologia de las enfermedades compartidas entre ungulados silvestres y ganado en Espana: aproximacion multidisciplinar [MEC AGL2005-07401]; International Cooperation Program of the European Union [510561]; Junta de Comunidades de Castilla-La Mancha, Spain	Epidemiologia de zoonosis transmitidas por garrapatas en Castilla La Mancha; Epidemiologia de las enfermedades compartidas entre ungulados silvestres y ganado en Espana: aproximacion multidisciplinar; International Cooperation Program of the European Union; Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha)	This research was supported by grants "Epidemiologia de zoonosis transmitidas por garrapatas en Castilla La Mancha" (06036-00 ICS-JCCM), Epidemiologia de las enfermedades compartidas entre ungulados silvestres y ganado en Espana: aproximacion multidisciplinar (MEC AGL2005-07401) and FEDER and was facilitated through the Integrated Consortium on Ticks and Tick-borne Diseases (ICTTD-3), financed by the International Cooperation Program of the European Union, coordination action project No. 510561. PA has a postdoc grant from the Junta de Comunidades de Castilla-La Mancha, Spain. Contributions intended to support the filed works and data collection. Sponsors are public and have no role in any activity.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; CARRANZA J, 1991, APPL ANIM BEHAV SCI, V30, P363, DOI 10.1016/0168-1591(91)90141-J; Corson MS, 2004, ECOL MODEL, V180, P487, DOI 10.1016/j.ecolmodel.2004.04.034; de la Fuente J, 2005, VECTOR-BORNE ZOONOT, V5, P390, DOI 10.1089/vbz.2005.5.390; de la Fuente J, 2004, EUR J WILDLIFE RES, V50, P187, DOI 10.1007/s10344-004-0060-1; de la Fuente J, 2004, VET MICROBIOL, V100, P163, DOI 10.1016/j.vetmic.2004.02.007; de la Fuente J, 2007, VET MICROBIOL, V119, P375, DOI 10.1016/j.vetmic.2006.09.011; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Estrada-Pena A, 2006, ECOL MODEL, V193, P663, DOI 10.1016/j.ecolmodel.2005.09.015; Estrada-Pena A, 2005, LANDSCAPE ECOL, V20, P529, DOI 10.1007/s10980-004-3318-9; FAHRIG L, 1985, ECOLOGY, V66, P1762, DOI 10.2307/2937372; Gilbert L, 2001, J ANIM ECOL, V70, P1053, DOI 10.1046/j.0021-8790.2001.00558.x; Ginsberg HS, 2002, J VECTOR ECOL, V27, P215; Ginsberg HS, 1996, EXP APPL ACAROL, V20, P533, DOI 10.1007/BF00048285; Hulinska D, 2004, APMIS, V112, P239, DOI 10.1111/j.1600-0463.2004.apm11204-0503.x; Kennedy M, 1997, BEHAVIOUR, V134, P905, DOI 10.1163/156853997X00223; KITRON K, 2007, EUROPEAN J WILDLIFE, DOI DOI 10.1007/S10344-007-0157-4; Kitron Uriela, 1994, P198; Knowles D, 1996, J CLIN MICROBIOL, V34, P2225, DOI 10.1128/JCM.34.9.2225-2230.1996; Kocan KA, 2003, VET PARASITOL, V112, P295, DOI 10.1016/S0304-4017(03)00018-9; Kocan KM, 2004, PARASITOLOGY, V129, pS285, DOI 10.1017/S0031182003004700; Massei G, 1997, J ZOOL, V242, P411, DOI 10.1111/j.1469-7998.1997.tb03845.x; MCGARIGAL K, 1995, PNW351 USDA FOR SERV; Ninyerola M, 2005, ATLAS CLIMATICO DIGI; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Randolph S.E., 2002, P119; Rosa R, 2003, J THEOR BIOL, V224, P359, DOI 10.1016/S0022-5193(03)00173-5; Rosa R, 2007, MATH BIOSCI, V208, P216, DOI 10.1016/j.mbs.2006.10.002; Ruiz-Fons F, 2006, VET PARASITOL, V140, P133, DOI 10.1016/j.vetpar.2006.03.033; Saura S, 2001, PHOTOGRAMM ENG REM S, V67, P1027; SINGER FJ, 1981, J WILDLIFE MANAGE, V45, P343, DOI 10.2307/3807917; THOMAS L, 2006, DISTANCE 5 RELEASE X; Torina A, 2007, ZOONOSES PUBLIC HLTH, V54, P8, DOI 10.1111/j.1863-2378.2007.00989.x; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; VANBUSKIRK J, 1995, ECOL APPL, V5, P1133, DOI 10.2307/2269360; Vicente J, 2007, OECOLOGIA, V152, P655, DOI 10.1007/s00442-007-0690-6; Vuilleumier S, 2006, ECOL MODEL, V190, P159, DOI 10.1016/j.ecolmodel.2005.04.017; Ward AI, 2004, MAMMAL REV, V34, P315, DOI 10.1111/j.1365-2907.2004.00046.x	38	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2999	10.1371/journal.pone.0002999	http://dx.doi.org/10.1371/journal.pone.0002999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714379	Green Submitted, Green Published, gold			2022-12-25	WOS:000264420900024
J	Hong, MG; Myers, AJ; Magnusson, PKE; Prince, JA				Hong, Mun-Gwan; Myers, Amanda J.; Magnusson, Patrik K. E.; Prince, Jonathan A.			Transcriptome-Wide Assessment of Human Brain and Lymphocyte Senescence	PLOS ONE			English	Article								Background: Identifying biological pathways that vary across the age spectrum can provide insight into fundamental mechanisms that impact disease and frailty in the elderly. Few methodological approaches offer the means to explore this question on as broad a scale as gene expression profiling. Here, we have evaluated mRNA expression profiles as a function of age in two populations; one consisting of 191 individuals with ages-at-death ranging from 65-100 years and with postmortem brain mRNA measurements of 13,216 genes and a second with 1240 individuals ages 15-94 and lymphocyte mRNA estimates for 18,519 genes. Principal Findings: Among negatively correlated transcripts, an enrichment of mitochondrial genes was evident in both populations, providing a replication of previous studies indicating this as a common signature of aging. Sample differences were prominent, the most significant being a decrease in expression of genes involved in translation in lymphocytes and an increase in genes involved in transcription in brain, suggesting that apart from energy metabolism other basic cell processes are affected by age but in a tissue-specific manner. In assessing genomic architecture, intron/exon sequence length ratios were larger among negatively regulated genes in both samples, suggesting that a decrease in the expression of non-compact genes may also be a general effect of aging. Variance in gene expression itself has been theorized to change with age due to accumulation of somatic mutations and/or increasingly heterogeneous environmental exposures, but we found no evidence for such a trend here. Significance: Results affirm that deteriorating mitochondrial gene expression is a common theme in senescence, but also highlight novel pathways and features of gene architecture that may be important for understanding the molecular consequences of aging.	[Hong, Mun-Gwan; Magnusson, Patrik K. E.; Prince, Jonathan A.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Myers, Amanda J.] Univ Miami, Miller Sch Med, Dept Psychiat, Coral Gables, FL 33124 USA	Karolinska Institutet; University of Miami	Hong, MG (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Jonathan.Prince@ki.se	Magnusson, Patrik KE/C-4458-2017; Hide, Winston A/V-2727-2017; Hide, Winston/R-3815-2019; Hide, Winston Hide/C-7217-2009; Myers, Amanda J/B-1796-2010; Hong, Mun-Gwan/J-2839-2013	Magnusson, Patrik KE/0000-0002-7315-7899; Hide, Winston A/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Myers, Amanda J/0000-0002-3100-9396; Hong, Mun-Gwan/0000-0001-8603-8293	The Swedish Medical Research Council; Swedish Alzheimer Foundation (Alzheimerfonden); Johnnie B Byrd Institute; National Institute on Aging (NIA) [AG05146, P50 AG16570, AG05128, P30 AG19610]; National Alzheimer's Coordinating Center (NACC) [U01 AG016976]; NINDS [NS39764]; NIMH [MH60451]; Glaxo Smith Kline; NIH [P50-AG08671, AG05144, P50AG05681, P50 AG05136, P30-AG13846, AG10161]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG016976, P50AG005144, P50AG008671, P50AG005128, P50AG005681, P50AG005146, P30AG010161, P30AG013846, P50AG016570, P30AG019610, P50AG005136] Funding Source: NIH RePORTER	The Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Alzheimer Foundation (Alzheimerfonden); Johnnie B Byrd Institute; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Alzheimer's Coordinating Center (NACC); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Glaxo Smith Kline(GlaxoSmithKline); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful for financial support from The Swedish Medical Research Council, the Swedish Alzheimer Foundation (Alzheimerfonden), and from the Johnnie B Byrd Institute. For the brain sample, data and biomaterials were collected from several National Institute on Aging (NIA) and National Alzheimer's Coordinating Center (NACC, grant #U01 AG016976) funded sites. John A. Hardy, PhD, Marcelle Morrison-Bogorad, PhD, Tony Phelps, PhD and Walter Kukull PhD are thanked for helping to co-ordinate this collection. The directors, pathologist and technicians involved include: National Institute on Aging: Ruth Seemann, John Hopkins Alzheimer's Disease Research Center (NIA grant # AG05146): Juan C. Troncoso, MD, Dr. Olga Pletnikova, University of California, Los Angeles (NIA grant # P50 AG16570):Harry Vinters, MD, The Kathleen Price Bryan Brain Bank, Duke University Medical Center (NIA grant #AG05128, NINDS grant # NS39764, NIMH MH60451 also funded by Glaxo Smith Kline): Christine Hulette, MD, Director, John F. Ervin, Stanford University: Dikran Horoupian, MD, Ahmad Salehi, MD, PhD, New York Brain Bank, Taub Institute, Columbia University (NYBB): Jean Paul Vonsattel, MD, Katerina Mancevska, Massachusetts General Hospital: E. Tessa Hedley-Whyte, MD, Karlotta Fitch, University of Michigan (NIH grant P50-AG08671): Dr. Roger Albin, University of Kentucky (NIH #AG05144): William Markesbery, MD, Mayo Clinic, Jacksonville: Dennis W. Dickson, MD, University Southern California: Caroll A. Miller, MD, Washington University, St Louis Alzheimer's Disease Research Center (NIH #P50AG05681): Dan McKeel, MD, John C. Morris, MD, Eugene Johnson, Jr., PhD, Virginia Buckles, PhD, University of Washington, Seattle (NIH #P50 AG05136):Thomas Montine, MD, PhD, University of Pennsylvania School of Medicine, Alzheimer's Disease Research Center: John Q Trojanowski, MD, Virginia M Lee, MD, Vivianna Van Deerlin, MD, Boston University Alzheimer's Disease Research Center (NIH grant P30-AG13846): Ann C. McKee, Sun Health Research Institute, Arizona (NIA #P30 AG19610): Joseph Rogers, PhD, Thomas G. Beach, MD, PhD, Emory University: Bruce H. Wainer, MD, PhD, Marla Gearing, PhD, University of Texas, Southwestern Medical School: Charles L. White, III, M.D., Roger Rosenberg, University of California, Davis: William Ellis, MD, Rush University Medical Center, Rush Alzheimer's Disease Center (NIH #AG10161): David A. Bennett, M.D. Julie A. Schneider, MD, MS, University of Miami/NPF Brain Endowment Bank: Deborah C. Mash, MD, Margaret J Basile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2005, CURR OPIN IMMUNOL, V17, P480, DOI 10.1016/j.coi.2005.07.019; Charmantier A, 2006, P NATL ACAD SCI USA, V103, P6587, DOI 10.1073/pnas.0511123103; Cichowski K, 2008, CELL, V133, P958, DOI 10.1016/j.cell.2008.05.027; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eriksen JL, 2005, TRENDS MOL MED, V11, P91, DOI 10.1016/j.molmed.2005.01.001; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; GOLDSTEIN S, 1991, P NATL ACAD SCI USA, V88, P9680, DOI 10.1073/pnas.88.21.9680; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hughes KA, 2002, P NATL ACAD SCI USA, V99, P14286, DOI 10.1073/pnas.222326199; Kluger A, 1997, J GERONTOL B-PSYCHOL, V52, pP28, DOI 10.1093/geronb/52B.1.P28; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Obara M, 2008, NEUROCHEM INT, V52, P905, DOI 10.1016/j.neuint.2007.10.015; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603; Terry RD, 2006, J GERIATR PSYCH NEUR, V19, P125, DOI 10.1177/0891988706291079; TOLLEFSBOL TO, 1986, EXP GERONTOL, V21, P129, DOI 10.1016/0531-5565(86)90067-7; Tumeh PC, 2007, SEMIN NUCL MED, V37, P69, DOI 10.1053/j.semnuclmed.2006.10.002; Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Yanai I, 2006, TRENDS GENET, V22, P132, DOI 10.1016/j.tig.2006.01.006; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115	36	49	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3024	10.1371/journal.pone.0003024	http://dx.doi.org/10.1371/journal.pone.0003024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714388	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900046
J	Leoni, G; Patel, HB; Sampaio, ALF; Gavins, FNE; Murray, JF; Grieco, P; Getting, SJ; Perretti, M				Leoni, Giovanna; Patel, Hetal B.; Sampaio, Andre L. F.; Gavins, Felicity N. E.; Murray, Joanne F.; Grieco, Paolo; Getting, Stephen J.; Perretti, Mauro			Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion	FASEB JOURNAL			English	Article						intravital microscopy; cell trafficking; GPCR	MELANOCYTE-STIMULATING HORMONE; EXPERIMENTAL HEART-TRANSPLANTATION; SPLANCHNIC ARTERY-OCCLUSION; YELLOW E/E MOUSE; NF-KAPPA-B; ALPHA-MSH; GENE-EXPRESSION; MATRIX METALLOPROTEINASES; NEUTROPHIL MIGRATION; INDUCED INFLAMMATION	The existence of anti-inflammatory circuits centered on melanocortin receptors (MCRs) has been supported by the inhibitory properties displayed by melanocortin peptides in models of inflammation and tissue injury. Here we addressed the pathophysiological effect that one MCR, MCR type 3 (MC3R), might have on vascular inflammation. After occlusion (35 min) and reopening of the superior mesenteric artery, MC3R-null mice displayed a higher degree of plasma extravasation (45 min postreperfusion) and cell adhesion and emigration (90 min postreperfusion). These cellular alterations were complemented by higher expression of mesenteric tissue CCL2 and CXCL1 (mRNA and protein) and myeloperoxydase, as compared with wild-type animals. MC1R and MC3R mRNA and protein were both expressed in the inflamed mesenteric tissue; however, no changes in vascular responses were observed in a mouse colony bearing an inactive MC1R. Pharmacological treatment of animals with a selective MC3R agonist ([D-Trp(8)]-gamma- melanocyte-stimulating hormone; 10 mu g i.v.) produced marked attenuation of cell adhesion, emigration, and chemokine generation; such effects were absent in MC3R-null mice. These new data reveal the existence of a tonic inhibitory signal provided by MC3R in the mesenteric microcirculation of the mouse, acting to down-regulate cell trafficking and local mediator generation.	[Leoni, Giovanna; Patel, Hetal B.; Sampaio, Andre L. F.; Gavins, Felicity N. E.; Perretti, Mauro] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Grieco, Paolo] Univ Naples Federico 2, Dept Pharmaceut Chem & Toxicol, Naples, Italy; [Murray, Joanne F.; Getting, Stephen J.] Univ Westminster, Sch Biosci, London W1R 8AL, England	University of London; Queen Mary University London; University of Naples Federico II; University of Westminster	Perretti, M (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	m.perretti@qmul.ac.uk	Murray, Joanne F/P-7034-2016; Gavins, Felicity N. E./AAU-6010-2020; Grieco, Paolo/AAB-9034-2019	Murray, Joanne F/0000-0003-4884-9153; Gavins, Felicity N. E./0000-0001-7008-5423; Grieco, Paolo/0000-0002-6854-8123	British Heart Foundation [FS/05/078/19406]; CNPq Brasil [201172/2004-06]	British Heart Foundation(British Heart Foundation); CNPq Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the British Heart Foundation (studentship FS/05/078/19406). A.L.F.S. is a Fellow of CNPq Brasil (201172/2004-06).	Artuc M, 2006, J INVEST DERMATOL, V126, P1976, DOI 10.1038/sj.jid.5700318; Bazzani C, 2001, J PHARMACOL EXP THER, V297, P1082; Butler AA, 2002, NEUROPEPTIDES, V36, P77, DOI 10.1054/npep.2002.0890; Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1; Catania A, 2000, TRENDS ENDOCRIN MET, V11, P304, DOI 10.1016/S1043-2760(00)00296-4; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Chiao H, 1996, J CLIN INVEST, V97, P2038, DOI 10.1172/JCI118639; Chiao H, 1997, J CLIN INVEST, V99, P1165, DOI 10.1172/JCI119272; Colombo G, 2005, J IMMUNOL, V175, P3391, DOI 10.4049/jimmunol.175.5.3391; Cuzzocrea S, 1997, J IMMUNOL, V159, P5089; Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410; Di Filippo C, 2004, J PHARMACOL EXP THER, V310, P1133, DOI 10.1124/jpet.104.068726; Ellacott KLJ, 2007, ENDOCRINOLOGY, V148, P6186, DOI 10.1210/en.2007-0699; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Gatti S, 2002, TRANSPLANTATION, V74, P1678, DOI 10.1097/01.TP.0000038865.87650.E8; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Getting SJ, 2004, J LEUKOCYTE BIOL, V76, P845, DOI 10.1189/jlb.0306175; Getting SJ, 2002, ARTHRITIS RHEUM, V46, P2765, DOI 10.1002/art.10526; Getting SJ, 1999, J IMMUNOL, V162, P7446; Getting SJ, 2003, J IMMUNOL, V170, P3323, DOI 10.4049/jimmunol.170.6.3323; Getting SJ, 2006, MOL PHARMACOL, V70, P1850, DOI 10.1124/mol.106.028878; Getting SJ, 2006, FASEB J, V20, P2234, DOI 10.1096/fj.06-6339com; Getting SJ, 2006, PHARMACOL THERAPEUT, V111, P1, DOI 10.1016/j.pharmthera.2005.06.022; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; Grieco P, 2000, J MED CHEM, V43, P4998, DOI 10.1021/jm000211e; Guarini S, 2002, N-S ARCH PHARMACOL, V366, P177, DOI 10.1007/s00210-002-0572-8; Kalden DH, 1999, ANN NY ACAD SCI, V885, P254; Lam CW, 2006, PEPTIDES, V27, P404, DOI 10.1016/j.peptides.2005.01.031; Lam CW, 2005, J IMMUNOL, V174, P2297, DOI 10.4049/jimmunol.174.4.2297; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lim LHK, 1998, P NATL ACAD SCI USA, V95, P14535, DOI 10.1073/pnas.95.24.14535; Luger TA, 2003, ANN NY ACAD SCI, V994, P133, DOI 10.1111/j.1749-6632.2003.tb03172.x; Luger TA, 2007, ANN RHEUM DIS, V66, P52, DOI 10.1136/ard.2007.079780; Lyons PD, 1997, J NEUROIMMUNOL, V78, P47, DOI 10.1016/S0165-5728(97)00081-7; Maaser C, 2006, GUT, V55, P1415, DOI 10.1136/gut.2005.083634; Manna SK, 1998, J IMMUNOL, V161, P2873; Mioni C, 2003, EUR J PHARMACOL, V477, P227, DOI 10.1016/S0014-2999(03)02184-8; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Paul-Clark M, 2000, BRIT J PHARMACOL, V131, P1345, DOI 10.1038/sj.bjp.0703704; Perretti M, 1997, TRENDS PHARMACOL SCI, V18, P418; RITTER J, 1994, J RHEUMATOL, V21, P696; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Squadrito F, 1999, BRIT J PHARMACOL, V128, P816, DOI 10.1038/sj.bjp.0702848; Wainwright CL, 2004, CURR OPIN PHARMACOL, V4, P132, DOI 10.1016/j.coph.2004.01.001	47	36	36	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4228	4238		10.1096/fj.08-113886	http://dx.doi.org/10.1096/fj.08-113886			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18757499	hybrid, Green Published			2022-12-25	WOS:000261254800022
J	Marathe, DD; Chandrasekaran, EV; Lau, JTY; Matta, KL; Neelamegham, S				Marathe, Dhananjay D.; Chandrasekaran, E. V.; Lau, Joseph T. Y.; Matta, Khushi L.; Neelamegham, Sriram			Systems-level studies of glycosyltransferase gene expression and enzyme activity that are associated with the selectin binding function of human leukocytes	FASEB JOURNAL			English	Article						systems biology; glycan; PSGL-1; inflammation; hydroxyurea	SIALYL-LEWIS-X; P-SELECTIN; HL-60 CELLS; GLYCOPROTEIN LIGAND-1; O-GLYCANS; GRANULOCYTIC DIFFERENTIATION; MOLECULAR-CLONING; RETINOIC ACID; MUCIN CORE-2; IN-VITRO	The application of systems biology methods in the emerging field of glycomics requires the collection and integration of glycosyltransferase data at the gene and enzyme level for the purpose of hypothesis generation. We systematically examined the relationship between gene expression, glycosyltransferase activity, glycan expression, and selectin-binding function in different systems, including human neutrophils, undifferentiated HL-60 (human promyelocytic cells), differentiated HL-60, and HL-60 synchronized in specific growth phases. Results demonstrate that 1) the sLe(X) (sialyl-Lewis-X) epitope is expressed in P-selectin glycoprotein ligand-1 (PSGL-1) from neutrophils at higher levels compared with HL-60. This variation may be due to differences in the relative activities of alpha 1,3-fucosyltransferases and alpha 2,3-sialyltransferases in these two cell types. 2) HL-60 cell differentiation along granulocyte lineage increased the activity of beta 1,4GalT and beta 1,3GlcNAcT by 1.6- to 3.2-fold. This may contribute to LacNAc chain extension as evidenced by the 1.7-fold increase in DSA-lectin (lectin recognizing LacNAc) binding to cells after differentiation. 3) The activity of enzymes contributing to sLeX formation in leukocytes likely varies as ST3[Gal beta 1,4GlcNAc] <= alpha 1,3FT[sialyl-LacNAc] < beta 1,3GlcNAcT. 4) O-glycan specific glycosyltransferase activity does not undergo periodic variation with cell cycle phases. Overall, gene expression and enzyme activity data combined with knowledge of biochemistry can predict the resulting glycan structures and yield viable experimentally testable hypothesis.	[Neelamegham, Sriram] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Chandrasekaran, E. V.; Matta, Khushi L.] Roswell Pk Canc Inst, Dept Canc Biol, Buffalo, NY 14263 USA; [Lau, Joseph T. Y.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Neelamegham, S (corresponding author), SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA.	neel@eng.buffalo.edu		Neelamegham, Sriram/0000-0002-1371-8500; Marathe, Dhananjay/0000-0003-0238-2252	National Institutes of Health [HL63014, HL76211, CA35329, AI56082]; NATIONAL CANCER INSTITUTE [R01CA035329] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL076211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (HL63014 and HL76211 to S.N., CA35329 to K.L.M. and AI56082 to J.T.Y.L.). Carbohydrate acceptors used in this work were synthesized by various members of Matta Laboratory.	Aeed PA, 1998, GLYCOCONJUGATE J, V15, P975, DOI 10.1023/A:1006985825141; Beauharnois Mark E., 2006, V347, P343; Beauharnois ME, 2005, BIOCHEMISTRY-US, V44, P9507, DOI 10.1021/bi0507130; Benkerrou M, 2002, BLOOD, V99, P2297, DOI 10.1182/blood.V99.7.2297; BROCKHAUSEN I, 1991, CANCER RES, V51, P1257; Chandrasekaran EV, 2005, BIOCHEMISTRY-US, V44, P15619, DOI 10.1021/bi050246m; Chandrasekaran EV, 2004, J BIOL CHEM, V279, P10032, DOI 10.1074/jbc.M311989200; Chandrasekaran EV, 1996, BIOCHEMISTRY-US, V35, P8925, DOI 10.1021/bi952194e; CHANDRASEKARAN EV, 1992, J BIOL CHEM, V267, P19929; Clarke JL, 1996, J BIOL CHEM, V271, P10317, DOI 10.1074/jbc.271.17.10317; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; FUKUDA M, 1986, J BIOL CHEM, V261, P2796; Giraudo CG, 2003, J BIOL CHEM, V278, P40262, DOI 10.1074/jbc.M305455200; Guo HB, 2000, BBA-MOL CELL RES, V1495, P297, DOI 10.1016/S0167-4889(99)00157-3; Hillery CA, 2000, BRIT J HAEMATOL, V109, P322, DOI 10.1046/j.1365-2141.2000.02040.x; Kawano S, 2005, BIOINFORMATICS, V21, P3976, DOI 10.1093/bioinformatics/bti666; Krambeck FJ, 2005, BIOTECHNOL BIOENG, V92, P711, DOI 10.1002/bit.20645; LEE N, 1990, J BIOL CHEM, V265, P20476; LeMarer N, 1997, GLYCOBIOLOGY, V7, P357; Leppanen A, 2002, J BIOL CHEM, V277, P39749, DOI 10.1074/jbc.M206281200; Li X, 2001, J LEUKOCYTE BIOL, V69, P565; Liu AH, 1998, CELL BIOL INT, V22, P545, DOI 10.1006/cbir.1998.0293; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Neelamegham S, 2004, CELL COMMUN ADHES, V11, P35, DOI 10.1080/15419060490471793; Ogawa J, 1997, CANCER, V79, P1678, DOI 10.1002/(SICI)1097-0142(19970501)79:9<1678::AID-CNCR7>3.0.CO;2-8; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; SASAKI K, 1993, J BIOL CHEM, V268, P22782; SASAKI K, 1994, J BIOL CHEM, V269, P14730; Sjogren F, 2000, INFLAMMATION, V24, P21, DOI 10.1023/A:1006983824890; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sperandio M, 2006, EUR J IMMUNOL, V36, P3207, DOI 10.1002/eji.200636157; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; Uchimura K, 1998, J BIOCHEM-TOKYO, V124, P670, DOI 10.1093/oxfordjournals.jbchem.a022164; Watson RWG, 1997, FEBS LETT, V412, P603, DOI 10.1016/S0014-5793(97)00779-5; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; Xiao ZH, 2006, BIOPHYS J, V90, P2221, DOI 10.1529/biophysj.105.065789; Young WW, 2004, J MEMBRANE BIOL, V198, P1, DOI 10.1007/s00232-004-0656-5	41	38	39	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4154	4167		10.1096/fj.07-104257	http://dx.doi.org/10.1096/fj.07-104257			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18716032	Green Published			2022-12-25	WOS:000261254800015
J	Fromigue, O; Hamidouche, Z; Marie, PJ				Fromigue, Olivia; Hamidouche, Zahia; Marie, Pierre J.			Blockade of the RhoA-JNK-c-Jun-MMP2 Cascade by Atorvastatin Reduces Osteosarcoma Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; BREAST-CANCER CELLS; MATRIX METALLOPROTEINASES; C-JUN; MMP-9 SECRETION; IV COLLAGENASE; MESSENGER-RNA; ACTIVATION; EXPRESSION; APOPTOSIS	Osteosarcoma is characterized by a high malignant and metastatic potential, which points to the need for new therapeutic strategies to prevent cell metastasis. In this study, we show that statin-induced HMG-CoA reductase inhibition reduces cell migration and invasion in human and murine osteosarcoma cells, independently of the genotype. The statin-induced reduction of cell migration and invasion was independent of induction of apoptosis and was geranylgeranylpyrophosphate-dependent. The statin reduced matrix metalloproteinase (MMP) 2, 9, and 14 and TIMP2 expression or activity in invading cells. Forced expression of MMP2 and MMP14 overcame the inhibitory effect of the statin on cell invasion, suggesting a role for these MMPs in invasive potential. We also investigated the mechanisms involved in the reduced MMP2 activity and cell invasion. Inhibition of JNK, but not ERK1/2 signaling, reduced MMP2 activity. Pharmacological or constitutive activation of JNK overcame the reduced MMP2 activity and cell invasion induced by the statin. The statin decreased JNK phosphorylation and c-Jun nuclear translocation, suggesting that HMG-CoA reductase inhibition targets the JNK-c-Jun signaling pathway. We showed that mevalonate or geranylgeranylpyrophosphate treatment prevented the statin-induced reduction in JNK phosphorylation, MMP2 activity, and cell invasion. Forced expression of a constitutively active form of RhoA increased JNK phosphorylation and overcame the inhibitory effect of atorvastatin on MMP2 activity and cell invasion. The data establish a link between RhoA, JNK, c-Jun, and MMP2 activity that is functionally involved in the reduction in osteosarcoma cell invasion by the statin. This suggests a novel strategy targeting RhoA-JNK-c-Jun signaling to reduce osteosarcoma cell tumorigenesis.	[Fromigue, Olivia] Hop Lariboisiere, INSERM, Lab Osteoblast Biol & Pathol, U606, F-75475 Paris 10, France; Univ Paris 07, Hop Lariboisiere, F-75475 Paris 10, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Fromigue, O (corresponding author), Hop Lariboisiere, INSERM, Lab Osteoblast Biol & Pathol, U606, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	olivia.fromigue@inserm.fr	Fromigue, Olivia/B-8225-2013	Fromigue, Olivia/0000-0002-3050-6155	INSERM; Association pour la Recherche Contre le Cancer [4315]; Association Rhumatisme et Travail (Paris, France)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Rhumatisme et Travail (Paris, France)	This work was supported in part by INSERM, Association pour la Recherche Contre le Cancer Contract 4315, and the Association Rhumatisme et Travail (Paris, France). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Behrens A, 2001, P NATL ACAD SCI USA, V98, P1769, DOI 10.1073/pnas.98.4.1769; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bjornland K, 2005, J SURG RES, V127, P151, DOI 10.1016/j.jss.2004.12.016; Bruland OS, 2005, CLIN CANCER RES, V11, P4666, DOI 10.1158/1078-0432.CCR-05-0165; Cheung LWT, 2006, CANCER RES, V66, P10902, DOI 10.1158/0008-5472.CAN-06-2217; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; Denoyelle C, 2003, CELL SIGNAL, V15, P327, DOI 10.1016/S0898-6568(02)00124-9; Denoyelle C, 2001, CARCINOGENESIS, V22, P1139, DOI 10.1093/carcin/22.8.1139; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Duncan RE, 2004, J BIOL CHEM, V279, P33079, DOI 10.1074/jbc.M400732200; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Franchi A, 1998, VIRCHOWS ARCH, V432, P515, DOI 10.1007/s004280050199; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Fromigue O, 2006, CELL DEATH DIFFER, V13, P1845, DOI 10.1038/sj.cdd.4401873; Fromigue O, 2001, J BONE MINER RES, V16, P1600, DOI 10.1359/jbmr.2001.16.9.1600; Graaf MR, 2004, CANCER TREAT REV, V30, P609, DOI 10.1016/j.ctrv.2004.06.010; Himelstein Bruce P., 1998, Current Opinion in Oncology, V10, P326, DOI 10.1097/00001622-199807000-00009; Hsieh YS, 2007, CARCINOGENESIS, V28, P977, DOI 10.1093/carcin/bgl221; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; Ispanovic E, 2006, AM J PHYSIOL-CELL PH, V291, pC579, DOI 10.1152/ajpcell.00300.2005; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Kusama T, 2006, INT J ONCOL, V29, P217; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Maquoi E, 2000, J BIOL CHEM, V275, P11368, DOI 10.1074/jbc.275.15.11368; Matsumoto Y, 2001, JPN J CANCER RES, V92, P429, DOI 10.1111/j.1349-7006.2001.tb01113.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Orosco A, 2007, CANCER RES, V67, P3708, DOI 10.1158/0008-5472.CAN-06-4164; Papachristou DJ, 2003, BONE, V32, P364, DOI 10.1016/S8756-3282(03)00026-7; Porter KE, 2004, CARDIOVASC RES, V64, P507, DOI 10.1016/j.cardiores.2004.07.020; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Reuben PM, 2006, FRONT BIOSCI-LANDMRK, V11, P1199, DOI 10.2741/1873; Rochet N, 1999, INT J CANCER, V82, P282, DOI 10.1002/(SICI)1097-0215(19990719)82:2<282::AID-IJC20>3.0.CO;2-R; RODAN SB, 1987, CANCER RES, V47, P4961; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sawada K, 2002, CANCER RES, V62, P6015; Stenner-Liewen Frank, 2003, Cancer Research, V63, P263; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Thunyakitpisal PD, 2004, J PHARMACOL SCI, V94, P403, DOI 10.1254/jphs.94.403; Turner NA, 2005, FASEB J, V19, P804, DOI 10.1096/fj.04-2852fje; Turner NA, 2007, J MOL CELL CARDIOL, V43, P168, DOI 10.1016/j.yjmcc.2007.05.006; Uchibori M, 2006, INT J ONCOL, V28, P33; Van Noorden CJF, 1998, ACTA HISTOCHEM, V100, P337, DOI 10.1016/S0065-1281(98)80030-5; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wang IK, 2000, ONCOLOGY-BASEL, V59, P245, DOI 10.1159/000012168; Waxman DJ, 2003, CANCER RES, V63, P8563; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F	51	111	123	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30549	30556		10.1074/jbc.M801436200	http://dx.doi.org/10.1074/jbc.M801436200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18757369	Green Published, hybrid			2022-12-25	WOS:000260544800013
J	Tavraz, NN; Friedrich, T; Durr, KL; Koenderink, JB; Bamberg, E; Freilinger, T; Dichgans, M				Tavraz, Neslihan N.; Friedrich, Thomas; Duerr, Katharina L.; Koenderink, Jan B.; Bamberg, Ernst; Freilinger, Tobias; Dichgans, Martin			Diverse Functional Consequences of Mutations in the Na+/K+-ATPase alpha(2)-Subunit Causing Familial Hemiplegic Migraine Type 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; ATP1A2 MUTATION; NA,K-ATPASE ALPHA; CRYSTAL-STRUCTURE; MESSENGER-RNAS; CALCIUM-PUMP; SUBUNIT; GENE; MECHANISMS; CHANNEL	Mutations in ATP1A2, the gene coding for the Na+/K+-ATPase alpha(2)-subunit, are associated with both familial hemiplegic migraine and sporadic cases of hemiplegic migraine. In this study, we examined the functional properties of 11 ATP1A2 mutations associated with familial or sporadic hemiplegic migraine, including missense mutations (T263M, T376M, R383H, A606T, R763H, M829R, R834Q, R937P, and X1021R), a deletion mutant (del(K935-S940) ins(I)), and a frameshift mutation (S966fs). According to the Na+/K+-ATPase crystal structure, a subset of the mutated residues (Ala(606), Arg(763), Met(829), and Arg(834)) is involved in important interdomain H-bond networks, and the C terminus of the enzyme, which is elongated by the X1021R mutation, has been implicated in voltage dependence and formation of a third Na+-binding site. Upon heterologous expression in Xenopus oocytes, the analysis of electrogenic transport properties, Rb+ uptake, and protein expression revealed pronounced and markedly diverse functional alterations in all ATP1A2 mutants. Abnormalities included a complete loss of function (T376M), impaired plasma membrane expression (del(K935-S940) ins(I) and S966fs), and altered apparent affinities for extracellular cations or reduced enzyme turnover (R383H, A606T, R763H, R834Q, and X1021R). In addition, changes in the voltage dependence of pump currents and the increased rate constants of the voltage jump-induced redistribution between E1P and E2P states were observed. Thus, mutations that disrupt distinct interdomain H-bond patterns can cause abnormal conformational flexibility and exert long range consequences on apparent cation affinities or voltage dependence. Of interest, the X1021R mutation severely impaired voltage dependence and kinetics of Na+-translocating partial reactions, corroborating the critical role of the C terminus of Na+/K+-ATPase in these processes.	[Tavraz, Neslihan N.; Friedrich, Thomas; Duerr, Katharina L.] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Koenderink, Jan B.] Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Bamberg, Ernst] Max Planck Inst Biophys, Dept Biophys Chem, D-60438 Frankfurt, Germany; [Freilinger, Tobias; Dichgans, Martin] Univ Munich, Klinikum Grosshadern, Neurol Klin, D-81377 Munich, Germany	Technical University of Berlin; Radboud University Nijmegen; Max Planck Society; University of Munich	Friedrich, T (corresponding author), Tech Univ Berlin, Inst Chem, Sekr PC-14,Str 17 Juni 135, D-10623 Berlin, Germany.	friedrich@chem.tu-berlin.de	Dichgans, Martin/HCH-3247-2022; Friedrich, Thomas/AAA-3418-2022; Koenderink, Jan/N-3578-2014; Duerr, Katharina/A-6975-2015	Dichgans, Martin/0000-0002-0654-387X; Duerr, Katharina/0000-0002-3245-4088	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft [DI 722/8-2, KFG K1 027, KFG K1 028, SFB 740 TPC4]	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max-Planck-Gesellschaft and Deutsche Forschungsgemeinschaft Grants (DI 722/8-2, KFG K1 027, KFG K1 028, and SFB 740 TPC4, Cluster of Excellence "Unifying Concepts in Catalysis").	ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; DEWEER P, 1994, SODIUM PUMP, P472; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Golovina VA, 2003, AM J PHYSIOL-CELL PH, V284, pC475, DOI 10.1152/ajpcell.00383.2002; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Jorgensen PL, 2001, J BIOENERG BIOMEMBR, V33, P367, DOI 10.1023/A:1010611322024; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1857, DOI 10.1212/01.WNL.0000127310.11526.FD; Kamsteeg EJ, 2001, BIOCHEM BIOPH RES CO, V282, P683, DOI 10.1006/bbrc.2001.4629; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kaunisto MA, 2004, NEUROGENETICS, V5, P141, DOI 10.1007/s10048-004-0178-z; Koenderink JB, 2005, BBA-BIOMEMBRANES, V1669, P61, DOI 10.1016/j.bbamem.2005.01.003; Koenderink JB, 2003, J BIOL CHEM, V278, P51213, DOI 10.1074/jbc.M306384200; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Moseley AE, 2003, J BIOL CHEM, V278, P5317, DOI 10.1074/jbc.M211315200; Moskowitz MA, 2004, ANN NEUROL, V55, P276, DOI 10.1002/ana.20035; NAKAO M, 1986, NATURE, V323, P628, DOI 10.1038/323628a0; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; Peng L, 1997, J NEUROSCI, V17, P3488; Pierelli F, 2006, CEPHALALGIA, V26, P324, DOI 10.1111/j.1468-2982.2006.01002.x; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; POST RL, 1972, J BIOL CHEM, V247, P6530; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; RAKOWSKI RF, 1991, J MEMBRANE BIOL, V121, P177, DOI 10.1007/BF01870531; Riant F, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9361; Segall L, 2005, P NATL ACAD SCI USA, V102, P11106, DOI 10.1073/pnas.0504323102; Segall L, 2004, J BIOL CHEM, V279, P43692, DOI 10.1074/jbc.M407471200; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Spadaro M, 2004, NEUROGENETICS, V5, P177, DOI 10.1007/s10048-004-0183-2; Swoboda KJ, 2004, ANN NEUROL, V55, P884, DOI 10.1002/ana.20134; Thomsen LL, 2007, BRAIN, V130, P346, DOI 10.1093/brain/awl334; Todt U, 2005, HUM MUTAT, V26, P315, DOI 10.1002/humu.20229; Tonelli A, 2007, CLIN GENET, V72, P517, DOI 10.1111/j.1399-0004.2007.00892.x; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Vanmolkot Kaate R J, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9486; Vanmolkot KR, 2006, EUR J HUM GENET, V14, P555, DOI 10.1038/sj.ejhg.5201607; Vanmolkot KRJ, 2006, ANN NEUROL, V59, P310, DOI 10.1002/ana.20760; Vanmolkot KRJ, 2003, LANCET NEUROL, V2, P721, DOI 10.1016/S1474-4422(03)00591-X; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; WATTS AG, 1991, P NATL ACAD SCI USA, V88, P7425, DOI 10.1073/pnas.88.16.7425	47	62	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31097	31106		10.1074/jbc.M802771200	http://dx.doi.org/10.1074/jbc.M802771200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18728015	Green Published, hybrid			2022-12-25	WOS:000260544800064
J	Wolf, I; Levanon-Cohen, S; Bose, S; Ligumsky, H; Sredni, B; Kanety, H; Kuro-o, M; Karlan, B; Kaufman, B; Koeffler, HP; Rubinek, T				Wolf, I.; Levanon-Cohen, S.; Bose, S.; Ligumsky, H.; Sredni, B.; Kanety, H.; Kuro-o, M.; Karlan, B.; Kaufman, B.; Koeffler, H. P.; Rubinek, T.			Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer	ONCOGENE			English	Article						breast cancer; klotho; insulin; insulin growth factor-1; tumor suppressor	GROWTH-FACTOR CONFERS; ADIPOCYTE DIFFERENTIATION; MOLECULAR-CLONING; TRPV5 CHANNEL; C/EBP-BETA; CELLS; PROTEIN; MOUSE; ACTIVATION; INHIBITION	Klotho is an anti-aging gene, which has been shown to inhibit the insulin and insulin-like growth factor 1 (IGF-1) pathways in mice hepatocytes and myocytes. As IGF-1 and insulin regulate proliferation, survival and metastasis of breast cancer, we studied klotho expression and activities in human breast cancer. Immunohistochemistry analysis of klotho expression in breast tissue arrays revealed high klotho expression in normal breast samples, but very low expression in breast cancer. In cancer samples, high klotho expression was associated with smaller tumor size and reduced KI67 staining. Forced expression of klotho reduced proliferation of MCF-7 and MDA-MB-231 breast cancer cells, whereas klotho silencing in MCF-7 cells, which normally express klotho, enhanced proliferation. Moreover, forced expression of klotho in these cells, or treatment with soluble klotho, inhibited the activation of IGF-1 and insulin pathways, and induced upregulation of the transcription factor CCAAT/enhancer-binding protein beta, a breast cancer growth inhibitor that is negatively regulated by the IGF-1-AKT axis. Co-immunoprecipitation revealed an interaction between klotho and the IGF-1 receptor. Klotho is also a known modulator of the fibroblast growth factor (FGF) pathway, a pathway that inhibits proliferation of breast cancer cells. Studies in breast cancer cells revealed increased activation of the FGF pathway by basic FGF following klotho overexpression. Klotho did not affect activation of the epidermal growth factor pathway in breast cancer cells. These data suggest klotho as a potential tumor suppressor and identify it as an inhibitor of the IGF-1 pathway and activator of the FGF pathway in human breast cancer.	[Wolf, I.; Levanon-Cohen, S.; Ligumsky, H.; Kaufman, B.; Rubinek, T.] Chaim Sheba Med Ctr, Inst Oncol, IL-52621 Ramat Gan, Israel; [Wolf, I.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Levanon-Cohen, S.; Sredni, B.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Safdie Inst AIDS & Immunol Res, Ramat Gan, Israel; [Bose, S.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Dept Anat Pathol, Los Angeles, CA 90048 USA; [Kanety, H.] Chaim Sheba Med Ctr, Inst Endocrinol, Ramat Gan, Israel; [Kuro-o, M.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Karlan, B.] Womens Canc Res Inst, Dept Obstet & Gynecol, Los Angeles, CA USA; [Koeffler, H. P.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Chaim Sheba Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wolf, I (corresponding author), Chaim Sheba Med Ctr, Inst Oncol, IL-52621 Ramat Gan, Israel.	wolf-i@inter.net.il			United States-Israel Binational Science Foundation (BSF) Jerusalem, Israel; Koschitzky Family Foundation; Israel Cancer Association; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel; The Talpiot Medical Leadership Program, Sheba Medical Center; Inger Fund; Rountree Trust; Mary Barry Foundation; Women's Cancer Research Institute; Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center	United States-Israel Binational Science Foundation (BSF) Jerusalem, Israel(US-Israel Binational Science Foundation); Koschitzky Family Foundation; Israel Cancer Association; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel; The Talpiot Medical Leadership Program, Sheba Medical Center; Inger Fund; Rountree Trust; Mary Barry Foundation; Women's Cancer Research Institute; Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center	This research was supported in part by grants from the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel; Koschitzky Family Foundation; the Israel Cancer Association; the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel; The Talpiot Medical Leadership Program, Sheba Medical Center; the Inger Fund, Rountree Trust and the Mary Barry Foundation and by grants from the Women's Cancer Research Institute, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center. HPK is a member of the Molecular Biology Institute and Jonsson Comprehensive Cancer Center at UCLA and holds the endowed Mark Goodson Chair of Oncology Research at Cedars-Sinai Medical Center/UCLA School of Medicine. IW is the Mary Barry Medical Bridges Foundation Fellow.	Arking DE, 2003, AM J HUM GENET, V72, P1154, DOI 10.1086/375035; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Bartucci M, 2001, CANCER RES, V61, P6747; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chihara Y, 2006, ENDOCRINOLOGY, V147, P3835, DOI 10.1210/en.2005-1529; de Oliveira RM, 2006, FEBS LETT, V580, P5753, DOI 10.1016/j.febslet.2006.09.036; den Dekker E, 2003, CELL CALCIUM, V33, P497, DOI 10.1016/S0143-4160(03)00065-4; Fenig E, 2002, ONCOL REP, V9, P875; Fenig E, 1997, CLIN CANCER RES, V3, P135; GEIER A, 1995, CANCER INVEST, V13, P480, DOI 10.3109/07357909509024911; Gery S, 2005, CLIN CANCER RES, V11, P3184, DOI 10.1158/1078-0432.CCR-04-2625; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Haimsohn M, 2002, ENDOCRINOLOGY, V143, P837, DOI 10.1210/en.143.3.837; Haluska P, 2006, CANCER RES, V66, P362, DOI 10.1158/0008-5472.CAN-05-1107; Hsiung R, 2002, CANCER J, V8, P303, DOI 10.1097/00130404-200207000-00006; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Kim Y, 2006, NEUROSCI LETT, V407, P189, DOI 10.1016/j.neulet.2006.08.039; Korah RM, 2000, CANCER RES, V60, P733; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; URAKAWA I, 2006, SCIENCE, V444, P770; Utsugi T, 2000, METABOLISM, V49, P1118, DOI 10.1053/meta.2000.8606; Vandermoere F, 2005, ONCOGENE, V24, P5482, DOI 10.1038/sj.onc.1208713; Wolf I, 2007, INT J CANCER, V120, P1013, DOI 10.1002/ijc.22389; Wolf I, 2006, CANCER RES, V66, P7818, DOI 10.1158/0008-5472.CAN-05-4368; Wolf I, 2006, EUR J CANCER, V42, P1077, DOI 10.1016/j.ejca.2006.01.027; Yee D, 2006, BRIT J CANCER, V94, P465, DOI 10.1038/sj.bjc.6602963; Zarrabeitia MT, 2007, CALCIFIED TISSUE INT, V80, P10, DOI 10.1007/s00223-006-0233-x	41	216	229	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2008	27	56					7094	7105		10.1038/onc.2008.292	http://dx.doi.org/10.1038/onc.2008.292			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	376PQ	18762812				2022-12-25	WOS:000261195900004
J	Du, JQ; Wu, J; Zhang, HJ; Zhang, YH; Qiu, BY; Wu, F; Chen, YH; Li, JY; Nan, FJ; Ding, JP; Li, J				Du, Jun-Qing; Wu, Jian; Zhang, Hua-Jie; Zhang, Ya-Hui; Qiu, Bei-Ying; Wu, Fang; Chen, Yi-Hua; Li, Jing-Ya; Nan, Fa-Jun; Ding, Jian-Ping; Li, Jia			Isoquinoline-1,3,4-trione Derivatives Inactivate Caspase-3 by Generation of Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE NONPEPTIDE INHIBITORS; HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; LIPOIC ACID; POTENT; CELLS; SPECIFICITY; DISCOVERY; OXIDATION; FEATURES	Caspase-3 is an attractive therapeutic target for treatment of diseases involving disregulated apoptosis. We report here the mechanism of caspase-3 inactivation by isoquinoline-1,3,4-trione derivatives. Kinetic analysis indicates the compounds can irreversibly inactivate caspase-3 in a 1,4-dithiothreitol (DTT)- and oxygen-dependent manner, implying that a redox cycle might take place in the inactivation process. Reactive oxygen species detection experiments using a chemical indicator, together with electron spin resonance measurement, suggest that ROS can be generated by reaction of isoquinoline-1,3,4-trione derivatives with DTT. Oxygen-free radical scavenger catalase and superoxide dismutase eliciting the inactivation of caspase-3 by the inhibitors confirm that ROS mediates the inactivation process. Crystal structures of caspase-3 in complexes with isoquinoline-1,3,4-trione derivatives show that the catalytic cysteine is oxidized to sulfonic acid (-SO3H) and isoquinoline-1,3,4-trione derivatives are bound at the dimer interface of caspase-3. Further mutagenesis study shows that the binding of the inhibitors with caspase-3 appears to be nonspecific. Isoquinoline-1,3,4-trione derivative-catalyzed caspase-3 inactivation could also be observed when DTT is substituted with dihydrolipoic acid, which exists widely in cells and might play an important role in the in vivo inactivation process in which the inhibitors inactivate caspase-3 in cells and then prevent the cells from apoptosis. These results provide valuable information for further development of small molecular inhibitors against caspase-3 or other oxidation-sensitive proteins.	[Du, Jun-Qing; Zhang, Hua-Jie; Zhang, Ya-Hui; Qiu, Bei-Ying; Wu, Fang; Chen, Yi-Hua; Li, Jing-Ya; Nan, Fa-Jun; Li, Jia] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Chinese Natl Ctr Drug Screening, 189 Guo Shou Jing Rd,Zhangjiang Hi Tech Pk, Shanghai 201203, Peoples R China; [Wu, Jian; Ding, Jian-Ping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Wu, Jian; Ding, Jian-Ping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Res Ctr Struct Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Nan, FJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Chinese Natl Ctr Drug Screening, 189 Guo Shou Jing Rd,Zhangjiang Hi Tech Pk, Shanghai 201203, Peoples R China.	fjnan@mail.shcnc.ac.cn; jpding@sibs.ac.cn; jli@mail.shcnc.ac.cn	Li, Jia/F-9116-2011; li, jia/GVT-7587-2022; Chen, Yihua/A-4323-2013; Chen, Yihua/O-2743-2019; Du, Junqing/B-7803-2016	Chen, Yihua/0000-0003-1733-7980; Chen, Yihua/0000-0003-1733-7980; Du, Junqing/0000-0001-7449-1170	Ministry of Science and Technology of China [2006AA02Z112, 2006AA02A313]; National Natural Science Foundation of China [90713046, 20730028]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by Ministry of Science and Technology of China Grants 2006AA02Z112 and 2006AA02A313 and National Natural Science Foundation of China Grants 90713046 and 20730028. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Afzal M, 2003, BIOCHEM BIOPH RES CO, V304, P619, DOI 10.1016/S0006-291X(03)00641-7; Agniswamy J, 2007, FEBS J, V274, P4752, DOI 10.1111/j.1742-4658.2007.05994.x; Becker JW, 2004, J MED CHEM, V47, P2466, DOI 10.1021/jm0305523; Borutaite V, 2001, FEBS LETT, V500, P114, DOI 10.1016/S0014-5793(01)02593-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Byun CH, 2005, J BONE MINER RES, V20, P1125, DOI 10.1359/JBMR.050302; Chen YH, 2006, J MED CHEM, V49, P1613, DOI 10.1021/jm050896o; Chu WH, 2005, J MED CHEM, V48, P7637, DOI 10.1021/jm0506625; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Copeland R. A., 2005, EVALUATION ENZYME IN; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Guertin KR, 2003, BIOORG MED CHEM LETT, V13, P2895, DOI 10.1016/S0960-894X(03)00623-1; Guo ZM, 2001, BIOORGAN MED CHEM, V9, P99, DOI 10.1016/S0968-0896(00)00222-4; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HENSON CP, 1964, BIOCHEMISTRY-US, V3, P338, DOI 10.1021/bi00891a007; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kravchenko DV, 2005, J MED CHEM, V48, P3680, DOI 10.1021/jm048987t; Lal M, 1997, J AM CHEM SOC, V119, P5735, DOI 10.1021/ja970744l; Lee D, 2001, J MED CHEM, V44, P2015, DOI 10.1021/jm0100537; Lee D, 2000, J BIOL CHEM, V275, P16007, DOI 10.1074/jbc.275.21.16007; Lee Y, 1999, J BIOL CHEM, V274, P19792, DOI 10.1074/jbc.274.28.19792; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Mottley C, 2001, J BIOL CHEM, V276, P42677, DOI 10.1074/jbc.M104889200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Nobel CSI, 1997, CHEM RES TOXICOL, V10, P1319, DOI 10.1021/tx970131m; Okun I, 2006, J BIOMOL SCREEN, V11, P694, DOI 10.1177/1087057106289231; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Packer L, 2001, NUTRITION, V17, P888, DOI 10.1016/S0899-9007(01)00658-X; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Samali A, 1999, BIOCHEM BIOPH RES CO, V255, P6, DOI 10.1006/bbrc.1998.0139; Scott CW, 2003, J PHARMACOL EXP THER, V304, P433, DOI 10.1124/jpet.102.039651; Smith GK, 2002, ARCH BIOCHEM BIOPHYS, V399, P195, DOI 10.1006/abbi.2002.2757; Stefan C, 1997, CHEM RES TOXICOL, V10, P636, DOI 10.1021/tx970006a; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TRAYNER ID, 1995, J IMMUNOL METHODS, V186, P275, DOI 10.1016/0022-1759(95)00152-Z; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Wang QP, 2004, BIOCHEMISTRY-US, V43, P4294, DOI 10.1021/bi035986e; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Zhang YH, 2006, FEBS J, V273, P4842, DOI 10.1111/j.1742-4658.2006.05483.x	49	50	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30205	30215		10.1074/jbc.M803347200	http://dx.doi.org/10.1074/jbc.M803347200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768468	Green Published, hybrid			2022-12-25	WOS:000260366900065
J	Mio, K; Ogura, T; Mio, M; Shimizu, H; Hwang, TC; Sato, C; Sohma, Y				Mio, Kazuhiro; Ogura, Toshihiko; Mio, Muneyo; Shimizu, Hiroyasu; Hwang, Tzyh-Chang; Sato, Chikara; Sohma, Yoshiro			Three-dimensional Reconstruction of Human Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Revealed an Ellipsoidal Structure with Orifices beneath the Putative Transmembrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATIC PARTICLE PICKUP; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; NUCLEOTIDE-BINDING; PLASMA-MEMBRANE; FUNCTIONAL UNIT; NEURAL-NETWORK; CFTR; PORE; PURIFICATION	The cystic fibrosis transmembrane conductance regulator ( CFTR) chloride channel is a membrane-integral protein that belongs to an ATP-binding cassette superfamily. Mutations in the CFTR gene cause cystic fibrosis in which salt, water, and protein transports are defective in various tissues. Here we expressed wild-type human CFTR as a FLAG-fused protein in HEK293 cells heterologously and purified it in three steps: anti-FLAG and wheat germ agglutinin affinity chromatographies and size exclusion chromatography. The stoichiometry of the protein was analyzed using various biochemical approaches, including chemical cross-linking, blue-native PAGE, size exclusion chromatography, and electron microscopy ( EM) observation of antibody-decorated CFTR. All these data support a dimeric assembly of CFTR. Using 5,039 automatically selected particles from negatively stained EM images, the three-dimensional structure of CFTR was reconstructed at 2-nm resolution assuming a 2-fold symmetry. CFTR, presumably in a closed state, was shown to be an ellipsoidal particle with dimensions of 120 x 106 x 162 angstrom. It comprises a small dome-shaped extracellular and membrane-spanning domain and a large cytoplasmic domain with orifices beneath the putative transmembrane domain. EM observation of CFTR.anti-regulatory domain antibody complex confirmed that two regulatory domains are located around the bottom end of the larger oval cytoplasmic domain.	[Mio, Kazuhiro; Ogura, Toshihiko; Mio, Muneyo; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Ogura, Toshihiko] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan; [Shimizu, Hiroyasu; Hwang, Tzyh-Chang; Sohma, Yoshiro] Univ Missouri, John M Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Shimizu, Hiroyasu] Osaka Med Coll, Dept Hyg & Publ Hlth, Osaka 5698686, Japan; [Sohma, Yoshiro] Osaka Med Coll, Dept Physiol, Osaka 5698686, Japan; [Sohma, Yoshiro] Keio Univ, Sch Med, Dept Pharmacol, Shinjyuku Ku, Tokyo 1608582, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); University of Missouri System; University of Missouri Columbia; Osaka Medical College; Osaka Medical College; Keio University	Sato, C (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Umezono 1-1-4, Tsukuba, Ibaraki 3058568, Japan.	ti-sato@aist.go.jp	Sohma, Yoshiro/K-9058-2013; Mio, Kazuhiro/L-7488-2018; Sato, Chikara/M-7183-2016; Ogura, Toshihiko/M-4089-2018	Mio, Kazuhiro/0000-0002-1655-8231; Sato, Chikara/0000-0001-5543-4496; 	National Institutes of Health [R01 DK55835-09, R01 HL53445-11]; Japan New Energy and Industrial Technology Development Organization (NEDO); Japan Science and Technology Agency; Japan Society for the Promotion of Science (JSPS) [19590215]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK55835-09 and R01 HL53445-11 (to T.-C. H.). This work was also supported by a grant-in-aid for scientific research on priority areas, structure of biological macromolecular assemblies ( to K. M. and C. S.); by a grant from the Japan New Energy and Industrial Technology Development Organization (NEDO) (to C. S.); by a grant from PRESTO of the Japan Science and Technology Agency (to T. O.); and by Japan Society for the Promotion of Science (JSPS) Grant 19590215 (to Y. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Awayn NH, 2005, BIOCHEM SOC T, V33, P996, DOI 10.1042/BST0330996; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Bhattacharya S K, 1995, J Indian Med Assoc, V93, P237; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Bompadre SG, 2005, J GEN PHYSIOL, V125, P377, DOI 10.1085/jgp.200409228; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Chen JH, 2002, J MEMBRANE BIOL, V188, P55, DOI 10.1007/s00232-001-0174-2; Chen TY, 2008, PHYSIOL REV, V88, P351, DOI 10.1152/physrev.00058.2006; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Frank J, 2006, 3 DIMENSIONAL ELECT; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Gadsby David C., 1999, Physiological Reviews, V79, pS77; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HARAUZ G, 1986, OPTIK, V73, P146; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; O'Riordan CR, 2000, GLYCOBIOLOGY, V10, P1225, DOI 10.1093/glycob/10.11.1225; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2001, J STRUCT BIOL, V136, P227, DOI 10.1006/jsbi.2002.4442; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Ramjeesingh M, 2001, BIOCHEMISTRY-US, V40, P10700, DOI 10.1021/bi0108195; RIORDAN JR, 1989, SCIENCE, V245, P1066; RIORDAN JR, 2005, ANNU REV PHYSIOL, V68, P809; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schillers H, 2004, CELL PHYSIOL BIOCHEM, V14, P1, DOI 10.1159/000076921; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; STECK T L, 1973, Journal of Supramolecular Structure, V1, P220, DOI 10.1002/jss.400010307; Tsui LC, 1997, HOSP PRACT, V32, P115, DOI 10.1080/21548331.1997.11443512; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Zerhusen B, 1999, J BIOL CHEM, V274, P7627, DOI 10.1074/jbc.274.12.7627; Zhang ZR, 2005, J BIOL CHEM, V280, P458, DOI 10.1074/jbc.M409626200; Zhou Z, 2005, J PHYSIOL-LONDON, V569, P447, DOI 10.1113/jphysiol.2005.095083; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	56	35	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30300	30310		10.1074/jbc.M803185200	http://dx.doi.org/10.1074/jbc.M803185200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723516	Green Published, hybrid			2022-12-25	WOS:000260366900074
J	Mastroianni, M; Watanabe, K; White, TB; Zhuang, FL; Vernon, J; Matsuura, M; Wallingford, J; Lambowitz, AM				Mastroianni, Marta; Watanabe, Kazuo; White, Travis B.; Zhuang, Fanglei; Vernon, Jamie; Matsuura, Manabu; Wallingford, John; Lambowitz, Alan M.			Group II Intron-Based Gene Targeting Reactions in Eukaryotes	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; RNA; RECOMBINATION; PROTEIN; ENDONUCLEASE; MANIPULATION; MUTAGENESIS; INTEGRATION; RECOGNITION; DROSOPHILA	Background: Mobile group II introns insert site-specifically into DNA target sites by a mechanism termed retrohoming in which the excised intron RNA reverse splices into a DNA strand and is reverse transcribed by the intron-encoded protein. Retrohoming is mediated by a ribonucleoprotein particle that contains the intron-encoded protein and excised intron RNA, with target specificity determined largely by base pairing of the intron RNA to the DNA target sequence. This feature enabled the development of mobile group II introns into bacterial gene targeting vectors ("targetrons'') with programmable target specificity. Thus far, however, efficient group II intron-based gene targeting reactions have not been demonstrated in eukaryotes. Methodology/Principal Findings: By using a plasmid-based Xenopus laevis oocyte microinjection assay, we show that group II intron RNPs can integrate efficiently into target DNAs in a eukaryotic nucleus, but the reaction is limited by low Mg2+ concentrations. By supplying additional Mg2+, site-specific integration occurs in up to 38% of plasmid target sites. The integration products isolated from X. laevis nuclei are sensitive to restriction enzymes specific for double-stranded DNA, indicating second-strand synthesis via host enzymes. We also show that group II intron RNPs containing either lariat or linear intron RNA can introduce a double-strand break into a plasmid target site, thereby stimulating homologous recombination with a co-transformed DNA fragment at frequencies up to 4.8% of target sites. Chromatinization of the target DNA inhibits both types of targeting reactions, presumably by impeding RNP access. However, by using similar RNP microinjection methods, we show efficient Mg2+-dependent group II intron integration into plasmid target sites in zebrafish (Danio rerio) embryos and into plasmid and chromosomal target sites in Drosophila melanogster embryos, indicating that DNA replication can mitigate effects of chromatinization. Conclusions/Significance: Our results provide an experimental foundation for the development of group II intron-based gene targeting methods for higher organisms.	[Mastroianni, Marta; Watanabe, Kazuo; White, Travis B.; Zhuang, Fanglei; Vernon, Jamie; Matsuura, Manabu; Wallingford, John; Lambowitz, Alan M.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Mastroianni, M (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	lambowitz@mail.utexas.edu		White, Travis/0000-0002-0069-5987	NIH [GM037949, HD054349]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104, R01GM037949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM037949 and HD054349.	Aizawa Y, 2003, MOL CELL, V11, P795, DOI 10.1016/S1097-2765(03)00069-8; Anderson WF, 1998, NATURE, V392, P25; Baum C, 2004, MOL THER, V9, P5, DOI 10.1016/j.ymthe.2003.10.013; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Bibikova M, 2002, GENETICS, V161, P1169; Bojanowski K, 1998, EXP CELL RES, V244, P286, DOI 10.1006/excr.1998.4205; Bunz F, 2002, CURR OPIN ONCOL, V14, P73, DOI 10.1097/00001622-200201000-00013; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2; Carroll D, 1996, PROG NUCLEIC ACID RE, V54, P101, DOI 10.1016/S0079-6603(08)60361-X; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; CAZENAVE C, 1994, J BIOL CHEM, V269, P25185; Chen Y, 2005, APPL ENVIRON MICROB, V71, P7542, DOI 10.1128/AEM.71.11.7542-7547.2005; Cousineau B, 1998, CELL, V94, P451, DOI 10.1016/S0092-8674(00)81586-X; Cui XX, 2004, J MOL BIOL, V340, P211, DOI 10.1016/j.jmb.2004.05.004; Daniels DL, 1996, J MOL BIOL, V256, P31, DOI 10.1006/jmbi.1996.0066; Dickson L, 2004, GENETICS, V168, P77, DOI 10.1534/genetics.104.027003; DION AS, 1967, P NATL ACAD SCI USA, V58, P2367, DOI 10.1073/pnas.58.6.2367; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Eskes R, 2000, MOL CELL BIOL, V20, P8432, DOI 10.1128/MCB.20.22.8432-8446.2000; Eskes R, 1997, CELL, V88, P865, DOI 10.1016/S0092-8674(00)81932-7; Fedorova O, 2002, METHODS, V28, P323, DOI 10.1016/S1046-2023(02)00239-6; Frazier CL, 2003, APPL ENVIRON MICROB, V69, P1121, DOI 10.1128/AEM.69.2.1121-1128.2003; Granlund M, 2001, J BACTERIOL, V183, P2560, DOI 10.1128/JB.183.8.2560-2569.2001; Gregan J, 2001, MOL GEN GENET, V264, P773, DOI 10.1007/s004380000366; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452; Guo HT, 1997, EMBO J, V16, P6835, DOI 10.1093/emboj/16.22.6835; Hagedorn M, 1998, BIOL REPROD, V59, P1240, DOI 10.1095/biolreprod59.5.1240; Handwerger KE, 2002, J CELL SCI, V115, P2011; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Jones JP, 2005, MOL THER, V11, P687, DOI 10.1016/j.ymthe.2005.01.014; Karberg M, 2001, NAT BIOTECHNOL, V19, P1162, DOI 10.1038/nbt1201-1162; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Marshall E, 2002, SCIENCE, V298, P34, DOI 10.1126/science.298.5591.34; MAZUR P, 1988, CRYOBIOLOGY, V25, P510, DOI 10.1016/0011-2240(88)90305-7; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; MICHELS WJ, 1995, BIOCHEMISTRY-US, V34, P2965, DOI 10.1021/bi00009a028; Minden J, 1999, ADV MOLEC BIOL, P471; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Mohr G, 2000, GENE DEV, V14, P559; MORL M, 1990, CELL, V60, P629, DOI 10.1016/0092-8674(90)90666-3; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Podar M, 1998, NATURE, V391, P915, DOI 10.1038/36142; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Pyle AM, 2006, COLD SPRING HARB MON, V43, P469; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Rodriguez SA, 2008, APPL ENVIRON MICROB, V74, P2619, DOI 10.1128/AEM.02905-07; Romani AMP, 2002, BIOMETALS, V15, P271, DOI 10.1023/A:1016082900838; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325; Saldanha R, 1999, BIOCHEMISTRY-US, V38, P9069, DOI 10.1021/bi982799l; San Filippo J, 2002, J MOL BIOL, V324, P933, DOI 10.1016/S0022-2836(02)01147-6; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; SEGAL DJ, 1995, P NATL ACAD SCI USA, V92, P806, DOI 10.1073/pnas.92.3.806; Shao L, 2007, CELL RES, V17, P963, DOI 10.1038/cr.2007.91; Singh NN, 2001, J MOL BIOL, V309, P361, DOI 10.1006/jmbi.2001.4658; Smith D, 2005, GENE DEV, V19, P2477, DOI 10.1101/gad.1345105; STEINBERG M, 1957, CARNEGIE I WASHINGTO, V56, P347; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Vogel J, 2002, EMBO J, V21, P3794, DOI 10.1093/emboj/cdf359; Westerfield M., 2000, GUIDE LAB USE ZEBRAF; WIESENBERGER G, 1992, J BIOL CHEM, V267, P6963; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Yao J, 2006, RNA, V12, P1271, DOI 10.1261/rna.68706	73	39	69	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3121	10.1371/journal.pone.0003121	http://dx.doi.org/10.1371/journal.pone.0003121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769669	Green Published, Green Submitted, gold			2022-12-25	WOS:000264416600009
J	Zhang, QJ; Li, XL; Wang, D; Huang, XC; Mathis, JM; Duan, WM; Knight, D; Shi, R; Glass, J; Zhang, DQ; Eisenbach, L; Jefferies, WA				Zhang, Qian-Jin; Li, Xiao-Lin; Wang, David; Huang, Xiao-Cong; Mathis, J. Michael; Duan, Wei-Ming; Knight, David; Shi, Runhua; Glass, Jonathan; Zhang, Dong-Qing; Eisenbach, Lea; Jefferies, Wilfred A.			Trogocytosis of MHC-I/Peptide Complexes Derived from Tumors and Infected Cells Enhances Dendritic Cell Cross-Priming and Promotes Adaptive T Cell Responses	PLOS ONE			English	Article								The transporter associated with antigen processing ( TAP) and the major histocompatibility complex class I (MHC-I), two important components of the MHC-I antigen presentation pathway, are often deficient in tumor cells. The restoration of their expression has been shown to restore the antigenicity and immunogenicity of tumor cells. However, it is unclear whether TAP and MHC-I expression in tumor cells can affect the induction phase of the T cell response. To address this issue, we expressed viral antigens in tumors that are either deficient or proficient in TAP and MHC-I expression. The relative efficiency of direct immunization or immunization through cross-presentation in promoting adaptive T cell responses was compared. The results demonstrated that stimulation of animals with TAP and MHC-I proficient tumor cells generated antigen specific T cells with greater killing activities than those of TAP and MHC-I deficient tumor cells. This discrepancy was traced to differences in the ability of dendritic cells (DCs) to access and sample different antigen reservoirs in TAP and MHC-I proficient versus deficient cells and thereby stimulate adaptive immune responses through the process of cross-presentation. In addition, our data suggest that the increased activity of T cells is caused by the enhanced DC uptake and utilization of MHC-I/peptide complexes from the proficient cells as an additional source of processed antigen. Furthermore, we demonstrate that immune-escape and metastasis are promoted in the absence of this DC 'arming' mechanism. Physiologically, this novel form of DC antigen sampling resembles trogocytosis, and acts to enhance T cell priming and increase the efficacy of adaptive immune responses against tumors and infectious pathogens.	[Zhang, Qian-Jin; Li, Xiao-Lin; Wang, David; Huang, Xiao-Cong; Mathis, J. Michael; Duan, Wei-Ming; Knight, David; Shi, Runhua; Glass, Jonathan] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Dept Cellular Biol & Anat,Gene Therapy Program, Shreveport, LA 71105 USA; [Zhang, Dong-Qing] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China; [Eisenbach, Lea] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Microbiol & Immunol & Zool, Biomed Res Ctr, Michael Smith Lab, Vancouver, BC V5Z 1M9, Canada	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Shanghai Jiao Tong University; Weizmann Institute of Science; University of British Columbia	Zhang, QJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Dept Cellular Biol & Anat,Gene Therapy Program, Shreveport, LA 71105 USA.	qzhang@lsuhsc.edu	; Mathis, J. Michael/J-1379-2018	Eisenbach, Lea R/0000-0002-4816-1968; Mathis, J. Michael/0000-0001-5528-5195	Louisiana Board of Regents; Feist-Weiller Cancer Center; Louisiana State Gene Therapy Program; Department of Cellular Biology & Anatomy at LSU Health Sciences Center-Shreveport; National Natural Science Foundation of China; Shanghai Commission of Science and Technology [07JC14033]; Shanghai Leading Academic Discipline Project [T0206]; CIHR; PCRF	Louisiana Board of Regents; Feist-Weiller Cancer Center; Louisiana State Gene Therapy Program; Department of Cellular Biology & Anatomy at LSU Health Sciences Center-Shreveport; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); CIHR(Canadian Institutes of Health Research (CIHR)); PCRF	This work was supported by Louisiana Board of Regents, Feist-Weiller Cancer Center, Louisiana State Gene Therapy Program and Department of Cellular Biology & Anatomy at LSU Health Sciences Center-Shreveport. Dr. Dong-Qing Zhang is supported by National Natural Science Foundation of China (No., No.), Shanghai Commission of Science and Technology (No. 07JC14033) and Shanghai Leading Academic Discipline Project (T0206). Dr. Wilfred A. Jefferies is supported by CIHR and PCRF.	Agrawal S, 2004, CELL IMMUNOL, V228, P130, DOI 10.1016/j.cellimm.2004.04.006; Alimonti J, 2000, NAT BIOTECHNOL, V18, P515, DOI 10.1038/75373; Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; BACIK I, 1994, J IMMUNOL, V152, P381; Bullock TNJ, 2003, J IMMUNOL, V170, P1822, DOI 10.4049/jimmunol.170.4.1822; Bullock TNJ, 2000, J IMMUNOL, V164, P2354, DOI 10.4049/jimmunol.164.5.2354; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chiang EY, 2003, J IMMUNOL, V170, P4515, DOI 10.4049/jimmunol.170.9.4515; Dai Jie, 2003, Cancer Immun, V3, P1; Evans M, 2001, J IMMUNOL, V167, P5420, DOI 10.4049/jimmunol.167.9.5420; Gabathuler R, 1998, J CELL BIOL, V140, P17, DOI 10.1083/jcb.140.1.17; GABATHULER R, 1994, J EXP MED, V180, P1415, DOI 10.1084/jem.180.4.1415; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Herrera OB, 2004, J IMMUNOL, V173, P4828, DOI 10.4049/jimmunol.173.8.4828; Hoffmann TK, 2006, INT J CANCER, V118, P1984, DOI 10.1002/ijc.21565; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Hudrisier D, 2005, EUR J IMMUNOL, V35, P2284, DOI 10.1002/eji.200526266; Hudrisier D, 2002, ELSO GAZ, V9, P1; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JEFFERIES WA, 1993, J IMMUNOL, V151, P2974; Johnsen AK, 1999, J IMMUNOL, V163, P4224; Kallfelz M, 1999, INT J CANCER, V81, P125, DOI 10.1002/(SICI)1097-0215(19990331)81:1<125::AID-IJC21>3.0.CO;2-2; LEVITSKY HI, 1994, J EXP MED, V179, P1215, DOI 10.1084/jem.179.4.1215; Li ZH, 2002, FRONT BIOSCI-LANDMRK, V7, pD731; LI ZH, 1994, CHINESE CARLIN TYPE, P37; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Lou YM, 2005, CANCER RES, V65, P7926, DOI 10.1158/0008-5472.CAN-04-3977; Momburg F, 1998, ADV IMMUNOL, V68, P191, DOI 10.1016/S0065-2776(08)60560-X; Noessner E, 2002, J IMMUNOL, V169, P5424, DOI 10.4049/jimmunol.169.10.5424; PLAKSIN D, 1988, P NATL ACAD SCI USA, V85, P4463, DOI 10.1073/pnas.85.12.4463; Ronchetti A, 1999, J IMMUNOL, V163, P130; ROWE M, 1995, EUR J IMMUNOL, V25, P1374, DOI 10.1002/eji.1830250536; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; Ueda G, 2004, CANCER SCI, V95, P248, DOI 10.1111/j.1349-7006.2004.tb02211.x; Vitalis TZ, 2005, PLOS PATHOG, V1, P289, DOI 10.1371/journal.ppat.0010036; Zhang Q. J., 2007, INT J CANC; Zhang QJ, 2000, J IMMUNOL, V164, P4513, DOI 10.4049/jimmunol.164.9.4513	43	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3097	10.1371/journal.pone.0003097	http://dx.doi.org/10.1371/journal.pone.0003097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769733	gold, Green Submitted, Green Published			2022-12-25	WOS:000264796800004
J	Adekar, SP; Takahashi, T; Jones, RM; Al-Saleem, FH; Ancharski, DM; Root, MJ; Kapadnis, BP; Simpson, LL; Dessain, SK				Adekar, Sharad P.; Takahashi, Tsuyoshi; Jones, R. Mark; Al-Saleem, Fetweh H.; Ancharski, Denise M.; Root, Michael J.; Kapadnis, B. P.; Simpson, Lance L.; Dessain, Scott K.			Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain	PLOS ONE			English	Article								Background: Botulinum neurotoxins (BoNT) are a family of category A select bioterror agents and the most potent biological toxins known. Cloned antibody therapeutics hold considerable promise as BoNT therapeutics, but the therapeutic utility of antibodies that bind the BoNT light chain domain (LC), a metalloprotease that functions in the cytosol of cholinergic neurons, has not been thoroughly explored. Methods and Findings: We used an optimized hybridoma method to clone a fully human antibody specific for the LC of serotype A BoNT (BoNT/A). The 4LCA antibody demonstrated potent in vivo neutralization when administered alone and collaborated with an antibody specific for the HC. In Neuro-2a neuroblastoma cells, the 4LCA antibody prevented the cleavage of the BoNT/A proteolytic target, SNAP-25. Unlike an antibody specific for the HC, the 4LCA antibody did not block entry of BoNT/A into cultured cells. Instead, it was taken up into synaptic vesicles along with BoNT/A. The 4LCA antibody also directly inhibited BoNT/A catalytic activity in vitro. Conclusions: An antibody specific for the BoNT/A LC can potently inhibit BoNT/A in vivo and in vitro, using mechanisms not previously associated with BoNT-neutralizing antibodies. Antibodies specific for BoNT LC may be valuable components of an antibody antidote for BoNT exposure.	[Adekar, Sharad P.; Dessain, Scott K.] Lankenau Inst Med Res, Wynnewood, PA USA; [Takahashi, Tsuyoshi; Al-Saleem, Fetweh H.; Ancharski, Denise M.; Simpson, Lance L.] Thomas Jefferson Univ, Div Infect Dis & Environm Med, Philadelphia, PA USA; [Jones, R. Mark; Root, Michael J.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA USA; [Kapadnis, B. P.] Univ Pune, Dept Microbiol, Pune, Maharashtra, India	Lankenau Medical Center; Lankenau Institute for Medical Research; Jefferson University; Jefferson University; Savitribai Phule Pune University	Adekar, SP (corresponding author), Lankenau Inst Med Res, Wynnewood, PA USA.	dessains@mlhs.org	Al-Saleem, Fetweh/AAE-4264-2019		National Institutes of Health [R01-AI065967]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health grant R01-AI065967.	Adekar SP, 2008, J IMMUNOL METHODS, V333, P156, DOI 10.1016/j.jim.2008.01.015; Adekar SP, 2008, HYBRIDOMA, V27, P11, DOI 10.1089/hyb.2007.0536; [Anonymous], 2004, TXB PEDIAT INFECT DI; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bagramyan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002041; Baldwin MR, 2004, PROTEIN EXPRES PURIF, V37, P187, DOI 10.1016/j.pep.2004.05.009; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Boldt GE, 2006, J COMB CHEM, V8, P513, DOI 10.1021/cc060010h; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; *CAL DEP HLTH SERV, 2003, BOT IMM GLOB INTR HU; CAMPBELL MJ, 1992, MOL IMMUNOL, V29, P193, DOI 10.1016/0161-5890(92)90100-C; Coronella JA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e85; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; Dessain SK, 2004, J IMMUNOL METHODS, V291, P109, DOI 10.1016/j.jim.2004.05.005; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; Krautz-Peterson G, 2008, INFECT IMMUN, V76, P1931, DOI 10.1128/IAI.01282-07; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Marks JD, 2004, MOVEMENT DISORD, V19, pS101, DOI 10.1002/mds.20023; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Ravichandran E, 2006, J PHARMACOL EXP THER, V318, P1343, DOI 10.1124/jpet.106.104661; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; URASHIMA M, 1995, BLOOD, V85, P1903, DOI 10.1182/blood.V85.7.1903.bloodjournal8571903; Verderio C, 2006, EMBO REP, V7, P995, DOI 10.1038/sj.embor.7400796; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Xie L, 2005, J IMMUNOL METHODS, V304, P1, DOI 10.1016/j.jim.2005.04.009	33	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3023	10.1371/journal.pone.0003023	http://dx.doi.org/10.1371/journal.pone.0003023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714390	Green Submitted, Green Published, gold			2022-12-25	WOS:000264420900045
J	Catron, DJ; Noor, MAF				Catron, Daniel J.; Noor, Mohamed A. F.			Gene Expression Disruptions of Organism versus Organ in Drosophila Species Hybrids	PLOS ONE			English	Article								Hybrid dysfunctions, such as sterility, may result in part from disruptions in the regulation of gene expression. Studies of hybrids within the Drosophila simulans clade have reported genes expressed above or below the expression observed in their parent species, and such misexpression is associated with male sterility in multigenerational backcross hybrids. However, these studies often examined whole bodies rather than testes or had limited replication using less-sensitive but global techniques. Here, we use a new RNA isolation technique to re-examine hybrid gene expression disruptions in both testes and whole bodies from single Drosophila males by real-time quantitative RT-PCR. We find two early-spermatogenesis transcripts are underexpressed in hybrid whole-bodies but not in assays of testes alone, while two late-spermatogenesis transcripts seem to be underexpressed in both whole-bodies and testes alone. Although the number of transcripts surveyed is limited, these results provide some support for a previous hypothesis that the spermatogenesis pathway in these sterile hybrids may be disrupted sometime after the expression of the early meiotic arrest genes.	[Catron, Daniel J.; Noor, Mohamed A. F.] Duke Univ, Dept Biol, Durham, NC 27710 USA	Duke University	Catron, DJ (corresponding author), Duke Univ, Dept Biol, Durham, NC 27710 USA.	NOOR@DUKE.EDU		Noor, Mohamed/0000-0002-5400-4408	National Science Foundation [0509780, 0715484]; National Institutes of Health [GM076051]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076051] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this research was provided by National Science Foundation grants 0509780 and 0715484 and National Institutes of Health grant GM076051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artieri CG, 2007, J MOL EVOL, V65, P697, DOI 10.1007/s00239-007-9048-2; Barbash DA, 2007, J EXP ZOOL PART B, V308B, P74, DOI 10.1002/jez.b.21128; Bertucci Lisa A., 2001, Drosophila Information Service, V84, P166; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Fuller MT, 1998, SEMIN CELL DEV BIOL, V9, P433, DOI 10.1006/scdb.1998.0227; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; Ginsberg SD, 2005, METHODS, V37, P229, DOI 10.1016/j.ymeth.2005.09.003; Haerty W, 2006, MOL BIOL EVOL, V23, P1707, DOI 10.1093/molbev/msl033; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Jiang JQ, 2003, DEVELOPMENT, V130, P563, DOI 10.1242/dev.00246; Johnson NA, 2000, J THEOR BIOL, V205, P527, DOI 10.1006/jtbi.2000.2070; Johnson NA, 2007, GENETICA, V129, P57, DOI 10.1007/s10709-006-0033-2; Lin David M., 2007, V399, P133, DOI 10.1007/978-1-59745-504-6_10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malone JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000781; McDermott SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002442; Michalak P, 2003, MOL BIOL EVOL, V20, P1070, DOI 10.1093/molbev/msg119; Michalak P, 2004, J MOL EVOL, V59, P277, DOI 10.1007/s00239-004-2622-y; Michalak P, 2008, GENE, V416, P61, DOI 10.1016/j.gene.2008.03.006; Michalak P, 2008, GENOMICS, V91, P158, DOI 10.1016/j.ygeno.2007.10.013; Moehring AJ, 2007, MOL BIOL EVOL, V24, P137, DOI 10.1093/molbev/msl142; Noor MAF, 2005, GENET RES, V85, P119, DOI 10.1017/S0016672305007500; Ortiz-Barrientos D, 2007, GENETICA, V129, P71, DOI 10.1007/s10709-006-0034-1; PEREZ DE, 1993, GENETICS, V134, P261; Porter AH, 2002, EVOLUTION, V56, P2103; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Ranz JM, 2004, GENOME RES, V14, P373, DOI 10.1101/gr.2019804; Rottscheidt R, 2007, GENETICS, V177, P1553, DOI 10.1534/genetics.107.076190; SCHARTL M, 1995, TRENDS GENET, V11, P185, DOI 10.1016/S0168-9525(00)89041-1; Schartl M, 1999, GENETICS, V153, P1385; White-Cooper H, 2000, DEVELOPMENT, V127, P5463; Wu C. I., 1992, MOL PALEOPOPULATION, P191	33	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3009	10.1371/journal.pone.0003009	http://dx.doi.org/10.1371/journal.pone.0003009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714377	gold, Green Published			2022-12-25	WOS:000264420900034
J	Kostarakos, K; Hartbauer, M; Romer, H				Kostarakos, Konstantinos; Hartbauer, Manfred; Roemer, Heiner			Matched Filters, Mate Choice and the Evolution of Sexually Selected Traits	PLOS ONE			English	Article								Background: Fundamental for understanding the evolution of communication systems is both the variation in a signal and how this affects the behavior of receivers, as well as variation in preference functions of receivers, and how this affects the variability of the signal. However, individual differences in female preference functions and their proximate causation have rarely been studied. Methodology/Principal Findings: Calling songs of male field crickets represent secondary sexual characters and are subject to sexual selection by female choice. Following predictions from the "matched filter hypothesis'' we studied the tuning of an identified interneuron in a field cricket, known for its function in phonotaxis, and correlated this with the preference of the same females in two-choice trials. Females vary in their neuronal frequency tuning, which strongly predicts the preference in a choice situation between two songs differing in carrier frequency. A second "matched filter'' exists in directional hearing, where reliable cues for sound localization occur only in a narrow frequency range. There is a strong correlation between the directional tuning and the behavioural preference in no-choice tests. This second "matched filter'' also varies widely in females, and surprisingly, differs on average by 400 Hz from the neuronal frequency tuning. Conclusions/Significance: Our findings on the mismatch of the two "matched filters'' would suggest that the difference in these two filters appears to be caused by their evolutionary history, and the different trade-offs which exist between sound emission, transmission and detection, as well as directional hearing under specific ecological settings. The mismatched filter situation may ultimately explain the maintenance of considerable variation in the carrier frequency of the male signal despite stabilizing selection.	[Kostarakos, Konstantinos; Hartbauer, Manfred; Roemer, Heiner] Karl Franzens Univ Graz, Graz, Austria	University of Graz	Kostarakos, K (corresponding author), Karl Franzens Univ Graz, Graz, Austria.	heinrich.roemer@uni-graz.at		Kostarakos, Konstantinos/0000-0003-3337-049X	Austrian Science Fund [P17986-B06]	Austrian Science Fund(Austrian Science Fund (FWF))	Research in this project was funded by the Austrian Science Fund (FWF, Project P17986-B06) to HR.	ATKINS G, 1992, J COMP PHYSIOL A, V170, P363; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; Bentsen CL, 2006, AM NAT, V167, pE102, DOI 10.1086/501376; Brooks R, 2005, EVOLUTION, V59, P871, DOI 10.1111/j.0014-3820.2005.tb01760.x; CAPRANICA RR, 1983, VERTEBRATE NEUROETHO, P701; Dawkins MS, 1996, AM NAT, V148, P937, DOI 10.1086/285964; DIRSH VM, 1975, B BRIT MUS NAT HIST, V10, P349; Ferreira M, 2002, J ZOOL, V257, P163, DOI 10.1017/S0952836902000766; Gerhardt H. Carl, 2001, P73; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gilbert F, 2000, J EXP BIOL, V203, P983; Greenfield MD, 2002, SIGNALLERS RECEIVERS; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Hedwig B, 2005, J EXP BIOL, V208, P915, DOI 10.1242/jeb.01452; Hedwig B, 2004, NATURE, V430, P781, DOI 10.1038/nature02787; HILL GE, 1994, BEHAV ECOL, V5, P64, DOI 10.1093/beheco/5.1.64; HILL KG, 1976, NATURE, V262, P390, DOI 10.1038/262390a0; HUBER F, 1984, J COMP PHYSIOL, V155, P725, DOI 10.1007/BF00611589; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; KIRKPATRICK M, 1987, SEXUAL SELECTION TES, P67; MICHELSEN A, 1995, J EXP BIOL, V198, P1817; MICHELSEN A, 1995, NATURE, V375, P639, DOI 10.1038/375639a0; MICHELSEN A, 1998, COMP HEARING INSECTS, P18; NOCKE H, 1972, J COMP PHYSIOL, V80, P141, DOI 10.1007/BF00696487; POLLACK GS, 1986, J COMP PHYSIOL A, V158, P549, DOI 10.1007/BF00603799; RHEINLAENDER J, 1986, J COMP PHYSIOL A, V158, P647, DOI 10.1007/BF00603821; RYAN MJ, 1993, PHILOS T ROY SOC B, V340, P187, DOI 10.1098/rstb.1993.0057; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; Scheuber H, 2003, P ROY SOC B-BIOL SCI, V270, P1779, DOI 10.1098/rspb.2003.2449; Scheuber H, 2003, ANIM BEHAV, V65, P721, DOI 10.1006/anbe.2003.2083; SCHILDBERGER K, 1988, J COMP PHYSIOL A, V163, P621, DOI 10.1007/BF00603846; SCHILDBERGER K, 1994, FORTS ZOOL, V39, P209; SHAROV AG, 1968, T PALEONTOL I ACAD S, V118, P1; SIMMONS L.W., 1996, P ROY SOC LOND B BIO, V236, P305; Simmons LW, 2001, EVOLUTION, V55, P1386, DOI 10.1111/j.0014-3820.2001.tb00660.x; Sun LX, 2000, BEHAV ECOL, V11, P102, DOI 10.1093/beheco/11.1.102; THORSON J, 1982, J COMP PHYSIOL, V146, P361, DOI 10.1007/BF00612706; Verburgt L, 2008, J COMP PHYSIOL A, V194, P79, DOI 10.1007/s00359-007-0292-0; Von Helversen D, 2004, ANIM BEHAV, V68, P131, DOI 10.1016/j.anbehav.2003.10.020; WENDLER G, 1993, J COMP PHYSIOL A, V173, P557, DOI 10.1007/BF00197764; WILCZYNSKI W, 1992, BRAIN BEHAV EVOLUT, V39, P229, DOI 10.1159/000114120; Witte K, 2005, BEHAV ECOL, V16, P571, DOI 10.1093/beheco/ari032	44	42	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3005	10.1371/journal.pone.0003005	http://dx.doi.org/10.1371/journal.pone.0003005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714350	Green Submitted, Green Published, gold			2022-12-25	WOS:000264420900030
J	Robach, P; Calbet, JAL; Thomsen, JJ; Boushel, R; Mollard, P; Rasmussen, P; Lundby, C				Robach, Paul; Calbet, Jose A. L.; Thomsen, Jonas J.; Boushel, Robert; Mollard, Pascal; Rasmussen, Peter; Lundby, Carsten			The Ergogenic Effect of Recombinant Human Erythropoietin on (V)over dotO(2)max Depends on the Severity of Arterial Hypoxemia	PLOS ONE			English	Article								Treatment with recombinant human erythropoietin (rhEpo) induces a rise in blood oxygen-carrying capacity (CaO2) that unequivocally enhances maximal oxygen uptake ((V)over dotO(2)max) during exercise in normoxia, but not when exercise is carried out in severe acute hypoxia. This implies that there should be a threshold altitude at which (V)over dotO(2)max is less dependent on CaO2. To ascertain which are the mechanisms explaining the interactions between hypoxia, CaO2 and (V)over dotO(2)max we measured systemic and leg O-2 transport and utilization during incremental exercise to exhaustion in normoxia and with different degrees of acute hypoxia in eight rhEpo-treated subjects. Following prolonged rhEpo treatment, the gain in systemic (V)over dotO(2)max observed in normoxia (6-7%) persisted during mild hypoxia (8% at inspired O-2 fraction (FIO2) of 0.173) and was even larger during moderate hypoxia (14-17% at FIO2 = 0.153-0.134). When hypoxia was further augmented to FIO2 = 0.115, there was no rhEpo-induced enhancement of systemic (V)over dotO(2)max or peak leg (V)over dotO(2). The mechanism highlighted by our data is that besides its strong influence on CaO2, rhEpo was found to enhance leg (V)over dotO(2)max in normoxia through a preferential redistribution of cardiac output toward the exercising legs, whereas this advantageous effect disappeared during severe hypoxia, leaving augmented CaO2 alone insufficient for improving peak leg O-2 delivery and (V)over dotO(2). Finally, that (V)over dotO(2)max was largely dependent on CaO2 during moderate hypoxia but became abruptly CaO2-independent by slightly increasing the severity of hypoxia could be an indirect evidence of the appearance of central fatigue.	[Robach, Paul] Ecole Natl Ski & Alpinisme, Chamonix Mt Blanc, France; [Calbet, Jose A. L.; Thomsen, Jonas J.; Rasmussen, Peter; Lundby, Carsten] Rigshosp, Copenhagen Muscle Res Ctr, Copenhagen, Denmark; [Rasmussen, Peter] Rigshosp, Dept Anaesthesia, Copenhagen, Denmark; [Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Ed, Las Palmas Gran Canaria, Spain; [Lundby, Carsten] Aarhus Univ, Dept Sport Sci, Aarhus, Denmark; [Boushel, Robert] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Robach, Paul; Mollard, Pascal] Univ Paris 13, Lab Reponses Cellulaires Fonctionnelles Hypoxie, EA 2363, Bobigny, France	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Universidad de Las Palmas de Gran Canaria; Aarhus University; University of Copenhagen; Universite Paris 13	Robach, P (corresponding author), Ecole Natl Ski & Alpinisme, Chamonix Mt Blanc, France.	paul.robach@jeunesse-sports.gouv.fr	Ernst-Rasmussen, Peter Bonde/B-8203-2013; Boushel, Robert/ABD-7840-2021; Calbet, Jose A L/H-6693-2015	Ernst-Rasmussen, Peter Bonde/0000-0003-1761-4562; Calbet, Jose A L/0000-0002-9215-6234; antunez, Ariel/0000-0002-2548-7885	Anti Doping Danmark (Denmark); Kulturministeriet (Denmark); Bundesamt fur Sport (Switzerland); Gobierno de Canarias (Ayudas para estancias postdoctorales)(Spain)	Anti Doping Danmark (Denmark); Kulturministeriet (Denmark); Bundesamt fur Sport (Switzerland); Gobierno de Canarias (Ayudas para estancias postdoctorales)(Spain)	This study was supported by research fundings from Anti Doping Danmark (Denmark), Kulturministeriet (Denmark) and Bundesamt fur Sport (Switzerland) to C.L. This study was also supported in part by research funding from Gobierno de Canarias (Ayudas para estancias postdoctorales)(Spain) to J.A.L.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2007, J PHYSIOL-LONDON, V581, P389, DOI 10.1113/jphysiol.2007.129700; ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Audran M, 1999, MED SCI SPORT EXER, V31, P639, DOI 10.1097/00005768-199905000-00003; BENDER PR, 1988, J APPL PHYSIOL, V65, P2592, DOI 10.1152/jappl.1988.65.6.2592; Birkeland KI, 2000, MED SCI SPORT EXER, V32, P1238, DOI 10.1097/00005768-200007000-00009; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boushel R, 2001, CIRCULATION, V104, P1785, DOI 10.1161/hc4001.097040; Calbet JAL, 2006, AM J PHYSIOL-REG I, V291, pR447, DOI 10.1152/ajpregu.00746.2005; Calbet JAL, 2004, J PHYSIOL-LONDON, V558, P319, DOI 10.1113/jphysiol.2003.059287; Calbet JAL, 2003, AM J PHYSIOL-REG I, V284, pR304, DOI 10.1152/ajpregu.00156.2002; Calbet JAL, 2002, J PHYSIOL-LONDON, V545, P715, DOI 10.1113/jphysiol.2002.029108; Charloux A, 2000, EUR J APPL PHYSIOL, V82, P313, DOI 10.1007/s004210000226; EKBLOM B, 1991, Scandinavian Journal of Medicine and Science in Sports, V1, P88; Gonzalez-Alonso J, 2003, CIRCULATION, V107, P824, DOI 10.1161/01.CIR.0000049746.29175.3F; Hansen J, 2000, J PHYSIOL-LONDON, V527, P387, DOI 10.1111/j.1469-7793.2000.00387.x; Hansen J, 2000, ACTA PHYSIOL SCAND, V168, P489, DOI 10.1046/j.1365-201x.2000.00701.x; HEIDENREICH S, 1991, KIDNEY INT, V39, P259, DOI 10.1038/ki.1991.31; KANSTRUP IL, 1984, MED SCI SPORT EXER, V16, P256; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Lundby C, 2008, J APPL PHYSIOL, V105, P581, DOI 10.1152/japplphysiol.90484.2008; Lundby C, 2006, SCAND J MED SCI SPOR, V16, P35, DOI 10.1111/j.1600-0838.2004.00434.x; Lundby C, 2004, AM J PHYSIOL-REG I, V287, pR1202, DOI 10.1152/ajpregu.00725.2003; Lundby C, 2008, J APPL PHYSIOL, V105, P417, DOI 10.1152/japplphysiol.90529.2008; Lundby C, 2008, J PHYSIOL-LONDON, V586, P123, DOI 10.1113/jphysiol.2007.146035; Lundby C, 2007, J PHYSIOL-LONDON, V578, P309, DOI 10.1113/jphysiol.2006.122689; Mollard P, 2007, EUR J APPL PHYSIOL, V100, P663, DOI 10.1007/s00421-007-0457-0; Parisotto R, 2000, HAEMATOLOGICA, V85, P564; Richard R, 2001, EUR J APPL PHYSIOL, V85, P202, DOI 10.1007/s004210100458; ROBERTSON RJ, 1988, J APPL PHYSIOL, V64, P1644, DOI 10.1152/jappl.1988.64.4.1644; ROBERTSON RJ, 1982, J APPL PHYSIOL, V53, P490, DOI 10.1152/jappl.1982.53.2.490; Russell G, 2002, EUR J APPL PHYSIOL, V86, P442, DOI 10.1007/s00421-001-0560-6; Saltin B, 2006, J APPL PHYSIOL, V100, P744, DOI 10.1152/japplphysiol.01395.2005; Schuler B, 2007, SCAND J MED SCI SPOR, V17, P588, DOI 10.1111/j.1600-0838.2006.00611.x; STENBERG J, 1966, J APPL PHYSIOL, V21, P1589, DOI 10.1152/jappl.1966.21.5.1589; Thomsen JJ, 2007, EUR J APPL PHYSIOL, V101, P481, DOI 10.1007/s00421-007-0522-8; VOGEL JA, 1974, J APPL PHYSIOL, V36, P169, DOI 10.1152/jappl.1974.36.2.169; Wagner PD, 2006, J APPL PHYSIOL, V100, P745, DOI 10.1152/japplphysiol.01395a.2005; Wagner PD, 1985, J APPL PHYSIOL, V100, P747; Warburton DER, 1999, SPORTS MED, V27, P241, DOI 10.2165/00007256-199927040-00004; Young AJ, 1996, J APPL PHYSIOL, V81, P252, DOI 10.1152/jappl.1996.81.1.252	41	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2996	10.1371/journal.pone.0002996	http://dx.doi.org/10.1371/journal.pone.0002996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714372	Green Submitted, Green Published, gold			2022-12-25	WOS:000264420900021
J	Ouchi, N; Oshima, Y; Ohashi, K; Higuchi, A; Ikegami, C; Izumiya, Y; Walsh, K				Ouchi, Noriyuki; Oshima, Yuichi; Ohashi, Koji; Higuchi, Akiko; Ikegami, Chiaki; Izumiya, Yasuhiro; Walsh, Kenneth			Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPONECTIN STIMULATES ANGIOGENESIS; RAT PLANTARIS MUSCLE; SKELETAL-MUSCLE; GROWTH-FACTOR; CARDIAC-HYPERTROPHY; FIBER TYPES; KINASE AKT; EXPRESSION; GENE; TSC-36	Myogenic Akt signaling coordinates blood vessel recruitment with normal tissue growth. Here, we investigated the role of Follistatin-like 1 (Fstl1) in the regulation of endothelial cell function and blood vessel growth in muscle. Transgenic Akt1 overexpression in skeletal muscle led to myofiber growth that was coupled to an increase in muscle capillary density. Myogenic Akt signaling or ischemic hind limb surgery led to the induction of Fstl1 in muscle and increased circulating levels of Fstl1. Intramuscular administration of an adenoviral vector expressing Fstl1 (Ad-Fstl1) accelerated flow recovery and increased capillary density in the ischemic hind limbs of wild-type mice, and this was associated with an increase in endothelial nitric oxide synthase (eNOS) phosphorylation at residue Ser-1179. In cultured endothelial cells, Ad-Fstl1 stimulated migration and differentiation into network structures and inhibited apoptosis under conditions of serum deprivation. These cell responses were associated with the activating phosphorylation of Akt and eNOS. Conversely, transduction with dominant-negative Akt or LY294002 blocked Fstl1-stimulated eNOS phosphorylation and inhibited Fstl1-stimulated cellular responses. Treatment with the eNOS inhibitor N-G-nitro-L-arginine methyl ester also reduced endothelial cell migration and differentiation induced by Ad-Fstl1. The stimulatory effect of Ad-Fstl1 on ischemic limb reperfusion was abolished in mice lacking eNOS. These data indicate that Fstl1 is a secreted muscle protein or myokine that can function to promote endothelial cell function and stimulates revascularization in response to ischemic insult through its ability to activate Akt-eNOS signaling.	[Ouchi, Noriyuki; Oshima, Yuichi; Ohashi, Koji; Higuchi, Akiko; Ikegami, Chiaki; Izumiya, Yasuhiro; Walsh, Kenneth] Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Boston University	Ouchi, N (corresponding author), Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, 715 Albany St,W611, Boston, MA 02118 USA.	nouchi@bu.edu	OHASHI, Koji/I-7307-2014; OUCHI, Noriyuki/I-7306-2014	Walsh, Kenneth/0000-0001-7580-2276	National Institutes of Health [HL77774, HL86785, AG15052, HL81587]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants HL77774, HL86785, AG15052, and HL81587 (to K.W.).	Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Breit S, 2000, CANCER RES, V60, P4596; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Couffinhal T, 1999, CIRCULATION, V99, P3188, DOI 10.1161/01.CIR.99.24.3188; DEGENS H, 1993, INT J BIOCHEM, V25, P1141, DOI 10.1016/0020-711X(93)90592-3; DEGENS H, 1992, J ANAT, V180, P455; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; INGJER F, 1979, EUR J APPL PHYSIOL, V40, P197, DOI 10.1007/BF00426942; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Johnston IMP, 2000, ONCOGENE, V19, P5348, DOI 10.1038/sj.onc.1203927; Kano Y, 1997, EUR J APPL PHYSIOL, V75, P97, DOI 10.1007/s004210050132; Kawashima S, 2004, ARTERIOSCL THROM VAS, V24, P998, DOI 10.1161/01.ATV.0000125114.88079.96; Kim HS, 2002, J BIOL CHEM, V277, P41888, DOI 10.1074/jbc.M206657200; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kozian DH, 1997, LAB INVEST, V76, P267; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lee RJ, 2000, CIRCULATION, V102, P898; Mashimo J, 1997, CANCER LETT, V113, P213, DOI 10.1016/S0304-3835(97)04700-9; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Rivard A, 1999, AM J PATHOL, V154, P355, DOI 10.1016/S0002-9440(10)65282-0; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Sumitomo K, 2000, CANCER LETT, V155, P37, DOI 10.1016/S0304-3835(00)00407-9; Takahashi A, 2002, MOL CELL BIOL, V22, P4803, DOI 10.1128/MCB.22.13.4803-4814.2002; Vale P R, 2001, J Interv Cardiol, V14, P511, DOI 10.1111/j.1540-8183.2001.tb00367.x	39	216	228	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32802	32811		10.1074/jbc.M803440200	http://dx.doi.org/10.1074/jbc.M803440200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18718903	Green Published, hybrid			2022-12-25	WOS:000260893700069
J	Stamler, R; Keutmann, HT; Sidis, Y; Kattamuri, C; Schneyer, A; Thompson, TB				Stamler, Robin; Keutmann, Henry T.; Sidis, Yisrael; Kattamuri, Chandramohan; Schneyer, Alan; Thompson, Thomas B.			The Structure of FSTL3.Activin A Complex DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MORPHOGENETIC PROTEIN; TGF-BETA SUPERFAMILY; ACTIVIN-BINDING; RECEPTOR-BINDING; FAMILY; GENE; CELL; MECHANISMS; MYOSTATIN; RECOGNITION	Transforming growth factor beta family ligands are neutralized by a number of structurally divergent antagonists. Follistatin-type antagonists, which include splice variants of follistatin (FS288 and FS315) and follistatin-like 3 (FSTL3), have high affinity for activin A but differ in their affinity for other ligands, particularly bone morphogenetic proteins. To understand the structural basis for ligand specificity within FS-type antagonists, we determined the x-ray structure of activin A in complex with FSTL3 to a resolution of 2.5 angstrom. Similar to the previously resolved FS.activin A structures, the ligand is encircled by two antagonist molecules blocking all ligand receptor-binding sites. Recently, the significance of the FS N-terminal domain interaction at the ligand type I receptor site has been questioned; however, our data show that for FSTL3, the N-terminal domain forms a more intimate contact with activin A, implying that this interaction is stronger than that for FS. Furthermore, binding studies revealed that replacing the FSTL3 N-terminal domain with the corresponding FS domain considerably lowers activin A affinity. Therefore, both structural and biochemical evidence support a significant interaction of the N-terminal domain of FSTL3 with activin A. In addition, structural comparisons with bone morphogenetic proteins suggest that the interface where the N-terminal domain binds may be the key site for determining FS-type antagonist specificity.	[Stamler, Robin; Kattamuri, Chandramohan; Thompson, Thomas B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Keutmann, Henry T.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Sidis, Yisrael] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; [Schneyer, Alan] Baystate Med Ctr, Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA	University System of Ohio; University of Cincinnati; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Baystate Medical Center	Thompson, TB (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Med Sci Bldg,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	tom.thompson@ucmail.uc.edu		Thompson, Thomas/0000-0002-7041-5047	National Institutes of Health [GM084186, DK053828]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM084186 ( to T. B. T.) and DK053828 ( to H. T. K.).	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Amthor H, 2002, DEV BIOL, V243, P115, DOI 10.1006/dbio.2001.0555; Arai KY, 2006, PROTEIN EXPRES PURIF, V49, P78, DOI 10.1016/j.pep.2006.04.003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Costantini S, 2008, BIOINFORMATION, V2, P271, DOI 10.6026/97320630002271; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glister C, 2004, REPRODUCTION, V127, P239, DOI 10.1530/rep.1.00090; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Harrison CA, 2006, ENDOCRINOLOGY, V147, P2744, DOI 10.1210/en.2006-0131; Hayette S, 1998, ONCOGENE, V16, P2949, DOI 10.1038/sj.onc.1201807; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; INOUYE S, 1991, ENDOCRINOLOGY, V129, P815, DOI 10.1210/endo-129-2-815; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Keutmann HT, 2004, MOL ENDOCRINOL, V18, P228, DOI 10.1210/me.2003-0112; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Korupolu RV, 2008, J BIOL CHEM, V283, P3782, DOI 10.1074/jbc.M704530200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lerch TF, 2007, J BIOL CHEM, V282, P15930, DOI 10.1074/jbc.M700737200; Lin SY, 2003, REPRODUCTION, V126, P133, DOI 10.1530/rep.0.1260133; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MICHEL U, 1993, MOL CELL ENDOCRINOL, V91, P1, DOI 10.1016/0303-7207(93)90248-I; Mukherjee A, 2007, P NATL ACAD SCI USA, V104, P1348, DOI 10.1073/pnas.0607966104; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Schneyer A, 2001, MOL CELL ENDOCRINOL, V180, P33, DOI 10.1016/S0303-7207(01)00501-9; Schneyer AL, 2004, J CLIN ENDOCR METAB, V89, P5067, DOI 10.1210/jc.2004-0162; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Sidis Y, 2001, J BIOL CHEM, V276, P17718, DOI 10.1074/jbc.M100736200; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Tsuchida K, 2004, MOL CELL ENDOCRINOL, V225, P1, DOI 10.1016/j.mce.2004.02.006; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200	50	52	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32831	32838		10.1074/jbc.M801266200	http://dx.doi.org/10.1074/jbc.M801266200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18768470	Green Published, hybrid			2022-12-25	WOS:000260893700072
J	Baugher, PJ; Richmond, A				Baugher, Paige J.; Richmond, Ann			The Carboxyl-terminal PDZ Ligand Motif of Chemokine Receptor CXCR2 Modulates Post-endocytic Sorting and Cellular Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; AGONIST-PROMOTED UBIQUITINATION; ETHYLMALEIMIDE-SENSITIVE FACTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; INTERLEUKIN-8 RECEPTOR; MULTIVESICULAR BODY; BETA-ARRESTIN; MEMBRANE-TRAFFICKING; SIGNAL-TRANSDUCTION; DOMAIN PROTEINS	Adaptor protein interaction with specific peptide motifs found within the intracellular, carboxyl terminus of chemokine receptor CXCR2 has been shown to modulate intracellular trafficking and receptor function. Efficient ligand-induced internalization of this receptor is dependent on the binding of adaptor protein 2 to the specific LLKIL motif found within the carboxyl terminus (1). In this study we show that the carboxyl-terminal type 1 PDZ ligand motif (-STTL) of CXCR2 plays an essential role in both proper intracellular receptor trafficking and efficient cellular chemotaxis. First, we show that CXCR2 is sorted to and degraded in the lysosome upon long-term ligand stimulation. We also show that receptor degradation is not dependent upon receptor ubiquitination, but is instead modulated by the carboxyl-terminal type I PDZ ligand of CXCR2. Deletion of this ligand results in increased degradation, earlier co-localization with the lysosome, and enhanced sorting to the Rab7-positive late endosome. We also show that deletion of this ligand effects neither receptor internalization nor receptor recycling. Furthermore, we demonstrate that deletion of the PDZ ligand motif results in impaired chemotactic response. The data presented here demonstrate that the type I PDZ ligand of CXCR2 acts to both delay lysosomal sorting and facilitate proper chemotactic response.	[Richmond, Ann] Vet Affairs Med Ctr, Dept Vet Affairs, Nashville, TN 37212 USA; [Baugher, Paige J.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Richmond, A (corresponding author), 771 PRB,23rd Ave S & Pierce, Nashville, TN 37232 USA.	ann.richmond@vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	National Institutes of Health NCI [CA34590]; Multidisciplinaryasic Research Training in Cance [T32CA09592]; Vanderbilt-Ingram Cancer Center [CA68485]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R23CA034590, R01CA034590, T32CA009592, P30CA068485] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Multidisciplinaryasic Research Training in Cance; Vanderbilt-Ingram Cancer Center; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health NCI Grant CA34590 ( to A. R.). This work was also supported by Multidisciplinaryasic Research Training in Cancer Grant T32CA09592 ( to P. B.), Vanderbilt-Ingram Cancer Center Support Grant CA68485, and a Senior Career Scientist Award from the Department of Veterans Affairs ( to A. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; BENBARUCH A, 1995, J BIOL CHEM, V270, P9121, DOI 10.1074/jbc.270.16.9121; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Delhaye M, 2007, MOL PHARMACOL, V72, P1497, DOI 10.1124/mol.107.038422; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; GABILONDO AM, 1994, PSYCHOPHARMACOLOGY, V115, P135, DOI 10.1007/BF02244763; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ishii M, 2003, LIFE SCI, V74, P163, DOI 10.1016/j.lfs.2003.09.004; James MF, 2004, J CELL SCI, V117, P2951, DOI 10.1242/jcs.01156; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lapierre LA, 2007, AM J PHYSIOL-GASTR L, V292, pG1249, DOI 10.1152/ajpgi.00505.2006; LEE J, 1992, J BIOL CHEM, V267, P16283; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; LOETSCHER P, 1994, FEBS LETT, V341, P187, DOI 10.1016/0014-5793(94)80454-0; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Neel NF, 2007, J CELL SCI, V120, P1559, DOI 10.1242/jcs.03437; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Orsini MJ, 2000, J BIOL CHEM, V275, P25876; Paasche JD, 2005, MOL PHARMACOL, V67, P1581, DOI 10.1124/mol.104.007013; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Richardson RM, 2003, J IMMUNOL, V170, P2904, DOI 10.4049/jimmunol.170.6.2904; Rincon E, 2007, MOL CELL PROTEOMICS, V6, P1073, DOI 10.1074/mcp.M700047-MCP200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Snow BE, 1998, J BIOL CHEM, V273, P17749, DOI 10.1074/jbc.273.28.17749; Snow BE, 1999, P NATL ACAD SCI USA, V96, P6489, DOI 10.1073/pnas.96.11.6489; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Trejo JA, 2005, MOL PHARMACOL, V67, P1388, DOI 10.1124/mol.105.011288; Tsao PI, 2001, PHARMACOL THERAPEUT, V89, P139, DOI 10.1016/S0163-7258(00)00107-8; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wente W, 2005, J BIOL CHEM, V280, P32419, DOI 10.1074/jbc.M507198200; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.008; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	78	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30868	30878		10.1074/jbc.M804054200	http://dx.doi.org/10.1074/jbc.M804054200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18755694	hybrid, Green Published			2022-12-25	WOS:000260544800042
J	Liu, LP; Wise, DR; Diehl, JA; Simon, MC				Liu, Liping; Wise, David R.; Diehl, J. Alan; Simon, M. Celeste			Hypoxic Reactive Oxygen Species Regulate the Integrated Stress Response and Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA TRANSLATION; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; KINASE PERK; IN-VIVO; PHOSPHORYLATION; ACTIVATION; GROWTH; HOMEOSTASIS	Under hypoxic conditions, cells suppress energy-intensive mRNA translation by modulating the mammalian target of rapamycin (mTOR) and pancreatic eIF2 alpha kinase ( PERK) pathways. Much is known about hypoxic inhibition of mTOR activity; however, the cellular processes activating PERK remain unclear. Since hypoxia is known to increase intracellular reactive oxygen species (ROS), we hypothesized that hypoxic ROS regulate mTOR and PERK to control mRNA translation and cell survival. Our data indicate that although exogenous ROS inhibit mTOR, eIF2 alpha, and eEF2, mTOR and eEF2 were largely refractory to ROS generated under moderate hypoxia (0.5% O-2). In direct contrast, the PERK/eIF2 alpha/ATF4 integrated stress response (ISR) was activated by hypoxic ROS and contributed to global protein synthesis inhibition and adaptive ATF4-mediated gene expression. The ISR as well as exogenous growth factors were critical for cell viability during extended hypoxia, since ISR inhibition decreased the viability of cells deprived of O2 and growth factors. Collectively, our data support an important role for ROS in hypoxic cell survival. Under conditions of moderate hypoxia, ROS induce the ISR, thereby promoting energy and redox homeostasis and enhancing cellular survival.	[Liu, Liping; Simon, M. Celeste] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Liu, Liping; Wise, David R.; Diehl, J. Alan; Simon, M. Celeste] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Simon, MC (corresponding author), 421 Curie Blvd, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	liu, li/HGC-0900-2022; Simon, Celeste/AAG-3941-2021	Wise, David/0000-0003-3419-4723	National Institutes of Health [PO1 CA 104838]; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [P01CA104838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 CA 104838. This work was also supported by the Abramson Family Cancer Research Institute.	Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Genestra M, 2007, CELL SIGNAL, V19, P1807, DOI 10.1016/j.cellsig.2007.04.009; Gess B, 2003, EUR J BIOCHEM, V270, P2228, DOI 10.1046/j.1432-1033.2003.03590.x; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HEACOCK CS, 1986, INT J RADIAT ONCOL, V12, P1287, DOI 10.1016/0360-3016(86)90155-0; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Kaelin WG, 2002, GENE DEV, V16, P1441, DOI 10.1101/gad.1003602; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koritzinsky M, 2007, RADIOTHER ONCOL, V83, P353, DOI 10.1016/j.radonc.2007.04.031; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Magagnin MG, 2006, DRUG RESIST UPDATE, V9, P185, DOI 10.1016/j.drup.2006.07.002; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Marciniak SJ, 2006, J CELL BIOL, V172, P201, DOI 10.1083/jcb.200508099; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Papandreou I, 2005, CANCER RES, V65, P3171, DOI 10.1158/0008-5472.CAN-04-3395; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200	57	147	151	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31153	31162		10.1074/jbc.M805056200	http://dx.doi.org/10.1074/jbc.M805056200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768473	Green Published, hybrid			2022-12-25	WOS:000260544800069
J	Maillet, M; Purcell, NH; Sargent, MA; York, AJ; Bueno, OF; Molkentin, JD				Maillet, Marjorie; Purcell, Nicole H.; Sargent, Michelle A.; York, Allen J.; Bueno, Orlando F.; Molkentin, Jeffery D.			DUSP6 (MKP3) Null Mice Show Enhanced ERK1/2 Phosphorylation at Baseline and Increased Myocyte Proliferation in the Heart Affecting Disease Susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MUSCLE CELL-PROLIFERATION; SIGNAL-REGULATED KINASE-2; PHOSPHATASE 2A; CARDIAC-HYPERTROPHY; GENETIC INHIBITION; P38 MAPK; ERK2; OVEREXPRESSION; SPECIFICITY	The strength and duration of mitogen-activated protein kinase signaling is regulated through phosphorylation and dephosphorylation by dedicated dual-specificity kinases and phosphatases, respectively. Here we investigated the physiological role that extracellular signal-regulated kinases 1/2 (ERK1/2) dephosphorylation plays in vivo through targeted disruption of the gene encoding dual-specificity phosphatase 6 (Dusp6) in the mouse. Dusp6(-/-) mice, which were viable, fertile, and otherwise overtly normal, showed an increase in basal ERK1/2 phosphorylation in the heart, spleen, kidney, brain, and fibroblasts, but no change in ERK5, p38, or c-Jun N-terminal kinases activation. However, loss of Dusp6 did not increase or prolong ERK1/2 activation after stimulation, suggesting that its function is more dedicated to basal ERK1/2 signaling tone. In-depth analysis of the physiological effect associated with increased baseline ERK1/2 signaling was performed in cultured mouse embryonic fibroblasts (MEFs) and the heart. Interestingly, mice lacking Dusp6 had larger hearts at every age examined, which was associated with greater rates of myocyte proliferation during embryonic development and in the early postnatal period, resulting in cardiac hypercellularity. This increase in myocyte content in the heart was protective against decompensation and hypertrophic cardiomyopathy following long term pressure overload and myocardial infarction injury in adult mice. Dusp6(-/-) MEFs also showed reduced apoptosis rates compared with wild-type MEFs. These results demonstrate that ERK1/2 signaling is physiologically restrained by DUSP6 in coordinating cellular development and survival characteristics, directly impacting disease-responsiveness in adulthood.	[Molkentin, Jeffery D.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Med Ctr,Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Molkentin, JD (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Med Ctr,Div Mol Cardiovasc Biol, 240 Albert Sabin Way,MLC7020, Cincinnati, OH 45229 USA.	Jeff.Molkentin@cchmc.org		Molkentin, Jeffery/0000-0002-3558-6529	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081104, P01HL069779, R01HL060562, P50HL077101, R01HL062927] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL077101, R01 HL081104, R01 HL062927, R01 HL060562, R01 HL081104-04, P01 HL069779-06A10003, P50 HL077101-050004, R01 HL060562-11, R01 HL062927-10A1, P01 HL069779] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Alvarado-Kristensson M, 2005, J BIOL CHEM, V280, P6238, DOI 10.1074/jbc.M409718200; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; CLAYCOMB WC, 1983, ADV EXP MED BIOL, V161, P249; Colomer JM, 2004, ENDOCRINOLOGY, V145, P1356, DOI 10.1210/en.2003-1119; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kajstura J, 2001, DIABETES, V50, P1414, DOI 10.2337/diabetes.50.6.1414; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Limana F, 2002, P NATL ACAD SCI USA, V99, P6257, DOI 10.1073/pnas.092672899; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Muda M, 1996, J BIOL CHEM, V271, P4319; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Parsons SA, 2006, AM J PATHOL, V168, P1975, DOI 10.2353/ajpath.2006.051316; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Sundaresan P, 2002, FEBS LETT, V528, P139, DOI 10.1016/S0014-5793(02)03277-5; Taigen T, 2000, P NATL ACAD SCI USA, V97, P1196, DOI 10.1073/pnas.97.3.1196; Theodosiou A, 2002, GENOME BIOL, V3; Weisleder N, 2004, P NATL ACAD SCI USA, V101, P769, DOI 10.1073/pnas.0303202101; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200; Zhou B, 2001, J BIOL CHEM, V276, P6506, DOI 10.1074/jbc.M009753200; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zhou B, 2006, J BIOL CHEM, V281, P38834, DOI 10.1074/jbc.M608916200; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	49	124	128	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31246	31255		10.1074/jbc.M806085200	http://dx.doi.org/10.1074/jbc.M806085200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18753132	Green Published, hybrid			2022-12-25	WOS:000260544800078
J	Mukai, H; Hokari, Y; Seki, T; Takao, T; Kubota, M; Matsuo, Y; Tsukagoshi, H; Kato, M; Kimura, H; Shimonishi, Y; Kiso, Y; Nishi, Y; Wakamatsu, K; Munekata, E				Mukai, Hidehito; Hokari, Yoshinori; Seki, Tetsuo; Takao, Toshifumi; Kubota, Makoto; Matsuo, Yuko; Tsukagoshi, Hiroyuki; Kato, Masahiko; Kimura, Hirokazu; Shimonishi, Yasutsugu; Kiso, Yoshiaki; Nishi, Yoshisuke; Wakamatsu, Kaori; Munekata, Eisuke			Discovery of Mitocryptide-1, a Neutrophil-activating Cryptide from Healthy Porcine Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN; LEUKEMIA-CELLS; HL-60 CELLS; RECEPTOR; PEPTIDES; BINDING; IDENTIFICATION; INVOLVEMENT; MASTOPARAN; INJURY	Although neutrophils are known to migrate in response to various chemokines and complement factors, the substances involved in the early stages of their transmigration and activation have been poorly characterized to date. Here we report the discovery of a peptide isolated from healthy porcine hearts that activated neutrophils. Its primary structure is H-Leu-Ser-Phe-Leu-Ile-Pro-Ala-Gly-Trp-Val-Leu-Ser-His-Leu-Asp-His-Tyr-Lys-Arg-Ser-Ser-Ala-Ala-OH, and it was indicated to originate from mitochondrial cytochrome c oxidase subunit VIII. This peptide caused chemotaxis at concentrations lower than that inducing beta-hexosaminidase release. Such responses were observed in neutrophilic/granulocytic differentiated HL-60 cells but not in undifferentiated cells, and G(i2)-type G proteins were suggested to be involved in the peptide signaling. Moreover the peptide activated human neutrophils to induce beta-hexosaminidase secretion. A number of other amphipathic neutrophil-activating peptides presumably originating from mitochondrial proteins were also found. The present results suggest that neutrophils monitor such amphipathic peptides including the identified peptide as an initiation signal for inflammation at injury sites.	[Mukai, Hidehito; Kiso, Yoshiaki] Kyoto Pharmaceut Univ, 21st Century COE Program, Kyoto 6078412, Japan; [Mukai, Hidehito; Hokari, Yoshinori; Seki, Tetsuo; Munekata, Eisuke] Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; [Mukai, Hidehito; Matsuo, Yuko] Mitsubishi Kagaku Inst Life Sci, Lab Peptide Biosignal Engn, Tokyo 1948511, Japan; [Mukai, Hidehito; Nishi, Yoshisuke] JT Inc, Lab Life Sci & Biomol Engn, Kanagawa 2278512, Japan; [Takao, Toshifumi; Shimonishi, Yasutsugu] Osaka Univ, Inst Prot Res, Osaka 5650871, Japan; [Kubota, Makoto; Wakamatsu, Kaori] Gunma Univ, Fac Engn, Dept Biol & Chem Engn, Gunma 3768515, Japan; [Tsukagoshi, Hiroyuki; Kato, Masahiko] Gunma Prefectural Inst Publ Hlth & Environm Sci, Gunma 3710052, Japan; [Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo 2080011, Japan	Kyoto Pharmaceutical University; University of Tsukuba; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Osaka University; Gunma University; National Institute of Infectious Diseases (NIID)	Mukai, H (corresponding author), Kyoto Pharmaceut Univ, 21st Century COE Program, 1 Shichono Cho, Kyoto 6078412, Japan.	hmukai-endo@umin.ac.jp	Wakamatsu, Kaori/AAQ-9690-2020	Wakamatsu, Kaori/0000-0003-1412-5691	Special Research Project on the Circulation Biosystem; University of Tsukuba; Naito Foundation; Mitsubishi Chemical Corp.; JT Inc.; Ministry of Education, Culture, Sports, Science and Technology of Japan [06680605]	Special Research Project on the Circulation Biosystem; University of Tsukuba; Naito Foundation(Naito Memorial Foundation); Mitsubishi Chemical Corp.; JT Inc.; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a research grant from the Special Research Project on the Circulation Biosystem, the University of Tsukuba, the Naito Foundation, Mitsubishi Chemical Corp., JT Inc., and Grant-in-aid for Scientific Research 06680605 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BLANK JL, 1991, J BIOL CHEM, V266, P18206; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; CHAPLINSKI TJ, 1982, J CLIN INVEST, V70, P953, DOI 10.1172/JCI110707; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; DOUGHERTY RW, 1984, BIOCHEM J, V222, P307, DOI 10.1042/bj2220307; Fukuhara S, 1996, J NEUROCHEM, V67, P1282; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; KAJIRO Y, 1991, ANNU REV BIOCHEM, V60, P349; KANGAWA K, 1983, BIOCHEM BIOPH RES CO, V114, P533, DOI 10.1016/0006-291X(83)90813-6; KANGAWA K, 1984, NATURE, V312, P152, DOI 10.1038/312152a0; Kato M, 2002, J IMMUNOL, V169, P5252, DOI 10.4049/jimmunol.169.9.5252; Klinker JF, 1996, GEN PHARMACOL, V27, P33, DOI 10.1016/0306-3623(95)00107-7; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; KORTHUIS RJ, 1988, AM J PHYSIOL, V254, pH823, DOI 10.1152/ajpheart.1988.254.5.H823; KRAUTWURST D, 1992, BIOCHEM J, V288, P1025, DOI 10.1042/bj2881025; LAGUNOFF D, 1987, IN VITRO METHODS STU, P13; Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1; McColl SR, 1999, J IMMUNOL, V163, P2829; MOUSLI M, 1990, TRENDS PHARMACOL SCI, V11, P358, DOI 10.1016/0165-6147(90)90179-C; MUKAI H, 1989, AM J PHYSIOL, V257, pE235, DOI 10.1152/ajpendo.1989.257.2.E235; MUKAI H, 1987, AM J PHYSIOL, V252, pE765, DOI 10.1152/ajpendo.1987.252.6.E765; MUKAI H, 1992, J BIOL CHEM, V267, P16237; MURPHY PM, 1991, J BIOL CHEM, V266, P12560; Nakajima T, 2000, METH TOOLS BIOSCI ME, P116; Nice Edouard C, 2007, Expert Rev Proteomics, V4, P705, DOI 10.1586/14789450.4.6.705; OINUMA M, 1987, J BIOL CHEM, V262, P8347; Pimenta DC, 2007, PEPTIDES, V28, P2403, DOI 10.1016/j.peptides.2007.10.005; REIM DF, 1997, CURRENT PROTOCOLS PR; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; SHAWAR SM, 1995, BIOCHEM BIOPH RES CO, V211, P812, DOI 10.1006/bbrc.1995.1884; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TAKAO T, 1993, ANAL CHEM, V65, P2394, DOI 10.1021/ac00065a037; Tanaka T, 1998, J BIOL CHEM, V273, P3247, DOI 10.1074/jbc.273.6.3247; Ueki N, 2007, BIOPOLYMERS, V88, P190, DOI 10.1002/bip.20687; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; VITALE N, 1993, J BIOL CHEM, V268, P14715; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; ZOGORSKI J, 1997, J IMMUNOL, V159, P1059	40	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30596	30605		10.1074/jbc.M803913200	http://dx.doi.org/10.1074/jbc.M803913200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768476	Green Published, hybrid			2022-12-25	WOS:000260544800018
J	Reeder, BJ; Grey, M; Silaghi-Dumitrescu, RL; Svistunenko, DA; Bulow, L; Cooper, CE; Wilson, MT				Reeder, Brandon J.; Grey, Marie; Silaghi-Dumitrescu, Radu-Lucian; Svistunenko, Dimitri A.; Bulow, Leif; Cooper, Chris E.; Wilson, Michael T.			Tyrosine Residues as Redox Cofactors in Human Hemoglobin IMPLICATIONS FOR ENGINEERING NONTOXIC BLOOD SUBSTITUTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; FERRYL MYOGLOBIN; HEME; RHABDOMYOLYSIS; MECHANISM; PEROXIDE; RADICALS; PROTECT; STATES; ACID	Respiratory proteins such as myoglobin and hemoglobin can, under oxidative conditions, form ferryl heme iron and protein-based free radicals. Ferryl myoglobin can safely be returned to the ferric oxidation state by electron donation from exogenous reductants via a mechanism that involves two distinct pathways. In addition to direct transfer between the electron donor and ferryl heme edge, there is a second pathway that involves "through-protein" electron transfer via a tyrosine residue (tyrosine 103, sperm whale myoglobin). Here we show that the heterogeneous subunits of human hemoglobin, the alpha and beta chains, display significantly different kinetics for ferryl reduction by exogenous reductants. By using selected hemoglobin mutants, we show that the alpha chain possesses two electron transfer pathways, similar to myoglobin. Furthermore, tyrosine 42 is shown to be a critical component of the high affinity, through-protein electron transfer pathway. We also show that the beta chain of hemoglobin, lacking the homologous tyrosine, does not possess this through-protein electron transfer pathways.However, such a pathway can be engineered into the protein by mutation of a specific phenylalanine residue to a tyrosine. High affinity through-protein electron transfer pathways, whether native or engineered, enhance the kinetics of ferryl removal by reductants, particularly at low reductant concentrations. Ferryl iron has been suggested to be a major cause of the oxidative toxicity of hemoglobin-based blood substitutes. Engineering hemoglobin with enhanced rates of ferryl removal, as we show here, is therefore likely to result in molecules better suited for in vivo oxygen delivery.	[Reeder, Brandon J.; Svistunenko, Dimitri A.; Cooper, Chris E.; Wilson, Michael T.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; [Grey, Marie; Bulow, Leif] Lund Univ, Dept Pure & Appl Biochem, SE-22100 Lund, Sweden; [Silaghi-Dumitrescu, Radu-Lucian] Univ Babes Bolyai, RO-400084 Cluj Napoca, Romania	University of Essex; Lund University; Babes Bolyai University from Cluj	Reeder, BJ (corresponding author), Univ Essex, Dept Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	reedb@essex.ac.uk	Cooper, Chris/AAK-9729-2020; Silaghi-Dumitrescu, Radu/A-2883-2008; Reeder, Brandon/AAI-1450-2020	Cooper, Chris/0000-0003-0381-3990; Silaghi-Dumitrescu, Radu/0000-0003-3038-7747; Reeder, Brandon/0000-0001-7474-2611; Svistunenko, Dimitri/0000-0001-8060-2738	European Union Framework VI; Biotechnology and Biological Sciences Research Council	European Union Framework VI(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by European Union Framework VI and Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alayash AI, 2007, EXPERT OPIN BIOL TH, V7, P665, DOI 10.1517/14712598.7.5.665; Antonini E., 1971, FRONT BIOL, P13; ARDUINI A, 1990, FREE RADICAL BIO MED, V9, P511, DOI 10.1016/0891-5849(90)90130-B; BULL C, 1975, P NATL ACAD SCI USA, V72, P3382, DOI 10.1073/pnas.72.9.3382; BURKERT LB, 1976, BLOOD, V48, P645; COOPER CE, 1994, FREE RADICAL RES, V20, P219, DOI 10.3109/10715769409147518; D'Agnillo F, 2002, FREE RADICAL BIO MED, V33, P1153, DOI 10.1016/S0891-5849(02)01007-9; GIULIVI C, 1993, FEBS LETT, V332, P287, DOI 10.1016/0014-5793(93)80651-A; Holt S, 1999, LANCET, V353, P1241, DOI 10.1016/S0140-6736(98)05768-7; IMAI K, 1991, J MOL BIOL, V218, P769, DOI 10.1016/0022-2836(91)90265-8; Kavanaugh JS, 2005, BIOCHEMISTRY-US, V44, P3806, DOI 10.1021/bi0484670; Lardinois OM, 2004, BIOCHEMISTRY-US, V43, P4601, DOI 10.1021/bi036241b; MAILLETT DH, 2006, DESIGNING RECOMBINAN; Moore KP, 1998, J BIOL CHEM, V273, P31731, DOI 10.1074/jbc.273.48.31731; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; OSAWA Y, 1991, P NATL ACAD SCI USA, V88, P7081, DOI 10.1073/pnas.88.16.7081; Panetta G, 2008, BBA-PROTEINS PROTEOM, V1784, P1462, DOI 10.1016/j.bbapap.2008.01.003; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; Reeder BJ, 2005, CHEM RES TOXICOL, V18, P1004, DOI 10.1021/tx049660y; Reeder BJ, 2002, BIOCHEM SOC T, V30, P745, DOI 10.1042/bst0300745; Reeder BJ, 2002, BIOCHEMISTRY-US, V41, P367, DOI 10.1021/bi011335b; Reeder BJ, 2008, FREE RADICAL BIO MED, V44, P264, DOI 10.1016/j.freeradbiomed.2007.08.006; Reeder BJ, 2008, FREE RADICAL BIO MED, V44, P274, DOI 10.1016/j.freeradbiomed.2007.06.030; Sambrook J, 2001, MOL CLONING LAB MAN; Svistunenko DA, 2002, BIOPHYS J, V83, P2845, DOI 10.1016/S0006-3495(02)75293-4; Svistunenko DA, 1997, J BIOL CHEM, V272, P7114, DOI 10.1074/jbc.272.11.7114; Vollaard NBJ, 2005, FREE RADICAL BIO MED, V39, P1216, DOI 10.1016/j.freeradbiomed.2005.06.012; Vuletich JL, 2000, BIOCHEM BIOPH RES CO, V269, P647, DOI 10.1006/bbrc.2000.2349; WALTERS FP, 1983, FEBS LETT, V163, P292, DOI 10.1016/0014-5793(83)80838-2; WEIL JA, 1994, ELECT PARAMAGNETIC R, P510; Winslow RM, 2006, VOX SANG, V91, P102, DOI 10.1111/j.1423-0410.2006.00789.x	31	105	111	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30780	30787		10.1074/jbc.M804709200	http://dx.doi.org/10.1074/jbc.M804709200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18728007	hybrid, Green Published			2022-12-25	WOS:000260544800083
J	Santelia, D; Henrichs, S; Vincenzetti, V; Sauer, M; Bigler, L; Klein, M; Bailly, A; Lee, Y; Friml, J; Geisler, M; Martinoia, E				Santelia, Diana; Henrichs, Sina; Vincenzetti, Vincent; Sauer, Michael; Bigler, Laurent; Klein, Markus; Bailly, Aurelien; Lee, Youngsook; Friml, Jiri; Geisler, Markus; Martinoia, Enrico			Flavonoids Redirect PIN-mediated Polar Auxin Fluxes during Root Gravitropic Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; P-GLYCOPROTEINS; ABC TRANSPORTERS; EFFLUX; REGULATORS; LOCALIZATION; PROTEINS; PLANTS; ACCUMULATION; GLYCOSIDES	The rate, polarity, and symmetry of the flow of the plant hormone auxin are determined by the polar cellular localization of PIN-FORMED (PIN) auxin efflux carriers. Flavonoids, a class of secondary plant metabolites, have been suspected to modulate auxin transport and tropic responses. Nevertheless, the identity of specific flavonoid compounds involved and their molecular function and targets in vivo are essentially unknown. Here we show that the root elongation zone of agravitropic pin2/eir1/wav6/agr1 has an altered pattern and amount of flavonol glycosides. Application of nanomolar concentrations of flavonols to pin2 roots is sufficient to partially restore root gravitropism. By employing a quantitative cell biological approach, we demonstrate that flavonoids partially restore the formation of lateral auxin gradients in the absence of PIN2. Chemical complementation by flavonoids correlates with an asymmetric distribution of the PIN1 protein. pin2 complementation probably does not result from inhibition of auxin efflux, as supply of the auxin transport inhibitor N-1-naphthylphthalamic acid failed to restore pin2 gravitropism. We propose that flavonoids promote asymmetric PIN shifts during gravity stimulation, thus redirecting basipetal auxin streams necessary for root bending.	[Santelia, Diana; Henrichs, Sina; Vincenzetti, Vincent; Klein, Markus; Bailly, Aurelien; Geisler, Markus; Martinoia, Enrico] Univ Zurich, Inst Plant Biol, Lab Mol Plant Physiol, CH-8008 Zurich, Switzerland; [Sauer, Michael; Friml, Jiri] Univ Gottingen, Dept Plant Cell Biol, D-30073 Gottingen, Germany; [Bigler, Laurent] Univ Zurich, Inst Organ Chem, CH-8057 Zurich, Switzerland; [Lee, Youngsook; Martinoia, Enrico] Pohang Univ Sci & Technol, Postech UZH Global Res Lab, Pohang 790784, South Korea	University of Zurich; University of Gottingen; University of Zurich; Pohang University of Science & Technology (POSTECH)	Geisler, M (corresponding author), Univ Zurich, Inst Plant Biol, Lab Mol Plant Physiol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	markus.geisler@botinst.uzh.ch; enrico.martinoia@botinst.uzh.ch	Martinoia, Enrico/AAH-8712-2021; Lee, Youngsook/E-6578-2016; Friml, Jiri/D-9511-2012; Geisler, Markus M/B-3921-2012; Bigler, Laurent/AAP-3799-2020; Santelia, Diana/AAQ-3967-2020; Sauer, Michael/F-6519-2014; Sauer, Michael/G-3424-2011	Lee, Youngsook/0000-0002-5808-9613; Friml, Jiri/0000-0002-8302-7596; Geisler, Markus M/0000-0002-6641-5810; Bigler, Laurent/0000-0003-3548-3594; Sauer, Michael/0000-0002-4014-9825; 	Swiss National Foundation [3100AO-111912]; Novartis foundation; Ministry of Science and Technology of South Korea	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis foundation(Novartis); Ministry of Science and Technology of South Korea(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by the Swiss National Foundation Grant 3100AO-111912 (to M.G.) and a grant to E.M. (within the NCCR Plant Survival), a grant from the Novartis foundation (to M.G.) and by a grant from the Ministry of Science and Technology of South Korea (to Y.L. and E.M.).	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Bailly A, 2008, J BIOL CHEM, V283, P21817, DOI 10.1074/jbc.M709655200; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Buer CS, 2007, PLANT PHYSIOL, V145, P478, DOI 10.1104/pp.107.101824; Buer CS, 2006, PLANT PHYSIOL, V140, P1384, DOI 10.1104/pp.105.075671; Buer CS, 2004, PLANT CELL, V16, P1191, DOI 10.1105/tpc.020313; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Conseil G, 1998, P NATL ACAD SCI USA, V95, P9831, DOI 10.1073/pnas.95.17.9831; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; JACOBS M, 1988, SCIENCE, V241, P346, DOI 10.1126/science.241.4863.346; Kerhoas L, 2006, J AGR FOOD CHEM, V54, P6603, DOI 10.1021/jf061043n; Kerr ID, 2007, BIOCHEM J, V401, P613, DOI 10.1042/BJ20061411; Lewis DR, 2007, PLANT CELL, V19, P1838, DOI 10.1105/tpc.107.051599; Lomax Terri L., 1995, P509; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Luschnig C, 2002, TRENDS PLANT SCI, V7, P329, DOI 10.1016/S1360-1385(02)02292-6; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Moore I, 2002, CURR BIOL, V12, pR452, DOI 10.1016/S0960-9822(02)00943-0; Morris DA, 2000, PLANT GROWTH REGUL, V32, P161, DOI 10.1023/A:1010701527848; Morris ME, 2006, LIFE SCI, V78, P2116, DOI 10.1016/j.lfs.2005.12.003; Muday GK, 2001, J PLANT GROWTH REGUL, V20, P226, DOI 10.1007/s003440010027; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Peer W.A., 2006, SCI FLAVONOIDS, P239, DOI [10.1007/978-0-387-28822-2_9, DOI 10.1007/978-0-387-28822-2_9]; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; Routaboul JM, 2006, PLANTA, V224, P96, DOI 10.1007/s00425-005-0197-5; Santner AA, 2006, PLANT J, V45, P752, DOI 10.1111/j.1365-313X.2005.02641.x; Stobiecki M, 1999, PHYTOCHEM ANALYSIS, V10, P198, DOI 10.1002/(SICI)1099-1565(199907/08)10:4&lt;198::AID-PCA454&gt;3.0.CO;2-C; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Utsuno K, 1998, PLANT CELL PHYSIOL, V39, P1111, DOI 10.1093/oxfordjournals.pcp.a029310; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777	52	137	143	1	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31218	31226		10.1074/jbc.M710122200	http://dx.doi.org/10.1074/jbc.M710122200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18718912	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000260544800075
J	Wu, Y; Siadaty, MS; Berens, ME; Hampton, GM; Theodorescu, D				Wu, Y.; Siadaty, M. S.; Berens, M. E.; Hampton, G. M.; Theodorescu, D.			Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration	ONCOGENE			English	Article						mechanism of cell movement; metastasis; gene expression; transcriptional profiling	STROMAL VERSICAN EXPRESSION; METASTASIS SUPPRESSOR GENE; BREAST-CANCER; CARCINOMA; IDENTIFICATION; MICROARRAYS; DISCOVERY; RHOGD12; PATHWAY; CD24	Cell migration is essential to cancer invasion and metastasis and is spatially and temporally integrated through transcriptionally dependent and independent mechanisms. As cell migration is studied in vitro, it is important to identify genes that both drive cell migration and are biologically relevant in promoting invasion and metastasis in patients with cancer. Here, gene expression profiling and a high-throughput cell migration system answers this question in human bladder cancer. In vitro migration rates of 40 microarray-profiled human bladder cancer cell lines were measured by radial migration assay. Genes whose expression was either directly or inversely associated with cell migration rate were identified and subsequently evaluated for their association with cancer stage in 61 patients. This analysis identified genes known to be associated with cell invasion such as versican, and novel ones, including metallothionein 1E (MT1E) and nicotinamide N-methyltransferase (NNMT), whose expression correlated positively with cancer cell migration and tumor stage. Using loss of function analysis, we show that MT1E and NNMT are necessary for cancer cell migration. These studies provide a general approach to identify the clinically relevant genes in cancer cell migration and mechanistically implicate two novel genes in this process in human bladder cancer.	[Wu, Y.; Theodorescu, D.] Univ Virginia, Hlth Sci Ctr, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Siadaty, M. S.] Univ Virginia, Hlth Sci Ctr, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Berens, M. E.] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA; [Hampton, G. M.] Novartis Res Fdn, Genom Inst, San Diego, CA USA	University of Virginia; University of Virginia; Translational Genomics Research Institute; Novartis	Theodorescu, D (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Mol Physiol & Biol Phys, Box 422, Charlottesville, VA 22908 USA.	dt9d@virginia.edu			NIH [CA075115]; NATIONAL CANCER INSTITUTE [R29CA075115, R01CA075115] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Jay Fox and Dr Yongde Bao of the University of Virginia Array Core facility for their assistance with chip hybridization. We also thank Dr Martin A Schwartz and Dr Konstadinos Moissoglu of the Cardiovascular Research Center, University of Virginia for their assistance with time-lapse microscopy. Mr Christian Beaudry at TGen performed the high-throughput cell migration experiments. This work was supported by NIH grant CA075115 to DT.	Aigner S, 1997, BLOOD, V89, P3385, DOI 10.1182/blood.V89.9.3385; AKSOY S, 1994, J BIOL CHEM, V269, P14835; AKSOY S, 1995, GENOMICS, V29, P555, DOI 10.1006/geno.1995.9966; Altevogt P, 1988, Adv Exp Med Biol, V233, P253; Berens ME, 2004, METH MOLEC MED, V88, P219; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chung MJ, 2006, J AGR FOOD CHEM, V54, P3819, DOI 10.1021/jf060510y; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Faried A, 2006, EUR J CANCER, V42, P1455, DOI 10.1016/j.ejca.2006.02.012; Friederichs J, 2000, CANCER RES, V60, P6714; Friedline JA, 1998, AM J PATHOL, V152, P23; Gildea JJ, 2002, CANCER RES, V62, P6418; GORDON JN, 1993, CANCER RES, V53, P4971; Grate LR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-97; Havaleshko DM, 2007, MOL CANCER THER, V6, P578, DOI 10.1158/1535-7163.MCT-06-0497; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jin R, 2000, BRIT J CANCER, V83, P319, DOI 10.1054/bjoc.2000.1276; JONES RF, 1992, J CANCER RES CLIN, V118, P411, DOI 10.1007/BF01629423; Kodama J, 2007, ANN ONCOL, V18, P269, DOI 10.1093/annonc/mdl370; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Lim BH, 2006, EXP MOL MED, V38, P455, DOI 10.1038/emm.2006.54; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Margolis EJ, 1996, CANCER LETT, V100, P163, DOI 10.1016/0304-3835(95)04096-X; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Modlich O, 2004, CLIN CANCER RES, V10, P3410, DOI 10.1158/1078-0432.CCR-03-0134; Mukai M, 2006, BIOCHEM BIOPH RES CO, V346, P74, DOI 10.1016/j.bbrc.2006.05.068; Nicholson BE, 2004, CANCER RES, V64, P7813, DOI 10.1158/0008-5472.CAN-04-0826; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Pukkila M, 2007, J CLIN PATHOL, V60, P267, DOI 10.1136/jcp.2005.034181; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ricciardelli C, 1999, CANCER RES, V59, P2324; Roessler M, 2005, CLIN CANCER RES, V11, P6550, DOI 10.1158/1078-0432.CCR-05-0983; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Sanchez-Carbayo M, 2003, AM J PATHOL, V163, P505, DOI 10.1016/S0002-9440(10)63679-6; Smith SC, 2006, CANCER RES, V66, P1917, DOI 10.1158/0008-5472.CAN-05-3855; Smith SC, 2007, CLIN CANCER RES, V13, P3803, DOI 10.1158/1078-0432.CCR-06-2419; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Su AI, 2001, CANCER RES, V61, P7388; *TEAM RDC, 2003, R REF MAN; Theodorescu D, 2004, CLIN CANCER RES, V10, P3800, DOI 10.1158/1078-0432.CCR-03-0653; Thykjaer T, 2001, CANCER RES, V61, P2492; Titus B, 2005, CANCER RES, V65, P7320, DOI 10.1158/0008-5472.CAN-05-1403; van Delft JHM, 2005, MUTAT RES-FUND MOL M, V575, P17, DOI 10.1016/j.mrfmmm.2005.02.006; Witjes JA, 2006, EUR UROL, V49, P790, DOI 10.1016/j.eururo.2006.01.017; Xu JM, 2003, J CLIN ENDOCR METAB, V88, P4990, DOI 10.1210/jc.2002-021843; Yao M, 2005, J PATHOL, V205, P377, DOI 10.1002/path.1693; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	52	120	127	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2008	27	52					6679	6689		10.1038/onc.2008.264	http://dx.doi.org/10.1038/onc.2008.264			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	368QY	18724390	Green Accepted			2022-12-25	WOS:000260638800006
J	Rousseau, F; Chevalier, S; Guillet, C; Ravon, E; Diveu, C; Froger, J; Barbier, F; Grimaud, L; Gascan, H				Rousseau, Francois; Chevalier, Sylvie; Guillet, Catherine; Ravon, Elisa; Diveu, Caroline; Froger, Josy; Barbier, Fabien; Grimaud, Linda; Gascan, Hugues			Ciliary Neurotrophic Factor, Cardiotrophin-like Cytokine, and Neuropoietin Share a Conserved Binding Site on the Ciliary Neurotrophic Factor Receptor alpha Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; IL-6 SIGNAL TRANSDUCER; CRYSTAL-STRUCTURE; INTERLEUKIN-6 RECEPTOR; MOLECULAR-CLONING; PROTEIN; GP130; CNTF; EXPRESSION; FORM	Ciliary neurotrophic factor, cardiotrophin-like cytokine, and neuropoietin are members of the four-helix bundle cytokine family. These proteins signal through a common tripartite receptor composed of leukemia inhibitory factor receptor, gp130, and ciliary neurotrophic factor receptor alpha. Binding to ciliary neurotrophic factor receptor alpha occurs through an interaction site located at the C terminus of the cytokine AB loop and alpha D helix, known as site 1. In the present study, we have generated a model of neuropoietin and identified a conserved binding site for the three cytokines interacting with ciliary neurotrophic factor receptor alpha. To identify the counterpart of this site on ciliary neurotrophic factor receptor alpha, its cytokine binding domain was modeled, and the physicochemical properties of its surface were analyzed. This analysis revealed an area displaying properties complementary to the site 1 of ciliary neurotrophic factor, cardiotrophin-like cytokine, and neuropoietin. Based on our computational predictions, residues were selected for their potential involvement in the ciliary neurotrophic factor receptor alpha binding epitope, and site-directed mutagenesis was carried out. Biochemical, cell proliferation, and cell signaling analyses showed that Phe(172) and Glu(286) of ciliary neurotrophic factor receptor alpha are key interaction residues. Our results demonstrated that ciliary neurotrophic factor, cardiotrophin-like cytokine, and neuropoietin share a conserved binding site on ciliary neurotrophic factor receptor alpha.	[Rousseau, Francois; Chevalier, Sylvie; Guillet, Catherine; Ravon, Elisa; Diveu, Caroline; Froger, Josy; Barbier, Fabien; Grimaud, Linda; Gascan, Hugues] INSERM, UMR 564, F-49033 Angers 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Gascan, H (corresponding author), INSERM, UMR 564, Batiment Monteclair,4 Rue Larrey, F-49033 Angers 01, France.	hugues.gascan@univ-angers.fr			Association Francaise contre les Myopathies [9884]; Ciblage Moleculaire et Application Therapeutique (CIMATH)	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Ciblage Moleculaire et Application Therapeutique (CIMATH)	This work was supported by Association Francaise contre les Myopathies Grant 9884 and by the Ciblage Moleculaire et Application Therapeutique (CIMATH) program of the region Pays de la Loire. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chevalier S, 1996, J BIOL CHEM, V271, P14764, DOI 10.1074/jbc.271.25.14764; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Cognet I, 2005, J IMMUNOL METHODS, V301, P53, DOI 10.1016/j.jim.2005.03.012; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CURTIS R, 1993, NATURE, V365, P253, DOI 10.1038/365253a0; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Duff E, 2003, NUTR REV, V61, P423, DOI 10.1301/nr.2003.dec.423-426; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Guillet C, 1999, J NEUROSCI, V19, P1257; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Kalai M, 1997, BLOOD, V89, P1319, DOI 10.1182/blood.V89.4.1319; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; PANAYOTATOS N, 1995, J BIOL CHEM, V270, P14007, DOI 10.1074/jbc.270.23.14007; Perret D, 2004, J BIOL CHEM, V279, P43961, DOI 10.1074/jbc.M407686200; Peters M, 1998, BLOOD, V92, P3495, DOI 10.1182/blood.V92.10.3495.422k47_3495_3504; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Plun-Favreau H, 2003, J BIOL CHEM, V278, P27169, DOI 10.1074/jbc.M303168200; Plun-Favreau H, 2001, EMBO J, V20, P1692, DOI 10.1093/emboj/20.7.1692; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; Robledo O, 1996, J NEUROCHEM, V66, P1391; Rousseau F, 2006, P NATL ACAD SCI USA, V103, P10068, DOI 10.1073/pnas.0509598103; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530	60	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30341	30350		10.1074/jbc.M803239200	http://dx.doi.org/10.1074/jbc.M803239200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18728012	Green Published, hybrid			2022-12-25	WOS:000260366900078
J	Seifert, JP; Zhou, YX; Hicks, SN; Sondek, J; Harden, TK				Seifert, Jason P.; Zhou, Yixing; Hicks, Stephanie N.; Sondek, John; Harden, T. Kendall			Dual Activation of Phospholipase C-epsilon by Rho and Ras GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; PLECKSTRIN HOMOLOGY DOMAIN; PROTEIN-KINASE; RECEPTOR; STIMULATION; EFFECTOR; CALCIUM; ISOZYME; G-ALPHA(12); PHOSPHATES	Phospholipase C-epsilon (PLC-epsilon) is a highly elaborated PLC required for a diverse set of signaling pathways. Here we use a combination of cellular assays and studies with purified proteins to show that activated RhoA and Ras isoforms directly engage distinct regions of PLC-epsilon to stimulate its phospholipase activity. Purified PLC-epsilon was activated in a guanine nucleotide- and concentration-dependent fashion by purified lipidated K-Ras reconstituted in PtdIns(4,5) P2-containing phospholipid vesicles. Whereas mutation of two critical lysine residues within the second Ras-association domain of PLC-epsilon prevented K-Ras-dependent activation of the purified enzyme, guanine nucleotide-dependent activation by RhoA was retained. Deletion of a loop unique to PLC-epsilon eliminated its activation by RhoA but not H-Ras. In contrast, removal of the autoinhibitory X/Y-linker region of the catalytic core of PLC-epsilon markedly activates the enzyme (Hicks, S. N., Jezyk, M. R., Gershburg, S., Seifert, J. P., Harden, T. K., and Sondek, J. ( 2008) Mol. Cell, 31, 383-394), but PLC-epsilon lacking this regulatory region retained activation by both Rho and Ras GTPases. Additive activation of PLC-epsilon by RhoA and K- or H-Ras was observed in intact cell studies, and this additivity was recapitulated in experiments in which activation of purified PLC-epsilon was quantified with PtdIns( 4,5) P2-containing phospholipid vesicles reconstituted with purified, isoprenylated GTPases. A maximally effective concentration of activated RhoA also increased the sensitivity of purified PLC-epsilon to activation by K- Ras. These results indicate that PLC-epsilon can be directly and concomitantly activated by both RhoA and individual Ras GTPases resulting in diverse upstream control of signaling cascades downstream of PLC-epsilon.	[Seifert, Jason P.; Zhou, Yixing; Hicks, Stephanie N.; Sondek, John; Harden, T. Kendall] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Sondek, John; Harden, T. Kendall] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Sondek, John] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Harden, TK (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, CB 7365, Chapel Hill, NC 27599 USA.	tkh@med.unc.edu		Sondek, John/0000-0002-1127-8310	National Institutes of Health [GM57391, GM65533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM065533, R01GM057391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM57391 and GM65533. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baek KJ, 2001, J BIOL CHEM, V276, P5591, DOI 10.1074/jbc.M008252200; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BLANK JL, 1992, J BIOL CHEM, V267, P23069; BOYER JL, 1992, J BIOL CHEM, V267, P25451; BROWN HA, 1991, MOL PHARMACOL, V40, P648; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CANTLEY LC, 1986, ANN NY ACAD SCI, V488, P481; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Illenberger D, 2003, J BIOL CHEM, V278, P3006, DOI 10.1074/jbc.M208282200; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kim YH, 1999, J BIOL CHEM, V274, P26127, DOI 10.1074/jbc.274.37.26127; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Niggli V, 2005, ANNU REV CELL DEV BI, V21, P57, DOI 10.1146/annurev.cellbio.21.021704.102317; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; RHEE SG, 1992, J BIOL CHEM, V267, P12393; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Seifert JP, 2006, METHOD ENZYMOL, V406, P260, DOI 10.1016/S0076-6879(06)06019-8; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Tadano M, 2005, MOL CELL BIOL, V25, P2191, DOI 10.1128/MCB.25.6.2191-2199.2005; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WAKELAM MJO, 1986, NATURE, V323, P173, DOI 10.1038/323173a0; WALDO GL, 1991, J BIOL CHEM, V266, P14217; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; Yoda A, 2004, DEV BIOL, V268, P245, DOI 10.1016/j.ydbio.2003.12.028; Zhou YX, 2008, BIOCHEMISTRY-US, V47, P4410, DOI 10.1021/bi800044n; Zhou YX, 2005, BIOCHEM J, V391, P667, DOI 10.1042/BJ20050839	54	30	32	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29690	29698		10.1074/jbc.M805038200	http://dx.doi.org/10.1074/jbc.M805038200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18765661	Green Published, hybrid			2022-12-25	WOS:000260366900012
J	Xiao, D; Powolny, AA; Singh, SV				Xiao, Dong; Powolny, Anna A.; Singh, Shivendra V.			Benzyl Isothiocyanate Targets Mitochondrial Respiratory Chain to Trigger Reactive Oxygen Species-dependent Apoptosis in Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; PROSTATE-CANCER; PHENETHYL ISOTHIOCYANATE; CYCLE ARREST; BAX ACTIVATION; HUMAN PLASMA; DEATH; INHIBITION; INDUCTION; RISK	Benzyl isothiocyanate (BITC), a dietary cancer chemopreventive agent, causes apoptosis in MDA-MB-231 and MCF-7 human breast cancer cells, but the mechanism of cell death is not fully understood. We now demonstrate that the BITC-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species (ROS) due to inhibition of complex III of the mitochondrial respiratory chain. The BITC-induced ROS production and apoptosis were significantly inhibited by overexpression of catalase and Cu,Zn-superoxide dismutase and pharmacological inhibition of the mitochondrial respiratory chain. The mitochondrial DNA-deficient Rho-0 variant of MDA-MB-231 cells was nearly completely resistant to BITC-mediated ROS generation and apoptosis. The Rho-0 MDA-MB-231 cells also resisted BITC-mediated mitochondrial translocation (activation) of Bax. Biochemical assays revealed inhibition of complex III activity in BITC-treated MDA-MB-231 cells as early as at 1 h of treatment. The BITC treatment caused activation of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK), which function upstream of Bax activation in apoptotic response to various stimuli. Pharmacological inhibition of both JNK and p38 MAPK conferred partial yet significant protection against BITC-induced apoptosis. Activation of JNK and p38 MAPK resulting from BITC exposure was abolished by overexpression of catalase. The BITC-mediated conformational change of Bax was markedly suppressed by ectopic expression of catalytically inactive mutant of JNK kinase 2 (JNKK2(AA)). Interestingly, a normal human mammary epithelial cell line was resistant to BITC-mediated ROS generation, JNK/p38 MAPK activation, and apoptosis. In conclusion, the present study indicates that the BITC-induced apoptosis in human breast cancer cells is initiated by mitochondria-derived ROS.	Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, SV (corresponding author), 2-32A Hillman Canc Ctr Res Pavil,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	singhs@upmc.edu			National Institutes of Health; NCI [CA129347, CA101753]; NATIONAL CANCER INSTITUTE [R01CA101753, R01CA129347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants CA129347 and CA101753. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antosiewicz J, 2006, CANCER RES, V66, P5379, DOI 10.1158/0008-5472.CAN-06-0356; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Braithwaite RS, 2003, J GEN INTERN MED, V18, P937, DOI 10.1046/j.1525-1497.2003.20724.x; Buccellato LJ, 2004, J BIOL CHEM, V279, P6753, DOI 10.1074/jbc.M310145200; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Cauley JA, 1999, ANN INTERN MED, V130, P270, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00004; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Choi S, 2005, CANCER RES, V65, P2035, DOI 10.1158/0008-5472.CAN-04-3616; Choi S, 2007, CARCINOGENESIS, V28, P151, DOI 10.1093/carcin/bgl144; Cohen JH, 2000, JNCI-J NATL CANCER I, V92, P61, DOI 10.1093/jnci/92.1.61; Conaway CC, 2002, CURR DRUG METAB, V3, P233, DOI 10.2174/1389200023337496; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Cuzick J, 2002, LANCET, V360, P817; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fowke JH, 2003, CANCER RES, V63, P3980; Gilkerson RW, 2000, FEBS LETT, V474, P1, DOI 10.1016/S0014-5793(00)01527-1; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Hankinson SE, 1998, JNCI-J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; Hecht SS, 2000, DRUG METAB REV, V32, P395, DOI 10.1081/DMR-100102342; HULKA BS, 1995, LANCET, V346, P883, DOI 10.1016/S0140-6736(95)92713-1; Jakubikova J, 2005, INT J ONCOL, V27, P1449; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Ji Y, 2003, ANAL BIOCHEM, V323, P39, DOI 10.1016/j.ab.2003.08.011; Jiang JF, 2008, BIOCHEM BIOPH RES CO, V368, P145, DOI 10.1016/j.bbrc.2008.01.055; Kawakami M, 2005, BIOSCI BIOTECH BIOCH, V69, P2439, DOI 10.1271/bbb.69.2439; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim WH, 2004, MOL PHARMACOL, V66, P1383, DOI 10.1124/mol.104.001347; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KOLM RH, 1995, BIOCHEM J, V311, P453, DOI 10.1042/bj3110453; Kolonel LN, 2000, CANCER EPIDEM BIOMAR, V9, P795; Liebes L, 2001, ANAL BIOCHEM, V291, P279, DOI 10.1006/abio.2001.5030; LIN JM, 1993, CANCER LETT, V74, P151, DOI 10.1016/0304-3835(93)90237-4; Longpre JM, 2008, FREE RADICAL RES, V42, P533, DOI 10.1080/10715760802126692; Lui VWY, 2003, CARCINOGENESIS, V24, P1705, DOI 10.1093/carcin/bgg127; MacKenzie EL, 2008, FREE RADICAL BIO MED, V44, P1762, DOI 10.1016/j.freeradbiomed.2008.01.031; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; Mi LX, 2007, CANCER RES, V67, P6409, DOI 10.1158/0008-5472.CAN-07-0340; Miyoshi N, 2004, CANCER RES, V64, P2134, DOI 10.1158/0008-5472.CAN-03-2296; Nakamura Y, 2000, CANCER RES, V60, P219; Nakamura Y, 2002, J BIOL CHEM, V277, P8492, DOI 10.1074/jbc.M109760200; Narayanan PK, 1997, CANCER RES, V57, P3963; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; Ricci JE, 2003, CELL DEATH DIFFER, V10, P488, DOI 10.1038/sj.cdd.4401225; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Srivastava SK, 2004, CARCINOGENESIS, V25, P1701, DOI 10.1093/carcin/bgh179; SUGIE S, 1993, JPN J CANCER RES, V84, P865, DOI 10.1111/j.1349-7006.1993.tb02059.x; Talalay P, 2001, J NUTR, V131, p3027S, DOI 10.1093/jn/131.11.3027S; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Verloop J, 2000, J NATL CANCER I, V92, P128, DOI 10.1093/jnci/92.2.128; WATTENBERG LW, 1977, J NATL CANCER I, V58, P395, DOI 10.1093/jnci/58.2.395; Wu XJ, 2007, CANCER BIOL THER, V6, P646, DOI 10.4161/cbt.6.5.4092; Wu ZG, 1997, MOL CELL BIOL, V17, P7407, DOI 10.1128/MCB.17.12.7407; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Xiao D, 2006, CARCINOGENESIS, V27, P2223, DOI 10.1093/carcin/bgl087; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Yang YM, 2002, CANCER RES, V62, P2; Zhang YS, 2003, MOL CANCER THER, V2, P1045	69	130	131	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30151	30163		10.1074/jbc.M802529200	http://dx.doi.org/10.1074/jbc.M802529200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768478	hybrid, Green Published			2022-12-25	WOS:000260366900060
J	Hu, QC; Nelson, WJ; Spiliotis, ET				Hu, Qicong; Nelson, W. James; Spiliotis, Elias T.			Forchlorfenuron Alters Mammalian Septin Assembly, Organization, and Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; BREAST-CANCER; MICROTUBULE-BINDING; FILAMENT FORMATION; CELL-LINES; EXPRESSION; YEAST; GENE; CYTOKINESIS; SCAFFOLD	Septins are filamentous GTPases that associate with cell membranes and the cytoskeleton and play essential roles in cell division and cellular morphogenesis. Septins are implicated in many human diseases including cancer and neuropathies. Small molecules that reversibly perturb septin organization and function would be valuable tools for dissecting septin functions and could be used for therapeutic treatment of septin-related diseases. Forchlorfenuron (FCF) is a plant cytokinin previously shown to disrupt septin localization in budding yeast. However, it is unknown whether FCF directly targets septins and whether it affects septin organization and functions in mammalian cells. Here, we show that FCF alters septin assembly in vitro without affecting either actin or tubulin polymerization. In live mammalian cells, FCF dampens septin dynamics and induces the assembly of abnormally large septin structures. FCF has a low level of cytotoxicity, and these effects are reversed upon FCF washout. Significantly, FCF treatment induces mitotic and cell migration defects that phenocopy the effects of septin depletion by small interfering RNA. We conclude that FCF is a promising tool to study mammalian septin organization and functions.	[Hu, Qicong; Nelson, W. James; Spiliotis, Elias T.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Spiliotis, ET (corresponding author), Drexel Univ, Dept Biosci & Biotechnol, Philadelphia, PA 19104 USA.	ets33@drexel.edu			National Institutes of Health [GM35527]; Cell and Molecular Biology Training; Department of Defense Breast Cancer Research Program Predoctoral Fellowship [BC083077]; Stanford Digestive Disease Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035527, R01GM035527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell and Molecular Biology Training; Department of Defense Breast Cancer Research Program Predoctoral Fellowship(United States Department of Defense); Stanford Digestive Disease Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM35527 (to W. J. N.). This work was also supported by a Cell and Molecular Biology Training Grant and by grants from the Department of Defense Breast Cancer Research Program Predoctoral Fellowship BC083077 (to Q. H.) and the Stanford Digestive Disease Center (N. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnir S, 2007, CANCER BIOL THER, V6, P1926, DOI 10.4161/cbt.6.12.4971; Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Bulinski JC, 2001, J CELL SCI, V114, P3885; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Capurso G, 2005, NEUROENDOCRINOLOGY, V81, P311, DOI 10.1159/000088449; Chacko AD, 2005, J PATHOL, V206, P458, DOI 10.1002/path.1794; Craven RA, 2006, PROTEOMICS, V6, P2853, DOI 10.1002/pmic.200500549; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Iwase M, 2004, GENES GENET SYST, V79, P199, DOI 10.1266/ggs.79.199; Joo E, 2007, DEV CELL, V13, P677, DOI 10.1016/j.devcel.2007.09.001; Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06; Kinoshita A, 1998, AM J PATHOL, V153, P1551, DOI 10.1016/S0002-9440(10)65743-4; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Larisch S, 2004, CELL CYCLE, V3, P1021; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Mendoza M, 2002, CURR BIOL, V12, P1858, DOI 10.1016/S0960-9822(02)01258-7; Montagna C, 2003, CANCER RES, V63, P2179; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Nagata KI, 2005, ONCOGENE, V24, P65, DOI 10.1038/sj.onc.1208101; Pizarro-Cerda J, 2002, CELL MICROBIOL, V4, P101, DOI 10.1046/j.1462-5822.2002.00169.x; Russell SEH, 2005, BRIT J CANCER, V93, P499, DOI 10.1038/sj.bjc.6602753; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Turner DP, 2007, CANCER RES, V67, P1618, DOI 10.1158/0008-5472.CAN-06-2913; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; ZHU M, 2008, J BIOL CHEM	47	79	84	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29563	29571		10.1074/jbc.M804962200	http://dx.doi.org/10.1074/jbc.M804962200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18713753	Green Published, hybrid			2022-12-25	WOS:000260179900082
J	Mareeva, T; Martinez-Hackert, E; Sykulev, Y				Mareeva, Tatiana; Martinez-Hackert, Erik; Sykulev, Yuri			How a T Cell Receptor-like Antibody Recognizes Major Histocompatibility Complex-bound Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TCR-MHC INTERACTION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ANTIGEN; BINDING; SELF; CD8; CD8-ALPHA-ALPHA; MECHANISM; MOLECULE	We determined the crystal structures of the T cell receptor (TCR)-like antibody 25-D1.16 Fab fragment bound to a complex of SIINFEKL peptide from ovalbumin and the H-2K(b) molecule. Remarkably, this antibody directly "reads" the structure of the major histocompatibility complex (MHC)-bound peptide, employing the canonical diagonal binding mode utilized by most TCRs. This is in marked contrast with another TCR-like antibody, Hyb3, bound to melanoma peptide MAGE-A1 in association with HLA-A1 MHC class I. Hyb3 assumes a non-canonical orientation over its cognate peptide-MHC and appears to recognize a conformational epitope in which the MHC contribution is dominant. We conclude that TCR-like antibodies can recognize MHC-bound peptide via two different mechanisms: one is similar to that exploited by the preponderance of TCRs and the other requires a non-canonical antibody orientation over the peptide-MHC complex.	[Sykulev, Yuri] Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Martinez-Hackert, Erik] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Jefferson University; Columbia University	Sykulev, Y (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, BLSB 650, Philadelphia, PA 19107 USA.	ysykulev@mail.jci.tju.edu		Martinez-Hackert, Erik/0000-0002-6182-7023	National Institutes of Health Research [AI058755]; New York Structural Biology Center; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058755] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Structural Biology Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Research Grant AI058755 (to Y. S.). Beamline X4A at the National Synchrotron Light Source, a Department of Energy facility, was supported by the New York Structural Biology Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Buslepp J, 2003, J IMMUNOL, V170, P373, DOI 10.4049/jimmunol.170.1.373; Cho BK, 2001, P NATL ACAD SCI USA, V98, P1723, DOI 10.1073/pnas.98.4.1723; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Eisen H. N., 1997, ANTIGEN BINDING MOL, P1; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Gakamsky DM, 1996, BIOCHEMISTRY-US, V35, P14841, DOI 10.1021/bi961707u; Gakamsky DM, 1999, BIOCHEMISTRY-US, V38, P12165, DOI 10.1021/bi9905821; Gao GF, 2000, J BIOL CHEM, V275, P15232, DOI 10.1074/jbc.275.20.15232; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; HUBER R, 1974, J MOL BIOL, V89, P73, DOI 10.1016/0022-2836(74)90163-6; Hulsmeyer M, 2005, J BIOL CHEM, V280, P2972, DOI 10.1074/jbc.M411323200; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Li H, 1997, P NATL ACAD SCI USA, V94, P3584, DOI 10.1073/pnas.94.8.3584; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Mareeva T, 2004, J BIOL CHEM, V279, P44243, DOI 10.1074/jbc.M407021200; Markvicheva EA, 2000, APPL BIOCHEM BIOTECH, V88, P145, DOI 10.1385/ABAB:88:1-3:145; MARQUART M, 1983, ACTA CRYSTALLOGR B, V39, P480, DOI 10.1107/S010876818300275X; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Reay PA, 2000, J IMMUNOL, V164, P5626, DOI 10.4049/jimmunol.164.11.5626; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Yachi PP, 2007, J EXP MED, V204, P2747, DOI 10.1084/jem.20062610	37	33	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29053	29059		10.1074/jbc.M804996200	http://dx.doi.org/10.1074/jbc.M804996200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703505	Green Published, hybrid			2022-12-25	WOS:000260179900032
J	Bradnam, KR; Korf, I				Bradnam, Keith R.; Korf, Ian			Longer First Introns Are a General Property of Eukaryotic Gene Structure	PLOS ONE			English	Article								While many properties of eukaryotic gene structure are well characterized, differences in the form and function of introns that occur at different positions within a transcript are less well understood. In particular, the dynamics of intron length variation with respect to intron position has received relatively little attention. This study analyzes all available data on intron lengths in GenBank and finds a significant trend of increased length in first introns throughout a wide range of species. This trend was found to be even stronger when using high-confidence gene annotation data for three model organisms Arabidopsis thaliana, Caenorhabditis elegans, and Drosophila melanogaster) which show that the first intron in the 5' UTR is - on average - significantly longer than all downstream introns within a gene. A partial explanation for increased first intron length in A. thaliana is suggested by the increased frequency of certain motifs that are present in first introns. The phenomenon of longer first introns can potentially be used to improve gene prediction software and also to detect errors in existing gene annotations.	[Bradnam, Keith R.; Korf, Ian] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis	Bradnam, KR (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	krbradnam@ucdavis.edu	Bradnam, Keith/A-5570-2009	Bradnam, Keith/0000-0002-3881-294X	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work funded by NIH grant	Akashi H, 2006, GENETICS, V172, P1711, DOI 10.1534/genetics.105.049676; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Blumenthal T, 2003, NAT REV GENET, V4, P110, DOI 10.1038/nrg995; Chamary JV, 2004, MOL BIOL EVOL, V21, P1014, DOI 10.1093/molbev/msh087; Chen Y, 2003, P NATL ACAD SCI USA, V100, P11499, DOI 10.1073/pnas.1932834100; Chung BYW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-120; Collins L, 2006, MOL BIOL EVOL, V23, P901, DOI 10.1093/molbev/msj084; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Duret L, 2001, TRENDS GENET, V17, P172, DOI 10.1016/S0168-9525(01)02236-3; Gaffney DJ, 2006, PLOS GENET, V2, P1912, DOI 10.1371/journal.pgen.0020204; Gazave E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r21; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Ho SH, 2001, DEV DYNAM, V221, P422, DOI 10.1002/dvdy.1161; Hong X, 2006, MOL BIOL EVOL, V23, P2392, DOI 10.1093/molbev/msl111; Jeon JS, 2000, PLANT PHYSIOL, V123, P1005, DOI 10.1104/pp.123.3.1005; JONSSON JJ, 1992, NUCLEIC ACIDS RES, V20, P3191, DOI 10.1093/nar/20.12.3191; Kalari Krishna R., 2006, In Silico Biology, V6, P237; Keightley PD, 2003, P NATL ACAD SCI USA, V100, P13402, DOI 10.1073/pnas.2233252100; Kriventseva EV, 1999, J BIOMOL STRUCT DYN, V17, P281, DOI 10.1080/07391102.1999.10508361; Levy S, 2001, BIOINFORMATICS, V17, P871, DOI 10.1093/bioinformatics/17.10.871; Li SW, 2007, BIOCHEM BIOPH RES CO, V360, P586, DOI 10.1016/j.bbrc.2007.06.085; Lin K, 2005, NUCLEIC ACIDS RES, V33, P6522, DOI 10.1093/nar/gki970; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Marais G, 2005, GENETICS, V170, P481, DOI 10.1534/genetics.104.037333; MASCARENHAS D, 1990, PLANT MOL BIOL, V15, P913, DOI 10.1007/BF00039430; Morello L, 2002, PLANT J, V29, P33, DOI 10.1046/j.0960-7412.2001.01192.x; Nielsen H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-256; PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478; Reese MG, 2000, GENOME RES, V10, P529, DOI 10.1101/gr.10.4.529; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; Rogers A, 2008, NUCLEIC ACIDS RES, V36, pD612, DOI 10.1093/nar/gkm975; Rose AB, 1997, PLANT J, V11, P455, DOI 10.1046/j.1365-313X.1997.11030455.x; Rose AB, 2002, RNA, V8, P1444, DOI 10.1017/S1355838202020551; Rose AB, 2008, PLANT CELL, V20, P543, DOI 10.1105/tpc.107.057190; RUSSELL CB, 1994, NUCLEIC ACIDS RES, V22, P1221, DOI 10.1093/nar/22.7.1221; Sakurai A, 2002, GENE, V300, P89, DOI 10.1016/S0378-1119(02)01035-1; SMITH MW, 1988, J MOL EVOL, V27, P45, DOI 10.1007/BF02099729; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stenoien HK, 2007, J EVOLUTION BIOL, V20, P1223, DOI 10.1111/j.1420-9101.2007.01301.x; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vinogradov AE, 2006, GENOME RES, V16, P347, DOI 10.1101/gr.4318206; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930	46	83	90	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3093	10.1371/journal.pone.0003093	http://dx.doi.org/10.1371/journal.pone.0003093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769727	Green Published, Green Submitted, gold			2022-12-25	WOS:000264796800003
J	Chrisanthar, R; Knappskog, S; Lokkevik, E; Anker, G; Ostenstad, B; Lundgren, S; Berge, EO; Risberg, T; Mjaaland, I; Maehle, L; Engebretsen, LF; Lillehaug, JR; Lonning, PE				Chrisanthar, Ranjan; Knappskog, Stian; Lokkevik, Erik; Anker, Gun; Ostenstad, Bjorn; Lundgren, Steinar; Berge, Elisabet O.; Risberg, Terje; Mjaaland, Ingvil; Maehle, Lovise; Engebretsen, Lars Fredrik; Lillehaug, Johan Richard; Lonning, Per Eystein			CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer	PLOS ONE			English	Article								Background: Chemoresistance is the main obstacle to cure in most malignant diseases. Anthracyclines are among the main drugs used for breast cancer therapy and in many other malignant conditions. Single parameter analysis or global gene expression profiles have failed to identify mechanisms causing in vivo resistance to anthracyclines. While we previously found TP53 mutations in the L2/L3 domains to be associated with drug resistance, some tumors harboring wild-type TP53 were also therapy resistant. The aim of this study was; 1) To explore alterations in the TP53 gene with respect to resistance to a regular dose epirubicin regimen (90 mg/m(2) every 3 week) in patients with primary, locally advanced breast cancer; 2) Identify critical mechanisms activating p53 in response to DNA damage in breast cancer; 3) Evaluate in vitro function of Chk2 and p14 proteins corresponding to identified mutations in the CHEK2 and p14((ARF)) genes; and 4) Explore potential CHEK2 or p14((ARF)) germline mutations with respect to family cancer incidence. Methods and Findings: Snap-frozen biopsies from 109 patients collected prior to epirubicin (as preoperative therapy were investigated for TP53, CHEK2 and p14((ARF)) mutations by sequencing the coding region and p14((ARF)) promoter methylations. TP53 mutastions were associated with chemoresistance, defined as progressive disease on therapy (p = 0.0358; p = 0.0136 for mutations affecting p53 loop domains L2/L3). Germline CHEK2 mutations (n = 3) were associated with therapy resistance (p = 0.0226). Combined, mutations affecting either CHEK2 or TP53 strongly predicted therapy resistance (p = 0.0101; TP53 mutations restricted to the L2/L3 domains: p = 0.0032). Two patients progressing on therapy harbored the CHEK2 mutation, Arg95Ter, completely abrogating Chk2 protein dimerization and kinase activity. One patient (Epi132) revealed family cancer occurrence resembling families harboring CHEK2 mutations in general, the other patient (epi203) was non-conclusive. No mutation or promoter hypermethylation in p14((ARF)) were detected. Conclusion: This study is the first reporting an association between CHEK2 mutations and therapy resistance in human cancers and to document mutations in two genes acting direct up/down-stream to each other to cause therapy failure, emphasizing the need to investigate functional cascades in future studies.	[Chrisanthar, Ranjan; Knappskog, Stian; Anker, Gun; Lonning, Per Eystein] Univ Bergen, Sect Oncol, Inst Med, Bergen, Norway; [Chrisanthar, Ranjan; Knappskog, Stian; Anker, Gun; Lonning, Per Eystein] Haukeland Hosp, Dept Oncol, Bergen, Norway; [Chrisanthar, Ranjan; Knappskog, Stian; Berge, Elisabet O.; Lillehaug, Johan Richard] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Lokkevik, Erik] Rikshospitalet Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway; [Ostenstad, Bjorn] Ullevaal Univ Hosp, Dept Oncol, Oslo, Norway; [Lundgren, Steinar] St Olavs Univ Hosp, Dept Oncol, Trondheim, Norway; [Risberg, Terje] Univ Tromso, Inst Clin Med, Univ Hosp N Norway, Dept Oncol, Tromso, Norway; [Mjaaland, Ingvil] Stavanger Univ Hosp, Div Hematol & Oncol, Stavanger, Norway; [Maehle, Lovise] Rikshospitalet Univ Hosp, Dept Med Genet, Oslo, Norway; [Engebretsen, Lars Fredrik] Haukeland Hosp, Ctr Med Genet & Mol Med, Bergen, Norway; [Lundgren, Steinar] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Trondheim, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; National Hospital Norway; University of Oslo; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University Hospital of North Norway; Stavanger University Hospital; University of Oslo; National Hospital Norway; University of Bergen; Haukeland University Hospital; Norwegian University of Science & Technology (NTNU)	Chrisanthar, R (corresponding author), Univ Bergen, Sect Oncol, Inst Med, Bergen, Norway.	per.lonning@helse-bergen.no		Lonning, Per Eystein/0000-0002-8890-6303; Knappskog, Stian/0000-0002-4153-1655	Norwegian Cancer Society; Rosa sloyfe Breast Cancer Fund Raising; Norwegian Health Region West (HelseVest) [fellowship]; Innovest program of Excellence	Norwegian Cancer Society(Norwegian Cancer Society); Rosa sloyfe Breast Cancer Fund Raising; Norwegian Health Region West (HelseVest); Innovest program of Excellence	This work was supported by grants from the Norwegian Cancer Society, the "Rosa sloyfe" Breast Cancer Fund Raising, the Norwegian Health Region West (HelseVest) and the Innovest program of Excellence. Ranjan Chrisanthar was a recipient of a fellowship from Helse Vest. The Clinical Trial research office is financially supported by the Norwegian Cancer Society. None of the funders had any role with respect to study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Alba E, 2004, J CLIN ONCOL, V22, P2587, DOI 10.1200/JCO.2004.08.125; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Berns EMJJ, 1998, BRIT J CANCER, V77, P1130, DOI 10.1038/bjc.1998.187; Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; BORRESEN AL, 1995, GENE CHROMOSOME CANC, V14, P71, DOI 10.1002/gcc.2870140113; Buscemi G, 2004, ONCOGENE, V23, P7691, DOI 10.1038/sj.onc.1207986; Chehab NH, 2000, GENE DEV, V14, P278; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen C, 2005, BIOCHEM BIOPH RES CO, V333, P427, DOI 10.1016/j.bbrc.2005.05.126; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2003, J CLIN IMMUNOL, V23, P355, DOI 10.1023/A:1025365432325; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; CLANTZ SA, 2002, PRIMER BIOSTATISTICS; Early Breast Cancer Trialists' Collaborative G., 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; ENOCH T, 1995, TRENDS BIOCHEM SCI, V20, P426, DOI 10.1016/S0968-0004(00)89093-3; Evans DG, 2008, J MED GENET, V45, P63, DOI 10.1136/jmg.2007.054700; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Falck J, 2001, ONCOGENE, V20, P5503, DOI 10.1038/sj.onc.1204811; Geisler S, 2003, CLIN CANCER RES, V9, P5582; Geisler S, 2001, CANCER RES, V61, P2505; Gurley KE, 2007, MOL CANCER RES, V5, P1312, DOI 10.1158/1541-7786.MCR-07-0223; HAHN M, 1993, CLIN CHEM, V39, P549; HALAZONETIS TD, 1993, EMBO J, V12, P5057, DOI 10.1002/j.1460-2075.1993.tb06199.x; Hannemann J, 2005, J CLIN ONCOL, V23, P3331, DOI 10.1200/JCO.2005.09.077; HAYWARD JL, 1977, BRIT J CANCER, V35, P292, DOI 10.1038/bjc.1977.42; Hernandez-Boussard T, 1999, HUM MUTAT, V14, P1; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; JONES MH, 1992, GENE CHROMOSOME CANC, V5, P89, DOI 10.1002/gcc.2870050113; Kandioler-Eckersberger D, 2000, CLIN CANCER RES, V6, P50; Khan S, 2004, ONCOGENE, V23, P6040, DOI 10.1038/sj.onc.1207824; Knoop AS, 2005, J CLIN ONCOL, V23, P7483, DOI 10.1200/JCO.2005.11.007; KRAJEWSKI S, 1995, CANCER RES, V55, P4471; Lee S, 2003, CURR OPIN GENET DEV, V13, P90, DOI 10.1016/S0959-437X(02)00014-X; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; Lonning PE, 2007, ANN ONCOL, V18, P1293, DOI 10.1093/annonc/mdm013; Lonning PE, 2005, NAT CLIN PRACT ONCOL, V2, P26, DOI 10.1038/ncponc0072; Lonning PE, 2004, TRENDS MOL MED, V10, P113, DOI 10.1016/j.molmed.2004.01.005; Lonning PE, 2003, LANCET ONCOL, V4, P177; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Nister M, 2005, ONCOGENE, V24, P3563, DOI 10.1038/sj.onc.1208354; Norberg T, 2001, CANCER RES, V61, P8317; Palmero I, 2002, ONCOGENE, V21, P2939, DOI 10.1038/sj/onc/1205371; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; Pivot X, 1999, INT J ONCOL, V15, P381; Reddy A, 2002, BRIT J CANCER, V86, P756, DOI 10.1038/sj.bjc.6600131; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Sekaric P, 2007, ONCOGENE, V26, P6261, DOI 10.1038/sj.onc.1210462; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Skotheim RI, 2001, CANCER GENET CYTOGEN, V127, P64, DOI 10.1016/S0165-4608(00)00433-7; Sorlie T, 2006, MOL CANCER THER, V5, P2914, DOI 10.1158/1535-7163.MCT-06-0126; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Staalesen V, 2004, ONCOGENE, V23, P8535, DOI 10.1038/sj.onc.1207928; Staalesen V, 2006, CLIN CANCER RES, V12, P6000, DOI 10.1158/1078-0432.CCR-05-2822; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Sullivan A, 2002, ONCOGENE, V21, P1316, DOI 10.1038/sj.onc.1205207; Tanner M, 2006, J CLIN ONCOL, V24, P2428, DOI 10.1200/JCO.2005.02.9264; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thuerigen O, 2006, J CLIN ONCOL, V24, P1839, DOI 10.1200/JCO.2005.04.7019; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tsang WP, 2005, INT J CANCER, V114, P331, DOI 10.1002/ijc.20818; Varley JM, 2003, HUM MUTAT, V21, P313, DOI 10.1002/humu.10185; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weischer M, 2007, J CLIN ONCOL, V25, P57, DOI 10.1200/JCO.2005.05.5160; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200	74	68	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3062	10.1371/journal.pone.0003062	http://dx.doi.org/10.1371/journal.pone.0003062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725978	Green Published, Green Submitted, gold			2022-12-25	WOS:000264796300008
J	Lee, H; Leamey, CA; Sawatari, A				Lee, Hyunchul; Leamey, Catherine A.; Sawatari, Atomu			Rapid Reversal of Chondroitin Sulfate Proteoglycan Associated Staining in Subcompartments of Mouse Neostriatum during the Emergence of Behaviour	PLOS ONE			English	Article							STRIATAL PROJECTION NEURONS; PARVALBUMIN-CONTAINING NEURONS; FAST-SPIKING INTERNEURONS; MONKEY CAUDATE NEURONS; PERINEURONAL NETS; EXTRACELLULAR-MATRIX; DOPAMINE NEURONS; BASAL GANGLIA; RAT-BRAIN; GABAERGIC INTERNEURONS	Background: The neostriatum, the mouse homologue of the primate caudate/putamen, is the input nucleus for the basal ganglia, receiving both cortical and dopaminergic input to each of its sub-compartments, the striosomes and matrix. The coordinated activation of corticostriatal pathways is considered vital for motor and cognitive abilities, yet the mechanisms which underlie the generation of these circuits are unknown. The early and specific targeting of striatal subcompartments by both corticostriatal and nigrostriatal terminals suggests activity-independent mechanisms, such as axon guidance cues, may play a role in this process. Candidates include the chondroitin sulfate proteoglycan (CSPG) family of glycoproteins which have roles not only in axon guidance, but also in the maturation and stability of neural circuits where they are expressed in lattice-like perineuronal nets (PNNs). Methodology/Principal Findings: The expression of CSPG-associated structures and PNNs with respect to neostriatal subcompartments has been examined qualitatively and quantitatively using double-labelling for Wisteria floribunda agglutinin (WFA), and the mu-opioid receptor (mu OR), a marker for striosomes, at six postnatal ages in mice. We find that at the earliest ages (postnatal day (P) 4 and P10), WFA-positive clusters overlap preferentially with the striosome compartment. By P14, these clusters disappear. In contrast, PNNs were first seen at P10 and continued to increase in density and spread throughout the caudate/putamen with maturation. Remarkably, the PNNs overlap almost exclusively with the neostriatal matrix. Conclusions/Significance: This is the first description of a reversal in the distribution of CSPG associated structures, as well as the emergence and maintenance of PNNs in specific subcompartments of the neostriatum. These results suggest diverse roles for CSPGs in the formation of functional corticostriatal and nigrostriatal connectivity within the striosome and matrix compartments of the developing caudate/putamen.	[Lee, Hyunchul; Leamey, Catherine A.; Sawatari, Atomu] Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia; [Lee, Hyunchul; Leamey, Catherine A.; Sawatari, Atomu] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Lee, H (corresponding author), Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia.	atomu@medsci.usyd.edu.au		Leamey, Catherine/0000-0002-3390-4933; Lee, Hyunchul/0000-0002-1427-6521	University of Sydney; NHMRC; Simons Foundation	University of Sydney(University of Sydney); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Simons Foundation	University of Sydney Research and Development Grant (AS), NHMRC Project Grant and Simons Foundation (CAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams I, 2001, NEUROSCIENCE, V108, P285, DOI 10.1016/S0306-4522(01)00419-5; Ajmo JM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-14; Alpar A, 2006, BRAIN RES, V1120, P13, DOI 10.1016/j.brainres.2006.08.069; ANDERSON KD, 1990, J COMP NEUROL, V295, P339, DOI 10.1002/cne.902950302; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; BENNETT BD, 1994, NEUROSCIENCE, V62, P707, DOI 10.1016/0306-4522(94)90471-5; Bracci E, 2002, J NEUROPHYSIOL, V87, P2190, DOI 10.1152/jn.00754.2001; BRAUER K, 1993, BRAIN RES, V631, P167, DOI 10.1016/0006-8993(93)91205-7; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Bruckner G, 1996, BRAIN RES, V720, P84, DOI 10.1016/0006-8993(96)00152-7; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; Bruckner G, 1996, J NEUROCYTOL, V25, P333, DOI 10.1007/BF02284806; BRUCKNER G, 1994, BRAIN RES, V658, P67; BRUCKNER G, 1994, J CHEM NEUROANAT, V8, P11, DOI 10.1016/0891-0618(94)90032-9; Bruckner G, 2003, J CHEM NEUROANAT, V26, P37, DOI 10.1016/S0891-0618(03)00036-X; CABOCHE J, 1991, DEV BRAIN RES, V58, P111, DOI 10.1016/0165-3806(91)90243-C; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Centonze D, 2003, J NEUROSCI, V23, P6245; CHANG HT, 1992, BRAIN RES, V574, P307, DOI 10.1016/0006-8993(92)90830-3; Charvet I, 1998, DEV BRAIN RES, V109, P229, DOI 10.1016/S0165-3806(98)00088-1; Charvet I, 1998, J NEUROSCI RES, V51, P612, DOI 10.1002/(SICI)1097-4547(19980301)51:5<612::AID-JNR8>3.0.CO;2-I; CHESSELET MF, 1983, LIFE SCI, V33, P37, DOI 10.1016/0024-3205(83)90438-1; COLE GJ, 1991, NEURON, V7, P1007, DOI 10.1016/0896-6273(91)90345-Z; Costa C, 2007, J CHEM NEUROANAT, V33, P111, DOI 10.1016/j.jchemneu.2007.01.006; COWAN RL, 1990, J COMP NEUROL, V302, P197, DOI 10.1002/cne.903020202; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; DONOGHUE JP, 1986, BRAIN RES, V365, P397, DOI 10.1016/0006-8993(86)91658-6; EDLEY SM, 1982, BRAIN RES, V249, P184, DOI 10.1016/0006-8993(82)90186-X; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; GATES MA, 1993, J CHEM NEUROANAT, V6, P179, DOI 10.1016/0891-0618(93)90040-B; GERFEN CR, 1985, J COMP NEUROL, V236, P454, DOI 10.1002/cne.902360404; GERFEN CR, 1987, J NEUROSCI, V7, P3915; GERFEN CR, 1984, NATURE, V311, P461, DOI 10.1038/311461a0; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; GERFEN CR, 1988, BRAIN RES, V460, P161, DOI 10.1016/0006-8993(88)91217-6; GIMENEZAMAYA JM, 1991, J NEUROSCI, V11, P779; GRAYBIEL AM, 1984, P NATL ACAD SCI-BIOL, V81, P7980, DOI 10.1073/pnas.81.24.7980; Grigoriadis N, 1996, PEDIATR NEUROL, V14, P41, DOI 10.1016/0887-8994(95)00225-1; HARTIG W, 1992, NEUROREPORT, V3, P869; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; HATTORI T, 1973, EXP NEUROL, V38, P70, DOI 10.1016/0014-4886(73)90008-3; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hoover JE, 2003, J NEUROPHYSIOL, V89, P1576, DOI 10.1152/jn.01009.2002; INIGUEZ C, 1990, DEV BRAIN RES, V57, P43, DOI 10.1016/0165-3806(90)90183-Y; Jacobs EC, 2007, EUR J NEUROSCI, V25, P17, DOI 10.1111/j.1460-9568.2006.05258.x; Janis LS, 1999, J NEUROSCI, V19, P4962; JIMENEZCASTELLANOS J, 1989, NEUROSCIENCE, V32, P297, DOI 10.1016/0306-4522(89)90080-8; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; KIMURA M, 1992, EXP BRAIN RES, V89, P473; KIMURA M, 1993, ADV NEUROL, V60, P62; Kincaid AE, 1998, J NEUROSCI, V18, P4722, DOI 10.1523/jneurosci.18-12-04722.1998; Kincaid AE, 1996, J COMP NEUROL, V374, P578; Kita H, 1996, NEUROSCIENCE, V70, P925, DOI 10.1016/0306-4522(95)00410-6; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; Koppe G, 1997, CELL TISSUE RES, V288, P33, DOI 10.1007/s004410050790; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; Leamey CA, 2008, CEREB CORTEX, V18, P53, DOI 10.1093/cercor/bhm031; Lee IH, 2006, J NEUROPHYSIOL, V95, P2391, DOI 10.1152/jn.01053.2005; Lee IH, 2003, J NEUROPHYSIOL, V89, P2528, DOI 10.1152/jn.01055.2002; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Levesque M, 2005, P NATL ACAD SCI USA, V102, P11888, DOI 10.1073/pnas.0502710102; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; Mace K, 2002, J NEUROSCI RES, V70, P46, DOI 10.1002/jnr.10381; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Matsui F, 1998, BRAIN RES, V790, P45, DOI 10.1016/S0006-8993(98)00009-2; McEwen ML, 1997, DEV PSYCHOBIOL, V30, P313, DOI 10.1002/(SICI)1098-2302(199705)30:4<313::AID-DEV5>3.0.CO;2-R; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Murakami T, 1997, ARCH HISTOL CYTOL, V60, P347, DOI 10.1679/aohc.60.347; Murakami T, 1999, ARCH HISTOL CYTOL, V62, P273, DOI 10.1679/aohc.62.273; Nagy A, 2006, EUR J NEUROSCI, V24, P917, DOI 10.1111/j.1460-9568.2006.04942.x; Nisenbaum LK, 1998, DEV NEUROSCI-BASEL, V20, P113, DOI 10.1159/000017307; OKANO K, 1987, EXP BRAIN RES, V66, P155; OOHIRA A, 1988, J BIOL CHEM, V263, P10240; OOHIRA A, 1994, NEUROSCI RES, V20, P195, DOI 10.1016/0168-0102(94)90088-4; OOHIRA A, 1994, NEUROSCIENCE, V60, P145, DOI 10.1016/0306-4522(94)90210-0; PARENT A, 1989, NEUROSCI LETT, V96, P140, DOI 10.1016/0304-3940(89)90047-5; Parthasarathy HB, 1997, J NEUROSCI, V17, P2477; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Plotkin JL, 2005, EUR J NEUROSCI, V22, P1097, DOI 10.1111/j.1460-9568.2005.04303.x; Ramanathan S, 2002, J NEUROSCI, V22, P8158; Reimers S, 2007, EUR J NEUROSCI, V25, P2640, DOI 10.1111/j.1460-9568.2007.05514.x; Satoh T, 2003, J NEUROSCI, V23, P9913; Schlosser B, 1999, J COMP NEUROL, V405, P185, DOI 10.1002/(SICI)1096-9861(19990308)405:2<185::AID-CNE4>3.0.CO;2-B; SCHULTZ W, 1993, PROG BRAIN RES, V99, P227; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Sieber BA, 2004, MOL CELL NEUROSCI, V26, P418, DOI 10.1016/j.mcn.2004.03.009; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; SUR M, 1988, J NEUROSCI, V8, P874; TEPPER JM, BRAIN RES REV; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; VANDERKOOY D, 1984, DEV BRAIN RES, V14, P300, DOI 10.1016/0165-3806(84)90318-3; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Wang HB, 2007, NEUROSCI LETT, V425, P195, DOI 10.1016/j.neulet.2007.08.033; Wegner F, 2003, EXP NEUROL, V184, P705, DOI 10.1016/S0014-4886(03)00313-3; WELKER C, 1974, J COMP NEUROL, V158, P437, DOI 10.1002/cne.901580405; WOOLSEY TA, 1975, J COMP NEUROL, V164, P79, DOI 10.1002/cne.901640107; Wu Y, 2000, NEUROSCI RES, V38, P49, DOI 10.1016/S0168-0102(00)00140-1; YOUNG NM, 1985, CAN J BIOCHEM CELL B, V63, P268, DOI 10.1139/o85-039	115	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3020	10.1371/journal.pone.0003020	http://dx.doi.org/10.1371/journal.pone.0003020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714376	Green Submitted, Green Published, gold			2022-12-25	WOS:000264420900043
J	Martin, KJ; Patrick, DR; Bissell, MJ; Fournier, MV				Martin, Katherine J.; Patrick, Denis R.; Bissell, Mina J.; Fournier, Marcia V.			Prognostic Breast Cancer Signature Identified from 3D Culture Model Accurately Predicts Clinical Outcome across Independent Datasets	PLOS ONE			English	Article								Background: One of the major tenets in breast cancer research is that early detection is vital for patient survival by increasing treatment options. To that end, we have previously used a novel unsupervised approach to identify a set of genes whose expression predicts prognosis of breast cancer patients. The predictive genes were selected in a well-defined three dimensional (3D) cell culture model of non-malignant human mammary epithelial cell morphogenesis as downregulated during breast epithelial cell acinar formation and cell cycle arrest. Here we examine the ability of this gene signature (3D-signature) to predict prognosis in three independent breast cancer microarray datasets having 295, 286, and 118 samples, respectively. Methods and Findings: Our results show that the 3D-signature accurately predicts prognosis in three unrelated patient datasets. At 10 years, the probability of positive outcome was 52, 51, and 47 percent in the group with a poor-prognosis signature and 91, 75, and 71 percent in the group with a good-prognosis signature for the three datasets, respectively (Kaplan-Meier survival analysis, p<0.05). Hazard ratios for poor outcome were 5.5 (95% CI 3.0 to 12.2, p<0.0001), 2.4 (95% CI 1.6 to 3.6, p<0.0001) and 1.9 (95% CI 1.1 to 3.2, p = 0.016) and remained significant for the two larger datasets when corrected for estrogen receptor (ER) status. Hence the 3D-signature accurately predicts breast cancer outcome in both ER-positive and ER-negative tumors, though individual genes differed in their prognostic ability in the two subtypes. Genes that were prognostic in ER+ patients are AURKA, CEP55, RRM2, EPHA2, FGFBP1, and VRK1, while genes prognostic in ER-patients include ACTB, FOXM1 and SERPINE2 (Kaplan-Meier p<0.05). Multivariable Cox regression analysis in the largest dataset showed that the 3D-signature was a strong independent factor in predicting breast cancer outcome. Conclusions: The 3D-signature accurately predicts breast cancer outcome across multiple datasets and holds prognostic value for both ER-positive and ER-negative breast cancer. The signature was selected using a novel biological approach and hence holds promise to represent the key biological processes of breast cancer.	[Martin, Katherine J.] Bioarray Consulting, Belmont, MA USA; [Patrick, Denis R.; Fournier, Marcia V.] GlaxoSmithKline, Oncol Ctr Excellence Drug Discovery, Dept Oncol Biol, Collegeville, PA USA; [Bissell, Mina J.] Lawrence Berkeley Natl Lab, Berkeley, CA USA	GlaxoSmithKline; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Martin, KJ (corresponding author), Bioarray Consulting, Belmont, MA USA.	Marcia.V.Fournier@GSK.com	Teh, Muy-Teck/B-9284-2016	Teh, Muy-Teck/0000-0002-7725-8355	GlaxoSmithKline; Office of Biological and Environmental Research (OBER) of the U.S. Department of Energy [DE-AC02-05CH11231]; Distinguished Fellow Award; Low Dose Radiation Program and the Office of Health and Environmental Research, Health Effects Division [03-76SF00098]; National Cancer Institute [R01CA064786, U54CA126552, U54CA112970-01]; NATIONAL CANCER INSTITUTE [U54CA126552, U54CA112970, R01CA064786] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Office of Biological and Environmental Research (OBER) of the U.S. Department of Energy(United States Department of Energy (DOE)); Distinguished Fellow Award; Low Dose Radiation Program and the Office of Health and Environmental Research, Health Effects Division; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	GlaxoSmithKline. MJB is supported by grants from the Office of Biological and Environmental Research (OBER) of the U.S. Department of Energy (DE-AC02-05CH11231), a Distinguished Fellow Award; Low Dose Radiation Program and the Office of Health and Environmental Research, Health Effects Division (03-76SF00098); by National Cancer Institute awards R01CA064786, U54CA126552 and U54CA112970-01.	Acharya CR, 2008, JAMA-J AM MED ASSOC, V299, P1574, DOI 10.1001/jama.299.13.1574; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bin Fang W, 2005, ONCOGENE, V24, P7859, DOI 10.1038/sj.onc.1208937; Bissell MJ, 2007, BIOCHEM SOC T, V35, P18, DOI 10.1042/BST0350018; Branca M, 2003, SCIENCE, V300, P238, DOI 10.1126/science.300.5617.238; Brantley-Sieders DM, 2005, FASEB J, V19, P1884, DOI 10.1096/fj.05-4038fje; Carles-Kinch K, 2002, CANCER RES, V62, P2840; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Edgren H, 2006, CANCER CELL, V10, P453, DOI 10.1016/j.ccr.2006.11.007; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Esteva FJ, 2004, BREAST CANCER RES, V6, P109, DOI 10.1186/bcr777; Fournier MV, 2006, CANCER RES, V66, P7095, DOI 10.1158/0008-5472.CAN-06-0515; Gruvberger SK, 2003, BREAST CANCER RES, V5, P23, DOI 10.1186/bcr548; Hinestrosa MC, 2007, NAT REV CANCER, V7, P309, DOI 10.1038/nrc2113; Loi S, 2007, CRIT REV ONCOL HEMAT, V61, P187, DOI 10.1016/j.critrevonc.2006.09.005; Lu M, 2003, CANCER RES, V63, P3425; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Teschendorff AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r101; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; 2007, CANC FACTS FIGURES	29	174	184	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2994	10.1371/journal.pone.0002994	http://dx.doi.org/10.1371/journal.pone.0002994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714348	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900020
J	Musgrove, EA; Sergio, CM; Loi, S; Inman, CK; Anderson, LR; Alles, MC; Pinese, M; Caldon, CE; Schutte, J; Gardiner-Garden, M; Ormandy, CJ; McArthur, G; Butt, AJ; Sutherland, RL				Musgrove, Elizabeth A.; Sergio, C. Marcelo; Loi, Sherene; Inman, Claire K.; Anderson, Luke R.; Alles, M. Chehani; Pinese, Mark; Caldon, C. Elizabeth; Schuette, Judith; Gardiner-Garden, Margaret; Ormandy, Christopher J.; McArthur, Grant; Butt, Alison J.; Sutherland, Robert L.			Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer	PLOS ONE			English	Article							DNA-REPLICATION; GROWTH-FACTOR; CYCLIN D1; ANTIESTROGEN RESISTANCE; TRANSCRIPTION FACTOR; ENDOCRINE THERAPY; MCF-7 CELLS; EXPRESSION; RECEPTOR; SURVIVAL	Background: Estrogen is a pivotal regulator of cell proliferation in the normal breast and breast cancer. Endocrine therapies targeting the estrogen receptor are effective in breast cancer, but their success is limited by intrinsic and acquired resistance. Methodology/Principal Findings: With the goal of gaining mechanistic insights into estrogen action and endocrine resistance, we classified estrogen-regulated genes by function, and determined the relationship between functionally-related genesets and the response to tamoxifen in breast cancer patients. Estrogen-responsive genes were identified by transcript profiling of MCF-7 breast cancer cells. Pathway analysis based on functional annotation of these estrogen-regulated genes identified gene signatures with known or predicted roles in cell cycle control, cell growth (i.e. ribosome biogenesis and protein synthesis), cell death/survival signaling and transcriptional regulation. Since inducible expression of c-Myc in antiestrogen-arrested cells can recapitulate many of the effects of estrogen on molecular endpoints related to cell cycle progression, the estrogen-regulated genes that were also targets of c-Myc were identified using cells inducibly expressing c-Myc. Selected genes classified as estrogen and c-Myc targets displayed similar levels of regulation by estrogen and c-Myc and were not estrogen-regulated in the presence of siMyc. Genes regulated by c-Myc accounted for 50% of all acutely estrogen-regulated genes but comprised 85% (110/129 genes) in the cell growth signature. siRNA-mediated inhibition of c-Myc induction impaired estrogen regulation of ribosome biogenesis and protein synthesis, consistent with the prediction that estrogen regulates cell growth principally via c-Myc. The 'cell cycle', 'cell growth' and 'cell death' gene signatures each identified patients with an attenuated response in a cohort of 246 tamoxifen-treated patients. In multivariate analysis the cell death signature was predictive independent of the cell cycle and cell growth signatures. Conclusions/Significance: These functionally-based gene signatures can stratify patients treated with tamoxifen into groups with differing outcome, and potentially identify distinct mechanisms of tamoxifen resistance.	[Musgrove, Elizabeth A.; Sergio, C. Marcelo; Inman, Claire K.; Anderson, Luke R.; Alles, M. Chehani; Pinese, Mark; Caldon, C. Elizabeth; Schuette, Judith; Gardiner-Garden, Margaret; Ormandy, Christopher J.; Butt, Alison J.; Sutherland, Robert L.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Musgrove, Elizabeth A.; Anderson, Luke R.; Alles, M. Chehani; Caldon, C. Elizabeth; Ormandy, Christopher J.; Butt, Alison J.; Sutherland, Robert L.] Univ New S Wales NSW, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia; [Loi, Sherene; McArthur, Grant] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [McArthur, Grant] Univ Melbourne, St Vincents Hosp, Dept Med, Parkville, Vic 3052, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Melbourne	Musgrove, EA (corresponding author), Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia.	e.musgrove@garvan.org.au	Ormandy, Chris/G-4165-2014; Caldon, Liz/C-1559-2009; Sutherland, Robert L/A-8378-2008; Anderson, Luke/D-1780-2012; Loi, Sherene/H-1979-2016	Caldon, Liz/0000-0003-1392-3472; Anderson, Luke/0000-0003-3654-1258; Loi, Sherene/0000-0001-6137-9171; Ormandy, Christopher/0000-0002-2504-7919; Pinese, Mark/0000-0001-5078-6687; Butt, Alison/0000-0002-6216-5105	Association for International Cancer Research; National Health and Medical Research Council of Australia; Cancer Institute NSW; Australian Cancer Research Foundation (ACRF Unit for the Molecular Genetics of Cancer); Cure Cancer Australia; Petre Foundation; RT Hall Trust; National Breast Cancer Foundation	Association for International Cancer Research; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; Australian Cancer Research Foundation (ACRF Unit for the Molecular Genetics of Cancer); Cure Cancer Australia; Petre Foundation; RT Hall Trust; National Breast Cancer Foundation	This research was supported by the Association for International Cancer Research, the National Health and Medical Research Council of Australia, the Cancer Institute NSW, the Australian Cancer Research Foundation (ACRF Unit for the Molecular Genetics of Cancer), Cure Cancer Australia, the Petre Foundation and the RT Hall Trust. EAM and AJB are Cancer Institute NSW Fellows. SL is a National Breast Cancer Foundation Scholar. LRA and CEC are Cancer Institute NSW Scholars. These funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Benjamini Y, 2001, ANN STAT, V29, P1165; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Butt AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1985; Butt AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1779; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; DALY RJ, 1991, CELL GROWTH DIFFER, V2, P457; Dellapasqua S, 2005, J CLIN ONCOL, V23, P1736, DOI 10.1200/JCO.2005.11.050; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HAMILTON TH, 1968, SCIENCE, V161, P649, DOI 10.1126/science.161.3842.649; Hinsby AM, 2006, MOL CELL, V22, P285, DOI 10.1016/j.molcel.2006.03.012; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; KIRKLAND JL, 1992, ENDOCRINOLOGY, V130, P3223, DOI 10.1210/en.130.6.3223; LEROY F, 1975, NATURE, V258, P259, DOI 10.1038/258259a0; Lobenhofer EK, 2002, MOL ENDOCRINOL, V16, P1215, DOI 10.1210/me.16.6.1215; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2007, CRIT REV ONCOL HEMAT, V61, P187, DOI 10.1016/j.critrevonc.2006.09.005; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; Mukherjee S, 2005, J BIOL CHEM, V280, P17617, DOI 10.1074/jbc.M502278200; MUSGROVE EA, 1989, CANCER RES, V49, P2398; Nicholson RI, 2005, J STEROID BIOCHEM, V93, P257, DOI 10.1016/j.jsbmb.2004.12.006; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Pratt MAC, 1998, FEBS LETT, V440, P403, DOI 10.1016/S0014-5793(98)01499-9; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rodrik V, 2005, MOL CELL BIOL, V25, P7917, DOI 10.1128/MCB.25.17.7917-7925.2005; SACEDA M, 1988, MOL ENDOCRINOL, V2, P1157, DOI 10.1210/mend-2-12-1157; Smith IE, 2005, J CLIN ONCOL, V23, P5108, DOI 10.1200/JCO.2005.04.005; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stender JD, 2007, MOL ENDOCRINOL, V21, P2112, DOI 10.1210/me.2006-0474; Strasser-Weippl K, 2005, J CLIN ONCOL, V23, P1751, DOI 10.1200/JCO.2005.11.038; SUTHERLAND RL, 1983, CANCER RES, V43, P3998; Tang SH, 2004, NUCLEIC ACIDS RES, V32, pD533, DOI 10.1093/nar/gkh083; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	56	79	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2987	10.1371/journal.pone.0002987	http://dx.doi.org/10.1371/journal.pone.0002987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714337	Green Published, gold			2022-12-25	WOS:000264420900013
J	Krauledat, M; Tangermann, M; Blankertz, B; Muller, KR				Krauledat, Matthias; Tangermann, Michael; Blankertz, Benjamin; Mueller, Klaus-Robert			Towards Zero Training for Brain-Computer Interfacing	PLOS ONE			English	Article								Electroencephalogram (EEG) signals are highly subject-specific and vary considerably even between recording sessions of the same user within the same experimental paradigm. This challenges a stable operation of Brain-Computer Interface (BCI) systems. The classical approach is to train users by neurofeedback to produce fixed stereotypical patterns of brain activity. In the machine learning approach, a widely adapted method for dealing with those variances is to record a so called calibration measurement on the beginning of each session in order to optimize spatial filters and classifiers specifically for each subject and each day. This adaptation of the system to the individual brain signature of each user relieves from the need of extensive user training. In this paper we suggest a new method that overcomes the requirement of these time-consuming calibration recordings for long-term BCI users. The method takes advantage of knowledge collected in previous sessions: By a novel technique, prototypical spatial filters are determined which have better generalization properties compared to single-session filters. In particular, they can be used in follow-up sessions without the need to recalibrate the system. This way the calibration periods can be dramatically shortened or even completely omitted for these 'experienced' BCI users. The feasibility of our novel approach is demonstrated with a series of online BCI experiments. Although performed without any calibration measurement at all, no loss of classification performance was observed.	[Krauledat, Matthias; Tangermann, Michael; Blankertz, Benjamin; Mueller, Klaus-Robert] Berlin Inst Technol, Machine Learning Lab, Berlin, Germany	Technical University of Berlin	Krauledat, M (corresponding author), Berlin Inst Technol, Machine Learning Lab, Berlin, Germany.	kraulem@cs.tu-berlin.de	Muller, Klaus R/C-3196-2013; Tangermann, Michael/ABE-4178-2020; Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685; Blankertz, Benjamin/0000-0002-2437-4846; Tangermann, Michael/0000-0001-6729-0290	Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 01IBE01A, FKZ 16SV2231]; Deutsche Forschungsgemeinschaft (DFG) [MU 987/3-1]; IST Programme of the European Community, under the PASCAL Network of Excellence [IST-2002-506778]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); IST Programme of the European Community, under the PASCAL Network of Excellence(European Commission)	The studies were supported by grants of the Bundesministerium fur Bildung und Forschung (BMBF), FKZ 01IBE01A and FKZ 16SV2231, the Deutsche Forschungsgemeinschaft (DFG), MU 987/3-1, and by the IST Programme of the European Community, under the PASCAL Network of Excellence, IST-2002-506778. This publication only reflects the authors' views.	Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Blanco A, 2002, TAPPI J, V1, P14; BLANKERTZ B, 2008, BERLIN BRAIN COMPUTE; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2007, LECT NOTES COMPUT SC, V4555, P759; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Blankertz B, 2006, J UNIVERS COMPUT SCI, V12, P581; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P147, DOI 10.1109/TNSRE.2006.875557; Dornhege G., 2007, BRAIN COMPUTER INTER; Dornhege G., 2006, ADV NEURAL INF PROCE, V18, P315, DOI 10.5555/2976248.2976288; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; Duda R.O., 2006, PATTERN CLASSIFICATI; Fukunaga K, 1990, INTRO STAT PATTERN R; Harmeling S, 2006, NEUROCOMPUTING, V69, P1608, DOI 10.1016/j.neucom.2005.05.015; Jasper HH, 1938, ARCH NEURO PSYCHIATR, V39, P96, DOI 10.1001/archneurpsyc.1938.02270010106010; KOLES ZJ, 1991, ELECTROENCEPHALOGR C, V796, P440; KRAULEDAT, 2007, ADV NEURAL INFORM PR, V19, P753; KRAULEDAT M, 2006, P 3 INT BRAIN COMP I, P60; Krauledat M., 2007, BRAIN COMPUTER INTER, P305; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; MEINECKE FC, 2005, INT J IMAGING SYSTEM; Muller KR, 2006, IEEE SIGNAL PROC MAG, V23, P128, DOI 10.1109/MSP.2006.1708426; Muller KR, 2003, IEEE T NEUR SYS REH, V11, P165, DOI 10.1109/TNSRE.2003.814484; Neuper C, 2001, CLIN NEUROPHYSIOL, V112, P2084, DOI 10.1016/S1388-2457(01)00661-7; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Popescu F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000637; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; Sugiyama M, 2007, J MACH LEARN RES, V8, P1027; Vidaurre C, 2006, IEEE T BIO-MED ENG, V53, P1214, DOI 10.1109/TBME.2006.873542	31	185	190	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2967	10.1371/journal.pone.0002967	http://dx.doi.org/10.1371/journal.pone.0002967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698427	gold, Green Submitted, Green Published			2022-12-25	WOS:000264412600052
J	Leveille, F; El Gaamouch, F; Gouix, E; Lecocq, M; Lobner, D; Nicole, O; Buisson, A				Leveille, F.; El Gaamouch, F.; Gouix, E.; Lecocq, M.; Lobner, D.; Nicole, O.; Buisson, A.			Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors	FASEB JOURNAL			English	Article						excitotoxicity; glutamate uptake; memantine; ERK signaling	LONG-TERM POTENTIATION; MOLECULAR-MECHANISMS; CALCIUM; EXCITOTOXICITY; ROLES; NEUROTOXICITY; SUBUNITS; SUBTYPES; DEATH; CA2+	N-methyl-D-aspartate receptors (NMDARs) are critical for synaptic plasticity that underlies learning and memory. But, they have also been described as a common source of neuronal damage during stroke and neurodegenerative diseases. Several studies have suggested that cellular location of NMDARs (synaptic or extrasynaptic) is a key parameter controlling their effect on neuronal viability. The aim of the study was to understand the relation between these two pools of receptors and to determine their implication in both beneficial and/or deleterious events related to NMDAR activation. We demonstrated that selective extrasynaptic NMDAR activation, as well as NMDA bath application, does not activate extracellular signal-regulated kinase (ERK) pathways, but induces mitochondrial membrane potential breakdown and triggers cell body and dendrite damages, whereas synaptic NMDAR activation is innocuous and induces a sustained ERK activation. The functional dichotomy between these two NMDAR pools is tightly controlled by glutamate uptake systems. Finally, we demonstrated that the only clinically approved NMDAR antagonist, memantine, preferentially antagonizes extrasynaptic NMDARs. Together, these results suggest that extrasynaptic NMDAR activation contributes to excitotoxicity and that a selective targeting of the extrasynaptic NMDARs represents a promising therapeutic strategy for brain injuries.	[Leveille, F.; El Gaamouch, F.; Gouix, E.; Lecocq, M.; Nicole, O.; Buisson, A.] Univ Caen, CNRS, UMR 6232, GIP CYCERON,CEA, F-14074 Caen, France; [Lobner, D.] Marquette Univ, Dept Physiol & Neurobiol, Milwaukee, WI 53233 USA	CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Marquette University	Buisson, A (corresponding author), Univ Caen, CNRS, UMR 6232, GIP CYCERON,CEA, Bd Henri Becquerel,BP 5229, F-14074 Caen, France.	buisson@cyceron.fr	Nicole, Olivier/AAZ-2865-2020; buisson, alain/AAI-8218-2020	Nicole, Olivier/0000-0001-9981-1820; buisson, alain/0000-0002-4281-7911	Association France Alzheimer et Maladies Apparentees; Institut Paul Hamel	Association France Alzheimer et Maladies Apparentees; Institut Paul Hamel	This work was supported by grants from the Association France Alzheimer et Maladies Apparentees and the Institut Paul Hamel.	Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Bengtson CP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-11; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Butterfield DA, 2003, CNS DRUGS, V17, P641, DOI 10.2165/00023210-200317090-00004; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Dingledine R, 1999, PHARMACOL REV, V51, P7; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Harris AZ, 2008, J NEUROPHYSIOL, V99, P524, DOI 10.1152/jn.01169.2007; Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; IKONOMIDOU C, 1989, J NEUROSCI, V9, P1693; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Nicholls DG, 2004, CURR MOL MED, V4, P149, DOI 10.2174/1566524043479239; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; OLNEY JW, 1971, J NEUROPATH EXP NEUR, V30, P75, DOI 10.1097/00005072-197101000-00008; OLNEY JW, 1979, BRAIN RES, V176, P91, DOI 10.1016/0006-8993(79)90872-2; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Rose K, 1993, IN VITRO BIOL METHOD, P46; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Sattler R, 1998, J NEUROCHEM, V71, P2349; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tovar KR, 2002, NEURON, V34, P253; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; White RJ, 1996, J NEUROSCI, V16, P5688; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhao J, 2008, J NEUROSCI, V28, P3060, DOI 10.1523/JNEUROSCI.5450-07.2008	50	190	191	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4258	4271		10.1096/fj.08-107268	http://dx.doi.org/10.1096/fj.08-107268			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18711223				2022-12-25	WOS:000261254800025
J	Chen, C; Zhou, Z; Liu, R; Li, Y; Azmi, PB; Seth, AK				Chen, C.; Zhou, Z.; Liu, R.; Li, Y.; Azmi, P. B.; Seth, A. K.			The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2 and EGFR through RING finger protein 11	ONCOGENE			English	Article						WWP1; ErbB2; EGFR; RNF11; PY motif; WW domain	GROWTH-FACTOR RECEPTOR; MEDIATES UBIQUITINATION; BREAST-CANCER; DEGRADATION; RNF11; TARGET; MONOUBIQUITINATION; LOCALIZATION; MECHANISMS; INTERACTS	The WW domain containing E3 ubiquitin protein ligase 1 (WWP1) is a homologous to the E6-associated protein C terminus-type E3 ligase frequently overexpressed in human prostate and breast cancers due to gene amplification. Previous studies suggest that WWP1 promotes cell proliferation and survival; however, the mechanism of WWP1 action is still poorly understood. Here, we showed that WWP1 upregulates and maintains erythroblastic leukemia viral oncogene homolog 2 (ErbB2) and epithelial growth factor receptor (EGFR) in multiple cell lines. WWP1 depletion dramatically attenuates the EGF-induced ERK phosphorylation. WWP1 forms a protein complex with RING finger protein 11 (RNF11), a negative regulator of ErbB2 and EGFR. The protein protein interaction is through the first and third WW domains of WWP1 and the PY motif of RNF11. Although WWP1 is able to ubiquitinate RNF11 in vitro and in vivo, WWP1 neither targets RNF11 for degradation nor changes RNF11's cellular localization. Importantly, inhibition of RNF11 can rescue WWP1 siRNA-induced ErbB2 and EGFR downregulation and growth arrest. Finally, we demonstrated that RNF11 is overexpressed in a panel of prostate and breast cancer cell lines with WWP1 expression. These findings suggest that WWP1 may promote cell proliferation and survival partially through suppressing RNF11-mediated ErbB2 and EGFR downregulation. Oncogene (2008) 27, 6845-6855; doi: 10.1038/onc.2008.288; published online 25 August 2008	[Chen, C.; Zhou, Z.; Liu, R.; Li, Y.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Azmi, P. B.; Seth, A. K.] Univ Toronto, Div Mol & Cellular Biol, Sunnybrook Res Inst, Toronto, ON, Canada; [Azmi, P. B.; Seth, A. K.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Albany Medical College; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Chen, C (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MS355,Mail Code 165,47 New Scotland Ave, Albany, NY 12208 USA.	chenc@mail.amc.edu			American Cancer Society; Department of Defense Prostate Cancer Research Program [W81XWH-07-1-0191]; Susan G Komen Breast Cancer Foundation [BCTR0503705]; Canadian Breast Cancer Research Alliance special program	American Cancer Society(American Cancer Society); Department of Defense Prostate Cancer Research Program(United States Department of Defense); Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Canadian Breast Cancer Research Alliance special program	We thank Dr Roger Y Tsien for the mCherry vector. This work was supported in part by a grant from American Cancer Society (Chen C), a grant from the Department of Defense Prostate Cancer Research Program (W81XWH-07-1-0191, Chen C), a grant (BCTR0503705) from the Susan G Komen Breast Cancer Foundation (Chen C), and from the Canadian Breast Cancer Research Alliance special program grant on metastasis to Arun Seth.	Anderson LR, 2007, J NEUROPATH EXP NEUR, V66, P955, DOI 10.1097/nen.0b013e3181567f17; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Azmi P, 2005, EUR J CANCER, V41, P2549, DOI 10.1016/j.ejca.2005.08.020; Burger A, 2006, NEOPLASIA, V8, P689, DOI 10.1593/neo.06469; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2007, INT J CANCER, V121, P2834; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; Flasza M, 2006, MOL MEMBR BIOL, V23, P269, DOI 10.1080/09687860600665010; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Kitching R, 2003, BBA-MOL BASIS DIS, V1639, P104, DOI 10.1016/j.bbadis.2003.07.001; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Li HX, 2004, ONCOGENE, V23, P1801, DOI 10.1038/sj.onc.1207319; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Mosser EA, 1998, BIOCHEMISTRY-US, V37, P13686, DOI 10.1021/bi981310l; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen R, 2006, J BIOL CHEM, V281, P3569, DOI 10.1074/jbc.M506761200; Subramaniam V, 2003, BRIT J CANCER, V89, P1538, DOI 10.1038/sj.bjc.6601301; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033	36	39	44	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV 20	2008	27	54					6845	6855		10.1038/onc.2008.288	http://dx.doi.org/10.1038/onc.2008.288			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	375IS	18724389				2022-12-25	WOS:000261108000005
J	Harrington, LS; Lucas, R; McMaster, SK; Moreno, L; Scadding, G; Warner, TD; Mitchell, JA				Harrington, Louise S.; Lucas, Ruth; McMaster, Shaun K.; Moreno, Laura; Scadding, Glenis; Warner, Timothy D.; Mitchell, Jane A.			COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma	FASEB JOURNAL			English	Article						nonsteroid drugs; bronchoconstriction; prostaglandins	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ARACHIDONIC-ACID; CYCLOOXYGENASE; SYNTHASE; CYCLO-OXYGENASE-2; ACETAMINOPHEN; INFLAMMATION; INHIBITION; MECHANISMS; EXPRESSION	Cyclooxygenase (COX) -1 and COX-2 are expressed in airway cells, where their activities influence functions such as airway hyperreactivity. Clinical data show that mixed COX-1/COX-2 inhibitors such as aspirin, but not COX-2 selective inhibitors such as rofecoxib, induce bronchoconstriction and asthma in sensitive individuals. This anomaly has not yet been explained. Here, we have used tissue from genetically modified mice lacking functional COX-1 (COX-1(-/-)), as well as airway tissue from "aspirin-sensitive" and control patients to address this issue. Bronchi from wild-type mice contained predominantly COX-1 immunoreactivity and contracted in vitro in response to acetylcholine and U46619. Bronchi from COX-1(-/-) mice were hyperresponsive to bronchoconstrictors. Inhibitors of COX (naproxen, diclofenac, or ibuprofen) increased bronchoconstriction in tissue from wild-type but not from COX-1(-/-) mice. Cells cultured from aspirin-sensitive or control human donors contained similar levels of COX-1 and COX-2 immunoreactivity. COX activity in cells from aspirin-sensitive or tolerant patients was inhibited by aspirin, SC560, which blocks COX-1 selectively, but not by rofecoxib, which is a selective inhibitor of COX-2. These observations show that despite the presence of COX-2, COX-1 is functionally predominant in the airways and explains clinical observations relating to drug specificity in patients with aspirin-sensitive asthma.-Harrington, L. S., Lucas, R., McMaster, S. K., Moreno, L., Scadding, G., Warner, T. D., Mitchell, J. A. COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma. FASEB J. 22, 4005-4010 (2008)	[Harrington, Louise S.; Lucas, Ruth; McMaster, Shaun K.; Moreno, Laura; Scadding, Glenis; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, NHLI, London SW3 6LY, England; [Warner, Timothy D.] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England	Imperial College London; University of London; Queen Mary University London	Mitchell, JA (corresponding author), Univ London Imperial Coll Sci Technol & Med, NHLI, Dovehouse St, London SW3 6LY, England.	j.a.mitchell@ic.ac.uk	Warner, Timothy D/A-1980-2009; Moreno, Laura/A-9433-2010; Lucas, Rut/H-6050-2015; Mackenzie, Louise/AAY-7585-2020; Mitchell, Jane A/A-1991-2009	Warner, Timothy D/0000-0003-3988-4408; Moreno, Laura/0000-0001-9028-2299; Lucas, Rut/0000-0002-4697-7832; Mackenzie, Louise/0000-0003-4271-379X; 	Wellcome Trust; European Community [LSHM-CT-2004-0050333]; Spanish Government	Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); Spanish Government(Spanish GovernmentEuropean Commission)	This research was supported by the Wellcome Trust, European Community FP6 funding (Eicosanox; LSHM-CT-2004-0050333), European Community FP7 funding (Marie Currie Fellowship) and the Spanish Government. This publication reflects only the authors' views. The European Community is not liable for any use that may be made of information herein.	BishopBailey D, 1997, ARTERIOSCL THROM VAS, V17, P1644, DOI 10.1161/01.ATV.17.9.1644; Demoly P, 1998, CLIN EXP ALLERGY, V28, P278; Gray PA, 2002, BRIT J PHARMACOL, V137, P1031, DOI 10.1038/sj.bjp.0704927; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; HULKOWER KI, 1993, AGENTS ACTIONS, V39, pC5, DOI 10.1007/BF01972703; Kakuyama M, 1999, AM J RESP CRIT CARE, V160, P2072, DOI 10.1164/ajrccm.160.6.9808105; Kowalski Marek L, 2007, Clin Allergy Immunol, V19, P147; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Lucas R, 2005, FASEB J, V19, P635, DOI 10.1096/fj.04-2437fje; MEADE EA, 1993, J BIOL CHEM, V268, P6610; Mitchell JA, 1997, MOL PHARMACOL, V51, P907, DOI 10.1124/mol.51.6.907; MITCHELL JA, 1994, BRIT J PHARMACOL, V113, P1008, DOI 10.1111/j.1476-5381.1994.tb17093.x; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; Mitchell JA, 2006, FASEB J, V20, P2468, DOI 10.1096/fj.06-6615com; Moreno L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-111; Parikh A, 2002, ACTA OTO-LARYNGOL, V122, P302, DOI 10.1080/000164802753648204; Picado C, 2006, CURR ALLERGY ASTHM R, V6, P198, DOI 10.1007/s11882-006-0035-2; Sampson AP, 1997, INT ARCH ALLERGY IMM, V113, P355, DOI 10.1159/000237600; Schonthal AH, 2007, BRIT J CANCER, V97, P1465, DOI 10.1038/sj.bjc.6604049; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Sousa AR, 1997, THORAX, V52, P940, DOI 10.1136/thx.52.11.940; Szczeklik A, 2001, CLIN EXP ALLERGY, V31, P219, DOI 10.1046/j.1365-2222.2001.01075.x; Warner TD, 2004, J PHARMACOL EXP THER, V310, P642, DOI 10.1124/jpet.103.063875	23	40	40	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2008	22	11					4005	4010		10.1096/fj.08-107979	http://dx.doi.org/10.1096/fj.08-107979			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	366SF	18753249	hybrid, Green Published			2022-12-25	WOS:000260503000028
J	Bitto, E; Bingman, CA; Bittova, L; Kondrashov, DA; Bannen, RM; Fox, BG; Markley, JL; Phillips, GN				Bitto, Eduard; Bingman, Craig A.; Bittova, Lenka; Kondrashov, Dmitry A.; Bannen, Ryan M.; Fox, Brian G.; Markley, John L.; Phillips, George N., Jr.			Structure of Human J-type Co-chaperone HscB Reveals a Tetracysteine Metal-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUSTER ASSEMBLY PROTEIN; IRON-SULFUR CLUSTERS; ZINC-FINGER DOMAIN; CRYSTAL-STRUCTURE; GENE-CLUSTER; ISCU; SCAFFOLD; 2FE-2S; BIOGENESIS; IDENTIFICATION	Iron-sulfur proteins play indispensable roles in a broad range of biochemical processes. The biogenesis of iron-sulfur proteins is a complex process that has become a subject of extensive research. The final step of iron-sulfur protein assembly involves transfer of an iron-sulfur cluster from a cluster-donor to a cluster-acceptor protein. This process is facilitated by a specialized chaperone system, which consists of a molecular chaperone from the Hsc70 family and a co-chaperone of the J-domain family. The 3.0 angstrom crystal structure of a human mitochondrial J-type co-chaperone HscB revealed an L-shaped protein that resembles Escherichia coli HscB. The important difference between the two homologs is the presence of an auxiliary metal-binding domain at the N terminus of human HscB that coordinates a metal via the tetracysteine consensus motif CWXCX(9-13)FCXXCXXXQ. The domain is found in HscB homologs from animals and plants as well as in magnetotactic bacteria. The metal-binding site of the domain is structurally similar to that of rubredoxin and several zinc finger proteins containing rubredoxin-like knuckles. The normal mode analysis of HscB revealed that this L-shaped protein preferentially undergoes a scissors-like motion that correlates well with the conformational changes of human HscB observed in the crystals.	[Bannen, Ryan M.; Fox, Brian G.; Markley, John L.; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Bitto, Eduard; Bingman, Craig A.; Bittova, Lenka; Fox, Brian G.; Markley, John L.; Phillips, George N., Jr.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53706 USA; [Kondrashov, Dmitry A.] Univ Chicago, Biol Sci Coll Div, Chicago, IL 60637 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Chicago	Phillips, GN (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	phillips@biochem.wisc.edu	Bittova, Lenka/K-4375-2015	Bittova, Lenka/0000-0002-3556-5234; Bannen, Ryan/0000-0002-6001-3060	National Institutes of Health [P50 GM64598, U54 GM074901]; Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM064598, U54GM074901, R01GM058667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 GM64598 and U54 GM074901 ( to J. L. M.). This work was also supported by the Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-ENG-38, by National Cancer Institute Grant Y1-CO-1020, and by National Institute of General Medical Science Grant Y1-GM-1104. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bilder PW, 2004, BIOCHEMISTRY-US, V43, P133, DOI 10.1021/bi035440s; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Cupp-Vickery JR, 2004, J MOL BIOL, V342, P1265, DOI 10.1016/j.jmb.2004.07.025; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Cupp-Vickery JR, 2000, J MOL BIOL, V304, P835, DOI 10.1006/jmbi.2000.4252; Dauter Z, 1996, P NATL ACAD SCI USA, V93, P8836, DOI 10.1073/pnas.93.17.8836; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delano W.L, 2002, PYMOL USERS MANUAL; Ding H, 2004, J BIOL CHEM, V279, P37499, DOI 10.1074/jbc.M404533200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fuzery AK, 2008, BIOCHEMISTRY-US, V47, P9394, DOI 10.1021/bi800502r; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Hagelueken G, 2007, P NATL ACAD SCI USA, V104, P12276, DOI 10.1073/pnas.0702919104; Hoff KG, 2002, J BIOL CHEM, V277, P27353, DOI 10.1074/jbc.M202814200; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jeon Won Bae, 2005, Journal of Structural and Functional Genomics, V6, P143, DOI 10.1007/s10969-005-1908-7; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Kondrashov DA, 2007, STRUCTURE, V15, P169, DOI 10.1016/j.str.2006.12.006; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Liu JY, 2005, PROTEINS, V59, P875, DOI 10.1002/prot.20421; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Marquet A, 2007, NAT PROD REP, V24, P1027, DOI 10.1039/b703109m; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Morimoto K, 2006, J MOL BIOL, V360, P117, DOI 10.1016/j.jmb.2006.04.067; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Patzer SI, 1999, J BACTERIOL, V181, P3307, DOI 10.1128/JB.181.10.3307-3309.1999; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Rawlings DE, 1999, MICROBIOL-UK, V145, P5, DOI 10.1099/13500872-145-1-5; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Rojas-Chapana JA, 2004, FEMS MICROBIOL ECOL, V47, P19, DOI 10.1016/S0168-6496(03)00221-6; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silberg JJ, 2004, J BIOL CHEM, V279, P53924, DOI 10.1074/jbc.M410117200; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Sun GF, 2003, J HUM GENET, V48, P415, DOI 10.1007/s10038-003-0048-9; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Tama F, 2006, ANNU REV BIOPH BIOM, V35, P115, DOI 10.1146/annurev.biophys.35.040405.102010; Thao Sandy, 2004, Journal of Structural and Functional Genomics, V5, P267, DOI 10.1007/s10969-004-7148-4; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Tokumoto U, 2004, J BIOCHEM, V136, P199, DOI 10.1093/jb/mvh104; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wang X, 2007, BIOCHEMISTRY-US, V46, P752, DOI 10.1021/bi061870h; Wu Q, 2006, APPL ENVIRON MICROB, V72, P3608, DOI 10.1128/AEM.72.5.3608-3614.2006; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yu GW, 2006, PROTEIN SCI, V15, P384, DOI 10.1110/ps.051927306; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264; Zolnai Zsolt, 2003, Journal of Structural and Functional Genomics, V4, P11, DOI 10.1023/A:1024684404761	72	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30184	30192		10.1074/jbc.M804746200	http://dx.doi.org/10.1074/jbc.M804746200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18713742	Green Published, hybrid			2022-12-25	WOS:000260366900063
J	Bose, JK; Wang, IF; Hung, L; Tarn, WY; Shen, CKJ				Bose, Jayarama Krishnan; Wang, I. -Fan; Hung, Li; Tarn, Woan-Yuh; Shen, C. -K. James			TDP-43 Overexpression Enhances Exon 7 Inclusion during the Survival of Motor Neuron Pre-mRNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; CFTR EXON-9; FUNCTIONAL IMPLICATIONS; SINGLE NUCLEOTIDE; SMN GENE; HNRNP-G; HTRA2-BETA-1	TDP-43 is a highly conserved, 43-kDa RNA-binding protein implicated to play a role in transcription repression, nuclear organization, and alternative splicing. More recently, this factor has been identified as the major disease protein of several neurodegenerative diseases, including frontotemporal lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis. For the splicing activity, the factor has been shown to be mainly an exon-skipping promoter. In this study using the survival of motor neuron (SMN) minigenes as the reporters in transfection assay, we show for the first time that TDP-43 could also act as an exon-inclusion factor. Furthermore, both RNA-recognition motif domains are required for its ability to enhance the SMN2 exon 7 inclusion. Combined protein-immunoprecipitation and RNA-immunoprecipitation experiments also suggested that this exon inclusion activity might be mediated by multimeric complex(es) consisting of this protein interacting with other splicing factors, including Htra2-beta 1. Our data further evidence TDP-43 as a multifunctional RNA-binding protein for a diverse set of cellular activities.	[Bose, Jayarama Krishnan; Shen, C. -K. James] Natl Taiwan Univ, Inst Mol Med, Taipei 106, Taiwan; [Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Bose, Jayarama Krishnan; Wang, I. -Fan; Hung, Li; Shen, C. -K. James] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Shen, CKJ (corresponding author), Natl Taiwan Univ, Inst Mol Med, Taipei 106, Taiwan.	ckshen@imb.sinica.edu.tw	shen, Che-Kun James/L-1343-2015; Tarn, Woan-Yuh/N-8464-2018	Wang, I-Fan/0000-0002-6856-0691	Academia Sinica and National Science Council, Taipei, Taiwan	Academia Sinica and National Science Council, Taipei, Taiwan	This work was supported by the Academia Sinica and National Science Council, Taipei, Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2006, FEBS LETT, V580, P1339, DOI 10.1016/j.febslet.2006.01.052; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Dickson DW, 2007, ACTA NEUROPATHOL, V114, P71, DOI 10.1007/s00401-007-0234-5; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Ince PG, 1998, NEUROPATH APPL NEURO, V24, P104, DOI 10.1046/j.1365-2990.1998.00108.x; Jin W, 2004, CANCER RES, V64, P8901, DOI 10.1158/0008-5472.CAN-04-0716; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Nasim MT, 2003, HUM MOL GENET, V12, P1337, DOI 10.1093/hmg/ddg136; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Shaw C E, 2001, Curr Neurol Neurosci Rep, V1, P69, DOI 10.1007/s11910-001-0078-7; Singh NN, 2004, CRIT REV EUKAR GENE, V14, P271, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.30; Singh NN, 2004, BIOCHEM BIOPH RES CO, V315, P381, DOI 10.1016/j.bbrc.2004.01.067; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; WANG IF, 2008, TRENDS MOL IN PRESS; Wang YZ, 2005, J BIOL CHEM, V280, P14230, DOI 10.1074/jbc.M413846200; WYATT JR, 1991, BIOTECHNIQUES, V11, P764; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577	34	148	155	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28852	28859		10.1074/jbc.M805376200	http://dx.doi.org/10.1074/jbc.M805376200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703504	Green Published, hybrid			2022-12-25	WOS:000260179900010
J	Edelblum, KL; Goettel, JA; Koyama, T; McElroy, SJ; Yan, F; Polk, DB				Edelblum, Karen L.; Goettel, Jeremy A.; Koyama, Tatsuki; McElroy, Steven J.; Yan, Fang; Polk, D. Brent			TNFR1 Promotes Tumor Necrosis Factor-mediated Mouse Colon Epithelial Cell Survival through RAF Activation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; CHRONIC INTESTINAL INFLAMMATION; MONOCLONAL-ANTIBODY CA2; FACTOR-ALPHA; PROTEIN-KINASE; NEUTRAL SPHINGOMYELINASE; TRANSCRIPTIONAL ACTIVATION; FACTOR RECEPTORS; CROHNS-DISEASE; C-RAF-1 GENE	Tumor necrosis factor (TNF) is a therapeutic target in the treatment of inflammatory bowel disease; however, the exact role of TNF signaling in the colon epithelium remains unclear. We demonstrate that TNF activation of TNF receptor (R) 1 stimulates both pro- and anti-apoptotic signaling pathways in the colon epithelium; however, TNFR1 protects against colon epithelial cell apoptosis following TNF exposure. To investigate anti-apoptotic signaling pathways downstream of TNFR1, we generated an intestinal epithelium-specific Raf knock-out mouse and identified Raf kinase as a key regulator of colon epithelial cell survival in response to TNF. Surprisingly, Raf promotes NF-kappa Bp65 phosphorylation, independent of MEK signaling, to support cell survival. Taken together, these data demonstrate a novel pathway in which Raf promotes colon epithelial cell survival through NF-kappa B downstream of TNFR1 activation. Thus, further understanding of colon epithelial cell-specific TNFR signaling may result in the identification of new targets for inflammatory bowel disease treatment and define novel mediators of colitis-associated cancer.	[Edelblum, Karen L.; Goettel, Jeremy A.; Polk, D. Brent] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Koyama, Tatsuki] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; [McElroy, Steven J.] Vanderbilt Univ, Sch Med, Dept Pediat, Div Neonatol, Nashville, TN 37232 USA; [Yan, Fang] Vanderbilt Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Polk, DB (corresponding author), 2215 Garland Ave,1025 MRB 4, Nashville, TN 37232 USA.	d-brent.polk@vanderbilt.edu	McElroy, Steven/AAC-7204-2019; McElroy, Steven/AGR-6835-2022	McElroy, Steven/0000-0002-4321-723X; McElroy, Steven/0000-0002-4321-723X	National Institutes of Health [DK56008, DK66176, CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; Frank Revetta and the Vanderbilt Ingram Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066176, P30DK020593, U24DK059637, U2CDK059637, P60DK020593, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frank Revetta and the Vanderbilt Ingram Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56008 and DK66176 (to D. B. P.), T32GM008554 (CBMS training grant) (to K. L. E.), and DK58404 (through Vanderbilt University Digestive Disease Research Center). This work was also supported by Frank Revetta and the Vanderbilt Ingram Cancer Center (for ARIOL image analysis). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; We thank Manuela Baccarini (Vienna Biocenter) for the Rafflx mice, Sylvie Robine (Curie Institute) for the villin-Cre mice, Mark Frey and Philip Dube for thoughtful discussions and manuscript suggestions. Differential interference contrast imaging was performed using the Vanderbilt University School of Medicine Cell Imaging Shared Resource (supported by National Institutes of Health Grants CA68485, DK20593, DK58404, HD15052, DK59637, and EY08126).	Abu-Amer Y, 2000, J BIOL CHEM, V275, P27307; Adam D, 1996, J BIOL CHEM, V271, P14617, DOI 10.1074/jbc.271.24.14617; AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Anrather J, 2005, J BIOL CHEM, V280, P244, DOI 10.1074/jbc.M409344200; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; BELKA C, 1995, EMBO J, V14, P1156, DOI 10.1002/j.1460-2075.1995.tb07099.x; Biragyn A, 2008, J LEUKOCYTE BIOL, V83, P998, DOI 10.1189/jlb.1007700; BREESE EJ, 1994, GASTROENTEROLOGY, V106, P1455, DOI 10.1016/0016-5085(94)90398-0; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; DAS DVM, 1984, BIOCHIM BIOPHYS ACTA, V777, P339; Declercq W, 1998, J IMMUNOL, V161, P390; Depuydt B, 2005, J CELL SCI, V118, P497, DOI 10.1242/jcs.01640; Edelblum KL, 2008, GASTROENTEROLOGY, V135, P539, DOI 10.1053/j.gastro.2008.04.025; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; Ferrero E, 2001, AM J PHYSIOL-CELL PH, V281, pC1173, DOI 10.1152/ajpcell.2001.281.4.C1173; Foo SY, 1999, TRENDS GENET, V15, P229; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gupta S., 2001, Current Molecular Medicine (Hilversum), V1, P317, DOI 10.2174/1566524013363780; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Jesenberger V, 2001, J EXP MED, V193, P353, DOI 10.1084/jem.193.3.353; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Kaiser GC, 1999, EXP CELL RES, V249, P349, DOI 10.1006/excr.1999.4488; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kubota T, 2001, J MOL CELL CARDIOL, V33, P1331, DOI 10.1006/jmcc.2001.1393; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Naito Y, 2003, J GASTROEN HEPATOL, V18, P560, DOI 10.1046/j.1440-1746.2003.03034.x; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; NICHOLLS S, 1993, J CLIN PATHOL, V46, P757, DOI 10.1136/jcp.46.8.757; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pearson G, 2000, J BIOL CHEM, V275, P37303, DOI 10.1074/jbc.C000570200; Piazzolla D, 2005, J CELL BIOL, V171, P1013, DOI 10.1083/jcb.200504137; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; PRZEMIOSLO RT, 1994, GUT, V35, P1398, DOI 10.1136/gut.35.10.1398; Reuter BK, 1999, AM J PHYSIOL-GASTR L, V277, pG847, DOI 10.1152/ajpgi.1999.277.4.G847; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schmidt M, 2000, J BIOL CHEM, V275, P41011, DOI 10.1074/jbc.M003716200; Stuber E, 1999, GUT, V45, P229, DOI 10.1136/gut.45.2.229; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; TEAM RDC, 2007, LANGUAGE ENV STAT CO; Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200; Vanden Berghe T, 2003, J BIOL CHEM, V278, P5622, DOI 10.1074/jbc.M208925200; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang J, 2005, IMMUNOL REV, V204, P144, DOI 10.1111/j.0105-2896.2005.00218.x; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Winkler DG, 1998, J BIOL CHEM, V273, P21578, DOI 10.1074/jbc.273.34.21578; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Xing HR, 2000, J BIOL CHEM, V275, P17276, DOI 10.1074/jbc.C900989199; Xing HR, 2001, J BIOL CHEM, V276, P9733, DOI 10.1074/jbc.M008096200; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022; Yan F, 2001, CANCER RES, V61, P8668; Yan F, 2001, CANCER RES, V61, P963; YAO B, 1995, NATURE, V378, P307, DOI 10.1038/378307a0; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	77	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29485	29494		10.1074/jbc.M801269200	http://dx.doi.org/10.1074/jbc.M801269200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18713739	Green Published, hybrid			2022-12-25	WOS:000260179900074
J	Du, ZH; Fenn, S; Tjhen, R; James, TL				Du, Zhihua; Fenn, Sebastian; Tjhen, Richard; James, Thomas L.			Structure of a construct of a human poly(C)-binding protein containing the first and second KH domains reveals insights into its regulatory mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; POLY(RC) BINDING-PROTEIN; HUMAN TELOMERIC DNA; C-RICH STRAND; 3' UNTRANSLATED REGION; ERYTHROID-DIFFERENTIATION; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; POLIOVIRUS RNA; HNRNP-K	Poly(C)-binding proteins (PCBPs) are important regulatory proteins that contain three KH (hnRNP K homology) domains. Binding poly(C) D/RNA sequences via KH domains is essential for multiple PCBP functions. To reveal the basis for PCBP-D/RNA interactions and function, we determined the structure of a construct containing the first two domains (KH1-KH2) of human PCBP2 by NMR. KH1 and KH2 form an intramolecular pseudodimer. The large hydrophobic dimerization surface of each KH domain is on the side opposite the D/RNA binding interface. Chemical shift mapping indicates both domains bind poly(C) DNA motifs without disrupting the KH1-KH2 interaction. Spectral comparison of KH1-KH2, KH3, and full-length PCBP2 constructs suggests that the KH1-KH2 pseudodimer forms, but KH3 does not interact with other parts of the protein. From NMR studies and modeling, we propose possible modes of cooperative binding tandem poly(C) motifs by the KH domains. D/RNA binding may induce pseudodimer dissociation or stabilize dissociated KH1 and KH2, making protein interaction surfaces available to PCBP-binding partners. This conformational change may represent a regulatory mechanism linking D/RNA binding to PCBP functions.	[Du, Zhihua; Fenn, Sebastian; Tjhen, Richard; James, Thomas L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	James, TL (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St,Genentech Hall, San Francisco, CA 94143 USA.	james@picasso.ucsf.edu			National Institutes of Health [AI46967]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI46967 (to T. L. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baber JL, 1999, J MOL BIOL, V289, P949, DOI 10.1006/jmbi.1999.2818; Backe PH, 2005, STRUCTURE, V13, P1055, DOI 10.1016/j.str.2005.04.008; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Blyn LB, 1996, P NATL ACAD SCI USA, V93, P11115, DOI 10.1073/pnas.93.20.11115; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Braddock DT, 2002, EMBO J, V21, P3476, DOI 10.1093/emboj/cdf352; Chkheidze AN, 1999, MOL CELL BIOL, V19, P4572; Chmiel NH, 2006, RNA, V12, P283, DOI 10.1261/rna.2175706; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Czyzyk-Krzeska MF, 1999, BLOOD, V93, P2111, DOI 10.1182/blood.V93.6.2111.406k24_2111_2120; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du ZH, 2005, J BIOL CHEM, V280, P38823, DOI 10.1074/jbc.M508183200; Du ZH, 2004, J BIOL CHEM, V279, P48126, DOI 10.1074/jbc.M405371200; Du Z, 2007, RNA, V13, P1043, DOI 10.1261/rna.410107; Emerald BS, 2007, J BIOL CHEM, V282, P680, DOI 10.1074/jbc.M600224200; Fenn S, 2007, NUCLEIC ACIDS RES, V35, P2651, DOI 10.1093/nar/gkm139; Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293; Gamarnik AV, 2000, J VIROL, V74, P2219, DOI 10.1128/JVI.74.5.2219-2226.2000; Gamarnik AV, 1997, RNA, V3, P882; Garcia-Mayoral MF, 2007, STRUCTURE, V15, P485, DOI 10.1016/j.str.2007.03.006; GODDARD TD, 1998, SPARKY 3 0; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Lindquist JN, 2000, NUCLEIC ACIDS RES, V28, P4306, DOI 10.1093/nar/28.21.4306; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Maguire ML, 2005, J MOL BIOL, V348, P265, DOI 10.1016/j.jmb.2005.02.058; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Malik AK, 2006, BRAIN RES, V1112, P33, DOI 10.1016/j.brainres.2006.07.019; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; OSTARECKLEDERER A, 1994, EMBO J, V13, P1476, DOI 10.1002/j.1460-2075.1994.tb06402.x; Parsley TB, 1997, RNA, V3, P1124; Paulding WR, 1999, J BIOL CHEM, V274, P2532, DOI 10.1074/jbc.274.4.2532; Persson PB, 2003, AM J PHYSIOL-REG I, V285, pR491, DOI 10.1152/ajpregu.00101.2003; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sidiqi M, 2005, NUCLEIC ACIDS RES, V33, P1213, DOI 10.1093/nar/gki265; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Waggoner SA, 2003, EXP BIOL MED, V228, P387, DOI 10.1177/153537020322800409; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; WEISS IM, 1995, MOL CELL BIOL, V15, P2457; Xiao XL, 2001, J BIOL CHEM, V276, P41510, DOI 10.1074/jbc.M106824200; Yu J, 2001, MOL CELL BIOL, V21, P5879, DOI 10.1128/MCB.21.17.5879-5888.2001	51	44	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28757	28766		10.1074/jbc.M803046200	http://dx.doi.org/10.1074/jbc.M803046200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701464	Green Published, hybrid			2022-12-25	WOS:000259969300078
J	Nissen, MS; Youn, BY; Knowles, BD; Ballinger, JW; Jun, SY; Belchik, SM; Xun, LY; Kang, CH				Nissen, Mark S.; Youn, Buhyun; Knowles, Benjamin D.; Ballinger, Jordan W.; Jun, Se-Young; Belchik, Sara M.; Xun, Luying; Kang, ChulHee			Crystal structures of NADH: FMN oxidoreductase (EmoB) at different stages of catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-HYDROXYPHENYLACETATE 3-MONOOXYGENASE; ESCHERICHIA-COLI; BACTERIUM BNC1; EDTA; REDUCTASE; DEGRADATION; MECHANISM; MONOOXYGENASE; SYSTEM; ENZYME	EDTA has become a major organic pollutant in the environment because of its extreme usage and resistance to biodegradation. Recently, two critical enzymes, EDTA monooxygenase (EmoA) and NADH:FMN oxidoreductase (EmoB), belonging to the newly established two-component flavin-diffusible monooxygenase family, were identified in the EDTA degradation pathway in Mesorhizobium sp. BNC1. EmoA is an FMNH2-dependent enzyme that requires EmoB to provide FMNH2 for the conversion of EDTA to ethylenediaminediacetate. To understand the molecular basis of this FMN-mediated reaction, the crystal structures of the apo-form, FMN.FMN complex, and FMN . NADH complex of EmoB were determined at 2.5 angstrom resolution. The structure of EmoB is a homotetramer consisting of four alpha/beta-single-domain monomers of five parallel beta-strands flanked by five alpha-helices, which is quite different from those of other known two-component flavin-diffusible monooxygenase family members, such as PheA2 and HpaC, in terms of both tertiary and quaternary structures. For the first time, the crystal structures of both the FMN.FMN and FMN.NADH complexes of an NADH: FMN oxidoreductase were determined. Two stacked isoalloxazine rings and nicotinamide/isoalloxazine rings were at a proper distance for hydride transfer. The structures indicated a ping-pong reaction mechanism, which was confirmed by activity assays. Thus, the structural data offer detailed mechanistic information for hydride transfer between NADH to an enzyme-bound FMN and between the bound FMNH2 and a diffusible FMN.	[Nissen, Mark S.; Youn, Buhyun; Knowles, Benjamin D.; Ballinger, Jordan W.; Jun, Se-Young; Belchik, Sara M.; Xun, Luying; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Kang, CH (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	chkang@wsu.edu		Kang, ChulHee/0000-0002-0693-7860	United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2006-35318-17452]; Office of Biological and Environmental Research of the Department of Energy [DE-FG02-05ER63974]; American Heart Association [0850084Z]	United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Office of Biological and Environmental Research of the Department of Energy(United States Department of Energy (DOE)); American Heart Association(American Heart Association)	The work was supported in part by National Research Initiative Grant 2006-35318-17452 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service, Grant DE-FG02-05ER63974 from the Environmental Remediation Sciences Division Program of the Office of Biological and Environmental Research of the Department of Energy, and American Heart Association Grant 0850084Z. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agarwal R, 2006, ACTA CRYSTALLOGR D, V62, P383, DOI [10.1107/S0907444906001600, 10.1107/S0904777906001600]; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; BARBER LB, 1995, ORGANIC CONTAMINATIO, P115; Bohuslavek J, 2001, APPL ENVIRON MICROB, V67, P688, DOI 10.1128/AEM.67.2.688-695.2001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bucheli-Witschel M, 2001, FEMS MICROBIOL REV, V25, P69, DOI 10.1111/j.1574-6976.2001.tb00572.x; Chen HZ, 2005, MICROBIOL-SGM, V151, P1433, DOI 10.1099/mic.0.27805-0; CLEVELAND JM, 1981, SCIENCE, V212, P1506, DOI 10.1126/science.212.4502.1506; Dirilgen N, 1998, CHEMOSPHERE, V37, P771, DOI 10.1016/S0045-6535(98)00080-0; Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x; Fang HY, 2003, APPL BIOCHEM BIOTECH, V111, P81, DOI 10.1385/ABAB:111:2:81; Filisetti L, 2003, J BIOL CHEM, V278, P296, DOI 10.1074/jbc.M209689200; Gao BL, 2005, BIOCHEM BIOPH RES CO, V331, P1137, DOI 10.1016/j.bbrc.2005.04.033; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; HASTINGS JW, 1975, J BIOL CHEM, V250, P7288; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahnert A, 2000, J BACTERIOL, V182, P2869, DOI 10.1128/JB.182.10.2869-2878.2000; Kim SH, 2008, PROTEINS, V70, P718, DOI 10.1002/prot.21534; LAUFF JJ, 1990, APPL ENVIRON MICROB, V56, P3346, DOI 10.1128/AEM.56.11.3346-3353.1990; LESK AM, 1989, PROTEINS, V5, P139, DOI 10.1002/prot.340050208; Liger D, 2004, J BIOL CHEM, V279, P34890, DOI 10.1074/jbc.M405404200; Liu Y, 2001, APPL ENVIRON MICROB, V67, P696, DOI 10.1128/AEM.67.2.696-701.2001; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47184, DOI 10.1074/jbc.M405791200; Louie TM, 2003, BIOCHEMISTRY-US, V42, P7509, DOI 10.1021/bi034092r; MEANS JL, 1978, SCIENCE, V200, P1477, DOI 10.1126/science.200.4349.1477; Natalello A, 2007, BIOCHEMISTRY-US, V46, P543, DOI 10.1021/bi061769c; Nortemann B, 1999, APPL MICROBIOL BIOT, V51, P751, DOI 10.1007/s002530051458; Okai M, 2006, BIOCHEMISTRY-US, V45, P5103, DOI 10.1021/bi052313i; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sillanpaa M, 1996, CHEMOSPHERE, V32, P1485, DOI 10.1016/0045-6535(96)00057-4; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THIBAUT D, 1995, J BACTERIOL, V177, P5199, DOI 10.1128/jb.177.18.5199-5205.1995; TOSTE AP, 1995, J RADIOAN NUCL CH AR, V194, P25, DOI 10.1007/BF02037609; van den Heuvel RHH, 2004, J BIOL CHEM, V279, P12860, DOI 10.1074/jbc.M313765200; Weilenmann HU, 2004, BIODEGRADATION, V15, P289, DOI 10.1023/B:BIOD.0000042184.35056.ab; Witschel M, 1997, J BACTERIOL, V179, P6937, DOI 10.1128/jb.179.22.6937-6943.1997; Xun LY, 2000, APPL ENVIRON MICROB, V66, P481, DOI 10.1128/AEM.66.2.481-486.2000; Youn BY, 2005, J BIOL CHEM, V280, P12917, DOI 10.1074/jbc.M413266200	43	38	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28710	28720		10.1074/jbc.M804535200	http://dx.doi.org/10.1074/jbc.M804535200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701448	hybrid, Green Published			2022-12-25	WOS:000259969300073
J	Evaul, K; Hammes, SR				Evaul, Kristen; Hammes, Stephen R.			Cross-talk between g protein-coupled and epidermal growth factor receptors regulates gonadotropin-mediated steroidogenesis in Leydig cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING-HORMONE; BETA(2)-ADRENERGIC RECEPTOR; KINASE CASCADES; EGF RECEPTOR; TUMOR-CELLS; CYCLIC-AMP; ACTIVATION; STAR; PHOSPHORYLATION; MECHANISMS	Gonadal steroid production is stimulated by gonadotropin binding to G protein-coupled receptors (GPCRs). Although GPCR-mediated increases in intracellular cAMP are known regulators of steroidogenesis, the roles of other signaling pathways in mediating steroid production are not well characterized. Recent studies suggest that luteinizing hormone (LH) receptor activation leads to trans-activation of epidermal growth factor (EGF) receptors in the testes and ovary. This pathway is critical for LH-induced steroid production in ovarian follicles, probably through matrix metalloproteinase (MMP)-mediated release of EGF receptor (EGFR) binding ectodomains. Here we examined LH and EGF receptor crosstalk in testicular steroidogenesis using mouse MLTC-1 Leydig cells. We demonstrated that, similar to the ovary, trans-activation of the EGF receptor was critical for gonadotropin-induced steroid production in Leydig cells. LH-induced increases in cAMP and cAMP-dependent protein kinase (PKA) activity mediated trans-activation of the EGF receptor and subsequent mitogen-activated protein kinase (MAPK) activation, ultimately leading to StAR phosphorylation and mitochondrial translocation. Steroidogenesis in Leydig cells was unaffected by MMP inhibitors, suggesting that cAMP and PKA trans-activated EGF receptors in an intracellular fashion. Interestingly, although cAMP was always needed for steroidogenesis, the EGFR/MAPK pathway was activated and necessary only for early (30-60 min), but not late (120 min or more), LH-induced steroidogenesis in vitro. In contrast, 36-h EGF receptor inhibition in vivo significantly reduced serum testosterone levels in male mice, demonstrating the physiologic importance of this cross-talk. These results suggest that GPCR-EGF receptor cross-talk is a conserved regulator of gonadotropin-induced steroidogenesis in the gonads, although the mechanisms of EGF receptor trans-activation may vary.	[Hammes, Stephen R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hammes, SR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	stephen.hammes@utsouthwestern.edu			National Institutes of Health [DK59913]; Welch Foundation Grant [1-1506]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation Grant(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK59913. This work was also supported by Welch Foundation Grant 1-1506. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Ashkenazi H, 2005, ENDOCRINOLOGY, V146, P77, DOI 10.1210/en.2004-0588; Barbier AJ, 1999, J BIOL CHEM, V274, P14067, DOI 10.1074/jbc.274.20.14067; CHASE DJ, 1992, J REPROD FERTIL, V95, P657, DOI 10.1530/jrf.0.0950657; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Drube S, 2006, CELL SIGNAL, V18, P1633, DOI 10.1016/j.cellsig.2006.01.003; DUFAU ML, 1977, P NATL ACAD SCI USA, V74, P3419, DOI 10.1073/pnas.74.8.3419; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; Jamnongjit M, 2005, P NATL ACAD SCI USA, V102, P16257, DOI 10.1073/pnas.0508521102; Jamnongjit M, 2006, CELL CYCLE, V5, P1178, DOI 10.4161/cc.5.11.2803; Keenan DM, 2004, AM J PHYSIOL-REG I, V286, pR381, DOI 10.1152/ajpregu.00376.2003; Kim J, 2002, J BIOL CHEM, V277, P32116, DOI 10.1074/jbc.M204895200; Kok SW, 2004, AM J PHYSIOL-ENDOC M, V287, pE630, DOI 10.1152/ajpendo.00060.2004; Lutz LB, 2000, J BIOL CHEM, V275, P41512, DOI 10.1074/jbc.M006757200; Manna PR, 2006, MOL ENDOCRINOL, V20, P362, DOI 10.1210/me.2004-0526; Manna PR, 2002, BIOL REPROD, V67, P1393, DOI 10.1095/biolreprod.102.007179; Manna PR, 2006, J MOL ENDOCRINOL, V37, P81, DOI 10.1677/jme.1.02065; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; Panigone S, 2008, MOL ENDOCRINOL, V22, P924, DOI 10.1210/me.2007-0246; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Piiper A, 2003, BIOCHEM BIOPH RES CO, V301, P848, DOI 10.1016/S0006-291X(03)00055-X; PODESTA EJ, 1978, BIOCHEMISTRY-US, V17, P1566, DOI 10.1021/bi00601a033; SCAGLIA HE, 1991, J ANDROL, V12, P273; Shah BH, 2005, MOL ENDOCRINOL, V19, P2535, DOI 10.1210/me.2005-0082; Shiraishi K, 2008, EXP CELL RES, V314, P25, DOI 10.1016/j.yexcr.2007.06.025; Shiraishi K, 2006, ENDOCRINOLOGY, V147, P3419, DOI 10.1210/en.2005-1478; Stocco DM, 1996, BIOCHEM PHARMACOL, V51, P197, DOI 10.1016/0006-2952(95)02093-4; Stocco DM, 1997, BIOL REPROD, V56, P328, DOI 10.1095/biolreprod56.2.328; STOCCO DM, 1990, CELL SIGNAL, V2, P161, DOI 10.1016/0898-6568(90)90019-7; TALBOT JA, 1990, ACTA ENDOCRINOL-COP, V122, P643, DOI 10.1530/acta.0.1220643; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	32	75	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27525	27533		10.1074/jbc.M803867200	http://dx.doi.org/10.1074/jbc.M803867200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18701461	hybrid, Green Published			2022-12-25	WOS:000259719200023
J	Borlido, J; Veltri, G; Jackson, AP; Mills, IG				Borlido, Joana; Veltri, Greg; Jackson, Antony P.; Mills, Ian G.			Clathrin Is Spindle-Associated but Not Essential for Mitosis	PLOS ONE			English	Article								Background: Clathrin is a multimeric protein involved in vesicle coat assembly. Recently clathrin distribution was reported to change during the cell cycle and was found to associate with the mitotic spindle. Here we test whether the recruitment of clathrin to the spindle is indicative of a critical functional contribution to mitosis. Methodology/Principal Findings: Previously a chicken pre-B lymphoma cell line (DKO-R) was developed in which the endogenous clathrin heavy chain alleles were replaced with the human clathrin heavy chain under the control of a tetracycline-regulatable promoter. Receptor-mediated and fluid-phase endocytosis were significantly inhibited in this line following clathrin knockout, and we used this to explore the significance of clathrin heavy chain expression for cell cycle progression. We confirmed using confocal microscopy that clathrin colocalised with tubulin at mitotic spindles. Using a propidium iodide flow cytometric assay we found no statistical difference in the cell cycle distribution of the knockout cells versus the wild-type. Additionally, we showed that the ploidy and the recovery kinetics following cell cycle arrest with nocodazole were unchanged by repressing clathrin heavy chain expression. Conclusions/Significance: We conclude that the association of clathrin with the mitotic spindle and the contribution of clathrin to endocytosis are evolutionarily conserved. However we find that the contribution of clathrin to mitosis is less robust and dependent on cellular context. In other cell-lines silencing RNA has been used by others to knockdown clathrin expression resulting in an increase in the mitotic index of the cells. We show an effect on the G2/M phase population of clathrin knockdown in HEK293 cells but show that repressing clathrin expression in the DKO-R cell-line has no effect on the size of this population. Consequently this work highlights the need for a more detailed molecular understanding of the recruitment and function of clathrin at the spindle, since the localisation but not the impact of clathrin on mitosis appears to be robust in plants, mammalian and chicken B-cells.	[Borlido, Joana; Mills, Ian G.] Li Ka Shing Canc Res Ctr, Urooncol Res Grp, CRUK Cambridge Res Inst, Cambridge, England; [Veltri, Greg] Li Ka Shing Canc Res Ctr, CRUK Cambridge Res Inst, Flow Cytomet Core, Cambridge, England; [Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge, England	CRUK Cambridge Institute; CRUK Cambridge Institute; University of Cambridge	Borlido, J (corresponding author), Li Ka Shing Canc Res Ctr, Urooncol Res Grp, CRUK Cambridge Res Inst, Cambridge, England.	ian.mills@cancer.org.uk	Mills, Ian/AAK-9292-2020	Mills, Ian/0000-0001-5347-5083; Jackson, Antony Philip/0000-0002-2895-7387; Sarabando Borlido, Joana/0000-0003-2622-0901	EU/Marie Curie Cancer Cure Early Stage Research Training (CANCURE) Fellowship; CRUK; MRC [G0500966] Funding Source: UKRI; Medical Research Council [G0500966] Funding Source: researchfish	EU/Marie Curie Cancer Cure Early Stage Research Training (CANCURE) Fellowship(European Commission); CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JB is the recipient of an EU/Marie Curie Cancer Cure Early Stage Research Training (CANCURE) Fellowship. GV and IGM are supported by core CRUK funding.	ACTON SL, 1990, J CELL BIOL, V111, P1419, DOI 10.1083/jcb.111.4.1419; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Boucrot E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001477; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; CROWTHER RA, 1981, J CELL BIOL, V91, P790, DOI 10.1083/jcb.91.3.790; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Hawkins TE, 2002, P NATL ACAD SCI USA, V99, P8054, DOI 10.1073/pnas.132598099; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; Pearse B M, 1982, Cold Spring Harb Symp Quant Biol, V46 Pt 2, P703; PYPAERT M, 1991, J CELL BIOL, V114, P1159, DOI 10.1083/jcb.114.6.1159; Radulescu AE, 2007, MOL BIOL CELL, V18, P94, DOI 10.1091/mbc.E06-06-0532; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Tahara H, 2007, PROTOPLASMA, V230, P1, DOI 10.1007/s00709-006-0226-7; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Wettey FR, 2002, SCIENCE, V297, P1521, DOI 10.1126/science.1074222; Wettey Frank R, 2006, Subcell Biochem, V40, P119	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3115	10.1371/journal.pone.0003115	http://dx.doi.org/10.1371/journal.pone.0003115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769625	gold, Green Published, Green Submitted			2022-12-25	WOS:000264418300007
J	Hase, K; Takahashi, D; Ebisawa, M; Kawano, S; Itoh, K; Ohno, H				Hase, Koji; Takahashi, Daisuke; Ebisawa, Masashi; Kawano, Sayaka; Itoh, Kikuji; Ohno, Hiroshi			Activation-Induced Cytidine Deaminase Deficiency Causes Organ-Specific Autoimmune Disease	PLOS ONE			English	Article								Activation-induced cytidine deaminase (AID) expressed by germinal center B cells is a central regulator of somatic hypermutation (SHM) and class switch recombination (CSR). Humans with AID mutations develop not only the autosomal recessive form of hyper-IgM syndrome (HIGM2) associated with B cell hyperplasia, but also autoimmune disorders by unknown mechanisms. We report here that AID(-/-) mice spontaneously develop tertiary lymphoid organs (TLOs) in non-lymphoid tissues including the stomach at around 6 months of age. At a later stage, AID(-/-) mice develop a severe gastritis characterized by loss of gastric glands and epithelial hyperplasia. The disease development was not attenuated even under germ-free (GF) conditions. Gastric autoantigen -specific serum IgM was elevated in AID(-/-) mice, and the serum levels correlated with the gastritis pathological score. Adoptive transfer experiments suggest that autoimmune CD4(+) T cells mediate gastritis development as terminal effector cells. These results suggest that abnormal B-cell expansion due to AID deficiency can drive B-cell autoimmunity, and in turn promote TLO formation, which ultimately leads to the propagation of organ-specific autoimmune effector CD4(+) T cells. Thus, AID plays an important role in the containment of autoimmune diseases by negative regulation of autoreactive B cells.	[Hase, Koji; Takahashi, Daisuke; Ebisawa, Masashi; Kawano, Sayaka; Ohno, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Kanagawa, Japan; [Takahashi, Daisuke; Ebisawa, Masashi; Ohno, Hiroshi] Yokohama City Univ, Int Grad Sch Arts & Sci, Kanagawa, Japan; [Itoh, Kikuji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	RIKEN; Yokohama City University; University of Tokyo	Hase, K (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Kanagawa, Japan.	ohno@rcai.riken.jp	Ohno, Hiroshi/L-7899-2014; Takahashi, Daisuke/C-3799-2019	Ohno, Hiroshi/0000-0001-8776-9661; Takahashi, Daisuke/0000-0001-8624-1160; Hase, Koji/0000-0001-9550-2334	Ministry of Education, Culture, Sports, Science and Technology of Japan [Grants-in-Aid]; Uehara Memorial Foundation; The Japan Science Society [Sasakawa Scientific Research]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); The Japan Science Society	This study was supported in part by Grants-in-Aid for Young Scientists (B) (K H), Scientific Research (B) (HO), and Scientific Research in Priority Areas (HO and KH) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Uehara Memorial Foundation (KH) and the Sasakawa Scientific Research Grant from The Japan Science Society (KH).	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Armengol MP, 2001, AM J PATHOL, V159, P861, DOI 10.1016/S0002-9440(10)61762-2; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Browning JL, 2006, NAT REV DRUG DISCOV, V5, P564, DOI 10.1038/nrd2085; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; FUKUMA K, 1988, GASTROENTEROLOGY, V94, P274, DOI 10.1016/0016-5085(88)90413-1; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Itoh K, 2000, J EXP MED, V192, P1151, DOI 10.1084/jem.192.8.1151; Katakai T, 2003, J IMMUNOL, V171, P4359, DOI 10.4049/jimmunol.171.8.4359; Kendall PL, 2007, J IMMUNOL, V178, P5643, DOI 10.4049/jimmunol.178.9.5643; KOJIMA A, 1980, LAB INVEST, V42, P387; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Murakami T, 2007, BLOOD, V110, P1215, DOI 10.1182/blood-2007-01-068387; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Narushima Seiko, 1999, Microbial Ecology in Health and Disease, V11, P55, DOI 10.1080/089106099435934; Nemazee D, 1996, IMMUNOL TODAY, V17, P25, DOI 10.1016/0167-5699(96)80565-2; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Quartier P, 2004, CLIN IMMUNOL, V110, P22, DOI 10.1016/j.clim.2003.10.007; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Shi KR, 2001, J IMMUNOL, V166, P650, DOI 10.4049/jimmunol.166.1.650; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; STRICKLAND RG, 1973, AM J DIG DIS, V18, P426, DOI 10.1007/BF01071995; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Yan J, 2006, J IMMUNOL, V177, P4481, DOI 10.4049/jimmunol.177.7.4481; Zhang ZX, 2001, ARTHRITIS RHEUM, V44, P2275, DOI 10.1002/1529-0131(200110)44:10<2275::AID-ART390>3.0.CO;2-K	36	48	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3033	10.1371/journal.pone.0003033	http://dx.doi.org/10.1371/journal.pone.0003033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716662	Green Published, Green Submitted, gold			2022-12-25	WOS:000264426800010
J	Kong, QP; Salas, A; Sun, C; Fuku, N; Tanaka, M; Zhong, L; Wang, CY; Yao, YG; Bandelt, HJ				Kong, Qing-Peng; Salas, Antonio; Sun, Chang; Fuku, Noriyuki; Tanaka, Masashi; Zhong, Li; Wang, Cheng-Ye; Yao, Yong-Gang; Bandelt, Hans-Juergen			Distilling Artificial Recombinants from Large Sets of Complete mtDNA Genomes	PLOS ONE			English	Article							MACROHAPLOGROUP-M; DNA-SEQUENCE; MITOCHONDRIAL; PHYLOGENY; LINEAGES; ERRORS; IDENTIFICATION; MUTATION; PHANTOM; SINGLE	Background: Large-scale genome sequencing poses enormous problems to the logistics of laboratory work and data handling. When numerous fragments of different genomes are PCR amplified and sequenced in a laboratory, there is a high immanent risk of sample confusion. For genetic markers, such as mitochondrial DNA ( mtDNA), which are free of natural recombination, single instances of sample mix-up involving different branches of the mtDNA phylogeny would give rise to reticulate patterns and should therefore be detectable. Methodology/Principal Findings: We have developed a strategy for comparing new complete mtDNA genomes, one by one, to a current skeleton of the worldwide mtDNA phylogeny. The mutations distinguishing the reference sequence from a putative recombinant sequence can then be allocated to two or more different branches of this phylogenetic skeleton. Thus, one would search for two ( or three) near-matches in the total mtDNA database that together best explain the variation seen in the recombinants. The evolutionary pathway from the mtDNA tree connecting this pair together with the recombinant then generate a grid-like median network, from which one can read off the exchanged segments. Conclusions: We have applied this procedure to a large collection of complete human mtDNA sequences, where several recombinants could be distilled by our method. All these recombinant sequences were subsequently corrected by de novo experiments - fully concordant with the predictions from our data-analytical approach.	[Kong, Qing-Peng; Sun, Chang; Wang, Cheng-Ye; Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Kong, Qing-Peng; Zhong, Li] Yunnan Univ, Laboratory for Conservat & Utilizat Bio Resource, Kunming, Peoples R China; [Salas, Antonio] Univ Santiago Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Galicia, Spain; [Fuku, Noriyuki; Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longevity & Hlth, Tokyo, Japan; [Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mechanisms, Beijing 100864, Peoples R China; [Bandelt, Hans-Juergen] Univ Hamburg, Dept Math, Hamburg, Germany	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Universidade de Santiago de Compostela; Tokyo Metropolitan Institute of Gerontology; Chinese Academy of Sciences; Kunming Institute of Zoology; University of Hamburg	Kong, QP (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China.	bandelt@math.uni-hamburg.de	Zhong, Li/GZM-4358-2022; Salas, Antonio/E-3977-2012; Salas, Antonio/U-2029-2019; Sun, Chang/I-6326-2012; Yao, Yong-Gang/AAH-2303-2021	Zhong, Li/0000-0003-1611-5171; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Yao, Yong-Gang/0000-0002-2955-0693; Fuku, Noriyuki/0000-0001-7792-5835	National Basic Research Program of China [2007CB507405]; Light in Western China" of the Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); Light in Western China" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	The work was supported by grants from National Basic Research Program of China (No. 2007CB507405) and "Light in Western China" of the Chinese Academy of Sciences (to Q-PK). Y-GY was supported by the Chinese Academy of Sciences.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2007, MOL PHYLOGENET EVOL, V42, P256, DOI 10.1016/j.ympev.2006.07.013; Bandelt HJ, 2006, NUCL ACID M, V18, P117; Bandelt HJ, 2005, REGNUM VEG, V143, P245; Bandelt HJ, 2006, ANN HUM GENET, V70, P314, DOI 10.1111/j.1469-1809.2005.00234.x; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Bandelt HJ, 2004, RECHTSMEDIZIN, V14, P251; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Brandstatter A, 2005, ELECTROPHORESIS, V26, P3414, DOI 10.1002/elps.200500307; Brandstatter A, 2003, INT J LEGAL MED, V117, P180, DOI 10.1007/s00414-002-0350-7; Budowle V, 2004, J FORENSIC SCI, V49, P1256; Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Elson JL, 2006, TRENDS GENET, V22, P603, DOI 10.1016/j.tig.2006.09.004; Furey TS, 2004, GENOME RES, V14, P2034, DOI 10.1101/gr.2467904; Gajer P, 2004, NUCLEIC ACIDS RES, V32, P562, DOI 10.1093/nar/gkh216; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kong QP, 2004, J HUM GENET, V49, P414, DOI 10.1007/s10038-004-0170-3; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Monson K.L., 2002, FORENSIC SCI COMMUN, V4, P2; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; POLANSKEY D, 2005, FORENSIC SCI COMMUN, V7, P1; Rajkumar R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-26; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Tanaka M, 1996, Methods Enzymol, V264, P407, DOI 10.1016/S0076-6879(96)64037-3; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; Tsaousis AD, 2005, MOL BIOL EVOL, V22, P925, DOI 10.1093/molbev/msi084; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yao YG, 2004, FORENSIC SCI INT, V141, P1, DOI 10.1016/j.forsciint.2003.12.004; Yao YG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000681; Young WY, 2006, AM J MED GENET A, V140A, P2188, DOI 10.1002/ajmg.a.31434	55	41	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3016	10.1371/journal.pone.0003016	http://dx.doi.org/10.1371/journal.pone.0003016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714389	Green Published, gold, Green Submitted			2022-12-25	WOS:000264420900040
J	Yang, SH; Peng, Q; Francisco, MS; Wang, YJ; Zeng, Q; Yang, CH				Yang, Shihui; Peng, Quan; Francisco, Michael San; Wang, Yongjun; Zeng, Quan; Yang, Ching-Hong			Type III Secretion System Genes of Dickeya dadantii 3937 Are Induced by Plant Phenolic Acids	PLOS ONE			English	Article							CAROTOVORA SUBSP CAROTOVORA; ERWINIA-CHRYSANTHEMI; REGULATORY RNA; SALICYLIC-ACID; IMPROVED GFP; HRP GENES; EXPRESSION; VIRULENCE; HOST; DEFENSE	Background: Dickeya dadantii is a broad-host range phytopathogen. D. dadantii 3937 (Ech3937) possesses a type III secretion system (T3SS), a major virulence factor secretion system in many Gram-negative pathogens of plants and animals. In Ech3937, the T3SS is regulated by two major regulatory pathways, HrpX/HrpY-HrpS-HrpL and GacS/GacA-rsmB-RsmA pathways. Although the plant apoplast environment, low pH, low temperature, and absence of complex nitrogen sources in media have been associated with the induction of T3SS genes of phytobacteria, no specific inducer has yet been identified. Methodology/Principal Findings: In this work, we identified two novel plant phenolic compounds, o-coumaric acid (OCA) and t-cinnamic acid (TCA), that induced the expression of T3SS genes dspE (a T3SS effector), hrpA (a structural protein of the T3SS pilus), and hrpN (a T3SS harpin) in vitro. Assays by qRT-PCR showed higher amounts of mRNA of hrpL (a T3SS alternative sigma factor) and rsmB (an untranslated regulatory RNA), but not hrpS (a sigma(54)- enhancer binding protein) of Ech3937 when these two plant compounds were supplemented into minimal medium (MM). However, promoter activity assays using flow cytometry showed similar promoter activities of hrpN in rsmB mutant Ech148 grown in MM and MM supplemented with these phenolic compounds. Compared with MM alone, only slightly higher promoter activities of hrpL were observed in bacterial cells grown in MM supplemented with OCA/TCA. Conclusion/Significance: The induction of T3SS expression by OCA and TCA is moderated through the rsmB-RsmA pathway. This is the first report of plant phenolic compounds that induce the expression T3SS genes of plant pathogenic bacteria.	[Yang, Shihui; Peng, Quan; Wang, Yongjun; Zeng, Quan; Yang, Ching-Hong] Univ Wisconsin Milwaukee, Dept Biol Sci, Milwaukee, WI USA; [Francisco, Michael San] Texas Tech Univ, Dept Biol Sci, Lubbock, TX USA	University of Wisconsin System; University of Wisconsin Milwaukee; Texas Tech University System; Texas Tech University	Yang, SH (corresponding author), Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA.	chyang@uwm.edu	Yang, Shihui/AAE-4100-2020; YANG, SHIHUI/A-6526-2008	Yang, Shihui/0000-0002-9394-9148; YANG, SHIHUI/0000-0002-9394-9148; Wang, Yongjun/0000-0002-8488-3423	Research Growth Initiative of the University of Wisconsin-Milwaukee; National Science Foundation [EF-0332163]	Research Growth Initiative of the University of Wisconsin-Milwaukee; National Science Foundation(National Science Foundation (NSF))	This project is supported by grants from a Research Growth Initiative of the University of Wisconsin-Milwaukee and the National Science Foundation (award no. EF-0332163).	Aldon D, 2000, TRENDS MICROBIOL, V8, P489, DOI 10.1016/S0966-842X(00)01859-X; Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alhenc-Gelas M, 2000, THROMB HAEMOSTASIS, V83, P86; ARLAT M, 1992, MOL PLANT MICROBE IN, V5, P187, DOI 10.1094/MPMI-5-187; Barabote RD, 2003, J BACTERIOL, V185, P5772, DOI 10.1128/JB.185.19.5772-5778.2003; BAUER DW, 1994, MOL PLANT MICROBE IN, V7, P573, DOI 10.1094/MPMI-7-0573; BAUER DW, 1995, MOL PLANT MICROBE IN, V8, P484, DOI 10.1094/MPMI-8-0484; Bouhenni R, 2005, APPL ENVIRON MICROB, V71, P4935, DOI 10.1128/AEM.71.8.4935-4937.2005; Brencic A, 2005, MICROBIOL MOL BIOL R, V69, P155, DOI 10.1128/MMBR.69.1.155-194.2005; Buttner D, 2006, CURR OPIN MICROBIOL, V9, P193, DOI 10.1016/j.mib.2006.02.006; Chang JH, 2004, CURR OPIN MICROBIOL, V7, P11, DOI 10.1016/j.mib.2003.12.006; Chatterjee A, 2003, MOL PLANT MICROBE IN, V16, P1106, DOI 10.1094/MPMI.2003.16.12.1106; Chatterjee A, 2002, J BACTERIOL, V184, P4089, DOI 10.1128/JB.184.15.4089-4095.2002; Chatterjee A, 2002, MOL PLANT MICROBE IN, V15, P971, DOI 10.1094/MPMI.2002.15.9.971; Cui Y, 1999, J BACTERIOL, V181, P6042, DOI 10.1128/JB.181.19.6042-6052.1999; Fagard M, 2007, MOL PLANT MICROBE IN, V20, P794, DOI 10.1094/MPMI-20-7-0794; Francis MS, 2002, CURR OPIN MICROBIOL, V5, P166, DOI 10.1016/S1369-5274(02)00301-6; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Ham JH, 2004, MOL PLANT MICROBE IN, V17, P184, DOI 10.1094/MPMI.2004.17.2.184; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Lopez-Solanilla E, 2001, MOL PLANT MICROBE IN, V14, P386, DOI 10.1094/MPMI.2001.14.3.386; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Miller WG, 1997, GENE, V191, P149, DOI 10.1016/S0378-1119(97)00051-6; Montesano M, 2005, MOL PLANT PATHOL, V6, P541, DOI [10.1111/j.1364-3703.2005.00305.x, 10.1111/J.1364-3703.2005.00305.X]; Mota LJ, 2005, FEMS MICROBIOL LETT, V252, P1, DOI 10.1016/j.femsle.2005.08.036; Nasser W, 2005, MOL PLANT MICROBE IN, V18, P1205, DOI 10.1094/MPMI-18-1205; Park D, 2006, MOL MICROBIOL, V61, P1397, DOI 10.1111/j.1365-2958.2006.05320.x; Peng Q, 2006, MOL PLANT MICROBE IN, V19, P451, DOI 10.1094/MPMI-19-0451; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ravirala RS, 2007, MOL PLANT MICROBE IN, V20, P313, DOI 10.1094/MPMI-20-3-0313; Tang XY, 2006, MOL PLANT MICROBE IN, V19, P1159, DOI 10.1094/MPMI-19-1159; Vidal S, 1997, PLANT J, V11, P115, DOI 10.1046/j.1365-313X.1997.11010115.x; YALPANI N, 1993, PLANT PHYSIOL, V103, P315, DOI 10.1104/pp.103.2.315; Yang CH, 2002, MOL PLANT MICROBE IN, V15, P472, DOI 10.1094/MPMI.2002.15.5.472; Yang SH, 2004, MOL PLANT MICROBE IN, V17, P999, DOI 10.1094/MPMI.2004.17.9.999; Yang SH, 2008, MOL PLANT MICROBE IN, V21, P133, DOI 10.1094/MPMI-21-1-0133; Yang SH, 2007, APPL ENVIRON MICROB, V73, P1079, DOI 10.1128/AEM.01770-06; Yap MN, 2005, J BACTERIOL, V187, P639, DOI 10.1128/JB.187.2.639-648.2005	41	60	66	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2973	10.1371/journal.pone.0002973	http://dx.doi.org/10.1371/journal.pone.0002973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698421	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600057
J	Noorlander, CW; Ververs, FFT; Nikkels, PGJ; van Echteld, CJA; Visser, GHA; Smidt, MP				Noorlander, Cornelle W.; Ververs, Frederique F. T.; Nikkels, Peter G. J.; van Echteld, Cees J. A.; Visser, Gerard H. A.; Smidt, Marten P.			Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities	PLOS ONE			English	Article								Background: Women are at great risk for mood and anxiety disorders during their childbearing years and may become pregnant while taking antidepressant drugs. In the treatment of depression and anxiety disorders, selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed drugs, while it is largely unknown whether this medication affects the development of the central nervous system of the fetus. The possible effects are the product of placental transfer efficiency, time of administration and dose of the respective SSRI. Methodology/Principal Findings: In order to attain this information we have setup a study in which these parameters were measured and the consequences in terms of physiology and behavior are mapped. The placental transfer of fluoxetine and fluvoxamine, two commonly used SSRIs, was similar between mouse and human, indicating that the fetal exposure of these SSRIs in mice is comparable with the human situation. Fluvoxamine displayed a relatively low placental transfer, while fluoxetine showed a relatively high placental transfer. Using clinical doses of fluoxetine the mortality of the offspring increased dramatically, whereas the mortality was unaffected after fluvoxamine exposure. The majority of the fluoxetine-exposed offspring died postnatally of severe heart failure caused by dilated cardiomyopathy. Molecular analysis of fluoxetine-exposed offspring showed long-term alterations in serotonin transporter levels in the raphe nucleus. Furthermore, prenatal fluoxetine exposure resulted in depressive- and anxiety-related behavior in adult mice. In contrast, fluvoxamine-exposed mice did not show alterations in behavior and serotonin transporter levels. Decreasing the dose of fluoxetine resulted in higher survival rates and less dramatic effects on the long-term behavior in the offspring. Conclusions: These results indicate that prenatal fluoxetine exposure affects fetal development, resulting in cardiomyopathy and a higher vulnerability to affective disorders in a dose-dependent manner.	[Noorlander, Cornelle W.; Smidt, Marten P.] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Ververs, Frederique F. T.] Univ Med Ctr Utrecht, Dept Pharm, Utrecht, Netherlands; [Nikkels, Peter G. J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van Echteld, Cees J. A.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Visser, Gerard H. A.] Univ Med Ctr Utrecht, Dept Obstet, Neonatol & Gynaecol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Noorlander, CW (corresponding author), Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	m.p.smidt-2@umcutrecht.nl		Smidt, Marten/0000-0002-8815-747X	Universtity of Utrecht; Hersenstichting [15F07(2).22]	Universtity of Utrecht; Hersenstichting	"Universtity of Utrecht" HIPO grant (M.P. Smidt), "Hersenstichting" grant (15F07(2).22) (C.W. Noorlander/M.P. Smidt)	ALWAN S, 2007, NEW ENGL J MED, V356, P2732; Bairy KL, 2007, PHARMACOLOGY, V79, P1, DOI 10.1159/000096645; Benmansour S, 1999, J NEUROSCI, V19, P10494; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Bennett HA, 2004, OBSTET GYNECOL, V103, P1344; Berard A, 2007, BIRTH DEFECTS RES B, V80, P18, DOI 10.1002/bdrb.20099; BODNOFF SR, 1989, PSYCHOPHARMACOLOGY, V97, P277, DOI 10.1007/BF00442264; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; CUZZELL JZ, 2006, DERMATOL NURS, V18, P6; GREENE MF, 2007, NEW ENGL J MED, V356, P26; Hendrick V, 2003, AM J OBSTET GYNECOL, V188, P812, DOI 10.1067/mob.2003.172; Hirano K, 2005, BRIT J PHARMACOL, V144, P695, DOI 10.1038/sj.bjp.0706108; Holmes A, 2003, BIOL PSYCHIAT, V54, P953, DOI 10.1016/j.biopsych.2003.09.003; Kallen B, 2006, REPROD TOXICOL, V21, P221, DOI 10.1016/j.reprotox.2005.11.006; Kallen B, 2004, BIRTH DEFECTS RES B, V71, P395, DOI 10.1002/bdrb.20025; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; Lisboa SFS, 2007, PHARMACOLOGY, V80, P49, DOI 10.1159/000103097; Llewellyn AM, 1997, J CLIN PSYCHIAT, V58, P26; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Mirza NR, 2007, PROG NEURO-PSYCHOPH, V31, P858, DOI 10.1016/j.pnpbp.2007.01.020; MOISEIWITSCH JRD, 1995, P NATL ACAD SCI USA, V92, P7182, DOI 10.1073/pnas.92.16.7182; Moses-Kolko EL, 2005, JAMA-J AM MED ASSOC, V293, P2372, DOI 10.1001/jama.293.19.2372; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Nebigil CG, 2001, CIRCULATION, V103, P2973, DOI 10.1161/01.CIR.103.24.2973; Nonacs R, 2003, PSYCHIAT CLIN N AM, V26, P547, DOI 10.1016/S0193-953X(03)00046-7; Rahimi R, 2006, REPROD TOXICOL, V22, P571, DOI 10.1016/j.reprotox.2006.03.019; Reefhuis J, 2006, NEW ENGL J MED, V354, P2188; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sanz EJ, 2005, LANCET, V365, P482, DOI 10.1016/S0140-6736(05)17865-9; SHUEY DL, 1992, TERATOLOGY, V46, P367, DOI 10.1002/tera.1420460407; van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371; Verney C, 2002, ANAT REC, V267, P87, DOI 10.1002/ar.10089; VORHEES CV, 1994, FUND APPL TOXICOL, V23, P194, DOI 10.1006/faat.1994.1098; Zeskind PS, 2004, PEDIATRICS, V113, P368, DOI 10.1542/peds.113.2.368	35	118	118	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2782	10.1371/journal.pone.0002782	http://dx.doi.org/10.1371/journal.pone.0002782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18716672	Green Submitted, gold, Green Published			2022-12-25	WOS:000264302900052
J	Wang, Q; Wang, YL; Minto, AW; Wang, JH; Shi, Q; Li, XM; Quigg, RJ				Wang, Qiang; Wang, Youli; Minto, Andrew W.; Wang, Jinhua; Shi, Qun; Li, Xinmin; Quigg, Richard J.			MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy	FASEB JOURNAL			English	Article						diabetes; microRNA; glomerulus; extracellular matrix	SUPEROXIDE-DISMUTASE; MESANGIAL CELLS; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; KIDNEY GLOMERULI; RENAL INJURY; ACTIVATION; APOPTOSIS; GLUCOSE; MECHANISM	Intrinsic glomerular cells in a diabetic milieu have transcriptional activation of genes that influence the development of diabetic nephropathy. The cellular repertoire of microRNAs can regulate translation of these expressed genes into proteins. Fibronectin is a key matrix protein accumulated in excess in diabetic nephropathy. Here, we exposed cultured human and mouse mesangial cells to high glucose and transforming growth factor-beta to simulate the diabetic milieu. In these conditions in vitro, as well as in mouse diabetic nephropathy models in vivo, microRNA-377 was consistently up-regulated relative to controls. Through a combination of computational and biological approaches, we identified relevant miR-377 target genes. Although fibronectin was induced by miR-377, it was not a direct target of miR-377. However, miR-377 led to reduced expressions of p21-activated kinase and superoxide dismutase, which enhanced fibronectin protein production. Thus, overexpression of miR-377 in diabetic nephropathy indirectly leads to increased fibronectin protein production; as such, miR-377 can have a critical role in the pathophysiology of this prevalent human disease.	[Wang, Qiang; Wang, Youli; Minto, Andrew W.; Wang, Jinhua; Shi, Qun; Li, Xinmin; Quigg, Richard J.] Univ Chicago, Nephrol Sect, Dept Med, Chicago, IL 60637 USA	University of Chicago	Quigg, RJ (corresponding author), Univ Chicago, Nephrol Sect, Dept Med, 5841 S Maryland Ave,MC5100,AMB-S523, Chicago, IL 60637 USA.	rquigg@uchicago.edu			Juvenile Diabetes Research Foundation; National Institutes of Health [R21DK057684, U24DK058820]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK057684, U24DK058820] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in its entirety by an innovation grant from the Juvenile Diabetes Research Foundation. Funding from the National Institutes of Health (R21DK057684 and U24DK058820) was essential for our earlier supporting studies in diabetic nephropathy.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chen C, 2006, FEBS LETT, V580, P813, DOI 10.1016/j.febslet.2005.12.097; Craven PA, 2001, METABOLISM, V50, P1043, DOI 10.1053/meta.2001.25802; Craven PA, 2001, DIABETES, V50, P2114, DOI 10.2337/diabetes.50.9.2114; DeRubertis FR, 2004, DIABETES, V53, P762, DOI 10.2337/diabetes.53.3.762; DeRubertis FR, 2007, METABOLISM, V56, P1256, DOI 10.1016/j.metabol.2007.04.024; DOI T, 1990, LAB INVEST, V63, P204; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FROST JA, 2000, J CELL BIOL, V162, P281; Haneda M, 2003, J AM SOC NEPHROL, V14, P1374, DOI 10.1097/01.ASN.0000064500.89551.76; Ismail N, 1999, KIDNEY INT, V55, P1, DOI 10.1046/j.1523-1755.1999.00232.x; Jakobi R, 2001, J BIOL CHEM, V276, P16624, DOI 10.1074/jbc.M007753200; Johnson Felicity, 2005, Molecular Aspects of Medicine, V26, P340, DOI 10.1016/j.mam.2005.07.006; Kang BPS, 2003, AM J PHYSIOL-RENAL, V284, pF455, DOI 10.1152/ajprenal.00137.2002; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; LEITER EH, 1987, AM J PATHOL, V128, P380; Lin CL, 2008, AM J NEPHROL, V28, P290, DOI 10.1159/000111142; Lin Xia, 2007, Journal of Genetics and Genomics, V34, P1, DOI 10.1016/S1673-8527(07)60001-0; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Neumann M, 2006, BIOL CHEM, V387, P79, DOI 10.1515/BC.2006.011; Noor Rana, 2002, Med Sci Monit, V8, pRA210; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; QUIGG RJ, 1995, KIDNEY INT, V48, P412, DOI 10.1038/ki.1995.309; Ramakrishna V, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-22; Rychlik I, 1998, NEPHROL DIAL TRANSPL, V13, P6, DOI 10.1093/ndt/13.suppl_8.6; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schiffer M, 2002, J AM SOC NEPHROL, V13, P2657, DOI 10.1097/01.ASN.0000033276.06451.50; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Uchimura K, 1999, J DIABETES COMPLICAT, V13, P264, DOI 10.1016/S1056-8727(99)00053-7; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wu DT, 2005, J AM SOC NEPHROL, V16, P3211, DOI 10.1681/ASN.2004121055; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	48	327	355	1	36	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4126	4135		10.1096/fj.08-112326	http://dx.doi.org/10.1096/fj.08-112326			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18716028	Green Published			2022-12-25	WOS:000261254800012
J	Zeerleder, S; Zwart, B; Velthuis, HT; Stephan, F; Manoe, R; Rensink, I; Aarden, LA				Zeerleder, Sacha; Zwart, Bas; Velthuis, Henk te; Stephan, Femke; Manoe, Rishi; Rensink, Irma; Aarden, Lucien A.			Nucleosome-releasing factor: a new role for factor VII-activating protease (FSAP)	FASEB JOURNAL			English	Article						apoptosis; hyaluronan; binding protein; SLE; plasmin; monoclonal; single chain	SYSTEMIC-LUPUS-ERYTHEMATOSUS; HYALURONAN-BINDING PROTEIN; SECONDARY NECROTIC CELLS; AMYLOID-P COMPONENT; APOPTOTIC CELLS; SERINE-PROTEASE; HUMAN PLASMA; AUTOANTIGENS; PURIFICATION; MACROPHAGES	Plasma proteins such as early complement components and IgM are involved in the removal of late apoptotic or secondary necrotic (sn) cells. We have recently described how a plasma protease that could be inhibited by the protease inhibitor aprotinin was essential to remove nucleosomes from sn cells. An obvious candidate, plasmin, did indeed have nucleosome-releasing factor (NRF) activity. However, recalcified plasma (r-plasma) retained its NRF activity after plasminogen depletion, which suggests the existence of another protease responsible for NRF activity in plasma. In this study we have used size-exclusion and anion-exchange chromatography to purify the protease responsible for NRF activity in plasma. SDS-PAGE analysis of chromatography fractions containing NRF activity revealed a protein band corresponding with NRF activity. Sequence analysis showed this band to be factor VII-activating protease (FSAP). We developed monoclonal antibodies to FSAP and were able to completely inhibit NRF activity in plasma with monoclonal antibodies to FSAP. Using affinity chromatography we were able to purify single-chain (sc) FSAP from r-plasma. Purified scFSAP efficiently removes nucleosomes from sn cells. We report that factor VII-activating protease may function in cellular homeostasis by catalyzing the release of nucleosomes from secondary necrotic cells.	[Zeerleder, Sacha; Zwart, Bas; Stephan, Femke; Manoe, Rishi; Rensink, Irma; Aarden, Lucien A.] Univ Amsterdam, Acad Med Ctr, Sanquin Res CLB, Dept Immunopathol,Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Velthuis, Henk te] Business Unit Reagents, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Zeerleder, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res CLB, Dept Immunopathol,Landsteiner Lab, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	s.zeerleder@sanquin.nl			Landsteiner Foundation for Blood Transfusion Research [LSBR 0422]; Dutch Arthritis Association [97.402.01]	Landsteiner Foundation for Blood Transfusion Research; Dutch Arthritis Association	S.Z. was supported by a grant of the Landsteiner Foundation for Blood Transfusion Research (LSBR 0422). B.Z. was supported by grant 97.402.01 of the Dutch Arthritis Association. We thank Piet Modderman for his helpful comments on the manuscript.	Amoura Z, 1997, ARTHRITIS RHEUM, V40, P2217, DOI 10.1002/art.1780401217; Bijl M, 2003, ARTHRITIS RHEUM, V48, P248, DOI 10.1002/art.10737; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; ChoiMiura NH, 1996, J BIOCHEM, V119, P1157; Cocca BA, 2002, J IMMUNOL, V169, P159, DOI 10.4049/jimmunol.169.1.159; Etscheid M, 2000, BIOL CHEM, V381, P1223, DOI 10.1515/BC.2000.150; Familian A, 2001, J IMMUNOL, V167, P647, DOI 10.4049/jimmunol.167.2.647; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Hunfeld A, 1999, FEBS LETT, V456, P290, DOI 10.1016/S0014-5793(99)00959-X; Kannemeier C, 2004, FASEB J, V18, P728, DOI 10.1096/fj.03-0898fje; Kannemeier C, 2001, EUR J BIOCHEM, V268, P3789, DOI 10.1046/j.1432-1327.2001.02285.x; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Nakazawa F, 2005, BIOCHEM J, V385, P831, DOI 10.1042/BJ20041021; Napirei M, 2004, ARTHRITIS RHEUM-US, V50, P1873, DOI 10.1002/art.20267; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; Romisch J, 1999, BLOOD COAGUL FIBRIN, V10, P471; Romisch J, 1999, HAEMOSTASIS, V29, P292; Romisch J, 2001, BLOOD COAGUL FIBRIN, V12, P375, DOI 10.1097/00001721-200107000-00007; RUMORE PM, 1990, J CLIN INVEST, V86, P69, DOI 10.1172/JCI114716; Sedding D, 2006, J EXP MED, V203, P2801, DOI 10.1084/jem.20052546; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; van Nieuwenhuijze AEM, 2003, ANN RHEUM DIS, V62, P10, DOI 10.1136/ard.62.1.10; Vostrov AR, 2000, J BIOL CHEM, V275, P22978, DOI 10.1074/jbc.M904640199; Zeerleder S, 2007, FEBS LETT, V581, P5382, DOI 10.1016/j.febslet.2007.10.037; Zwart B, 2004, AUTOIMMUNITY, V37, P95, DOI 10.1080/0891693042000196183	30	47	47	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2008	22	12					4077	4084		10.1096/fj.08-110429	http://dx.doi.org/10.1096/fj.08-110429			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18753248				2022-12-25	WOS:000261254800007
J	Page, MJ; Di Cera, E				Page, Michael J.; Di Cera, Enrico			Evolution of Peptidase Diversity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCESSING PEPTIDASE; PROTEASE; FAMILY; CLASSIFICATION; SUPERFAMILY; CASPASES; CLEAVAGE; COHESIN; REVEAL; SYSTEM	A wide variety of peptidases associate with vital biological pathways, but the origin and evolution of their tremendous diversity are poorly defined. Application of the MEROPS classification to a comprehensive set of genomes yields a simple pattern of peptidase distribution and provides insight into the organization of proteolysis in all forms of life. Unexpectedly, a near ubiquitous core set of peptidases is shown to contain more types than those unique to higher multicellular organisms. From this core group, an array of eukaryote-specific peptidases evolved to yield well known intracellular and extracellular processes. The paucity of peptidase families unique to higher metazoa suggests gains in proteolytic network complexity required a limited number of biochemical inventions. These findings provide a framework for deeper investigation into the evolutionary forces that shaped each peptidase family and a roadmap to develop a time-line for their expansion as an interconnected system.	[Page, Michael J.; Di Cera, Enrico] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Di Cera, E (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	enrico@wustl.edu			National Institutes of Health [HL49413, HL58141, HL73813]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL049413, R01HL049413, R01HL058141, R01HL073813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49413, HL58141, and HL73813 (to E. D. C.). This work was also supported by a postdoctoral fellowship from the American Heart Association (to M. J. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Barrett AJ, 2007, BIOL CHEM, V388, P1151, DOI 10.1515/BC.2007.151; BECKER AB, 1992, P NATL ACAD SCI USA, V89, P3835, DOI 10.1073/pnas.89.9.3835; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Doolittle RF, 2005, CURR OPIN STRUC BIOL, V15, P248, DOI 10.1016/j.sbi.2005.04.001; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evans JS, 2007, J NEUROCHEM, V103, P849, DOI 10.1111/j.1471-4159.2007.04815.x; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Johnson KA, 2006, EMBO J, V25, P1977, DOI 10.1038/sj.emboj.7601080; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Krem MM, 2001, EMBO J, V20, P3036, DOI 10.1093/emboj/20.12.3036; Leiting B, 2003, BIOCHEM J, V371, P525, DOI 10.1042/BJ20021643; Liu Z, 2006, PLANT CELL, V18, P1213, DOI 10.1105/tpc.105.036913; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Puente XS, 2005, GENOMICS, V86, P638, DOI 10.1016/j.ygeno.2005.07.009; Puente XS, 2005, BIOCHEM SOC T, V33, P331, DOI 10.1042/BST0330331; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rea D, 2006, CELL BIOCHEM BIOPHYS, V44, P349, DOI 10.1385/CBB:44:3:349; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; STOCKER W, 1995, PROTEIN SCI, V4, P823; Suzuki H, 2002, J BIOL CHEM, V277, P43536, DOI 10.1074/jbc.M207680200; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wu WF, 1999, J BACTERIOL, V181, P3681, DOI 10.1128/JB.181.12.3681-3687.1999; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102; Yao R, 1996, P NATL ACAD SCI USA, V93, P10134, DOI 10.1073/pnas.93.19.10134	58	70	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30010	30014		10.1074/jbc.M804650200	http://dx.doi.org/10.1074/jbc.M804650200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768474	Green Published, hybrid			2022-12-25	WOS:000260366900045
J	Rusconi, L; Salvatoni, L; Giudici, L; Bertani, I; Kilstrup-Nielsen, C; Broccoli, V; Landsberger, N				Rusconi, Laura; Salvatoni, Lisa; Giudici, Laura; Bertani, Ilaria; Kilstrup-Nielsen, Charlotte; Broccoli, Vania; Landsberger, Nicoletta			CDKL5 Expression Is Modulated during Neuronal Development and Its Subcellular Distribution Is Tightly Regulated by the C-terminal Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-ONSET SEIZURES; RETT-SYNDROME; INFANTILE SPASMS; BDNF TRANSCRIPTION; MECP2; MUTATIONS; GENE; DNA; PHOSPHORYLATION; INCLUSION	Mutations in the human X-linked cyclin-dependent kinase-like 5 (CDKL5) gene have been identified in patients with Rett syndrome (RTT), West syndrome, and X-linked infantile spasms, sharing the common feature of mental retardation and early seizures. CDKL5 is a rather uncharacterized kinase, but its involvement in RTT seems to be explained by the fact that it works upstream of MeCP2, the main cause of Rett syndrome. To understand the role of this kinase for nervous system functions and to address if molecular mechanisms are involved in regulating its distribution and activity, we studied the ontogeny of CDKL5 expression in developing mouse brains by immunostaining and Western blotting. The expression profile of CDKL5 was compared with that of MeCP2. The two proteins share a general expression profile in the adult mouse brain, but CDKL5 levels appear to be highly modulated at the regional level. Its expression is strongly induced in early postnatal stages, and in the adult brain CDKL5 is present in mature neurons, but not in astroglia. Interestingly, the presence of CDKL5 in the cell nucleus varies at the regional level of the adult brain and is developmentally regulated. CDKL5 shuttles between the cytoplasm and the nucleus and the C-terminal tail is involved in localizing the protein to the cytoplasm in a mechanism depending on active nuclear export. Accordingly, Rett derivatives containing disease-causing truncations of the C terminus are constitutively nuclear, suggesting that they might act as gain of function mutations in this cellular compartment.	[Rusconi, Laura; Giudici, Laura; Bertani, Ilaria; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta] Univ Insubria, Dept Struct & Funct Biol, I-21052 Busto Arsizio, VA, Italy; [Salvatoni, Lisa; Broccoli, Vania] Ist Sci San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy	University of Insubria; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Landsberger, N (corresponding author), Univ Insubria, Dept Struct & Funct Biol, Via Alberto da Giussano 12, I-21052 Busto Arsizio, VA, Italy.	landsben@uninsubria.it	Kilstrup-Nielsen, Charlotte/A-6348-2014; Broccoli, Vania/K-3464-2016	Broccoli, Vania/0000-0003-4050-0926; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077; Landsberger, Nicoletta/0000-0003-0820-3155; Bertani, Ilaria/0000-0003-3175-8677	Rett Syndrome Research Foundation; Telethon; Ministero dell'Istruzione dell'Universita e della Ricerca; Fondazione Cariplo; E-rare EuroRETT network	Rett Syndrome Research Foundation; Telethon(Fondazione Telethon); Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo); E-rare EuroRETT network	This work was supported by the Rett Syndrome Research Foundation (to C. K.-N. and V. B.), Telethon (to N. L.), Ministero dell'Istruzione dell'Universita e della Ricerca (to N. L.), Fondazione Cariplo (to C. K.-N. and N. L.), and the E-rare EuroRETT network (to V. B., C. K.-N., and N. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Archer HL, 2006, J MED GENET, V43, P729, DOI 10.1136/jmg.2006.041467; Armstrong DD, 2002, MENT RETARD DEV D R, V8, P72, DOI 10.1002/mrdd.10027; Bahi-Buisson N, 2008, EPILEPSIA, V49, P1027, DOI 10.1111/j.1528-1167.2007.01520.x; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Cheadle JP, 2000, HUM MOL GENET, V9, P1119, DOI 10.1093/hmg/9.7.1119; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Evans JC, 2005, EUR J HUM GENET, V13, P1113, DOI 10.1038/sj.ejhg.5201451; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG B, 1985, BRAIN DEV-JPN, V7, P372, DOI 10.1016/S0387-7604(85)80048-6; HAGBERG BA, 1994, PEDIATR NEUROL, V11, P5, DOI 10.1016/0887-8994(94)90082-5; HANEFELD F, 1985, BRAIN DEV-JPN, V7, P320, DOI 10.1016/S0387-7604(85)80037-1; Ishibashi T, 2008, FEBS LETT, V582, P1157, DOI 10.1016/j.febslet.2008.03.005; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jung BP, 2003, J NEUROBIOL, V55, P86, DOI 10.1002/neu.10201; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Kaufmann WE, 2005, BRAIN DEV-JPN, V27, pS77, DOI 10.1016/j.braindev.2004.10.008; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lin C, 2005, HUM MOL GENET, V14, P3775, DOI 10.1093/hmg/ddi391; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; Mullaney BC, 2004, NEUROSCIENCE, V123, P939, DOI 10.1016/j.neuroscience.2003.11.025; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Rosas-Vargas H, 2008, J MED GENET, V45, P172, DOI 10.1136/jmg.2007.053504; Scala E, 2005, J MED GENET, V42, P103, DOI 10.1136/jmg.2004.026237; Schmid RS, 2008, NEUROREPORT, V19, P393, DOI 10.1097/WNR.0b013e3282f5661c; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Tao J, 2004, AM J HUM GENET, V75, P1149, DOI 10.1086/426460; Van Esch H, 2007, AM J MED GENET A, V143A, P364, DOI 10.1002/ajmg.a.31572; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Weaving LS, 2004, AM J HUM GENET, V75, P1079, DOI 10.1086/426462; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	40	119	125	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30101	30111		10.1074/jbc.M804613200	http://dx.doi.org/10.1074/jbc.M804613200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18701457	Green Published, hybrid			2022-12-25	WOS:000260366900055
J	Uhrig, RG; She, YM; Leach, CA; Plaxton, WC				Uhrig, R. Glen; She, Yi-Min; Leach, Craig A.; Plaxton, William C.			Regulatory Monoubiquitination of Phosphoenolpyruvate Carboxylase in Germinating Castor Oil Seeds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL REGULATION; UBIQUITINATED PROTEINS; BACTERIAL-TYPE; IN-VIVO; ENDOSPERM; IDENTIFICATION; PURIFICATION; COMPLEX; ENZYME; PLANT	Phosphoenolpyruvate carboxylase ( PEPC) is a tightly regulated enzyme situated at the core of plant C-metabolism. Although its anaplerotic role and control by allosteric effectors, reversible phosphorylation, and oligomerization have been well documented in the endosperm of developing castor oil seeds (COS), relatively little is known about PEPC in germinating COS. The initial phase of COS germination was accompanied by elevated PEPC activity and accumulation of comparable amounts of pre-existing 107-kDa and inducible 110-kDa immunoreactive PEPC polypeptides (p107 and p110, respectively). A 440-kDa PEPC heterotetramer composed of an equivalent ratio of non-phosphorylated p110 and p107 subunits was purified from germinated COS. N-terminal microsequencing, mass spectrometry, and immunoblotting revealed that both subunits arose from the same gene (RcPpc3) that encodes the p107 subunit of a phosphorylated 410-kDa PEP Chomotetramer in developing COS but that p110 is a monoubiquitinated form of p107. Tandem mass spectrometry sequencing of a diglycinated tryptic peptide identified Lys-628 as p110's monoubiquitination site. This residue is conserved in vascular plant PEPCs and is proximal to a PEP-binding/catalytic domain. Incubation with a human deubiquitinating enzyme (USP-2 core) converted the p110: p107 PEPC heterotetramer into a p107 homotetramer while significantly reducing the enzyme's Km(PEP) and sensitivity to allosteric activators (hexose-Ps, glycerol-3-P) and inhibitors (malate, aspartate). Monoubiquitination is a non-destructive and reversible post-translational modification involved in the control of diverse processes such as transcription, endocytosis, and signal transduction. The current study demonstrates that tissue-specific monoubiquitination of a metabolic enzyme can also occur and that this modification influences its kinetic and regulatory properties.	[Uhrig, R. Glen; Plaxton, William C.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [She, Yi-Min] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada; [Plaxton, William C.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Leach, Craig A.] Progenra Inc, Malvern, PA 19355 USA	Queens University - Canada; Queens University - Canada; Queens University - Canada	Plaxton, WC (corresponding author), Queens Univ, Dept Biol, Biosci Complex, Kingston, ON K7L 3N6, Canada.	plaxton@queensu.ca	Gruissem, Wilhelm/H-1752-2013; Plaxton, William C/O-3353-2013	Plaxton, William C/0000-0002-8447-7249; She, Yi-Min/0000-0002-0571-4630; Uhrig, R Glen/0000-0003-2773-4381	Natural Sciences and Engineering Research Council of Canada; Queen's Research Chairs program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Queen's Research Chairs program	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada and the Queen's Research Chairs program (to W.C.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Agetsuma M, 2005, PLANT CELL PHYSIOL, V46, P389, DOI 10.1093/pcp/pci043; Baret P, 1999, CR ACAD SCI III-VIE, V322, P29, DOI 10.1016/S0764-4469(99)80014-6; Blonde JD, 2003, J BIOL CHEM, V278, P11867, DOI 10.1074/jbc.M211269200; BOTHA FC, 1992, PLANT GROWTH REGUL, V11, P211, DOI 10.1007/BF00024560; BROOKS SPJ, 1992, BIOTECHNIQUES, V13, P906; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Crowley V, 2005, PLANT CELL PHYSIOL, V46, P1855, DOI 10.1093/pcp/pci203; Downes B, 2005, BIOCHEM SOC T, V33, P393, DOI 10.1042/BST0330393; Gennidakis S, 2007, PLANT J, V52, P839, DOI 10.1111/j.1365-313X.2007.03274.x; Glevarec G, 2004, PLANTA, V219, P286, DOI 10.1007/s00425-004-1214-9; Gonzalez MC, 1998, PLANT PHYSIOL, V116, P1249, DOI 10.1104/pp.116.4.1249; Gousseva N, 2003, GENE EXPRESSION, V11, P163, DOI 10.3727/000000003108749053; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; Izui K, 2004, ANNU REV PLANT BIOL, V55, P69, DOI 10.1146/annurev.arplant.55.031903.141619; KOBR MJ, 1971, PLANT PHYSIOL, V47, P48, DOI 10.1104/pp.47.1.48; LAW RD, 1995, BIOCHEM J, V307, P807, DOI 10.1042/bj3070807; Lin HJ, 2001, J BIOL CHEM, V276, P20357, DOI 10.1074/jbc.M008761200; Manzano C, 2008, PLANT MOL BIOL, V68, P145, DOI 10.1007/s11103-008-9358-9; Maor R, 2007, MOL CELL PROTEOMICS, V6, P601, DOI 10.1074/mcp.M600408-MCP200; Martin M, 2007, PHYSIOL PLANTARUM, V130, P484, DOI 10.1111/j.1399-3054.2007.00917.x; MOORHEAD GBG, 1994, ARCH BIOCHEM BIOPHYS, V312, P326, DOI 10.1006/abbi.1994.1316; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Murmu J, 2007, PLANTA, V226, P1299, DOI 10.1007/s00425-007-0551-x; Nhiri M, 2000, PLANT SCI, V151, P29, DOI 10.1016/S0168-9452(99)00191-0; Osuna L, 1996, PLANT PHYSIOL, V111, P551, DOI 10.1104/pp.111.2.551; Osuna L, 1999, PLANT PHYSIOL, V119, P511, DOI 10.1104/pp.119.2.511; Plaxton WC, 2006, CRIT REV PLANT SCI, V25, P159, DOI 10.1080/07352680600563876; SALON C, 1988, J BIOL CHEM, V263, P12278; SANGWAN RS, 1992, PLANT PHYSIOL, V99, P445, DOI 10.1104/pp.99.2.445; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; SCHULZ M, 1993, BOT ACTA, V106, P143, DOI 10.1111/j.1438-8677.1993.tb00350.x; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Tripodi KE, 2005, PLANT PHYSIOL, V139, P969, DOI 10.1104/pp.105.066647; Uhrig RG, 2008, PLANT PHYSIOL, V146, P1346, DOI 10.1104/pp.107.110361; Usuba T, 2001, INT J CANCER, V94, P662, DOI 10.1002/ijc.1524; Wang DX, 2006, ANAL CHEM, V78, P3681, DOI 10.1021/ac051904b; Wang DX, 2005, ANAL CHEM, V77, P1458, DOI 10.1021/ac048834d	37	56	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29650	29657		10.1074/jbc.M806102200	http://dx.doi.org/10.1074/jbc.M806102200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18728004	Green Published, hybrid			2022-12-25	WOS:000260366900008
J	Garcia-Lecea, M; Kondrychyn, I; Fong, SH; Ye, ZR; Korzh, V				Garcia-Lecea, Marta; Kondrychyn, Igor; Fong, Steven H.; Ye, Zhang-Rui; Korzh, Vladimir			In vivo Analysis of Choroid Plexus Morphogenesis in Zebrafish	PLOS ONE			English	Article							ROOF PLATE; ENHANCER TRAP; MIND-BOMB; EXPRESSION; BRAIN; HEDGEHOG; GENE; CELLS; SPECIFICATION; NEUROGENESIS	Background: The choroid plexus (ChP), a component of the blood-brain barrier (BBB), produces the cerebrospinal fluid (CSF) and as a result plays a role in (i) protecting and nurturing the brain as well as (ii) in coordinating neuronal migration during neurodevelopment. Until now ChP development was not analyzed in living vertebrates due to technical problems. Methodology/Principal Findings: We have analyzed the formation of the fourth ventricle ChP of zebrafish in the GFP-tagged enhancer trap transgenic line SqET33-E20 (Gateways) by a combination of in vivo imaging, histology and mutant analysis. This process includes the formation of the tela choroidea (TC), the recruitment of cells from rhombic lips and, finally, the coalescence of TC resulting in formation of ChP. In Notch-deficient mib mutants the first phase of this process is affected with premature GFP expression, deficient cell recruitment into TC and abnormal patterning of ChP. In Hedgehog-deficient smu mutants the second phase of the ChP morphogenesis lacks cell recruitment and TC cells undergo apoptosis. Conclusions/Significance: This study is the first to demonstrate the formation of ChP in vivo revealing a role of Notch and Hedgehog signalling pathways during different developmental phases of this process.	[Garcia-Lecea, Marta; Kondrychyn, Igor; Fong, Steven H.; Ye, Zhang-Rui; Korzh, Vladimir] ASTAR, Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Garcia-Lecea, M (corresponding author), ASTAR, Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore, Singapore.	mgarcia@imcb.a-star.edu.sg; vlad@imcb.a-star.edu.sg	Kondrychyn, Igor/AAC-6237-2022; Kondrychyn, Igor/C-2621-2016; Kondrychyn, Igor/A-9468-2010; Korzh, Vladimir P/H-1596-2011	Kondrychyn, Igor/0000-0002-2268-7291; Kondrychyn, Igor/0000-0002-2268-7291; Korzh, Vladimir P/0000-0002-6580-7986	Agency for Science, Technology and Research (A-STAR) of Singapore	Agency for Science, Technology and Research (A-STAR) of Singapore(Agency for Science Technology & Research (A*STAR))	VK's lab is supported by the Agency for Science, Technology and Research (A-STAR) of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1980, J COMP NEUROL, V194, P1, DOI 10.1002/cne.901940102; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Baehr C, 2006, FLUIDS BARRIERS CNS, V3, DOI 10.1186/1743-8454-3-13; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; BILL B, PLOS ONE IN PRESS; Bingham S, 2003, DEV DYNAM, V228, P451, DOI 10.1002/dvdy.10429; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Chandrasekhar A, 2004, DEV DYNAM, V229, P143, DOI 10.1002/dvdy.10444; Chen WB, 2001, DEVELOPMENT, V128, P2385; Chizhikov VV, 2005, DEV BIOL, V277, P287, DOI 10.1016/j.ydbio.2004.10.011; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; CSERR HF, 1984, AM J PHYSIOL, V246, pR277, DOI 10.1152/ajpregu.1984.246.3.R277; Dang L, 2006, ONCOGENE, V25, P487, DOI 10.1038/sj.onc.1209074; Dziegielewska KM, 2001, MICROSC RES TECHNIQ, V52, P5, DOI 10.1002/1097-0029(20010101)52:1<5::AID-JEMT3>3.3.CO;2-A; Estrach S, 2007, J CELL SCI, V120, P2944, DOI 10.1242/jcs.016253; Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933; FRANZ T, 1994, ACTA ANAT, V150, P38; Gingras S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000808; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Hashimoto Paulo H., 1992, Arteriosclerosis and Thrombosis, V67, P595; HIGUCHI M, 1995, MOL BRAIN RES, V29, P263, DOI 10.1016/0169-328X(94)00257-F; Hunter NL, 2007, DEVELOPMENT, V134, P3449, DOI 10.1242/dev.003095; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Irvin DK, 2004, J NEUROSCI RES, V75, P330, DOI 10.1002/jnr.10843; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; JACOBSEN M, 1982, DEV BRAIN RES, V3, P239, DOI 10.1016/0165-3806(82)90024-4; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Jiang YJ, 1996, DEVELOPMENT, V123, P205; JOHANSON CE, 2003, NEUROSCIENCE MED, P165; Joly JS, 2007, SEMIN CELL DEV BIOL, V18, P512, DOI 10.1016/j.semcdb.2007.06.001; Ke ZY, 2008, MOL CELL NEUROSCI, V37, P388, DOI 10.1016/j.mcn.2007.10.013; Ke ZY, 2005, DEV DYNAM, V232, P479, DOI 10.1002/dvdy.20242; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Korzh V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S8; Lam CS, 2003, MOL CELL NEUROSCI, V22, P501, DOI 10.1016/S1044-7431(03)00031-9; LAMETSCHWANDTNER A, 1983, Z MIKROSK ANAT FORSC, V97, P265; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Lundberg F, 1999, J NEUROSURG, V90, P101, DOI 10.3171/jns.1999.90.1.0101; Netsky M G, 1970, Neurosci Res (N Y), V3, P131; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pons S, 2001, DEVELOPMENT, V128, P1481; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; STRONG LH, 1956, AM J ANAT, V99, P249, DOI 10.1002/aja.1000990204; STURROCK RR, 1979, J ANAT, V129, P777; Szmydynger-Chodobska J, 2006, NEUROENDOCRINOLOGY, V84, P339, DOI 10.1159/000097989; TSUNEKI K, 1986, J HIRNFORSCH, V27, P441; TURKEVICH N. G., 1963, ARKH ANAT GISTOL I EMBRIOL, V44, P81; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Wang XK, 2003, DEV DYNAM, V227, P587, DOI 10.1002/dvdy.10331; Wechsler-Reya RJ, 2001, TRENDS NEUROSCI, V24, P680, DOI 10.1016/S0166-2236(00)02058-0; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	54	53	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3090	10.1371/journal.pone.0003090	http://dx.doi.org/10.1371/journal.pone.0003090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769618	Green Published, Green Submitted, gold			2022-12-25	WOS:000264416600001
J	Paganin, F; Schouler, L; Cuissard, L; Noel, JB; Becquart, JP; Besnard, M; Verdier, L; Rousseau, D; Arvin-Berod, C; Bourdin, A				Paganin, Fabrice; Schouler, Laurent; Cuissard, Laurent; Noel, Jean Baptiste; Becquart, Jean-Philippe; Besnard, Mathieu; Verdier, Laurent; Rousseau, Denis; Arvin-Berod, Claude; Bourdin, Arnaud			Airway and Esophageal Stenting in Patients with Advanced Esophageal Cancer and Pulmonary Involvement	PLOS ONE			English	Article								Background: Most inoperable patients with esophageal-advanced cancer (EGC) have a poor prognosis. Esophageal stenting, as part of a palliative therapy management has dramatically improved the quality of live of EGC patients. Airway stenting is generally proposed in case of esophageal stent complication, with a high failure rate. The study was conducted to assess the efficacy and safety of scheduled and non-scheduled airway stenting in case of indicated esophageal stenting for EGC. Methods and Findings: The study is an observational study conducted in pulmonary and gastroenterology endoscopy units. Consecutive patients with EGC were referred to endoscopy units. We analyzed the outcome of airway stenting in patients with esophageal stent indication admitted in emergency or with a scheduled intervention. Forty-four patients (58 +/-\-8 years of age) with esophageal stenting indication were investigated. Seven patients (group 1) were admitted in emergency due to esophageal stent complication in the airway (4 fistulas, 3 cases with malignant infiltration and compression). Airway stenting failed for 5 patients. Thirty-seven remaining patients had a scheduled stenting procedure (group 2): stent was inserted for 13 patients with tracheal or bronchial malignant infiltration, 12 patients with fistulas, and 12 patients with airway extrinsic compression (preventive indication). Stenting the airway was well tolerated. Life-threatening complications were related to group 1. Overall mean survival was 26+/-10 weeks and was significantly shorter in group 1 (6+/-7.6 weeks) than in group 2 (28+/-11 weeks), p < 0.001). Scheduled double stenting significantly improved symptoms (95% at day 7) with a low complication rate (13%), and achieved a specific cancer treatment (84%) in most cases. Conclusion: Stenting the airway should always be considered in case of esophageal stent indication. A multidisciplinary approach with initial airway evaluation improved prognosis and decreased airways complications related to esophageal stent. Emergency procedures were rarely efficient in our experience.	[Paganin, Fabrice; Arvin-Berod, Claude; Bourdin, Arnaud] GHSR, Serv Pneumol, St Pierre, France; [Schouler, Laurent; Cuissard, Laurent; Becquart, Jean-Philippe] GHSR, Serv Gastroenterol, St Pierre, France; [Noel, Jean Baptiste] GHSR, Serv Radiol, St Pierre, France; [Besnard, Mathieu] GHSR, Serv Chirurg Thorac, St Pierre, France; [Verdier, Laurent; Rousseau, Denis] GHSR, Serv Anesth Reanimat, St Pierre, France	CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion	Paganin, F (corresponding author), GHSR, Serv Pneumol, St Pierre, France.	f.paganin@orange.fr						Acunas B, 1996, RADIOLOGY, V199, P648, DOI 10.1148/radiology.199.3.8637981; Alvares JF, 2002, ENDOSCOPY, V34, P592, DOI 10.1055/s-2002-33215; Baron Todd H, 2007, Gastrointest Endosc Clin N Am, V17, P83, DOI 10.1016/j.giec.2007.01.004; Belleguic C, 1999, ENDOSCOPY, V31, P232, DOI 10.1055/s-1999-13674; Bolliger CT, 2006, EUR RESPIR J, V27, P1258, DOI 10.1183/09031936.06.00013906; Chan KPW, 2002, CHEST, V122, P1069, DOI 10.1378/chest.122.3.1069; COLT HG, 1992, GASTROINTEST ENDOSC, V38, P485, DOI 10.1016/S0016-5107(92)70482-9; Conio M, 2007, AM J GASTROENTEROL, V102, P2667, DOI 10.1111/j.1572-0241.2007.01565.x; Dahan L, 2006, GASTROEN CLIN BIOL, V30, P253, DOI 10.1016/S0399-8320(06)73162-1; Dasgupta A, 1998, GASTROINTEST ENDOSC, V47, P532, DOI 10.1016/S0016-5107(98)70258-5; De Olabozal J, 2001, AM J GASTROENTEROL, V96, P2800, DOI 10.1016/S0002-9270(01)02709-5; DEPALMA GD, 1995, AM J GASTROENTEROL, V90, P2140; DO YS, 1993, RADIOLOGY, V187, P673, DOI 10.1148/radiology.187.3.7684529; Freitag L, 1996, CHEST, V110, P1155, DOI 10.1378/chest.110.5.1155; GUDOVSKY LM, 1993, ANN THORAC SURG, V55, P868, DOI 10.1016/0003-4975(93)90108-T; Hasan S, 2004, ENDOSCOPY, V36, P731, DOI 10.1055/s-2004-825668; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Horns MYV, 2004, ENDOSCOPY, V36, P880, DOI 10.1055/s-2004-825855; Lecleire S, 2007, ALIMENT PHARM THER, V25, P955, DOI 10.1111/j.1365-2036.2007.03280.x; Lee SH, 2001, BRIT J RADIOL, V74, P891, DOI 10.1259/bjr.74.886.740891; Morgan RA, 1997, RADIOLOGY, V204, P527, DOI 10.1148/radiology.204.2.9240548; Nomori H, 2000, ANN THORAC SURG, V70, P1803, DOI 10.1016/S0003-4975(00)02042-7; Saxon RR, 1995, J VASC INTERV RADIOL, V6, P747, DOI 10.1016/S1051-0443(95)71180-0; SCHAER J, 1992, GASTROINTEST ENDOSC, V38, P7, DOI 10.1016/S0016-5107(92)70322-8; Shimi S M, 2000, Semin Laparosc Surg, V7, P9; Shin JH, 2004, RADIOLOGY, V232, P252, DOI 10.1148/radiol.2321030733; Sihoe ADL, 2004, SURG ONCOL, V13, P17, DOI 10.1016/j.suronc.2004.01.001; Takamori S, 1996, ANN THORAC SURG, V62, P844, DOI 10.1016/S0003-4975(96)00394-3; TUEBERGEN D, 2008, J GASTROINTEST  0304; UTTS SJ, 1985, GASTROINTEST ENDOSC, V31, P383, DOI 10.1016/S0016-5107(85)72253-5; van den Bongard HJG, 2002, GASTROINTEST ENDOSC, V55, P110, DOI 10.1067/mge.2002.119731; Wang MQ, 2001, J VASC INTERV RADIOL, V12, P465, DOI 10.1016/S1051-0443(07)61886-7; Yamamoto Ryoji, 2002, Jpn J Thorac Cardiovasc Surg, V50, P1	33	21	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3101	10.1371/journal.pone.0003101	http://dx.doi.org/10.1371/journal.pone.0003101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769726	Green Published, Green Submitted, gold			2022-12-25	WOS:000264796800008
J	Hagni, K; Eng, K; Hepp-Reymond, MC; Holper, L; Keisker, B; Siekierka, E; Kiper, DC				Haegni, Karin; Eng, Kynan; Hepp-Reymond, Marie-Claude; Holper, Lisa; Keisker, Birgit; Siekierka, Ewa; Kiper, Daniel C.			Observing Virtual Arms that You Imagine Are Yours Increases the Galvanic Skin Response to an Unexpected Threat	PLOS ONE			English	Article								Multi-modal visuo-tactile stimulation of the type performed in the rubber hand illusion can induce the brain to temporarily incorporate external objects into the body image. In this study we show that audio-visual stimulation combined with mental imagery more rapidly elicits an elevated physiological response (skin conductance) after an unexpected threat to a virtual limb, compared to audio-visual stimulation alone. Two groups of subjects seated in front of a monitor watched a first-person perspective view of slow movements of two virtual arms intercepting virtual balls rolling towards the viewer. One group was instructed to simply observe the movements of the two virtual arms, while the other group was instructed to observe the virtual arms and imagine that the arms were their own. After 84 seconds the right virtual arm was unexpectedly "stabbed'' by a knife and began "bleeding''. This aversive stimulus caused both groups to show a significant increase in skin conductance. In addition, the observation-with-imagery group showed a significantly higher skin conductance (p<0.05) than the observation-only group over a 2-second period shortly after the aversive stimulus onset. No corresponding change was found in subjects' heart rates. Our results suggest that simple visual input combined with mental imagery may induce the brain to measurably temporarily incorporate external objects into its body image.	[Haegni, Karin; Kiper, Daniel C.] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Zurich, Switzerland; [Eng, Kynan; Hepp-Reymond, Marie-Claude; Holper, Lisa] Univ Zurich, ETH, Inst Neuroinformat, CH-8006 Zurich, Switzerland; [Keisker, Birgit] Univ Hosp Zurich, Inst Neuroradiol, Zurich, Switzerland; [Siekierka, Ewa] Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Hagni, K (corresponding author), Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Zurich, Switzerland.	kynan@ini.phys.ethz.ch		Eng, Kynan/0000-0002-1434-8767; Holper, Lisa/0000-0002-2599-3649	Swiss National Center of Competence in Neural Plasticity and Repair; Gebert Ruf Foundation [GRS-059-05]	Swiss National Center of Competence in Neural Plasticity and Repair; Gebert Ruf Foundation	This work was supported by the Swiss National Center of Competence in Neural Plasticity and Repair, and by the Gebert Ruf Foundation grant GRS-059-05.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Binkofski F, 2000, HUM BRAIN MAPP, V11, P273, DOI 10.1002/1097-0193(200012)11:4<273::AID-HBM40>3.0.CO;2-0; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick M, 2004, SCIENCE, V305, P782, DOI 10.1126/science.1101836; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Critchley HD, 2000, J NEUROSCI, V20, P3033; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; ENG K, 2007, MED BIOL ENG COMPUTI; Eng K, 2007, MED BIOL ENG COMPUT, V45, P901, DOI 10.1007/s11517-007-0239-1; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Mandryk RL, 2004, PHYSL INDICATORS EVA; Meehan M, 2005, APPL PSYCHOPHYS BIOF, V30, P239, DOI 10.1007/s10484-005-6381-3; Meehan M, 2002, ACM T GRAPHIC, V21, P645, DOI 10.1145/566570.566630; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pertaub DP, 2001, STUD HEALTH TECHNOL, V81, P372; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Scherberger H, 2007, J NEUROSCI, V27, P2001, DOI 10.1523/JNEUROSCI.4274-06.2007; SHERMER CD, 2000, ACAD EMERG MED, V7, P530; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Slater M, 2006, CYBERPSYCHOL BEHAV, V9, P627, DOI 10.1089/cpb.2006.9.627; SVEBAK S, 1982, BIOL PSYCHOL, V14, P113, DOI 10.1016/0301-0511(82)90019-9; Sveistrup Heidi, 2004, J Neuroeng Rehabil, V1, P10, DOI 10.1186/1743-0003-1-10	30	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3082	10.1371/journal.pone.0003082	http://dx.doi.org/10.1371/journal.pone.0003082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769476	Green Published, gold			2022-12-25	WOS:000264796600004
J	Merabet, LB; Hamilton, R; Schlaug, G; Swisher, JD; Kiriakopoulos, ET; Pitskel, NB; Kauffman, T; Pascual-Leone, A				Merabet, Lotfi B.; Hamilton, Roy; Schlaug, Gottfried; Swisher, Jascha D.; Kiriakopoulos, Elaine T.; Pitskel, Naomi B.; Kauffman, Thomas; Pascual-Leone, Alvaro			Rapid and Reversible Recruitment of Early Visual Cortex for Touch	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; TACTILE PERCEPTION; MULTISENSORY INTEGRATION; CORTICAL ACTIVITY; OCCIPITAL CORTEX; ADAPTIVE-CHANGES; NEURAL-NETWORKS; BLIND HUMANS; BRAILLE; ACTIVATION	Background: The loss of vision has been associated with enhanced performance in non-visual tasks such as tactile discrimination and sound localization. Current evidence suggests that these functional gains are linked to the recruitment of the occipital visual cortex for non-visual processing, but the neurophysiological mechanisms underlying these crossmodal changes remain uncertain. One possible explanation is that visual deprivation is associated with an unmasking of non-visual input into visual cortex. Methodology/Principal Findings: We investigated the effect of sudden, complete and prolonged visual deprivation (five days) in normally sighted adult individuals while they were immersed in an intensive tactile training program. Following the five-day period, blindfolded subjects performed better on a Braille character discrimination task. In the blindfold group, serial fMRI scans revealed an increase in BOLD signal within the occipital cortex in response to tactile stimulation after five days of complete visual deprivation. This increase in signal was no longer present 24 hours after blindfold removal. Finally, reversible disruption of occipital cortex function on the fifth day ( by repetitive transcranial magnetic stimulation; rTMS) impaired Braille character recognition ability in the blindfold group but not in non-blindfolded controls. This disruptive effect was no longer evident once the blindfold had been removed for 24 hours. Conclusions/Significance: Overall, our findings suggest that sudden and complete visual deprivation in normally sighted individuals can lead to profound, but rapidly reversible, neuroplastic changes by which the occipital cortex becomes engaged in processing of non-visual information. The speed and dynamic nature of the observed changes suggests that normally inhibited or masked functions in the sighted are revealed by visual loss. The unmasking of pre-existing connections and shifts in connectivity represent rapid, early plastic changes, which presumably can lead, if sustained and reinforced, to slower developing, but more permanent structural changes, such as the establishment of new neural connections in the blind.	[Merabet, Lotfi B.; Hamilton, Roy; Schlaug, Gottfried; Swisher, Jascha D.; Kiriakopoulos, Elaine T.; Pitskel, Naomi B.; Kauffman, Thomas; Pascual-Leone, Alvaro] Beth Israel Deaconess Med Ctr, Dept Neurol, Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Merabet, LB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA.	apleone@bidmc.harvard.edu	Pascual-Leone, Alvaro/AAC-5101-2019; Merabet, Lotfi B./V-2735-2017; merabet, lotfi/AAU-8259-2020; Pascual-Leone, Alvaro/G-6566-2011	Pascual-Leone, Alvaro/0000-0001-8975-0382; Merabet, Lotfi B./0000-0002-8094-9536; merabet, lotfi/0000-0002-8094-9536; 	National Institutes of Health [RO1 EY12091, K24 RR018875, RR 01032]; Milton Foundation; Spanish Organization for the Blind; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875, M01RR001032] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milton Foundation; Spanish Organization for the Blind; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by grants from the National Institutes of Health (RO1 EY12091, K24 RR018875), the Milton Foundation, the Spanish Organization for the Blind, and grant RR 01032 from the National Institutes of Health to the GCRC at BIDMC.	Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2006, HUM BRAIN MAPP, V27, P325, DOI 10.1002/hbm.20188; Burton H, 2004, HUM BRAIN MAPP, V23, P210, DOI 10.1002/hbm.20064; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Carroll T, 1961, BLINDNESS WHAT IT IS; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Deibert E, 1999, NEUROLOGY, V52, P1413, DOI 10.1212/WNL.52.7.1413; Falchier A, 2002, J NEUROSCI, V22, P5749; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goldreich D, 2003, J NEUROSCI, V23, P3439; Goldreich D, 2006, PERCEPT PSYCHOPHYS, V68, P1363, DOI 10.3758/BF03193735; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Grant AC, 2000, PERCEPT PSYCHOPHYS, V62, P301, DOI 10.3758/BF03205550; Gugino LD, 2001, CLIN NEUROPHYSIOL, V112, P1781, DOI 10.1016/S1388-2457(01)00633-2; Hamilton R, 2000, NEUROREPORT, V11, P237, DOI 10.1097/00001756-200002070-00003; Hamilton RH, 1998, TRENDS COGN SCI, V2, P168, DOI 10.1016/S1364-6613(98)01172-3; HOLLINS M, 1988, PERCEPT PSYCHOPHYS, V43, P380, DOI 10.3758/BF03208809; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; JOHANSSON RS, 1980, BRAIN RES, V184, P343, DOI 10.1016/0006-8993(80)90803-3; Kadosh RC, 2006, CURR BIOL, V16, pR962, DOI 10.1016/j.cub.2006.10.017; Kauffman T, 2002, NEUROREPORT, V13, P571, DOI 10.1097/00001756-200204160-00007; KUJALA T, 1995, NEUROSCI LETT, V183, P143, DOI 10.1016/0304-3940(94)11135-6; Kupers R, 2007, NEUROLOGY, V68, P691, DOI 10.1212/01.wnl.0000255958.60530.11; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Merabet L, 2004, NEURON, V42, P173, DOI 10.1016/S0896-6273(04)00147-3; Merabet LB, 2004, J NEURO-OPHTHALMOL, V24, P109, DOI 10.1097/00041327-200406000-00003; Merabet LB, 2007, J NEUROPHYSIOL, V97, P1633, DOI 10.1152/jn.00806.2006; Negyessy L, 2006, EUR J NEUROSCI, V23, P1919, DOI 10.1111/j.1460-9568.2006.04678.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Pascual-Leone A, 1999, NEUROPSYCHOLOGIA, V37, P207; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Pitskel NB, 2007, NEUROREPORT, V18, P1703, DOI 10.1097/WNR.0b013e3282f0d2c1; Prather SC, 2002, COGNITIVE BRAIN RES, V14, P91, DOI 10.1016/S0926-6410(02)00063-0; Ramos-Estebanez C, 2007, J NEUROSCI, V27, P4178, DOI 10.1523/JNEUROSCI.5468-06.2007; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Sadato N, 2005, NEUROSCIENTIST, V11, P577, DOI 10.1177/1073858405277314; Sadato N, 1998, BRAIN, V121, P1213, DOI 10.1093/brain/121.7.1213; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sadato Norihiro, 2006, Suppl Clin Neurophysiol, V59, P75; SATHIAN K, 1991, PERCEPT PSYCHOPHYS, V50, P237, DOI 10.3758/BF03206747; Sathian K, 1997, NEUROREPORT, V8, P3877, DOI 10.1097/00001756-199712220-00008; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Stevens AA, 2007, J NEUROSCI, V27, P10734, DOI 10.1523/JNEUROSCI.1669-07.2007; Stoesz MR, 2003, INT J PSYCHOPHYSIOL, V50, P41, DOI 10.1016/S0167-8760(03)00123-5; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Theoret H, 2004, J PHYSIOL-PARIS, V98, P221, DOI 10.1016/j.jphysparis.2004.03.009; Van Boven RW, 2000, NEUROLOGY, V54, P2230; Van Boven RW, 2005, P NATL ACAD SCI USA, V102, P12601, DOI 10.1073/pnas.0505907102; Wittenberg GF, 2004, EUR J NEUROSCI, V20, P1923, DOI 10.1111/j.1460-9568.2004.03630.x; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; Zhang MM, 2005, HUM BRAIN MAPP, V25, P370, DOI 10.1002/hbm.20107	62	178	179	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3046	10.1371/journal.pone.0003046	http://dx.doi.org/10.1371/journal.pone.0003046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728773	Green Published, Green Submitted, gold			2022-12-25	WOS:000264796400004
J	Zhang, Z; Chen, J; Guo, FZ; He, LR; Wu, YZ; Zeng, CQ; Xiao, XY; He, DC				Zhang, Zhao; Chen, Jian; Guo, Fuzheng; He, Liren; Wu, Yizhou; Zeng, Changqing; Xiao, Xueyuan; He, Dacheng			A High-Temporal Resolution Technology for Dynamic Proteomic Analysis Based on S-35 Labeling	PLOS ONE			English	Article								As more and more research efforts have been attracted to dynamic or differential proteomics, a method with high temporal resolution and high throughput is required. In present study, a S-35 in vivo Labeling Analysis for Dynamic Proteomics (SiLAD) was designed and tested by analyzing the dynamic proteome changes in the highly synchronized A549 cells, as well as in the rat liver 2/3 partial hepatectomy surgery. The results validated that SiLAD technique, in combination with 2-Dimensional Electrophoresis, provided a highly sensitivity method to illustrate the non-disturbed endogenous proteins dynamic changes with a good temporal resolution and high signal/noise ratio. A significant number of differential proteins can be discovered or re-categorized by this technique. Another unique feature of SiLAD is its capability of quantifying the rate of protein expression, which reflects the cellular physiological turn points more effectively. Finally, the prescribed SiLAD proteome snapshot pattern could be potentially used as an exclusive symbol for characterizing each stage in well regulated biological processes.	[Zhang, Zhao; Chen, Jian; Guo, Fuzheng; He, Liren; Wu, Yizhou; Zeng, Changqing; Xiao, Xueyuan; He, Dacheng] Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Univ Confederated Inst Prote, Beijing 100875, Peoples R China	Beijing Normal University	Zhang, Z (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Univ Confederated Inst Prote, Beijing 100875, Peoples R China.	dhe@bnu.edu.cn	Wang, Limin/O-3724-2015		Major State Basic Research Program of China [2006CB910100]; NSF [90208020]; Natural Science Foundation of Beijing [30671066]; Science Technology Committee of Beijing [Y0204002040111]	Major State Basic Research Program of China(National Basic Research Program of China); NSF(National Science Foundation (NSF)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Science Technology Committee of Beijing	This work was supported by Special Grant of the Major State Basic Research Program of China (No. 2006CB910100), NSF Major Plans Grant (90208020), Natural Science Foundation of Beijing (No. 30671066) and Science Technology Committee of Beijing (No. Y0204002040111).	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Dasgupta P, 2004, MOL CELL BIOL, V24, P9527, DOI 10.1128/MCB.24.21.9527-9541.2004; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; Fatatis A, 1999, FASEB J, V13, P1291, DOI 10.1096/fasebj.13.11.1291; Guo FZ, 2006, PROTEOMICS, V6, P3075, DOI 10.1002/pmic.200500322; Halligan BD, 2004, NUCLEIC ACIDS RES, V32, pW638, DOI 10.1093/nar/gkh356; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Hu VW, 2001, FASEB J, V15, P1562, DOI 10.1096/fj.01-0102com; Julka Samir, 2005, Briefings in Functional Genomics & Proteomics, V4, P158, DOI 10.1093/bfgp/4.2.158; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mazzotti G, 1998, MICROSC RES TECHNIQ, V40, P418, DOI 10.1002/(SICI)1097-0029(19980301)40:5<418::AID-JEMT8>3.0.CO;2-M; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Monteoliva Lucia, 2004, Briefings in Functional Genomics & Proteomics, V3, P220, DOI 10.1093/bfgp/3.3.220; Motiwala T, 2004, P NATL ACAD SCI USA, V101, P13844, DOI 10.1073/pnas.0405451101; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Schubert P, 2006, ANAL BIOANAL CHEM, V386, P482, DOI 10.1007/s00216-006-0609-9; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; VISHWANATHA JK, 1992, J CELL SCI, V101, P25; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Zwijsen RML, 1996, MOL CELL BIOL, V16, P2554	24	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2991	10.1371/journal.pone.0002991	http://dx.doi.org/10.1371/journal.pone.0002991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714357	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900017
J	Chapple, CE; Guigo, R				Chapple, Charles E.; Guigo, Roderic			Relaxation of Selective Constraints Causes Independent Selenoprotein Extinction in Insect Genomes	PLOS ONE			English	Article							SELENOCYSTEINE INSERTION SYSTEM; MULTIPLE SEQUENCE ALIGNMENT; IN-SILICO IDENTIFICATION; DROSOPHILA; ANTIOXIDANT; MITOCHONDRIAL; DISRUPTION; REDUCTASE; DEFENSE; PATTERN	Background: Selenoproteins are a diverse family of proteins notable for the presence of the 21st amino acid, selenocysteine. Until very recently, all metazoan genomes investigated encoded selenoproteins, and these proteins had therefore been believed to be essential for animal life. Challenging this assumption, recent comparative analyses of insect genomes have revealed that some insect genomes appear to have lost selenoprotein genes. Methodology/Principal Findings: In this paper we investigate in detail the fate of selenoproteins, and that of selenoprotein factors, in all available arthropod genomes. We use a variety of in silico comparative genomics approaches to look for known selenoprotein genes and factors involved in selenoprotein biosynthesis. We have found that five insect species have completely lost the ability to encode selenoproteins and that selenoprotein loss in these species, although so far confined to the Endopterygota infraclass, cannot be attributed to a single evolutionary event, but rather to multiple, independent events. Loss of selenoproteins and selenoprotein factors is usually coupled to the deletion of the entire no-longer functional genomic region, rather than to sequence degradation and consequent pseudogenisation. Such dynamics of gene extinction are consistent with the high rate of genome rearrangements observed in Drosophila. We have also found that, while many selenoprotein factors are concomitantly lost with the selenoproteins, others are present and conserved in all investigated genomes, irrespective of whether they code for selenoproteins or not, suggesting that they are involved in additional, non-selenoprotein related functions. Conclusions/Significance: Selenoproteins have been independently lost in several insect species, possibly as a consequence of the relaxation in insects of the selective constraints acting across metazoans to maintain selenoproteins. The dispensability of selenoproteins in insects may be related to the fundamental differences in antioxidant defense between these animals and other metazoans.	[Chapple, Charles E.] Inst Municipal Invest Med, Barcelona, Spain; [Guigo, Roderic] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Chapple, CE (corresponding author), Univ Pompeu Fabra, Ctr Genom Regulat, Catalonia, Spain.	roderic.guigo@crg.es	Guigo, Roderic/D-1303-2010	Guigo, Roderic/0000-0002-5738-4477	Spanish Ministery of Education and Science [pre-doctoral fellowship]; BioSapiens European Network of Excellence	Spanish Ministery of Education and Science(Spanish Government); BioSapiens European Network of Excellence	The work described here is funded by grants from the Spanish Ministery of Education and Science and from the BioSapiens European Network of Excellence to RG. CEC is reciepient of a pre-doctoral fellowship from the Spanish Ministery of Education and Science.	Allmang C, 2006, BIOCHIMIE, V88, P1561, DOI 10.1016/j.biochi.2006.04.015; Alsina B, 1999, J CELL SCI, V112, P2875; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bock A., 2006, SELENIUM ITS MOL BIO, V2nd, P9, DOI DOI 10.1007/0-387-33827-6_2; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Cameron Stephen L., 2006, Arthropod Systematics & Phylogeny, V64, P27; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Castellano S, 2004, EMBO REP, V5, P71, DOI 10.1038/sj.embor.7400036; Castellano S, 2001, EMBO REP, V2, P697, DOI 10.1093/embo-reports/kve151; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Chen P, 2006, CHINESE SCI BULL, V51, P2860, DOI 10.1007/s11434-006-2206-x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gromer S, 2003, P NATL ACAD SCI USA, V100, P12618, DOI 10.1073/pnas.2134510100; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harrell L, 2002, NUCLEIC ACIDS RES, V30, P2011, DOI 10.1093/nar/30.9.2011; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Hirosawa-Takamori M, 2004, EMBO REP, V5, P317, DOI 10.1038/sj.embor.7400097; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kwon SY, 2003, MOL CELL BIOL, V23, P8495, DOI 10.1128/MCB.23.23.8495-8504.2003; Lescure A, 2002, GENE, V291, P279, DOI 10.1016/S0378-1119(02)00629-7; Lobanov AV, 2008, PROTEIN SCI, V17, P176, DOI 10.1110/ps.073261508; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu CL, 2006, FEBS LETT, V580, P5189, DOI 10.1016/j.febslet.2006.08.065; Maiorino M, 2007, J MOL BIOL, V365, P1033, DOI 10.1016/j.jmb.2006.10.033; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Missirlis F, 2002, J BIOL CHEM, V277, P11521, DOI 10.1074/jbc.M111692200; Missirlis F, 2001, CURR BIOL, V11, P1272, DOI 10.1016/S0960-9822(01)00393-1; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Morozova N, 2003, GENES CELLS, V8, P963, DOI 10.1046/j.1365-2443.2003.00687.x; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Novoselov SV, 2002, EMBO J, V21, P3681, DOI 10.1093/emboj/cdf372; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sato M, 2003, BIOINFORMATICS, V19, P1371, DOI 10.1093/bioinformatics/btg183; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; SMALLHOWARD A, 2006, SELENIUM ITS MOL BIO, P81; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Taskov K, 2005, NUCLEIC ACIDS RES, V33, P2227, DOI 10.1093/nar/gki507; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whiting MF, 2002, MOLECULAR SYSTEMATICS AND EVOLUTION: THEORY AND PRACTICE, P69; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2007, BIOCHEM J, V404, P115, DOI 10.1042/BJ20070165; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	57	54	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2968	10.1371/journal.pone.0002968	http://dx.doi.org/10.1371/journal.pone.0002968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698431	Green Published, gold			2022-12-25	WOS:000264412600053
J	Shi, W; Ma, ZF; Willers, H; Akhtar, K; Scott, SP; Zhang, JQ; Powell, S; Zhang, JR				Shi, Wei; Ma, Zhefu; Willers, Henning; Akhtar, Kamal; Scott, Shaun P.; Zhang, Jiuqin; Powell, Simon; Zhang, Junran			Disassembly of MDC1 Foci Is Controlled by Ubiquitin-Proteasome-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; REPAIR PROTEINS; HOMOLOGOUS RECOMBINATION; CONJUGATED UBIQUITIN; SIGNALING PATHWAYS; MAMMALIAN-CELLS; HISTONE H2AX; REPLICATION; CHECKPOINT	The orderly recruitment, retention, and disassembly of DNA damage response proteins at sites of damaged DNA is a conserved process throughout eukaryotic evolution. The recruitment and retention of DNA repair factors in foci is mediated by a complex network of protein-protein interactions; however, the mechanisms of focus disassembly remain to be defined. Mediator of DNA damage checkpoint protein 1 (MDC1) is an early and key component of the genome surveillance network activated by DNA double-strand breaks (DSBs). Here, we investigated the disassembly of MDC1 foci. First, we show that ubiquitylation directs the MDC1 protein for proteasome-dependent degradation. Ubiquitylated MDC1 associates with chromatin before and after exposure of cells to ionizing radiation (IR). In addition, increased MDC1 ubiquitylation in the chromatin fraction is observed in response to IR, which is correlated with a reduction in total MDC1 protein levels. We demonstrate that blocking MDC1 degradation by proteasome inhibitors leads to a persistence of MDC1 foci. Consistent with this observation, chromatin immunoprecipitation experiments reveal increased MDC1 protein at site-specific DSBs. Interestingly, we show that the persistence of MDC1 foci is associated with an abrogated recruitment of the downstream factor BRCA1 in a manner that is RNF8 independent. Collectively, the evidence presented here supports a novel mechanism for the disassembly of MDC1 foci via ubiquitin-proteasome dependent degradation, which appears to be a key step for the efficient assembly of BRCA1 foci.	[Shi, Wei; Akhtar, Kamal; Scott, Shaun P.; Zhang, Jiuqin; Zhang, Junran] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63108 USA; [Ma, Zhefu] Nanchang Univ, Affiliated Hosp 1, Dept Surg, Breast Ctr, Nanchang 330006, Peoples R China; [Willers, Henning] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Powell, Simon] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA	Washington University (WUSTL); Nanchang University; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center	Zhang, JR (corresponding author), Washington Univ, Sch Med, Dept Radiat Oncol, 4511 Forest Pk Blvd, St Louis, MO 63108 USA.	jzhang@radonc.wustl.edu	Shi, Wei/AAX-6450-2021	Shi, Wei/0000-0002-0378-8361	Department of Radiation Oncology, Washington University School of Medicine; Dr. Joseph Roti Roti and Stephanie Pagano Fund for Mesothelioma Research [IRG-58-010-51]; American Cancer Society	Department of Radiation Oncology, Washington University School of Medicine; Dr. Joseph Roti Roti and Stephanie Pagano Fund for Mesothelioma Research; American Cancer Society(American Cancer Society)	This work was supported by a seed grant and startup fund from the Department of Radiation Oncology, Washington University School of Medicine, by the Dr. Joseph Roti Roti and Stephanie Pagano Fund for Mesothelioma Research, and by Grant IRG-58-010-51 from the American Cancer Society (to J. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adori C, 2006, J HISTOCHEM CYTOCHEM, V54, P263, DOI 10.1369/jhc.5B6752.2005; Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Blickwedehl J, 2007, RADIAT RES, V167, P663, DOI 10.1667/RR0690.1; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Dimitrova DS, 2000, EXP CELL RES, V254, P321, DOI 10.1006/excr.1999.4770; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Everett RD, 2000, J VIROL, V74, P9994, DOI 10.1128/JVI.74.21.9994-10005.2000; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Golding SE, 2007, CANCER RES, V67, P1046, DOI 10.1158/0008-5472.CAN-06-2371; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; HUGLE B, 1983, EUR J CELL BIOL, V32, P157; Jackson SP, 2001, BIOCHEM SOC T, V29, P655, DOI 10.1042/BST0290655; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Kirschner M, 1999, TRENDS CELL BIOL, V9, pM42, DOI 10.1016/S0962-8924(99)01666-9; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2005, BIOCHIMIE, V87, P579, DOI 10.1016/j.biochi.2004.10.023; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; MacNeill SA, 2005, CURR BIOL, V15, pR21, DOI 10.1016/j.cub.2004.12.014; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Murakawa Y, 2007, CANCER RES, V67, P8536, DOI 10.1158/0008-5472.CAN-07-1166; NISSEN S, 1994, POULTRY SCI, V73, P137, DOI 10.3382/ps.0730137; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng AM, 2003, J BIOL CHEM, V278, P8873, DOI 10.1074/jbc.C300001200; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Shang YL, 2003, J BIOL CHEM, V278, P6323, DOI 10.1074/jbc.M210749200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991	63	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31608	31616		10.1074/jbc.M801082200	http://dx.doi.org/10.1074/jbc.M801082200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18757370	hybrid			2022-12-25	WOS:000260760800041
J	Kawamura, S; Hervold, K; Ramirez-Weber, FA; Kornberg, TB				Kawamura, Shiho; Hervold, Kieran; Ramirez-Weber, Felipe-Andres; Kornberg, Thomas B.			Two Patched Protein Subtypes and a Conserved Domain of Group I Proteins That Regulates Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; MULTIPLE SEQUENCE ALIGNMENT; STEROL-SENSING DOMAIN; SONIC HEDGEHOG; SUBCELLULAR-LOCALIZATION; VESICULAR TRAFFICKING; HUMAN HOMOLOG; GENE; DROSOPHILA; MUTATIONS	Patched (Ptc) is a 12-cross membrane protein that binds the secreted Hedgehog protein. Its regulation of the Hedgehog signaling pathway is critical to normal development and to a number of human diseases. This report analyzes features of sequence similarity and divergence in the Ptc protein family and identifies two subtypes distinguished by novel conserved domains. We used these results to propose a rational basis for classification. We show that one of the conserved sequence regions in the C-terminal domain of Ptch1 is responsible, at least in part, for rapid turnover. This sequence is absent in the stable Ptch2 protein.	[Kawamura, Shiho; Kornberg, Thomas B.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kawamura, Shiho; Hervold, Kieran; Ramirez-Weber, Felipe-Andres] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	University of California System; University of California San Francisco; California State University System; San Francisco State University	Kornberg, TB (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 1550 4th St, San Francisco, CA 94158 USA.	tkornberg@ucsf.edu			National Institutes of Health [GM077407]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077407 (to T.B.K.).	Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Lee Y, 2006, CANCER RES, V66, P6964, DOI 10.1158/0008-5472.CAN-06-0505; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osborne TF, 1998, CURR OPIN LIPIDOL, V9, P137, DOI 10.1097/00041433-199804000-00010; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	33	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30964	30969		10.1074/jbc.M806242200	http://dx.doi.org/10.1074/jbc.M806242200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768465	Green Published, hybrid			2022-12-25	WOS:000260544800051
J	Martinez, HD; Jasavala, RJ; Hinkson, I; Fitzgerald, LD; Trimmer, JS; Kung, HJ; Wright, ME				Martinez, Harryl D.; Jasavala, Rohini J.; Hinkson, Izumi; Fitzgerald, Latricia D.; Trimmer, James S.; Kung, Hsing-Jien; Wright, Michael E.			RNA Editing of Androgen Receptor Gene Transcripts in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; MOLECULAR CHARACTERIZATION; LNCAP CELLS; LINE LNCAP; CARCINOMA; MUTATIONS; PROLIFERATION; CWR22; PC-3; DNA	Reactivation of the androgen receptor (AR) signaling pathway represents a critical step in the growth and survival of androgen-independent (AI) prostate cancer (CaP). In this study we show the DU145 and PC3 AI human CaP cell lines respond to androgens and require AR expression for optimal proliferation in vitro. Interestingly, AR gene transcripts in DU145 and PC3 cells harbored a large number of single base pair nucleotide transitions that resulted in missense mutations in selected AR codons. The most notable lesion detected in AR gene transcripts included the oncogenic codon 877T -> Again-of-function mutation. Surprisingly, AR gene transcript nucleotide transitions were not genome-encoded substitutions, but instead the mutations co-localized to putative A-to-I, U-to-C, C-to-U, and G-to-A RNA editing sites, suggesting the lesions were mediated through RNA editing mechanisms. Higher levels of mRNA encoding the A-to-I RNA editing enzymes ADAR1 and ADARB1 were observed in DU145 and PC3 cells relative to the androgen-responsive LNCaP and 22Rv1 human CaP cell lines, which correlated with higher levels of AR gene transcript A-to-I editing detected in DU145 and PC3 cells. Our results suggest that AR gene transcripts are targeted by different RNA editing enzymes in DU145 and PC3 cells. Thus RNA editing of AR gene transcripts may contribute to the etiology of hormone-refractory phenotypes in advanced stage AI CaP.	[Martinez, Harryl D.; Jasavala, Rohini J.; Hinkson, Izumi; Wright, Michael E.] Univ Calif Davis, Genome Ctr, Dept Pharmacol, Davis, CA 95616 USA; [Fitzgerald, Latricia D.; Kung, Hsing-Jien] Calif State Univ Sacramento, Sch Med, Univ Calif Davis Canc Ctr, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Trimmer, James S.] Univ Calif Davis, Coll Biol Sci, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Trimmer, James S.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis; California State University System; California State University Sacramento; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Wright, ME (corresponding author), Univ Calif Davis, Genome Ctr, Dept Pharmacol, SOM,451 E Hlth Sci Dr,GBSF 4511,1 Shields Ave, Davis, CA 95616 USA.	mewright@ucdavis.edu	Kung, Hsing-Jien/C-7651-2013	Wright, Michael/0000-0002-4243-2931				Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BERNS EMJJ, 1986, PROSTATE, V9, P247, DOI 10.1002/pros.2990090305; Bourara K, 2000, SCIENCE, V289, P1564, DOI 10.1126/science.289.5484.1564; Buchanan G, 2001, CLIN CANCER RES, V7, P1273; Chlenski A, 2001, PROSTATE, V47, P66; Clegg N, 2003, PROSTATE, V55, P55, DOI 10.1002/pros.10217; CULIG Z, 1993, PROSTATE, V22, P11, DOI 10.1002/pros.2990220103; Duff J, 2005, MOL ENDOCRINOL, V19, P2943, DOI 10.1210/me.2005-0231; ECHAN LA, 1996, CURRENT PROTOCOLS PR; Gottlieb B, 1998, NUCLEIC ACIDS RES, V26, P234, DOI 10.1093/nar/26.1.234; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hiort O, 1998, J PEDIATR-US, V132, P939, DOI 10.1016/S0022-3476(98)70387-7; Jasavala R, 2007, MOL CELL PROTEOMICS, V6, P252, DOI 10.1074/mcp.M600169-MCP200; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; KINGSTON RE, 1987, CURRENT PROTOCOLS MO; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; LANGELER EG, 1993, PROSTATE, V23, P213, DOI 10.1002/pros.2990230304; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Marcelli M, 2000, CANCER RES, V60, P944; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Richter E, 2007, PROSTATE CANCER P D, V10, P114, DOI 10.1038/sj.pcan.4500936; Sathya G, 2003, CANCER RES, V63, P8029; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Sun C, 2006, ONCOGENE, V25, P3905, DOI 10.1038/sj.onc.1209424; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Tepper CG, 2002, CANCER RES, V62, P6606; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TILLEY WD, 1990, CANCER RES, V50, P5382; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Wright ME, 2003, MOL ENDOCRINOL, V17, P1726, DOI 10.1210/me.2003-0031; Yang WD, 2005, J BIOL CHEM, V280, P3946, DOI 10.1074/jbc.M407876200; YUAN SX, 1993, CANCER RES, V53, P1304; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	36	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29938	29949		10.1074/jbc.M800534200	http://dx.doi.org/10.1074/jbc.M800534200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18708348	Green Published, hybrid			2022-12-25	WOS:000260366900039
J	Walliser, C; Retlich, M; Harris, R; Everett, KL; Josephs, MB; Vatter, P; Esposito, D; Driscoll, PC; Katan, M; Gierschik, P; Bunney, TD				Walliser, Claudia; Retlich, Michael; Harris, Richard; Everett, Katy L.; Josephs, Michelle B.; Vatter, Petra; Esposito, Diego; Driscoll, Paul C.; Katan, Matilda; Gierschik, Peter; Bunney, Tom D.			Rac Regulates Its Effector Phospholipase C gamma(2) through Interaction with a Split Pleckstrin Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOZYME-SPECIFIC STIMULATION; BETA-GAMMA DIMERS; B-CELL; C-EPSILON; RHO GTPASES; CHEMICAL-SHIFT; PROTEIN; ACTIVATION; C-BETA(2); RECEPTOR	Several isoforms of phospholipase C (PLC) are regulated through interactions with Ras superfamily GTPases, including Rac proteins. Interestingly, of two closely related PLC gamma isoforms, only PLC gamma(2) has previously been shown to be activated by Rac. Here, we explore the molecular basis of this interaction as well as the structural properties of PLC gamma(2) required for activation. Based on reconstitution experiments with isolated PLC gamma variants and Rac2, we show that an unusual pleckstrin homology (PH) domain, designated as the split PH domain (spPH), is both necessary and sufficient to effect activation of PLC gamma(2) by Rac2. We also demonstrate that Rac2 directly binds to PLC gamma(2) as well as to the isolated spPH of this isoform. Furthermore, through the use of NMR spectroscopy and mutational analysis, we determine the structure of spPH, define the structural features of spPH required for Rac interaction, and identify critical amino acid residues at the interaction interface. We further discuss parallels and differences between PLC gamma(1) and PLC gamma(2) and the implications of our findings for their respective signaling roles.	[Everett, Katy L.; Josephs, Michelle B.; Katan, Matilda; Bunney, Tom D.] Inst Canc Res, Chester Beatty Labs, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England; [Walliser, Claudia; Retlich, Michael; Vatter, Petra; Gierschik, Peter] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, D-89070 Ulm, Germany; [Harris, Richard; Driscoll, Paul C.] UCL, Div Biosci, Inst Struct & Mol Biol, London WC1E 6BT, England; [Esposito, Diego; Driscoll, Paul C.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Ulm University; University of London; Birkbeck University London; University College London; MRC National Institute for Medical Research	Bunney, TD (corresponding author), Inst Canc Res, Chester Beatty Labs, Canc Res UK Ctr Cell & Mol Biol, Fulham Rd, London SW3 6JB, England.	tom.bunney@icr.ac.uk	Driscoll, Paul C/B-8007-2010	Driscoll, Paul C/0000-0002-4124-6950; Harris, Richard/0000-0001-7459-1745; Bunney, Tom/0000-0002-0281-8813	MRC [MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887, MC_U117574559] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BOUCHER W, 1996, THESIS U CAMBRIDGE C; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; CAMPS M, 1990, BIOCHEM J, V271, P743, DOI 10.1042/bj2710743; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DeBell K, 2007, MOL CELL BIOL, V27, P854, DOI 10.1128/MCB.01400-06; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIETRICH A, 1992, FEBS LETT, V313, P220, DOI 10.1016/0014-5793(92)81195-R; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Frankel P, 2005, EMBO J, V24, P54, DOI 10.1038/sj.emboj.7600497; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Horstman DA, 1996, P NATL ACAD SCI USA, V93, P7518, DOI 10.1073/pnas.93.15.7518; Horstman DA, 1999, ARCH BIOCHEM BIOPHYS, V361, P149, DOI 10.1006/abbi.1998.0978; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Illenberger D, 2000, METHOD ENZYMOL, V325, P167; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Illenberger D, 2003, J BIOL CHEM, V278, P3006, DOI 10.1074/jbc.M208282200; Illenberger D, 1997, EUR J BIOCHEM, V246, P71, DOI 10.1111/j.1432-1033.1997.t01-1-00071.x; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Inabe K, 2002, FEBS LETT, V514, P260, DOI 10.1016/S0014-5793(02)02375-X; Inabe K, 2002, J EXP MED, V195, P189, DOI 10.1084/jem.20011571; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Katan Matilda, 2005, Biochem J, V391, pe7; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kim YJ, 2004, MOL CELL BIOL, V24, P9986, DOI 10.1128/MCB.24.22.9986-9999.2004; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Matsuda M, 2001, J CELL BIOL, V153, P599, DOI 10.1083/jcb.153.3.599; McAlister MSB, 1996, BIOCHEMISTRY-US, V35, P5982, DOI 10.1021/bi952756u; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Plevin MJ, 2004, J MOL BIOL, V341, P171, DOI 10.1016/j.jmb.2004.05.057; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rodriguez R, 2001, J BIOL CHEM, V276, P47982, DOI 10.1074/jbc.M107577200; Sekiya F, 2004, J BIOL CHEM, V279, P32181, DOI 10.1074/jbc.M405116200; Sidhu RS, 2005, J BIOL CHEM, V280, P21933, DOI 10.1074/jbc.M412966200; Singh SM, 2003, PROTEIN SCI, V12, P1934, DOI 10.1110/ps.0358803; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Sorli SC, 2005, ONCOGENE, V24, P90, DOI 10.1038/sj.onc.1208168; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Thompson Gladstone, 1997, Biochemical Society Transactions, V25, p509S; Upshaw JL, 2005, J IMMUNOL, V175, P213, DOI 10.4049/jimmunol.175.1.213; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wen WY, 2006, J BIOL CHEM, V281, P12060, DOI 10.1074/jbc.M600336200; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Zhou C, 1999, J BIOL CHEM, V274, P2786, DOI 10.1074/jbc.274.5.2786	64	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30351	30362		10.1074/jbc.M803316200	http://dx.doi.org/10.1074/jbc.M803316200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18728011	hybrid, Green Published			2022-12-25	WOS:000260366900079
J	Case, N; Ma, MY; Sen, B; Xie, ZH; Gross, TS; Rubin, J				Case, Natasha; Ma, Meiyun; Sen, Buer; Xie, Zhihui; Gross, Ted S.; Rubin, Janet			beta-Catenin Levels Influence Rapid Mechanical Responses in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; DOWN-REGULATION; IN-VITRO; WNT; BONE; PHOSPHORYLATION; ACTIVATION; EXPRESSION; CAVEOLIN-1; CYCLOOXYGENASE-2	Mechanical loading of bone initiates an anabolic, anticatabolic pattern of response, yet the molecular events involved in mechanical signal transduction are not well understood. Wnt/beta-catenin signaling has been recognized in promoting bone anabolism, and application of strain has been shown to induce beta-catenin activation. In this work, we have used a preosteoblastic cell line to study the effects of dynamic mechanical strain on beta-catenin signaling. We found that mechanical strain caused a rapid, transient accumulation of active beta-catenin in the cytoplasm and its translocation to the nucleus. This was followed by up-regulation of the Wnt/beta-catenin target genes Wisp1 and Cox2, with peak responses at 4 and 1 h of strain, respectively. The increase of beta-catenin was temporally related to the activation of Akt and subsequent inactivation of GSK3 beta, and caveolin-1 was not required for these molecular events. Application of Dkk-1, which disrupts canonical Wnt/LRP5 signaling, did not block strain-induced nuclear translocation of beta-catenin or up-regulation of Wisp1 and Cox2 expression. Conditions that increased basal beta-catenin levels, such as lithium chloride treatment or repression of caveolin-1 expression, were shown to enhance the effects of strain. In summary, mechanical strain activates Akt and inactivates GSK3 beta to allow beta-catenin translocation, and Wnt signaling through LRP5 is not required for these strain-mediated responses. Thus, beta-catenin serves as both a modulator and effector of mechanical signals in bone cells.	[Case, Natasha; Ma, Meiyun; Sen, Buer; Xie, Zhihui; Rubin, Janet] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Gross, Ted S.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Case, N (corresponding author), Univ N Carolina, Dept Med, 5030 Burnett Womack,CB 7170, Chapel Hill, NC 27599 USA.	ncase@med.unc.edu			National Institutes of Health [AR42360, AR52014]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042360, R56AR042360, R01AR056655, R01AR052014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR42360 and AR52014. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Araki Y, 2003, CANCER RES, V63, P728; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Fan M, 2006, J CELL PHYSIOL, V207, P454, DOI 10.1002/jcp.20581; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Hasaneen NA, 2007, AM J PHYSIOL-LUNG C, V293, pL1059, DOI 10.1152/ajplung.00480.2006; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Kim SJ, 2002, BIOCHEM BIOPH RES CO, V296, P221, DOI 10.1016/S0006-291X(02)00824-0; Kippenberger S, 2005, J BIOL CHEM, V280, P3060, DOI 10.1074/jbc.M409590200; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; Ragab AA, 2002, AM J PHYSIOL-CELL PH, V283, pC679, DOI 10.1152/ajpcell.00421.2001; Rice KM, 2007, EXP PHYSIOL, V92, P963, DOI 10.1113/expphysiol.2007.037275; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Rubin J, 1999, J ORTHOPAED RES, V17, P639, DOI 10.1002/jor.1100170504; Rubin J, 2003, J BIOL CHEM, V278, P34018, DOI 10.1074/jbc.M302822200; Rubin J, 2007, J BONE MINER RES, V22, P1408, DOI 10.1359/jbmr.070601; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Torres VA, 2007, MOL CELL BIOL, V27, P7703, DOI 10.1128/MCB.01991-06; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P270, DOI 10.1016/j.bbrc.2007.09.129; Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005	36	118	126	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29196	29205		10.1074/jbc.M801907200	http://dx.doi.org/10.1074/jbc.M801907200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18723514	hybrid, Green Published			2022-12-25	WOS:000260179900047
J	Garud, DR; Tran, VM; Victor, XV; Koketsu, M; Kuberan, B				Garud, Dinesh R.; Tran, Vy M.; Victor, Xylophone V.; Koketsu, Mamoru; Kuberan, Balagurunathan			Inhibition of Heparan Sulfate and Chondroitin Sulfate Proteoglycan Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; BETA-D-XYLOSIDES; BREFELDIN-A; RAT CHONDROSARCOMA; MOLECULAR-CLONING; XT-II; CELLS; GLYCOSAMINOGLYCAN; EXPRESSION; CARTILAGE	Proteoglycans (PGs) are composed of a protein moiety and a complex glycosaminoglycan ( GAG) polysaccharide moiety. GAG chains are responsible for various biological activities. GAG chains are covalently attached to serine residues of the core protein. The first step in PG biosynthesis is xylosylation of certain serine residues of the core protein. A specific linker tetrasaccharide is then assembled and serves as an acceptor for elongation of GAG chains. If the production of endogenous GAG chains is selectively inhibited, one could determine the role of these endogenous molecules in physiological and developmental functions in a spatiotemporal manner. Biosynthesis of PGs is often blocked with the aid of nonspecific agents such as chlorate, a bleaching agent, and brefeldin A, a fungal metabolite, to elucidate the biological roles of GAG chains. Unfortunately, these agents are highly lethal to model organisms. Xylosides are known to prime GAG chains. Therefore, we hypothesized that modified xylose analogs may able to inhibit the biosynthesis of PGs. To test this, we synthesized a library of novel 4-deoxy-4-fluoroxylosides with various aglycones using click chemistry and examined each for its ability to inhibit heparan sulfate and chondroitin sulfate using Chinese hamster ovary cells as a model cellular system.	[Victor, Xylophone V.; Kuberan, Balagurunathan] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Garud, Dinesh R.] Gifu Univ, Fac Engn, Dept Chem, Gifu 5011193, Japan; [Koketsu, Mamoru] Gifu Univ, Life Sci Res Ctr, Div Instrumental Anal, Gifu 5011193, Japan; [Tran, Vy M.; Kuberan, Balagurunathan] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Gifu University; Gifu University; Utah System of Higher Education; University of Utah	Kuberan, B (corresponding author), Univ Utah, Dept Med Chem, Skaggs Hall,Rm 307,30 South 2000 East, Salt Lake City, UT 84112 USA.	KUBY@pharm.utah.edu	Tran, Vy/GWC-8836-2022; Garud, Dinesh Ramesh/X-2586-2018	Garud, Dinesh Ramesh/0000-0002-8735-7920; Balagurunathan, Kuberan/0000-0001-9203-8118	National Institutes of Health [GM075168]; Human Frontiers Science Program; Ministry of Education, Culture, Sports, Science, and Technology of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, by National Institutes of Health Grant GM075168 (to B. K.). This work was also supported by the Human Frontiers Science Program (to B. K.) and by a grant-in-aid for science research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; BAILEY DS, 1981, BIOCHEM J, V195, P139, DOI 10.1042/bj1950139; BATEY JF, 1975, CARBOHYD RES, V43, P43; Berkin A, 2005, GLYCOCONJUGATE J, V22, P443, DOI 10.1007/s10719-005-5060-1; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; CALABRO A, 1994, J BIOL CHEM, V269, P22764; Cuellar K, 2007, J BIOL CHEM, V282, P5195, DOI 10.1074/jbc.M611048200; Dax K, 2000, CARBOHYD RES, V327, P47, DOI 10.1016/S0008-6215(00)00022-7; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; GREVE H, 1988, J BIOL CHEM, V263, P12886; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; HUMPHRIES DE, 1988, BIOCHEM BIOPH RES CO, V154, P365, DOI 10.1016/0006-291X(88)90694-8; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kuberan B, 2008, CHEMBIOCHEM, V9, P198, DOI 10.1002/cbic.200700494; LINDAHL U, 1966, J BIOL CHEM, V241, P2113; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Moses J, 1997, EUR J BIOCHEM, V248, P521, DOI 10.1111/j.1432-1033.1997.00521.x; MUIR H, 1958, BIOCHEM J, V69, P195, DOI 10.1042/bj0690195; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; OEGEMA TR, 1984, J BIOL CHEM, V259, P1720; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; Prydz K, 2000, J CELL SCI, V113, P193; ROBINSON HC, 1975, BIOCHEM J, V148, P25, DOI 10.1042/bj1480025; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SAMPATH D, 1992, J BIOL CHEM, V267, P4440; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Schon S, 2006, J BIOL CHEM, V281, P14224, DOI 10.1074/jbc.M510690200; Schwartz NB, 2004, GLYCOCONJUGATE J, V21, P329, DOI 10.1023/B:GLYC.0000046278.34016.36; SHERWOOD AL, 1992, J BIOL CHEM, V267, P25328; SUGUMARAN G, 1992, J BIOL CHEM, V267, P8802; Turnbull JE, 2007, NAT CHEM BIOL, V3, P74, DOI 10.1038/nchembio0207-74; UHLINHANSEN L, 1993, J BIOL CHEM, V268, P17370; Wicki J, 2007, BIOCHEMISTRY-US, V46, P6996, DOI 10.1021/bi700359e; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; Zhang LJ, 2001, J BIOL CHEM, V276, P42311, DOI 10.1074/jbc.M101441200	39	32	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28881	28887		10.1074/jbc.M805939200	http://dx.doi.org/10.1074/jbc.M805939200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708345	Green Published, hybrid			2022-12-25	WOS:000260179900013
J	Kawamata, H; Magrane, J; Kunst, C; King, MP; Manfredi, G				Kawamata, Hibiki; Magrane, Jordi; Kunst, Catherine; King, Michael P.; Manfredi, Giovanni			Lysyl-tRNA synthetase is a target for mutant SOD1 toxicity in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; PROTEIN INTERACTIONS; TRANSGENIC MICE; G93A-SOD1 MICE; DEGENERATION; DYSFUNCTION; CELLS; ALS; DISEASE	Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease affecting the motor neurons. The majority of familial forms of ALS are caused by mutations in the Cu,Zn-superoxide dismutase (SOD1). In mutant SOD1 spinal cord motor neurons, mitochondria develop abnormal morphology, bioenergetic defects, and degeneration. However, the mechanisms of mitochondrial toxicity are still unclear. One possibility is that mutant SOD1 establishes aberrant interactions with nuclear-encoded mitochondrial proteins, which can interfere with their normal trafficking from the cytosol to mitochondria. Lysyl-tRNA synthetase (KARS), an enzyme required for protein translation that was shown to interact with mutant SOD1 in yeast, is a good candidate as a target for interaction with mutant SOD1 at the mitochondrion in mammals because of its dual cytosolic and mitochondrial localization. Here, we show that in mammalian cells mutant SOD1 interacts preferentially with the mitochondrial form of KARS (mitoKARS). KARS-SOD1 interactions occur also in the mitochondria of the nervous system in transgenic mice. In the presence of mutant SOD1, mitoKARS displays a high propensity to misfold and aggregate prior to its import into mitochondria, becoming a target for proteasome degradation. Impaired mitoKARS import correlates with decreased mitochondrial protein synthesis. Ultimately, the abnormal interactions between mutant SOD1 and mitoKARS result in mitochondrial morphological abnormalities and cell toxicity. mitoKARS is the first described member of a group of mitochondrial proteins whose interaction with mutant SOD1 contributes to mitochondrial dysfunction in ALS.	[Kawamata, Hibiki; Magrane, Jordi; Manfredi, Giovanni] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA; [Kunst, Catherine] Univ Denver, Eleanor Roosevelt Inst, Denver, CO 80206 USA; [King, Michael P.] Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA	Cornell University; University of Denver; Jefferson University	Manfredi, G (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, 525 E 68th St,A-505, New York, NY 10065 USA.	gim2004@med.cornell.edu	Magrané, Jordi/AAJ-2967-2020	Magrané, Jordi/0000-0002-6785-2166	National Institutes of Health [P01-NS011766, R01-NS051419, F31 NS054554]; Robert Packard ALS Research Center; New York Community Trust; Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, R01NS051419, F31NS054554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Packard ALS Research Center; New York Community Trust; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-NS011766, R01-NS051419, and F31 NS054554. This work was also supported by the Robert Packard ALS Research Center, The New York Community Trust, and the Muscular Dystrophy Association.	Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Brandina I, 2007, FEBS LETT, V581, P4248, DOI 10.1016/j.febslet.2007.08.013; Cen S, 2002, J VIROL, V76, P13111, DOI 10.1128/JVI.76.24.13111-13115.2002; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hervias I, 2006, MUSCLE NERVE, V33, P598, DOI 10.1002/mus.20489; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Jung CW, 2002, J NEUROSCI METH, V114, P165, DOI 10.1016/S0165-0270(01)00524-6; Kabashi E, 2006, BBA-MOL BASIS DIS, V1762, P1038, DOI 10.1016/j.bbadis.2006.06.006; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; Kong JM, 1998, J NEUROSCI, V18, P3241; Kunst CB, 1997, NAT GENET, V15, P91, DOI 10.1038/ng0197-91; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Menzies FM, 2002, BRAIN, V125, P1522, DOI 10.1093/brain/awf167; MIRANDE M, 1985, EUR J BIOCHEM, V147, P281, DOI 10.1111/j.1432-1033.1985.tb08748.x; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pearce DA, 1997, J BIOL CHEM, V272, P31829, DOI 10.1074/jbc.272.50.31829; Raimondi A, 2006, EUR J NEUROSCI, V24, P387, DOI 10.1111/j.1460-9568.2006.04922.x; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yannay-Cohen N, 2006, MOL CELLS, V22, P127; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	42	36	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28321	28328		10.1074/jbc.M805599200	http://dx.doi.org/10.1074/jbc.M805599200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18715867	Green Published, hybrid			2022-12-25	WOS:000259969300034
J	Shinnakasu, R; Yamashita, M; Kuwahara, M; Hosokawa, H; Hasegawa, A; Motohashi, S; Nakayama, T				Shinnakasu, Ryo; Yamashita, Masakatsu; Kuwahara, Makoto; Hosokawa, Hiroyuki; Hasegawa, Akihiro; Motohashi, Shinichiro; Nakayama, Toshinori			Gfi1-mediated stabilization of GATA3 protein is required for Th2 cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-3; ZINC-FINGER PROTEIN; HEMATOPOIETIC STEM-CELLS; CIS-REGULATORY ELEMENTS; T-CELLS; GENE LOCUS; HISTONE HYPERACETYLATION; PROTEASOMAL DEGRADATION; TH2-SPECIFIC EXPRESSION; INTERLEUKIN-5 GENE	The differentiation of naive CD4 T cells into Th2 cells requires the T cell receptor-mediated activation of the ERK MAPK cascade. Little is known, however, in regard to how the ERK MAPK cascade regulates Th2 cell differentiation. We herein identified Gfi1 (growth factor independent-1) as a downstream target of the ERK MAPK cascade for Th2 cell differentiation. In the absence of Gfi1, interleukin-5 production and the change of histone modification at the interleukin-5 gene locus were severely impaired. Furthermore, the interferon gamma gene showed a striking activation in the Gfi1(-/-) Th2 cells. An enhanced ubiquitin/proteasome-dependent degradation of GATA3 protein was observed in Gfi1(-/-) Th2 cells, and the overexpression of GATA3 eliminated the defect of Th2 cell function in Gfi1-deficient Th2 cells. These data suggest that the T cell receptor-mediated induction of Gfi1 controls Th2 cell differentiation through the regulation of GATA3 protein stability.	[Shinnakasu, Ryo; Yamashita, Masakatsu; Kuwahara, Makoto; Hosokawa, Hiroyuki; Hasegawa, Akihiro; Motohashi, Shinichiro; Nakayama, Toshinori] Chiba Univ, Dept Immunol, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan	Chiba University	Yamashita, M (corresponding author), Chiba Univ, Dept Immunol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	yamamasa@faculty.chiba-u.jp	Nakayama, Toshinori/E-1067-2017	Nakayama, Toshinori/0000-0002-1434-2007; Hosokawa, Hiroyuki/0000-0002-9592-2889	Ministry of Education, Culture, Sports, Science and Technology [20060003, 17390139, 20590485, 19659121, 19890041]; Ministry of Health, Labor and Welfar, the Kanae Foundation, the Uehara Memorial Foundation, the Astellas Foundation, and the Sagawa Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfar, the Kanae Foundation, the Uehara Memorial Foundation, the Astellas Foundation, and the Sagawa Foundation	This work was supported by Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research on Priority Areas 20060003, Scientific Research (B) 17390139, Scientific Research (C) 20590485, Exploratory Research 19659121, and Young Scientists (Start-up) 19890041; by Special Coordination Funds for Promoting Science and Technology; and by the Ministry of Health, Labor and Welfar, the Kanae Foundation, the Uehara Memorial Foundation, the Astellas Foundation, and the Sagawa Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Inami M, 2004, J BIOL CHEM, V279, P23123, DOI 10.1074/jbc.M401248200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaminuma O, 2004, FEBS LETT, V570, P63, DOI 10.1016/j.febslet.2004.06.026; Karsunky H, 2002, ONCOGENE, V21, P1571, DOI 10.1038/sj/onc/1205216; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kimura MY, 2005, J EXP MED, V201, P397, DOI 10.1084/jem.20040733; Lee HJ, 1998, J IMMUNOL, V160, P2343; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marteijn JAF, 2007, BLOOD, V110, P3128, DOI 10.1182/blood-2006-11-058602; Marteijn JAF, 2007, BLOOD, V109, P100, DOI 10.1182/blood-2006-02-003590; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Omori M, 2003, IMMUNITY, V19, P281, DOI 10.1016/S1074-7613(03)00210-3; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schwenger GTF, 2001, J BIOL CHEM, V276, P48502, DOI 10.1074/jbc.M107836200; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shibata Y, 2002, J IMMUNOL, V169, P2134, DOI 10.4049/jimmunol.169.4.2134; Shinnakasu R, 2006, J IMMUNOL, V177, P5801, DOI 10.4049/jimmunol.177.9.5801; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wan YSY, 2006, IMMUNOL REV, V212, P114, DOI 10.1111/j.0105-2896.2006.00407.x; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yamashita M, 1998, INT IMMUNOL, V10, P577, DOI 10.1093/intimm/10.5.577; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamashita M, 2000, J EXP MED, V191, P1869, DOI 10.1084/jem.191.11.1869; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	51	43	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28216	28225		10.1074/jbc.M804174200	http://dx.doi.org/10.1074/jbc.M804174200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701459	Green Published, hybrid			2022-12-25	WOS:000259969300023
J	Hilvo, M; Baranauskiene, L; Salzano, AM; Scaloni, A; Matulis, D; Innocenti, A; Scozzafava, A; Monti, SM; Di Fiore, A; De Simone, G; Lindfors, M; Janis, J; Valjakka, J; Pastorekova, S; Pastorek, J; Kulomaa, MS; Nordlund, HR; Supuran, CT; Parkkila, S				Hilvo, Mika; Baranauskiene, Lina; Salzano, Anna Maria; Scaloni, Andrea; Matulis, Daumantas; Innocenti, Alessio; Scozzafava, Andrea; Monti, Simona Maria; Di Fiore, Anna; De Simone, Giuseppina; Lindfors, Mikaela; Janis, Janne; Valjakka, Jarkko; Pastorekova, Silvia; Pastorek, Jaromir; Kulomaa, Markku S.; Nordlund, Henri R.; Supuran, Claudiu T.; Parkkila, Seppo			Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; BREAST-CANCER; CDNA CLONING; KERATAN SULFATE; CELL-LINES; DOMAIN; MUCIN; LOCALIZATION; INHIBITION; INDUCTION	Carbonic anhydrase IX (CA IX) is an exceptional member of the CA protein family; in addition to its classical role in pH regulation, it has also been proposed to participate in cell proliferation, cell adhesion, and tumorigenic processes. To characterize the biochemical properties of this membrane protein, two soluble recombinant forms were produced using the baculovirus-insect cell expression system. The recombinant proteins consisted of either the CA IX catalytic domain only (CA form) or the extracellular domain, which included both the proteoglycan and catalytic domains (PG + CA form). The produced proteins lacked the small transmembrane and intracytoplasmic regions of CA IX. Stopped-flow spectrophotometry experiments on both proteins demonstrated that in the excess of certain metal ions the PG + CA form exhibited the highest catalytic activity ever measured for any CA isozyme. Investigations on the oligomerization and stability of the enzymes revealed that both recombinant proteins form dimers that are stabilized by intermolecular disulfide bond(s). Mass spectrometry experiments showed that CA IX contains an intramolecular disulfide bridge (Cys(119)-Cys(299)) and a unique N-linked glycosylation site (Asn(309)) that bears high mannosetype glycan structures. Parallel experiments on a recombinant protein obtained by a mammalian cell expression system demonstrated the occurrence of an additional O-linked glycosylation site (Thr(78)) and characterized the nature of the oligosaccharide structures. This study provides novel information on the biochemical properties of CA IX and may help characterize the various cellular and pathophysiological processes in which this unique enzyme is involved.	[Hilvo, Mika; Lindfors, Mikaela; Valjakka, Jarkko; Kulomaa, Markku S.; Nordlund, Henri R.; Parkkila, Seppo] Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland; [Parkkila, Seppo] Univ Tampere, Sch Med, FI-33014 Tampere, Finland; [Parkkila, Seppo] Tampere Univ Hosp, FI-33014 Tampere, Finland; [Baranauskiene, Lina; Matulis, Daumantas] Inst Biotechnol, Lab Biothermodynam & Drug Design, LT-02241 Vilnius, Lithuania; [Salzano, Anna Maria; Scaloni, Andrea] CNR, ISPAAM, Proteom & Mass Spectrometry Lab, I-80147 Naples, Italy; [Innocenti, Alessio; Scozzafava, Andrea; Supuran, Claudiu T.] Univ Florence, Bioinorgan Chem Lab, I-50019 Florence, Italy; [Monti, Simona Maria; Di Fiore, Anna; De Simone, Giuseppina] CNR, Inst Biostruct & Bioimages, I-80134 Naples, Italy; [Janis, Janne] Univ Joensuu, Dept Chem, FI-80101 Joensuu, Finland; [Pastorekova, Silvia; Pastorek, Jaromir] Slovak Acad Sci, Ctr Mol Med, Inst Virol, Bratislava 84505, Slovakia	Tampere University; Tampere University; Tampere University; Tampere University Hospital; Vilnius University; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Eastern Finland; Slovak Academy of Sciences	Hilvo, M (corresponding author), Univ Tampere, Inst Med Technol, Biokatu 6, FI-33014 Tampere, Finland.	Mika.Hilvo@uta.fi	Baranauskiene, Lina/P-5088-2016; Kulomaa, Markku S/C-9063-2014; Matulis, Daumantas/F-9367-2010; Hilvo, Mika/AAC-7468-2020; Pastorekova, Silvia/C-6685-2018; Di Fiore, Anna/AAX-5655-2020; Monti, Simona M/J-5214-2012; Pastorek, Jaromir/AAR-2647-2020; Jänis, Janne/B-7326-2014; Supuran, Claudiu T/A-5151-2008; Di Fiore, Anna/AAW-3780-2020; De Simone, Giuseppina/AAJ-4964-2021; Salzano, Anna Maria/C-7139-2012; MONTI, SIMONA MARIA/GQQ-0129-2022	Baranauskiene, Lina/0000-0002-9924-9177; Matulis, Daumantas/0000-0002-6178-6276; Di Fiore, Anna/0000-0003-2924-5194; Salzano, Anna Maria/0000-0001-7192-8760; Parkkila, Seppo/0000-0001-7323-8536; Hilvo, Mika/0000-0003-0663-5843; Supuran, Claudiu/0000-0003-4262-0323; Scozzafava, Andrea/0000-0001-5020-3322; De Simone, Giuseppina/0000-0001-9783-5431; MONTI, SIMONA MARIA/0000-0001-9647-7089; Scaloni, Andrea/0000-0001-9362-8515	Finnish Cultural Foundation; European Union projects Euroxy and DeZnIT; Lithuanian State Science and Studies Foundation; Italian National Research Council [RSTL 862, MERIT]	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); European Union projects Euroxy and DeZnIT(European Commission); Lithuanian State Science and Studies Foundation(Research Council of Lithuania (LMTLT)); Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR))	This work was supported in part by grants from the Finnish Cultural Foundation, European Union projects Euroxy and DeZnIT, the Lithuanian State Science and Studies Foundation, and the Italian National Research Council (RSTL 862 and MERIT). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bernardini G, 2004, PROTEOMICS, V4, P2893, DOI 10.1002/pmic.200400946; Brockhausen I, 2003, BIOCHEM SOC T, V31, P318, DOI 10.1042/BST0310318; BROCKHAUSEN I, 1995, EUR J BIOCHEM, V233, P607, DOI 10.1111/j.1432-1033.1995.607_2.x; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Chandrasekaran EV, 2006, CARBOHYD RES, V341, P983, DOI 10.1016/j.carres.2006.02.017; Delcommenne M, 2002, GLYCOBIOLOGY, V12, P613, DOI 10.1093/glycob/cwf080; FOGHANDERSEN N, 1995, CLIN CHEM, V41, P1522; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Fujikawa-Adachi K, 1999, J BIOL CHEM, V274, P21228, DOI 10.1074/jbc.274.30.21228; Fujikawa-Adachi K, 1999, GENOMICS, V61, P74, DOI 10.1006/geno.1999.5938; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; Gasbarri A, 2003, MELANOMA RES, V13, P325, DOI 10.1097/00008390-200308000-00001; Grillo C, 2007, J BIOL CHEM, V282, P10299, DOI 10.1074/jbc.M700966200; Gross N, 2001, MED PEDIATR ONCOL, V36, P139; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hilvo M, 2004, J HISTOCHEM CYTOCHEM, V52, P1313, DOI 10.1369/jhc.3A6225.2004; Hilvo M, 2008, CURR PHARM DESIGN, V14, P672, DOI 10.2174/138161208783877811; Hilvo M, 2005, BIOCHEM J, V392, P83, DOI 10.1042/BJ20051102; Holland JW, 2004, PROTEOMICS, V4, P743, DOI 10.1002/pmic.200300613; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehtonen J, 2004, J BIOL CHEM, V279, P2719, DOI 10.1074/jbc.M308984200; Lloyd KO, 1996, J BIOL CHEM, V271, P33325, DOI 10.1074/jbc.271.52.33325; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; MAJUMDER K, 1992, GENE, V116, P115; MONTGOMERY JC, 1991, GENOMICS, V11, P835, DOI 10.1016/0888-7543(91)90006-Z; MURAKAMI H, 1987, J BIOL CHEM, V262, P1382; Nishimori I, 2007, BIOORG MED CHEM LETT, V17, P1037, DOI 10.1016/j.bmcl.2006.11.028; Opavsky R, 1996, GENOMICS, V33, P480, DOI 10.1006/geno.1996.0223; ORTOVAGUT M, 2002, GASTROENTEROLOGY, V123, P1889; Ozensoy O, 2005, BIOORG MED CHEM LETT, V15, P4862, DOI 10.1016/j.bmcl.2005.08.048; PASTOREK J, 1994, ONCOGENE, V9, P2877; Pastorekova S, 2004, CRC ENZYM INHIB SER, P255; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pastorekova S, 1997, GASTROENTEROLOGY, V112, P398, DOI 10.1053/gast.1997.v112.pm9024293; Pastorekova S, 2004, CANC THER, V2, P245; Rafajova M, 2004, INT J ONCOL, V24, P995; Salzano AM, 2007, PROTEOMICS, V7, P1420, DOI 10.1002/pmic.200601030; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Supuran CT, 2004, CRC ENZYM INHIB SER, P1, DOI 10.1201/9780203475300.ch1; Takahashi K, 1996, J BIOL CHEM, V271, P9490, DOI 10.1074/jbc.271.16.9490; Tureci O, 1998, P NATL ACAD SCI USA, V95, P7608, DOI 10.1073/pnas.95.13.7608; Whittington DA, 2004, J BIOL CHEM, V279, P7223, DOI 10.1074/jbc.M310809200; Wingo T, 2001, BIOCHEM BIOPH RES CO, V288, P666, DOI 10.1006/bbrc.2001.5824; Zat'ovicova M, 2003, J IMMUNOL METHODS, V282, P117, DOI 10.1016/j.jim.2003.08.011; ZAVADA J, 1993, INT J CANCER, V54, P268, DOI 10.1002/ijc.2910540218; ZHU XL, 1990, J BIOL CHEM, V265, P8795	49	216	225	0	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27799	27809		10.1074/jbc.M800938200	http://dx.doi.org/10.1074/jbc.M800938200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18703501	hybrid			2022-12-25	WOS:000259719200051
J	Lisewski, AM				Lisewski, Andreas Martin			Random Amino Acid Mutations and Protein Misfolding Lead to Shannon Limit in Sequence-Structure Communication	PLOS ONE			English	Article							ALGORITHMIC COMPLEXITY; INFORMATION-THEORY; DEGRADATION; FOLD	The transmission of genomic information from coding sequence to protein structure during protein synthesis is subject to stochastic errors. To analyze transmission limits in the presence of spurious errors, Shannon's noisy channel theorem is applied to a communication channel between amino acid sequences and their structures established from a large-scale statistical analysis of protein atomic coordinates. While Shannon's theorem confirms that in close to native conformations information is transmitted with limited error probability, additional random errors in sequence (amino acid substitutions) and in structure (structural defects) trigger a decrease in communication capacity toward a Shannon limit at 0.010 bits per amino acid symbol at which communication breaks down. In several controls, simulated error rates above a critical threshold and models of unfolded structures always produce capacities below this limiting value. Thus an essential biological system can be realistically modeled as a digital communication channel that is (a) sensitive to random errors and (b) restricted by a Shannon error limit. This forms a novel basis for predictions consistent with observed rates of defective ribosomal products during protein synthesis, and with the estimated excess of mutual information in protein contact potentials.	[Lisewski, Andreas Martin] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Lisewski, AM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	lisewski@bcm.edu			W. M. Keck Center for Computational and Structural Biology [training fellowship]; National Science Foundation [DBI-0547695]; National Institutes of Health [R01 GM066099]; March of Dimes [FY06-371]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066099] Funding Source: NIH RePORTER	W. M. Keck Center for Computational and Structural Biology; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by a training fellowship from the Gulf Coast Consortia through the W. M. Keck Center for Computational and Structural Biology (AML), as well as through grants from the National Science Foundation (DBI-0547695), National Institutes of Health (R01 GM066099), and March of Dimes (MOD FY06-371).	Adami C, 2004, PHYS LIFE REV, V1, P3, DOI 10.1016/j.plrev.2004.01.002; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Ay J, 1998, PROTEINS, V30, P155, DOI 10.1002/(SICI)1097-0134(19980201)30:2<155::AID-PROT5>3.0.CO;2-M; Berezovsky IN, 2001, PROTEIN ENG, V14, P403, DOI 10.1093/protein/14.6.403; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BRILLOUIN L, 1962, SCI INFORM THEORY, pCH10; Cline MS, 2002, PROTEINS, V49, P7, DOI 10.1002/prot.10198; Crooks GE, 2004, PROTEINS, V57, P804, DOI 10.1002/prot.20262; Crooks GE, 2004, BIOINFORMATICS, V20, P1603, DOI 10.1093/bioinformatics/bth132; Dewey TG, 1996, PHYS REV E, V54, pR39, DOI 10.1103/PhysRevE.54.R39; Dewey TG, 1997, PHYS REV E, V56, P4545, DOI 10.1103/PhysRevE.56.4545; Dobson CM, 2003, NAT REV DRUG DISCOV, V2, P154, DOI 10.1038/nrd1013; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; ELLIS N, 1982, MOL GEN GENET, V188, P169, DOI 10.1007/BF00332670; GALLAGER RG, 1965, IEEE T INFORM THEORY, V11, P3, DOI 10.1109/TIT.1965.1053730; Gupta MK, 2006, IEEE ENG MED BIOL, V25, P46, DOI 10.1109/MEMB.2006.1578663; HERZEL H, 1995, PHYSICA A, V216, P518, DOI 10.1016/0378-4371(95)00104-F; HERZEL H, 1994, CHAOS SOLITON FRACT, V4, P97, DOI 10.1016/0960-0779(94)90020-5; HOBOHM U, 1994, PROTEIN SCI, V3, P522; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Lisewski AM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl788; Mandelbrot B., 1953, COMMUN THEOR, P486; May EE, 2006, IEEE ENG MED BIOL, V25, P28, DOI 10.1109/MEMB.2006.1578660; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Miller EJ, 2002, P NATL ACAD SCI USA, V99, P10359, DOI 10.1073/pnas.162219099; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ofran Y, 2006, PROTEINS, V64, P275, DOI 10.1002/prot.20964; Orengo C A, 2003, Methods Biochem Anal, V44, P249; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Qian Shu-Bing, 2005, V301, P271; Scheibel T, 2006, HANDB EXP PHARM, V172, P199; Schlegel C, 1999, IEEE COMMUN LETT, V3, P205, DOI 10.1109/4234.775255; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shannon C., 1964, MATH THEORY COMMUNIC; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Taguchi YH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-404; Thangavel K, 2006, ANN OPER RES, V143, P317, DOI 10.1007/s10479-006-7391-0; Vendruscolo M, 1997, FOLD DES, V2, P295, DOI 10.1016/S1359-0278(97)00041-2; Weiss MS, 2001, TRENDS BIOCHEM SCI, V26, P521, DOI 10.1016/S0968-0004(01)01935-1; Yockey H.P., 2005, INFORM THEORY EVOLUT; YOCKEY HP, 1974, J THEOR BIOL, V46, P369, DOI 10.1016/0022-5193(74)90005-8; YOCKEY HP, 1958, S INF THEOR BIOL GAT; ZHU J, 2005, PROTEINS, V14, P417	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3110	10.1371/journal.pone.0003110	http://dx.doi.org/10.1371/journal.pone.0003110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769673	Green Submitted, Green Published, gold			2022-12-25	WOS:000264416600006
J	Elfakess, R; Dikstein, R				Elfakess, Rofa; Dikstein, Rivka			A Translation Initiation Element Specific to mRNAs with Very Short 5 ' UTR that Also Regulates Transcription	PLOS ONE			English	Article								Transcription is controlled by cis regulatory elements, which if localized downstream to the transcriptional start site (TSS), in the 5'UTR, could influence translation as well. However presently there is little evidence for such composite regulatory elements. We have identified by computational analysis an abundant element located downstream to the TSS up to position +30, which controls both transcription and translation. This element has an invariable ATG sequence, which serves as the translation initiation codon in 64% of the genes bearing it. In these genes the initiating AUG is preceded by an extremely short 5'UTR. We show that translation in vitro and in vivo is initiated exclusively from the AUG of this motif, and that the AUG flanking sequences create a strong translation initiation context. This motif is distinguished from the well-known Kozak in its unique ability to direct efficient and accurate translation initiation from mRNAs with a very short 5'UTR. We therefore named it TISU for Translation Initiator of Short 5'UTR. Interestingly, this translation initiation element is also an essential transcription regulatory element of Yin Yang 1. Our characterization of a common transcription and translation element points to a link between mammalian transcription and translation initiation.	[Elfakess, Rofa; Dikstein, Rivka] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Elfakess, R (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	rivka.dikstein@weizmann.ac.il			Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by a grant from the Israel Science Foundation, founded by the Israel Academy of Sciences and Humanities.	Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Amir-Zilberstein L, 2008, J BIOL CHEM, V283, P1317, DOI 10.1074/jbc.M706767200; Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; BUSHMEYER S, 1995, J BIOL CHEM, V270, P30213; ELKAN TLB, 1994, FITTING MIXTURE MODE, P28; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Johansson E, 1998, J BIOL CHEM, V273, P29816, DOI 10.1074/jbc.273.45.29816; KOZAK M, 1994, BIOCHIMIE, V76, P815, DOI 10.1016/0300-9084(94)90182-1; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LEE JS, 1995, NUCLEIC ACIDS RES, V23, P925, DOI 10.1093/nar/23.6.925; LEE YM, 1994, DNA CELL BIOL, V13, P1029, DOI 10.1089/dna.1994.13.1029; Moshonov S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-92; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; RIGGS KJ, 1991, MOL CELL BIOL, V11, P1765, DOI 10.1128/MCB.11.3.1765; SATYAMOORTHY K, 1993, MOL CELL BIOL, V13, P6621, DOI 10.1128/MCB.13.11.6621; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6	21	57	62	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3094	10.1371/journal.pone.0003094	http://dx.doi.org/10.1371/journal.pone.0003094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769482	gold, Green Published, Green Submitted			2022-12-25	WOS:000264796600011
J	Sissoko, D; Moendandze, A; Malvy, D; Giry, C; Ezzedine, K; Solet, JL; Pierre, V				Sissoko, Daouda; Moendandze, Amrat; Malvy, Denis; Giry, Claude; Ezzedine, Khaled; Solet, Jean Louis; Pierre, Vincent			Seroprevalence and Risk Factors of Chikungunya Virus Infection in Mayotte, Indian Ocean, 2005-2006: A Population-Based Survey	PLOS ONE			English	Article								Background: Since 2006, Chikungunya virus (CHIKV) has re-emerged as an important pathogen of global concern. However, individual and household factors associated with the acquisition and the magnitude of clinically silent CHIKV infections remain poorly understood. In this present study, we aimed to investigate the seroprevalence, estimate the proportion of symptomatic illness and identify the risk factors for CHIKV infection in the primo-exposed population of Mayotte. Methods/Principal Findings: We conducted a household-based cross sectional serosurvey in Mayotte in November and December 2006 using complex multistage cluster sampling. To produce the results representative of the island population aged 2 years or older, sample data were adjusted with sample weights. Explanatory and multiple logistic regression analyses were performed to investigate associations between CHIKV infection seropositivity (presence of IgM and/or IgG to CHIKV by enzyme-linked immunoabsorbent assay) and risk factors. A total of 1154 individuals were analyzed. The overall seroprevalence of CHIKV infection was 37.2% (95% CI = 33.9-40.5), 318 (72.3%) of the seropositive participants reported symptoms consistent with a CHIKV infection during the epidemic period. Risk factors for CHIKV seropositivity among adults (aged 15 years and older) were male gender, low socioeconomic index, schooling <= 6 years and living in makeshift housing. Conclusions: Our findings indicate that roughly one out of four CHIKV infections is asymptomatic. Conditions associated with poverty may be considered as critical in CHIKV acquisition. Thus, these conditions should be taken into account in the development of future prevention strategies of CHIKV disease.	[Sissoko, Daouda; Solet, Jean Louis; Pierre, Vincent] Inst Veille Sanitaire Cellule Intterreg Epidemiol, St Denis, Reunion, France; [Moendandze, Amrat] Direct Affaires Sanitaires Sociales Mayotte, Mamoudzou, France; [Malvy, Denis; Ezzedine, Khaled] Ctr Hosp Region Univ, Hop St Andre, Serv Med Interne Maladies Trop, Bordeaux, France; [Malvy, Denis; Ezzedine, Khaled] Univ Bordeaux, Fac Med, Inst Med Trop, Bordeaux, France; [Giry, Claude] Ctr Hosp Mayotte, Lab Biol, Mamoudzou, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Sissoko, D (corresponding author), Inst Veille Sanitaire Cellule Intterreg Epidemiol, St Denis, Reunion, France.	daouda.sissoko@sante.gouv.fr	Ezzedine, Khaled/A-3072-2009; Ezzedine, Khaled/F-2716-2017; Sissoko, Daouda/L-9193-2013; MALVY, Denis/T-7930-2019	Ezzedine, Khaled/0000-0002-5468-4589; Sissoko, Daouda/0000-0002-8890-7170; 	French Health Ministry	French Health Ministry	The study was sponsored by the French Health Ministry. The sponsor of the study had no role in the study design, data collection, analysis, interpretation, or writing of the report. All authors had full access to all data. DS had the final responsibility for the decision to submit for publication.	Beesoon S, 2008, EMERG INFECT DIS, V14, P337, DOI 10.3201/eid1402.071024; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; BRIGHTON SW, 1983, S AFR MED J, V63, P313; Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; da Rosa APAT, 2000, EMERG INFECT DIS, V6, P298; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Josseran L, 2006, EMERG INFECT DIS, V12, P1994; Jupp P. G., 1988, The arboviruses: epidemiology and ecology. Volume II., P137; Jupp PG, 1996, S AFR MED J, V86, P35; Klar, 1990, ADEQUACY SAMPLE SIZE; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Mackenzie JS, 2001, EMERG INFECT DIS, V7, P497, DOI 10.3201/eid0707.017703; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9; Muyembe-Tamfum J J, 2003, Med Trop (Mars), V63, P637; MYERS RM, 1965, INDIAN J MED RES, V53, P694; OBEYESEKERE I, 1972, BRIT HEART J, V34, P821; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f; Reiskind MH, 2008, AM J TROP MED HYG, V78, P422, DOI 10.4269/ajtmh.2008.78.422; Reiter P, 2003, EMERG INFECT DIS, V9, P86; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; ROBINSON M C, 1956, Cent Afr J Med, V2, P394; Romi R, 1999, J AM MOSQUITO CONTR, V15, P425; SALMON CT, 1983, PUBLIC OPIN QUART, V47, P270, DOI 10.1086/268785; Sang RC, 2008, AM J TROP MED HYG, V78, P77; SARKAR JK, 1965, INDIAN J MED RES, V53, P921; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189; Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018; Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168	46	134	134	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3066	10.1371/journal.pone.0003066	http://dx.doi.org/10.1371/journal.pone.0003066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725980	gold, Green Published, Green Submitted			2022-12-25	WOS:000264796300012
J	Sironen, T; Klingstrom, J; Vaheri, A; Andersson, LC; Lundkvist, A; Plyusnin, A				Sironen, Tarja; Klingstrom, Jonas; Vaheri, Antti; Andersson, Leif C.; Lundkvist, Ake; Plyusnin, Alexander			Pathology of Puumala Hantavirus Infection in Macaques	PLOS ONE			English	Article								Hantaviruses are globally important human pathogens that cause hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Capillary leakage is central to hantaviral diseases, but how it develops, has remained unknown. It has been hypothesized that the pathogenesis of hantavirus infection would be a complex interplay between direct viral effects and immunopathological mechanisms. Both of these were studied in the so far best model of mild hemorrhagic fever with renal syndrome, i.e. cynomolgus macaques infected with wild-type Puumala hantavirus. Viral RNA detected by in situ hybridization and nucleocapsid protein detected by immunohistochemical staining were observed in kidney, spleen and liver tissues. Inflammatory cell infiltrations and tubular damage were found in the kidneys, and these infiltrations contained mainly CD8-type T-cells. Importantly, these results are consistent with those obtained from patients with hantaviral disease, thus showing that the macaque model of hantavirus infection mimics human infection also on the tissue level. Furthermore, both the markers of viral replication and the T-cells appeared to co-localize in the kidneys to the sites of tissue damage, suggesting that these two together might be responsible for the pathogenesis of hantavirus infection.	[Sironen, Tarja; Vaheri, Antti; Plyusnin, Alexander] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Klingstrom, Jonas; Lundkvist, Ake] Karolinska Inst, MTC, Swedish Inst Infect Dis Control, Stockholm, Sweden; [Andersson, Leif C.] Univ Helsinki, Haartman Inst, Dept Pathol, HUSLAB, Helsinki, Finland	University of Helsinki; Karolinska Institutet; Swedish Institute for Infectious Disease Control; University of Helsinki	Sironen, T (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	Tarja.Sironen@helsinki.fi	Vaheri, Antti/AAV-1523-2020	Sironen, Tarja/0000-0002-2344-2755; Klingstrom, Jonas/0000-0001-9076-1441	The Academy of Finland; Helsinki Biomedical Graduate School; Sigrid Juselius Foundation; Finnish Cultural Foundation; Swedish Medical Research Council	The Academy of Finland(Academy of Finland); Helsinki Biomedical Graduate School; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This work was supported by grants from The Academy of Finland, Helsinki Biomedical Graduate School, Sigrid Juselius Foundation, Finnish Cultural Foundation, and from the Swedish Medical Research Council. None of these had any role in the study.	Bustamante EA, 1997, CHEST, V112, P1133, DOI 10.1378/chest.112.4.1133; GROEN J, 1995, J INFECT DIS, V172, P38, DOI 10.1093/infdis/172.1.38; Groen J, 1996, CLIN NEPHROL, V46, P379; Hautala T, 2002, CLIN INFECT DIS, V35, P96, DOI 10.1086/340859; Hayasaka D, 2007, VIRUS RES, V123, P120, DOI 10.1016/j.virusres.2006.08.006; Hooper JW, 2008, J VIROL, V82, P1332, DOI 10.1128/JVI.01822-07; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Kilpatrick ED, 2004, J IMMUNOL, V172, P3297, DOI 10.4049/jimmunol.172.5.3297; KIM GR, 1985, AM J TROP MED HYG, V34, P388, DOI 10.4269/ajtmh.1985.34.388; Klingstrom J, 2006, J VIROL, V80, P8279, DOI 10.1128/JVI.00742-06; Klingstrom J, 2002, J VIROL, V76, P444, DOI 10.1128/JVI.76.1.444-449.2002; Klingstrom J, 2008, ANTIVIR THER, V13, P125; Linderholm M, 1996, J INFECT DIS, V173, P38, DOI 10.1093/infdis/173.1.38; Lundkvist A, 1997, J VIROL, V71, P9515, DOI 10.1128/JVI.71.12.9515-9523.1997; Makela S, 2004, AM J KIDNEY DIS, V43, P809, DOI 10.1053/j.ajkd.2003.12.044; McElroy AK, 2002, J INFECT DIS, V186, P1706, DOI 10.1086/345768; Milazzo ML, 2002, J INFECT DIS, V186, P1390, DOI 10.1086/344735; Mori M, 1999, J INFECT DIS, V179, P295, DOI 10.1086/314597; Mustonen J, 1996, KIDNEY INT, V49, P217, DOI 10.1038/ki.1996.29; Nemirov K, 2003, J VIROL, V77, P8793, DOI 10.1128/JVI.77.16.8793-8800.2003; Nichol S. T., 2005, VIRUS TAXONOMY, P695; Niikura M, 2004, ARCH VIROL, V149, P1279, DOI 10.1007/s00705-004-0306-y; NOLTE KB, 1995, HUM PATHOL, V26, P110, DOI 10.1016/0046-8177(95)90123-X; Plyusnin A, 1997, J CLIN MICROBIOL, V35, P1090, DOI 10.1128/JCM.35.5.1090-1096.1997; Price P, 1999, IMMUNOL REV, V167, P257, DOI 10.1111/j.1600-065X.1999.tb01398.x; Temonen M, 1996, CLIN IMMUNOL IMMUNOP, V78, P47, DOI 10.1006/clin.1996.0007; Terajima M, 2007, IMMUNOL LETT, V113, P117, DOI 10.1016/j.imlet.2007.08.003; Tuuminen T, 2007, J IMMUNOL, V179, P1988, DOI 10.4049/jimmunol.179.3.1988; VAPALAHTI O, 1995, J MED VIROL, V46, P293, DOI 10.1002/jmv.1890460402; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Waeckerle-Men Y, 2007, NEPHROL DIAL TRANSPL, V22, P1527, DOI 10.1093/ndt/gfl818; Wahl-Jensen V, 2007, J VIROL, V81, P7449, DOI 10.1128/JVI.00238-07; YANAGIHARA R, 1988, ARCH VIROL, V101, P125, DOI 10.1007/BF01314657; ZAKI SR, 1995, AM J PATHOL, V146, P552	34	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3035	10.1371/journal.pone.0003035	http://dx.doi.org/10.1371/journal.pone.0003035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716663	gold, Green Submitted, Green Published			2022-12-25	WOS:000264426800012
J	Morel, E; Fouquet, S; Strup-Perrot, C; Thievend, CP; Petit, C; Loew, D; Faussat, AM; Yvernault, L; Pincon-Raymond, M; Chambaz, J; Rousset, M; Thenet, S; Clair, C				Morel, Etienne; Fouquet, Stephane; Strup-Perrot, Carine; Thievend, Cathy Pichol; Petit, Constance; Loew, Damarys; Faussat, Anne-Marie; Yvernault, Lucile; Pincon-Raymond, Martine; Chambaz, Jean; Rousset, Monique; Thenet, Sophie; Clair, Caroline			The Cellular Prion Protein PrPc Is Involved in the Proliferation of Epithelial Cells and in the Distribution of Junction-Associated Proteins	PLOS ONE			English	Article								Background: The physiological function of the ubiquitous cellular prion protein, PrPc, is still under debate. It was essentially studied in nervous system, but poorly investigated in epithelial cells. We previously reported that PrPc is targeted to cell-cell junctions of polarized epithelial cells, where it interacts with c-Src. Methodology/Findings: We show here that, in cultured human enterocytes and in intestine in vivo, the mature PrPc is differentially targeted either to the nucleus in dividing cells or to cell-cell contacts in polarized/differentiated cells. By proteomic analysis, we demonstrate that the junctional PrPc interacts with cytoskeleton-associated proteins, such as gamma-and beta-actin, alpha-spectrin, annexin A2, and with the desmosome-associated proteins desmoglein, plakoglobin and desmoplakin. In addition, co-immunoprecipitation experiments revealed complexes associating PrPc, desmoglein and c-Src in raft domains. Through siRNA strategy, we show that PrPc is necessary to complete the process of epithelial cell proliferation and for the sub-cellular distribution of proteins involved in cell architecture and junctions. Moreover, analysis of the architecture of the intestinal epithelium of PrPc knock-out mice revealed a net decrease in the size of desmosomal junctions and, without change in the amount of BrdU incorporation, a shortening of the length of intestinal villi. Conclusions/Significance: From these results, PrPc could be considered as a new partner involved in the balance between proliferation and polarization/differentiation in epithelial cells.	[Morel, Etienne; Fouquet, Stephane; Thievend, Cathy Pichol; Petit, Constance; Faussat, Anne-Marie; Yvernault, Lucile; Pincon-Raymond, Martine; Chambaz, Jean; Rousset, Monique; Thenet, Sophie; Clair, Caroline] Univ Pierre & Marie Curie 6, Ctr Rech Cordeliers, F-75006 Paris, France; [Morel, Etienne; Fouquet, Stephane; Thievend, Cathy Pichol; Petit, Constance; Faussat, Anne-Marie; Yvernault, Lucile; Pincon-Raymond, Martine; Chambaz, Jean; Rousset, Monique; Thenet, Sophie; Clair, Caroline] INSERM, U 872, F-75006 Paris, France; [Morel, Etienne; Fouquet, Stephane; Thievend, Cathy Pichol; Petit, Constance; Faussat, Anne-Marie; Yvernault, Lucile; Pincon-Raymond, Martine; Chambaz, Jean; Rousset, Monique; Thenet, Sophie; Clair, Caroline] Univ Paris Descartes Paris 5, UMR S 872, F-75006 Paris, France; [Strup-Perrot, Carine] Inst Gustave Roussy PRI, UPRES EA 27 10, F-94805 Villejuif, France; [Loew, Damarys] Inst Curie, Lab Spectromet Masse Proteom, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Morel, E (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland.	caroline.clair@crc.jussieu.fr	MOREL, Etienne L/F-4765-2010; MOREL, Etienne/N-2194-2014; Thenet, Sophie/GQY-5726-2022	MOREL, Etienne L/0000-0001-7340-1313; MOREL, Etienne/0000-0002-4763-4954; Thenet, Sophie/0000-0002-0336-2942; Damarys, Loew/0000-0002-9111-8842	Ministere National de la Recherche et de la Technologie fellowship; F. Aupetit Association; INSERM; Ministere de la recherche	Ministere National de la Recherche et de la Technologie fellowship; F. Aupetit Association; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de la recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	E. Morel was recipient of a Ministere National de la Recherche et de la Technologie fellowship. S. Fouquet was recipient of a grant from F. Aupetit association. This work was supported in part by grants from INSERM (ATC Prion) and from Ministere de la recherche (GIS Prion).	Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Brockes JP, 1999, CURR OPIN NEUROBIOL, V9, P571, DOI 10.1016/S0959-4388(99)00016-1; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CASHMAN NR, 1990, CELL, V61, P185, DOI 10.1016/0092-8674(90)90225-4; CHANTRET I, 1994, J CELL SCI, V107, P213; Crozet C, 2006, MOL CELL NEUROSCI, V32, P315, DOI 10.1016/j.mcn.2006.05.004; Dong CF, 2008, ARCH BIOCHEM BIOPHYS, V470, P83, DOI 10.1016/j.abb.2007.11.007; Dusek RL, 2007, J DERMATOL SCI, V45, P7, DOI 10.1016/j.jdermsci.2006.10.006; FEVRIER B, 2004, P NATL ACAD SCI US; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2001, ADV PROTEIN CHEM, V57, P229; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Holthofer B, 2007, INT REV CYTOL, V264, P65, DOI 10.1016/S0074-7696(07)64003-0; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; Hosokawa T, 2008, BIOCHEM BIOPH RES CO, V366, P657, DOI 10.1016/j.bbrc.2007.11.163; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; KALINA M, 1977, J CELL BIOL, V74, P726, DOI 10.1083/jcb.74.3.726; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Mange A, 2004, J CELL SCI, V117, P2411, DOI 10.1242/jcs.01094; Martins VR, 2001, BRAZ J MED BIOL RES, V34, P585, DOI 10.1590/S0100-879X2001000500005; Meyer RK, 2000, J BIOL CHEM, V275, P38081, DOI 10.1074/jbc.M007114200; Morel E, 2004, J BIOL CHEM, V279, P1499, DOI 10.1074/jbc.M308578200; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nieznanski K, 2005, BIOCHEM BIOPH RES CO, V334, P403, DOI 10.1016/j.bbrc.2005.06.092; Pammer J, 2000, VIRCHOWS ARCH, V436, P466, DOI 10.1007/s004280050474; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Rouvinski A, 2003, BIOCHEM BIOPH RES CO, V308, P750, DOI 10.1016/S0006-291X(03)01470-0; Rybner C, 2002, J CELL BIOCHEM, V84, P408, DOI 10.1002/jcb.10017; Sarnataro D, 2002, TRAFFIC, V3, P810, DOI 10.1034/j.1600-0854.2002.31106.x; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Shmakov AN, 2000, J PATHOL, V191, P318, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH640>3.0.CO;2-4; Simmen FA, 2007, AM J PHYSIOL-GASTR L, V292, pG1757, DOI 10.1152/ajpgi.00013.2007; Spielhaupter C, 2001, J BIOL CHEM, V276, P44604, DOI 10.1074/jbc.M103289200; Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5; Sugaya M, 2002, J DERMATOL SCI, V28, P126, DOI 10.1016/S0923-1811(01)00160-8; Viegas P, 2006, J CELL SCI, V119, P4634, DOI 10.1242/jcs.03222; Villagra NT, 2006, NEUROBIOL DIS, V21, P181, DOI 10.1016/j.nbd.2005.07.003; WEISSMANN C, 1994, ANN NY ACAD SCI, V724, P235, DOI 10.1111/j.1749-6632.1994.tb38913.x	48	55	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3000	10.1371/journal.pone.0003000	http://dx.doi.org/10.1371/journal.pone.0003000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714380	Green Published, gold, Green Submitted			2022-12-25	WOS:000264420900025
J	Henstridge, CM; Balenga, NAB; Ford, LA; Ross, RA; Waldhoer, M; Irving, AJ				Henstridge, Christopher M.; Balenga, Nariman A. B.; Ford, Lesley A.; Ross, Ruth A.; Waldhoer, Maria; Irving, Andrew J.			The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation	FASEB JOURNAL			English	Article						GPCR; cannabinoid; LPI; AM251; transcription; ROCK	CANNABINOID RECEPTOR; CONSTITUTIVE ENDOCYTOSIS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; ANANDAMIDE; CALCIUM; NEURONS	The endogenous phospholipid L-alpha-lysophosphatidylinositol (LPI) was recently identified as a novel ligand for the orphan G protein-coupled receptor 55 (GPR55). In this study we define the downstream signaling pathways activated by LPI in a human embryonic kidney (HEK) 293 cell line engineered to stably express recombinant human GPR55. We find that treatment with LPI induces marked GPR55 internalization and stimulates a sustained, oscillatory Ca2+ release pathway, which is dependent on G alpha 13 and requires RhoA activation. We then establish that this signaling cascade leads to the efficient activation of NFAT (nuclear factor of activated T cells) family transcription factors and their nuclear translocation. Analysis of cannabinoid ligand activity at GPR55 revealed no clear effect of the endocannabinoids anandamide and 2-arachidonoylglycerol; however, the classical CB1 antagonist AM251 evoked GPR55-mediated Ca2+ signaling. Thus, LPI is a potent and efficacious ligand at GPR55, which is likely to be a key plasma membrane mediator of LPI- mediated signaling events and changes in gene expression.-Henstridge, C. M., Balenga, N. A. B., Ford, L. A., Ross, R. A., Waldhoer, M., Irving, A. J. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA- dependent Ca2+ signaling and NFAT activation. FASEB J. 23, 183-193 (2009)	[Balenga, Nariman A. B.; Waldhoer, Maria] Med Univ Graz, Inst Expt & Clin Pharmacol, A-8010 Graz, Austria; [Henstridge, Christopher M.; Irving, Andrew J.] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Neurosci, Dundee DD1 9SY, Scotland; [Ford, Lesley A.; Ross, Ruth A.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	Medical University of Graz; University of Dundee; University of Aberdeen	Waldhoer, M (corresponding author), Med Univ Graz, Inst Expt & Clin Pharmacol, Univ Pl 4, A-8010 Graz, Austria.	maria.waldhoer@meduni-graz.at; a.j.irving@dundee.ac.uk	Aghaei Balenga, Nariman/A-5895-2011; Ross, R./AAG-7468-2019; Henstridge, Christopher/J-3848-2019; Waldhoer, Maria/HDO-0619-2022	Aghaei Balenga, Nariman/0000-0002-2741-9595; Henstridge, Christopher/0000-0002-0393-180X; Waldhoer, Maria/0000-0003-3534-1959	Tenovus Scotland; Royal Society; Medical Research Council; Anonymous Trust; Austrian Science Foundation; Jubilaumsfonds of the Austrian National Bank; Lanyar Stiftung Graz; Schering-Plough Corporation; Medical University of Graz, Austria	Tenovus Scotland; Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Anonymous Trust; Austrian Science Foundation(Austrian Science Fund (FWF)); Jubilaumsfonds of the Austrian National Bank; Lanyar Stiftung Graz; Schering-Plough Corporation(Merck & CompanySchering Plough Corporation); Medical University of Graz, Austria	This work was supported by Tenovus Scotland, the Royal Society, the Medical Research Council, and the Anonymous Trust (all to A.J.I.); a grant by the Austrian Science Foundation (F.W.F.); the Jubilaumsfonds of the Austrian National Bank and the Lanyar Stiftung Graz (M.W.); Schering-Plough Corporation (R.A.R., L.F., and A.J.I.) and a fellowship within the molecular medicine Ph.D. program from the Medical University of Graz, Austria (N.B.). We thank Jennifer Whistler for critical reading of the manuscript and David Lee for assistance in generating the stable cell line.	Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; Brown AJ, 2007, BRIT J PHARMACOL, V152, P567, DOI 10.1038/sj.bjp.0707481; Bugaj V, 2005, J BIOL CHEM, V280, P16790, DOI 10.1074/jbc.M500192200; Bushell TJ, 2006, NEUROPHARMACOLOGY, V50, P714, DOI 10.1016/j.neuropharm.2005.11.024; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Evans RM, 2004, BRIT J PHARMACOL, V141, P1223, DOI 10.1038/sj.bjp.0705723; FALASCA M, 1995, ONCOGENE, V10, P2113; FALASCA M, 1994, EUR J BIOCHEM, V221, P383, DOI 10.1111/j.1432-1033.1994.tb18750.x; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Helms WS, 2007, J LEUKOCYTE BIOL, V82, P361, DOI 10.1189/jlb.0206120; Im SH, 2004, MOL CELLS, V18, P1; Johns DG, 2007, BRIT J PHARMACOL, V152, P825, DOI 10.1038/sj.bjp.0707419; Kofalvi A, 2007, BRIT J PHARMACOL, V151, P551, DOI 10.1038/sj.bjp.0707252; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Mombouli JV, 1999, BRIT J PHARMACOL, V126, P1593, DOI 10.1038/sj.bjp.0702483; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Ryan D, 2007, EUR J NEUROSCI, V25, P2093, DOI 10.1111/j.1460-9568.2007.05448.x; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Scragg JL, 2005, BIOCHEM BIOPH RES CO, V331, P1239, DOI 10.1016/j.bbrc.2005.04.037; STATON PC, 2008, PUTATIVE CA IN PRESS, DOI DOI 10.1016/J.PAIN.2008.04.006; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Waldhoer M, 2003, J BIOL CHEM, V278, P19473, DOI 10.1074/jbc.M213179200; Waldhoer M, 2002, J VIROL, V76, P8161, DOI 10.1128/JVI.76.16.8161-8168.2002; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118	31	218	227	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					183	193		10.1096/fj.08-108670	http://dx.doi.org/10.1096/fj.08-108670			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18757503				2022-12-25	WOS:000262095500021
J	Wu, QF; Law, PY; Wei, LN; Loh, HH				Wu, Qifang; Law, Ping-Yee; Wei, Li-Na; Loh, Horace H.			Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3 ' untranslated region: a role for microRNA23b	FASEB JOURNAL			English	Article						polysome-mRNA association; translation repression; K box	MESSENGER-RNA; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; NEURONAL CELLS; 3'-UNTRANSLATED REGION; TRANSLATIONAL CONTROL; 3'-NONCODING REGION; BINDING-PROTEIN; SEQUENCE MOTIF; K-BOX	Expression of the mu opioid receptor (MOR1) protein is regulated temporally and spatially. Although transcription of its gene has been studied extensively, regulation of MOR1 protein production at the level of translation is poorly understood. Using reporter assays, we found that the MOR1 3'-untranslated region (UTR) represses reporter expression at the post-transcriptional level. Suppression by the 3'-UTR of MOR1 is mediated through decreased mRNA association with polysomes, which requires microRNA23b (miRNA23b), a specific miRNA that is expressed in mouse brain and NS20Y mouse neuroblastoma cells. miRNA23b interacts with the MOR1 3'-UTR via a K box motif. By knocking down endogenous miRNA23b in NS20Y cells, we confirmed that miRNA23b inhibits MOR1 protein expression in vivo. This is the first study reporting a translationally repressive role for the MOR1 3'-UTR. We propose a mechanism in which miRNA23b blocks the association of MOR1 mRNA with polysomes, thereby arresting its translation and suppressing the production of MOR1 protein.	[Wu, Qifang; Law, Ping-Yee; Wei, Li-Na; Loh, Horace H.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Wu, QF (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	wuxx0285@umn.edu		Law, Ping-Yee/0000-0002-5364-1093	National Institutes of Health [DA00564, DA01583, DA11806, DA11190, K05-DA00153, K05-DA70554, K02-DA13926]; Minnesota Medical Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA001583, R01DA000564, R56DA000564, K02DA013926, R01DA001583, P50DA011806, K05DA070554, R01DA011190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Medical Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health research grants DA00564, DA01583, DA11806, DA11190, K05-DA00153, K05-DA70554, and K02-DA13926 and by the F&A Stark Fund of the Minnesota Medical Foundation. We thank Dr. Yan Zeng for his advice on miRNA and for kindly providing the psuper and pRlu-luc plasmids. Anti-MOR1 antibody was a generous gift from Dr. Lee-Yuan Liu-Chen (Temple University, Philadelphia, PA, USA). Dr. Kyu Young Song (University of Minnesota, Minneapolis, MN, USA) provided the pL1.33N plasmid. TopoUTR plasmid was constructed by Dr. Cheol Kyu Hwang (University of Minnesota, Minneapolis, MN, USA); we are grateful to him for valuable discussions and critical comments on the manuscript. We also thank Tammy Butterick and Jonathan Beckley for helpful manuscript review.	Balmer LA, 2001, MOL CELL BIOL, V21, P2070, DOI 10.1128/MCB.21.6.2070-2084.2001; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Bi J, 2007, P NATL ACAD SCI USA, V104, P13810, DOI 10.1073/pnas.0703805104; Bi J, 2006, P NATL ACAD SCI USA, V103, P19919, DOI 10.1073/pnas.0607394104; Choe CY, 1998, J BIOL CHEM, V273, P34926, DOI 10.1074/jbc.273.52.34926; Choi HS, 2007, FASEB J, V21, P3963, DOI 10.1096/fj.07-8561com; Choi HS, 2005, MOL PHARMACOL, V67, P1674, DOI 10.1124/mol.104.008284; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Del Prete MJ, 2007, RNA, V13, P414, DOI 10.1261/rna.79407; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Enright AJ, 2004, GENOME BIOL, V5; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Han WH, 2006, PHARMACOGENET GENOM, V16, P451, DOI 10.1097/01.fpc.0000215072.36965.8d; Hu XL, 2002, MOL PHARMACOL, V62, P881, DOI 10.1124/mol.62.4.881; Hwang CK, 2007, MOL CELL BIOL, V27, P4720, DOI 10.1128/MCB.00073-07; Hwang CK, 2004, J BIOL CHEM, V279, P19764, DOI 10.1074/jbc.M400755200; Hwang CK, 2003, J BIOL CHEM, V278, P3742, DOI 10.1074/jbc.M208780200; Ide S, 2005, GENE, V364, P139, DOI 10.1016/j.gene.2005.05.040; Ikeda K, 2001, J NEUROSCI, V21, P1334; Kasai S, 2006, PSYCHIAT CLIN NEUROS, V60, pS11, DOI 10.1111/j.1440-1819.2006.01523.x-i1; Kieffer BL, 1995, CELL MOL NEUROBIOL, V15, P615, DOI 10.1007/BF02071128; Kim CS, 2006, NUCLEIC ACIDS RES, V34, P6392, DOI 10.1093/nar/gkl724; Kim CS, 2004, J BIOL CHEM, V279, P46464, DOI 10.1074/jbc.M403633200; Kimura Hitomi, 2004, Nucleic Acids Symp Ser (Oxf), P213; Ko JL, 2005, J NEUROCHEM, V93, P749, DOI 10.1111/j.1471-4159.2005.03089.x; Ko JL, 2003, MOL BRAIN RES, V112, P153, DOI 10.1016/S0169-328X(03)00086-X; Ko JL, 2001, J BIOL CHEM, V276, P788, DOI 10.1074/jbc.M004279200; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Lai EC, 2005, CURR BIOL, V15, pR458, DOI 10.1016/j.cub.2005.06.015; Lai EC, 1998, DEVELOPMENT, V125, P4077; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee KJ, 2006, VIRUS GENES, V32, P171, DOI 10.1007/s11262-005-6873-5; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; MIN BH, 1994, P NATL ACAD SCI USA, V91, P9081, DOI 10.1073/pnas.91.19.9081; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Palmieri A, 2007, NANOMED-NANOTECHNOL, V3, P138, DOI 10.1016/j.nano.2007.03.004; Pasternak GW, 2001, LIFE SCI, V68, P2213, DOI 10.1016/S0024-3205(01)01008-6; Qin XL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r63; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; SACHS A, 1993, J BIOL CHEM, V268, P22955; Shabalina SA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-105; Sonenberg N, 2000, TRANSLATIONAL CONTRO; Song KY, 2007, NUCLEIC ACIDS RES, V35, P1501, DOI 10.1093/nar/gkm034; Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415; Wei LN, 2004, FRONT BIOSCI-LANDMRK, V9, P1665, DOI 10.2741/1362; WILKINSON M, 1988, NUCLEIC ACIDS RES, V16, P10934, DOI 10.1093/nar/16.22.10934; Wu QF, 2005, MOL PHARMACOL, V68, P279, DOI 10.1124/mol.105.012567; Yang Q, 1997, J BIOL CHEM, V272, P15466, DOI 10.1074/jbc.272.24.15466; Zhang WY, 2007, AM J PATHOL, V171, P728, DOI 10.2353/ajpath.2007.070070; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P391, DOI 10.1093/pcp/pcm008; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	56	44	52	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4085	4095		10.1096/fj.08-108175	http://dx.doi.org/10.1096/fj.08-108175			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18716031	Green Published			2022-12-25	WOS:000261254800008
J	Ang, XL; Seeburg, DP; Sheng, M; Harper, JW				Ang, Xiaolu L.; Seeburg, Daniel P.; Sheng, Morgan; Harper, J. Wade			Regulation of Postsynaptic RapGAP SPAR by Polo-like Kinase 2 and the SCF beta-TRCP Ubiquitin Ligase in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE PROMOTING COMPLEX; VENTRAL NERVE CORD; GLUTAMATE RECEPTORS; PROTEIN-DEGRADATION; E3 LIGASE; DESTRUCTION; PHOSPHORYLATION; CLASPIN; CATENIN; PROGRESSION	The ubiquitin-proteasome pathway (UPP) regulates synaptic function, but little is known about specific UPP targets and mechanisms in mammalian synapses. We report here that the SCF beta-TRCP complex, a multisubunit E3 ubiquitin ligase, targets the postsynaptic spine-associated Rap GTPase activating protein (SPAR) for degradation in neurons. SPAR degradation by SCF(beta-TRCP)depended on the activity-inducible protein kinase Polo-like kinase 2 (Plk2). In the presence of Plk2, SPAR physically associated with the SCF beta-TRCP complex through a canonical phosphodegron. In hippocampal neurons, disruption of the SCF beta-TRCP complex by overexpression of dominant interfering beta-TRCP or Cul1 constructs prevented Plk2-dependent degradation of SPAR. Our results identify a specific E3 ubiquitin ligase that mediates degradation of a key postsynaptic regulator of synaptic morphology and function.	[Ang, Xiaolu L.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Seeburg, Daniel P.; Sheng, Morgan] MIT, Howard Hughes Med Inst, Neurosci Res Ctr, RIKEN,Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur,NRB 940, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Cambronne, Xiaolu Ang/GRY-7149-2022	Cambronne, Xiaolu Ang/0000-0002-3547-448X; Sheng, Morgan/0000-0002-8703-5366; Harper, Jeffrey/0000-0002-6944-7236	National Institutes of Health [AG11085, GM54137]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG11085 and GM54137 (to J. W. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cline H, 2003, CURR BIOL, V13, pR514, DOI 10.1016/S0960-9822(03)00443-3; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Jurd R, 2008, J BIOL CHEM, V283, P301, DOI 10.1074/jbc.M705580200; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Newton SS, 2003, J NEUROSCI, V23, P10841; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Piva R, 2002, MOL CELL BIOL, V22, P8375, DOI 10.1128/MCB.22.23.8375-8387.2002; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008	56	47	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29424	29432		10.1074/jbc.M802475200	http://dx.doi.org/10.1074/jbc.M802475200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18723513	hybrid, Green Published			2022-12-25	WOS:000260179900069
J	Lebreton, S; Paladino, S; Zurzolo, C				Lebreton, Stephanie; Paladino, Simona; Zurzolo, Chiara			Selective Roles for Cholesterol and Actin in Compartmentalization of Different Proteins in the Golgi and Plasma Membrane of Polarized Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; INFLUENZA-VIRUS HEMAGGLUTININ; RESONANCE ENERGY-TRANSFER; THYROID EPITHELIAL-CELLS; MDCK CELLS; APICAL MEMBRANE; LIPID RAFTS; SURFACE; DYNAMICS; CYCLODEXTRINS	To determine the roles of cholesterol and the actin cytoskeleton in apical and basolateral protein organization and sorting, we have performed comprehensive confocal fluorescence recovery after photobleaching analyses of apical and basolateral and raft- and non-raft-associated proteins, both at the plasma membrane and in the Golgi apparatus of polarized MDCK cells. We show that at both the apical and basolateral plasma membrane domains, raft- associated proteins diffuse faster than non-raft-associated proteins and that, different from the latter, they become restricted upon depletion of cholesterol. Furthermore, only transmembrane apical proteins are restricted by the actin network. This indicates that cholesterol-dependent domains exist both at the apical and basolateral membranes of polarized cells and that the actin cytoskeleton has a predominant role in the organization of transmembrane proteins independent of their association with rafts at the apical membrane. In the Golgi apparatus apical proteins appear to be segregated from the basolateral ones in a compartment that is sensitive both to cholesterol depletion and actin rearrangements. Furthermore, consistent with the role of actin rearrangements in apical protein sorting, we found that apical proteins exhibit a differential sensitivity to actin depolymerization in the Golgi of polarized and nonpolarized cells.	[Lebreton, Stephanie; Zurzolo, Chiara] Inst Pasteur, Unite Traf Membranaire & Pathogenese, F-75015 Paris, France; [Paladino, Simona; Zurzolo, Chiara] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Naples Federico II	Zurzolo, C (corresponding author), Inst Pasteur, Unite Traf Membranaire & Pathogenese, 25 Rue Dr Roux, F-75015 Paris, France.	zurzolo@pasteur.fr	Zurzolo, Chiara/AAH-5225-2019; Paladino, Simona/J-5383-2018; Paladino, Simona/ABH-7826-2020	Paladino, Simona/0000-0001-5332-6774; ZURZOLO, Chiara/0000-0001-6048-6602; Lebreton, Stephanie/0000-0002-9879-0404	Agence Nationale de la Recherche [05-BLAN 296-01]; Ministero dell' Universita e della Ricerca Scientifica e Tecnologica	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministero dell' Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This work was supported by Agence Nationale de la Recherche Grant 05-BLAN 296-01 and Ministero dell' Universita e della Ricerca Scientifica e Tecnologica Grant PRIN 2006. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benting JH, 1999, J CELL BIOL, V146, P313, DOI 10.1083/jcb.146.2.313; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Christian AE, 1997, J LIPID RES, V38, P2264; Delacour D, 2006, CELL MOL LIFE SCI, V63, P2491, DOI 10.1007/s00018-006-6210-8; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Jacob R, 2003, CURR BIOL, V13, P607, DOI 10.1016/S0960-9822(03)00188-X; Jacob R, 2001, CURR BIOL, V11, P1444, DOI 10.1016/S0960-9822(01)00446-8; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kenworthy AK, 1999, METH MOL B, V116, P37; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Lazaro-Dieguez F, 2007, FEBS LETT, V581, P3875, DOI 10.1016/j.febslet.2007.07.015; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; Lipardi C, 1999, BIOCHIMIE, V81, P347, DOI 10.1016/S0300-9084(99)80080-7; Lipardi C, 2000, MOL BIOL CELL, V11, P531, DOI 10.1091/mbc.11.2.531; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; Mirchev R, 2001, BLOOD CELL MOL DIS, V27, P143, DOI 10.1006/bcmd.2000.0367; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Nguyen DH, 2004, MOL INTERV, V4, P318, DOI 10.1124/mi4.6.3; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Remaley AT, 1998, J LIPID RES, V39, P1231; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tivodar S, 2006, FEBS LETT, V580, P5705, DOI 10.1016/j.febslet.2006.09.022; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026; ZURZOLO C, 1993, J CELL BIOL, V121, P1031, DOI 10.1083/jcb.121.5.1031	50	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29545	29553		10.1074/jbc.M803819200	http://dx.doi.org/10.1074/jbc.M803819200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18701450	Green Published, hybrid			2022-12-25	WOS:000260179900080
J	Nishitani, H; Shiomi, Y; Iida, H; Michishita, M; Takami, T; Tsurimoto, T				Nishitani, Hideo; Shiomi, Yasushi; Iida, Hiroka; Michishita, Masato; Takami, Toshihiro; Tsurimoto, Toshiki			CDK Inhibitor p21 Is Degraded by a Proliferating Cell Nuclear Antigen-coupled Cul4-DDB1(Cdt2) Pathway during S Phase and after UV Irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCFSKP2 UBIQUITIN LIGASE; LICENSING FACTOR CDT1; REG-GAMMA-PROTEASOME; DNA-DAMAGE; MEDIATED DEGRADATION; ESCHERICHIA-COLI; SLIDING CLAMP; CYCLE CONTROL; REPLICATION; PROTEOLYSIS	Previous reports showed that chromatin-associated PCNA couples DNA replication with Cul4-DDB1(Cdt2)-dependent proteolysis of the licensing factor Cdt1. The CDK inhibitor p21, another PCNA-binding protein, is also degraded both in S phase and after UV irradiation. Here we show that p21 is degraded by the same ubiquitin-proteasome pathway as Cdt1 in HeLa cells. When PCNA or components of Cul4-DDB1(Cdt2) were silenced or when the PCNA binding site on p21 was mutated, degradation of p21 was prevented both in S phase and after UV irradiation. p21 was co-immunoprecipitated with Cul4A and DDB1 proteins when expressed in cells. The purified Cul4A-DDB1(Cdt2) complex ubiquitinated p21 in vitro. Consistently, p21 protein levels are low during S phase and increase around G(2) phase. Mutational analysis suggested that in addition to the PCNA binding domain, its flanking regions are also important for recognition by Cul4-DDB1(Cdt2). Our findings provide a new aspect of proteolytic control of p21 during the cell cycle.	[Nishitani, Hideo; Shiomi, Yasushi; Michishita, Masato; Takami, Toshihiro] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Nishitani, Hideo; Iida, Hiroka] Kyushu Univ, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128581, Japan; [Tsurimoto, Toshiki] Kyushu Univ, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan	University of Hyogo; Kyushu University; Kyushu University	Nishitani, H (corresponding author), Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan.	hideon@sci.u-hyogo.ac.jp		Tsurimoto, Toshiki/0000-0001-7597-2216; Nishitani, Hideo/0000-0001-5907-9380	Ministry of Education, Culture, Sport, Science, and Technology of Japan	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research (C) and Scientific Research on Priority Areas from the Ministry of Education, Culture, Sport, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Chuang LC, 2005, J BIOL CHEM, V280, P35299, DOI 10.1074/jbc.M506429200; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Lee H, 2006, J BIOL CHEM, V281, P26876, DOI 10.1074/jbc.M605366200; Lee JY, 2007, MOL CELL BIOL, V27, P3187, DOI 10.1128/MCB.01461-06; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiomi Y, 2004, GENES CELLS, V9, P279, DOI 10.1111/j.1356-9597.2004.00724.x; Su'etsugu M, 2004, GENES CELLS, V9, P509, DOI 10.1111/j.1356-9597.2004.00741.x; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wang W, 2005, BIOCHEMISTRY-US, V44, P14553, DOI 10.1021/bi051071j; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	43	187	195	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29045	29052		10.1074/jbc.M806045200	http://dx.doi.org/10.1074/jbc.M806045200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703516	hybrid, Green Published			2022-12-25	WOS:000260179900031
J	Yamasaki, K; Wang, GL; Daiho, T; Danko, S; Suzuki, H				Yamasaki, Kazuo; Wang, Guoli; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi			Roles of Tyr(122)-hydrophobic Cluster and K+ Binding in Ca2+-releasing Process of ADP-insensitive Phosphoenzyme of Sarcoplasmic Reticulum Ca2(+)-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST TRANSMEMBRANE HELIX; CALCIUM-PUMP; ADENOSINE-TRIPHOSPHATASE; SKELETAL-MUSCLE; A-DOMAIN; PHOSPHORYLATED INTERMEDIATE; TRANSPORT ACTIVITY; KINETIC-PROPERTIES; REACTION-MECHANISM; CRYSTAL-STRUCTURES	Tyr(122)-hydrophobic cluster (Y122-HC) is an interaction network formed by the top part of the second transmembrane helix and the cytoplasmic actuator and phosphorylation domains of sarcoplasmic reticulum Ca2+-ATPase. We have previously found that Y122-HC plays critical roles in the processing of ADP-insensitive phosphoenzyme (E2P) after its formation by the isomerization from ADP-sensitive phosphoenzyme (E1PCa(2)) (Wang, G., Yamasaki, K., Daiho, T., and Suzuki, H. (2005) J. Biol. Chem. 280, 26508-26516). Here, we further explored kinetic properties of the alanine-substitution mutants of Y122-HC to examine roles of Y122-HC for Ca2+ release process in E2P. In the steady state, the amount of E2P decreased so that of E1PCa(2) increased with increasing lumenal Ca2+ concentration in the mutants with K-0.5 110-320 mu M at pH 7.3. These lumenal Ca2+ affinities in E2P agreed with those estimated from the forward and lumenal Ca2+-induced reverse kinetics of the E1PCa(2)-E2P isomerization. K-0.5 of the wild type in the kinetics was estimated to be 1.5 mM. Thus, E2P of the mutants possesses significantly higher affinities for lumenal Ca2+ than that of the wild type. The kinetics further indicated that the rates of lumenal Ca2+ access and binding to the transport sites of E2P were substantially slowed by the mutations. Therefore, the proper formation of Y122-HC and resulting compactly organized structure are critical for both decreasing Ca2+ affinity and opening the lumenal gate, thus for Ca2+ release from E2PCa(2). Interestingly, when K+ was omitted from the medium of the wild type, the properties of the wild type became similar to those of Y122-HC mutants. K+ binding likely functions via producing the compactly organized structure, in this sense, similarly to Y122-HC.	[Yamasaki, Kazuo; Wang, Guoli; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi] Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Yamasaki, K (corresponding author), Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	kyamasak@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research (C) (to K. Y.) and (B) (to H. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Champeil P, 1997, BIOCHEMISTRY-US, V36, P12383, DOI 10.1021/bi9709699; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; COAN C, 1979, J BIOL CHEM, V254, P2968; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; Fersht A, 1999, STRUCTURE MECH PROTE, P132; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; KANAZAWA T, 1970, J BIOCHEM-TOKYO, V67, P693, DOI 10.1093/oxfordjournals.jbchem.a129297; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LEE AG, 1995, BIOCHEM J, V305, P225, DOI 10.1042/bj3050225; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PRAGER R, 1979, EUR J BIOCHEM, V97, P239, DOI 10.1111/j.1432-1033.1979.tb13108.x; Sato K, 2004, J BIOL CHEM, V279, P35595, DOI 10.1074/jbc.M404887200; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6947; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; WAKABAYASHI S, 1987, J BIOL CHEM, V262, P11524; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200	48	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29144	29155		10.1074/jbc.M804596200	http://dx.doi.org/10.1074/jbc.M804596200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728008	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000260179900042
J	Matsuoka, Y; Takumi, S; Kawahara, T				Matsuoka, Yoshihiro; Takumi, Shigeo; Kawahara, Taihachi			Flowering Time Diversification and Dispersal in Central Eurasian Wild Wheat Aegilops tauschii Coss.: Genealogical and Ecological Framework	PLOS ONE			English	Article								Timing of flowering is a reproductive trait that has significant impact on fitness in plants. In contrast to recent advances in understanding the molecular basis of floral transition, few empirical studies have addressed questions concerning population processes of flowering time diversification within species. We analyzed chloroplast DNA genealogical structure of flowering time variation in central Eurasian wild wheat Aegilops tauschii Coss. using 200 accessions that represent the entire species range. Flowering time measured as days from germination to flowering varied from 144.0 to 190.0 days (average 161.3 days) among accessions in a common garden/greenhouse experiment. Subsequent genealogical and statistical analyses showed that (1) there exist significant longitudinal and latitudinal clines in flowering time at the species level, (2) the early-flowering phenotype evolved in two intraspecific lineages, (3) in Asia, winter temperature was an environmental factor that affected the longitudinal clinal pattern of flowering time variation, and (4) in Transcaucasus-Middle East, some latitudinal factors affected the geographic pattern of flowering time variation. On the basis of palaeoclimatic, biogeographic, and genetic evidence, the northern part of current species' range [which was within the temperate desert vegetation (TDV) zone at the Last Glacial Maximum] is hypothesized to have harbored species refugia. Postglacial southward dispersal from the TDV zone seems to have been driven by lineages that evolved short-flowering time phenotypes through different genetic mechanisms in Transcaucasus-Middle East and Asia.	[Matsuoka, Yoshihiro] Fukui Prefectural Univ, Fukui, Japan; [Takumi, Shigeo] Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Kobe, Hyogo, Japan; [Kawahara, Taihachi] Kyoto Univ, Grad Sch Agr, Kyoto, Japan	Fukui Prefectural University; Kobe University; Kyoto University	Matsuoka, Y (corresponding author), Fukui Prefectural Univ, Fukui, Japan.	matsuoka@fpu.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [GD2006]; Ministry of Education, Culture, Sports, Science and Technology, Japan [17201045]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Integrated research project for plant, insect and animal using genome technology, GD2006) to Y.M. and, in part, by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Basic Research A, No. 17201045) to T.K., S.T., and Y.M.	[Anonymous], 2005, PHYLIP PHYLOGENY INF; Ansari MH, 2007, REV PALAEOBOT PALYNO, V145, P201, DOI 10.1016/j.revpalbo.2006.10.005; BANDELT HJ, 1995, GENETICS, V141, P743; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Dvorak J, 1998, THEOR APPL GENET, V97, P657, DOI 10.1007/s001220050942; Franzke A, 2004, MOL ECOL, V13, P2789, DOI 10.1111/j.1365-294X.2004.02272.x; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Hauser TP, 2000, HEREDITAS, V132, P95, DOI 10.1111/j.1601-5223.2000.00095.x; Hijmans R.J., 2001, PLANT GENETIC RESOUR, V127, P15, DOI DOI 10.1016/j.compositesa.2008.10.018; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Ishii T, 2001, THEOR APPL GENET, V103, P896, DOI 10.1007/s001220100715; Kihara H., 1965, RESULTS KYOTO U SCI, P1; Kihara H, 1944, AGR HORTIC, V19, P889; Matsuoka Y, 2005, THEOR APPL GENET, V111, P265, DOI 10.1007/s00122-005-2020-x; Matsuoka Y, 2007, THEOR APPL GENET, V115, P509, DOI 10.1007/s00122-007-0584-3; McFadden E.S., 1944, REC GENET SOC AM, V13, P26; Minch E, 1997, MICROSAT COMPUTER PR; PUGSLEY AT, 1965, NATURE, V207, P108, DOI 10.1038/207108a0; Ray N., 2001, INTERNET ARCHAEOLOGY, V11, P1, DOI [DOI 10.11141/IA.11.2, 10.11141/ia.11.2]; Rhone B, 2008, MOL ECOL, V17, P930, DOI 10.1111/j.1365-294X.2007.03619.x; Roberts Neil, 1993, P194; Schmid K, 2006, THEOR APPL GENET, V112, P1104, DOI 10.1007/s00122-006-0212-7; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tanaka M., 1991, Wheat Information Service, P33; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Van Slageren M.W., 1994, ICARDA WAGENINGEN AG; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344; Welsh J. R., 1973, Proceedings of the fourth international wheat genetics symposium. Biochemical and physiological genetics., P879; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077; ZOHARY D, 1969, EUPHYTICA, V18, P58	36	58	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3138	10.1371/journal.pone.0003138	http://dx.doi.org/10.1371/journal.pone.0003138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769547	Green Published, gold, Green Submitted			2022-12-25	WOS:000264419100006
J	Rajalingam, K; Sharma, M; Lohmann, C; Oswald, M; Thieck, O; Froelich, CJ; Rudel, T				Rajalingam, Krishnaraj; Sharma, Manu; Lohmann, Christine; Oswald, Monique; Thieck, Oliver; Froelich, Christopher J.; Rudel, Thomas			Mcl-1 Is a Key Regulator of Apoptosis Resistance in Chlamydia trachomatis-Infected Cells	PLOS ONE			English	Article								Chlamydia are obligate intracellular bacteria that cause variety of human diseases. Host cells infected with Chlamydia are protected against many different apoptotic stimuli. The induction of apoptosis resistance is thought to be an important immune escape mechanism allowing Chlamydia to replicate inside the host cell. Infection with C. trachomatis activates the Raf/MEK/ERK pathway and the PI3K/AKT pathway. Here we show that inhibition of these two pathways by chemical inhibitors sensitized C. trachomatis infected cells to granzyme B-mediated cell death. Infection leads to the Raf/MEK/ERK-mediated up-regulation and PI3K-dependent stabilization of the anti-apoptotic Bcl-2 family member Mcl-1. Consistently, interfering with Mcl-1 up-regulation sensitized infected cells for apoptosis induced via the TNF receptor, DNA damage, granzyme B and stress. Our data suggest that Mcl-1 up-regulation is primarily required to maintain apoptosis resistance in C. trachomatis-infected cells.	[Rajalingam, Krishnaraj; Sharma, Manu; Lohmann, Christine; Oswald, Monique; Thieck, Oliver; Rudel, Thomas] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Froelich, Christopher J.] Evanston Northwestern Res Inst, Evanston, IL USA	Max Planck Society	Rajalingam, K (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Emmy Noether Grp DFG, Frankfurt, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de	Rajalingam, krishnaraj/D-3081-2011; Sharma, Manu/AAF-5854-2019	Sharma, Manu/0000-0003-3120-9854	Sixth Research Framework Program of the European Union, Project RIGHT [LSHB-CT-2004 005276]	Sixth Research Framework Program of the European Union, Project RIGHT	We acknowledge the help of the EURIT team (www.eurit-network.org) with the validation of siRNAs. We thank Dr. Ulrich Steinhoff for excellent advice and valuable discussions, Dr. Sri. Raja for sharing fluorescently labelled GrB and Kathleen Gottschalk for help with generating shMcl-1 stable cell lines. Dr. Sonja Kimmig and Dr. Claudia Sievers are thanked for providing the viral particles and Dr. Volker Brinkmann for measuring the inclusion sizes. This work was supported by funding under the Sixth Research Framework Program of the European Union, Project RIGHT (LSHB-CT-2004 005276) to T.R.	Al-Younes HM, 2001, CELL MICROBIOL, V3, P427, DOI 10.1046/j.1462-5822.2001.00125.x; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Byrne GI, 2004, NAT REV MICROBIOL, V2, P802, DOI 10.1038/nrmicro1007; Clifton DR, 1998, P NATL ACAD SCI USA, V95, P4646, DOI 10.1073/pnas.95.8.4646; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Dean D, 2001, INFECT IMMUN, V69, P2442, DOI 10.1128/IAI.69.4.2442-2447.2001; Dong F, 2005, INFECT IMMUN, V73, P1861, DOI 10.1128/IAI.73.3.1861-1864.2005; Dong F, 2004, INFECT IMMUN, V72, P3863, DOI 10.1128/IAI.72.7.3863-3868.2004; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402; Fischer SF, 2004, INFECT IMMUN, V72, P1107, DOI 10.1128/IAI.72.2.1107-1115.2004; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Goping IS, 2003, IMMUNITY, V18, P355, DOI 10.1016/S1074-7613(03)00032-3; GRAYSTON JT, 1992, ANNU REV MED, V43, P317, DOI 10.1146/annurev.med.43.1.317; GRAYSTON JT, 1975, J INFECT DIS, V132, P87, DOI 10.1093/infdis/132.1.87; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; Hess S, 2001, ARTHRITIS RHEUM-US, V44, P2392, DOI 10.1002/1529-0131(200110)44:10<2392::AID-ART404>3.0.CO;2-I; HILBI H, 1997, PARASITOLOGY, V115, P79; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; MAURER F, 1906, HDB VERGLEICHENDEN 1, V3, P1; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Muller A, 2001, INT J MED MICROBIOL, V291, P197, DOI 10.1078/1438-4221-00125; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Paland N, 2006, CELL MICROBIOL, V8, P1643, DOI 10.1111/j.1462-5822.2006.00739.x; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Rajalingam K, 2007, APOPTOSIS, V12, P1503, DOI 10.1007/s10495-007-0067-7; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Xia MS, 2003, J INFECT DIS, V187, P424, DOI 10.1086/367962; Xiao YM, 2004, INFECT IMMUN, V72, P5470, DOI 10.1128/IAI.72.9.5470-5474.2004; YING S, 2007, MICROBES INFECT; Ying SM, 2005, INFECT IMMUN, V73, P1399, DOI 10.1128/IAI.73.3.1399-1403.2005	41	83	97	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3102	10.1371/journal.pone.0003102	http://dx.doi.org/10.1371/journal.pone.0003102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769617	Green Published, gold, Green Submitted			2022-12-25	WOS:000264416600002
J	Hartmann, K; Bruehl, C; Golovko, T; Draguhn, A				Hartmann, Kristin; Bruehl, Claus; Golovko, Tatyana; Draguhn, Andreas			Fast Homeostatic Plasticity of Inhibition via Activity-Dependent Vesicular Filling	PLOS ONE			English	Article								Synaptic activity in the central nervous system undergoes rapid state-dependent changes, requiring constant adaptation of the homeostasis between excitation and inhibition. The underlying mechanisms are, however, largely unclear. Chronic changes in network activity result in enhanced production of the inhibitory transmitter GABA, indicating that presynaptic GABA content is a variable parameter for homeostatic plasticity. Here we tested whether such changes in inhibitory transmitter content do also occur at the fast time scale required to ensure inhibition-excitation-homeostasis in dynamic cortical networks. We found that intense stimulation of afferent fibers in the CA1 region of mouse hippocampal slices yielded a rapid and lasting increase in quantal size of miniature inhibitory postsynaptic currents. This potentiation was mediated by the uptake of GABA and glutamate into presynaptic endings of inhibitory interneurons (the latter serving as precursor for the synthesis of GABA). Thus, enhanced release of inhibitory and excitatory transmitters from active networks leads to enhanced presynaptic GABA content. Thereby, inhibitory efficacy follows local neuronal activity, constituting a negative feedback loop and providing a mechanism for rapid homeostatic scaling in cortical circuits.	[Hartmann, Kristin; Bruehl, Claus; Golovko, Tatyana; Draguhn, Andreas] Univ Heidelberg, Dept Physiol & Pathophysiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Hartmann, K (corresponding author), Univ Heidelberg, Dept Physiol & Pathophysiol, Heidelberg, Germany.	andreas.draguhn@physiologie.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [SFB488, FoGru577]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft SFB488 and FoGru577	Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Axmacher N, 2004, J NEUROPHYSIOL, V91, P25, DOI 10.1152/jn.00797.2003; Barberis A, 2004, EUR J NEUROSCI, V20, P1803, DOI 10.1111/j.1460-9568.2004.03624.x; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Chiu CS, 2002, J NEUROSCI, V22, P10251; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; Diamond JS, 2002, NAT NEUROSCI, V5, P291, DOI 10.1038/nn0402-291; DINGLEDINE R, 1985, J PHYSIOL-LONDON, V366, P387, DOI 10.1113/jphysiol.1985.sp015804; DURING MJ, 1995, NATURE, V376, P174, DOI 10.1038/376174a0; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; Engel D, 2001, J PHYSIOL-LONDON, V535, P473, DOI 10.1111/j.1469-7793.2001.00473.x; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Esclapez M, 1999, J COMP NEUROL, V412, P488; Fisher JL, 2004, J PHYSIOL-LONDON, V561, P433, DOI 10.1113/jphysiol.2003.051839; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Frerking M, 1997, J NEUROPHYSIOL, V78, P1293, DOI 10.1152/jn.1997.78.3.1293; Fricke MN, 2007, J NEUROCHEM, V102, P1895, DOI 10.1111/j.1471-4159.2007.04649.x; GARRAGHTY PE, 1991, SOMATOSENS MOT RES, V8, P347, DOI 10.3109/08990229109144757; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Hajos N, 2000, EUR J NEUROSCI, V12, P810, DOI 10.1046/j.1460-9568.2000.00964.x; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hartmann K, 2004, EUR J PHARMACOL, V497, P139, DOI 10.1016/j.ejphar.2004.06.044; He Y, 2000, J COMP NEUROL, V418, P255; Hsu CC, 2000, J BIOL CHEM, V275, P20822, DOI 10.1074/jbc.M001403200; Iwai Y, 2003, J NEUROSCI, V23, P6695; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Liang SL, 2006, J NEUROSCI, V26, P8537, DOI 10.1523/JNEUROSCI.0329-06.2006; Masson J, 2006, J NEUROSCI, V26, P4660, DOI 10.1523/JNEUROSCI.4241-05.2006; Mathews GC, 2003, J NEUROSCI, V23, P2040; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mellor JR, 1997, J PHYSIOL-LONDON, V503, P353, DOI 10.1111/j.1469-7793.1997.353bh.x; Melone M, 2004, CEREB CORTEX, V14, P562, DOI 10.1093/cercor/bhh018; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perrais D, 1999, J NEUROSCI, V19, P578; Rae C, 2003, J NEUROCHEM, V85, P503, DOI 10.1046/j.1471-4159.2003.01713.x; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; ROEPSTORFF A, 1992, NEUROSCI LETT, V146, P131, DOI 10.1016/0304-3940(92)90060-K; Schousboe A, 2004, BIOCHEM PHARMACOL, V68, P1557, DOI 10.1016/j.bcp.2004.06.041; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sulzer D, 2000, REV NEUROSCIENCE, V11, P159; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Van der Kloot W, 2002, J PHYSIOL-LONDON, V541, P385, DOI 10.1113/jphysiol.2001.014407	50	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2979	10.1371/journal.pone.0002979	http://dx.doi.org/10.1371/journal.pone.0002979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714334	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900006
J	Steinert, S; Lee, E; Tresset, G; Zhang, DW; Hortsch, R; Wetzel, R; Hebbar, S; Sundram, JR; Kesavapany, S; Boschke, E; Kraut, R				Steinert, Steffen; Lee, Esther; Tresset, Guillaume; Zhang, Dawei; Hortsch, Ralf; Wetzel, Richard; Hebbar, Sarita; Sundram, Jeyapriya Raja; Kesavapany, Sashi; Boschke, Elke; Kraut, Rachel			A Fluorescent Glycolipid-Binding Peptide Probe Traces Cholesterol Dependent Microdomain-Derived Trafficking Pathways	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; LIPID RAFTS; CHOLERA-TOXIN; MEMBRANE DOMAINS; CELL-SURFACE; ENDOCYTIC PATHWAY; ENDOGENOUS SEED; MODEL MEMBRANES; GM1 GANGLIOSIDE; BETA-PROTEIN	Background: The uptake and intracellular trafficking of sphingolipids, which self-associate into plasma membrane microdomains, is associated with many pathological conditions, including viral and toxin infection, lipid storage disease, and neurodegenerative disease. However, the means available to label the trafficking pathways of sphingolipids in live cells are extremely limited. In order to address this problem, we have developed an exogenous, non-toxic probe consisting of a 25-amino acid sphingolipid binding domain, the SBD, derived from the amyloid peptide A beta, and conjugated by a neutral linker with an organic fluorophore. The current work presents the characterization of the sphingolipid binding and live cell trafficking of this novel probe, the SBD peptide. SBD was the name given to a motif originally recognized by Fantini et al [1] in a number of glycolipid-associated proteins, and was proposed to interact with sphingolipids in membrane microdomains. Methodology/Principal Findings: In accordance with Fantini's model, optimal SBD binding to membranes depends on the presence of sphingolipids and cholesterol. In synthetic membrane binding assays, SBD interacts preferentially with raft-like lipid mixtures containing sphingomyelin, cholesterol, and complex gangliosides in a pH-dependent manner, but is less glycolipid-specific than Cholera toxin B (CtxB). Using quantitative time-course colocalization in live cells, we show that the uptake and intracellular trafficking route of SBD is unlike that of either the non-raft marker Transferrin or the raft markers CtxB and Flotillin2-GFP. However, SBD traverses an endolysosomal route that partially intersects with raft-associated pathways, with a major portion being diverted at a late time point to rab11-positive recycling endosomes. Trafficking of SBD to acidified compartments is strongly disrupted by cholesterol perturbations, consistent with the regulation of sphingolipid trafficking by cholesterol. Conclusions/Significance: The current work presents the characterization and trafficking behavior of a novel sphingolipid-binding fluorescent probe, the SBD peptide. We show that SBD binding to membranes is dependent on the presence of cholesterol, sphingomyelin, and complex glycolipids. In addition, SBD targeting through the endolysosomal pathway in neurons is highly sensitive to cholesterol perturbations, making it a potentially useful tool for the analysis of sphingolipid trafficking in disease models that involve changes in cholesterol metabolism and storage.	[Steinert, Steffen; Lee, Esther; Tresset, Guillaume; Zhang, Dawei; Hortsch, Ralf; Wetzel, Richard; Hebbar, Sarita; Kraut, Rachel] ASTAR, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Sundram, Jeyapriya Raja; Kesavapany, Sashi] Natl Univ Singapore, Dept Biochem, Neurobiol Programme, Singapore, Singapore; [Wetzel, Richard; Boschke, Elke] Tech Univ Dresden, Inst Lebensmittel Bioverfahrenstech, Dresden, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore; Technische Universitat Dresden	Steinert, S (corresponding author), Tech Univ Stuttgart, Inst Phys 3, Stuttgart, Germany.	rkraut@ibn.a-star.edu.sg	Kraut, Rachel/A-2221-2011	Zhang, Dawei/0000-0001-6613-945X	Institute of Bioengineering and Nanotechnology; Singapore Bioimaging Consortium (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)	Institute of Bioengineering and Nanotechnology(Agency for Science Technology & Research (A*STAR)); Singapore Bioimaging Consortium (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)	Institute of Bioengineering and Nanotechnology and the Singapore Bioimaging Consortium (Biomedical Research Council, Agency for Science, Technology and Research, Singapore).	ANTES P, 1992, CHEM PHYS LIPIDS, V62, P269, DOI 10.1016/0009-3084(92)90064-V; Ariga T, 2001, ARCH BIOCHEM BIOPHYS, V388, P225, DOI 10.1006/abbi.2001.2304; BIEDLER JL, 1978, CANCER RES, V38, P3751; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown RE, 1998, J CELL SCI, V111, P1; CALORINI L, 1987, LIPIDS, V22, P651, DOI 10.1007/BF02533944; CHENG ZJ, 2006, MOL BIOL CELL; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; de Almeida RFM, 2005, J MOL BIOL, V346, P1109, DOI 10.1016/j.jmb.2004.12.026; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; DELEAU M, 1996, B PSYCHOL, V3, P1; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Fantini J, 2003, CELL MOL LIFE SCI, V60, P1027, DOI 10.1007/s00018-003-3003-1; Fantini J, 1997, J BIOL CHEM, V272, P7245, DOI 10.1074/jbc.272.11.7245; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hammache D, 1998, J BIOL CHEM, V273, P7967, DOI 10.1074/jbc.273.14.7967; Han Xianlin, 2005, Current Alzheimer Research, V2, P65, DOI 10.2174/1567205052772786; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Hao MM, 2004, J BIOL CHEM, V279, P14171, DOI 10.1074/jbc.M309793200; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Hebbar S, 2008, J LIPID RES, V49, P1077, DOI 10.1194/jlr.M700543-JLR200; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Hua W, 2006, J CELL BIOL, V172, P1035, DOI 10.1083/jcb.200512012; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; ICHIKAWA S, 1994, P NATL ACAD SCI USA, V91, P2703, DOI 10.1073/pnas.91.7.2703; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; KOVAL M, 1991, BIOCHIM BIOPHYS ACTA, V1082, P113, DOI 10.1016/0005-2760(91)90184-J; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; LENCER W, 1995, TARGETING CHOLERA TO; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; MacKenzie CR, 1997, J BIOL CHEM, V272, P5533, DOI 10.1074/jbc.272.9.5533; Mahfoud R, 2002, J BIOL CHEM, V277, P11292, DOI 10.1074/jbc.M111679200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marks DL, 2002, TRENDS CELL BIOL, V12, P605, DOI 10.1016/S0962-8924(02)02399-1; Massol RH, 2004, MOL BIOL CELL, V15, P3631, DOI 10.1091/mbc.E04-04-0283; Mattson MP, 2005, NAT CELL BIOL, V7, P1045, DOI 10.1038/ncb1105-1045; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McLaurin J, 1998, J BIOL CHEM, V273, P4506, DOI 10.1074/jbc.273.8.4506; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Pagano RE, 2000, TRAFFIC, V1, P807, DOI 10.1034/j.1600-0854.2000.011101.x; Pagano RE, 2003, PHILOS T R SOC B, V358, P885, DOI 10.1098/rstb.2003.1275; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; PELKMANS L, 2001, CAVEOLAR ENDOCYTOSIS, V3, P473; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SALZMAN NH, 1989, J CELL BIOL, V109, P2097, DOI 10.1083/jcb.109.5.2097; Sandvig K, 2004, INT J MED MICROBIOL, V293, P483, DOI 10.1078/1438-4221-00294; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sharma P, 2002, SEMIN CELL DEV BIOL, V13, P205, DOI 10.1016/S1084-9521(02)00049-6; Shogomori H, 2001, J BIOL CHEM, V276, P9182, DOI 10.1074/jbc.M009414200; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Smith DC, 2004, SEMIN CELL DEV BIOL, V15, P397, DOI 10.1016/j.semcdb.2004.03.005; Soreghan M, 2003, ADV DRUG DELIVER REV, V55, P1515, DOI 10.1016/j.addr.2003.07.007; Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Torgersen ML, 2001, J CELL SCI, V114, P3737; TRAN D, 1987, P NATL ACAD SCI USA, V84, P7957, DOI 10.1073/pnas.84.22.7957; UI K, 1994, IN VITRO CELL DEV-AN, V30A, P209; Vruchte DT, 2004, J BIOL CHEM, V279, P26167, DOI 10.1074/jbc.M311591200; Wang TY, 2000, BIOPHYS J, V79, P1478, DOI 10.1016/S0006-3495(00)76399-5; WIEGANDT H, 1992, BIOCHIM BIOPHYS ACTA, V1123, P117, DOI 10.1016/0005-2760(92)90101-Z; Wolf AA, 1998, J CELL BIOL, V141, P917, DOI 10.1083/jcb.141.4.917; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yanagisawa K, 2005, NEUROSCIENTIST, V11, P250, DOI 10.1177/1073858405275177; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Zheng YL, 2005, EMBO J, V24, P209, DOI 10.1038/sj.emboj.7600441	102	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2933	10.1371/journal.pone.0002933	http://dx.doi.org/10.1371/journal.pone.0002933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18716682	Green Published, gold, Green Submitted			2022-12-25	WOS:000264412600019
J	Vivian, JP; Scoullar, J; Robertson, AL; Bottomley, SP; Horne, J; Chin, Y; Wielens, J; Thompson, PE; Velkov, T; Piek, S; Byres, E; Beddoe, T; Wilce, MCJ; Kahler, CM; Rossjohn, J; Scanlon, MJ				Vivian, Julian P.; Scoullar, Jessica; Robertson, Amy L.; Bottomley, Stephen P.; Horne, James; Chin, Yanni; Wielens, Jerome; Thompson, Philip E.; Velkov, Tony; Piek, Susannah; Byres, Emma; Beddoe, Travis; Wilce, Matthew C. J.; Kahler, Charlene M.; Rossjohn, Jamie; Scanlon, Martin J.			Structural and Biochemical Characterization of the Oxidoreductase NmDsbA3 from Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; STAPHYLOCOCCUS-AUREUS DSBA; ESCHERICHIA-COLI DSBA; DESTABILIZING DISULFIDE; CRYSTAL-STRUCTURE; PROTEINS; IDENTIFICATION; THIOREDOXIN; ISOMERASE	DsbA is an enzyme found in the periplasm of Gram-negative bacteria that catalyzes the formation of disulfide bonds in a diverse array of protein substrates, many of which are involved in bacterial pathogenesis. Although most bacteria possess only a single essential DsbA, Neisseria meningitidis is unusual in that it possesses three DsbAs, although the reason for this additional redundancy is unclear. Two of these N. meningitidis enzymes (NmDsbA1 and NmDsbA2) play an important role in meningococcal attachment to human epithelial cells, whereas NmDsbA3 is considered to have a narrow substrate repertoire. To begin to address the role of DsbAs in the pathogenesis of N. meningitidis, we have determined the structure of NmDsbA3 to 2.3-angstrom resolution. Although the sequence identity between NmDsbA3 and other DsbAs is low, the NmDsbA3 structure adopted a DsbA-like fold. Consistent with this finding, we demonstrated that NmDsbA3 acts as a thiol-disulfide oxidoreductase in vitro and is reoxidized by Escherichia coli DsbB (EcDsbB). However, pronounced differences in the structures between DsbA3 and EcDsbA, which are clustered around the active site of the enzyme, suggested a structural basis for the unusual substrate specificity that is observed for NmDsbA3.	[Scoullar, Jessica; Piek, Susannah; Kahler, Charlene M.] Univ Western Australia, QEII Med Ctr, Sch Biomed Biomol & Chem Sci, Crawley, WA 6009, Australia; [Vivian, Julian P.; Robertson, Amy L.; Bottomley, Stephen P.; Byres, Emma; Beddoe, Travis; Wilce, Matthew C. J.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, ARC Ctr Excellence Struct & Funct Microbial Genom, Prot Crystallog Unit, Clayton, Vic 3800, Australia; [Horne, James; Chin, Yanni; Wielens, Jerome; Thompson, Philip E.; Velkov, Tony; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia	University of Western Australia; Monash University; Monash University	Kahler, CM (corresponding author), Univ Western Australia, QEII Med Ctr, Sch Biomed Biomol & Chem Sci, Crawley, WA 6009, Australia.	ckahler@cyllene.uwa.edu.au; Jamie.rossjohn@med.monash.edu.au; Martin.Scanlon@pharm.monash.edu.au	Chin, Yanni/D-2139-2017; Kahler, Charlene M/H-5159-2014; Rossjohn, Jamie/F-9032-2013; Beddoe, Travis/F-3415-2014	Chin, Yanni/0000-0002-3367-6897; Kahler, Charlene M/0000-0003-4322-3055; Rossjohn, Jamie/0000-0002-2020-7522; Beddoe, Travis/0000-0003-4550-2277; Wielens, Jerome/0000-0003-3406-4136; Horne, James/0000-0002-1935-2378; velkov, tony/0000-0002-0017-7952; Vivian, Julian/0000-0002-9400-4437; Scanlon, Martin/0000-0002-9230-7506; Thompson, Philip/0000-0002-5910-7625	Australian Research Council (ARC) [LP0455508]; National Health and Medical Research Council (NHMRC) [455860]; Ada Bartholomew Medical Research Trust; Medical and Health Research Infrastructure Fund of Western Australia	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ada Bartholomew Medical Research Trust; Medical and Health Research Infrastructure Fund of Western Australia	This work was supported in part by Australian Research Council (ARC) Grant LP0455508 and National Health and Medical Research Council (NHMRC) Grant 455860. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by grants from the Ada Bartholomew Medical Research Trust and the Medical and Health Research Infrastructure Fund of Western Australia.	AKIYAMA Y, 1992, J BIOL CHEM, V267, P22440; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BOURDOULOUS S, 2006, HDB MENINGOCOCCAL DI; CHUNG CT, 1988, NUCLEIC ACIDS RES, V16, P3580, DOI 10.1093/nar/16.8.3580; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Dumoulin A, 2005, ARCH MICROBIOL, V184, P117, DOI 10.1007/s00203-005-0024-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guddat LW, 1997, PROTEIN SCI, V6, P1148, DOI 10.1002/pro.5560060603; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Hiniker A, 2007, P NATL ACAD SCI USA, V104, P11670, DOI 10.1073/pnas.0704692104; Hizukuri Y, 2006, J BACTERIOL, V188, P4190, DOI 10.1128/JB.01896-05; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Horne J, 2007, J MOL BIOL, V371, P703, DOI 10.1016/j.jmb.2007.05.067; Hu SH, 1997, J MOL BIOL, V268, P137, DOI 10.1006/jmbi.1997.0940; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; MACNAB RM, 1986, METHOD ENZYMOL, V125, P563; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; MARTIN JL, 1993, J MOL BIOL, V230, P1097, DOI 10.1006/jmbi.1993.1226; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; MISSIAKAS D, 1994, EMBO J, V13, P2013, DOI 10.1002/j.1460-2075.1994.tb06471.x; MISSIAKAS D, 1995, EMBO J, V14, P3415, DOI 10.1002/j.1460-2075.1995.tb07347.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sardesai AA, 2003, EMBO J, V22, P1461, DOI 10.1093/emboj/cdg152; Sinha S, 2004, MICROBIOL-SGM, V150, P2993, DOI 10.1099/mic.0.27216-0; Sinha S, 2008, MICROBIOL-SGM, V154, P217, DOI 10.1099/mic.0.2007/010496-0; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; STEPHENS DS, 1981, J INFECT DIS, V143, P525, DOI 10.1093/infdis/143.4.525; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tinsley CR, 2004, J BIOL CHEM, V279, P27078, DOI 10.1074/jbc.M313404200; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	42	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32452	32461		10.1074/jbc.M803990200	http://dx.doi.org/10.1074/jbc.M803990200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18715864	hybrid			2022-12-25	WOS:000260893700033
J	Ghosh, S; Hamdan, SM; Cook, TE; Richardson, CC				Ghosh, Sharmistha; Hamdan, Samir M.; Cook, Timothy E.; Richardson, Charles C.			Interactions of Escherichia coli Thioredoxin, the Processivity Factor, with Bacteriophage T7 DNA Polymerase and Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION IN-VITRO; DEOXYRIBONUCLEIC-ACID; CONFERS PROCESSIVITY; CRYSTAL-STRUCTURE; MECHANISMS; BINDING; PROTEIN; PRIMASE	Escherichia coli thioredoxin binds to a unique flexible loop of 71 amino acid residues, designated the thioredoxin binding domain (TBD), located in the thumb subdomain of bacteriophage T7 gene 5 DNA polymerase. The initial designation of thioredoxin as a processivity factor was premature. Rather it remodels the TBD for interaction with DNA and the other replication proteins. The binding of thioredoxin exposes a number of basic residues on the TBD that lie over the duplex region of the primer-template and increases the processivity of nucleotide polymerization. Two small solvent-exposed loops (loops A and B) located within TBD electrostatically interact with the acidic C-terminal tail of T7 gene 4 helicase-primase, an interaction that is enhanced by the binding of thioredoxin. Several basic residues on the surface of thioredoxin in the polymerase-thioredoxin complex lie in close proximity to the TBD. One of these residues, lysine 36, is located proximal to loop A. The substitution of glutamate for lysine has a dramatic effect on the binding of gene 4 helicase to a DNA polymerase-thioredoxin complex lacking charges on loop B; binding is decreased 15-fold relative to that observed with wild-type thioredoxin. This defective interaction impairs the ability of T7 DNA polymerase-thioredoxin together with T7 helicase to mediate strand displacement synthesis. This is the first demonstration that thioredoxin interacts with replication proteins other than T7 DNA polymerase.	[Ghosh, Sharmistha; Hamdan, Samir M.; Cook, Timothy E.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 200 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu		Hamdan, Samir/0000-0001-5192-1852	National Institutes of Health [GM 54397 (USPHS)]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 54397 (USPHS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAMBARA RA, 1978, J BIOL CHEM, V253, P413; Bedford E, 1997, P NATL ACAD SCI USA, V94, P479, DOI 10.1073/pnas.94.2.479; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; BRYANT FR, 1983, BIOCHEMISTRY-US, V22, P3537, DOI 10.1021/bi00284a001; Cannistraro VJ, 2004, J BIOL CHEM, V279, P18288, DOI 10.1074/jbc.M400282200; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P4129, DOI 10.1021/bi00469a016; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Himawan JS, 1996, J BIOL CHEM, V271, P19999, DOI 10.1074/jbc.271.33.19999; HIMAWAN JS, 1992, P NATL ACAD SCI USA, V89, P9774, DOI 10.1073/pnas.89.20.9774; HUBER HE, 1986, J BIOL CHEM, V261, P5006; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Johnson DE, 2003, J BIOL CHEM, V278, P23762, DOI 10.1074/jbc.M301366200; Johnson DE, 2007, P NATL ACAD SCI USA, V104, P5312, DOI 10.1073/pnas.0701062104; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kelman Z, 1998, STRUCTURE, V6, P121, DOI 10.1016/S0969-2126(98)00014-8; Kumar JK, 2001, J BIOL CHEM, V276, P46151, DOI 10.1074/jbc.M106319200; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; MARK DF, 1976, P NATL ACAD SCI USA, V73, P780, DOI 10.1073/pnas.73.3.780; MODRICH P, 1975, J BIOL CHEM, V250, P5515; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; TABOR S, 1987, J BIOL CHEM, V262, P16212; Yang XM, 1997, J BIOL CHEM, V272, P6599, DOI 10.1074/jbc.272.10.6599	28	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32077	32084		10.1074/jbc.M805062200	http://dx.doi.org/10.1074/jbc.M805062200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18757858	Green Published, hybrid			2022-12-25	WOS:000260760800089
J	Hast, MA; Beese, LS				Hast, Michael A.; Beese, Lorena S.			Structure of Protein Geranylgeranyltransferase-I from the Human Pathogen Candida albicans Complexed with a Lipid Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL TRANSFERASE INHIBITORS; X-RAY CRYSTALLOGRAPHY; ANGSTROM RESOLUTION; ENZYME-INHIBITORS; CRYSTAL-STRUCTURE; FARNESYLTRANSFERASE; BINDING; STATE; PRENYLATION; EXPRESSION	Protein geranylgeranyltransferase-I (GGTase-I) catalyzes the transfer of a 20-carbon isoprenoid lipid to the sulfur of a cysteine residue located near the C terminus of numerous cellular proteins, including members of the Rho superfamily of small GTPases and other essential signal transduction proteins. In humans, GGTase-I and the homologous protein farnesyltransferase ( FTase) are targets of anticancer therapeutics because of the role small GTPases play in oncogenesis. Protein prenyltransferases are also essential for many fungal and protozoan pathogens that infect humans, and have therefore become important targets for treating infectious diseases. Candida albicans, a causative agent of systemic fungal infections in immunocompromised individuals, is one pathogen for which protein prenylation is essential for survival. Here we present the crystal structure of GGTase-I from C. albicans (CaGGTase-I) in complex with its cognate lipid substrate, geranylgeranylpyrophosphate. This structure provides a high-resolution picture of a non-mammalian protein prenyltransferase. There are significant variations between species in critical areas of the active site, including the isoprenoid-binding pocket, as well as the putative product exit groove. These differences indicate the regions where specific protein prenyltransferase inhibitors with antifungal activity can be designed.	[Hast, Michael A.; Beese, Lorena S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Beese, LS (corresponding author), 212 Nanaline Duke Bldg,Box 3711,Res Dr, Durham, NC 27710 USA.	lsb@biochem.duke.edu	beese, lorena/G-4993-2010		National Institutes of Health; United States Dept. of Energy; Office of Science; Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052382, R37GM052382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Dept. of Energy; Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52382 (to L. S. B.). Use of the Advanced Photon Source was supported by the United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.	Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Bishop WR, 2003, CANCER BIOL THER, V2, pS96; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; CHEN WJ, 1993, J BIOL CHEM, V268, P9675; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Delano W.L., 2002, DELANO SCI; Dolence JM, 1995, BIOCHEMISTRY-US, V34, P16687, DOI 10.1021/bi00051a017; Dolence JM, 1997, BIOCHEMISTRY-US, V36, P9246, DOI 10.1021/bi970039p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar N., 2007, CURR PROTOC PROTEIN; FURFINE ES, 1995, BIOCHEMISTRY-US, V34, P6857, DOI 10.1021/bi00020a032; Hartman HL, 2004, J BIOL CHEM, V279, P30546, DOI 10.1074/jbc.M403469200; Hightower KE, 1998, BIOCHEMISTRY-US, V37, P15555, DOI 10.1021/bi981525v; Huang CC, 2000, BIOCHEMISTRY-US, V39, P2593, DOI 10.1021/bi992356x; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Kelly R, 2000, J BACTERIOL, V182, P704, DOI 10.1128/JB.182.3.704-713.2000; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Long SB, 2000, STRUCTURE, V8, P209, DOI 10.1016/S0969-2126(00)00096-4; Long SB, 2002, NATURE, V419, P645, DOI 10.1038/nature00986; Long SB, 2001, P NATL ACAD SCI USA, V98, P12948, DOI 10.1073/pnas.241407898; Mathis JR, 1997, BIOCHEMISTRY-US, V36, P6367, DOI 10.1021/bi9629182; MAYER ML, 1992, J BIOL CHEM, V267, P20589; Mazur P, 1999, MICROBIOL-UK, V145, P1123, DOI 10.1099/13500872-145-5-1123; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murthi KK, 2003, BIOORG MED CHEM LETT, V13, P1935, DOI 10.1016/S0960-894X(03)00320-2; Pappas PG, 2007, CLIN INFECT DIS, V45, P883, DOI 10.1086/520980; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; Pickett JS, 2003, J BIOL CHEM, V278, P51243, DOI 10.1074/jbc.M309226200; Pickett JS, 2003, BIOCHEMISTRY-US, V42, P9741, DOI 10.1021/bi0346852; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Reid TS, 2004, BIOCHEMISTRY-US, V43, P9000, DOI 10.1021/bi049280b; Saderholm MJ, 2000, BIOCHEMISTRY-US, V39, P12398, DOI 10.1021/bi0011781; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Smalera I, 2000, BBA-PROTEIN STRUCT M, V1480, P132, DOI 10.1016/S0167-4838(00)00067-4; Song JL, 2003, MICROBIOL-SGM, V149, P249, DOI 10.1099/mic.0.25887-0; STIRTAN WG, 1995, ARCH BIOCHEM BIOPHYS, V321, P182, DOI 10.1006/abbi.1995.1384; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sunami S, 2002, BIOORG MED CHEM LETT, V12, P629, DOI 10.1016/S0960-894X(01)00813-7; Taylor JS, 2003, EMBO J, V22, P5963, DOI 10.1093/emboj/cdg571; Terry KL, 2006, BIOCHEMISTRY-US, V45, P9746, DOI 10.1021/bi060295e; Tschantz WR, 1997, J BIOL CHEM, V272, P9989; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Witter DJ, 1996, BIOCHEMISTRY-US, V35, P10454, DOI 10.1021/bi960500y; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922; Zhang FL, 1996, BIOCHEM J, V320, P925, DOI 10.1042/bj3200925	46	17	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31933	31940		10.1074/jbc.M805330200	http://dx.doi.org/10.1074/jbc.M805330200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18713740	Green Published, hybrid			2022-12-25	WOS:000260760800075
J	Gonzalez-Guerrero, M; Eren, E; Rawat, S; Stemmler, TL; Arguello, JM				Gonzalez-Guerrero, Manuel; Eren, Elif; Rawat, Swati; Stemmler, Timothy L.; Argueello, Jose M.			Structure of the Two Transmembrane Cu+ Transport Sites of the Cu+-ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-ABSORPTION SPECTROSCOPY; WILSON-DISEASE PROTEIN; SODIUM-POTASSIUM PUMP; METAL-BINDING DOMAIN; P-TYPE-ATPASE; ARCHAEOGLOBUS-FULGIDUS; SARCOPLASMIC-RETICULUM; COPPER UPTAKE; MECHANISM; COPA	Cu+-ATPases drive metal efflux from the cell cytoplasm. Paramount to this function is the binding of Cu+ within the transmembrane region and its coupled translocation across the permeability barrier. Here, we describe the two transmembrane Cu+ transport sites present in Archaeoglobus fulgidus CopA. Both sites can be independently loaded with Cu+. However, their simultaneous occupation is associated with enzyme turnover. Site I is constituted by two Cys in transmembrane segment (TM) 6 and a Tyr in TM7. An Asn in TM7 and Met and Ser in TM8 form Site II. Single site x-ray spectroscopic analysis indicates a trigonal coordination in both sites. This architecture is distinct from that observed in Cu+-trafficking chaperones and classical cuproproteins. The high affinity of these sites for Cu+ (Site I K-a = 1.3 fM(-1), Site II K-a = 1.1 fM(-1)), in conjunction with reversible direct Cu+ transfer from chaperones, points to a transport mechanism where backward release of free Cu+ to the cytoplasm is largely prevented.	[Gonzalez-Guerrero, Manuel; Eren, Elif; Argueello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA; [Rawat, Swati; Stemmler, Timothy L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Worcester Polytechnic Institute; Wayne State University	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	arguello@wpi.edu	Gonzalez-Guerrero, Manuel/N-2281-2019; Gonzalez-Guerrero, Manuel/E-7338-2011; Arguello, Jose/D-1997-2012	Gonzalez-Guerrero, Manuel/0000-0001-7334-5286; Gonzalez-Guerrero, Manuel/0000-0001-7334-5286; Eren, Elif/0000-0002-7942-4943; Arguello, Jose/0000-0003-3940-6297	National Institutes of Health [DK068139]; National Science Foundation [MCB-0743901]; United States Department of Energy; Office of Science; Office of Basic Energy Sciences [DE-AC02-06CH11357]; Department of Energy; Office of Biological and Environmental Research; National Center for Research Resources; Biomedical Technology Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK068139 (to T. L. S.). This work was also supported by National Science Foundation Grant MCB-0743901 (to J. M. A.). This work was also supported in part by United States Department of Energy, Office of Science, Office of Basic Energy Sciences Contract DE-AC02-06CH11357, by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Ankudinov AL, 1997, PHYS REV B, V56, pR1712, DOI 10.1103/PhysRevB.56.R1712; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bagai I, 2007, J BIOL CHEM, V282, P35695, DOI 10.1074/jbc.M703937200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER AJ, 1995, ANAL BIOCHEM, V226, P80, DOI 10.1006/abio.1995.1194; Cattoni DI, 2008, ARCH BIOCHEM BIOPHYS, V471, P198, DOI 10.1016/j.abb.2007.12.013; Chintalapati S, 2008, J MOL BIOL, V378, P581, DOI 10.1016/j.jmb.2008.01.094; Cox DW, 2002, J BIOENERG BIOMEMBR, V34, P333, DOI 10.1023/A:1021293818125; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; Frausto da Silva J, 2001, BIOL CHEM ELEMENTS, P418; FUJIMORI T, 1990, J BIOL CHEM, V265, P16262; GLYNN IM, 1982, J PHYSIOL-LONDON, V330, P17, DOI 10.1113/jphysiol.1982.sp014326; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Lowe J, 2004, J BIOL CHEM, V279, P25986, DOI 10.1074/jbc.M308736200; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; MacPherson IS, 2007, CELL MOL LIFE SCI, V64, P2887, DOI 10.1007/s00018-007-7310-9; Mandal AK, 2004, J BIOL CHEM, V279, P54802, DOI 10.1074/jbc.M410854200; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; MISSIAEN L, 1988, BIOCHEM J, V253, P827, DOI 10.1042/bj2530827; Moreira OC, 2005, BBA-BIOENERGETICS, V1708, P411, DOI 10.1016/j.bbabio.2005.05.010; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PRITZ RA, 1997, J INVEST DERMATOL, V109, P207; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Ralle M, 1998, J AM CHEM SOC, V120, P13525, DOI 10.1021/ja982990i; Rosenzweig AC, 2006, CURR OPIN STRUC BIOL, V16, P729, DOI 10.1016/j.sbi.2006.09.005; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P9949, DOI 10.1021/bi0610045; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P386, DOI 10.1016/S0753-3322(03)00012-X; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Xue Y, 2008, NAT CHEM BIOL, V4, P107, DOI 10.1038/nchembio.2007.57; Yang Y, 2007, BBA-BIOMEMBRANES, V1768, P495, DOI 10.1016/j.bbamem.2006.09.013; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200	51	80	80	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29753	29759		10.1074/jbc.M803248200	http://dx.doi.org/10.1074/jbc.M803248200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18772137	Green Published, hybrid			2022-12-25	WOS:000260366900019
J	Leoff, C; Choudhury, B; Saile, E; Quinn, CP; Carlson, RW; Kannenberg, EL				Leoff, Christine; Choudhury, Biswa; Saile, Elke; Quinn, Conrad P.; Carlson, Russell W.; Kannenberg, Elmar L.			Structural Elucidation of the Nonclassical Secondary Cell Wall Polysaccharide from Bacillus cereus ATCC 10987 COMPARISON WITH THE POLYSACCHARIDES FROM BACILLUS ANTHRACIS AND B. CEREUS TYPE STRAIN ATCC 14579 REVEALS BOTH UNIQUE AND COMMON STRUCTURAL FEATURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENES; IDENTIFICATION; THURINGIENSIS; SEQUENCE	Nonclassical secondary cell wall polysaccharides constitute a major cell wall structure in the Bacillus cereus group of bacteria. The structure of the secondary cell wall polysaccharide from Bacillus cereus ATCC 10987, a strain that is closely related to Bacillus anthracis, was determined. This polysaccharide was released from the cell wall with aqueous hydrogen fluoride (HF) and purified by gel filtration chromatography. The purified polysaccharide, HF-PS, was characterized by glycosyl composition and linkage analyses, mass spectrometry, and one-and two-dimensional NMR analysis. The results showed that the B. cereus ATCC 10987 HF-PS has a repeating oligosaccharide consisting of a -> 6)-alpha-GalNAc-(1 -> 4)-beta-ManNAc-(1 -> 4)-beta-GlcNAc-(1 -> trisaccharide that is substituted with beta-Gal at O3 of the alpha-GalNAc residue and nonstoichiometrically acetylated at O3 of the N-acetylmannosamine (ManNAc) residue. Comparison of this structure with that of the B. anthracis HF-PS and with structural data obtained for the HF-PS from B. cereus type strain ATCC 14579 revealed that each HF-PS had the same general structural theme consisting of three HexNAc and one Hex residues. A common structural feature in the HF-PSs from B. cereus ATCC 10987 and B. anthracis was the presence of a repeating unit consisting of a HexNAc(3) trisaccharide backbone in which two of the three HexNAc residues are GlcNAc and ManNAc and the third can be either GlcNAc or GalNAc. The implications of these results with regard to the possible functions of the HF-PSs are discussed.	[Leoff, Christine; Choudhury, Biswa; Saile, Elke; Carlson, Russell W.; Kannenberg, Elmar L.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Saile, Elke; Quinn, Conrad P.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Leoff, Christine; Kannenberg, Elmar L.] Univ Tubingen, Dept Microbiol, D-72076 Tubingen, Germany; [Leoff, Christine; Kannenberg, Elmar L.] Univ Tubingen, Dept Biotechnol, D-72076 Tubingen, Germany	University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Carlson, RW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	rcarlson@ccrc.uga.edu			National Institutes of Health; NIAID [R21 AI059577]; Department of Energy [DE-FG02-93ER20097]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Energy(United States Department of Energy (DOE))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant R21 AI059577 (to R. W. C.). This work was also supported in part by Department of Energy Grant DE-FG02-93ER20097 (to the CCRC). Patent pending (University of Georgia Research Foundation, Inc. and United States Centers for Disease Control and Prevention). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMANO K, 1977, EUR J BIOCHEM, V75, P513, DOI 10.1111/j.1432-1033.1977.tb11552.x; BROWN WC, 1973, APPL MICROBIOL, V25, P295, DOI 10.1128/AEM.25.2.295-300.1973; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Claesson MJ, 2006, P NATL ACAD SCI USA, V103, P6718, DOI 10.1073/pnas.0511060103; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Fischetti VA, 2006, NAT BIOTECHNOL, V24, P1508, DOI 10.1038/nbt1206-1508; GONZALEZ JM, 1982, P NATL ACAD SCI-BIOL, V79, P6951, DOI 10.1073/pnas.79.22.6951; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; Kim W, 2008, J MED MICROBIOL, V57, P279, DOI 10.1099/jmm.0.47642-0; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; KOJIMA N, 1985, EUR J BIOCHEM, V148, P479, DOI 10.1111/j.1432-1033.1985.tb08864.x; Leendertz FH, 2006, PLOS PATHOG, V2, P632, DOI 10.1371/journal.ppat.0020008; Leoff C, 2008, J BACTERIOL, V190, P112, DOI 10.1128/JB.01292-07; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; YORK WS, 1986, METHOD ENZYMOL, V118, P3	27	33	36	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29812	29821		10.1074/jbc.M803234200	http://dx.doi.org/10.1074/jbc.M803234200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18757856	hybrid, Green Published			2022-12-25	WOS:000260366900025
J	Chen, YB; Wang, XH; Di, L; Fu, GP; Chen, YH; Bai, L; Liu, JZ; Feng, X; McDonald, JM; Michalek, S; He, YH; Yu, M; Fu, YX; Wen, RR; Wu, H; Wang, DM				Chen, Yabing; Wang, Xiaohong; Di, Lie; Fu, Guoping; Chen, Yuhong; Bai, Li; Liu, Jianzhong; Feng, Xu; McDonald, Jay M.; Michalek, Sue; He, Yinghong; Yu, Mei; Fu, Yang-Xin; Wen, Renren; Wu, Hui; Wang, Demin			Phospholipase C gamma 2 Mediates RANKL-stimulated Lymph Node Organogenesis and Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; CELL ANTIGEN-RECEPTOR; SIGNAL-REGULATED KINASE; LYMPHOTOXIN-BETA-RECEPTOR; JUN NH2-TERMINAL KINASE; ALPHA-DEFICIENT MICE; ORGAN DEVELOPMENT; NUCLEAR-FACTOR; C-FOS	Phospholipase C gamma 2 (PLC gamma 2) is an important signaling effector of multiple receptors in the immune system. Here we show that PLC gamma 2-deficient mice displayed impaired lymph node organogenesis but normal splenic structure and Peyer's patches. Receptor activator of NF-kappa Bligand (RANKL) is a tumor necrosis factor family cytokine and is essential for lymph node organogenesis. Importantly, PLC gamma 2 deficiency severely impaired RANKL signaling, resulting in marked reduction of RANKL-induced activation of MAPKs, p38 and JNK, but not ERK. The lack of PLC gamma 2 markedly diminished RANKL-induced activation of NF-kappa B, AP-1, and NFATc1. Moreover, PLC gamma 2 deficiency impaired RANKL-mediated biological function, leading to failure of the PLC gamma 2- deficient bone marrow macrophage precursors to differentiate into osteoclasts after RANKL stimulation. Re-introduction of PLC gamma 2 but not PLC gamma 1 restores RANKL-mediated osteoclast differentiation of PLC gamma 2- deficient bone marrow-derived monocyte/macrophage. Taken together, PLC gamma 2 is essential for RANK signaling, and its deficiency leads to defective lymph node organogenesis and osteoclast differentiation.	[Wang, Xiaohong; Wu, Hui] Univ Alabama, Dept Pediat Dent, Birmingham, AL 35294 USA; [Chen, Yabing; Liu, Jianzhong; Feng, Xu; McDonald, Jay M.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Michalek, Sue] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [McDonald, Jay M.] Vet Affairs Med Ctr, Birmingham, AL 35294 USA; [Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Di, Lie; Fu, Guoping; Chen, Yuhong; Bai, Li; He, Yinghong; Yu, Mei; Wen, Renren; Wang, Demin] Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53226 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Chicago; Versiti Blood Center of Wisconsin	Wu, H (corresponding author), Univ Alabama, Dept Pediat Dent, Birmingham, AL 35294 USA.	hwu@uab.edu; demin.wang@bcw.edu	Yu, Mei/K-2206-2017; Wang, Demin/AAX-4449-2020	Wang, Demin/0000-0001-5549-3795; fu, yang-xin/0000-0001-8441-6617	National Institutes of Health [AR055339, AR046031-080003, AI52327, HL073284, AI079087]; University of Alabama at Birmingham Center; Metabolic Bone Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087, R01AI052327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046031, R03AR055339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Center; Metabolic Bone Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR055339 (to Yabing Chen), AR046031-080003 (to H. W.), AI52327 (to R. W.), and HL073284 and AI079087 (to D. W.). This work was also supported by a University of Alabama at Birmingham Center for Metabolic Bone Disease pilot project award (to Yabing Chen), a Scholar Award from the Leukemia and Lymphoma Society, and a grant from Advancing a Healthier Wisconsin endowment fund (to D. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abu-Amer Y, 2001, J CLIN INVEST, V107, P1375, DOI 10.1172/JCI10530; Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BANKS TA, 1995, J IMMUNOL, V155, P1685; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Bunting KD, 1998, NAT MED, V4, P58, DOI 10.1038/nm0198-058; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; CHAO TSO, 1994, J BIOL CHEM, V269, P7337; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Chen YB, 2004, J CELL BIOCHEM, V92, P178, DOI 10.1002/jcb.20058; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Feng X, 2002, ENDOCRINOLOGY, V143, P4868, DOI 10.1210/en.2002-220467; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HIRASAWA N, 1995, J IMMUNOL, V154, P5391; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawakami Y, 1998, J IMMUNOL, V161, P1795; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Leibson PJ, 1997, IMMUNITY, V6, P655, DOI 10.1016/S1074-7613(00)80441-0; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Muller G, 2003, CURR OPIN IMMUNOL, V15, P217, DOI 10.1016/S0952-7915(03)00014-1; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; RHEE SG, 1992, J BIOL CHEM, V267, P12393; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Roa M, 1997, J IMMUNOL, V159, P2815; Rodriguez R, 2001, J BIOL CHEM, V276, P47982, DOI 10.1074/jbc.M107577200; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; Wen RR, 2004, EMBO J, V23, P4007, DOI 10.1038/sj.emboj.7600405; Wen RR, 2003, J BIOL CHEM, V278, P43654, DOI 10.1074/jbc.M307318200; Wen RR, 2002, J IMMUNOL, V169, P6743, DOI 10.4049/jimmunol.169.12.6743; Wen RR, 2001, MOL CELL BIOL, V21, P678, DOI 10.1128/MCB.21.2.678-689.2001; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhang C, 1997, J IMMUNOL, V158, P4968	83	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29593	29601		10.1074/jbc.M802493200	http://dx.doi.org/10.1074/jbc.M802493200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728019	Green Published, hybrid			2022-12-25	WOS:000260179900085
J	Li, WL; Ju, JH; Rajski, SR; Osada, H; Shen, B				Li, Wenli; Ju, Jianhua; Rajski, Scott R.; Osada, Hiroyuki; Shen, Ben			Characterization of the tautomycin biosynthetic gene cluster from Streptomyces spiroverticillatus unveiling new insights into dialkylmaleic anhydride and polyketide biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE-1; OKADAIC ACID; SACCHAROPOLYSPORA-ERYTHRAEA; ENZYMATIC DOMAINS; CRYSTAL-STRUCTURE; CALYCULIN-A; IN-VITRO; INHIBITOR; ORGANIZATION; SYNTHASE	Tautomycin (TTM) is a highly potent and specific protein phosphatase inhibitor isolated from Streptomyces spiroverticillatus. The biological activity of TTM makes it an important lead for drug discovery, whereas its spiroketal-containing polyketide chain and rare dialkylmaleic anhydride moiety draw attention to novel biosynthetic chemistries responsible for its production. To elucidate the biosynthetic machinery associated with these novel molecular features, the ttm biosynthetic gene cluster from S. spiroverticillatus was isolated and characterized, and its involvement in TTM biosynthesis was confirmed by gene inactivation and complementation experiments. The ttm cluster was localized to a 86-kb DNA region, consisting of 20 open reading frames that encode three modular type I polyketide synthases (TtmHIJ), one type II thioesterase (TtmT), five proteins for methoxymalonyl-S-acyl carrier protein biosynthesis (Ttm-ABCDE), eight proteins for dialkylmaleic anhydride biosynthesis and regulation (TtmKLMNOPRS), as well as two additional regulatory proteins (TtmF and TtmQ) and one tailoring enzyme (TtmG). A model for TTM biosynthesis is proposed based on functional assignments from sequence analysis, which agrees well with previous feeding experiments, and has been further supported by in vivo gene inactivation experiments. These findings set the stage to fully investigate TTM biosynthesis and to biosynthetically engineer new TTM analogs.	[Li, Wenli; Ju, Jianhua; Rajski, Scott R.; Shen, Ben] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Osada, Hiroyuki] RIKEN, Discovery Res Inst, Antibiot Lab, Wako, Saitama 3510198, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; RIKEN	Shen, B (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu	Osada, Hiroyuki/N-4305-2014; Osada, Hiroyuki/AAY-6254-2020		National Institutes of Health [CA113297]; NATIONAL CANCER INSTITUTE [U19CA113297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113297. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; BEVITT DJ, 1992, EUR J BIOCHEM, V204, P39, DOI 10.1111/j.1432-1033.1992.tb16603.x; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; CHENG XC, 1990, J ANTIBIOT, V43, P809, DOI 10.7164/antibiotics.43.809; CHENG XC, 1987, J ANTIBIOT, V40, P907, DOI 10.7164/antibiotics.40.907; CHENG XC, 1990, J ANTIBIOT, V43, P890, DOI 10.7164/antibiotics.43.890; CHENG XC, 1989, J ANTIBIOT, V42, P141; Colby DA, 2003, BIOORG MED CHEM LETT, V13, P1601, DOI 10.1016/S0960-894X(03)00106-9; Dai JP, 1996, TETRAHEDRON LETT, V37, P491, DOI 10.1016/0040-4039(95)02188-4; DONADIO S, 1992, GENE, V111, P51, DOI 10.1016/0378-1119(92)90602-L; Dorrestein PC, 2006, J AM CHEM SOC, V128, P10386, DOI 10.1021/ja0639362; Frank B, 2007, CHEM BIOL, V14, P221, DOI 10.1016/j.chembiol.2006.11.013; Giddens SR, 2002, MOL MICROBIOL, V45, P769, DOI 10.1046/j.1365-2958.2002.03048.x; Goulding CW, 2007, J MOL BIOL, V365, P275, DOI 10.1016/j.jmb.2006.09.086; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Han DJ, 2003, TRANSPL P, V35, P547, DOI 10.1016/S0041-1345(02)03905-2; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Horswill AR, 2001, BIOCHEMISTRY-US, V40, P4703, DOI 10.1021/bi015503b; Ikeda H, 1999, P NATL ACAD SCI USA, V96, P9509, DOI 10.1073/pnas.96.17.9509; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim BS, 2002, J BIOL CHEM, V277, P48028, DOI 10.1074/jbc.M207770200; Kita A, 2002, STRUCTURE, V10, P715, DOI 10.1016/S0969-2126(02)00764-5; LESKIW BK, 1991, MOL MICROBIOL, V5, P2861, DOI 10.1111/j.1365-2958.1991.tb01845.x; Li WL, 2006, J BACTERIOL, V188, P4148, DOI 10.1128/JB.00172-06; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Liu W, 2000, ANTIMICROB AGENTS CH, V44, P382, DOI 10.1128/AAC.44.2.382-392.2000; Lomovskaya N, 1998, J BACTERIOL, V180, P2379, DOI 10.1128/JB.180.9.2379-2386.1998; MACKINTOSH C, 1990, FEBS LETT, V277, P137, DOI 10.1016/0014-5793(90)80828-7; Mitsuhashi S, 2003, J BIOL CHEM, V278, P82, DOI 10.1074/jbc.M208888200; Mitsuhashi S, 2001, BIOCHEM BIOPH RES CO, V287, P328, DOI 10.1006/bbrc.2001.5596; Montero-Moran GM, 2007, BIOCHEMISTRY-US, V46, P5293, DOI 10.1021/bi700065h; NAGAE J, 1988, J ANTIBIOT, V41, P932; Oikawa H, 2002, CURR MED CHEM, V9, P2033, DOI 10.2174/0929867023368818; OIKAWA H, 1994, TETRAHEDRON LETT, V35, P4809, DOI 10.1016/S0040-4039(00)76974-7; OIKAWA M, 1995, J ORG CHEM, V60, P5048, DOI 10.1021/jo00121a026; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Quigley PM, 2004, PROTEIN SCI, V13, P269, DOI 10.1110/ps.03399604; RETZLAFF L, 1995, MOL MICROBIOL, V18, P151, DOI 10.1111/j.1365-2958.1995.mmi_18010151.x; Sakoff JA, 2004, CURR PHARM DESIGN, V10, P1139, DOI 10.2174/1381612043452686; Schleheck D, 2007, APPL ENVIRON MICROB, V73, P4725, DOI 10.1128/AEM.00632-07; Serre L, 2001, J MOL BIOL, V310, P617, DOI 10.1006/jmbi.2001.4784; Shen B, 1996, P NATL ACAD SCI USA, V93, P6600, DOI 10.1073/pnas.93.13.6600; Sheppeck JE, 1997, J ORG CHEM, V62, P387, DOI 10.1021/jo961633s; Shim JH, 2002, P NATL ACAD SCI USA, V99, P10617, DOI 10.1073/pnas.162522099; SITNIKOV DM, 1995, MOL MICROBIOL, V17, P801, DOI 10.1111/j.1365-2958.1995.mmi_17050801.x; Spiller B, 1999, P NATL ACAD SCI USA, V96, P12305, DOI 10.1073/pnas.96.22.12305; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Stenmark P, 2004, BIOCHEMISTRY-US, V43, P13996, DOI 10.1021/bi048481c; Tao MF, 2007, MOL BIOSYST, V3, P60, DOI 10.1039/b615284h; UBUKATA M, 1995, J CHEM SOC P1, V19, P2399; UBUKATA M, 1990, CHEM COMMUN, V3, P244; UBUKATA M, 1993, J CHEM SOC P1, V5, P617	55	39	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28607	28617		10.1074/jbc.M804279200	http://dx.doi.org/10.1074/jbc.M804279200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18708355	Green Published, hybrid			2022-12-25	WOS:000259969300063
J	Melgari, JM; Pasqualetti, P; Pauri, F; Rossini, PM				Melgari, Jean-Marc; Pasqualetti, Patrizio; Pauri, Flavia; Rossini, Paolo Maria			Muscles in "Concert'': Study of Primary Motor Cortex Upper Limb Functional Topography	PLOS ONE			English	Article								Background: Previous studies with Transcranial Magnetic Stimulation (TMS) have focused on the cortical representation of limited group of muscles. No attempts have been carried out so far to get simultaneous recordings from hand, forearm and arm with TMS in order to disentangle a 'functional' map providing information on the rules orchestrating muscle coupling and overlap. The aim of the present study is to disentangle functional associations between 12 upper limb muscles using two measures: cortical overlapping and cortical covariation of each pair of muscles. Interhemispheric differences and the influence of posture were evaluated as well. Methodology/Principal Findings: TMS mapping studies of 12 muscles belonging to hand, forearm and arm were performed. Findings demonstrate significant differences between the 66 pairs of muscles in terms of cortical overlapping: extremely high for hand-forearm muscles and very low for arm vs hand/forearm muscles. When right and left hemispheres were compared, overlapping between all possible pairs of muscles in the left hemisphere (62.5%) was significantly higher than in the right one (53.5%). The arm/hand posture influenced both measures of cortical association, the effect of Position being significant [p=.021] on overlapping, resulting in 59.5% with prone vs 53.2% with supine hand, but only for pairs of muscles belonging to hand and forearm, while no changes occurred in the overlapping of proximal muscles with those of more distal districts. Conclusions/Significance: Larger overlapping in the left hemisphere could be related to its lifetime higher training of all twelve muscles studied with respect to the right hemisphere, resulting in larger intra-cortical connectivity within primary motor cortex. Altogether, findings with prone hand might be ascribed to mechanisms facilitating coupling of muscles for object grasping and lifting -with more proximal involvement for joint stabilization- compared to supine hand facilitating actions like catching. TMS multiple-muscle mapping studies permit a better understanding of motor control and 'plastic' reorganization of motor system.	[Melgari, Jean-Marc; Rossini, Paolo Maria] Univ Campus Biomed, Rome, Italy; [Pasqualetti, Patrizio; Rossini, Paolo Maria] Fatebenefratelli Hosp, AFaR, Rome, Italy; [Pasqualetti, Patrizio; Rossini, Paolo Maria] IRCCS SAN RAFFAELE, Casa Cura SAN RAFFAELE Cassino, Rome, Italy; [Pauri, Flavia] Univ Roma La Sapienza, ORL, Dept Neurol, Rome, Italy	University Campus Bio-Medico - Rome Italy; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sapienza University Rome	Melgari, JM (corresponding author), Univ Campus Biomed, Rome, Italy.	j.melgari@unicampus.it	Rossini, Paolo M./D-4994-2013; Pasqualetti, Patrizio/D-4496-2013	Rossini, Paolo M./0000-0003-2665-534X; Pasqualetti, Patrizio/0000-0001-5560-1979	AFaR, Fatebenefratelli Hospital-Isola Tiberina, Roma	AFaR, Fatebenefratelli Hospital-Isola Tiberina, Roma	AFaR, Fatebenefratelli Hospital-Isola Tiberina, Roma	ANDERSEN P, 1975, PROC R SOC SER B-BIO, V188, P31, DOI 10.1098/rspb.1975.0002; Arunachalam R, 2005, J NEUROPHYSIOL, V94, P2162, DOI 10.1152/jn.01173.2004; BARKER AT, 1985, LANCET, V1, P1106; BERARDELLI A, 1991, CURR OPIN NEUROL NEU, V4, P770; BERARDELLI A, 1994, EXP BRAIN RES, V98, P501; Bohning DE, 2003, CLIN NEUROPHYSIOL, V114, P2210, DOI 10.1016/S1388-2457(03)00232-3; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cantello R, 2002, J CLIN NEUROPHYSIOL, V19, P272, DOI 10.1097/00004691-200208000-00003; Capaday C, 2004, NEUROSCIENTIST, V10, P207, DOI 10.1177/107385403262109; Cheung VCK, 2005, J NEUROSCI, V25, P6419, DOI 10.1523/JNEUROSCI.4904-04.2005; Cicinelli P, 2003, STROKE, V34, P2653, DOI 10.1161/01.STR.0000092122.96722.72; Cicinelli P, 2000, NEUROREPORT, V11, P701, DOI 10.1097/00001756-200003200-00010; Cicinelli P, 1997, ELECTROMYOGR MOTOR C, V105, P438, DOI 10.1016/S0924-980X(97)00052-0; Cicinelli P, 1997, MUSCLE NERVE, V20, P535, DOI 10.1002/(SICI)1097-4598(199705)20:5<535::AID-MUS1>3.0.CO;2-A; CICINELLI P, 2005, CEREB CORTEX; COHEN LG, 1990, ELECTROEN CLIN NEURO, V75, P350, DOI 10.1016/0013-4694(90)90113-X; COHEN LG, 1988, NEUROLOGY, V38, P904, DOI 10.1212/WNL.38.6.904; COHEN LG, 1991, ELECTROEN CLIN NEURO, P36; Devanne H, 2002, J NEUROPHYSIOL, V87, P3006, DOI 10.1152/jn.2002.87.6.3006; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; DONOGHUE JP, 1992, EXP BRAIN RES, V89, P1; Ferreri F, 2003, ANN NEUROL, V53, P102, DOI 10.1002/ana.10416; Foltys H, 2003, CLIN NEUROPHYSIOL, V114, P2404, DOI 10.1016/S1388-2457(03)00263-3; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GOULD HJ, 1986, J COMP NEUROL, V247, P297, DOI 10.1002/cne.902470303; Gregori B, 2005, EXP BRAIN RES, V166, P43, DOI 10.1007/s00221-005-2337-3; Gugino LD, 2001, CLIN NEUROPHYSIOL, V112, P1781, DOI 10.1016/S1388-2457(01)00633-2; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; HUMPHREY DR, 1986, FED PROC, V45, P2687; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; JABRE JF, 2000, CLIN NEUROPHYSIOL, V53, P171; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Korvenoja A, 1999, HUM BRAIN MAPP, V8, P13, DOI 10.1002/(SICI)1097-0193(1999)8:1<13::AID-HBM2>3.0.CO;2-B; Krings T, 1998, ELECTROMYOGR MOTOR C, V109, P85, DOI 10.1016/S0924-980X(97)00078-7; Krings T, 2001, NEUROSURG REV, V24, P171, DOI 10.1007/s101430100151; KRINGS T, 2001, NEUROL CLIN NEUROPHY, V1, P2; KWAN HC, 1978, J NEUROPHYSIOL, V41, P1120, DOI 10.1152/jn.1978.41.5.1120; LEMON RN, 1987, EXP BRAIN RES, V66, P621, DOI 10.1007/BF00270695; Liepert J, 2004, RESTOR NEUROL NEUROS, V22, P269; Liepert J, 1999, CURR OPIN NEUROL, V12, P709, DOI 10.1097/00019052-199912000-00009; Lotze M, 2003, CLIN NEUROPHYSIOL, V114, P306, DOI 10.1016/S1388-2457(02)00380-2; MERTON PA, 1980, J PHYSIOL-LONDON, V305, pP9; MERTON PA, 1980, NATURE, V285, P227, DOI 10.1038/285227a0; MERTON PA, 1982, LANCET, V2, P597; Mills KR, 1999, EEG CL N SU, P239; Neggers SFW, 2004, NEUROIMAGE, V21, P1805, DOI 10.1016/j.neuroimage.2003.12.006; Nielsen JF, 1996, J CLIN NEUROPHYSIOL, V13, P423, DOI 10.1097/00004691-199609000-00005; Nithi KA, 2000, MUSCLE NERVE, V23, P1542, DOI 10.1002/1097-4598(200010)23:10<1542::AID-MUS10>3.0.CO;2-A; NUDO RJ, 1992, J NEUROSCI, V12, P2918, DOI 10.1523/JNEUROSCI.12-08-02918.1992; Pascual-Leone A, 1999, EEG CL N SU, P157; PASCUALLEONE A, 1994, ELECTROEN CLIN NEURO, V93, P42, DOI 10.1016/0168-5597(94)90090-6; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Rossini P M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P171; Rossini PM, 2007, NEUROLOGY, V68, P484, DOI 10.1212/01.wnl.0000250268.13789.b2; Rossini Paolo M, 2004, Phys Med Rehabil Clin N Am, V15, P263, DOI 10.1016/S1047-9651(03)00124-4; Rossini PM, 1996, NEUROSCI LETT, V214, P191, DOI 10.1016/0304-3940(96)12940-2; Rossini PM, 2000, BRAIN RES REV, V33, P131, DOI 10.1016/S0169-328X(00)00090-5; Rossini PM, 2003, LANCET NEUROL, V2, P493, DOI 10.1016/S1474-4422(03)00485-X; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rossini PM, 2004, RESTOR NEUROL NEUROS, V22, P193; Rossini PM, 1998, ELECTROEN CLIN NEURO, V106, P180, DOI 10.1016/S0013-4694(97)00097-7; ROSSINI PM, 1995, BRAIN RES, V676, P314, DOI 10.1016/0006-8993(95)00113-5; ROSSINI PM, 1985, ELECTROEN CLIN NEURO, V61, P272, DOI 10.1016/0013-4694(85)91094-6; ROSSINI PM, 1985, ELECTROEN CLIN NEURO, V60, P320, DOI 10.1016/0013-4694(85)90006-9; Rossini PM, 1998, NEUROREPORT, V9, P2141, DOI 10.1097/00001756-199806220-00043; Rossini PM, 1999, CEREB CORTEX, V9, P161, DOI 10.1093/cercor/9.2.161; Rossini PM, 1999, EEG CL N SU, V50, P210; ROTHWELL JC, 1987, NEUROSURGERY, V20, P156; Sanes JN, 1997, ADV NEUROL, V73, P277; SANES JN, 1995, SCIENCE, V268, P1775, DOI 10.1126/science.7792606; Sanes JN, 2001, NEUROIMAGE, V13, P968, DOI 10.1006/nimg.2000.0733; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; SATO KC, 1989, J NEUROPHYSIOL, V62, P959, DOI 10.1152/jn.1989.62.4.959; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; SESSLE BJ, 1982, J PHYSIOL-LONDON, V323, P245, DOI 10.1113/jphysiol.1982.sp014071; STRICK PL, 1982, J NEUROPHYSIOL, V48, P139, DOI 10.1152/jn.1982.48.1.139; Traversa R, 1997, STROKE, V28, P110, DOI 10.1161/01.STR.28.1.110; Wassermann EM, 1996, NEUROIMAGE, V3, P1, DOI 10.1006/nimg.1996.0001; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; WILSON SA, 1993, J NEUROL SCI, V118, P134, DOI 10.1016/0022-510X(93)90102-5; ZIEMANN U, 1993, NEUROSCI LETT, V156, P167, DOI 10.1016/0304-3940(93)90464-V; Ziemann U, 2001, CLIN NEUROPHYSIOL, V112, P107, DOI 10.1016/S1388-2457(00)00502-2	84	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3069	10.1371/journal.pone.0003069	http://dx.doi.org/10.1371/journal.pone.0003069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728785	Green Published, gold, Green Submitted			2022-12-25	WOS:000264796400009
J	Leal, WS; Barbosa, RMR; Xu, W; Ishida, Y; Syed, Z; Latte, N; Chen, AM; Morgan, TI; Cornel, AJ; Furtado, A				Leal, Walter S.; Barbosa, Rosangela M. R.; Xu, Wei; Ishida, Yuko; Syed, Zainulabeuddin; Latte, Nicolas; Chen, Angela M.; Morgan, Tania I.; Cornel, Anthony J.; Furtado, Andre			Reverse and Conventional Chemical Ecology Approaches for the Development of Oviposition Attractants for Culex Mosquitoes	PLOS ONE			English	Article							PHEROMONE-BINDING-PROTEIN; YELLOW-FEVER MOSQUITO; LIGAND RELEASE; MOTH PHEROMONE; QUINQUEFASCIATUS; RESPONSES; IDENTIFICATION; DIPTERA; FIELD; PH	Synthetic mosquito oviposition attractants are sorely needed for surveillance and control programs for Culex species, which are major vectors of pathogens causing various human diseases, including filariasis, encephalitis, and West Nile encephalomyelitis. We employed novel and conventional chemical ecology approaches to identify potential attractants, which were demonstrated in field tests to be effective for monitoring populations of Cx. p. quinquefasciatus in human dwellings. Immunohistochemistry studies showed that an odorant-binding protein from this species, CquiOBP1, is expressed in trichoid sensilla on the antennae, including short, sharp-tipped trichoid sensilla type, which house an olfactory receptor neuron sensitive to a previously identified mosquito oviposition pheromone (MOP), 6-acetoxy-5-hexadecanolide. CquiOBP1 exists in monomeric and dimeric forms. Monomeric CquiOBP1 bound MOP in a pH-dependent manner, with a change in secondary structure apparently related to the loss of binding at low pH. The pheromone antipode showed higher affinity than the natural stereoisomer. By using both CquiOBP1 as a molecular target in binding assays and gas chromatography-electroantennographic detection (GC-EAD), we identified nonanal, trimethylamine (TMA), and skatole as test compounds. Extensive field evaluations in Recife, Brazil, a region with high populations of Cx. p. quinquefasciatus, showed that a combination of TMA (0.9 mu g/l) and nonanal (0.15 ng/ml) is equivalent in attraction to the currently used infusion-based lure, and superior in that the offensive smell of infusions was eliminated in the newly developed synthetic mixture.	[Leal, Walter S.; Xu, Wei; Ishida, Yuko; Syed, Zainulabeuddin; Latte, Nicolas; Chen, Angela M.; Morgan, Tania I.] Univ Calif Davis, Dept Entomol, Honorary Maeda Duffey Lab, Davis, CA 95616 USA; [Barbosa, Rosangela M. R.; Furtado, Andre] Ctr Pesquisas Ageu Magalhaes Fiocruz, Dept Entomol, Recife, PE, Brazil; [Cornel, Anthony J.] Univ Calif Davis, Dept Entomol, Mosquito Control Res Lab, Davis, CA USA	University of California System; University of California Davis; Fundacao Oswaldo Cruz; University of California System; University of California Davis	Leal, WS (corresponding author), Univ Calif Davis, Dept Entomol, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021; Xu, Wei/G-4709-2010; Barbosa, Rosângela/AAC-3339-2020; syed, zainulabeuddin/L-4961-2016	Barbosa, Rosângela/0000-0002-1171-598X; Leal Filho, Walter/0000-0002-1241-5225; Latte, Nicolas/0000-0002-3822-315X; Xu, Wei/0000-0003-4019-5140; syed, zainulabeuddin/0000-0002-6235-7115; Leal, Walter/0000-0002-6800-1240	National Institutes of Health [1U01AI05826-01]; Bedoukian Research Inc (BRI)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bedoukian Research Inc (BRI)	This work was supported in part by the National Institutes of Health (1U01AI05826-01) and a research agreement with Bedoukian Research Inc (BRI). BRI provided samples of the mosquito oviposition pheromone, but funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SA, 2004, J VECTOR ECOL, V29, P285; Ban LP, 2002, BIOCHEM BIOPH RES CO, V293, P50, DOI 10.1016/S0006-291X(02)00185-7; Barbosa RMR, 2007, MEM I OSWALDO CRUZ, V102, P523, DOI 10.1590/S0074-02762007005000058; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Braks MAH, 2007, J CHEM ECOL, V33, P567, DOI 10.1007/s10886-006-9223-8; CHRISTIANSEN JA, 2005, P PAP CAL MOSQ CONTR, P89; Clements A. N., 1999, BIOL MOSQUITOES SENS; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; DAWSON GW, 1990, J CHEM ECOL, V16, P1779, DOI 10.1007/BF01020494; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Du YJ, 1999, J MED ENTOMOL, V36, P158, DOI 10.1093/jmedent/36.2.158; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; HWANG YS, 1987, J CHEM ECOL, V13, P245, DOI 10.1007/BF01025885; Ishida Y, 2004, NATURWISSENSCHAFTEN, V91, P426, DOI 10.1007/s00114-004-0551-7; Ishida Y, 2002, J CHEM ECOL, V28, P867, DOI 10.1023/A:1015253214273; Ishida Yuko, 2003, Journal of Asia-Pacific Entomology, V6, P45, DOI 10.1016/S1226-8615(08)60166-1; Kline DL, 2007, MED VET ENTOMOL, V21, P323, DOI 10.1111/j.1365-2915.2007.00697.x; KOTSUKI H, 1990, J ORG CHEM, V55, P4417, DOI 10.1021/jo00301a038; LAURENCE BR, 1985, J CHEM ECOL, V11, P643, DOI 10.1007/BF00988573; LAURENCE BR, 1982, J CHEM SOC CHEM COMM, P59, DOI 10.1039/c39820000059; Lautenschlager C, 2005, BIOCHEM BIOPH RES CO, V335, P1044, DOI 10.1016/j.bbrc.2005.07.176; Leal WS, 2005, J CHEM ECOL, V31, P2493, DOI 10.1007/s10886-005-7458-4; Leal WS, 2000, BIOCHEM BIOPH RES CO, V268, P521, DOI 10.1006/bbrc.2000.2158; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Mboera LEG, 2000, J CHEM ECOL, V26, P1193, DOI 10.1023/A:1005432010721; McAbee RD, 2008, AM J TROP MED HYG, V78, P303, DOI 10.4269/ajtmh.2008.78.303; MILLAR JG, 1994, J AM MOSQUITO CONTR, V10, P374; Nasci Roger S., 1996, P85; Olagbemiro TO, 2004, J CHEM ECOL, V30, P965, DOI 10.1023/B:JOEC.0000028461.86243.19; Olagbemiro TO, 1999, J AGR FOOD CHEM, V47, P3411, DOI 10.1021/jf990294b; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; REISEN WK, 1987, J AM MOSQUITO CONTR, V3, P601; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Trexler JD, 2003, J AM MOSQUITO CONTR, V19, P228; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278; Xu W, 2008, BIOCHEM BIOPH RES CO, V372, P559, DOI 10.1016/j.bbrc.2008.05.087; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; 2008, CALIFORNIA MOSQUITO	42	114	125	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3045	10.1371/journal.pone.0003045	http://dx.doi.org/10.1371/journal.pone.0003045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725946	gold, Green Published, Green Submitted			2022-12-25	WOS:000264428800010
J	van Sorge, NM; Ebrahimi, CM; McGillivray, SM; Quach, D; Sabet, M; Guiney, DG; Doran, KS				van Sorge, Nina M.; Ebrahimi, Celia M.; McGillivray, Shauna M.; Quach, Darin; Sabet, Mojgan; Guiney, Donald G.; Doran, Kelly S.			Anthrax Toxins Inhibit Neutrophil Signaling Pathways in Brain Endothelium and Contribute to the Pathogenesis of Meningitis	PLOS ONE			English	Article								Background: Anthrax meningitis is the main neurological complication of systemic infection with Bacillus anthracis approaching 100% mortality. The presence of bacilli in brain autopsies indicates that vegetative bacteria are able to breach the blood-brain barrier (BBB). The BBB represents not only a physical barrier but has been shown to play an active role in initiating a specific innate immune response that recruits neutrophils to the site of infection. Currently, the basic pathogenic mechanisms by which B. anthracis penetrates the BBB and causes anthrax meningitis are poorly understood. Methodology/Principal Findings: Using an in vitro BBB model, we show for the first time that B. anthracis efficiently invades human brain microvascular endothelial cells (hBMEC), the single cell layer that comprises the BBB. Furthermore, transcriptional profiling of hBMEC during infection with B. anthracis revealed downregulation of 270 (87%) genes, specifically key neutrophil chemoattractants IL-8, CXCL1 (Gro alpha) and CXCL2 (Gro beta), thereby strongly contrasting hBMEC responses observed with other meningeal pathogens. Further studies using specific anthrax toxin-mutants, quantitative RTPCR, ELISA and in vivo assays indicated that anthrax toxins actively suppress chemokine production and neutrophil recruitment during infection, allowing unrestricted proliferation and dissemination of the bacteria. Finally, mice challenged with B. anthracis Sterne, but not the toxin-deficient strain, developed meningitis. Conclusions/Significance: These results suggest a significant role for anthrax toxins in thwarting the BBB innate defense response promoting penetration of bacteria into the central nervous system. Furthermore, establishment of a mouse model for anthrax meningitis will aid in our understanding of disease pathogenesis and development of more effective treatment strategies.	[van Sorge, Nina M.; McGillivray, Shauna M.; Doran, Kelly S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA USA; [Ebrahimi, Celia M.; Quach, Darin; Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA USA; [Ebrahimi, Celia M.; Quach, Darin; Doran, Kelly S.] San Diego State Univ, Ctr Microb Sci, San Diego, CA USA; [Sabet, Mojgan; Guiney, Donald G.] Univ Calif San Diego, Dept Med, La Jolla, CA USA	University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego	van Sorge, NM (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA USA.	kdoran@sciences.sdsu.edu	McGillivray, Shauna/AAN-3074-2021; van Sorge, Nina/E-3290-2017	McGillivray, Shauna/0000-0002-8863-1522; van Sorge, Nina/0000-0002-2695-5863; Quach, Darin/0000-0002-3244-5376	NIH [1U01AI077989]; NINDS/NIH [R01NS051247]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant 1U01AI077989 from the NIH to D.G.G. and R01NS051247 from the NINDS/NIH to K.S.D.	ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Batty S, 2006, CELL MICROBIOL, V8, P130, DOI 10.1111/j.1462-5822.2005.00606.x; Betz A L, 1992, NIDA Res Monogr, V120, P54; BETZ AL, 1985, FED PROC, V44, P2614; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Cleret A, 2007, J IMMUNOL, V178, P7994, DOI 10.4049/jimmunol.178.12.7994; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Drysdale M, 2007, INFECT IMMUN, V75, P1757, DOI 10.1128/IAI.01712-06; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; During RL, 2005, J INFECT DIS, V192, P837, DOI 10.1086/432516; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; FRITZ DL, 1995, LAB INVEST, V73, P691; GLEISER CA, 1967, FED PROC, V26, P1518; Guidi-Rontani C, 2002, TRENDS MICROBIOL, V10, P405, DOI 10.1016/S0966-842X(02)02422-8; Heninger S, 2006, INFECT IMMUN, V74, P6067, DOI 10.1128/IAI.00719-06; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; Kim KS, 2001, INFECT IMMUN, V69, P5217, DOI 10.1128/IAI.69.9.5217-5222.2001; Lanska DJ, 2002, NEUROLOGY, V59, P327, DOI 10.1212/WNL.59.3.327; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Popov SG, 2004, CELL MICROBIOL, V6, P225, DOI 10.1046/j.1462-5822.2003.00358.x; Russell BH, 2007, CELL MICROBIOL, V9, P1262, DOI 10.1111/j.1462-5822.2006.00869.x; Sasik R, 2002, BIOINFORMATICS, V18, P1633, DOI 10.1093/bioinformatics/18.12.1633; Schubert-Unkmeir A, 2007, INFECT IMMUN, V75, P899, DOI 10.1128/IAI.01508-06; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; STINS MF, 1994, AM J PATHOL, V145, P1228; Stins MF, 1997, IN VITRO CELL DEV-AN, V33, P243; Storie I, 2003, CYTOM PART B-CLIN CY, V55B, P1, DOI 10.1002/cyto.b.10051; TURNBULL PCB, 1991, VACCINE, V9, P533, DOI 10.1016/0264-410X(91)90237-Z; Unwin RD, 2006, CELL CYCLE, V5, P1587, DOI 10.4161/cc.5.15.3101; WELKOS SL, 1988, MICROB PATHOGENESIS, V4, P53, DOI 10.1016/0882-4010(88)90048-4; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	39	52	53	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2964	10.1371/journal.pone.0002964	http://dx.doi.org/10.1371/journal.pone.0002964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698416	Green Submitted, Green Published, gold			2022-12-25	WOS:000264412600049
J	Yuki, K; Astrof, NS; Bracken, C; Yoo, R; Silkworth, W; Soriano, SG; Shimaoka, M				Yuki, Koichi; Astrof, Nathan S.; Bracken, Clay; Yoo, Ronnie; Silkworth, Whitney; Soriano, Sulpicio G.; Shimaoka, Motomu			The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity	FASEB JOURNAL			English	Article						NMR; structure; small-molecule antagonist; leukocyte; cell adhesion	FUNCTION-ASSOCIATED ANTIGEN-1; I-DOMAIN; HIGH-AFFINITY; STRUCTURAL BASIS; DISULFIDE BOND; A-DOMAIN; ADHESION; PROTEIN; NMR; INFLAMMATION	The molecular and structural basis of anesthetic interactions with conformations and functionalities of cell surface receptors remains to be elucidated. We have demonstrated that the widely used volatile anesthetic isoflurane blocks the activation-dependent conformational conversion of integrin lymphocyte function associated antigen-1 (LFA-1), the major leukocyte cell adhesion molecule, to a high-affinity configuration. Perturbation of LFA-1 activation by isoflurane at clinically relevant concentrations leads to the inhibition of T-cell interactions with target cells as well as ligand-triggered intracellular signaling. Nuclear magnetic resonance spectroscopy reveals that isoflurane binds within a cavity in the LFA-1 ligand-binding domain, which is a previously identified drug-binding site for allosteric small-molecule antagonists that stabilize LFA-1 in a low-affinity conformation. These results provide a potential mechanism for the immunomodulatory properties of isoflurane.	[Yuki, Koichi; Astrof, Nathan S.; Yoo, Ronnie; Silkworth, Whitney; Shimaoka, Motomu] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Yuki, Koichi; Soriano, Sulpicio G.; Shimaoka, Motomu] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA; [Astrof, Nathan S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Yuki, Koichi; Soriano, Sulpicio G.] Childrens Hosp Boston, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Astrof, Nathan S.] Cornell Med Sch, New York, NY USA; [Bracken, Clay] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Cornell University; Cornell University	Shimaoka, M (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 200 Longwood Ave,Rm 253, Boston, MA 02115 USA.	shimaoka@idi.harvard.edu	Bracken, Clay/A-7811-2009; Soriano, Sulpicio/K-3501-2019		National Institutes of Health [AI063421, HL048675]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Song and T. A. Springer (Harvard Medical School, Boston, MA, USA) for providing reagents; T. Shimizu (University of Tokyo, Tokyo, Japan) for providing reagents and insightful comments; E. J. Park, D. Peer, and Y. Imai for technical support; S. Piva for insightful comments and stimulating our interest in integrin-isoflurane interactions; and T. Zimmerman and F. J. Blanco for sending the unpublished NMR assignments. This work was supported by grants from the National Institutes of Health, AI063421 and HL048675 (M.S.). K.Y. designed research, performed research, analyzed data, and wrote the paper; N.S.A. designed research, performed research, analyzed data, and wrote the paper; C.B. performed research and analyzed data; R.Y. performed research; W.S. performed research; S.G.S. designed research, analyzed data, and wrote the paper; M.S. designed research, performed research, analyzed data, and wrote the paper. The authors declare no conflicts of interest.	Chen X, 2007, P NATL ACAD SCI USA, V104, P6329, DOI 10.1073/pnas.0611655104; Chiang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001879; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DUBOIS BW, 1992, BIOCHEMISTRY-US, V31, P7069, DOI 10.1021/bi00146a007; Eckenhoff RG, 2001, BIOCHEMISTRY-US, V40, P10819, DOI 10.1021/bi010691r; Fang M, 2003, J BIOL CHEM, V278, P36669, DOI 10.1074/jbc.M303520200; FRANKS NP, 1991, SCIENCE, V254, P427, DOI 10.1126/science.1925602; Frenette PS, 2001, NEW ENGL J MED, V345, P1419, DOI 10.1056/NEJM200111083451911; Hayes JK, 2004, ANESTH ANALG, V98, P999, DOI 10.1213/01.ANE.0000104584.91385.1D; Heindl B, 1999, ANESTHESIOLOGY, V91, P521, DOI 10.1097/00000542-199908000-00027; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kriwacki RW, 2000, J BIOMOL NMR, V16, P271, DOI 10.1023/A:1008358912334; Lee HT, 2007, AM J PHYSIOL-RENAL, V293, pF713, DOI 10.1152/ajprenal.00161.2007; Lee HT, 2007, SHOCK, V27, P373, DOI 10.1097/01.shk.0000248595.17130.24; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Liu RY, 2005, FASEB J, V19, P567, DOI 10.1096/fj.04-3171com; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398; Manderson GA, 2002, BIOCHEMISTRY-US, V41, P4080, DOI 10.1021/bi0160718; McBride WT, 1996, ANAESTHESIA, V51, P465, DOI 10.1111/j.1365-2044.1996.tb07793.x; Mobert J, 1999, ANESTHESIOLOGY, V90, P1372, DOI 10.1097/00000542-199905000-00022; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; Tang P, 1997, BIOPHYS J, V72, P1676, DOI 10.1016/S0006-3495(97)78813-1; Vemparala S, 2006, BIOPHYS J, V91, P2815, DOI 10.1529/biophysj.106.085324; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yonkunas MJ, 2005, BIOPHYS J, V89, P2350, DOI 10.1529/biophysj.105.063396; Zimmerman T, 2007, CHEM BIOL DRUG DES, V70, P347, DOI 10.1111/j.1747-0285.2007.00566.x	36	39	40	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4109	4116		10.1096/fj.08-113324	http://dx.doi.org/10.1096/fj.08-113324			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18708587	Green Published			2022-12-25	WOS:000261254800010
J	Elgan, TH; Berndt, KD				Elgan, Tobias H.; Berndt, Kurt D.			Quantifying Escherichia coli Glutaredoxin-3 Substrate Specificity Using Ligand-induced Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED DISULFIDE; CONFORMATIONAL STABILITY; HUMAN THIOREDOXIN; NMR STRUCTURE; GLUTATHIONE; BINDING; MUTANT; THIOLTRANSFERASE; STABILIZATION; PROTEINS	Traditionally, quantification of protein-ligand affinity is performed using kinetic or equilibrium measurements. However, if the binding reaction proceeds via a stable covalent complex, these approaches are often limited. By exploiting the fact that the conformational stabilization of a protein is altered upon ligand binding due to specific interactions, and using an array of selectively chosen ligand analogs, one can quantify the contribution individual interactions have on specificity. We have used ligand-induced stability as a basis to dissect the interaction between glutaredoxin-3 (Grx3) and one of its native substrates, the tripeptide glutathione. Taking advantage of the fact that Grx3 can be trapped in a covalent mixed disulfide to glutathione or to selected synthetic glutathione analogs as part of the natural catalytic cycle, individual contributions to binding of specific molecular groups can be quantified by changes in ligand-induced stability. These changes in conformational stability are interpreted in terms of interaction energies (i.e. specificity) of the particular groups present on the ligand analog. Our results illustrate that although Grx3 recognizes glutathione predominantly through independent and additive ionic interactions at the N- and C-terminal of glutathione, van der Waals interactions from the unique gamma-glutamate moiety of glutathione also play an important role. This study places us closer to understanding the complex task of accommodating multiple substrate specificities in proteins of the thioredoxin superfamily and underscores the general applicability of ligand-induced stability to probe substrate specificity.	[Elgan, Tobias H.; Berndt, Kurt D.] Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; [Elgan, Tobias H.; Berndt, Kurt D.] Sodertorns Hgsk, Sch Life Sci, S-14189 Huddinge, Sweden	Karolinska Institutet; Sodertorn University	Berndt, KD (corresponding author), Halsovagen 7, S-14157 Huddinge, Sweden.	kurt.berndt@ki.se	Berndt, Kurt/J-8574-2015; Elgan, Tobias H/B-8573-2017; Elgan, Tobias/AAD-5281-2019	Berndt, Kurt/0000-0002-3049-967X; Elgan, Tobias H/0000-0001-6406-4685; Elgan, Tobias/0000-0001-6406-4685	Karolinska Institutet and Sodertorns Hogskola	Karolinska Institutet and Sodertorns Hogskola	This work was supported by grants from the Karolinska Institutet and Sodertorns Hogskola.	Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Berardi MJ, 1999, J MOL BIOL, V292, P151, DOI 10.1006/jmbi.1999.3067; BUSHWELLER JH, 1994, J MOL BIOL, V235, P1585, DOI 10.1006/jmbi.1994.1108; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Chan WC, 2000, FMOC SOLID PHASE PEP; Erlanson DA, 2004, ANNU REV BIOPH BIOM, V33, P199, DOI 10.1146/annurev.biophys.33.110502.140409; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Fountoulakis M, 1998, J CHROMATOGR A, V826, P109, DOI 10.1016/S0021-9673(98)00721-3; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; KLEANTHOUS C, 1991, J BIOL CHEM, V266, P10893; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Nagarajan R, 2004, BIOCHEMISTRY-US, V43, P9664, DOI 10.1021/bi049309b; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Nordstrand K, 2000, J MOL BIOL, V303, P423, DOI 10.1006/jmbi.2000.4145; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; PACE CN, 1980, J BIOL CHEM, V255, P3862; PACE CN, 1988, J BIOL CHEM, V263, P11820; PACE CN, 1990, TRENDS BIOCHEM SCI, V15, P14, DOI 10.1016/0968-0004(90)90124-T; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Powell KD, 2002, J AM CHEM SOC, V124, P10256, DOI 10.1021/ja026574g; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Sagemark J, 2007, PROTEINS, V68, P879, DOI 10.1002/prot.21416; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; VlamisGardikas A, 1997, J BIOL CHEM, V272, P11236; Wurth C, 2001, PROTEIN SCI, V10, P63, DOI 10.1110/ps.27401; Xie D, 2000, J AM CHEM SOC, V122, P11533, DOI 10.1021/ja003230m; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504; Yu J, 2008, PROTEINS, V72, P1077, DOI 10.1002/prot.22096	36	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32839	32847		10.1074/jbc.M804019200	http://dx.doi.org/10.1074/jbc.M804019200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18757366	hybrid			2022-12-25	WOS:000260893700073
J	Goldshmidt, H; Sheiner, L; Butikofer, P; Roditi, I; Uliel, S; Gunzel, M; Engstler, M; Michaeli, S				Goldshmidt, Hanoch; Sheiner, Lilach; Buetikofer, Peter; Roditi, Isabel; Uliel, Shai; Guenzel, Mark; Engstler, Markus; Michaeli, Shulamit			Role of Protein Translocation Pathways across the Endoplasmic Reticulum in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION-PARTICLE; PROCYCLIC CULTURE FORMS; RNA-LIKE MOLECULE; MEMBRANE-PROTEINS; AFRICAN TRYPANOSOMES; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SURFACE PROTEIN; ER MEMBRANE; FUNCTIONAL-CHARACTERIZATION	The translocation of secretory and membrane proteins across the endoplasmic reticulum (ER) membrane is mediated by co-translational (via the signal recognition particle (SRP)) and post-translational mechanisms. In this study, we investigated the relative contributions of these two pathways in trypanosomes. A homologue of SEC71, which functions in the post-translocation chaperone pathway in yeast, was identified and silenced by RNA interference. This factor is essential for parasite viability. In SEC71-silenced cells, signal peptide (SP)-containing proteins traversed the ER, but several were mislocalized, whereas polytopic membrane protein biogenesis was unaffected. Surprisingly trypanosomes can interchangeably utilize two of the pathways to translocate SP-containing proteins except for glycosylphosphatidylinositol-anchored proteins, whose level was reduced in SEC71-silenced cells but not in cells depleted for SRP68, an SRP-binding protein. Entry of SP-containing proteins to the ER was significantly blocked only in cells co-silenced for the two translocation pathways (SEC71 and SRP68). SEC63, a factor essential for both translocation pathways in yeast, was identified and silenced by RNA interference. SEC63 silencing affected entry to the ER of both SP-containing proteins and polytopic membrane proteins, suggesting that, as in yeast, this factor is essential for both translocation pathways in vivo. This study suggests that, unlike bacteria or other eukaryotes, trypanosomes are generally promiscuous in their choice of mechanism for translocating SP-containing proteins to the ER, although the SRP-independent pathway is favored for glycosylphosphatidylinositol-anchored proteins, which are the most abundant surface proteins in these parasites.	[Goldshmidt, Hanoch; Sheiner, Lilach; Uliel, Shai; Michaeli, Shulamit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Roditi, Isabel] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Guenzel, Mark; Engstler, Markus] Tech Univ Darmstadt, Dept Genet & Microbiol, Cellular Dynam Unit, D-64287 Darmstadt, Germany	Bar Ilan University; University of Bern; University of Bern; Technical University of Darmstadt	Michaeli, S (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	michaes@mail.biu.ac.il	Engstler, Markus/E-6054-2010; Michaeli, Shulamit/AAC-8255-2022	Roditi, Isabel/0000-0003-2812-6513	Israeli Science Foundation; European Molecular Biology Organization	Israeli Science Foundation(Israel Science Foundation); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was initially supported by a grant from the Israeli Science Foundation. The collaboration between our groups was initiated through funding by a European Molecular Biology Organization short term fellowship (to L. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bangs JD, 1998, CURR OPIN MICROBIOL, V1, P448, DOI 10.1016/S1369-5274(98)80064-7; Barth S, 2005, J BIOL CHEM, V280, P34558, DOI 10.1074/jbc.M503465200; BASSFORD P, 1991, CELL, V65, P367, DOI 10.1016/0092-8674(91)90453-6; BEJA O, 1993, MOL BIOCHEM PARASIT, V57, P223, DOI 10.1016/0166-6851(93)90198-7; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; BROWN JD, 1994, EMBO J, V13, P4390, DOI 10.1002/j.1460-2075.1994.tb06759.x; BRUN R, 1979, ACTA TROP, V36, P289; Butikofer P, 1997, BIOCHEM J, V326, P415; Butikofer P, 2002, MOL BIOCHEM PARASIT, V119, P87, DOI 10.1016/S0166-6851(01)00398-X; Corsi AK, 1996, J BIOL CHEM, V271, P30299, DOI 10.1074/jbc.271.48.30299; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; FANG H, 1994, MOL BIOL CELL, V5, P933, DOI 10.1091/mbc.5.9.933; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; FERGUSON MAJ, 1994, PARASITOLOGY, V108, pS45, DOI 10.1017/S0031182000075715; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; Henriques C, 2003, MOL BIOCHEM PARASIT, V130, P101, DOI 10.1016/S0166-6851(03)00167-1; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; Jermy AJ, 2006, J BIOL CHEM, V281, P7899, DOI 10.1074/jbc.M511402200; Kalies KU, 1998, EUR J BIOCHEM, V254, P1, DOI 10.1046/j.1432-1327.1998.2540001.x; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; LEE MGS, 1994, J BIOL CHEM, V269, P8408; LEE MGS, 1990, MOL CELL BIOL, V10, P4506, DOI 10.1128/MCB.10.9.4506; Liu L, 2003, J BIOL CHEM, V278, P18271, DOI 10.1074/jbc.M209215200; Liu L, 2002, J BIOL CHEM, V277, P47348, DOI 10.1074/jbc.M207736200; Lustig Y, 2005, J CELL SCI, V118, P4551, DOI 10.1242/jcs.02578; Lustig Y, 2007, EUKARYOT CELL, V6, P1865, DOI 10.1128/EC.00134-07; Lustig Y, 2007, EMBO REP, V8, P408, DOI 10.1038/sj.embor.7400930; Mandelboim M, 2003, J BIOL CHEM, V278, P51469, DOI 10.1074/jbc.M308997200; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; Mutomba MC, 1997, MOL BIOCHEM PARASIT, V90, P491, DOI 10.1016/S0166-6851(97)00197-7; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; RIFKIN MR, 1995, J BIOL CHEM, V270, P16160, DOI 10.1074/jbc.270.27.16160; Roditi I, 1999, MOL BIOCHEM PARASIT, V103, P99, DOI 10.1016/S0166-6851(99)00124-3; Roditi I, 1998, MOL BIOCHEM PARASIT, V91, P117, DOI 10.1016/S0166-6851(97)00195-3; Rothmann C, 2000, COMP BIOCHEM PHYS A, V125, P75, DOI 10.1016/S1095-6433(99)00157-9; SCHLENSTEDT G, 1990, J BIOL CHEM, V265, P13960; SCHLENSTEDT G, 1987, EMBO J, V6, P699, DOI 10.1002/j.1460-2075.1987.tb04810.x; Schwartz KJ, 2005, J CELL SCI, V118, P5499, DOI 10.1242/jcs.02667; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066; Triggs VP, 2003, EUKARYOT CELL, V2, P76, DOI 10.1128/EC.2.1.76-83.2003; Tuteja R, 2007, ARCH BIOCHEM BIOPHYS, V467, P249, DOI 10.1016/j.abb.2007.08.031; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Willer M, 2003, YEAST, V20, P133, DOI 10.1002/yea.954; Wittke S, 2000, MOL BIOL CELL, V11, P3859, DOI 10.1091/mbc.11.11.3859; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zimmermann R, 1998, BIOL CHEM, V379, P275	65	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32085	32098		10.1074/jbc.M801499200	http://dx.doi.org/10.1074/jbc.M801499200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18768469	hybrid			2022-12-25	WOS:000260760800090
J	Mochizuki, H; Yoshida, K; Shibata, Y; Kimata, K				Mochizuki, Hideo; Yoshida, Keiichi; Shibata, Yuniko; Kimata, Koji			Tetrasulfated Disaccharide Unit in Heparan Sulfate ENZYMATIC FORMATION AND TISSUE DISTRIBUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE; TUMOR SUPPRESSORS; MOLECULAR-CLONING; DOMAIN-STRUCTURE; FINE-STRUCTURE; BINDING SITE; HUMAN CDNAS; PROTEOGLYCANS; SPECIFICITY	We previously reported that the heparan sulfate 3-O-sulfo-transferase (3OST)-5 produces a novel component of heparan sulfate, i.e. the tetrasulfated disaccharide (Di-tetraS) unit (Mochizuki, H., Yoshida, K., Gotoh, M., Sugioka, S., Kikuchi, N., Kwon, Y.-D., Tawada, A., Maeyama, K., Inaba, N., Hiruma, T., Kimata, K., and Narimatsu, H. (2003) J. Biol. Chem. 278, 26780 26787). In the present study, we investigated the potential of other 3OST isoforms to produce Di-tetraS with heparan sulfate and heparin as acceptor substrates. 3OST-2, 3OST-3, and 3OST-4 produce Di-tetraS units as a major product from both substrates. 3OST-5 showed the same specificity for heparin, but the production from heparan sulfate was very low. Di-tetraS production by 3OST-1 was negligible. We then investigated the presence of Di-tetraS units in heparan sulfates from various rat tissues. Di-tetraS was detected in all of the tissues analyzed. Liver and spleen contain relatively high levels of Di-tetraS, 1.6 and 0.95%, respectively. However, the content of this unit in heart, large intestine, ileum, and lung is low, less than 0.2%. We further determined the expression levels of 3OST transcripts by quantitative real time PCR. The 3OST-3 transcripts are highly expressed in spleen and liver. The 3OST-2 and -4 are specifically expressed in brain. These results indicate that the Di-tetraS unit is widely distributed throughout the body as a rare and unique component of heparan sulfate and is synthesized by tissue-specific 3OST isoforms specific for Di-tetraS production.	[Mochizuki, Hideo] Seikagaku Corp, Cent Res Labs, Tokyo 2070021, Japan; [Yoshida, Keiichi] Mizutani Fdn Glycosci, Chiyoda Ku, Tokyo 1000005, Japan; [Shibata, Yuniko] Seikagaku Biobusiness Corp, Res Labs, Tokyo 2070021, Japan; [Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan	Seikagaku Corporation; Aichi Medical University	Mochizuki, H (corresponding author), Seikagaku Corp, Cent Res Labs, 3-1253 Tateno, Tokyo 2070021, Japan.	hideo.mochizuki@seikagaku.co.jp						Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; DESAI UR, 1993, ARCH BIOCHEM BIOPHYS, V306, P461, DOI 10.1006/abbi.1993.1538; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; HEINEGARD D, 1987, METHOD ENZYMOL, V144, P319; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; KARIYA Y, 1992, COMP BIOCHEM PHYS B, V103, P473, DOI 10.1016/0305-0491(92)90323-J; Kuberan B, 2004, J BIOL CHEM, V279, P5053, DOI 10.1074/jbc.C300492200; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Lawrence R, 2004, GLYCOBIOLOGY, V14, P467, DOI 10.1093/glycob/cwh057; Lawrence R, 2007, MATRIX BIOL, V26, P442, DOI 10.1016/j.matbio.2007.03.002; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; Liu J, 2002, J BIOL CHEM, V277, P33456, DOI 10.1074/jbc.M202034200; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; LYON M, 1994, J BIOL CHEM, V269, P11208; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Mochizuki H, 2003, J BIOL CHEM, V278, P26780, DOI 10.1074/jbc.M301861200; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Wu ZLL, 2004, J BIOL CHEM, V279, P1861, DOI 10.1074/jbc.M311398200; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; YAMADA S, 1995, J BIOL CHEM, V270, P8696; YAMADA SH, 1993, J BIOL CHEM, V268, P4780; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451	53	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31237	31245		10.1074/jbc.M801586200	http://dx.doi.org/10.1074/jbc.M801586200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18757372	Green Published, hybrid			2022-12-25	WOS:000260544800077
J	Wang, Q; Zhang, X; Zhang, L; He, F; Zhang, GW; Jamrich, M; Wensel, TG				Wang, Qiong; Zhang, Xue; Zhang, Li; He, Feng; Zhang, Guowei; Jamrich, Milan; Wensel, Theodore G.			Activation-dependent Hindrance of Photoreceptor G Protein Diffusion by Lipid Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT MEMBRANE RAFTS; GTPASE-ACCELERATING PROTEIN; ROD OUTER SEGMENTS; TRANSGENIC XENOPUS-LAEVIS; LATERAL DIFFUSION; DISK MEMBRANES; FUSION PROTEIN; ROTATIONAL DIFFUSION; COUPLED RECEPTORS; DOMAIN FORMATION	The dynamics of G protein-mediated signal transduction depend on the two-dimensional diffusion of membrane-bound G proteins and receptors, which has been suggested to be rate-limiting for vertebrate phototransduction, a highly amplified G protein-coupled signaling pathway. Using fluorescence recovery after photobleaching (FRAP), we measured the diffusion of the G protein transducin alpha-subunit (G alpha(t)) and the G protein-coupled receptor rhodopsin on disk membranes of living rod photoreceptors from transgenic Xenopus laevis. Treatment with either methyl-beta-cyclodextrin or filipin III to disrupt cholesterol-containing lipid microdomains dramatically accelerated diffusion of G alpha(t) in its GTP-bound state and of the rhodopsin-G alpha beta gamma(t) complex but not of rhodopsin or inactive GDP-bound G alpha beta gamma. These results imply an activity-dependent sequestration of G proteins into cholesterol-dependent lipid microdomains, which limits diffusion and exclude the majority of free rhodopsin and the free G protein heterotrimer. Our data offer a novel demonstration of lipid microdomains in the internal membranes of living sensory neurons.	[Wang, Qiong; Zhang, Xue; He, Feng; Zhang, Guowei; Wensel, Theodore G.] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Zhang, Li] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Jamrich, Milan] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wensel, TG (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	twensel@bcm.edu		Wensel, Theodore/0000-0003-3518-9352	National Institutes of Health [R01-EY07981, R01-EY12505]; Welch Foundation [Q0035]; NATIONAL EYE INSTITUTE [R01EY007981, R01EY012505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-EY07981 and R01-EY12505 from NEI. This work was also supported by Welch Foundation Grant Q0035. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; BIRRELL GB, 1976, BIOCHEMISTRY-US, V15, P2925, DOI 10.1021/bi00658a035; Boesze-Battaglia K, 2002, J BIOL CHEM, V277, P41843, DOI 10.1074/jbc.M207111200; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chabre M, 2003, NATURE, V426, P30, DOI 10.1038/426030b; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; CRANK J, 1975, MATH DIFFFUSION; DUMKE CL, 1994, J GEN PHYSIOL, V103, P1071, DOI 10.1085/jgp.103.6.1071; Edrington TC, 2008, BIOPHYS J, V95, P2859, DOI 10.1529/biophysj.108.128868; Elias R, 2004, MOL VIS, V10, P672; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; GUPTA BD, 1990, J PHYSIOL-LONDON, V430, P483, DOI 10.1113/jphysiol.1990.sp018303; HAMM HE, 1986, BIOCHEMISTRY-US, V25, P4512, DOI 10.1021/bi00364a010; Harlow E., 1988, ANTIBODIES LAB MANUA; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Jin S, 2003, FEBS LETT, V542, P142, DOI 10.1016/S0014-5793(03)00368-5; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; KOUTALOS Y, 1995, BIOPHYS J, V68, P373, DOI 10.1016/S0006-3495(95)80198-0; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; Liu H, 2003, BIOCHEM BIOPH RES CO, V303, P19, DOI 10.1016/S0006-291X(03)00284-5; Lobanova ES, 2007, J NEUROSCI, V27, P1151, DOI 10.1523/JNEUROSCI.5010-06.2007; Malinski JA, 1996, J BIOL CHEM, V271, P12919, DOI 10.1074/jbc.271.22.12919; Mani SS, 2001, J BIOL CHEM, V276, P36557, DOI 10.1074/jbc.M101685200; Martin RE, 2005, INVEST OPHTH VIS SCI, V46, P1147, DOI 10.1167/iovs.04-1207; Mbamala EC, 2005, BIOPHYS J, V88, P1702, DOI 10.1529/biophysj.104.048132; Melia TJ, 1999, J STRUCT BIOL, V128, P119, DOI 10.1006/jsbi.1999.4151; Moritz OL, 2001, J BIOL CHEM, V276, P28242, DOI 10.1074/jbc.M101476200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Niu SL, 2002, J BIOL CHEM, V277, P20139, DOI 10.1074/jbc.M200594200; Perkins BD, 2002, VISUAL NEUROSCI, V19, P257, DOI 10.1017/S0952523802192030; PETERS R, 1982, P NATL ACAD SCI-BIOL, V79, P4317, DOI 10.1073/pnas.79.14.4317; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; Poveda JA, 2002, BIOCHEMISTRY-US, V41, P12253, DOI 10.1021/bi0200099; Rajala RVS, 2006, ADV EXP MED BIOL, V572, P491; RIETVELD A, 1987, EUR J BIOCHEM, V164, P137, DOI 10.1111/j.1432-1033.1987.tb11004.x; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Senin II, 2004, J BIOL CHEM, V279, P48647, DOI 10.1074/jbc.M402516200; Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Wensel Theodore G., 2005, V307, P289; WEY CL, 1981, BIOPHYS J, V33, P225, DOI 10.1016/S0006-3495(81)84883-7; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; YAMANAKA G, 1985, BIOCHEMISTRY-US, V24, P8094, DOI 10.1021/bi00348a039; Zhang ZX, 2004, J BIOL CHEM, V279, P33937, DOI 10.1074/jbc.M403404200	59	42	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30015	30024		10.1074/jbc.M803953200	http://dx.doi.org/10.1074/jbc.M803953200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18713731	hybrid, Green Published			2022-12-25	WOS:000260366900046
J	Ilioaia, C; Johnson, MP; Horton, P; Ruban, AV				Ilioaia, Cristian; Johnson, Matthew P.; Horton, Peter; Ruban, Alexander V.			Induction of Efficient Energy Dissipation in the Isolated Light-harvesting Complex of Photosystem II in the Absence of Protein Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIME-RESOLVED FLUORESCENCE; ABSORBED EXCITATION-ENERGY; CHLOROPHYLL-A FLUORESCENCE; PH-DEPENDENT DISSIPATION; PHOTOSYNTHETIC MEMBRANES; MECHANISM; STATE; ZEAXANTHIN; KINETICS; BINDING	Under excess illumination, the Photosystem II light-harvesting antenna of higher plants has the ability to switch into an efficient photoprotective mode, allowing safe dissipation of excitation energy into heat. In this study, we show induction of the energy dissipation state, monitored by chlorophyll fluorescence quenching, in the isolated major light-harvesting complex (LHCII) incorporated into a solid gel system. Removal of detergent caused strong fluorescence quenching, which was totally reversible. Singlet-singlet annihilation and gel electrophoresis experiments suggested that the quenched complexes were in the trimeric not aggregated state. Both the formation and recovery of this quenching state were inhibited by a cross-linker, implying involvement of conformational changes. Absorption and CD measurements performed on the samples in the quenched state revealed specific alterations in the spectral bands assigned to the red forms of chlorophyll a, neoxanthin, and lutein 1 molecules. The majority of these alterations were similar to those observed during LHCII aggregation. This suggests that not the aggregation process as such but rather an intrinsic conformational transition in the complex is responsible for establishment of quenching. 77 K fluorescence measurements showed red-shifted chlorophyll a fluorescence in the 690-705 nm region, previously observed in aggregated LHCII. The fact that all spectral changes associated with the dissipative mode observed in the gel were different from those of the partially denatured complex strongly argues against the involvement of protein denaturation in the observed quenching. The implications of these findings for proposed mechanisms of energy dissipation in the Photosystem II antenna are discussed.	[Johnson, Matthew P.; Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Ilioaia, Cristian; Horton, Peter] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of London; Queen Mary University London; University of Sheffield	Ruban, AV (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd,Fogg Bldg, London E1 4NS, England.	a.ruban@qmul.ac.uk	Horton, Peter/A-3958-2012	Horton, Peter/0000-0002-6095-1460; Johnson, Matthew/0000-0002-1663-0205; ILIOAIA, Cristian/0000-0001-7505-1900	Biotechnology and Biological Sciences Research Council; The Royal Society; INTRO2 Marie Curie Research Training Network	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The Royal Society(Royal Society of London); INTRO2 Marie Curie Research Training Network(European Commission)	This work was supported by grants (to A. V. R. and P. H.) from the Biotechnology and Biological Sciences Research Council and The Royal Society and by the INTRO2 Marie Curie Research Training Network of the European Union. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Amarie S, 2007, J PHYS CHEM B, V111, P3481, DOI 10.1021/jp066458q; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Barzda V, 2001, BIOPHYS J, V80, P2409, DOI 10.1016/S0006-3495(01)76210-8; Busch F, 2007, PLANT PHYSIOL, V143, P1242, DOI 10.1104/pp.106.092312; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DENHOLLANDER WTF, 1993, BIOCHIM BIOPHYS ACTA, V725, P492; GILMORE AM, 1995, P NATL ACAD SCI USA, V92, P2273, DOI 10.1073/pnas.92.6.2273; Gilmore AM, 1998, BIOCHEMISTRY-US, V37, P13582, DOI 10.1021/bi981384x; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; IDE JP, 1987, BIOCHIM BIOPHYS ACTA, V893, P349, DOI 10.1016/0005-2728(87)90056-9; Kirchhoff H, 2003, BBA-BIOENERGETICS, V1606, P105, DOI 10.1016/S0005-2728(03)00105-1; KWA SLS, 1992, BIOCHIM BIOPHYS ACTA, V1101, P143, DOI 10.1016/0005-2728(92)90198-B; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; QUICK WP, 1984, P ROY SOC LOND B BIO, V226, P237; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 1998, BIOCHEMISTRY-US, V37, P11586, DOI 10.1021/bi9809369; RUBAN AV, 1994, PLANT PHYSIOL, V104, P227, DOI 10.1104/pp.104.1.227; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P39, DOI 10.1016/0167-4838(92)90496-Z; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Ruban AV, 1997, BBA-BIOENERGETICS, V1321, P61, DOI 10.1016/S0005-2728(97)00047-9; SCHREIBER U, 1986, PHOTOSYNTH RES, V9, P261, DOI 10.1007/BF00029749; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Tang YL, 2007, PLANT PHYSIOL, V143, P629, DOI 10.1104/pp.106.090712; Wagner B, 1996, J PHOTOCH PHOTOBIO B, V36, P339, DOI 10.1016/S1011-1344(96)07391-5	34	88	88	5	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29505	29512		10.1074/jbc.M802438200	http://dx.doi.org/10.1074/jbc.M802438200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728016	Green Published, hybrid			2022-12-25	WOS:000260179900076
J	Mori, T; Kitano, K; Terawaki, S; Maesaki, R; Fukami, Y; Hakoshima, T				Mori, Tomoyuki; Kitano, Ken; Terawaki, Shin-ichi; Maesaki, Ryoko; Fukami, Yayoi; Hakoshima, Toshio			Structural Basis for CD44 Recognition by ERM Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE GLYCOPROTEIN; HYALURONIC-ACID; CYTOPLASMIC DOMAIN; CRYSTALLOGRAPHIC CHARACTERIZATION; INTRAMEMBRANE PROTEOLYSIS; INTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; BINDING DOMAIN; FERM DOMAIN; F-ACTIN	CD44 is an important adhesion molecule that functions as the major hyaluronan receptor which mediates cell adhesion and migration in a variety of physiological and pathological processes. Although full activity of CD44 requires binding to ERM (ezrin/radixin/moesin) proteins, the CD44 cytoplasmic region, consisting of 72 amino acid residues, lacks the Motif-1 consensus sequence for ERM binding found in intercellular adhesion molecule (ICAM)-2 and other adhesion molecules of the immunoglobulin superfamily. Ultracentrifugation sedimentation studies and circular dichroism measurements revealed an extended monomeric form of the cytoplasmic peptide in solution. The crystal structure of the radixin FERM domain complexed with a CD44 cytoplasmic peptide reveals that the KKKLVIN sequence of the peptide forms a beta strand followed by a short loop structure that binds subdomain C of the FERM domain. Like Motif-1 binding, theCD44 beta strand binds the shallow groove between strand beta 5C and helix alpha 1C and augments the beta sheet beta 5C-beta 7C from subdomain C. Two hydrophobic CD44 residues, Leu and Ile, are docked into a hydrophobic pocket with the formation of hydrogen bonds between Asn of the CD44 short loop and loop beta 4C-beta 5C from subdomain C. This binding mode resembles that of NEP (neutral endopeptidase 24.11) rather than ICAM-2. Our results reveal a characteristic versatility of peptide recognition by the FERM domains from ERM proteins, suggest a possible mechanism by which the CD44 tail is released from the cytoskeleton for nuclear translocation by regulated intramembrane proteolysis, and provide a structural basis for Smad1 interactions with activated CD44 bound to ERM protein.	[Mori, Tomoyuki; Kitano, Ken; Terawaki, Shin-ichi; Maesaki, Ryoko; Fukami, Yayoi; Hakoshima, Toshio] Nara Inst Sci & Technol, Struct Biol Lab, Nara 6300192, Japan; [Hakoshima, Toshio] Japan Sci & Technol Agcy, CREST, Nara 6300192, Japan	Nara Institute of Science & Technology; Japan Science & Technology Agency (JST)	Hakoshima, T (corresponding author), Nara Inst Sci & Technol, Struct Biol Lab, 8916-5 Takayama, Nara 6300192, Japan.	hakosima@bs.naist.jp	Terawaki, Shin-ichi/V-7082-2019	Terawaki, Shin-ichi/0000-0002-2859-0589; Mori, Tomoyuki/0000-0003-2019-5370	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research ( A) and scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to T. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bajorath J, 2000, PROTEINS, V39, P103, DOI 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.3.CO;2-7; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Bonilha VL, 1999, J CELL BIOL, V147, P1533, DOI 10.1083/jcb.147.7.1533; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dhalluin C, 2000, MOL CELL, V6, P921, DOI 10.1016/S1097-2765(00)00089-7; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Hamada K, 2000, ACTA CRYSTALLOGR D, V56, P922, DOI 10.1107/S0907444900006363; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Ishikawa H, 2001, J MOL BIOL, V310, P973, DOI 10.1006/jmbi.2001.4818; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawano Y, 2000, J BIOL CHEM, V275, P29628, DOI 10.1074/jbc.M002440200; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Lesley J, 2000, J BIOL CHEM, V275, P26967; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Liu DC, 1996, CELL IMMUNOL, V174, P73, DOI 10.1006/cimm.1996.0295; LOKESHWAR VB, 1991, J BIOL CHEM, V266, P17983; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Mori T, 2007, ACTA CRYSTALLOGR F, V63, P844, DOI 10.1107/S1744309107041152; Moustakas A, 2001, J CELL SCI, V114, P4359; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Oliferenko S, 2000, J CELL BIOL, V148, P1159, DOI 10.1083/jcb.148.6.1159; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; PERSCHL A, 1995, EUR J IMMUNOL, V25, P495, DOI 10.1002/eji.1830250228; Peterson RS, 2004, J CELL BIOL, V166, P1081, DOI 10.1083/jcb.200402138; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Sainio M, 1997, J CELL SCI, V110, P2249; Sasaki A, 2001, J BIOL CHEM, V276, P17871, DOI 10.1074/jbc.M008422200; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; THOMAS L, 1992, J CELL BIOL, V118, P971, DOI 10.1083/jcb.118.4.971; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 2002, J CELL SCI, V115, P2569; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	74	86	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29602	29612		10.1074/jbc.M803606200	http://dx.doi.org/10.1074/jbc.M803606200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18753140	Green Published, hybrid			2022-12-25	WOS:000260179900086
J	Shi, ZH; Rudzinski, M; Meerovitch, K; Lebrun-Julien, F; Birman, E; Di Polo, A; Saragovi, HU				Shi, ZhiHua; Rudzinski, Marcelo; Meerovitch, Karen; Lebrun-Julien, Frederic; Birman, Elena; Di Polo, Adriana; Saragovi, H. Uri			alpha 2-Macroglobulin Is a Mediator of Retinal Ganglion Cell Death in Glaucoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; ELEVATED INTRAOCULAR-PRESSURE; DIFFERENTIAL GENE-EXPRESSION; PROMOTED NEURITE OUTGROWTH; METHYL-D-ASPARTATE; OPTIC-NERVE HEAD; MICROARRAY ANALYSIS; AMYLOID-BETA; TNF-ALPHA; ALPHA(2)-MACROGLOBULIN	Glaucoma is defined as a chronic and progressive optic nerve neuropathy, characterized by apoptosis of retinal ganglion cells (RGC) that leads to irreversible blindness. Ocular hypertension is a major risk factor, but in glaucoma RGC death can persist after ocular hypertension is normalized. To understand the mechanism underlying chronic RGC death we identified and characterized a gene product, alpha 2-macroglobulin (alpha 2M), whose expression is up-regulated early in ocular hypertension and remains up-regulated long after ocular hypertension is normalized. In ocular hypertension retinal glia up-regulate alpha 2M, which binds to low-density lipoprotein receptor-related protein-1 receptors in RGCs, and is neurotoxic in a paracrine fashion. Neutralization of alpha 2M delayed RGC loss during ocular hypertension; whereas delivery of alpha 2M to normal eyes caused progressive apoptosis of RGC mimicking glaucoma without ocular hypertension. This work adds to our understanding of the pathology and molecular mechanisms of glaucoma, and illustrates emerging paradigms for studying chronic neurodegeneration in glaucoma and perhaps other disorders.	[Shi, ZhiHua; Birman, Elena; Saragovi, H. Uri] McGill Univ, Lady Davis Inst Jewish Gen Hosp, Montreal, PQ, Canada; [Rudzinski, Marcelo; Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Meerovitch, Karen] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Ctr Canc, Montreal, PQ, Canada; [Lebrun-Julien, Frederic; Di Polo, Adriana] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada; [Lebrun-Julien, Frederic; Di Polo, Adriana] Univ Montreal, Dept Ophthalmol, Montreal, PQ H3T 1J4, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal	Saragovi, HU (corresponding author), 3755 Cote St Catherine,E-535, Montreal, PQ H3T 1E2, Canada.	uri.saragovi@mcgill.ca			National Institutes of Health [CA82642]; Canadian Institutes of Health Research [MT13265, MOP57690]; NATIONAL CANCER INSTITUTE [R01CA082642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA82642. This work was also supported by Canadian Institutes of Health Research Grants MT13265 and MOP57690. Patents have been licensed to Mimetogen Pharmaceuticals Inc., and H. U. S. discloses interest in the company. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmed F, 2004, INVEST OPHTH VIS SCI, V45, P1247, DOI 10.1167/iovs.03-1123; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Birkenmeier G, 1997, FEBS LETT, V416, P193, DOI 10.1016/S0014-5793(97)01201-5; Bruno MA, 2004, J NEUROSCI, V24, P8009, DOI 10.1523/JNEUROSCI.1508-04.2004; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Chiabrando GA, 2002, J NEUROSCI RES, V70, P57, DOI 10.1002/jnr.10369; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; Esson DW, 2004, INVEST OPHTH VIS SCI, V45, P4450, DOI 10.1167/iovs.04-0375; Fabrizi C, 1999, EXP NEUROL, V155, P252, DOI 10.1006/exnr.1998.6978; Fabrizi C, 2001, J NEUROCHEM, V78, P406, DOI 10.1046/j.1471-4159.2001.00419.x; Farkas RH, 2001, INT OPHTHALMOL CLIN, V41, P111, DOI 10.1097/00004397-200101000-00011; Gonias SL, 2000, J BIOL CHEM, V275, P5826, DOI 10.1074/jbc.275.8.5826; Gourine AV, 2002, AM J PHYSIOL-REG I, V283, pR218, DOI 10.1152/ajpregu.00746.2001; Guo L, 2007, P NATL ACAD SCI USA, V104, P13444, DOI 10.1073/pnas.0703707104; Halpern D Lynn, 2002, Ophthalmol Clin North Am, V15, P61, DOI 10.1016/S0896-1549(01)00012-8; HART WM, 1982, OPHTHALMOLOGY, V89, P268; Hartwick ATE, 2001, OPTOMETRY VISION SCI, V78, P85, DOI 10.1097/00006324-200102000-00008; Hashimoto Y, 2000, J NEUROSCI, V20, P8401, DOI 10.1523/JNEUROSCI.20-22-08401.2000; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hernandez MR, 2002, GLIA, V38, P45, DOI 10.1002/glia.10051; Herz J, 2003, J CLIN INVEST, V112, P1483, DOI 10.1172/JCI200320337; Huang W, 2005, P NATL ACAD SCI USA, V102, P12242, DOI 10.1073/pnas.0505138102; JAMES K, 1992, IMMUNOL LETT, V32, P49, DOI 10.1016/0165-2478(92)90198-W; Ji JZ, 2005, VISION RES, V45, P169, DOI 10.1016/j.visres.2004.08.008; KASS MA, 1989, ARCH OPHTHALMOL-CHIC, V107, P1590, DOI 10.1001/archopht.1989.01070020668025; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Kovacs DM, 2000, EXP GERONTOL, V35, P473, DOI 10.1016/S0531-5565(00)00113-3; Kwon YH, 2003, J GLAUCOMA, V12, P409, DOI 10.1097/00061198-200310000-00003; Laquis S, 1998, BRAIN RES, V784, P100, DOI 10.1016/S0006-8993(97)01189-X; Lee PG, 1999, J NEUROSCI RES, V57, P872, DOI 10.1002/(SICI)1097-4547(19990915)57:6<872::AID-JNR13>3.3.CO;2-9; Levin LA, 2001, J GLAUCOMA, V10, pS19, DOI 10.1097/00061198-200110001-00008; Lipton S A, 2001, Prog Brain Res, V131, P712; Lo WR, 2003, INVEST OPHTH VIS SCI, V44, P473, DOI 10.1167/iovs.02-0444; Maliartchouk S, 2000, MOL PHARMACOL, V57, P385; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; Miyahara T, 2003, INVEST OPHTH VIS SCI, V44, P4347, DOI 10.1167/iovs.02-1032; MOORE CG, 1995, CURR EYE RES, V14, P711, DOI 10.3109/02713689508998499; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; OBRIEN C, 1991, AM J OPHTHALMOL, V111, P491, DOI 10.1016/S0002-9394(14)72386-4; Pang IH, 2005, INVEST OPHTH VIS SCI, V46, P1313, DOI 10.1167/iovs.04-0829; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Qiu ZH, 2002, J BIOL CHEM, V277, P14458, DOI 10.1074/jbc.M112066200; Qiu ZH, 2001, J NEUROPATH EXP NEUR, V60, P430, DOI 10.1093/jnen/60.5.430; Rudzinski M, 2004, J NEUROBIOL, V58, P341, DOI 10.1002/neu.10293; Rudzinski Marcelo, 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P43; Saragovi HU, 2005, J NEUROCHEM, V95, P1472, DOI 10.1111/j.1471-4159.2005.03479.x; Shi Z, 2007, DEV NEUROBIOL, V67, P884, DOI 10.1002/dneu.20360; Siu AW, 2002, EXP EYE RES, V75, P401, DOI 10.1006/exer.2002.2029; Skornicka EL, 2002, J NEUROSCI RES, V67, P346, DOI 10.1002/jnr.10097; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Vorwerk CK, 2000, INVEST OPHTH VIS SCI, V41, P3615; Waldron E, 2006, NEURODEGENER DIS, V3, P233, DOI 10.1159/000095261; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; WoldeMussie E, 2002, J GLAUCOMA, V11, P474, DOI 10.1097/00061198-200212000-00003; WOLF BB, 1994, BIOCHEMISTRY-US, V33, P11270, DOI 10.1021/bi00203a024; Wu SM, 1998, J IMMUNOL, V161, P4356; Zenkel M, 2005, INVEST OPHTH VIS SCI, V46, P3742, DOI 10.1167/iovs.05-0249; Zhou Y, 2005, MOL THER, V12, P402, DOI 10.1016/j.ymthe.2005.04.004	60	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29156	29165		10.1074/jbc.M802365200	http://dx.doi.org/10.1074/jbc.M802365200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18701465	hybrid, Green Published			2022-12-25	WOS:000260179900043
J	Gupta, PK; Moayeri, M; Crown, D; Fattah, RJ; Leppla, SH				Gupta, Pradeep K.; Moayeri, Mahtab; Crown, Devorah; Fattah, Rasem J.; Leppla, Stephen H.			Role of N-Terminal Amino Acids in the Potency of Anthrax Lethal Factor	PLOS ONE			English	Article								Anthrax lethal factor (LF) is a Zn+2-dependent metalloprotease that cleaves several MAPK kinases and is responsible for the lethality of anthrax lethal toxin (LT). We observed that a recombinant LF (LF-HMA) which differs from wild type LF (LF-A) by the addition of two residues (His-Met) to the native Ala (A) terminus as a result of cloning manipulations has 3-fold lower potency toward cultured cells and experimental animals. We hypothesized that the "N-end rule'', which relates the half-life of proteins in cells to the identity of their N-terminal residue, might be operative in the case of LF, so that the N-terminal residue of LF would determine the cytosolic stability and thereby the potency of LF. Mutational studies that replaced the native N-terminal residue of LF with known N-end rule stabilizing or destabilizing residues confirmed that the N-terminal residue plays a significant role in determining the potency of LT for cultured cells and experimental animals. The fact that a commercially-available LF preparation (LF-HMA) that is widely used in basic research studies and for evaluation of vaccines and therapeutics is 3-fold less potent than native LF (LF-A) should be considered when comparing published studies and in the design of future experiments.	[Gupta, Pradeep K.; Moayeri, Mahtab; Crown, Devorah; Fattah, Rasem J.; Leppla, Stephen H.] NIAID, Lab Bacterial Dis, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gupta, PK (corresponding author), NIAID, Lab Bacterial Dis, Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sleppla@niaid.nih.gov		Moayeri, Mahtab/0000-0002-4448-8883	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001031, Z01AI001031] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Baillie L, 1998, J APPL MICROBIOL, V84, P741; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; EZZELL JW, 1984, INFECT IMMUN, V45, P761, DOI 10.1128/IAI.45.3.761-767.1984; Falnes PO, 1998, EMBO J, V17, P615, DOI 10.1093/emboj/17.2.615; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; GONDA DK, 1989, J BIOL CHEM, V264, P16700; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; Gupta P, 1998, INFECT IMMUN, V66, P862, DOI 10.1128/IAI.66.2.862-865.1998; Gupta PK, 2008, CELL MICROBIOL, V10, P1687, DOI 10.1111/j.1462-5822.2008.01159.x; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Kim J, 2003, PROTEIN EXPRES PURIF, V30, P293, DOI 10.1016/S1046-5928(03)00132-3; Lacy DB, 2002, J BIOL CHEM, V277, P3006, DOI 10.1074/jbc.M109997200; LEPPLA SH, 1988, METHOD ENZYMOL, V165, P103; LEPPLA SH, 1991, METHOD ENZYMOL, V195, P153; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; LEPPLA SH, 2006, COMPREHENSIVE SOURCE, P323; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; LONDON E, 1989, BIOCHEM BIOPH RES CO, V160, P333, DOI 10.1016/0006-291X(89)91660-4; Malatynska E, 1998, PHARMACOLOGY, V57, P117, DOI 10.1159/000028232; Meinnel T, 2006, BIOL CHEM, V387, P839, DOI 10.1515/BC.2006.107; Melnyk RA, 2006, J BIOL CHEM, V281, P1630, DOI 10.1074/jbc.M511164200; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Mourez M, 2005, REV PHYSIOL BIOCH P, V152, P135, DOI 10.1007/s10254-004-0028-2; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pellizzari R, 2000, INT J MED MICROBIOL, V290, P421; Pomerantsev AP, 2004, INFECT IMMUN, V72, P5814, DOI 10.1128/IAI.72.10.5814-5823.2004; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Schnupf P, 2007, INFECT IMMUN, V75, P5135, DOI 10.1128/IAI.00164-07; SINGH Y, 1989, J BIOL CHEM, V264, P19103; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Varughese M, 1998, MOL MED, V4, P87, DOI 10.1007/BF03401732; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Webster JI, 2003, P NATL ACAD SCI USA, V100, P5706, DOI 10.1073/pnas.1036973100; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; WRIGHT GG, 1962, J BACTERIOL, V83, P515, DOI 10.1002/path.1700830225; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101	41	45	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3130	10.1371/journal.pone.0003130	http://dx.doi.org/10.1371/journal.pone.0003130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769623	Green Published, gold, Green Submitted			2022-12-25	WOS:000264418300011
J	Comoy, EE; Casalone, C; Lescoutra-Etchegaray, N; Zanusso, G; Freire, S; Marce, D; Auvre, F; Ruchoux, MM; Ferrari, S; Monaco, S; Sales, N; Caramelli, M; Leboulch, P; Brown, P; Lasmezas, CI; Deslys, JP				Comoy, Emmanuel E.; Casalone, Cristina; Lescoutra-Etchegaray, Nathalie; Zanusso, Gianluigi; Freire, Sophie; Marce, Dominique; Auvre, Frederic; Ruchoux, Marie-Magdeleine; Ferrari, Sergio; Monaco, Salvatore; Sales, Nicole; Caramelli, Maria; Leboulch, Philippe; Brown, Paul; Lasmezas, Corinne I.; Deslys, Jean-Philippe			Atypical BSE (BASE) Transmitted from Asymptomatic Aging Cattle to a Primate	PLOS ONE			English	Article								Background: Human variant Creutzfeldt-Jakob Disease (vCJD) results from foodborne transmission of prions from slaughtered cattle with classical Bovine Spongiform Encephalopathy (cBSE). Atypical forms of BSE, which remain mostly asymptomatic in aging cattle, were recently identified at slaughterhouses throughout Europe and North America, raising a question about human susceptibility to these new prion strains. Methodology/Principal Findings: Brain homogenates from cattle with classical BSE and atypical (BASE) infections were inoculated intracerebrally into cynomolgus monkeys (Macacca fascicularis), a non-human primate model previously demonstrated to be susceptible to the original strain of cBSE. The resulting diseases were compared in terms of clinical signs, histology and biochemistry of the abnormal prion protein (PrPres). The single monkey infected with BASE had a shorter survival, and a different clinical evolution, histopathology, and prion protein (PrPres) pattern than was observed for either classical BSE or vCJD-inoculated animals. Also, the biochemical signature of PrPres in the BASE-inoculated animal was found to have a higher proteinase K sensitivity of the octa-repeat region. We found the same biochemical signature in three of four human patients with sporadic CJD and an MM type 2 PrP genotype who lived in the same country as the infected bovine. Conclusion/Significance: Our results point to a possibly higher degree of pathogenicity of BASE than classical BSE in primates and also raise a question about a possible link to one uncommon subset of cases of apparently sporadic CJD. Thus, despite the waning epidemic of classical BSE, the occurrence of atypical strains should temper the urge to relax measures currently in place to protect public health from accidental contamination by BSE-contaminated products.	[Comoy, Emmanuel E.; Lescoutra-Etchegaray, Nathalie; Freire, Sophie; Marce, Dominique; Auvre, Frederic; Ruchoux, Marie-Magdeleine; Leboulch, Philippe; Brown, Paul; Deslys, Jean-Philippe] CEA, Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France; [Casalone, Cristina; Caramelli, Maria] Ist Zooprofilattico Sperimentale Piemonte, Turin, Italy; [Zanusso, Gianluigi; Ferrari, Sergio; Monaco, Salvatore] Policlin GB Rossi, Verona, Italy; [Sales, Nicole; Lasmezas, Corinne I.] Scripps Florida, Jupiter, FL USA; [Leboulch, Philippe] Brigham & Womens Hosp, Harvard Med Sch, Genet Div, Boston, MA USA	CEA; UDICE-French Research Universities; Universite Paris Saclay; IZS Piemonte Liguria e Valle D'aosta; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Comoy, EE (corresponding author), CEA, Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France.	emmanuel.comoy@cea.fr	Ferrari, Sergio/AAE-5649-2019; Casalone, Cristina/J-6763-2018; Zanusso, Gianluigi/K-2823-2018; Monaco, Salvatore/K-4659-2018	Casalone, Cristina/0000-0001-5271-832X; Zanusso, Gianluigi/0000-0001-5199-6264; Monaco, Salvatore/0000-0003-3191-8597; ferrari, sergio/0000-0003-3855-5135	Network of Excellence NeuroPrion	Network of Excellence NeuroPrion	This work has been supported by the Network of Excellence NeuroPrion.	Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Brown P, 2006, EMERG INFECT DIS, V12, P1816; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; DESLYS JP, 1999, Patent No. 9914242; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Krasnianski A, 2006, ARCH NEUROL-CHICAGO, V63, P876, DOI 10.1001/archneur.63.6.876; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; WILL RG, 1996, LANCET, V347, P925; Williams L, 2007, J GEN VIROL, V88, P688, DOI 10.1099/vir.0.81957-0; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766; Yutzy B, 2007, J GEN VIROL, V88, P3469, DOI 10.1099/vir.0.83128-0	26	104	106	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3017	10.1371/journal.pone.0003017	http://dx.doi.org/10.1371/journal.pone.0003017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714385	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900041
J	Thompson, EC; Travers, AA				Thompson, Elizabeth C.; Travers, Andrew A.			A Drosophila Smyd4 Homologue Is a Muscle-Specific Transcriptional Modulator Involved in Development	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; ACUTE-LEUKEMIA; CELL FATES; MELANOGASTER; EXPRESSION; REPRESSION; DOMAIN; MYND; DIVERSIFICATION; IDENTIFICATION	Background: SET and MYND domain (Smyd) proteins are involved in the transcriptional regulation of cellular proliferation and development in vertebrates. However, the in vivo functions and mechanisms by which these proteins act are poorly understood. Methodology/Principal Findings: We have used biochemical and genetic approaches to study the role of a Smyd protein in Drosophila. We identified eleven Drosophila genes that encode Smyd proteins. CG14122 encodes a Smyd4 homologue that we have named dSmyd4. dSmyd4 repressed transcription and recruited class I histone deacetylases (HDACs). A region of dSmyd4 including the MYND domain interacted directly with,150 amino acids at the N-termini of dHDAC1 and dHDAC3. dSmyd4 interacts selectively with Ebi, a component of the dHDAC3/SMRTER co-repressor complex. During embryogenesis dSmyd4 was expressed throughout the mesoderm, with highest levels in the somatic musculature. Muscle-specific RNAi against dSmyd4 resulted in depletion of the protein and lead to severe lethality. Eclosion is the final moulting stage of Drosophila development when adult flies escape from the pupal case. 80% of dSmyd4 knockdown flies were not able to eclose, resulting in late pupal lethality. However, many aspects of eclosion were still able to occur normally, indicating that dSmyd4 is likely to be involved in the development or function of adult muscle. Conclusions/Significance: Repression of transcription by dSmyd4 and the involvement of this protein in development suggests that aspects of Smyd protein function are conserved between vertebrates and invertebrates.	[Thompson, Elizabeth C.; Travers, Andrew A.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Thompson, EC (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ect26@mrc-lmb.cam.ac.uk		Thompson, Elizabeth/0000-0003-3506-0401	MRC [studentship]; MRC [MC_U105184288] Funding Source: UKRI; Medical Research Council [MC_U105184288] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ECT was supported by an MRC studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Baker PW, 2005, GENETICS, V170, P1747, DOI 10.1534/genetics.105.041749; BATE M, 1991, DEVELOPMENT, V113, P79; BATE M, 1990, DEVELOPMENT, V110, P791; BODMER R, 1993, DEVELOPMENT, V118, P719; Borkowski OMD, 1995, DEVELOPMENT, V121, P4183; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; BRAND AH, 1993, DEVELOPMENT, V118, P401; BREEN TR, 1993, DEVELOPMENT, V117, P119; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Dworak HA, 2002, BIOESSAYS, V24, P591, DOI 10.1002/bies.10115; Frasch M, 1999, CURR OPIN GENET DEV, V9, P522, DOI 10.1016/S0959-437X(99)00014-3; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; JONES RS, 1990, GENETICS, V126, P185; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Qi D, 2008, EMBO J, V27, P898, DOI 10.1038/emboj.2008.26; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Riechmann V, 1997, DEVELOPMENT, V124, P2915; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	35	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3008	10.1371/journal.pone.0003008	http://dx.doi.org/10.1371/journal.pone.0003008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714374	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900033
J	Chong, YE; Yang, XL; Schimmel, P				Chong, Yeeting E.; Yang, Xiang-Lei; Schimmel, Paul			Natural Homolog of tRNA Synthetase Editing Domain Rescues Conditional Lethality Caused by Mistranslation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID SYNTHETASE; ISOLEUCYL-TRANSFER-RNA; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; CELL VIABILITY; ENZYME; VALINE; DISCRIMINATION; DEACYLATION; REJECTION	AlaXp is a widely distributed (from bacteria to humans) genome-encoded homolog of the editing domain of alanyl-tRNA synthetases. Editing repairs the confusion of serine and glycine for alanine through clearance of mischarged (with Ser or Gly) tRNA(Ala). Because genome-encoded fragments of editing domains of other synthetases are scarce, the AlaXp redundancy of the editing domain of alanyl-tRNA synthetase is thought to reflect an unusual sensitivity of cells to mistranslation at codons for Ala. Indeed, a small defect in the editing activity of alanyl-tRNA synthetase is causally linked to neurodegeneration in the mouse. Although limited earlier studies demonstrated that AlaXp deacylated mischarged tRNAAla in vitro, the significance of this activity in vivo has not been clear. Here we describe a bacterial system specifically designed to investigate activity of AlaXp in vivo. Serine toxicity, experienced by a strain harboring an editing-defective alanyl-tRNA synthetase, was rescued by an AlaXp-encoding transgene. Rescue was dependent on amino acid residues in AlaXp that are needed for its in vitro catalytic activity. Thus, the editing activity per se of AlaXp was essential for suppressing mistranslation. The results support the idea that the unique widespread distribution of AlaXp arises from the singular difficulties, for translation, poised by alanine.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schimmel, P (corresponding author), BCC379,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Chong, Yeeting/AAE-3792-2020; Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health [GM 23562]; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 23562. This work was also supported by a fellowship from the National Foundation for Cancer Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; Bacher JM, 2005, P NATL ACAD SCI USA, V102, P1697, DOI 10.1073/pnas.0409064102; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; Fukunaga R, 2007, ACTA CRYSTALLOGR D, V63, P390, DOI 10.1107/S090744490605640X; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; JASIN M, 1984, J BACTERIOL, V159, P783, DOI 10.1128/JB.159.2.783-786.1984; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Larkin DC, 2002, NUCLEIC ACIDS RES, V30, P2103, DOI 10.1093/nar/30.10.2103; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Martinis S A, 1997, Nucleic Acids Symp Ser, V36, P125; Miller J. H., 1972, EXPT MOL GENETICS, P431; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; REGAN L, 1987, SCIENCE, V235, P1651, DOI 10.1126/science.2435005; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; SCHREIER AA, 1972, BIOCHEMISTRY-US, V11, P1582, DOI 10.1021/bi00759a006; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Wong FC, 2003, J BIOL CHEM, V278, P52857, DOI 10.1074/jbc.M309627200; YARUS M, 1972, P NATL ACAD SCI USA, V69, P1915, DOI 10.1073/pnas.69.7.1915	34	45	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30073	30078		10.1074/jbc.M805943200	http://dx.doi.org/10.1074/jbc.M805943200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723508	Green Published, hybrid			2022-12-25	WOS:000260366900052
J	Fluhrer, R; Fukumori, A; Martin, L; Grammer, G; Haug-Kroper, M; Klier, B; Winkler, E; Kremmer, E; Condron, MM; Teplow, DB; Steiner, H; Haass, C				Fluhrer, Regina; Fukumori, Akio; Martin, Lucas; Grammer, Gudula; Haug-Kroeper, Martina; Klier, Baerbel; Winkler, Edith; Kremmer, Elisabeth; Condron, Margaret M.; Teplow, David B.; Steiner, Harald; Haass, Christian			Intramembrane Proteolysis of GXGD-type Aspartyl Proteases Is Slowed by a Familial Alzheimer Disease-like Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL PEPTIDE PEPTIDASE; GAMMA-SECRETASE ACTIVITY; TRANSMEMBRANE DOMAIN; PRESENILIN HOMOLOGS; TALKING POINT; ZETA-CLEAVAGE; BETA-PEPTIDE; TNF-ALPHA; IN-VIVO	More than 150 familial Alzheimer disease (FAD)-associated missense mutations in presenilins (PS1 and PS2), the catalytic subunit of the gamma-secretase complex, cause aberrant amyloid beta-peptide (A beta) production, by increasing the relative production of the highly amyloidogenic 42-amino acid variant. The molecular mechanism behind this pathological activity is unclear, and different possibilities ranging from a gain of function to a loss of function have been discussed. gamma-Secretase, signal peptide peptidase (SPP) and SPP-like proteases (SPPLs) belong to the same family of GXGD-type intramembrane cleaving aspartyl proteases and share several functional similarities. We have introduced the FAD-associated PS1 G384A mutation, which occurs within the highly conserved GXGD motif of PS1 right next to the catalytically critical aspartate residue, into the corresponding GXGD motif of the signal peptide peptidase-like 2b (SPPL2b). Compared with wild-type SPPL2b, mutant SPPL2b slowed intramembrane proteolysis of tumor necrosis factor alpha and caused a relative increase of longer intracellular cleavage products. Because the N termini of the secreted counterparts remain unchanged, the mutation selectively affects the liberation of the intracellular processing products. In vitro experiments demonstrate that the apparent accumulation of longer intracellular cleavage products is the result of slowed sequential intramembrane cleavage. The longer cleavage products are still converted to shorter peptides, however only after prolonged incubation time. This suggests that FAD-associated PS mutation may also result in reduced intramembrane cleavage of beta-amyloid precursor protein (beta APP). Indeed, in vitro experiments demonstrate slowed intramembrane proteolysis by gamma-secretase containing PS1 with the G384A mutation. As compared with wildtype PS1, the mutation selectively slowed A beta 40 production, whereas A beta 42 generation remained unaffected. Thus, the PS1 G384A mutation causes a selective loss of function by slowing the processing pathway leading to the benign A beta 40.	[Fluhrer, Regina; Fukumori, Akio; Martin, Lucas; Grammer, Gudula; Haug-Kroeper, Martina; Klier, Baerbel; Winkler, Edith; Steiner, Harald; Haass, Christian] Univ Munich, Ctr Integrated Prot Sci Munich, D-80336 Munich, Germany; [Fluhrer, Regina; Fukumori, Akio; Martin, Lucas; Grammer, Gudula; Haug-Kroeper, Martina; Klier, Baerbel; Winkler, Edith; Steiner, Harald; Haass, Christian] Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Haass, C (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, D-80336 Munich, Germany.	chaass@med.uni-muenchen.de	Fluhrer, Regina/F-2642-2011		National Institutes of Health [NS038328]; Leibniz Award of Deutsche Forschungsgemeinschaft [NS038328]; Collaborative Research Center Molecular Mechanisms of Neurodegeneration [SFB 596]; DFG [HA1737-11-1]; Center for Integrated Protein Science Munich; Hans and Ilse Breuer Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leibniz Award of Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Collaborative Research Center Molecular Mechanisms of Neurodegeneration; DFG(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; Hans and Ilse Breuer Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS038328 (to D. B. T.). This work was also supported by the Leibniz Award of Deutsche Forschungsgemeinschaft (DFG, to C. H.), by the Collaborative Research Center Molecular Mechanisms of Neurodegeneration (Grant SFB 596 to C. H., H. S., and E. K.), by DFG Grant HA1737-11-1 (to C. H. and R. F.), and by the Center for Integrated Protein Science Munich and the Alzheimer Research Award of the Hans and Ilse Breuer Foundation (to H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baumeister R, 1997, Genes Funct, V1, P149; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Davis JA, 1998, NEURON, V20, P603, DOI 10.1016/S0896-6273(00)80998-8; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Fluhrer R, 2007, NEURODEGENER DIS, V4, P112, DOI 10.1159/000101835; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; HAASS C, 1992, NATURE, V359, P325; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Lemberg MK, 2007, MOL CELL, V28, P930, DOI 10.1016/j.molcel.2007.12.003; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shimojo M, 2008, J BIOL CHEM, V283, P16488, DOI 10.1074/jbc.M801279200; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200	52	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30121	30128		10.1074/jbc.M806092200	http://dx.doi.org/10.1074/jbc.M806092200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768471	hybrid, Green Published			2022-12-25	WOS:000260366900057
J	Das, A; Xi, L; Kukreja, RC				Das, Anindita; Xi, Lei; Kukreja, Rakesh C.			Protein Kinase G-dependent Cardioprotective Mechanism of Phosphodiesterase-5 Inhibition Involves Phosphorylation of ERK and GSK3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; NITRIC-OXIDE SYNTHASE; RABBIT VENTRICULAR MYOCYTES; CYCLIC-GMP; MOUSE HEART; CARDIOMYOCYTE APOPTOSIS; ERECTILE DYSFUNCTION; CARDIAC-HYPERTROPHY; IN-VIVO; SILDENAFIL	Sildenafil, a potent inhibitor of phosphodiesterase-5 (PDE-5) induces powerful protection against myocardial ischemia-reperfusion injury. PDE-5 inhibition increases cGMP levels that activate cGMP-dependent protein kinase (PKG). However, the cause and effect relationship of PKG in sildenafil-induced cardioprotection and the downstream targets of PKG remain unclear. Adult ventricular myocytes were treated with sildenafil and subjected to simulated ischemia and reoxygenation. Sildenafil treatment significantly decreased cardiomyocyte necrosis and apoptosis. The PKG inhibitors, KT5823, guanosine 3', 5'-cyclic monophosphorothioate, 8-(4-chloro-phenylthio) (R-p-8-pCPT-cGMPs), or DT-2 blocked the anti-necrotic and anti-apoptotic effect of sildenafil. Selective knockdown of PKG in cardiomyocytes with adenoviral vector containing short hairpin RNA of PKG also abolished sildenafil-induced protection. Furthermore, intra-coronary infusion of sildenafil in Langendorffisolated mouse hearts prior to ischemia-reperfusion significantly reduced myocardial infarct size after 20 min ischemia and 30 min reperfusion, which was abrogated by KT5823. Sildenafil significantly increased PKG activity in intact hearts and cardiomyocytes. Sildenafil also enhanced the Bcl-2/Bax ratio, phosphorylation of Akt, ERK1/2, and glycogen synthase kinase 3 beta. All these changes ( except Akt phosphorylation) were significantly blocked by KT5823 and short hairpin RNA of PKG. These studies provide the first evidence for an essential role of PKG in sildenafil-induced cardioprotection. Moreover, our results demonstrate that sildenafil activates a PKG-dependent novel signaling cascade that involves activation of ERK and inhibition of glycogen synthase kinase 3 beta leading to cytoprotection.	[Das, Anindita; Xi, Lei; Kukreja, Rakesh C.] Virginia Commonwealth Univ, Div Cardiol, Dept Internal Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Kukreja, RC (corresponding author), Virginia Commonwealth Univ, Div Cardiol, Dept Internal Med, Box 980204,1101 E Marshall St,Rm 7-046, Richmond, VA 23298 USA.	rakesh@vcu.edu	Xi, Lei/A-3078-2008; Das, Anindita/K-8003-2013	Xi, Lei/0000-0002-7569-3329; Das, Anindita/0000-0003-4422-7277	National Institutes of Health [HL51045, HL59469, HL79424, HL093685]; American Heart Association Mid-Atlantic Affiliate Beginning [0765273U]; National Scientist Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL051045, R01HL051045, R01HL079424, R01HL059469, R01HL093685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Mid-Atlantic Affiliate Beginning(American Heart Association); National Scientist Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL51045, HL59469, HL79424, and HL093685 ( to R. C. K.). This work was also supported by American Heart Association Mid-Atlantic Affiliate Beginning Grant-in-Aid 0765273U ( to A. D.) and National Scientist Development Grant 0530157N ( to L. X.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bergmann MW, 2004, J MOL CELL CARDIOL, V37, P681, DOI 10.1016/j.yjmcc.2004.05.025; Boolell M, 1996, Int J Impot Res, V8, P47; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Costa ADT, 2005, CIRC RES, V97, P329, DOI 10.1161/01.RES.0000178451.08719.5b; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dang VC, 2006, AM J PHYSIOL-HEART C, V290, pH1808, DOI 10.1152/ajpheart.00772.2005; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Das A, 2004, AM J PHYSIOL-HEART C, V286, pH1455, DOI 10.1152/ajpheart.01040.2003; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gambaryan S, 2001, HISTOCHEM CELL BIOL, V116, P535, DOI 10.1007/s00418-001-0353-3; Ghofrani HA, 2006, NAT REV DRUG DISCOV, V5, P689, DOI 10.1038/nrd2030; Hall JL, 2001, DIABETES, V50, P1171, DOI 10.2337/diabetes.50.5.1171; Han J, 2002, AM J PHYSIOL-HEART C, V283, pH1545, DOI 10.1152/ajpheart.01052.2001; Han J, 2001, J BIOL CHEM, V276, P22140, DOI 10.1074/jbc.M010103200; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; He B, 1998, MOL CELL BIOL, V18, P6624, DOI 10.1128/MCB.18.11.6624; Hetman M, 2002, J BIOL CHEM, V277, P49577, DOI 10.1074/jbc.M111227200; Hirotani S, 2007, CIRC RES, V101, P1164, DOI 10.1161/CIRCRESAHA.107.160614; Hofmann F, 2000, J CELL SCI, V113, P1671; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kaga S, 2006, J MOL CELL CARDIOL, V40, P138, DOI 10.1016/j.yjmcc.2005.09.009; KEILBACH A, 1992, EUR J BIOCHEM, V208, P467, DOI 10.1111/j.1432-1033.1992.tb17209.x; Komalavilas P, 1999, J BIOL CHEM, V274, P34301, DOI 10.1074/jbc.274.48.34301; Krieg T, 2005, AM J PHYSIOL-HEART C, V288, pH1976, DOI 10.1152/ajpheart.00883.2004; Kukreja RC, 2007, BRIT J PHARMACOL, V150, P538, DOI 10.1038/sj.bjp.0707132; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; Maas O, 2008, BRIT J PHARMACOL, V154, P25, DOI 10.1038/bjp.2008.71; Matsui T, 2001, CIRCULATION, V104, P330; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Ockaili R, 2002, AM J PHYSIOL-HEART C, V283, pH1263, DOI 10.1152/ajpheart.00324.2002; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pilz RB, 2003, CIRC RES, V93, P1034, DOI 10.1161/01.RES.0000103311.52853.48; Ping PP, 1999, AM J PHYSIOL-HEART C, V276, pH1468, DOI 10.1152/ajpheart.1999.276.5.H1468; Porst H, 2001, INT J IMPOT RES, V13, P192, DOI 10.1038/sj.ijir.3900713; Qin QN, 2004, AM J PHYSIOL-HEART C, V287, pH712, DOI 10.1152/ajpheart.00954.2003; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Senzaki H, 2001, FASEB J, V15, P1718, DOI 10.1096/fj.00-0538com; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Takimoto E, 2005, CIRC RES, V96, P100, DOI 10.1161/01.RES.0000152262.22968.72; Tong HY, 2002, CIRC RES, V90, P377, DOI 10.1161/01.RES.0000012567.95445.55; Wang XY, 2008, J MOL CELL CARDIOL, V44, P105, DOI 10.1016/j.yjmcc.2007.10.006; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; Xi L, 1999, CIRCULATION, V99, P2157, DOI 10.1161/01.CIR.99.16.2157; Xi L, 1998, MOL CELL BIOCHEM, V186, P69, DOI 10.1023/A:1006811128561; Zhao X, 2005, J BIOL CHEM, V280, P32683, DOI 10.1074/jbc.M505486200	55	155	160	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29572	29585		10.1074/jbc.M801547200	http://dx.doi.org/10.1074/jbc.M801547200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18723505	hybrid, Green Published			2022-12-25	WOS:000260179900083
J	Giordano, RJ; Lahdenranta, J; Zhen, LJ; Chukwueke, U; Petrache, I; Langley, RR; Fidler, IJ; Pasqualini, R; Tuder, RM; Arap, W				Giordano, Ricardo J.; Lahdenranta, Johanna; Zhen, Lijie; Chukwueke, Ugonma; Petrache, Irina; Langley, Robert R.; Fidler, Isaiah J.; Pasqualini, Renata; Tuder, Rubin M.; Arap, Wadih			Targeted Induction of Lung Endothelial Cell Apoptosis Causes Emphysema-like Changes in the Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; VEGF; VASCULATURE; ANGIOGENESIS; PATHOGENESIS; DESTRUCTION; INHIBITION; EXPRESSION; RECEPTORS; ABLATION	Pulmonary gas exchange relies on a rich capillary network, which, together with alveolar epithelial type I and II cells, form alveolar septa, the functional units in the lung. Alveolar capillary endothelial cells are critical in maintaining alveolar structure, because disruption of endothelial cell integrity underlies several lung diseases. Here we show that targeted ablation of lung capillary endothelial cells recapitulates the cellular events involved in cigarette smoke-induced emphysema, one of the most prevalent nonneoplastic lung diseases. Based on phage library screening on an immortalized lung endothelial cell line, we identified a lung endothelial cell-binding peptide, which preferentially homes to lung blood vessels. This peptide fused to a proapoptotic motif specifically induced programmed cell death of lung endothelial cells in vitro as well as targeted apoptosis of the lung microcirculation in vivo. As early as 4 days following peptide administration, mice developed air space enlargement associated with enhanced oxidative stress, influx of macrophages, and up-regulation of ceramide. Given that these are all critical elements of the corresponding human emphysema caused by cigarette smoke, these data provide evidence for a central role for the alveolar endothelial cells in the maintenance of lung structure and of endothelial cell apoptosis in the pathogenesis of emphysema-like changes. Thus, our data enable the generation of a convenient mouse model of human emphysema. Finally, combinatorial screenings on immortalized cells followed by in vivo targeting establishes an experimental framework for discovery and validation of additional ligand-directed pharmacodelivery systems.	[Giordano, Ricardo J.; Lahdenranta, Johanna; Langley, Robert R.; Fidler, Isaiah J.; Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Zhen, Lijie; Chukwueke, Ugonma; Petrache, Irina; Tuder, Rubin M.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Petrache, Irina] Indiana Univ, Indianapolis, IN 46204 USA; [Tuder, Rubin M.] Univ Colorado, Sch Med, Denver, CO 80262 USA	University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Pasqualini, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	rpasqual@mdanderson.org; rubin.tuder@uchsc.edu; warap@mdanderson.org	Giordano, Ricardo/A-2074-2010; Petrache, Irina/AAZ-9648-2020	Giordano, Ricardo/0000-0001-8116-6771; 	National Institutes of Health [HL 066554, HL 077328, CA 122568]; Department of Defense [W91ZSQ-4348-N602, DAMD17-01-1-0644]; American Thoracic Society/Alpha One Foundation Research; American Lung Association; AngelWorks, the Gillson-Longenbaugh Foundation; V Foundation; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA122568] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066554, R01HL077328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Thoracic Society/Alpha One Foundation Research; American Lung Association; AngelWorks, the Gillson-Longenbaugh Foundation; V Foundation; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 066554 (to R. M. T.) and HL 077328 (to I. P.) and Grant CA 122568 (to W. A. and R. P.). This work was also supported by Department of Defense IMPACT Grant W91ZSQ-4348-N602 (to W. A. and R. P.) and a Department of Defense Grant DAMD17-01-1-0644 (to R. J. G.); an American Thoracic Society/Alpha One Foundation Research Grant (to R. M. T.); a grant from the American Lung Association (to I. P.); and awards from AngelWorks, the Gillson-Longenbaugh Foundation, the V Foundation (to W. A. and R. P.). Robert Black fellow of the Damon Runyon Cancer Research Foundation (J. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aird WC, 2003, CRIT CARE MED, V31, pS221, DOI 10.1097/01.CCM.0000057847.32590.C1; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Aoshiba K, 2003, AM J RESP CELL MOL, V28, P555, DOI 10.1165/rcmb.2002-0090OC; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Arap MA, 2004, MOL THER, V9, P305, DOI 10.1016/j.ymthe.2003.11.016; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown KRS, 2001, AM J PHYSIOL-LUNG C, V281, pL1001, DOI 10.1152/ajplung.2001.281.4.L1001; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Dobrowsky RT, 2001, METHOD CELL BIOL, V66, P135; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Hajitou A, 2008, P NATL ACAD SCI USA, V105, P4471, DOI 10.1073/pnas.0712184105; Healy AM, 2000, DEV DYNAM, V219, P341, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1061>3.0.CO;2-M; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kanazawa H, 2003, EUR RESPIR J, V22, P609, DOI 10.1183/09031936.03.00030403; Kanazawa H, 2003, AM J MED, V114, P354, DOI 10.1016/S0002-9343(02)01562-0; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kelly JJ, 1998, AM J PHYSIOL-LUNG C, V274, pL810, DOI 10.1152/ajplung.1998.274.5.L810; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kolonin MG, 2002, P NATL ACAD SCI USA, V99, P13055, DOI 10.1073/pnas.162468499; Koyama S, 2002, AM J RESP CRIT CARE, V166, P382, DOI 10.1164/rccm.2103112; Lahdenranta J, 2007, FASEB J, V21, P3272, DOI 10.1096/fj.07-8273com; Langley RR, 2003, CANCER RES, V63, P2971; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; LIEBOW AA, 1959, AM REV RESPIR DIS, V80, P67; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; Oh Y, 2005, CHEST, V128, p596S, DOI 10.1378/chest.128.6_suppl.596S; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Sato M, 2007, ONCOLOGY-NY, V21, P1346; Shapiro SD, 1995, P ASSOC AM PHYSICIAN, V107, P346; Sirianni FE, 2003, AM J RESP CRIT CARE, V168, P1532, DOI 10.1164/rccm.200303-371OC; SNIDER GL, 1985, AM REV RESPIR DIS, V132, P182; Stevens Troy, 2001, American Journal of Physiology, V281, pC1422; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Tuder RM, 2003, AM J RESP CELL MOL, V28, P551, DOI 10.1165/rcmb.F269; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P503, DOI 10.1513/pats.200603-054MS; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; Yao VJ, 2005, AM J PATHOL, V166, P625, DOI 10.1016/S0002-9440(10)62283-3; Zheng T, 2005, J IMMUNOL, V174, P8106, DOI 10.4049/jimmunol.174.12.8106	54	92	93	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29447	29460		10.1074/jbc.M804595200	http://dx.doi.org/10.1074/jbc.M804595200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18718906	Green Published, hybrid			2022-12-25	WOS:000260179900071
J	Matsubara, T; Kida, K; Yamaguchi, A; Hata, K; Ichida, F; Meguro, H; Aburatani, H; Nishimura, R; Yoneda, T				Matsubara, Takuma; Kida, Kumiko; Yamaguchi, Akira; Hata, Kenji; Ichida, Fumitaka; Meguro, Hiroko; Aburatani, Hiroyuki; Nishimura, Riko; Yoneda, Toshiyuki			BMP2 Regulates Osterix through Msx2 and Runx2 during Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; GENE-EXPRESSION; CELLS; GROWTH; C2C12; CBFA1; SMAD5; OSSIFICATION; COOPERATION; INDUCTION	Osterix/Sp7, a member of the Sp1 transcription factor family, plays an essential role in bone formation and osteoblastogenesis. Although Osterix has been shown to be induced by BMP2 in a mesenchymal cell line, the molecular basis of the regulation, expression and function of Osterix during osteoblast differentiation, is not fully understood. Thus we examined the role of BMP2 signaling in the regulation of Osterix using the mesenchymal cell lines C3H10T1/2 and C2C12. Osterix overexpression induced alkaline phosphatase activity and osteocalcin expression in C2C12 cells and stimulated calcification of murine primary osteoblasts. Considering that Runx2 overexpression induces Osterix, these results suggest that Osterix functions as downstream of Runx2. Surprisingly, BMP2 treatment induced Osterix expression and alkaline phosphatase activity in mesenchymal cells derived from Runx2-deficient mice. Furthermore, overexpression of Smad1 and Smad4 up-regulated Osterix expression, and an inhibitory Smad, Smad6, markedly suppressed BMP2-induced Osterix expression in the Runx2-deficient cells. Moreover, overexpression of a homeobox gene, Msx2, which is up-regulated by BMP2 and promotes osteoblastic differentiation, induced Osterix expression in the Runx2-deficient cells. Knockdown of Msx2 clearly inhibited induction of Osterix by BMP2 in the Runx2-deficient mesenchymal cells. Interestingly, microarray analyses using the Runx2-deficient cells revealed that the role of Osterix was distinct from that of Runx2. These findings suggest that Osterix is regulated via both Runx2-dependent and -independent mechanisms, and that Osterix controls osteoblast differentiation, at least in part, by regulating the expression of genes not controlled by Runx2.	[Matsubara, Takuma; Kida, Kumiko; Hata, Kenji; Ichida, Fumitaka; Nishimura, Riko; Yoneda, Toshiyuki] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, Osaka 5650871, Japan; [Yamaguchi, Akira] Tokyo Med & Dent Univ, Dept Oral Pathol, Bunkyo Ku, Tokyo 1138549, Japan; [Meguro, Hiroko; Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Osaka University; Tokyo Medical & Dental University (TMDU); University of Tokyo	Nishimura, R (corresponding author), Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, 1-8 Yamadaoka, Osaka 5650871, Japan.	rikonisi@dent.osaka-u.ac.jp	Yamaguchi, Akira/AAX-9286-2020; Matsubara, Takuma/B-5031-2019	Matsubara, Takuma/0000-0002-8505-0431; Nishimura, Riko/0000-0001-7279-8363	Ministry of Education, Science, and Sports of Japan [A 17209059, B15390560]; Naito Foundation; Novartis Foundation	Ministry of Education, Science, and Sports of Japan; Naito Foundation(Naito Memorial Foundation); Novartis Foundation(Novartis)	This work was supported in part by the Ministry of Education, Science, and Sports of Japan, Culture Grants-in-aid for Scientific Research A 17209059, B15390560, the Naito Foundation, and the Novartis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Cohen MM, 2002, AM J MED GENET, V109, P87, DOI 10.1002/ajmg.10289; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; Igarashi M, 2007, MOL CELL BIOL, V27, P7947, DOI 10.1128/MCB.00813-07; Ishii M, 2000, GENOMICS, V68, P136, DOI 10.1006/geno.2000.6284; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; Milona M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-43; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568	31	386	422	3	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29119	29125		10.1074/jbc.M801774200	http://dx.doi.org/10.1074/jbc.M801774200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703512	Green Published, hybrid			2022-12-25	WOS:000260179900039
J	Schieke, SM; Ma, MC; Cao, L; Mccoy, JP; Liu, CY; Hensel, NF; Barrett, AJ; Boehm, M; Finkel, T				Schieke, Stefan M.; Ma, Mingchao; Cao, Liu; Mccoy, J. Philip, Jr.; Liu, Chengyu; Hensel, Nancy F.; Barrett, A. John; Boehm, Manfred; Finkel, Toren			Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW; HYPOXIA; OXYGEN; MESODERM; MTOR; PROLIFERATION; PRECURSORS; PATHWAY; GROWTH	Relatively little is known regarding the role of mitochondrial metabolism in stem cell biology. Here we demonstrate that mouse embryonic stem cells sorted for low and high resting mitochondrial membrane potential ( Delta Psi L-m and Delta Psi H-m) are indistinguishable morphologically and by the expression of pluripotency markers, whereas markedly differing in metabolic rates. Interestingly, Delta Psi L-m cells are highly efficient at in vitro mesodermal differentiation yet fail to efficiently form teratomas in vivo, whereas Delta Psi H-m cells behave in the opposite fashion. We further demonstrate that Delta Psi(m) reflects the degree of overall mammalian target of rapamycin ( mTOR) activation and that the (mTOR) inhibitor rapamycin reduces metabolic rate, augments differentiation, and inhibits tumor formation of the mouse embryonic stem cells with a high metabolic rate. Taken together, our results suggest a coupling between intrinsic metabolic parameters and stem cell fate that might form a basis for novel enrichment strategies and therapeutic options.	[Schieke, Stefan M.; Ma, Mingchao; Cao, Liu; Boehm, Manfred; Finkel, Toren] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA; [Hensel, Nancy F.; Barrett, A. John] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Boehm, M (corresponding author), Bldg 10-CRC 5-3132,10 Ctr Dr Bethesda, Bethesda, MD 20892 USA.	Manfred.Boehm@nih.gov; finkelt@nih.gov	mccoy, john philip/ABD-9348-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005012, ZIAHL002342, ZICHL005905, Z01HL005012, ZICHL005907, Z01HL005907, Z01HL005066, Z01HL002342, ZIAHL005066, Z01HL005905] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Deb KD, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-7; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Ivanovic Z, 2000, TRANSFUSION, V40, P1482, DOI 10.1046/j.1537-2995.2000.40121482.x; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Studer L, 2000, J NEUROSCI, V20, P7377; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	25	147	151	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28506	28512		10.1074/jbc.M802763200	http://dx.doi.org/10.1074/jbc.M802763200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713735	hybrid, Green Published			2022-12-25	WOS:000259969300053
J	Yamashita, T; Suzuki, R; Backlund, PS; Yamashita, Y; Yergey, AL; Rivera, J				Yamashita, Toshiyuki; Suzuki, Ryo; Backlund, Peter S.; Yamashita, Yumi; Yergey, Alfred L.; Rivera, Juan			Differential dephosphorylation of the FcR gamma immunoreceptor tyrosine-based activation motif tyrosines with dissimilar potential for activating Syk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY IGE RECEPTOR; LEUKEMIA RBL-2H3 CELLS; EPSILON-RI; MAST-CELLS; IMMUNOGLOBULIN-E; KINASE SYK; MEDIATED DEGRANULATION; PHOSPHATASES SHP-1; BETA-SUBUNIT; PHOSPHORYLATION	The cell surface-expressed gamma chain of the high affinity receptor for IgE (Fc epsilon RI) can be phosphorylated on two tyrosine residues of the immunoreceptor tyrosine-based activation motif (ITAM), leading to recruitment and activation of spleen tyrosine kinase (Syk), a kinase that is essential for mast cell signaling and allergic responses. However, it is not known whether preferential phosphorylation or dephosphorylation of the two individual FcR gamma tyrosines (the N-terminal Tyr(47) and C-terminal Tyr(58)) could regulate Syk activation. Herein we report that phosphorylation of only Tyr(58) was able to elicit Syk phosphorylation and a weak rise in intracellular calcium, suggesting that Tyr(58) phosphorylation may be distinctively important for Syk activation. In vitro and in vivo studies revealed that both Tyr(47) and Tyr(58) could be similarly phosphorylated. However, mass spectrometric analysis of the phosphorylated Fc epsilon R gamma from bone marrow-derived mast cells showed that phosphorylation at Tyr(47) was at least 2-fold greater than at Tyr(58). This suggested that, once phosphorylated, Tyr(58) is preferentially dephosphorylated. In vitro studies demonstrated more efficient dephosphorylation of Tyr(58) (by the receptor-associated phosphatases SHP-1 and SHP-2) than of Tyr(47). Analysis of Syk binding to wild type and mutant phosphorylated Fc epsilon RI revealed that mutation at Tyr(58) almost completely ablated Syk binding, whereas mutation at Tyr(47) moderately reduced Syk binding. The findings argue for a novel regulatory mechanism, where dephosphorylation of phospho-Tyr(58) is likely to promote the down-regulation of Syk activation and suppression of mast cell responses.	[Yamashita, Toshiyuki; Suzuki, Ryo; Yamashita, Yumi; Rivera, Juan] NIAMS, Lab Immune Cell Signaling, Bethesda, MD 20892 USA; [Backlund, Peter S.; Yergey, Alfred L.] NICHD, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rivera, J (corresponding author), NIAMS, NIH, Bldg 10,Rm 13C103, Bethesda, MD 20892 USA.	juan_rivera@nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD001421] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041101, Z01AR041101] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adachi T, 2007, BIOCHEM BIOPH RES CO, V364, P111, DOI 10.1016/j.bbrc.2007.09.100; Arias-Palomo E, 2007, BBA-PROTEINS PROTEOM, V1774, P1493, DOI 10.1016/j.bbapap.2007.10.008; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Bruhns P, 2005, CURR OPIN IMMUNOL, V17, P662, DOI 10.1016/j.coi.2005.09.012; Chen T, 1996, J BIOL CHEM, V271, P25308, DOI 10.1074/jbc.271.41.25308; Costello PS, 1996, ONCOGENE, V13, P2595; ElHillal O, 1997, P NATL ACAD SCI USA, V94, P1919, DOI 10.1073/pnas.94.5.1919; Furumoto Y, 2004, J BIOL CHEM, V279, P49177, DOI 10.1074/jbc.M404730200; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Huang ZY, 2003, J LEUKOCYTE BIOL, V73, P823, DOI 10.1189/jlb.0902454; Huber M, 2002, IMMUNOL LETT, V82, P17, DOI 10.1016/S0165-2478(02)00012-3; Huber M, 1998, EMBO J, V17, P7311, DOI 10.1093/emboj/17.24.7311; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kimura T, 1996, J BIOL CHEM, V271, P27962, DOI 10.1074/jbc.271.44.27962; Kimura T, 1997, J IMMUNOL, V159, P4426; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; LIU FT, 1980, J IMMUNOL, V124, P2728; MENDOZA G, 1976, NATURE, V264, P548, DOI 10.1038/264548a0; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; On M, 2004, J BIOL CHEM, V279, P45782, DOI 10.1074/jbc.M404890200; PAOLINI R, 1993, EMBO J, V12, P779, DOI 10.1002/j.1460-2075.1993.tb05712.x; PAOLINI R, 1991, NATURE, V353, P855, DOI 10.1038/353855a0; PRIBLUDA VS, 1994, P NATL ACAD SCI USA, V91, P11246, DOI 10.1073/pnas.91.23.11246; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; Rivera J, 2002, CURR OPIN IMMUNOL, V14, P688, DOI 10.1016/S0952-7915(02)00396-5; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; Sada K, 2000, J IMMUNOL, V164, P338, DOI 10.4049/jimmunol.164.1.338; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; SWIETER M, 1995, J IMMUNOL, V155, P5330; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Xie ZH, 2000, J IMMUNOL, V164, P1521, DOI 10.4049/jimmunol.164.3.1521; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P11251, DOI 10.1073/pnas.91.23.11251; Zhang J, 2004, J IMMUNOL, V173, P1811, DOI 10.4049/jimmunol.173.3.1811; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	38	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28584	28594		10.1074/jbc.M802679200	http://dx.doi.org/10.1074/jbc.M802679200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18715866	Green Published, hybrid			2022-12-25	WOS:000259969300061
J	Ravetti, MG; Moscato, P				Ravetti, Martin Gomez; Moscato, Pablo			Identification of a 5-Protein Biomarker Molecular Signature for Predicting Alzheimer's Disease	PLOS ONE			English	Article								Background: Alzheimer's disease (AD) is a progressive brain disease with a huge cost to human lives. The impact of the disease is also a growing concern for the governments of developing countries, in particular due to the increasingly high number of elderly citizens at risk. Alzheimer's is the most common form of dementia, a common term for memory loss and other cognitive impairments. There is no current cure for AD, but there are drug and non-drug based approaches for its treatment. In general the drug-treatments are directed at slowing the progression of symptoms. They have proved to be effective in a large group of patients but success is directly correlated with identifying the disease carriers at its early stages. This justifies the need for timely and accurate forms of diagnosis via molecular means. We report here a 5-protein biomarker molecular signature that achieves, on average, a 96% total accuracy in predicting clinical AD. The signature is composed of the abundances of IL-1 alpha, IL-3, EGF, TNF-alpha and G-CSF. Methodology/Principal Findings: Our results are based on a recent molecular dataset that has attracted worldwide attention. Our paper illustrates that improved results can be obtained with the abundance of only five proteins. Our methodology consisted of the application of an integrative data analysis method. This four step process included: a) abundance quantization, b) feature selection, c) literature analysis, d) selection of a classifier algorithm which is independent of the feature selection process. These steps were performed without using any sample of the test datasets. For the first two steps, we used the application of Fayyad and Irani's discretization algorithm for selection and quantization, which in turn creates an instance of the (alpha-beta)-k-Feature Set problem; a numerical solution of this problem led to the selection of only 10 proteins. Conclusions/Significance: the previous study has provided an extremely useful dataset for the identification of AD biomarkers. However, our subsequent analysis also revealed several important facts worth reporting: 1. A 5-protein signature (which is a subset of the 18-protein signature of Ray et al.)has the same overall performance (when using the same classifier). 2. Using more than 20 different classifiers available in the widely-used Weka software package, our 5-protein signature has, on average, a smaller prediction error indicating the independence of the classifier and the robustness of this set of biomarkers (i.e. 96% accuracy when predicting AD against non-demented control). 3. Using very simple classifiers, like Simple Logistic or Logistic Model Trees, we have achieved the following results on 92 samples: 100 percent success to predict Alzheimer's Disease and 92 percent to predict Non Demented Control on the AD dataset.	[Ravetti, Martin Gomez; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia	University of Newcastle	Ravetti, MG (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	martin.ravetti@newcastle.edu.au; pablo.moscato@newcastle.edu.au	Ravetti, Martin/K-1108-2012; Abrams, William R/A-5782-2008; MOSCATO, PABLO ALBERTO/G-7668-2013	Ravetti, Martin/0000-0001-7781-0034; Moscato, Pablo/0000-0003-2570-5966				BERRETTA R, 2008, BIOINFORMATICS, V2; Berretta R, 2007, J RES PRACT INF TECH, V39, P287; Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357; COTTA C, 2004, EVOLUTIONARY SEARCH, P21; COTTA C, 2007, HDB APPROXIMATION AL; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Landwehr N, 2005, MACH LEARN, V59, P161, DOI 10.1007/s10994-005-0466-3; Magaki S, 2007, EXP GERONTOL, V42, P233, DOI 10.1016/j.exger.2006.09.015; MENDES A, 2008, MICROARRAYS IDENTIFY, P131; MOSCATO P, 2005, GENES RELATED ALZHEI, P84; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Witten I. H., 2005, DATA MINING PRACTICA; 2007, ARIADNE GENOMICS, V1	13	80	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3111	10.1371/journal.pone.0003111	http://dx.doi.org/10.1371/journal.pone.0003111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769539	gold, Green Submitted, Green Published			2022-12-25	WOS:000264418300003
J	Essien, K; Hannenhalli, S; Stoeckert, CJ				Essien, Kobby; Hannenhalli, Sridhar; Stoeckert, Christian J., Jr.			Computational Analysis of Constraints on Noncoding Regions, Coding Regions and Gene Expression in Relation to Plasmodium Phenotypic Diversity	PLOS ONE			English	Article							MALARIA PARASITE; REGULATORY MOTIFS; GENOME SEQUENCE; DNA-BINDING; FALCIPARUM; EVOLUTION; LIFE; REVEALS; DISCOVERY; ALIGNMENT	Background: Malaria-causing Plasmodium species exhibit marked differences including host choice and preference for invading particular cell types. The genetic bases of phenotypic differences between parasites can be understood, in part, by investigating constraints on gene expression and genic sequences, both coding and regulatory. Methodology/Principal Findings: We investigated the evolutionary constraints on sequence and expression of parasitic genes by applying comparative genomics approaches to 6 Plasmodium genomes and 2 genome-wide expression studies. We found that the coding regions of Plasmodium transcription factor and sexual development genes are relatively less constrained, as are those of genes encoding CCCH zinc fingers and invasion proteins, which all play important roles in these parasites. Transcription factors and genes with stage-restricted expression have conserved upstream regions and so do several gene classes critical to the parasite's lifestyle, namely, ion transport, invasion, chromatin assembly and CCCH zinc fingers. Additionally, a cross-species comparison of expression patterns revealed that Plasmodium-specific genes exhibit significant expression divergence. Conclusions/Significance: Overall, constraints on Plasmodium's protein coding regions confirm observations from other eukaryotes in that transcription factors are under relatively lower constraint. Proteins relevant to the parasite's unique lifestyle also have lower constraint on their coding regions. Greater conservation between Plasmodium species in terms of promoter motifs suggests tight regulatory control of lifestyle genes. However, an interspecies divergence in expression patterns of these genes suggests that either expression is controlled via genomic or epigenomic features not encoded in the proximal promoter sequence, or alternatively, the combinatorial interactions between motifs confer species-specific expression patterns.	[Essien, Kobby] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Essien, Kobby; Hannenhalli, Sridhar; Stoeckert, Christian J., Jr.] Univ Penn, Ctr Bioinformat, Philadelphia, PA 19104 USA; [Hannenhalli, Sridhar; Stoeckert, Christian J., Jr.] Univ Penn, Sch Med, Dept Genet, Philadelphia 19104, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Essien, K (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	stoeckrt@pcbi.upenn.edu	Hide, Winston Hide/C-7217-2009; Hide, Winston/R-3815-2019; Hide, Winston A/V-2727-2017	Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271	National Human Genome Research Institute [T32HG000046, 5R01AI058515-05, 5R21GM078203-02]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078203] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	KE was supported by grants T32HG000046 from the National Human Genome Research Institute and 5R01AI058515-05 (to CJS). SH was supported by 5R21GM078203-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chow CS, 2003, MOL BIOCHEM PARASIT, V129, P199, DOI 10.1016/S0166-6851(03)00101-4; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Farre D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r140; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Iwama H, 2004, P NATL ACAD SCI USA, V101, P17156, DOI 10.1073/pnas.0407670101; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; LANZER M, 1992, NUCLEIC ACIDS RES, V20, P3051, DOI 10.1093/nar/20.12.3051; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Lee S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-168; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lopez-Bigas N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r33; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; OLDHAM MC, 2006, P NATL ACAD SCI USA; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tirosh I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100198; *US CDCP, MAL YELL BOOK, pCH4; van Noort V, 2006, TRENDS GENET, V22, P73, DOI 10.1016/j.tig.2005.12.002; Vardhanabhuti S, 2007, NUCLEIC ACIDS RES, V35, P3203, DOI 10.1093/nar/gkm201; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570; Zhou YY, 2005, BIOINFORMATICS, V21, P1237, DOI 10.1093/bioinformatics/bti111	41	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3122	10.1371/journal.pone.0003122	http://dx.doi.org/10.1371/journal.pone.0003122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769675	gold, Green Published, Green Submitted			2022-12-25	WOS:000264416600010
J	de Smith, AJ; Walters, RG; Coin, LJM; Steinfeld, I; Yakhini, Z; Sladek, R; Froguel, P; Blakemore, AIF				de Smith, Adam J.; Walters, Robin G.; Coin, Lachlan J. M.; Steinfeld, Israel; Yakhini, Zohar; Sladek, Rob; Froguel, Philippe; Blakemore, Alexandra I. F.			Small Deletion Variants Have Stable Breakpoints Commonly Associated with Alu Elements	PLOS ONE			English	Article								Copy number variants (CNVs) contribute significantly to human genomic variation, with over 5000 loci reported, covering more than 18% of the euchromatic human genome. Little is known, however, about the origin and stability of variants of different size and complexity. We investigated the breakpoints of 20 small, common deletions, representing a subset of those originally identified by array CGH, using Agilent microarrays, in 50 healthy French Caucasian subjects. By sequencing PCR products amplified using primers designed to span the deleted regions, we determined the exact size and genomic position of the deletions in all affected samples. For each deletion studied, all individuals carrying the deletion share identical upstream and downstream breakpoints at the sequence level, suggesting that the deletion event occurred just once and later became common in the population. This is supported by linkage disequilibrium (LD) analysis, which has revealed that most of the deletions studied are in moderate to strong LD with surrounding SNPs, and have conserved long-range haplotypes. Analysis of the sequences flanking the deletion breakpoints revealed an enrichment of microhomology at the breakpoint junctions. More significantly, we found an enrichment of Alu repeat elements, the overwhelming majority of which intersected deletion breakpoints at their poly-A tails. We found no enrichment of LINE elements or segmental duplications, in contrast to other reports. Sequence analysis revealed enrichment of a conserved motif in the sequences surrounding the deletion breakpoints, although whether this motif has any mechanistic role in the formation of some deletions has yet to be determined. Considered together with existing information on more complex inherited variant regions, and reports of de novo variants associated with autism, these data support the presence of different subgroups of CNV in the genome which may have originated through different mechanisms.	[de Smith, Adam J.; Walters, Robin G.; Froguel, Philippe; Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, London, England; [Coin, Lachlan J. M.] Imperial Coll London, Dept Epidemiol & Publ Hlth, London, England; [Steinfeld, Israel; Yakhini, Zohar] Agilent Lab, Petah Tiqwa, Israel; [Sladek, Rob] McGill Univ, Genome Quebec Innovat Ctr, Dept Human Genet, Montreal, PQ H3A 2T5, Canada; [Sladek, Rob] McGill Univ, Genome Quebec Innovat Ctr, Dept Med, Montreal, PQ H3A 2T5, Canada; [Froguel, Philippe] Inst Pasteur, Inst Biol, CNRS 8090, Lille, France	Imperial College London; Imperial College London; Agilent Technologies; McGill University; McGill University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	de Smith, AJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, London, England.	a.blakemore@imperial.ac.uk	Walters, Robin G/E-6069-2010; Blakemore, Alexandra I F/D-2253-2009; Coin, Lachlan/O-4976-2019; Coin, Lachlan JM/A-9001-2014; FROGUEL, Philippe/O-6799-2017; Sladek, Robert/R-2391-2019	Walters, Robin G/0000-0002-9179-0321; Blakemore, Alexandra I F/0000-0003-0661-564X; Coin, Lachlan/0000-0002-4300-455X; Coin, Lachlan JM/0000-0002-4300-455X; FROGUEL, Philippe/0000-0003-2972-0784; Sladek, Robert/0000-0002-2730-1204; Yakhini, Zohar/0000-0002-0420-5412; de Smith, Adam/0000-0003-4880-7543	Hammersmith Hospital Trust; Genome Quebec; MRC [G0600331] Funding Source: UKRI; Medical Research Council [G0600331] Funding Source: researchfish	Hammersmith Hospital Trust; Genome Quebec; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Hammersmith Hospital Trust, and SNP genotyping was funded by Genome Quebec.	Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Callinan PA, 2005, J MOL BIOL, V348, P791, DOI 10.1016/j.jmb.2005.02.043; Chan CY, 2007, NUCLEIC ACIDS RES, V35, P5051, DOI 10.1093/nar/gkm442; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Dewannieux M, 2005, GENOMICS, V86, P378, DOI 10.1016/j.ygeno.2005.05.009; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez-Barrera S, 2002, GENETICS, V162, P603; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; KIM PM, 2007, COPY NUMBER VA UNPUB; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; KRAWCZAK M, 1991, HUM GENET, V86, P425; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee K, 2007, GENETICS, V176, P2003, DOI 10.1534/genetics.107.076539; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rozen S, 2000, Methods Mol Biol, V132, P365; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; SMIT AFA, 1996 2004 REPEATMASK; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; DATABASE GENOMIC VAR	42	42	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3104	10.1371/journal.pone.0003104	http://dx.doi.org/10.1371/journal.pone.0003104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769679	Green Published, gold			2022-12-25	WOS:000264796800009
J	Smith, SA; Tank, DC; Boulanger, LA; Bascom-Slack, CA; Eisenman, K; Kingery, D; Babbs, B; Fenn, K; Greene, JS; Hann, BD; Keehner, J; Kelley-Swift, EG; Kembaiyan, V; Lee, SJ; Li, PY; Light, DY; Lin, EH; Ma, C; Moore, E; Schorn, MA; Vekhter, D; Nunez, PV; Strobel, GA; Donoghue, MJ; Strobel, SA				Smith, Stephen A.; Tank, David C.; Boulanger, Lori-Ann; Bascom-Slack, Carol A.; Eisenman, Kaury; Kingery, David; Babbs, Beatrice; Fenn, Kathleen; Greene, Joshua S.; Hann, Bradley D.; Keehner, Jocelyn; Kelley-Swift, Elizabeth G.; Kembaiyan, Vivek; Lee, Sun Jin; Li, Puyao; Light, David Y.; Lin, Emily H.; Ma, Cong; Moore, Emily; Schorn, Michelle A.; Vekhter, Daniel; Nunez, Percy V.; Strobel, Gart A.; Donoghue, Michael J.; Strobel, Scott A.			Bioactive Endophytes Warrant Intensified Exploration and Conservation	PLOS ONE			English	Article								Background: A key argument in favor of conserving biodiversity is that as yet undiscovered biodiversity will yield products of great use to humans. However, the link between undiscovered biodiversity and useful products is largely conjectural. Here we provide direct evidence from bioassays of endophytes isolated from tropical plants and bioinformatic analyses that novel biology will indeed yield novel chemistry of potential value. Methodology/Principal Findings: We isolated and cultured 135 endophytic fungi and bacteria from plants collected in Peru. nrDNAs were compared to samples deposited in GenBank to ascertain the genetic novelty of cultured specimens. Ten endophytes were found to be as much as 15-30% different than any sequence in GenBank. Phylogenetic trees, using the most similar sequences in GenBank, were constructed for each endophyte to measure phylogenetic distance. Assays were also conducted on each cultured endophyte to record bioactivity, of which 65 were found to be bioactive. Conclusions/Significance: The novelty of our contribution is that we have combined bioinformatic analyses that document the diversity found in environmental samples with culturing and bioassays. These results highlight the hidden hyperdiversity of endophytic fungi and the urgent need to explore and conserve hidden microbial diversity. This study also showcases how undergraduate students can obtain data of great scientific significance.	[Smith, Stephen A.; Tank, David C.; Donoghue, Michael J.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Boulanger, Lori-Ann; Bascom-Slack, Carol A.; Eisenman, Kaury; Kingery, David; Babbs, Beatrice; Fenn, Kathleen; Greene, Joshua S.; Hann, Bradley D.; Keehner, Jocelyn; Kelley-Swift, Elizabeth G.; Kembaiyan, Vivek; Lee, Sun Jin; Li, Puyao; Light, David Y.; Lin, Emily H.; Ma, Cong; Moore, Emily; Schorn, Michelle A.; Vekhter, Daniel; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Nunez, Percy V.] Univ Nacl San Antonio Abad Cusco, Cuzco, Peru; [Strobel, Gart A.] Montana State Univ, Dept Plant Sci, Bozeman, MT USA	Yale University; Yale University; Universidad Nacional de San Antonio Abad del Cusco; Montana State University System; Montana State University Bozeman	Smith, SA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	stephen.smith@yale.edu	Fenn, Kathleen/L-6371-2019; Smith, Stephen/AAE-8623-2019; schorn, michelle/AAD-6284-2020; Smith, Stephen/B-3451-2010	Smith, Stephen/0000-0003-2035-9531; Fenn, Kathleen/0000-0001-6327-4365	Yale University; Howard Hughes Medical Institute; NSF [OISE-0636212]	Yale University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF))	This program was supported in part by a grant to Yale University, in support of S. Strobel, from the Howard Hughes Medical Institute through the HHMI Professors Program and by NSF grant OISE-0636212. The funding sources had no role in the design or conduct of the study.	Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Bacon C. W., 2000, MICROBIAL ENDOPHYTES, DOI 10.1201/9781482277302; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; HAWKSWORTH DL, 2004, STUD MYCOL, V50, P9; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SMITH SA, 2008, PHYUTILITY PHYLOINFO; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel SA, 2007, NAT CHEM BIOL, V3, P356, DOI 10.1038/nchembio0707-356; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	14	64	89	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3052	10.1371/journal.pone.0003052	http://dx.doi.org/10.1371/journal.pone.0003052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LJ	18725962	Green Published, Green Submitted, gold			2022-12-25	WOS:000264429000005
J	Work, TM; Aeby, GS; Maragos, JE				Work, Thierry M.; Aeby, Greta S.; Maragos, James E.			Phase Shift from a Coral to a Corallimorph-Dominated Reef Associated with a Shipwreck on Palmyra Atoll	PLOS ONE			English	Article							RHODACTIS-RHODOSTOMA; MASS MORTALITY; IRON; ACROPORA; PHYTOPLANKTON; COMMUNITIES; TENTACLES; OCEAN	Coral reefs can undergo relatively rapid changes in the dominant biota, a phenomenon referred to as phase shift. Various reasons have been proposed to explain this phenomenon including increased human disturbance, pollution, or changes in coral reef biota that serve a major ecological function such as depletion of grazers. However, pinpointing the actual factors potentially responsible can be problematic. Here we show a phase shift from coral to the corallimorpharian Rhodactis howesii associated with a long line vessel that wrecked in 1991 on an isolated atoll (Palmyra) in the central Pacific Ocean. We documented high densities of R. howesii near the ship that progressively decreased with distance from the ship whereas R. howesii were rare to absent in other parts of the atoll. We also confirmed high densities of R. howesii around several buoys recently installed on the atoll in 2001. This is the first time that a phase shift on a coral reef has been unambiguously associated with man-made structures. This association was made, in part, because of the remoteness of Palmyra and its recent history of minimal human habitation or impact. Phase shifts can have long-term negative ramification for coral reefs, and eradication of organisms responsible for phase shifts in marine ecosystems can be difficult, particularly if such organisms cover a large area. The extensive R. howesii invasion and subsequent loss of coral reef habitat at Palmyra also highlights the importance of rapid removal of shipwrecks on corals reefs to mitigate the potential of reef overgrowth by invasives.	[Work, Thierry M.] US Geol Survey, Natl Wildlife Hlth Ctr, Honolulu Field Stn, Honolulu, HI USA; [Aeby, Greta S.] Univ Hawaii, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA; [Maragos, James E.] US Fish & Wildlife Serv, Pacific Isl Refuges, Honolulu, HI USA	United States Department of the Interior; United States Geological Survey; University of Hawaii System; United States Department of the Interior; US Fish & Wildlife Service	Work, TM (corresponding author), US Geol Survey, Natl Wildlife Hlth Ctr, Honolulu Field Stn, Honolulu, HI USA.	thierry_work@usgs.gov	Work, Thierry M/F-1550-2015	Work, Thierry M/0000-0002-4426-9090	US Geological Survey; Hawaii Institute of Marine Biology (University of Hawaii)	US Geological Survey(United States Geological Survey); Hawaii Institute of Marine Biology (University of Hawaii)	Funding provided by the US Geological Survey and Hawaii Institute of Marine Biology (University of Hawaii).	Anderson LWJ, 2005, BIOL INVASIONS, V7, P1003, DOI 10.1007/s10530-004-3123-z; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BRAINARD R, 2005, STATE CORAL REEF ECO, P338; Butler A, 1998, SCIENCE, V281, P207, DOI 10.1126/science.281.5374.207; CHADWICK NE, 1991, HYDROBIOLOGIA, V216, P263, DOI 10.1007/BF00026473; CHADWICK NE, 1987, BIOL BULL, V173, P110, DOI 10.2307/1541866; Chadwick-Furman NE, 2000, INVERTEBR BIOL, V119, P351; Chen CA, 2004, CORAL REEFS, V23, P508, DOI 10.1007/s00338-004-0423-9; CHISHOLM SW, 1991, LIMNOL OCEANOGR, V36, pU1507; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; ENTSCH B, 1983, MAR BIOL, V73, P17, DOI 10.1007/BF00396281; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; Kuguru B, 2007, MAR BIOL, V151, P1287, DOI 10.1007/s00227-006-0589-5; Kuguru BL, 2004, MAR BIOL, V145, P875, DOI 10.1007/s00227-004-1376-9; Langmead O, 1999, MAR BIOL, V134, P479, DOI 10.1007/s002270050564; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; Maragos James, 2008, V1, P643, DOI 10.1007/978-1-4020-6847-8_16; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; PETERS EC, 1981, MAR POLLUT BULL, V12, P333, DOI 10.1016/0025-326X(81)90106-5; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V61, P31, DOI 10.1016/0022-0981(82)90020-X; Schroeder RE, 2008, B MAR SCI, V82, P345; Tkachenko KS, 2007, MAR BIOL, V151, P185, DOI 10.1007/s00227-006-0467-1; Tortell PD, 1999, FEMS MICROBIOL ECOL, V29, P1; WILLIAMS RB, 1991, HYDROBIOLOGIA, V216, P539, DOI 10.1007/BF00026511; Work TM, 2008, DIS AQUAT ORGAN, V78, P255, DOI 10.3354/dao01881	30	65	68	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2989	10.1371/journal.pone.0002989	http://dx.doi.org/10.1371/journal.pone.0002989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714355	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420900015
J	van Roermund, CWT; Visser, WF; Ijlst, L; van Cruchten, A; Boek, M; Kulik, W; Waterham, HR; Wanders, RJA				van Roermund, Carlo W. T.; Visser, Wouter F.; Ijlst, Lodewijk; van Cruchten, Arno; Boek, Maxim; Kulik, Wim; Waterham, Hans R.; Wanders, Ronald J. A.			The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters	FASEB JOURNAL			English	Article						beta-oxidation; ATP-binding-cassette transporter; FA transport; carrier	X-LINKED ADRENOLEUKODYSTROPHY; ACID BETA-OXIDATION; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; FATTY-ACIDS; GENE; IDENTIFICATION; MITOCHONDRIA; METABOLISM	Peroxisomes play a major role in human cellular lipid metabolism, including the beta-oxidation of fatty acids. The most frequent peroxisomal disorder is X-linked adrenoleukodystrophy (X-ALD), which is caused by mutations in the ABCD1 gene. The protein involved, called ABCD1, or alternatively ALDP, is a member of the ATP-binding-cassette (ABC) transporter family and is located in the peroxisomal membrane. The biochemical hallmark of X-ALD is the accumulation of very long-chain fatty acids (VLCFAs), due to an impaired peroxisomal beta-oxidation. Although this suggests a role of ALDP in VLCFA import, no experimental evidence is available to substantiate this. In the yeast Saccharomyces cerevisiae, peroxisomes are the exclusive site of fatty acid beta-oxidation. Earlier work has shown that uptake of fatty acids into peroxisomes may occur via two routes, either as free fatty acids thus requiring intraperoxisomal activation into acyl-CoA esters or as long-chain acyl-CoA esters. The latter route involves the two peroxisomal half ABC transporters Pxa1p and Pxa2p that form a heterodimeric complex in the peroxisomal membrane. Using different strategies, including the analysis of intracellular acyl-CoA esters by tandem-MS, we show that the Pxa1p/Pxa2p heterodimer is involved in the transport of a spectrum of acyl-CoA esters. Interestingly, we found that the mutant phenotype of the pxa1/pxa2 Delta mutant can be rescued, at least partially, by the sole expression of the human ABCD1 cDNA coding for ALDP, the protein that is defective in the human disease X-linked adrenoleukodystrophy. Our data indicate that ALDP can function as a homodimer and is involved in the transport of acyl-CoA esters across the peroxisomal membrane.	Univ Amsterdam, Lab Genet Metab Dis, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Lab Genet Metab Dis, Acad Med Ctr, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Roermund, CWT (corresponding author), Univ Amsterdam, Lab Genet Metab Dis, Acad Med Ctr, Dept Pediat, Rm F0-226,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.vanroermund@amc.uva.nl			EU X-ALD [LSHM-CT2004-502987X-ALD, LSHG-CT2004-512018]	EU X-ALD	This work was supported by the EU X-ALD project (Project No. LSHM-CT2004-502987X-ALD) and the EU peroxisome project (Project No. LSHG-CT2004-512018).	Berger J, 2006, BBA-MOL CELL RES, V1763, P1721, DOI 10.1016/j.bbamcr.2006.07.010; CONTRERAS M, 1994, FEBS LETT, V344, P211, DOI 10.1016/0014-5793(94)00400-5; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V237, P152, DOI 10.1006/bbrc.1997.7102; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; Pohl A, 2005, BBA-MOL CELL BIOL L, V1733, P29, DOI 10.1016/j.bbalip.2004.12.007; Rottensteiner H, 2006, BBA-MOL CELL RES, V1763, P1527, DOI 10.1016/j.bbamcr.2006.08.012; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Takahashi N, 2007, J NEUROCHEM, V101, P1632, DOI 10.1111/j.1471-4159.2007.04457.x; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; van Roermund CWT, 2003, CELL MOL LIFE SCI, V60, P1838, DOI 10.1007/s00018-003-3076-x; van Roermund CWT, 2001, MOL CELL BIOL, V21, P4321, DOI 10.1128/MCB.21.13.4321-4329.2001; VANDERLEIJ I, 1992, J CELL BIOL, V119, P153, DOI 10.1083/jcb.119.1.153; Verleur N, 1997, EUR J BIOCHEM, V249, P657, DOI 10.1111/j.1432-1033.1997.00657.x; Visser WF, 2007, BIOCHEM BIOPH RES CO, V357, P335, DOI 10.1016/j.bbrc.2007.03.083; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352; WANDERS RJA, 1992, BIOCHEM BIOPH RES CO, V188, P1139, DOI 10.1016/0006-291X(92)91350-Y; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424	26	169	172	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2008	22	12					4201	4208		10.1096/fj.08-110866	http://dx.doi.org/10.1096/fj.08-110866			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18757502				2022-12-25	WOS:000261254800019
J	Cooper, MP; Uldry, M; Kajimura, S; Arany, Z; Spiegelman, BM				Cooper, Marcus P.; Uldry, Marc; Kajimura, Shingo; Arany, Zoltan; Spiegelman, Bruce M.			Modulation of PGC-1 Coactivator Pathways in Brown Fat Differentiation through LRP130	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL UNCOUPLING PROTEIN; C-OXIDASE DEFICIENCY; ADIPOSE CELL LINE; MESSENGER-RNA; ADIPOCYTE DIFFERENTIATION; TRANSGENIC MICE; IN-VIVO; ADAPTIVE THERMOGENESIS; INDUCIBLE COACTIVATOR; ENERGY-METABOLISM	The PGC-1 coactivators are important regulators of oxidative metabolism. We previously demonstrated that LRP130 is a binding partner of PGC-1 alpha, required for hepatic gluconeogenesis. LRP130 is the gene mutated in Leigh syndrome French Canadian variant, a rare neurodegenerative disease. The importance of LRP130 in other, non-hepatocyte biology remains obscure. To better understand PGC-1 coactivator function in brown fat development, we explored the metabolic role of LRP130 in brown adipocyte differentiation. We show that LRP130 is preferentially enriched in brown fat compared with white, and induced in a PGC-1-dependent manner during differentiation. Despite intact PGC-1 coactivator expression, brown fat cells deficient for LRP130 exhibit attenuated expression of several genes characteristic of brown fat, including uncoupling protein 1. Oxygen consumption studies support a specific defect in proton leak due to attenuated uncoupling protein 1 expression. Notably, brown fat cell development common to both PGC-1 coactivators is governed by LRP130. Conversely, the cAMP response controlled by PGC-1 alpha is not regulated by LRP130. These data implicate LRP130 in brown fat cell development and differentiation.	[Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.	marcus.cooper@umassmed.edu; bruce_spiegelman@dfci.harvard.edu	Kajimura, Shingo/AAC-5090-2019	Kajimura, Shingo/0000-0003-0672-5910	National Institutes of Health [R01DK61562, K08DK071017]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK081564, K08DK071017, R01DK061562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK61562 (to B. M. S.) and K08DK071017 (to M. P. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; BEARDEN JC, 1978, BIOCHIM BIOPHYS ACTA, V533, P525, DOI 10.1016/0005-2795(78)90398-7; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; DAWKINS MJR, 1964, J PHYSIOL-LONDON, V172, P216, DOI 10.1113/jphysiol.1964.sp007414; Debevec D, 2007, MOL ENDOCRINOL, V21, P1581, DOI 10.1210/me.2007-0103; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; HULL D, 1965, J PHYSIOL-LONDON, V181, P468, DOI 10.1113/jphysiol.1965.sp007775; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Melnyk A, 1997, AM J PHYSIOL-REG I, V272, pR1088, DOI 10.1152/ajpregu.1997.272.4.R1088; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; MORIN C, 1993, AM J HUM GENET, V53, P488; Murray R, 2006, HARPERS ILLUSTRATED; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RICQUIER D, 1982, J CLIN ENDOCR METAB, V54, P803; RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4; RICQUIER D, 1983, J BIOL CHEM, V258, P6675; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; SIMON HE, 1950, AM J SURG, V80, P127, DOI 10.1016/0002-9610(50)90575-7; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Tai TAC, 1996, J BIOL CHEM, V271, P29909, DOI 10.1074/jbc.271.47.29909; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Tsuchiya N, 2004, BIOCHEM BIOPH RES CO, V317, P736, DOI 10.1016/j.bbrc.2004.03.103; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469	50	43	48	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31960	31967		10.1074/jbc.M805431200	http://dx.doi.org/10.1074/jbc.M805431200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18728005	Green Published, hybrid			2022-12-25	WOS:000260760800078
J	Huang, X; Swanson, R; Broze, GJ; Olson, ST				Huang, Xin; Swanson, Richard; Broze, George J., Jr.; Olson, Steven T.			Kinetic Characterization of the Protein Z-dependent Protease Inhibitor Reaction with Blood Coagulation Factor Xa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; TICK ANTICOAGULANT PEPTIDE; ANTITHROMBIN-III; Z DEFICIENCY; FACTOR IXA; COMPLEX; HEPARIN; SERPIN; MECHANISM; PROTHROMBINASE	Protein Z-dependent protease inhibitor (ZPI) is a recently identified member of the serpin superfamily that functions as a cofactor-dependent regulator of blood coagulation factors Xa (FXa) and XIa. Here we show that ZPI and its cofactor, protein Z (PZ), inhibit procoagulant membrane-bound factor Xa by the branched pathway acyl-intermediate trapping mechanism used by other serpins, but with significant variations of this mechanism that are unique to ZPI. Rapid kinetic analyses showed that the reaction proceeded by the initial assembly of a membrane-associated PZ-ZPI-FXa Michaelis complex (K-M 53 +/- 5 nM) followed by conversion to a stable ZPI-FXa complex (k(lim) 1.2 +/- 0.1 s(-1)). Cofactor premixing experiments together with independent kinetic analyses of ZPI-PZ and factor Xa-PZ-membrane complex formation suggested that assembly of the Michaelis complex through either ZPI-PZ-lipid or factor Xa-PZ-lipid intermediates was rate-limiting. Reaction stoichiometry analyses and native PAGE showed that for every factor Xa molecule inhibited by ZPI, two serpin molecules were cleaved. Native PAGE and immunoblotting showed that PZ dissociated from ZPI once ZPI forms a stable complex with FXa, and kinetic analyses confirmed that PZ acted catalytically to accelerate the membrane-dependent ZPI-factor Xa reaction. The ZPI-FXa complex was only transiently stable and dissociated with a rate constant that showed a bell-shaped pH dependence indicative of participation of factor Xa active-site residues. The complex was detectable by SDS-PAGE when denatured at low pH, consistent with it being a kinetically trapped covalent acyl-intermediate. Together our findings show that ZPI functions like other serpins to regulate the activity of FXa but in a manner uniquely dependent on protein Z, procoagulant membranes, and pH.	[Huang, Xin; Swanson, Richard; Olson, Steven T.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Broze, George J., Jr.] Washington Univ, Sch Med, Div Hematol, St Louis, MO 63110 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington University (WUSTL)	Olson, ST (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, 801 S Paulina St,Rm 530C M-C 860, Chicago, IL 60612 USA.	stolson@uic.edu		Huang, Xin/0000-0002-4730-9318	National Institutes of Health [HL-78827, HL-060782]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060782, R01HL078827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-78827 (to S. T. O.) and HL-060782 (to G. J. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barker-Carlson K, 2002, J BIOL CHEM, V277, P46852, DOI 10.1074/jbc.M207740200; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; Broze GJ, 2001, THROMB HAEMOSTASIS, V86, P8; Brufatto N, 2001, J BIOL CHEM, V276, P17663, DOI 10.1074/jbc.M011586200; Calugaru SV, 2001, J BIOL CHEM, V276, P32446, DOI 10.1074/jbc.M104731200; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; ERSDALBADJU E, 1995, BIOCHEM J, V310, P323, DOI 10.1042/bj3100323; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Han JH, 1998, BIOCHEMISTRY-US, V37, P3203, DOI 10.1021/bi9722195; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Heeb MJ, 2005, J BIOL CHEM, V280, P33819, DOI 10.1074/jbc.M506502200; HEEB MJ, 1993, J BIOL CHEM, V268, P2872; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; JORDAN SP, 1992, BIOCHEMISTRY-US, V31, P5374, DOI 10.1021/bi00138a019; Kvassman JO, 1998, BIOCHEMISTRY-US, V37, P15491, DOI 10.1021/bi9814787; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; MAO SS, 1995, BIOCHEMISTRY-US, V34, P5098, DOI 10.1021/bi00015a021; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; OLSON ST, 1985, J BIOL CHEM, V260, P153; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Plotnick MI, 2002, BIOCHEMISTRY-US, V41, P334, DOI 10.1021/bi015650+; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; Rezaie AR, 2001, BLOOD, V97, P2308, DOI 10.1182/blood.V97.8.2308; Tabatabai A, 2001, THROMB HAEMOSTASIS, V85, P655, DOI 10.1055/s-0037-1615649; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897; Zhang J, 2008, BLOOD, V111, P4973, DOI 10.1182/blood-2007-12-126391; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	38	36	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29770	29783		10.1074/jbc.M805214200	http://dx.doi.org/10.1074/jbc.M805214200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768472	Green Published, hybrid			2022-12-25	WOS:000260366900021
J	Shi, J; Huang, GR; Kandror, KV				Shi, Jun; Huang, Guanrong; Kandror, Konstantin V.			Self-assembly of Glut4 Storage Vesicles during Differentiation of 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESPONSIVE AMINOPEPTIDASE; REGULATED MEMBRANE AMINOPEPTIDASE; ENDOSOMAL RECYCLING COMPARTMENT; GLUCOSE-TRANSPORTER GLUT4; RAT ADIPOSE-CELLS; GLUT4-CONTAINING VESICLES; PLASMA-MEMBRANE; MAJOR PROTEIN; SORTILIN; TRANSLOCATION	Glut4 storage vesicles (GSVs) represent translocation-competent vesicular carriers in fat and skeletal muscle cells that deliver Glut4 to the plasma membrane in response to insulin stimulation. GSVs include three major cargo proteins: Glut4, insulin-responsive aminopeptidase ( IRAP), and sortilin. Previous work has suggested that the lumenal interaction between Glut4 and sortilin and the cytoplasmic interaction between sortilin and GGA adaptors play an important role in recruitment of Glut4 into the GSVs. However, the mechanism of IRAP targeting to this compartment remains unknown. To address this question, we show that in differentiating adipocytes IRAP enters the GSVs from the "donor" membranes on day 3 of differentiation. Forced expression of sortilin in undifferentiated cells does not recruit IRAP into the vesicles. However, double expression of sortilin and Glut4 reconstitutes functional GSVs that incorporate endogenous IRAP. To explain this process, we show by a yeast two-hybrid system and chemical cross-linking that the lumenal domain of IRAP can interact with the lumenal loop of Glut4. IRAP without the lumenal domain is faithfully targeted to the donor membranes but has significantly lower insulin responsiveness than full-length IRAP. We suggest that lumenal interactions between Glut4 and IRAP play an important role in the assembly of the GSVs.	[Shi, Jun; Huang, Guanrong; Kandror, Konstantin V.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Kandror, KV (corresponding author), Boston Univ, Sch Med, Dept Biochem, K124D,715 Albany St, Boston, MA 02118 USA.	kandror@biochem.bumc.bu.edu		Kandror, Konstantin/0000-0002-8601-9313	National Institutes of Health [DK52057, DK56736]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052057, R01DK056736, R01DK052057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK52057 and DK56736. This work was also supported by a Research Award from the American Diabetes Association ( to K. V. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abel ED, 2004, MOL ENDOCRINOL, V18, P2491, DOI 10.1210/me.2004-0175; Ariga M, 2008, J BIOL CHEM, V283, P10208, DOI 10.1074/jbc.M710604200; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bose A, 2001, MOL CELL BIOL, V21, P5262, DOI 10.1128/MCB.21.15.5262-5275.2001; CAIN CC, 1992, J BIOL CHEM, V267, P11681; Carvalho E, 2004, J BIOL CHEM, V279, P21598, DOI 10.1074/jbc.M312269200; El-Jack AK, 1999, MOL BIOL CELL, V10, P1581, DOI 10.1091/mbc.10.5.1581; Gross DN, 2004, MOL CELL BIOL, V24, P7151, DOI 10.1128/MCB.24.16.7151-7162.2004; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Hou JC, 2006, J BIOL CHEM, V281, P33457, DOI 10.1074/jbc.M601583200; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; HUDSON AW, 1992, J CELL BIOL, V116, P785, DOI 10.1083/jcb.116.3.785; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jiang H, 2001, BIOCHEM BIOPH RES CO, V284, P519, DOI 10.1006/bbrc.2001.4994; Johnson AO, 2001, MOL BIOL CELL, V12, P367, DOI 10.1091/mbc.12.2.367; KANDROR KV, 1994, J BIOL CHEM, V269, P30777; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kandror KV, 1999, J BIOL CHEM, V274, P25210, DOI 10.1074/jbc.274.36.25210; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Keller SR, 2002, J BIOL CHEM, V277, P17677, DOI 10.1074/jbc.M202037200; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kupriyanova TA, 2000, J BIOL CHEM, V275, P36263, DOI 10.1074/jbc.M002797200; Kupriyanova TA, 2002, J BIOL CHEM, V277, P9133, DOI 10.1074/jbc.M106999200; Lampson MA, 2001, MOL BIOL CELL, V12, P3489, DOI 10.1091/mbc.12.11.3489; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Li LV, 2005, MOL ENDOCRINOL, V19, P2145, DOI 10.1210/me.2005-0032; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Ross SA, 1998, BIOCHEM J, V330, P1003; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2007, J BIOL CHEM, V282, P9008, DOI 10.1074/jbc.M608971200; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Subtil A, 2000, J BIOL CHEM, V275, P4787, DOI 10.1074/jbc.275.7.4787; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071	47	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30311	30321		10.1074/jbc.M805182200	http://dx.doi.org/10.1074/jbc.M805182200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18713752	hybrid, Green Published			2022-12-25	WOS:000260366900075
J	Hou, ZJ; Kelly, EM; Robia, SL				Hou, Zhanjia; Kelly, Eileen M.; Robia, Seth L.			Phosphomimetic Mutations Increase Phospholamban Oligomerization and Alter the Structure of Its Regulatory Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; RESONANCE ENERGY-TRANSFER; DEPENDENT PROTEIN-KINASE; MONOCLONAL-ANTIBODY; LIPID-BILAYERS; CALCIUM-PUMP; PHOSPHORYLATION; INHIBITION; ATPASE; CA2+	To investigate the effect of phosphorylation on the interactions of phospholamban (PLB) with itself and its regulatory target, SERCA, we measured FRET from CFP-SERCA or CFP-PLB to YFP-PLB in live AAV-293 cells. Phosphorylation of PLB was mimicked by mutations S16E (PKA site) or S16E/T17E (PKA + CaMKII sites). FRET increased with protein concentration up to a maximum (FRETmax) that was taken to represent the intrinsic FRET of the bound complex. The concentration dependence of FRET yielded dissociation constants (K-D) for the PLB-PLB and PLB-SERCA interactions. PLB-PLB FRET data suggest pseudo-phosphorylation of PLB increased oligomerization of PLB but did not alter PLB pentamer quaternary structure. PLB-SERCA FRET experiments showed an apparent decrease in binding of PLB to SERCA and an increase in the apparent PLB-SERCA binding cooperativity. It is likely that these changes are secondary effects of increased oligomerization of PLB; a change in the inherent affinity of monomeric PLB for SERCA was not detected. In addition, PLB-SERCA complex FRETmax was reduced by phosphomimetic mutations, suggesting the conformation of the regulatory complex is significantly altered by PLB phosphorylation.	[Hou, Zhanjia; Kelly, Eileen M.; Robia, Seth L.] Loyola Univ Chicago, Dept Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Physiol, 2160 S 1st Ave, Maywood, IL 60153 USA.	srobia@lumc.edu			National Institutes of Health Mentored Research Scientist Development Award [EB006061]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106189, R01HL092321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB006061] Funding Source: NIH RePORTER	National Institutes of Health Mentored Research Scientist Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Mentored Research Scientist Development Award EB006061. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antipenko AY, 1997, BIOCHEMISTRY-US, V36, P12903, DOI 10.1021/bi971109v; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Brittsan AG, 2000, J BIOL CHEM, V275, P12129, DOI 10.1074/jbc.275.16.12129; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Clayton JC, 2005, BIOCHEMISTRY-US, V44, P17016, DOI 10.1021/bi0511383; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; Hutter MC, 2002, CHEMBIOCHEM, V3, P1200, DOI 10.1002/1439-7633(20021202)3:12<1200::AID-CBIC1200>3.0.CO;2-H; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Karim CB, 2004, P NATL ACAD SCI USA, V101, P14437, DOI 10.1073/pnas.0402801101; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li JH, 2004, BIOCHEMISTRY-US, V43, P3870, DOI 10.1021/bi036183u; Li JH, 2003, BIOCHEMISTRY-US, V42, P10674, DOI 10.1021/bi034708c; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mahaney JE, 2005, BIOCHEMISTRY-US, V44, P7713, DOI 10.1021/bi048011i; Negash S, 2000, BIOCHEM J, V351, P195, DOI 10.1042/0264-6021:3510195; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Oxenoid K, 2007, PROTEIN SCI, V16, P1977, DOI 10.1110/ps.072975107; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Robia SL, 2005, BIOCHEMISTRY-US, V44, P4302, DOI 10.1021/bi0478446; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Smith SO, 2001, J MOL BIOL, V313, P1139, DOI 10.1006/jmbi.2001.5101; TADA M, 1975, J BIOL CHEM, V250, P2640; TATULIAN SA, 1995, BIOCHEMISTRY-US, V34, P4448, DOI 10.1021/bi00013a038; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5	39	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28996	29003		10.1074/jbc.M804782200	http://dx.doi.org/10.1074/jbc.M804782200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708665	hybrid, Green Published			2022-12-25	WOS:000260179900025
J	Li, HY; Xu, LL; Masuda, K; Raymundo, E; Mcleod, DG; Dobi, A; Srivastava, S				Li, Hongyun; Xu, Linda L.; Masuda, Katsuaki; Raymundo, Eliza; Mcleod, David G.; Dobi, Albert; Srivastava, Shiv			A Feedback Loop between the Androgen Receptor and a NEDD4-binding Protein, PMEPA1, in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGASE NEDD4; TUMOR SUPPRESSION; UBIQUITIN LIGASE; HOMEOBOX GENE; WW DOMAINS; EXPRESSION; GROWTH; NKX3.1; PTEN; DIFFERENTIATION	PMEPA1 was identified originally as a highly androgen-inducible gene with prostate-abundant expression that was restricted to prostatic epithelial cells. PMEPA1 protein is a NEDD4 (ubiquitin-protein isopeptide ligase)-binding protein, which negatively regulates prostate cancer cell growth. In this study we establish that PMEPA1 is a direct transcriptional target of the androgen receptor (AR). We also demonstrate that PMEPA1 negatively regulates AR protein levels in different cell culture models. Transient expression of PMEPA1 down-regulates AR protein levels and AR transcriptional targets in prostate cancer cells. Conversely, knockdown of PMEPA1 leads to elevated levels of AR protein, AR transcriptional targets (prostate-specific antigen), and increased cell cycle S phase. We define that the PMEPA1-dependent down-regulation of AR is because of AR ubiquitination and proteasome-mediated degradation. The mutant PMEPA1 (PY1/2 motif mutation) that is impaired in NEDD4 recruitment shows attenuated AR ubiquitination and AR protein down-regulation. These data support the hypothesis that PMEPA1 negatively regulates the stability of AR protein by enhancing AR ubiquitination and proteasome-mediated degradation through NEDD4. The effect of PMEPA1 on AR ubiquitination and degradation appears to be MDM2-independent. Thus, the PMEPA1-AR degradation pathway may represent a new androgen-dependent mechanism for regulating AR levels in prostate epithelial cells. These findings underscore that the decreased PMEPA1 expression frequently noted in prostate cancers may lead to increased AR functions and strengthen the biological role of PMEPA1 in prostate cancers.	[Li, Hongyun; Xu, Linda L.; Masuda, Katsuaki; Raymundo, Eliza; Mcleod, David G.; Dobi, Albert; Srivastava, Shiv] Uniformed Serv Univ Hlth Sci, Dept Surg, Ctr Prostate Dis Res, Rockville, MD 20852 USA; [Mcleod, David G.] Walter Reed Army Med Ctr, Dept Surg, Urol Serv, Washington, DC 20307 USA; [Mcleod, David G.; Dobi, Albert; Srivastava, Shiv] Walter Reed Army Med Ctr, US Mil Canc Inst, Washington, DC 20307 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Dobi, A (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Surg, Ctr Prostate Dis Res, Rockville, MD 20852 USA.	adobi@cpdr.org; ssrivastava@cpdr.org			National Institutes of Health (NCI) [1R01CA106653]; Center for Prostate Disease Research Program [HU001-04-C-1502]; NATIONAL CANCER INSTITUTE [R01CA106653] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Prostate Disease Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA106653 (NCI) (to S. S. and A. D.). This work was also supported by the Center for Prostate Disease Research Program through the Henry M. Jackson Foundation for the Advancement of Military Medicine under Contract HU001-04-C-1502 (2004) with the Uniformed Services University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Bowen C, 2000, CANCER RES, V60, P6111; Brunschwig EB, 2003, CANCER RES, V63, P1568; Chen H, 2002, CANCER RES, V62, P338; Crosetto N, 2006, MOL CANCER RES, V4, P899, DOI 10.1158/1541-7786.MCR-06-0328; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gregory CW, 2001, CANCER RES, V61, P2892; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; Ing NH, 2005, BIOL REPROD, V72, P1290, DOI 10.1095/biolreprod.105.040014; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Lange CA, 2007, ANNU REV PHYSIOL, V69, P171, DOI 10.1146/annurev.physiol.69.031905.160319; Lee DK, 2003, J CLIN ENDOCR METAB, V88, P4043, DOI 10.1210/jc.2003-030261; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Masuda K, 2005, J MOL BIOL, V353, P763, DOI 10.1016/j.jmb.2005.09.009; Mostaghel Elahe A, 2007, Curr Urol Rep, V8, P224, DOI 10.1007/s11934-007-0010-z; Nieto M, 2007, INT J BIOCHEM CELL B, V39, P1562, DOI 10.1016/j.biocel.2007.01.005; Poukka H, 2000, J CELL SCI, V113, P2991; Richter E, 2007, PROSTATE CANCER P D, V10, P114, DOI 10.1038/sj.pcan.4500936; Richter E, 2007, EPIGENETICS-US, V2, P100, DOI 10.4161/epi.2.2.4611; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Sheflin L, 2000, BIOCHEM BIOPH RES CO, V276, P144, DOI 10.1006/bbrc.2000.3424; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Sun C, 2006, ONCOGENE, V25, P3905, DOI 10.1038/sj.onc.1209424; Thompson IM, 2007, CAN MED ASSOC J, V176, P1853, DOI 10.1503/cmaj.060955; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wu C P, 1991, Prog Clin Biol Res, V370, P249; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Xu LL, 2003, CANCER RES, V63, P4299; Yeh SY, 2000, P NATL ACAD SCI USA, V97, P11256, DOI 10.1073/pnas.190353897	44	55	57	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28988	28995		10.1074/jbc.M710528200	http://dx.doi.org/10.1074/jbc.M710528200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703514	Green Published, hybrid			2022-12-25	WOS:000260179900024
J	Marjanovic, JA; Stojanovic, A; Brovkovych, VM; Skidgel, RA; Du, XP				Marjanovic, Jasna A.; Stojanovic, Aleksandra; Brovkovych, Viktor M.; Skidgel, Randal A.; Du, Xiaoping			Signaling-mediated Functional Activation of Inducible Nitric-oxide Synthase and Its Role in Stimulating Platelet Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DIRECT ELECTROCHEMICAL MEASUREMENT; HUMAN-BLOOD PLATELETS; IN-VITRO; NO; AGGREGATION; INHIBITION; SECRETION; APOPTOSIS; ISOFORMS	Nitric oxide (NO) is a short lived secondary messenger, synthesized by nitric-oxide synthases (NOS). It is believed that the activity of inducible NOS (iNOS) is regulated primarily at the transcription level by inducing expression of iNOS mRNA and protein, which then continuously produces NO, until its degradation. Platelets do not have the nuclear transcriptional regulatory mechanisms of the iNOS gene and are believed to generate NO in response to agonist stimulation via endothelial NOS (eNOS). However, here we show that agonist-induced NO production is only partially eNOS-dependent and is also mediated by iNOS. Platelet agonist-induced NO production is significantly reduced in iNOS-knockout platelets. Platelet NO production occurs within seconds after agonist addition and is not accompanied by changes in iNOS protein levels, indicating a signaling-mediated functional activation mechanism of iNOS. Importantly, iNOS knock-out and iNOS inhibitors reduce agonist-induced platelet secretion and aggregation and cGMP levels, indicating that iNOS activation is important in stimulating platelets via the newly identified NO-cGMP-dependent platelet secretion pathway. Furthermore, iNOS knock-out mice have prolonged bleeding time, suggesting that this novel mode of regulation of iNOS activity plays a physiologically relevant role in hemostasis.	[Marjanovic, Jasna A.; Stojanovic, Aleksandra; Brovkovych, Viktor M.; Skidgel, Randal A.; Du, Xiaoping] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Du, XP (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave, Chicago, IL 60612 USA.	xdu@uic.edu			National Institutes of Health [HL062350, HL068819, HL080264, HL60678]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678, R01HL062350, R01HL068819, R01HL080264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL062350, HL068819, and HL080264 (to X. D.) and HL60678 (to R. A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; Browning DD, 1999, J BIOL CHEM, V274, P537, DOI 10.1074/jbc.274.1.537; Browning DD, 2000, J BIOL CHEM, V275, P2811, DOI 10.1074/jbc.275.4.2811; Brune B, 2002, KIDNEY INT, V61, P786, DOI 10.1046/j.1523-1755.2002.00221.x; Cambien B, 2003, J CLIN INVEST, V112, P1589, DOI 10.1172/JCI200319284; Cauwels A, 2006, J CLIN INVEST, V116, P2244, DOI 10.1172/JCI25426; Chen LY, 1996, J CARDIOVASC PHARM, V27, P154, DOI 10.1097/00005344-199601000-00024; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Freedman JE, 1999, CIRC RES, V84, P1416; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; GRIFFITHS MJD, 1993, BRIT J PHARMACOL, V110, P963, DOI 10.1111/j.1476-5381.1993.tb13907.x; HASLAM RJ, 1974, BIOCHEM J, V138, P317, DOI 10.1042/bj1380317; Jang EK, 2002, BRIT J HAEMATOL, V117, P664, DOI 10.1046/j.1365-2141.2002.03479.x; KIEFFER N, 1987, EUR J BIOCHEM, V164, P189, DOI 10.1111/j.1432-1033.1987.tb11010.x; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Li ZY, 2004, J BIOL CHEM, V279, P42469, DOI 10.1074/jbc.M401532200; Li ZY, 2003, J BIOL CHEM, V278, P30725, DOI 10.1074/jbc.M301838200; Li ZY, 2003, BLOOD, V101, P4423, DOI 10.1182/blood-2002-10-3210; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V194, P960, DOI 10.1006/bbrc.1993.1914; Marjanovic JA, 2005, J BIOL CHEM, V280, P37430, DOI 10.1074/jbc.M506518200; MELLION BT, 1981, BLOOD, V57, P946; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Razavi HM, 2005, PHARMACOL THERAPEUT, V106, P147, DOI 10.1016/j.pharmthera.2004.11.006; Roy A, 2003, J BIOL CHEM, V278, P4397, DOI 10.1074/jbc.M207295200; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Schlossmann J, 2003, ANN MED, V35, P21, DOI 10.1080/07853890310004093; Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200; Stojanovic A, 2006, J BIOL CHEM, V281, P16333, DOI 10.1074/jbc.M512378200; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; TOJO A, 1994, J AM SOC NEPHROL, V4, P1438; ULMER AJ, 1979, J IMMUNOL METHODS, V30, P1, DOI 10.1016/0022-1759(79)90268-0; Vodovotz Y, 2004, CURR MOL MED, V4, P753, DOI 10.2174/1566524043359944; Wallerath T, 1997, THROMB HAEMOSTASIS, V77, P163; WARSHAW AL, 1967, J BIOL CHEM, V242, P2094; Weyrich AS, 1998, P NATL ACAD SCI USA, V95, P5556, DOI 10.1073/pnas.95.10.5556	42	27	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28827	28834		10.1074/jbc.M801646200	http://dx.doi.org/10.1074/jbc.M801646200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18753139	hybrid, Green Published			2022-12-25	WOS:000260179900007
J	Milic, D; Demidkina, TV; Faleev, NG; Matkovic-Calogovic, D; Antson, AA				Milic, Dalibor; Demidkina, Tatyana V.; Faleev, Nicolai G.; Matkovic-Calogovic, Dubravka; Antson, Alfred A.			Insights into the Catalytic Mechanism of Tyrosine Phenol-lyase from X-ray Structures of Quinonoid Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CRYSTALLINE BETA-TYROSINASE; TRYPTOPHAN INDOLE-LYASE; CITROBACTER-FREUNDII; ALANINE RACEMASE; ESCHERICHIA-INTERMEDIA; SUBSTRATE-SPECIFICITY; AMINO-ACIDS; MODEL; REFINEMENT	Amino acid transformations catalyzed by a number of pyridoxal 5'-phosphate (PLP)-dependent enzymes involve abstraction of the C alpha proton from an external aldimine formed between a substrate and the cofactor leading to the formation of a quinonoid intermediate. Despite the key role played by the quinonoid intermediates in the catalysis by PLP-dependent enzymes, limited accurate information is available about their structures. We trapped the quinonoid intermediates of Citrobacter freundii tyrosine phenol-lyase with L-alanine and L-methionine in the crystalline state and determined their structures at 1.9- and 1.95-angstrom resolution, respectively, by cryo-crystallography. The data reveal a network of protein-PLP substrate interactions that stabilize the planar geometry of the quinonoid intermediate. In both structures the protein subunits are found in two conformations, open and closed, uncovering the mechanism by which binding of the substrate and restructuring of the active site during its closure protect the quinonoid intermediate from the solvent and bring catalytically important residues into positions suitable for the abstraction of phenol during the beta-elimination of L-tyrosine. In addition, the structural data indicate a mechanism for alanine racemization involving two bases, Lys-257 and a water molecule. These two bases are connected by a hydrogen bonding system allowing internal transfer of the C alpha proton.	[Milic, Dalibor; Matkovic-Calogovic, Dubravka] Univ Zagreb, Lab Gen & Inorgan Chem, Dept Chem, Fac Sci, HR-10000 Zagreb, Croatia; [Demidkina, Tatyana V.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; [Faleev, Nicolai G.] Russian Acad Sci, AN Nesmeyanov Organoelement Cpds Inst, Moscow 119991, Russia; [Antson, Alfred A.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England	University of Zagreb; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Nesmeyanov Institute of Organoelement Compounds; University of York - UK	Milic, D (corresponding author), Univ Zagreb, Lab Gen & Inorgan Chem, Dept Chem, Fac Sci, Horvatovac 102A, HR-10000 Zagreb, Croatia.	dmilic@chem.pmf.hr	Demidkina, Tatyana/AAD-9427-2019; Milić, Dalibor/B-4882-2011; Antson, Alfred/N-2551-2016	Milić, Dalibor/0000-0001-5760-6677; Antson, Alfred/0000-0002-4533-3816	Ministry of Science, Education and Sports of the Republic of Croatia [119-1193079-1084]; Russian Foundation for Basic Research [08-04-00117, 07-04-01138]; Fogarty Foundation [R03 TW00604501-2A]; Wellcome Trust [081916]; FOGARTY INTERNATIONAL CENTER [R03TW006045] Funding Source: NIH RePORTER; Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Fogarty Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Ministry of Science, Education and Sports of the Republic of Croatia (Grant 119-1193079-1084 (to D. M. and D. M.-C..)), by the Russian Foundation for Basic Research(Grants 08-04-00117(to T. V. D.) and 07-04-01138 (to N.G.F.)), by the Fogarty Foundation (Grant R03 TW00604501-2A (to T. V. D.)), and by the Wellcome Trust (Fellowship 081916, to A. A. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANTSON AA, 1993, BIOCHEMISTRY-US, V32, P4195, DOI 10.1021/bi00067a006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbolina MV, 2000, PROTEIN ENG, V13, P207, DOI 10.1093/protein/13.3.207; Barends TRM, 2008, CHEMBIOCHEM, V9, P1024, DOI 10.1002/cbic.200700703; CHEN HY, 1995, BIOCHEMISTRY-US, V34, P12276, DOI 10.1021/bi00038a023; CHEN HY, 1995, EUR J BIOCHEM, V229, P540, DOI 10.1111/j.1432-1033.1995.tb20496.x; CHEN HY, 1993, BIOCHEMISTRY-US, V32, P11591, DOI 10.1021/bi00094a016; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEMIDKINA TV, 1989, BIOCHIMIE, V71, P565, DOI 10.1016/0300-9084(89)90188-0; Demidkina TV, 2002, BIOCHEM J, V363, P745, DOI 10.1042/0264-6021:3630745; DEMIDKINA TV, 1987, EUR J BIOCHEM, V170, P311, DOI 10.1111/j.1432-1033.1987.tb13701.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENEI H, 1972, FEBS LETT, V21, P39, DOI 10.1016/0014-5793(72)80157-1; FALEEV NG, 1988, EUR J BIOCHEM, V177, P395, DOI 10.1111/j.1432-1033.1988.tb14388.x; FALEEV NG, 1983, ENZYME MICROB TECH, V5, P219, DOI 10.1016/0141-0229(83)90099-6; Faleev NG, 2000, EUR J BIOCHEM, V267, P6897, DOI 10.1046/j.1432-1327.2000.01794.x; Faleev NG, 2004, EUR J BIOCHEM, V271, P4565, DOI 10.1111/j.1432-1033.2004.04428.x; Faleev NG, 1996, J CHEM SOC PERK T 2, P2001, DOI 10.1039/p29960002001; FALEEV NG, 2003, PROTEIN STRUCTURES K; Hasek J, 2006, Z KRISTALLOGR, P613; IVANOV VI, 1969, ADV ENZYMOL RAMB, V32, P21; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUMAGAI H, 1970, J BIOL CHEM, V245, P1773; KUMAGAI H, 1969, BIOCHEM BIOPH RES CO, V34, P266, DOI 10.1016/0006-291X(69)90826-2; KUMAGAI H, 1970, BIOCHEM BIOPH RES CO, V39, P796, DOI 10.1016/0006-291X(70)90393-1; KUMAGAI H, 1970, J BIOL CHEM, V245, P1767; Milic D, 2006, BIOCHEMISTRY-US, V45, P7544, DOI 10.1021/bi0601858; Mouratou B, 1999, J BIOL CHEM, V274, P1320, DOI 10.1074/jbc.274.3.1320; MURO T, 1978, J BIOCHEM-TOKYO, V84, P633, DOI 10.1093/oxfordjournals.jbchem.a132168; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALCIC MM, 1987, Z NATURFORSCH C, V42, P307; Papisova A I, 2003, Dokl Biochem Biophys, V391, P225, DOI 10.1023/A:1025117626374; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PHILLIPS RS, 1987, ARCH BIOCHEM BIOPHYS, V256, P302, DOI 10.1016/0003-9861(87)90450-4; Phillips RS, 2003, BBA-PROTEINS PROTEOM, V1647, P167, DOI 10.1016/S1570-9639(03)00089-X; Phillips RS, 2002, J BIOL CHEM, V277, P21592, DOI 10.1074/jbc.M200216200; PHILLIPS RS, 1989, ENZYME MICROB TECH, V11, P80, DOI 10.1016/0141-0229(89)90064-1; Pletnev SV, 1997, CRYSTALLOGR REP+, V42, P809; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Schnackerz KD, 2006, BBA-PROTEINS PROTEOM, V1764, P230, DOI 10.1016/j.bbapap.2005.10.009; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; Sun SX, 1999, BIOCHEMISTRY-US, V38, P4058, DOI 10.1021/bi982924t; Sundararaju B, 1997, BIOCHEMISTRY-US, V36, P6502, DOI 10.1021/bi962917+; Szebenyi DME, 2000, BIOCHEMISTRY-US, V39, P13313, DOI 10.1021/bi000635a; UENO T, 1970, BIOCHIM BIOPHYS ACTA, V206, P476, DOI 10.1016/0005-2744(70)90163-4; Watanabe A, 1999, J BIOCHEM-TOKYO, V126, P781, DOI 10.1093/oxfordjournals.jbchem.a022517; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YAMADA H, 1972, BIOCHEM BIOPH RES CO, V46, P370, DOI 10.1016/S0006-291X(72)80148-7; Yamada H, 1975, Adv Appl Microbiol, V19, P249, DOI 10.1016/S0065-2164(08)70431-3	53	32	33	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29206	29214		10.1074/jbc.M802061200	http://dx.doi.org/10.1074/jbc.M802061200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18715865	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000260179900048
J	Plate, I; Hallwyl, SCL; Shi, I; Krejci, L; Muller, C; Albertsen, L; Sung, P; Mortensen, UH				Plate, Iben; Hallwyl, Swee C. L.; Shi, Idina; Krejci, Lumir; Muller, Christian; Albertsen, Line; Sung, Patrick; Mortensen, Uffe H.			Interaction with RPA Is Necessary for Rad52 Repair Center Formation and for Its Mediator Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND-BREAK; REPLICATION PROTEIN-A; DNA-BINDING-PROTEIN; HOMOLOGOUS RECOMBINATION; N-TERMINUS; LOCALIZATION; EXCHANGE; COMPLEX; ASSOCIATION; CHECKPOINT	Homologous recombination (HR) is a major DNA repair pathway and therefore essential for maintaining the integrity of the genome. HR is catalyzed by proteins encoded by genes of the RAD52 epistasis group, including the recombinase Rad51 and its mediator Rad52. HR proteins fused with green fluorescent protein form foci at damaged DNA reflecting the assembly of repair centers that harbor a high concentration of repair proteins. Rad52 mediates the recruitment of Rad51 and other HR proteins to DNA damage. To understand the mechanism for the assembly of Rad52-dependent DNA repair centers, we used a mutational strategy to identify a Rad52 domain essential for its recruitment to DNA repair foci. We present evidence to implicate an acidic domain in Rad52 in DNA repair focus formation. Mutations in this domain confer marked DNA damage sensitivity and recombination deficiency. Importantly, these Rad52 mutants are specifically compromised for interaction with the single-stranded DNA-binding factor RPA. Based on these findings, we propose a model where Rad52 displaces RPA from single-stranded DNA using the acidic domain as a molecular lever.	[Plate, Iben; Hallwyl, Swee C. L.; Muller, Christian; Albertsen, Line; Mortensen, Uffe H.] Tech Univ Denmark, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Shi, Idina; Krejci, Lumir; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06530 USA	Technical University of Denmark; Yale University	Mortensen, UH (corresponding author), Bldg 223, DK-2800 Lyngby, Denmark.	um@biocentrum.dtu.dk	Mortensen, Uffe/AAQ-1150-2021; Krejci, Lumir/B-7842-2009; Classen, Scott/AAY-8176-2020	Krejci, Lumir/0000-0002-4732-1405; 	National Institutes of Health [ES07061, GM57814, P01CA92584]; Danish Research Council for Technology and Production Sciences; Hartmann Foundation; Lundbeck Foundation; Technical University of Denmark; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Research Council for Technology and Production Sciences; Hartmann Foundation; Lundbeck Foundation(Lundbeckfonden); Technical University of Denmark; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES07061, GM57814, and P01CA92584 (to P. S.). This work was also supported by the Danish Research Council for Technology and Production Sciences (to U. H. M.), the Hartmann Foundation (to U. H. M.), the Lundbeck Foundation (to U. H. M.), and the Technical University of Denmark (to S. C. L. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asleson EN, 1999, GENETICS, V153, P681; BENDIXEN C, 1994, NUCLEIC ACIDS RES, V22, P1778, DOI 10.1093/nar/22.9.1778; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; BOUNDYMILLS KL, 1993, GENETICS, V133, P39; de Mayolo AA, 2006, NUCLEIC ACIDS RES, V34, P2587, DOI 10.1093/nar/gkl280; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Feng Q, 2007, DNA REPAIR, V6, P27, DOI 10.1016/j.dnarep.2006.08.007; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; Lettier G, 2006, PLOS GENET, V2, P1773, DOI 10.1371/journal.pgen.0020194; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2005, BIOCHIMIE, V87, P579, DOI 10.1016/j.biochi.2004.10.023; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu YL, 1999, CURR BIOL, V9, P975, DOI 10.1016/S0960-9822(99)80427-8; MALONE RE, 1988, CURR GENET, V14, P211, DOI 10.1007/BF00376741; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Mortensen UH, 2002, GENETICS, V161, P549; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Plate I, 2008, DNA REPAIR, V7, P57, DOI 10.1016/j.dnarep.2007.07.016; PRAKASH L, 1977, GENETICS, V86, P33; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Sherman F., 1986, METHODS YEAST GENETI; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; SMITH J, 1995, MOL CELL BIOL, V15, P1632; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tan TLR, 1999, CURR BIOL, V9, P325, DOI 10.1016/S0960-9822(99)80142-0; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Thorpe PH, 2006, MOL CELL BIOL, V26, P3752, DOI 10.1128/MCB.26.10.3752-3763.2006; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9	53	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29077	29085		10.1074/jbc.M804881200	http://dx.doi.org/10.1074/jbc.M804881200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703507	Green Published, hybrid			2022-12-25	WOS:000260179900035
J	Lu, CW; Lin, SC; Chen, KF; Lai, YY; Tsai, SJ				Lu, Chun-Wun; Lin, Shih-Chieh; Chen, Ko-Fan; Lai, Yen-Yu; Tsai, Shaw-Jenq			Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMETRIOTIC STROMAL CELLS; ACUTE REGULATORY PROTEIN; FACTOR 1-ALPHA; GROWTH-FACTOR; UP-REGULATION; EXPRESSION; COMPLEX; CANCER; HIF-1; GENE	The switch of cellular metabolism from mitochondrial respiration to glycolysis is the hallmark of cancer cells and associated with tumor malignancy. However, the mechanism of this metabolic switch remains largely unknown. Herein, we reported that hypoxia-inducible factor-1 (HIF-1) induced pyruvate dehydrogenase kinase-3 ( PDK3) expression leading to inhibition of mitochondrial respiration. Promoter activity assay, small interference RNA knockdown assay, and chromatin immunoprecipitation assay demonstrated that hypoxia-induced PDK3 gene activity was regulated by HIF-1 at the transcriptional level. Forced expression of PDK3 in cancer cells resulted in increased lactic acid accumulation and drugs resistance, whereas knocking down PDK3 inhibited hypoxia-induced cytoplasmic glycolysis and cell survival. These data demonstrated that increased PDK3 expression due to elevated HIF-1 alpha in cancer cells may play critical roles in metabolic switch during cancer progression and chemoresistance in cancer therapy.	[Lu, Chun-Wun; Lin, Shih-Chieh; Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 701, Taiwan; [Chen, Ko-Fan; Lai, Yen-Yu; Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University	Tsai, SJ (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, 1 Univ Rd, Tainan 701, Taiwan.	seantsai@mail.ncku.edu.tw	Tsai, Shaw-Jenq/AAG-6569-2019; Lin, Shih-Chieh/AAK-1978-2020	TSAI, SHAW-JENQ/0000-0002-3569-5813; Chen, Ko-Fan/0000-0002-7305-6254	National Research Program [NSC94-3112-B-006-010]; National Cheng Kung University, Taiwan [A-0123]	National Research Program; National Cheng Kung University, Taiwan	This work was supported by the National Research Program of Genome Medicine (Grant NSC94-3112-B-006-010) and the Landmark Project (Grant A-0123) of National Cheng Kung University, Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brown JM, 1998, CANCER RES, V58, P1408; Chen KF, 2005, NUCLEIC ACIDS RES, V33, P5190, DOI 10.1093/nar/gki839; Chuang PC, 2006, MOL CELL BIOL, V26, P8281, DOI 10.1128/MCB.00941-06; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Holness MJ, 2000, DIABETES, V49, P775, DOI 10.2337/diabetes.49.5.775; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Sun HS, 2003, ENDOCRINOLOGY, V144, P3934, DOI 10.1210/en.2003-0289; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tsai SJ, 2002, ENDOCRINOLOGY, V143, P2715, DOI 10.1210/en.143.7.2715; Tsai SJ, 2001, J CLIN ENDOCR METAB, V86, P5765, DOI 10.1210/jc.86.12.5765; Tuganova A, 2002, BIOCHEM J, V366, P129, DOI 10.1042/BJ20020301; Warburg O., 1930, METABOLISM TUMORS, P254; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wu MH, 2007, AM J PATHOL, V170, P590, DOI 10.2353/ajpath.2007.060477; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Wu PF, 1999, DIABETES, V48, P1593, DOI 10.2337/diabetes.48.8.1593; Zhong H, 1999, CANCER RES, V59, P5830	36	211	223	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28106	28114		10.1074/jbc.M803508200	http://dx.doi.org/10.1074/jbc.M803508200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18718909	Green Published, hybrid			2022-12-25	WOS:000259969300013
J	Imbeault, D; Gamar, L; Rufiange, A; Paquet, E; Nourani, A				Imbeault, David; Gamar, Lynda; Rufiange, Anne; Paquet, Eric; Nourani, Amine			The Rtt106 histone chaperone is functionally linked to transcription elongation and is involved in the regulation of spurious transcription from cryptic promoters in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; INITIATION; CHROMATIN; ASF1	Rtt106 is a histone chaperone that has been suggested to play a role in heterochromatin-mediated silencing in Saccharomyces cerevisiae. It interacts physically and functionally with the chromatin assembly factor-1 (CAF-1), which is associated with replication-coupled nucleosomal deposition. In this work, we have taken several approaches to study Rtt106 in greater detail and have identified a previously unknown function of Rtt106. We found genetic interactions between rtt106 Delta and mutations in genes encoding transcription elongation factors, including Spt6, TFIIS, and members of the PAF and yeast DSIF complexes. In addition, chromatin immunoprecipitation analysis indicates that Rtt106 is associated with transcribed regions of active genes. Furthermore, our results show that Rtt106 is required for the repression of transcription from a cryptic promoter within a coding region. This observation strongly suggests that Rtt106 is involved in the regulation of chromatin structure of transcribed regions. Finally, we provide evidence that Rtt106 plays a role in regulating the levels of histone H3 transcription-coupled deposition over transcribed regions. Taken together, our results indicate a direct link for Rtt106 with transcription elongation and the chromatin dynamics associated with RNA polymerase II passage.	[Imbeault, David; Gamar, Lynda; Rufiange, Anne; Paquet, Eric; Nourani, Amine] Univ Laval, Hotel Dieu Quebec CHUQ, Ctr Rech Cancerol, Quebec City, PQ G1R 2J6, Canada	Laval University	Nourani, A (corresponding author), Univ Laval, Hotel Dieu Quebec CHUQ, Ctr Rech Cancerol, Quebec City, PQ G1R 2J6, Canada.	Amine.Nourani@crhdq.ulaval.ca		Paquet, Eric/0000-0001-9194-1655	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from the Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council of Canada (to A.N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; HUANG S, 2005, P NATL ACAD SCI US; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Nourani A, 2006, MOL CELL BIOL, V26, P1496, DOI 10.1128/MCB.26.4.1496-1509.2006; Prather D, 2005, MOL CELL BIOL, V25, P10122, DOI 10.1128/MCB.25.22.10122-10135.2005; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schermer UJ, 2005, MOL CELL, V19, P279, DOI 10.1016/j.molcel.2005.05.028; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Williams LR, 2007, SIGHT SOUND, V17, P93; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	17	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27350	27354		10.1074/jbc.C800147200	http://dx.doi.org/10.1074/jbc.C800147200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18708354	hybrid			2022-12-25	WOS:000259719200002
J	Bentley, RA				Bentley, R. Alexander			Random Drift versus Selection in Academic Vocabulary: An Evolutionary Analysis of Published Keywords	PLOS ONE			English	Article								The evolution of vocabulary in academic publishing is characterized via keyword frequencies recorded in the ISI Web of Science citations database. In four distinct case-studies, evolutionary analysis of keyword frequency change through time is compared to a model of random copying used as the null hypothesis, such that selection may be identified against it. The case studies from the physical sciences indicate greater selection in keyword choice than in the social sciences. Similar evolutionary analyses can be applied to a wide range of phenomena; wherever the popularity of multiple items through time has been recorded, as with web searches, or sales of popular music and books, for example.	[Bentley, R. Alexander] Univ Durham, Dept Anthropol, Durham, England	Durham University	Bentley, RA (corresponding author), Univ Durham, Dept Anthropol, Durham, England.	r.a.bentley@durham.ac.uk	Bentley, R Alexander/GWZ-8982-2022	Bentley, R. Alexander/0000-0001-9086-2197				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bentley RA, 2007, EVOL HUM BEHAV, V28, P151, DOI 10.1016/j.evolhumbehav.2006.10.002; Bentley RA, 2006, ANTIQUITY, V80, P196, DOI 10.1017/S0003598X00093364; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Bentley RA, 2003, AM ANTIQUITY, V68, P459, DOI 10.2307/3557104; Bordieu P., 1977, OUTLINE THEORY PRACT; Fryer RG, 2004, Q J ECON, V119, P767, DOI 10.1162/0033553041502180; Gillespie J. H., 2004, POPULATION GENETICS; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Hahn MW., 2003, P R SOC LOND B, V270, pS1, DOI [10.1098/rspb.2002.2234, DOI 10.1098/RSPB.2002.2234]; Hayes B, 2008, AM SCI, V96, P274, DOI 10.1511/2008.73.3822; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; HULL DL, 2001, SCI SELECTION; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Kuhn, 1962, STRUCTURE SCI REVOLU, P148; MESOUDI A, EVOLUTION H IN PRESS; Minnhagen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001690; Nahapiet J, 1998, ACAD MANAGE REV, V23, P242, DOI 10.2307/259373; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Shennan SJ, 2001, AM ANTIQUITY, V66, P577, DOI 10.2307/2694174; Shennan S, 2008, P NATL ACAD SCI USA, V105, P3175, DOI 10.1073/pnas.0800666105; Simkin M.V., 2003, COMPLEX SYSTEMS, V14, P269, DOI DOI 10.1111/J.1740-9713.2006.00202.X; Simkin MV, 2007, J AM SOC INF SCI TEC, V58, P1661, DOI 10.1002/asi.20653; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	30	32	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3057	10.1371/journal.pone.0003057	http://dx.doi.org/10.1371/journal.pone.0003057			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RM	18728786	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000264796400006
J	Rodriguez-Girones, MA; Llandres, AL				Rodriguez-Girones, Miguel A.; Llandres, Ana L.			Resource Competition Triggers the Co-Evolution of Long Tongues and Deep Corolla Tubes	PLOS ONE			English	Article								Background: It is normally thought that deep corolla tubes evolve when a plant's successful reproduction is contingent on having a corolla tube longer than the tongue of the flower's pollinators, and that pollinators evolve ever-longer tongues because individuals with longer tongues can obtain more nectar from flowers. A recent model shows that, in the presence of pollinators with long and short tongues that experience resource competition, coexisting plant species can diverge in corolla-tube depth, because this increases the proportion of pollen grains that lands on co-specific flowers. Methodology/Principal Findings: We have extended the model to study whether resource competition can trigger the co-evolution of tongue length and corolla-tube depth. Starting with two plant and two pollinator species, all of them having the same distribution of tongue length or corolla-tube depth, we show that variability in corolla-tube depth leads to divergence in tongue length, provided that increasing tongue length is not equally costly for both species. Once the two pollinator species differ in tongue length, divergence in corolla-tube depth between the two plant species ensues. Conclusions/Significance: Co-evolution between tongue length and corolla-tube depth is a robust outcome of the model, obtained for a wide range of parameter values, but it requires that tongue elongation is substantially easier for one pollinator species than for the other, that pollinators follow a near-optimal foraging strategy, that pollinators experience competition for resources and that plants experience pollination limitation.	[Rodriguez-Girones, Miguel A.; Llandres, Ana L.] CSIC, Estac Expt Zonas Aridas, Dept Funct & Evolutionary Ecol, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Rodriguez-Girones, MA (corresponding author), CSIC, Estac Expt Zonas Aridas, Dept Funct & Evolutionary Ecol, Almeria, Spain.	rgirones@eeza.csic.es	Rodriguez-Girones, Miguel A/H-1859-2015	Rodriguez-Girones, Miguel A/0000-0002-5619-9819	Spanish Ministry of Science and Technology [CGL2007-63223]; CSIC [I3P-BPD2005]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC	This work was supported by the Spanish Ministry of Science and Technology (project CGL2007-63223 to MARG)and CSIC (studentship I3P-BPD2005 to ALL). Funders played no role in this study.	Alexandersson R, 2002, P ROY SOC B-BIOL SCI, V269, P631, DOI 10.1098/rspb.2001.1928; Belt T., 1874, NATURALIST NICARAGUA; Castellanos MC, 2004, J EVOLUTION BIOL, V17, P876, DOI 10.1111/j.1420-9101.2004.00729.x; Darwin C., 1877, VARIOUS CONTRIVANCES; Darwin C. R., 1904, VARIOUS CONTRIVANCES; Heinrich B., 1979, BUMBLEBEE EC; JOHNSON SD, 1995, PLANT SYST EVOL, V195, P169, DOI 10.1007/BF00989293; Johnson SD, 1997, EVOLUTION, V51, P45, DOI 10.1111/j.1558-5646.1997.tb02387.x; Kitching IJ, 2002, ZOOL J LINN SOC-LOND, V135, P471, DOI 10.1046/j.1096-3642.2002.00021.x; LAVERTY TM, 1980, CAN J ZOOL, V58, P1324, DOI 10.1139/z80-184; LAVERTY TM, 1994, ANIM BEHAV, V47, P531, DOI 10.1006/anbe.1994.1077; Lindberg AB, 2001, J TROP ECOL, V17, P323, DOI 10.1017/S0266467401001213; Muchhala N, 2006, NATURE, V444, P701, DOI 10.1038/444701a; NILSSON LA, 1988, NATURE, V334, P147, DOI 10.1038/334147a0; PELEG B, 1992, GAME ECON BEHAV, V4, P232, DOI 10.1016/0899-8256(92)90017-M; Rodriguez-Girones MA, 2007, AM NAT, V170, P455, DOI 10.1086/520121; Rodriguez-Girones MA, 2006, BEHAV ECOL, V17, P905, DOI 10.1093/beheco/arl024; STEVENS SS, 1960, AM SCI, V48, P226; Wasserthal LT, 1997, BOT ACTA, V110, P343, DOI 10.1111/j.1438-8677.1997.tb00650.x; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857	20	22	22	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2992	10.1371/journal.pone.0002992	http://dx.doi.org/10.1371/journal.pone.0002992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714343	gold, Green Submitted, Green Published			2022-12-25	WOS:000264420900018
J	Saez, ME; Gonzalez-Sanchez, JL; Ramirez-Lorca, R; Martinez-Larrad, MT; Zabena, C; Gonzalez, A; Moron, FJ; Ruiz, A; Serrano-Rios, M				Saez, Maria E.; Gonzalez-Sanchez, Jose L.; Ramirez-Lorca, Reposo; Martinez-Larrad, Maria T.; Zabena, Carina; Gonzalez, Alejandro; Moron, Francisco J.; Ruiz, Agustin; Serrano-Rios, Manuel			The CAPN10 Gene Is Associated with Insulin Resistance Phenotypes in the Spanish Population	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; HUMAN SKELETAL-MUSCLE; CALPAIN-10 GENE; METABOLIC SYNDROME; HAPLOTYPE STRUCTURE; VARIANTS; GLUCOSE; EXPRESSION; RISK; SUSCEPTIBILITY	Cardiovascular disease is the leading cause of morbidity and mortality in the industrialized world. Familial aggregation of cardiovascular risk factors is a frequent finding, but genetic factors affecting its presentation are still poorly understood. The calpain 10 gene (CAPN10) has been associated with type 2 diabetes (T2DM), a complex metabolic disorder with increased risk of cardiovascular disease. Moreover, the CAPN10 gene has been associated with the presence of metabolic syndrome (MS) in T2DM and in polycystic ovary syndrome (PCOS). In this work, we have analysed whether the polymorphisms UCSNP44, -43, -19 and -63 are related to several cardiovascular risk factors in the context of MS. Molecular analysis of CAPN10 gene was performed in 899 individuals randomly chosen from a cross-sectional population-based epidemiological survey. We have found that CAPN10 gene in our population is mainly associated with two indicators of the presence of insulin resistance: glucose levels two hours after a 75-g oral glucose tolerance test (OGTT) and HOMA values, although cholesterol levels and blood pressure values are also influenced by CAPN10 variants. In addition, the 1221/1121 haplogenotype is under-represented in individuals that fulfil the International Diabetes Federation (IDF) diagnostic criteria for MS. Our results suggest that CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.	[Saez, Maria E.; Ramirez-Lorca, Reposo; Moron, Francisco J.; Ruiz, Agustin] Neocodex, Dept Genom Estruct, Seville, Spain; [Gonzalez-Sanchez, Jose L.; Martinez-Larrad, Maria T.; Zabena, Carina; Serrano-Rios, Manuel] Hosp Clin San Carlos, Dept Med Interna 2, Madrid, Spain; [Gonzalez, Alejandro] Ctr Avanzado Fertilidad CAF, Unidad Reprod Genet Humana, Cadiz, Spain	Hospital Clinico San Carlos	Saez, ME (corresponding author), Neocodex, Dept Genom Estruct, Seville, Spain.	mesaez@neocodex.es	Ramirez-Lorca, Reposo/A-5807-2012; Reposo, Ramirez-Lorca/D-7907-2014; Ruiz, Agustín/L-4469-2019; Morón, Francisco J/A-4852-2012; Ruiz, Agustin/G-5677-2012; Saez, Maria E/C-8093-2012; Serrano Ríos, Manuel/E-4625-2019	Ruiz, Agustín/0000-0003-2633-2495; Serrano Ríos, Manuel/0000-0002-3214-1444; Ramirez Lorca, Reposo/0000-0002-1594-0404; MORON CIVANTO, FRANCISCO J./0000-0002-1961-2723; Saez, Maria/0000-0001-9299-2534	Ministerio de Ciencia y Tecnologia of Spain [FIT-010000-2003-36, FIT-010000-2003-89, FIT-0100002003-70, PTQ2003-0783, PTQ2003-0546, PTQ2003-0549]; Fondo de Investigaciones Sanitarias [FISS 03/1618]; Red de Centros RCMN, Madrid, Spain [C03/08]; CIBERDEM (Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas)	Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Red de Centros RCMN, Madrid, Spain; CIBERDEM (Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas)	This work has been partially funded by the Ministerio de Ciencia y Tecnologia of Spain (FIT-010000-2003-36, FIT-010000-2003-89, FIT-0100002003-70, PTQ2003-0783, PTQ2003-0546 and PTQ2003-0549). It has been also supported by grants FISS 03/1618 from Fondo de Investigaciones Sanitarias, a grant from Red de Centros RCMN (C03/08), Madrid, Spain and by CIBERDEM (Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], CIRCULATION, V106, P3143; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Brown AE, 2007, MOL GENET METAB, V91, P318, DOI 10.1016/j.ymgme.2007.05.001; Carlsson E, 2004, J CLIN ENDOCR METAB, V89, P3601, DOI 10.1210/jc.2003-032105; Chen SF, 2007, CHINESE MED J-PEKING, V120, P2218, DOI 10.1097/00029330-200712020-00012; Clark VJ, 2005, HUM GENET, V117, P258, DOI 10.1007/s00439-005-1305-0; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Cox NJ, 2004, DIABETES, V53, pS19, DOI 10.2337/diabetes.53.2007.S19; DIAZVILLASENOR A, 2007, BLOOD CELLS MOL 1025; Ehrmann DA, 2002, J CLIN ENDOCR METAB, V87, P1669, DOI 10.1210/jc.87.4.1669; Elbein SC, 2002, J CLIN ENDOCR METAB, V87, P650, DOI 10.1210/jc.87.2.650; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Fingerlin TE, 2002, DIABETES, V51, P1644, DOI 10.2337/diabetes.51.5.1644; Fullerton SM, 2002, AM J HUM GENET, V70, P1096, DOI 10.1086/339930; Garant MJ, 2002, DIABETES, V51, P231, DOI 10.2337/diabetes.51.1.231; Genuth S, 2003, DIABETES CARE, V26, P3160; Gonzalez A, 2003, J CLIN ENDOCR METAB, V88, P5529, DOI 10.1210/jc.2003-030322; Gonzalez A, 2002, J CLIN ENDOCR METAB, V87, P3971, DOI 10.1210/jc.87.8.3971; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hong Jing, 2002, Zhonghua Nei Ke Za Zhi, V41, P370; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Kang ES, 2006, DIABETES RES CLIN PR, V73, P268, DOI 10.1016/j.diabres.2006.01.011; Lynn S, 2002, DIABETES, V51, P247, DOI 10.2337/diabetes.51.1.247; Martinez-Larrad MT, 2005, MED CLIN-BARCELONA, V125, P481; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; NEEL JV, 1962, AM J HUM GENET, V14, P353; Norton L, 2008, J CLIN ENDOCR METAB, V93, P992, DOI 10.1210/jc.2007-1981; Orho-Melander M, 2002, DIABETES, V51, P2658, DOI 10.2337/diabetes.51.8.2658; PORETSKY L, 1987, ENDOCR REV, V8, P132, DOI 10.1210/edrv-8-2-132; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Shima Y, 2003, CLIN CHIM ACTA, V336, P89, DOI 10.1016/S0009-8981(03)00320-6; Song YQ, 2004, AM J HUM GENET, V74, P208, DOI 10.1086/381400; Stumvoll M, 2001, DIABETES, V50, P2161, DOI 10.2337/diabetes.50.9.2161; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Tschritter O, 2003, DIABETES CARE, V26, P1026, DOI 10.2337/diacare.26.4.1026; Tsuchiya T, 2006, MOL GENET METAB, V89, P174, DOI 10.1016/j.ymgme.2006.05.013; Vander Molen J, 2005, AM J HUM GENET, V76, P548, DOI 10.1086/428784; Vollmert C, 2007, AM J PHYSIOL-ENDOC M, V292, pE836, DOI 10.1152/ajpendo.00584.2005; Weedon MN, 2003, AM J HUM GENET, V73, P1208, DOI 10.1086/379285; Wu B, 2005, DIABETES RES CLIN PR, V68, P155, DOI 10.1016/j.diabres.2004.09.015; Xu Qing-song, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P100	46	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2953	10.1371/journal.pone.0002953	http://dx.doi.org/10.1371/journal.pone.0002953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698425	gold, Green Published, Green Submitted			2022-12-25	WOS:000264412600039
J	Hasler, U; Leroy, V; Jeon, US; Bouley, R; Dimitrov, M; Kim, JA; Brown, D; Kwon, HM; Martin, PY; Feraille, E				Hasler, Udo; Leroy, Valeeie; Jeon, Un Sil; Bouley, Richard; Dimitrov, Mitko; Kim, Jeong Ah; Brown, Dennis; Kwon, H. Moo; Martin, Pierre-Yves; Feraille, Eric			NF-kappa B modulates aquaporin-2 transcription in renal collecting duct principal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED NEPHROTIC SYNDROME; ENHANCER-BINDING PROTEIN; WATER CHANNEL EXPRESSION; DOWN-REGULATION; NULL MICE; ACTIVATION; MECHANISM; GENE; HYPERTONICITY; PERMEABILITY	Renal tubulo-interstitial inflammation is frequently associated with polyuria and urine concentration defects. This led us to investigate the effects of the major pro-inflammatory nuclear factor kappa B (NF-kappa B) pathway on aquaporin 2 (AQP2) expression by the collecting duct. Using immortalized collecting duct principal cells (mpkCCD(c14)), we found that, acting independently of vasopressin, activation of NF-kappa B by lipopolysaccharide (LPS) decreased AQP2 mRNA and protein levels in a time-and dose-dependent manner but did not decrease AQP2 mRNA stability. Consistently, constitutively active I kappa B kinase beta decreased AQP2 expression. The LPS-induced decrease in AQP2 mRNA levels was confirmed in rat kidney slices and was reproduced both under conditions of elevated cAMP concentration and V-2 receptor antagonism. Computer analysis of the AQP2 promoter revealed two putative kappa B elements. Mutation of either kappa B element abolished the LPS-induced decrease of luciferase activity in cells expressing AQP2 promoter-luciferase plasmid constructs. Chromatin immunoprecipitation revealed that LPS challenge decreased p65, increased p50 and p52, and had no effect on RelB and c-Rel binding to kappa B elements of the AQP2 promoter. RNA-mediated interference silencing of p65, p50, and p52 confirmed controlled AQP2 transcription by these NF-kappa B subunits. We additionally found that hypertonicity activated NF-kappa B in mpkCCD(c14) cells, an effect that may counteract the Tonicity-responsive enhancer binding protein (TonEBP)-dependent increase in AQP2 gene transcription. Taken together, these findings indicate that NF-kappa B is an important physiological regulator of AQP2 transcription.	[Hasler, Udo; Leroy, Valeeie; Dimitrov, Mitko; Martin, Pierre-Yves; Feraille, Eric] Fdn Rech Med, Serv Nephrol, CH-1211 Geneva 4, Switzerland; [Hasler, Udo; Leroy, Valeeie; Dimitrov, Mitko; Martin, Pierre-Yves; Feraille, Eric] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Jeon, Un Sil; Kim, Jeong Ah; Kwon, H. Moo] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Bouley, Richard; Brown, Dennis] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bouley, Richard; Brown, Dennis] Massachusetts Gen Hosp, MGH Ctr Syst Biol, Program Membrane Biol, Boston, MA USA; [Bouley, Richard; Brown, Dennis] Massachusetts Gen Hosp, Div Nephrol, Boston, MA USA	University of Geneva; University of Geneva; University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Feraille, E (corresponding author), Fdn Rech Med, Serv Nephrol, 64 Ave Roseraie, CH-1211 Geneva 4, Switzerland.	Eric.Feraille@medecine.unige.ch	Dimitrov, Mitko/C-9822-2009; Lee-Kwon, Whaseon/D-6021-2011; Nunes-Hasler, Paula/N-4337-2015	Nunes-Hasler, Paula/0000-0002-4598-685X; Feraille, Eric/0000-0003-1656-8365	National Institutes of Health [R01-DK-42479, DK38452]; Swiss National Foundation [31-67878.02, 31-109473]; Elsie de Reuter Foundation; Ernest Boninchi Foundation; Fondation pour la Recherche Medicale	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Elsie de Reuter Foundation; Ernest Boninchi Foundation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK-42479 (to H. M. K.) and DK38452 (to D. B). This work was also supported in part by Swiss National Foundation Grants 31-67878.02 and 31-109473, a Carlos and Elsie de Reuter Foundation grant, a Ernest Boninchi Foundation grant (to E. F.), and a Fondation pour la Recherche Medicale grant (to U. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apostol E, 1997, J AM SOC NEPHROL, V8, P15; Bouley R, 2008, SEMIN NEPHROL, V28, P266, DOI 10.1016/j.semnephrol.2008.03.010; Breton S, 1998, J AM SOC NEPHROL, V9, P155; Bustamante M, 2005, AM J PHYSIOL-RENAL, V288, pF334, DOI 10.1152/ajprenal.00180.2004; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Carranza ML, 1996, AM J PHYSIOL-CELL PH, V271, pC136, DOI 10.1152/ajpcell.1996.271.1.C136; Chou CL, 1999, J CLIN INVEST, V103, P491, DOI 10.1172/JCI5704; Fernandez-Llama P, 1998, KIDNEY INT, V53, P1244, DOI 10.1046/j.1523-1755.1998.00878.x; Fernandez-Llama P, 1998, KIDNEY INT, V54, P170, DOI 10.1046/j.1523-1755.1998.00984.x; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Frokiaer J, 1997, AM J PHYSIOL-RENAL, V273, pF213, DOI 10.1152/ajprenal.1997.273.2.F213; Frokiaer J, 1999, AM J PHYSIOL-RENAL, V276, pF179; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Furuno M, 1996, AM J PHYSIOL-RENAL, V271, pF854, DOI 10.1152/ajprenal.1996.271.4.F854; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grinevich V, 2004, KIDNEY INT, V65, P54, DOI 10.1111/j.1523-1755.2004.00378.x; Han KH, 2004, AM J PHYSIOL-RENAL, V287, pF878, DOI 10.1152/ajprenal.00047.2004; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hasler U, 2006, AM J PHYSIOL-RENAL, V290, pF177, DOI 10.1152/ajprenal.00056.2005; Hasler U, 2005, J AM SOC NEPHROL, V16, P1571, DOI 10.1681/ASN.2004110930; Hasler U, 2003, J BIOL CHEM, V278, P21639, DOI 10.1074/jbc.M212388200; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hozawa S, 1996, AM J PHYSIOL-CELL PH, V270, pC1695, DOI 10.1152/ajpcell.1996.270.6.C1695; Husted RF, 1998, AM J PHYSIOL-RENAL, V275, pF946, DOI 10.1152/ajprenal.1998.275.6.F946; KLAHR S, 1988, PEDIATR NEPHROL, V2, P34, DOI 10.1007/BF00870378; KOHAN DE, 1994, J LAB CLIN MED, V123, P668; Kumar A, 2001, NEPHROL DIAL TRANSPL, V16, P1062, DOI 10.1093/ndt/16.5.1062; LEROY V, J AM SOC NE IN PRESS; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li CL, 2001, AM J PHYSIOL-RENAL, V281, pF163, DOI 10.1152/ajprenal.2001.281.1.F163; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Mordasini D, 2005, AM J PHYSIOL-RENAL, V289, pF1031, DOI 10.1152/ajprenal.00128.2005; Nejsum LN, 2005, CELL MOL LIFE SCI, V62, P1692, DOI 10.1007/s00018-005-4549-x; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Oyama T, 1998, J IMMUNOL, V160, P1224; Ping DS, 1999, J IMMUNOL, V162, P727; Ryser S, 2007, J BIOL CHEM, V282, P5075, DOI 10.1074/jbc.M607847200; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Shi XZ, 2005, GASTROENTEROLOGY, V129, P1518, DOI 10.1053/j.gastro.2005.07.058; Storm R, 2003, AM J PHYSIOL-RENAL, V284, pF189, DOI 10.1152/ajprenal.00245.2002; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Xu DL, 1997, J CLIN INVEST, V99, P1500, DOI 10.1172/JCI119312; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Zhang LP, 2005, CANCER RES, V65, P457	54	104	107	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28095	28105		10.1074/jbc.M708350200	http://dx.doi.org/10.1074/jbc.M708350200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18664568	Green Published, hybrid			2022-12-25	WOS:000259969300012
J	Kao, CY; Kim, C; Huang, F; Wu, R				Kao, Cheng-Yuan; Kim, Christy; Huang, Fei; Wu, Reen			Requirements for two proximal NF-kappa B binding sites and I kappa B-zeta in IL-17A-induced human beta-defensin 2 expression by conducting airway epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED TRANSCRIPTIONAL REGULATION; KLEBSIELLA-PNEUMONIAE INFECTION; COLONY-STIMULATING FACTOR; NEUTROPHIL RECRUITMENT; GENE-EXPRESSION; UP-REGULATION; T-CELL; INTERLEUKIN-17 FAMILY; ADAPTIVE IMMUNITY; BETA-DEFENSINS	Among a panel of 21 cytokines (IL-1 alpha, -1 beta, -2-13, and -15-18; interferon-gamma granulocyte-macrophage colony-stimulating factor; and tumor necrosis factor a), we have recently observed that IL-17A is the most potent inducer for human P-defensin 2 (hBD-2) in conducting airway epithelial cells (Kao, C. Y., Chen, Y., Thai, P., Wachi, S., Huang, F., Kim, C., Harper, R. W., and Wu, R. (2004) J. Immunol. 173,3482-3491). The molecular basis of this regulation is not known. In this study, we demonstrated a coordinated degradation of inhibitory kappa B (I kappa B)-alpha followed by a nuclear translocation of p50 and p65 NF-kappa B subunits and their binding to NF-kappa B sites of hBD-2 promoter region. With site-directed mutagenesis, we demonstrated the requirement of two proximal NF-kappa B binding sites (p kappa B1, -205 to -186; p kappa B2, -596 to -572) but not the distal site (d kappa B, -2193 to -2182) in supporting IL-17A-induced hBD-2 promoter activity. These results are consistent with the data of the chromatin immunoprecipitation assay, which showed enhanced p50 binding to these p kappa B sites but not the d kappa B site in cells after IL-17A treatment. We also found that the NF-kappa B binding cofactor, I kappa B-zeta, was up-regulated by IL-17A, and the knockdown of I kappa B-zeta significantly diminished the IL-17A-induced hBD-2 expression. This is the first demonstration of the involvement of two proximal NF-kappa B sites and I kappa B-zeta in the regulation of hBD-2 by IL-17A, two important genes responsible for host defense.	[Wu, Reen] Univ Calif Davis, Ctr Comparat Resp Biol & Med, Genome & Biomed Sci Facil, Davis, CA 95616 USA	University of California System; University of California Davis	Wu, R (corresponding author), Univ Calif Davis, Ctr Comparat Resp Biol & Med, Genome & Biomed Sci Facil, Suite 6523,451 Hlth Sci Dr, Davis, CA 95616 USA.	rwu@ucdavis.edu	Macheroux, Peter/AAB-5157-2019; KAO, CHENG-YUAN/A-7531-2010	Macheroux, Peter/0000-0002-0242-454X; KAO, CHENG-YUAN/0000-0003-0946-9270	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077902, R01HL077315, R01HL035635, R37HL035635] Funding Source: NIH RePORTER; Austrian Science Fund FWF [W 901] Funding Source: Medline; NHLBI NIH HHS [HL 077902, HL 35635, HL 077315] Funding Source: Medline; NIEHS NIH HHS [ES 00628] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Becker MN, 2000, J BIOL CHEM, V275, P29731, DOI 10.1074/jbc.M000184200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Duits LA, 2003, FEMS IMMUNOL MED MIC, V38, P59, DOI 10.1016/S0928-8244(03)00106-8; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.018; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hoshino H, 1999, AM J RESP CRIT CARE, V159, P1423, DOI 10.1164/ajrccm.159.5.9806008; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Jang BC, 2004, BIOCHEM BIOPH RES CO, V320, P1026, DOI 10.1016/j.bbrc.2004.06.049; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kawaguchi M, 2001, J ALLERGY CLIN IMMUN, V108, P804, DOI 10.1067/mai.2001.119027; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kolls JK, 2003, AM J RESP CELL MOL, V28, P9, DOI 10.1165/rcmb.2002-0255PS; Krisanaprakornkit S, 2002, J IMMUNOL, V168, P316, DOI 10.4049/jimmunol.168.1.316; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Liao F, 1999, J IMMUNOL, V162, P186; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Liu LD, 2003, J IMMUNOL, V170, P575, DOI 10.4049/jimmunol.170.1.575; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Tsutsumi-Ishii Y, 2002, J LEUKOCYTE BIOL, V71, P154; Uehara N, 2003, J MED MICROBIOL, V52, P41, DOI 10.1099/jmm.0.04985-0; Wada A, 2001, CELL MICROBIOL, V3, P115, DOI 10.1046/j.1462-5822.2001.00096.x; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	51	70	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15309	15318		10.1074/jbc.M708289200	http://dx.doi.org/10.1074/jbc.M708289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18362142	hybrid, Green Published			2022-12-25	WOS:000256232000049
